Variant and risk allele,P-value,P-value annotation,RAF,OR,Beta,CI,Mapped gene,Reported trait,Trait(s),Study accession,Location
rs4702-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,FURIN,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,15:90883330
rs12552-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,OLFM4,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,13:53051646
rs27419-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,MOCS2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:53125108
rs2057884-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,SRPK2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:105289803
rs2098651-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,TENM2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:167564265
rs2103655-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"PPP1R16B, ACTR5","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,20:38797315
rs2300861-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,AKAP6,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:32825575
rs2332700-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,RGS6,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:71950609
rs2388334-<b>?</b>,1 x 10-11,,'-,'-,'-,'-,"EIF4EBP2P3, HLA-DRB5","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,6:98143746
rs2391734-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"CAMTA1, RNU1-130P","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:96139035
rs1002656-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"GRIK3, FTLP18","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:36727140
rs1226412-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LINC01876,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:156254801
rs1484144-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,"LINC01088, NAA11","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,4:79296443
rs1501361-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,HCN1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:45326671
rs1518367-<b>?</b>,1 x 10-11,,'-,'-,'-,'-,PLCL1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:197942291
rs2522831-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,PCLO,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:82818784
rs2693698-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,Mapping not available
rs1730054-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,RSRC1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:158237129
rs2842198-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"PTPRF, HYI-AS1","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:43465067
rs1950829-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LRFN5,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:41628734
rs2003490-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,RPS6KL1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:74910852
rs2047568-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,SPPL3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:120805987
rs174592-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,FADS2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:61851136
rs247910-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,TMEM161B-AS1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:88334952
rs301799-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"RERE, RERE-AS1","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:8429242
rs395138-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,ENOX1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,13:43696758
rs631399-<b>?</b>,7 x 10-11,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,15:37393066
rs732381-<b>?</b>,7 x 10-11,,'-,'-,'-,'-,CACNA1I,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,22:39655161
rs746839-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,MROH5,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:141607161
rs760648-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,TCF20,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,22:42175022
rs778353-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,NGEF,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:232923640
rs832190-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,THOC7,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:63856953
rs880090-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,GMIP,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,19:19629920
rs915057-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,"ESR2, SYNE2","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:64219489
rs2391769-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,"RN7SL831P, EEF1A1P11","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:96513405
rs2414718-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,15:61570934
rs2514218-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,DRD2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:113522272
rs1615350-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,MPHOSPH9,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:123165788
rs1702294-<b>?</b>,3 x 10-16,,'-,'-,'-,'-,MIR137HG,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:98036428
rs2801578-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,PDE4B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:65866972
rs1806153-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,PAUPAR,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:31828558
rs2910032-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,LINC01470,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:153160794
rs3001723-<b>?</b>,7 x 10-14,,'-,'-,'-,'-,PTPRF,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:43572014
rs3798869-<b>?</b>,8 x 10-11,,'-,'-,'-,'-,SNAP91,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,6:83618941
rs3812984-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,PMFBP1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:72173898
rs4129585-<b>?</b>,2 x 10-15,,'-,'-,'-,'-,TSNARE1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:142231572
rs4242470-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,PXDNL,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:51733738
rs4244354-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"ARL3, TRIM8","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,10:102666420
rs4298967-<b>?</b>,8 x 10-20,,'-,'-,'-,'-,CACNA1C,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:2299028
rs4391122-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,LINC02057,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:61302716
rs4481150-<b>?</b>,5 x 10-17,,'-,'-,'-,'-,ITIH3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:52803777
rs4495234-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,PPP2R2B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:146899328
rs4526442-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,ZCCHC7,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,9:37207272
rs4619651-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"LMAN2L, CNNM4","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:96750416
rs4647903-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,FGFR1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:38415064
rs4682973-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,TCAIM,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:44383347
rs4730387-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:109460357
rs4766428-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,ATP2A2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:110285440
rs4906364-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,PPP1R13B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:103748005
rs4916723-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,LINC00461,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:88558577
rs5757717-<b>?</b>,9 x 10-11,,'-,'-,'-,'-,"CACNA1I, RPS19BP1","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,22:39546229
rs5758265-<b>?</b>,5 x 10-14,,'-,'-,'-,'-,"L3MBTL2, L3MBTL2-AS1","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,22:41221893
rs6047287-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,"KIZ, KIZ-AS1","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,20:21170477
rs6125656-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,KCNB1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,20:49474242
rs6471814-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,ZFPM2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:59785315
rs6694545-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,LINC01648,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:29964421
rs6969410-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:110428958
rs7071123-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,CACNB2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,10:18437289
rs7085104-<b>?</b>,3 x 10-16,,'-,'-,'-,'-,BORCS7-ASMT,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,10:102869116
rs7193263-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,RBFOX1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:6265879
rs7200826-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,SHISA9,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:12972976
rs7405404-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:13656002
rs7521492-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:163758686
rs7531118-<b>?</b>,1 x 10-15,,'-,'-,'-,'-,RPL31P12,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:72371556
rs7618871-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,STAG1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:136681578
rs7785663-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,DGKI,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:137385552
rs7968921-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,SOX5,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:23807243
rs8054556-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,TMEM219,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:29946895
rs8066384-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,RPTOR,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,17:80651956
rs8084351-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,DCC,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,18:53200189
rs9360557-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,RIMS1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,6:72423043
rs9636107-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,TCF4,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,18:55532886
rs9677504-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,SPAG16,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:214317165
rs9787523-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,SORCS3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,10:104700702
rs9834970-<b>?</b>,2 x 10-17,,'-,'-,'-,'-,"LINC02033, HSPD1P6","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:36814539
rs9922678-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,GRIN2A,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:9852462
rs10043984-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,KDM3B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:138376432
rs10108980-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,CSMD1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:4333924
rs10149470-<b>?</b>,5 x 10-13,,'-,'-,'-,'-,"RNU7-160P, BAG5","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:103551616
rs10211550-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"MOB4, HSPE1-MOB4","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:197518575
rs10265001-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,"CCT4P1, BRAF","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:140965721
rs10491964-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,CACNA1C,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:2391265
rs10514301-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,LINC00461,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:88643836
rs10745841-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,ANKS1B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:99099957
rs10791097-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,LINC02551,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:130848735
rs10883832-<b>?</b>,3 x 10-14,,'-,'-,'-,'-,NT5C2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,10:103111522
rs11231640-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,"NAA40, RCOR2","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:63923577
rs11570190-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,CTNND1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:57792980
rs11658257-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,GID4,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,17:18053145
rs4380187-<b>?</b>,8 x 10-12,,'-,'-,'-,'-,ZNF804A,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:184947213
rs11688767-<b>?</b>,2 x 10-14,,'-,'-,'-,'-,ACTG1P22,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:57761059
rs11693528-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,"FTCDNL1, RN7SL717P","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:199871784
rs11866581-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,16:66130620
rs11874716-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,LINC01929,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,18:55083457
rs11887562-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,LINC01830,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:22400520
rs12129573-<b>?</b>,5 x 10-17,,'-,'-,'-,'-,LINC01360,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:73302683
rs12474906-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,"MRPL33, RBKS","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:27810671
rs12658451-<b>?</b>,2 x 10-16,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:104568336
rs12668848-<b>?</b>,1 x 10-13,,'-,'-,'-,'-,MAD1L1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:1981360
rs12704290-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,"GRM3-AS1, GRM3","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:86798310
rs12712388-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,RNA5SP87,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:22323759
rs12826178-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,"NXPH4, SHMT2","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:57228588
rs12894153-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,RTN1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:59689975
rs12898460-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,LINC02694,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,15:38694612
rs12958048-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,TCF4,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,18:55434367
rs13217619-<b>?</b>,1 x 10-27,,'-,'-,'-,'-,ZSCAN31,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,6:28338894
rs13240464-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,IMMP2L,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:111258859
rs28669119-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,MEF2C-AS1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:88909036
rs28681284-<b>?</b>,6 x 10-12,,'-,'-,'-,'-,CHRNA3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,15:78616223
rs34215985-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,SLC30A9,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,4:42045761
rs35225200-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,SLC39A8,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,4:102225731
rs35346733-<b>?</b>,8 x 10-10,,'-,'-,'-,'-,CNTN4,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,3:2479638
rs35610290-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:193514178
rs35774874-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"SNX19, RN7SL167P","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:130941461
rs36063234-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,NPAS3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,14:32940606
rs55648125-<b>?</b>,9 x 10-9,,'-,'-,'-,'-,"RPS17P5, TFAP2B","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,6:50849005
rs55661361-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,NRGN,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:124744061
rs58235352-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,"ACADS, SPPL3","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:120748443
rs59979824-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:192983614
rs61867293-<b>?</b>,8 x 10-15,,'-,'-,'-,'-,SORCS3,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,10:104804166
rs61882743-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,AMBRA1,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:46527204
rs62526783-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:110458937
rs71395455-<b>?</b>,5 x 10-14,,'-,'-,'-,'-,ZSCAN2,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,15:84610573
rs75059851-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,IGSF9B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:133952674
rs77135925-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,MYO18A,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,17:29168251
rs78337797-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,SOX5,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,12:23834991
rs79879286-<b>?</b>,7 x 10-11,,'-,'-,'-,'-,"GSDME, OSBPL3","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,7:24786970
rs80256351-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,"ACTG1P22, VRK2","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,2:57844458
rs80318442-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,'-,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:34428027
rs111294930-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,LINC01470,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:152797561
rs116755193-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,LINC02240,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,5:124916190
rs117956829-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,FOLH1B,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,11:89606498
rs140505938-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,"OTUD7B, VPS45","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:150059494
rs142462188-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,LINC01645,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,1:177405627
rs144158419-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,LINC01416,"Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,18:55887502
rs188099135-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"GULOP, EPHX2","Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy)","anorexia nervosa, obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST009600,8:27554275
rs113209956-<b>C</b>,6 x 10-8,,NR,1.2077295,'-,[1.13-1.29],'-,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,9:25211195
rs79928194-<b>C</b>,1 x 10-6,,NR,1.1600928,'-,[1.09-1.23],GIGYF2,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,2:232784580
rs7528604-<b>G</b>,5 x 10-11,,NR,1.1235955,'-,[1.09-1.16],PDE4B,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,1:65941669
rs1458103-<b>C</b>,6 x 10-8,,NR,1.1135857,'-,[1.07-1.16],'-,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,11:81336231
rs6462203-<b>C</b>,1 x 10-7,,NR,1.1098778,'-,[1.07-1.15],SDK1,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,7:3636370
rs16916239-<b>G</b>,9 x 10-7,,NR,1.1074197,'-,[1.06-1.15],CNGB3,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,8:86631513
rs342422-<b>G</b>,1 x 10-6,,NR,1.0869565,'-,[1.05-1.14],EDIL3,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,5:84175168
rs11855560-<b>T</b>,7 x 10-7,,NR,1.089,'-,[1.053-1.126],RAD51,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,15:40732105
rs6030245-<b>T</b>,5 x 10-7,,NR,1.12,'-,[1.072-1.170],PTPRT,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,20:42441919
rs2451828-<b>T</b>,7 x 10-7,,NR,1.34,'-,[1.193-1.505],ADCY2,Anxiety and stress-related disorders,"anxiety disorder, stress-related disorder",GCST008559,5:7448683
rs7528604-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,PDE4B,Anxiety and stress-related disorders (excluding adjustment disorder),"anxiety disorder, stress-related disorder",GCST008565,1:65941669
rs7528604-<b>?</b>,4 x 10-10,,NR,1.12,'-,[1.10-1.16],PDE4B,Anxiety and stress-related disorders (excluding co-morbid schizophrenia),"anxiety disorder, stress-related disorder",GCST008564,1:65941669
rs7528604-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,PDE4B,Anxiety and stress-related disorders (including obsessive-compulsive disorder),"anxiety disorder, stress-related disorder",GCST008563,1:65941669
rs7528604-<b>?</b>,1 x 10-11,,NR,1.14,'-,[1.10-1.18],PDE4B,Anxiety and stress-related disorders (psychiatric co-morbidity weighting design),"anxiety disorder, stress-related disorder",GCST008562,1:65941669
rs7528604-<b>?</b>,2 x 10-8,,NR,1.11,'-,[1.08-1.15],PDE4B,Anxiety and stress-related disorders (psychiatric co-morbidity covariate model),"anxiety disorder, stress-related disorder",GCST008561,1:65941669
rs9354352-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,'-,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,6:65986379
rs7766730-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,'-,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,6:65987110
rs679895-<b>?</b>,2 x 10-7,(African),NR,'-,'-,'-,LINC02109,Anti-saccade error rate in psychotic disorders,"antisaccade response measurement, schizophrenia, bipolar disorder, schizoaffective disorder",GCST005027,5:29091578
rs11125080-<b>?</b>,2 x 10-7,(African),NR,'-,'-,'-,ATP6V1E2,Anti-saccade error rate in psychotic disorders,"antisaccade response measurement, schizophrenia, bipolar disorder, schizoaffective disorder",GCST005027,2:46505266
rs201048567-<b>?</b>,2 x 10-7,(African),NR,'-,'-,'-,'-,Anti-saccade error rate in psychotic disorders,"antisaccade response measurement, schizophrenia, bipolar disorder, schizoaffective disorder",GCST005027,7:125615031
rs16839220-<b>G</b>,5 x 10-6,,0.8,1.8867927,'-,[1.61-2.16],'-,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,Mapping not available
rs2289506-<b>T</b>,3 x 10-7,,0.34,1.61,'-,[1.43-1.79],NIT2,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,3:100346058
rs9369477-<b>C</b>,2 x 10-7,,0.08,2.0408163,'-,[1.77-2.32],"AARS2, SPATS1",Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,6:44340892
rs9372110-<b>A</b>,2 x 10-7,,0.06,2.16,'-,[1.87-2.45],RN7SKP211,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,6:105869321
rs2046197-<b>C</b>,3 x 10-7,,0.59,1.66,'-,[1.46-1.86],CSMD1,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,8:3762230
rs8021600-<b>G</b>,3 x 10-6,,0.08,1.9607843,'-,[1.69-2.24],'-,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,14:43701423
rs8091629-<b>G</b>,2 x 10-6,,0.1,1.8518518,'-,[1.60-2.11],SLC14A2,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,18:45640366
rs2795228-<b>T</b>,6 x 10-7,,0.18,1.6949153,'-,[1.48-1.91],LINC01712,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,1:83475611
rs484947-<b>C</b>,2 x 10-6,,0.38,1.5625,'-,[1.37-1.76],LINC02815,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,1:229029741
rs76082815-<b>?</b>,6 x 10-9,(African),NR,'-,'-,'-,LMO7,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,13:75821206
rs115777110-<b>?</b>,2 x 10-8,(African),NR,'-,'-,'-,LINC01774,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,1:208936211
rs62482377-<b>?</b>,3 x 10-7,(African),NR,'-,'-,'-,Y_RNA,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,7:156250946
rs57646126-<b>?</b>,8 x 10-8,(African),NR,'-,'-,'-,LTN1,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,21:28959613
rs77867520-<b>?</b>,2 x 10-7,(African),NR,'-,'-,'-,'-,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,4:11186225
rs105633-<b>?</b>,8 x 10-12,(African),NR,'-,'-,'-,PCDH12,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,5:141945684
rs2299682-<b>?</b>,9 x 10-8,(African),NR,'-,'-,'-,PLCB4,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,20:9448697
rs74417947-<b>?</b>,2 x 10-8,(African),NR,'-,'-,'-,RPN2,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,20:37181711
rs138449918-<b>?</b>,1 x 10-7,(African),NR,'-,'-,'-,SLC8A1-AS1,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,2:39936810
rs137928907-<b>?</b>,2 x 10-8,(African),NR,'-,'-,'-,STX2,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,12:130827204
rs74796725-<b>?</b>,2 x 10-8,(African),NR,'-,'-,'-,ZNF740,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,12:53187599
rs2997119-<b>?</b>,3 x 10-7,(EA),NR,'-,'-,'-,'-,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,13:55819766
rs142754383-<b>?</b>,9 x 10-13,,NR,'-,'-,'-,IPO8,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,12:30661250
rs76082815-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LMO7,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,13:75821206
rs146330533-<b>?</b>,3 x 10-7,(African),NR,'-,'-,'-,ARHGEF10L,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,1:17669971
rs13001243-<b>?</b>,2 x 10-7,(African),NR,'-,'-,'-,RPS20P12,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,2:234306004
rs4800149-<b>?</b>,7 x 10-8,(African),NR,'-,'-,'-,CABLES1,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,18:23164290
rs34486957-<b>?</b>,4 x 10-7,(African),NR,'-,'-,'-,"RTN1, CCDC175",Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,14:59578879
rs142754383-<b>?</b>,8 x 10-12,(African),NR,'-,'-,'-,IPO8,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,12:30661250
rs75062117-<b>?</b>,5 x 10-7,(African),NR,'-,'-,'-,LINC02822,Initial pursuit acceleration in psychotic disorders,"schizophrenia, initial pursuit acceleration, bipolar disorder, schizoaffective disorder",GCST005026,12:90883555
rs188839109-<b>?</b>,2 x 10-8,(African),NR,'-,'-,'-,C11orf21,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,11:2301859
rs12052005-<b>?</b>,3 x 10-7,(African),NR,'-,'-,'-,CCDC102B,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,18:68832311
rs506597-<b>?</b>,1 x 10-7,(African),NR,'-,'-,'-,"POP7, EPO",Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,7:100715797
rs221798-<b>?</b>,1 x 10-8,(African),NR,'-,'-,'-,GIGYF1,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,7:100689872
rs56196471-<b>?</b>,9 x 10-8,(African),NR,'-,'-,'-,'-,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,4:178642661
rs2571521-<b>?</b>,3 x 10-7,(African),NR,'-,'-,'-,'-,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,9:26133810
rs221774-<b>?</b>,1 x 10-8,(African),NR,'-,'-,'-,"POP7, GIGYF1",Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,7:100701361
rs7939917-<b>?</b>,4 x 10-7,(African),NR,'-,'-,'-,TMPRSS5,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,11:113697374
rs61945387-<b>?</b>,2 x 10-7,(EA),NR,'-,'-,'-,KSR2,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,12:117921609
rs6738485-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,UXS1,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,2:106193504
rs56031956-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,ACTL7A,Pursuit maintenance gain in psychotic disorders,"schizophrenia, pursuit maintenance gain measurement, bipolar disorder, schizoaffective disorder",GCST005028,9:108863349
rs28715896-<b>G</b>,4 x 10-6,,0.43,1.5873016,'-,[1.39-1.78],ERBB4,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,2:211695376
rs75337321-<b>T</b>,5 x 10-6,,0.06,2.21,'-,[1.88-2.54],CACNA2D3,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,3:54550560
rs13374908-<b>A</b>,2 x 10-6,,0.24,1.59,'-,[1.39-1.79],FAM163A,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,1:179780639
rs10222981-<b>T</b>,1 x 10-6,,0.08,2.06,'-,[1.77-2.35],"BLOC1S4, KIAA0232",Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,4:6759326
rs61835453-<b>C</b>,8 x 10-7,,0.06,2.173913,'-,[1.86-2.49],'-,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,10:2717604
rs365521-<b>G</b>,1 x 10-6,,0.53,1.5873016,'-,[1.39-1.78],"MIR633, TRMT112P3",Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,17:62944934
rs72737330-<b>C</b>,9 x 10-7,(AA),0.163,'-,1.003 unit decrease,'-,ESRRG,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,1:216600151
rs488109-<b>G</b>,4 x 10-6,(AA),0.395,'-,0.475 unit decrease,'-,C1orf100,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,1:244265229
rs7556950-<b>C</b>,8 x 10-6,(AA),0.099,'-,0.655 unit increase,'-,'-,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:41582921
rs112525781-<b>C</b>,9 x 10-6,(AA),NR,'-,0.911 unit decrease,'-,AHCYP4,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:138961777
rs115182184-<b>G</b>,8 x 10-6,(AA),NR,'-,0.952 unit increase,'-,NR4A2,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:156342049
rs10198241-<b>C</b>,1 x 10-6,(AA),0.608,'-,0.487 unit increase,'-,RNA5SP89,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:226115660
rs13064447-<b>C</b>,4 x 10-6,(AA),0.454,'-,0.437 unit decrease,'-,"CRIP1P1, TMEM40",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,3:12711632
rs11919880-<b>G</b>,6 x 10-6,(AA),0.313,'-,0.509 unit decrease,'-,"TRIM71, CCR4",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,3:32920559
rs11129574-<b>C</b>,4 x 10-6,(AA),0.936,'-,1.079 unit increase,'-,LINC01811,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,3:33972800
rs1693457-<b>C</b>,7 x 10-6,(AA),0.206,'-,0.514 unit decrease,'-,'-,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,Mapping not available
rs113942939-<b>G</b>,3 x 10-6,(AA),NR,'-,1.158 unit decrease,'-,EBF1,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,5:158659196
rs12180309-<b>C</b>,5 x 10-7,(AA),NR,'-,0.947 unit increase,'-,'-,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,6:91209048
rs6930781-<b>C</b>,3 x 10-6,(AA),0.514,'-,0.46 unit increase,'-,"WASF1, GPR6",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,6:110006481
rs73017046-<b>G</b>,6 x 10-6,(AA),0.853,'-,0.83 unit increase,'-,"SASH1, SNRPEP6",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,6:148560592
rs2905347-<b>G</b>,6 x 10-6,(AA),0.439,'-,0.455 unit increase,'-,STEAP1B,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,7:22580700
rs34929064-<b>C</b>,7 x 10-6,(AA),0.247,'-,0.498 unit decrease,'-,STEAP1B,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,7:22688653
rs60617249-<b>G</b>,4 x 10-6,(AA),0.505,'-,0.436 unit decrease,'-,"COBL, VWDE",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,7:50944161
rs139438618-<b>G</b>,2 x 10-11,(AA),NR,'-,0.869 unit increase,'-,SEMA3A,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,7:84008281
rs79246196-<b>C</b>,1 x 10-6,(AA),NR,'-,1.016 unit increase,'-,STAG3,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,7:100185286
rs12544026-<b>G</b>,1 x 10-6,(AA),0.136,'-,0.969 unit decrease,'-,NCALD,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,8:101819970
rs115357105-<b>G</b>,9 x 10-7,(AA),NR,'-,1.132 unit increase,'-,TOPORSLP,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,9:104376689
rs2886497-<b>G</b>,6 x 10-6,(AA),0.547,'-,0.44 unit decrease,'-,"C10orf67, OTUD1",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,10:23381413
rs2243668-<b>G</b>,9 x 10-6,(AA),0.909,'-,0.868 unit increase,'-,NRP1,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,10:33274965
rs12222290-<b>G</b>,4 x 10-6,(AA),0.503,'-,0.447 unit decrease,'-,GALNT18,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,11:11455298
rs3018100-<b>G</b>,5 x 10-6,(AA),0.275,'-,0.616 unit increase,'-,RPS3,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,11:75417295
rs73513496-<b>G</b>,4 x 10-6,(AA),NR,'-,0.939 unit decrease,'-,LINC02720,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,11:80799224
rs11825659-<b>G</b>,1 x 10-6,(AA),NR,'-,0.484 unit decrease,'-,IGSF9B,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,11:133925624
rs74067914-<b>C</b>,7 x 10-6,(AA),NR,'-,0.646 unit increase,'-,RERGL,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,12:18036994
rs11179306-<b>C</b>,3 x 10-6,(AA),0.924,'-,0.821 unit decrease,'-,TRHDE,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,12:72653857
rs544475121-<b>AT</b>,5 x 10-6,(AA),NR,'-,0.561 unit increase,'-,"LPAR6, RB1",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,13:48442207
rs1471450-<b>G</b>,2 x 10-6,(AA),0.25,'-,0.789 unit increase,'-,'-,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,13:54670721
rs75104126-<b>C</b>,3 x 10-6,(AA),0.878,'-,1.011 unit decrease,'-,'-,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,13:54883367
rs58598658-<b>C</b>,1 x 10-6,(AA),0.446,'-,0.465 unit increase,'-,KLF12,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,13:73887726
rs77993859-<b>G</b>,8 x 10-6,(AA),NR,'-,0.82 unit decrease,'-,FOXB1,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,15:60155639
rs797003128-<b>C</b>,5 x 10-6,(AA),NR,'-,0.651 unit decrease,'-,BBS4,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,15:72730279
rs73459955-<b>C</b>,2 x 10-6,(AA),0.839,'-,0.603 unit decrease,'-,LINC01197,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,15:95109294
rs12597282-<b>C</b>,7 x 10-6,(AA),0.534,'-,0.446 unit decrease,'-,"CTRB2, RBFOX1",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,16:7794410
rs2345546-<b>C</b>,2 x 10-6,(AA),0.882,'-,0.855 unit increase,'-,LINC02191,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,16:25416151
rs2094081-<b>G</b>,4 x 10-7,(EA),NR,'-,1.519 unit decrease,'-,RHBDL2,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,1:38927359
rs7595950-<b>C</b>,3 x 10-6,(EA),0.388,'-,0.521 unit increase,'-,TMEM178A,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:59916057
rs13031275-<b>C</b>,5 x 10-6,(EA),NR,'-,1.032 unit increase,'-,"NEB, RIF1",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:151489980
rs12109691-<b>G</b>,2 x 10-6,(EA),0.72,'-,0.601 unit decrease,'-,"HSD17B4, FAM170A",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,5:119630805
rs55702914-<b>G</b>,1 x 10-6,,0.354,'-,0.371 unit decrease,[0.22-0.52],"NPM1P46, ANKRD44",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:197349672
rs58335266-<b>G</b>,6 x 10-6,,0.364,'-,0.341 unit increase,[0.19-0.49],"HSPE1-MOB4, HSPD1",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,2:197505616
rs9844985-<b>C</b>,2 x 10-6,,0.552,'-,0.364 unit increase,[0.22-0.51],LSAMP,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,3:117163885
rs543964416-<b>AA</b>,7 x 10-6,,0.258,'-,0.404 unit decrease,[0.23-0.58],"ADH1B, ADH1A",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,4:99302636
rs10940051-<b>C</b>,6 x 10-6,,0.706,'-,0.366 unit increase,[0.21-0.52],NLN,Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,5:65811762
rs60490907-<b>?</b>,1 x 10-7,(AA),NR,'-,'-,'-,"MTSS1, NDUFB9",Cognitive performance in schizophrenia or bipolar disorder,"schizophrenia, cognitive function measurement, bipolar I disorder",GCST009678,8:124570463
rs10042968-<b>G</b>,8 x 10-7,"(Combined, AA replication)",NR,1.42,'-,[NR],'-,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001769,5:63737891
rs7445832-<b>A</b>,1 x 10-9,"(Combined, Australian replication)",NR,1.15,'-,[NR],'-,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001769,5:63290474
rs2197706-<b>A</b>,3 x 10-10,,0.351,8.1,'-,[4.24-15.49],"SLIRPP1, RNU6-382P",Fragile X syndrome,Fragile X syndrome,GCST007233,X:147813602
rs1970606-<b>G</b>,8 x 10-9,,NR,'-,0.06 unit increase,[0.04-0.08],"RBBP4P4, GAPDHP15",Opioid dependence,opioid dependence,GCST008424,6:58042294
rs1557219-<b>C</b>,9 x 10-9,,NR,'-,0.06 unit increase,[0.04-0.08],"GAPDHP15, RBBP4P4",Opioid dependence,opioid dependence,GCST008424,6:58044647
rs59675243-<b>A</b>,1 x 10-7,,NR,'-,0.13 unit increase,[0.091-0.169],TACC2,Opioid dependence,opioid dependence,GCST008424,10:122011107
rs75449825-<b>G</b>,2 x 10-7,,NR,'-,0.13 unit increase,[0.091-0.169],TACC2,Opioid dependence,opioid dependence,GCST008424,10:122010374
rs17300532-<b>T</b>,2 x 10-7,,NR,'-,0.06 unit increase,[0.04-0.08],MAP1B,Opioid dependence,opioid dependence,GCST008424,5:72084528
rs58356853-<b>T</b>,3 x 10-7,,NR,'-,0.12 unit increase,[0.081-0.159],TACC2,Opioid dependence,opioid dependence,GCST008424,10:122011617
rs4300379-<b>G</b>,9 x 10-7,,NR,'-,0.06 unit decrease,[0.04-0.08],"OR4C46, OR4C7P",Opioid dependence,opioid dependence,GCST008424,11:54614287
rs977145-<b>A</b>,7 x 10-6,,NR,'-,'-,'-,"NEGR1, ZRANB2-AS2",Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004271,1:71463606
rs7853333-<b>A</b>,4 x 10-6,,NR,'-,'-,'-,"DCAF12, RN7SKP114",Venlafaxine response in generalised anxiety disorder (HAMA-A score reduction after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004271,9:34065661
rs76778048-<b>A</b>,8 x 10-6,(CGI),0.25,10.2,'-,'-,LINC02549,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004270,6:68220040
rs3819595-<b>A</b>,4 x 10-6,(HAM-A),0.35,6.45,'-,'-,PCP4,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004270,21:39910773
rs2070419-<b>A</b>,5 x 10-6,(CGI),0.47,6.09,'-,'-,"TIAM1, FBXW11P1",Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004270,21:31560711
rs3020264-<b>A</b>,3 x 10-6,(HAM-A),0.48,4.7,'-,'-,"MCPH1-AS1, MCPH1",Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004273,8:6631056
rs10914746-<b>G</b>,9 x 10-6,(CGI),0.43,4.63,'-,'-,CSMD2,Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004273,1:33574244
rs7984972-<b>A</b>,8 x 10-6,(CGI),0.57,4.17,'-,'-,'-,Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004273,13:31433871
rs13129231-<b>A</b>,6 x 10-6,(CGI),0.9,5.88,'-,'-,CAMK2D,Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004274,4:113431725
rs2236295-<b>A</b>,5 x 10-6,(CGI),0.52,4.14,'-,'-,ADO,Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004274,10:62805132
rs7152947-<b>A</b>,3 x 10-6,(HAM-A),0.89,5.88,'-,'-,ANGEL1,Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004274,14:76825750
rs8020289-<b>G</b>,9 x 10-6,(HAM-A),0.88,5.26,'-,'-,LRRC74A,Venlafaxine response in generalised anxiety disorder (remitters vs non-remitters after 12 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004274,14:76827177
rs2307441-<b>G</b>,3 x 10-6,(HAM-A),0.22,14.38,'-,'-,POLG,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004275,15:89318595
rs6712232-<b>G</b>,5 x 10-6,(CGI),0.22,14.28,'-,'-,RPS20P10,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004275,2:71903902
rs3013580-<b>G</b>,2 x 10-6,(CGI),0.59,6.23,'-,'-,LINC00364,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004275,13:67329484
rs75965524-<b>G</b>,4 x 10-6,(CGI),0.22,14.47,'-,'-,AGAP1,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004275,2:235921494
rs6918679-<b>A</b>,8 x 10-7,(CGI),0.28,11.97,'-,'-,'-,Venlafaxine response in generalised anxiety disorder (responders vs non-responders after 24 weeks),"response to venlafaxine, generalized anxiety disorder",GCST004275,6:74822861
rs7528604-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,PDE4B,Stress-related disorders,stress-related disorder,GCST008567,1:65941669
rs11725502-<b>T</b>,5 x 10-15,,0.0983607,'-,'-,'-,UGT2B10,Plasma norclozapine levels in treatment-resistant schizophrenia,"treatment refractory schizophrenia, response to clozapine",GCST007686,4:68815224
rs2011425-<b>G</b>,8 x 10-9,,0.0864838,'-,'-,'-,"UGT1A9, UGT1A7, UGT1A4, UGT1A5, UGT1A10, UGT1A6, UGT1A8",Plasma norclozapine levels in treatment-resistant schizophrenia,"treatment refractory schizophrenia, response to clozapine",GCST007686,2:233718962
rs10023464-<b>T</b>,9 x 10-66,,0.101,'-,'-,'-,UGT2B10,Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia,"treatment refractory schizophrenia, response to clozapine",GCST007684,4:68794020
rs12767583-<b>T</b>,5 x 10-14,,0.143,'-,'-,'-,CYP2C19,Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia,"treatment refractory schizophrenia, response to clozapine",GCST007684,10:94787706
rs7668556-<b>A</b>,4 x 10-13,,0.466,'-,'-,'-,"UGT2B7, UGT2B11",Plasma clozapine-norclozapine ratio in treatment-resistant schizophrenia,"treatment refractory schizophrenia, response to clozapine",GCST007684,4:69164555
rs2472297-<b>T</b>,4 x 10-10,,0.280027,'-,'-,'-,"CYP1A2, CYP1A1",Plasma clozapine levels in treatment-resistant schizophrenia,"treatment refractory schizophrenia, response to clozapine",GCST007685,15:74735539
rs10121366-<b>T</b>,7 x 10-6,,NR,'-,0.2785 unit decrease,[0.16-0.4],DELEC1,Cocaine dependence,cocaine dependence,GCST008399,9:115481743
rs11086525-<b>C</b>,3 x 10-6,,NR,'-,0.2013 unit increase,[0.12-0.29],CBLN4,Cocaine dependence,cocaine dependence,GCST008399,20:55941282
rs112252907-<b>T</b>,4 x 10-6,,NR,'-,0.4268 unit increase,[0.24-0.61],RBFOX1,Cocaine dependence,cocaine dependence,GCST008399,16:6625140
rs148179194-<b>T</b>,7 x 10-6,,NR,'-,0.8813 unit increase,[0.5-1.27],DOCK3,Cocaine dependence,cocaine dependence,GCST008399,3:50761221
rs1484873-<b>A</b>,4 x 10-6,,NR,'-,0.473 unit decrease,[0.27-0.68],SLC14A2,Cocaine dependence,cocaine dependence,GCST008399,18:45627020
rs247831-<b>C</b>,9 x 10-6,,NR,'-,0.2177 unit increase,[0.12-0.31],MEAK7,Cocaine dependence,cocaine dependence,GCST008399,16:84548287
rs334878-<b>A</b>,8 x 10-6,,NR,'-,0.2703 unit decrease,[0.15-0.39],MCIDAS,Cocaine dependence,cocaine dependence,GCST008399,5:55224050
rs35735220-<b>T</b>,7 x 10-6,,NR,'-,0.3091 unit decrease,[0.17-0.44],MIR873,Cocaine dependence,cocaine dependence,GCST008399,9:28963291
rs4410642-<b>C</b>,9 x 10-6,,NR,'-,0.288 unit increase,[0.16-0.42],RNU6-381P,Cocaine dependence,cocaine dependence,GCST008399,5:44129321
rs4734387-<b>A</b>,4 x 10-6,,NR,'-,0.2126 unit decrease,[0.12-0.3],"POP1, NIPAL2",Cocaine dependence,cocaine dependence,GCST008399,8:98181537
rs56401801-<b>A</b>,3 x 10-6,,NR,'-,0.3592 unit decrease,[0.21-0.51],"ZNF204P, VN1R10P",Cocaine dependence,cocaine dependence,GCST008399,6:27333733
rs57361543-<b>A</b>,5 x 10-6,,NR,'-,0.2015 unit decrease,[0.11-0.29],"GHSR, TNFSF10",Cocaine dependence,cocaine dependence,GCST008399,3:172494354
rs62357000-<b>T</b>,9 x 10-6,,NR,'-,0.5584 unit increase,[0.31-0.81],SPRY4-AS1,Cocaine dependence,cocaine dependence,GCST008399,5:30884808
rs67769911-<b>A</b>,6 x 10-6,,NR,'-,0.264 unit increase,[0.15-0.38],ACTN4P1,Cocaine dependence,cocaine dependence,GCST008399,4:116685914
rs71575441-<b>T</b>,2 x 10-6,,NR,'-,0.6574 unit increase,[0.38-0.93],EFNA5,Cocaine dependence,cocaine dependence,GCST008399,5:107453116
rs72685414-<b>A</b>,2 x 10-6,,NR,'-,0.3838 unit increase,[0.23-0.54],'-,Cocaine dependence,cocaine dependence,GCST008399,1:104424250
rs7332726-<b>A</b>,7 x 10-6,,NR,'-,0.5565 unit increase,[0.31-0.8],MIR4500HG,Cocaine dependence,cocaine dependence,GCST008399,13:87498629
rs73973283-<b>A</b>,6 x 10-6,,NR,'-,0.5633 unit increase,[0.32-0.81],'-,Cocaine dependence,cocaine dependence,GCST008399,18:76045951
rs7675557-<b>A</b>,2 x 10-6,,NR,'-,0.2157 unit decrease,[0.13-0.31],"HNRNPA3P13, RASGEF1B",Cocaine dependence,cocaine dependence,GCST008399,4:82049663
rs79309473-<b>T</b>,2 x 10-6,,NR,'-,0.2331 unit decrease,[0.14-0.33],"CCNA1, SPART",Cocaine dependence,cocaine dependence,GCST008399,13:36398065
rs806973-<b>A</b>,3 x 10-6,,NR,'-,0.2008 unit increase,[0.12-0.29],"H2AC6, H1-4",Cocaine dependence,cocaine dependence,GCST008399,6:26148098
rs12442183-<b>T</b>,1 x 10-8,(EA),0.59,'-,0.44 unit increase,'-,'-,Opioid dependence,opioid dependence,GCST005368,15:93204756
rs8036747-<b>?</b>,8 x 10-8,(EA),NR,'-,0.39 unit increase,'-,'-,Opioid dependence,opioid dependence,GCST005368,15:93209226
rs1872052-<b>?</b>,2 x 10-7,(EA),NR,'-,0.37 unit decrease,'-,'-,Opioid dependence,opioid dependence,GCST005368,15:93209649
rs192590503-<b>?</b>,3 x 10-7,(EA),NR,'-,1.4 unit decrease,'-,NKAIN2,Opioid dependence,opioid dependence,GCST005368,6:124215869
rs74641711-<b>?</b>,6 x 10-7,(EA),NR,'-,1.74 unit decrease,'-,CTDP1,Opioid dependence,opioid dependence,GCST005368,18:79727394
rs13097862-<b>?</b>,9 x 10-7,(EA),NR,'-,0.68 unit decrease,'-,"SNTN, C3orf49",Opioid dependence,opioid dependence,GCST005368,3:63733563
rs10995853-<b>?</b>,9 x 10-7,(EA),NR,'-,1.6 unit decrease,'-,DBF4P1,Opioid dependence,opioid dependence,GCST005368,10:64259979
rs13279512-<b>?</b>,9 x 10-7,(EA),NR,'-,0.4 unit increase,'-,CLVS1,Opioid dependence,opioid dependence,GCST005368,8:61045943
rs11163319-<b>?</b>,1 x 10-6,(EA),NR,'-,0.81 unit decrease,'-,ADGRL2,Opioid dependence,opioid dependence,GCST005368,1:81506757
rs10738186-<b>?</b>,1 x 10-6,(EA),NR,'-,1.61 unit decrease,'-,IMP3P1,Opioid dependence,opioid dependence,GCST005368,9:10753414
rs12442183-<b>T</b>,3 x 10-8,,0.59,'-,'-,'-,'-,Opioid dependence,opioid dependence,GCST005368,15:93204756
rs57602752-<b>A</b>,1 x 10-7,,NR,'-,0.2866 unit decrease,[0.18-0.39],"LDHAP5, RPL17P36",Cannabis dependence,cannabis dependence,GCST005133,10:118890460
rs7528604-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,PDE4B,Anxiety disorders,anxiety disorder,GCST008566,1:65941669
rs77109747-<b>A</b>,5 x 10-7,(AA),'-,'-,0.14 unit decrease,[0.081-0.199],"GPR199P, DLGAP3",Nicotine dependence,nicotine dependence,GCST004294,1:34947470
rs1060061-<b>T</b>,4 x 10-6,(AA),'-,'-,0.06 unit decrease,[0.04-0.08],NR5A2,Nicotine dependence,nicotine dependence,GCST004294,1:200174314
rs890622-<b>C</b>,2 x 10-6,(AA),'-,'-,0.08 unit decrease,[0.041-0.119],TANC1,Nicotine dependence,nicotine dependence,GCST004294,2:159108877
rs56247223-<b>A</b>,4 x 10-8,(AA),'-,'-,0.07 unit decrease,[0.05-0.09],CACNA2D3,Nicotine dependence,nicotine dependence,GCST004294,3:54608201
rs77114337-<b>T</b>,4 x 10-6,(AA),'-,'-,0.25 unit increase,[0.15-0.35],SULT1B1,Nicotine dependence,nicotine dependence,GCST004294,4:69758944
rs55644503-<b>T</b>,2 x 10-6,(AA),'-,'-,0.13 unit decrease,[0.071-0.189],LINC02240,Nicotine dependence,nicotine dependence,GCST004294,5:125190620
rs9503551-<b>A</b>,4 x 10-6,(AA),'-,'-,0.09 unit increase,[0.051-0.129],SLC22A23,Nicotine dependence,nicotine dependence,GCST004294,6:3340483
rs1760803-<b>A</b>,4 x 10-6,(EA),'-,'-,0.03 unit decrease,[0.01-0.05],"HAX1, RNU6-239P",Nicotine dependence,nicotine dependence,GCST004294,1:154285418
rs56020557-<b>T</b>,5 x 10-6,(EA),'-,'-,0.05 unit increase,[0.03-0.07],GABBR1,Nicotine dependence,nicotine dependence,GCST004294,6:29596985
rs17198023-<b>A</b>,5 x 10-6,(EA),'-,'-,0.04 unit increase,[0.02-0.06],ADAMTSL1,Nicotine dependence,nicotine dependence,GCST004294,9:18194385
rs12680810-<b>A</b>,1 x 10-6,,'-,'-,0.03 unit increase,[0.01-0.05],'-,Nicotine dependence,nicotine dependence,GCST004294,8:77231908
rs12348139-<b>T</b>,1 x 10-6,,'-,'-,0.05 unit decrease,[0.03-0.07],GLIS3,Nicotine dependence,nicotine dependence,GCST004294,9:4232743
rs10759883-<b>T</b>,1 x 10-6,,'-,'-,0.02 unit decrease,[0.0004-0.0396],LINC00476,Nicotine dependence,nicotine dependence,GCST004294,9:95790481
rs62392942-<b>T</b>,1 x 10-6,,'-,'-,0.06 unit decrease,[0.04-0.08],"SUMO2P1, GABBR1",Nicotine dependence,nicotine dependence,GCST004294,6:29634161
rs113851554-<b>T</b>,4 x 10-19,,0.056,'-,8.94 z-score increase,'-,MEIS1,Insomnia complaints,insomnia,GCST004695,2:66523432
rs574753165-<b>G</b>,5 x 10-9,,0.005,'-,5.85 z-score decrease,'-,SCFD2,Insomnia complaints,insomnia,GCST004695,4:53111094
undefined,6 x 10-22,,NR,'-,0.087 unit increase,[0.069-0.105],MEIS1,Insomnia complaints (continuous),insomnia,GCST004701,2:66523432
rs113851554-<b>?</b>,2 x 10-19,,'-,1.27,'-,[1.21-1.34],MEIS1,Insomnia complaints (dichotomous),insomnia,GCST004702,2:66523432
rs113851554-<b>T</b>,7 x 10-13,,0.056,'-,7.19 z-score increase,'-,MEIS1,Insomnia complaints,insomnia,GCST006487,2:66523432
rs71554396-<b>GT</b>,8 x 10-8,,0.137,'-,5.36 z-score increase,'-,"LINC02519, WDR27",Insomnia complaints,insomnia,GCST006488,6:169440978
rs13192566-<b>C</b>,2 x 10-8,,0.146,'-,5.63 z-score decrease,'-,WDR27,Insomnia complaints,insomnia,GCST006488,6:169561539
rs3749448-<b>A</b>,2 x 10-6,,0.2,2.96,'-,[2.52-3.4],GRM7,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003450,3:7146429
rs1800625-<b>G</b>,3 x 10-9,,0.084,3.78,'-,[3.34-4.22],"AGER, PBX2",Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003450,6:32184665
rs564309-<b>?</b>,2 x 10-9,,0.19,5.55,'-,[3.22-10.0],TRIM11,Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy,Progressive supranuclear palsy,GCST006276,1:228397861
rs621042-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,PIK3C2G,Non-Richardson's syndrome vs Richardson's syndrome in progressive supranuclear palsy,Progressive supranuclear palsy,GCST006276,12:18636073
rs2242367-<b>A</b>,1 x 10-10,,0.282,1.37,'-,[1.25-1.51],'-,Survival in progressive supranuclear palsy,"overall survival, Progressive supranuclear palsy",GCST011977,Mapping not available
rs242557-<b>G</b>,2 x 10-22,,0.48,1.9061,'-,'-,MAPT,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST007845,17:45942346
APOE-<b>?</b>,1 x 10-49,,NR,'-,'-,'-,'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST006806,Mapping not available
rs59979824-<b>?</b>,6 x 10-9,,'-,1.0638298,'-,[1.04-1.09],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:192983614
rs9656169-<b>?</b>,3 x 10-8,,'-,1.0526316,'-,[1.04-1.08],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:110434219
rs34487851-<b>G</b>,2 x 10-7,,NR,'-,'-,'-,ECRG4,Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),"neuritic plaque measurement, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST005514,2:106026098
rs79524815-<b>G</b>,1 x 10-7,,NR,'-,'-,'-,HDAC9,Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),"neuritic plaque measurement, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST005514,7:18658708
rs35067331-<b>T</b>,6 x 10-7,,NR,'-,'-,'-,TRAPPC12,Neuritic plaques or neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),"neuritic plaque measurement, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST005514,2:3470314
rs429358-<b>?</b>,5 x 10-40,,NR,'-,'-,'-,'-,Neuritic plaques or cerebral amyloid angiopathy (pleiotropy),"neuritic plaque measurement, cerebral amyloid angiopathy",GCST005515,Mapping not available
rs34487851-<b>G</b>,3 x 10-6,,0.27,'-,'-,'-,ECRG4,Neuritic plaques or cerebral amyloid angiopathy (pleiotropy),"neuritic plaque measurement, cerebral amyloid angiopathy",GCST005515,2:106026098
rs79524815-<b>G</b>,3 x 10-6,,0.03,'-,'-,'-,HDAC9,Neuritic plaques or cerebral amyloid angiopathy (pleiotropy),"neuritic plaque measurement, cerebral amyloid angiopathy",GCST005515,7:18658708
rs429358-<b>?</b>,6 x 10-35,,NR,'-,'-,'-,'-,Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),"cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST005517,Mapping not available
rs79524815-<b>G</b>,1 x 10-8,,0.03,'-,'-,'-,HDAC9,Neurofibrillary tangles or cerebral amyloid angiopathy (pleiotropy),"cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST005517,7:18658708
rs7578149-<b>?</b>,2 x 10-6,,NR,'-,1.917254 unit increase,NR,"RPS16P2, LAPTM4A-DT",Obsessive compulsive disorder severity,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009818,2:20112677
rs6436908-<b>?</b>,8 x 10-6,,NR,'-,1.754016 unit decrease,NR,"SLC16A14, SP110",Obsessive compulsive disorder severity,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009818,2:230130731
rs11924650-<b>?</b>,6 x 10-6,,NR,'-,1.979962 unit increase,NR,CACNA2D3,Obsessive compulsive disorder severity,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009818,3:54224911
rs229836-<b>?</b>,8 x 10-6,,NR,'-,1.950295 unit increase,NR,'-,Obsessive compulsive disorder severity,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009818,14:83401191
rs9615637-<b>?</b>,2 x 10-6,,NR,'-,2.343338 unit decrease,NR,'-,Obsessive compulsive disorder severity,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009818,22:47789133
rs1285950-<b>?</b>,4 x 10-6,,NR,'-,1.4286808 unit decrease,NR,"CLEC5A, MGAM",Compulsion score in obsessive compulsive disorder,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009819,7:141936763
rs6569819-<b>?</b>,4 x 10-6,,NR,'-,1.3260514 unit decrease,NR,"TAAR1, TAAR2",Compulsion score in obsessive compulsive disorder,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009819,6:132641902
rs2220130-<b>?</b>,9 x 10-6,,NR,'-,1.246142 unit decrease,NR,TMTC1,Compulsion score in obsessive compulsive disorder,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009819,12:29862356
rs16876441-<b>?</b>,9 x 10-6,,NR,'-,2.7562728 unit decrease,NR,MIR3683,Compulsion score in obsessive compulsive disorder,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009819,7:7053681
rs6764121-<b>?</b>,9 x 10-6,,NR,'-,1.1443635 unit decrease,NR,ATP13A4,Obsession score in obsessive compulsive disorder,"obsessive-compulsive disorder, obsessive-compulsive symptom measurement",GCST009820,3:193412595
rs4622308-<b>T</b>,4 x 10-9,,0.44,1.2,'-,[1.14-1.26],"ERBB3, RPS26",Anorexia nervosa,anorexia nervosa,GCST004367,12:56075401
rs200312312-<b>T</b>,7 x 10-8,,0.677,1.2,'-,[1.14-1.26],'-,Anorexia nervosa,anorexia nervosa,GCST004367,5:104666645
rs117957029-<b>C</b>,2 x 10-7,,0.023,1.72,'-,[1.52-1.92],LINC02376,Anorexia nervosa,anorexia nervosa,GCST004367,12:127200688
rs11174202-<b>A</b>,3 x 10-7,,0.547,1.17,'-,[1.11-1.23],TAFA2,Anorexia nervosa,anorexia nervosa,GCST004367,12:61858476
chr12:69435103-<b>GTATATATACATA</b>,7 x 10-7,,0.807,1.24,'-,[1.16-1.32],'-,Anorexia nervosa,anorexia nervosa,GCST004367,Mapping not available
rs13125782-<b>T</b>,9 x 10-7,,0.215,1.19,'-,[1.11-1.27],SORCS2,Anorexia nervosa,anorexia nervosa,GCST004367,4:7426539
rs34361428-<b>G</b>,1 x 10-6,(model 1),0.2,'-,0.47 unit increase,[0.27-0.67],"ADH1B, ADH7",Alcohol dependence,alcohol dependence,GCST011955,4:99391552
rs11950-<b>G</b>,3 x 10-6,(model 1),0.14,'-,0.52 unit increase,[0.3-0.74],"TMEM14A, TRAM2-AS1",Alcohol dependence,alcohol dependence,GCST011955,6:52668952
rs2294231-<b>T</b>,6 x 10-6,(model 1),0.58,'-,0.33 unit decrease,[0.19-0.47],LINC02518,Alcohol dependence,alcohol dependence,GCST011955,6:113433202
rs11245976-<b>A</b>,7 x 10-6,(model 1),0.22,'-,0.4 unit increase,[0.22-0.58],"MUC5AC, MUC2",Alcohol dependence,alcohol dependence,GCST011955,11:1136660
rs1519302-<b>C</b>,7 x 10-6,(model 2),0.31,'-,0.47 unit increase,[0.27-0.67],'-,Alcohol dependence,alcohol dependence,GCST011955,2:123207111
rs1442493-<b>G</b>,7 x 10-6,(model 1),0.85,'-,0.42 unit decrease,[0.24-0.6],"ADH1B, ADH7",Alcohol dependence,alcohol dependence,GCST011955,4:99400208
rs6693815-<b>T</b>,9 x 10-6,(model 2),0.24,'-,0.53 unit increase,[0.43-0.63],"GSTM5, EPS8L3",Alcohol dependence,alcohol dependence,GCST011955,1:109758638
rs429358-<b>?</b>,6 x 10-17,,NR,2.28,'-,[NR],'-,Dementia with Lewy bodies,Lewy body dementia,GCST007881,Mapping not available
rs12734374-<b>?</b>,1 x 10-9,,NR,4.31,'-,[NR],ASH1L,Dementia with Lewy bodies,Lewy body dementia,GCST007881,1:155419060
rs9461856-<b>A</b>,6 x 10-12,,'-,1.07,'-,[1.05-1.09],SYNGAP1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:33427422
rs113397282-<b>T</b>,6 x 10-12,,'-,1.11,'-,[1.08-1.15],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32520273
rs35828350-<b>?</b>,6 x 10-11,,'-,1.0752687,'-,[1.05-1.11],"ALPK3, ZNF592",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:84812610
rs764284-<b>A</b>,6 x 10-11,,'-,1.07,'-,[1.05-1.09],"VN1R10P, ZNF204P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27344299
rs115325719-<b>T</b>,6 x 10-11,,'-,1.12,'-,[1.08-1.16],HLA-DMA,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32963018
rs3735025-<b>T</b>,6 x 10-10,,'-,1.06,'-,[1.04-1.09],DGKI,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:137390098
rs115283957-<b>C</b>,6 x 10-10,,'-,1.08,'-,[1.05-1.10],"HLA-B, LINC02571",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31308658
rs1080500-<b>?</b>,6 x 10-9,,'-,1.0638298,'-,[1.04-1.09],"PRKCD, RFT1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:53141001
rs171748-<b>A</b>,6 x 10-9,,'-,1.06,'-,[1.04-1.08],"SMIM15-AS1, LINC02057",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:61203304
rs139480376-<b>A</b>,6 x 10-9,,'-,1.09,'-,[1.06-1.12],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32522469
rs17292804-<b>A</b>,6 x 10-9,,'-,1.1,'-,[1.06-1.13],PPP1R13B,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:103738786
rs116408368-<b>T</b>,7 x 10-17,,'-,1.15,'-,[1.12-1.19],TRIM26,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30202733
rs59574136-<b>T</b>,7 x 10-16,,'-,1.08,'-,[1.06-1.11],MAD1L1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:1996825
rs149979052-<b>?</b>,7 x 10-14,,'-,1.1235955,'-,[1.09-1.15],PSORS1C1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31137370
rs115682897-<b>?</b>,7 x 10-14,,'-,1.1111112,'-,[1.09-1.14],"MTCO3P1, HLA-DQB3",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32725517
rs185717927-<b>C</b>,7 x 10-13,,'-,1.23,'-,[1.16-1.31],"HLA-DRB1, HLA-DRB6",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32568724
rs113205291-<b>A</b>,7 x 10-12,,'-,1.11,'-,[1.08-1.14],"HLA-H, HLA-T",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29894844
rs149915948-<b>?</b>,7 x 10-11,,'-,1.098901,'-,[1.08-1.14],ATAT1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30639723
rs17843707-<b>T</b>,7 x 10-11,,'-,1.14,'-,[1.09-1.18],"HLA-DQA1, HLA-DQB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32654605
rs116593970-<b>?</b>,7 x 10-10,,'-,1.0752687,'-,[1.05-1.1],HLA-DQA2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32742213
rs4523957-<b>T</b>,7 x 10-10,,'-,1.07,'-,[1.04-1.09],SRR,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,17:2305605
rs191239160-<b>?</b>,7 x 10-9,,'-,1.0752687,'-,[1.05-1.1],HLA-DRB6,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32558215
rs301798-<b>?</b>,7 x 10-9,,'-,1.0638298,'-,[1.04-1.09],"RERE, RERE-AS1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:8428505
rs10211550-<b>?</b>,7 x 10-9,,'-,1.0638298,'-,[1.04-1.09],"MOB4, HSPE1-MOB4",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:197518575
rs9607782-<b>A</b>,9 x 10-9,,'-,1.07,'-,[1.04-1.09],EP300-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,22:41191552
rs151267808-<b>T</b>,1 x 10-22,,'-,1.24,'-,[1.19-1.30],"HLA-H, HCP5B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29882943
rs7746199-<b>?</b>,1 x 10-20,,'-,1.1363636,'-,[1.1-1.16],POM121L2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27293545
rs115123779-<b>?</b>,1 x 10-17,,'-,1.1494253,'-,[1.11-1.18],LINC02829,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29510044
rs115960997-<b>?</b>,1 x 10-11,,'-,1.098901,'-,[1.08-1.14],"HLA-A, HLA-U",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29934332
rs1793889-<b>?</b>,1 x 10-11,,'-,1.0869565,'-,[1.06-1.11],"HLA-C, HCG27",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31254404
rs142790902-<b>T</b>,1 x 10-11,,'-,1.22,'-,[1.15-1.29],HLA-DRB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32582137
rs145501595-<b>?</b>,1 x 10-10,,'-,1.0869565,'-,[1.06-1.12],OR11A1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29445191
rs4642619-<b>A</b>,1 x 10-10,,'-,1.08,'-,[1.06-1.11],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:110475239
rs2910032-<b>?</b>,1 x 10-9,,'-,1.0638298,'-,[1.04-1.09],LINC01470,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:153160794
rs9270074-<b>T</b>,1 x 10-9,,'-,1.08,'-,[1.05-1.11],HLA-DRB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32586352
rs35131895-<b>?</b>,1 x 10-8,,'-,1.0638298,'-,[1.04-1.09],KDM3B,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:138413188
rs1977199-<b>A</b>,1 x 10-8,,'-,1.07,'-,[1.04-1.09],BTN2A1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26466161
rs4380187-<b>A</b>,7 x 10-9,,'-,1.06,'-,[1.04-1.08],ZNF804A,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:184947213
rs184538485-<b>A</b>,7 x 10-9,,'-,1.08,'-,[1.05-1.10],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32522589
rs75782365-<b>T</b>,8 x 10-24,,'-,1.21,'-,[1.16-1.25],BTN3A1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26408323
rs114115252-<b>?</b>,8 x 10-20,,'-,1.1627907,'-,[1.12-1.2],SFTA2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30931418
rs1024582-<b>A</b>,8 x 10-14,,'-,1.08,'-,[1.06-1.10],CACNA1C,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,12:2293080
rs2851447-<b>?</b>,8 x 10-12,,'-,1.0752687,'-,[1.05-1.1],MPHOSPH9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,12:123180566
rs1150688-<b>T</b>,8 x 10-11,,'-,1.07,'-,[1.05-1.09],"TOB2P1, ZNF192P2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28195002
rs189600472-<b>T</b>,8 x 10-11,,'-,1.12,'-,[1.08-1.16],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32526320
rs169738-<b>?</b>,8 x 10-10,,'-,1.0638298,'-,[1.04-1.09],GGNBP1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:33569769
rs115625073-<b>T</b>,9 x 10-14,,'-,1.11,'-,[1.08-1.14],"HCG4B, MCCD1P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29924456
rs12954356-<b>?</b>,9 x 10-10,,'-,1.0869565,'-,[1.05-1.11],TCF4,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,18:55586179
rs7907645-<b>T</b>,9 x 10-10,,'-,1.12,'-,[1.08-1.16],"TRIM8, ARL3",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,10:102664043
rs10520163-<b>T</b>,9 x 10-9,,'-,1.06,'-,[1.04-1.08],CLCN3,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,4:169705401
rs114810457-<b>A</b>,5 x 10-10,,'-,1.08,'-,[1.05-1.10],PBX2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32186508
rs17194490-<b>T</b>,5 x 10-10,,'-,1.09,'-,[1.06-1.12],CNTN4,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:2506102
rs145470632-<b>A</b>,5 x 10-10,,'-,1.12,'-,[1.08-1.16],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32525469
rs9267057-<b>?</b>,5 x 10-9,,'-,1.1627907,'-,[1.1-1.22],"MICA, LINC01149",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31429613
rs4309187-<b>?</b>,5 x 10-9,,'-,1.0638298,'-,[1.04-1.09],DRD2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:113541721
rs149544854-<b>?</b>,5 x 10-9,,'-,1.0638298,'-,[1.04-1.09],"MSH5-SAPCD1, MSH5",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31755003
rs116502302-<b>A</b>,5 x 10-9,,'-,1.08,'-,[1.05-1.11],"MUC21, MUC22",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31005088
rs191269336-<b>A</b>,5 x 10-9,,'-,1.09,'-,[1.06-1.12],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32521819
rs78696503-<b>?</b>,5 x 10-8,,'-,1.0752687,'-,[1.05-1.11],"RNU7-147P, SATB2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:199194489
rs9292918-<b>?</b>,5 x 10-8,,'-,1.0638298,'-,[1.04-1.1],HCN1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:45300933
rs9368481-<b>?</b>,5 x 10-8,,'-,1.0638298,'-,[1.04-1.09],LINC00240,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26993982
rs148820910-<b>?</b>,5 x 10-8,,'-,1.0638298,'-,[1.04-1.08],"LYPLA2P1, MYL12BP3",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:33343402
rs7837860-<b>?</b>,5 x 10-8,,'-,1.0638298,'-,[1.04-1.09],MMP16,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:88322031
rs7521492-<b>A</b>,5 x 10-8,,'-,1.06,'-,[1.04-1.08],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:163758686
rs7129727-<b>A</b>,5 x 10-8,,'-,1.06,'-,[1.04-1.08],TMX2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:57717188
rs4904167-<b>T</b>,5 x 10-8,,'-,1.06,'-,[1.04-1.08],MTCYBP27,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:84234400
rs7752643-<b>C</b>,5 x 10-8,,'-,1.06,'-,[1.03-1.08],SNAP91,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:83570556
rs190065944-<b>A</b>,5 x 10-8,,'-,1.07,'-,[1.05-1.10],CHRNA5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:78567268
rs72986630-<b>T</b>,5 x 10-8,,'-,1.14,'-,[1.09-1.20],ZNF823,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,19:11738921
rs115707823-<b>?</b>,6 x 10-18,,'-,1.1904762,'-,[1.14-1.23],"MICC, UBQLN1P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30374976
rs116633139-<b>?</b>,6 x 10-18,,'-,1.1627907,'-,[1.12-1.2],"MTCO3P1, HLA-DQB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32700133
rs2007044-<b>?</b>,6 x 10-14,,'-,1.0752687,'-,[1.05-1.1],CACNA1C,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,12:2235794
rs144660248-<b>?</b>,6 x 10-13,,'-,1.1764705,'-,[1.12-1.23],HLA-DRB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32583926
rs13218591-<b>T</b>,6 x 10-13,,'-,1.08,'-,[1.06-1.10],BTN3A2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26376604
rs114455101-<b>T</b>,6 x 10-13,,'-,1.15,'-,[1.11-1.20],HLA-DRB9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32465853
rs353547-<b>?</b>,4 x 10-8,,'-,1.0526316,'-,[1.03-1.08],TWF2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:52234850
rs880446-<b>A</b>,4 x 10-8,,'-,1.06,'-,[1.04-1.09],"PPDPF, EEF1A2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,20:63501824
rs2115780-<b>A</b>,4 x 10-8,,'-,1.06,'-,[1.04-1.08],RFT1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:53108964
rs114277634-<b>A</b>,4 x 10-8,,'-,1.06,'-,[1.04-1.08],HCP5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31474954
rs140849564-<b>A</b>,4 x 10-8,,'-,1.07,'-,[1.05-1.10],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32522830
rs76994193-<b>A</b>,4 x 10-8,,'-,1.09,'-,[1.06-1.12],MEF2C-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:89131520
rs114875775-<b>A</b>,4 x 10-8,,'-,1.13,'-,[1.08-1.17],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32521255
rs9348739-<b>?</b>,5 x 10-17,,'-,1.1363636,'-,[1.1-1.16],GUSBP2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26955320
rs116427960-<b>?</b>,5 x 10-16,,'-,1.1363636,'-,[1.1-1.16],"LINC02571, HLA-B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31351449
rs114963521-<b>?</b>,5 x 10-15,,'-,1.1494253,'-,[1.11-1.19],HCG20,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30791080
rs140502984-<b>T</b>,5 x 10-15,,'-,1.13,'-,[1.10-1.17],MICB-DT,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31481775
rs144911693-<b>?</b>,5 x 10-14,,'-,1.0869565,'-,[1.06-1.11],"RPSAP2, LINC00533",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28691630
rs145076523-<b>?</b>,5 x 10-13,,'-,1.098901,'-,[1.06-1.12],"FKBPL, PRRT1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32147408
rs55661361-<b>?</b>,5 x 10-13,,'-,1.0752687,'-,[1.05-1.1],NRGN,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:124744061
rs911186-<b>A</b>,5 x 10-13,,'-,1.09,'-,[1.07-1.12],"MIR3143, RPL10P2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27182820
rs144304366-<b>T</b>,5 x 10-13,,'-,1.11,'-,[1.08-1.15],"HLA-A, HLA-U",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29936216
rs186229361-<b>T</b>,5 x 10-12,,'-,1.15,'-,[1.11-1.20],HLA-DRB9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32468178
rs114204022-<b>?</b>,5 x 10-11,,'-,1.098901,'-,[1.06-1.12],"MICD, HCG9",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29972902
rs115165987-<b>?</b>,5 x 10-11,,'-,1.098901,'-,[1.06-1.12],"TSBP1-AS1, NOTCH4",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32239404
rs9636107-<b>?</b>,5 x 10-11,,'-,1.0638298,'-,[1.04-1.09],TCF4,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,18:55532886
rs41563-<b>A</b>,5 x 10-11,,'-,1.07,'-,[1.05-1.09],SRPK2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:105212207
rs1498232-<b>T</b>,5 x 10-10,,'-,1.07,'-,[1.05-1.09],LINC01648,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:29961104
rs8042374-<b>A</b>,5 x 10-10,,'-,1.07,'-,[1.05-1.10],CHRNA3,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:78615690
rs142520578-<b>A</b>,5 x 10-10,,'-,1.07,'-,[1.05-1.09],EHMT2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31894038
rs114771361-<b>A</b>,5 x 10-10,,'-,1.07,'-,[1.05-1.10],MTCO3P1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32706552
rs180778602-<b>?</b>,4 x 10-12,,'-,1.1494253,'-,[1.1-1.19],"RNU1-61P, HLA-DRB5",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32534622
rs707939-<b>A</b>,4 x 10-12,,'-,1.07,'-,[1.05-1.09],"MSH5-SAPCD1, MSH5",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31758911
rs2760981-<b>?</b>,4 x 10-11,,'-,1.0752687,'-,[1.05-1.1],"HLA-DRB1, HLA-DQA1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32597688
rs116067082-<b>A</b>,4 x 10-11,,'-,1.07,'-,[1.05-1.10],"HLA-C, HCG27",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31222761
rs142601889-<b>T</b>,4 x 10-11,,'-,1.1,'-,[1.07-1.13],"NOTCH4, TSBP1-AS1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32228798
rs147976543-<b>A</b>,4 x 10-11,,'-,1.1,'-,[1.07-1.13],"HLA-DRB6, HLA-DRB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32566867
rs116254153-<b>T</b>,4 x 10-11,,'-,1.11,'-,[1.07-1.14],"TSBP1-AS1, TSBP1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32371870
rs12826178-<b>?</b>,4 x 10-10,,'-,1.1494253,'-,[1.1-1.2],"NXPH4, SHMT2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,12:57228588
rs2237234-<b>?</b>,4 x 10-10,,'-,1.0752687,'-,[1.05-1.1],BTN2A2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26391166
rs11210892-<b>?</b>,4 x 10-10,,'-,1.0638298,'-,[1.04-1.09],"PTPRF, KDM4A",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:43634413
rs8054556-<b>?</b>,4 x 10-10,,'-,1.0638298,'-,[1.04-1.09],TMEM219,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,16:29946895
rs67756423-<b>A</b>,4 x 10-10,,'-,1.08,'-,[1.05-1.10],TSNARE1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:142252164
rs17659437-<b>?</b>,4 x 10-9,,'-,1.0869565,'-,[1.05-1.12],"BRINP2, LINC01645",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:177337251
rs11641947-<b>?</b>,4 x 10-9,,'-,1.0869565,'-,[1.05-1.11],"SLC38A7, CNOT1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,16:58636004
rs139099016-<b>?</b>,4 x 10-9,,'-,1.0869565,'-,[1.05-1.11],"DHFRP2, HLA-B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31361514
rs72687362-<b>?</b>,4 x 10-9,,'-,1.0752687,'-,[1.05-1.1],TSNARE1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:142276955
rs57709857-<b>?</b>,4 x 10-9,,'-,1.0752687,'-,[1.05-1.1],FGFR1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:38432906
rs11210195-<b>?</b>,4 x 10-9,,'-,1.0638298,'-,[1.04-1.08],"RN7SKP19, LINC01360",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:73283600
rs3020736-<b>?</b>,4 x 10-9,,'-,1.0638298,'-,[1.04-1.09],CYP2D7,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,22:42141117
rs12592967-<b>T</b>,4 x 10-9,,'-,1.06,'-,[1.04-1.08],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:61578744
rs5995756-<b>T</b>,4 x 10-9,,'-,1.06,'-,[1.04-1.08],CACNA1I,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,22:39604308
rs385492-<b>T</b>,4 x 10-9,,'-,1.06,'-,[1.04-1.08],"ZFP57, ZDHHC20P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29681770
rs115443066-<b>A</b>,4 x 10-9,,'-,1.08,'-,[1.05-1.11],HLA-DQA1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32646583
rs7122181-<b>?</b>,4 x 10-8,,'-,1.0526316,'-,[1.03-1.08],MTND4LP18,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:81491868
rs221902-<b>?</b>,4 x 10-8,,'-,1.0526316,'-,[1.04-1.08],PCNX1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:71134362
rs115963308-<b>?</b>,3 x 10-8,,'-,1.0752687,'-,[1.04-1.1],NOTCH4,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32223264
rs149961934-<b>?</b>,3 x 10-8,,'-,1.0752687,'-,[1.04-1.1],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32520992
rs61847307-<b>?</b>,3 x 10-8,,'-,1.0638298,'-,[1.04-1.09],PRKG1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,10:52184682
rs146827975-<b>?</b>,3 x 10-8,,'-,1.0638298,'-,[1.04-1.09],PBX2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32185632
rs1339227-<b>?</b>,3 x 10-8,,'-,1.0638298,'-,[1.04-1.08],RIMS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:72445999
rs36350-<b>?</b>,3 x 10-8,,'-,1.0526316,'-,[1.03-1.08],RGS6,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:71920923
rs7432375-<b>?</b>,3 x 10-8,,'-,1.0526316,'-,[1.03-1.08],STAG1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:136569563
rs28758902-<b>T</b>,3 x 10-8,,'-,1.06,'-,[1.04-1.08],"LINC01415, TCF4",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,18:55740956
rs760648-<b>A</b>,3 x 10-8,,'-,1.06,'-,[1.04-1.08],TCF20,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,22:42175022
rs427691-<b>A</b>,3 x 10-8,,'-,1.06,'-,[1.04-1.09],"KRT18P42, MAN2A1-DT",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:109678809
rs2293751-<b>A</b>,3 x 10-8,,'-,1.06,'-,[1.04-1.08],"C2-AS1, C2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31940060
rs182087722-<b>A</b>,3 x 10-8,,'-,1.09,'-,[1.06-1.13],ZSCAN16-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28044305
rs73416724-<b>A</b>,3 x 10-8,,'-,1.09,'-,[1.06-1.13],"ZNF318, ABCC10",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:43370064
rs61884307-<b>C</b>,3 x 10-8,,'-,1.1,'-,[1.06-1.13],F2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:46733838
rs141342723-<b>T</b>,4 x 10-24,,'-,1.2,'-,[1.16-1.24],"LINC01012, RPL8P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27654305
rs114276265-<b>?</b>,4 x 10-16,,'-,1.098901,'-,[1.08-1.12],"HLA-C, HCG27",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31219298
rs9269271-<b>T</b>,4 x 10-15,,'-,1.11,'-,[1.08-1.14],"HLA-DRB6, HLA-DRB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32571330
rs7752195-<b>?</b>,4 x 10-14,,'-,1.1627907,'-,[1.12-1.22],"CARMIL1, CMAHP",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:25418866
rs115497191-<b>?</b>,4 x 10-14,,'-,1.1627907,'-,[1.12-1.22],HLA-DMB,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32936262
rs116676919-<b>?</b>,4 x 10-14,,'-,1.1494253,'-,[1.11-1.19],"TRIM31-AS1, TRIM31",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30112719
rs11191582-<b>?</b>,4 x 10-14,,'-,1.1363636,'-,[1.1-1.18],NT5C2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,10:103153896
rs115344853-<b>A</b>,4 x 10-14,,'-,1.12,'-,[1.08-1.15],NOTCH4,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32197667
rs9274299-<b>?</b>,4 x 10-13,,'-,1.1111112,'-,[1.08-1.14],HLA-DQB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32664181
rs138984909-<b>A</b>,4 x 10-13,,'-,1.14,'-,[1.10-1.19],HLA-DRB9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32466042
rs114882497-<b>T</b>,2 x 10-16,,'-,1.13,'-,[1.10-1.17],"HLA-DRA, TSBP1-AS1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32423415
rs114867672-<b>T</b>,2 x 10-16,,'-,1.15,'-,[1.11-1.18],"MUC21, NAPGP2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30964067
rs114964506-<b>?</b>,2 x 10-15,,'-,1.1494253,'-,[1.11-1.18],LINC00243,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30814428
rs111639056-<b>?</b>,2 x 10-15,,'-,1.1494253,'-,[1.11-1.19],"HLA-DRB6, HLA-DRB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32570699
rs6939532-<b>?</b>,2 x 10-15,,'-,1.1235955,'-,[1.09-1.15],"HMGN4, HCG11",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26533796
rs6940116-<b>A</b>,2 x 10-15,,'-,1.11,'-,[1.08-1.14],"RSL24D1P1, GPR89P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27740953
rs116663187-<b>A</b>,2 x 10-15,,'-,1.11,'-,[1.08-1.14],ZBED9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28610509
rs9274390-<b>T</b>,2 x 10-14,,'-,1.13,'-,[1.09-1.16],HLA-DQB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32664882
rs184153866-<b>A</b>,2 x 10-13,,'-,1.1,'-,[1.08-1.13],"HLA-DRB5, HLA-DRB9",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32514520
rs115558405-<b>A</b>,2 x 10-13,,'-,1.12,'-,[1.09-1.15],"TSBP1-AS1, TSBP1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32368989
rs35225200-<b>?</b>,2 x 10-12,,'-,1.1363636,'-,[1.1-1.18],SLC39A8,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,4:102225731
rs114950038-<b>?</b>,2 x 10-12,,'-,1.098901,'-,[1.08-1.12],"DDX39BP2, HCG9",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29983056
rs140865314-<b>?</b>,2 x 10-12,,'-,1.098901,'-,[1.08-1.12],PBX2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32185629
rs4129585-<b>A</b>,2 x 10-12,,'-,1.07,'-,[1.05-1.09],TSNARE1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:142231572
rs12887734-<b>T</b>,2 x 10-12,,'-,1.08,'-,[1.06-1.10],"KLC1, COA8",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:103580497
rs36057735-<b>C</b>,2 x 10-12,,'-,1.1,'-,[1.07-1.13],"LINC02571, HLA-B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31352146
rs115052633-<b>C</b>,2 x 10-12,,'-,1.1,'-,[1.07-1.13],PRRC2A,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31621487
rs186129480-<b>T</b>,2 x 10-12,,'-,1.1,'-,[1.07-1.13],"HLA-DQA1, HLA-DRB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32627606
rs2507989-<b>A</b>,2 x 10-12,,'-,1.11,'-,[1.08-1.14],HLA-B,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31356638
rs193267147-<b>?</b>,2 x 10-11,,'-,1.2195122,'-,[1.15-1.28],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32528783
rs41293179-<b>?</b>,2 x 10-11,,'-,1.1111112,'-,[1.08-1.14],HLA-DRB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32582101
rs200986-<b>?</b>,2 x 10-11,,'-,1.098901,'-,[1.06-1.12],"H2BC15, H2BC16P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27856988
rs34787248-<b>?</b>,2 x 10-11,,'-,1.0869565,'-,[1.06-1.12],ZSCAN9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28230108
rs140364877-<b>?</b>,2 x 10-11,,'-,1.0869565,'-,[1.06-1.11],MAD1L1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:1845542
rs13240464-<b>T</b>,2 x 10-11,,'-,1.07,'-,[1.05-1.09],IMMP2L,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:111258859
rs369637-<b>?</b>,2 x 10-10,,'-,1.098901,'-,[1.06-1.12],TNXB,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32058086
rs114291394-<b>?</b>,2 x 10-10,,'-,1.0752687,'-,[1.05-1.1],"MICA, HLA-S",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31383745
rs11740474-<b>?</b>,2 x 10-10,,'-,1.0638298,'-,[1.04-1.09],GALNT10,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:154301187
rs12925872-<b>T</b>,2 x 10-10,,'-,1.08,'-,[1.05-1.10],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,16:13658499
rs116460775-<b>T</b>,2 x 10-10,,'-,1.08,'-,[1.06-1.11],"NOTCH4, TSBP1-AS1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32243308
rs114838832-<b>A</b>,2 x 10-10,,'-,1.09,'-,[1.06-1.11],"SFTA2, MUCL3",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30937536
rs115915654-<b>?</b>,2 x 10-9,,'-,1.098901,'-,[1.06-1.12],LINC00243,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30801949
rs11223651-<b>?</b>,2 x 10-9,,'-,1.0752687,'-,[1.05-1.1],"IGSF9B, LINC02730",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:133971139
rs62378245-<b>?</b>,2 x 10-9,,'-,1.0752687,'-,[1.05-1.1],MEF2C-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:89448145
rs8009147-<b>?</b>,2 x 10-9,,'-,1.0638298,'-,[1.04-1.09],PPP1R13B,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:103798325
rs7191183-<b>?</b>,2 x 10-9,,'-,1.0638298,'-,[1.04-1.09],GRIN2A,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,16:9806200
rs4391122-<b>?</b>,2 x 10-9,,'-,1.0638298,'-,[1.04-1.08],LINC02057,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:61302716
rs77502336-<b>C</b>,2 x 10-9,,'-,1.06,'-,[1.04-1.09],GRAMD1B,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:123523928
rs3849046-<b>T</b>,2 x 10-9,,'-,1.06,'-,[1.04-1.08],ETF1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:138515503
rs2332700-<b>C</b>,2 x 10-9,,'-,1.07,'-,[1.05-1.09],RGS6,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,14:71950609
rs1131275-<b>C</b>,2 x 10-9,,'-,1.07,'-,[1.05-1.09],HLA-B,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31356183
rs61747867-<b>T</b>,2 x 10-9,,'-,1.08,'-,[1.05-1.11],H2AC10P,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26272320
rs116047537-<b>T</b>,2 x 10-9,,'-,1.08,'-,[1.05-1.11],"HLA-DRA, TSBP1-AS1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32413695
rs41293330-<b>T</b>,2 x 10-9,,'-,1.09,'-,[1.06-1.12],"HLA-DRB1, HLA-DRB6",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32574236
rs61789073-<b>T</b>,2 x 10-9,,'-,1.12,'-,[1.08-1.17],"DPYD, MIR137HG",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:97938540
rs12443170-<b>?</b>,2 x 10-8,,'-,1.098901,'-,[1.06-1.12],CHRNA3,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:78615394
rs114441450-<b>?</b>,2 x 10-8,,'-,1.0869565,'-,[1.05-1.11],TUBB,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30719037
rs146201420-<b>?</b>,2 x 10-8,,'-,1.0869565,'-,[1.05-1.11],"HLA-S, MICA",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31390620
rs184981897-<b>?</b>,2 x 10-8,,'-,1.0869565,'-,[1.05-1.11],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32519189
rs138850297-<b>?</b>,2 x 10-8,,'-,1.0752687,'-,[1.04-1.1],"PSMB9, PPP1R2P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32875944
rs1782810-<b>A</b>,1 x 10-19,,'-,1.12,'-,[1.09-1.15],MIR137HG,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:98036784
rs6921919-<b>C</b>,1 x 10-19,,'-,1.12,'-,[1.09-1.14],ZKSCAN3,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28357424
rs11191419-<b>?</b>,1 x 10-16,,'-,1.0869565,'-,[1.06-1.11],"BORCS7, PTGES3P4",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,10:102852578
rs115242751-<b>T</b>,1 x 10-16,,'-,1.17,'-,[1.13-1.22],TRIM10,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30154846
rs114041423-<b>?</b>,1 x 10-15,,'-,1.1111112,'-,[1.09-1.14],"SUMO2P1, MOG",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29639270
rs115035678-<b>A</b>,1 x 10-14,,'-,1.14,'-,[1.10-1.18],TSBP1-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32381780
rs9273177-<b>?</b>,1 x 10-13,,'-,1.1363636,'-,[1.1-1.16],HLA-DQA1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32645524
rs61472021-<b>T</b>,1 x 10-13,,'-,1.12,'-,[1.09-1.15],HFE,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26089797
rs144649399-<b>?</b>,1 x 10-12,,'-,1.1111112,'-,[1.08-1.15],"OR2J3, OR2J2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29150075
rs114086406-<b>?</b>,1 x 10-12,,'-,1.1111112,'-,[1.08-1.14],TSBP1-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32374760
rs11682175-<b>?</b>,1 x 10-12,,'-,1.0752687,'-,[1.05-1.09],ACTG1P22,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:57760458
rs142972412-<b>T</b>,1 x 10-12,,'-,1.09,'-,[1.06-1.12],"HLA-DRB5, HLA-DRB9",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32487060
rs138748649-<b>T</b>,1 x 10-12,,'-,1.12,'-,[1.08-1.15],"TSBP1-AS1, NOTCH4",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32242482
rs144532965-<b>?</b>,1 x 10-11,,'-,1.1111112,'-,[1.08-1.14],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32522018
rs75968099-<b>T</b>,1 x 10-11,,'-,1.07,'-,[1.05-1.09],"LINC02033, HSPD1P6",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:36817092
rs115661163-<b>T</b>,1 x 10-11,,'-,1.09,'-,[1.06-1.12],OR5V1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29369298
rs111312615-<b>T</b>,1 x 10-11,,'-,1.12,'-,[1.08-1.15],"HLA-A, HLA-W",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29955302
rs117616320-<b>?</b>,1 x 10-10,,'-,1.098901,'-,[1.06-1.12],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32526927
rs12704290-<b>?</b>,1 x 10-10,,'-,1.098901,'-,[1.08-1.14],"GRM3-AS1, GRM3",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:86798310
rs4702-<b>?</b>,1 x 10-10,,'-,1.0638298,'-,[1.04-1.09],FURIN,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:90883330
rs2176546-<b>C</b>,1 x 10-10,,'-,1.07,'-,[1.05-1.09],VRK2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:57929637
rs149787317-<b>T</b>,1 x 10-10,,'-,1.09,'-,[1.06-1.12],HLA-DQA1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32631878
rs6855246-<b>?</b>,1 x 10-9,,'-,1.1363636,'-,[1.1-1.19],SLC39A8,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,4:102191313
rs72934570-<b>?</b>,1 x 10-9,,'-,1.1235955,'-,[1.09-1.16],"LINC01416, LINC01415",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,18:55865958
rs147793969-<b>?</b>,1 x 10-9,,'-,1.1111112,'-,[1.08-1.15],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32526115
rs115487448-<b>?</b>,1 x 10-9,,'-,1.0869565,'-,[1.06-1.12],MUC22,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31025536
rs150430679-<b>T</b>,3 x 10-13,,'-,1.12,'-,[1.09-1.15],HCG20,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30762562
rs1899546-<b>?</b>,1 x 10-9,,'-,1.0638298,'-,[1.04-1.08],Y_RNA,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:24377044
rs6071524-<b>?</b>,1 x 10-9,,'-,1.0638298,'-,[1.04-1.09],"ACTR5, PPP1R16B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,20:38797937
rs11874716-<b>T</b>,1 x 10-9,,'-,1.06,'-,[1.04-1.08],LINC01929,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,18:55083457
rs72761442-<b>A</b>,1 x 10-9,,'-,1.08,'-,[1.05-1.10],ZSWIM6,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:61400496
rs3132556-<b>A</b>,1 x 10-9,,'-,1.08,'-,[1.05-1.11],"RNU6-1133P, C6orf15",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31111032
rs116139966-<b>C</b>,1 x 10-9,,'-,1.08,'-,[1.06-1.11],HLA-DQA1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32635879
rs139547629-<b>T</b>,1 x 10-9,,'-,1.09,'-,[1.06-1.12],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32518167
rs28724212-<b>A</b>,1 x 10-9,,'-,1.14,'-,[1.09-1.19],HLA-DRB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32588824
rs145607970-<b>?</b>,1 x 10-8,,'-,1.1363636,'-,[1.09-1.19],"HLA-DQB1, HLA-DQA1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32656240
rs115569272-<b>?</b>,1 x 10-8,,'-,1.0869565,'-,[1.05-1.12],"HLA-DOA, BRD2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32995105
rs116552815-<b>?</b>,1 x 10-8,,'-,1.0752687,'-,[1.05-1.1],DDR1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30888130
rs6803008-<b>?</b>,1 x 10-8,,'-,1.0638298,'-,[1.04-1.08],FOXP1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:71522194
rs35998080-<b>T</b>,1 x 10-8,,'-,1.06,'-,[1.04-1.08],LINC02797,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,1:72812932
rs10791097-<b>T</b>,1 x 10-8,,'-,1.06,'-,[1.04-1.08],LINC02551,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:130848735
rs10791111-<b>T</b>,1 x 10-8,,'-,1.06,'-,[1.04-1.08],"RN7SL167P, SNX19",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:130986204
rs2944591-<b>T</b>,1 x 10-8,,'-,1.06,'-,[1.04-1.09],NGEF,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:232930111
rs1353545-<b>C</b>,1 x 10-8,,'-,1.06,'-,[1.04-1.08],FHIT,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:60302116
rs9274657-<b>A</b>,1 x 10-8,,'-,1.07,'-,[1.04-1.09],"MTCO3P1, HLA-DQB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32668587
rs115437294-<b>A</b>,1 x 10-8,,'-,1.08,'-,[1.05-1.10],"LINC02571, HLA-B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31345265
rs133047-<b>T</b>,1 x 10-8,,'-,1.1,'-,[1.06-1.14],MRTFA,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,22:40631815
rs115329265-<b>A</b>,2 x 10-27,,'-,1.17,'-,[1.14-1.21],"NOP56P1, RPSAP2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28744470
rs116326873-<b>A</b>,2 x 10-17,,'-,1.13,'-,[1.10-1.16],"HLA-G, HCP5B",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29842049
rs116385615-<b>T</b>,2 x 10-16,,'-,1.12,'-,[1.09-1.16],C2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31913532
rs115937317-<b>C</b>,3 x 10-12,,'-,1.09,'-,[1.07-1.12],OR5V1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29387425
rs144018888-<b>T</b>,3 x 10-12,,'-,1.11,'-,[1.08-1.15],"HLA-V, IFITM4P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:29783215
rs182908437-<b>?</b>,3 x 10-11,,'-,1.1494253,'-,[1.1-1.2],"HLA-DRB5, RNU1-61P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32542425
rs149721896-<b>?</b>,3 x 10-11,,'-,1.1111112,'-,[1.08-1.14],"HLA-DRA, TSBP1-AS1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32410726
rs6434928-<b>?</b>,3 x 10-11,,'-,1.0752687,'-,[1.05-1.09],"RNU6-1029P, SF3B1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:197439853
rs4713071-<b>A</b>,3 x 10-11,,'-,1.09,'-,[1.07-1.12],"RPL10P2, PRSS16",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27220140
rs11753207-<b>A</b>,3 x 10-11,,'-,1.1,'-,[1.07-1.13],HLA-DRB1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32584671
rs191843781-<b>T</b>,3 x 10-11,,'-,1.14,'-,[1.09-1.18],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32525190
rs116182620-<b>A</b>,3 x 10-11,,'-,1.19,'-,[1.13-1.25],"HLA-DRB5, HLA-DRB9",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32511744
rs114812317-<b>?</b>,3 x 10-10,,'-,1.1363636,'-,[1.09-1.18],"HLA-DRB5, RNU1-61P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32531497
rs9469174-<b>?</b>,3 x 10-10,,'-,1.098901,'-,[1.06-1.12],HLA-DRB6,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32557141
rs7801375-<b>?</b>,3 x 10-10,,'-,1.0869565,'-,[1.06-1.12],CAPZA1P4,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:131882504
rs114508985-<b>?</b>,3 x 10-10,,'-,1.0752687,'-,[1.05-1.11],"HLA-DMB, HLA-Z",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32932241
rs6704768-<b>?</b>,3 x 10-10,,'-,1.0638298,'-,[1.04-1.09],GIGYF2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:232727791
rs4580973-<b>A</b>,3 x 10-10,,'-,1.06,'-,[1.04-1.09],SRPK2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,7:105263212
rs147875011-<b>T</b>,3 x 10-10,,'-,1.08,'-,[1.05-1.10],"HLA-DQB1, MTCO3P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32668836
rs7893279-<b>T</b>,3 x 10-10,,'-,1.1,'-,[1.07-1.14],CACNB2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,10:18456176
rs56223946-<b>?</b>,3 x 10-9,,'-,1.098901,'-,[1.06-1.14],"EPHX2, GULOP",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:27556469
rs2434529-<b>?</b>,3 x 10-9,,'-,1.0752687,'-,[1.05-1.1],GALNT10,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:154260486
rs115641444-<b>C</b>,3 x 10-9,,'-,1.1,'-,[1.06-1.13],"HLA-DRB9, HLA-DRB5",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32517285
rs149998036-<b>A</b>,3 x 10-9,,'-,1.12,'-,[1.08-1.16],HLA-DRB9,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32470272
rs184123737-<b>T</b>,3 x 10-9,,'-,1.13,'-,[1.08-1.17],"HLA-DRB6, HLA-DRB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32569865
rs188190243-<b>?</b>,3 x 10-8,,'-,1.1111112,'-,[1.08-1.15],"HLA-DRB9, HLA-DRB5",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32510807
rs41294271-<b>?</b>,3 x 10-8,,'-,1.1111112,'-,[1.06-1.15],"HLA-DRB6, HLA-DRB1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32575798
rs114830752-<b>?</b>,3 x 10-8,,'-,1.0869565,'-,[1.06-1.12],"HLA-DQB3, MTCO3P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32715035
rs8032315-<b>?</b>,2 x 10-8,,'-,1.0638298,'-,[1.04-1.09],FURIN,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,15:90875067
rs7184114-<b>?</b>,2 x 10-8,,'-,1.0638298,'-,[1.04-1.08],CNOT1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,16:58551465
rs115136442-<b>?</b>,2 x 10-8,,'-,1.0638298,'-,[1.04-1.09],"RNU6-1133P, C6orf15",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31086734
rs2767713-<b>?</b>,2 x 10-8,,'-,1.0638298,'-,[1.04-1.09],DDX10P2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,9:82184622
rs2828478-<b>A</b>,2 x 10-8,,'-,1.06,'-,[1.04-1.08],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,21:23732894
rs9879311-<b>T</b>,2 x 10-8,,'-,1.06,'-,[1.04-1.08],ATP2B2,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:10373659
rs114142645-<b>T</b>,2 x 10-8,,'-,1.06,'-,[1.04-1.09],"HCG27, HLA-C",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31245806
rs111977918-<b>A</b>,2 x 10-8,,'-,1.06,'-,[1.04-1.09],"HLA-C, HCG27",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31268274
rs7819570-<b>T</b>,2 x 10-8,,'-,1.07,'-,[1.05-1.10],'-,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,8:88576397
rs112209031-<b>T</b>,2 x 10-8,,'-,1.09,'-,[1.06-1.13],HLA-DRB5,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32524630
rs116137698-<b>A</b>,3 x 10-26,,'-,1.22,'-,[1.17-1.26],"RPSAP2, LINC00533",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28699892
rs12522290-<b>C</b>,2 x 10-8,,'-,1.08,'-,[1.05-1.11],GRIA1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,5:153418096
rs9467711-<b>A</b>,3 x 10-19,,'-,1.16,'-,[1.12-1.19],"H3C9P, BTN3A2",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:26332377
rs144762289-<b>?</b>,3 x 10-17,,'-,1.1627907,'-,[1.12-1.2],"HCG27, HLA-C",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31229085
rs202906-<b>T</b>,3 x 10-16,,'-,1.13,'-,[1.10-1.17],ZSCAN16-AS1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:28043874
rs13212562-<b>A</b>,3 x 10-16,,'-,1.14,'-,[1.11-1.18],"VN1R10P, ZNF204P",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:27332531
rs114904464-<b>?</b>,3 x 10-15,,'-,1.1363636,'-,[1.1-1.16],"ZDHHC20P2, FGFR3P1",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31380300
rs145547914-<b>?</b>,3 x 10-15,,'-,1.1235955,'-,[1.1-1.16],"TSBP1-AS1, NOTCH4",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32238466
rs78110044-<b>?</b>,3 x 10-14,,'-,1.2195122,'-,[1.15-1.28],HLA-DRB6,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:32559333
rs150680405-<b>?</b>,3 x 10-14,,'-,1.1627907,'-,[1.11-1.2],"HCG27, HLA-C",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31255998
rs115687605-<b>?</b>,3 x 10-13,,'-,1.1494253,'-,[1.1-1.19],"UBQLN1P1, MICC",Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:30397852
rs35324223-<b>?</b>,3 x 10-13,,'-,1.098901,'-,[1.08-1.12],MDK,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,11:46381302
rs3617-<b>?</b>,3 x 10-12,,'-,1.0752687,'-,[1.05-1.09],ITIH3,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,3:52799789
rs114274203-<b>T</b>,3 x 10-12,,'-,1.08,'-,[1.06-1.10],LINC02571,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,6:31300843
rs281768-<b>A</b>,3 x 10-12,,'-,1.09,'-,[1.06-1.11],MAIP1,Autism spectrum disorder or schizophrenia,"schizophrenia, autism spectrum disorder",GCST004521,2:199960517
rs929626-<b>?</b>,2 x 10-7,,'-,1.4277556,'-,[1.25-1.63],EBF1,Anorexia nervosa (excluding migration to or from binge-eating disorder or bulimia nervosa),anorexia nervosa,GCST004585,5:158883623
rs144481999-<b>T</b>,4 x 10-8,,NR,'-,0.079 unit increase,[0.052-0.106],ARHGAP25,Nicotine dependence,nicotine dependence,GCST011754,2:68746800
rs2714674-<b>T</b>,7 x 10-9,,NR,'-,0.018 unit increase,[0.012-0.024],GNAI1,Nicotine dependence,nicotine dependence,GCST011754,7:79755934
rs4950-<b>A</b>,2 x 10-9,,NR,'-,0.022 unit increase,[0.015-0.029],CHRNB3,Nicotine dependence,nicotine dependence,GCST011754,8:42697490
rs56116178-<b>A</b>,2 x 10-13,,NR,'-,0.04 unit decrease,[0.029-0.051],FAM163B,Nicotine dependence,nicotine dependence,GCST011754,9:133595102
rs8034191-<b>T</b>,1 x 10-70,,NR,'-,0.06 unit decrease,[0.053-0.067],'-,Nicotine dependence,nicotine dependence,GCST011754,Mapping not available
rs56113850-<b>T</b>,4 x 10-16,,NR,'-,0.031 unit decrease,[0.023-0.039],CYP2A6,Nicotine dependence,nicotine dependence,GCST011754,19:40847202
rs6011779-<b>T</b>,4 x 10-16,,NR,'-,0.031 unit decrease,[0.023-0.039],CHRNA4,Nicotine dependence,nicotine dependence,GCST011754,20:63352965
rs7783012-<b>A</b>,2 x 10-9,,'-,'-,'-,'-,FOXP2,Cannabis use disorder,cannabis dependence,GCST011179,7:114476826
rs7783012-<b>A</b>,2 x 10-9,(EA),'-,1.11,'-,[1.07-1.15],FOXP2,Cannabis use disorder,cannabis dependence,GCST011179,7:114476826
rs4732724-<b>C</b>,3 x 10-9,,'-,'-,'-,'-,GULOP,Cannabis use disorder,cannabis dependence,GCST011179,8:27565545
rs4732724-<b>C</b>,6 x 10-9,(EA),'-,0.89,'-,[0.85-0.93],GULOP,Cannabis use disorder,cannabis dependence,GCST011179,8:27565545
rs2898883-<b>?</b>,2 x 10-8,(Repetitive use of objects),NR,'-,'-,'-,PHB,Restricted and repetitive behaviours in autism spectrum disorder,"autism spectrum disorder, behavior or behavioral disorder measurement",GCST004377,17:49405591
rs1372680-<b>A</b>,3 x 10-6,,0.08583,1.482,'-,'-,"ADH1B, ADH7",Alcohol dependence,alcohol dependence,GCST004756,4:99383388
rs1789924-<b>T</b>,1 x 10-7,,0.387,1.314,'-,'-,"ADH7, ADH1B",Alcohol dependence,alcohol dependence,GCST004756,4:99353129
rs1789891-<b>A</b>,2 x 10-8,,0.1407,1.469,'-,'-,ADH1B,Alcohol dependence,alcohol dependence,GCST004756,4:99329262
rs1000579-<b>G</b>,2 x 10-7,,0.3981,1.315,'-,'-,STX18-AS1,Alcohol dependence,alcohol dependence,GCST004756,4:4717767
rs6809441-<b>?</b>,6 x 10-6,,0.6626,1.29,'-,'-,ULK4,Alcohol dependence,alcohol dependence,GCST004756,3:41453114
rs2066702-<b>G</b>,5 x 10-24,(AA),0.193,1.1889193,'-,[1.16-1.22],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99307860
rs1154433-<b>G</b>,1 x 10-14,(EA),0.596,1.0699764,'-,[1.05-1.09],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99332551
rs11075992-<b>T</b>,2 x 10-10,(EA),0.395,1.056859,'-,[1.04-1.07],FTO,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,16:53786154
rs13107325-<b>C</b>,3 x 10-14,(EA),0.921,1.1325,'-,[1.1-1.16],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs17125651-<b>C</b>,8 x 10-9,(EA),0.134,1.074,'-,[1.05-1.1],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,10:109063325
rs4715221-<b>A</b>,1 x 10-8,(EA),0.698,1.0546,'-,[1.04-1.07],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,6:51495005
rs4936277-<b>A</b>,3 x 10-11,(EA),0.56,1.059,'-,[1.04-1.08],DRD2,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,11:113561238
rs1229984-<b>C</b>,6 x 10-17,(Latino),0.938,1.7746,'-,[1.64-1.91],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99318162
rs1229984-<b>C</b>,5 x 10-85,,0.969,'-,19.54 z score increase,NR,ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99318162
rs1612735-<b>T</b>,8 x 10-19,,0.656,'-,8.86 z score decrease,NR,"ADH1B, ADH1C",Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99336850
rs13107325-<b>C</b>,3 x 10-14,,0.937,'-,7.6 z score increase,NR,'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs9378160-<b>C</b>,2 x 10-8,(Latino),0.719,1.1890606,'-,[1.13-1.25],MICB,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,6:31500215
rs570436-<b>T</b>,2 x 10-10,(EA),0.423,1.0577533,'-,[1.04-1.08],LINC01833,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,2:44915534
rs72716801-<b>G</b>,5 x 10-8,"(AA, women)",0.968,1.886,'-,[1.66-2.11],CASC11,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,8:127636481
rs72900220-<b>A</b>,3 x 10-9,(AA),0.961,1.2376,'-,[1.17-1.31],"BTF3P13, TSPAN5",Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:98671846
rs1229984-<b>C</b>,5 x 10-74,(EA),0.97,1.742,'-,[1.68-1.8],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99318162
rs1260326-<b>C</b>,1 x 10-16,(EA),0.591,1.0749,'-,[1.06-1.09],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs141424017-<b>T</b>,3 x 10-8,(EA),0.222,1.059,'-,[1.04-1.08],LINC01392,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,7:115311377
rs1260326-<b>C</b>,2 x 10-13,,0.651,'-,7.33 z score increase,NR,'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs4936277-<b>A</b>,1 x 10-13,,0.599,'-,7.44 z score increase,NR,DRD2,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,11:113561238
rs1421085-<b>T</b>,2 x 10-11,,0.67,'-,6.69 z score increase,NR,FTO,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,16:53767042
rs540606-<b>A</b>,9 x 10-11,,0.409,'-,6.49 z score decrease,NR,"LINC01833, LINC00299",Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,2:44911368
rs5860563-<b>?</b>,1 x 10-9,,0.722,'-,6.21 z score decrease,NR,ADH4,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99126007
rs7906104-<b>T</b>,3 x 10-9,,0.271,'-,5.98 z score decrease,NR,LINC02661,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,10:108737343
rs61902812-<b>A</b>,2 x 10-8,,0.306,'-,5.59 z score decrease,NR,DRD2,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,11:113503698
rs1229984-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,ADH1B,Alcohol dependence,alcohol dependence,GCST008284,4:99318162
rs2165472-<b>C</b>,4 x 10-6,,NR,3.71,'-,[2.13-6.48],TLR10,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,4:60075606
rs35872837-<b>?</b>,4 x 10-6,,NR,2.0408163,'-,[1.52-2.78],'-,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,5:51694846
rs723840-<b>C</b>,4 x 10-6,,NR,1.63,'-,[1.33-2.00],CMTM5,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,14:23379102
rs2109112-<b>T</b>,4 x 10-6,,NR,1.7,'-,[1.36-2.13],PARP11-AS1,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,12:3878307
rs117358046-<b>T</b>,4 x 10-6,,NR,4.65,'-,[2.42-8.94],IFT43,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,14:76050199
rs3087749-<b>?</b>,8 x 10-6,,NR,1.6393442,'-,[1.32-2],FOXK1,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,7:4740883
rs13236432-<b>C</b>,8 x 10-6,,NR,1.77,'-,[1.38-2.27],"OR9A3P, PRSS37",Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,7:141850980
rs113365723-<b>A</b>,9 x 10-6,,NR,5.61,'-,[2.62-12.00],ERAP1,Emotional lability in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, mood instability measurement",GCST007880,5:96789227
rs10392-<b>A</b>,8 x 10-7,,0.1801,1.252,'-,'-,PPP1R16B,Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis,"alcoholic liver cirrhosis, alcohol dependence, alcoholic pancreatitis",GCST004757,20:38922292
rs454510-<b>A</b>,3 x 10-6,,0.02702,1.206,'-,'-,PHGDH,Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis,"alcoholic liver cirrhosis, alcohol dependence, alcoholic pancreatitis",GCST004757,1:119652419
rs2028201-<b>T</b>,5 x 10-6,,0.3763,1.183,'-,'-,SPATS2L,Alcohol dependence or chronic alcoholic pancreatitis or alcohol-related liver cirrhosis,"alcoholic liver cirrhosis, alcohol dependence, alcoholic pancreatitis",GCST004757,2:200438287
rs2075650-<b>?</b>,2 x 10-7,,'-,1.5,'-,[NR],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST006121,19:44892362
rs2075650-<b>?</b>,5 x 10-7,,NR,1.5,'-,[NR],TOMM40,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST006120,19:44892362
rs10496731-<b>G</b>,2 x 10-8,,0.48,'-,'-,'-,"CCNT2-AS1, ACMSD",Alzheimer's disease or body fat percentage (pleiotropy),"Alzheimer's disease, body fat percentage",GCST90013832,2:134840058
rs442495-<b>T</b>,2 x 10-10,,0.65,'-,'-,'-,ADAM10,Alzheimer's disease or diastolic blood pressure (pleiotropy),"Alzheimer's disease, diastolic blood pressure",GCST90013835,15:58730416
rs4308-<b>G</b>,7 x 10-15,,0.63,'-,'-,'-,ACE,Alzheimer's disease or diastolic blood pressure (pleiotropy),"Alzheimer's disease, diastolic blood pressure",GCST90013835,17:63482264
rs144867634-<b>T</b>,8 x 10-8,,0.98,'-,'-,'-,DOCK4,Alzheimer's disease or diastolic blood pressure (pleiotropy),"Alzheimer's disease, diastolic blood pressure",GCST90013835,7:111940111
rs12595082-<b>C</b>,3 x 10-8,,0.81,'-,'-,'-,SPPL2A,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST90013836,15:50715532
rs4308-<b>G</b>,8 x 10-15,,0.63,'-,'-,'-,ACE,Alzheimer's disease or systolic blood pressure (pleiotropy),"Alzheimer's disease, systolic blood pressure",GCST90013838,17:63482264
rs4575098-<b>A</b>,4 x 10-13,,0.22,'-,'-,'-,ADAMTS4,Alzheimer's disease or waist-hip ratio (pleiotropy),"Alzheimer's disease, waist-hip ratio",GCST90013842,1:161185602
rs2715157-<b>?</b>,3 x 10-8,,0.52,1.27,'-,[1.16-1.37],PCLO,Major depressive disorder,unipolar depression,GCST004486,7:82839058
rs4685959-<b>?</b>,1 x 10-6,,'-,'-,1.1 unit decrease,[NR],'-,Duloxetine response in major depressive disorder (% change in symptom score),"unipolar depression, response to duloxetine",GCST004738,3:5645577
rs13147572-<b>?</b>,8 x 10-6,,'-,'-,0.44 unit decrease,[NR],SORBS2,Duloxetine response in major depressive disorder (% change in symptom score),"unipolar depression, response to duloxetine",GCST004738,4:18291521
rs76767803-<b>?</b>,1 x 10-8,,'-,'-,0.69 unit increase,[NR],RFC3P1,Placebo response in major depressive disorder (% change in symptom score),"unipolar depression, response to placebo",GCST004739,3:36230378
rs78456975-<b>?</b>,3 x 10-6,,'-,'-,0.59 unit increase,[NR],"TPO, PXDN",Placebo response in major depressive disorder (% change in symptom score),"unipolar depression, response to placebo",GCST004739,2:1550418
rs10514650-<b>A</b>,2 x 10-6,,NR,4.2,'-,NR,NUTF2P8,Depression in multiple sclerosis (pre-diagnosis),"multiple sclerosis, unipolar depression",GCST011679,2:21296299
rs10832000-<b>G</b>,2 x 10-6,,NR,4.27,'-,NR,ARNTL,Depression in multiple sclerosis (pre-diagnosis),"multiple sclerosis, unipolar depression",GCST011679,11:13228852
rs28758178-<b>A</b>,3 x 10-6,,NR,4.44,'-,NR,TM2D3,Depression in multiple sclerosis (pre-diagnosis),"multiple sclerosis, unipolar depression",GCST011679,15:101648782
rs74696548-<b>G</b>,3 x 10-6,,NR,5.1,'-,NR,SGO1-AS1,Depression in multiple sclerosis (pre-diagnosis),"multiple sclerosis, unipolar depression",GCST011679,3:20734902
rs12612334-<b>C</b>,3 x 10-6,,NR,1.91,'-,NR,UBBP1,Depression in multiple sclerosis (post-diagnosis),"multiple sclerosis, unipolar depression",GCST011678,2:75885737
rs898-<b>C</b>,4 x 10-6,,NR,2.02,'-,NR,PTGFR,Depression in multiple sclerosis (post-diagnosis),"multiple sclerosis, unipolar depression",GCST011678,1:78537573
rs10513196-<b>A</b>,4 x 10-7,,NR,1.9,'-,NR,"BBX, LINC01990",Depression in multiple sclerosis,"multiple sclerosis, unipolar depression",GCST011680,3:107506831
rs3003482-<b>G</b>,3 x 10-6,,NR,1.83,'-,NR,PADI1,Depression in multiple sclerosis,"multiple sclerosis, unipolar depression",GCST011680,1:17224106
rs17090219-<b>?</b>,9 x 10-8,,'-,'-,5.15 unit increase,[3.33-6.97],TXNL1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,18:56523802
rs3936289-<b>?</b>,5 x 10-7,,'-,'-,3.34 unit increase,[2.09-4.59],ST6GAL1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,3:187037169
rs56378310-<b>?</b>,2 x 10-6,,'-,'-,2.98 unit decrease,[1.8-4.16],RAB20,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,13:110537326
rs192470679-<b>?</b>,2 x 10-6,,'-,'-,2.89 unit increase,[1.73-4.05],PDS5B,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,13:32716722
rs11121365-<b>?</b>,2 x 10-6,,'-,'-,5.76 unit increase,[3.45-8.07],SPSB1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,1:9297665
rs2484-<b>?</b>,3 x 10-6,,'-,'-,4.53 unit increase,[2.69-6.37],BDH1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,3:197541698
rs10903488-<b>?</b>,3 x 10-6,,'-,'-,4.58 unit increase,[2.7-6.46],ADARB2,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,10:1563803
rs6016505-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,TOP1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,20:41049649
rs314277-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,LIN28B,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,6:104959787
rs57905270-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,C2orf83,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,2:227621998
rs12525341-<b>?</b>,8 x 10-6,,'-,'-,'-,'-,TIAM2,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,6:155173590
rs698842-<b>A</b>,2 x 10-6,,0.22,1.96,'-,[1.69-2.23],NRXN1,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,2:50662958
rs10175975-<b>T</b>,3 x 10-6,,0.19,1.99,'-,[1.7-2.28],LINC01793,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,2:59202672
rs78872508-<b>C</b>,2 x 10-6,,0.13,2.2222223,'-,[1.89-2.56],HDAC9,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,7:18976853
rs4348488-<b>C</b>,3 x 10-6,,0.21,1.97,'-,[1.68-2.26],BMP1,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,8:22166649
rs17089546-<b>A</b>,3 x 10-6,,0.25,1.86,'-,[1.61-2.11],NKX2-6,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,8:23714294
rs74717330-<b>A</b>,2 x 10-6,,0.05,3.09,'-,[2.62-3.56],"HNF4G, PKMP4",Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,8:75384073
rs191325450-<b>G</b>,2 x 10-6,,0.09,2.3255813,'-,[1.97-2.68],RPS19P6,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,9:80763069
rs4543939-<b>A</b>,4 x 10-6,,0.43,2.43,'-,[2.06-2.8],"LINC02746, SNRPGP16",Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,11:92934492
rs1977412-<b>C</b>,6 x 10-7,,0.14,1.5625,'-,[1.39-1.74],AGT,Alzheimer's disease with memory domain impairment,"Alzheimer's disease, memory impairment",GCST007330,1:230716523
rs9937469-<b>T</b>,2 x 10-6,,0.06,2.14,'-,[1.83-2.45],RPL21P119,Alzheimer's disease with memory domain impairment,"Alzheimer's disease, memory impairment",GCST007330,16:9158799
rs8059356-<b>A</b>,6 x 10-7,,0.21,2.23,'-,[1.92-2.54],"LINC00917, LINC01081",Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,16:86323639
rs4972634-<b>T</b>,4 x 10-6,,0.59,1.31,'-,[1.19-1.43],"RPSAP24, LINC01960",Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,2:174042477
rs11708767-<b>A</b>,3 x 10-7,,0.43,1.33,'-,[1.21-1.45],MED12L,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,3:151401938
rs4533991-<b>T</b>,2 x 10-6,,0.46,1.32,'-,[1.2-1.44],'-,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,6:51233850
rs78358979-<b>A</b>,5 x 10-7,,0.06,1.76,'-,[1.54-1.98],'-,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,6:86795185
rs6978679-<b>A</b>,2 x 10-6,,0.73,1.36,'-,[1.24-1.48],"CDHR3, SYPL1",Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,7:106078297
rs72839770-<b>T</b>,4 x 10-6,,0.36,1.31,'-,[1.19-1.43],DVL2,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,17:7228873
rs7264688-<b>T</b>,5 x 10-6,,0.67,1.47,'-,[1.31-1.63],"MGME1, OVOL2",Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,20:17974063
rs11642612-<b>A</b>,2 x 10-8,,0.62,'-,'-,'-,DOC2A,Alzheimer's disease or LDL levels (pleiotropy),"Alzheimer's disease, low density lipoprotein cholesterol measurement",GCST90013837,16:30018874
rs4435501-<b>A</b>,4 x 10-6,,NR,'-,0.13 unit increase,[0.071-0.189],SNRNP200,Major depressive disorder,unipolar depression,GCST005231,2:96315631
rs6893200-<b>T</b>,5 x 10-6,(females),NR,'-,0.11 unit decrease,[0.071-0.149],DAP-DT,Major depressive disorder,unipolar depression,GCST005231,5:10806645
rs73063271-<b>A</b>,6 x 10-6,,NR,'-,0.17 unit decrease,[0.092-0.248],"ACVR2B-AS1, XYLB",Major depressive disorder,unipolar depression,GCST005231,3:38425758
rs9648182-<b>A</b>,9 x 10-8,(females),0.12,'-,0.17 unit decrease,[0.11-0.23],'-,Major depressive disorder,unipolar depression,GCST005231,7:13755224
rs10227749-<b>T</b>,4 x 10-6,(females),NR,'-,0.12 unit increase,[0.061-0.179],DGKB,Major depressive disorder,unipolar depression,GCST005231,7:14404267
rs17176546-<b>A</b>,8 x 10-7,(females),0.04,'-,0.26 unit increase,[0.16-0.36],CACNA2D1,Major depressive disorder,unipolar depression,GCST005231,7:82251598
rs79225303-<b>T</b>,2 x 10-6,(females),NR,'-,0.17 unit decrease,[0.092-0.248],TRAPPC9,Major depressive disorder,unipolar depression,GCST005231,8:140119737
rs61842316-<b>T</b>,3 x 10-6,(females),NR,'-,0.27 unit increase,[0.15-0.39],RSU1,Major depressive disorder,unipolar depression,GCST005231,10:16711721
rs11613048-<b>A</b>,8 x 10-6,(females),NR,'-,0.1 unit decrease,[0.061-0.139],LINC02386,Major depressive disorder,unipolar depression,GCST005231,12:30201042
rs1448094-<b>T</b>,1 x 10-6,(females),NR,'-,0.1 unit increase,[0.061-0.139],"MGAT4C, NTS",Major depressive disorder,unipolar depression,GCST005231,12:85949356
rs73228161-<b>A</b>,6 x 10-6,(females),NR,'-,0.19 unit increase,[0.11-0.27],PLXNC1,Major depressive disorder,unipolar depression,GCST005231,12:94268895
rs139073054-<b>T</b>,2 x 10-6,(females),NR,'-,0.35 unit increase,[0.21-0.49],LINC00430,Major depressive disorder,unipolar depression,GCST005231,13:86999003
rs79306025-<b>A</b>,2 x 10-6,(females),NR,'-,0.44 unit increase,[0.26-0.62],'-,Major depressive disorder,unipolar depression,GCST005231,14:85132448
rs17705482-<b>T</b>,9 x 10-6,(females),NR,'-,0.11 unit decrease,[0.051-0.169],COX6CP4,Major depressive disorder,unipolar depression,GCST005231,15:36543587
rs74031748-<b>A</b>,7 x 10-6,(females),NR,'-,0.19 unit decrease,[0.11-0.27],"LINC00923, ARRDC4",Major depressive disorder,unipolar depression,GCST005231,15:97950924
rs35888008-<b>A</b>,6 x 10-6,(females),NR,'-,0.12 unit increase,[0.061-0.179],"C16orf78, LINC02179",Major depressive disorder,unipolar depression,GCST005231,16:49443361
rs12240686-<b>A</b>,6 x 10-6,,NR,'-,0.18 unit decrease,[0.1-0.26],ENO4,Major depressive disorder,unipolar depression,GCST005231,10:116878671
rs115736167-<b>C</b>,2 x 10-7,(males),0.02,'-,0.46 unit decrease,[0.28-0.64],PKLR,Major depressive disorder,unipolar depression,GCST005231,1:155296818
rs80208956-<b>A</b>,6 x 10-6,,NR,'-,0.3 unit increase,[0.16-0.44],"FGF19, LTO1",Major depressive disorder,unipolar depression,GCST005231,11:69682501
rs40493-<b>C</b>,4 x 10-6,(males),NR,'-,0.13 unit increase,[0.071-0.189],PTPRG,Major depressive disorder,unipolar depression,GCST005231,3:61989275
rs73108923-<b>A</b>,6 x 10-6,(males),NR,'-,0.3 unit decrease,[0.16-0.44],SYNPR,Major depressive disorder,unipolar depression,GCST005231,3:63339904
rs13127214-<b>C</b>,7 x 10-6,(males),NR,'-,0.19 unit increase,[0.11-0.27],GABRB1,Major depressive disorder,unipolar depression,GCST005231,4:47278539
rs140555-<b>T</b>,2 x 10-6,,NR,'-,0.09 unit decrease,[0.051-0.129],PHF21B,Major depressive disorder,unipolar depression,GCST005231,22:45020016
rs12464040-<b>T</b>,2 x 10-6,(females),NR,'-,0.15 unit increase,[0.091-0.209],DNAH6,Major depressive disorder,unipolar depression,GCST005231,2:84628488
rs1874256-<b>A</b>,4 x 10-6,(females),NR,'-,0.1 unit increase,[0.061-0.139],RBMS3,Major depressive disorder,unipolar depression,GCST005231,3:28952692
rs116569570-<b>A</b>,5 x 10-6,(females),NR,'-,0.16 unit decrease,[0.082-0.238],NPFFR2,Major depressive disorder,unipolar depression,GCST005231,4:71950372
rs116078874-<b>A</b>,4 x 10-6,(males),NR,'-,0.47 unit increase,[0.27-0.67],GLO1,Major depressive disorder,unipolar depression,GCST005231,6:38684649
rs10758202-<b>A</b>,2 x 10-6,(males),NR,'-,0.14 unit increase,[0.081-0.199],"AQP3, AQP7",Major depressive disorder,unipolar depression,GCST005231,9:33420010
rs78245978-<b>T</b>,6 x 10-6,(males),NR,'-,0.43 unit increase,[0.25-0.61],LINC02645,Major depressive disorder,unipolar depression,GCST005231,10:2564784
rs117778141-<b>T</b>,1 x 10-6,(males),NR,'-,0.5 unit decrease,[0.3-0.7],'-,Major depressive disorder,unipolar depression,GCST005231,10:55896368
rs150439352-<b>A</b>,4 x 10-6,(males),NR,'-,0.47 unit increase,[0.27-0.67],MS4A13,Major depressive disorder,unipolar depression,GCST005231,11:60524031
rs113485090-<b>A</b>,2 x 10-7,(males),0.04,'-,0.32 unit decrease,[0.2-0.44],MRPL48,Major depressive disorder,unipolar depression,GCST005231,11:73861450
rs666723-<b>A</b>,7 x 10-6,(males),NR,'-,0.12 unit increase,[0.061-0.179],CASP4,Major depressive disorder,unipolar depression,GCST005231,11:104955877
rs1380551-<b>A</b>,4 x 10-7,(males),0.15,'-,0.18 unit decrease,[0.1-0.26],PWRN4,Major depressive disorder,unipolar depression,GCST005231,15:23879557
rs74002781-<b>T</b>,7 x 10-6,(males),NR,'-,0.21 unit decrease,[0.11-0.31],PKD1,Major depressive disorder,unipolar depression,GCST005231,16:2096287
rs117621296-<b>T</b>,9 x 10-6,(males),NR,'-,0.31 unit decrease,[0.17-0.45],MARCHF2,Major depressive disorder,unipolar depression,GCST005231,19:8417300
rs114508355-<b>C</b>,9 x 10-6,,NR,'-,0.46 unit decrease,[0.26-0.66],"CLCC1, AKNAD1",Recurrent major depressive disorder,unipolar depression,GCST005230,1:108957621
rs13011737-<b>A</b>,1 x 10-6,,NR,'-,0.1 unit increase,[0.061-0.139],SLC8A1-AS1,Recurrent major depressive disorder,unipolar depression,GCST005230,2:39839482
rs288342-<b>T</b>,7 x 10-6,,NR,'-,0.09 unit decrease,[0.051-0.129],"Y_RNA, DNAJC10",Recurrent major depressive disorder,unipolar depression,GCST005230,2:182800480
rs507385-<b>A</b>,9 x 10-6,,NR,'-,0.13 unit decrease,[0.071-0.189],GRM7,Recurrent major depressive disorder,unipolar depression,GCST005230,3:6969030
rs2291479-<b>A</b>,1 x 10-6,,0.4,'-,0.1 unit decrease,[0.061-0.139],"LINC01014, KCNMB2",Recurrent major depressive disorder,unipolar depression,GCST005230,3:178457156
rs2964802-<b>T</b>,2 x 10-6,,NR,'-,0.1 unit increase,[0.061-0.139],DAP-DT,Recurrent major depressive disorder,unipolar depression,GCST005230,5:10820731
rs114927772-<b>A</b>,3 x 10-6,,NR,'-,0.35 unit increase,[0.21-0.49],"MAK, TMEM14B",Recurrent major depressive disorder,unipolar depression,GCST005230,6:10818696
rs117901488-<b>T</b>,6 x 10-6,,NR,'-,0.2 unit increase,[0.12-0.28],SLC22A2,Recurrent major depressive disorder,unipolar depression,GCST005230,6:160182100
rs7835340-<b>A</b>,3 x 10-6,,NR,'-,0.09 unit increase,[0.051-0.129],TRIM55,Recurrent major depressive disorder,unipolar depression,GCST005230,8:66140334
rs79802045-<b>A</b>,5 x 10-6,,NR,'-,0.25 unit decrease,[0.13-0.37],"MIR4471, RNF19A",Recurrent major depressive disorder,unipolar depression,GCST005230,8:100336905
rs10959631-<b>T</b>,8 x 10-7,,0.2,'-,0.12 unit decrease,[0.081-0.159],'-,Recurrent major depressive disorder,unipolar depression,GCST005230,9:11220986
rs2460546-<b>A</b>,4 x 10-6,,NR,'-,0.29 unit increase,[0.17-0.41],RASGEF1A,Recurrent major depressive disorder,unipolar depression,GCST005230,10:43241126
rs11033303-<b>A</b>,6 x 10-7,,0.37,'-,0.11 unit increase,[0.071-0.149],"TRIM44, KRT18P14",Recurrent major depressive disorder,unipolar depression,GCST005230,11:35849716
rs17615103-<b>T</b>,6 x 10-6,,NR,'-,0.22 unit increase,[0.12-0.32],"MS4A1, MS4A12",Recurrent major depressive disorder,unipolar depression,GCST005230,11:60470932
rs1031396-<b>T</b>,5 x 10-6,,NR,'-,0.4 unit decrease,[0.22-0.58],LINC00410,Recurrent major depressive disorder,unipolar depression,GCST005230,13:90907558
rs187279821-<b>A</b>,5 x 10-6,(females),NR,'-,0.42 unit decrease,[0.24-0.6],HSPA4L,Major depressive disorder,unipolar depression,GCST005231,4:127836228
rs1874256-<b>A</b>,9 x 10-6,,NR,'-,0.07 unit increase,[0.031-0.109],RBMS3,Major depressive disorder,unipolar depression,GCST005231,3:28952692
rs111404313-<b>A</b>,4 x 10-6,(females),NR,'-,0.32 unit decrease,[0.18-0.46],CASP8AP2,Major depressive disorder,unipolar depression,GCST005231,6:89859111
rs11099341-<b>A</b>,7 x 10-6,,NR,'-,0.09 unit decrease,[0.051-0.129],KRT18P54,Major depressive disorder,unipolar depression,GCST005231,4:135407047
rs342318-<b>A</b>,6 x 10-6,,NR,'-,0.1 unit increase,[0.061-0.139],PDGFC,Major depressive disorder,unipolar depression,GCST005231,4:156867803
rs115981586-<b>A</b>,8 x 10-6,,NR,'-,0.21 unit increase,[0.11-0.31],RPS14P7,Major depressive disorder,unipolar depression,GCST005231,4:160773745
rs56390503-<b>T</b>,9 x 10-7,,0.11,'-,0.13 unit increase,[0.071-0.189],FAT1,Major depressive disorder,unipolar depression,GCST005231,4:186631422
rs2964802-<b>T</b>,7 x 10-7,,0.28,'-,0.09 unit increase,[0.051-0.129],DAP-DT,Major depressive disorder,unipolar depression,GCST005231,5:10820731
rs11743328-<b>T</b>,7 x 10-6,,NR,'-,0.1 unit decrease,[0.061-0.139],"APC, LINC02200",Major depressive disorder,unipolar depression,GCST005231,5:112679858
rs144735131-<b>A</b>,2 x 10-6,,NR,'-,0.4 unit decrease,[0.24-0.56],H2BC4,Major depressive disorder,unipolar depression,GCST005231,6:26121050
rs9648182-<b>A</b>,8 x 10-6,,NR,'-,0.11 unit decrease,[0.051-0.169],'-,Major depressive disorder,unipolar depression,GCST005231,7:13755224
rs117715236-<b>A</b>,4 x 10-6,,NR,'-,0.24 unit decrease,[0.14-0.34],NRG1,Major depressive disorder,unipolar depression,GCST005231,8:32600452
rs12547341-<b>A</b>,5 x 10-6,,NR,'-,0.08 unit increase,[0.041-0.119],"COLEC10, RN7SKP231",Major depressive disorder,unipolar depression,GCST005231,8:91690290
rs145478122-<b>A</b>,9 x 10-6,,NR,'-,0.3 unit decrease,[0.16-0.44],C8orf37-AS1,Major depressive disorder,unipolar depression,GCST005231,8:95436361
rs10959631-<b>T</b>,4 x 10-6,,NR,'-,0.1 unit decrease,[0.061-0.139],'-,Major depressive disorder,unipolar depression,GCST005231,9:11220986
rs41287894-<b>T</b>,3 x 10-6,(males),NR,'-,0.45 unit increase,[0.25-0.65],SKINT1L,Major depressive disorder,unipolar depression,GCST005231,1:48161782
rs11033303-<b>A</b>,2 x 10-7,,0.37,'-,0.09 unit increase,[0.051-0.129],"TRIM44, KRT18P14",Major depressive disorder,unipolar depression,GCST005231,11:35849716
rs4478037-<b>A</b>,2 x 10-8,(males),0.08,'-,0.29 unit increase,[0.19-0.39],CRTAP,Major depressive disorder,unipolar depression,GCST005231,3:33118915
rs10736455-<b>A</b>,4 x 10-6,,NR,'-,0.16 unit decrease,[0.082-0.238],"LINC02550, C11orf53",Major depressive disorder,unipolar depression,GCST005231,11:111193999
rs8050755-<b>T</b>,9 x 10-6,,NR,'-,0.11 unit increase,[0.071-0.149],TSC2,Major depressive disorder,unipolar depression,GCST005231,16:2069186
rs35888008-<b>A</b>,4 x 10-6,,NR,'-,0.09 unit increase,[0.051-0.129],"C16orf78, LINC02179",Major depressive disorder,unipolar depression,GCST005231,16:49443361
rs6822806-<b>T</b>,5 x 10-6,(males),NR,'-,0.18 unit decrease,[0.1-0.26],UNC5C,Major depressive disorder,unipolar depression,GCST005231,4:95377791
rs116233998-<b>A</b>,7 x 10-6,(males),NR,'-,0.47 unit decrease,[0.27-0.67],MRPS33P3,Major depressive disorder,unipolar depression,GCST005231,4:115213661
rs255428-<b>A</b>,3 x 10-6,(males),NR,'-,0.13 unit increase,[0.071-0.189],'-,Major depressive disorder,unipolar depression,GCST005231,5:63551062
rs213862-<b>A</b>,7 x 10-6,,0.14,'-,0.51 unit decrease,[NR],"EEF1GP6, GPR63",Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,6:96786910
rs74826345-<b>T</b>,4 x 10-6,,0.01,'-,1.63 unit decrease,[NR],TMEM106B,Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,7:12158819
rs17137566-<b>C</b>,6 x 10-6,,0.17,'-,0.47 unit decrease,[NR],AHR,Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,7:17320897
rs5743467-<b>G</b>,8 x 10-7,,0.25,'-,0.43 unit increase,[NR],"GS1-24F4.2, DEFB1",Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,8:6874007
rs61475845-<b>A</b>,1 x 10-6,,0.02,'-,2.2 unit decrease,[NR],CNTN5,Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,11:99948244
rs982422-<b>A</b>,5 x 10-7,,0.24,'-,0.47 unit decrease,[NR],LINC02424,Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,12:78453479
rs2236231-<b>A</b>,5 x 10-6,,0.32,'-,0.4 unit decrease,[NR],PLEKHH1,Plasma kynurenine levels in major depressive disorder,"unipolar depression, kynurenine measurement",GCST005342,14:67572310
rs5743467-<b>G</b>,2 x 10-7,,0.25,'-,0.46 unit increase,[NR],"GS1-24F4.2, DEFB1",Plasma kynurenine to tryptophan ratio in major depressive disorder,"unipolar depression, kynurenine:tryptophan ratio",GCST005343,8:6874007
rs75921243-<b>G</b>,6 x 10-8,,0.02,'-,1.51 unit decrease,[NR],"MIR124-1HG, MSRA",Plasma kynurenine to tryptophan ratio in major depressive disorder,"unipolar depression, kynurenine:tryptophan ratio",GCST005343,8:9988356
rs116609693-<b>T</b>,5 x 10-7,,0.03,'-,1.35 unit decrease,[NR],ANKRD19P,Plasma kynurenine to tryptophan ratio in major depressive disorder,"unipolar depression, kynurenine:tryptophan ratio",GCST005343,9:92811394
rs9300648-<b>T</b>,6 x 10-6,,NR,'-,0.16 unit decrease,[0.1-0.22],NALCN,Recurrent major depressive disorder,unipolar depression,GCST005230,13:101106989
rs4438172-<b>A</b>,9 x 10-7,,0.25,'-,0.11 unit increase,[0.071-0.149],"LINC00567, RPL21P107",Recurrent major depressive disorder,unipolar depression,GCST005230,13:110796311
rs60716536-<b>A</b>,3 x 10-6,,NR,'-,0.13 unit decrease,[0.071-0.189],LINC02304,Recurrent major depressive disorder,unipolar depression,GCST005230,14:97156881
rs1486437-<b>A</b>,9 x 10-6,,NR,'-,0.13 unit decrease,[0.071-0.189],LINC01571,Recurrent major depressive disorder,unipolar depression,GCST005230,16:51865949
rs1792737-<b>C</b>,2 x 10-6,,NR,'-,0.1 unit decrease,[0.061-0.139],LINC01539,Recurrent major depressive disorder,unipolar depression,GCST005230,18:56179136
rs4941058-<b>C</b>,1 x 10-6,,NR,'-,0.13 unit decrease,[0.071-0.189],"LINC01544, RNF152",Recurrent major depressive disorder,unipolar depression,GCST005230,18:61780992
rs8140097-<b>T</b>,2 x 10-6,,NR,'-,0.12 unit increase,[0.081-0.159],"LINC00895, CLDN5",Recurrent major depressive disorder,unipolar depression,GCST005230,22:19549739
rs5760842-<b>A</b>,2 x 10-6,,NR,'-,0.09 unit decrease,[0.051-0.129],KIAA1671,Recurrent major depressive disorder,unipolar depression,GCST005230,22:25087024
rs149415148-<b>G</b>,4 x 10-7,,0.0123,'-,0.0317 unit increase,[0.02-0.044],"LINC01395, RPS27P20",Major depressive disorder (probable),unipolar depression,GCST005904,11:129576071
rs218987-<b>T</b>,1 x 10-7,,0.3052,'-,0.0074 unit increase,[0.0047-0.0101],"GRIK3, FTLP18",Major depressive disorder (probable),unipolar depression,GCST005904,1:36701732
rs10929355-<b>G</b>,6 x 10-9,,0.4558,'-,0.0075 unit decrease,[0.005-0.01],NBAS,Major depressive disorder (probable),unipolar depression,GCST005904,2:15258840
rs3806572-<b>A</b>,8 x 10-7,,0.292,'-,0.007 unit decrease,[0.0043-0.0097],RTN4,Major depressive disorder (probable),unipolar depression,GCST005904,2:55011541
rs117911063-<b>T</b>,4 x 10-7,,0.031,'-,0.019 unit increase,[0.012-0.026],CDC42BPB,Major depressive disorder (probable),unipolar depression,GCST005904,14:103037856
rs77685443-<b>T</b>,7 x 10-7,,0.0363,'-,0.018 unit increase,[0.011-0.025],"RNU6-788P, RNU6-922P",Major depressive disorder (probable),unipolar depression,GCST005904,3:23634522
rs1304150-<b>T</b>,9 x 10-7,,0.8684,'-,0.0094 unit increase,[0.0057-0.0131],RNU1-43P,Major depressive disorder (probable),unipolar depression,GCST005904,3:103112741
rs5011432-<b>C</b>,2 x 10-8,,0.4118,'-,0.0073 unit increase,[0.0048-0.0098],TMEM106B,Major depressive disorder (probable),unipolar depression,GCST005904,7:12229042
rs62544433-<b>G</b>,4 x 10-7,,0.1144,'-,0.0103 unit increase,[0.0064-0.0142],"SPINK4, B4GALT1-AS1",Major depressive disorder (probable),unipolar depression,GCST005904,9:33215364
rs7512599-<b>A</b>,5 x 10-7,,0.7079,'-,0.0032 unit increase,[0.002-0.0044],CAMTA1,Major depressive disorder (ICD-10 coded),unipolar depression,GCST005903,1:7255971
rs62195769-<b>A</b>,6 x 10-8,,0.1074,'-,0.0052 unit increase,[0.0032-0.0072],"DIRC3, CACYBPP2",Major depressive disorder (ICD-10 coded),unipolar depression,GCST005903,2:183618431
rs56072378-<b>G</b>,9 x 10-7,,0.2197,'-,0.0035 unit decrease,[0.0021-0.0049],MAD1L1,Major depressive disorder (ICD-10 coded),unipolar depression,GCST005903,7:2064729
rs12667733-<b>G</b>,6 x 10-8,,0.4964,'-,0.0032 unit decrease,[0.002-0.0044],'-,Major depressive disorder (ICD-10 coded),unipolar depression,GCST005903,7:19365025
rs10767735-<b>C</b>,7 x 10-7,,0.3949,'-,0.006 unit decrease,[0.0036-0.0084],"LINC02758, METTL15",Depression (broad),unipolar depression,GCST005902,11:28621014
rs1791684-<b>G</b>,3 x 10-7,,0.5255,'-,0.0061 unit increase,[0.0037-0.0085],CCS,Depression (broad),unipolar depression,GCST005902,11:66601740
rs6483414-<b>C</b>,3 x 10-8,,0.6437,'-,0.0069 unit increase,[0.0045-0.0093],GRM5,Depression (broad),unipolar depression,GCST005902,11:88744046
rs10501696-<b>G</b>,7 x 10-11,,0.4987,'-,0.0079 unit decrease,[0.0055-0.0103],GRM5,Depression (broad),unipolar depression,GCST005902,11:89014994
rs621313-<b>G</b>,3 x 10-10,,0.4908,'-,0.0074 unit increase,[0.005-0.0098],TYR,Depression (broad),unipolar depression,GCST005902,11:89180495
rs598769-<b>T</b>,9 x 10-7,,0.47,'-,0.0058 unit increase,[0.0034-0.0082],TYR,Depression (broad),unipolar depression,GCST005902,11:89286569
rs578174-<b>G</b>,3 x 10-7,,0.1043,'-,0.0099 unit decrease,[0.0062-0.0136],"CHORDC1, DISC1FP1",Depression (broad),unipolar depression,GCST005902,11:90226469
rs4936275-<b>T</b>,1 x 10-7,,0.6217,'-,0.0065 unit increase,[0.0041-0.0089],DRD2,Depression (broad),unipolar depression,GCST005902,11:113494362
rs60545357-<b>C</b>,7 x 10-7,,0.1739,'-,0.0077 unit increase,[0.0046-0.0108],ATP5MG,Depression (broad),unipolar depression,GCST005902,11:118410703
rs521048-<b>G</b>,5 x 10-7,,0.7309,'-,0.0067 unit increase,[0.0042-0.0092],SUDS3,Depression (broad),unipolar depression,GCST005902,12:118393153
rs9530139-<b>T</b>,3 x 10-9,,0.1955,'-,0.0089 unit decrease,[0.006-0.0118],B3GLCT,Depression (broad),unipolar depression,GCST005902,13:31273187
rs1755255-<b>C</b>,8 x 10-7,,0.7119,'-,0.0064 unit increase,[0.0039-0.0089],SPRY2,Depression (broad),unipolar depression,GCST005902,13:80301287
rs6487668-<b>C</b>,7 x 10-7,(EA),0.2181,'-,'-,'-,PZP,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,12:9200312
rs9432230-<b>C</b>,5 x 10-7,(AA),0.893,'-,'-,'-,"C1orf198, RN7SL837P",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:230882365
rs734152-<b>G</b>,1 x 10-6,(EA),0.8804,'-,'-,'-,"FAM222A, FAM222A-AS1",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,12:109759971
rs59711329-<b>G</b>,1 x 10-6,(AA),0.9039,'-,'-,'-,ZNF417,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,19:57901128
rs79309730-<b>C</b>,2 x 10-6,(EA),0.9427,'-,'-,'-,SH3BP4,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:235039304
rs139018470-<b>T</b>,2 x 10-6,(AA),0.9549,'-,'-,'-,"GPR88, LINC01349",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:100602039
rs17506336-<b>C</b>,2 x 10-6,(AA),0.9017,'-,'-,'-,EXT1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,8:118097589
rs186167755-<b>C</b>,2 x 10-6,(AA),0.9796,'-,'-,'-,ADAMTSL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,9:18600278
rs6485603-<b>G</b>,5 x 10-6,(EA),0.5506,'-,'-,'-,"PRDM11, SYT13",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,11:45238465
rs143756124-<b>T</b>,5 x 10-6,(EA),0.932,'-,'-,'-,"RNMT, MC5R",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:13823130
rs6743806-<b>C</b>,5 x 10-6,(EA),0.7326,'-,'-,'-,"HIGD1AP4, RN7SL807P",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:223344398
rs13171357-<b>G</b>,5 x 10-6,(EA),0.7185,'-,'-,'-,SLC1A3,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,5:36694954
rs7194099-<b>A</b>,5 x 10-6,(EA),0.5561,'-,'-,'-,"BCAR4, ZC3H7A",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,16:11808105
rs180931486-<b>T</b>,6 x 10-6,(EA),0.9334,'-,'-,'-,MBP,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:77055585
rs536504-<b>C</b>,7 x 10-6,(EA),0.6995,'-,'-,'-,RASGEF1B,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,4:81840312
rs79652026-<b>C</b>,3 x 10-6,(AA),0.9413,'-,'-,'-,FIG4,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109737837
rs74932355-<b>T</b>,3 x 10-6,(AA),0.9063,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:236758796
rs28680895-<b>T</b>,4 x 10-6,(AA),0.9532,'-,'-,'-,"ZNF506, ZNF56",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,19:19814290
rs57091543-<b>C</b>,4 x 10-6,(AA),0.9511,'-,'-,'-,GALM,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:38677624
rs55894909-<b>G</b>,4 x 10-6,(AA),0.7259,'-,'-,'-,"RNU6-1304P, ENAH",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:225711351
rs13257626-<b>G</b>,9 x 10-6,(EA),0.9769,'-,'-,'-,U8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,8:71780350
rs570456-<b>C</b>,9 x 10-6,(EA),0.7392,'-,'-,'-,ALG8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,11:78112182
rs143916815-<b>G</b>,1 x 10-7,(AA),0.9768,'-,'-,'-,"C15orf54, LINC02694",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,15:39191714
rs7897478-<b>A</b>,1 x 10-7,(AA),0.9418,'-,'-,'-,JCAD,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,10:29945955
rs10243383-<b>T</b>,1 x 10-7,(AA),0.626,'-,'-,'-,RAPGEF5,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,7:22242733
rs115319209-<b>G</b>,2 x 10-7,(AA),0.969,'-,'-,'-,LINC01220,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,14:75298968
rs114969316-<b>A</b>,2 x 10-7,(AA),0.952,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:88460643
rs9487114-<b>C</b>,3 x 10-7,(AA),0.0635,'-,'-,'-,MICAL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109460597
rs76782312-<b>C</b>,4 x 10-7,(AA),0.94,'-,'-,'-,AK9,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109643865
rs35426224-<b>G</b>,1 x 10-6,(EA),0.9255,'-,'-,'-,EML1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,14:99783354
rs142383097-<b>A</b>,6 x 10-7,(AA),0.97,'-,'-,'-,DFFA,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:10461101
rs12036147-<b>A</b>,1 x 10-6,(EA),0.9116,'-,'-,'-,CHRM3,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:239835413
rs141980369-<b>G</b>,1 x 10-6,(AA),0.8988,'-,'-,'-,MCM9,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:118888344
rs7298108-<b>C</b>,2 x 10-6,(EA),0.8217,'-,'-,'-,"A2MP1, PZP",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,12:9223572
rs17118176-<b>A</b>,4 x 10-6,(EA),0.9373,'-,'-,'-,MDGA2,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,14:47216656
rs2252932-<b>A</b>,2 x 10-6,(AA),0.7384,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,13:55740831
rs185973901-<b>C</b>,2 x 10-6,(AA),0.9707,'-,'-,'-,ACTBP8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:88351556
rs2576789-<b>A</b>,2 x 10-6,(AA),0.41,'-,'-,'-,"GPR45, LINC01918",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:105194762
rs148701910-<b>C</b>,2 x 10-6,(AA),0.9333,'-,'-,'-,KLF2-DT,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,19:16310721
rs78489263-<b>A</b>,2 x 10-6,(AA),0.9488,'-,'-,'-,CDKAL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:20723562
rs13138395-<b>T</b>,2 x 10-6,(AA),0.6502,'-,'-,'-,LINC00290,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,4:181009808
rs80127896-<b>A</b>,3 x 10-6,(AA),0.965,'-,'-,'-,GMDS-DT,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:2518145
rs76913336-<b>C</b>,3 x 10-6,(AA),0.965,'-,'-,'-,GMDS-DT,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:2518745
rs9487113-<b>T</b>,3 x 10-6,(AA),0.9391,'-,'-,'-,MICAL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109458971
rs17744447-<b>A</b>,8 x 10-6,(EA),0.3458,'-,'-,'-,"CABYRP1, CACNA2D3",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,3:54059392
rs567697-<b>T</b>,8 x 10-6,(EA),0.8451,'-,'-,'-,ALG8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,11:78096117
rs76088896-<b>T</b>,9 x 10-6,(EA),0.8925,'-,'-,'-,LINC02246,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,21:14892473
rs73359384-<b>G</b>,4 x 10-6,(AA),0.9183,'-,'-,'-,LINC02074,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,17:74078057
rs150466001-<b>C</b>,4 x 10-6,(AA),0.9653,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:66348267
rs71358652-<b>C</b>,4 x 10-6,(AA),0.9742,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:64934582
rs16832899-<b>G</b>,4 x 10-6,(AA),0.205,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,3:182144627
rs76400352-<b>G</b>,4 x 10-6,(AA),0.9684,'-,'-,'-,FYB1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,5:39230117
rs184666-<b>T</b>,5 x 10-6,(AA),0.9142,'-,'-,'-,LINC02195,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,16:26606344
rs113021743-<b>C</b>,5 x 10-6,(AA),0.9525,'-,'-,'-,STX17-AS1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,9:99757506
rs56361249-<b>?</b>,3 x 10-10,,NR,1.12,'-,'-,LMAN2L,Bipolar disorder,bipolar disorder,GCST003962,2:96714492
rs9834970-<b>?</b>,2 x 10-10,,NR,1.11,'-,'-,"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST003962,3:36814539
rs2302417-<b>?</b>,3 x 10-9,,NR,1.11,'-,'-,ITIH1,Bipolar disorder,bipolar disorder,GCST003962,3:52780240
rs1203233-<b>?</b>,4 x 10-8,,NR,1.1,'-,'-,SYNE1,Bipolar disorder,bipolar disorder,GCST003962,6:152393471
rs10994299-<b>?</b>,1 x 10-9,,NR,1.23,'-,'-,ANK3,Bipolar disorder,bipolar disorder,GCST003962,10:60316870
rs10884920-<b>?</b>,3 x 10-8,,NR,1.12,'-,'-,ADD3,Bipolar disorder,bipolar disorder,GCST003962,10:110015049
rs4765913-<b>?</b>,3 x 10-9,,NR,1.13,'-,'-,CACNA1C,Bipolar disorder,bipolar disorder,GCST003962,12:2310730
rs10459221-<b>?</b>,2 x 10-8,,NR,1.1,'-,'-,"RHEBL1, DHH",Bipolar disorder,bipolar disorder,GCST003962,12:49073211
rs4947962-<b>G</b>,1 x 10-6,,0.11,1.35,'-,[NR],EGFR,Subjective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003158,7:55008114
rs146727601-<b>?</b>,1 x 10-8,,0.01,3.98,'-,[NR],PTS,Objective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003159,11:112247868
"rs9486815-<b>G</b>, rs4245535-<b>G</b>, rs17069173-<b>A</b>, rs9374021-<b>G</b>, rs9374007-<b>A</b>, rs9386694-<b>A</b>, rs9374002-<b>G</b>, rs218289-<b>A</b>, rs1064346-<b>A</b>, rs9374013-<b>G</b>, rs6921166-<b>G</b>, rs12567-<b>A</b>, rs4332013-<b>A</b>, rs2001144-<b>A</b>, rs17069274-<b>A</b>, rs218294-<b>A</b>, rs6919324-<b>G</b>, rs4946900-<b>G</b>, rs7769514-<b>A</b>, rs2097525-<b>G</b>, rs9400180-<b>G</b>, rs7769535-<b>A</b>, rs9320250-<b>A</b>, rs9372177-<b>A</b>, rs2027876-<b>G</b>, rs17069204-<b>A</b>, rs12180499-<b>A</b>",3 x 10-7,,NR,1.26,'-,[1.16-1.37],OSTM1; OSTM1-AS1; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Major depressive disorder,unipolar depression,GCST005108,6:108126842
"rs11070668-A,rs11070670-A, rs12440434-A, rs11636875-A, rs2413923-A, rs16961929-G, rs934741-G, rs8031813-A, rs7178573-G, rs11070665-G, rs10519201-C, rs12593599-G, rs12915940-G, rs16952958-A, rs11070664-A, rs4608275-G, rs1007662-G, rs17384124-A, rs12915772-A, rs4775789-A, rs10851473-G, rs4491452-A, rs11638748-G, rs4774529-G, rs7178085-C, rs7164451-A, rs4474633-G, rs10519199-<b>A</b>",4 x 10-6,,NR,1.41,'-,[1.22-1.61],SHC4,Major depressive disorder,unipolar depression,GCST005108,15:48946587
rs3825243-<b>A</b>,4 x 10-8,,NR,'-,'-,'-,"YEATS4, LYZ",Response to SSRI in MDD or conscientiouness,"conscientiousness measurement, unipolar depression, response to selective serotonin reuptake inhibitor",GCST005836,12:69357059
rs2979204-<b>T</b>,8 x 10-11,,NR,'-,'-,'-,PRAG1,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,8:8441347
rs11990063-<b>T</b>,9 x 10-9,,NR,'-,'-,'-,MSRA,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,8:10307685
rs35792458-<b>C</b>,1 x 10-12,,NR,'-,'-,'-,XKR6,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,8:10964921
rs12555870-<b>G</b>,1 x 10-8,,NR,'-,'-,'-,'-,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,9:23347726
rs4761545-<b>G</b>,8 x 10-10,,NR,'-,'-,'-,RN7SKP263,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,12:94032692
rs144733372-<b>G</b>,3 x 10-11,,NR,'-,'-,'-,PLEKHM1,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,17:45486856
rs11082011-<b>C</b>,4 x 10-8,,NR,'-,'-,'-,CELF4,Remission after SSRI treatment in MDD or neuroticism,"unipolar depression, neuroticism measurement, response to selective serotonin reuptake inhibitor",GCST005835,18:37565159
rs55679149-<b>T</b>,8 x 10-7,,NR,'-,'-,'-,"GBP1, PTGES3P1",Remission after SSRI treatment in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005833,1:89068655
rs11728985-<b>T</b>,4 x 10-7,,NR,'-,'-,'-,C4orf33,Remission after SSRI treatment in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005833,4:129115280
rs11155372-<b>T</b>,1 x 10-7,,NR,'-,'-,'-,UTRN,Remission after SSRI treatment in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005833,6:144698602
rs7828021-<b>C</b>,4 x 10-7,,NR,'-,'-,'-,PSAT1P1,Remission after SSRI treatment in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005833,8:49727454
rs1411216-<b>A</b>,5 x 10-7,,NR,'-,'-,'-,IZUMO3,Remission after SSRI treatment in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005833,9:24520196
rs7189979-<b>C</b>,3 x 10-7,,NR,'-,'-,'-,SNX29,Remission after SSRI treatment in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005833,16:12536330
rs7555693-<b>A</b>,1 x 10-6,,NR,'-,'-,'-,'-,Response to SSRI in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005834,1:106295917
rs9321987-<b>A</b>,5 x 10-7,,NR,'-,'-,'-,UTRN,Response to SSRI in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005834,6:144709148
rs352759-<b>T</b>,6 x 10-7,,NR,'-,'-,'-,TUSC3,Response to SSRI in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005834,8:15742205
rs7828021-<b>C</b>,7 x 10-8,,NR,'-,'-,'-,PSAT1P1,Response to SSRI in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005834,8:49727454
rs11591827-<b>A</b>,9 x 10-7,,NR,'-,'-,'-,RPA2P2,Response to SSRI in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005834,10:81128126
rs7189979-<b>C</b>,2 x 10-7,,NR,'-,'-,'-,SNX29,Response to SSRI in MDD or openness,"unipolar depression, response to selective serotonin reuptake inhibitor, openness measurement",GCST005834,16:12536330
rs4146081-<b>A</b>,4 x 10-6,,0.1,'-,0.39 unit increase,[0.23-0.55],SCN7A,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,2:166500077
rs1996455-<b>A</b>,5 x 10-6,,0.3,'-,0.26 unit decrease,[0.14-0.38],PRDM8,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,4:80185028
rs13239350-<b>A</b>,6 x 10-6,,0.46,'-,0.23 unit increase,[0.13-0.33],HIP1,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,7:75717941
rs7835763-<b>A</b>,2 x 10-6,,'-,1.1,'-,[1.06-1.14],EXT1,Autism spectrum disorder,autism spectrum disorder,GCST004520,8:118082680
rs115254791-<b>G</b>,4 x 10-6,,'-,1.0869565,'-,[1.05-1.14],HLA-A,Autism spectrum disorder,autism spectrum disorder,GCST004520,6:29942680
rs142968358-<b>T</b>,1 x 10-6,,'-,1.1,'-,[1.06-1.14],SPTLC1P2,Autism spectrum disorder,autism spectrum disorder,GCST004520,6:23819007
kgp5929161-<b>?</b>,6 x 10-7,,NR,'-,0.06 unit increase,'-,'-,White matter microstructure in first episode schizophrenia (right posterior cingulate cortex),"schizophrenia, white matter microstructure measurement, cingulate cortex measurement",GCST004992,Mapping not available
rs11901793-<b>?</b>,4 x 10-8,,NR,'-,0.02 unit decrease,'-,ACKR3,Total mean fractional anisotropy measurement in first episode schizophrenia,"schizophrenia, mean fractional anisotropy measurement, white matter microstructure measurement",GCST004996,2:236588594
rs10509852-<b>?</b>,5 x 10-8,,NR,'-,0.04 unit decrease,'-,LINC01435,White matter microstructure in first episode schizophrenia (left posterior cingulate cortex),"schizophrenia, white matter microstructure measurement, cingulate cortex measurement",GCST004995,10:107815336
rs7559992-<b>?</b>,9 x 10-8,,NR,'-,0.03 unit decrease,'-,MPP4,White matter microstructure in first episode schizophrenia (left inferior parietal cortex),"parietal cortex measurement, schizophrenia, white matter microstructure measurement",GCST004991,2:201666824
rs10509852-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,LINC01435,Abnormal white matter microstructure in first episode schizophrenia (multivariate analysis),"parietal cortex measurement, schizophrenia, white matter microstructure measurement, cingulate cortex measurement",GCST004997,10:107815336
rs8009925-<b>?</b>,7 x 10-8,,NR,'-,0.04 unit increase,'-,TEP1,White matter microstructure in first episode schizophrenia (left anterior cingulate cortex),"schizophrenia, white matter microstructure measurement, cingulate cortex measurement",GCST004994,14:20403486
rs193091397-<b>?</b>,1 x 10-7,,NR,'-,2.83 unit decrease,'-,NFATC2,White matter microstructure in first episode schizophrenia (right anterior cingulate cortex),"schizophrenia, white matter microstructure measurement, cingulate cortex measurement",GCST004993,20:51467037
rs155346-<b>C</b>,4 x 10-6,,NR,'-,0.25 unit decrease,[0.15-0.35],NRG2,Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia,"schizophrenia, gamma wave measurement",GCST004953,5:140010792
rs2292354-<b>T</b>,4 x 10-6,,NR,'-,0.243 unit increase,[0.14-0.34],"TCHP, GIT2",Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia,"schizophrenia, gamma wave measurement",GCST004953,12:109930396
rs2073958-<b>C</b>,8 x 10-6,,NR,'-,0.252 unit decrease,[0.14-0.36],"SUPT20HL2, ZFX",Disturbances of the gamma-frequency band of electroencephalography measures in schizophrenia,"schizophrenia, gamma wave measurement",GCST004953,X:24235758
chr17:60904543-<b>C</b>,3 x 10-6,(GLM),NR,'-,26.3702 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,Mapping not available
rs67357741-<b>?</b>,3 x 10-6,(MLM),NR,'-,0.556851 unit increase,[0.32-0.79],CA12,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,15:63378609
rs200136777-<b>GAC</b>,3 x 10-6,(GLM),NR,'-,4.3976 unit increase,[NR],NXN,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,17:913294
chr2:230347877-<b>T</b>,4 x 10-6,(GLM),NR,'-,27.2427 unit increase,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,Mapping not available
rs11439302-<b>G</b>,5 x 10-6,(GLM),NR,'-,4.8086 unit decrease,[NR],LINC02246,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,21:14869414
chr16:8606507-<b>G</b>,8 x 10-6,(GLM),NR,'-,14.7557 unit increase,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,Mapping not available
rs2429929-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.6971282 unit increase,[0.39-1],TNRC6C,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,17:71725783
rs2560471-<b>A</b>,8 x 10-6,(GLM),NR,'-,5.8753 unit increase,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:5811952
rs77301145-<b>C</b>,8 x 10-6,(GLM),NR,'-,8.4108 unit decrease,[NR],"ZC3HAV1L, KIAA1549",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,7:139012454
rs181534711-<b>G</b>,3 x 10-8,(GLM),NR,'-,20.6563 unit decrease,[NR],"LINC00390, NRAD1",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,13:44069329
rs147515995-<b>G</b>,8 x 10-6,(GLM),NR,'-,11.2777 unit increase,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,19:28059504
rs115342620-<b>A</b>,9 x 10-6,(GLM),NR,'-,12.8016 unit decrease,[NR],"LNX1-AS1, LNX1",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,4:53526544
rs8094969-<b>A</b>,7 x 10-6,(GLM),NR,'-,3.1476 unit increase,[NR],LINC01899,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,18:71833874
rs76131026-<b>G</b>,8 x 10-8,(GLM),NR,'-,30.5578 unit decrease,[NR],"KCNIP1, LINC01366",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:170352321
rs4903318-<b>G</b>,8 x 10-6,(GLM),NR,'-,2.9084 unit increase,[NR],JDP2,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,14:75399932
rs7268897-<b>?</b>,7 x 10-6,(MLM),NR,'-,0.4867662 unit increase,[0.27-0.7],NFS1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,20:35678548
rs34252091-<b>?</b>,6 x 10-6,(MLM),NR,'-,0.2247672 unit increase,[0.13-0.32],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,1:189924464
rs117673608-<b>G</b>,8 x 10-7,(GLM),NR,'-,26.3182 unit decrease,[NR],PRKN,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,6:161931643
rs17093238-<b>A</b>,2 x 10-6,(GLM),NR,'-,8.986 unit decrease,[NR],PHF20,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,20:35913170
rs17093238-<b>?</b>,2 x 10-6,(MLM),NR,'-,0.5214499 unit increase,[0.31-0.74],PHF20,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,20:35913170
rs9993696-<b>T</b>,8 x 10-6,(GLM),NR,'-,6.3351 unit decrease,[NR],"POLN, HAUS3",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,4:2185650
rs1923775-<b>?</b>,9 x 10-6,(MLM),NR,'-,0.1839497 unit increase,[0.1-0.26],"POLN, HAUS3",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,4:2101369
rs4945082-<b>A</b>,5 x 10-6,(GLM),NR,'-,4.651 unit decrease,[NR],GVQW3,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,11:76401041
rs74370740-<b>C</b>,6 x 10-6,(GLM),NR,'-,8.9397 unit decrease,[NR],PRLR,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:35162774
rs2634458-<b>?</b>,6 x 10-6,(MLM),NR,'-,0.489852 unit decrease,[0.28-0.7],PSD3,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,8:18600936
rs73006788-<b>C</b>,1 x 10-6,(GLM),NR,'-,13.0042 unit decrease,[NR],NECTIN1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,11:119793235
rs142794624-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.5155792 unit increase,[0.3-0.73],RNA5SP214,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,6:117132166
rs1906727-<b>C</b>,8 x 10-6,(GLM),NR,'-,3.2907 unit increase,[NR],"MYO5A, SEPHS1P2",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,15:93411839
rs4901536-<b>?</b>,1 x 10-6,(MLM),NR,'-,0.2108473 unit increase,[0.13-0.3],SAMD4A,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,14:54733816
rs62380867-<b>?</b>,1 x 10-8,(MLM),NR,'-,0.5614234 unit increase,[0.37-0.75],SGCD,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:156619236
rs62380867-<b>A</b>,6 x 10-7,(GLM),NR,'-,7.9915 unit decrease,[NR],SGCD,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:156619236
rs62382696-<b>A</b>,1 x 10-6,(GLM),NR,'-,7.5388 unit decrease,[NR],SGCD,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:156466557
rs11082490-<b>?</b>,5 x 10-6,(MLM),NR,'-,0.2760101 unit increase,[0.16-0.39],SIGLEC15,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,18:45832663
rs1447514-<b>?</b>,5 x 10-6,(MLM),NR,'-,0.2921513 unit increase,[0.17-0.42],SLC17A6,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,11:22340750
rs111527967-<b>G</b>,7 x 10-6,(GLM),NR,'-,12.4453 unit decrease,[NR],SLC5A10,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,17:19008954
rs59721556-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.2285079 unit increase,[0.13-0.33],"COX6CP11, SPTLC2",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,14:77646050
rs76989557-<b>G</b>,1 x 10-6,(GLM),NR,'-,9.38 unit decrease,[NR],LINC00898,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,22:47616362
rs12915820-<b>T</b>,1 x 10-7,(GLM),NR,'-,3.4619 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,15:81716770
rs12915820-<b>?</b>,2 x 10-6,(MLM),NR,'-,0.1859238 unit increase,[0.11-0.26],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,15:81716770
rs73249047-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.4501463 unit increase,[0.25-0.65],TOX,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,8:58871645
rs111916630-<b>A</b>,5 x 10-6,(GLM),NR,'-,6.7737 unit decrease,[NR],NPM1P28,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,3:147592931
rs146460178-<b>C</b>,9 x 10-6,(GLM),NR,'-,15.8127 unit decrease,[NR],ZNF326,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,1:90109901
rs28785552-<b>?</b>,9 x 10-6,(MLM),NR,'-,0.1835087 unit increase,[0.1-0.26],ZNF611,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,19:52730908
rs138538719-<b>?</b>,5 x 10-8,(MLM),NR,'-,'-,'-,SGCD,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,5:156578156
rs80052780-<b>?</b>,4 x 10-7,(MLM),NR,'-,'-,'-,LINC00499,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,4:138346969
rs61854820-<b>?</b>,4 x 10-7,(MLM),NR,'-,'-,'-,ZWINT,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,10:56294881
rs74065827-<b>?</b>,7 x 10-7,(MLM),NR,'-,'-,'-,ADCK1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,14:77902942
rs9815738-<b>?</b>,7 x 10-7,(MLM),NR,'-,'-,'-,C3orf38,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,3:88155583
rs61857276-<b>?</b>,8 x 10-7,(MLM),NR,'-,'-,'-,ZWINT,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,10:56434080
rs78547569-<b>?</b>,2 x 10-6,(MLM),NR,'-,'-,'-,CCDC122,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,13:43866062
rs59721556-<b>?</b>,2 x 10-6,(MLM),NR,'-,'-,'-,"COX6CP11, SPTLC2",Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,14:77646050
rs118106993-<b>?</b>,3 x 10-6,(MLM),NR,'-,'-,'-,"OR10D3, OR10D1P",Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,11:124166986
rs72706301-<b>?</b>,3 x 10-6,(MLM),NR,'-,'-,'-,SERPINA1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,14:94385882
rs56175057-<b>?</b>,3 x 10-6,(MLM),NR,'-,'-,'-,MIR3681HG,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,2:12647004
rs7267005-<b>?</b>,4 x 10-6,(MLM),NR,'-,'-,'-,PHF20,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,20:35901643
rs145463728-<b>?</b>,5 x 10-6,(MLM),NR,'-,'-,'-,ENOX1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,13:43665045
rs12323387-<b>?</b>,6 x 10-6,(MLM),NR,'-,'-,'-,JDP2,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,14:75398548
rs7963446-<b>?</b>,6 x 10-6,(MLM),NR,'-,'-,'-,PTPN6,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,12:6956243
rs464250-<b>?</b>,6 x 10-6,(MLM),NR,'-,'-,'-,EFNA5,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,5:107528014
rs10758913-<b>?</b>,7 x 10-6,(MLM),NR,'-,'-,'-,DMAC1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,9:7887951
rs76297747-<b>?</b>,7 x 10-6,(MLM),NR,'-,'-,'-,HDHD2,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,18:47139286
rs77217161-<b>?</b>,7 x 10-6,(MLM),NR,'-,'-,'-,'-,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,10:56074184
rs7268897-<b>?</b>,8 x 10-6,(MLM),NR,'-,'-,'-,NFS1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,20:35678548
rs6055808-<b>?</b>,8 x 10-6,(MLM),NR,'-,'-,'-,PLCB1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,20:8426427
rs145252195-<b>?</b>,8 x 10-6,(MLM),NR,'-,'-,'-,COL26A1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,7:101528955
rs55728704-<b>?</b>,8 x 10-6,(MLM),NR,'-,'-,'-,IQGAP2,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,5:76647574
rs80058639-<b>?</b>,9 x 10-6,(MLM),NR,'-,'-,'-,DLGAP2,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,8:1214070
rs202106186-<b>?</b>,9 x 10-6,(MLM),NR,'-,'-,'-,"SMC5, KLF9",Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,9:70368818
rs6566288-<b>?</b>,9 x 10-6,(MLM),NR,'-,'-,'-,DSEL-AS1,Response to paliperidone in schizophrenia (Multivariate),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004043,18:67518184
rs2685441-<b>?</b>,2 x 10-6,(MLM),NR,'-,0.1840039 unit decrease,[0.11-0.26],LINC01899,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,18:71851474
rs644939-<b>?</b>,6 x 10-7,(MLM),NR,'-,0.2339642 unit increase,[0.14-0.33],ANO4,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,12:101060211
rs59721556-<b>?</b>,3 x 10-7,(MLM),NR,'-,0.2564292 unit increase,[0.16-0.35],"COX6CP11, SPTLC2",Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,14:77646050
rs11256768-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.23322 unit increase,[0.13-0.34],'-,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,10:10683500
rs17288586-<b>?</b>,7 x 10-6,(MLM),NR,'-,0.23989 unit increase,[0.14-0.34],CLIC5,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,6:45852033
rs56374507-<b>?</b>,3 x 10-8,(MLM),NR,'-,0.3768625 unit increase,[0.24-0.51],ADCK1,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,14:77914190
rs116144992-<b>?</b>,6 x 10-6,(MLM),NR,'-,0.3702252 unit decrease,[0.21-0.53],'-,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,3:6254168
rs11624682-<b>?</b>,9 x 10-6,(MLM),NR,'-,0.4273234 unit increase,[0.24-0.62],VIPAS39,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,14:77429295
rs7675231-<b>?</b>,5 x 10-6,(MLM),NR,'-,0.6654135 unit decrease,[0.38-0.95],RN7SL776P,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,4:167404683
rs56240334-<b>A</b>,8 x 10-8,(GLM),NR,'-,0.3808 unit decrease,[NR],ADCK1,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,14:77905060
rs72838804-<b>C</b>,5 x 10-7,(GLM),NR,'-,0.7565 unit decrease,[NR],B9D1,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,17:19338052
rs8094969-<b>A</b>,6 x 10-7,(GLM),NR,'-,0.206 unit increase,[NR],LINC01899,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,18:71833874
rs201061212-<b>TA</b>,1 x 10-6,(GLM),NR,'-,0.2113 unit increase,[NR],ZFAND6,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,15:80091637
rs59721556-<b>G</b>,2 x 10-6,(GLM),NR,'-,0.2371 unit decrease,[NR],"COX6CP11, SPTLC2",Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,14:77646050
rs183993610-<b>C</b>,2 x 10-6,(GLM),NR,'-,0.5537 unit decrease,[NR],"LNX1-AS1, LNX1",Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,4:53540709
rs2127826-<b>A</b>,3 x 10-6,(GLM),NR,'-,0.2289 unit decrease,[NR],"PDE5A, SEPTIN7P14",Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,4:119504060
rs111751755-<b>C</b>,3 x 10-6,(GLM),NR,'-,0.7606 unit decrease,[NR],SGCD,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,5:156553408
rs17555185-<b>G</b>,4 x 10-6,(GLM),NR,'-,0.6987 unit decrease,[NR],SGCD,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,5:156354547
chr3:67336707-<b>G</b>,4 x 10-6,(GLM),NR,'-,0.2255 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,Mapping not available
rs190585232-<b>C</b>,6 x 10-6,(GLM),NR,'-,0.5843 unit decrease,[NR],RASGRF2,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,5:81060251
rs34804741-<b>C</b>,7 x 10-6,(GLM),NR,'-,0.5383 unit decrease,[NR],EVL,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,14:100050504
rs502697-<b>G</b>,7 x 10-6,(GLM),NR,'-,0.2112 unit decrease,[NR],ANO4,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,12:101057493
chr4:7352632-<b>C</b>,6 x 10-6,(GLM),NR,'-,0.21 unit increase,[NR],'-,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,Mapping not available
rs10894895-<b>C</b>,9 x 10-6,(GLM),NR,'-,0.1931 unit decrease,[NR],LINC02697,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,11:134882140
rs76008570-<b>G</b>,9 x 10-6,(GLM),NR,'-,0.274 unit decrease,[NR],MIR5702,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,2:226611691
rs2944499-<b>T</b>,9 x 10-6,(GLM),NR,'-,0.1741 unit decrease,[NR],TCERG1L,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,10:131235052
rs9900497-<b>G</b>,4 x 10-6,(GLM),NR,'-,0.1968 unit decrease,[NR],SLC47A2,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,17:19714080
rs2560471-<b>A</b>,5 x 10-6,(GLM),NR,'-,0.3525 unit increase,[NR],'-,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,5:5811952
rs61909487-<b>C</b>,8 x 10-6,(GLM),NR,'-,0.6787 unit increase,[NR],PRMT8,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,12:3435254
rs113925979-<b>G</b>,8 x 10-6,(GLM),NR,'-,0.8082 unit increase,[NR],PTPN13,Response to paliperidone in schizophrenia (CGI-S score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004039,4:86797215
rs73506161-<b>C</b>,6 x 10-6,(GLM),NR,'-,1.3697 unit increase,[NR],ADGRE3,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,19:14643177
rs111527967-<b>G</b>,2 x 10-6,(GLM),NR,'-,4.2893 unit decrease,[NR],SLC5A10,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,17:19008954
rs73309282-<b>T</b>,3 x 10-6,(GLM),NR,'-,1.9187 unit increase,[NR],OXR1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,8:106483376
rs1451608-<b>G</b>,7 x 10-6,(GLM),NR,'-,3.2311 unit decrease,[NR],"GAPDHP70, CTSC",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,11:88386364
rs145847018-<b>G</b>,3 x 10-6,(GLM),NR,'-,3.2111 unit decrease,[NR],"PPM1AP1, TUSC3",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,8:15786716
rs75528631-<b>G</b>,8 x 10-6,(GLM),NR,'-,3.0592 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,11:37269808
rs147692810-<b>C</b>,5 x 10-6,(GLM),NR,'-,2.9933 unit decrease,[NR],STEAP2-AS1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,7:89924805
rs138538719-<b>C</b>,3 x 10-7,(GLM),NR,'-,2.5963 unit decrease,[NR],SGCD,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,5:156578156
rs5020196-<b>C</b>,2 x 10-6,(GLM),NR,'-,2.5638 unit decrease,[NR],RBFOX1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,16:7718619
rs62382696-<b>A</b>,7 x 10-7,(GLM),NR,'-,2.514 unit decrease,[NR],SGCD,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,5:156466557
rs2532643-<b>C</b>,9 x 10-7,(GLM),NR,'-,2.4204 unit decrease,[NR],"PDZD8, EMX2OS",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,10:117452370
rs4335177-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.1834814 unit increase,[0.11-0.26],LINC01505,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,9:106581778
rs3006553-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.186628 unit increase,[0.11-0.27],SVIL,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,10:29800065
rs4901536-<b>?</b>,9 x 10-6,(MLM),NR,'-,0.1919267 unit increase,[0.11-0.28],SAMD4A,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:54733816
rs59721556-<b>?</b>,1 x 10-7,(MLM),NR,'-,0.2615917 unit increase,[0.16-0.36],"COX6CP11, SPTLC2",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:77646050
rs34252091-<b>?</b>,1 x 10-6,(MLM),NR,'-,0.2422166 unit increase,[0.15-0.34],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,1:189924464
rs149053538-<b>?</b>,6 x 10-6,(MLM),NR,'-,0.247486 unit decrease,[0.14-0.35],PLD1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:171750468
rs11082490-<b>?</b>,2 x 10-6,(MLM),NR,'-,0.2858119 unit increase,[0.17-0.4],SIGLEC15,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,18:45832663
rs74065827-<b>?</b>,1 x 10-7,(MLM),NR,'-,0.3707302 unit increase,[0.24-0.51],ADCK1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:77902942
rs74405815-<b>?</b>,3 x 10-6,(MLM),NR,'-,0.3438862 unit increase,[0.2-0.49],CHCHD6,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:126800994
rs4903318-<b>G</b>,4 x 10-7,(GLM),NR,'-,1.0842 unit increase,[NR],JDP2,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:75399932
rs1906727-<b>C</b>,7 x 10-6,(GLM),NR,'-,1.086 unit increase,[NR],"MYO5A, SEPHS1P2",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,15:93411839
rs6777098-<b>T</b>,8 x 10-6,(GLM),NR,'-,1.1964 unit increase,[NR],ZBBX,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:167260917
rs56161922-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.3874831 unit decrease,[0.22-0.55],CR1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,1:207636488
rs2532643-<b>?</b>,1 x 10-6,(MLM),NR,'-,0.4471507 unit increase,[0.27-0.63],"PDZD8, EMX2OS",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,10:117452370
rs138538719-<b>?</b>,7 x 10-9,(MLM),NR,'-,0.5380868 unit increase,[0.36-0.72],SGCD,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,5:156578156
rs142794624-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.4962775 unit increase,[0.28-0.71],RNA5SP214,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,6:117132166
rs72838804-<b>C</b>,2 x 10-7,(GLM),NR,'-,4.3391 unit decrease,[NR],B9D1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,17:19338052
rs11984453-<b>G</b>,7 x 10-6,(GLM),NR,'-,1.8088 unit increase,[NR],CSMD1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,8:4647009
rs147466853-<b>C</b>,2 x 10-6,(GLM),NR,'-,3.7236 unit decrease,[NR],LINC00898,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,22:47716296
rs10769859-<b>G</b>,1 x 10-6,(GLM),NR,'-,2.9542 unit increase,[NR],EIF3F,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,11:7979900
chr8:102010440-<b>T</b>,6 x 10-6,(GLM),NR,'-,3.6429 unit increase,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,Mapping not available
rs77730715-<b>G</b>,5 x 10-6,(GLM),NR,'-,3.724 unit increase,[NR],CWH43,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,4:49027406
chr3:24752415-<b>C</b>,6 x 10-6,(GLM),NR,'-,4.5708 unit increase,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,Mapping not available
rs3767510-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.1748027 unit decrease,[0.1-0.25],CACNA1S,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,1:201075216
rs8008002-<b>?</b>,8 x 10-7,(MLM),NR,'-,0.1891768 unit decrease,[0.11-0.26],JDP2,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:75398980
rs28403489-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.1723415 unit increase,[0.097-0.248],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,15:81718161
rs9993696-<b>T</b>,3 x 10-6,(GLM),NR,'-,2.1804 unit decrease,[NR],"POLN, HAUS3",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,4:2185650
rs56240334-<b>A</b>,2 x 10-7,(GLM),NR,'-,2.0543 unit decrease,[NR],ADCK1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:77905060
rs6911131-<b>A</b>,5 x 10-6,(GLM),NR,'-,1.9021 unit decrease,[NR],PHACTR2,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,6:143544084
rs11439302-<b>G</b>,8 x 10-7,(GLM),NR,'-,1.6969 unit decrease,[NR],LINC02246,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,21:14869414
rs12434701-<b>C</b>,1 x 10-6,(GLM),NR,'-,1.3434 unit decrease,[NR],"COX6CP11, SPTLC2",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:77643001
rs4102217-<b>G</b>,7 x 10-6,(GLM),NR,'-,1.2945 unit decrease,[NR],"MALAT1, LINC02736",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,11:65496424
rs73878431-<b>G</b>,4 x 10-7,(GLM),NR,'-,1.248 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:166933488
rs57425123-<b>A</b>,8 x 10-6,(GLM),NR,'-,1.1038 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,7:25763634
rs3934047-<b>T</b>,3 x 10-6,(GLM),NR,'-,0.9856 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,15:81715972
rs6440475-<b>C</b>,6 x 10-6,(GLM),NR,'-,0.9637 unit decrease,[NR],RPL21P71,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:147221219
rs3006553-<b>G</b>,5 x 10-6,(GLM),NR,'-,1.0728 unit increase,[NR],SVIL,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,10:29800065
rs6911131-<b>?</b>,7 x 10-6,(MLM),NR,'-,0.3302258 unit increase,[0.19-0.47],PHACTR2,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,6:143544084
rs9930542-<b>?</b>,6 x 10-6,(MLM),NR,'-,0.3371169 unit increase,[0.19-0.48],RBFOX1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,16:7718742
rs139132350-<b>G</b>,8 x 10-6,(GLM),NR,'-,3.7624 unit decrease,[NR],MIR4432HG,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:60357702
rs45496701-<b>G</b>,9 x 10-6,(GLM),NR,'-,3.1538 unit decrease,[NR],ZNF362,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,1:33300620
rs141443024-<b>G</b>,9 x 10-6,(GLM),NR,'-,3.4524 unit decrease,[NR],TDRP,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:510240
rs1647768-<b>G</b>,9 x 10-6,(GLM),NR,'-,1.4641 unit decrease,[NR],PECR,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:216078567
rs34272020-<b>?</b>,3 x 10-7,(MLM),NR,'-,0.3507382 unit increase,[0.22-0.48],ADCK1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,14:77907829
rs56240334-<b>A</b>,9 x 10-7,(GLM),NR,'-,5.936 unit decrease,[NR],ADCK1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,14:77905060
rs2567700-<b>C</b>,7 x 10-6,(GLM),NR,'-,3.4596 unit decrease,[NR],AMBP,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,9:114076463
rs12344124-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.3106994 unit increase,[0.17-0.45],AMBP,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,9:114075465
rs73105738-<b>G</b>,5 x 10-6,(GLM),NR,'-,19.8193 unit decrease,[NR],ARHGEF28,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:73931380
rs77584330-<b>G</b>,3 x 10-6,(GLM),NR,'-,9.5184 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,13:70766522
rs72838804-<b>C</b>,2 x 10-6,(GLM),NR,'-,12.1314 unit decrease,[NR],B9D1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,17:19338052
rs6443921-<b>C</b>,7 x 10-6,(GLM),NR,'-,3.3779 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,3:166955476
rs141443024-<b>G</b>,9 x 10-6,(GLM),NR,'-,12.905 unit decrease,[NR],TDRP,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,8:510240
rs10247392-<b>?</b>,5 x 10-6,(MLM),NR,'-,0.1695217 unit decrease,[0.097-0.242],CALD1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,7:134883505
rs10247392-<b>G</b>,5 x 10-6,(GLM),NR,'-,2.9047 unit increase,[NR],CALD1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,7:134883505
rs182333180-<b>C</b>,1 x 10-6,(GLM),NR,'-,11.3945 unit decrease,[NR],CCDC122,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,13:43857773
rs115212412-<b>T</b>,9 x 10-6,(GLM),NR,'-,17.1602 unit decrease,[NR],"HSP90B3P, WDR82P2",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,1:91544232
rs56161922-<b>?</b>,7 x 10-6,(MLM),NR,'-,0.3780124 unit decrease,[0.21-0.54],CR1,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,1:207636488
rs145712811-<b>A</b>,2 x 10-6,(GLM),NR,'-,13.4185 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,8:113555989
rs55774002-<b>C</b>,7 x 10-6,(GLM),NR,'-,6.2895 unit decrease,[NR],CWH43,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,4:49037941
rs73506161-<b>C</b>,5 x 10-6,(GLM),NR,'-,4.1977 unit increase,[NR],ADGRE3,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,19:14643177
rs151233144-<b>C</b>,5 x 10-6,(GLM),NR,'-,9.3214 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,22:47765137
rs144212837-<b>T</b>,2 x 10-6,(GLM),NR,'-,23.0292 unit decrease,[NR],IGLC7,Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,22:22956986
rs192381152-<b>A</b>,3 x 10-6,(GLM),NR,'-,4.0968 unit decrease,[NR],"FLJ31104, ANKRD55",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,5:56031173
rs201581573-<b>TA</b>,2 x 10-6,(GLM),NR,'-,10.6514 unit decrease,[NR],"TUSC3, PPM1AP1",Response to paliperidone in schizophrenia (PANSS score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004042,8:15777526
rs117858172-<b>G</b>,2 x 10-6,(GLM),NR,'-,3.8171 unit decrease,[NR],ETS1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,11:128440905
rs7419486-<b>T</b>,3 x 10-6,(GLM),NR,'-,1.4142 unit decrease,[NR],DPP10,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:115672654
rs146790986-<b>C</b>,3 x 10-6,(GLM),NR,'-,3.6312 unit decrease,[NR],SGCZ,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:14810524
chr2:71975709-<b>C</b>,3 x 10-6,(GLM),NR,'-,7.5668 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,Mapping not available
rs143325061-<b>A</b>,3 x 10-6,(GLM),NR,'-,2.7622 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:56579595
rs76799118-<b>T</b>,3 x 10-6,(GLM),NR,'-,5.8703 unit decrease,[NR],FAP,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:162222501
rs146767487-<b>T</b>,3 x 10-6,(GLM),NR,'-,4.0595 unit decrease,[NR],LINC02152,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,16:8352071
rs182734081-<b>C</b>,4 x 10-6,(GLM),NR,'-,5.7984 unit decrease,[NR],"FSTL5, MTHFD2P4",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,4:162231756
rs74757231-<b>G</b>,4 x 10-6,(GLM),NR,'-,3.7011 unit decrease,[NR],TENM2,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,5:168087215
rs189688109-<b>T</b>,4 x 10-6,(GLM),NR,'-,2.713 unit decrease,[NR],ENOX1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,13:43442961
rs77561866-<b>A</b>,4 x 10-6,(GLM),NR,'-,4.5798 unit decrease,[NR],LINC02177,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,16:9282898
chr17:60904543-<b>C</b>,4 x 10-6,(GLM),NR,'-,6.9554 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,Mapping not available
rs61854820-<b>C</b>,5 x 10-6,(GLM),NR,'-,2.4396 unit decrease,[NR],ZWINT,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:56294881
rs150863502-<b>G</b>,5 x 10-6,(GLM),NR,'-,5.6704 unit decrease,[NR],RSPH14,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,22:23029925
rs117612853-<b>C</b>,6 x 10-6,(GLM),NR,'-,3.4459 unit increase,[NR],"LINC00709, CACNB2",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:9385373
rs117295891-<b>G</b>,6 x 10-6,(GLM),NR,'-,2.4809 unit decrease,[NR],VWC2,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,7:49691344
rs4562622-<b>C</b>,6 x 10-6,(GLM),NR,'-,1.6989 unit increase,[NR],CR1L,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,1:207703232
rs11956350-<b>A</b>,6 x 10-6,(GLM),NR,'-,4.9287 unit increase,[NR],LINC02223,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,5:17706242
rs77217161-<b>A</b>,6 x 10-6,(GLM),NR,'-,2.5732 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:56074184
rs59000197-<b>T</b>,6 x 10-6,(GLM),NR,'-,2.5473 unit increase,[NR],HIBCH,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:190244144
rs56031646-<b>T</b>,7 x 10-6,(GLM),NR,'-,3.4102 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,6:76863427
rs182020790-<b>G</b>,7 x 10-6,(GLM),NR,'-,4.7248 unit decrease,[NR],"PRG4, HMCN1",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,1:186258139
rs116557595-<b>G</b>,7 x 10-6,(GLM),NR,'-,3.8348 unit decrease,[NR],FSTL5,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,4:161980073
rs188710179-<b>A</b>,7 x 10-6,(GLM),NR,'-,7.3835 unit decrease,[NR],MAILR,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:102985733
rs7554419-<b>C</b>,8 x 10-6,(GLM),NR,'-,0.9641 unit decrease,[NR],VPS45,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,1:150069348
rs2382999-<b>G</b>,3 x 10-7,(GLM),NR,'-,1.8534 unit decrease,[NR],"LINC00964, ZNF572",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:124967335
rs188803409-<b>A</b>,3 x 10-7,(GLM),NR,'-,7.2424 unit decrease,[NR],RBFOX1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,16:6990147
rs79862545-<b>C</b>,3 x 10-7,(GLM),NR,'-,6.1924 unit decrease,[NR],"U8, CLMP",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,11:123278215
rs149776388-<b>C</b>,5 x 10-7,(GLM),NR,'-,6.7037 unit decrease,[NR],XKR6,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:11008861
rs7036881-<b>C</b>,7 x 10-7,(GLM),NR,'-,4.5047 unit decrease,[NR],CACNA1B,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,9:138076309
rs73177327-<b>C</b>,7 x 10-7,(GLM),NR,'-,3.781 unit decrease,[NR],NRAD1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,13:43983531
rs138707712-<b>T</b>,7 x 10-7,(GLM),NR,'-,4.7564 unit decrease,[NR],OSCP1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,1:36447523
rs141473550-<b>A</b>,9 x 10-7,(GLM),NR,'-,4.864 unit decrease,[NR],"SH3GL2, ADAMTSL1",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,9:17878240
rs117673608-<b>G</b>,1 x 10-6,(GLM),NR,'-,6.9628 unit decrease,[NR],PRKN,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,6:161931643
rs73006788-<b>C</b>,1 x 10-6,(GLM),NR,'-,3.4802 unit decrease,[NR],NECTIN1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,11:119793235
rs12001041-<b>A</b>,1 x 10-6,(GLM),NR,'-,1.2081 unit increase,[NR],"PAEPP1, GLT6D1",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,9:135600269
rs182333180-<b>C</b>,1 x 10-6,(GLM),NR,'-,3.0708 unit decrease,[NR],CCDC122,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,13:43857773
rs180968789-<b>T</b>,1 x 10-6,(GLM),NR,'-,3.8855 unit increase,[NR],MIR3147,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,7:57356326
rs150202118-<b>G</b>,1 x 10-6,(GLM),NR,'-,7.3719 unit decrease,[NR],IQGAP2,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,5:76459601
rs201447509-<b>ATC</b>,1 x 10-6,(GLM),NR,'-,1.8871 unit decrease,[NR],NSMCE2,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:125236380
rs2083117-<b>G</b>,1 x 10-6,(GLM),NR,'-,2.1099 unit increase,[NR],Metazoa_SRP,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,15:96536103
rs147237795-<b>G</b>,2 x 10-6,(GLM),NR,'-,4.1116 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,11:127546637
rs116939006-<b>C</b>,2 x 10-6,(GLM),NR,'-,3.5749 unit decrease,[NR],SGCZ,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:14416309
rs28425639-<b>T</b>,2 x 10-6,(GLM),NR,'-,3.0464 unit decrease,[NR],AFF3,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:99936050
rs78178087-<b>G</b>,2 x 10-6,(GLM),NR,'-,3.9925 unit decrease,[NR],CACNA1B,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,9:137974654
rs78309295-<b>A</b>,2 x 10-6,(GLM),NR,'-,6.5925 unit decrease,[NR],TRIB1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:125516480
rs79886049-<b>A</b>,2 x 10-6,(GLM),NR,'-,2.8136 unit increase,[NR],PTPRT,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,20:42702075
rs79851935-<b>T</b>,2 x 10-6,(GLM),NR,'-,5.7487 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,17:54257841
rs191581512-<b>G</b>,2 x 10-6,(GLM),NR,'-,4.7236 unit decrease,[NR],LINC00390,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,13:44105194
rs2103655-<b>A</b>,1 x 10-10,(EA),NR,1.0796,'-,[1.06-1.1],"PPP1R16B, ACTR5",Schizophrenia,schizophrenia,GCST007201,20:38797315
rs7893279-<b>T</b>,1 x 10-10,(EA),NR,1.119,'-,[1.08-1.15],CACNB2,Schizophrenia,schizophrenia,GCST007201,10:18456176
rs760648-<b>A</b>,1 x 10-10,(EA),NR,1.079,'-,[1.06-1.1],TCF20,Schizophrenia,schizophrenia,GCST007201,22:42175022
rs3617-<b>C</b>,1 x 10-10,(EA),NR,1.073,'-,[1.05-1.09],ITIH3,Schizophrenia,schizophrenia,GCST007201,3:52799789
rs2414718-<b>A</b>,2 x 10-10,(EA),NR,1.072,'-,[1.05-1.09],'-,Schizophrenia,schizophrenia,GCST007201,15:61570934
rs28437878-<b>C</b>,2 x 10-10,(EA),NR,1.087,'-,[1.06-1.11],HYKK,Schizophrenia,schizophrenia,GCST007201,15:78515530
rs12691307-<b>A</b>,2 x 10-10,(EA),NR,1.075,'-,[1.05-1.1],"TMEM219, KCTD13",Schizophrenia,schizophrenia,GCST007201,16:29928556
rs12704290-<b>G</b>,3 x 10-10,(EA),NR,1.112,'-,[1.08-1.14],"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST007201,7:86798310
rs4271249-<b>T</b>,3 x 10-10,(EA),NR,1.074,'-,[1.05-1.1],DPYD,Schizophrenia,schizophrenia,GCST007201,1:97933063
rs6918354-<b>T</b>,4 x 10-10,(EA),NR,1.081,'-,[1.06-1.11],"CARMIL1, CMAHP",Schizophrenia,schizophrenia,GCST007201,6:25444386
rs758117-<b>C</b>,8 x 10-10,,NR,1.0695187,'-,[1.05-1.09],CACNA1C,Schizophrenia,schizophrenia,GCST007201,12:2404143
rs302321-<b>C</b>,7 x 10-10,,NR,1.0626993,'-,[1.04-1.08],TMTC1,Schizophrenia,schizophrenia,GCST007201,12:29775455
rs10878577-<b>A</b>,2 x 10-7,,NR,1.063,'-,[1.04-1.09],"GGTA2P, RAB11AP2",Schizophrenia,schizophrenia,GCST007201,12:67200061
rs4240748-<b>G</b>,1 x 10-9,,NR,1.0626993,'-,[1.04-1.08],LINC02404,Schizophrenia,schizophrenia,GCST007201,12:91853010
rs4766428-<b>T</b>,3 x 10-10,,NR,1.07,'-,[1.05-1.09],ATP2A2,Schizophrenia,schizophrenia,GCST007201,12:110285440
rs28607014-<b>C</b>,1 x 10-7,,NR,1.0537407,'-,[1.03-1.07],NOS1,Schizophrenia,schizophrenia,GCST007201,12:117270806
rs1615350-<b>C</b>,1 x 10-17,,NR,1.0928961,'-,[1.07-1.11],MPHOSPH9,Schizophrenia,schizophrenia,GCST007201,12:123165788
rs34102591-<b>G</b>,1 x 10-6,,NR,1.0626993,'-,[1.04-1.09],"ZNF664, RFLNA",Schizophrenia,schizophrenia,GCST007201,12:123996254
rs1411740-<b>A</b>,8 x 10-7,,NR,1.051,'-,[1.03-1.07],LINC00571,Schizophrenia,schizophrenia,GCST007201,13:38256005
rs10148671-<b>C</b>,3 x 10-7,,NR,1.0526316,'-,[1.03-1.07],LINC02326,Schizophrenia,schizophrenia,GCST007201,14:29000167
rs2383377-<b>A</b>,1 x 10-9,,NR,1.09,'-,[1.06-1.12],AKAP6,Schizophrenia,schizophrenia,GCST007201,14:32788708
rs12431410-<b>C</b>,8 x 10-8,,NR,1.0548522,'-,[1.04-1.07],RTN1,Schizophrenia,schizophrenia,GCST007201,14:59699304
rs11625793-<b>G</b>,2 x 10-6,,NR,1.0504202,'-,[1.03-1.07],NCOA4P1,Schizophrenia,schizophrenia,GCST007201,14:65849165
rs2526882-<b>G</b>,2 x 10-7,,NR,1.0537407,'-,[1.03-1.07],PCNX1,Schizophrenia,schizophrenia,GCST007201,14:70907985
rs35607894-<b>A</b>,6 x 10-10,,NR,1.09,'-,[1.06-1.12],RGS6,Schizophrenia,schizophrenia,GCST007201,14:71941921
rs7619427-<b>G</b>,4 x 10-7,,NR,1.0857763,'-,[1.05-1.12],RNU6-367P,Schizophrenia,schizophrenia,GCST007201,3:44035549
rs9882618-<b>T</b>,2 x 10-6,,NR,1.097,'-,[1.06-1.14],"SLC38A3, GNAT1",Schizophrenia,schizophrenia,GCST007201,3:50200112
rs2577831-<b>C</b>,2 x 10-13,,NR,1.0695187,'-,[1.05-1.09],PBRM1,Schizophrenia,schizophrenia,GCST007201,3:52594040
rs2358740-<b>G</b>,3 x 10-7,,NR,1.0515248,'-,[1.03-1.07],CACNA1D,Schizophrenia,schizophrenia,GCST007201,3:53421542
rs1353545-<b>C</b>,2 x 10-8,,NR,1.062,'-,[1.04-1.08],FHIT,Schizophrenia,schizophrenia,GCST007201,3:60302116
rs832190-<b>C</b>,5 x 10-9,,NR,1.059322,'-,[1.04-1.08],THOC7,Schizophrenia,schizophrenia,GCST007201,3:63856953
rs7372960-<b>T</b>,4 x 10-7,,NR,1.065,'-,[1.04-1.09],FOXP1,Schizophrenia,schizophrenia,GCST007201,3:71205600
rs1838472-<b>C</b>,4 x 10-7,,NR,1.0526316,'-,[1.03-1.07],KALRN,Schizophrenia,schizophrenia,GCST007201,3:124332814
rs6804239-<b>C</b>,9 x 10-10,,NR,1.0604454,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,3:162062700
rs66691851-<b>C</b>,2 x 10-13,,NR,1.0752687,'-,[1.06-1.09],STAG1,Schizophrenia,schizophrenia,GCST007201,3:136435986
rs192812-<b>C</b>,3 x 10-8,,NR,1.0570824,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,3:161774043
rs4391122-<b>A</b>,9 x 10-13,(EA),NR,1.0811,'-,[1.06-1.1],LINC02057,Schizophrenia,schizophrenia,GCST007201,5:61302716
rs1150754-<b>C</b>,3 x 10-12,(EA),NR,1.117,'-,[1.09-1.15],TNXB,Schizophrenia,schizophrenia,GCST007201,6:32082981
rs9607782-<b>A</b>,4 x 10-12,(EA),NR,1.0928,'-,[1.07-1.12],EP300-AS1,Schizophrenia,schizophrenia,GCST007201,22:41191552
rs114377514-<b>C</b>,4 x 10-12,(EA),NR,1.112,'-,[1.08-1.14],"HLA-DOB, HLA-DQB2",Schizophrenia,schizophrenia,GCST007201,6:32793729
rs111312615-<b>T</b>,4 x 10-12,(EA),NR,1.137,'-,[1.1-1.17],"HLA-A, HLA-W",Schizophrenia,schizophrenia,GCST007201,6:29955302
rs214467-<b>A</b>,5 x 10-12,(EA),NR,1.0833,'-,[1.06-1.11],IMMP2L,Schizophrenia,schizophrenia,GCST007201,7:111218212
rs114508985-<b>G</b>,5 x 10-12,(EA),NR,1.101,'-,[1.07-1.13],"HLA-DMB, HLA-Z",Schizophrenia,schizophrenia,GCST007201,6:32932241
rs55661361-<b>G</b>,1 x 10-11,(EA),NR,1.082,'-,[1.06-1.1],NRGN,Schizophrenia,schizophrenia,GCST007201,11:124744061
rs75059851-<b>A</b>,2 x 10-11,(EA),NR,1.0956,'-,[1.07-1.12],IGSF9B,Schizophrenia,schizophrenia,GCST007201,11:133952674
rs7907645-<b>T</b>,2 x 10-11,(EA),NR,1.155,'-,[1.11-1.2],"TRIM8, ARL3",Schizophrenia,schizophrenia,GCST007201,10:102664043
rs5995756-<b>T</b>,3 x 10-11,(EA),NR,1.075,'-,[1.05-1.1],CACNA1I,Schizophrenia,schizophrenia,GCST007201,22:39604308
rs17514846-<b>C</b>,6 x 10-11,(EA),NR,1.076,'-,[1.05-1.1],FURIN,Schizophrenia,schizophrenia,GCST007201,15:90873320
rs12902973-<b>G</b>,9 x 10-11,(EA),NR,1.082,'-,[1.06-1.11],UBE2Q2P1,Schizophrenia,schizophrenia,GCST007201,15:84562751
rs28758902-<b>T</b>,1 x 10-10,(EA),NR,1.073,'-,[1.05-1.09],"LINC01415, TCF4",Schizophrenia,schizophrenia,GCST007201,18:55740956
rs117325001-<b>T</b>,7 x 10-6,(East Asian),NR,1.076,'-,[1.04-1.11],BNIP3L,Schizophrenia,schizophrenia,GCST007201,8:26384756
rs117900362-<b>C</b>,5 x 10-6,(East Asian),NR,1.198,'-,[1.12-1.28],KIAA1217,Schizophrenia,schizophrenia,GCST007201,10:23861388
rs3759413-<b>T</b>,1 x 10-6,(East Asian),NR,1.108,'-,[1.07-1.15],CLSTN3,Schizophrenia,schizophrenia,GCST007201,12:7138610
rs10744422-<b>T</b>,6 x 10-7,(East Asian),NR,1.093,'-,[1.06-1.13],HIP1R,Schizophrenia,schizophrenia,GCST007201,12:122852242
rs61990820-<b>A</b>,4 x 10-6,(East Asian),NR,1.114,'-,[1.07-1.16],NRXN3,Schizophrenia,schizophrenia,GCST007201,14:79899927
rs76528668-<b>T</b>,9 x 10-6,(East Asian),NR,1.161,'-,[1.08-1.24],RYR3,Schizophrenia,schizophrenia,GCST007201,15:33465539
rs1792709-<b>G</b>,3 x 10-8,(East Asian),NR,1.1428571,'-,[1.1-1.19],"LINC01905, LINC01539",Schizophrenia,schizophrenia,GCST007201,18:56101744
rs172531-<b>G</b>,1 x 10-9,,NR,1.0683761,'-,[1.05-1.09],RERE,Schizophrenia,schizophrenia,GCST007201,1:8435530
rs4949526-<b>T</b>,6 x 10-11,,NR,1.069,'-,[1.05-1.09],LINC01648,Schizophrenia,schizophrenia,GCST007201,1:29959372
rs2970610-<b>T</b>,1 x 10-10,,NR,1.066,'-,[1.05-1.09],"KDM4A, PTPRF",Schizophrenia,schizophrenia,GCST007201,1:43631859
rs12138061-<b>A</b>,1 x 10-7,,NR,1.059,'-,[1.04-1.08],ELAVL4,Schizophrenia,schizophrenia,GCST007201,1:50106424
rs4347184-<b>T</b>,1 x 10-7,,NR,1.051,'-,[1.03-1.07],PDE4B,Schizophrenia,schizophrenia,GCST007201,1:65848311
rs11210195-<b>C</b>,2 x 10-9,,NR,1.059322,'-,[1.04-1.08],"RN7SKP19, LINC01360",Schizophrenia,schizophrenia,GCST007201,1:73283600
rs36025579-<b>G</b>,2 x 10-6,,NR,1.049318,'-,[1.03-1.07],DPYD,Schizophrenia,schizophrenia,GCST007201,1:97337068
rs1198589-<b>C</b>,8 x 10-14,,NR,1.1049724,'-,[1.08-1.13],NFU1P2,Schizophrenia,schizophrenia,GCST007201,1:98084855
rs3756766-<b>A</b>,1 x 10-8,,NR,1.067,'-,[1.04-1.09],"FAM53C, CDC25C",Schizophrenia,schizophrenia,GCST007201,5:138337478
rs13164092-<b>G</b>,2 x 10-10,,NR,1.0638298,'-,[1.04-1.08],"ETF1, RPL7P19",Schizophrenia,schizophrenia,GCST007201,5:138505171
rs7733403-<b>A</b>,1 x 10-8,,NR,1.055,'-,[1.04-1.07],"PCDHA1, VTRNA1-3",Schizophrenia,schizophrenia,GCST007201,5:140774630
rs319204-<b>T</b>,5 x 10-6,,NR,1.047,'-,[1.03-1.07],PPP2R2B,Schizophrenia,schizophrenia,GCST007201,5:146882926
rs113568682-<b>A</b>,5 x 10-9,,NR,1.069,'-,[1.05-1.09],LINC01470,Schizophrenia,schizophrenia,GCST007201,5:152920194
rs2910032-<b>C</b>,6 x 10-9,,NR,1.0582011,'-,[1.04-1.08],LINC01470,Schizophrenia,schizophrenia,GCST007201,5:153160794
rs7727515-<b>G</b>,6 x 10-7,,NR,1.0799136,'-,[1.05-1.11],GRIA1,Schizophrenia,schizophrenia,GCST007201,5:153512744
rs11740474-<b>T</b>,2 x 10-8,,NR,1.0626993,'-,[1.04-1.08],GALNT10,Schizophrenia,schizophrenia,GCST007201,5:154301187
rs6903570-<b>C</b>,2 x 10-8,,NR,1.0582011,'-,[1.04-1.08],EYS,Schizophrenia,schizophrenia,GCST007201,6:64156964
rs34321714-<b>G</b>,1 x 10-7,,NR,1.0526316,'-,[1.03-1.07],RIMS1,Schizophrenia,schizophrenia,GCST007201,6:72454442
rs7915131-<b>C</b>,3 x 10-7,,NR,1.0504202,'-,[1.03-1.07],ALDH7A1P4,Schizophrenia,schizophrenia,GCST007201,10:62658896
rs111364339-<b>C</b>,1 x 10-8,,NR,1.1061947,'-,[1.07-1.14],RNU6-543P,Schizophrenia,schizophrenia,GCST007201,10:63098112
rs11191424-<b>G</b>,3 x 10-16,,NR,1.0775862,'-,[1.06-1.1],BORCS7-ASMT,Schizophrenia,schizophrenia,GCST007201,10:102866129
rs10786736-<b>G</b>,8 x 10-12,,NR,1.0952903,'-,[1.07-1.12],"CNNM2, NT5C2",Schizophrenia,schizophrenia,GCST007201,10:103089359
rs17234749-<b>G</b>,2 x 10-8,,NR,1.0582011,'-,[1.04-1.08],"Y_RNA, LINC02686",Schizophrenia,schizophrenia,GCST007201,11:24360352
rs61882743-<b>G</b>,2 x 10-11,,NR,1.0928961,'-,[1.07-1.12],AMBRA1,Schizophrenia,schizophrenia,GCST007201,11:46527204
rs9420-<b>A</b>,2 x 10-8,,NR,1.061,'-,[1.04-1.08],SELENOH,Schizophrenia,schizophrenia,GCST007201,11:57742822
rs7934083-<b>C</b>,2 x 10-7,,NR,1.0548522,'-,[1.03-1.08],MTND4LP18,Schizophrenia,schizophrenia,GCST007201,11:81492479
rs1864774-<b>C</b>,2 x 10-8,,NR,1.0548522,'-,[1.04-1.07],DLG2,Schizophrenia,schizophrenia,GCST007201,11:83488233
rs12421382-<b>C</b>,2 x 10-8,,NR,1.0570824,'-,[1.04-1.08],C11orf87,Schizophrenia,schizophrenia,GCST007201,11:109507345
rs4987094-<b>A</b>,2 x 10-8,,NR,1.072,'-,[1.05-1.1],TTC12,Schizophrenia,schizophrenia,GCST007201,11:113345201
rs2514218-<b>C</b>,1 x 10-10,,NR,1.0752687,'-,[1.05-1.1],DRD2,Schizophrenia,schizophrenia,GCST007201,11:113522272
rs77502336-<b>C</b>,1 x 10-10,,NR,1.068,'-,[1.05-1.09],GRAMD1B,Schizophrenia,schizophrenia,GCST007201,11:123523928
rs55661361-<b>G</b>,4 x 10-13,,NR,1.0752687,'-,[1.06-1.09],NRGN,Schizophrenia,schizophrenia,GCST007201,11:124744061
rs10894308-<b>G</b>,9 x 10-9,,NR,1.0582011,'-,[1.04-1.08],RN7SL167P,Schizophrenia,schizophrenia,GCST007201,11:131022000
rs75059851-<b>A</b>,1 x 10-12,,NR,1.098,'-,[1.07-1.12],IGSF9B,Schizophrenia,schizophrenia,GCST007201,11:133952674
rs2159100-<b>T</b>,6 x 10-18,,NR,1.099,'-,[1.08-1.12],CACNA1C,Schizophrenia,schizophrenia,GCST007201,12:2237227
rs11708578-<b>G</b>,1 x 10-10,,NR,1.0799136,'-,[1.06-1.1],CNTN4,Schizophrenia,schizophrenia,GCST007201,3:2474210
rs10199182-<b>A</b>,4 x 10-7,,NR,1.054,'-,[1.03-1.07],LINC01884,Schizophrenia,schizophrenia,GCST007201,2:22524252
rs4330281-<b>C</b>,3 x 10-8,,NR,1.0604454,'-,[1.04-1.08],TBC1D5,Schizophrenia,schizophrenia,GCST007201,3:17817874
rs10803138-<b>G</b>,3 x 10-8,,NR,1.0706638,'-,[1.05-1.09],SDCCAG8,Schizophrenia,schizophrenia,GCST007201,1:243391917
rs35978510-<b>C</b>,2 x 10-10,,NR,1.066098,'-,[1.05-1.09],AKT3,Schizophrenia,schizophrenia,GCST007201,1:243612815
rs1506297-<b>T</b>,3 x 10-7,,NR,1.06,'-,[1.04-1.08],RBMS3,Schizophrenia,schizophrenia,GCST007201,3:30030816
rs10510653-<b>A</b>,7 x 10-7,,NR,1.068,'-,[1.04-1.09],OSBPL10,Schizophrenia,schizophrenia,GCST007201,3:32017067
rs3732386-<b>T</b>,4 x 10-11,,NR,1.074,'-,[1.05-1.1],TRANK1,Schizophrenia,schizophrenia,GCST007201,3:36830502
rs35324223-<b>G</b>,2 x 10-10,(EA),NR,1.0964912,'-,[1.07-1.12],MDK,Schizophrenia,schizophrenia,GCST007201,11:46381302
rs61882743-<b>G</b>,3 x 10-10,(EA),NR,1.0944512,'-,[1.07-1.12],AMBRA1,Schizophrenia,schizophrenia,GCST007201,11:46527204
rs36068923-<b>G</b>,4 x 10-10,(EA),NR,1.0869565,'-,[1.06-1.11],SINHCAFP3,Schizophrenia,schizophrenia,GCST007201,8:110473532
rs66492629-<b>A</b>,4 x 10-10,(EA),NR,1.098901,'-,[1.07-1.13],CNTN4,Schizophrenia,schizophrenia,GCST007201,3:2496596
rs35998080-<b>T</b>,7 x 10-10,(EA),NR,1.0718113,'-,[1.05-1.09],LINC02797,Schizophrenia,schizophrenia,GCST007201,1:72812932
rs2332700-<b>C</b>,7 x 10-10,(EA),NR,1.0799136,'-,[1.06-1.1],RGS6,Schizophrenia,schizophrenia,GCST007201,14:71950609
rs11874716-<b>T</b>,1 x 10-9,(EA),NR,1.0695187,'-,[1.05-1.09],LINC01929,Schizophrenia,schizophrenia,GCST007201,18:55083457
rs10890032-<b>T</b>,1 x 10-9,(EA),NR,1.0706638,'-,[1.05-1.09],LINC01360,Schizophrenia,schizophrenia,GCST007201,1:73323641
rs2015244-<b>A</b>,1 x 10-9,(EA),NR,1.0741138,'-,[1.05-1.1],LINC01648,Schizophrenia,schizophrenia,GCST007201,1:29956096
rs13176930-<b>T</b>,1 x 10-9,(EA),NR,1.0718113,'-,[1.05-1.09],LINC01470,Schizophrenia,schizophrenia,GCST007201,5:153285161
rs8055219-<b>A</b>,1 x 10-9,(EA),NR,1.0799136,'-,[1.06-1.1],MIR4719,Schizophrenia,schizophrenia,GCST007201,16:13659527
rs7596038-<b>C</b>,2 x 10-9,(EA),NR,1.068262,'-,[1.05-1.09],VRK2,Schizophrenia,schizophrenia,GCST007201,2:58156685
rs56007784-<b>C</b>,1 x 10-7,,NR,1.052,'-,[1.03-1.07],YWHAE,Schizophrenia,schizophrenia,GCST007201,17:1387656
rs4523957-<b>T</b>,4 x 10-9,,NR,1.063,'-,[1.04-1.08],SRR,Schizophrenia,schizophrenia,GCST007201,17:2305605
rs8082590-<b>G</b>,9 x 10-10,,NR,1.0695187,'-,[1.05-1.09],GID4,Schizophrenia,schizophrenia,GCST007201,17:18055088
rs72843506-<b>A</b>,1 x 10-8,,NR,1.073,'-,[1.05-1.1],SPECC1,Schizophrenia,schizophrenia,GCST007201,17:20042974
rs35065479-<b>A</b>,5 x 10-6,,NR,1.054,'-,[1.03-1.08],MSI2,Schizophrenia,schizophrenia,GCST007201,17:57659374
rs12327082-<b>T</b>,3 x 10-7,,NR,1.0548522,'-,[1.03-1.08],NOL4,Schizophrenia,schizophrenia,GCST007201,18:34011495
rs4632195-<b>T</b>,7 x 10-7,,NR,1.053,'-,[1.03-1.07],DCC,Schizophrenia,schizophrenia,GCST007201,18:53220378
rs7233277-<b>A</b>,3 x 10-7,,NR,1.049,'-,[1.03-1.07],LINC01929,Schizophrenia,schizophrenia,GCST007201,18:55074287
rs17598729-<b>C</b>,9 x 10-11,,NR,1.0893246,'-,[1.06-1.12],TCF4,Schizophrenia,schizophrenia,GCST007201,18:55584331
rs715170-<b>C</b>,1 x 10-11,,NR,1.0775862,'-,[1.06-1.1],"LINC01539, LINC01905",Schizophrenia,schizophrenia,GCST007201,18:56128283
rs28735056-<b>G</b>,5 x 10-9,,NR,1.059322,'-,[1.04-1.08],KCNG2,Schizophrenia,schizophrenia,GCST007201,18:79862879
rs3764567-<b>T</b>,4 x 10-8,,NR,1.045,'-,[1.03-1.06],MAU2,Schizophrenia,schizophrenia,GCST007201,19:19329257
rs2053079-<b>G</b>,5 x 10-9,,NR,1.066098,'-,[1.04-1.09],ZNF536,Schizophrenia,schizophrenia,GCST007201,19:30496516
rs2194545-<b>G</b>,9 x 10-7,(EA),NR,1.054741,'-,[1.03-1.08],"SNF8P1, LINC01807",Schizophrenia,schizophrenia,GCST007201,2:228418495
rs61847307-<b>C</b>,1 x 10-6,(EA),NR,1.0616838,'-,[1.04-1.09],PRKG1,Schizophrenia,schizophrenia,GCST007201,10:52184682
rs12623170-<b>C</b>,1 x 10-6,(EA),NR,1.0670081,'-,[1.04-1.09],"RBKS, MRPL33",Schizophrenia,schizophrenia,GCST007201,2:27797290
rs6500596-<b>G</b>,1 x 10-6,(EA),NR,1.0632641,'-,[1.04-1.09],"CORO7-PAM16, CORO7",Schizophrenia,schizophrenia,GCST007201,16:4420026
rs28607014-<b>C</b>,1 x 10-6,(EA),NR,1.056859,'-,[1.03-1.08],NOS1,Schizophrenia,schizophrenia,GCST007201,12:117270806
rs11625793-<b>G</b>,1 x 10-6,(EA),NR,1.0557432,'-,[1.03-1.08],NCOA4P1,Schizophrenia,schizophrenia,GCST007201,14:65849165
rs9292918-<b>G</b>,1 x 10-6,(EA),NR,1.0699764,'-,[1.04-1.1],HCN1,Schizophrenia,schizophrenia,GCST007201,5:45300933
rs2358740-<b>G</b>,1 x 10-6,(EA),NR,1.0577533,'-,[1.04-1.08],CACNA1D,Schizophrenia,schizophrenia,GCST007201,3:53421542
rs1864774-<b>C</b>,2 x 10-6,(EA),NR,1.0532968,'-,[1.03-1.07],DLG2,Schizophrenia,schizophrenia,GCST007201,11:83488233
rs3824451-<b>C</b>,3 x 10-6,(EA),NR,1.0733069,'-,[1.04-1.1],GABBR2,Schizophrenia,schizophrenia,GCST007201,9:98309240
rs221780-<b>G</b>,3 x 10-6,(EA),NR,1.0719262,'-,[1.04-1.1],"POP7, GIGYF1",Schizophrenia,schizophrenia,GCST007201,7:100699412
rs7619427-<b>G</b>,3 x 10-6,(EA),NR,1.0833063,'-,[1.05-1.12],RNU6-367P,Schizophrenia,schizophrenia,GCST007201,3:44035549
rs7915131-<b>C</b>,3 x 10-6,(EA),NR,1.0521885,'-,[1.03-1.07],ALDH7A1P4,Schizophrenia,schizophrenia,GCST007201,10:62658896
rs12431410-<b>C</b>,3 x 10-6,(EA),NR,1.0539628,'-,[1.03-1.08],RTN1,Schizophrenia,schizophrenia,GCST007201,14:59699304
rs4626214-<b>G</b>,4 x 10-6,(EA),NR,1.0530751,'-,[1.03-1.08],LINC02267,Schizophrenia,schizophrenia,GCST007201,4:96805918
rs12139672-<b>G</b>,4 x 10-6,(EA),NR,1.064396,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST007201,1:190971497
rs10124101-<b>G</b>,5 x 10-6,(EA),NR,1.0516353,'-,[1.03-1.07],"HMGB3P24, RNF38",Schizophrenia,schizophrenia,GCST007201,9:36308830
rs7529073-<b>C</b>,6 x 10-6,(EA),NR,1.0504202,'-,[1.03-1.07],PROX1-AS1,Schizophrenia,schizophrenia,GCST007201,1:213974546
rs758129-<b>G</b>,6 x 10-6,(EA),NR,1.0526316,'-,[1.03-1.07],"POLG-DT, MIR9-3HG",Schizophrenia,schizophrenia,GCST007201,15:89357656
rs13259407-<b>C</b>,9 x 10-6,(EA),NR,1.0500892,'-,[1.03-1.07],PSD3,Schizophrenia,schizophrenia,GCST007201,8:18565413
rs115329265-<b>A</b>,6 x 10-33,(EA),NR,1.217,'-,[1.18-1.25],"NOP56P1, RPSAP2",Schizophrenia,schizophrenia,GCST007201,6:28744470
rs150817755-<b>T</b>,1 x 10-29,(EA),NR,1.261,'-,[1.22-1.3],"OR2U1P, OR2G1P",Schizophrenia,schizophrenia,GCST007201,6:29238906
rs116757206-<b>G</b>,1 x 10-25,(EA),NR,1.239,'-,[1.2-1.28],"OR2AD1P, ZNF311",Schizophrenia,schizophrenia,GCST007201,6:29015497
rs114071887-<b>G</b>,7 x 10-25,(EA),NR,1.239,'-,[1.2-1.28],"OR5V1, OR12D3",Schizophrenia,schizophrenia,GCST007201,6:29374998
rs17720293-<b>C</b>,3 x 10-23,(EA),NR,1.197,'-,[1.16-1.23],ZKSCAN4,Schizophrenia,schizophrenia,GCST007201,6:28246920
rs13217239-<b>T</b>,5 x 10-14,(EA),NR,1.091,'-,[1.07-1.11],POM121L2,Schizophrenia,schizophrenia,GCST007201,6:27287188
rs629444-<b>C</b>,2 x 10-13,(EA),NR,1.141,'-,[1.11-1.18],H2BP5,Schizophrenia,schizophrenia,GCST007201,6:25885586
rs9636107-<b>G</b>,2 x 10-13,(EA),NR,1.083,'-,[1.06-1.1],TCF4,Schizophrenia,schizophrenia,GCST007201,18:55532886
rs12887734-<b>T</b>,4 x 10-13,(EA),NR,1.0923,'-,[1.07-1.12],"KLC1, COA8",Schizophrenia,schizophrenia,GCST007201,14:103580497
rs28681284-<b>C</b>,6 x 10-13,(EA),NR,1.107,'-,[1.08-1.13],CHRNA3,Schizophrenia,schizophrenia,GCST007201,15:78616223
rs1892252-<b>C</b>,7 x 10-13,(EA),NR,1.121,'-,[1.09-1.15],SLC17A4,Schizophrenia,schizophrenia,GCST007201,6:25772411
rs2239063-<b>A</b>,2 x 10-8,(EA),NR,1.071,'-,[1.05-1.09],CACNA1C,Schizophrenia,schizophrenia,GCST007201,12:2402665
rs16867576-<b>A</b>,2 x 10-8,(EA),NR,1.101,'-,[1.07-1.13],MEF2C-AS1,Schizophrenia,schizophrenia,GCST007201,5:89450514
rs10860964-<b>T</b>,2 x 10-8,(EA),NR,1.065,'-,[1.04-1.09],C12orf42,Schizophrenia,schizophrenia,GCST007201,12:103202677
rs4711350-<b>G</b>,2 x 10-8,(EA),NR,1.082,'-,[1.05-1.11],LEMD2,Schizophrenia,schizophrenia,GCST007201,6:33773939
rs4445544-<b>C</b>,3 x 10-8,(EA),NR,1.074,'-,[1.05-1.1],NSUN6,Schizophrenia,schizophrenia,GCST007201,10:18587155
rs7801375-<b>G</b>,3 x 10-8,(EA),NR,1.087,'-,[1.06-1.12],CAPZA1P4,Schizophrenia,schizophrenia,GCST007201,7:131882504
rs3735025-<b>T</b>,3 x 10-8,(EA),NR,1.0647,'-,[1.04-1.09],DGKI,Schizophrenia,schizophrenia,GCST007201,7:137390098
rs6846161-<b>A</b>,4 x 10-8,(EA),NR,1.071,'-,[1.05-1.1],GPM6A,Schizophrenia,schizophrenia,GCST007201,4:175945308
rs1191551-<b>T</b>,4 x 10-8,(EA),NR,1.0743,'-,[1.05-1.1],"RNU11-5P, PRKD1",Schizophrenia,schizophrenia,GCST007201,14:29531199
rs715170-<b>C</b>,5 x 10-8,(EA),NR,1.069,'-,[1.05-1.09],"LINC01539, LINC01905",Schizophrenia,schizophrenia,GCST007201,18:56128283
rs11778040-<b>C</b>,5 x 10-8,(EA),NR,1.079,'-,[1.05-1.11],GULOP,Schizophrenia,schizophrenia,GCST007201,8:27562290
rs2767713-<b>C</b>,6 x 10-8,(EA),NR,1.071,'-,[1.05-1.1],DDX10P2,Schizophrenia,schizophrenia,GCST007201,9:82184622
rs1353545-<b>C</b>,7 x 10-8,(EA),NR,1.064,'-,[1.04-1.09],FHIT,Schizophrenia,schizophrenia,GCST007201,3:60302116
rs7193419-<b>T</b>,7 x 10-8,(EA),NR,1.0605,'-,[1.04-1.08],"LINC02858, LINC02165",Schizophrenia,schizophrenia,GCST007201,16:63663230
rs28730912-<b>T</b>,7 x 10-8,(EA),NR,1.071,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST007201,3:162062168
rs6670165-<b>T</b>,8 x 10-8,(EA),NR,1.0771,'-,[1.05-1.1],"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST007201,1:177310985
rs3858402-<b>G</b>,9 x 10-8,(EA),NR,1.064,'-,[1.04-1.09],LINC02715,Schizophrenia,schizophrenia,GCST007201,11:109685112
rs77502336-<b>C</b>,1 x 10-7,(EA),NR,1.0642,'-,[1.04-1.09],GRAMD1B,Schizophrenia,schizophrenia,GCST007201,11:123523928
rs12129037-<b>T</b>,1 x 10-7,(EA),NR,1.0971,'-,[1.06-1.13],"FALEC, ADAMTSL4-AS2",Schizophrenia,schizophrenia,GCST007201,1:150519638
rs7099380-<b>A</b>,2 x 10-6,(EA),NR,1.0531,'-,[1.03-1.07],CACNB2,Schizophrenia,schizophrenia,GCST007201,10:18260087
rs35662245-<b>A</b>,2 x 10-6,(EA),NR,1.0554,'-,[1.03-1.08],LINC01911,Schizophrenia,schizophrenia,GCST007201,2:146825619
rs11240341-<b>T</b>,3 x 10-6,(EA),NR,1.056,'-,[1.03-1.08],CNTN2,Schizophrenia,schizophrenia,GCST007201,1:205046156
rs56775891-<b>T</b>,3 x 10-6,(EA),NR,1.0592,'-,[1.04-1.08],"KCNG2, CTDP1",Schizophrenia,schizophrenia,GCST007201,18:79815613
rs7807720-<b>A</b>,3 x 10-6,(EA),NR,1.0538,'-,[1.03-1.08],'-,Schizophrenia,schizophrenia,GCST007201,7:110433698
rs9384900-<b>T</b>,4 x 10-6,(EA),NR,1.0576,'-,[1.03-1.08],HDAC2-AS2,Schizophrenia,schizophrenia,GCST007201,6:114389931
rs8012642-<b>C</b>,4 x 10-6,(EA),NR,1.0553,'-,[1.03-1.08],MTCYBP27,Schizophrenia,schizophrenia,GCST007201,14:84203137
rs248083-<b>A</b>,5 x 10-6,(EA),NR,1.0542,'-,[1.03-1.08],"MRPS5P3, SELENOTP2",Schizophrenia,schizophrenia,GCST007201,5:127174476
rs2247870-<b>A</b>,6 x 10-6,(EA),NR,1.0504,'-,[1.03-1.07],ADGRV1,Schizophrenia,schizophrenia,GCST007201,5:90855772
rs11102159-<b>T</b>,8 x 10-6,(EA),NR,1.0573,'-,[1.03-1.08],"NRBF2P3, Y_RNA",Schizophrenia,schizophrenia,GCST007201,1:110782105
rs7273691-<b>T</b>,8 x 10-6,(EA),NR,1.0624,'-,[1.04-1.09],PHACTR3,Schizophrenia,schizophrenia,GCST007201,20:59678449
rs12911832-<b>A</b>,8 x 10-6,(EA),NR,1.0556,'-,[1.03-1.08],ADAM10,Schizophrenia,schizophrenia,GCST007201,15:58693705
rs4632195-<b>T</b>,9 x 10-6,(EA),NR,1.0494,'-,[1.03-1.07],DCC,Schizophrenia,schizophrenia,GCST007201,18:53220378
rs11682175-<b>C</b>,2 x 10-11,(EA),NR,1.0764263,'-,[1.06-1.1],ACTG1P22,Schizophrenia,schizophrenia,GCST007201,2:57760458
rs11693094-<b>C</b>,2 x 10-11,(EA),NR,1.0764263,'-,[1.05-1.1],ZNF804A,Schizophrenia,schizophrenia,GCST007201,2:184736693
rs9841616-<b>T</b>,7 x 10-8,,NR,1.0729614,'-,[1.05-1.1],SOX2-OT,Schizophrenia,schizophrenia,GCST007201,3:181449797
rs215411-<b>A</b>,4 x 10-9,,NR,1.066,'-,[1.04-1.09],RFPL4AP3,Schizophrenia,schizophrenia,GCST007201,4:23421980
rs4626214-<b>G</b>,2 x 10-7,,NR,1.0526316,'-,[1.03-1.07],LINC02267,Schizophrenia,schizophrenia,GCST007201,4:96805918
rs11722779-<b>G</b>,4 x 10-8,,NR,1.0515248,'-,[1.03-1.07],SLC9B1,Schizophrenia,schizophrenia,GCST007201,4:102906331
rs2905627-<b>T</b>,8 x 10-7,,NR,1.054,'-,[1.03-1.07],CXXC4-AS1,Schizophrenia,schizophrenia,GCST007201,4:104528928
rs4833558-<b>C</b>,4 x 10-8,,NR,1.0570824,'-,[1.04-1.08],NDST3,Schizophrenia,schizophrenia,GCST007201,4:117998342
rs7438-<b>A</b>,1 x 10-8,,NR,1.058,'-,[1.04-1.08],CLCN3,Schizophrenia,schizophrenia,GCST007201,4:169721095
rs6846161-<b>A</b>,4 x 10-8,,NR,1.062,'-,[1.04-1.08],GPM6A,Schizophrenia,schizophrenia,GCST007201,4:175945308
rs35751669-<b>G</b>,1 x 10-6,,NR,1.0604454,'-,[1.04-1.08],TENM3,Schizophrenia,schizophrenia,GCST007201,4:182716504
rs9292918-<b>G</b>,1 x 10-9,,NR,1.0683761,'-,[1.05-1.09],HCN1,Schizophrenia,schizophrenia,GCST007201,5:45300933
rs17439799-<b>C</b>,1 x 10-8,(EA),NR,1.0672358,'-,[1.05-1.09],"IMMP2L, LRRN3",Schizophrenia,schizophrenia,GCST007201,7:111101521
rs3849046-<b>T</b>,1 x 10-8,(EA),NR,1.0649627,'-,[1.04-1.09],ETF1,Schizophrenia,schizophrenia,GCST007201,5:138515503
rs11685299-<b>C</b>,1 x 10-8,(EA),NR,1.0684903,'-,[1.05-1.09],CUL3,Schizophrenia,schizophrenia,GCST007201,2:224526579
rs10894308-<b>G</b>,2 x 10-8,(EA),NR,1.064396,'-,[1.04-1.09],RN7SL167P,Schizophrenia,schizophrenia,GCST007201,11:131022000
rs13261481-<b>T</b>,2 x 10-8,(EA),NR,1.0638298,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST007201,8:59789242
rs2053079-<b>G</b>,2 x 10-8,(EA),NR,1.07446,'-,[1.05-1.1],ZNF536,Schizophrenia,schizophrenia,GCST007201,19:30496516
rs11027827-<b>C</b>,2 x 10-8,(EA),NR,1.0638298,'-,[1.04-1.09],LINC02686,Schizophrenia,schizophrenia,GCST007201,11:24353633
rs11740474-<b>T</b>,2 x 10-8,(EA),NR,1.0647359,'-,[1.04-1.09],GALNT10,Schizophrenia,schizophrenia,GCST007201,5:154301187
rs12421382-<b>C</b>,2 x 10-8,(EA),NR,1.0672358,'-,[1.04-1.09],C11orf87,Schizophrenia,schizophrenia,GCST007201,11:109507345
rs172531-<b>G</b>,3 x 10-8,(EA),NR,1.0663254,'-,[1.04-1.09],RERE,Schizophrenia,schizophrenia,GCST007201,1:8435530
rs2693698-<b>G</b>,3 x 10-8,(EA),NR,1.0636035,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST007201,Mapping not available
rs6716963-<b>A</b>,3 x 10-8,(EA),NR,1.0649627,'-,[1.04-1.09],NAB1,Schizophrenia,schizophrenia,GCST007201,2:193502815
rs1065861-<b>T</b>,4 x 10-8,(EA),NR,1.1380448,'-,[1.09-1.18],MEF2C,Schizophrenia,schizophrenia,GCST007201,5:88796133
rs67082009-<b>A</b>,4 x 10-8,(EA),NR,1.0834236,'-,[1.06-1.11],'-,Schizophrenia,schizophrenia,GCST007201,2:145662536
rs35751669-<b>G</b>,4 x 10-8,(EA),NR,1.085305,'-,[1.06-1.11],TENM3,Schizophrenia,schizophrenia,GCST007201,4:182716504
rs17687067-<b>C</b>,4 x 10-8,(EA),NR,1.0793308,'-,[1.05-1.11],ZDHHC2,Schizophrenia,schizophrenia,GCST007201,8:17178692
rs783540-<b>G</b>,5 x 10-8,(EA),NR,1.0616838,'-,[1.04-1.08],CPEB1,Schizophrenia,schizophrenia,GCST007201,15:82585958
rs55833108-<b>T</b>,5 x 10-8,(EA),NR,1.0764263,'-,[1.05-1.1],CNNM2,Schizophrenia,schizophrenia,GCST007201,10:102981826
rs2068012-<b>C</b>,6 x 10-8,(EA),NR,1.0729614,'-,[1.05-1.1],PRKD1,Schizophrenia,schizophrenia,GCST007201,14:29721110
rs7653924-<b>T</b>,6 x 10-8,(EA),NR,1.0615711,'-,[1.04-1.08],SH3RF1,Schizophrenia,schizophrenia,GCST007201,4:169281711
rs12325245-<b>T</b>,6 x 10-8,(EA),NR,1.0893246,'-,[1.06-1.12],"CNOT1, SLC38A7",Schizophrenia,schizophrenia,GCST007201,16:58647489
rs9695226-<b>G</b>,7 x 10-8,(EA),NR,1.0648494,'-,[1.04-1.09],LINC01239,Schizophrenia,schizophrenia,GCST007201,9:22759397
rs302321-<b>C</b>,8 x 10-8,(EA),NR,1.0629252,'-,[1.04-1.09],TMTC1,Schizophrenia,schizophrenia,GCST007201,12:29775455
rs1451488-<b>G</b>,1 x 10-7,(EA),NR,1.0604454,'-,[1.04-1.08],RNU7-147P,Schizophrenia,schizophrenia,GCST007201,2:199125384
rs4330281-<b>C</b>,1 x 10-7,(EA),NR,1.0594343,'-,[1.04-1.08],TBC1D5,Schizophrenia,schizophrenia,GCST007201,3:17817874
rs182812355-<b>A</b>,7 x 10-23,(EA),NR,1.206,'-,[1.17-1.24],TRIM27,Schizophrenia,schizophrenia,GCST007201,6:28913267
rs9467711-<b>A</b>,2 x 10-22,(EA),NR,1.195,'-,[1.16-1.23],"H3C9P, BTN3A2",Schizophrenia,schizophrenia,GCST007201,6:26332377
rs115123779-<b>G</b>,4 x 10-22,(EA),NR,1.189,'-,[1.15-1.22],LINC02829,Schizophrenia,schizophrenia,GCST007201,6:29510044
rs116408368-<b>T</b>,1 x 10-21,(EA),NR,1.203,'-,[1.17-1.24],TRIM26,Schizophrenia,schizophrenia,GCST007201,6:30202733
rs401754-<b>T</b>,2 x 10-21,(EA),NR,1.188,'-,[1.15-1.22],H2AC14,Schizophrenia,schizophrenia,GCST007201,6:27814760
rs16894116-<b>G</b>,3 x 10-21,(EA),NR,1.141,'-,[1.11-1.17],COX11P1,Schizophrenia,schizophrenia,GCST007201,6:28447190
rs115031589-<b>G</b>,3 x 10-20,(EA),NR,1.142,'-,[1.11-1.17],ZBED9,Schizophrenia,schizophrenia,GCST007201,6:28594812
rs115123027-<b>T</b>,4 x 10-20,(EA),NR,1.179,'-,[1.14-1.21],"SFTA2, MUCL3",Schizophrenia,schizophrenia,GCST007201,6:30939558
rs142536810-<b>C</b>,5 x 10-20,(EA),NR,1.179,'-,[1.14-1.21],"HSPA1A, HSPA1B",Schizophrenia,schizophrenia,GCST007201,6:31819390
rs116509918-<b>G</b>,6 x 10-20,(EA),NR,1.179,'-,[1.14-1.21],"HLA-B, LINC02571",Schizophrenia,schizophrenia,GCST007201,6:31345252
rs34104395-<b>C</b>,9 x 10-20,(EA),NR,1.19,'-,[1.15-1.23],BTN1A1P1,Schizophrenia,schizophrenia,GCST007201,6:26478024
rs116396069-<b>C</b>,3 x 10-19,(EA),NR,1.189,'-,[1.15-1.23],"LINC00243, LINC02570",Schizophrenia,schizophrenia,GCST007201,6:30830920
rs77296290-<b>C</b>,4 x 10-19,(EA),NR,1.149,'-,[1.12-1.18],HLA-DQB1,Schizophrenia,schizophrenia,GCST007201,6:32667519
rs149979052-<b>C</b>,7 x 10-19,(EA),NR,1.161,'-,[1.13-1.19],PSORS1C1,Schizophrenia,schizophrenia,GCST007201,6:31137370
rs115406947-<b>G</b>,2 x 10-18,(EA),NR,1.163,'-,[1.13-1.2],HLA-DRB9,Schizophrenia,schizophrenia,GCST007201,6:32464869
rs35741362-<b>T</b>,2 x 10-18,(EA),NR,1.164,'-,[1.13-1.2],LINC00240,Schizophrenia,schizophrenia,GCST007201,6:27039908
rs1702294-<b>C</b>,1 x 10-17,(EA),NR,1.126,'-,[1.1-1.15],MIR137HG,Schizophrenia,schizophrenia,GCST007201,1:98036428
rs144373461-<b>C</b>,2 x 10-17,(EA),NR,1.166,'-,[1.13-1.2],"HLA-V, IFITM4P",Schizophrenia,schizophrenia,GCST007201,6:29783228
rs115344853-<b>A</b>,2 x 10-17,(EA),NR,1.147,'-,[1.12-1.18],NOTCH4,Schizophrenia,schizophrenia,GCST007201,6:32197667
rs138488080-<b>G</b>,3 x 10-16,(EA),NR,1.141,'-,[1.11-1.17],"SUMO2P1, MOG",Schizophrenia,schizophrenia,GCST007201,6:29638984
rs114618162-<b>G</b>,6 x 10-16,(EA),NR,1.126,'-,[1.1-1.15],LINC01149,Schizophrenia,schizophrenia,GCST007201,6:31446032
rs114261345-<b>A</b>,9 x 10-16,(EA),NR,1.169,'-,[1.13-1.21],FLOT1,Schizophrenia,schizophrenia,GCST007201,6:30730764
rs115687605-<b>C</b>,2 x 10-15,(EA),NR,1.18,'-,[1.14-1.22],"UBQLN1P1, MICC",Schizophrenia,schizophrenia,GCST007201,6:30397852
rs56275179-<b>G</b>,2 x 10-15,(EA),NR,1.15,'-,[1.12-1.18],HFE,Schizophrenia,schizophrenia,GCST007201,6:26089112
rs144959664-<b>G</b>,1 x 10-14,(EA),NR,1.174,'-,[1.13-1.21],"ABCF1, PPP1R10",Schizophrenia,schizophrenia,GCST007201,6:30598076
rs308693-<b>G</b>,1 x 10-7,(EA),NR,1.064,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST007201,3:161767619
rs4347184-<b>T</b>,1 x 10-7,(EA),NR,1.0598,'-,[1.04-1.08],PDE4B,Schizophrenia,schizophrenia,GCST007201,1:65848311
rs3756766-<b>A</b>,2 x 10-7,(EA),NR,1.0661,'-,[1.04-1.09],"FAM53C, CDC25C",Schizophrenia,schizophrenia,GCST007201,5:138337478
rs12148337-<b>T</b>,2 x 10-7,(EA),NR,1.0586,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,15:70296933
rs7372960-<b>T</b>,2 x 10-7,(EA),NR,1.0693,'-,[1.04-1.09],FOXP1,Schizophrenia,schizophrenia,GCST007201,3:71205600
rs4987094-<b>A</b>,2 x 10-7,(EA),NR,1.0974,'-,[1.06-1.13],TTC12,Schizophrenia,schizophrenia,GCST007201,11:113345201
rs1506297-<b>T</b>,2 x 10-7,(EA),NR,1.0625,'-,[1.04-1.09],RBMS3,Schizophrenia,schizophrenia,GCST007201,3:30030816
rs7523273-<b>A</b>,3 x 10-7,(EA),NR,1.0613,'-,[1.04-1.08],MIR29B2CHG,Schizophrenia,schizophrenia,GCST007201,1:207803738
rs12619354-<b>T</b>,3 x 10-7,(EA),NR,1.0609,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,2:193138056
rs112509803-<b>C</b>,3 x 10-7,(EA),NR,1.0919,'-,[1.06-1.13],"GSDME, MPP6",Schizophrenia,schizophrenia,GCST007201,7:24695385
rs9420-<b>A</b>,4 x 10-7,(EA),NR,1.0599,'-,[1.04-1.08],SELENOH,Schizophrenia,schizophrenia,GCST007201,11:57742822
rs12543645-<b>C</b>,4 x 10-7,(EA),NR,1.059,'-,[1.04-1.08],MSRA,Schizophrenia,schizophrenia,GCST007201,8:10388815
rs73219805-<b>A</b>,4 x 10-7,(EA),NR,1.0772,'-,[1.05-1.11],BNIP3L,Schizophrenia,schizophrenia,GCST007201,8:26415252
rs14403-<b>C</b>,4 x 10-7,(EA),NR,1.069,'-,[1.04-1.1],AKT3,Schizophrenia,schizophrenia,GCST007201,1:243500591
rs9970077-<b>A</b>,5 x 10-7,(EA),NR,1.0756,'-,[1.05-1.1],LINC01741,Schizophrenia,schizophrenia,GCST007201,1:177791783
rs55757091-<b>A</b>,5 x 10-7,(EA),NR,1.0747,'-,[1.05-1.1],"SLC7A6, SLC7A6OS",Schizophrenia,schizophrenia,GCST007201,16:68289751
rs56873913-<b>T</b>,7 x 10-7,(EA),NR,1.0679,'-,[1.04-1.09],"NOSIP, PRRG2",Schizophrenia,schizophrenia,GCST007201,19:49587942
rs72843506-<b>A</b>,9 x 10-7,(EA),NR,1.0683,'-,[1.04-1.09],SPECC1,Schizophrenia,schizophrenia,GCST007201,17:20042974
rs2905627-<b>T</b>,9 x 10-7,(EA),NR,1.0597,'-,[1.04-1.08],CXXC4-AS1,Schizophrenia,schizophrenia,GCST007201,4:104528928
rs2383377-<b>A</b>,1 x 10-6,(EA),NR,1.0862,'-,[1.05-1.12],AKAP6,Schizophrenia,schizophrenia,GCST007201,14:32788708
rs112537273-<b>T</b>,1 x 10-6,(EA),NR,1.0675,'-,[1.04-1.09],LETM2,Schizophrenia,schizophrenia,GCST007201,8:38390788
rs61712019-<b>T</b>,1 x 10-6,(EA),NR,1.0612,'-,[1.04-1.09],LRRTM4,Schizophrenia,schizophrenia,GCST007201,2:77477763
rs10878577-<b>A</b>,2 x 10-6,(EA),NR,1.0623,'-,[1.04-1.09],"GGTA2P, RAB11AP2",Schizophrenia,schizophrenia,GCST007201,12:67200061
rs17002069-<b>C</b>,2 x 10-6,(EA),NR,1.0679,'-,[1.04-1.09],"MRTFA, GAPDHP37",Schizophrenia,schizophrenia,GCST007201,22:40654982
rs4388249-<b>T</b>,2 x 10-6,(EA),NR,1.0692,'-,[1.04-1.1],MAN2A1,Schizophrenia,schizophrenia,GCST007201,5:109700365
rs9488343-<b>?</b>,7 x 10-7,,NR,'-,0.0437 unit increase,[NR],"HDAC2-AS2, HS3ST5",Gray matter volume (schizophrenia interaction),"schizophrenia, grey matter volume measurement",GCST002203,6:114226817
rs10277664-<b>?</b>,1 x 10-7,,NR,'-,0.0432 unit decrease,[NR],TBXAS1,Gray matter volume (schizophrenia interaction),"schizophrenia, grey matter volume measurement",GCST002203,7:139806781
rs11044045-<b>?</b>,3 x 10-6,,NR,'-,0.0445 unit decrease,[NR],PIK3C2G,Gray matter volume (schizophrenia interaction),"schizophrenia, grey matter volume measurement",GCST002203,12:18355318
rs12144699-<b>A</b>,6 x 10-7,,0.04,1.67,'-,[NR],"FGGY-DT, LINC01358",Subjective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003158,1:59139525
rs9834970-<b>C</b>,8 x 10-7,,0.5,1.22,'-,[NR],"LINC02033, HSPD1P6",Subjective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003158,3:36814539
rs12493050-<b>G</b>,9 x 10-7,,0.2,1.27,'-,[NR],LAMP3,Subjective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003158,3:183147285
rs73918339-<b>C</b>,4 x 10-7,,0.09,1.79,'-,[NR],"RPL7P3, SLCO4A1",Subjective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003160,20:62608205
rs7240206-<b>G</b>,4 x 10-7,,0.91,1.67,'-,[NR],"ARL2BPP1, CCND3P2",Subjective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003160,18:76723198
rs116927879-<b>G</b>,5 x 10-7,,0.85,1.53,'-,[NR],"RNU6-326P, CICP20",Subjective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003160,7:45825128
rs78295376-<b>C</b>,7 x 10-7,,0.1,1.75,'-,[NR],"CDKL2, ODAPH",Subjective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003160,4:75570281
rs116323614-<b>A</b>,3 x 10-8,,0.03,3.14,'-,[NR],SESTD1,Objective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003159,2:179120817
rs77866734-<b>T</b>,1 x 10-7,,0.02,3.7,'-,[NR],TCF3,Objective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003159,19:1637053
rs142643109-<b>G</b>,4 x 10-7,,0.02,3.57,'-,[NR],"TBC1D3P2, EFCAB3",Objective response to lithium treatment,"bipolar disorder, response to lithium ion",GCST003159,17:62310560
rs438475-<b>A</b>,2 x 10-6,,0.12,2.04,'-,[NR],NOTCH4,Objective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003161,6:32218468
rs113262272-<b>A</b>,4 x 10-6,,0.71,1.93,'-,[NR],CNTN5,Objective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003161,11:99428262
rs809-<b>T</b>,4 x 10-6,,0.47,1.64,'-,[NR],"FXNP1, NRXN3",Objective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003161,14:78090121
rs181812561-<b>A</b>,6 x 10-6,,0.02,7.69,'-,[NR],'-,Objective response to lithium treatment in bipolar disorder,"bipolar disorder, response to lithium ion",GCST003161,6:74372527
rs168193-<b>?</b>,9 x 10-7,(model 1),'-,0.79,'-,[0.72-0.87],RN7SL553P,Alzheimer's disease,Alzheimer's disease,GCST011696,3:5260392
rs2633682-<b>?</b>,9 x 10-7,(model 1),'-,0.78,'-,[0.71-0.86],'-,Alzheimer's disease,Alzheimer's disease,GCST011696,3:104690364
rs9516245-<b>?</b>,4 x 10-7,(model 2),'-,1.73,'-,[1.39-2.15],GPC6,Alzheimer's disease,Alzheimer's disease,GCST011696,13:93507547
rs3745495-<b>?</b>,4 x 10-7,(model 2),'-,1.39,'-,[1.23-1.56],VRK3,Alzheimer's disease,Alzheimer's disease,GCST011696,19:50021075
rs115684722-<b>?</b>,6 x 10-7,(model 1),'-,12.6,'-,[4.66-34.45],RN7SL299P,Alzheimer's disease,Alzheimer's disease,GCST011696,1:232240417
rs184179037-<b>?</b>,2 x 10-7,(model 1),'-,5,'-,[2.27-9.18],WDR70,Alzheimer's disease,Alzheimer's disease,GCST011696,5:37483838
rs569584007-<b>?</b>,9 x 10-8,(model 2),'-,10.48,'-,[4.42-24.83],HNRNPKP3,Alzheimer's disease,Alzheimer's disease,GCST011696,11:43145292
rs115816806-<b>?</b>,5 x 10-7,(model 2),'-,6.55,'-,[3.17-13.53],"ACER3, TSKU",Alzheimer's disease,Alzheimer's disease,GCST011696,11:76830796
rs75739461-<b>?</b>,1 x 10-6,(model 2),'-,3.03,'-,[1.93-4.76],"RERGL, PIK3C2G",Alzheimer's disease,Alzheimer's disease,GCST011696,12:18318612
rs570487962-<b>?</b>,2 x 10-9,(model 2),'-,0.1,'-,[0.05-0.22],LINC02254,Alzheimer's disease,Alzheimer's disease,GCST011696,15:97449455
rs79537509-<b>?</b>,5 x 10-7,(model 2),'-,4.61,'-,[2.51-8.47],LINC02152,Alzheimer's disease,Alzheimer's disease,GCST011696,16:8238399
rs145848414-<b>?</b>,2 x 10-6,(model 1),'-,1.78,'-,[1.41-2.25],"HIGD1AP3, SUMO2P6",Alzheimer's disease,Alzheimer's disease,GCST011696,5:174587111
rs115550680-<b>?</b>,4 x 10-7,(model 2),'-,1.58,'-,[1.32-1.88],ABCA7,Alzheimer's disease,Alzheimer's disease,GCST011696,19:1050421
rs157591-<b>?</b>,2 x 10-25,(model 1),'-,1.93,'-,[1.72-2.17],"APOC1P1, APOC1",Alzheimer's disease,Alzheimer's disease,GCST011696,19:44920677
rs112404845-<b>A</b>,5 x 10-6,(model 2),0.008,'-,1.05 unit increase,[0.60-1.50],ROBO2P1,Alzheimer's disease,Alzheimer's disease,GCST011696,7:51510325
rs60026510-<b>?</b>,2 x 10-6,,NR,'-,0.1974 unit increase,[0.12-0.28],DAW1,Cognitive ability in schizophrenia,"schizophrenia, intelligence",GCST008387,2:227901491
rs7814396-<b>?</b>,6 x 10-6,,NR,'-,0.3207 unit increase,[0.18-0.46],"RNU105C, RN7SL250P",Cognitive ability in schizophrenia,"schizophrenia, intelligence",GCST008387,8:54412644
rs11177934-<b>?</b>,8 x 10-6,,NR,'-,0.2696 unit decrease,[0.15-0.39],CNTN1,Cognitive ability in schizophrenia,"schizophrenia, intelligence",GCST008387,12:40705890
"rs7893291-<b>C</b>, rs10904299-<b>A</b>, rs11252672-<b>G</b>, rs1901632-<b>A</b>, rs11252715-<b>G</b>, rs11818567-<b>A</b>, rs11252622-<b>G</b>, rs7906409-<b>A</b>, rs416990-<b>A</b>, rs10904323-<b>G</b>, rs1039197-<b>C</b>, rs12251644-<b>C</b>, rs10795187-<b>A</b>, rs313452-<b>C</b>, rs4881340-<b>A</b>, rs11252688-<b>A</b>, rs12775823-<b>A</b>, rs7896112-<b>G</b>, rs10508287-<b>A</b>, rs1838238-<b>A</b>, rs11252674-<b>G</b>, rs313462-<b>G</b>, rs12413638-<b>G</b>, rs2165953-<b>G</b>, rs313435-<b>G</b>, rs2028690-<b>A</b>, rs11252631-<b>G</b>, rs10508290-<b>G</b>, rs387673-<b>G</b>, rs11252679-<b>A</b>, rs372744-<b>A</b>, rs10904321-<b>G</b>, rs10904300-<b>A</b>, rs10904328-<b>G</b>, rs1008042-<b>A</b>, rs1498273-<b>A</b>, rs2088500-<b>G</b>, rs17297024-<b>G</b>, rs7082636-<b>A</b>, rs7900146-<b>A</b>, rs17133585-<b>A</b>, rs313500-<b>G</b>, rs11598678-<b>C</b>, rs2397839-<b>A</b>, rs11252717-<b>G</b>, rs11814411-<b>A</b>, rs10904333-<b>G</b>, rs1498274-<b>A</b>, rs745782-<b>A</b>, rs433430-<b>G</b>, rs2647337-<b>A</b>, rs2123348-<b>G</b>, rs7899916-<b>G</b>, rs10904319-<b>A</b>, rs2894969-<b>G</b>, rs17372054-<b>G</b>, rs569744-<b>G</b>, rs7089195-<b>A</b>, rs374802-<b>G</b>, rs17298157-<b>G</b>, rs7068675-<b>C</b>, rs11252615-<b>A</b>, rs12357812-<b>A</b>, rs313451-<b>A</b>, rs715987-<b>A</b>, rs313445-<b>A</b>, rs1869210-<b>A</b>, rs7080649-<b>A</b>, rs10458787-<b>G</b>, rs1353703-<b>A</b>, rs1838239-<b>G</b>, rs11252607-<b>G</b>, rs7096965-<b>G</b>, rs313438-<b>A</b>, rs10904332-<b>C</b>, rs4146653-<b>A</b>, rs6601855-<b>G</b>, rs11596789-<b>A</b>, rs313455-<b>G</b>, rs1391511-<b>G</b>, rs12255709-<b>A</b>, rs381443-<b>A</b>, rs6601853-<b>G</b>, rs7916170-<b>G</b>, rs17133449-<b>G</b>, rs1443852-<b>A</b>, rs1498271-<b>A</b>, rs10508288-<b>A</b>, rs9423544-<b>A</b>, rs313430-<b>A</b>, rs10904290-<b>A</b>, rs167511-<b>A</b>",8 x 10-8,,NR,1.67,'-,[1.4-1.98],LINC00705 - AKR1E2; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; LINC00705 - AKR1E2; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; MANCR; LINC00705; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Major depressive disorder,unipolar depression,GCST005108,10:4769511|10:4706048|10:4674350
rs13267290-<b>?</b>,2 x 10-9,,NR,'-,0.015136181 unit increase,[0.01-0.02],DEFB130B,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:110466092
rs11166628-<b>?</b>,3 x 10-8,,NR,'-,0.011256048 unit increase,[0.0073-0.0152],LINC02055,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:136066082
rs13266268-<b>?</b>,6 x 10-16,,NR,'-,0.017007658 unit decrease,[0.013-0.021],MROH5,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:141601871
rs4129585-<b>?</b>,4 x 10-12,,NR,'-,0.013844145 unit decrease,[0.0099-0.0178],TSNARE1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:142231572
rs11774212-<b>?</b>,1 x 10-9,,NR,'-,0.012295297 unit increase,[0.0083-0.0163],CYHR1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:144461122
rs4741594-<b>?</b>,1 x 10-15,,NR,'-,0.017274031 unit increase,[0.013-0.021],RGS3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:1748795
rs10961430-<b>?</b>,1 x 10-10,,NR,'-,0.013740266 unit increase,[0.0095-0.0179],NFIB,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:14224064
rs10757417-<b>?</b>,2 x 10-12,,NR,'-,0.014378082 unit increase,[0.01-0.018],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:23347855
rs4744899-<b>?</b>,1 x 10-11,,NR,'-,0.013456284 unit increase,[0.0096-0.0173],APBA1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:69461631
rs2889964-<b>?</b>,2 x 10-8,,NR,'-,0.011488603 unit increase,[0.0075-0.0155],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:85386557
rs4240470-<b>?</b>,2 x 10-9,,NR,'-,0.013416334 unit increase,[0.009-0.0178],TTLL11,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:121859450
rs10993909-<b>?</b>,3 x 10-8,,NR,'-,0.01164415 unit increase,[0.0075-0.0158],BRD3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,9:134067044
rs10752262-<b>?</b>,2 x 10-9,,NR,'-,0.012595058 unit increase,[0.0085-0.0167],CAMK1D,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:12353101
rs4748466-<b>?</b>,5 x 10-11,,NR,'-,0.020889463 unit decrease,[0.015-0.027],CACNB2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:18444364
rs10994707-<b>?</b>,1 x 10-9,,NR,'-,0.020189252 unit increase,[0.014-0.027],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:61291201
rs11598767-<b>?</b>,5 x 10-9,,NR,'-,0.02437906 unit decrease,[0.016-0.033],ZNF365,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:62421587
rs10995426-<b>?</b>,2 x 10-10,,NR,'-,0.013567267 unit decrease,[0.0094-0.0177],RNU6-543P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:63080258
rs12773625-<b>?</b>,3 x 10-8,,NR,'-,0.011237123 unit increase,[0.0073-0.0152],CTNNA3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:66919791
rs1408579-<b>?</b>,2 x 10-8,,NR,'-,0.011130868 unit increase,[0.0073-0.015],ERLIN1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:100152437
rs12764899-<b>?</b>,3 x 10-20,,NR,'-,0.02186565 unit increase,[0.017-0.027],"AS3MT, BORCS7-ASMT","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:102875346
rs11192193-<b>?</b>,7 x 10-9,,NR,'-,0.011813877 unit decrease,[0.0078-0.0158],SORCS3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:104809495
rs55771711-<b>?</b>,4 x 10-8,,NR,'-,0.01327301 unit increase,[0.0085-0.018],"BNIP3, JAKMIP3","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,10:131989233
rs10831912-<b>?</b>,4 x 10-11,,NR,'-,0.013660304 unit decrease,[0.0096-0.0177],TEAD1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:12834867
rs12365432-<b>?</b>,1 x 10-8,,NR,'-,0.011204787 unit decrease,[0.0073-0.0151],Y_RNA,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:24364037
rs11038927-<b>?</b>,8 x 10-10,,NR,'-,0.016444193 unit decrease,[0.011-0.022],AMBRA1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:46577698
rs9375031-<b>?</b>,4 x 10-15,,NR,'-,0.015950212 unit decrease,[0.012-0.02],MIR2113,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:97968029
rs4945816-<b>?</b>,9 x 10-15,,NR,'-,0.01703199 unit increase,[0.013-0.021],FOXO3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:108680839
rs9372208-<b>?</b>,3 x 10-9,,NR,'-,0.012000529 unit decrease,[0.008-0.016],CCDC162P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:109274965
rs77578042-<b>?</b>,1 x 10-10,,NR,'-,0.0134931365 unit decrease,[0.0094-0.0176],FAM184A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:119015301
rs9371912-<b>?</b>,1 x 10-10,,NR,'-,0.016804537 unit decrease,[0.012-0.022],RNU7-152P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:155673423
rs58120505-<b>?</b>,7 x 10-13,,NR,'-,0.014750185 unit decrease,[0.011-0.019],MAD1L1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:1990232
rs6952006-<b>?</b>,2 x 10-8,,NR,'-,0.015582459 unit increase,[0.01-0.021],"GLCCI1, ICA1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:8094664
rs2390982-<b>?</b>,4 x 10-11,,NR,'-,0.02193995 unit decrease,[0.015-0.028],MPP6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:24614159
rs1376289-<b>?</b>,8 x 10-11,,NR,'-,0.013688673 unit decrease,[0.0096-0.0178],"SLC25A5P5, PDE1C","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:32447368
rs35417702-<b>?</b>,1 x 10-10,,NR,'-,0.01316949 unit decrease,[0.0092-0.0172],CALN1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:72274931
rs12704290-<b>?</b>,8 x 10-9,,NR,'-,0.01778797 unit increase,[0.012-0.024],"GRM3-AS1, GRM3","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:86798310
rs2188179-<b>?</b>,1 x 10-9,,NR,'-,0.012436936 unit decrease,[0.0084-0.0164],"RN7SL7P, SAMD9","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:93052129
rs7776707-<b>?</b>,1 x 10-8,,NR,'-,0.011871369 unit decrease,[0.0078-0.0159],LINC01004,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:104965083
rs12532143-<b>?</b>,4 x 10-12,,NR,'-,0.014428311 unit decrease,[0.01-0.019],IMMP2L,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:111385892
rs7783012-<b>?</b>,1 x 10-9,,NR,'-,0.012378814 unit decrease,[0.0084-0.0164],FOXP2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:114476826
rs1362739-<b>?</b>,1 x 10-9,,NR,'-,0.012072104 unit increase,[0.0082-0.0159],EXOC4,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:133746181
rs4732129-<b>?</b>,2 x 10-8,,NR,'-,0.012016234 unit increase,[0.0078-0.0162],"NUP205, CNOT4","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:135540408
rs320700-<b>?</b>,1 x 10-17,,NR,'-,0.017973443 unit increase,[0.014-0.022],"PTN, DGKI","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:137364731
rs11765189-<b>?</b>,2 x 10-8,,NR,'-,0.011864782 unit increase,[0.0077-0.016],PTPRN2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,7:157743285
rs73191547-<b>?</b>,3 x 10-8,,NR,'-,0.01215576 unit increase,[0.0079-0.0165],MSRA,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:10175915
rs73219806-<b>?</b>,7 x 10-9,,NR,'-,0.015538963 unit decrease,[0.01-0.021],BNIP3L,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:26421657
rs12541339-<b>?</b>,8 x 10-9,,NR,'-,0.01788938 unit increase,[0.012-0.024],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:34146657
rs1870571-<b>?</b>,5 x 10-9,,NR,'-,0.012430782 unit increase,[0.0083-0.0166],SGCZ,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:79322335
rs11786685-<b>?</b>,3 x 10-8,,NR,'-,0.0116070295 unit decrease,[0.0075-0.0157],RNU6-1213P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:80363600
rs3890699-<b>?</b>,7 x 10-9,,NR,'-,0.012198768 unit increase,[0.0081-0.0163],"NUDCD1, TRHR","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,8:109201735
rs72945305-<b>?</b>,3 x 10-8,,NR,'-,0.012761661 unit decrease,[0.0082-0.0173],MTND4LP18,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:81479198
rs556587-<b>?</b>,2 x 10-8,,NR,'-,0.016310493 unit decrease,[0.011-0.022],FAT3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:92588310
rs607816-<b>?</b>,8 x 10-9,,NR,'-,0.012457913 unit decrease,[0.0082-0.0167],MAML2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:95990161
rs12421382-<b>?</b>,3 x 10-8,,NR,'-,0.011863449 unit increase,[0.0077-0.0161],C11orf87,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:109507345
rs12574893-<b>?</b>,1 x 10-10,,NR,'-,0.016520007 unit decrease,[0.012-0.022],NCAM1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:113046389
rs2514218-<b>?</b>,2 x 10-9,,NR,'-,0.012419877 unit increase,[0.0083-0.0165],DRD2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:113522272
rs10892806-<b>?</b>,1 x 10-8,,NR,'-,0.01153827 unit increase,[0.0076-0.0155],MIR100HG,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:122127545
rs75261250-<b>?</b>,2 x 10-8,,NR,'-,0.018791549 unit decrease,[0.012-0.025],"OR8B4, OR8X1P","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:124409893
rs55661361-<b>?</b>,3 x 10-10,,NR,'-,0.013403604 unit increase,[0.0092-0.0176],NRGN,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:124744061
rs10791106-<b>?</b>,1 x 10-15,,NR,'-,0.016241916 unit increase,[0.012-0.02],"RN7SL167P, SNX19","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:130976537
rs1550972-<b>?</b>,1 x 10-8,,NR,'-,0.0118359495 unit decrease,[0.0078-0.0159],NTM,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:131421915
rs4936216-<b>?</b>,2 x 10-10,,NR,'-,0.015728297 unit increase,[0.011-0.021],"IGSF9B, LINC02730","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:133983113
rs2007044-<b>?</b>,2 x 10-15,,NR,'-,0.016178014 unit increase,[0.012-0.02],CACNA1C,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:2235794
rs11055980-<b>?</b>,2 x 10-12,,NR,'-,0.014355132 unit increase,[0.01-0.018],ATF7IP,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:14458588
rs708212-<b>?</b>,8 x 10-9,,NR,'-,0.013338349 unit increase,[0.0088-0.0179],DENND5B,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:31400104
rs1054442-<b>?</b>,4 x 10-8,,NR,'-,0.011417595 unit decrease,[0.0073-0.0155],DDN,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:48995537
rs117124817-<b>?</b>,9 x 10-9,,NR,'-,0.037650615 unit decrease,[0.025-0.05],PRPF40B,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:49615386
rs3741434-<b>?</b>,1 x 10-10,,NR,'-,0.019061647 unit increase,[0.013-0.025],RARG,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:53211560
rs7302200-<b>?</b>,1 x 10-14,,NR,'-,0.016756827 unit increase,[0.013-0.021],"ERBB3, RPS26","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:56055651
rs12826178-<b>?</b>,9 x 10-11,,NR,'-,0.024255138 unit increase,[0.017-0.032],"NXPH4, SHMT2","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:57228588
rs7131944-<b>?</b>,3 x 10-9,,NR,'-,0.012889822 unit increase,[0.0086-0.0171],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:91765780
rs4766428-<b>?</b>,2 x 10-8,,NR,'-,0.011449439 unit decrease,[0.0075-0.0154],ATP2A2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:110285440
rs1615350-<b>?</b>,1 x 10-25,,NR,'-,0.02327281 unit decrease,[0.019-0.028],MPHOSPH9,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,12:123165788
rs7321596-<b>?</b>,3 x 10-8,,NR,'-,0.01094624 unit decrease,[0.0071-0.0148],"NRAD1, LACC1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,13:43898119
rs7319102-<b>?</b>,1 x 10-15,,NR,'-,0.020173358 unit increase,[0.015-0.025],PCDH17,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,13:57678667
rs1076884-<b>?</b>,7 x 10-11,,NR,'-,0.015163777 unit decrease,[0.011-0.02],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:13653946
rs2966157-<b>?</b>,6 x 10-11,,NR,'-,0.015330326 unit decrease,[0.011-0.02],"PDXDC1, RRN3","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:15062041
rs11130-<b>?</b>,4 x 10-8,,NR,'-,0.010989607 unit increase,[0.0071-0.0149],"NDE1, MYH11","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:15724453
rs7359397-<b>?</b>,7 x 10-11,,NR,'-,0.013461787 unit decrease,[0.0094-0.0175],"ATP2A1, SH2B1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:28874338
rs3814883-<b>?</b>,2 x 10-9,,NR,'-,0.012003836 unit increase,[0.0081-0.0159],TAOK2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:29983601
rs16953305-<b>?</b>,2 x 10-8,,NR,'-,0.011788915 unit increase,[0.0077-0.0159],"IRX3, LINC02169","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:54278937
rs818415-<b>?</b>,5 x 10-8,,NR,'-,0.013718705 unit decrease,[0.0088-0.0186],LINC00922,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:65414176
rs11861362-<b>?</b>,6 x 10-11,,NR,'-,0.015396307 unit increase,[0.011-0.02],SMPD3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:68384889
rs11647188-<b>?</b>,9 x 10-9,,NR,'-,0.011853027 unit increase,[0.0078-0.0159],CDH13,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:82614909
rs7214058-<b>?</b>,6 x 10-9,,NR,'-,0.011757166 unit increase,[0.0078-0.0157],GAS7,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,17:10080017
rs12602286-<b>?</b>,2 x 10-8,,NR,'-,0.01702477 unit decrease,[0.011-0.023],EPN2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,17:19333641
rs17638867-<b>?</b>,2 x 10-9,,NR,'-,0.014580288 unit increase,[0.0098-0.0193],"AP2B1, TAF15","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,17:35725494
rs35076622-<b>?</b>,3 x 10-12,,NR,'-,0.01452853 unit decrease,[0.01-0.019],LINC02210-CRHR1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,17:45779092
rs28584904-<b>?</b>,2 x 10-8,,NR,'-,0.01435964 unit increase,[0.0093-0.0194],CASC17,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,17:70999077
rs3809912-<b>?</b>,1 x 10-8,,NR,'-,0.0121842045 unit increase,[0.008-0.0164],SEH1L,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:12947463
rs4800490-<b>?</b>,1 x 10-10,,NR,'-,0.013046194 unit decrease,[0.0091-0.017],NPC1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:23546117
rs56791590-<b>?</b>,8 x 10-9,,NR,'-,0.011698486 unit increase,[0.0077-0.0157],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:28799186
rs1941955-<b>?</b>,6 x 10-15,,NR,'-,0.016086996 unit decrease,[0.012-0.02],"MIR4318, CELF4","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:37582875
rs12967828-<b>?</b>,1 x 10-9,,NR,'-,0.015142529 unit decrease,[0.01-0.02],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:38549487
rs2576035-<b>?</b>,8 x 10-12,,NR,'-,0.014188748 unit decrease,[0.01-0.018],KATNAL2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:47061283
rs1431196-<b>?</b>,6 x 10-11,,NR,'-,0.013083531 unit increase,[0.0092-0.017],DCC,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:53305732
rs9636107-<b>?</b>,6 x 10-13,,NR,'-,0.014222787 unit increase,[0.01-0.018],TCF4,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:55532886
rs28491529-<b>?</b>,8 x 10-10,,NR,'-,0.014192207 unit increase,[0.0097-0.0187],RNU6-655P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,18:78129301
rs72986630-<b>?</b>,5 x 10-9,,NR,'-,0.024804784 unit decrease,[0.017-0.033],ZNF823,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,19:11738921
rs12462428-<b>?</b>,2 x 10-8,,NR,'-,0.014301331 unit increase,[0.0093-0.0193],MED26,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,19:16583799
rs4144797-<b>?</b>,4 x 10-16,,NR,1.085,'-,[1.07-1.1],GIGYF2,Schizophrenia,schizophrenia,GCST006803,2:232697487
rs36043959-<b>?</b>,4 x 10-12,,NR,1.07,'-,[1.05-1.09],SGCZ,Schizophrenia,schizophrenia,GCST006803,8:110459785
rs12293670-<b>?</b>,2 x 10-15,,NR,1.084,'-,[1.06-1.1],NRGN,Schizophrenia,schizophrenia,GCST006803,11:124743036
rs6694545-<b>?</b>,6 x 10-12,,NR,1.08,'-,[1.06-1.1],LINC01648,Schizophrenia,schizophrenia,GCST006803,1:29964421
rs6002655-<b>?</b>,2 x 10-14,,NR,1.0775862,'-,[1.06-1.10],TCF20,Schizophrenia,schizophrenia,GCST006803,22:42207808
rs4648845-<b>?</b>,7 x 10-12,,NR,1.0799136,'-,[1.06-1.10],PLCH2,Schizophrenia,schizophrenia,GCST006803,1:2455662
rs10083370-<b>?</b>,3 x 10-14,,NR,1.078,'-,[1.06-1.1],LINC00637,Schizophrenia,schizophrenia,GCST006803,14:103847845
rs111294930-<b>?</b>,9 x 10-12,,NR,1.086,'-,[1.06-1.11],LINC01470,Schizophrenia,schizophrenia,GCST006803,5:152797561
rs7701440-<b>?</b>,4 x 10-14,,NR,1.0752687,'-,[1.06-1.09],"ZSWIM6, LINC02057",Schizophrenia,schizophrenia,GCST006803,5:61325153
rs56807175-<b>?</b>,1 x 10-11,,NR,1.091703,'-,[1.07-1.12],'-,Schizophrenia,schizophrenia,GCST006803,2:145678655
rs4936215-<b>?</b>,5 x 10-14,,NR,1.096,'-,[1.07-1.12],"LINC02730, IGSF9B",Schizophrenia,schizophrenia,GCST006803,11:133982789
rs7951870-<b>?</b>,3 x 10-13,,NR,1.0976949,'-,[1.07-1.12],DGKZ,Schizophrenia,schizophrenia,GCST006803,11:46351761
rs6434928-<b>?</b>,4 x 10-13,,NR,1.076,'-,[1.06-1.1],"RNU6-1029P, SF3B1",Schizophrenia,schizophrenia,GCST006803,2:197439853
rs7893279-<b>?</b>,5 x 10-13,,NR,1.118,'-,[1.09-1.15],CACNB2,Schizophrenia,schizophrenia,GCST006803,10:18456176
rs11646127-<b>?</b>,6 x 10-13,,NR,1.073,'-,[1.05-1.09],TMEM219,Schizophrenia,schizophrenia,GCST006803,16:29954956
rs9607782-<b>?</b>,6 x 10-13,,NR,1.0845987,'-,[1.06-1.11],EP300-AS1,Schizophrenia,schizophrenia,GCST006803,22:41191552
rs217287-<b>?</b>,1 x 10-12,,NR,1.072,'-,[1.05-1.09],SNAP91,Schizophrenia,schizophrenia,GCST006803,6:83697747
rs62606711-<b>?</b>,1 x 10-12,,NR,1.075,'-,[1.06-1.09],PJA1,Schizophrenia,schizophrenia,GCST006803,X:69157361
rs5757730-<b>?</b>,2 x 10-12,,NR,1.0741138,'-,[1.05-1.09],CACNA1I,Schizophrenia,schizophrenia,GCST006803,22:39571425
rs7596038-<b>?</b>,2 x 10-12,,NR,1.07,'-,[1.05-1.09],VRK2,Schizophrenia,schizophrenia,GCST006803,2:58156685
rs35346733-<b>?</b>,2 x 10-12,,NR,1.075,'-,[1.05-1.1],CNTN4,Schizophrenia,schizophrenia,GCST006803,3:2479638
rs2514218-<b>?</b>,2 x 10-12,,NR,1.0905125,'-,[1.07-1.11],DRD2,Schizophrenia,schizophrenia,GCST006803,11:113522272
rs2332700-<b>?</b>,2 x 10-10,,NR,1.073,'-,[1.05-1.09],RGS6,Schizophrenia,schizophrenia,GCST006803,14:71950609
rs3743078-<b>?</b>,3 x 10-12,,NR,1.081081,'-,[1.06-1.10],CHRNA3,Schizophrenia,schizophrenia,GCST006803,15:78602417
rs34796896-<b>?</b>,3 x 10-12,,NR,1.087,'-,[1.06-1.11],FXR1,Schizophrenia,schizophrenia,GCST006803,3:180905467
rs7432375-<b>?</b>,4 x 10-12,,NR,1.0834236,'-,[1.06-1.11],STAG1,Schizophrenia,schizophrenia,GCST006803,3:136569563
rs2851447-<b>?</b>,6 x 10-16,,NR,1.091,'-,[1.07-1.11],MPHOSPH9,Schizophrenia,schizophrenia,GCST006803,12:123180566
rs1451488-<b>?</b>,5 x 10-12,,NR,1.0695187,'-,[1.05-1.09],RNU7-147P,Schizophrenia,schizophrenia,GCST006803,2:199125384
rs12129573-<b>?</b>,9 x 10-15,,NR,1.0799136,'-,[1.06-1.10],LINC01360,Schizophrenia,schizophrenia,GCST006803,1:73302683
rs2905432-<b>?</b>,7 x 10-12,,NR,1.071,'-,[1.05-1.09],"MAU2, GATAD2A",Schizophrenia,schizophrenia,GCST006803,19:19373486
rs4766428-<b>?</b>,3 x 10-14,,NR,1.0787487,'-,[1.06-1.10],ATP2A2,Schizophrenia,schizophrenia,GCST006803,12:110285440
rs11783093-<b>?</b>,8 x 10-12,,NR,1.098,'-,[1.07-1.12],GULOP,Schizophrenia,schizophrenia,GCST006803,8:27567832
rs12704290-<b>?</b>,4 x 10-14,,NR,1.121,'-,[1.09-1.15],"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST006803,7:86798310
rs62334820-<b>?</b>,1 x 10-11,,NR,1.0845987,'-,[1.06-1.11],GPM6A,Schizophrenia,schizophrenia,GCST006803,4:175934070
rs5825114-<b>?</b>,5 x 10-14,,NR,1.0752687,'-,[1.06-1.09],LINC01929,Schizophrenia,schizophrenia,GCST006803,18:55081986
rs2970610-<b>?</b>,1 x 10-11,,NR,1.07,'-,[1.05-1.09],"KDM4A, PTPRF",Schizophrenia,schizophrenia,GCST006803,1:43631859
rs16867576-<b>?</b>,2 x 10-11,,NR,1.106,'-,[1.08-1.14],MEF2C-AS1,Schizophrenia,schizophrenia,GCST006803,5:89450514
rs35774874-<b>?</b>,2 x 10-11,,NR,1.071,'-,[1.05-1.09],"SNX19, RN7SL167P",Schizophrenia,schizophrenia,GCST006803,11:130941461
rs61937595-<b>?</b>,3 x 10-11,,NR,1.133,'-,[1.1-1.17],R3HDM2,Schizophrenia,schizophrenia,GCST006803,12:57289173
rs1473594-<b>?</b>,3 x 10-11,,NR,1.066,'-,[1.05-1.08],'-,Schizophrenia,schizophrenia,GCST006803,8:59783967
rs7508148-<b>?</b>,4 x 10-11,,NR,1.08,'-,[1.06-1.1],SCAF1,Schizophrenia,schizophrenia,GCST006803,19:49648885
rs12705761-<b>?</b>,5 x 10-11,,NR,1.068,'-,[1.05-1.09],IMMP2L,Schizophrenia,schizophrenia,GCST006803,7:111336208
rs16902086-<b>?</b>,6 x 10-11,,NR,1.0683761,'-,[1.05-1.09],HCN1,Schizophrenia,schizophrenia,GCST006803,5:45285650
rs7789569-<b>?</b>,7 x 10-11,,NR,1.067,'-,[1.05-1.09],SRPK2,Schizophrenia,schizophrenia,GCST006803,7:105287139
rs3735025-<b>?</b>,7 x 10-11,,NR,1.067,'-,[1.05-1.09],DGKI,Schizophrenia,schizophrenia,GCST006803,7:137390098
rs1319017-<b>?</b>,8 x 10-11,,NR,1.0683761,'-,[1.05-1.09],DDX10P2,Schizophrenia,schizophrenia,GCST006803,9:82121388
rs75968099-<b>?</b>,9 x 10-11,,NR,1.0683761,'-,[1.05-1.09],"LINC02033, HSPD1P6",Schizophrenia,schizophrenia,GCST006803,3:36817092
rs704373-<b>?</b>,1 x 10-10,,NR,1.067,'-,[1.05-1.09],ATXN7,Schizophrenia,schizophrenia,GCST006803,3:63881679
rs17514846-<b>?</b>,3 x 10-12,,NR,1.0706638,'-,[1.05-1.09],FURIN,Schizophrenia,schizophrenia,GCST006803,15:90873320
rs14403-<b>?</b>,2 x 10-10,,NR,1.077,'-,[1.05-1.1],AKT3,Schizophrenia,schizophrenia,GCST006803,1:243500591
rs215411-<b>?</b>,1 x 10-8,,NR,1.059322,'-,[1.04-1.08],RFPL4AP3,Schizophrenia,schizophrenia,GCST006803,4:23421980
rs1120004-<b>?</b>,1 x 10-8,,NR,1.064,'-,[1.04-1.09],SOX5,Schizophrenia,schizophrenia,GCST006803,12:23480498
rs146678232-<b>?</b>,2 x 10-8,,NR,1.0729614,'-,[1.05-1.10],GSDME,Schizophrenia,schizophrenia,GCST006803,7:24737471
rs35604463-<b>?</b>,2 x 10-8,,NR,1.058,'-,[1.04-1.08],BCL11B,Schizophrenia,schizophrenia,GCST006803,14:99245695
rs4240748-<b>?</b>,2 x 10-8,,NR,1.0570824,'-,[1.04-1.08],LINC02404,Schizophrenia,schizophrenia,GCST006803,12:91853010
rs56282503-<b>?</b>,2 x 10-8,,NR,1.0638298,'-,[1.04-1.09],PAK6,Schizophrenia,schizophrenia,GCST006803,15:40274558
rs4925114-<b>?</b>,3 x 10-8,,NR,1.058,'-,[1.04-1.08],RAI1,Schizophrenia,schizophrenia,GCST006803,17:17807956
rs10520163-<b>?</b>,3 x 10-8,,NR,1.0548522,'-,[1.04-1.07],CLCN3,Schizophrenia,schizophrenia,GCST006803,4:169705401
rs1975802-<b>?</b>,4 x 10-8,,NR,1.0718113,'-,[1.05-1.10],PLA2G15,Schizophrenia,schizophrenia,GCST006803,16:68251944
rs11165867-<b>?</b>,4 x 10-8,,NR,1.0718113,'-,[1.05-1.10],"DPYD-IT1, DPYD",Schizophrenia,schizophrenia,GCST006803,1:97412512
rs117074560-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,"FUT9, KRT18P50",Schizophrenia,schizophrenia,GCST006803,6:96011775
rs77502336-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,GRAMD1B,Schizophrenia,schizophrenia,GCST006803,11:123523928
rs200327371-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,EPC2,Schizophrenia,schizophrenia,GCST006803,2:148671610
rs71575306-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,MAN2A1,Schizophrenia,schizophrenia,GCST006803,5:109710509
rs11740474-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,GALNT10,Schizophrenia,schizophrenia,GCST006803,5:154301187
rs12421382-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,C11orf87,Schizophrenia,schizophrenia,GCST006803,11:109507345
rs679087-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,TMTC1,Schizophrenia,schizophrenia,GCST006803,12:29764332
rs10863593-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,MIR29B2CHG,Schizophrenia,schizophrenia,GCST006803,1:207844729
rs7267348-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,PTGIS,Schizophrenia,schizophrenia,GCST006803,20:49514499
rs34685708-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,SLC4A10,Schizophrenia,schizophrenia,GCST006803,2:161972220
rs70988775-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,"VTRNA1-3, PCDHA1",Schizophrenia,schizophrenia,GCST006803,5:140776321
rs3617-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,ITIH3,Schizophrenia,schizophrenia,GCST006803,3:52799789
rs10860964-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,C12orf42,Schizophrenia,schizophrenia,GCST006803,12:103202677
rs2053079-<b>?</b>,2 x 10-10,,NR,1.0729614,'-,[1.05-1.09],ZNF536,Schizophrenia,schizophrenia,GCST006803,19:30496516
rs3130820-<b>?</b>,2 x 10-44,,NR,1.281,'-,[1.25-1.32],"OR2U1P, OR2G1P",Schizophrenia,schizophrenia,GCST006803,6:29238906
rs12009217-<b>?</b>,2 x 10-10,,NR,1.0672358,'-,[1.05-1.09],NLGN4X,Schizophrenia,schizophrenia,GCST006803,X:6002841
rs42945-<b>?</b>,2 x 10-10,,NR,1.0649627,'-,[1.05-1.08],NDRG4,Schizophrenia,schizophrenia,GCST006803,16:58511522
rs1339227-<b>?</b>,4 x 10-10,,NR,1.065,'-,[1.05-1.08],RIMS1,Schizophrenia,schizophrenia,GCST006803,6:72445999
rs1191551-<b>?</b>,4 x 10-10,,NR,1.076,'-,[1.05-1.1],"RNU11-5P, PRKD1",Schizophrenia,schizophrenia,GCST006803,14:29531199
rs7499750-<b>?</b>,4 x 10-10,,NR,1.073,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST006803,16:13655408
rs7216638-<b>?</b>,5 x 10-10,,NR,1.067,'-,[1.05-1.09],SMG6,Schizophrenia,schizophrenia,GCST006803,17:2253159
rs10156310-<b>?</b>,6 x 10-10,,NR,1.076,'-,[1.05-1.1],NSD3,Schizophrenia,schizophrenia,GCST006803,8:38351611
rs12991836-<b>?</b>,6 x 10-10,,NR,1.0626993,'-,[1.04-1.08],ZEB2,Schizophrenia,schizophrenia,GCST006803,2:144383974
rs140505938-<b>?</b>,7 x 10-10,,NR,1.087,'-,[1.06-1.11],"OTUD7B, VPS45",Schizophrenia,schizophrenia,GCST006803,1:150059494
rs13169274-<b>?</b>,7 x 10-10,,NR,1.0615711,'-,[1.04-1.08],ETF1,Schizophrenia,schizophrenia,GCST006803,5:138519616
rs12908161-<b>?</b>,9 x 10-10,,NR,1.069,'-,[1.05-1.09],"SEC11A, NMB",Schizophrenia,schizophrenia,GCST006803,15:84664594
rs1899543-<b>?</b>,1 x 10-9,,NR,1.059322,'-,[1.04-1.08],Y_RNA,Schizophrenia,schizophrenia,GCST006803,11:24384873
rs7129727-<b>?</b>,1 x 10-9,,NR,1.0649627,'-,[1.04-1.09],TMX2,Schizophrenia,schizophrenia,GCST006803,11:57717188
rs11409090-<b>?</b>,2 x 10-9,,NR,1.0615711,'-,[1.04-1.08],TBC1D5,Schizophrenia,schizophrenia,GCST006803,3:17846144
rs211829-<b>?</b>,2 x 10-9,,NR,1.061,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST006803,7:110408836
rs12898315-<b>?</b>,3 x 10-9,,NR,1.0582011,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST006803,15:61561804
rs34269918-<b>?</b>,3 x 10-9,,NR,1.0626993,'-,[1.04-1.08],RERE,Schizophrenia,schizophrenia,GCST006803,1:8364925
rs11685299-<b>?</b>,4 x 10-9,,NR,1.062,'-,[1.04-1.08],CUL3,Schizophrenia,schizophrenia,GCST006803,2:224526579
rs10196799-<b>?</b>,5 x 10-9,,NR,1.058,'-,[1.04-1.08],ZNF804A,Schizophrenia,schizophrenia,GCST006803,2:184776001
rs7801375-<b>?</b>,6 x 10-9,,NR,1.0799136,'-,[1.05-1.11],CAPZA1P4,Schizophrenia,schizophrenia,GCST006803,7:131882504
rs7191183-<b>?</b>,6 x 10-9,,NR,1.0615711,'-,[1.04-1.08],GRIN2A,Schizophrenia,schizophrenia,GCST006803,16:9806200
rs7010876-<b>?</b>,7 x 10-9,,NR,1.064,'-,[1.04-1.08],MMP16,Schizophrenia,schizophrenia,GCST006803,8:88252522
rs139425113-<b>?</b>,8 x 10-9,,NR,1.0683761,'-,[1.05-1.09],CSMD1,Schizophrenia,schizophrenia,GCST006803,8:4323090
rs4650963-<b>?</b>,1 x 10-8,,NR,1.056,'-,[1.04-1.07],"LINC01645, BRINP2",Schizophrenia,schizophrenia,GCST006803,1:177340354
rs12148337-<b>?</b>,1 x 10-8,,NR,1.0857763,'-,[1.06-1.11],'-,Schizophrenia,schizophrenia,GCST006803,15:70296933
rs2007044-<b>?</b>,6 x 10-20,,NR,1.0928961,'-,[1.07-1.11],CACNA1C,Schizophrenia,schizophrenia,GCST006803,12:2235794
rs10650434-<b>?</b>,1 x 10-18,,NR,1.0893246,'-,[1.07-1.11],MAD1L1,Schizophrenia,schizophrenia,GCST006803,7:1985462
rs2660304-<b>?</b>,2 x 10-18,,NR,1.1148272,'-,[1.09-1.14],MIR137HG,Schizophrenia,schizophrenia,GCST006803,1:98046571
rs12416331-<b>?</b>,7 x 10-18,,NR,1.157,'-,[1.12-1.19],NT5C2,Schizophrenia,schizophrenia,GCST006803,10:103169157
rs58033671-<b>?</b>,9 x 10-18,,NR,1.087,'-,[1.07-1.11],TSNARE1,Schizophrenia,schizophrenia,GCST006803,8:142238758
rs2949006-<b>?</b>,4 x 10-17,,NR,1.105,'-,[1.08-1.13],FTCDNL1,Schizophrenia,schizophrenia,GCST006803,2:199850665
rs6065094-<b>?</b>,8 x 10-17,,NR,1.0893246,'-,[1.07-1.11],PPP1R16B,Schizophrenia,schizophrenia,GCST006803,20:38824551
rs13107325-<b>?</b>,1 x 10-16,,NR,1.1737089,'-,[1.14-1.21],'-,Schizophrenia,schizophrenia,GCST006803,Mapping not available
rs11682175-<b>C</b>,5 x 10-9,,0.48,1.0309278,'-,[1.02-1.04],ACTG1P22,Depression,unipolar depression,GCST005839,2:57760458
rs7430565-<b>G</b>,3 x 10-9,,0.42,1.0309278,'-,[1.02-1.04],RSRC1,Depression,unipolar depression,GCST005839,3:158389391
chr5_87992715-<b>?</b>,8 x 10-11,,0.42,1.0309278,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,Mapping not available
rs116755193-<b>C</b>,7 x 10-9,,0.62,1.0309278,'-,[1.02-1.04],LINC02240,Depression,unipolar depression,GCST005839,5:124916190
rs11135349-<b>C</b>,1 x 10-9,,0.52,1.0309278,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,5:165096466
rs4869056-<b>G</b>,7 x 10-9,,0.37,1.0309278,'-,[1.02-1.04],TENM2,Depression,unipolar depression,GCST005839,5:167565073
rs7856424-<b>C</b>,9 x 10-9,,0.71,1.0309278,'-,[1.02-1.04],ASTN2,Depression,unipolar depression,GCST005839,9:116971316
rs4074723-<b>C</b>,3 x 10-8,,0.59,1.0309278,'-,[1.02-1.04],SOX5,Depression,unipolar depression,GCST005839,12:23794803
rs4904738-<b>C</b>,3 x 10-9,,0.43,1.0309278,'-,[1.02-1.04],LRFN5,Depression,unipolar depression,GCST005839,14:41710529
rs915057-<b>G</b>,8 x 10-10,,0.58,1.0309278,'-,[1.02-1.04],"ESR2, SYNE2",Depression,unipolar depression,GCST005839,14:64219489
rs10149470-<b>G</b>,3 x 10-9,,0.51,1.0309278,'-,[1.02-1.04],"RNU7-160P, BAG5",Depression,unipolar depression,GCST005839,14:103551616
rs8025231-<b>C</b>,2 x 10-12,,0.43,1.0309278,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,15:37356201
rs8063603-<b>G</b>,7 x 10-9,,0.35,1.0309278,'-,[1.02-1.04],RBFOX1,Depression,unipolar depression,GCST005839,16:6260644
rs62099069-<b>T</b>,1 x 10-8,,0.58,1.0309278,'-,[1.02-1.04],MIR924HG,Depression,unipolar depression,GCST005839,18:39303773
rs34215985-<b>G</b>,3 x 10-9,,0.76,1.0416667,'-,[1.03-1.05],SLC30A9,Depression,unipolar depression,GCST005839,4:42045761
rs115507122-<b>G</b>,3 x 10-11,,0.82,1.0416667,'-,[1.03-1.05],HCG20,Depression,unipolar depression,GCST005839,6:30769814
rs61867293-<b>C</b>,7 x 10-10,,0.8,1.0416667,'-,[1.03-1.05],SORCS3,Depression,unipolar depression,GCST005839,10:104804166
rs4143229-<b>C</b>,3 x 10-8,,0.08,1.0526316,'-,[1.03-1.07],ENOX1,Depression,unipolar depression,GCST005839,13:43753663
rs17727765-<b>C</b>,9 x 10-9,,0.08,1.0526316,'-,[1.04-1.07],CRYBA1,Depression,unipolar depression,GCST005839,17:29249944
rs7029033-<b>T</b>,3 x 10-8,,0.07,1.05,'-,[1.03-1.07],DENND1A,Depression,unipolar depression,GCST005839,9:123919789
rs1432639-<b>A</b>,5 x 10-15,,0.63,1.04,'-,[1.03-1.05],RPL31P12,Depression,unipolar depression,GCST005839,1:72347535
rs12129573-<b>A</b>,4 x 10-12,,0.37,1.04,'-,[1.03-1.05],LINC01360,Depression,unipolar depression,GCST005839,1:73302683
rs1806153-<b>T</b>,1 x 10-9,,0.22,1.04,'-,[1.03-1.05],PAUPAR,Depression,unipolar depression,GCST005839,11:31828558
rs12552-<b>A</b>,6 x 10-19,,0.44,1.04,'-,[1.03-1.05],OLFM4,Depression,unipolar depression,GCST005839,13:53051646
rs2389016-<b>T</b>,1 x 10-8,,0.28,1.03,'-,[1.02-1.04],HMGB1P18,Depression,unipolar depression,GCST005839,1:80333644
rs1226412-<b>T</b>,2 x 10-8,,0.79,1.03,'-,[1.02-1.04],LINC01876,Depression,unipolar depression,GCST005839,2:156254801
chr3_44287760-<b>?</b>,5 x 10-8,,0.34,1.03,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,Mapping not available
chr5_103942055-<b>?</b>,8 x 10-12,,0.48,1.03,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,Mapping not available
rs9402472-<b>A</b>,3 x 10-8,,0.24,1.03,'-,[1.02-1.04],"TRIM26, MIR548AI",Depression,unipolar depression,GCST005839,6:99118645
rs10950398-<b>A</b>,3 x 10-8,,0.41,1.03,'-,[1.02-1.04],TMEM106B,Depression,unipolar depression,GCST005839,7:12225245
rs12666117-<b>A</b>,1 x 10-8,,0.47,1.03,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,7:109465554
rs1354115-<b>A</b>,2 x 10-8,,0.62,1.03,'-,[1.02-1.04],CARM1P1,Depression,unipolar depression,GCST005839,9:2983774
rs10959913-<b>T</b>,5 x 10-9,,0.76,1.03,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,9:11544964
chr14_75356855-<b>?</b>,4 x 10-9,,0.49,1.03,'-,[1.02-1.04],'-,Depression,unipolar depression,GCST005839,Mapping not available
rs7198928-<b>T</b>,1 x 10-8,,0.62,1.03,'-,[1.02-1.04],RBFOX1,Depression,unipolar depression,GCST005839,16:7616400
rs7200826-<b>T</b>,2 x 10-8,,0.25,1.03,'-,[1.02-1.04],SHISA9,Depression,unipolar depression,GCST005839,16:12972976
rs11643192-<b>A</b>,3 x 10-8,,0.41,1.03,'-,[1.02-1.04],"LINC01572, PMFBP1",Depression,unipolar depression,GCST005839,16:72180377
rs11663393-<b>A</b>,2 x 10-8,,0.45,1.03,'-,[1.02-1.04],DCC,Depression,unipolar depression,GCST005839,18:53088362
rs1833288-<b>A</b>,3 x 10-8,,0.72,1.03,'-,[1.02-1.04],RAB27B,Depression,unipolar depression,GCST005839,18:54850675
rs12958048-<b>A</b>,4 x 10-11,,0.33,1.03,'-,[1.02-1.04],TCF4,Depression,unipolar depression,GCST005839,18:55434367
rs5758265-<b>A</b>,8 x 10-9,,0.28,1.03,'-,[1.02-1.04],"L3MBTL2, L3MBTL2-AS1",Depression,unipolar depression,GCST005839,22:41221893
rs159963-<b>C</b>,3 x 10-8,,0.44,1.0309278,'-,[1.02-1.04],RERE,Depression,unipolar depression,GCST005839,1:8444361
rs4261101-<b>G</b>,1 x 10-8,,0.63,1.0309278,'-,[1.02-1.04],RNU6-695P,Depression,unipolar depression,GCST005839,1:90330495
rs9427672-<b>G</b>,3 x 10-8,,0.76,1.0309278,'-,[1.02-1.04],DENND1B,Depression,unipolar depression,GCST005839,1:197785611
rs2133896-<b>T</b>,4 x 10-9,,0.2215,'-,0.104 unit increase,[0.069-0.139],ANKS1B,Alcohol dependence or heroin dependence or methamphetamine dependence,"alcohol dependence, heroin dependence, methamphetamine dependence",GCST008645,12:99455122
rs147247472-<b>A</b>,3 x 10-12,,0.0174,'-,0.348 unit increase,[0.25-0.45],"AGBL4-IT1, AGBL4",Alcohol dependence or heroin dependence or methamphetamine dependence,"alcohol dependence, heroin dependence, methamphetamine dependence",GCST008645,1:49441901
rs10196867-<b>C</b>,5 x 10-9,,0.0297,'-,0.243 unit increase,[0.16-0.33],CTNNA2,Alcohol dependence or heroin dependence or methamphetamine dependence,"alcohol dependence, heroin dependence, methamphetamine dependence",GCST008645,2:79751234
rs13072940-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"LINC02033, HSPD1P6",Psychiatric diseases (pleiotropy) (HIPO component 1),"attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST006668,3:36801132
rs35546597-<b>?</b>,2 x 10-8,(EA),NR,'-,'-,'-,"AURKB, BORCS6",Anxiety disorders,"anxiety disorder, panic disorder",GCST009838,17:8201734
rs10534613-<b>?</b>,5 x 10-8,(EA),NR,'-,'-,'-,IQCE,Anxiety disorders,"anxiety disorder, panic disorder",GCST009838,7:2592402
rs141994868-<b>T</b>,7 x 10-6,,0.027,'-,4.508 z score increase,'-,STK24,Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,13:98570168
rs28655387-<b>T</b>,3 x 10-6,,0.9457,'-,4.649 z score decrease,'-,"LINC01572, PMFBP1",Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,16:72225293
rs59197085-<b>A</b>,4 x 10-7,,0.07971,'-,5.076 z score decrease,'-,CCDC136,Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,7:128820702
rs5995177-<b>A</b>,5 x 10-7,,0.08049,'-,5.026 z score decrease,'-,RBFOX2,Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,22:35913505
rs6737417-<b>A</b>,3 x 10-6,,0.5384,'-,4.672 z score increase,'-,EPHA4,Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,2:221346292
rs10774547-<b>T</b>,4 x 10-6,,0.6702,'-,4.632 z score increase,'-,"RPS27P25, COX6A1",Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,12:120424913
rs72626581-<b>T</b>,6 x 10-6,,0.7458,'-,4.531 z score decrease,'-,ZFP64,Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,20:52166910
rs13384469-<b>T</b>,9 x 10-6,,0.1183,'-,4.45 z score increase,'-,RNU6ATAC37P,Reading disability or specific language impairment (pleiotropy),"specific language impairment, dyslexia",GCST004401,2:7509390
rs10774547-<b>T</b>,1 x 10-6,,0.6702,'-,4.852 z score increase,'-,"RPS27P25, COX6A1",Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy),"intelligence, specific language impairment, dyslexia",GCST004402,12:120424913
rs6737417-<b>A</b>,9 x 10-6,,0.5384,'-,4.452 z score increase,'-,EPHA4,Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy),"intelligence, specific language impairment, dyslexia",GCST004402,2:221348323
rs59197085-<b>A</b>,3 x 10-7,,0.07971,'-,5.123 z score decrease,'-,CCDC136,Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy),"intelligence, specific language impairment, dyslexia",GCST004402,7:128820702
rs1711745-<b>A</b>,1 x 10-6,,0.09122,'-,4.888 z score increase,'-,INIP,Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy),"intelligence, specific language impairment, dyslexia",GCST004402,9:112690629
rs28655387-<b>T</b>,8 x 10-6,,0.9457,'-,4.478 z score decrease,'-,"LINC01572, PMFBP1",Reading disability or specific language impairment adjusted for intelligence quotient (pleiotropy),"intelligence, specific language impairment, dyslexia",GCST004402,16:72225293
rs6703335-<b>?</b>,4 x 10-9,,0.562,'-,'-,'-,SDCCAG8,"Schizophrenia, schizoaffective disorder or bipolar disorder","schizophrenia, bipolar disorder, schizoaffective disorder",GCST002254,1:243445665
rs2710323-<b>?</b>,3 x 10-8,,0.466,'-,'-,'-,ITIH1,"Schizophrenia, schizoaffective disorder or bipolar disorder","schizophrenia, bipolar disorder, schizoaffective disorder",GCST002254,3:52781889
rs17693963-<b>?</b>,2 x 10-9,,0.904,'-,'-,'-,"GPR89P, RSL24D1P1","Schizophrenia, schizoaffective disorder or bipolar disorder","schizophrenia, bipolar disorder, schizoaffective disorder",GCST002254,6:27742386
rs4721295-<b>?</b>,6 x 10-10,,0.378,'-,'-,'-,MAD1L1,"Schizophrenia, schizoaffective disorder or bipolar disorder","schizophrenia, bipolar disorder, schizoaffective disorder",GCST002254,7:1997034
rs6558872-<b>?</b>,5 x 10-8,,0.571,'-,'-,'-,CSMD1,"Schizophrenia, schizoaffective disorder or bipolar disorder","schizophrenia, bipolar disorder, schizoaffective disorder",GCST002254,8:4380617
rs6484218-<b>A</b>,4 x 10-8,,0.14,'-,'-,'-,AMPD3,"Schizophrenia, bipolar disorder and depression (combined)","unipolar depression, mental or behavioural disorder, bipolar disorder",GCST000774,11:10369034
rs4982029-<b>A</b>,4 x 10-6,,0.02,'-,'-,'-,NPAS3,"Schizophrenia, bipolar disorder and depression (combined)","unipolar depression, mental or behavioural disorder, bipolar disorder",GCST000774,14:33007060
rs7326068-<b>A</b>,3 x 10-6,,0.19,'-,'-,'-,IFT88,"Schizophrenia, bipolar disorder and depression (combined)","unipolar depression, mental or behavioural disorder, bipolar disorder",GCST000774,13:20635373
rs3758354-<b>C</b>,3 x 10-6,,0.03,'-,'-,'-,"ALDH1A1, ANXA1","Schizophrenia, bipolar disorder and depression (combined)","unipolar depression, mental or behavioural disorder, bipolar disorder",GCST000774,9:73149649
rs1001021-<b>A</b>,2 x 10-6,,0.02,'-,'-,'-,MYO18B,"Schizophrenia, bipolar disorder and depression (combined)","unipolar depression, mental or behavioural disorder, bipolar disorder",GCST000774,22:26007633
rs28754845-<b>?</b>,1 x 10-8,,NR,'-,0.0131 unit increase,NR,NUBPL,Obsessive compulsive disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"obsessive-compulsive disorder, Tourette syndrome",GCST90016617,14:31560176
rs9847154-<b>?</b>,4 x 10-9,,NR,'-,0.0214 unit increase,NR,FOXP1,Anorexia nervosa vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"anorexia nervosa, Tourette syndrome",GCST90016601,3:70944855
rs1906252-<b>?</b>,7 x 10-11,,NR,'-,0.0236 unit decrease,NR,"MIR2113, EIF4EBP2P3",Anorexia nervosa vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"anorexia nervosa, Tourette syndrome",GCST90016601,6:98102413
rs1715-<b>T</b>,6 x 10-7,(5 degree of freedom test),NR,1.41,'-,[1.29-1.53],ZNF615,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,19:51991525
rs3132581-<b>G</b>,2 x 10-7,(Modelling analysis),'-,'-,'-,'-,"MUCL3, SFTA2","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,6:30945681
rs447-<b>C</b>,4 x 10-6,(5 degree of freedom test),NR,1.025,'-,[1.00-1.05],SEMA3A,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:84143099
rs7799006-<b>C</b>,5 x 10-6,(5 degree of freedom test),NR,1.059,'-,[1.03-1.08],MRM2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:2238591
rs363598-<b>C</b>,5 x 10-6,(5 degree of freedom test),NR,1.006,'-,[0.98-1.03],GRIK1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,21:29640839
rs2675968-<b>T</b>,5 x 10-6,(5 degree of freedom test),NR,1.016,'-,[0.99-1.04],SNORC,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:232871534
rs703970-<b>C</b>,5 x 10-6,(5 degree of freedom test),NR,1.01,'-,[0.99-1.03],ZMIZ1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:79193379
rs7948661-<b>C</b>,5 x 10-6,(5 degree of freedom test),NR,1.05,'-,[1.00-1.10],KMT2A,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,11:118470934
rs11827962-<b>C</b>,6 x 10-6,(5 degree of freedom test),NR,1.044,'-,[0.94-1.15],"SLC17A6, ANO5","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,11:22291020
rs159788-<b>G</b>,7 x 10-6,(5 degree of freedom test),NR,1.012,'-,[0.97-1.05],'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,20:4371457
rs11587682-<b>C</b>,7 x 10-6,(5 degree of freedom test),NR,1.086,'-,[1.05-1.12],PRPF3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:150351808
rs7597593-<b>T</b>,8 x 10-6,(5 degree of freedom test),NR,1.055,'-,[1.03-1.08],ZNF804A,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:184668853
rs6435387-<b>G</b>,8 x 10-6,(5 degree of freedom test),NR,1.129,'-,[1.06-1.19],KIF5C,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:149008736
rs7849973-<b>?</b>,8 x 10-6,(5 degree of freedom test),NR,1.05,'-,[1.02-1.08],LINC01239,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,9:22819577
rs10250997-<b>C</b>,8 x 10-6,(5 degree of freedom test),NR,1.03,'-,[0.99-1.07],ZP3P2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:136461788
rs4741652-<b>T</b>,7 x 10-6,(Modelling analysis),NR,1.07,'-,[1.04-1.12],"SMARCA2, RN7SL592P","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,9:2194227
rs10994359-<b>C</b>,3 x 10-9,(5 degree of freedom test),NR,1.081,'-,[1.03-1.13],ANK3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:60462349
rs1006737-<b>?</b>,5 x 10-9,(5 degree of freedom test),NR,1.071,'-,[1.05-1.10],CACNA1C,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,12:2236129
rs8321-<b>?</b>,8 x 10-9,(5 degree of freedom test),NR,1.081,'-,[1.04-1.12],POLR1H,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,6:30064745
rs8058295-<b>A</b>,7 x 10-6,(Modelling analysis),'-,1.06,'-,[1.04-1.09],GRIN2A,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,16:9817529
rs10860392-<b>T</b>,2 x 10-6,(Modelling analysis),'-,1.06,'-,[1.04-1.09],ANKS1B,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,12:99104409
rs7700191-<b>A</b>,4 x 10-6,(Modelling analysis),'-,1.12,'-,[1.06-1.17],BANK1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,4:101668126
rs249954-<b>A</b>,2 x 10-6,(Modelling analysis),'-,1.07,'-,[1.04-1.10],PALB2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,16:23629146
rs2721800-<b>C</b>,6 x 10-7,(Modelling analysis),'-,1.08,'-,[1.05-1.12],MPP6,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:24652933
rs6694545-<b>A</b>,1 x 10-6,(Modelling analysis),'-,1.07,'-,[1.04-1.11],LINC01648,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:29964421
rs11731175-<b>T</b>,5 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.09],'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,4:188940097
rs4650608-<b>T</b>,1 x 10-6,(5 degree of freedom test),NR,1.06,'-,[1.03-1.09],'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:78772330
rs12576775-<b>?</b>,4 x 10-8,(Modelling analysis),0.175,'-,'-,'-,'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,Mapping not available
rs2021722-<b>?</b>,2 x 10-12,(Modelling analysis),0.789,'-,'-,'-,TRIM26,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,6:30206354
rs12966547-<b>?</b>,3 x 10-10,(Modelling analysis),0.588,'-,'-,'-,LINC01929,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,18:55084786
rs7914558-<b>?</b>,2 x 10-9,(Modelling analysis),0.587,'-,'-,'-,CNNM2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:103016151
rs11191580-<b>?</b>,1 x 10-8,(Modelling analysis),0.911,'-,'-,'-,NT5C2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:103146454
rs10503253-<b>?</b>,4 x 10-8,(Modelling analysis),0.193,'-,'-,'-,CSMD1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,8:4323322
rs17662626-<b>?</b>,5 x 10-8,(Modelling analysis),0.915,'-,'-,'-,'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:193119895
rs548181-<b>?</b>,9 x 10-7,(Modelling analysis),0.884,'-,'-,'-,"FEZ1, STT3A","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,11:125591814
rs6990255-<b>T</b>,2 x 10-6,(5 degree of freedom test),NR,1.146,'-,[1.09-1.20],"PPP1R3B, RPL10AP3","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,8:34269430
rs9834970-<b>C</b>,2 x 10-6,(5 degree of freedom test),NR,1.051,'-,[1.03-1.07],"LINC02033, HSPD1P6","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,3:36814539
rs7004633-<b>?</b>,3 x 10-8,(Modelling analysis),0.184,'-,'-,'-,'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,8:88748082
rs7565792-<b>C</b>,7 x 10-6,(5 degree of freedom test),NR,1.03,'-,[1.00-1.06],"FOXN2, PPP1R21-DT","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:48422566
rs10994397-<b>?</b>,7 x 10-9,,0.065,'-,'-,'-,ANK3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:60519366
rs1533087-<b>T</b>,9 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.09],"TCF15, SRXN1","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,20:614136
rs1107592-<b>A</b>,5 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.09],MAD1L1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:2001797
rs6602217-<b>T</b>,2 x 10-6,(Modelling analysis),'-,1.12,'-,[1.07-1.17],LINC00707,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:6904301
rs12325410-<b>T</b>,1 x 10-6,(Modelling analysis),'-,1.09,'-,[1.05-1.13],"RNA5SP403, RNA5SP404","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,16:9581389
rs2252865-<b>T</b>,5 x 10-7,(5 degree of freedom test),NR,1.03,'-,[1.00-1.06],RERE,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:8362616
rs7254215-<b>A</b>,7 x 10-6,(Modelling analysis),'-,1.09,'-,[1.05-1.13],CLEC17A,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,19:14602681
rs2799573-<b>?</b>,4 x 10-8,(Modelling analysis),0.715,1.08,'-,[1.05-1.12],CACNB2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:18312999
rs9297357-<b>T</b>,4 x 10-7,(Modelling analysis),NR,1.07,'-,[1.04-1.10],ZFPM2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,8:105130105
rs4730430-<b>T</b>,3 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.08],'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:110407907
rs9371601-<b>?</b>,4 x 10-9,(Modelling analysis),0.346,'-,'-,'-,SYNE1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,6:152469438
rs9275524-<b>T</b>,2 x 10-7,(Modelling analysis),'-,1.07,'-,[1.04-1.09],"HLA-DQB3, MTCO3P1","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,6:32707332
rs2609653-<b>T</b>,3 x 10-6,(Modelling analysis),'-,1.13,'-,[1.07-1.19],RPL10AP3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,8:34379474
rs13072940-<b>A</b>,9 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.08],"LINC02033, HSPD1P6","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,3:36801132
rs9951150-<b>A</b>,6 x 10-7,(Modelling analysis),'-,1.06,'-,[1.04-1.09],"TCF4, RNA5SP459","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,18:55153893
rs11152369-<b>A</b>,2 x 10-7,(Modelling analysis),NR,1.19,'-,[1.12-1.28],TCF4,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,18:55399097
rs6765687-<b>T</b>,5 x 10-6,(Modelling analysis),'-,1.07,'-,[1.04-1.11],GLT8D1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,3:52699090
rs2535629-<b>?</b>,3 x 10-12,,0.651,1.1,'-,[1.07-1.12],ITIH3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,3:52799203
rs10873998-<b>T</b>,4 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.09],ADGRL4,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:78798120
rs1104918-<b>T</b>,6 x 10-6,(Modelling analysis),'-,1.07,'-,[1.04-1.10],NTRK3,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,15:88180481
rs12443954-<b>A</b>,1 x 10-6,(Modelling analysis),'-,1.08,'-,[1.04-1.11],"SPATA33, CDK10","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,16:89675088
rs1625579-<b>?</b>,2 x 10-11,(Modelling analysis),0.801,'-,'-,'-,MIR137HG,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:98037378
rs2310173-<b>T</b>,3 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.08],"IL1R2, IL1R1","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:102047167
rs11191454-<b>?</b>,1 x 10-8,,0.91,1.13,'-,[1.08-1.18],"AS3MT, BORCS7-ASMT","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:102900247
rs7069733-<b>C</b>,7 x 10-6,(Modelling analysis),'-,1.08,'-,[1.04-1.12],NEURL1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,10:103538013
rs2186903-<b>A</b>,4 x 10-6,(Modelling analysis),'-,1.07,'-,[1.04-1.11],SLC35F2,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,11:107885825
rs12871532-<b>T</b>,1 x 10-6,(Modelling analysis),'-,1.06,'-,[1.04-1.09],'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,13:108016199
rs6867265-<b>A</b>,2 x 10-6,(Modelling analysis),'-,1.11,'-,[1.06-1.16],HINT1,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,5:131078288
rs10255295-<b>A</b>,5 x 10-6,(Modelling analysis),'-,1.1,'-,[1.06-1.14],"RCC2P3, Y_RNA","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,7:138174020
rs609412-<b>A</b>,2 x 10-6,(Modelling analysis),'-,1.07,'-,[1.04-1.10],PPP2R2B,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,5:146845681
rs360932-<b>A</b>,8 x 10-6,(Modelling analysis),'-,1.06,'-,[1.03-1.08],RNA5SP169,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,4:151987017
rs13418455-<b>T</b>,1 x 10-6,(Modelling analysis),'-,1.06,'-,[1.04-1.09],'-,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:180212022
rs2297909-<b>A</b>,2 x 10-6,(Modelling analysis),'-,1.06,'-,[1.04-1.09],KIF21B,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,1:200991179
rs3791556-<b>A</b>,8 x 10-6,(Modelling analysis),'-,1.08,'-,[1.04-1.11],HDAC4,"Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,2:239191276
rs1480380-<b>C</b>,6 x 10-7,(Modelling analysis),0.908,'-,'-,'-,"HLA-DMB, HLA-DMA","Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)","attention deficit hyperactivity disorder, unipolar depression, schizophrenia, autism spectrum disorder, bipolar disorder",GCST001877,6:32945469
rs1553441-<b>?</b>,6 x 10-6,(adaptative permutation),'-,2.44,'-,[NR],PLD5,Hypersomnia during a major depressive episode in bipolar disorder,"major depressive episode, bipolar disorder, hypersomnia",GCST003016,1:242546741
rs726170-<b>T</b>,3 x 10-8,,0.12,1.923077,'-,[NR],"ARHGAP8, PRR5-ARHGAP8",Binge eating behaviour in bipolar disorder,"binge eating, bipolar disorder",GCST005387,22:44855931
rs7904579-<b>G</b>,1 x 10-7,,0.37,1.56,'-,[NR],CUBN,Binge eating behaviour in bipolar disorder,"binge eating, bipolar disorder",GCST005387,10:17089754
rs1950038-<b>T</b>,7 x 10-7,,0.3,1.6,'-,[NR],"FAM228B, CACYBPP2",Binge eating behaviour in bipolar disorder,"binge eating, bipolar disorder",GCST005387,2:183579642
rs182107583-<b>C</b>,1 x 10-6,,0.04,3.2258062,'-,[NR],MMADHC-DT,Binge eating behaviour in bipolar disorder,"binge eating, bipolar disorder",GCST005387,2:149675023
rs76087671-<b>T</b>,1 x 10-6,,0.05,2.3255813,'-,[NR],RNU1-23P,Binge eating behaviour in bipolar disorder,"binge eating, bipolar disorder",GCST005387,20:24330541
rs111940429-<b>T</b>,1 x 10-8,,0.04,2.857143,'-,[NR],"LINC01789, LINC01885",Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST005386,2:107366232
rs17810023-<b>T</b>,9 x 10-8,,0.02,3.846154,'-,[NR],"RPSAP72, RPL17P25",Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST005386,6:80443056
rs7337127-<b>T</b>,3 x 10-7,,0.15,1.754386,'-,[NR],'-,Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST005386,13:104623579
rs145763646-<b>A</b>,3 x 10-7,,0.1,2.0833335,'-,[NR],SLC25A26,Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST005386,3:66173478
rs73057489-<b>C</b>,1 x 10-6,,0.07,2,'-,[NR],PSMC1P8,Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST005386,12:17370820
rs12568997-<b>?</b>,3 x 10-8,,NR,'-,0.018 unit increase,NR,PKN2-AS1,Autism spectrum disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),"obsessive-compulsive disorder, autism spectrum disorder",GCST90016602,1:88401502
rs254013-<b>?</b>,3 x 10-9,,NR,'-,0.0183 unit decrease,NR,'-,Anorexia nervosa vs autism spectrum disorder (ordinary least squares (OLS)),"anorexia nervosa, autism spectrum disorder",GCST90016599,5:104590343
rs7206188-<b>T</b>,9 x 10-6,(EA),0.56,'-,'-,'-,HS3ST4,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,16:26140834
rs12142743-<b>G</b>,1 x 10-5,(EA),0.89,'-,'-,'-,NBPF13P,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,1:147114038
rs560380-<b>A</b>,1 x 10-5,(EA),0.55,'-,'-,'-,PTPRD,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,9:9112698
rs429358-<b>T</b>,3 x 10-33,(EA),0.85,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
chr3:197113961-<b>C</b>,7 x 10-8,(EA),0.96,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
chr15:41258121-<b>C</b>,1 x 10-6,(EA),0.96,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
rs4145953-<b>A</b>,1 x 10-6,(EA),0.8,'-,'-,'-,POLD3,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,11:74620834
chr6:44535225-<b>G</b>,1 x 10-6,(EA),0.95,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
rs2291354-<b>A</b>,1 x 10-6,(EA),0.48,'-,'-,'-,ATP10A,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,15:25707742
rs11584308-<b>C</b>,1 x 10-6,(EA),0.8,'-,'-,'-,KAZN,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,1:14479497
rs72723271-<b>T</b>,2 x 10-6,(EA),0.94,'-,'-,'-,"LINC02514, LINC02515",Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,4:187387101
rs2446485-<b>G</b>,2 x 10-6,(EA),0.82,'-,'-,'-,CDKAL1,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,6:21140068
rs59008350-<b>C</b>,2 x 10-6,(EA),0.96,'-,'-,'-,"GGCTP2, RN7SL14P",Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,20:18239041
rs11765038-<b>A</b>,4 x 10-6,(EA),0.32,'-,'-,'-,SLC29A4,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,7:5296474
chr3:70929100-<b>G</b>,5 x 10-6,(EA),0.91,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
rs7107464-<b>T</b>,5 x 10-6,(EA),0.91,'-,'-,'-,RAG1,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,11:36563394
rs6540796-<b>A</b>,5 x 10-6,(EA),0.7,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,1:213648324
rs9321429-<b>C</b>,6 x 10-6,(EA),0.64,'-,'-,'-,"RN7SL408P, SGK1",Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,6:134154611
chr1:245947879-<b>A</b>,7 x 10-6,(EA),0.99,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
rs10836184-<b>T</b>,7 x 10-6,(EA),0.21,'-,'-,'-,ABTB2,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,11:34303703
rs348147-<b>G</b>,7 x 10-6,(EA),0.89,'-,'-,'-,"KCNB2, RNA5SP271",Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,8:72440962
rs66657970-<b>C</b>,9 x 10-6,(EA),0.97,'-,'-,'-,'-,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,Mapping not available
rs9845942-<b>T</b>,5 x 10-6,,0.27,1.68,'-,[NR],'-,Eating disorder in bipolar disorder,"eating disorder, bipolar disorder",GCST003132,3:3523843
rs1805576-<b>G</b>,4 x 10-6,,0.21,1.71,'-,[NR],FXR1,Eating disorder in bipolar disorder,"eating disorder, bipolar disorder",GCST003132,3:180949777
rs13086738-<b>G</b>,2 x 10-7,,0.2,1.84,'-,[NR],SOX2-OT,Eating disorder in bipolar disorder,"eating disorder, bipolar disorder",GCST003132,3:181080939
rs12149074-<b>G</b>,4 x 10-7,,0.63,1.8867927,'-,[NR],'-,Eating disorder in bipolar disorder,"eating disorder, bipolar disorder",GCST003132,16:80071969
rs4148087-<b>A</b>,4 x 10-7,,0.13,2,'-,[NR],ABCG1,Eating disorder in bipolar disorder,"eating disorder, bipolar disorder",GCST003132,21:42202157
rs16841832-<b>G</b>,9 x 10-6,,0.76,2,'-,[NR],CADM3,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,1:159184522
rs2685295-<b>A</b>,7 x 10-6,,0.61,1.724138,'-,[NR],RYR2,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,1:237735135
rs1805576-<b>G</b>,1 x 10-6,,0.21,1.79,'-,[NR],FXR1,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,3:180949777
rs4854912-<b>T</b>,9 x 10-8,,0.19,1.91,'-,[NR],SOX2-OT,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,3:181063312
rs10965890-<b>C</b>,4 x 10-6,,0.06,2.27,'-,[NR],'-,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,9:23516290
rs7912575-<b>G</b>,3 x 10-6,,0.01,4.52,'-,[NR],'-,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,Mapping not available
rs10858583-<b>C</b>,2 x 10-7,,0.23,1.84,'-,[NR],'-,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,12:87334666
rs314580-<b>G</b>,8 x 10-6,,0.04,2.41,'-,[NR],LINC00440,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,13:89259450
rs9554752-<b>T</b>,6 x 10-6,,0.36,1.65,'-,[NR],NALCN,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,13:101073961
rs12149074-<b>G</b>,4 x 10-6,,0.63,1.7857143,'-,[NR],'-,Bipolar disorder and eating disorder,"eating disorder, bipolar disorder",GCST003135,16:80071969
rs429358-<b>C</b>,6 x 10-14,,0.17,1.69,'-,[1.93-1.47],'-,Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+),"Alzheimer's disease, vascular dementia",GCST009025,Mapping not available
rs117834366-<b>A</b>,2 x 10-8,,0.011,6.03,'-,[3.22-11.2],CNTNAP2,Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++),"Alzheimer's disease, vascular dementia",GCST009026,7:147937799
rs1906252-<b>?</b>,2 x 10-11,,NR,'-,0.0213 unit decrease,NR,"MIR2113, EIF4EBP2P3",Autism spectrum disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, autism spectrum disorder",GCST90016603,6:98102413
rs701157-<b>C</b>,4 x 10-6,,0.45,'-,'-,'-,LINC01737,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,1:230539080
rs9512900-<b>C</b>,9 x 10-6,,0.37,'-,'-,'-,PLUT,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,13:27855601
rs7236632-<b>A</b>,6 x 10-6,,0.86,'-,'-,'-,ATP8B1,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,18:57766970
rs16973500-<b>C</b>,7 x 10-6,,0.86,'-,'-,'-,PKD1L3,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,16:71931293
rs2180233-<b>C</b>,9 x 10-6,,0.31,'-,'-,'-,'-,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,1:30154865
rs6733379-<b>G</b>,4 x 10-6,,0.28,'-,'-,'-,LINC01320,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,2:34255008
rs10797919-<b>G</b>,9 x 10-6,,0.59,'-,'-,'-,RGL1,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,1:183883780
rs10229603-<b>C</b>,5 x 10-6,,0.31,'-,'-,'-,HRAT17,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,7:112988318
rs10492664-<b>C</b>,1 x 10-6,,0.84,'-,'-,'-,LIG4,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,13:108163877
rs4889240-<b>T</b>,7 x 10-6,,0.45,'-,'-,'-,PKD1L2,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,16:81122917
rs6427356-<b>G</b>,8 x 10-6,,0.28,'-,'-,'-,ETV3,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,1:157160775
rs1521882-<b>A</b>,8 x 10-6,,0.82,'-,'-,'-,"KIAA2012-AS1, KIAA2012",Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,2:202085128
rs1644305-<b>A</b>,8 x 10-6,,0.41,'-,'-,'-,WSPAR,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,5:133867905
rs2764980-<b>A</b>,9 x 10-6,,0.51,'-,'-,'-,LINC02668,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,10:3241815
rs1951082-<b>T</b>,5 x 10-6,,0.43,'-,'-,'-,"LINC02294, LINC02588",Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,14:26790837
rs12921846-<b>A</b>,9 x 10-6,,0.4,'-,'-,'-,RBFOX1,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,16:6860384
rs1381102-<b>A</b>,6 x 10-6,,0.4,'-,'-,'-,'-,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,16:63921543
rs7595103-<b>A</b>,7 x 10-6,,0.64,'-,'-,'-,"LINC01851, RPL38P2",Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,2:77848118
rs10815798-<b>A</b>,6 x 10-6,,0.48,'-,'-,'-,PTPRD,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,9:8235633
rs10831284-<b>G</b>,2 x 10-6,,0.13,'-,'-,'-,"ST13P11, CWC15",Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,11:94934799
rs789560-<b>G</b>,7 x 10-6,,0.87,'-,'-,'-,"PRANCR, MYRFL",Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,12:69938047
rs1557488-<b>T</b>,5 x 10-6,,0.18,'-,'-,'-,KIRREL3,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,11:126749295
rs4533251-<b>T</b>,4 x 10-6,,0.15,'-,'-,'-,FAM149B1P1,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,15:96719197
rs7297018-<b>A</b>,4 x 10-6,,0.19,'-,'-,'-,PAWR,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,12:79668450
rs931812-<b>C</b>,5 x 10-6,,0.74,'-,'-,'-,"YWHAZ, Metazoa_SRP",Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,8:100907093
rs2826340-<b>T</b>,2 x 10-6,,0.17,'-,'-,'-,RPS3AP1,Attention deficit hyperactivity disorder and conduct disorder,"attention deficit hyperactivity disorder, conduct disorder",GCST000253,21:20512990
rs1222064-<b>?</b>,4 x 10-8,,NR,'-,0.0186 unit increase,NR,RNU1-130P,ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, Tourette syndrome",GCST90016598,1:96136829
rs933738-<b>?</b>,3 x 10-8,,NR,'-,0.0187 unit decrease,NR,KCNH3,ADHD vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, Tourette syndrome",GCST90016598,12:49549339
rs227378-<b>?</b>,2 x 10-8,,NR,'-,0.0235 unit decrease,NR,MANBA,ADHD vs obsessive compulsive disorder (ordinary least squares (OLS)),"obsessive-compulsive disorder, attention deficit hyperactivity disorder",GCST90016597,4:102699228
rs9961367-<b>?</b>,2 x 10-8,,NR,'-,0.0237 unit increase,NR,KC6,ADHD vs obsessive compulsive disorder (ordinary least squares (OLS)),"obsessive-compulsive disorder, attention deficit hyperactivity disorder",GCST90016597,18:41672373
rs12671090-<b>G</b>,4 x 10-6,,0.6,2.2727273,'-,[1.27-11.11],"MNX1-AS1, UBE3C",Language impairment in frontotemporal lobe dementia,"language impairment, Frontotemporal dementia",GCST006152,7:157088226
rs10959548-<b>T</b>,6 x 10-6,,0.3,2.12,'-,[1.79-2.45],"DMRT2, RPS27AP14",Language impairment in frontotemporal lobe dementia,"language impairment, Frontotemporal dementia",GCST006152,9:1121085
rs12755914-<b>?</b>,7 x 10-9,,NR,'-,0.0206 unit increase,NR,EEF1A1P11,ADHD vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, attention deficit hyperactivity disorder",GCST90016595,1:96469305
rs62176532-<b>?</b>,1 x 10-8,,NR,'-,0.0203 unit increase,NR,'-,ADHD vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, attention deficit hyperactivity disorder",GCST90016595,2:184138194
rs147831713-<b>?</b>,3 x 10-10,,NR,'-,0.0225 unit increase,NR,LINC02163,ADHD vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, attention deficit hyperactivity disorder",GCST90016595,5:104451467
rs35999374-<b>?</b>,3 x 10-9,,NR,'-,0.0211 unit increase,NR,LINC01572,ADHD vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, attention deficit hyperactivity disorder",GCST90016595,16:72475596
rs12504244-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,"KIT, LINC02260",Anorexia nervosa or obsessive-compulsive disorder,"anorexia nervosa, obsessive-compulsive disorder",GCST006576,4:54619021
rs75063949-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,CARMIL1,Anorexia nervosa or obsessive-compulsive disorder,"anorexia nervosa, obsessive-compulsive disorder",GCST006576,6:25590813
rs11174202-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,TAFA2,Anorexia nervosa or obsessive-compulsive disorder,"anorexia nervosa, obsessive-compulsive disorder",GCST006576,12:61858476
rs6006893-<b>?</b>,9 x 10-7,,NR,1.99,'-,[NR],"ARHGAP8, PRR5-ARHGAP8",Binge eating behaviour in bipolar disorder,"binge eating, bipolar disorder",GCST002420,22:44858015
rs10198175-<b>?</b>,1 x 10-6,,NR,1.92,'-,[NR],"APOB, LINC02850",Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST002419,2:20934123
rs13233490-<b>?</b>,4 x 10-6,,NR,4.89,'-,[NR],'-,Binge eating behaviour and bipolar disorder,"binge eating, bipolar disorder",GCST002419,7:9030639
rs2075650-<b>?</b>,6 x 10-14,,NR,2.03167,'-,[1.67959-2.45755],TOMM40,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,19:44892362
rs6714710-<b>?</b>,1 x 10-6,,NR,1.48999,'-,[1.26062-1.7611],ZAP70,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,2:97728623
rs4965006-<b>?</b>,4 x 10-6,,NR,1.59605,'-,[1.29704-1.96399],PUS1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,12:131934988
rs2777802-<b>?</b>,6 x 10-6,,NR,1.4778666,'-,[NR],ABCA1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,9:104807056
rs11637445-<b>?</b>,6 x 10-6,,NR,1.4859304,'-,[NR],MAP2K5,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,15:67699268
rs1014897-<b>?</b>,6 x 10-6,,NR,1.4817307,'-,[NR],ANGPT4,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,20:914814
rs8038734-<b>?</b>,6 x 10-6,,NR,2.1375377,'-,[NR],ARIH1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,15:72519061
rs4997950-<b>?</b>,7 x 10-6,,NR,1.6716651,'-,[NR],"LINC01098, LINC01099",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,4:177819494
rs10061074-<b>?</b>,7 x 10-6,,NR,2.73556,'-,[1.72367-4.34148],"HIGD1AP3, MSX2",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,5:174705751
rs17125439-<b>?</b>,8 x 10-6,,NR,1.51359,'-,[1.2572-1.82226],"BCL10, DDAH1",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,1:85302696
rs433852-<b>?</b>,8 x 10-6,,NR,1.6849171,'-,[NR],FAM83E,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,19:48613847
rs7805053-<b>?</b>,8 x 10-6,,NR,1.5306224,'-,[NR],PER3P1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,7:9684086
rs1340425-<b>?</b>,8 x 10-6,,NR,1.63103,'-,[1.28704-2.06695],RNU4ATAC8P,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,1:73920165
rs12134133-<b>?</b>,9 x 10-6,,NR,1.46044,'-,[1.22756-1.73751],"C4BPAP2, CD55",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,1:207284500
rs10071932-<b>?</b>,9 x 10-6,,NR,1.4506525,'-,[NR],"SALL4P1, GPBP1",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,5:57358044
rs2525776-<b>?</b>,1 x 10-8,,NR,3.3,'-,[2.1-5.1],'-,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,7:81272303
rs76854344-<b>?</b>,8 x 10-10,,NR,1.9,'-,[1.5-2.3],CNTNAP5,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,2:123995579
rs72907046-<b>?</b>,1 x 10-9,,NR,3.2,'-,[2.1-4.9],TENT5A,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,6:81418166
rs78087832-<b>?</b>,6 x 10-7,,'-,2.731,'-,[1.933-3.857],CUL3,Response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003806,2:224600060
rs114465512-<b>?</b>,5 x 10-7,,'-,12.987013,'-,[3.98-43.48],"IGLVIV-66-1, IGLV10-67",Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003801,22:22047895
rs73425402-<b>?</b>,1 x 10-6,,'-,20.833332,'-,[8.26-52.63],NAV3,Response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003806,12:77503518
rs117198528-<b>?</b>,9 x 10-7,,'-,1.823,'-,[1.437-2.313],"ACAA2, SMUG1P1",Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003801,18:49694188
rs141746753-<b>?</b>,1 x 10-6,,'-,3.2467532,'-,[1.84-5.71],"RNU6-13P, BPNT2",Response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003809,8:56934154
rs111365677-<b>?</b>,1 x 10-7,,'-,17.54386,'-,[4.33-71.43],LINC01708,Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,1:99463578
rs6545694-<b>?</b>,2 x 10-6,,'-,1.096,'-,[1.056-1.137],LINC01122,Response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003809,2:58620818
rs188843168-<b>?</b>,4 x 10-7,,'-,449.83,'-,[5.402-Inf],ATP5MK,Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,10:103390184
rs6063349-<b>?</b>,7 x 10-7,,'-,1.183432,'-,[1.11-1.27],CSE1L,Non-response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003810,20:49065345
rs142641502-<b>?</b>,8 x 10-7,,'-,4.565,'-,[2.155-9.671],CSTF3,Non-response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003810,11:33109861
rs201569130-<b>?</b>,9 x 10-7,,'-,3.009,'-,[1.785-5.073],FOXF2,Non-response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003810,6:1402916
rs1548076-<b>?</b>,1 x 10-6,,'-,2.4937656,'-,[1.63-3.82],DRAIC,Non-response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003810,15:69934284
rs182377406-<b>?</b>,1 x 10-6,,'-,5.773,'-,[3.250-10.254],"CORO1B, GPR152",Non-response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003810,11:67449378
rs143934587-<b>?</b>,7 x 10-7,,'-,6.711409,'-,[3.61-12.5],SLC24A3,Response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003811,20:19165806
rs74860738-<b>?</b>,3 x 10-7,,'-,1.2870014,'-,[1.17-1.41],"LINC02720, ARL6IP1P3",Response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003811,11:80671683
rs189864513-<b>?</b>,8 x 10-7,,'-,12.345678,'-,[5.65-27.03],LINC01618,Response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003811,4:52767390
rs11924809-<b>?</b>,1 x 10-6,,'-,1.215,'-,[1.122-1.316],DGKG,Response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003811,3:186353656
rs117375960-<b>?</b>,2 x 10-6,,'-,142.85713,'-,[2.9-∞],NT5C2,Response to citalopram or escitalopram and depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003811,10:103161907
rs190544851-<b>?</b>,3 x 10-7,,'-,14.29,'-,[3.555-57.454],"ERG, LINC01423",Non-response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003812,21:38360474
rs57043326-<b>?</b>,8 x 10-7,,'-,2.65252,'-,[1.69-4.17],C6orf99,Non-response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003812,6:158893901
rs12068879-<b>?</b>,1 x 10-6,,'-,2.221,'-,[1.667-2.958],KAZN,Non-response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003812,1:14959860
rs1322281-<b>?</b>,1 x 10-6,,'-,1.242,'-,[1.139-1.354],PTPRD,Non-response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003812,9:10582445
rs13418410-<b>?</b>,2 x 10-6,,'-,1.212,'-,[1.121-1.311],"FAM98A, RASGRP3",Non-response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003812,2:33575832
rs112538845-<b>?</b>,6 x 10-7,,'-,1.637,'-,[1.366-1.961],"STOX2, ENPP6",Response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003806,4:184084475
rs113378111-<b>?</b>,7 x 10-7,,'-,1.579,'-,[1.303-1.912],"RNU4-73P, TAF1B",Non-response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003808,2:9788024
rs80164876-<b>?</b>,4 x 10-7,,'-,2.09,'-,[1.551-2.815],EGFLAM,Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003801,5:38464142
rs112106319-<b>?</b>,1 x 10-6,,'-,2.3255813,'-,[1.59-3.4],"TNC, DELEC1",Response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003806,9:115094539
rs35863382-<b>?</b>,7 x 10-7,,'-,1.540832,'-,[1.3-1.83],PPP4R3A,Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003801,14:91472532
rs150175932-<b>?</b>,1 x 10-7,,'-,15.22,'-,[3.318-69.804],DCLK2,Response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003809,4:150101495
rs138472420-<b>?</b>,1 x 10-6,,'-,5.628,'-,[2.692-11.767],BICRA,Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003801,19:47657765
rs73720034-<b>?</b>,1 x 10-6,,'-,1.256,'-,[1.142-1.381],'-,Response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003809,7:125794995
rs142484554-<b>?</b>,3 x 10-7,,'-,1.459854,'-,[1.26-1.69],SPSB4,Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,3:141059454
rs61519662-<b>?</b>,2 x 10-6,,'-,1.1013216,'-,[1.06-1.15],'-,Response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003809,2:2696619
rs6546604-<b>?</b>,5 x 10-7,,'-,1.2787724,'-,[1.16-1.41],"TGFA, BRD7P6",Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,2:70415675
rs34177316-<b>?</b>,6 x 10-7,,'-,1.355,'-,[1.203-1.528],APBB2,Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,4:40985283
rs201921722-<b>?</b>,7 x 10-7,,'-,1.2642225,'-,[1.15-1.39],"ZNF202, SCN3B",Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,11:123680000
rs80278479-<b>?</b>,8 x 10-7,,'-,14.492754,'-,[3.88-55.56],TFAP2D,Response to citalopram or escitalopram in depression,"unipolar depression, response to escitalopram, response to citalopram, mood disorder",GCST003802,6:50758466
rs1375194-<b>?</b>,2 x 10-7,,'-,1.2578616,'-,[1.15-1.37],"ATP6V0E1P3, FAM98A",Response to antidepressants in depression,"unipolar depression, mood disorder, response to antidepressant",GCST003803,2:33601810
rs190662943-<b>?</b>,7 x 10-7,,'-,14.419,'-,[5.177-40.161],DPP10,Response to antidepressants in depression,"unipolar depression, mood disorder, response to antidepressant",GCST003803,2:115195009
rs75507262-<b>?</b>,1 x 10-6,,'-,2.3255813,'-,[1.69-3.21],"TMEM78, LINC02814",Response to antidepressants in depression,"unipolar depression, mood disorder, response to antidepressant",GCST003803,1:229213737
rs10847303-<b>?</b>,2 x 10-6,,'-,1.242236,'-,[1.14-1.36],LINC02376,Response to antidepressants in depression,"unipolar depression, mood disorder, response to antidepressant",GCST003803,12:127251320
rs73086581-<b>?</b>,2 x 10-6,,'-,1.299,'-,[1.169-1.444],RNF24,Response to antidepressants in depression,"unipolar depression, mood disorder, response to antidepressant",GCST003803,20:3996678
rs190783615-<b>?</b>,2 x 10-17,,'-,15.18,'-,[3.095-74.439],'-,Non-response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003804,X:142772620
rs201203751-<b>?</b>,5 x 10-7,,'-,4.009,'-,[2.537-6.336],FYB1,Non-response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003804,5:39203496
rs183124483-<b>?</b>,6 x 10-7,,'-,14.925372,'-,[6.85-32.26],NLK,Non-response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003804,17:28110028
rs56388524-<b>?</b>,7 x 10-7,,'-,1.798,'-,[1.451-2.228],HCN1,Non-response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003804,5:45757459
rs143405544-<b>?</b>,7 x 10-7,,'-,6.711409,'-,[2.44-18.52],ADAMTS6,Non-response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003804,5:65459777
rs183042538-<b>?</b>,8 x 10-7,,'-,1.431,'-,[1.249-1.638],ZHX3,Non-response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003804,20:41197420
rs200855945-<b>?</b>,4 x 10-7,,'-,4.929,'-,[2.35-10.34],"SSPN, BHLHE41",Response to bupropion and depression,"unipolar depression, response to bupropion, mood disorder",GCST003806,12:26124961
rs1994321-<b>?</b>,5 x 10-7,,'-,1.1547344,'-,[1.09-1.22],"MICAL2, LINC02547",Non-response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003808,11:12065766
rs73788091-<b>?</b>,1 x 10-6,,'-,3.011,'-,[2.044-4.437],FSTL4,Non-response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003808,5:133429517
rs9951011-<b>?</b>,2 x 10-6,,'-,1.1806375,'-,[1.1-1.26],'-,Non-response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003808,18:67366441
rs78620960-<b>?</b>,2 x 10-6,,'-,1.2033695,'-,[1.12-1.3],LINC01720,Non-response to selective serotonin reuptake inhibitors and depression,"unipolar depression, response to selective serotonin reuptake inhibitor, mood disorder",GCST003808,1:190812369
rs34807503-<b>?</b>,5 x 10-7,,'-,1.0905125,'-,[1.05-1.13],"SLC4A8, SCN8A",Response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003813,12:51525350
rs2402960-<b>?</b>,8 x 10-7,,'-,1.098901,'-,[1.06-1.14],"NRF1, MIR182",Response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003813,7:129765934
rs200312707-<b>?</b>,1 x 10-6,,'-,1.0881393,'-,[1.05-1.13],CDH8,Response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003813,16:62031776
rs400736-<b>?</b>,2 x 10-6,,'-,1.0857763,'-,[1.05-1.12],ERRFI1,Response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003813,1:8018249
rs35265457-<b>?</b>,2 x 10-6,,'-,1.508,'-,[1.261-1.803],NDC1,Response to antidepressants and depression,"unipolar depression, mood disorder, response to antidepressant",GCST003813,1:53807606
rs1908557-<b>T</b>,3 x 10-8,,'-,1.348,'-,[1.213-1.497],'-,Response to bupropion in depression,"unipolar depression, response to bupropion, mood disorder",GCST003800,4:89500202
rs77945277-<b>?</b>,2 x 10-7,,'-,11.111111,'-,[3.83-32.26],BAZ1A,Response to bupropion in depression,"unipolar depression, response to bupropion, mood disorder",GCST003800,14:34840969
rs4839421-<b>?</b>,5 x 10-7,,'-,1.249,'-,[1.146-1.362],"CYMP, PROK1",Response to bupropion in depression,"unipolar depression, response to bupropion, mood disorder",GCST003800,1:110479338
rs75995702-<b>?</b>,7 x 10-7,,'-,12.857,'-,[3.496-47.288],'-,Response to bupropion in depression,"unipolar depression, response to bupropion, mood disorder",GCST003800,11:42785177
rs34102224-<b>?</b>,1 x 10-6,,'-,1.354,'-,[1.197-1.531],'-,Response to bupropion in depression,"unipolar depression, response to bupropion, mood disorder",GCST003800,8:5364506
rs720090-<b>?</b>,2 x 10-8,,NR,'-,0.014 unit decrease,NR,PTBP2,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, unipolar depression",GCST90016613,1:96800136
rs2287348-<b>?</b>,3 x 10-8,,NR,'-,0.0137 unit decrease,NR,"ASB3, ERLEC1",Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, unipolar depression",GCST90016613,2:53812676
rs9873726-<b>?</b>,2 x 10-13,,NR,'-,0.0183 unit decrease,NR,NCKIPSD,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, unipolar depression",GCST90016613,3:48674934
rs4629334-<b>?</b>,2 x 10-8,,NR,'-,0.0139 unit increase,NR,WDR82P1,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, unipolar depression",GCST90016613,3:94862302
rs323509-<b>?</b>,2 x 10-9,,NR,'-,0.015 unit decrease,NR,RNU6-334P,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, unipolar depression",GCST90016613,5:104746478
rs72994087-<b>?</b>,8 x 10-10,,NR,'-,0.0152 unit decrease,NR,CADM1,Major depressive disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, unipolar depression",GCST90016613,11:115263915
rs4785741-<b>T</b>,7 x 10-7,,NR,'-,70.9925 unit increase,[42.97-99.02],"DEF8, TUBB3",Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,16:89939045
rs72722664-<b>A</b>,2 x 10-6,,NR,'-,30.6385 unit increase,[17.99-43.29],"BCL10, DDAH1",Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,1:85313923
rs2075824-<b>T</b>,4 x 10-6,,NR,'-,56.9756 unit increase,[32.75-81.2],IMPA2,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,18:11981209
rs11735612-<b>A</b>,4 x 10-6,,NR,'-,66.5774 unit increase,[38.14-95.02],LINC02172,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,4:137582680
rs75216060-<b>A</b>,7 x 10-6,,NR,'-,61.3145 unit decrease,[34.62-88.01],'-,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,8:13943870
rs17080138-<b>T</b>,7 x 10-6,,NR,'-,22 unit increase,[12.41-31.59],FBXW12,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,3:48372784
rs59093387-<b>A</b>,7 x 10-6,,NR,'-,52.5822 unit increase,[29.65-75.52],RHOJ,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,14:63217357
rs12045323-<b>T</b>,7 x 10-6,,NR,'-,57.5469 unit increase,[32.42-82.68],DRAXIN,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,1:11704224
rs9731813-<b>A</b>,7 x 10-6,,NR,'-,27.618 unit decrease,[15.56-39.68],LRRC20,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,10:70368301
rs8032150-<b>C</b>,7 x 10-6,,NR,'-,59.4319 unit decrease,[33.47-85.39],FOXB1,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,15:60080022
rs6034559-<b>T</b>,8 x 10-6,,NR,'-,66.7955 unit decrease,[37.45-96.14],"RPLP0P1, Y_RNA",Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,20:16640453
rs78907274-<b>A</b>,9 x 10-6,,NR,'-,33.5591 unit decrease,[18.75-48.37],PTH2R,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,2:208389154
rs767619-<b>T</b>,9 x 10-6,,NR,'-,45.9769 unit decrease,[25.63-66.32],UFL1-AS1,Obsessive-compulsive disorder or autism spectrum disorder,"obsessive-compulsive disorder, autism spectrum disorder",GCST004703,6:96391163
rs1067352-<b>T</b>,5 x 10-6,(DDD),NR,'-,0.2124 unit decrease,NR,CAMKMT,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,2:44442585
rs981975-<b>T</b>,9 x 10-7,(CPZe),NR,'-,0.1941 unit decrease,[NR],RGS6,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,14:72119843
rs789859-<b>A</b>,2 x 10-6,(CPZe),NR,'-,0.1696 unit increase,[NR],"LSG1, FAM43A",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,3:194685159
rs7428850-<b>T</b>,2 x 10-6,(CPZe),NR,'-,0.5773 unit decrease,[NR],"THRB, LINC00691",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,3:24116906
rs75905933-<b>T</b>,4 x 10-6,(CPZe),NR,'-,0.572 unit decrease,[NR],"LINC02352, KLF13",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,15:31256793
rs2017387-<b>A</b>,4 x 10-6,(CPZe),NR,'-,0.2115 unit decrease,[NR],"ZNF473, IZUMO2",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,19:50065316
rs7358770-<b>G</b>,4 x 10-6,(CPZe),NR,'-,0.2193 unit decrease,[NR],'-,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,12:61451443
rs12358815-<b>T</b>,4 x 10-6,(CPZe),NR,'-,0.2554 unit decrease,[NR],NRG3,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,10:81908569
rs4731662-<b>T</b>,5 x 10-6,(CPZe),NR,'-,0.2149 unit increase,[NR],"KLHDC10, TMEM209",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,7:130142537
rs79323383-<b>G</b>,7 x 10-7,(DDD),NR,'-,0.4768 unit decrease,[NR],SNTB1,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,8:120839185
rs9347865-<b>A</b>,1 x 10-6,(DDD),NR,'-,0.2568 unit increase,[NR],'-,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,6:164507108
rs698833-<b>T</b>,2 x 10-6,(DDD),NR,'-,0.2322 unit decrease,[NR],CAMKMT,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,2:44508299
rs4470690-<b>C</b>,4 x 10-6,(DDD),NR,'-,0.2568 unit increase,[NR],ADAM20P3,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,4:187800358
rs698761-<b>G</b>,5 x 10-6,(DDD),NR,'-,0.2023 unit decrease,[NR],"SLC3A1, PREPL",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,2:44320435
rs4470690-<b>C</b>,7 x 10-8,(PM %),NR,'-,0.2959 unit increase,[NR],ADAM20P3,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,4:187800358
rs75583333-<b>A</b>,9 x 10-7,(PM %),NR,'-,0.4132 unit increase,[NR],"PWWP2A, FABP6",antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,5:160168028
rs75023836-<b>T</b>,2 x 10-6,(PM %),NR,'-,0.3619 unit decrease,[NR],STX8,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,17:9285281
rs80285556-<b>A</b>,2 x 10-6,(PM %),NR,'-,0.4259 unit decrease,[NR],ZNF473,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,19:50036913
rs1808797-<b>A</b>,3 x 10-6,(PM %),NR,'-,0.2789 unit increase,[NR],'-,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,2:5484874
rs60994771-<b>C</b>,3 x 10-6,(PM %),NR,'-,0.2674 unit decrease,[NR],'-,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,17:70804643
rs12511747-<b>A</b>,5 x 10-6,(PM %),NR,'-,0.2764 unit decrease,[NR],NSG1,antipsychotic drug dosage in schizophrenia or schizoaffective disorder,"schizophrenia, antipsychotic drug use measurement, schizoaffective disorder",GCST003341,4:4370929
rs3791033-<b>?</b>,4 x 10-9,,NR,'-,0.0151 unit decrease,NR,KDM4A,ADHD vs autism spectrum disorder (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, autism spectrum disorder",GCST90016596,1:43668406
rs4887069-<b>?</b>,4 x 10-8,,NR,'-,0.0181 unit decrease,NR,CHRNA3,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,15:78616728
rs35630683-<b>?</b>,5 x 10-9,,NR,'-,0.0193 unit decrease,NR,ZNF592,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,15:84806000
rs144158419-<b>?</b>,1 x 10-8,,NR,'-,0.0188 unit decrease,NR,LINC01416,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,18:55887502
rs2905432-<b>?</b>,6 x 10-10,,NR,'-,0.0209 unit decrease,NR,"MAU2, GATAD2A",Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,19:19373486
rs2748660-<b>?</b>,4 x 10-8,,NR,'-,0.0181 unit decrease,NR,"ACTR5, SLC32A1",Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,20:38746749
rs34328150-<b>?</b>,4 x 10-8,,NR,'-,0.0182 unit decrease,NR,LINC00320,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,21:20741130
rs301818-<b>?</b>,1 x 10-9,,NR,'-,0.02 unit increase,NR,RERE,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,1:8443182
rs1198572-<b>?</b>,6 x 10-11,,NR,'-,0.0216 unit increase,NR,MIR137HG,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,1:98031620
rs72696880-<b>?</b>,2 x 10-8,,NR,'-,0.0186 unit decrease,NR,RPRD2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,1:150435120
rs9428966-<b>?</b>,9 x 10-11,,NR,'-,0.0214 unit decrease,NR,AKT3,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,1:243504598
rs56145559-<b>?</b>,1 x 10-8,,NR,'-,0.0189 unit increase,NR,ALMS1,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,2:73396311
rs4850788-<b>?</b>,5 x 10-9,,NR,'-,0.0193 unit increase,NR,"NPM1P46, ANKRD44",Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,2:197318216
rs2949006-<b>?</b>,2 x 10-10,,NR,'-,0.0211 unit decrease,NR,FTCDNL1,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,2:199850665
rs11685299-<b>?</b>,9 x 10-12,,NR,'-,0.0225 unit decrease,NR,CUL3,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,2:224526579
rs978212-<b>?</b>,5 x 10-8,,NR,'-,0.018 unit decrease,NR,"LINC01807, SNF8P1",Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,2:228408068
rs4144797-<b>?</b>,1 x 10-10,,NR,'-,0.0213 unit decrease,NR,GIGYF2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,2:232697487
rs6796313-<b>?</b>,8 x 10-9,,NR,'-,0.0191 unit increase,NR,CNTN4,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,3:2473219
rs13096210-<b>?</b>,1 x 10-9,,NR,'-,0.02 unit decrease,NR,FXR1,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,3:180881530
rs17537703-<b>?</b>,2 x 10-8,,NR,'-,0.0187 unit increase,NR,SOX2-OT,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,3:181412484
rs13135092-<b>?</b>,6 x 10-9,,NR,'-,0.0192 unit increase,NR,SLC39A8,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,4:102276925
rs6880469-<b>?</b>,2 x 10-9,,NR,'-,0.0198 unit increase,NR,'-,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,5:44975887
rs10223052-<b>?</b>,7 x 10-9,,NR,'-,0.0191 unit increase,NR,ZSWIM6,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,5:61504509
rs72802868-<b>?</b>,1 x 10-10,,NR,'-,0.0212 unit decrease,NR,LINC01470,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,5:152855655
rs74864822-<b>?</b>,1 x 10-8,,NR,'-,0.0188 unit increase,NR,LINC01470,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,5:153204097
rs58120505-<b>?</b>,2 x 10-13,,NR,'-,0.0242 unit decrease,NR,MAD1L1,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,7:1990232
rs7790864-<b>?</b>,4 x 10-8,,NR,'-,0.0182 unit increase,NR,CREB5,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,7:28439006
rs6968335-<b>?</b>,4 x 10-9,,NR,'-,0.0194 unit decrease,NR,SRPK2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,7:105258269
rs38751-<b>?</b>,1 x 10-8,,NR,'-,0.0188 unit decrease,NR,IMMP2L,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,7:111429890
rs11783093-<b>?</b>,9 x 10-9,,NR,'-,0.019 unit decrease,NR,GULOP,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,8:27567832
rs1473594-<b>?</b>,2 x 10-8,,NR,'-,0.0186 unit decrease,NR,'-,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,8:59783967
rs7837860-<b>?</b>,3 x 10-8,,NR,'-,0.0182 unit increase,NR,MMP16,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,8:88322031
rs10883816-<b>?</b>,4 x 10-11,,NR,'-,0.0218 unit decrease,NR,CNNM2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,10:102989968
rs11191648-<b>?</b>,5 x 10-9,,NR,'-,0.0193 unit decrease,NR,"PCGF6, INA",Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,10:103300139
rs12577142-<b>?</b>,7 x 10-9,,NR,'-,0.0191 unit increase,NR,DGKZ,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,11:46356220
rs12294291-<b>?</b>,1 x 10-8,,NR,'-,0.0189 unit decrease,NR,DLG2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,11:83486679
rs10458969-<b>?</b>,1 x 10-8,,NR,'-,0.0188 unit increase,NR,CADM1,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,11:115232473
rs2159100-<b>?</b>,4 x 10-15,,NR,'-,0.0259 unit increase,NR,CACNA1C,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,12:2237227
rs4766428-<b>?</b>,2 x 10-8,,NR,'-,0.0185 unit increase,NR,ATP2A2,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,12:110285440
rs2102949-<b>?</b>,1 x 10-12,,NR,'-,0.0236 unit decrease,NR,MPHOSPH9,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,12:123192216
rs7142769-<b>?</b>,6 x 10-11,,NR,'-,0.0216 unit increase,NR,PPP1R13B,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,14:103762504
rs6493279-<b>?</b>,3 x 10-8,,NR,'-,0.0183 unit increase,NR,SEMA6D,Schizophrenia vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, schizophrenia",GCST90016619,15:47447247
rs12563424-<b>?</b>,3 x 10-8,,NR,'-,0.0213 unit increase,NR,"ALG14, TLCD4",Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, bipolar disorder",GCST90016609,1:95112651
rs3804640-<b>?</b>,1 x 10-8,,NR,'-,0.0221 unit decrease,NR,CD47,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, bipolar disorder",GCST90016609,3:108074862
rs2388334-<b>?</b>,1 x 10-12,,NR,'-,0.0274 unit increase,NR,"EIF4EBP2P3, HLA-DRB5",Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, bipolar disorder",GCST90016609,6:98143746
rs1511237-<b>?</b>,5 x 10-8,,NR,'-,0.0211 unit increase,NR,TENM4,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, bipolar disorder",GCST90016609,11:79403640
rs2011503-<b>?</b>,6 x 10-9,,NR,'-,0.0225 unit decrease,NR,MAU2,Bipolar disorder vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, bipolar disorder",GCST90016609,19:19333177
rs6675366-<b>?</b>,4 x 10-8,,NR,'-,0.018 unit increase,NR,"PTPRC, ATP6V1G3",Bipolar disorder vs obsessive compulsive disorder (ordinary least squares (OLS)),"obsessive-compulsive disorder, bipolar disorder",GCST90016608,1:198548178
rs2011503-<b>?</b>,2 x 10-8,,NR,'-,0.0205 unit decrease,NR,MAU2,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, bipolar disorder",GCST90016605,19:19333177
rs6846584-<b>?</b>,9 x 10-9,,NR,'-,0.021 unit decrease,NR,SLC10A7,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, bipolar disorder",GCST90016605,4:146346985
rs34162609-<b>?</b>,2 x 10-8,,NR,'-,0.0204 unit decrease,NR,ZNF592,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, bipolar disorder",GCST90016605,15:84761215
rs323509-<b>?</b>,2 x 10-9,,NR,'-,0.022 unit decrease,NR,RNU6-334P,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, bipolar disorder",GCST90016605,5:104746478
rs2159100-<b>?</b>,5 x 10-9,,NR,'-,0.0213 unit increase,NR,CACNA1C,Bipolar disorder vs anorexia nervosa (ordinary least squares (OLS)),"anorexia nervosa, bipolar disorder",GCST90016605,12:2237227
rs4681346-<b>?</b>,3 x 10-6,(MCS),NR,'-,'-,'-,'-,"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia","unipolar depression, schizophrenia, bipolar disorder, functional impairment measurement",GCST002188,3:147098924
rs7535475-<b>?</b>,3 x 10-6,(MCS),NR,'-,'-,'-,"FCGR2A, RNU6-481P","Functional impairment in major depressive disorder, bipolar disorder and schizophrenia","unipolar depression, schizophrenia, bipolar disorder, functional impairment measurement",GCST002188,1:161493797
rs2736871-<b>?</b>,3 x 10-6,(MCS),NR,'-,'-,'-,ST3GAL1,"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia","unipolar depression, schizophrenia, bipolar disorder, functional impairment measurement",GCST002188,8:133462834
rs16875288-<b>?</b>,6 x 10-8,(PCS),NR,'-,'-,'-,ADAMTS16,"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia","unipolar depression, schizophrenia, bipolar disorder, functional impairment measurement",GCST002188,5:5297087
rs7221595-<b>?</b>,5 x 10-6,(PCS),NR,'-,'-,'-,ZZEF1,"Functional impairment in major depressive disorder, bipolar disorder and schizophrenia","unipolar depression, schizophrenia, bipolar disorder, functional impairment measurement",GCST002188,17:4104300
rs17158930-<b>G</b>,3 x 10-7,,0.193,'-,0.3082 unit decrease,[NR],DOCK4,Pharmacokinetics of antidepressant drugs in severe mental disorder (concentration dose ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to antidepressant",GCST002891,7:111871082
rs16935279-<b>C</b>,5 x 10-10,,0.014,'-,0.7918 unit decrease,[NR],LINC01592,Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to anticonvulsant",GCST002887,8:68961217
rs11829119-<b>C</b>,1 x 10-7,,0.063,'-,0.4991 unit decrease,[NR],RPL7P6,Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to anticonvulsant",GCST002887,12:19040597
rs17066873-<b>C</b>,2 x 10-7,,0.039,'-,0.9277 unit decrease,[NR],"KCTD12, BTF3P11",Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to anticonvulsant",GCST002887,13:76889874
rs17790731-<b>A</b>,2 x 10-7,,0.034,'-,0.531 unit decrease,[NR],RFESD,Pharmacokinetics of antiepileptic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to anticonvulsant",GCST002887,5:95647825
rs2302045-<b>T</b>,4 x 10-7,,0.067,'-,0.4064 unit decrease,[NR],"SNED1, MTERF4",Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to antipsychotic drug",GCST002888,2:241081801
rs6586354-<b>A</b>,1 x 10-7,,0.226,'-,0.2802 unit decrease,[NR],"RN7SL668P, RNY4P16",Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to antipsychotic drug",GCST002888,1:234897489
rs17154917-<b>T</b>,3 x 10-7,,0.022,'-,0.6656 unit decrease,[NR],'-,Pharmacokinetics of antipsychotic drugs in severe mental disorder (concentration drug ratio),"unipolar depression, schizophrenia, bipolar disorder, concentration dose ratio, response to antipsychotic drug",GCST002888,7:81207393
rs9862857-<b>C</b>,6 x 10-8,,NR,'-,0.7386 unit decrease,[NR],LINC01985,Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio),"unipolar depression, schizophrenia, bipolar disorder, response to olanzapine, concentration dose ratio",GCST002885,3:30453840
rs17673138-<b>C</b>,6 x 10-8,,NR,'-,0.4143 unit decrease,[NR],NRG1,Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio),"unipolar depression, schizophrenia, bipolar disorder, response to olanzapine, concentration dose ratio",GCST002885,8:32840440
rs10968749-<b>G</b>,2 x 10-7,,NR,'-,0.8345 unit decrease,[NR],LINGO2,Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio),"unipolar depression, schizophrenia, bipolar disorder, response to olanzapine, concentration dose ratio",GCST002885,9:28752486
rs10405744-<b>A</b>,2 x 10-7,,NR,'-,0.5736 unit decrease,[NR],ZNF93,Pharmacokinetics of olanzapine in severe mental disorder (concentration dose ratio),"unipolar depression, schizophrenia, bipolar disorder, response to olanzapine, concentration dose ratio",GCST002885,19:19948684
rs12137398-<b>T</b>,1 x 10-8,,NR,'-,0.01683 unit increase,[0.011-0.023],CAMTA1,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:7730488
rs3795310-<b>T</b>,3 x 10-9,,NR,'-,0.01376 unit increase,[0.0092-0.0183],RERE,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:8371547
rs11209175-<b>C</b>,2 x 10-9,,NR,'-,0.01453 unit increase,[0.0098-0.0193],GNG12-AS1,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:67909145
rs12137936-<b>G</b>,3 x 10-8,,NR,'-,0.01381 unit increase,[0.0089-0.0187],NEGR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:72254674
rs116362708-<b>A</b>,4 x 10-8,,NR,'-,0.02983 unit decrease,[0.019-0.04],SLC44A5,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:75464629
rs12030991-<b>G</b>,3 x 10-8,,NR,'-,0.01502 unit decrease,[0.0097-0.0203],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:106683737
rs75650221-<b>T</b>,3 x 10-9,,NR,'-,0.03572 unit decrease,[0.024-0.048],RABGAP1L,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:174452856
rs17432675-<b>C</b>,4 x 10-8,,NR,'-,0.01373 unit decrease,[0.0088-0.0186],LMOD1,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:201918593
rs34668726-<b>G</b>,1 x 10-11,,NR,'-,0.02109 unit increase,[0.015-0.027],KLHL29,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:23673031
rs2717043-<b>C</b>,2 x 10-10,,NR,'-,0.01528 unit decrease,[0.011-0.02],VRK2,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:57951884
rs13413953-<b>G</b>,3 x 10-9,,NR,'-,0.01436 unit decrease,[0.0096-0.0191],ARHGAP15,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:143479467
rs2042555-<b>A</b>,9 x 10-10,,NR,'-,0.0144 unit increase,[0.0098-0.019],"ACVR2A, RNA5SP106",Depressed affect,"unipolar depression, mood disorder",GCST006475,2:147797920
rs76923064-<b>C</b>,3 x 10-8,,NR,'-,0.05634 unit increase,[0.036-0.076],"NR4A2, LINC01876",Depressed affect,"unipolar depression, mood disorder",GCST006475,2:156300636
rs11693031-<b>G</b>,5 x 10-10,,NR,'-,0.01573 unit decrease,[0.011-0.021],ERBB4,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:211813206
rs17711053-<b>G</b>,4 x 10-8,,NR,'-,0.01842 unit decrease,[0.012-0.025],VWC2L,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:214574984
rs9858071-<b>C</b>,3 x 10-10,,NR,'-,0.01607 unit increase,[0.011-0.021],PLCL2,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:16803898
rs1542212-<b>G</b>,2 x 10-8,,NR,'-,0.0133 unit increase,[0.0086-0.018],ARPP21,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:35642443
rs4625-<b>G</b>,4 x 10-10,,NR,'-,0.01564 unit decrease,[0.011-0.021],DAG1,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:49534707
rs10891564-<b>?</b>,2 x 10-9,,NR,'-,0.01424 unit increase,[0.0096-0.0189],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113503291
rs10965780-<b>?</b>,2 x 10-9,,NR,'-,0.01412 unit increase,[0.0095-0.0187],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:23341717
rs11039409-<b>?</b>,9 x 10-10,,NR,'-,0.01574 unit increase,[0.011-0.021],NUP160,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47814169
rs11152363-<b>?</b>,1 x 10-10,,NR,'-,0.01941 unit increase,[0.013-0.025],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55389957
rs11214589-<b>?</b>,2 x 10-8,,NR,'-,0.01339 unit increase,[0.0087-0.018],TTC12,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113374326
rs11214607-<b>?</b>,2 x 10-9,,NR,'-,0.01928 unit increase,[0.013-0.026],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113441417
rs11663393-<b>?</b>,7 x 10-9,,NR,'-,0.01346 unit increase,[0.0089-0.018],DCC,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:53088362
rs11664123-<b>?</b>,2 x 10-8,,NR,'-,0.01428 unit decrease,[0.0093-0.0193],DCC,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:53440658
rs12420205-<b>?</b>,7 x 10-11,,NR,'-,0.01631 unit decrease,[0.011-0.021],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113523313
rs12457157-<b>?</b>,4 x 10-9,,NR,'-,0.01366 unit decrease,[0.0091-0.0182],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55629696
rs1261070-<b>?</b>,6 x 10-12,,NR,'-,0.02838 unit decrease,[0.02-0.036],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55235854
rs1261114-<b>?</b>,5 x 10-8,,NR,'-,0.01303 unit increase,[0.0084-0.0177],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55271138
rs12938031-<b>?</b>,1 x 10-9,,NR,'-,0.01436 unit increase,[0.0097-0.019],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45777136
rs12963463-<b>?</b>,3 x 10-8,,NR,'-,0.01434 unit increase,[0.0093-0.0194],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55431862
rs13060816-<b>?</b>,3 x 10-9,,NR,'-,0.01381 unit increase,[0.0093-0.0184],BBX,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:107561639
rs13296664-<b>?</b>,5 x 10-9,,NR,'-,0.01521 unit increase,[0.01-0.02],RPL35AP22,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:117684418
rs13381817-<b>?</b>,2 x 10-8,,NR,'-,0.02374 unit increase,[0.015-0.032],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55230988
rs1360380-<b>?</b>,2 x 10-10,,NR,'-,0.01503 unit increase,[0.01-0.02],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:23378490
rs1427027-<b>?</b>,1 x 10-8,,NR,'-,0.015 unit increase,[0.0099-0.0201],"RPL12P40, MIR4318",Depressed affect,"unipolar depression, mood disorder",GCST006475,18:37666359
rs145097508-<b>?</b>,2 x 10-9,,NR,'-,0.03206 unit increase,[0.022-0.043],"RPSAP2, LINC00533",Depressed affect,"unipolar depression, mood disorder",GCST006475,6:28714629
rs1490176-<b>?</b>,2 x 10-8,,NR,'-,0.01435 unit increase,[0.0093-0.0194],SORCS3,Depressed affect,"unipolar depression, mood disorder",GCST006475,10:104800467
rs1560312-<b>?</b>,1 x 10-16,,NR,'-,0.02016 unit increase,[0.015-0.025],MAPT,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45901622
rs1724422-<b>?</b>,1 x 10-11,,NR,'-,0.01616 unit increase,[0.012-0.021],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45699947
rs17508548-<b>?</b>,1 x 10-8,,NR,'-,0.02016 unit increase,[0.013-0.027],GABBR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,6:29595290
rs17570807-<b>?</b>,2 x 10-8,,NR,'-,0.03203 unit increase,[0.021-0.043],"MIR4318, RPL12P40",Depressed affect,"unipolar depression, mood disorder",GCST006475,18:37662673
rs1875560-<b>?</b>,3 x 10-11,,NR,'-,0.01545 unit increase,[0.011-0.02],DCC,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:53434318
rs1940728-<b>?</b>,1 x 10-8,,NR,'-,0.01354 unit increase,[0.0089-0.0182],NCAM1,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:112981473
rs199505-<b>?</b>,1 x 10-18,,NR,'-,0.02469 unit increase,[0.019-0.03],WNT3,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:46782044
rs2090408-<b>?</b>,2 x 10-9,,NR,'-,0.01416 unit decrease,[0.0095-0.0188],"LINC01990, BBX",Depressed affect,"unipolar depression, mood disorder",GCST006475,3:107479604
rs2215939-<b>?</b>,5 x 10-8,,NR,'-,0.0135 unit decrease,[0.0087-0.0183],LINC01122,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:58492312
rs2278609-<b>?</b>,9 x 10-9,,NR,'-,0.01622 unit increase,[0.011-0.022],PLCL2,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:16882947
rs2298489-<b>?</b>,2 x 10-11,,NR,'-,0.01668 unit increase,[0.012-0.022],TTC12,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113364697
rs242947-<b>?</b>,6 x 10-9,,NR,'-,0.01361 unit increase,[0.009-0.0182],MAPT-AS1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45839770
rs2435200-<b>?</b>,6 x 10-9,,NR,'-,0.01363 unit increase,[0.009-0.0182],MAPT,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45994485
rs2867972-<b>?</b>,2 x 10-9,,NR,'-,0.01654 unit increase,[0.011-0.022],ARFGAP2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47169687
rs34030812-<b>?</b>,3 x 10-8,,NR,'-,0.01334 unit increase,[0.0086-0.018],ARHGAP15,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:143491336
rs34186148-<b>?</b>,7 x 10-13,,NR,'-,0.01715 unit increase,[0.012-0.022],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45777289
rs34467936-<b>?</b>,4 x 10-11,,NR,'-,0.01605 unit decrease,[0.011-0.021],"NUP160, PTPRJ",Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47893747
rs35609938-<b>?</b>,2 x 10-8,,NR,'-,0.01321 unit decrease,[0.0086-0.0178],LINC01122,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:58529594
rs35738585-<b>?</b>,2 x 10-13,,NR,'-,0.01722 unit decrease,[0.013-0.022],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113515625
rs35825582-<b>?</b>,3 x 10-8,,NR,'-,0.01277 unit decrease,[0.0082-0.0173],ARHGAP15,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:143491193
rs35909029-<b>?</b>,2 x 10-8,,NR,'-,0.01299 unit increase,[0.0085-0.0175],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45774132
rs3758667-<b>?</b>,3 x 10-11,,NR,'-,0.01798 unit decrease,[0.013-0.023],DDB2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47214747
rs3819325-<b>?</b>,3 x 10-8,,NR,'-,0.0129 unit increase,[0.0084-0.0174],UBA7,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:49806290
rs3936093-<b>?</b>,1 x 10-8,,NR,'-,0.01338 unit decrease,[0.0088-0.018],LINGO1,Depressed affect,"unipolar depression, mood disorder",GCST006475,15:77809567
rs4257287-<b>?</b>,2 x 10-9,,NR,'-,0.02217 unit decrease,[0.015-0.029],LINC01929,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55076600
rs4373974-<b>?</b>,2 x 10-8,,NR,'-,0.01295 unit decrease,[0.0084-0.0175],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113559764
rs4800995-<b>?</b>,7 x 10-13,,NR,'-,0.01996 unit decrease,[0.015-0.025],"LINC01415, TCF4",Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55748146
rs4801157-<b>?</b>,2 x 10-10,,NR,'-,0.01921 unit increase,[0.013-0.025],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55497462
rs56403421-<b>?</b>,2 x 10-10,,NR,'-,0.01579 unit increase,[0.011-0.021],LINC01929,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55098052
rs9852417-<b>C</b>,3 x 10-8,,NR,'-,0.0131 unit increase,[0.0085-0.0177],LINC02040,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:65175479
rs600011-<b>C</b>,2 x 10-10,,NR,'-,0.01613 unit increase,[0.011-0.021],BBX,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:107576545
rs59382200-<b>G</b>,2 x 10-11,,NR,'-,0.01581 unit decrease,[0.011-0.02],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:117240427
rs6795372-<b>G</b>,1 x 10-9,,NR,'-,0.0145 unit increase,[0.0098-0.0192],"SLC35G2, STAG1-DT",Depressed affect,"unipolar depression, mood disorder",GCST006475,3:136765048
rs10020288-<b>A</b>,3 x 10-8,,NR,'-,0.01346 unit decrease,[0.0087-0.0182],RN7SL101P,Depressed affect,"unipolar depression, mood disorder",GCST006475,4:28686220
rs13122395-<b>A</b>,4 x 10-8,,NR,'-,0.01356 unit increase,[0.0087-0.0184],EMCN,Depressed affect,"unipolar depression, mood disorder",GCST006475,4:100829496
rs77087420-<b>G</b>,1 x 10-10,,NR,'-,0.03284 unit decrease,[0.023-0.043],KIAA1109,Depressed affect,"unipolar depression, mood disorder",GCST006475,4:122201701
rs6818081-<b>T</b>,3 x 10-8,,NR,'-,0.01805 unit increase,[0.012-0.024],GPM6A,Depressed affect,"unipolar depression, mood disorder",GCST006475,4:175919665
rs55965054-<b>C</b>,3 x 10-9,,NR,'-,0.01391 unit increase,[0.0093-0.0185],C5orf17,Depressed affect,"unipolar depression, mood disorder",GCST006475,5:24032269
rs1422192-<b>A</b>,1 x 10-9,,NR,'-,0.01917 unit increase,[0.013-0.025],LINC00461,Depressed affect,"unipolar depression, mood disorder",GCST006475,5:88663205
rs7714426-<b>C</b>,1 x 10-8,,NR,'-,0.01829 unit increase,[0.012-0.025],PRR16,Depressed affect,"unipolar depression, mood disorder",GCST006475,5:120683373
rs28893517-<b>G</b>,5 x 10-10,,NR,'-,0.02848 unit increase,[0.019-0.037],GABBR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,6:29597596
rs6900114-<b>A</b>,2 x 10-8,,NR,'-,0.01464 unit decrease,[0.0095-0.0198],EYS,Depressed affect,"unipolar depression, mood disorder",GCST006475,6:64099644
rs11514731-<b>G</b>,3 x 10-8,,NR,'-,0.01657 unit decrease,[0.011-0.022],MAD1L1,Depressed affect,"unipolar depression, mood disorder",GCST006475,7:2011868
rs10950393-<b>C</b>,2 x 10-11,,NR,'-,0.01561 unit increase,[0.011-0.02],TMEM106B,Depressed affect,"unipolar depression, mood disorder",GCST006475,7:12223920
rs2396133-<b>G</b>,1 x 10-8,,NR,'-,0.01326 unit increase,[0.0087-0.0178],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,7:109557010
rs7827176-<b>T</b>,2 x 10-8,,NR,'-,0.01316 unit decrease,[0.0086-0.0177],RN7SKP231,Depressed affect,"unipolar depression, mood disorder",GCST006475,8:91637324
rs10156548-<b>G</b>,3 x 10-13,,NR,'-,0.01776 unit increase,[0.013-0.023],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:23318435
rs2895249-<b>A</b>,2 x 10-8,,NR,'-,0.0133 unit decrease,[0.0086-0.018],PHF2,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:93603471
rs2149351-<b>T</b>,2 x 10-9,,NR,'-,0.0162 unit increase,[0.011-0.022],TLR4,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:117739366
rs60393230-<b>A</b>,4 x 10-9,,NR,'-,0.01397 unit decrease,[0.0093-0.0186],LINC01613,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:119893005
rs11599236-<b>C</b>,3 x 10-11,,NR,'-,0.01585 unit decrease,[0.011-0.021],SORCS3,Depressed affect,"unipolar depression, mood disorder",GCST006475,10:104694914
rs7912226-<b>A</b>,8 x 10-10,,NR,'-,0.01462 unit decrease,[0.01-0.0193],LINC02627,Depressed affect,"unipolar depression, mood disorder",GCST006475,10:105892386
rs297346-<b>A</b>,2 x 10-11,,NR,'-,0.0162 unit increase,[0.011-0.021],SOX6,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:16334225
rs7927724-<b>A</b>,4 x 10-8,,NR,'-,0.01416 unit increase,[0.0091-0.0192],CREB3L1,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:46301658
rs57506017-<b>?</b>,2 x 10-9,,NR,'-,0.01519 unit increase,[0.01-0.02],TMEM106B,Depressed affect,"unipolar depression, mood disorder",GCST006475,7:12205599
rs599550-<b>?</b>,4 x 10-17,,NR,'-,0.02725 unit decrease,[0.021-0.034],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55585157
rs6074013-<b>?</b>,1 x 10-9,,NR,'-,0.01402 unit increase,[0.0095-0.0186],NCOA5,Depressed affect,"unipolar depression, mood disorder",GCST006475,20:46080900
rs611439-<b>?</b>,6 x 10-12,,NR,'-,0.02861 unit decrease,[0.02-0.037],TCF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55537633
rs61572747-<b>?</b>,4 x 10-11,,NR,'-,0.01768 unit increase,[0.012-0.023],"RNA5SP443, ARHGAP27",Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45383525
rs61687445-<b>?</b>,4 x 10-10,,NR,'-,0.01464 unit decrease,[0.01-0.019],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113567370
rs62081501-<b>?</b>,2 x 10-8,,NR,'-,0.02377 unit increase,[0.015-0.032],"MIR4318, CELF4",Depressed affect,"unipolar depression, mood disorder",GCST006475,18:37627749
rs62183032-<b>?</b>,3 x 10-8,,NR,'-,0.01331 unit decrease,[0.0086-0.018],ERBB4,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:211774137
rs6774721-<b>?</b>,4 x 10-8,,NR,'-,0.01855 unit decrease,[0.012-0.025],"GPX1, USP4",Depressed affect,"unipolar depression, mood disorder",GCST006475,3:49344465
rs6779928-<b>?</b>,5 x 10-10,,NR,'-,0.01827 unit increase,[0.013-0.024],"CDYLP1, PLCL2",Depressed affect,"unipolar depression, mood disorder",GCST006475,3:16717777
rs6804663-<b>?</b>,3 x 10-8,,NR,'-,0.01349 unit increase,[0.0087-0.0182],PLCL2,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:16833950
rs7104036-<b>?</b>,3 x 10-11,,NR,'-,0.0158 unit increase,[0.011-0.02],RAPSN,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47440589
rs7107356-<b>?</b>,2 x 10-13,,NR,'-,0.01703 unit decrease,[0.013-0.022],"AGBL2, MTCH2",Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47654618
rs7128325-<b>?</b>,2 x 10-8,,NR,'-,0.01376 unit decrease,[0.0089-0.0186],C11orf49,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47025003
rs7212450-<b>?</b>,4 x 10-8,,NR,'-,0.01306 unit decrease,[0.0084-0.0177],"PAFAH1B1, CLUH",Depressed affect,"unipolar depression, mood disorder",GCST006475,17:2688646
rs7225002-<b>?</b>,3 x 10-9,,NR,'-,0.01401 unit increase,[0.0094-0.0186],KANSL1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:46111701
rs7225384-<b>?</b>,5 x 10-9,,NR,'-,0.01379 unit increase,[0.0092-0.0184],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45731730
rs72788286-<b>?</b>,1 x 10-9,,NR,'-,0.01967 unit increase,[0.013-0.026],ATAD2B,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:23875451
rs72789910-<b>?</b>,4 x 10-10,,NR,'-,0.01638 unit increase,[0.011-0.022],FAM228B,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:24165740
rs72995548-<b>?</b>,5 x 10-8,,NR,'-,0.02569 unit decrease,[0.016-0.035],"NCAM1, NCAM1-AS1",Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113268199
rs74338595-<b>?</b>,3 x 10-8,,NR,'-,0.01412 unit decrease,[0.0091-0.0191],ERBB4,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:211885061
rs754593-<b>?</b>,3 x 10-9,,NR,'-,0.01397 unit increase,[0.0094-0.0186],MAPT,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45977330
rs7583068-<b>?</b>,3 x 10-8,,NR,'-,0.01376 unit increase,[0.0089-0.0187],ERBB4,Depressed affect,"unipolar depression, mood disorder",GCST006475,2:211769383
rs7613360-<b>?</b>,2 x 10-8,,NR,'-,0.01326 unit increase,[0.0086-0.0179],"MST1R, ACTL11P",Depressed affect,"unipolar depression, mood disorder",GCST006475,3:49879277
rs7927693-<b>?</b>,9 x 10-9,,NR,'-,0.01361 unit decrease,[0.009-0.0182],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113554746
rs7937477-<b>?</b>,1 x 10-8,,NR,'-,0.01326 unit decrease,[0.0087-0.0178],DRD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:113545374
rs7939345-<b>?</b>,9 x 10-11,,NR,'-,0.01846 unit increase,[0.013-0.024],PTPRJ,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47959016
rs80035064-<b>?</b>,3 x 10-11,,NR,'-,0.01852 unit increase,[0.013-0.024],"MIR4318, CELF4",Depressed affect,"unipolar depression, mood disorder",GCST006475,18:37566403
rs8004430-<b>?</b>,4 x 10-8,,NR,'-,0.01426 unit decrease,[0.0092-0.0193],AREL1,Depressed affect,"unipolar depression, mood disorder",GCST006475,14:74704980
rs8067056-<b>?</b>,1 x 10-12,,NR,'-,0.017 unit increase,[0.012-0.022],MAPT,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:46006582
rs8089865-<b>?</b>,6 x 10-9,,NR,'-,0.01369 unit decrease,[0.0091-0.0183],DCC,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:53431552
rs8097041-<b>?</b>,2 x 10-11,,NR,'-,0.01603 unit decrease,[0.011-0.021],DCC,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:53371847
rs8100891-<b>?</b>,2 x 10-9,,NR,'-,0.01578 unit decrease,[0.011-0.021],"ZNF507, RNA5SP472",Depressed affect,"unipolar depression, mood disorder",GCST006475,19:32338607
rs836927-<b>?</b>,4 x 10-10,,NR,'-,0.01484 unit increase,[0.01-0.019],"LINC01990, BBX",Depressed affect,"unipolar depression, mood disorder",GCST006475,3:107482581
rs896686-<b>?</b>,5 x 10-8,,NR,'-,0.01717 unit decrease,[0.011-0.023],"TCF4-AS1, TCF4",Depressed affect,"unipolar depression, mood disorder",GCST006475,18:55455800
rs913687-<b>?</b>,2 x 10-8,,NR,'-,0.01442 unit decrease,[0.0094-0.0195],RABGAP1L,Depressed affect,"unipolar depression, mood disorder",GCST006475,1:174805993
rs9303521-<b>?</b>,1 x 10-9,,NR,'-,0.01413 unit increase,[0.0096-0.0187],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45727828
rs9586-<b>?</b>,4 x 10-9,,NR,'-,0.01634 unit increase,[0.011-0.022],KLHDC8B,Depressed affect,"unipolar depression, mood disorder",GCST006475,3:49176204
rs9904290-<b>?</b>,2 x 10-9,,NR,'-,0.01443 unit decrease,[0.0097-0.0191],MAPT,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45924905
rs11039149-<b>G</b>,6 x 10-14,,NR,'-,0.01936 unit increase,[0.014-0.024],NR1H3,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47255124
rs11826064-<b>T</b>,7 x 10-10,,NR,'-,0.01562 unit decrease,[0.011-0.021],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:50818695
rs2688708-<b>C</b>,4 x 10-9,,NR,'-,0.01501 unit decrease,[0.01-0.02],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:55073194
rs1940709-<b>A</b>,3 x 10-9,,NR,'-,0.01576 unit increase,[0.011-0.021],NCAM1,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:112978997
rs11605020-<b>G</b>,4 x 10-9,,NR,'-,0.01387 unit decrease,[0.0093-0.0185],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:127110970
rs11608355-<b>C</b>,5 x 10-9,,NR,'-,0.01457 unit increase,[0.0097-0.0195],MYO1H,Depressed affect,"unipolar depression, mood disorder",GCST006475,12:109441487
rs3843954-<b>C</b>,4 x 10-8,,NR,'-,0.01402 unit increase,[0.009-0.019],RNA5SP30,Depressed affect,"unipolar depression, mood disorder",GCST006475,13:57974377
rs77607745-<b>C</b>,5 x 10-8,,NR,'-,0.01614 unit increase,[0.01-0.022],ZDHHC20P4,Depressed affect,"unipolar depression, mood disorder",GCST006475,13:69001052
rs1782179-<b>T</b>,2 x 10-8,,NR,'-,0.01471 unit decrease,[0.0096-0.0198],LINC02315,Depressed affect,"unipolar depression, mood disorder",GCST006475,14:41224737
rs4902704-<b>G</b>,1 x 10-8,,NR,'-,0.01353 unit decrease,[0.0089-0.0182],EXD2,Depressed affect,"unipolar depression, mood disorder",GCST006475,14:69236871
rs10144845-<b>C</b>,1 x 10-10,,NR,'-,0.01604 unit decrease,[0.011-0.021],YLPM1,Depressed affect,"unipolar depression, mood disorder",GCST006475,14:74771067
rs35755513-<b>T</b>,4 x 10-8,,NR,'-,0.02414 unit increase,[0.016-0.033],CSNK1G1,Depressed affect,"unipolar depression, mood disorder",GCST006475,15:64355987
rs7175083-<b>T</b>,2 x 10-10,,NR,'-,0.01467 unit increase,[0.01-0.019],LINGO1,Depressed affect,"unipolar depression, mood disorder",GCST006475,15:77714500
rs9930139-<b>A</b>,1 x 10-8,,NR,'-,0.01351 unit decrease,[0.0089-0.0182],RBFOX1,Depressed affect,"unipolar depression, mood disorder",GCST006475,16:7239569
rs12938775-<b>G</b>,2 x 10-8,,NR,'-,0.01288 unit increase,[0.0084-0.0174],PAFAH1B1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:2671527
rs62057061-<b>G</b>,2 x 10-22,,NR,'-,0.02689 unit increase,[0.021-0.032],LINC02210-CRHR1,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:45779273
rs7502590-<b>G</b>,3 x 10-8,,NR,'-,0.01801 unit decrease,[0.012-0.024],BAIAP2,Depressed affect,"unipolar depression, mood disorder",GCST006475,17:81108281
rs12967855-<b>A</b>,2 x 10-12,,NR,'-,0.01741 unit increase,[0.013-0.022],CELF4,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:37558282
rs17487484-<b>T</b>,2 x 10-12,,NR,'-,0.0163 unit decrease,[0.012-0.021],DCC,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:53196913
rs28687557-<b>G</b>,4 x 10-8,,NR,'-,0.0152 unit decrease,[0.0098-0.0206],RAB27B,Depressed affect,"unipolar depression, mood disorder",GCST006475,18:54879826
rs10405382-<b>G</b>,7 x 10-11,,NR,'-,0.02012 unit decrease,[0.014-0.026],DPY19L3,Depressed affect,"unipolar depression, mood disorder",GCST006475,19:32405810
rs6130328-<b>A</b>,2 x 10-9,,NR,'-,0.01467 unit decrease,[0.0099-0.0195],PPIAP21,Depressed affect,"unipolar depression, mood disorder",GCST006475,20:43256482
rs4578918-<b>T</b>,1 x 10-11,,NR,'-,0.01792 unit increase,[0.013-0.023],"RPL13P2, NCOA5",Depressed affect,"unipolar depression, mood disorder",GCST006475,20:46093017
rs10429537-<b>?</b>,1 x 10-8,,NR,'-,0.01332 unit decrease,[0.0087-0.0179],'-,Depressed affect,"unipolar depression, mood disorder",GCST006475,9:23346844
rs1055447-<b>?</b>,6 x 10-12,,NR,'-,0.01623 unit decrease,[0.012-0.021],ARFGAP2,Depressed affect,"unipolar depression, mood disorder",GCST006475,11:47164873
rs8068883-<b>T</b>,2 x 10-6,,0.32,'-,0.16 unit decrease,[0.1-0.22],B3GNTL1,Response to cognitive-behavioural therapy in anxiety and major depressive disorders,"anxiety disorder, unipolar depression, cognitive behavioural therapy",GCST008358,17:83007988
rs56686332-<b>T</b>,5 x 10-6,,0.08,'-,0.25 unit increase,[0.13-0.37],DNAJC15,Response to cognitive-behavioural therapy in anxiety and major depressive disorders,"anxiety disorder, unipolar depression, cognitive behavioural therapy",GCST008358,13:43057762
rs34724549-<b>A</b>,5 x 10-6,,0.07,'-,0.29 unit increase,[0.17-0.41],TRA2B,Response to cognitive-behavioural therapy in anxiety and major depressive disorders,"anxiety disorder, unipolar depression, cognitive behavioural therapy",GCST008358,3:118668737
rs13219957-<b>A</b>,7 x 10-7,,0.144,'-,0.081 unit increase,[0.050-0.112],UST,Job-related exhaustion,occupation-related stress disorder,GCST001983,6:148949693
rs12591257-<b>A</b>,4 x 10-6,,0.817,5.26,'-,[NR],AGBL1,Psychosis (methamphetamine induced),methamphetamine-induced psychosis,GCST001975,15:86520858
rs159961-<b>?</b>,4 x 10-10,,NR,'-,0.023 unit increase,NR,RERE,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,1:8424168
rs778371-<b>?</b>,3 x 10-15,,NR,'-,0.0291 unit increase,NR,SNORC,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,2:232878399
rs7632834-<b>?</b>,2 x 10-8,,NR,'-,0.0206 unit increase,NR,TBC1D5,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,3:17845186
rs1884117-<b>?</b>,5 x 10-8,,NR,'-,0.0201 unit decrease,NR,PHF3,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,6:63657468
rs9401593-<b>?</b>,8 x 10-11,,NR,'-,0.0239 unit increase,NR,"EIF4EBP2P3, MIR2113",Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,6:98101925
rs7845911-<b>?</b>,8 x 10-9,,NR,'-,0.0213 unit decrease,NR,NSD3,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,8:38277894
rs1727302-<b>?</b>,3 x 10-16,,NR,'-,0.0301 unit decrease,NR,PITPNM2,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,12:123148383
rs10846580-<b>?</b>,1 x 10-8,,NR,'-,0.0209 unit increase,NR,"CCDC92, DNAH10, DNAH10OS",Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,12:123930906
rs12941866-<b>?</b>,3 x 10-8,,NR,'-,0.0204 unit increase,NR,"GGNBP2, MYO19",Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,17:36544271
rs4808967-<b>?</b>,4 x 10-10,,NR,'-,0.0231 unit increase,NR,YJEFN3,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,19:19529715
rs2053079-<b>?</b>,2 x 10-8,,NR,'-,0.0207 unit increase,NR,ZNF536,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,19:30496516
rs1008677-<b>?</b>,1 x 10-11,,NR,'-,0.025 unit increase,NR,CACNA1I,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,22:39613331
rs6002655-<b>?</b>,5 x 10-10,,NR,'-,0.023 unit increase,NR,TCF20,Schizophrenia vs Tourette's syndrome and other tic disorders (ordinary least squares (OLS)),"Tourette syndrome, schizophrenia",GCST90016624,22:42207808
rs10501320-<b>C</b>,7 x 10-12,,0.25471,'-,6.85 z score increase,'-,MADD,Suffering from nerves,nervousness,GCST006949,11:47272248
rs12787112-<b>A</b>,4 x 10-16,,0.340851,'-,8.13 z score increase,'-,AGBL2,Suffering from nerves,nervousness,GCST006949,11:47665595
rs11039391-<b>A</b>,1 x 10-15,,0.339514,'-,7.98 z score decrease,'-,"FNBP4, NUP160",Suffering from nerves,nervousness,GCST006949,11:47775110
rs34467936-<b>A</b>,1 x 10-15,,0.35405,'-,8.01 z score increase,'-,"NUP160, PTPRJ",Suffering from nerves,nervousness,GCST006949,11:47893747
rs2193596-<b>T</b>,5 x 10-9,,0.309866,'-,5.86 z score decrease,'-,YLPM1,Suffering from nerves,nervousness,GCST006949,14:74767398
rs17093914-<b>T</b>,1 x 10-8,,0.312717,'-,5.69 z score decrease,'-,'-,Suffering from nerves,nervousness,GCST006949,Mapping not available
rs9854869-<b>A</b>,1 x 10-10,,0.220189,'-,6.46 z score decrease,'-,CADM2,Suffering from nerves,nervousness,GCST006949,3:85371574
rs35344466-<b>A</b>,2 x 10-10,,0.221978,'-,6.37 z score increase,'-,CADM2,Suffering from nerves,nervousness,GCST006949,3:85583871
rs7611991-<b>A</b>,3 x 10-9,,0.248899,'-,5.93 z score decrease,'-,CADM2,Suffering from nerves,nervousness,GCST006949,3:85710408
rs62081501-<b>A</b>,1 x 10-8,,0.0813367,'-,5.69 z score increase,'-,"MIR4318, CELF4",Suffering from nerves,nervousness,GCST006949,18:37627749
rs11665052-<b>A</b>,5 x 10-10,,0.263176,'-,6.21 z score increase,'-,RNU4-17P,Suffering from nerves,nervousness,GCST006949,18:60241442
rs6478623-<b>T</b>,4 x 10-8,,0.279275,'-,5.51 z score decrease,'-,DENND1A,Suffering from nerves,nervousness,GCST006949,9:123552844
rs11731003-<b>T</b>,4 x 10-9,,0.15,'-,0.9 unit increase,'-,SORCS2,Alcohol withdrawal symptoms,alcohol withdrawal,GCST008137,4:7388545
rs9834970-<b>?</b>,2 x 10-11,,NR,'-,0.0217 unit increase,NR,"LINC02033, HSPD1P6",Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),"autism spectrum disorder, bipolar disorder",GCST90016606,3:36814539
rs11724116-<b>?</b>,3 x 10-8,,NR,'-,0.0179 unit decrease,NR,FSTL5,Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),"autism spectrum disorder, bipolar disorder",GCST90016606,4:161372886
rs10744560-<b>?</b>,5 x 10-9,,NR,'-,0.019 unit increase,NR,"CACNA1C, CACNA1C-IT3",Bipolar disorder vs autism spectrum disorder (ordinary least squares (OLS)),"autism spectrum disorder, bipolar disorder",GCST90016606,12:2277933
rs404005-<b>T</b>,3 x 10-7,(SPEED),NR,'-,'-,'-,"SLC8A1-AS1, SLC8A1",HIV-associated dementia,AIDS dementia,GCST001542,2:40168938
rs7996217-<b>T</b>,7 x 10-7,(SPEED),NR,'-,'-,'-,NALCN,HIV-associated dementia,AIDS dementia,GCST001542,13:101348594
rs12742923-<b>T</b>,8 x 10-7,(NCI),NR,'-,'-,'-,LINC01362,HIV-associated dementia,AIDS dementia,GCST001542,1:83024161
rs17154929-<b>T</b>,1 x 10-7,(SPEED),NR,'-,'-,'-,"TSPAN14, LINC00841",HIV-associated dementia,AIDS dementia,GCST001542,10:44029227
chr2:103117777-<b>T</b>,1 x 10-8,,0.01005,4.2627,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr2:195210106-<b>C</b>,1 x 10-7,,0.009259,3.9218,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr7:112660783-<b>G</b>,1 x 10-7,,0.01138,3.2253,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr6:136207021-<b>T</b>,1 x 10-7,,0.007672,4.2492,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr10:132654411-<b>A</b>,5 x 10-7,,0.04471,1.9776,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr20:58629940-<b>A</b>,5 x 10-7,,0.0172,2.784,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr10:9361099-<b>T</b>,8 x 10-7,,0.1735,1.5455,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr21:46223727-<b>C</b>,8 x 10-7,,0.008995,2.8734,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr15:27902427-<b>T</b>,8 x 10-7,,0.01693,2.6031,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr9:27486453-<b>G</b>,9 x 10-7,,0.109,1.6432,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr3:144544936-<b>C</b>,1 x 10-6,,0.04921,1.8532,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr8:125540043-<b>G</b>,1 x 10-6,,0.01561,2.9867,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr22:30558994-<b>A</b>,1 x 10-6,,0.01376,2.6843,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr2:64791014-<b>G</b>,1 x 10-6,,0.004762,7.5551,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr20:56336051-<b>C</b>,1 x 10-6,,0.03122,2.1033,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr9:80076247-<b>A</b>,1 x 10-6,,0.345,1.4254,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr11:116579473-<b>T</b>,3 x 10-6,,0.01085,2.887,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr11:94271846-<b>T</b>,3 x 10-6,,0.02381,2.2854,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr12:82288694-<b>T</b>,3 x 10-6,,0.01005,2.7773,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr10:117894879-<b>T</b>,3 x 10-6,,0.0246,2.1635,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr6:151635146-<b>G</b>,3 x 10-6,,0.0254,2.1612,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr5:121652214-<b>T</b>,3 x 10-6,,0.01323,2.778,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr1:225773031-<b>G</b>,4 x 10-6,,0.00873,3.1939,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr6:153879321-<b>G</b>,4 x 10-6,,0.009788,2.6641,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr7:43366306-<b>A</b>,5 x 10-6,,0.01561,2.566,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr11:116988389-<b>A</b>,5 x 10-6,,0.01005,3.4048,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
chr17:56369857-<b>A</b>,5 x 10-6,,0.0119,2.7455,'-,'-,'-,Delirium,delirium,GCST005851,Mapping not available
rs4916723-<b>?</b>,5 x 10-8,,NR,'-,0.0108 unit decrease,NR,LINC00461,Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS)),"unipolar depression, autism spectrum disorder",GCST90016614,5:88558577
rs112635299-<b>?</b>,2 x 10-8,,NR,'-,0.011 unit decrease,NR,"SERPINA1, SERPINA2",Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS)),"unipolar depression, autism spectrum disorder",GCST90016614,14:94371805
rs910805-<b>?</b>,5 x 10-8,,NR,'-,0.0108 unit increase,NR,"XRN2, ZNF877P",Major depressive disorder vs autism spectrum disorder (ordinary least squares (OLS)),"unipolar depression, autism spectrum disorder",GCST90016614,20:21267478
rs4703129-<b>?</b>,1 x 10-6,,0.41,'-,'-,'-,CTBP2P4,Asperger disorder,Asperger syndrome,GCST000904,5:98553032
rs7179456-<b>?</b>,7 x 10-6,,0.39,'-,'-,'-,"RNF111, SLTM",Asperger disorder,Asperger syndrome,GCST000904,15:58882340
rs1550976-<b>?</b>,2 x 10-6,,0.33,'-,'-,'-,NTM,Asperger disorder,Asperger syndrome,GCST000904,11:131450176
rs892055-<b>?</b>,5 x 10-6,,0.33,'-,'-,'-,RASGRP4,Asperger disorder,Asperger syndrome,GCST000904,19:38422124
rs10510837-<b>?</b>,4 x 10-6,,0.12,'-,'-,'-,FHIT,Asperger disorder,Asperger syndrome,GCST000904,3:60304113
rs290227-<b>G</b>,7 x 10-11,,0.4,2.2,'-,[1.73-2.78],SYK,Vascular dementia,vascular dementia,GCST000993,9:90874382
rs2237457-<b>T</b>,6 x 10-7,(Recessive model),0.36,1.74,'-,[NR],GRB10,Schizophrenia (treatment resistant),treatment refractory schizophrenia,GCST002604,7:50658447
rs12410444-<b>?</b>,2 x 10-10,,NR,'-,0.0145 unit increase,NR,"ST3GAL3-AS1, ST3GAL3",Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,1:43723048
rs227378-<b>?</b>,5 x 10-8,,NR,'-,0.0124 unit decrease,NR,MANBA,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,4:102699228
rs226488-<b>?</b>,2 x 10-10,,NR,'-,0.0146 unit decrease,NR,LINC00461,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,5:88600512
rs304132-<b>?</b>,2 x 10-9,,NR,'-,0.0137 unit decrease,NR,MEF2C-AS1,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,5:88919777
rs74760947-<b>?</b>,2 x 10-8,,NR,'-,0.0128 unit decrease,NR,'-,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,8:34495092
rs704061-<b>?</b>,5 x 10-8,,NR,'-,0.0124 unit decrease,NR,"POC1B, DUSP6",Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,12:89378126
rs8039398-<b>?</b>,1 x 10-8,,NR,'-,0.013 unit decrease,NR,SEMA6D,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,15:47438673
rs8058677-<b>?</b>,4 x 10-8,,NR,'-,0.0125 unit decrease,NR,CDH8,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,16:61934401
rs212178-<b>?</b>,3 x 10-8,,NR,'-,0.0126 unit increase,NR,LINC01572,Major depressive disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, unipolar depression",GCST90016612,16:72544232
rs359268-<b>C</b>,1 x 10-6,(recessive),0.431,2.81,'-,[1.84-4.30],'-,Hypersomnia (HLA-DQB1*06:02 negative),hypersomnia,GCST001971,2:60232671
rs16826005-<b>G</b>,1 x 10-7,(recessive),0.319,3.52,'-,[2.17-5.70],NCKAP5,Hypersomnia (HLA-DQB1*06:02 negative),hypersomnia,GCST001971,2:133508430
rs16966389-<b>G</b>,7 x 10-7,(dominant),0.642,2.73,'-,[1.82-4.10],"LINC01852, SPRED1",Hypersomnia (HLA-DQB1*06:02 negative),hypersomnia,GCST001971,15:38172673
rs10988217-<b>G</b>,3 x 10-6,(recessive),0.233,3.85,'-,[2.11-7.04],PTPA,Hypersomnia (HLA-DQB1*06:02 negative),hypersomnia,GCST001971,9:129125837
rs7725217-<b>C</b>,1 x 10-6,(dominant),0.223,2.66,'-,[1.78-3.98],LINC02112,Hypersomnia (HLA-DQB1*06:02 negative),hypersomnia,GCST001971,5:9756217
rs60924036-<b>G</b>,8 x 10-6,,0.321933348,'-,0.13361064 unit increase,[0.075-0.192],"GJD2, LINC02252",Menstruation quality of life impact (sleepiness),"quality of life during menstruation measurement, sleepiness",GCST006651,15:34743665
rs9327007-<b>G</b>,8 x 10-6,,0.319504311,'-,0.13501824 unit decrease,[0.076-0.194],SEMA6A,Menstruation quality of life impact (sleepiness),"quality of life during menstruation measurement, sleepiness",GCST006651,5:116563436
rs7207701-<b>T</b>,5 x 10-7,,0.30059775,'-,0.15388642 unit increase,[0.094-0.214],"CDRT7, CDRT8",Menstruation quality of life impact (sleepiness),"quality of life during menstruation measurement, sleepiness",GCST006651,17:15052017
rs6065904-<b>?</b>,1 x 10-6,(Adjusted for PC1-5),NR,1.8867927,'-,[1.45-2.44],PLTP,Pathological gambling,pathological gambling,GCST003648,20:45906012
rs3943418-<b>A</b>,7 x 10-6,(Adjusted for PC1-5),NR,1.71,'-,[1.36-2.16],XYLT1,Pathological gambling,pathological gambling,GCST003648,16:17243867
rs7591351-<b>T</b>,6 x 10-6,"(Adjusted for PC1-5, age and sex)",NR,1.67,'-,[1.34-2.09],PRKCE,Pathological gambling,pathological gambling,GCST003648,2:45836267
rs528301-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,LINC01833,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,2:44927769
rs9636470-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,RGPD2,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,2:87866942
rs1318937-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,"CAPN7, SH3BP5-AS1",Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,3:15253857
rs1570989-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,HIVEP1,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,6:12048594
rs17427389-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,PLEKHG1,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,6:150841979
rs1426153-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,PKNOX2,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,11:125300743
rs728115-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,KCND2,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,7:120665095
rs6028335-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,LINC01734,Alcohol and nicotine co-dependence,alcohol and nicotine codependence,GCST001471,20:39216834
rs149268645-<b>G</b>,4 x 10-7,,0.85,1.1764705,'-,[1.11-1.25],"WDR12, CARF",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,2:202968295
rs73577700-<b>T</b>,3 x 10-6,,0.15,1.1494253,'-,[1.09-1.22],'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,16:80246864
rs4870888-<b>C</b>,5 x 10-7,,0.46,1.1235955,'-,[1.08-1.16],"FER1L6-AS2, FER1L6",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,8:124096736
chr4_23273116-I-<b>?</b>,5 x 10-7,,0.18,1.16,'-,1.09-1.23,'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,Mapping not available
rs35107435-<b>T</b>,2 x 10-6,,0.15,1.17,'-,1.10-1.24,BBOX1-AS1,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,11:27227783
rs73348245-<b>G</b>,2 x 10-6,,0.06,1.27,'-,1.15-1.40,TCL1B,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,14:95691735
rs11004733-<b>C</b>,1 x 10-6,,0.04,1.34,'-,1.19-1.50,PCDH15,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,10:55089584
rs142055939-<b>C</b>,2 x 10-6,,0.02,1.48,'-,1.26-1.75,FYCO1,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,3:45954062
rs113988902-<b>C</b>,2 x 10-6,,0.04,1.52,'-,1.28-1.80,PHF2P2,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,13:18950965
rs138689899-<b>C</b>,2 x 10-6,,0.02,1.53,'-,1.29-1.82,"IWS1, MYO7B",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,2:127530586
chr13_73243177-D-<b>?</b>,2 x 10-6,,0.03,1.59,'-,1.32-1.93,'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,Mapping not available
rs75633108-<b>C</b>,3 x 10-6,,0.02,1.59,'-,1.31-1.93,LINC01787,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,1:96269629
rs186672572-<b>C</b>,2 x 10-6,,0.01,1.64,'-,1.33-2.00,LINC00992,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,5:117542337
rs6426297-<b>C</b>,2 x 10-6,,0.01,1.65,'-,1.34-2.04,SMYD3,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,1:246375079
rs141252918-<b>G</b>,6 x 10-7,,0.01,1.73,'-,1.39-2.14,CCDC170,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,6:151506923
rs76371172-<b>G</b>,8 x 10-7,,0.02,1.6393442,'-,[1.35-2],OTUD7A,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,15:31522252
rs113386487-<b>T</b>,2 x 10-6,,0.02,1.4925373,'-,[1.27-1.79],"RBISP1, SEPHS1",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,10:13316583
rs72756712-<b>G</b>,3 x 10-6,,0.05,1.2820514,'-,[1.16-1.43],'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,9:126140627
rs9577511-<b>G</b>,6 x 10-7,,0.13,1.2048193,'-,[1.12-1.3],GRTP1,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,13:113337508
rs62173322-<b>G</b>,8 x 10-7,,0.13,1.1904762,'-,[1.11-1.28],KLHL23,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,2:169754519
rs149268645-<b>G</b>,4 x 10-7,,0.85,1.1764705,'-,[1.11-1.25],"WDR12, CARF",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,2:202968295
rs73577700-<b>T</b>,3 x 10-6,,0.15,1.1494253,'-,[1.09-1.22],'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,16:80246864
rs4870888-<b>C</b>,5 x 10-7,,0.46,1.1235955,'-,[1.08-1.16],"FER1L6-AS2, FER1L6",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,8:124096736
chr4_23273116-I-<b>?</b>,5 x 10-7,,0.18,1.16,'-,1.09-1.23,'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,Mapping not available
rs35107435-<b>T</b>,2 x 10-6,,0.15,1.17,'-,1.10-1.24,BBOX1-AS1,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,11:27227783
rs73348245-<b>G</b>,2 x 10-6,,0.06,1.27,'-,1.15-1.40,TCL1B,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,14:95691735
rs11004733-<b>C</b>,1 x 10-6,,0.04,1.34,'-,1.19-1.50,PCDH15,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,10:55089584
rs142055939-<b>C</b>,2 x 10-6,,0.02,1.48,'-,1.26-1.75,FYCO1,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,3:45954062
rs113988902-<b>C</b>,2 x 10-6,,0.04,1.52,'-,1.28-1.80,PHF2P2,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,13:18950965
rs138689899-<b>C</b>,2 x 10-6,,0.02,1.53,'-,1.29-1.82,"IWS1, MYO7B",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,2:127530586
chr13_73243177-D-<b>?</b>,2 x 10-6,,0.03,1.59,'-,1.32-1.93,'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,Mapping not available
rs75633108-<b>C</b>,3 x 10-6,,0.02,1.59,'-,1.31-1.93,LINC01787,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,1:96269629
rs186672572-<b>C</b>,2 x 10-6,,0.01,1.64,'-,1.33-2.00,LINC00992,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,5:117542337
rs6426297-<b>C</b>,2 x 10-6,,0.01,1.65,'-,1.34-2.04,SMYD3,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,1:246375079
rs141252918-<b>G</b>,6 x 10-7,,0.01,1.73,'-,1.39-2.14,CCDC170,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,6:151506923
rs76371172-<b>G</b>,8 x 10-7,,0.02,1.6393442,'-,[1.35-2],OTUD7A,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,15:31522252
rs113386487-<b>T</b>,2 x 10-6,,0.02,1.4925373,'-,[1.27-1.79],"RBISP1, SEPHS1",Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,10:13316583
rs72756712-<b>G</b>,3 x 10-6,,0.05,1.2820514,'-,[1.16-1.43],'-,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,9:126140627
rs9577511-<b>G</b>,6 x 10-7,,0.13,1.2048193,'-,[1.12-1.3],GRTP1,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,13:113337508
rs62173322-<b>G</b>,8 x 10-7,,0.13,1.1904762,'-,[1.11-1.28],KLHL23,Suicide attempts in major depressive disorder or bipolar disorder or schizophrenia,"unipolar depression, schizophrenia, bipolar disorder, attempted suicide",GCST008123,2:169754519
rs1546733-<b>?</b>,6 x 10-6,,NR,'-,4.524 z-score decrease,'-,CBLB,Antipsychotic drug-induced weight gain in schizophrenia or autism,"schizophrenia, autism spectrum disorder, antipsychotic drug related weight gain",GCST009301,3:105690477
rs4976976-<b>?</b>,4 x 10-11,,NR,'-,0.0199 unit decrease,NR,TSNARE1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,8:142230292
rs9644880-<b>?</b>,1 x 10-8,,NR,'-,0.017 unit increase,NR,"HMGB3P24, RNF38",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,9:36318848
rs11556063-<b>?</b>,3 x 10-8,,NR,'-,0.0168 unit increase,NR,"SLC25A6P5, TMEM38B",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,9:105819760
rs12764899-<b>?</b>,3 x 10-12,,NR,'-,0.021 unit decrease,NR,"AS3MT, BORCS7-ASMT",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,10:102875346
rs515997-<b>?</b>,3 x 10-9,,NR,'-,0.0179 unit increase,NR,"ARL14EP, FSHB",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,11:30245491
rs2514218-<b>?</b>,7 x 10-9,,NR,'-,0.0174 unit decrease,NR,DRD2,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,11:113522272
rs4936215-<b>?</b>,1 x 10-8,,NR,'-,0.0172 unit decrease,NR,"LINC02730, IGSF9B",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,11:133982789
rs2007044-<b>?</b>,2 x 10-17,,NR,'-,0.0256 unit increase,NR,CACNA1C,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,12:2235794
rs116940627-<b>?</b>,2 x 10-8,,NR,'-,0.0169 unit decrease,NR,"GLTP, TCHP",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,12:109898741
rs4766428-<b>?</b>,4 x 10-9,,NR,'-,0.0177 unit increase,NR,ATP2A2,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,12:110285440
rs2102949-<b>?</b>,2 x 10-11,,NR,'-,0.0202 unit decrease,NR,MPHOSPH9,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,12:123192216
rs10148671-<b>?</b>,6 x 10-9,,NR,'-,0.0175 unit increase,NR,LINC02326,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,14:29000167
rs12892815-<b>?</b>,4 x 10-8,,NR,'-,0.0166 unit increase,NR,"UNGP3, DYNLL1P1",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,14:81249645
rs246193-<b>?</b>,1 x 10-8,,NR,'-,0.0171 unit increase,NR,"NDRG4, SETD6",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,16:58513954
rs12948749-<b>?</b>,2 x 10-9,,NR,'-,0.0182 unit decrease,NR,GID4,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,17:18046488
rs199503-<b>?</b>,3 x 10-9,,NR,'-,0.0179 unit decrease,NR,WNT3,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,17:46784796
rs11874716-<b>?</b>,2 x 10-8,,NR,'-,0.017 unit decrease,NR,LINC01929,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,18:55083457
rs28758902-<b>?</b>,8 x 10-9,,NR,'-,0.0174 unit increase,NR,"LINC01415, TCF4",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,18:55740956
rs2053079-<b>?</b>,4 x 10-9,,NR,'-,0.0177 unit increase,NR,ZNF536,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,19:30496516
rs6065094-<b>?</b>,7 x 10-11,,NR,'-,0.0196 unit increase,NR,PPP1R16B,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,20:38824551
rs5750857-<b>?</b>,2 x 10-10,,NR,'-,0.0191 unit increase,NR,CACNA1I,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,22:39604216
rs35998080-<b>?</b>,3 x 10-8,,NR,'-,0.0166 unit increase,NR,LINC02797,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,1:72812932
rs11165872-<b>?</b>,4 x 10-8,,NR,'-,0.0165 unit decrease,NR,DPYD,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,1:97437034
rs72700813-<b>?</b>,7 x 10-10,,NR,'-,0.0186 unit decrease,NR,"ADAMTSL4-AS2, FALEC",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,1:150537068
rs11693094-<b>?</b>,3 x 10-9,,NR,'-,0.0178 unit decrease,NR,ZNF804A,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,2:184736693
rs260755-<b>?</b>,3 x 10-9,,NR,'-,0.0178 unit increase,NR,"SATB2, RNU7-147P",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,2:199256438
rs2949006-<b>?</b>,1 x 10-11,,NR,'-,0.0205 unit decrease,NR,FTCDNL1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,2:199850665
rs11685299-<b>?</b>,6 x 10-10,,NR,'-,0.0186 unit decrease,NR,CUL3,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,2:224526579
rs4144797-<b>?</b>,5 x 10-15,,NR,'-,0.0235 unit decrease,NR,GIGYF2,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,2:232697487
rs9876421-<b>?</b>,2 x 10-8,,NR,'-,0.0168 unit increase,NR,"LINC02033, HSPD1P6",Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,3:36806825
rs940174-<b>?</b>,5 x 10-10,,NR,'-,0.0188 unit decrease,NR,STAG1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,3:136590868
rs34796896-<b>?</b>,3 x 10-9,,NR,'-,0.0179 unit decrease,NR,FXR1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,3:180905467
rs3846343-<b>?</b>,4 x 10-8,,NR,'-,0.0165 unit decrease,NR,LINC02261,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,4:27348195
rs223332-<b>?</b>,3 x 10-8,,NR,'-,0.0167 unit increase,NR,CISD2,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,4:102869029
rs1986252-<b>?</b>,8 x 10-14,,NR,'-,0.0225 unit increase,NR,ZSWIM6,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,5:61458592
rs58120505-<b>?</b>,5 x 10-12,,NR,'-,0.0208 unit decrease,NR,MAD1L1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,7:1990232
rs860003-<b>?</b>,8 x 10-9,,NR,'-,0.0174 unit increase,NR,CALN1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,7:72115777
rs973044-<b>?</b>,3 x 10-8,,NR,'-,0.0167 unit decrease,NR,DMTF1,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,7:87170864
rs12546760-<b>?</b>,4 x 10-8,,NR,'-,0.0165 unit increase,NR,RN7SL178P,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,8:8517326
rs11993663-<b>?</b>,1 x 10-9,,NR,'-,0.0183 unit increase,NR,MSRA,Schizophrenia vs autism spectrum disorder (ordinary least squares (OLS)),"schizophrenia, autism spectrum disorder",GCST90016620,8:10175384
rs7524258-<b>T</b>,8 x 10-6,,0.4,1.16,'-,[NR],CAMTA1,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,1:7232169
rs35881094-<b>G</b>,7 x 10-6,,0.43,1.16,'-,[NR],LINC01122,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,2:58695786
rs73070160-<b>T</b>,3 x 10-6,,0.14,1.24,'-,[NR],FECHP1,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,3:34883533
rs4988462-<b>T</b>,4 x 10-7,,0.42,1.18,'-,[NR],POU1F1,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,3:87264203
rs149183310-<b>T</b>,2 x 10-6,,0.044,1.52,'-,[NR],LSAMP,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,3:116214742
rs61792199-<b>G</b>,9 x 10-6,,0.15,1.23,'-,[NR],DMP1,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,4:22921626
rs859980-<b>C</b>,7 x 10-6,,0.53,1.15,'-,[NR],NPM1P10,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,6:104053323
rs10973956-<b>A</b>,7 x 10-6,,0.16,1.23,'-,[NR],"YWHABP1, RNU6-765P",Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,9:38645058
rs7848024-<b>A</b>,5 x 10-6,,0.27,1.19,'-,[NR],'-,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,9:102810755
rs11021169-<b>G</b>,8 x 10-6,,0.92,1.3,'-,[NR],'-,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,11:95467263
rs4271390-<b>T</b>,1 x 10-6,,0.25,1.2,'-,[NR],NECTIN1,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,11:119655426
rs6563569-<b>C</b>,6 x 10-6,,0.44,1.16,'-,[NR],TRPC4,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,13:37686271
rs11149058-<b>T</b>,1 x 10-6,,0.78,1.22,'-,[NR],"RPL7P44, ACOD1",Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,13:76978136
rs12959570-<b>G</b>,4 x 10-6,,0.23,1.2,'-,[NR],WDR7,Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,18:56666353
rs55797066-<b>C</b>,8 x 10-6,,0.06,1.33,'-,[NR],"ATP9A, NFATC2",Tourette's syndrome or obsessive-compulsive disorder,"obsessive-compulsive disorder, Tourette syndrome",GCST002682,20:51593381
rs4791746-<b>?</b>,2 x 10-7,,0.6133,2.15,'-,'-,"MYH10, CCDC42",Heroin dependence,heroin dependence,GCST003878,17:8723039
rs4739179-<b>?</b>,4 x 10-6,,0.6523,1.98,'-,'-,'-,Heroin dependence,heroin dependence,GCST003878,8:77873757
rs1881509-<b>?</b>,4 x 10-6,,0.5908,2.02,'-,'-,BRSK2,Heroin dependence,heroin dependence,GCST003878,11:1404375
rs78158938-<b>?</b>,6 x 10-6,,0.90234,4.93,'-,'-,"NPM1P18, AOAH",Heroin dependence,heroin dependence,GCST003878,7:36747191
rs2288156-<b>?</b>,3 x 10-7,,0.8271,2.5608194,'-,'-,CCDC42,Heroin dependence,heroin dependence,GCST003878,17:8741536
chr17:8631468-<b>?</b>,4 x 10-7,,0.6201,2.1303794,'-,'-,'-,Heroin dependence,heroin dependence,GCST003878,Mapping not available
chr8:78718310-<b>?</b>,5 x 10-6,,0.6475,1.961169,'-,'-,'-,Heroin dependence,heroin dependence,GCST003878,Mapping not available
chr11:1421138-<b>?</b>,5 x 10-6,,0.5898,2.0008004,'-,'-,'-,Heroin dependence,heroin dependence,GCST003878,Mapping not available
rs75608493-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,LINC01741,Schizophrenia or schizoaffective disorder,"schizophrenia, schizoaffective disorder",GCST009283,1:177796886
rs2077586-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,EMX1,Schizophrenia or schizoaffective disorder,"schizophrenia, schizoaffective disorder",GCST009283,2:72934422
rs776877-<b>?</b>,3 x 10-9,(Latino),NR,1.39,'-,[1.28-1.50],GALNT13,Schizophrenia or schizoaffective disorder,"schizophrenia, schizoaffective disorder",GCST009283,2:153941017
rs1451488-<b>?</b>,2 x 10-11,,NR,'-,0.023 unit increase,NR,RNU7-147P,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,2:199125384
rs796364-<b>?</b>,5 x 10-10,,NR,'-,0.0213 unit decrease,NR,"RN7SL717P, FTCDNL1",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,2:199851396
rs6704768-<b>?</b>,3 x 10-17,,NR,'-,0.029 unit decrease,NR,GIGYF2,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,2:232727791
rs9882879-<b>?</b>,1 x 10-9,,NR,'-,0.0208 unit increase,NR,"HSPD1P6, LINC02033",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,3:36802580
rs1080500-<b>?</b>,2 x 10-8,,NR,'-,0.0193 unit decrease,NR,"PRKCD, RFT1",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,3:53141001
rs9845457-<b>?</b>,2 x 10-8,,NR,'-,0.0193 unit decrease,NR,MSL2,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,3:136195634
rs13135092-<b>?</b>,4 x 10-8,,NR,'-,0.0189 unit increase,NR,SLC39A8,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,4:102276925
rs223346-<b>?</b>,8 x 10-10,,NR,'-,0.0211 unit increase,NR,UBE2D3,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,4:102859339
rs62367473-<b>?</b>,2 x 10-8,,NR,'-,0.0193 unit increase,NR,HCN1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,5:45216147
rs34635-<b>?</b>,2 x 10-8,,NR,'-,0.0194 unit increase,NR,"SMIM15-AS1, LINC02057",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,5:61217674
rs13361438-<b>?</b>,1 x 10-8,,NR,'-,0.0196 unit decrease,NR,LINC01470,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,5:152627515
rs12668848-<b>?</b>,8 x 10-11,,NR,'-,0.0223 unit decrease,NR,MAD1L1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,7:1981360
rs42694-<b>?</b>,8 x 10-9,,NR,'-,0.0198 unit increase,NR,CREB5,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,7:28389624
rs56150095-<b>?</b>,5 x 10-12,,NR,'-,0.0238 unit decrease,NR,CALN1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,7:72294084
rs12704290-<b>?</b>,2 x 10-10,,NR,'-,0.0219 unit decrease,NR,"GRM3-AS1, GRM3",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,7:86798310
rs12539177-<b>?</b>,3 x 10-10,,NR,'-,0.0216 unit decrease,NR,IMMP2L,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,7:111337645
rs10954580-<b>?</b>,1 x 10-8,,NR,'-,0.0196 unit decrease,NR,DGKI,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,7:137391966
rs1473594-<b>?</b>,1 x 10-8,,NR,'-,0.0195 unit decrease,NR,'-,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,8:59783967
rs4129585-<b>?</b>,4 x 10-12,,NR,'-,0.0239 unit decrease,NR,TSNARE1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,8:142231572
rs295268-<b>?</b>,6 x 10-10,,NR,'-,0.0212 unit increase,NR,GKAP1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,9:83814390
rs713240-<b>?</b>,5 x 10-9,,NR,'-,0.0201 unit decrease,NR,ARID5B,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,10:62050693
rs12244388-<b>?</b>,4 x 10-8,,NR,'-,0.0189 unit decrease,NR,"AS3MT, BORCS7-ASMT",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,10:102880295
rs57159364-<b>?</b>,2 x 10-9,,NR,'-,0.0207 unit decrease,NR,ZNF804A,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,2:184643769
rs4298967-<b>?</b>,1 x 10-11,,NR,'-,0.0234 unit decrease,NR,CACNA1C,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,12:2299028
rs324017-<b>?</b>,3 x 10-9,,NR,'-,0.0205 unit increase,NR,NAB2,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,12:57094031
rs704061-<b>?</b>,2 x 10-8,,NR,'-,0.0194 unit decrease,NR,"POC1B, DUSP6",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,12:89378126
rs3764002-<b>?</b>,3 x 10-10,,NR,'-,0.0217 unit increase,NR,WSCD2,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,12:108224853
rs2102949-<b>?</b>,2 x 10-13,,NR,'-,0.0252 unit decrease,NR,MPHOSPH9,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,12:123192216
rs11844846-<b>?</b>,4 x 10-8,,NR,'-,0.0188 unit increase,NR,LINC02326,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,14:29018462
rs8009147-<b>?</b>,5 x 10-9,,NR,'-,0.02 unit increase,NR,PPP1R13B,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,14:103798325
rs12592235-<b>?</b>,1 x 10-8,,NR,'-,0.0197 unit decrease,NR,SEMA6D,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,15:47495773
rs12898315-<b>?</b>,1 x 10-10,,NR,'-,0.0221 unit increase,NR,'-,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,15:61561804
rs4925114-<b>?</b>,3 x 10-9,,NR,'-,0.0204 unit decrease,NR,RAI1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,17:17807956
rs17594665-<b>?</b>,6 x 10-9,,NR,'-,0.02 unit increase,NR,TCF4,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,18:55396488
rs2053079-<b>?</b>,3 x 10-8,,NR,'-,0.019 unit increase,NR,ZNF536,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,19:30496516
rs603985-<b>?</b>,3 x 10-8,,NR,'-,0.019 unit increase,NR,FUT2,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,19:48704000
rs2263655-<b>?</b>,8 x 10-10,,NR,'-,0.0211 unit increase,NR,"SIRPB2, RNU6-917P",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,20:1527453
rs6071524-<b>?</b>,3 x 10-11,,NR,'-,0.0229 unit increase,NR,"ACTR5, PPP1R16B",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,20:38797937
rs10802742-<b>?</b>,3 x 10-8,,NR,'-,0.019 unit increase,NR,'-,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,1:239038351
rs12058508-<b>?</b>,3 x 10-8,,NR,'-,0.0191 unit decrease,NR,SDCCAG8,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,1:243324559
rs12025137-<b>?</b>,8 x 10-10,,NR,'-,0.0211 unit decrease,NR,"UBE2WP1, LINC01787",Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,1:96417671
rs9659624-<b>?</b>,8 x 10-14,,NR,'-,0.0257 unit increase,NR,MIR137HG,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,1:98021777
rs79366331-<b>?</b>,3 x 10-8,,NR,'-,0.0191 unit decrease,NR,MINDY1,Schizophrenia vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, schizophrenia",GCST90016618,1:150998719
rs8180817-<b>C</b>,2 x 10-8,,0.492,'-,'-,'-,FOXP2,Insomnia,insomnia,GCST010097,7:114407487
rs9894577-<b>A</b>,1 x 10-10,,0.3519,'-,'-,'-,"ACBD4, HEXIM1",Insomnia,insomnia,GCST010097,17:45145925
rs113851554-<b>T</b>,1 x 10-21,,0.05268,'-,'-,'-,MEIS1,Insomnia,insomnia,GCST010097,2:66523432
rs77217059-<b>A</b>,4 x 10-9,,0.1302,'-,'-,'-,LINC01122,Insomnia,insomnia,GCST010097,2:58762745
rs79545773-<b>A</b>,7 x 10-9,,0.04274,'-,'-,'-,"DNMT3AP1, LINC01798",Insomnia,insomnia,GCST010097,2:66798413
rs62264767-<b>C</b>,1 x 10-8,,0.164,'-,'-,'-,'-,Insomnia,insomnia,GCST010097,3:117923158
rs12658032-<b>G</b>,5 x 10-9,,0.3559,'-,'-,'-,'-,Insomnia,insomnia,GCST010097,5:104568525
rs325500-<b>G</b>,3 x 10-8,,0.3966,'-,'-,'-,'-,Insomnia,insomnia,GCST010097,5:104670966
rs370771-<b>T</b>,1 x 10-11,,0.4692,'-,'-,'-,LIN28B,Insomnia,insomnia,GCST010097,6:104950211
rs6938026-<b>G</b>,3 x 10-10,,0.173,'-,'-,'-,CUL9,Insomnia,insomnia,GCST010097,6:43217995
rs10087341-<b>C</b>,7 x 10-11,,0.167,'-,'-,'-,MSRA,Insomnia,insomnia,GCST010097,8:10382146
rs10838708-<b>A</b>,2 x 10-8,,0.4503,'-,'-,'-,PSMC3,Insomnia,insomnia,GCST010097,11:47419962
rs4073582-<b>A</b>,6 x 10-9,,0.3618,'-,'-,'-,CNIH2,Insomnia,insomnia,GCST010097,11:66283241
rs2408766-<b>T</b>,1 x 10-10,,0.4523,'-,'-,'-,LINC01065,Insomnia,insomnia,GCST010097,13:53112746
rs4883690-<b>G</b>,2 x 10-8,,0.3698,'-,'-,'-,ZNF646P1,Insomnia,insomnia,GCST010097,13:53444958
rs4884332-<b>A</b>,9 x 10-9,,0.3489,'-,'-,'-,RPP40P2,Insomnia,insomnia,GCST010097,13:59326231
rs6561715-<b>A</b>,2 x 10-11,,0.3628,'-,'-,'-,"RN7SL618P, ZNF646P1",Insomnia,insomnia,GCST010097,13:53314391
rs6589075-<b>T</b>,3 x 10-7,,0.118184092,'-,0.2592224 unit increase,[0.16-0.36],LINC02713,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,11:97888820
rs12477098-<b>T</b>,7 x 10-6,,0.527396834,'-,0.15764286 unit increase,[0.089-0.226],SNTG2,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,2:1099816
rs6437450-<b>C</b>,4 x 10-6,,0.829839437,'-,0.22219077 unit increase,[0.13-0.32],XXYLT1,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,3:195016009
rs13113956-<b>A</b>,3 x 10-6,,0.26968404,'-,0.18722807 unit decrease,[0.11-0.27],'-,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,4:125938393
rs1158326-<b>G</b>,7 x 10-6,,0.127768339,'-,0.2249695 unit increase,[0.13-0.32],MAML3,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,4:139810806
rs870306-<b>G</b>,3 x 10-7,,0.240383055,'-,0.20160586 unit increase,[0.12-0.28],IGF1R,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,15:98776578
rs508296-<b>T</b>,9 x 10-6,,0.288755799,'-,0.16685836 unit increase,[0.093-0.241],'-,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,5:114791832
rs1925191-<b>G</b>,6 x 10-6,,0.573070651,'-,0.1554631 unit decrease,[0.088-0.223],SPTLC1P2,Menstruation quality of life impact (loss of concentration),"quality of life during menstruation measurement, decreased attention",GCST006648,6:23835115
rs58502974-<b>A</b>,2 x 10-8,,0.44,1.13,'-,[NR],ADCY2,Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004002,5:7755787
rs1334489-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,SLC35F1,Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004002,6:118318224
rs2134095-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,RXRG,Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004002,1:165408315
rs16998572-<b>?</b>,8 x 10-6,,'-,'-,'-,'-,"BCAS1, SUMO1P1",Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004002,20:53935345
rs11162556-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,ADGRL4,Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004002,1:78795698
rs12761122-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"TRUB1, LINC02626",Bipolar disorder (age of onset <21) or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004002,10:114993789
rs7089973-<b>C</b>,2 x 10-8,,0.74,1.1111112,'-,[NR],TAF9BP2,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,10:114809806
rs11756438-<b>A</b>,4 x 10-8,,0.34,1.1,'-,[NR],CEP85L,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,6:118672469
rs34096808-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,NLGN1,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,3:173822316
rs58502974-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ADCY2,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,5:7755787
rs10489744-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,RXRG,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,1:165411386
rs9608816-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,ASCC2,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,22:29820911
rs16998572-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,"BCAS1, SUMO1P1",Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,20:53935345
rs36030485-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,VLDLR-AS1,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,9:2411646
rs11162556-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,ADGRL4,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,1:78795698
rs56037433-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,SLC4A10,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,2:161719475
rs71420669-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,'-,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,2:194986941
rs13061878-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,PTPRG,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,3:61634560
rs1334489-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,SLC35F1,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,6:118318224
rs12661338-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,CEP85L,Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,6:118473527
rs968847-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,"ATRNL1, LINC02626",Bipolar disorder or attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, bipolar disorder",GCST004001,10:114998320
rs571017-<b>?</b>,4 x 10-9,,NR,'-,0.0207 unit increase,NR,LINC01748,Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,1:60638487
rs17183814-<b>?</b>,7 x 10-11,,NR,'-,0.0229 unit decrease,NR,SCN2A,Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,2:165295879
rs7707252-<b>?</b>,2 x 10-8,,NR,'-,0.0198 unit increase,NR,Y_RNA,Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,5:79544787
rs7969091-<b>?</b>,2 x 10-9,,NR,'-,0.0212 unit increase,NR,"DHH, RHEBL1",Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,12:49070666
rs12898460-<b>?</b>,2 x 10-9,,NR,'-,0.0211 unit decrease,NR,LINC02694,Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,15:38694612
rs9834970-<b>?</b>,6 x 10-12,,NR,'-,0.0242 unit increase,NR,"LINC02033, HSPD1P6",Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,3:36814539
rs6829845-<b>?</b>,1 x 10-8,,NR,'-,0.0199 unit decrease,NR,IL21,Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,4:122589611
rs79360559-<b>?</b>,2 x 10-9,,NR,'-,0.0212 unit decrease,NR,FSTL5,Bipolar disorder vs ADHD (ordinary least squares (OLS)),"attention deficit hyperactivity disorder, bipolar disorder",GCST90016604,4:161378979
rs299362-<b>A</b>,3 x 10-6,,0.886,'-,0.062 unit decrease,[0.037-0.087],"PCBD2, CATSPER3",Bulimia nervosa,bulimia nervosa,GCST001958,5:134985856
rs28631020-<b>G</b>,3 x 10-6,,0.925,'-,0.08 unit decrease,[0.047-0.113],'-,Bulimia nervosa,bulimia nervosa,GCST001958,6:66943386
rs11708304-<b>C</b>,6 x 10-6,,0.853,'-,0.059 unit decrease,[0.034-0.084],"BFSP2, CDV3",Bulimia nervosa,bulimia nervosa,GCST001958,3:133542030
rs8024343-<b>A</b>,6 x 10-6,,0.831,'-,0.045 unit decrease,[0.025-0.065],'-,Bulimia nervosa,bulimia nervosa,GCST001958,15:87166835
rs7724774-<b>G</b>,7 x 10-6,,0.884,'-,0.054 unit decrease,[0.03-0.078],CCDC69,Bulimia nervosa,bulimia nervosa,GCST001958,5:151206306
rs145379083-<b>G</b>,3 x 10-6,,0.51,'-,0.037 unit decrease,[0.021-0.053],'-,Bulimia nervosa,bulimia nervosa,GCST001958,4:63027560
rs117124364-<b>C</b>,9 x 10-6,,0.977,'-,0.16 unit decrease,[0.089-0.231],"LINC01690, OLIG2",Bulimia nervosa,bulimia nervosa,GCST001958,21:32997453
rs1445130-<b>A</b>,1 x 10-7,,0.864,'-,0.056 unit decrease,[0.036-0.076],NT5C1B,Bulimia nervosa,bulimia nervosa,GCST001958,2:18653385
rs142014203-<b>T</b>,9 x 10-7,,0.974,'-,0.126 unit decrease,[0.075-0.177],NKAIN3,Bulimia nervosa,bulimia nervosa,GCST001958,8:62346358
rs77600076-<b>A</b>,1 x 10-6,,0.971,'-,0.124 unit decrease,[0.075-0.173],CHODL,Bulimia nervosa,bulimia nervosa,GCST001958,21:18159125
rs1556640-<b>T</b>,2 x 10-6,,0.88,'-,0.075 unit decrease,[0.044-0.106],'-,Bulimia nervosa,bulimia nervosa,GCST001958,Mapping not available
rs8040855-<b>C</b>,3 x 10-6,,0.634,'-,0.035 unit increase,[0.021-0.049],"PDE8A, NIFKP8",Bulimia nervosa,bulimia nervosa,GCST001958,15:85155976
rs12986207-<b>G</b>,4 x 10-6,,0.817,'-,0.044 unit decrease,[0.024-0.064],VSTM2B-DT,Bulimia nervosa,bulimia nervosa,GCST001958,19:29412770
rs56148675-<b>T</b>,5 x 10-6,,0.942,'-,0.076 unit decrease,[0.043-0.109],ASB3,Bulimia nervosa,bulimia nervosa,GCST001958,2:53529404
rs2910124-<b>C</b>,6 x 10-6,,0.858,'-,0.059 unit decrease,[0.034-0.084],COL23A1,Bulimia nervosa,bulimia nervosa,GCST001958,5:178381674
rs61742849-<b>G</b>,6 x 10-6,,0.975,'-,0.179 unit decrease,[0.1-0.26],MAGI3,Bulimia nervosa,bulimia nervosa,GCST001958,1:113683521
rs117096873-<b>C</b>,2 x 10-6,,0.974,'-,0.129 unit decrease,[0.076-0.182],RMI2,Bulimia nervosa,bulimia nervosa,GCST001958,16:11293103
rs78661745-<b>C</b>,7 x 10-6,,0.908,'-,0.068 unit decrease,[0.039-0.097],MIR1263,Bulimia nervosa,bulimia nervosa,GCST001958,3:164137281
rs115694618-<b>A</b>,4 x 10-6,,0.979,'-,0.123 unit decrease,[0.07-0.176],"AFF1, KLHL8",Bulimia nervosa,bulimia nervosa,GCST001958,4:87154977
rs74879986-<b>G</b>,6 x 10-6,,0.975,'-,0.14 unit decrease,[0.079-0.201],"PCDH7, LINC02497",Bulimia nervosa,bulimia nervosa,GCST001958,4:31154556
rs6999631-<b>C</b>,8 x 10-6,,0.965,'-,0.09 unit decrease,[0.051-0.129],MSRA,Bulimia nervosa,bulimia nervosa,GCST001958,8:10228901
rs985795-<b>T</b>,2 x 10-6,,0.946,'-,0.094 unit decrease,[0.055-0.133],DAB1,Bulimia nervosa,bulimia nervosa,GCST001958,1:57854156
rs111383589-<b>C</b>,2 x 10-6,,0.892,'-,0.087 unit decrease,[0.052-0.122],"RN7SL633P, TUG1",Bulimia nervosa,bulimia nervosa,GCST001958,22:31042375
rs4806846-<b>A</b>,8 x 10-6,,0.14,'-,'-,'-,TMPRSS9,Neuroticism,neurotic disorder,GCST001771,19:2410486
rs9829896-<b>?</b>,4 x 10-10,(AA),0.78,1.47,'-,[1.27-2.86],KAT2B,Drug abuse,drug dependence,GCST003601,3:20135980
rs118129027-<b>C</b>,8 x 10-8,(Arabian),0.04,3.7,'-,[2.21-6.36],"POU6F2, YAE1",Substance use disorder,drug dependence,GCST007700,7:39545812
rs12284594-<b>G</b>,7 x 10-8,(EA women),NR,1.77,'-,[NR],PKNOX2,Substance dependence,drug dependence,GCST000956,11:125309957
rs1417205-<b>A</b>,8 x 10-7,,0.95,'-,0.064 unit decrease,'-,GNG5P5,Cannabis use (initiation),drug dependence,GCST001616,13:47324744
rs9900808-<b>A</b>,2 x 10-6,,0.04,'-,0.082 unit increase,'-,'-,Cannabis use (initiation),drug dependence,GCST001616,17:13159478
rs1573535-<b>A</b>,4 x 10-6,,0.56,'-,0.026 unit increase,'-,NELL1,Cannabis use (initiation),drug dependence,GCST001616,11:21599402
rs4789400-<b>A</b>,5 x 10-6,,0.08,'-,0.069 unit decrease,'-,"Metazoa_SRP, MGAT5B",Cannabis use (initiation),drug dependence,GCST001616,17:77001815
rs10455657-<b>T</b>,6 x 10-6,,0.81,'-,0.032 unit decrease,'-,LINC02549,Cannabis use (initiation),drug dependence,GCST001616,6:68275038
rs9458975-<b>T</b>,7 x 10-6,,0.45,'-,0.026 unit increase,'-,"SYNJ2, SNX9",Cannabis use (initiation),drug dependence,GCST001616,6:157968709
rs2377339-<b>G</b>,1 x 10-11,(Opiates - African ancestry men - allelic test),0.0159,'-,13.87 unit increase,NR,'-,Addiction,drug dependence,GCST001880,Mapping not available
rs2377339-<b>G</b>,2 x 10-8,(codependence - African ancestry men - adjusted analysis),0.0159,'-,'-,'-,'-,Addiction,drug dependence,GCST001880,Mapping not available
rs3816995-<b>?</b>,2 x 10-7,,0.03,'-,'-,'-,SDK2,Panic disorder,panic disorder,GCST000320,17:73339121
rs4702982-<b>?</b>,6 x 10-6,,0.16,'-,'-,'-,"RN7SKP62, FAM174A",Panic disorder,panic disorder,GCST000320,5:100655944
rs2103868-<b>?</b>,5 x 10-6,,0.26,'-,'-,'-,TNFRSF21,Panic disorder,panic disorder,GCST000320,6:47262879
rs860554-<b>?</b>,5 x 10-8,,0.05,'-,'-,'-,PKP1,Panic disorder,panic disorder,GCST000320,1:201293304
rs941184-<b>?</b>,3 x 10-7,,0.03,'-,'-,'-,CALCOCO1,Panic disorder,panic disorder,GCST000320,12:53720374
rs9372078-<b>?</b>,5 x 10-7,,0.11,'-,'-,'-,PLEKHG1,Panic disorder,panic disorder,GCST000320,6:150592825
rs12579350-<b>?</b>,4 x 10-9,,0.01,'-,'-,'-,ANO2,Panic disorder,panic disorder,GCST000320,12:5687935
rs7299940-<b>?</b>,7 x 10-6,,0.29,'-,'-,'-,"Y_RNA, RAN",Panic disorder,panic disorder,GCST000320,12:130906209
rs17466684-<b>?</b>,7 x 10-7,,0.09,'-,'-,'-,"GULOP, CLU",Panic disorder,panic disorder,GCST000320,8:27595330
rs3749380-<b>?</b>,2 x 10-6,,0.25,'-,'-,'-,GRM7,Panic disorder,panic disorder,GCST000320,3:6861610
rs2823455-<b>?</b>,9 x 10-6,,0.03,'-,'-,'-,"USP25, RAD23BP3",Panic disorder,panic disorder,GCST000320,21:15696847
rs9302001-<b>?</b>,3 x 10-7,,0.2,'-,'-,'-,SOX21-AS1,Panic disorder,panic disorder,GCST000320,13:94811138
rs2731006-<b>?</b>,4 x 10-6,,0.29,'-,'-,'-,LINC02450,Panic disorder,panic disorder,GCST000320,12:42767023
rs12061304-<b>?</b>,1 x 10-6,,0.1,'-,'-,'-,"KCNA3, Y_RNA",Panic disorder,panic disorder,GCST000320,1:110695063
rs4901869-<b>?</b>,6 x 10-6,,0.02,'-,'-,'-,LINC01500,Panic disorder,panic disorder,GCST000320,14:58867410
rs16989303-<b>?</b>,6 x 10-6,,0.21,'-,'-,'-,"LINC01433, SMOX",Panic disorder,panic disorder,GCST000320,20:4188432
rs3810265-<b>?</b>,4 x 10-6,,0.07,'-,'-,'-,"TSKS, CPT1C",Panic disorder,panic disorder,GCST000320,19:49720009
rs6854861-<b>C</b>,8 x 10-6,,0.784706911,'-,0.15640192 unit increase,[0.088-0.225],USP38,Menstruation quality of life impact (nervousness),"nervousness, quality of life during menstruation measurement",GCST006649,4:143131938
rs11100785-<b>C</b>,4 x 10-6,,0.786230458,'-,0.16219163 unit increase,[0.093-0.231],"USP38, Y_RNA",Menstruation quality of life impact (nervousness),"nervousness, quality of life during menstruation measurement",GCST006649,4:143274404
rs722208-<b>G</b>,3 x 10-6,,0.35,'-,0.22 unit increase,[NR],ESR1,Developmental language disorder,specific language impairment,GCST003396,6:152001750
rs1559831-<b>T</b>,4 x 10-6,,0.06,'-,0.34 unit decrease,[NR],LINC02694,Developmental language disorder,specific language impairment,GCST003396,15:38844103
rs6496012-<b>G</b>,4 x 10-6,,0.06,'-,0.34 unit decrease,[NR],LINC02694,Developmental language disorder,specific language impairment,GCST003396,15:38858723
rs3787751-<b>C</b>,5 x 10-6,,0.05,'-,0.07 unit decrease,[NR],HLCS,Developmental language disorder,specific language impairment,GCST003396,21:36787862
rs3787751-<b>C</b>,5 x 10-7,,0.45,'-,0.07 unit decrease,[NR],HLCS,Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,21:36787862
rs10504229-<b>A</b>,6 x 10-6,,0.16,'-,0.5 unit increase,[NR],LINC00588,Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,8:57283936
rs2180386-<b>A</b>,7 x 10-6,,0.38,'-,0.21 unit decrease,[NR],"RTL1, MEG8",Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,14:100898928
rs12121864-<b>C</b>,8 x 10-6,,0.09,'-,0.28 unit increase,[NR],"GPR157, MIR34AHG",Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,1:9145273
rs3787751-<b>?</b>,2 x 10-7,(Well-formedness),0.448,'-,0.385 unit decrease,[0.24-0.53],HLCS,Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,21:36787862
rs10504229-<b>?</b>,4 x 10-7,(Semantic/pragmatic),0.162,'-,0.508 unit increase,[0.31-0.7],LINC00588,Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,8:57283936
rs12121864-<b>?</b>,7 x 10-7,(Phonetic/prosodic),0.088,'-,0.642 unit increase,[0.39-0.89],"GPR157, MIR34AHG",Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,1:9145273
rs5761618-<b>?</b>,2 x 10-6,(Well-formedness),0.494,'-,0.349 unit increase,[0.21-0.49],"TPST2, CRYBB1",Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,22:26597742
rs4895970-<b>?</b>,5 x 10-6,(Phonetic/prosodic),0.497,'-,0.355 unit increase,[0.2-0.51],TARID,Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,6:133543112
rs3789868-<b>G</b>,4 x 10-6,,0.47,'-,'-,'-,"DELEC1, TNC",Developmental language disorder (syntactic complexity),"syntactic complexity measurement, specific language impairment",GCST003398,9:115113402
rs3789867-<b>?</b>,3 x 10-6,(Mean utterance length),0.469,'-,0.345 unit decrease,[0.2-0.49],"TNC, DELEC1",Developmental language disorder (syntactic complexity),"syntactic complexity measurement, specific language impairment",GCST003398,9:115113409
rs4796604-<b>?</b>,5 x 10-6,(Complex structures),0.444,'-,0.358 unit increase,[0.21-0.51],HAP1,Developmental language disorder (syntactic complexity),"syntactic complexity measurement, specific language impairment",GCST003398,17:41734624
rs4129566-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,HAND2-AS1,Cocaine dependence,cocaine dependence,GCST002142,4:173626006
rs75686122-<b>?</b>,3 x 10-6,(AA),NR,'-,'-,'-,RIMS2,Cocaine dependence,cocaine dependence,GCST002142,8:103561561
rs2629540-<b>?</b>,4 x 10-8,(Symptom count),NR,'-,'-,'-,FAM53B,Cocaine dependence,cocaine dependence,GCST002142,10:124737579
rs6677435-<b>?</b>,9 x 10-6,(EA),NR,'-,'-,'-,'-,Cocaine dependence,cocaine dependence,GCST002142,1:195821528
rs4129566-<b>?</b>,3 x 10-6,(AA),NR,'-,'-,'-,HAND2-AS1,Cocaine dependence,cocaine dependence,GCST002142,4:173626006
rs11944332-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,HAND2-AS1,Cocaine dependence,cocaine dependence,GCST002142,4:173633681
rs2005290-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,OR3A2,Cocaine dependence,cocaine dependence,GCST002142,17:3284718
rs2629540-<b>?</b>,1 x 10-6,"(Symptom count, AA)",NR,'-,'-,'-,FAM53B,Cocaine dependence,cocaine dependence,GCST002142,10:124737579
rs2456778-<b>?</b>,3 x 10-6,(Cocaine–induced paranoia),NR,'-,'-,'-,CDK1,Cocaine dependence,cocaine dependence,GCST002142,10:60792132
rs72840936-<b>?</b>,3 x 10-6,(EA),NR,'-,'-,'-,STEAP3-AS1,Cocaine dependence,cocaine dependence,GCST002142,2:119266116
rs111325002-<b>?</b>,4 x 10-7,(AA),NR,'-,'-,'-,'-,Cocaine dependence,cocaine dependence,GCST002142,3:96134788
rs11944332-<b>?</b>,2 x 10-6,(AA),NR,'-,'-,'-,HAND2-AS1,Cocaine dependence,cocaine dependence,GCST002142,4:173633681
rs2005290-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,OR3A2,Cocaine dependence,cocaine dependence,GCST002142,17:3284718
rs150954431-<b>?</b>,5 x 10-7,"(Symptom count, EA)",NR,'-,'-,'-,NCOR2,Cocaine dependence,cocaine dependence,GCST002142,12:124517777
rs2456778-<b>?</b>,5 x 10-6,"(Cocaine–induced paranoia, AA)",NR,'-,'-,'-,CDK1,Cocaine dependence,cocaine dependence,GCST002142,10:60792132
rs245914-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,"CPVL, CHN2",Psychosis (atypical),psychosis,GCST002211,7:29178543
rs12196860-<b>?</b>,2 x 10-7,,'-,'-,'-,'-,COL21A1,Psychosis (atypical),psychosis,GCST002211,6:56085576
rs12105421-<b>?</b>,5 x 10-7,,'-,'-,'-,'-,TMEM182,Psychosis (atypical),psychosis,GCST002211,2:102959630
rs1959536-<b>?</b>,8 x 10-7,,'-,'-,'-,'-,TRIM9,Psychosis (atypical),psychosis,GCST002211,14:50980053
rs6081541-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,SLC24A3,Psychosis (atypical),psychosis,GCST002211,20:19232246
rs4619807-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,"UBE2E2-AS1, RPL24P7",Psychosis (atypical),psychosis,GCST002211,3:23152437
rs16902460-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,PVT1,Psychosis (atypical),psychosis,GCST002211,8:127907951
rs1572591-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,NALCN,Psychosis (atypical),psychosis,GCST002211,13:101407725
rs8029989-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,"SPRED1, FAM98B",Psychosis (atypical),psychosis,GCST002211,15:38441646
rs2736172-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,"PRRC2A, SNORA38",Psychosis (atypical),psychosis,GCST002211,6:31623121
rs7912580-<b>A</b>,1 x 10-6,(Total PANSS scores),0.057,'-,'-,'-,"RTKN2, ARID5B",Response to haloperidol in psychosis,"psychosis, response to haloperidol",GCST002465,10:62156213
rs2412459-<b>C</b>,9 x 10-6,(Total PANSS scores),0.218,'-,'-,'-,EIF2AK4,Response to haloperidol in psychosis,"psychosis, response to haloperidol",GCST002465,15:40003758
rs10513025-<b>?</b>,2 x 10-7,,NR,1.81,'-,[NR],"SNHG18, TAS2R1",Autism,autism,GCST000496,5:9623510
rs6453278-<b>?</b>,5 x 10-6,,NR,1.25,'-,[NR],ZBED3-AS1,Autism,autism,GCST000496,5:77121217
rs978597-<b>G</b>,7 x 10-8,,0.167,22.4151,'-,[5.1219-98.0966],AMELY,Autism,autism,GCST010733,Y:6885470
rs1865680-<b>G</b>,2 x 10-8,,0.174,24.6226,'-,[5.6469-107.3643],TBL1Y,Autism,autism,GCST010733,Y:7000077
rs2032624-<b>A</b>,2 x 10-8,,0.165,20.8868,'-,[4.7675-91.5071],DDX3Y,Autism,autism,GCST010733,Y:12914512
rs2032658-<b>A</b>,3 x 10-9,,0.155,46.3585,'-,[6.1221-351.0397],UTY,Autism,autism,GCST010733,Y:13470103
rs2032631-<b>G</b>,2 x 10-8,,0.174,24.2308,'-,[5.5455-105.8754],KDM5D,Autism,autism,GCST010733,Y:19705901
rs9786153-<b>T</b>,3 x 10-9,,0.151,1.7955,'-,[0.1597-20.1843],EIF1AY,Autism,autism,GCST010733,Y:20577481
rs13447352-<b>A</b>,5 x 10-6,,0.62,4.970179,'-,[1.91-12.95],EIF1AY,Autism,autism,GCST010733,Y:20587967
"rs2280840-<b>G</b>, rs6599528-<b>A</b>",9 x 10-6,,0.625,'-,'-,'-,SLC52A2; FBXL6; No mapped genes,Autism,autism,GCST010733,8:144357897
"rs1545620-<b>G</b>, rs7248508-<b>C</b>",9 x 10-6,,0.426,'-,'-,'-,MYO9B; No mapped genes,Autism,autism,GCST010733,19:17192965
rs112082427-<b>A</b>,1 x 10-6,,NR,'-,4.845 z score decrease,'-,LINC01320,Reading disability,dyslexia,GCST009897,2:33710835
rs116532258-<b>T</b>,2 x 10-6,,NR,'-,4.779 z score increase,'-,"MIR4418, PPIAP34",Reading disability,dyslexia,GCST009897,1:22300272
rs6788994-<b>A</b>,8 x 10-6,,NR,'-,4.476 z score increase,'-,"CPA3, UBQLN4P1",Reading disability,dyslexia,GCST009897,3:148974528
rs143623248-<b>A</b>,7 x 10-6,,NR,'-,4.492 z score increase,'-,HDAC9,Reading disability,dyslexia,GCST009897,7:18854370
rs7011522-<b>T</b>,2 x 10-6,,'-,'-,4.725 z score decrease,'-,MYOM2,Reading disability,dyslexia,GCST009897,8:35029242
rs62060986-<b>T</b>,7 x 10-6,NR,NR,'-,4.48 z score decrease,'-,AIPL1,Reading disability,dyslexia,GCST009897,17:6406736
rs73033157-<b>T</b>,4 x 10-6,,NR,'-,4.638 z score decrease,'-,CHST8,Reading disability,dyslexia,GCST009897,19:33695450
rs11855415-<b>A</b>,2 x 10-8,,0.25,'-,0.35 SD increase,[0.23-0.47],"PCSK6, PCSK6-AS1",Handedness in dyslexia,"handedness, dyslexia",GCST000868,15:101334918
rs7322916-<b>G</b>,8 x 10-7,,0.501,'-,0.089 unit increase,[0.054-0.124],ATP8A2,Eating disorders,eating disorder,GCST001960,13:25433839
rs3120667-<b>A</b>,2 x 10-6,,0.845,'-,0.118 unit decrease,[0.069-0.167],FLG-AS1,Eating disorders,eating disorder,GCST001960,1:152345685
rs2115200-<b>T</b>,2 x 10-6,,0.768,'-,0.098 unit increase,[0.057-0.139],"SAYSD1, KCNK5",Eating disorders,eating disorder,GCST001960,6:39149922
rs10906233-<b>C</b>,4 x 10-6,,0.979,'-,0.288 unit decrease,[0.17-0.41],CAMK1D,Eating disorders,eating disorder,GCST001960,10:12833208
rs138206701-<b>A</b>,4 x 10-6,,0.98,'-,0.425 unit decrease,[0.24-0.61],RASGRF2,Eating disorders,eating disorder,GCST001960,5:81110747
rs2221433-<b>G</b>,5 x 10-6,,0.682,'-,0.087 unit decrease,[0.05-0.124],EMP2,Eating disorders,eating disorder,GCST001960,16:10569770
rs148915469-<b>C</b>,8 x 10-6,,0.979,'-,0.279 unit decrease,[0.16-0.4],"ADH7, C4orf17",Eating disorders,eating disorder,GCST001960,4:99474257
rs74566133-<b>C</b>,7 x 10-7,,0.969,'-,0.249 unit decrease,[0.15-0.35],MTCO1P49,Eating disorders (purging via substances),eating disorder,GCST001959,8:133766099
rs10175070-<b>A</b>,2 x 10-6,,0.75,'-,0.124 unit increase,[0.073-0.175],CCL20,Eating disorders (purging via substances),eating disorder,GCST001959,2:227805859
rs1516459-<b>C</b>,3 x 10-6,,0.968,'-,0.27 unit decrease,[0.16-0.38],ROBO2,Eating disorders (purging via substances),eating disorder,GCST001959,3:76212669
rs10998035-<b>C</b>,4 x 10-6,,0.945,'-,0.151 unit decrease,[0.086-0.216],"LINC02640, KRT19P4",Eating disorders (purging via substances),eating disorder,GCST001959,10:68254473
rs514024-<b>A</b>,5 x 10-6,,0.572,'-,0.061 unit increase,[0.036-0.086],SH2D3C,Eating disorders (purging via substances),eating disorder,GCST001959,9:127741791
rs142816172-<b>C</b>,6 x 10-6,,0.976,'-,0.273 unit decrease,[0.16-0.39],CSMD1,Eating disorders (purging via substances),eating disorder,GCST001959,8:3298698
rs145433814-<b>G</b>,6 x 10-6,,0.976,'-,0.239 unit decrease,[0.14-0.34],'-,Eating disorders (purging via substances),eating disorder,GCST001959,2:59899176
rs1506203-<b>G</b>,8 x 10-6,,0.849,'-,0.083 unit decrease,[0.048-0.118],'-,Eating disorders (purging via substances),eating disorder,GCST001959,3:30999011
rs138206701-<b>A</b>,1 x 10-7,,0.98,'-,0.327 unit decrease,[0.21-0.45],RASGRF2,Eating disorders (purging via substances),eating disorder,GCST001959,5:81110747
rs11087123-<b>A</b>,4 x 10-6,,0.738,'-,0.12 unit decrease,[0.069-0.171],MACROD2,Eating disorders,eating disorder,GCST001960,20:15140098
rs12475512-<b>G</b>,7 x 10-7,,0.543,'-,0.108 unit increase,[0.065-0.151],"B3GNT7, ZBTB8OSP2",Eating disorders (purging via substances),eating disorder,GCST001959,2:231433365
rs13077017-<b>C</b>,1 x 10-6,,0.71,'-,0.073 unit decrease,[0.044-0.102],FLNB,Eating disorders (purging via substances),eating disorder,GCST001959,3:58120049
rs2103655-<b>?</b>,3 x 10-6,,NR,'-,0.025 unit increase,NR,"PPP1R16B, ACTR5",Schizophrenia vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, schizophrenia",GCST90016622,20:38797315
rs4280164-<b>G</b>,4 x 10-8,,0.767,'-,3.872 unit increase,[NR],NOP9,Parent of origin effect on language impairment (paternal),language impairment,GCST002371,14:24302079
rs7801303-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,"SUGCT, LINC01450",Parent of origin effect on language impairment (paternal),language impairment,GCST002371,7:40878471
rs16924016-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,PTCSC2,Parent of origin effect on language impairment (paternal),language impairment,GCST002371,9:97749049
rs2209852-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,"LINC00557, SOX21-AS1",Parent of origin effect on language impairment (paternal),language impairment,GCST002371,13:94865368
rs16836940-<b>A</b>,6 x 10-8,,0.22,'-,'-,'-,RPRD2,Broad depression or bipolar disorder,"unipolar depression, bipolar disorder",GCST007255,1:150444437
rs2535629-<b>A</b>,1 x 10-9,,0.33,'-,'-,'-,ITIH3,Broad depression or bipolar disorder,"unipolar depression, bipolar disorder",GCST007255,3:52799203
rs4765914-<b>T</b>,5 x 10-9,,0.79,'-,'-,'-,CACNA1C,Broad depression or bipolar disorder,"unipolar depression, bipolar disorder",GCST007255,12:2311211
rs55945116-<b>G</b>,6 x 10-7,,0.7892,'-,23.3347 unit increase,[14.59-32.08],SEC11A,Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,15:84676882
rs112647602-<b>G</b>,5 x 10-6,,0.7875,'-,23.135 unit decrease,[13.6-32.67],KRASP1,Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,6:54731957
rs1846786-<b>T</b>,6 x 10-6,,0.6951,'-,19.0893 unit decrease,[11.14-27.04],'-,Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,4:130998547
rs5997786-<b>C</b>,6 x 10-6,,0.7995,'-,22.0315 unit increase,[12.83-31.23],OSBP2,Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,22:30858049
rs1524145-<b>G</b>,6 x 10-6,,0.5,'-,17.3121 unit decrease,[10.07-24.55],'-,Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,2:35897322
rs6689906-<b>C</b>,7 x 10-6,,0.9364,'-,35.6552 unit increase,[20.7-50.61],"LINC01779, MAB21L3",Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,1:116140919
rs79749176-<b>T</b>,9 x 10-6,,0.9468,'-,39.0894 unit increase,[22.49-55.69],LINC01649,Response to ketamine in bipolar disorder or major depression (antidepressant effects),"unipolar depression, depressive symptom measurement, response to ketamine, bipolar disorder",GCST007316,1:115918397
rs17211233-<b>T</b>,2 x 10-7,,0.939,'-,26.9757 unit decrease,[17.75-36.2],RASGRF2,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,5:81072944
rs1400237-<b>T</b>,2 x 10-6,,0.0778,'-,21.4345 unit increase,[13.27-29.6],ROBO2,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,3:76123081
rs12236015-<b>C</b>,3 x 10-6,,0.833,'-,13.9838 unit decrease,[8.54-19.43],'-,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,9:120055542
rs9713737-<b>A</b>,5 x 10-6,,0.244,'-,13.5351 unit increase,[8.15-18.92],ROBO2,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,3:76248023
rs77987715-<b>A</b>,5 x 10-6,,0.6547,'-,11.7152 unit decrease,[7.04-16.39],KRT18P33,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,2:65727945
rs3900502-<b>C</b>,6 x 10-6,,0.4877,'-,12.2832 unit decrease,[7.36-17.21],'-,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,4:188948079
rs3018154-<b>C</b>,6 x 10-6,,0.9111,'-,19.9461 unit decrease,[11.92-27.98],"LINC02700, AMOTL1",Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,11:94687142
rs1287071-<b>A</b>,6 x 10-6,,0.7111,'-,11.3492 unit decrease,[6.77-15.93],SHLD1,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,20:5847729
rs11127199-<b>G</b>,7 x 10-6,,0.6335,'-,11.445 unit increase,[6.82-16.07],TOGARAM2,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,2:28990695
rs4855976-<b>A</b>,8 x 10-6,,0.0702,'-,23.7477 unit increase,[14.02-33.48],ROBO2,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,3:76218217
rs11907319-<b>T</b>,9 x 10-6,,0.8099,'-,14.3351 unit increase,[8.45-20.22],"FITM2, GDAP1L1",Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,20:44294659
rs4558394-<b>A</b>,9 x 10-6,,0.85,'-,15.6495 unit decrease,[9.19-22.11],LINC00923,Response to ketamine in bipolar disorder or major depression (dissociation effects),"unipolar depression, response to ketamine, dissociation measurement, bipolar disorder",GCST007317,15:97779155
rs34215985-<b>G</b>,2 x 10-10,,NR,1.0309278,'-,'-,SLC30A9,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,4:42045761
rs61990288-<b>G</b>,2 x 10-10,,NR,1.0309278,'-,'-,LRFN5,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,14:41605523
rs4143229-<b>C</b>,3 x 10-10,,NR,1.0526316,'-,'-,ENOX1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,13:43753663
rs12935276-<b>G</b>,5 x 10-10,,NR,1.0309278,'-,'-,SHISA9,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,16:12944866
rs910187-<b>G</b>,3 x 10-9,,NR,1.0309278,'-,'-,ZMYND8,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,20:47212407
rs4074723-<b>C</b>,3 x 10-9,,NR,1.0309278,'-,'-,SOX5,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,12:23794803
rs4753209-<b>T</b>,4 x 10-9,,NR,1.0309278,'-,'-,GRM5,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:89010040
rs4529173-<b>C</b>,4 x 10-9,,NR,1.0309278,'-,'-,SCAMP1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:78413606
rs4869056-<b>G</b>,5 x 10-9,,NR,1.0309278,'-,'-,TENM2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:167565073
rs62099069-<b>T</b>,1 x 10-9,,NR,1.0309278,'-,'-,MIR924HG,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,18:39303773
rs7771570-<b>C</b>,1 x 10-9,,NR,1.0309278,'-,'-,"GRIK2, ASCC3",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,6:100891524
rs1828385-<b>C</b>,1 x 10-8,,NR,1.0309278,'-,'-,LINC02853,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,15:36063667
rs1518367-<b>T</b>,1 x 10-8,,NR,1.0309278,'-,'-,PLCL1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,2:197942291
rs977509-<b>C</b>,1 x 10-8,,NR,1.0309278,'-,'-,SOX6,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:16272134
rs117763335-<b>C</b>,1 x 10-8,,NR,1.0309278,'-,'-,SETBP1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,18:44680383
rs4526442-<b>C</b>,8 x 10-11,,NR,1.0416667,'-,'-,ZCCHC7,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:37207272
rs113872034-<b>G</b>,1 x 10-9,,NR,1.0416667,'-,'-,TUBGCP6,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,22:50241007
rs1531188-<b>C</b>,2 x 10-9,,NR,1.0416667,'-,'-,MYH15,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,3:108429710
rs16851203-<b>C</b>,2 x 10-9,,NR,1.0416667,'-,'-,LINC01645,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:177400897
rs78821730-<b>G</b>,3 x 10-8,,NR,1.0416667,'-,'-,CNNM2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,10:102924787
rs8037355-<b>C</b>,4 x 10-15,,NR,1.0309278,'-,'-,'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,15:37351630
rs11682175-<b>C</b>,2 x 10-11,,NR,1.0309278,'-,'-,ACTG1P22,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,2:57760458
rs7430565-<b>G</b>,2 x 10-11,,NR,1.0309278,'-,'-,RSRC1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,3:158389391
rs12658032-<b>A</b>,2 x 10-16,,NR,1.04,'-,[1.03-1.05],'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:104568525
rs11135349-<b>C</b>,3 x 10-11,,NR,1.0309278,'-,'-,'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:165096466
rs61533748-<b>C</b>,4 x 10-11,,NR,1.0309278,'-,'-,"RNA5SP87, LINC01830",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,2:22360096
rs102275-<b>C</b>,5 x 10-11,,NR,1.0309278,'-,'-,TMEM258,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:61790331
rs8063603-<b>G</b>,5 x 10-11,,NR,1.0309278,'-,'-,RBFOX1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,16:6260644
rs6667297-<b>G</b>,6 x 10-11,,NR,1.0309278,'-,'-,HMGB1P18,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:80330304
rs4721057-<b>G</b>,7 x 10-11,,NR,1.0309278,'-,'-,TMEM106B,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,7:12227595
rs1045430-<b>G</b>,1 x 10-10,,NR,1.0309278,'-,'-,AREL1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,14:74663532
rs10149470-<b>G</b>,1 x 10-10,,NR,1.0309278,'-,'-,"RNU7-160P, BAG5",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,14:103551616
rs10913112-<b>C</b>,1 x 10-10,,NR,1.0309278,'-,'-,"RPS29P5, COP1",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:175944692
rs116755193-<b>C</b>,1 x 10-10,,NR,1.0309278,'-,'-,LINC02240,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:124916190
rs145410455-<b>G</b>,7 x 10-18,,NR,1.0638298,'-,'-,"LINC00533, RPSAP2",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,6:28706221
rs58235352-<b>G</b>,2 x 10-10,,NR,1.0526316,'-,'-,"ACADS, SPPL3",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,12:120748443
rs2514218-<b>C</b>,3 x 10-10,,NR,1.0309278,'-,'-,DRD2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:113522272
rs7531118-<b>C</b>,1 x 10-16,,NR,1.0416667,'-,'-,RPL31P12,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:72371556
rs10959753-<b>C</b>,1 x 10-13,,NR,1.0416667,'-,'-,'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:11379630
rs61867293-<b>C</b>,6 x 10-12,,NR,1.0416667,'-,'-,SORCS3,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,10:104804166
rs4261101-<b>G</b>,2 x 10-8,,NR,1.0309278,'-,'-,RNU6-695P,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:90330495
rs55993664-<b>C</b>,2 x 10-8,,NR,1.0309278,'-,'-,PSMC1P5,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:107267781
rs1933802-<b>G</b>,1 x 10-8,,NR,1.0204082,'-,'-,LIN28B-AS1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,6:104918016
rs10818400-<b>G</b>,1 x 10-8,,NR,1.0204082,'-,'-,LINC01613,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:119902190
rs915057-<b>G</b>,2 x 10-8,,NR,1.0204082,'-,'-,"ESR2, SYNE2",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,14:64219489
rs10792422-<b>G</b>,2 x 10-8,,NR,1.0204082,'-,'-,MARK2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:63865201
rs1504721-<b>C</b>,2 x 10-8,,NR,1.0204082,'-,'-,CNTN5,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:99397886
rs12552-<b>A</b>,1 x 10-23,,NR,1.04,'-,[1.03-1.05],OLFM4,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,13:53051646
rs1002656-<b>C</b>,3 x 10-11,,NR,1.0309278,'-,'-,"GRIK3, FTLP18",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:36727140
rs12958048-<b>A</b>,5 x 10-14,,NR,1.04,'-,[1.03-1.05],TCF4,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,18:55434367
rs2179744-<b>A</b>,4 x 10-12,,NR,1.03,'-,[1.02-1.04],"L3MBTL2-AS1, L3MBTL2",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,22:41225710
rs11643192-<b>A</b>,1 x 10-11,,NR,1.03,'-,[1.02-1.04],"LINC01572, PMFBP1",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,16:72180377
rs79879286-<b>C</b>,2 x 10-11,,NR,1.04,'-,[1.03-1.05],"GSDME, OSBPL3",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,7:24786970
rs7403810-<b>T</b>,8 x 10-11,,NR,1.03,'-,[1.02-1.04],'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,16:13656400
rs11663393-<b>A</b>,2 x 10-10,,NR,1.03,'-,[1.02-1.04],DCC,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,18:53088362
rs447801-<b>T</b>,2 x 10-10,,NR,1.03,'-,[1.02-1.04],MEF2C-AS2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:88706836
rs75581564-<b>A</b>,2 x 10-10,,NR,1.04,'-,[1.03-1.05],PIPOX,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,17:29036732
rs11077206-<b>C</b>,5 x 10-10,,NR,1.03,'-,[1.02-1.04],RBFOX1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,16:7617330
rs1806153-<b>T</b>,3 x 10-9,,NR,1.03,'-,[1.02-1.04],PAUPAR,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:31828558
rs71639293-<b>A</b>,6 x 10-9,,NR,1.03,'-,[1.02-1.04],FAM172A,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,5:93659307
rs58104186-<b>A</b>,7 x 10-9,,NR,1.03,'-,[1.02-1.04],'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,7:109459862
rs10759881-<b>A</b>,9 x 10-9,,NR,1.03,'-,[1.02-1.04],ASTN2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:116971101
rs4534926-<b>C</b>,9 x 10-9,,NR,1.03,'-,[1.02-1.04],"NOL4, ASXL3",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,18:33769108
rs11137850-<b>A</b>,1 x 10-8,,NR,1.03,'-,[1.02-1.04],MTND2P8,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:78798498
rs1226412-<b>T</b>,1 x 10-8,,NR,1.03,'-,[1.02-1.04],LINC01876,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,2:156254801
rs143864773-<b>T</b>,2 x 10-8,,NR,1.04,'-,[1.02-1.06],CCDC73,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,11:32744320
rs34866621-<b>T</b>,2 x 10-8,,NR,1.03,'-,[1.02-1.04],PCLO,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,7:82884773
rs7029033-<b>T</b>,3 x 10-8,,NR,1.04,'-,[1.02-1.06],DENND1A,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:123919789
rs769087-<b>A</b>,3 x 10-8,,NR,1.03,'-,[1.02-1.04],CACNA1C,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,12:2235478
rs33431-<b>T</b>,4 x 10-8,,NR,1.02,'-,[1.01-1.03],ZNF536,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,19:30449082
rs1833288-<b>A</b>,5 x 10-8,,NR,1.03,'-,[1.02-1.04],RAB27B,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,18:54850675
rs1331012-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,WASF3,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,13:26541287
rs420628-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,"GGNBP1, LINC00336",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,6:33588251
rs2388840-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,"MIR548AI, BDH2P1",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,6:99150880
rs4147207-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,"RNU4ATAC8P, RNA5SP50",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:73785442
rs9427672-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,DENND1B,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:197785611
rs7649917-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ATP13A4,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,3:193571760
rs6471081-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,LINC00534,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,8:90451197
rs2149351-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,TLR4,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:117739366
rs41278104-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,EMILIN3,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,20:41362060
rs9869821-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,TCAIM,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,3:44351644
rs6842422-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,SPCS3,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,4:176425164
rs13251959-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,PXDNL,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,8:51674515
rs1354115-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,CARM1P1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:2983774
rs17229439-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,ARHGAP15,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,2:143338665
rs301799-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,"RERE, RERE-AS1",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:8429242
rs2332571-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,CACNA1E,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,1:181656566
rs9365760-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,6:164708845
rs7962128-<b>A</b>,4 x 10-8,,NR,1.02,'-,[1.01-1.03],KDM2B,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,12:121469533
rs7288411-<b>A</b>,4 x 10-8,,NR,1.03,'-,[1.02-1.04],NFAM1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,22:42419352
rs11140773-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,NTRK2,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,9:84829143
rs1956351-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,RTN1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST010416,14:59674825
rs835436-<b>T</b>,3 x 10-6,,'-,'-,0.243 unit decrease,[0.14-0.34],FGGY,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,1:59374380
rs113067418-<b>A</b>,8 x 10-6,,'-,'-,0.913 unit decrease,[0.51-1.31],"CASP3P1, LINC01788",Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,1:70690888
rs1323097-<b>T</b>,4 x 10-6,,'-,'-,0.257 unit increase,[0.15-0.37],MGC27382,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,1:78236428
rs3754450-<b>T</b>,3 x 10-6,,'-,'-,0.244 unit increase,[0.14-0.35],"GSTM4, RPL7P8",Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,1:109654510
rs17498753-<b>A</b>,5 x 10-6,,'-,'-,0.328 unit increase,[0.19-0.47],CAMKMT,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,2:44420692
rs4904644-<b>A</b>,2 x 10-6,,'-,'-,0.245 unit decrease,[0.14-0.35],"PSMC1, KCNK13",Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,14:90199345
rs582066-<b>A</b>,6 x 10-6,,'-,'-,0.328 unit increase,[0.19-0.47],RANP7,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,3:22827865
rs7646282-<b>T</b>,4 x 10-6,,'-,'-,0.448 unit decrease,[0.26-0.64],ZBTB20,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,3:114883493
rs139459337-<b>T</b>,8 x 10-7,,'-,'-,0.49 unit increase,[0.29-0.69],ZBTB20,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,3:114997018
rs17756220-<b>A</b>,2 x 10-6,,'-,'-,0.469 unit decrease,[0.27-0.66],EIF4E2P2,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,3:115270438
rs7190761-<b>A</b>,6 x 10-6,,'-,'-,0.307 unit decrease,[0.17-0.44],PDPR,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,16:82329628
rs55685444-<b>C</b>,2 x 10-6,,'-,'-,0.278 unit decrease,[0.16-0.39],"TARS1, TOMM40P3",Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,5:33470746
rs77826363-<b>T</b>,1 x 10-6,,'-,'-,0.759 unit increase,[0.45-1.06],LINC01622,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,6:1128802
rs9364726-<b>A</b>,1 x 10-6,,'-,'-,0.567 unit decrease,[0.34-0.79],'-,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,6:164236705
rs190675597-<b>A</b>,6 x 10-6,,'-,'-,0.7 unit increase,[0.4-1],DGKB,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,7:14648124
rs2835473-<b>A</b>,4 x 10-6,,'-,'-,0.288 unit decrease,[0.16-0.41],HLCS,Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,21:36823805
rs2646392-<b>A</b>,2 x 10-6,,'-,'-,0.239 unit decrease,[0.14-0.34],"CHCHD3P1, KRT8P37",Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,10:8523138
rs61852182-<b>T</b>,6 x 10-6,,'-,'-,0.351 unit decrease,[0.2-0.5],"PSAP, CHST3",Seasonality and depression,"unipolar depression, seasonality measurement, bipolar disorder",GCST007102,10:71878300
rs4619651-<b>?</b>,4 x 10-8,,NR,'-,0.0151 unit decrease,NR,"LMAN2L, CNNM4",Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,2:96750416
rs9834970-<b>?</b>,2 x 10-12,,NR,'-,0.0194 unit increase,NR,"LINC02033, HSPD1P6",Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,3:36814539
rs11724116-<b>?</b>,1 x 10-8,,NR,'-,0.0157 unit decrease,NR,FSTL5,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,4:161372886
rs4447398-<b>?</b>,2 x 10-8,,NR,'-,0.0154 unit decrease,NR,STARD9,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,15:42612706
rs111444407-<b>?</b>,3 x 10-10,,NR,'-,0.0174 unit increase,NR,NCAN,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,19:19247398
rs11908600-<b>?</b>,4 x 10-8,,NR,'-,0.0151 unit decrease,NR,STK4,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,20:45004777
rs28565152-<b>?</b>,3 x 10-8,,NR,'-,0.0153 unit increase,NR,ADCY2,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,5:7542798
rs12538191-<b>?</b>,2 x 10-8,,NR,'-,0.0154 unit decrease,NR,"MYO1G, PURB",Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,7:44941225
rs1024432-<b>?</b>,7 x 10-9,,NR,'-,0.0159 unit decrease,NR,CTTNBP2,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,7:117939275
rs12275195-<b>?</b>,7 x 10-9,,NR,'-,0.016 unit increase,NR,TENM4,Bipolar disorder vs major depressive disorder (ordinary least squares (OLS)),"unipolar depression, bipolar disorder",GCST90016607,11:79394755
rs10097555-<b>A</b>,5 x 10-6,(additive model),'-,2.5,'-,[1.67-3.7],NRG1,Obstructive sleep apnea,obstructive sleep apnea,GCST003012,8:32488779
rs10777373-<b>?</b>,5 x 10-6,(dominant model),'-,2.3809524,'-,[1.64-3.45],LINC01619,Obstructive sleep apnea,obstructive sleep apnea,GCST003012,12:92014509
rs17552189-<b>?</b>,4 x 10-6,,NR,1.4,'-,[1.21-1.61],LINC01122,Cannabis dependence,cannabis dependence,GCST000861,2:58845834
rs12491921-<b>?</b>,1 x 10-6,,NR,1.39,'-,[1.22-1.58],LINC00882,Cannabis dependence,cannabis dependence,GCST000861,3:106570103
rs12811699-<b>?</b>,8 x 10-6,,NR,1.74,'-,[1.36-2.21],CHST11,Cannabis dependence,cannabis dependence,GCST000861,12:104623386
rs1431318-<b>?</b>,9 x 10-7,,NR,1.41,'-,[1.23-1.62],ANKFN1,Cannabis dependence,cannabis dependence,GCST000861,17:56115162
rs9507041-<b>?</b>,8 x 10-6,,NR,1.55,'-,[1.28-1.88],LINC00362,Cannabis dependence,cannabis dependence,GCST000861,13:23170240
rs1019238-<b>?</b>,6 x 10-7,,NR,1.45,'-,[1.25-1.68],ANKFN1,Cannabis dependence,cannabis dependence,GCST000861,17:56201354
rs8065311-<b>?</b>,2 x 10-6,,NR,1.43,'-,[1.23-1.66],ANKFN1,Cannabis dependence,cannabis dependence,GCST000861,17:56125999
rs28372448-<b>?</b>,8 x 10-6,,NR,1.68,'-,[1.34-2.11],"PIM3, CRELD2",Cannabis dependence,cannabis dependence,GCST000861,22:49957323
rs9427573-<b>?</b>,5 x 10-6,,NR,2.56,'-,[1.71-3.82],UCHL5,Cannabis dependence,cannabis dependence,GCST000861,1:193026083
rs11007350-<b>?</b>,3 x 10-6,,NR,1.37,'-,[1.20-1.56],LINC01517,Cannabis dependence,cannabis dependence,GCST000861,10:29000102
rs34071003-<b>?</b>,4 x 10-6,,NR,1.328,'-,[1.1789-1.4980],"PDCD1, NEU4",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST011662,2:241837710
rs58475214-<b>?</b>,5 x 10-6,,NR,1.393,'-,[1.2090-1.6060],"CPOX, WWP1P1",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST011662,3:98635818
rs3908007-<b>?</b>,4 x 10-6,,NR,0.7397,'-,[0.6511-0.8475],RPS14P7,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST011662,4:160738233
rs10942340-<b>?</b>,9 x 10-6,,NR,1.322,'-,[1.1690-1.4960],"EDIL3, ZP3P1",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST011662,5:83937200
rs17882041-<b>?</b>,1 x 10-6,,NR,0.6593,'-,[0.5568-0.7807],"MMP7, TMEM123",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST011662,11:102519612
rs932831-<b>?</b>,7 x 10-6,,NR,1.346,'-,[1.1830-1.5310],LINC00598,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST011662,13:40251245
rs62171220-<b>G</b>,4 x 10-6,,0.1064,'-,2.71275 unit increase,[1.55-3.87],THSD7B,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,2:137045285
rs2067390-<b>A</b>,6 x 10-6,,0.0382,'-,4.74017 unit increase,[2.68-6.8],INPP1,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,2:190344302
rs144891322-<b>C</b>,5 x 10-6,,0.0214,'-,6.09914 unit increase,[3.48-8.72],RPS2P25,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,5:85839569
rs11529293-<b>T</b>,3 x 10-6,,0.1184,'-,2.71476 unit decrease,[1.57-3.86],ATG13,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,11:36833838
rs7480166-<b>A</b>,4 x 10-6,,0.4038,'-,1.86279 unit decrease,[1.07-2.66],'-,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,11:42963203
rs72660056-<b>A</b>,4 x 10-6,,0.06823,'-,3.29105 unit decrease,[1.89-4.69],ATP11A,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,13:112853229
rs11857349-<b>G</b>,3 x 10-6,,0.05841,'-,4.57624 unit decrease,[2.64-6.51],LRRC28,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,15:99384652
rs8141510-<b>T</b>,4 x 10-6,,0.4254,'-,1.82703 unit increase,[1.05-2.6],NFAM1,Machado-Joseph disease (age at onset),"Machado-Joseph disease, age at onset",GCST010248,22:42425179
rs1232027-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,LINC01337,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,5:80619201
rs73786719-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,ADGB,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,6:146716848
rs114688092-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,KIF9,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,3:47274048
rs79029191-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,PTPRM,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,18:8053865
rs932428-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"ATG3P1, LINC01734",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,20:39248129
rs114643193-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,ADD1,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,4:2868202
rs6882169-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"TENM2, CTB-178M22.2",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,5:168241225
rs80260687-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,PTDSS1,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,8:96292461
rs28406206-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,BRF1,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,14:105221745
rs4736525-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,EFR3A,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,8:131971460
rs78621558-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,MSH3,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,5:80716916
rs72715653-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"LINC01098, LINC01099",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,4:177805806
rs4720024-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"MINDY4, AQP1",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,7:30901640
rs117933444-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,RNASET2,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,6:166949385
rs116220136-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"PRDM9, Y_RNA",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,5:23353146
rs8031584-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,"TRPM1, MTMR10",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,15:30995140
rs3013648-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,'-,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,13:84755019
rs11197481-<b>G</b>,9 x 10-6,,0.176,'-,0.193 unit increase,[0.12-0.27],'-,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,Mapping not available
rs117440785-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,"ST8SIA6, PRPF38AP2",Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,10:17483962
rs3889139-<b>?</b>,2 x 10-6,,NR,'-,2.795 unit increase,[1.65-3.94],OR10A2,Huntington's disease progression,"Huntington disease, disease progression measurement",GCST004691,11:6864198
rs12668183-<b>C</b>,2 x 10-8,(Hispanic),0.277,'-,2.8 years decrease,[NR],CRPPA,Huntington's disease (age at onset),"Huntington disease, age at onset",GCST007113,7:16455781
rs150393409-<b>A</b>,2 x 10-20,(EA),0.0014,'-,6.4 years decrease,[NR],FAN1,Huntington's disease (age at onset),"Huntington disease, age at onset",GCST007113,15:30910758
"rs4851870-<b>C</b>, rs12043259-<b>A</b>, rs6747023-<b>G</b>, rs7589342-<b>T</b>, rs2377339-<b>G</b>, rs7589561-<b>T</b>, rs1465641-<b>A</b>, rs1465639-<b>G</b>, rs2163349-<b>T</b>, rs12995849-<b>T</b>, rs12995333-<b>T</b>, rs6741172-<b>A</b>, rs2163350-<b>C</b>, rs4851095-<b>C</b>",2 x 10-11,(Opiates),NR,'-,'-,'-,NCK2; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Addiction,drug dependence,GCST001880,2:105820800
rs10988217-<b>G</b>,8 x 10-9,,0.244,2.63,'-,[1.88-3.69],PTPA,Hypersomnia (HLA-DQB1*06:02 negative),hypersomnia,GCST007191,9:129125837
chr14:22325242-<b>?</b>,3 x 10-7,,NR,1.48,'-,'-,'-,Insomnia,insomnia,GCST005566,Mapping not available
rs10012282-<b>C</b>,7 x 10-7,(Hispanic),NR,2.857143,'-,'-,WDR17,Insomnia,insomnia,GCST005566,4:176155096
rs73578849-<b>G</b>,3 x 10-7,(AA),NR,1.724138,'-,'-,"ZNF616, ZNF841",Insomnia,insomnia,GCST005566,19:52101049
rs6906656-<b>A</b>,1 x 10-7,(Hispanic),NR,1.57,'-,'-,"TDGF1P4, FAM50B",Insomnia,insomnia,GCST005566,6:3919326
rs35796756-<b>A</b>,8 x 10-7,(Hispanic),NR,2.89,'-,'-,DELEC1,Insomnia,insomnia,GCST005566,9:115355120
chr2:5693308-<b>?</b>,1 x 10-6,,NR,1.6666665,'-,'-,'-,Insomnia,insomnia,GCST005566,Mapping not available
rs74081827-<b>A</b>,7 x 10-7,(EA),NR,1.66,'-,'-,ANO6,Insomnia,insomnia,GCST005566,12:45439972
rs185334926-<b>T</b>,5 x 10-7,(AA),NR,4.38,'-,'-,CACNA1D,Insomnia,insomnia,GCST005566,3:53733862
rs34670506-<b>C</b>,2 x 10-8,(AA),NR,2.7027025,'-,'-,'-,Insomnia,insomnia,GCST005566,16:7905132
rs72699704-<b>A</b>,2 x 10-7,(Hispanic),NR,1.67,'-,'-,ENPP6,Insomnia,insomnia,GCST005566,4:184162053
chr5:119118370-<b>?</b>,3 x 10-7,(EA),NR,1.2195122,'-,'-,'-,Insomnia,insomnia,GCST005566,Mapping not available
rs56676520-<b>A</b>,9 x 10-7,(EA),NR,1.5,'-,'-,"RNA5SP167, IQCM",Insomnia,insomnia,GCST005566,4:149900958
rs76941679-<b>G</b>,3 x 10-7,(AA),NR,2.2727273,'-,'-,'-,Insomnia,insomnia,GCST005566,18:73885569
chr4:142518082-<b>?</b>,9 x 10-7,,NR,2.88,'-,'-,'-,Insomnia,insomnia,GCST005566,Mapping not available
rs148431766-<b>C</b>,2 x 10-7,(AA),NR,2.0833335,'-,'-,'-,Insomnia,insomnia,GCST005566,14:39899882
rs55710816-<b>G</b>,9 x 10-7,(EA),NR,1.4285715,'-,'-,'-,Insomnia,insomnia,GCST005566,4:60483414
rs147549871-<b>G</b>,5 x 10-9,(EA),NR,1.8518518,'-,'-,MTND4P3,Insomnia,insomnia,GCST005566,7:68334613
rs111858442-<b>G</b>,4 x 10-7,,NR,2.2727273,'-,'-,"ADH1A, RNU6-578P",Insomnia,insomnia,GCST005566,4:12350898
rs13013037-<b>A</b>,7 x 10-7,(Hispanic),NR,1.68,'-,'-,'-,Insomnia,insomnia,GCST005566,2:128986770
rs60353720-<b>A</b>,3 x 10-6,,NR,1.1717,'-,'-,'-,Insomnia,insomnia,GCST005566,7:68450298
rs1687657-<b>T</b>,3 x 10-7,(Hispanic),NR,2.34,'-,'-,"LINC00917, FENDRR",Insomnia,insomnia,GCST005566,16:86386755
rs58777020-<b>T</b>,6 x 10-7,,NR,2.84,'-,'-,LINC00989,Insomnia,insomnia,GCST005566,4:79513892
rs76049381-<b>C</b>,3 x 10-7,,NR,1.23,'-,'-,"MIR548Y, MDGA2",Insomnia,insomnia,GCST005566,14:47680311
rs7138947-<b>A</b>,2 x 10-8,(AA),NR,3.15,'-,'-,NTF3,Insomnia,insomnia,GCST005566,12:5509782
chr13:67376132-<b>?</b>,7 x 10-7,(EA),NR,1.99,'-,'-,'-,Insomnia,insomnia,GCST005566,Mapping not available
rs7003908-<b>C</b>,5 x 10-7,(AA),NR,1.5625,'-,'-,PRKDC,Insomnia,insomnia,GCST005566,8:47858141
rs7855172-<b>G</b>,1 x 10-7,(EA),NR,1.3888888,'-,'-,RFX3,Insomnia,insomnia,GCST005566,9:3245127
rs190721506-<b>C</b>,7 x 10-7,(AA),NR,5.5555553,'-,'-,ANXA10,Insomnia,insomnia,GCST005566,4:168005343
rs2725544-<b>C</b>,2 x 10-6,,0.23,'-,0.12 unit decrease,[0.061-0.179],"FBN1, CEP152",Insomnia,"insomnia, insomnia measurement",GCST002052,15:48700700
rs12471454-<b>T</b>,6 x 10-6,,0.41,'-,0.1 unit decrease,[0.061-0.139],RNU7-147P,Insomnia,"insomnia, insomnia measurement",GCST002052,2:199149760
rs12350534-<b>T</b>,4 x 10-6,,NR,'-,0.0447 unit increase,[NR],GAS1,White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy,"CADASIL, white matter hyperintensity measurement",GCST002377,9:86943149
rs12542166-<b>C</b>,6 x 10-6,,NR,'-,0.1056 unit increase,[NR],HAS2-AS1,White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy,"CADASIL, white matter hyperintensity measurement",GCST002377,8:121970599
rs271674-<b>T</b>,6 x 10-6,,NR,'-,0.0267 unit increase,[NR],"RNU6-1313P, TAC4",White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy,"CADASIL, white matter hyperintensity measurement",GCST002377,17:49901622
rs1014137-<b>C</b>,8 x 10-6,,NR,'-,0.0241 unit increase,[NR],ITPRID1,White matter hyperintensity volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy,"CADASIL, white matter hyperintensity measurement",GCST002377,7:31584132
rs75928006-<b>?</b>,9 x 10-8,,NR,2.58,'-,[1.86-3.60],"RNU6-751P, MIR522",Bipolar disorder (early vs late onset),bipolar I disorder,GCST011908,19:53751134
rs11127876-<b>?</b>,5 x 10-8,,NR,2.39,'-,[1.73-3.31],CADM2,Bipolar disorder (early vs late onset),bipolar I disorder,GCST011908,3:85075546
rs7914868-<b>?</b>,7 x 10-7,,NR,2.1,'-,[1.59-2.76],CUBN,Bipolar disorder (early vs late onset),bipolar I disorder,GCST011908,10:16931723
rs10106565-<b>?</b>,1 x 10-7,,NR,2.31,'-,[1.68-3.16],"RPL10P19, ERI1",Bipolar disorder (early vs late onset),bipolar I disorder,GCST011908,8:8997522
rs11265461-<b>C</b>,2 x 10-7,,0.41,1.45,'-,[1.26-1.67],"SLAMF1, SETP9",Schizophrenia (treatment resistant),treatment refractory schizophrenia,GCST001458,1:160660353
rs230529-<b>T</b>,2 x 10-7,,0.47,1.45,'-,[1.26-1.66],NFKB1,Schizophrenia (treatment resistant),treatment refractory schizophrenia,GCST001458,4:102536261
rs2814778-<b>C</b>,4 x 10-21,,0.8838,'-,0.856 unit decrease,[0.68-1.03],"ACKR1, CADM3-AS1",Neutrophil level response to clozapine in treatment-resistant schizophrenia,"neutrophil count, treatment refractory schizophrenia, response to clozapine",GCST006987,1:159204893
rs77198048-<b>T</b>,9 x 10-9,,0.107,'-,1.625 unit increase,[1.07-2.18],ZNF618,Neutrophil level response to clozapine in treatment-resistant schizophrenia,"neutrophil count, treatment refractory schizophrenia, response to clozapine",GCST006987,9:114026974
rs3117099-<b>?</b>,3 x 10-6,,NR,1.25,'-,[NR],TSBP1-AS1,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,6:32390493
rs17746001-<b>T</b>,3 x 10-7,,NR,1.75,'-,[NR],'-,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,4:179734472
rs17746001-<b>?</b>,3 x 10-7,,NR,1.75,'-,[NR],'-,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,4:179734472
rs886424-<b>?</b>,9 x 10-7,,NR,1.37,'-,[NR],LINC00243,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,6:30814225
rs2054399-<b>?</b>,1 x 10-6,,NR,1.22,'-,[NR],"KCNMB2-AS1, KCNMB2",Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,3:178623794
rs821470-<b>A</b>,3 x 10-6,,NR,1.25,'-,[NR],NLRC5,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,16:57024670
rs1484642-<b>C</b>,3 x 10-6,,NR,1.43,'-,[NR],MSRA,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,8:10129145
rs181500-<b>T</b>,5 x 10-6,,NR,1.24,'-,[NR],"PDZD8, EMX2OS",Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,10:117422360
rs4262150-<b>?</b>,7 x 10-6,,NR,1.22,'-,[NR],LINC01470,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,5:152908893
rs253959-<b>T</b>,8 x 10-6,,NR,1.21,'-,[NR],COMMD10,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,5:116233060
rs2058710-<b>A</b>,9 x 10-6,,NR,1.24,'-,[NR],GPR1-AS,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,2:206257058
rs2524005-<b>?</b>,5 x 10-7,,NR,1.32,'-,[NR],"HLA-K, HLA-U",Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,6:29931900
rs7872515-<b>?</b>,6 x 10-7,,NR,1.39,'-,[NR],SPTLC1,Bipolar disorder and schizophrenia,"schizophrenia, bipolar disorder",GCST001567,9:92060258
rs2660304-<b>?</b>,2 x 10-9,,NR,'-,0.0141 unit increase,NR,MIR137HG,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,1:98046571
rs6701877-<b>?</b>,6 x 10-10,,NR,'-,0.0146 unit decrease,NR,"LINC02776, RPL30P1",Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,1:174046121
rs9866687-<b>?</b>,4 x 10-8,,NR,'-,0.013 unit increase,NR,LINC00879,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,3:95109346
rs1278493-<b>?</b>,1 x 10-8,,NR,'-,0.0135 unit increase,NR,PPP2R3A,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,3:136095167
rs7790864-<b>?</b>,2 x 10-8,,NR,'-,0.0132 unit increase,NR,CREB5,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,7:28439006
rs11778040-<b>?</b>,5 x 10-8,,NR,'-,0.0129 unit decrease,NR,GULOP,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,8:27562290
rs12554512-<b>?</b>,4 x 10-8,,NR,'-,0.013 unit decrease,NR,'-,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,9:23352295
rs3764002-<b>?</b>,6 x 10-11,,NR,'-,0.0155 unit increase,NR,WSCD2,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,12:108224853
rs28637922-<b>?</b>,8 x 10-12,,NR,'-,0.0162 unit decrease,NR,ANAPC7,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,12:110381334
rs9319540-<b>?</b>,4 x 10-8,,NR,'-,0.013 unit increase,NR,'-,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,16:79424125
rs1054972-<b>?</b>,2 x 10-8,,NR,'-,0.0133 unit decrease,NR,KLF16,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,19:1852583
rs11696888-<b>?</b>,1 x 10-9,,NR,'-,0.0143 unit decrease,NR,STAU1,Schizophrenia vs bipolar disorder (ordinary least squares (OLS)),"schizophrenia, bipolar disorder",GCST90016621,20:49136728
rs1256531-<b>G</b>,4 x 10-6,,0.234,'-,0.09 unit increase,[NR],PTBP1P,Conduct disorder (symptom count),conduct disorder,GCST000713,14:65281041
rs16831128-<b>G</b>,5 x 10-6,,0.189,'-,0.08 unit increase,[NR],"RNU6-175P, FAM201B",Conduct disorder (symptom count),conduct disorder,GCST000713,2:132386819
rs8179116-<b>A</b>,3 x 10-6,,0.021,'-,0.23 unit increase,[NR],SELPLG,Conduct disorder (symptom count),conduct disorder,GCST000713,12:108631651
rs4434872-<b>T</b>,8 x 10-6,,0.263,'-,0.08 unit increase,[NR],GATAD2B,Conduct disorder (symptom count),conduct disorder,GCST000713,1:153801800
rs11838918-<b>C</b>,1 x 10-8,,0.022,'-,0.28 unit increase,[NR],LINC00331,Conduct disorder (symptom count),conduct disorder,GCST000713,13:78836439
rs12302829-<b>G</b>,8 x 10-6,,0.008,'-,0.35 unit decrease,[NR],KCNA5,Conduct disorder (symptom count),conduct disorder,GCST000713,12:5031318
rs4792394-<b>C</b>,9 x 10-6,,0.469,'-,0.06 unit decrease,[NR],COX10-AS1,Conduct disorder (symptom count),conduct disorder,GCST000713,17:13781600
rs16891867-<b>G</b>,3 x 10-9,,0.097,'-,0.15 unit increase,[NR],"C1QTNF7-AS1, C1QTNF7",Conduct disorder (symptom count),conduct disorder,GCST000713,4:15395740
rs7762160-<b>C</b>,1 x 10-6,,0.365,'-,0.07 unit increase,[NR],PDE10A,Conduct disorder (symptom count),conduct disorder,GCST000713,6:165601943
rs6031252-<b>A</b>,6 x 10-6,,0.142,'-,0.11 unit decrease,[NR],TOX2,Conduct disorder (symptom count),conduct disorder,GCST000713,20:43945182
rs3136202-<b>A</b>,6 x 10-6,,0.429,'-,0.07 unit decrease,[NR],ERCC4,Conduct disorder (symptom count),conduct disorder,GCST000713,16:13944317
rs7950811-<b>A</b>,1 x 10-8,,0.071,'-,0.16 unit increase,[NR],"SNRPGP16, LINC02746",Conduct disorder (symptom count),conduct disorder,GCST000713,11:92917836
rs2122554-<b>A</b>,3 x 10-6,,0.162,'-,0.1 unit decrease,[NR],'-,Conduct disorder (symptom count),conduct disorder,GCST000713,5:166530081
rs6750486-<b>T</b>,6 x 10-6,,0.126,'-,0.1 unit increase,[NR],SMIM7P1,Conduct disorder (symptom count),conduct disorder,GCST000713,2:35301852
rs16891867-<b>G</b>,4 x 10-6,(AA),0.218,'-,0.148 unit increase,[NR],"C1QTNF7-AS1, C1QTNF7",Conduct disorder (symptom count),conduct disorder,GCST000713,4:15395740
rs11838918-<b>C</b>,3 x 10-7,(AA),0.066,'-,0.278 unit increase,[NR],LINC00331,Conduct disorder (symptom count),conduct disorder,GCST000713,13:78836439
rs13398848-<b>G</b>,1 x 10-6,(AA),0.181,'-,0.168 unit increase,[NR],CRLF3P3,Conduct disorder (symptom count),conduct disorder,GCST000713,2:84018044
rs10776612-<b>T</b>,2 x 10-6,,0.519,1.33,'-,[1.18-1.49],ARHGAP22,Conduct disorder,conduct disorder,GCST000714,10:48527518
rs2184898-<b>A</b>,3 x 10-6,,0.327,1.33,'-,[1.18-1.50],LINC02674,Conduct disorder,conduct disorder,GCST000714,10:117658593
rs2720508-<b>C</b>,7 x 10-6,,0.907,1.61,'-,[1.31-1.97],"SLC7A2, ADAM24P",Conduct disorder,conduct disorder,GCST000714,8:17472318
rs1861046-<b>A</b>,6 x 10-8,,0.095,1.65,'-,[1.38-1.98],"C1QTNF7, C1QTNF7-AS1",Conduct disorder,conduct disorder,GCST000714,4:15396282
rs7581919-<b>C</b>,8 x 10-6,,0.041,1.85,'-,[1.41-2.43],NBAS,Conduct disorder,conduct disorder,GCST000714,2:15524632
rs11838918-<b>C</b>,3 x 10-6,,0.022,2.26,'-,[1.61-3.18],LINC00331,Conduct disorder,conduct disorder,GCST000714,13:78836439
rs16831128-<b>G</b>,4 x 10-7,,0.189,1.45,'-,[1.26-1.67],"RNU6-175P, FAM201B",Conduct disorder,conduct disorder,GCST000714,2:132386819
rs1550057-<b>C</b>,4 x 10-6,,0.757,1.39,'-,[1.21-1.61],RNF150,Conduct disorder,conduct disorder,GCST000714,4:141196270
rs1861050-<b>T</b>,8 x 10-6,,0.063,1.63,'-,[1.31-2.01],CC2D2A,Conduct disorder,conduct disorder,GCST000714,4:15480736
rs17007017-<b>G</b>,7 x 10-6,,0.685,1.34,'-,[1.18-1.52],ZNF330,Conduct disorder,conduct disorder,GCST000714,4:141221575
rs7950811-<b>A</b>,9 x 10-7,,0.071,1.65,'-,[1.35-2.00],"SNRPGP16, LINC02746",Conduct disorder,conduct disorder,GCST000714,11:92917836
rs13398848-<b>G</b>,5 x 10-6,,0.074,1.59,'-,[1.30-1.95],CRLF3P3,Conduct disorder,conduct disorder,GCST000714,2:84018044
rs78310016-<b>G</b>,4 x 10-8,,0.0726,'-,1.052 unit increase,NR,"PRELID3BP7, PRELID3BP6",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,5:42949533
rs57818938-<b>T</b>,1 x 10-6,,0.0611,'-,0.9321 unit increase,NR,"EBF1, Y_RNA",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,5:2277955
rs10278819-<b>C</b>,2 x 10-6,,0.1023,'-,0.873 unit increase,NR,TMBIM7P,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,7:92428006
rs7024062-<b>A</b>,2 x 10-6,,0.1931,'-,0.5885 unit decrease,NR,TJP2,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,9:69130157
rs10070777-<b>A</b>,4 x 10-6,,0.0743,'-,0.8786 unit increase,NR,TMEM161B,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,5:88128948
rs13230004-<b>A</b>,4 x 10-6,,0.2724,'-,0.5336 unit increase,NR,SLC29A4,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,7:5305719
rs1048163-<b>G</b>,5 x 10-6,,0.3383,'-,0.4495 unit increase,NR,"BUB1B-PAK6, C15orf56, PAK6",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,15:40251022
rs927899-<b>C</b>,9 x 10-6,,NR,'-,0.7423 unit increase,NR,"TNNI1, PHLDA3",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,1:201459425
rs2129108-<b>A</b>,8 x 10-6,,NR,'-,0.7948 unit increase,NR,TTN,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,2:178810202
rs9836481-<b>A</b>,8 x 10-6,,NR,'-,0.9768 unit increase,NR,MRPS31P1,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,3:41148232
rs41501-<b>A</b>,8 x 10-6,,NR,'-,0.5127 unit increase,NR,"LINC02112, TAS2R1",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,5:9663747
rs28800-<b>A</b>,5 x 10-6,,NR,'-,0.5223 unit increase,NR,"LINC02112, TAS2R1",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,5:9666433
rs28716841-<b>C</b>,9 x 10-6,,NR,'-,0.8716 unit increase,NR,FSTL4,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,5:133397775
rs11979775-<b>C</b>,5 x 10-6,,NR,'-,0.5007 unit increase,NR,SLC29A4,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,7:5302782
rs112045010-<b>C</b>,5 x 10-6,,NR,'-,0.9056 unit increase,NR,C12orf56,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,12:64331934
rs17834779-<b>A</b>,7 x 10-6,,NR,'-,0.4471 unit increase,NR,"KCNH5, ATP5F1AP4",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,14:62656081
rs1048164-<b>A</b>,9 x 10-6,,NR,'-,0.4365 unit increase,NR,"C15orf56, PAK6, BUB1B-PAK6",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,15:40250903
rs76356591-<b>T</b>,6 x 10-6,,NR,'-,0.5878 unit increase,NR,"SRL, ADCY9",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,16:4137064
rs17546654-<b>A</b>,7 x 10-6,,NR,'-,0.5526 unit increase,NR,"GFAP, KIF18B",Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,17:44917727
rs8092589-<b>A</b>,9 x 10-6,,NR,'-,0.4724 unit increase,NR,SLC14A2,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,18:45649289
rs10426669-<b>G</b>,6 x 10-6,,NR,'-,0.7649 unit increase,NR,SEMA6B,Weight gain in amisulpride-treated first-episode psychosis,"psychosis, longitudinal BMI measurement, response to amisulpride",GCST010007,19:4564769
nsv831124-<b>?</b>,3 x 10-6,,0.54,1.4285715,'-,'-,'-,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,Mapping not available
nsv527355-<b>A</b>,5 x 10-6,,0.47,1.44,'-,[1.28-1.6],'-,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,Mapping not available
rs242999-<b>C</b>,1 x 10-6,,0.39,1.85,'-,[1.44-2.37],LINC01643,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,22:34109914
rs73837957-<b>A</b>,2 x 10-6,,0.15,2.73,'-,[1.81-4.11],CCSER1,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,4:91682958
rs9895559-<b>A</b>,2 x 10-6,,0.45,1.85,'-,[1.43-2.38],"SLC13A5, RPL23AP73",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,17:6732054
rs80080484-<b>?</b>,4 x 10-6,,0.97,5.882353,'-,[2.7-12.5],"LARP7P3, LINC01910",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,18:70403190
rs12745534-<b>?</b>,5 x 10-6,,0.87,2.2222223,'-,[1.59-3.12],HIVEP3,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,1:41890579
rs12564480-<b>?</b>,9 x 10-7,,0.88,2.4390244,'-,[1.72-3.57],"WDR64, OPN3",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,1:241666284
rs1841915-<b>?</b>,1 x 10-6,,0.61,1.8518518,'-,[1.45-2.33],"ZNF385D-AS1, ZNF385D",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007667,3:21573947
rs2030272-<b>?</b>,5 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90730025
rs2366929-<b>?</b>,2 x 10-9,,NR,'-,0.11 unit increase,[0.075-0.145],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90730817
rs2222243-<b>?</b>,5 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90737880
rs2443067-<b>?</b>,5 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90738485
rs2443066-<b>?</b>,4 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90738967
rs2460186-<b>?</b>,4 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90741163
rs2460187-<b>?</b>,4 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90742633
rs2443065-<b>?</b>,4 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90757239
rs2443064-<b>?</b>,4 x 10-8,,NR,'-,0.1 unit increase,[0.063-0.137],ADGRV1,Opioid dependence x sex interaction,opioid dependence,GCST009419,5:90757463
rs116112440-<b>G</b>,9 x 10-6,(AA),0.060959791,'-,0.708 unit increase,[0.39-1.02],"ST6GALNAC4P1, PSPC1",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,13:19813749
rs9360217-<b>G</b>,7 x 10-7,(EA),0.216185394,'-,0.2613 unit decrease,[0.16-0.36],'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,6:66628700
rs145629202-<b>G</b>,2 x 10-6,(EA),0.061505745,'-,0.436 unit decrease,[0.26-0.62],LINC01776,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,1:98301098
rs2802887-<b>A</b>,2 x 10-6,(EA),0.084479552,'-,0.3963 unit decrease,[0.23-0.56],"MIR4422HG, GOT2P1",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,1:55327761
rs112655778-<b>A</b>,3 x 10-6,(EA),0.062709932,'-,0.4224 unit decrease,[0.25-0.6],LINC01776,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,1:98286625
rs58376190-<b>A</b>,3 x 10-6,(EA),0.209114606,'-,0.2639 unit increase,[0.15-0.37],CASC8,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,8:127452704
rs12644077-<b>G</b>,3 x 10-6,(EA),0.29121149,'-,0.2268 unit decrease,[0.13-0.32],CCSER1,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,4:91491426
rs4683142-<b>G</b>,3 x 10-6,(EA),0.158771762,'-,0.2773 unit decrease,[0.16-0.39],"LZTFL1, SLC6A20",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,3:45810884
rs6584756-<b>T</b>,4 x 10-6,(EA),0.087717819,'-,0.3594 unit increase,[0.21-0.51],SORCS1,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,10:106609480
rs4563143-<b>G</b>,6 x 10-6,(EA),0.229274391,'-,0.2465 unit increase,[0.14-0.35],MAN1A2P1,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,19:28776315
rs4438643-<b>G</b>,7 x 10-6,(EA),0.485513145,'-,0.2085 unit increase,[0.12-0.3],LINC02020,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,3:186445130
rs722611-<b>G</b>,9 x 10-6,(EA),0.211303505,'-,0.2486 unit increase,[0.14-0.36],CHN2,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,7:29474443
rs7578347-<b>T</b>,3 x 10-7,(AA),0.432054308,'-,0.3926 unit increase,[0.24-0.54],'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,2:12981042
rs12104412-<b>T</b>,6 x 10-7,(AA),0.145400783,'-,0.4939 unit increase,[0.3-0.69],ZNF565,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,19:36240156
rs1772578-<b>G</b>,1 x 10-6,(AA),0.424498956,'-,0.3538 unit decrease,[0.21-0.5],HNRNPA1P31,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,13:80614113
rs1002107-<b>C</b>,2 x 10-6,(AA),0.340901305,'-,0.3548 unit increase,[0.21-0.5],LINC02464,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,12:77271314
rs12317967-<b>T</b>,2 x 10-6,(AA),0.380468146,'-,0.402 unit decrease,[0.23-0.57],'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,12:114815233
rs3858777-<b>C</b>,3 x 10-6,(AA),0.296663446,'-,0.3693 unit increase,[0.21-0.52],STK24,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,13:98517417
rs28526168-<b>A</b>,4 x 10-6,(AA),0.051614621,'-,0.8405 unit decrease,[0.48-1.2],"PRSS1, PRSS2",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,7:142759371
rs5010454-<b>G</b>,4 x 10-6,(AA),0.224326371,'-,0.4428 unit increase,[0.25-0.63],'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,5:164094459
rs2543607-<b>C</b>,4 x 10-6,(AA),0.455810966,'-,0.352 unit decrease,[0.2-0.5],"TEX15, PURG",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,8:30989367
rs4338575-<b>C</b>,4 x 10-6,(AA),0.319017755,'-,0.3418 unit increase,[0.2-0.49],LINC02464,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,12:77283110
rs7731783-<b>C</b>,4 x 10-6,(AA),0.461332898,'-,0.3409 unit decrease,[0.2-0.49],"FAM153A, B4GALT7",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,5:177633311
rs7938889-<b>T</b>,6 x 10-6,(AA),0.391512794,'-,0.3338 unit increase,[0.19-0.48],MAML2,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,11:96231355
rs799227-<b>C</b>,6 x 10-6,(AA),0.230271802,'-,0.4082 unit increase,[0.23-0.58],"MTCYBP4, EYA4",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,6:133166301
rs114685959-<b>A</b>,6 x 10-6,(AA),0.058703394,'-,0.7616 unit increase,[0.43-1.09],FHIT,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,3:60851944
rs11695541-<b>C</b>,6 x 10-6,(AA),0.08851671,'-,0.6257 unit increase,[0.36-0.9],"RN7SL361P, BCL11A",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,2:60617175
rs9667035-<b>T</b>,6 x 10-6,(AA),0.22464517,'-,0.4227 unit increase,[0.24-0.61],LSP1,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,11:1886423
rs4738399-<b>T</b>,6 x 10-6,(AA),0.315951436,'-,0.3543 unit increase,[0.2-0.51],TMEM68,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,8:55694444
rs74920379-<b>G</b>,6 x 10-6,(AA),0.216581723,'-,0.4025 unit decrease,[0.23-0.58],"WDR36, RPS3AP21",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,5:111148341
rs75738991-<b>C</b>,6 x 10-6,(AA),0.167622977,'-,0.4681 unit increase,[0.27-0.67],"MS4A4E, MS4A4A",Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,11:60232321
rs1992676-<b>T</b>,7 x 10-6,(AA),0.36033577,'-,0.3408 unit increase,[0.19-0.49],'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,12:33135239
rs2012694-<b>A</b>,7 x 10-6,(AA),0.239205483,'-,0.3672 unit decrease,[0.21-0.53],PATJ,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,1:62122048
rs528418-<b>G</b>,7 x 10-6,(AA),0.09246893,'-,0.583 unit increase,[0.33-0.84],EXOC2,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,6:145271136
rs1453995-<b>C</b>,9 x 10-6,(AA),0.378784856,'-,0.3565 unit decrease,[0.2-0.51],NELL1,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,11:21148813
rs9705479-<b>T</b>,9 x 10-6,(AA),0.494996345,'-,0.3593 unit decrease,[0.2-0.52],'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,12:34495891
rs73568641-<b>C</b>,3 x 10-8,(AA),0.099152219,'-,0.6808 unit increase,[0.44-0.92],RNU6-896P,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST004136,6:153704004
rs551966-<b>?</b>,1 x 10-6,,'-,'-,9.7472 unit decrease,[5.89-13.61],'-,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,10:29185269
rs77609995-<b>?</b>,3 x 10-6,,'-,'-,34.2748 unit decrease,[20.16-48.39],SORCS1,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,10:106586194
rs117717236-<b>?</b>,5 x 10-6,,'-,'-,27.4409 unit decrease,[15.81-39.07],"NANOS1, LDHAP5",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,10:118939899
rs11052682-<b>?</b>,5 x 10-6,,'-,'-,20.1464 unit decrease,[11.57-28.72],SYT10,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,12:33400846
rs11465988-<b>?</b>,4 x 10-8,,'-,'-,51.5905 unit decrease,[33.52-69.66],IRAK3,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,12:66248033
rs1092013-<b>?</b>,9 x 10-6,,'-,'-,10.7514 unit decrease,[6.04-15.46],SLC35F4,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,14:57735711
rs116975924-<b>?</b>,7 x 10-6,,'-,'-,35.0775 unit decrease,[19.89-50.27],"DIO2-AS1, DIO2",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,14:80346020
rs77861730-<b>?</b>,4 x 10-6,,'-,'-,23.8526 unit increase,[13.8-33.91],LINC01169,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,15:66628157
rs111384268-<b>?</b>,8 x 10-6,,'-,'-,11.3007 unit increase,[6.39-16.21],TMEM266,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,15:76174302
rs7191671-<b>?</b>,9 x 10-6,,'-,'-,11.7671 unit decrease,[6.63-16.91],SNX29,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,16:12378793
rs79490404-<b>?</b>,7 x 10-6,,'-,'-,32.6871 unit decrease,[18.54-46.83],XPO6,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,16:28200424
rs116974145-<b>?</b>,5 x 10-6,,'-,'-,38.5584 unit decrease,[22.16-54.96],"ZFHX3, LINC01568",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,16:73399546
rs56853567-<b>?</b>,1 x 10-7,,'-,'-,52.5556 unit decrease,[33.38-71.73],'-,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,18:15091840
psy_rs112341441-<b>?</b>,7 x 10-6,,'-,'-,24.4593 unit decrease,[13.89-35.03],'-,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,Mapping not available
exm2273047-<b>?</b>,4 x 10-6,,'-,'-,6.4963 unit increase,[3.77-9.22],'-,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,Mapping not available
rs113784139-<b>?</b>,5 x 10-6,,'-,7.8275,'-,[6.94-8.71],"RPL27AP4, RPS21P2",Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,2:106292093
rs76151810-<b>?</b>,6 x 10-6,,'-,6.8437,'-,[6.01-7.67],OR5H14,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,3:98149189
rs10957273-<b>?</b>,8 x 10-7,,'-,0.3297,'-,[-0.1111-0.7705],"TTPA, TARDBPP4",Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,8:63116532
rs4621851-<b>?</b>,3 x 10-6,,'-,0.3408,'-,[-0.11372-0.79532],SNTB1,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,8:120843272
rs12778632-<b>?</b>,8 x 10-6,,'-,5.5519,'-,[4.8-6.31],TNKS2,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,10:91808653
rs7191671-<b>?</b>,4 x 10-6,,'-,4.9988,'-,[4.31-5.69],SNX29,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,16:12378793
rs57202603-<b>?</b>,3 x 10-6,,'-,22.9068,'-,[21.6-24.21],ALOX12B,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,17:8082544
rs6004421-<b>?</b>,2 x 10-6,,'-,4.2574,'-,[3.66-4.86],KIAA1671,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,22:25069861
rs9607045-<b>?</b>,5 x 10-6,,'-,0.3586,'-,[-0.08181-0.79901],LARGE1,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,22:33428461
exm2273047-<b>?</b>,8 x 10-6,,'-,0.3053,'-,[-0.21606-0.82666],'-,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,Mapping not available
rs147333636-<b>?</b>,8 x 10-6,,'-,'-,46.9233 unit increase,[26.52-67.33],DAB1,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,1:57634958
rs115141868-<b>?</b>,8 x 10-7,,'-,'-,46.7739 unit decrease,[28.46-65.09],"TGFA, ADD2",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,2:70589473
rs113784139-<b>?</b>,3 x 10-6,,'-,'-,17.3441 unit decrease,[10.16-24.53],"RPL27AP4, RPS21P2",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,2:106292093
rs76281048-<b>?</b>,9 x 10-6,,'-,'-,42.9841 unit decrease,[24.16-61.81],"MIR5703, RNU6-627P",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,2:163332850
rs74833943-<b>?</b>,3 x 10-6,,'-,'-,9.7351 unit increase,[5.69-13.78],SCN11A,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,3:38881542
rs116374079-<b>?</b>,5 x 10-6,,'-,'-,28.8083 unit decrease,[16.52-41.1],SAMMSON,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,3:70116547
rs113873241-<b>?</b>,2 x 10-6,,'-,'-,37.1242 unit decrease,[21.88-52.37],MBNL1,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,3:152280042
rs13141139-<b>?</b>,2 x 10-6,,'-,'-,52.0532 unit decrease,[30.69-73.41],MAEA,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,4:1317139
rs150512710-<b>?</b>,2 x 10-6,,'-,'-,35.9753 unit decrease,[21.29-50.66],"EVC, CRMP1",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,4:5801387
rs141153844-<b>?</b>,2 x 10-6,,'-,'-,27.5742 unit decrease,[16.29-38.86],"PACRGL, SLIT2",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,4:20653548
rs137976722-<b>?</b>,2 x 10-6,,'-,'-,31.4511 unit decrease,[18.58-44.32],EEF1A1P21,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,4:29742673
rs151184257-<b>?</b>,5 x 10-7,,'-,'-,40.4986 unit decrease,[24.97-56.03],CXXC4-AS1,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,4:104793600
rs79939184-<b>?</b>,7 x 10-6,,'-,'-,38.3288 unit decrease,[21.76-54.9],MARCHF11,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,5:16157247
rs72759613-<b>?</b>,7 x 10-6,,'-,'-,14.3869 unit decrease,[8.16-20.61],PDZD2,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,5:31957178
rs67702993-<b>?</b>,3 x 10-6,,'-,'-,7.7028 unit decrease,[4.53-10.88],MROH2B,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,5:41030620
rs199699215-<b>?</b>,9 x 10-6,,'-,'-,25.1097 unit decrease,[14.14-36.08],"NR3C1, ARHGAP26",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,5:143260638
rs142489926-<b>?</b>,5 x 10-6,,'-,'-,42.1954 unit decrease,[24.25-60.14],"PNISR, USP45",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,6:99431370
7_9352308-<b>?</b>,7 x 10-6,,'-,'-,40.4638 unit decrease,[22.95-57.98],'-,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,Mapping not available
rs4276687-<b>?</b>,4 x 10-6,,'-,'-,6.8847 unit decrease,[4-9.77],NKAIN3,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,8:62872146
YTHDF3-<b>AS1</b>,6 x 10-8,,'-,'-,7.4888 unit increase,[4.82-10.16],"TTPA, TARDBPP4",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,8:63122188
rs76381578-<b>?</b>,2 x 10-6,,'-,'-,15.2371 unit decrease,[9.05-21.42],MMP16,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,8:88144744
rs202236734-<b>?</b>,9 x 10-7,,'-,'-,7.8351 unit increase,[4.74-10.93],SNTB1,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,8:120845353
rs138256067-<b>?</b>,6 x 10-6,,'-,'-,43.956 unit decrease,[25.11-62.8],DOCK8,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,9:339720
rs189749048-<b>?</b>,9 x 10-6,,'-,'-,41.4729 unit decrease,[23.39-59.55],"ZDHHC21, CDCA4P1",Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,9:14595487
rs143769938-<b>?</b>,4 x 10-6,,'-,'-,45.7384 unit increase,[26.58-64.9],'-,Response to esketamine in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011398,9:103509163
rs2133627-<b>?</b>,1 x 10-5,,'-,2.9914,'-,[2.51-3.48],FOXP1,Response to esketamine (responder status) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011397,3:71502719
rs7105146-<b>?</b>,2 x 10-6,,'-,2.216,'-,[1.89-2.54],PPFIBP2,Response to esketamine (remission) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011396,11:7546770
rs114035480-<b>?</b>,3 x 10-6,,'-,0.3902,'-,[-0.00611-0.78651],METTL8,Response to esketamine (remission) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011396,2:171381449
rs146423616-<b>?</b>,4 x 10-6,,'-,0.3912,'-,[-0.00629-0.78869],KRT18P24,Response to esketamine (remission) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011396,9:79101991
rs57279992-<b>?</b>,6 x 10-6,,'-,0.4654,'-,[0.13-0.8],LINC02436,Response to esketamine (remission) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011396,4:185085185
rs62218079-<b>?</b>,1 x 10-5,,'-,2.7539,'-,[2.3-3.2],"LINC02891, CCDC188",Response to esketamine (remission) in treatment resistant depression,"treatment resistant depression, response to ketamine",GCST011396,22:20165339
rs9561329-<b>?</b>,1 x 10-7,,0.09,'-,0.17 unit decrease,[0.11-0.23],GPC6,Neuroticism (age interaction),"neurotic disorder, age at assessment",GCST000724,13:93358916
rs9491140-<b>?</b>,3 x 10-7,,0.33,'-,0.91 unit decrease,[0.56-1.26],NKAIN2,Neuroticism,neurotic disorder,GCST004569,6:124370091
rs4965121-<b>?</b>,1 x 10-6,,0.38,'-,0.84 unit decrease,[0.51-1.17],"LINC02251, ARRDC4",Neuroticism,neurotic disorder,GCST004569,15:97975562
rs702543-<b>A</b>,2 x 10-6,,0.55,1.27,'-,[1.15-1.40],PDE4D,Neuroticism,neurotic disorder,GCST000063,5:59546948
rs12883384-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,MDGA2,Neuroticism,neurotic disorder,GCST000226,14:46934481
rs2349775-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,NXPH1,Neuroticism,neurotic disorder,GCST000226,7:8678450
rs2705293-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,'-,Neuroticism,neurotic disorder,GCST000226,8:137906702
rs10886472-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST006856,Mapping not available
"rs11198907-<b>A</b>, rs4752300-<b>A</b>, rs10886472-<b>A</b>",9 x 10-6,,0.17,'-,12.51 unit increase,'-,GRK5; No mapped genes; No mapped genes,Methadone dose in opioid dependence,"opioid dependence, methadone dose measurement",GCST006856,10:119398118
rs4773054-<b>?</b>,7 x 10-8,(Autism paternal model),NR,2.9,'-,[1.91-4.39],'-,Autism spectrum disorder-related traits,autism,GCST002639,13:109501681
rs10038113-<b>T</b>,3 x 10-6,,0.59,1.33,'-,[1.11-1.43],MSNP1,Autism,autism,GCST000411,5:25902233
rs325506-<b>C</b>,3 x 10-11,,0.423,'-,0.057 unit increase,[0.039-0.075],'-,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,5:104676602
rs10149470-<b>A</b>,9 x 10-9,,0.487,'-,0.049 unit increase,[0.033-0.065],"RNU7-160P, BAG5",Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,14:103551616
rs1620977-<b>A</b>,7 x 10-9,,0.26,'-,0.056 unit increase,[0.036-0.076],NEGR1,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,1:72263459
rs16854048-<b>A</b>,1 x 10-8,,0.858,'-,0.069 unit increase,[0.045-0.093],BEND4,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,4:42121711
rs12552-<b>A</b>,4 x 10-8,,0.424,'-,0.047 unit increase,[0.029-0.065],OLFM4,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,13:53051646
rs1806153-<b>T</b>,4 x 10-8,,0.213,'-,0.057 unit increase,[0.037-0.077],PAUPAR,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,11:31828558
rs8063603-<b>A</b>,7 x 10-6,,0.673,'-,0.041 unit decrease,[0.023-0.059],RBFOX1,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,16:6260644
rs61867293-<b>T</b>,1 x 10-6,,0.216,'-,0.05 unit decrease,[0.03-0.07],SORCS3,Autism and major depressive disorder (MTAG),"unipolar depression, autism spectrum disorder",GCST007553,10:104804166
rs718073-<b>?</b>,5 x 10-6,,0.84,'-,0.35 unit increase,[0.20-0.50],LINC00511,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,17:72588126
rs169313-<b>?</b>,8 x 10-6,,0.44,'-,0.25 unit increase,[0.14-0.36],"SCO1, MYH3",Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,17:10664166
rs7182874-<b>T</b>,9 x 10-9,,0.71,'-,0.37 unit decrease,[0.24-0.50],PCSK6,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,15:101325267
rs10802047-<b>?</b>,2 x 10-6,,0.38,'-,0.25 unit decrease,[0.15-0.36],PSMC1P12,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,1:118601809
rs4684792-<b>?</b>,9 x 10-6,,0.18,'-,0.28 unit decrease,[0.16-0.4],VGLL4,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,3:11652993
rs10216189-<b>?</b>,4 x 10-6,,0.39,'-,0.24 unit decrease,[0.14-0.34],FBXL18,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,7:5485174
rs1996369-<b>?</b>,9 x 10-6,,0.21,'-,0.27 unit increase,[0.15-0.39],PAMR1,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,11:35473893
rs227869-<b>?</b>,4 x 10-6,,0.32,'-,0.25 unit decrease,[0.14-0.36],"TRAJ50, TRAJ51",Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,14:22487722
rs6493858-<b>?</b>,4 x 10-6,,0.41,'-,0.25 unit increase,[0.14-0.35],"TEX9, MNS1",Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,15:56444280
rs2962462-<b>?</b>,2 x 10-6,,0.56,'-,0.29 unit increase,[0.17-0.41],'-,Relative hand skill in reading disability,"handedness, dyslexia",GCST002183,16:62764948
rs9937053-<b>A</b>,3 x 10-9,,0.43,1.09,'-,[1.06-1.12],FTO,Obstructive sleep apnea,obstructive sleep apnea,GCST011922,16:53765595
rs10507084-<b>T</b>,1 x 10-9,,0.18,1.12,'-,[1.08-1.17],"RMST, LINC02409",Obstructive sleep apnea (BMI adjusted),obstructive sleep apnea,GCST011921,12:97359374
rs185932673-<b>T</b>,9 x 10-6,,0.0033,1.75,'-,[1.37-2.26],CAMK1D,Obstructive sleep apnea (BMI adjusted),obstructive sleep apnea,GCST011921,10:12656440
rs72923401-<b>C</b>,6 x 10-6,(EA),0.86,'-,'-,'-,"LINC00466, LINC01739",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,1:63111542
rs7413698-<b>A</b>,1 x 10-6,(EA),0.53,'-,'-,'-,"RAB7B, SLC26A9",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,1:205952731
rs6735649-<b>T</b>,9 x 10-6,(EA),0.66,'-,'-,'-,"RN7SL468P, STEAP3",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,2:119215330
rs72998656-<b>G</b>,7 x 10-6,(EA),0.96,'-,'-,'-,'-,Dementia with Lewy bodies,Lewy body dementia,GCST90012831,3:5524015
rs6876430-<b>C</b>,9 x 10-6,(EA),0.91,'-,'-,'-,'-,Dementia with Lewy bodies,Lewy body dementia,GCST90012831,5:23728181
rs6940679-<b>C</b>,3 x 10-6,(EA),0.62,'-,'-,'-,FARS2,Dementia with Lewy bodies,Lewy body dementia,GCST90012831,6:5377247
rs215971-<b>T</b>,1 x 10-6,(EA),0.45,'-,'-,'-,"LINC02857, CYB5R4",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,6:83992044
rs2758145-<b>G</b>,6 x 10-7,(EA),0.81,'-,'-,'-,"SGK1, RN7SL408P",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,6:134160827
rs7863880-<b>T</b>,2 x 10-7,(EA),0.66,'-,'-,'-,"GAS2L1P2, CTSV",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,9:97079041
rs7970261-<b>A</b>,7 x 10-6,(EA),0.97,'-,'-,'-,PLXNC1,Dementia with Lewy bodies,Lewy body dementia,GCST90012831,12:94271637
rs7141848-<b>C</b>,1 x 10-5,(EA),0.94,'-,'-,'-,FOXN3,Dementia with Lewy bodies,Lewy body dementia,GCST90012831,14:89450829
rs7206657-<b>C</b>,8 x 10-6,(EA),0.33,'-,'-,'-,JPH3,Dementia with Lewy bodies,Lewy body dementia,GCST90012831,16:87634866
rs7275655-<b>G</b>,9 x 10-6,(EA),0.87,'-,'-,'-,"MRPS6, LINC00649",Dementia with Lewy bodies,Lewy body dementia,GCST90012831,21:33985948
rs2834188-<b>?</b>,2 x 10-8,,0.705,1.3,'-,[1.18-1.41],"IFNAR1, IL10RB",Narcolepsy,narcolepsy with cataplexy,GCST002260,21:33316948
rs1154155-<b>G</b>,5 x 10-49,,0.148,1.64,'-,[1.53-1.75],"TRAJ9, TRAJ10",Narcolepsy,narcolepsy with cataplexy,GCST002260,14:22533736
rs1551570-<b>?</b>,4 x 10-10,,0.458,1.32,'-,[1.2-1.43],"PPAN, PPAN-P2RY11",Narcolepsy,narcolepsy with cataplexy,GCST002260,19:10107354
rs2854536-<b>?</b>,4 x 10-8,,0.292,1.28,'-,[1.18-1.41],"TRBV8-1, TRBV7-2",Narcolepsy,narcolepsy with cataplexy,GCST002260,7:142357119
rs10995245-<b>A</b>,1 x 10-11,,0.348,1.23,'-,[1.16-1.31],'-,Narcolepsy,narcolepsy with cataplexy,GCST002260,10:62631615
rs5770917-<b>C</b>,6 x 10-8,,0.17,1.63,'-,[1.37-1.95],CHKB-CPT1B,Narcolepsy,narcolepsy with cataplexy,GCST000236,22:50578924
rs56372821-<b>G</b>,9 x 10-12,,0.856,1.25,'-,[NR],GULOP,Cannabis use disorder,"cannabis dependence, substance abuse",GCST008414,8:27578983
rs7141336-<b>C</b>,6 x 10-6,"(AA, factor score analysis)",'-,'-,0.19 unit increase,[NR],"LINC02321, TTC7B",Anxiety disorder,anxiety disorder,GCST002696,14:90819884
rs17548918-<b>C</b>,9 x 10-6,"(AA, factor score analysis)",'-,'-,0.26 unit increase,[NR],VENTXP7,Anxiety disorder,anxiety disorder,GCST002696,3:21338599
rs241257-<b>A</b>,9 x 10-6,"(AA, factor score analysis)",'-,'-,0.17 unit increase,[NR],LINC01646,Anxiety disorder,anxiety disorder,GCST002696,1:4554762
rs12120353-<b>A</b>,3 x 10-6,"(AA, case-control analysis)",'-,2.13,'-,[NR],LINC01646,Anxiety disorder,anxiety disorder,GCST002696,1:4560936
rs10762651-<b>?</b>,6 x 10-6,"(AA, case-control analysis)",'-,1.85,'-,[NR],DUSP29,Anxiety disorder,anxiety disorder,GCST002696,10:75062359
rs17105932-<b>?</b>,7 x 10-6,"(AA, case-control analysis)",'-,2.22,'-,[NR],GUCY1A2,Anxiety disorder,anxiety disorder,GCST002696,11:106672739
rs6799682-<b>A</b>,8 x 10-6,"(AA, case-control analysis)",'-,1.79,'-,[NR],LINC00578,Anxiety disorder,anxiety disorder,GCST002696,3:177458728
rs4692589-<b>C</b>,9 x 10-7,"(EA, factor score analysis)",'-,'-,0.067 unit decrease,[NR],MFAP3L,Anxiety disorder,anxiety disorder,GCST002696,4:170014094
rs10893268-<b>T</b>,1 x 10-6,"(EA, factor score analysis)",'-,'-,0.069 unit decrease,[NR],OR8A1,Anxiety disorder,anxiety disorder,GCST002696,11:124568716
rs12153327-<b>C</b>,2 x 10-6,"(EA, factor score analysis)",'-,'-,0.064 unit decrease,[NR],'-,Anxiety disorder,anxiety disorder,GCST002696,5:101365896
rs2170820-<b>C</b>,5 x 10-6,"(EA, factor score analysis)",'-,'-,0.063 unit decrease,[NR],TMEM132D,Anxiety disorder,anxiety disorder,GCST002696,12:129538158
rs1551277-<b>A</b>,7 x 10-6,"(EA, factor score analysis)",'-,'-,0.068 unit increase,[NR],PKD1L1,Anxiety disorder,anxiety disorder,GCST002696,7:47789719
rs12703441-<b>C</b>,7 x 10-6,"(EA, factor score analysis)",'-,'-,0.062 unit decrease,[NR],MGAM2,Anxiety disorder,anxiety disorder,GCST002696,7:142192907
rs4736192-<b>A</b>,9 x 10-6,"(EA, factor score analysis)",'-,'-,0.073 unit increase,[NR],COL22A1,Anxiety disorder,anxiety disorder,GCST002696,8:138967582
rs2115691-<b>?</b>,4 x 10-6,"(EA, case-control analysis)",'-,1.49,'-,[NR],"HNRNPA1P55, CXCL1",Anxiety disorder,anxiety disorder,GCST002696,4:73877974
rs12407717-<b>T</b>,2 x 10-8,,0.13,'-,'-,'-,LINC01648,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,1:29953167
rs12128108-<b>T</b>,3 x 10-9,,0.23,'-,'-,'-,AGBL4,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,1:49827749
rs2318763-<b>A</b>,5 x 10-11,,0.17,'-,'-,'-,VPS45,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,1:150143798
rs7597593-<b>T</b>,3 x 10-12,,0.62,'-,'-,'-,ZNF804A,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,2:184668853
rs2535629-<b>A</b>,2 x 10-11,,0.33,'-,'-,'-,ITIH3,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,3:52799203
rs1966136-<b>A</b>,6 x 10-11,,0.41,'-,'-,'-,FHIT,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,3:61167905
rs911186-<b>A</b>,4 x 10-18,,0.23,'-,'-,'-,"MIR3143, RPL10P2",Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,6:27182820
rs1265099-<b>A</b>,2 x 10-10,,0.41,'-,'-,'-,"PSORS1C1, PSORS1C2",Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,6:31137636
rs389883-<b>T</b>,1 x 10-12,,0.68,'-,'-,'-,STK19,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,6:31979683
rs4976976-<b>A</b>,4 x 10-12,,0.4,'-,'-,'-,TSNARE1,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,8:142230292
rs2026194-<b>T</b>,2 x 10-9,,0.24,'-,'-,'-,MTCO3P40,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,9:82467984
rs10774037-<b>A</b>,8 x 10-12,,0.79,'-,'-,'-,CACNA1C,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,12:2311360
rs2182139-<b>T</b>,8 x 10-10,,0.75,'-,'-,'-,RTN1,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,14:59682515
rs4906335-<b>A</b>,9 x 10-16,,0.28,'-,'-,'-,"RNU7-160P, BAG5",Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,14:103554804
rs4843613-<b>T</b>,5 x 10-9,,0.83,'-,'-,'-,ZCCHC14,Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,16:87456092
rs9951150-<b>A</b>,7 x 10-9,,0.46,'-,'-,'-,"TCF4, RNA5SP459",Broad depression or schizophrenia,"unipolar depression, schizophrenia",GCST007257,18:55153893
rs1342884-<b>C</b>,2 x 10-6,(EA),0.24,'-,'-,'-,KCTD12,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,13:76816186
rs12915729-<b>C</b>,8 x 10-6,(EA),0.41,'-,'-,'-,SLC28A1,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,15:84930976
chr16:11818707-<b>T</b>,4 x 10-6,(EA),0.96,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,Mapping not available
rs429358-<b>T</b>,5 x 10-25,(EA),0.86,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,Mapping not available
chr2:59140917-<b>T</b>,7 x 10-6,(EA),0.96,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,Mapping not available
chr4:96130211-<b>G</b>,2 x 10-6,(EA),0.98,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,Mapping not available
rs6842817-<b>C</b>,6 x 10-6,(EA),0.08,'-,'-,'-,LINC02433,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,4:157609711
rs10518032-<b>G</b>,3 x 10-6,(EA),0.93,'-,'-,'-,"SH3RF1, CBR4",Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,4:169026883
rs2405952-<b>C</b>,4 x 10-6,(EA),0.99,'-,'-,'-,PRR16,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,5:120518680
chr7:16819506-<b>C</b>,5 x 10-6,(EA),0.97,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,Mapping not available
rs3988345-<b>T</b>,3 x 10-6,(EA),0.44,'-,'-,'-,"ADAM24P, SLC7A2",Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,8:17479161
chr2:23743850-<b>T</b>,6 x 10-7,(EA),0.95,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,Mapping not available
rs4853365-<b>G</b>,3 x 10-6,(EA),0.6,'-,'-,'-,'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST90012828,2:78045971
rs187632-<b>A</b>,7 x 10-7,,0.4621,'-,0.08813937 unit decrease,[0.05-0.12],'-,Nicotine dependence,nicotine dependence,GCST006302,5:5786589
rs374098-<b>T</b>,7 x 10-6,,0.06049,'-,0.1679786 unit increase,[0.09-0.24],"Metazoa_SRP, CDH10",Nicotine dependence,nicotine dependence,GCST006302,5:24459734
rs78018149-<b>A</b>,6 x 10-6,,0.053808,'-,0.1796756 unit increase,[0.10-0.26],SLC25A48,Nicotine dependence,nicotine dependence,GCST006302,5:135785156
rs6461441-<b>C</b>,9 x 10-7,,0.15607,'-,0.1180899 unit decrease,[0.07-0.16],'-,Nicotine dependence,nicotine dependence,GCST006302,7:19526663
rs11779702-<b>G</b>,8 x 10-6,,0.36742,'-,0.0799917 unit decrease,[0.04-0.12],GFRA2,Nicotine dependence,nicotine dependence,GCST006302,8:21639886
rs5894994-<b>A</b>,5 x 10-6,,0.34552,'-,0.0818196 unit decrease,[0.05-0.12],CCDC26,Nicotine dependence,nicotine dependence,GCST006302,8:129445289
rs28714232-<b>T</b>,8 x 10-6,,0.34728,'-,0.08618749 unit increase,[0.05-0.12],DKFZP434A062,Nicotine dependence,nicotine dependence,GCST006302,9:136323035
rs61873668-<b>G</b>,2 x 10-6,,0.16679,'-,0.1112913 unit decrease,[0.07-0.16],CRTAC1,Nicotine dependence,nicotine dependence,GCST006302,10:98030641
rs144182682-<b>A</b>,7 x 10-6,,0.49829,'-,0.07826248 unit decrease,[0.04-0.11],"LINC02870, LINC01165",Nicotine dependence,nicotine dependence,GCST006302,10:132474917
rs148586747-<b>A</b>,7 x 10-7,,0.027409,'-,0.2729256 unit decrease,[0.17-0.38],NELL1,Nicotine dependence,nicotine dependence,GCST006302,11:21450957
rs75012440-<b>A</b>,5 x 10-6,,0.077808,'-,0.1466377 unit increase,[0.08-0.21],KLF12,Nicotine dependence,nicotine dependence,GCST006302,13:74057103
rs188595723-<b>G</b>,2 x 10-6,,0.01956,'-,0.3098676 unit increase,[0.18-0.44],C14orf177,Nicotine dependence,nicotine dependence,GCST006302,14:98809200
rs72868658-<b>A</b>,8 x 10-6,,0.10947,'-,0.1237771 unit increase,[0.07-0.18],GNAL,Nicotine dependence,nicotine dependence,GCST006302,18:11838174
rs199563603-<b>T</b>,5 x 10-6,,0.19379,'-,0.1009577 unit increase,[0.06-0.14],AK2,Nicotine dependence,nicotine dependence,GCST006302,1:33075512
rs61109704-<b>C</b>,4 x 10-6,,0.053041,'-,0.1823332 unit decrease,[0.11-0.26],"CAMSAP2, DDX59-AS1",Nicotine dependence,nicotine dependence,GCST006302,1:200703078
rs16892135-<b>G</b>,3 x 10-6,,0.21778,'-,0.0989546 unit increase,[0.06-0.14],CC2D2A,Nicotine dependence,nicotine dependence,GCST006302,4:15540574
rs61735963-<b>?</b>,4 x 10-6,(AA),0.2268,1.319,'-,'-,DVL1,Nicotine dependence,nicotine dependence,GCST009957,1:1341803
rs2836823-<b>T</b>,2 x 10-6,,0.4,1.46,'-,[1.23-1.73],LINC01700,Nicotine dependence,nicotine dependence,GCST000010,21:39008323
rs4142041-<b>G</b>,6 x 10-6,,0.34,1.14,'-,[0.97-1.35],CTNNA3,Nicotine dependence,nicotine dependence,GCST000010,10:66881193
rs55661361-<b>A</b>,1 x 10-7,,0.348,'-,0.047 unit decrease,'-,NRGN,Autism and schizophrenia (MTAG),"schizophrenia, autism spectrum disorder",GCST007555,11:124744061
rs2535627-<b>T</b>,3 x 10-7,,0.516,'-,0.047 unit increase,'-,"ITIH3, ITIH4",Autism and schizophrenia (MTAG),"schizophrenia, autism spectrum disorder",GCST007555,3:52811089
rs7405404-<b>T</b>,1 x 10-6,,0.215,'-,0.054 unit increase,'-,'-,Autism and schizophrenia (MTAG),"schizophrenia, autism spectrum disorder",GCST007555,16:13656002
rs6466055-<b>A</b>,2 x 10-6,,0.345,'-,0.046 unit increase,'-,SRPK2,Autism and schizophrenia (MTAG),"schizophrenia, autism spectrum disorder",GCST007555,7:105288617
rs10748045-<b>G</b>,1 x 10-6,,0.354,1.78,'-,[1.41-2.25],GRIP1,Suicidal ideation in depression or bipolar disorder,"unipolar depression, suicidal ideation, bipolar disorder",GCST002505,12:66422359
rs17173608-<b>G</b>,2 x 10-7,,0.058,1.93,'-,[1.69-2.19],RARRES2,Suicide attempts in depression or bipolar disorder,"unipolar depression, bipolar disorder, attempted suicide",GCST002503,7:150339575
rs17387100-<b>G</b>,8 x 10-7,,0.078,1.76,'-,[1.54-1.99],PROM1,Suicide attempts in depression or bipolar disorder,"unipolar depression, bipolar disorder, attempted suicide",GCST002503,4:15993502
rs3781878-<b>?</b>,2 x 10-6,,0.728,1.54,'-,[1.2-2.08],NCAM1,Suicide attempts in depression or bipolar disorder,"unipolar depression, bipolar disorder, attempted suicide",GCST002503,11:113249490
rs1395241-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,FAT4,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,4:125438301
rs12912251-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,LINC02694,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,15:38694167
rs11773103-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,DMTF1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,7:87192664
rs1006737-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CACNA1C,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,12:2236129
rs17082664-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,SYNE1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,6:152417619
rs1262778-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,DLEU1,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,13:50492487
rs10994338-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,ANK3,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,10:60421370
rs7226677-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"COLEC12, THOC1-DT",Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,18:278796
rs4972755-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder or major depressive disorder,"unipolar depression, bipolar disorder",GCST000641,2:175375121
rs4663116-<b>?</b>,7 x 10-6,,'-,1.2540758,'-,[NR],RPS20P12,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009977,2:234236143
rs1541227-<b>G</b>,3 x 10-6,,'-,1.362,'-,[NR],LINC02520,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009977,6:37534090
rs9297733-<b>G</b>,5 x 10-6,,'-,1.252,'-,[NR],LINC00861,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009977,8:126235667
rs5014463-<b>?</b>,5 x 10-6,,'-,1.3347571,'-,[NR],"RBM17, PFKFB3",Post-traumatic stress disorder,post-traumatic stress disorder,GCST009977,10:6129672
rs9725031-<b>?</b>,8 x 10-6,,'-,'-,1.13 unit increase,[0.64-1.62],"RN7SL299P, SIPA1L2",Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,1:232308709
rs1915919-<b>?</b>,8 x 10-6,,'-,'-,0.74 unit increase,[0.43-1.05],KAT2B,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,3:20042389
rs71534169-<b>?</b>,4 x 10-6,,'-,'-,1.63 unit increase,[0.94-2.32],DPP6,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,7:154801156
rs2460905-<b>?</b>,5 x 10-6,,'-,'-,1.38 unit increase,[0.79-1.97],TRMT9B,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,8:12977091
rs263232-<b>?</b>,6 x 10-7,,'-,'-,1.43 unit increase,[0.88-1.98],ADCY8,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,8:130795923
rs682457-<b>?</b>,1 x 10-6,,'-,'-,1.11 unit increase,[0.68-1.54],"CTSC, MIR3166",Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,11:88216364
rs77963519-<b>?</b>,4 x 10-6,,'-,'-,1.56 unit increase,[0.91-2.21],'-,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002401,15:81901505
rs893971-<b>T</b>,7 x 10-6,(maternal warmth),0.6,'-,1.15 unit decrease,[NR],PPM1K,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,4:88282518
rs4321143-<b>G</b>,7 x 10-6,(maternal criticism),0.28,'-,1.13 unit increase,[NR],'-,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,15:95613139
rs604381-<b>A</b>,8 x 10-6,(maternal warmth),0.32,'-,1.26 unit increase,[NR],"CDC42EP3, LINC00211",Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,2:37749874
rs8073783-<b>C</b>,8 x 10-6,(maternal warmth),0.49,'-,1.76 unit decrease,[NR],MTCO1P40,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,17:53160580
rs332034-<b>A</b>,6 x 10-6,(maternal warmth),0.85,'-,1.05 unit increase,[NR],MFHAS1,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,8:8859497
rs13188771-<b>A</b>,2 x 10-6,(maternal warmth),0.17,'-,4.24 unit decrease,[NR],RN7SL802P,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,5:101612841
rs719593-<b>T</b>,5 x 10-6,(maternal criticism),0.86,'-,2.05 unit decrease,[NR],LDHAP3,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,2:41777857
rs16880441-<b>G</b>,9 x 10-6,(maternal criticism),0.08,'-,1.63 unit increase,[NR],"ACTBP8, CNR1",Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,6:88266258
rs17116334-<b>T</b>,9 x 10-6,(maternal criticism),0.16,'-,1.3 unit increase,[NR],ZBTB16,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,11:114091040
rs9990174-<b>T</b>,6 x 10-6,(maternal warmth),0.33,'-,2.52 unit decrease,[NR],SLC6A1,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,3:10998753
rs2395528-<b>T</b>,6 x 10-6,(maternal warmth),0.23,'-,1.46 unit decrease,[NR],LINC00856,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,10:78341104
rs2282301-<b>A</b>,7 x 10-6,(maternal warmth),0.23,'-,2.88 unit increase,[NR],RIT1,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,1:155898834
rs17664267-<b>T</b>,7 x 10-6,(maternal warmth),0.19,'-,1.39 unit increase,[NR],SYT4,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,18:43228833
rs1789891-<b>A</b>,3 x 10-6,(maternal warmth),0.14,'-,1.47 unit increase,[NR],ADH1B,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,4:99329262
rs6500744-<b>C</b>,3 x 10-6,(maternal warmth),0.53,'-,0.91 unit increase,[NR],RBFOX1,Conduct disorder (maternal expressed emotions interaction),"parental emotion expression measurmement, conduct disorder",GCST000245,16:6063660
rs149104283-<b>T</b>,2 x 10-8,,0.0152,4.3198,'-,'-,SLCO1B3-SLCO1B7,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,12:20930928
rs80208670-<b>C</b>,2 x 10-7,,0.0124,4.6904316,'-,'-,SLITRK1,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,13:83863953
rs184597564-<b>A</b>,8 x 10-7,,0.0282,3.0647,'-,'-,ADGRL2,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,1:81770721
rs78900159-<b>A</b>,2 x 10-6,,0.0244,2.7947,'-,'-,GSAP,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,7:77339061
rs16916041-<b>T</b>,2 x 10-6,,0.0973,1.9778,'-,'-,TMEM26,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,10:61386789
rs11649311-<b>T</b>,2 x 10-6,,0.3413,1.6818029,'-,'-,"AQP8, RN7SL557P",Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,16:25214699
rs117202297-<b>T</b>,5 x 10-6,,0.0122,4.9702,'-,'-,TMEM100,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,17:55691674
rs80282661-<b>T</b>,5 x 10-6,,0.0121,4.1666,'-,'-,LINC02093,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,17:13348756
rs185053659-<b>A</b>,8 x 10-6,,0.0142,3.7968,'-,'-,"LINC02778, FCGR3A",Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,1:60238578
rs143888465-<b>?</b>,4 x 10-6,ANC <1000/mm3,NR,4.94,'-,NR,SCN8A,Clozapine-induced agranulocytosis/granulocytopenia in treatment-resistant schizophrenia,"treatment refractory schizophrenia, Drug-induced agranulocytosis, response to clozapine",GCST003628,12:51616324
rs7665833-<b>A</b>,1 x 10-7,,0.14,2.03,'-,[1.78-2.28],"LINC02479, PGBD4P4",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,4:130459962
rs7735612-<b>C</b>,6 x 10-7,,0.4,1.63,'-,[1.43-1.83],SLIT3,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,5:169082727
rs2898168-<b>?</b>,2 x 10-6,,0.68,1.6666665,'-,'-,"KRTAP13-1, KRTAP13-3",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,21:30410284
rs4863995-<b>T</b>,4 x 10-6,,0.22,1.67,'-,[1.45-1.89],"PGBD4P4, GAPDHP56",Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,4:130496927
rs6852702-<b>A</b>,4 x 10-6,,0.09,2.07,'-,[1.76-2.38],GAPDHP56,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,4:130515632
rs12006913-<b>A</b>,4 x 10-6,,0.12,2.13,'-,[1.82-2.44],PTCHD1,Treatment resistant depression,"treatment resistant depression, response to antidepressant",GCST007665,X:23358454
rs35738585-<b>G</b>,4 x 10-16,,0.4334,'-,0.01561 unit decrease,[0.012-0.019],DRD2,Neuroticism,neurotic disorder,GCST010017,11:113515625
rs11665070-<b>G</b>,3 x 10-16,,0.3313,'-,0.01565 unit increase,[0.012-0.019],"MIR4318, CELF4",Neuroticism,neurotic disorder,GCST010017,18:37572600
rs10144845-<b>C</b>,4 x 10-13,,0.317,'-,0.01389 unit decrease,[0.01-0.018],YLPM1,Neuroticism,neurotic disorder,GCST010017,14:74771067
rs2042555-<b>A</b>,5 x 10-12,,0.418,'-,0.01323 unit increase,[0.0095-0.017],"ACVR2A, RNA5SP106",Neuroticism,neurotic disorder,GCST010017,2:147797920
rs7107356-<b>A</b>,5 x 10-12,,0.4943,'-,0.01319 unit decrease,[0.0094-0.0169],"AGBL2, MTCH2",Neuroticism,neurotic disorder,GCST010017,11:47654618
rs28377268-<b>T</b>,2 x 10-9,,0.1071,'-,0.01142 unit increase,[0.0077-0.0152],PTCH1,Neuroticism,neurotic disorder,GCST010017,9:95462774
rs34796300-<b>T</b>,3 x 10-9,,0.4254,'-,0.01137 unit increase,[0.0076-0.0151],ARNTL,Neuroticism,neurotic disorder,GCST010017,11:13293658
rs297343-<b>T</b>,7 x 10-9,,0.3604,'-,0.01107 unit increase,[0.0073-0.0148],SOX6,Neuroticism,neurotic disorder,GCST010017,11:16333107
rs674437-<b>G</b>,9 x 10-9,,0.4843,'-,0.01098 unit increase,[0.0072-0.0147],GRM5,Neuroticism,neurotic disorder,GCST010017,11:88956785
rs2210903-<b>G</b>,1 x 10-9,,0.3692,'-,0.01168 unit decrease,[0.0079-0.0154],"SNRPFP3, ZDHHC20P4",Neuroticism,neurotic disorder,GCST010017,13:69002843
rs12903563-<b>T</b>,1 x 10-9,,0.4798,'-,0.01176 unit increase,[0.008-0.0155],LINGO1,Neuroticism,neurotic disorder,GCST010017,15:77741393
rs12938775-<b>G</b>,2 x 10-9,,0.4989,'-,0.0114 unit increase,[0.0077-0.0151],PAFAH1B1,Neuroticism,neurotic disorder,GCST010017,17:2671527
rs8097041-<b>A</b>,3 x 10-9,,0.3644,'-,0.01159 unit decrease,[0.0078-0.0154],DCC,Neuroticism,neurotic disorder,GCST010017,18:53371847
rs1028321-<b>A</b>,7 x 10-9,,0.3052,'-,0.0111 unit decrease,[0.0073-0.0149],RPS19BP1,Neuroticism,neurotic disorder,GCST010017,22:39530924
rs4561025-<b>A</b>,3 x 10-8,,0.3521,'-,0.01059 unit increase,[0.0068-0.0143],LINC02609,Neuroticism,neurotic disorder,GCST010017,1:90798200
rs12466146-<b>T</b>,4 x 10-8,,0.4219,'-,0.01055 unit increase,[0.0068-0.0143],MYCNOS,Neuroticism,neurotic disorder,GCST010017,2:15937077
rs7567451-<b>G</b>,4 x 10-8,,0.2672,'-,0.01054 unit decrease,[0.0068-0.0143],LINC01876,Neuroticism,neurotic disorder,GCST010017,2:156196868
rs10497655-<b>C</b>,3 x 10-8,,0.3206,'-,0.0106 unit decrease,[0.0069-0.0143],"ZNF804A, LINC01812",Neuroticism,neurotic disorder,GCST010017,2:184597314
rs57838764-<b>C</b>,3 x 10-8,,0.1142,'-,0.01062 unit increase,[0.0069-0.0144],RASSF1,Neuroticism,neurotic disorder,GCST010017,3:50337137
rs836927-<b>A</b>,4 x 10-8,,0.4257,'-,0.01067 unit increase,[0.0069-0.0145],"LINC01990, BBX",Neuroticism,neurotic disorder,GCST010017,3:107482581
rs7772160-<b>C</b>,3 x 10-8,,0.4783,'-,0.01061 unit decrease,[0.0069-0.0144],"ZNF184, MCFD2P1",Neuroticism,neurotic disorder,GCST010017,6:27444607
rs6916891-<b>T</b>,3 x 10-8,,0.1176,'-,0.01064 unit increase,[0.0069-0.0144],MIR2113,Neuroticism,neurotic disorder,GCST010017,6:98009719
rs56226325-<b>T</b>,4 x 10-8,,0.1534,'-,0.01052 unit decrease,[0.0068-0.0143],MAD1L1,Neuroticism,neurotic disorder,GCST010017,7:2039346
rs73167875-<b>A</b>,2 x 10-8,,0.2022,'-,0.01083 unit decrease,[0.0071-0.0146],SEMA3E,Neuroticism,neurotic disorder,GCST010017,7:83309780
rs6976111-<b>A</b>,1 x 10-8,,0.2993,'-,0.01101 unit increase,[0.0072-0.0148],CTTNBP2,Neuroticism,neurotic disorder,GCST010017,7:117855613
rs7869969-<b>G</b>,1 x 10-8,,0.3321,'-,0.01087 unit decrease,[0.0071-0.0146],FAM120A,Neuroticism,neurotic disorder,GCST010017,9:93455165
rs2094580-<b>G</b>,3 x 10-8,,0.2825,'-,0.01071 unit increase,[0.0069-0.0145],TLR4,Neuroticism,neurotic disorder,GCST010017,9:117728579
rs35982947-<b>C</b>,1 x 10-8,,0.3692,'-,0.01109 unit decrease,[0.0073-0.0149],MED24,Neuroticism,neurotic disorder,GCST010017,17:40058022
rs9952522-<b>C</b>,2 x 10-8,,0.4084,'-,0.01074 unit decrease,[0.007-0.0145],ASXL3,Neuroticism,neurotic disorder,GCST010017,18:33706165
rs30266-<b>A</b>,4 x 10-6,,NR,1.009,'-,[1.005-1.013],'-,Neuroticism,neurotic disorder,GCST010017,5:104636656
rs13226841-<b>C</b>,6 x 10-11,,0.4896,'-,0.0125 unit increase,[0.0088-0.0162],GRM8,Neuroticism,neurotic disorder,GCST010017,7:126749354
rs7845515-<b>A</b>,7 x 10-11,,0.2875,'-,0.01267 unit increase,[0.0089-0.0165],"SNORA70, CSMD1",Neuroticism,neurotic disorder,GCST010017,8:5088706
rs2071754-<b>C</b>,4 x 10-11,,0.201,'-,0.01262 unit increase,[0.0089-0.0164],PAX6,Neuroticism,neurotic disorder,GCST010017,11:31791034
rs10896636-<b>G</b>,3 x 10-11,,0.3449,'-,0.01281 unit increase,[0.009-0.0166],ZDHHC5,Neuroticism,neurotic disorder,GCST010017,11:57680560
rs4140799-<b>G</b>,4 x 10-11,,0.47,'-,0.01268 unit increase,[0.0089-0.0164],SIPA1L1,Neuroticism,neurotic disorder,GCST010017,14:71704252
rs11090045-<b>A</b>,1 x 10-11,,0.3031,'-,0.01321 unit increase,[0.0094-0.017],ZC3H7B,Neuroticism,neurotic disorder,GCST010017,22:41357599
rs1002656-<b>C</b>,8 x 10-10,,0.2905,'-,0.01183 unit increase,[0.0081-0.0156],"GRIK3, FTLP18",Neuroticism,neurotic disorder,GCST010017,1:36727140
rs1542212-<b>G</b>,4 x 10-10,,0.3917,'-,0.01205 unit increase,[0.0083-0.0158],ARPP21,Neuroticism,neurotic disorder,GCST010017,3:35642443
rs4413518-<b>A</b>,1 x 10-10,,0.2189,'-,0.01234 unit increase,[0.0086-0.0161],FBXL17,Neuroticism,neurotic disorder,GCST010017,5:108402300
rs11509880-<b>A</b>,2 x 10-10,,0.3278,'-,0.01211 unit increase,[0.0084-0.0159],TMEM106B,Neuroticism,neurotic disorder,GCST010017,7:12222285
rs11608355-<b>C</b>,7 x 10-10,,0.3132,'-,0.01181 unit increase,[0.0081-0.0156],MYO1H,Neuroticism,neurotic disorder,GCST010017,12:109441487
rs3741475-<b>A</b>,4 x 10-10,,0.1944,'-,0.01194 unit increase,[0.0082-0.0157],NOS1,Neuroticism,neurotic disorder,GCST010017,12:117232109
rs274632-<b>A</b>,2 x 10-9,,0.4229,'-,0.01153 unit decrease,[0.0078-0.0153],GRM3,Neuroticism,neurotic disorder,GCST010017,7:86639865
rs2380937-<b>C</b>,5 x 10-9,,0.4011,'-,0.01119 unit decrease,[0.0074-0.0149],GLIS3,Neuroticism,neurotic disorder,GCST010017,9:4145781
rs56084168-<b>T</b>,1 x 10-10,,0.1478,'-,0.0123 unit decrease,[0.0086-0.016],"AATK, BAIAP2",Neuroticism,neurotic disorder,GCST010017,17:81110774
rs56403421-<b>C</b>,4 x 10-10,,0.3309,'-,0.01207 unit increase,[0.0083-0.0159],LINC01929,Neuroticism,neurotic disorder,GCST010017,18:55098052
rs12145171-<b>C</b>,7 x 10-9,,0.4283,'-,0.01105 unit decrease,[0.0073-0.0148],DNM3,Neuroticism,neurotic disorder,GCST010017,1:171874109
rs6743916-<b>A</b>,3 x 10-9,,0.2927,'-,0.01136 unit decrease,[0.0076-0.0151],LINC01122,Neuroticism,neurotic disorder,GCST010017,2:58477314
rs10935184-<b>C</b>,1 x 10-9,,0.4093,'-,0.01165 unit decrease,[0.0079-0.0154],STAG1,Neuroticism,neurotic disorder,GCST010017,3:136434626
rs13102162-<b>G</b>,7 x 10-9,,0.3591,'-,0.01124 unit decrease,[0.0074-0.015],MMRN1,Neuroticism,neurotic disorder,GCST010017,4:90018416
rs7696796-<b>A</b>,5 x 10-9,,0.2464,'-,0.01116 unit increase,[0.0074-0.0149],TENM3,Neuroticism,neurotic disorder,GCST010017,4:182245316
rs2148254-<b>G</b>,4 x 10-9,,0.4928,'-,0.01133 unit decrease,[0.0076-0.0151],HIVEP1,Neuroticism,neurotic disorder,GCST010017,6:11994529
rs4977844-<b>C</b>,4 x 10-9,,0.3598,'-,0.01136 unit increase,[0.0076-0.0152],'-,Neuroticism,neurotic disorder,GCST010017,9:23295901
rs1518395-<b>?</b>,1 x 10-6,,NR,1.0090817,'-,[1.01-1.01],VRK2,Neuroticism,neurotic disorder,GCST010017,2:57980939
rs301806-<b>C</b>,4 x 10-6,,NR,1.009,'-,[1.005-1.013],RERE,Neuroticism,neurotic disorder,GCST010017,1:8422018
rs4543289-<b>?</b>,9 x 10-6,,NR,1.0080645,'-,[1.01-1.01],'-,Neuroticism,neurotic disorder,GCST010017,5:165057942
rs17699030-<b>?</b>,8 x 10-6,,NR,1.7062,'-,[NR],DOCK6,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,19:11220266
rs17764205-<b>?</b>,5 x 10-6,,NR,1.3597,'-,[NR],CELF5,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,19:3251221
rs2018368-<b>?</b>,1 x 10-6,,NR,1.2392,'-,[NR],"Y_RNA, IRAG1",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,11:10718819
rs2367911-<b>?</b>,5 x 10-6,,NR,1.771,'-,[NR],CACNA2D1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:82156904
rs2530215-<b>?</b>,7 x 10-6,,NR,1.2196,'-,[NR],CTNND2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:11298111
rs2841307-<b>?</b>,1 x 10-6,,NR,1.3621,'-,[NR],SIM1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,6:100308811
rs4332358-<b>?</b>,5 x 10-6,,NR,1.2615,'-,[NR],"NGF, NGF-AS1",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,1:115333024
rs4822752-<b>?</b>,9 x 10-6,,NR,1.216,'-,[NR],CRYBB1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,22:26615456
rs4949526-<b>?</b>,4 x 10-7,,NR,1.2805,'-,[NR],LINC01648,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,1:29959372
rs17323670-<b>?</b>,7 x 10-6,,NR,1.7476,'-,[NR],MCC,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:113244593
rs10486158-<b>?</b>,6 x 10-6,,NR,1.2739,'-,[NR],COL28A1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:7359773
rs10508558-<b>?</b>,9 x 10-6,,NR,1.5425,'-,[NR],"SLC39A12, CACNB2",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,10:18099505
rs1092015-<b>?</b>,8 x 10-6,,NR,2.0443,'-,[NR],SLC35F4,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,14:57734007
rs11880706-<b>?</b>,2 x 10-6,,NR,1.4393,'-,[NR],RFX2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,19:6080471
rs10949808-<b>?</b>,1 x 10-7,,NR,1.2699,'-,[NR],Y_RNA,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:156255955
rs1106634-<b>?</b>,4 x 10-6,,NR,1.344,'-,[NR],ATP6V1B2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:20208538
rs11072089-<b>?</b>,3 x 10-6,,NR,1.8896,'-,[NR],PAQR5,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,15:69357714
rs11097407-<b>?</b>,4 x 10-6,,NR,1.2498,'-,[NR],SMARCAD1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,4:94224984
rs11156606-<b>?</b>,3 x 10-6,,NR,1.4169,'-,[NR],ABCD1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:153741041
rs11168351-<b>?</b>,9 x 10-6,,NR,1.2231,'-,[NR],"COL2A1, SENP1",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,12:48009982
rs11258317-<b>?</b>,6 x 10-6,,NR,1.2306,'-,[NR],"PRKCQ, LINC02649",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,10:6365775
rs11740562-<b>?</b>,1 x 10-6,,NR,1.5638,'-,[NR],ADAM19,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:157515277
rs11789399-<b>?</b>,6 x 10-9,,NR,1.2935,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,9:118597008
rs10042348-<b>?</b>,5 x 10-6,,NR,1.2948,'-,[NR],"KATNBL1P4, RNA5SP182",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:51922017
rs12003180-<b>?</b>,5 x 10-6,,NR,1.6032,'-,[NR],TTC39B,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,9:15283099
rs12201676-<b>?</b>,4 x 10-8,,NR,1.3139,'-,[NR],"RNGTT, RNU2-61P",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,6:89022382
rs12282742-<b>?</b>,1 x 10-6,,NR,1.6703,'-,[NR],"SAA2, SAA2-SAA4",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,11:18244252
rs12321565-<b>?</b>,5 x 10-6,,NR,1.3481,'-,[NR],IFNG-AS1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,12:68138297
rs7512769-<b>?</b>,2 x 10-6,,NR,1.2898,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,Mapping not available
rs6952808-<b>?</b>,2 x 10-6,,NR,1.2541,'-,[NR],MAD1L1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:1846899
rs1107592-<b>?</b>,2 x 10-6,,NR,1.2384,'-,[NR],MAD1L1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:2001797
rs11239177-<b>?</b>,3 x 10-6,,NR,1.2306,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,10:44627931
rs6607284-<b>?</b>,7 x 10-6,,NR,1.2262,'-,[NR],"HNF1B, DDX52",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,17:37666305
rs2398668-<b>?</b>,7 x 10-6,,NR,1.2261,'-,[NR],SNX8,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:2258592
rs2424635-<b>?</b>,7 x 10-6,,NR,1.2261,'-,[NR],SYNDIG1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,20:24736449
rs992564-<b>?</b>,4 x 10-6,,NR,1.6221,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,Mapping not available
rs6986718-<b>?</b>,9 x 10-6,,NR,1.5223,'-,[NR],SNTB1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:120623156
rs17166499-<b>?</b>,5 x 10-6,,NR,1.5129,'-,[NR],"RBMX2P4, RN7SKP228",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:12897630
rs6627057-<b>?</b>,1 x 10-6,,NR,1.4569,'-,[NR],RN7SKP189,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:145059799
rs10929808-<b>?</b>,4 x 10-6,,NR,1.3678,'-,[NR],MIR3681HG,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,2:12428870
rs4143844-<b>?</b>,4 x 10-6,,NR,1.4298,'-,[NR],VPS13C,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,15:62020641
rs17002034-<b>?</b>,4 x 10-6,,NR,1.3976,'-,[NR],MRTFA,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,22:40600363
rs10496702-<b>?</b>,7 x 10-7,,NR,1.3968,'-,[NR],NCKAP5,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,2:133247997
rs6444931-<b>?</b>,6 x 10-7,,NR,1.3421,'-,[NR],CLDN11,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,3:170445686
rs240444-<b>?</b>,2 x 10-6,,NR,1.3094,'-,[NR],BAGE2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,21:10510446
rs7727102-<b>?</b>,1 x 10-6,,NR,1.3053,'-,[NR],LINC02114,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:4720472
rs2044117-<b>?</b>,5 x 10-7,,NR,1.3006,'-,[NR],"NALCN-AS1, NALCN",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:101055958
rs7533906-<b>?</b>,4 x 10-6,,NR,1.2982,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,1:79668438
rs7248363-<b>?</b>,1 x 10-6,,NR,1.296,'-,[NR],PGPEP1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,19:18357076
rs11955175-<b>?</b>,6 x 10-6,,NR,1.467,'-,[NR],TTC33,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:40626651
rs12444931-<b>?</b>,5 x 10-6,,NR,1.2244,'-,[NR],RBFOX1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,16:7703702
rs13064588-<b>?</b>,4 x 10-6,,NR,1.2367,'-,[NR],CACNA2D3,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,3:54598520
rs134882-<b>?</b>,7 x 10-6,,NR,1.2196,'-,[NR],"TCF20, OGFRP1",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,22:42274959
rs1410530-<b>?</b>,4 x 10-6,,NR,1.3746,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:83280161
rs1456737-<b>?</b>,5 x 10-6,,NR,1.2492,'-,[NR],DMD,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:32207138
rs1605834-<b>?</b>,8 x 10-6,,NR,1.3206,'-,[NR],"RNA5SP87, LINC01830",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,2:22353228
rs1704734-<b>?</b>,6 x 10-6,,NR,1.3235,'-,[NR],TMX3,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,18:68646835
rs17069122-<b>?</b>,1 x 10-6,,NR,2.3265,'-,[NR],"MTHFD2P3, RPL3P7",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,6:108002555
rs17176973-<b>?</b>,5 x 10-6,,NR,1.776,'-,[NR],DAP-DT,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:10811362
rs173896-<b>?</b>,7 x 10-6,,NR,1.4282,'-,[NR],NREP,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:111771418
rs1806864-<b>?</b>,1 x 10-6,,NR,1.4392,'-,[NR],DAPK1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,9:87416754
rs1992045-<b>?</b>,2 x 10-7,,NR,1.563,'-,[NR],LINC01602,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:57928365
rs213443-<b>?</b>,6 x 10-6,,NR,1.248,'-,[NR],POU3F4,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:83456934
rs2276498-<b>?</b>,7 x 10-6,,NR,1.3111,'-,[NR],BCAS1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,20:53993957
rs2509843-<b>?</b>,2 x 10-7,,NR,1.2684,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,11:98254676
rs252817-<b>?</b>,2 x 10-6,,NR,1.2431,'-,[NR],EFNA5,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:107388887
rs2235121-<b>?</b>,8 x 10-6,,NR,1.221,'-,[NR],MYOM2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:2092276
rs10815468-<b>?</b>,7 x 10-6,,NR,1.2194,'-,[NR],KDM4C,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,9:6784726
rs2643217-<b>?</b>,6 x 10-6,,NR,1.2713,'-,[NR],LINC02694,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,15:38711562
rs2774292-<b>?</b>,3 x 10-6,,NR,2.0874,'-,[NR],SYT6,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,1:114172962
rs28890483-<b>?</b>,9 x 10-6,,NR,1.3904,'-,[NR],FAM81A,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,15:59426970
rs4006360-<b>?</b>,4 x 10-6,,NR,1.2328,'-,[NR],"KRTAP4-7, KRTAP4-8",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,17:41094387
rs435746-<b>?</b>,3 x 10-6,,NR,1.283,'-,[NR],VAT1L,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,16:77882294
rs4770837-<b>?</b>,5 x 10-6,,NR,1.246,'-,[NR],ATP8A2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:25463822
rs4870684-<b>?</b>,5 x 10-6,,NR,1.2718,'-,[NR],BSNDP4,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:57639445
rs493187-<b>?</b>,3 x 10-6,,NR,1.2298,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,6:86756774
rs4996815-<b>?</b>,1 x 10-7,,NR,1.2764,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:105999312
rs5907577-<b>?</b>,5 x 10-6,,NR,1.2743,'-,[NR],"HNRNPA3P3, RN7SL727P",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:140084524
rs5955415-<b>?</b>,2 x 10-6,,NR,1.4612,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,X:140231900
rs6046396-<b>?</b>,4 x 10-7,,NR,1.2815,'-,[NR],RIN2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,20:19871859
rs6561750-<b>?</b>,9 x 10-6,,NR,1.2266,'-,[NR],LINC00558,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:53861102
rs7386474-<b>?</b>,3 x 10-6,,NR,1.2301,'-,[NR],"GPR20, LINC01300",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:141349451
rs7465272-<b>?</b>,9 x 10-6,,NR,1.2559,'-,[NR],"ARC, MROH4P",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:142610477
rs767770-<b>?</b>,6 x 10-6,,NR,1.7173,'-,[NR],"STOM, GSN",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,9:121336257
rs7941534-<b>?</b>,8 x 10-6,,NR,1.2722,'-,[NR],LINC02151,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,11:116529665
rs802568-<b>?</b>,2 x 10-7,,NR,2.0307,'-,[NR],CNTNAP2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,7:146262151
rs830407-<b>?</b>,8 x 10-6,,NR,1.3581,'-,[NR],"SPINK4, B4GALT1-AS1",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,9:33217268
rs913246-<b>?</b>,7 x 10-6,,NR,1.9374,'-,[NR],LINC00598,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:40374014
rs915071-<b>?</b>,2 x 10-6,,NR,1.2346,'-,[NR],LINC02313,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,14:31964652
rs9377619-<b>?</b>,2 x 10-6,,NR,1.3421,'-,[NR],'-,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,6:104145992
rs9561428-<b>?</b>,9 x 10-6,,NR,1.8346,'-,[NR],GPC6,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:93688843
rs993804-<b>?</b>,1 x 10-6,,NR,1.2846,'-,[NR],RNA5SP125,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,3:25070680
rs1124376-<b>?</b>,5 x 10-6,,NR,1.2753,'-,[NR],KAT2B,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,3:20067054
rs278567-<b>?</b>,8 x 10-6,,NR,1.247,'-,[NR],C8orf87,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:93157121
rs1395103-<b>?</b>,9 x 10-6,,NR,1.2382,'-,[NR],SGO1-AS1,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,3:20573781
rs7735699-<b>?</b>,6 x 10-6,,NR,1.2285,'-,[NR],CMYA5,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:79803641
rs13183791-<b>?</b>,6 x 10-6,,NR,1.5749,'-,[NR],ADAMTS6,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,5:65238814
rs1446682-<b>?</b>,6 x 10-6,,NR,1.2633,'-,[NR],STMN4,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,8:27219081
rs16822582-<b>?</b>,8 x 10-6,,NR,1.4994,'-,[NR],PYDC2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,3:191478803
rs17111920-<b>?</b>,3 x 10-6,,NR,2.4079,'-,[NR],MIR4307HG,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,14:26937686
rs12745968-<b>?</b>,8 x 10-7,,NR,1.2527,'-,[NR],DIPK1A,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,1:92936280
rs7319311-<b>?</b>,4 x 10-6,,NR,1.2452,'-,[NR],COL4A2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,13:110378231
rs6024905-<b>?</b>,1 x 10-6,,NR,1.2399,'-,[NR],BPI,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,20:38329435
rs12125383-<b>?</b>,5 x 10-8,,NR,1.28,'-,'-,"LINC01705, LINC02474",Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,1:221995092
rs147124286-<b>?</b>,4 x 10-7,,NR,1.3513513,'-,'-,SP1,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,12:53394219
rs2045091-<b>?</b>,5 x 10-7,,NR,1.25,'-,'-,ASAP1,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,8:130063613
rs114573015-<b>?</b>,6 x 10-7,,NR,2.1,'-,'-,"MIR4423, SYDE2",Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,1:85137368
rs71920662-<b>?</b>,4 x 10-113,,'-,'-,'-,'-,'-,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,Mapping not available
rs10675541-<b>?</b>,7 x 10-19,,'-,'-,'-,'-,MOBP,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,3:39468796
rs57113693-<b>?</b>,9 x 10-16,,'-,'-,'-,'-,STX6,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,1:180983158
rs35740963-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,RUNX2,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,6:45531877
rs7966334-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,SLCO1A2,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,12:21314281
rs12125383-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,"LINC01705, LINC02474",Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,1:221995092
rs147124286-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,SP1,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,12:53394219
rs2045091-<b>?</b>,5 x 10-7,,'-,'-,'-,'-,ASAP1,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,8:130063613
rs114573015-<b>?</b>,6 x 10-7,,'-,'-,'-,'-,"MIR4423, SYDE2",Progressive supranuclear palsy,Progressive supranuclear palsy,GCST006418,1:85137368
"rs8453-<b>G</b>, rs926938-<b>A</b>",3 x 10-8,,0.481,'-,'-,'-,CSDE1; No mapped genes,Autism,autism,GCST002268,1:114716978
"rs1877455-<b>T</b>, rs11587400-<b>C</b>",7 x 10-8,,0.449,'-,'-,'-,PKMP1 - BCAS2; No mapped genes,Autism,autism,GCST002268,1:114556471
rs6537825-<b>A</b>,3 x 10-8,,NR,1.4,'-,[NR],'-,Autism,autism,GCST002268,Mapping not available
rs926938-<b>A</b>,4 x 10-8,,0.5,1.27,'-,[NR],'-,Autism,autism,GCST002268,Mapping not available
rs6538761-<b>A</b>,2 x 10-6,,NR,1.24,'-,[NR],Y_RNA,Autism,autism,GCST002268,12:97040442
rs11588454-<b>T</b>,3 x 10-6,(Males),0.75,'-,0.069 unit decrease,[0.040-0.098],LINC02770,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,1:191832003
rs999944-<b>A</b>,2 x 10-7,(Hispanic),0.112,'-,0.104 unit decrease,[0.065-0.143],"RN7SL341P, Y_RNA",Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,2:64822719
rs999944-<b>A</b>,1 x 10-6,,0.112,'-,0.072 unit decrease,[0.043-0.101],"RN7SL341P, Y_RNA",Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,2:64822719
rs199803244-<b>A</b>,5 x 10-7,"(Hispanic, females)",0.945,'-,0.187 unit increase,[0.11-0.26],SMCO2,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,12:27501431
rs11588454-<b>T</b>,8 x 10-8,"(Hispanic, males)",0.75,'-,0.124 unit decrease,[0.079-0.169],LINC02770,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,1:191832003
rs140743827-<b>A</b>,5 x 10-6,(Hispanic),NR,'-,0.218 unit increase,[0.12-0.31],RNU6-755P,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,1:165016519
rs11897825-<b>A</b>,3 x 10-7,(Females),NR,'-,0.08 unit decrease,[0.049-0.111],LINC01121,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,2:21471579
rs75108997-<b>A</b>,8 x 10-6,,0.013,'-,0.21 unit decrease,[0.12-0.3],"ATP2B4, LAX1",Obstructive sleep apnea (average oxygen saturation during sleep),"sleep apnea measurement, obstructive sleep apnea",GCST003673,1:203747715
rs7108263-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,LINC02697,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,11:134887988
rs7960954-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,LINC02408,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,12:67500839
rs149640-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,RGS6,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,14:72187545
rs56979833-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,"SYNGR2P1, NCAPGP2",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,15:30008518
rs2725797-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,LINC02694,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,15:38817032
rs74643788-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,XYLT1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,16:17268972
rs11641605-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,LINC02141,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,16:60022652
rs35693284-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,"CYB5A, RN7SL551P",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,18:74229912
rs1698919-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,'-,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,18:77654787
rs710160-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SHKBP1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,19:40581585
rs841163-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,"OR14K1, OR1C1",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,1:247747158
rs78864163-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"TBC1D5, SATB1",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,3:18369916
rs1426040-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,CLSTN2,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,3:139978453
rs35396788-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,TAPT1-AS1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,4:16240096
rs3822095-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,SNCA,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,4:89815366
rs72737007-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,LINC02112,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,5:9972483
rs6891905-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,SPEF2,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,5:35670639
rs77093473-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"NSG2, LINC01411",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,5:174306555
rs12524310-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,Y_RNA,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,6:67669441
rs12196063-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,PREP,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,6:105460080
rs73262722-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,UNCX,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,7:1277531
rs73679687-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,DGKB,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,7:14211096
rs1078793-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,RAMP3,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,7:45127042
rs17567824-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,ADCY1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,7:45593023
rs12547243-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,ADCY8,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,8:130909710
rs754118-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,PTPN1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,20:50575367
rs2829877-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,JAM2,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,21:25714732
rs9975725-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,"EIF4A1P1, RPL10P1",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,21:27416024
rs11017928-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,DOCK1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,10:127409786
rs61903333-<b>?</b>,7 x 10-6,(EA),NR,'-,'-,'-,"OR5AN2P, RN7SL435P",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,11:59292111
rs72680082-<b>?</b>,9 x 10-6,(EA),NR,'-,'-,'-,LINC01588,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,14:49997780
rs2725797-<b>?</b>,8 x 10-7,(EA),NR,'-,'-,'-,LINC02694,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,15:38817032
rs74643788-<b>?</b>,5 x 10-8,(EA),NR,'-,'-,'-,XYLT1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,16:17268972
rs6499854-<b>?</b>,7 x 10-6,(EA),NR,'-,'-,'-,NUP93,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,16:56846930
rs12451924-<b>?</b>,7 x 10-6,(EA),NR,'-,'-,'-,SLFN12L,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,17:35497512
rs1698919-<b>?</b>,4 x 10-7,(EA),NR,'-,'-,'-,'-,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,18:77654787
rs710160-<b>?</b>,6 x 10-7,(EA),NR,'-,'-,'-,SHKBP1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,19:40581585
rs6736607-<b>?</b>,6 x 10-6,(EA),NR,'-,'-,'-,"SLC8A1-AS1, SLC8A1",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,2:40207400
rs6788567-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,"LINC02042, CCDC80",Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,3:112718200
rs72737007-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,LINC02112,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,5:9972483
rs6891905-<b>?</b>,6 x 10-6,(EA),NR,'-,'-,'-,SPEF2,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,5:35670639
rs201158842-<b>?</b>,5 x 10-6,(EA),NR,'-,'-,'-,SLC25A48,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,5:135769260
rs12524310-<b>?</b>,9 x 10-7,(EA),NR,'-,'-,'-,Y_RNA,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,6:67669441
rs73262722-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,UNCX,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,7:1277531
rs17567824-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,ADCY1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,7:45593023
rs12547243-<b>?</b>,3 x 10-7,(EA),NR,'-,'-,'-,ADCY8,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,8:130909710
rs754118-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,PTPN1,Age at loss of ambulation in Duchenne muscular dystrophy,"Duchenne muscular dystrophy, disease progression measurement",GCST006286,20:50575367
rs3181077-<b>T</b>,6 x 10-6,,0.87,1.63,'-,[1.32-2.02],CCR3,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST002912,3:46209161
rs198811-<b>A</b>,1 x 10-8,,0.81,1.69,'-,[1.41-2.03],H2AC6,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST002912,6:26128218
rs4290173-<b>C</b>,5 x 10-6,,0.902,1.8,'-,[1.4-2.32],"A1CF, MIX23P2",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST002912,10:50890011
rs1154155-<b>C</b>,1 x 10-11,,0.431,1.71,'-,[NR],"TRAJ9, TRAJ10",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST002912,14:22533736
rs9270965-<b>?</b>,5 x 10-12,,NR,1.72,'-,[NR],"HLA-DQA1, HLA-DRB1",Narcolepsy (onset before 2009 H1N1 influenza pandemic),narcolepsy with cataplexy,GCST002259,6:32605694
rs9271117-<b>?</b>,6 x 10-14,,NR,1.75,'-,[NR],"HLA-DRB1, HLA-DQA1",Narcolepsy (onset before 2009 H1N1 influenza pandemic),narcolepsy with cataplexy,GCST002259,6:32609018
rs17212223-<b>T</b>,3 x 10-8,,0.191,'-,1.95 year decrease,'-,"HLA-DQB1, MTCO3P1",Narcolepsy (age of onset),"narcolepsy with cataplexy, age at onset",GCST002261,6:32683763
rs7744020-<b>A</b>,8 x 10-9,,0.272,'-,1.9 year decrease,'-,"HLA-DQB1, HLA-DQA1",Narcolepsy (age of onset),"narcolepsy with cataplexy, age at onset",GCST002261,6:32658353
rs9274477-<b>G</b>,2 x 10-8,,0.292,'-,1.82 year decrease,'-,HLA-DQB1,Narcolepsy (age of onset),"narcolepsy with cataplexy, age at onset",GCST002261,6:32665936
rs1154155-<b>G</b>,5 x 10-7,,0.15,1.54,'-,[1.30-1.95],"TRAJ9, TRAJ10",Narcolepsy,narcolepsy with cataplexy,GCST000771,14:22533736
rs2858884-<b>A</b>,3 x 10-8,,0.81,1.79,'-,[1.45-2.17],"HLA-DQB3, HLA-DQA2",Narcolepsy,narcolepsy with cataplexy,GCST000771,6:32732306
rs16966122-<b>?</b>,2 x 10-6,(ESS),NR,'-,1.601 unit decrease,[NR],RNA5SP471,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST001909,19:31667558
rs2859998-<b>?</b>,1 x 10-7,(Age EDS onset),NR,'-,4.4145 unit decrease,[NR],UBXN2B,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST001909,8:58411603
rs12425451-<b>?</b>,2 x 10-7,(Age cataplexy onset),NR,'-,6.7866 unit decrease,[NR],"TSPAN9, TEAD4",Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST001909,12:3055757
rs2426087-<b>?</b>,2 x 10-6,(SE),NR,'-,10.463 unit increase,[NR],PREX1,Narcolepsy with cataplexy,narcolepsy with cataplexy,GCST001909,20:48763274
rs10275045-<b>?</b>,2 x 10-9,(SCZ or BP vs. controls),'-,'-,'-,'-,MAD1L1,Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,7:1881190
rs4356203-<b>?</b>,6 x 10-9,(SCZ or BP vs. controls),'-,'-,'-,'-,PIK3C2A,Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,11:17138601
rs4650608-<b>?</b>,8 x 10-9,(SCZ or BP vs. controls),'-,'-,'-,'-,'-,Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,1:78772330
rs1006737-<b>?</b>,6 x 10-13,(SCZ or BP vs. controls),'-,'-,'-,'-,CACNA1C,Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,12:2236129
rs17693963-<b>?</b>,3 x 10-11,(SCZ or BP vs. controls),'-,'-,'-,'-,"GPR89P, RSL24D1P1",Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,6:27742386
rs9834970-<b>?</b>,1 x 10-10,(SCZ or BP vs. controls),'-,'-,'-,'-,"LINC02033, HSPD1P6",Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,3:36814539
rs7219021-<b>?</b>,1 x 10-7,(SCZ vs. BP),'-,'-,'-,'-,TTLL6,Schizophrenia or bipolar disorder,"schizophrenia, bipolar disorder",GCST002295,17:48763179
rs6857-<b>T</b>,3 x 10-21,,0.3429,'-,0.6708 unit increase,[0.53-0.81],NECTIN2,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,19:44888997
rs16989979-<b>T</b>,2 x 10-6,,0.2408,'-,0.3325 unit decrease,[0.2-0.47],'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,4:34543724
rs17014760-<b>A</b>,7 x 10-6,,0.2465,'-,0.3262 unit increase,[0.18-0.47],'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,4:129419725
rs1116547-<b>T</b>,7 x 10-6,,0.1269,'-,0.396 unit decrease,[0.22-0.57],MCC,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,5:113344640
rs11075138-<b>G</b>,8 x 10-6,,0.9067,'-,0.5115 unit decrease,[0.29-0.74],"SNX29, CPPED1",Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,16:12629954
rs7817714-<b>C</b>,9 x 10-6,,0.859,'-,0.4448 unit decrease,[0.25-0.64],NCALD,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,8:102036582
chr7:18698331-<b>G</b>,9 x 10-6,,0.9733,'-,1.1568 unit decrease,[0.65-1.67],'-,Cerebral amyloid angiopathy,cerebral amyloid angiopathy,GCST002588,Mapping not available
rs2273500-<b>C</b>,8 x 10-9,,0.15,'-,0.058 unit increase,[NR],CHRNA4,Nicotine dependence,nicotine dependence,GCST003185,20:63355597
rs34684276-<b>A</b>,4 x 10-17,,0.35,'-,0.067 unit increase,[NR],HYKK,Nicotine dependence,nicotine dependence,GCST003185,15:78520813
rs55828312-<b>G</b>,1 x 10-6,,0.22,'-,0.034 unit decrease,[NR],CHRNB3,Nicotine dependence,nicotine dependence,GCST003185,8:42734459
rs910083-<b>C</b>,4 x 10-8,,NR,'-,0.032 unit increase,[0.021-0.043],DNMT3B,Nicotine dependence,nicotine dependence,GCST008496,20:32790884
rs6062901-<b>G</b>,8 x 10-7,(EA),NR,'-,0.043 unit increase,[0.026-0.06],CHRNA4,Nicotine dependence,nicotine dependence,GCST008496,20:63348909
rs6062901-<b>G</b>,3 x 10-7,,NR,'-,0.034 unit increase,[0.021-0.047],CHRNA4,Nicotine dependence,nicotine dependence,GCST008496,20:63348909
rs2273500-<b>C</b>,2 x 10-6,(EA),NR,'-,0.046 unit increase,[0.027-0.065],CHRNA4,Nicotine dependence,nicotine dependence,GCST008496,20:63355597
rs56116178-<b>G</b>,5 x 10-7,(EA),NR,'-,0.053 unit increase,[0.033-0.073],FAM163B,Nicotine dependence,nicotine dependence,GCST008496,9:133595102
rs56116178-<b>G</b>,5 x 10-7,,NR,'-,0.053 unit increase,[0.033-0.073],FAM163B,Nicotine dependence,nicotine dependence,GCST008496,9:133595102
rs1451240-<b>?</b>,7 x 10-16,,NR,'-,'-,'-,CHRNB3,Nicotine dependence,nicotine dependence,GCST001490,8:42691568
rs1755715-<b>?</b>,9 x 10-7,(female),'-,'-,0.235 unit decrease,[0.14-0.33],GPR135,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,14:59440374
rs12769537-<b>?</b>,2 x 10-6,(female),'-,'-,0.458 unit increase,[0.27-0.65],"NHLRC2, ADRB1",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,10:113985179
rs76983293-<b>?</b>,2 x 10-6,(female),'-,'-,0.549 unit increase,[0.32-0.78],LINC00702,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,10:4174671
rs75502311-<b>?</b>,3 x 10-6,(female),'-,'-,0.397 unit increase,[0.23-0.56],LMO7,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,13:75856884
rs13110899-<b>?</b>,3 x 10-6,(female),'-,'-,0.225 unit decrease,[0.13-0.32],GRID2,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,4:92380531
rs352766-<b>?</b>,4 x 10-6,(female),'-,'-,0.296 unit decrease,[0.17-0.42],"PPM1AP1, TUSC3",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,8:15787050
rs1017722-<b>?</b>,5 x 10-6,(female),'-,'-,0.401 unit increase,[0.23-0.57],'-,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,12:84644357
rs1840717-<b>?</b>,6 x 10-6,(female),'-,'-,0.205 unit decrease,[0.12-0.29],GRID2,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,4:93035284
rs12635725-<b>?</b>,6 x 10-8,(male),'-,'-,0.291 unit decrease,[0.19-0.4],RPL21P17,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,3:1895465
rs28696717-<b>?</b>,1 x 10-6,(male),'-,'-,0.436 unit decrease,[0.26-0.61],"RN7SL44P, S100A7",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,1:153493087
rs2927709-<b>?</b>,3 x 10-6,(male),'-,'-,0.262 unit decrease,[0.15-0.37],CD320,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,19:8304859
rs11502414-<b>?</b>,3 x 10-6,(male),'-,'-,0.546 unit decrease,[0.32-0.77],"SLCO1B3, SLCO1C1",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,12:20773248
rs73001203-<b>?</b>,3 x 10-6,(male),'-,'-,0.403 unit decrease,[0.23-0.57],Y_RNA,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,18:78450570
rs7183340-<b>?</b>,3 x 10-6,(male),'-,'-,0.415 unit increase,[0.24-0.59],TUBGCP5,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,15:22987562
rs118110667-<b>?</b>,3 x 10-6,(male),'-,'-,0.54 unit decrease,[0.31-0.77],"HCAR3, HCAR2",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,12:122703817
rs11768490-<b>?</b>,4 x 10-6,(male),'-,'-,0.239 unit decrease,[0.14-0.34],"SEC61G, RPL31P35",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,7:54719568
rs6450514-<b>?</b>,4 x 10-6,(male),'-,'-,0.244 unit decrease,[0.14-0.35],PDE4D,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,5:59254713
rs1260555-<b>?</b>,5 x 10-6,(male),'-,'-,0.245 unit decrease,[0.14-0.35],"LSM14A, CHCHD2P3",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,19:34149686
rs12536521-<b>?</b>,3 x 10-7,(female),'-,'-,1.378 unit increase,[0.85-1.9],"FLNC, ZNF804B",Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,7:89349373
rs2364841-<b>?</b>,8 x 10-7,(female),'-,'-,0.322 unit increase,[0.19-0.45],ADCK1,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST007208,14:77817693
rs2077613-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,LINC01987,Obsessive-compulsive disorder x sex interaction,"obsessive-compulsive disorder, sex interaction measurement",GCST007207,17:77643885
rs79886445-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"LINC01526, SNORA70",Obsessive-compulsive disorder x sex interaction,"obsessive-compulsive disorder, sex interaction measurement",GCST007207,6:81808083
rs1844437-<b>C</b>,2 x 10-6,,0.22,'-,0.62 unit decrease,[NR],LINC02101,Hoarding,obsessive-compulsive disorder,GCST000932,5:58025127
rs2388436-<b>G</b>,6 x 10-6,,0.42,'-,0.51 unit increase,[NR],"LINC01581, H3P40",Hoarding,obsessive-compulsive disorder,GCST000932,15:94146424
rs3747767-<b>A</b>,7 x 10-7,,0.03,'-,1.81 unit increase,[NR],"SH3BGRL2, LCA5",Hoarding,obsessive-compulsive disorder,GCST000932,6:79547564
rs12265655-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,SORCS3,Mental disorder (without autoimmune disease),mental or behavioural disorder,GCST011007,10:104984776
rs6780942-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,'-,Mental disorder (without autoimmune disease),mental or behavioural disorder,GCST011007,3:118109831
rs148532090-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,IP6K2,Mental disorder (without autoimmune disease),mental or behavioural disorder,GCST011007,3:48714495
rs189071385-<b>?</b>,1 x 10-8,,NR,10.65,'-,[3.21-35.36],FBXL13,Autoimmune disease and mental disorder,"mental or behavioural disorder, autoimmune disease",GCST011009,7:102881823
rs7690467-<b>T</b>,7 x 10-6,(OCPD),0.715,1.12,'-,[1.07-1.18],ELL2P2,Eating disorders,mental or behavioural disorder,GCST001644,4:132405240
rs7624327-<b>A</b>,3 x 10-6,(Bulimia),0.098,1.13,'-,[1.06-1.16],"LINC00881, LINC00880",Eating disorders,mental or behavioural disorder,GCST001644,3:157119117
rs6894268-<b>A</b>,3 x 10-6,(Body Dissatisfaction),0.354,'-,1.439 unit increase,[0.84-2.04],RUFY1,Eating disorders,mental or behavioural disorder,GCST001644,5:179605487
rs1557305-<b>C</b>,5 x 10-6,(OCPD),0.628,1.11,'-,[1.06-1.16],'-,Eating disorders,mental or behavioural disorder,GCST001644,18:4721359
rs218361-<b>G</b>,7 x 10-6,(WF),0.429,1.061,'-,[1.03-1.08],'-,Eating disorders,mental or behavioural disorder,GCST001644,8:115098496
rs1898111-<b>A</b>,8 x 10-6,(OCPD),0.837,1.15,'-,[1.08-1.22],SEMA6D,Eating disorders,mental or behavioural disorder,GCST001644,15:47600101
rs10519201-<b>T</b>,6 x 10-6,(OCPD),0.132,1.158,'-,[1.09-1.23],'-,Eating disorders,mental or behavioural disorder,GCST001644,Mapping not available
rs7065696-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,PHF8,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000862,X:53947621
rs17645023-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,"CACNG4, RNA5SP446",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000862,17:66920916
rs11210359-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,RNU4ATAC8P,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000862,1:73873484
rs1795648-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,ERC2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000862,3:55537732
rs17075286-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,"SNRK, POMGNT2",Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000862,3:43189231
rs6459804-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,PTPRN2,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000862,7:157717503
rs144783209-<b>T</b>,3 x 10-7,,NR,1.47,'-,NR,SMAD1,Panic disorder,panic disorder,GCST009525,4:145482377
rs79919349-<b>A</b>,2 x 10-6,,NR,1.77,'-,NR,"RNU6-929P, PTMAP6",Panic disorder,panic disorder,GCST009525,20:56707790
rs41280169-<b>T</b>,3 x 10-6,,NR,1.4,'-,NR,PTBP3,Panic disorder,panic disorder,GCST009525,9:112220657
rs2554444-<b>T</b>,3 x 10-6,,NR,1.2048193,'-,NR,SNHG14,Panic disorder,panic disorder,GCST009525,15:25012438
rs6914428-<b>G</b>,5 x 10-6,,NR,1.1764705,'-,NR,DHFRP5,Panic disorder,panic disorder,GCST009525,6:62520835
rs17504106-<b>?</b>,5 x 10-6,AA,NR,2.97,'-,[NR],'-,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,5:161042632
rs12232346-<b>?</b>,2 x 10-6,,NR,'-,'-,[NR],"ACTC1, GJD2",Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,15:34768262
rs10768747-<b>?</b>,5 x 10-6,AA,NR,1.66,'-,[NR],LINC01499,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,11:41798900
rs73419609-<b>?</b>,6 x 10-6,AA,NR,2.22,'-,[NR],UNC13C,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,15:54423444
rs834811-<b>?</b>,7 x 10-6,AA,NR,1.63,'-,[NR],Y_RNA,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,7:136199823
rs7866350-<b>?</b>,1 x 10-6,EA,NR,2.27,'-,[NR],TBC1D2,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,9:98221544
rs1116255-<b>?</b>,5 x 10-6,EA,NR,2.19,'-,[NR],'-,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,13:54914870
rs2437772-<b>?</b>,6 x 10-6,EA,NR,1.79,'-,[NR],SDC2,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,8:96500749
rs61793204-<b>?</b>,9 x 10-6,EA,NR,2.5,'-,[NR],LINC02497,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002963,4:31288660
rs6812849-<b>?</b>,3 x 10-9,(Whole cohort; EA),NR,'-,'-,'-,TLL1,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002038,4:165951384
rs6812849-<b>?</b>,1 x 10-6,(Trauma Exposed controls; EA),NR,'-,'-,'-,TLL1,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002038,4:165951384
rs7158872-<b>?</b>,3 x 10-6,(Trauma exposed controls; AA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,14:48957639
rs7076096-<b>?</b>,5 x 10-6,(Trauma exposed controls; AA),NR,'-,'-,'-,GRID1,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,10:85848703
rs406001-<b>?</b>,2 x 10-8,(Whole cohort; EA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,7:51938719
rs4491792-<b>?</b>,4 x 10-6,(Whole cohort; EA),NR,'-,'-,'-,OTOR,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,20:16760180
rs2272651-<b>?</b>,3 x 10-6,(Whole cohort; EA),NR,'-,'-,'-,NDRG1,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,8:133258305
rs2779551-<b>?</b>,2 x 10-6,(Whole cohort; EA),NR,'-,'-,'-,GABBR2,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,9:98490944
rs6812849-<b>?</b>,1 x 10-7,(Whole cohort; EA),NR,'-,'-,'-,TLL1,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,4:165951384
rs16907840-<b>?</b>,8 x 10-6,(Whole cohort; EA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,10:55789536
rs406001-<b>?</b>,3 x 10-8,(Trauma exposed controls; EA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,7:51938719
rs6812849-<b>?</b>,5 x 10-7,(Trauma exposed controls; EA),NR,'-,'-,'-,TLL1,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,4:165951384
rs16904179-<b>?</b>,7 x 10-7,(Whole cohort; AA),NR,'-,'-,'-,CYRIB,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,8:129946705
rs7014900-<b>?</b>,4 x 10-6,(Trauma exposed controls; AA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,8:114566078
rs4430311-<b>?</b>,6 x 10-6,(Trauma exposed controls; EA),NR,'-,'-,'-,"LINC02774, AKT3",Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,1:243852691
rs1425392-<b>?</b>,7 x 10-6,(Trauma exposed controls; EA),NR,'-,'-,'-,"MTCO3P27, DPP3P1",Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,4:64526494
rs7014900-<b>?</b>,2 x 10-6,(Whole cohort; AA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,8:114566078
rs13006863-<b>?</b>,3 x 10-6,(Whole cohort; AA),NR,'-,'-,'-,SLC4A5,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,2:74236439
rs7158872-<b>?</b>,2 x 10-6,(Whole cohort; AA),NR,'-,'-,'-,'-,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,14:48957639
rs4955793-<b>?</b>,2 x 10-6,(Whole cohort; AA),NR,'-,'-,'-,ZMAT3,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,3:179064233
rs7207499-<b>?</b>,5 x 10-6,(Whole cohort; AA),NR,'-,'-,'-,PRKCA,Post-traumatic stress disorder (asjusted for relatedness),post-traumatic stress disorder,GCST002037,17:66451047
rs1033962-<b>A</b>,2 x 10-9,,0.22,1.43,'-,[1.31-1.55],PRTFDC1,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,10:24927877
rs2312236-<b>T</b>,3 x 10-6,(Hispanic),0.056,3.31,'-,[2.81-3.81],"POGK, CNN2P10",Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,1:166824980
rs4511180-<b>A</b>,8 x 10-7,(African American),0.268,4.178,'-,[3.62-4.74],PTPRVP,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,1:202180311
rs3100127-<b>A</b>,1 x 10-6,(African American),0.25,4.31,'-,[3.73-4.89],"PTPRVP, LGR6",Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,1:202191842
rs10457838-<b>C</b>,2 x 10-6,(African American),0.724,6.702,'-,[5.93-7.48],UST,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,6:149036411
rs2616978-<b>T</b>,3 x 10-6,(Hispanic),0.607,2.004,'-,[1.71-2.29],CSMD1,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,8:4620822
rs58649573-<b>T</b>,9 x 10-7,(African American),0.441,5.277,'-,[4.62-5.93],LHX2,Post-traumatic stress disorder,post-traumatic stress disorder,GCST002681,9:124005148
rs7789850-<b>?</b>,2 x 10-6,,0.026,4.6,'-,[2.70–7.83],AGK,Mood disorder and prion disease,"prion disease, mood disorder",GCST002862,7:141600811
rs12789145-<b>?</b>,4 x 10-6,,0.084,'-,'-,'-,"AMOTL1, LINC02700",Mood disorder and prion disease,"prion disease, mood disorder",GCST002862,11:94674570
rs6867820-<b>?</b>,6 x 10-6,,0.224,2.24,'-,[1.60–3.12],MGC32805,Mood disorder and prion disease,"prion disease, mood disorder",GCST002862,5:122518830
rs1219407-<b>?</b>,4 x 10-6,,0.073,7.6,'-,[2.83–20.39],'-,Mood disorder in prion disease,"prion disease, mood disorder",GCST002864,11:121873470
rs761998-<b>?</b>,7 x 10-6,,0.352,2.86,'-,[1.82-4.55],"FLRT3, MACROD2",Mood disorder in prion disease,"prion disease, mood disorder",GCST002864,20:14329306
rs12789145-<b>?</b>,8 x 10-6,,0.084,'-,'-,'-,"AMOTL1, LINC02700",Mood disorder in prion disease,"prion disease, mood disorder",GCST002864,11:94674570
rs28441017-<b>G</b>,9 x 10-6,,0.827,'-,0.086 unit decrease,[0.049-0.123],ALDH4A1,Anorexia nervosa,anorexia nervosa,GCST001961,1:18879840
rs62090893-<b>G</b>,3 x 10-7,,0.921,'-,0.085 unit decrease,[0.052-0.118],"SMIM21, TSHZ1",Anorexia nervosa,anorexia nervosa,GCST001961,18:75338379
rs56156506-<b>A</b>,1 x 10-6,,0.813,'-,0.053 unit decrease,[0.031-0.075],"SYTL5, SRPX",Anorexia nervosa,anorexia nervosa,GCST001961,X:38140399
rs469339-<b>A</b>,3 x 10-6,,0.977,'-,0.144 unit decrease,[0.083-0.205],MCTP1,Anorexia nervosa,anorexia nervosa,GCST001961,5:94812833
rs114945094-<b>G</b>,4 x 10-6,,0.959,'-,0.135 unit decrease,[0.078-0.192],TMEM106B,Anorexia nervosa,anorexia nervosa,GCST001961,7:12153806
rs1937020-<b>T</b>,4 x 10-6,,0.681,'-,0.041 unit decrease,[0.023-0.059],IFI44,Anorexia nervosa,anorexia nervosa,GCST001961,1:78762271
rs75263140-<b>A</b>,6 x 10-6,,0.974,'-,0.172 unit decrease,[0.098-0.246],CAMK1D,Anorexia nervosa,anorexia nervosa,GCST001961,10:12660570
rs8050187-<b>T</b>,7 x 10-6,,0.736,'-,0.044 unit decrease,[0.024-0.064],WWOX,Anorexia nervosa,anorexia nervosa,GCST001961,16:79152989
rs55946907-<b>C</b>,9 x 10-6,,0.901,'-,0.066 unit decrease,[0.037-0.095],QSOX1,Anorexia nervosa,anorexia nervosa,GCST001961,1:180161588
rs145241704-<b>T</b>,2 x 10-7,,0.952,'-,0.143 unit decrease,[0.09-0.196],"MTND1P3, MYL6P4",Anorexia nervosa,anorexia nervosa,GCST001961,7:141805287
rs76765968-<b>T</b>,2 x 10-6,,0.856,'-,0.064 unit decrease,[0.037-0.091],GRID1,Anorexia nervosa,anorexia nervosa,GCST001961,10:85934535
rs2043090-<b>A</b>,3 x 10-6,,0.959,'-,0.119 unit decrease,[0.068-0.17],LRMDA,Anorexia nervosa,anorexia nervosa,GCST001961,10:75538851
rs9531686-<b>T</b>,9 x 10-6,,0.571,'-,0.038 unit decrease,[0.022-0.054],LINC00375,Anorexia nervosa,anorexia nervosa,GCST001961,13:84975601
rs77742018-<b>A</b>,4 x 10-6,,0.946,'-,0.117 unit decrease,[0.068-0.166],C8orf37-AS1,Anorexia nervosa,anorexia nervosa,GCST001961,8:95492244
rs17496827-<b>C</b>,7 x 10-6,,0.55,'-,0.042 unit decrease,[0.024-0.06],SGPP2,Anorexia nervosa,anorexia nervosa,GCST001961,2:222488727
rs830998-<b>?</b>,9 x 10-6,,0.19,'-,'-,'-,LRP2,Anorexia nervosa,anorexia nervosa,GCST000873,2:169276576
rs17725255-<b>?</b>,2 x 10-6,,0.11,'-,'-,'-,"RNU7-137P, Y_RNA",Anorexia nervosa,anorexia nervosa,GCST000873,20:18098487
rs2383378-<b>?</b>,6 x 10-6,,0.41,'-,'-,'-,AKAP6,Anorexia nervosa,anorexia nervosa,GCST000873,14:32813264
rs410644-<b>?</b>,7 x 10-6,,0.47,'-,'-,'-,SSBP2,Anorexia nervosa,anorexia nervosa,GCST000873,5:81791715
rs6782029-<b>?</b>,9 x 10-6,,0.24,'-,'-,'-,VGLL4,Anorexia nervosa,anorexia nervosa,GCST000873,3:11634315
rs6959888-<b>?</b>,2 x 10-6,,0.11,'-,'-,'-,ZNF804B,Anorexia nervosa,anorexia nervosa,GCST000873,7:88967071
rs10494067-<b>?</b>,6 x 10-6,,0.06,'-,'-,'-,NTNG1,Anorexia nervosa,anorexia nervosa,GCST000873,1:107288236
rs4479806-<b>?</b>,8 x 10-6,,0.1,'-,'-,'-,CCNB3P1,Anorexia nervosa,anorexia nervosa,GCST000873,5:26723674
rs957788-<b>?</b>,8 x 10-6,,0.31,'-,'-,'-,FAM155A,Anorexia nervosa,anorexia nervosa,GCST000873,13:107604872
rs10799590-<b>G</b>,4 x 10-9,,0.49,1.56,'-,[1.35-1.82],CNIH3,Opioid dependence,opioid dependence,GCST003614,1:224634780
rs62062288-<b>A</b>,7 x 10-22,,0.2181,'-,0.01863 unit increase,[0.015-0.022],MAPT,Neuroticism,neurotic disorder,GCST010017,17:46019187
rs2921036-<b>T</b>,3 x 10-20,,0.4898,'-,0.01775 unit increase,[0.014-0.022],RN7SL178P,Neuroticism,neurotic disorder,GCST010017,8:8506387
rs11250117-<b>A</b>,3 x 10-19,,0.4667,'-,0.0172 unit increase,[0.013-0.021],XKR6,Neuroticism,neurotic disorder,GCST010017,8:11115230
rs477860-<b>T</b>,6 x 10-14,,0.2968,'-,0.01439 unit decrease,[0.011-0.018],MIR124-1HG,Neuroticism,neurotic disorder,GCST010017,8:9954255
rs2269426-<b>A</b>,3 x 10-12,,0.3594,'-,0.01334 unit increase,[0.0096-0.0171],TNXB,Neuroticism,neurotic disorder,GCST010017,6:32108722
rs2278609-<b>C</b>,6 x 10-10,,0.216,'-,0.01191 unit increase,[0.0081-0.0157],PLCL2,Neuroticism,neurotic disorder,GCST010017,3:16882947
rs10032297-<b>A</b>,4 x 10-9,,0.3958,'-,0.01136 unit decrease,[0.0076-0.0151],"LINC00616, SLC7A11-AS1",Neuroticism,neurotic disorder,GCST010017,4:138092247
rs3135296-<b>?</b>,6 x 10-6,,NR,1.0090817,'-,[1.01-1.01],"LINC01623, NOP56P1",Neuroticism,neurotic disorder,GCST010017,6:28828079
rs906175-<b>T</b>,1 x 10-7,,0.48,1.58,'-,[1.33-1.87],'-,Frontotemporal dementia,Frontotemporal dementia,GCST002960,Mapping not available
rs17042852-<b>C</b>,2 x 10-7,,0.04,2.82,'-,[1.91-4.18],LINC01867,Frontotemporal dementia,Frontotemporal dementia,GCST002960,2:52372929
rs11099660-<b>C</b>,3 x 10-6,,0.7,1.57,'-,[1.37-1.77],LINC02507,Frontotemporal dementia,Frontotemporal dementia,GCST002960,4:147592468
rs4980079-<b>T</b>,5 x 10-6,,0.45,1.46,'-,[1.30-1.62],ZCCHC24,Frontotemporal dementia,Frontotemporal dementia,GCST002960,10:79434463
rs6857-<b>T</b>,8 x 10-6,,0.13,1.7,'-,[1.46-1.94],NECTIN2,Frontotemporal dementia,Frontotemporal dementia,GCST002960,19:44888997
"rs9319617-<b>?</b>, rs969413-<b>?</b>, rs2255166-<b>?</b>, rs906175-<b>?</b>, rs2725391-<b>?</b>, rs1048775-<b>?</b>, rs2659030-<b>?</b>",8 x 10-7,,NR,1.49,'-,[1.27-1.72],CEP131; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Frontotemporal dementia,Frontotemporal dementia,GCST002960,17:81218646
"rs9319617-<b>T</b>, rs969413-<b>A</b>, rs2255166-<b>C</b>, rs906175-<b>T</b>, rs2725391-<b>T</b>, rs1048775-<b>C</b>, rs2659030-<b>A</b>",4 x 10-6,,0.43,1.45,'-,[1.23-1.69],CEP131; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Frontotemporal dementia,Frontotemporal dementia,GCST002960,17:81218646
rs3110643-<b>C</b>,4 x 10-6,,0.16,1.65,'-,[1.43-1.87],HNF1B,Frontotemporal dementia,Frontotemporal dementia,GCST002960,17:37713484
rs9527836-<b>?</b>,8 x 10-6,,NR,1.23,'-,'-,CTAGE16P,Frontotemporal dementia (age at onset),"age at onset, Frontotemporal dementia",GCST004096,13:58556158
rs12608932-<b>C</b>,7 x 10-6,,0.35,1.46,'-,[NR],UNC13A,Frontotemporal dementia,Frontotemporal dementia,GCST002508,19:17641880
rs144573434-<b>T</b>,5 x 10-7,(liability model),0.997,'-,1.14 unit decrease,[0.69-1.59],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:81079667
rs145282773-<b>T</b>,2 x 10-6,(liability model),0.997,'-,1.04 unit decrease,[0.61-1.47],"HMGA2, HMGA2-AS1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:65859519
rs147285445-<b>T</b>,4 x 10-6,(liability model),0.998,'-,1.03 unit decrease,[0.6-1.46],ANKRD22,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,10:88850285
rs186891871-<b>C</b>,9 x 10-6,(liability model),0.998,'-,0.98 unit decrease,[0.55-1.41],ADGRL2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:81589710
rs141976661-<b>A</b>,5 x 10-7,(liability model),0.997,'-,0.88 unit decrease,[0.55-1.21],LINC00624,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:147483513
rs139638356-<b>T</b>,2 x 10-6,(liability model),0.996,'-,0.83 unit decrease,[0.48-1.18],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:80903300
rs185170954-<b>A</b>,9 x 10-6,(liability model),0.997,'-,0.82 unit decrease,[0.47-1.17],SEMA3A,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:83870966
rs115798104-<b>A</b>,9 x 10-7,(liability model),0.997,'-,0.8 unit decrease,[0.49-1.11],MECOM,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:169273046
rs181696879-<b>A</b>,4 x 10-7,(liability model),0.994,'-,0.67 unit decrease,[0.42-0.92],MCPH1-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:6680850
rs138449900-<b>C</b>,3 x 10-6,(liability model),0.996,'-,0.66 unit decrease,[0.39-0.93],"CNTNAP5, RN7SKP102",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:123951121
rs141846544-<b>T</b>,9 x 10-6,(liability model),0.996,'-,0.65 unit decrease,[0.36-0.94],"RNU6-1213P, Y_RNA",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:80432793
rs117022236-<b>A</b>,4 x 10-6,(liability model),0.995,'-,0.63 unit decrease,[0.36-0.9],AKR7A3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:19288434
rs140587050-<b>C</b>,5 x 10-6,(liability model),0.995,'-,0.63 unit decrease,[0.36-0.9],IRAK1BP1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:78889320
rs183291664-<b>T</b>,3 x 10-6,(liability model),0.996,'-,0.58 unit decrease,[0.34-0.82],SCAPER,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:76713822
rs8077028-<b>T</b>,1 x 10-6,(liability model),0.751,'-,0.09 unit decrease,[0.051-0.129],"CEP295NL, TIMP2",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:78891959
rs2244526-<b>T</b>,6 x 10-6,(liability model),0.824,'-,0.09 unit decrease,[0.051-0.129],SELP,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:169617708
rs17022021-<b>T</b>,8 x 10-6,(liability model),0.843,'-,0.09 unit decrease,[0.051-0.129],RBMS3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:28837197
rs1034435-<b>A</b>,3 x 10-6,(liability model),0.659,'-,0.07 unit decrease,[0.031-0.109],TAFA5,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,22:48492443
rs4760243-<b>A</b>,8 x 10-6,(liability model),0.566,'-,0.07 unit decrease,[0.031-0.109],"LINC02388, LRIG3",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:58828030
rs7260181-<b>T</b>,8 x 10-6,(liability model),0.57,'-,0.07 unit decrease,[0.031-0.109],PPP5D1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:46595170
rs12716755-<b>A</b>,6 x 10-6,(liability model),0.608,'-,0.07 unit increase,[0.031-0.109],"USP10, KLHL36",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:84699678
rs3820443-<b>T</b>,1 x 10-6,(liability model),0.611,'-,0.07 unit increase,[0.031-0.109],PIFO,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:111350283
rs846858-<b>A</b>,3 x 10-6,(liability model),0.272,'-,0.08 unit increase,[0.041-0.119],IGSF23,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:44625528
rs5771225-<b>T</b>,5 x 10-6,(liability model),0.217,'-,0.09 unit increase,[0.051-0.129],SELENOO,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,22:50201044
rs7313581-<b>T</b>,8 x 10-7,(liability model),0.218,'-,0.09 unit increase,[0.051-0.129],KRAS,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:25269783
rs2699450-<b>A</b>,4 x 10-6,(liability model),0.211,'-,0.09 unit increase,[0.051-0.129],"CDCA7L, RAPGEF5",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:22018573
rs6945197-<b>T</b>,6 x 10-6,(liability model),0.16,'-,0.09 unit increase,[0.051-0.129],"ZP3P2, PLXNA4",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:136477062
rs184992198-<b>T</b>,2 x 10-6,(liability model),0.816,'-,0.11 unit increase,[0.071-0.149],"BNIP3P13, ZNF90",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:20064649
rs115972394-<b>A</b>,6 x 10-6,(liability model),0.147,'-,0.11 unit increase,[0.051-0.169],ATP6V0E2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:149924921
rs73215707-<b>T</b>,8 x 10-6,(liability model),0.908,'-,0.12 unit increase,[0.061-0.179],CYRIA,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:16736702
rs79926713-<b>T</b>,8 x 10-6,(liability model),0.082,'-,0.13 unit increase,[0.071-0.189],SYNGAP1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:33427745
rs73732514-<b>A</b>,2 x 10-6,(liability model),0.929,'-,0.14 unit increase,[0.081-0.199],CTD-2194D22.4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:1983817
rs62177277-<b>T</b>,2 x 10-6,(liability model),0.056,'-,0.16 unit increase,[0.1-0.22],SESTD1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:179139721
rs73681522-<b>A</b>,4 x 10-6,(liability model),0.051,'-,0.16 unit increase,[0.082-0.238],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:13656708
rs2234017-<b>C</b>,7 x 10-6,(liability model),0.056,'-,0.17 unit increase,[0.092-0.248],TAS2R5,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:141791266
rs147597631-<b>T</b>,2 x 10-6,(liability model),0.061,'-,0.18 unit increase,[0.1-0.26],"TCF15, CSNK2A1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,20:566915
rs145848414-<b>A</b>,3 x 10-6,(liability model),0.04,'-,0.21 unit increase,[0.13-0.29],"HIGD1AP3, SUMO2P6",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:174587111
rs147985478-<b>A</b>,3 x 10-6,(liability model),0.977,'-,0.25 unit increase,[0.15-0.35],PRANCR,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:69997949
rs116050881-<b>T</b>,6 x 10-7,(liability model),0.026,'-,0.25 unit increase,[0.15-0.35],LINC01725,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:29684252
rs181990369-<b>A</b>,4 x 10-6,(liability model),0.988,'-,0.37 unit decrease,[0.21-0.53],DLC1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:13182155
rs181228315-<b>A</b>,2 x 10-6,(liability model),0.986,'-,0.35 unit decrease,[0.21-0.49],TMEM94,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:75453551
rs147150305-<b>A</b>,4 x 10-7,(liability model),0.984,'-,0.35 unit decrease,[0.21-0.49],PLCL1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:198252846
rs187295598-<b>T</b>,6 x 10-6,(liability model),0.988,'-,0.34 unit decrease,[0.18-0.5],GPR180,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,13:94628579
rs142660142-<b>T</b>,2 x 10-6,(liability model),0.986,'-,0.34 unit decrease,[0.2-0.48],LINGO1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:77611050
rs77544685-<b>T</b>,5 x 10-6,(liability model),0.013,'-,0.33 unit decrease,[0.19-0.47],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:116082456
rs144167489-<b>T</b>,2 x 10-6,(liability model),0.017,'-,0.32 unit decrease,[0.18-0.46],"SUMO1P2, LINC00626",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:168874774
rs75635567-<b>T</b>,5 x 10-6,(liability model),0.985,'-,0.3 unit decrease,[0.16-0.44],"BAALC-AS1, BAALC",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:103186989
rs146997164-<b>C</b>,9 x 10-6,(liability model),0.97,'-,0.26 unit decrease,[0.14-0.38],"OR7E39P, CCZ1B",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:6830481
rs146322114-<b>A</b>,2 x 10-6,(liability model),0.029,'-,0.25 unit decrease,[0.15-0.35],PCSK6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:101501820
rs12661302-<b>C</b>,3 x 10-6,(liability model),0.977,'-,0.25 unit decrease,[0.15-0.35],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:103817252
rs186588455-<b>A</b>,6 x 10-6,(liability model),0.964,'-,0.22 unit decrease,[0.12-0.32],"MRPL45, NPEPPSP1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:38287606
rs115443594-<b>T</b>,4 x 10-6,(liability model),0.966,'-,0.22 unit decrease,[0.12-0.32],PRPF19P1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,18:65993723
rs114179644-<b>T</b>,8 x 10-6,(liability model),0.969,'-,0.21 unit decrease,[0.11-0.31],CPSF6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:69160349
rs145840463-<b>A</b>,6 x 10-6,(liability model),0.036,'-,0.21 unit decrease,[0.11-0.31],CFAP74,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:1950293
rs10075047-<b>A</b>,5 x 10-6,(liability model),0.032,'-,0.21 unit decrease,[0.11-0.31],"CCDC112, CTNNA1P1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:115357977
rs10060040-<b>A</b>,8 x 10-6,(liability model),0.053,'-,0.17 unit decrease,[0.092-0.248],"ADGRV1, CTNND2",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:11930025
rs62179067-<b>T</b>,8 x 10-7,(liability model),0.941,'-,0.16 unit decrease,[0.1-0.22],SESTD1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:179270456
rs56249755-<b>A</b>,5 x 10-7,(liability model),0.939,'-,0.16 unit decrease,[0.1-0.22],FAM240B,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:38711009
rs115317194-<b>T</b>,2 x 10-6,(liability model),0.067,'-,0.15 unit decrease,[0.091-0.209],SLMAP,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:57830215
rs75770912-<b>A</b>,8 x 10-6,(liability model),0.074,'-,0.14 unit decrease,[0.081-0.199],AOX1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:200653321
rs7698880-<b>C</b>,2 x 10-6,(liability model),0.124,'-,0.14 unit decrease,[0.081-0.199],UNC93B4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:4148701
rs76816469-<b>T</b>,1 x 10-6,(liability model),0.101,'-,0.12 unit decrease,[0.061-0.179],CDH1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:68759780
rs61233297-<b>A</b>,8 x 10-6,(liability model),0.094,'-,0.11 unit decrease,[0.051-0.169],IQGAP2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:76567335
rs853656-<b>T</b>,4 x 10-6,(liability model),0.167,'-,0.09 unit decrease,[0.051-0.129],RASSF8,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:25965239
rs142076474-<b>A</b>,4 x 10-6,(liability model),0.994,'-,0.58 unit decrease,[0.34-0.82],CEP63,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:134501479
rs181299481-<b>A</b>,4 x 10-6,(liability model),0.994,'-,0.58 unit decrease,[0.33-0.83],RNY4P18,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:111149099
rs191404864-<b>A</b>,5 x 10-6,(liability model),0.006,'-,0.53 unit decrease,[0.29-0.77],BICRA,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:47635083
rs112404845-<b>A</b>,4 x 10-8,(liability model),0.991,'-,0.47 unit decrease,[0.29-0.65],ROBO2P1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:51510325
rs183256737-<b>A</b>,2 x 10-6,(liability model),0.993,'-,0.46 unit decrease,[0.26-0.66],SEC24B-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:109373310
rs79930850-<b>A</b>,3 x 10-6,(liability model),0.99,'-,0.45 unit decrease,[0.25-0.65],CASP12,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:104874043
rs143261188-<b>C</b>,3 x 10-6,(liability model),0.992,'-,0.44 unit decrease,[0.24-0.64],TENM4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:78938571
rs115078773-<b>A</b>,7 x 10-6,(liability model),0.992,'-,0.44 unit decrease,[0.24-0.64],TMCO4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:19693032
rs139195876-<b>A</b>,2 x 10-6,(liability model),0.99,'-,0.43 unit decrease,[0.25-0.61],NACAP6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:16262936
rs16961023-<b>C</b>,5 x 10-8,(liability model),0.985,'-,0.41 unit decrease,[0.27-0.55],SLC10A2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,13:103011595
rs72842919-<b>A</b>,5 x 10-7,(liability model),0.985,'-,0.38 unit decrease,[0.22-0.54],RPS20P10,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:71938176
rs116530595-<b>T</b>,9 x 10-6,(liability model),0.018,'-,0.26 unit increase,[0.14-0.38],"TXN, C9orf152",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:110213589
rs147582129-<b>T</b>,9 x 10-6,(liability model),0.016,'-,0.28 unit increase,[0.16-0.4],FAT3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:92422052
rs72998574-<b>T</b>,2 x 10-6,(liability model),0.022,'-,0.28 unit increase,[0.16-0.4],R3HDM2P2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:103969846
rs144471255-<b>A</b>,3 x 10-6,(liability model),0.018,'-,0.31 unit increase,[0.17-0.45],RDX,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:110058188
rs144216026-<b>A</b>,8 x 10-6,(liability model),0.017,'-,0.31 unit increase,[0.17-0.45],ABCA8,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:68920354
rs137869973-<b>T</b>,2 x 10-7,(liability model),0.025,'-,0.31 unit increase,[0.19-0.43],KCTD9P6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:31236084
rs72840936-<b>C</b>,5 x 10-7,(liability model),0.018,'-,0.32 unit increase,[0.2-0.44],STEAP3-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:119266116
rs148587130-<b>T</b>,7 x 10-6,(liability model),0.013,'-,0.36 unit increase,[0.2-0.52],NEK10,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:27236975
rs185126971-<b>A</b>,8 x 10-6,(liability model),0.011,'-,0.37 unit increase,[0.21-0.53],"ERO1A, PSMC6",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,14:52702250
rs73239797-<b>A</b>,2 x 10-6,(liability model),0.013,'-,0.39 unit increase,[0.23-0.55],"RNU7-188P, SEM1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:96446404
rs113884973-<b>C</b>,8 x 10-6,(liability model),0.008,'-,0.43 unit increase,[0.23-0.63],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:53256902
rs182972826-<b>T</b>,4 x 10-6,(liability model),0.007,'-,0.44 unit increase,[0.24-0.64],SEC24B,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:109534350
rs112920270-<b>A</b>,9 x 10-6,(liability model),0.008,'-,0.45 unit increase,[0.25-0.65],STK31,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:23931916
rs141104697-<b>A</b>,8 x 10-6,(liability model),0.007,'-,0.46 unit increase,[0.26-0.66],GTF2H3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:123635804
rs144464515-<b>C</b>,2 x 10-6,(liability model),0.01,'-,0.46 unit increase,[0.26-0.66],"ZNRF4, PTPRS",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:5417482
rs191707442-<b>T</b>,6 x 10-6,(liability model),0.008,'-,0.47 unit increase,[0.27-0.67],PPP1R3B,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:9182000
rs150269952-<b>T</b>,6 x 10-6,(liability model),0.009,'-,0.48 unit increase,[0.26-0.7],RASSF5,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:206526352
rs144998240-<b>A</b>,8 x 10-7,(liability model),0.006,'-,0.5 unit increase,[0.3-0.7],COL25A1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:109251730
rs138543081-<b>T</b>,1 x 10-6,(liability model),0.009,'-,0.5 unit increase,[0.3-0.7],ZNF462,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:107043881
rs192013290-<b>T</b>,1 x 10-6,(liability model),0.006,'-,0.51 unit increase,[0.29-0.73],HMCN1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:185780742
rs144077517-<b>A</b>,2 x 10-6,(liability model),0.005,'-,0.54 unit increase,[0.32-0.76],SCAPER,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:76352686
rs142835438-<b>A</b>,8 x 10-7,(liability model),0.007,'-,0.54 unit increase,[0.32-0.76],"ZBTB10, RPSAP47",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:80555470
rs184695264-<b>T</b>,4 x 10-6,(liability model),0.005,'-,0.58 unit increase,[0.33-0.83],LINC02421,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:67780260
rs921390-<b>T</b>,1 x 10-6,(liability model),0.005,'-,0.58 unit increase,[0.34-0.82],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:4515659
rs150291119-<b>A</b>,3 x 10-6,(liability model),0.005,'-,0.6 unit increase,[0.35-0.85],NAALADL2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:174769522
rs186542490-<b>A</b>,8 x 10-6,(liability model),0.006,'-,0.6 unit increase,[0.35-0.85],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:78644638
rs186076999-<b>T</b>,7 x 10-6,(liability model),0.006,'-,0.62 unit increase,[0.35-0.89],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:20013543
rs141521929-<b>T</b>,4 x 10-6,(liability model),0.005,'-,0.62 unit increase,[0.37-0.87],TUSC1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:25669750
rs73865608-<b>A</b>,1 x 10-6,(liability model),0.004,'-,0.63 unit increase,[0.38-0.88],"LINC02273, RNA5SP169",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:152043740
rs184614511-<b>T</b>,6 x 10-6,(liability model),0.005,'-,0.64 unit increase,[0.37-0.91],KSR2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:117861676
rs193129245-<b>A</b>,1 x 10-6,(liability model),0.005,'-,0.67 unit increase,[0.4-0.94],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:23318629
rs150061627-<b>T</b>,5 x 10-6,(liability model),0.004,'-,0.68 unit increase,[0.39-0.97],"MIR548Y, MDGA2",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,14:47737481
rs190457471-<b>A</b>,5 x 10-6,(liability model),0.004,'-,0.68 unit increase,[0.39-0.97],"OSER1-DT, GDAP1L1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,20:44233181
rs141387448-<b>T</b>,4 x 10-6,(liability model),0.005,'-,0.68 unit increase,[0.39-0.97],"ZNF438, LINC02664",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,10:31115466
rs117760708-<b>T</b>,3 x 10-6,(liability model),0.004,'-,0.73 unit increase,[0.42-1.04],JPH3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:87653662
rs187423924-<b>A</b>,4 x 10-6,(liability model),0.004,'-,0.74 unit increase,[0.43-1.05],AQP4-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,18:26735845
rs181634374-<b>T</b>,8 x 10-6,(liability model),0.003,'-,0.77 unit increase,[0.44-1.1],RPL23AP44,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:121563422
rs145228677-<b>C</b>,7 x 10-6,(liability model),0.004,'-,0.79 unit increase,[0.44-1.14],RPS18P12,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:14641688
rs188699384-<b>A</b>,5 x 10-6,(liability model),0.003,'-,0.79 unit increase,[0.46-1.12],MIR924HG,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,18:39619094
rs148003968-<b>A</b>,5 x 10-6,(liability model),0.003,'-,0.81 unit increase,[0.46-1.16],TFEB,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:41696609
rs185867524-<b>A</b>,5 x 10-6,(liability model),0.004,'-,0.86 unit increase,[0.49-1.23],DNAH6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:84597852
rs117756856-<b>A</b>,9 x 10-6,(liability model),0.003,'-,0.89 unit increase,[0.5-1.28],HDAC9,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:18212452
rs184457411-<b>A</b>,8 x 10-6,(liability model),0.003,'-,0.92 unit increase,[0.51-1.33],SHANK2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:70820116
rs180751169-<b>T</b>,5 x 10-6,(liability model),0.002,'-,0.94 unit increase,[0.53-1.35],"ADAM18, ADAM3A",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:39576416
rs188392327-<b>A</b>,2 x 10-6,(liability model),0.002,'-,0.99 unit increase,[0.58-1.4],"UGT1A8, UGT1A10",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:233651485
rs192232892-<b>T</b>,3 x 10-6,(liability model),0.002,'-,0.99 unit increase,[0.58-1.4],TBXAS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:139942249
rs149839710-<b>A</b>,9 x 10-6,(liability model),0.002,'-,1 unit increase,[0.55-1.45],"KIFC3, CNGB1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:57869386
rs150631144-<b>T</b>,1 x 10-7,(liability model),0.002,'-,1.13 unit increase,[0.72-1.54],RNU6-909P,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:28577827
rs1316543-<b>?</b>,1 x 10-9,(AA),0.9315,'-,'-,'-,GRK5,Risky sexual behaviors in alcohol dependence,"alcohol dependence, risky sexual behaviour measurement",GCST004955,10:119445148
rs10211296-<b>?</b>,7 x 10-9,(AA),0.7414,'-,'-,'-,CSRNP3,Risky sexual behaviors in alcohol dependence,"alcohol dependence, risky sexual behaviour measurement",GCST004955,2:165633833
rs73135175-<b>?</b>,3 x 10-8,(AA),0.9044,'-,'-,'-,RNU6-931P,Risky sexual behaviors in alcohol dependence,"alcohol dependence, risky sexual behaviour measurement",GCST004955,4:45545051
rs3824435-<b>?</b>,6 x 10-8,(women),0.532,'-,'-,'-,PLGRKT,Risky sexual behaviors in alcohol dependence,"alcohol dependence, risky sexual behaviour measurement",GCST004955,9:5377115
rs2075633-<b>?</b>,5 x 10-21,,NR,2.52,'-,[2.38-2.66],ADH1B,Alcohol dependence,alcohol dependence,GCST008966,4:99317841
rs11066001-<b>?</b>,7 x 10-12,,NR,4.76,'-,[4.47-5.05],BRAP,Alcohol dependence,alcohol dependence,GCST008966,12:111681367
rs55768019-<b>G</b>,8 x 10-7,,0.42,1.25,'-,[1.17-1.33],LINC02268,Alcohol dependence,alcohol dependence,GCST003121,4:174106365
rs2253612-<b>C</b>,8 x 10-7,,0.09,1.4285715,'-,[1.29-1.57],"AOX3P, AOX3P-AOX2P",Alcohol dependence,alcohol dependence,GCST003121,2:200703710
rs74745534-<b>T</b>,1 x 10-6,,0.02,2.5,'-,[2.15-2.85],"RHAG, CYP2AC1P",Alcohol dependence,alcohol dependence,GCST003121,6:49589080
rs181048070-<b>A</b>,1 x 10-6,,0.02,2,'-,[1.73-2.27],LINC01793,Alcohol dependence,alcohol dependence,GCST003121,2:59316241
rs117557854-<b>A</b>,2 x 10-6,,0.02,2.0833335,'-,[1.79-2.38],CNTN5,Alcohol dependence,alcohol dependence,GCST003121,11:100268439
rs75433892-<b>A</b>,2 x 10-6,,0.01,3.7037036,'-,[3.17-4.23],GNAL,Alcohol dependence,alcohol dependence,GCST003121,18:11712923
rs2400954-<b>C</b>,4 x 10-6,,0.37,1.2345679,'-,[1.16-1.31],PPFIA2,Alcohol dependence,alcohol dependence,GCST003121,12:81539202
rs79978308-<b>T</b>,5 x 10-6,,0.03,1.7857143,'-,[1.55-2.02],B3GALT5,Alcohol dependence,alcohol dependence,GCST003121,21:39648618
rs7199896-<b>T</b>,5 x 10-6,,0.06,1.5873016,'-,[1.41-1.76],GINS3,Alcohol dependence,alcohol dependence,GCST003121,16:58339080
rs10649162-<b>?</b>,5 x 10-6,,NR,1.2658228,'-,[1.17-1.36],'-,Alcohol dependence,alcohol dependence,GCST003121,6:153299421
rs62191099-<b>A</b>,5 x 10-6,,0.3,1.25,'-,[1.17-1.33],LINC01940,Alcohol dependence,alcohol dependence,GCST003121,2:238936057
rs12632235-<b>T</b>,5 x 10-6,,0.01,2.173913,'-,[1.86-2.49],ABI3BP,Alcohol dependence,alcohol dependence,GCST003121,3:100817440
rs17620991-<b>C</b>,6 x 10-6,,0.14,1.3333333,'-,[1.22-1.45],SUGCT,Alcohol dependence,alcohol dependence,GCST003121,7:40796922
rs57126985-<b>C</b>,6 x 10-6,,0.03,1.754386,'-,[1.52-1.99],'-,Alcohol dependence,alcohol dependence,GCST003121,21:15217712
rs10741210-<b>G</b>,9 x 10-6,,0.58,1.22,'-,[1.14-1.3],"LINC02646, GLRX3",Alcohol dependence,alcohol dependence,GCST003121,10:130186048
rs11076221-<b>G</b>,9 x 10-6,,0.94,1.57,'-,[1.37-1.77],C16orf97,Alcohol dependence,alcohol dependence,GCST003121,16:51927631
rs13340561-<b>G</b>,9 x 10-6,,0.03,1.6949153,'-,[1.48-1.91],MSR1,Alcohol dependence,alcohol dependence,GCST003121,8:16201396
rs75562159-<b>A</b>,9 x 10-6,,0.01,2.7027025,'-,[2.27-3.13],CAMTA1,Alcohol dependence,alcohol dependence,GCST003121,1:7444081
rs1229984-<b>?</b>,3 x 10-21,,NR,2.35,'-,[1.95-2.84],ADH1B,Alcohol dependence,alcohol dependence,GCST001883,4:99318162
rs3131513-<b>G</b>,2 x 10-6,,0.401,'-,0.353 unit decrease,[NR],"RUNX3, CLIC4",Alcohol dependence,alcohol dependence,GCST002134,1:24866664
rs4440177-<b>A</b>,6 x 10-6,,0.338,'-,0.347 unit increase,[NR],MTHFD2P4,Alcohol dependence,alcohol dependence,GCST002134,4:162321901
rs804292-<b>G</b>,2 x 10-6,,0.234,'-,0.414 unit decrease,[NR],NEIL2,Alcohol dependence,alcohol dependence,GCST002134,8:11786406
rs1793257-<b>A</b>,7 x 10-6,,0.037,'-,0.83 unit increase,[NR],OPCML,Alcohol dependence,alcohol dependence,GCST002134,11:132714224
rs1318937-<b>?</b>,3 x 10-6,(EA + AA),NR,'-,'-,'-,"CAPN7, SH3BP5-AS1",Alcohol dependence,alcohol dependence,GCST001254,3:15253857
rs9636231-<b>?</b>,8 x 10-6,(EA + AA),NR,'-,'-,'-,AHCYP4,Alcohol dependence,alcohol dependence,GCST001254,2:138914385
rs10893366-<b>?</b>,8 x 10-6,(EA + AA),NR,'-,'-,'-,PKNOX2,Alcohol dependence,alcohol dependence,GCST001254,11:125308507
rs237899-<b>?</b>,2 x 10-6,,NR,1.69,'-,[1.36-2.10],"OXTR, CAV3",Depression and alcohol dependence,alcohol dependence,GCST001313,3:8766829
rs5968205-<b>?</b>,3 x 10-6,,NR,2.2,'-,[1.58-3.07],TERF1P4,Depression and alcohol dependence,alcohol dependence,GCST001313,X:83699482
rs3827730-<b>?</b>,4 x 10-6,,NR,1.72,'-,[1.36-2.16],FAF1,Depression and alcohol dependence,alcohol dependence,GCST001313,1:50472176
rs8111589-<b>?</b>,4 x 10-6,,NR,1.64,'-,[1.33-2.03],OPA3,Depression and alcohol dependence,alcohol dependence,GCST001313,19:45531300
rs5922838-<b>?</b>,5 x 10-6,,NR,2.17,'-,[1.55-3.02],POMPP1,Depression and alcohol dependence,alcohol dependence,GCST001313,X:83616187
rs17750015-<b>?</b>,8 x 10-6,,NR,1.68,'-,[1.34-2.11],WDR7,Depression and alcohol dependence,alcohol dependence,GCST001313,18:56730391
rs10090288-<b>?</b>,8 x 10-6,,NR,2.55,'-,[1.69-3.84],MICU3,Depression and alcohol dependence,alcohol dependence,GCST001313,8:17072126
rs9805786-<b>?</b>,7 x 10-6,,NR,1.65,'-,[1.33-2.05],SPATA13,Depression and alcohol dependence,alcohol dependence,GCST001313,13:24084217
rs11933661-<b>?</b>,4 x 10-6,,'-,'-,0.538 unit decrease,'-,'-,Alcohol dependence,alcohol dependence,GCST002293,4:130091985
rs671-<b>?</b>,5 x 10-8,,NR,'-,0.88 unit increase,'-,ALDH2,Alcohol dependence,alcohol dependence,GCST002293,12:111803962
rs8062326-<b>T</b>,4 x 10-6,(BPALC),0.02,'-,'-,'-,"ITPRIPL2, SYT17",Alcohol dependence,alcohol dependence,GCST001211,16:19144694
rs6777876-<b>G</b>,4 x 10-7,(AA),0.086,'-,'-,'-,"RN7SL147P, MARK2P14",Alcohol dependence,alcohol dependence,GCST000977,3:11915124
rs12020569-<b>C</b>,5 x 10-6,(AA),0.103,'-,'-,'-,"RPS20P32, RPS21P8",Alcohol dependence,alcohol dependence,GCST000977,13:27012736
rs3738443-<b>A</b>,4 x 10-6,(AA),0.033,'-,'-,'-,"ZNF731P, ZNF124",Alcohol dependence,alcohol dependence,GCST000977,1:247184887
rs4478858-<b>G</b>,3 x 10-8,,NR,1.26,'-,'-,SERINC2,Alcohol dependence,alcohol dependence,GCST001874,1:31411078
rs6701037-<b>C</b>,2 x 10-7,,0.46,'-,'-,'-,"KIAA0040, TNN",Alcohol dependence,alcohol dependence,GCST001121,1:175150943
rs750338-<b>C</b>,1 x 10-6,,0.22,'-,'-,'-,PKNOX2,Alcohol dependence,alcohol dependence,GCST001121,11:125302697
chr12:85076811-<b>C</b>,3 x 10-6,(Ordinal I),0.966,'-,0.7577 unit decrease,[0.44-1.07],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
chr1:228841770-<b>A</b>,3 x 10-6,(Ordinal I),0.1068,'-,0.3993 unit increase,[0.23-0.57],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs12590995-<b>C</b>,3 x 10-6,(Ordinal I),0.9191,'-,0.4494 unit decrease,[0.26-0.64],LINC02307,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,14:44213661
rs6127813-<b>T</b>,3 x 10-6,(Ordinal I),0.2983,'-,0.2697 unit decrease,[0.16-0.38],"RNU6-1146P, RN7SL170P",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,20:56679998
rs2124379-<b>T</b>,3 x 10-6,(Ordinal I),0.423,'-,0.2774 unit decrease,[0.16-0.39],"HPS5, SAA1",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,11:18276016
rs55770291-<b>A</b>,4 x 10-6,(Ordinal I),0.0114,'-,1.6201 unit increase,[0.93-2.31],MYO7A,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,11:77211536
rs262741-<b>G</b>,5 x 10-6,(Ordinal I),0.5416,'-,0.2447 unit increase,[0.14-0.35],RN7SKP60,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,5:165705969
chr1:155733245-<b>T</b>,5 x 10-6,(Ordinal I),0.0602,'-,0.7777 unit increase,[0.44-1.11],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs28523990-<b>T</b>,7 x 10-6,(Ordinal I),0.282,'-,0.2719 unit decrease,[0.15-0.39],"POT1, C7orf77",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,7:124796085
rs133911-<b>G</b>,7 x 10-6,(Ordinal I),0.7038,'-,0.3047 unit decrease,[0.17-0.44],PARVB,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,22:44127282
rs2452591-<b>A</b>,8 x 10-6,(Ordinal I),0.3832,'-,0.2693 unit decrease,[0.15-0.39],PDLIM5,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,4:94555568
rs7078209-<b>G</b>,8 x 10-6,(Ordinal I),0.6751,'-,0.2658 unit increase,[0.15-0.38],"ACADSB, HMX3",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,10:123100510
rs2584363-<b>T</b>,8 x 10-6,(Ordinal I),0.1921,'-,0.3098 unit decrease,[0.17-0.45],"HMGB1P46, ANK1",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,8:107146155
rs6887317-<b>A</b>,9 x 10-6,(Ordinal I),0.407,'-,0.2466 unit increase,[0.14-0.36],CTNND2,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,5:11370935
rs11148252-<b>C</b>,9 x 10-6,(Ordinal I),0.5913,'-,0.2351 unit decrease,[0.13-0.34],VPS36,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,13:52434913
rs913351-<b>G</b>,9 x 10-6,(Ordinal I),0.9798,'-,0.811 unit decrease,[0.45-1.17],GARNL3,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,9:127271268
chr15:52443375-<b>A</b>,9 x 10-6,(Ordinal I),0.0103,'-,2.0434 unit increase,[1.14-2.95],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
chr2:228891013-<b>G</b>,6 x 10-6,(Ordinal II),0.9785,'-,1.1721 unit decrease,[0.66-1.68],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
chr4:185384861-<b>G</b>,1 x 10-6,(Ordinal II),0.9531,'-,0.6523 unit decrease,[0.39-0.91],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs11739210-<b>C</b>,8 x 10-6,(Ordinal II),0.9824,'-,1.1285 unit decrease,[0.63-1.62],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs727505-<b>A</b>,6 x 10-6,(Ordinal II),0.2875,'-,0.2777 unit decrease,[0.16-0.4],"C7orf77, POT1",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,7:124822027
rs1570582-<b>C</b>,9 x 10-6,(Ordinal II),0.9476,'-,0.502 unit decrease,[0.28-0.72],FRMD3,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,9:83295597
rs7078209-<b>G</b>,5 x 10-6,(Ordinal II),0.6747,'-,0.2772 unit increase,[0.16-0.4],"ACADSB, HMX3",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,10:123100510
rs11024598-<b>G</b>,9 x 10-6,(Ordinal II),0.4741,'-,0.2593 unit increase,[0.14-0.37],"HPS5, SAA1",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,11:18270189
rs7132746-<b>C</b>,2 x 10-6,(Ordinal II),0.8751,'-,0.3623 unit decrease,[0.21-0.51],"NTS, RASSF9",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,12:85865680
rs12590995-<b>C</b>,5 x 10-6,(Ordinal II),0.9192,'-,0.4532 unit decrease,[0.26-0.65],LINC02307,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,14:44213661
rs429358-<b>C</b>,5 x 10-12,(Ordinal II),0.7347,'-,0.508 unit decrease,[0.36-0.65],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs6127813-<b>T</b>,2 x 10-6,(Ordinal II),0.2985,'-,0.2843 unit decrease,[0.17-0.4],"RNU6-1146P, RN7SL170P",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,20:56679998
chr2:228891013-<b>G</b>,8 x 10-6,(Case/control),0.9785,'-,1.1951 unit decrease,[0.67-1.72],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
chr4:185384861-<b>G</b>,9 x 10-7,(Case/control),0.9531,'-,0.659 unit decrease,[0.4-0.92],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs727505-<b>A</b>,5 x 10-6,(Case/control),0.2876,'-,0.2807 unit decrease,[0.25-0.31],"C7orf77, POT1",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,7:124822027
rs7078209-<b>G</b>,4 x 10-6,(Case/control),0.6744,'-,0.2812 unit increase,[0.16-0.4],"ACADSB, HMX3",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,10:123100510
rs11024598-<b>G</b>,8 x 10-6,(Case/control),0.4743,'-,0.262 unit increase,[0.15-0.38],"HPS5, SAA1",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,11:18270189
rs7132746-<b>C</b>,9 x 10-6,(Case/control),0.8751,'-,0.3439 unit decrease,[0.19-0.5],"NTS, RASSF9",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,12:85865680
rs2803904-<b>C</b>,5 x 10-6,(Case/control),0.5791,'-,0.2574 unit increase,[0.15-0.37],SSTR1,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,14:38172501
rs429358-<b>C</b>,3 x 10-11,(Case/control),0.7344,'-,0.4905 unit decrease,[0.35-0.63],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs6127813-<b>T</b>,2 x 10-6,(Case/control),0.2984,'-,0.282 unit decrease,[0.16-0.4],"RNU6-1146P, RN7SL170P",Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,20:56679998
rs429358-<b>C</b>,1 x 10-12,(Ordinal I),0.732,'-,0.4997 unit decrease,[0.36-0.64],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
chr4:185405621-<b>A</b>,2 x 10-6,(Ordinal I),0.0524,'-,0.528 unit increase,[0.31-0.74],'-,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,Mapping not available
rs1570582-<b>C</b>,2 x 10-6,(Ordinal I),0.9471,'-,0.5137 unit decrease,[0.3-0.73],FRMD3,Lewy body disease,"Lewy body dementia, Lewy body dementia measurement",GCST002591,9:83295597
rs1411478-<b>?</b>,4 x 10-11,,0.58,1.27,'-,[1.19-1.37],STX6,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,1:180993146
rs7571971-<b>?</b>,4 x 10-13,,0.74,1.33,'-,[1.22-1.43],EIF2AK3,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,2:88595833
rs1768208-<b>?</b>,5 x 10-17,,0.71,1.37,'-,[1.28-1.49],MOBP,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,3:39481512
rs6852535-<b>?</b>,1 x 10-7,,0.34,1.23,'-,[1.13-1.32],IL21,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,4:122557561
rs6547705-<b>?</b>,1 x 10-8,(controlling for rs7571971),0.23,1.28,'-,[1.18-1.40],CD8B,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,2:86817193
rs242557-<b>?</b>,9 x 10-18,(controlling for rs8070723),0.35,1.43,'-,[1.32-1.54],MAPT,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,17:45942346
rs12203592-<b>?</b>,6 x 10-15,,0.19,1.48,'-,[1.34-1.63],IRF4,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,6:396321
rs8070723-<b>?</b>,2 x 10-118,,0.23,5.11,'-,[4.43-5.91],MAPT,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,17:46003698
rs6687758-<b>?</b>,6 x 10-8,,0.81,1.27,'-,[1.16-1.39],"LINC02474, LINC01705",Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,1:221991606
rs2142991-<b>?</b>,3 x 10-7,,0.17,1.3,'-,[1.18-1.44],"BMS1, LINC02623",Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,10:42845657
rs11568563-<b>?</b>,7 x 10-8,,0.95,1.47,'-,[1.28-1.69],SLCO1A2,Progressive supranuclear palsy,Progressive supranuclear palsy,GCST001116,12:21304500
"rs8453-<b>G</b>, rs10489525-<b>G</b>, rs926938-<b>A</b>",9 x 10-8,,0.465,'-,'-,'-,CSDE1; No mapped genes; No mapped genes,Autism,autism,GCST002268,1:114716978
"rs11582563-<b>G</b>, rs7511633-<b>G</b>, rs6537825-<b>A</b>, rs11585926-<b>T</b>, rs6661053-<b>T</b>, rs11589568-<b>T</b>",2 x 10-7,,0.382,'-,'-,'-,TRIM33; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Autism,autism,GCST002268,1:114416918
"rs11582563-<b>G</b>, rs7511633-<b>G</b>, rs11102800-<b>C</b>, rs6537825-<b>A</b>, rs11585926-<b>T</b>, rs6661053-<b>T</b>, rs11589568-<b>T</b>",6 x 10-8,,0.382,'-,'-,'-,TRIM33; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Autism,autism,GCST002268,1:114416918
"rs3827735-<b>C</b>, rs11582563-<b>G</b>, rs7511633-<b>G</b>, rs11102800-<b>C</b>, rs6537825-<b>A</b>, rs11585926-<b>T</b>, rs6661053-<b>T</b>, rs11589568-<b>T</b>",6 x 10-8,,0.382,'-,'-,'-,TRIM33; TRIM33; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Autism,autism,GCST002268,1:114510087|1:114416918
"rs3827735-<b>C</b>, rs11582563-<b>G</b>, rs11102807-<b>A</b>, rs7511633-<b>G</b>, rs11102800-<b>C</b>, rs6537825-<b>A</b>, rs11585926-<b>T</b>, rs6661053-<b>T</b>, rs11589568-<b>T</b>",4 x 10-8,,0.382,'-,'-,'-,TRIM33; TRIM33; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Autism,autism,GCST002268,1:114510087|1:114416918
"rs10858047-<b>T</b>, rs1877455-<b>T</b>, rs11587400-<b>C</b>",8 x 10-8,,0.444,'-,'-,'-,TRIM33 - PKMP1; PKMP1 - BCAS2; No mapped genes,Autism,autism,GCST002268,1:114531255|1:114556471
rs4307059-<b>T</b>,2 x 10-10,,0.61,1.19,'-,[NR],'-,Autism,autism,GCST000382,Mapping not available
rs16823934-<b>?</b>,6 x 10-6,(post-treatment),0.238,'-,'-,'-,GAP43,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,3:115616837
rs460214-<b>?</b>,6 x 10-6,(post-treatment),0.269,'-,'-,'-,ERG,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,21:38634157
rs11581859-<b>?</b>,9 x 10-6,(post-treatment),0.218,'-,'-,'-,"PLPPR5, SNX7",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,1:98809579
rs72711240-<b>?</b>,4 x 10-7,(6-month follow-up),0.0269,'-,'-,'-,'-,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,4:134774652
rs9875578-<b>?</b>,1 x 10-6,(6-month follow-up),0.424,'-,'-,'-,"LINC00620, WNT7A",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,3:13752941
rs6813264-<b>?</b>,5 x 10-6,(6-month follow-up),0.41,'-,'-,'-,MMAA,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,4:145603408
rs12850751-<b>?</b>,7 x 10-6,(6-month follow-up),0.0655,'-,'-,'-,MIR891A,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,X:146055912
rs13432654-<b>?</b>,8 x 10-6,(6-month follow-up),0.0939,'-,'-,'-,SLC4A10,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,2:161443775
rs10881475-<b>?</b>,2 x 10-6,(post-treatment),0.187,'-,'-,'-,VAV3,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,1:107638974
rs11834041-<b>?</b>,4 x 10-6,(post-treatment),0.135,'-,'-,'-,'-,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,12:127750084
rs12464559-<b>?</b>,4 x 10-6,(post-treatment),0.041,'-,'-,'-,"NEB, ARL5A",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,2:151741146
rs881301-<b>?</b>,4 x 10-6,(post-treatment),0.403,'-,'-,'-,"C8orf86, FGFR1",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST003469,8:38474800
rs1709393-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LINC02085,Asthma and anxiety disorder,"anxiety disorder, asthma",GCST008920,3:101980310
rs10959883-<b>C</b>,3 x 10-11,(EA),0.09,'-,0.15 unit decrease,[NR],'-,Lifetime anxiety disorder,anxiety disorder,GCST009575,9:11519984
rs1187280-<b>G</b>,7 x 10-9,(EA),0.88,'-,0.13 unit increase,[NR],NTRK2,Lifetime anxiety disorder,anxiety disorder,GCST009575,9:84801910
rs4855559-<b>T</b>,4 x 10-8,(EA),0.21,'-,0.12 unit decrease,[NR],MYH15,Lifetime anxiety disorder,anxiety disorder,GCST009575,3:108396189
rs2861139-<b>C</b>,3 x 10-9,(EA),0.62,'-,0.13 unit increase,[NR],LINC01938,Lifetime anxiety disorder,anxiety disorder,GCST009575,5:165166549
rs3807866-<b>A</b>,5 x 10-8,(EA),0.48,'-,0.12 unit increase,[NR],TMEM106B,Lifetime anxiety disorder,anxiety disorder,GCST009575,7:12210752
rs1709393-<b>C</b>,2 x 10-8,,0.42,1.16,'-,[1.10-1.23],LINC02085,Anxiety disorder,anxiety disorder,GCST003370,3:101980310
rs6728642-<b>A</b>,5 x 10-8,,'-,'-,'-,'-,FAM178B,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,2:96941334
rs62200793-<b>T</b>,1 x 10-8,,'-,'-,'-,'-,ZNF804A,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,2:184885915
rs7588746-<b>A</b>,4 x 10-8,,'-,'-,'-,'-,'-,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,2:200121622
rs3919583-<b>A</b>,5 x 10-9,,'-,'-,'-,'-,LINC02488,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,5:87651774
rs144373461-<b>A</b>,1 x 10-17,,'-,'-,'-,'-,"HLA-V, IFITM4P",Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,6:29783228
rs209474-<b>A</b>,2 x 10-8,,'-,'-,'-,'-,HLA-DMA,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,6:32956807
rs1521470-<b>A</b>,3 x 10-8,,'-,'-,'-,'-,ADCY1,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,7:45607253
rs79403677-<b>T</b>,2 x 10-8,,'-,'-,'-,'-,FAM177A1,Bipolar disorder lithium response (continuous) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005081,14:35069925
rs324899-<b>A</b>,2 x 10-8,,'-,'-,'-,'-,LINC00461,Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,5:88619764
rs6942227-<b>A</b>,3 x 10-8,,'-,'-,'-,'-,CMAHP,Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,6:25177280
rs142425863-<b>T</b>,5 x 10-11,,'-,'-,'-,'-,"HLA-V, IFITM4P",Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,6:29783976
rs59724122-<b>T</b>,5 x 10-9,,'-,'-,'-,'-,GULOP,Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,8:27567179
rs61123830-<b>A</b>,5 x 10-8,,'-,'-,'-,'-,GRAMD1B,Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,11:123522138
rs7959663-<b>C</b>,3 x 10-8,,'-,'-,'-,'-,MYO1H,Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,12:109446562
rs66486766-<b>A</b>,1 x 10-11,,'-,'-,'-,'-,"EFL1P1, DNM1P41",Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,15:84137308
rs7405404-<b>T</b>,5 x 10-11,,'-,'-,'-,'-,'-,Bipolar disorder lithium response (categorical) or schizophrenia,"schizophrenia, bipolar disorder, response to lithium ion",GCST005082,16:13656002
rs12925656-<b>C</b>,3 x 10-6,,0.1,1.2195122,'-,[1.12-1.32],CDH11,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,16:65074017
chr8_80591790-D-<b>?</b>,8 x 10-6,,0.37,1.1363636,'-,[1.08-1.2],'-,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,Mapping not available
rs3007305-<b>G</b>,9 x 10-6,,0.32,1.1363636,'-,[1.08-1.2],"SCCPDH, CNST",Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,1:246699270
rs9475195-<b>C</b>,7 x 10-6,,0.39,1.1235955,'-,[1.08-1.19],HCRTR2,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,6:55196220
rs38758-<b>A</b>,9 x 10-6,,0.44,1.12,'-,1.07-1.18,'-,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,7:110303710
rs8022689-<b>A</b>,9 x 10-6,,0.35,1.14,'-,1.07-1.20,"RNU6-252P, OR5AU1",Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,14:21140827
rs66666015-<b>T</b>,9 x 10-6,,0.74,1.16,'-,1.09-1.24,DPF1,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,19:38226503
chr4_23273116-D-<b>?</b>,9 x 10-7,,0.17,1.19,'-,1.11-1.27,'-,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,Mapping not available
rs73122740-<b>T</b>,4 x 10-6,,0.91,1.26,'-,1.14-1.39,LINC01446,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,7:53627819
chr4_82106147-I-<b>?</b>,8 x 10-6,,0.06,1.29,'-,1.15-1.44,'-,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,Mapping not available
rs2353181-<b>T</b>,5 x 10-6,,0.94,1.33,'-,1.17-1.49,"BBS5, LRP2",Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,2:169448746
rs118102650-<b>A</b>,2 x 10-6,,0.01,1.79,'-,1.41-2.28,SCUBE2,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,11:9078300
rs26318-<b>C</b>,1 x 10-6,,0.01,1.923077,'-,[1.49-2.5],COMMD10,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,5:116352208
rs56342621-<b>G</b>,7 x 10-6,,0.01,1.6393442,'-,[1.33-2.04],"SCGB2B2, SCGB1B2P",Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,19:34580876
rs189924441-<b>G</b>,8 x 10-6,,0.03,1.4925373,'-,[1.25-1.79],"IDE, MARK2P9",Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,10:92422486
rs72924216-<b>G</b>,9 x 10-6,,0.04,1.3888888,'-,[1.2-1.59],'-,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,6:93861140
rs75237141-<b>G</b>,6 x 10-6,,0.08,1.25,'-,[1.14-1.37],RIMS1,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,6:72256893
rs10892827-<b>G</b>,8 x 10-6,,0.08,1.25,'-,[1.14-1.37],MIR100HG,Suicide attempts in bipolar disorder or schizophrenia,"schizophrenia, bipolar disorder, attempted suicide",GCST008122,11:122340282
rs116791765-<b>T</b>,2 x 10-8,(Hispanic),0.989,'-,0.345 unit decrease,[0.23-0.46],"GPR83, IZUMO1R",Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,11:94347083
rs11897825-<b>A</b>,5 x 10-7,"(Hispanic, females)",0.606,'-,0.09 unit decrease,[0.055-0.125],LINC01121,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,2:21471579
rs140743827-<b>A</b>,2 x 10-7,"(Hispanic, men)",0.018,'-,0.428 unit increase,[0.27-0.59],RNU6-755P,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,1:165016519
rs111942351-<b>A</b>,4 x 10-7,"(Hispanic, males, BMI-adjusted)",0.981,'-,0.363 unit increase,[0.22-0.5],MIR5197,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,5:143693985
rs47996285-<b>A</b>,7 x 10-6,"(Hispanic, males)",0.581,'-,0.092 unit decrease,[0.053-0.131],LHX1-DT,Obstructive sleep apnea trait (apnea hypopnea index),"sleep apnea measurement, obstructive sleep apnea",GCST003674,17:36824731
rs75108997-<b>A</b>,7 x 10-7,"(Hispanic, females)",NR,'-,0.365 unit decrease,[0.22-0.51],SLC35F3,Obstructive sleep apnea (average oxygen saturation during sleep),"sleep apnea measurement, obstructive sleep apnea",GCST003673,1:233818485
rs75108997-<b>A</b>,4 x 10-7,(Hispanic),0.013,'-,0.296 unit decrease,[0.18-0.41],"ATP2B4, LAX1",Obstructive sleep apnea (average oxygen saturation during sleep),"sleep apnea measurement, obstructive sleep apnea",GCST003673,1:203747715
rs116133558-<b>T</b>,2 x 10-7,"(Hispanic, BMI-adjusted)",0.014,'-,0.291 unit increase,[0.18-0.4],"ATP2B4, LAX1",Obstructive sleep apnea (average oxygen saturation during sleep),"sleep apnea measurement, obstructive sleep apnea",GCST003673,1:203747715
rs11074782-<b>T</b>,2 x 10-6,"(Hispanic, males)",0.23,'-,0.113 unit decrease,[0.066-0.16],LINC02195,Obstructive sleep apnea (average oxygen saturation during sleep),"sleep apnea measurement, obstructive sleep apnea",GCST003673,16:26493690
rs35424364-<b>A</b>,2 x 10-8,(Hispanic),0.129,'-,0.032 unit increase,[0.020-0.044],CCDC162P,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,6:109322403
rs74472562-<b>T</b>,6 x 10-8,(Hispanic),0.086,'-,0.035 unit decrease,[0.023-0.047],TSPAN18,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,11:44741205
rs2743173-<b>T</b>,2 x 10-7,(Hispanic),0.567,'-,0.019 unit increase,[0.011-0.027],PLCB1,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,20:8264646
rs72699765-<b>A</b>,5 x 10-7,(Hispanic),0.11,'-,0.029 unit increase,[0.017-0.041],"ATP10A, LINC02250",Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,15:25584050
rs2033354-<b>T</b>,4 x 10-7,(Hispanic),0.784,'-,0.022 unit decrease,[0.014-0.030],NBAS,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,2:15076492
rs78897171-<b>A</b>,1 x 10-7,"(Hispanic, females)",0.023,'-,0.108 unit increase,[0.069-0.147],CDH4,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,20:61868195
rs35329661-<b>T</b>,2 x 10-7,"(Hispanic, females)",0.013,'-,0.134 unit increase,[0.083-0.185],ARRB1,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,11:75263946
rs148024591-<b>T</b>,7 x 10-8,"(Hispanic, males)",0.017,'-,0.117 unit increase,[0.074-0.16],SEPHS1P2,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,15:93371222
rs4849682-<b>T</b>,5 x 10-7,"(Hispanic, males)",0.29,'-,0.03 unit decrease,[0.018-0.042],THORLNC,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,2:118185307
rs11610782-<b>A</b>,4 x 10-7,"(Hispanic, males)",0.024,'-,0.108 unit increase,[0.067-0.149],TMEM132B,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,12:125711743
rs35329661-<b>T</b>,7 x 10-6,(Females),NR,'-,0.033 unit increase,[-0.00032-0.06632],ARRB1,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,11:75263946
rs78897171-<b>A</b>,8 x 10-7,(Females),NR,'-,0.091 unit increase,[0.054-0.128],CDH4,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,20:61868195
rs2033354-<b>T</b>,8 x 10-6,"(Hispanic, females)",NR,'-,0.026 unit decrease,[0.014-0.038],NBAS,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,2:15076492
rs35424364-<b>A</b>,8 x 10-8,"(Hispanic, females)",NR,'-,0.04 unit increase,[0.024-0.056],CCDC162P,Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,6:109322403
rs1154155-<b>G</b>,9 x 10-30,,0.148,1.72,'-,[1.54-1.91],"TRAJ9, TRAJ10",Narcolepsy,narcolepsy with cataplexy,GCST005522,14:22533736
rs2289702-<b>?</b>,1 x 10-9,,NR,1.34,'-,[1.18-1.52],CTSH,Narcolepsy,narcolepsy with cataplexy,GCST005522,15:78944951
rs7553711-<b>C</b>,4 x 10-8,,0.285,1.33,'-,[1.21-1.46],"TNFSF4, GOT2P2",Narcolepsy,narcolepsy with cataplexy,GCST005522,1:173162769
rs10995245-<b>A</b>,3 x 10-7,,0.348,1.2,'-,[1.09-1.31],'-,Narcolepsy,narcolepsy with cataplexy,GCST005522,10:62631615
rs10915020-<b>A</b>,5 x 10-7,,0.084,1.32,'-,[1.15-1.52],"SMIM12, MIR552",Narcolepsy,narcolepsy with cataplexy,GCST005522,1:34692115
rs306336-<b>C</b>,2 x 10-6,,0.023,1.65,'-,[1.30-2.09],PKN2-AS1,Narcolepsy,narcolepsy with cataplexy,GCST005522,1:88507196
rs2834168-<b>?</b>,5 x 10-6,,NR,1.1363636,'-,[1.04-1.25],IL10RB,Narcolepsy,narcolepsy with cataplexy,GCST005522,21:33278486
rs1027327-<b>C</b>,9 x 10-6,,0.095,1.36,'-,[1.19-1.56],"LMCD1-AS1, LMCD1",Narcolepsy,narcolepsy with cataplexy,GCST005522,3:8565153
rs1154155-<b>C</b>,3 x 10-22,,0.14,1.69,'-,[1.52-1.88],"TRAJ9, TRAJ10",Narcolepsy,narcolepsy with cataplexy,GCST000385,14:22533736
rs4401971-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,'-,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST002451,9:11890045
rs6876547-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST002451,5:25572192
rs2251219-<b>?</b>,2 x 10-9,,0.59,1.14,'-,[1.09-1.18],"PBRM1, SMIM4",Major mood disorders,mood disorder,GCST000570,3:52550771
rs4554696-<b>C</b>,6 x 10-9,,NR,1.1748121,'-,[1.07-1.28],PDE4B,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,1:65942328
rs384005-<b>T</b>,4 x 10-7,,NR,1.1630613,'-,[1.05-1.28],MEF2C-AS2,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,5:88709286
rs6661750-<b>G</b>,5 x 10-7,,NR,1.1432,'-,[1.04-1.25],PDE4B,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,1:66081201
rs6475417-<b>G</b>,7 x 10-7,,NR,1.1434,'-,[1.04-1.25],'-,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,9:20212043
rs16841143-<b>A</b>,4 x 10-7,,NR,1.2309,'-,[1.07-1.39],PTH2R,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,2:208384849
rs62199592-<b>G</b>,6 x 10-7,,NR,1.6071,'-,[1.24-1.97],'-,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,2:183858773
rs182087934-<b>A</b>,7 x 10-8,,NR,1.8276,'-,[1.4-2.26],'-,Affective disorder and suicide attempts,"attempted suicide, mood disorder",GCST006420,2:183742707
rs10854398-<b>C</b>,6 x 10-6,,NR,1.178,'-,'-,B3GALT5,Suicide risk,"mental or behavioural disorder, attempted suicide",GCST000854,21:39649825
rs12373805-<b>A</b>,9 x 10-6,,NR,1.2169,'-,'-,PRKCE,Suicide risk,"mental or behavioural disorder, attempted suicide",GCST000854,2:46093955
rs4918918-<b>T</b>,3 x 10-6,,NR,1.18,'-,'-,SORBS1,Suicide risk,"mental or behavioural disorder, attempted suicide",GCST000854,10:95362484
rs2462021-<b>C</b>,8 x 10-6,,NR,1.1755,'-,'-,"RNU6-598P, JCAD",Suicide risk,"mental or behavioural disorder, attempted suicide",GCST000854,10:30201775
rs1051730-<b>T</b>,6 x 10-20,,0.35,'-,0.1 cigarettes per day increase,[0.08-0.12],'-,Nicotine dependence,nicotine dependence,GCST000171,Mapping not available
rs34997829-<b>?</b>,3 x 10-8,,0.732,'-,'-,'-,LHPP,Risky sexual behaviors (alcohol dependence interaction),"behavioural disinhibition measurement, alcohol dependence, risky sexual behaviour measurement",GCST003860,10:124546821
rs6810498-<b>A</b>,2 x 10-6,(AA),0.265,1.44,'-,NR,LINC02357,Alcohol dependence,alcohol dependence,GCST004712,4:26064749
rs10483282-<b>T</b>,9 x 10-6,(AA),0.437,1.32,'-,NR,"RN7SKP205, BRD7P1",Alcohol dependence,alcohol dependence,GCST004712,14:23784487
rs1229984-<b>C</b>,1 x 10-31,(EA),0.971,6.5789475,'-,NR,ADH1B,Alcohol dependence,alcohol dependence,GCST004712,4:99318162
rs1437396-<b>T</b>,6 x 10-6,(EA),0.235,1.25,'-,NR,"MTIF2, PRORSD1P",Alcohol dependence,alcohol dependence,GCST004712,2:55278320
rs1437396-<b>T</b>,1 x 10-10,,'-,'-,'-,'-,"MTIF2, PRORSD1P",Alcohol dependence,alcohol dependence,GCST004712,2:55278320
rs59551326-<b>A</b>,5 x 10-6,(AA),0.868,1.3495277,'-,NR,"RPL13AP7, LINC00158",Alcohol dependence,alcohol dependence,GCST004712,21:25384656
rs4699741-<b>T</b>,6 x 10-8,(EA),0.9437,1.5698587,'-,NR,"ADH7, ADH1B",Alcohol dependence,alcohol dependence,GCST004712,4:99357540
rs2173201-<b>C</b>,2 x 10-6,,0.773,1.2004802,'-,NR,ADH1B,Alcohol dependence,alcohol dependence,GCST004712,4:99329813
rs2066702-<b>G</b>,4 x 10-11,(AA),0.813,1.3908206,'-,NR,ADH1B,Alcohol dependence,alcohol dependence,GCST004712,4:99307860
rs1789882-<b>G</b>,2 x 10-9,(AA),0.769,1.303781,'-,NR,ADH1B,Alcohol dependence,alcohol dependence,GCST004712,4:99313896
rs1693457-<b>T</b>,2 x 10-9,(AA),0.768,1.3020833,'-,NR,'-,Alcohol dependence,alcohol dependence,GCST004712,Mapping not available
rs904092-<b>G</b>,5 x 10-9,(AA),0.763,1.3003901,'-,NR,"ADH1B, ADH1A",Alcohol dependence,alcohol dependence,GCST004712,4:99293007
rs17028615-<b>A</b>,6 x 10-8,(AA),0.792,1.3297873,'-,NR,ADH4,Alcohol dependence,alcohol dependence,GCST004712,4:99150767
rs2173201-<b>C</b>,1 x 10-7,(AA),0.548,1.3297873,'-,NR,ADH1B,Alcohol dependence,alcohol dependence,GCST004712,4:99329813
rs1614972-<b>C</b>,4 x 10-7,(AA),0.478,1.3297873,'-,NR,"ADH1B, ADH1C",Alcohol dependence,alcohol dependence,GCST004712,4:99336998
rs12639833-<b>C</b>,7 x 10-7,(AA),0.541,1.3192612,'-,NR,"ADH1C, ADH1B",Alcohol dependence,alcohol dependence,GCST004712,4:99346215
rs2241894-<b>T</b>,8 x 10-7,(AA),0.542,1.3192612,'-,NR,"ADH1C, ADH1B",Alcohol dependence,alcohol dependence,GCST004712,4:99344976
rs6822348-<b>T</b>,3 x 10-6,(AA),0.17,1.34,'-,NR,ADH4,Alcohol dependence,alcohol dependence,GCST004712,4:99132743
rs1437396-<b>T</b>,2 x 10-6,(AA),0.112,1.56,'-,NR,"MTIF2, PRORSD1P",Alcohol dependence,alcohol dependence,GCST004712,2:55278320
rs2002594-<b>?</b>,5 x 10-8,(men),0.399,'-,'-,'-,FAM162A,Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,3:122392714
rs12898370-<b>?</b>,4 x 10-8,"(AA, men)",0.872,'-,'-,'-,"HMG20A, LINGO1",Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,15:77516256
rs62313897-<b>?</b>,8 x 10-10,"(EA, men)",0.942,'-,'-,'-,CCSER1,Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,4:90215590
rs1867877-<b>?</b>,2 x 10-9,"(EA, men)",0.9489,'-,'-,'-,IGSF22,Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,11:18705901
rs7913179-<b>?</b>,1 x 10-8,"(EA, men)",0.933,'-,'-,'-,"MARVELD1, AVPI1",Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,10:97705109
rs115460205-<b>?</b>,4 x 10-8,"(EA, men)",0.9307,'-,'-,'-,FSTL5,Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,4:161890417
rs17536732-<b>?</b>,4 x 10-8,"(EA, men)",0.9315,'-,'-,'-,FSTL5,Risky sexual behaviors (alcohol dependence interaction),"alcohol dependence, risky sexual behaviour measurement",GCST004956,4:161903214
rs1344694-<b>?</b>,5 x 10-6,,NR,1.27,'-,[1.15-1.41],"MREG, PECR",Alcohol dependence,alcohol dependence,GCST001281,2:216028914
rs9825310-<b>?</b>,8 x 10-6,,NR,1.25,'-,[1.14-1.38],"CMTM8, RPSAP11",Alcohol dependence,alcohol dependence,GCST001281,3:32198627
rs1000579-<b>?</b>,4 x 10-7,,NR,1.3,'-,[1.17-1.43],STX18-AS1,Alcohol dependence,alcohol dependence,GCST001281,4:4717767
rs4770403-<b>?</b>,6 x 10-6,,NR,1.33,'-,[1.17-1.50],SGCG,Alcohol dependence,alcohol dependence,GCST001281,13:23180988
rs2810114-<b>?</b>,4 x 10-6,,NR,1.29,'-,[1.16-1.44],PCNX1,Alcohol dependence,alcohol dependence,GCST001281,14:70928887
rs1789891-<b>?</b>,1 x 10-8,,NR,1.46,'-,[1.28-1.67],ADH1B,Alcohol dependence,alcohol dependence,GCST001281,4:99329262
rs1896857-<b>A</b>,8 x 10-6,,0.74,1.3,'-,[1.18-1.42],"ANKRD44, ANKRD44-IT1",Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,2:197299806
chr3:182062276-<b>C</b>,8 x 10-6,,0.1,1.44,'-,[1.28-1.60],'-,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,Mapping not available
rs62184315-<b>T</b>,4 x 10-6,,0.84,1.47,'-,[1.31-1.63],C2orf88,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,2:189907219
rs2168784-<b>T</b>,5 x 10-9,,0.11,1.46,'-,[1.34-1.58],LINC01324,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,3:164872151
rs35951-<b>G</b>,1 x 10-8,,0.14,1.43,'-,[1.31-1.55],ARL15,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,5:54296531
rs57083693-<b>C</b>,4 x 10-8,,0.22,1.35,'-,[1.23-1.47],UTP20,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,12:101348402
rs61776290-<b>T</b>,2 x 10-7,,0.11,1.48,'-,[1.32-1.64],"PEX14, CASZ1",Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,1:10634850
rs1362153-<b>C</b>,7 x 10-6,,0.1,1.47,'-,[1.29-1.65],SLC6A9,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,1:44003359
rs1874252-<b>G</b>,7 x 10-6,,0.69,1.32,'-,[1.20-1.44],LINC02694,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,15:38670555
rs11840092-<b>C</b>,2 x 10-6,,0.16,1.37,'-,[1.23-1.51],PCDH17,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,13:57540614
rs5754638-<b>T</b>,8 x 10-6,,0.11,1.44,'-,[1.28-1.60],LARGE1,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,22:33682071
rs1660895-<b>A</b>,7 x 10-7,,0.47,1.3,'-,[1.20-1.40],LINC01854,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,2:129236759
rs896543-<b>G</b>,1 x 10-6,,0.81,1.54,'-,[1.36-1.72],ACKR3,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,2:236600564
rs9874556-<b>A</b>,9 x 10-6,,0.47,1.3,'-,[1.18-1.42],'-,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,3:3314490
rs16824395-<b>A</b>,6 x 10-6,,0.94,1.92,'-,[1.63-2.21],LSAMP,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,3:116021872
rs16897978-<b>C</b>,5 x 10-6,,0.05,1.53,'-,[1.35-1.71],RNU6-909P,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,5:28696397
rs7448080-<b>T</b>,4 x 10-6,,0.05,1.69,'-,[1.47-1.91],LINC01170,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,5:124062405
chr7:112984787-<b>A</b>,9 x 10-6,,0.06,1.54,'-,[1.34-1.74],'-,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,Mapping not available
rs10810935-<b>A</b>,2 x 10-6,,0.73,1.35,'-,[1.23-1.47],ADAMTSL1,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,9:18251857
rs12348435-<b>C</b>,2 x 10-6,,0.04,1.59,'-,[1.39-1.79],LINGO2,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,9:28600144
rs10969853-<b>T</b>,5 x 10-6,,0.94,1.61,'-,[1.41-1.81],"RBMXP2, KRT18P66",Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,9:30751222
rs17625382-<b>G</b>,3 x 10-6,,0.84,1.41,'-,[1.27-1.55],BICC1,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,10:57812948
rs10519005-<b>T</b>,5 x 10-6,,0.46,1.26,'-,[1.16-1.36],FAM81A,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,15:59419492
rs9947276-<b>T</b>,9 x 10-6,,0.72,1.39,'-,[1.25-1.53],ZNF407,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,18:74780733
rs2826659-<b>A</b>,7 x 10-6,,0.75,1.35,'-,[1.21-1.49],NCAM2,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,21:21115536
rs17362650-<b>C</b>,8 x 10-6,,0.26,1.33,'-,[1.21-1.45],ADAM17,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,2:9536284
rs514341-<b>T</b>,6 x 10-6,,0.08,1.5,'-,[1.32-1.68],"LINC01397, UBL4B",Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,1:110110258
rs35738462-<b>T</b>,2 x 10-6,,0.57,1.32,'-,[1.20-1.44],DAB1,Alcohol dependence (age at onset),"age at onset, alcohol dependence",GCST002477,1:57790872
rs9310862-<b>G</b>,4 x 10-6,(Illicit drug use),0.496,'-,'-,'-,CMC1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,3:28165386
rs2887631-<b>G</b>,4 x 10-6,(Illicit drug use),0.275,'-,'-,'-,"CACNA2D4, LRTM2",Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,12:1825415
rs7979367-<b>C</b>,6 x 10-6,(Illicit drug use),0.402,'-,'-,'-,TMEM132D,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,12:129745862
rs4821261-<b>A</b>,9 x 10-6,(Illicit drug use),0.132,'-,'-,'-,'-,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,22:34545584
rs138229-<b>G</b>,9 x 10-6,(Illicit drug use),0.467,'-,'-,'-,MOV10L1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,22:50118978
rs3847794-<b>G</b>,7 x 10-6,(Nicotine use),0.357,'-,'-,'-,PLXNC1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,12:94135049
rs1190596-<b>A</b>,4 x 10-6,(Nicotine use),0.18,'-,'-,'-,HSP90AA1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,14:102129288
rs11681792-<b>A</b>,4 x 10-7,(Non-substance related behavioral disinhibition),0.179,'-,'-,'-,NRXN1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,2:49957256
rs1027841-<b>A</b>,2 x 10-6,(Non-substance related behavioral disinhibition),0.162,'-,'-,'-,ZNF827,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,4:145847922
rs3743832-<b>A</b>,9 x 10-7,(Non-substance related behavioral disinhibition),0.39,'-,'-,'-,C16orf72,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,16:9120023
rs9656709-<b>C</b>,5 x 10-6,(Alcohol consumption),0.488,'-,'-,'-,"FKBP9P1, TUBBP6",Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,7:55656752
rs9871864-<b>G</b>,6 x 10-6,(Alcohol dependence),0.464,'-,'-,'-,SGO1-AS1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,3:20311274
rs13259667-<b>A</b>,8 x 10-6,(Alcohol dependence),0.074,'-,'-,'-,'-,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,8:77413649
rs12311304-<b>G</b>,4 x 10-6,(Alcohol dependence),0.328,'-,'-,'-,RERG,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,12:15236703
rs4761097-<b>G</b>,2 x 10-6,(Alcohol dependence),0.449,'-,'-,'-,SLC6A15,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,12:84793732
rs642899-<b>C</b>,8 x 10-6,(Alcohol dependence),0.233,'-,'-,'-,STARD13,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,13:33106717
rs9782914-<b>G</b>,8 x 10-6,(Illicit drug use),0.145,'-,'-,'-,WDR64,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,1:241728933
rs10037670-<b>G</b>,4 x 10-6,(Illicit drug use),0.208,'-,'-,'-,SAP30L-AS1,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,5:154431930
rs2071214-<b>G</b>,8 x 10-6,(Non-substance related behavioral disinhibition),0.054,'-,'-,'-,BIRC5,Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,17:78223510
rs2380220-<b>A</b>,4 x 10-6,(Alcohol dependence),0.159,'-,'-,'-,"MANEA-DT, CYCSP17",Behavioural disinhibition (generation interaction),"nicotine use, generational effect measurement, illegal drug consumption, non-substance related disinhibited behaviour, alcohol drinking, alcohol dependence",GCST002131,6:95519536
rs7181753-<b>T</b>,3 x 10-6,,0.199,'-,0.128 unit increase,[NR],NR2F2-AS1,Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,15:96301498
rs2835872-<b>G</b>,5 x 10-10,,0.681,'-,0.145 unit decrease,[NR],KCNJ6,Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,21:37654970
rs2766692-<b>G</b>,2 x 10-6,,0.691,'-,0.11 unit decrease,[NR],"DEGS2, YY1",Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,14:100217855
rs16992796-<b>G</b>,3 x 10-6,,0.05,'-,0.236 unit decrease,[NR],"ARHGAP8, PRR5-ARHGAP8",Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,22:44787134
rs9860340-<b>A</b>,4 x 10-6,,0.749,'-,0.122 unit decrease,[NR],RNU6-873P,Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,3:87734826
rs9395865-<b>T</b>,6 x 10-6,,0.279,'-,0.106 unit increase,[NR],"GCLC, NANOGP3",Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,6:53442896
rs10897449-<b>T</b>,7 x 10-6,,0.453,'-,0.099 unit decrease,[NR],SPINDOC,Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,11:63825149
rs4256430-<b>A</b>,8 x 10-6,,0.465,'-,0.099 unit decrease,[NR],RIPOR2,Electroencephalographic traits in alcoholism,"frontal theta oscillation measurement, alcohol dependence",GCST001503,6:24862847
rs195204-<b>T</b>,9 x 10-6,,0.24,'-,0.1 unit increase,[NR],"NGF-AS1, LINC01765",Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,1:115191470
rs2369955-<b>A</b>,2 x 10-6,,0.16,'-,0.136 unit decrease,[NR],TMEM108,Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,3:132974744
rs1109501-<b>G</b>,5 x 10-6,,0.24,'-,0.1 unit increase,[NR],MUC7,Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,4:70463773
rs10908907-<b>G</b>,6 x 10-6,,0.25,'-,0.099 unit increase,[NR],"GADD45G, UNQ6494",Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,9:89634669
rs9512637-<b>C</b>,1 x 10-7,,0.32,'-,0.105 unit decrease,[NR],"LINC01079, RNU6-70P",Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,13:27346474
rs1380131-<b>C</b>,9 x 10-6,,0.07,'-,0.147 unit increase,[NR],RPS3AP46,Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,14:53606140
rs8040009-<b>T</b>,3 x 10-7,,0.21,'-,0.123 unit decrease,[NR],C15orf32,Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,15:92501109
rs2827312-<b>G</b>,8 x 10-6,,0.32,'-,0.089 unit increase,[NR],RNU4-45P,Alcoholism (heaviness of drinking),alcohol dependence,GCST001052,21:22259356
rs2154294-<b>G</b>,3 x 10-6,,0.44,'-,0.08 unit increase,[NR],'-,Alcoholism (12-month weekly alcohol consumption),alcohol dependence,GCST001055,14:42186072
rs237238-<b>A</b>,7 x 10-6,,0.07,'-,0.156 unit increase,[NR],HIP1,Alcoholism (12-month weekly alcohol consumption),alcohol dependence,GCST001055,7:75582098
rs6716455-<b>G</b>,7 x 10-7,,0.13,'-,0.123 unit increase,[NR],LINC01818,Alcoholism (alcohol use disorder factor score),alcohol dependence,GCST001053,2:150269889
rs3930234-<b>C</b>,8 x 10-6,,0.15,'-,0.104 unit increase,[NR],"LINC02054, LINC01839",Alcoholism (alcohol use disorder factor score),alcohol dependence,GCST001053,3:184498342
rs2548145-<b>G</b>,2 x 10-6,,0.47,'-,0.081 unit decrease,[NR],KRT18P56,Alcoholism (alcohol use disorder factor score),alcohol dependence,GCST001053,5:40134675
rs2140418-<b>C</b>,4 x 10-6,,0.22,'-,0.101 unit increase,[NR],ANKS1A,Alcoholism (alcohol use disorder factor score),alcohol dependence,GCST001053,6:35007638
rs9556711-<b>G</b>,2 x 10-6,,0.08,'-,0.163 unit decrease,[NR],MBNL2,Alcoholism (alcohol use disorder factor score),alcohol dependence,GCST001053,13:97364162
rs768048-<b>C</b>,8 x 10-6,,0.12,'-,0.11 unit increase,[NR],DCC,Alcoholism (alcohol use disorder factor score),alcohol dependence,GCST001053,18:52759028
rs6716455-<b>G</b>,9 x 10-6,,0.13,'-,0.109 unit increase,[NR],LINC01818,Alcoholism (alcohol dependence factor score),alcohol dependence,GCST001054,2:150269889
rs2140418-<b>C</b>,4 x 10-6,,0.22,'-,0.1 unit increase,[NR],ANKS1A,Alcoholism (alcohol dependence factor score),alcohol dependence,GCST001054,6:35007638
rs10253361-<b>T</b>,6 x 10-6,,0.38,'-,0.076 unit decrease,[NR],'-,Alcoholism (alcohol dependence factor score),alcohol dependence,GCST001054,7:121635175
rs9556711-<b>G</b>,8 x 10-7,,0.08,'-,0.167 unit decrease,[NR],MBNL2,Alcoholism (alcohol dependence factor score),alcohol dependence,GCST001054,13:97364162
rs933769-<b>T</b>,7 x 10-6,,0.19,'-,0.097 unit decrease,[NR],LINC00924,Alcoholism (alcohol dependence factor score),alcohol dependence,GCST001054,15:95509513
rs4293630-<b>A</b>,7 x 10-6,,0.14,'-,0.108 unit increase,[NR],"PSMA6P3, COL6A1",Alcoholism (alcohol dependence factor score),alcohol dependence,GCST001054,21:46025877
rs159572-<b>A</b>,6 x 10-8,African Americans,'-,1.51,'-,[1.3-1.75],ANKRD55,Post-traumatic stress disorder,post-traumatic stress disorder,GCST003495,5:56211219
rs201123820-<b>T</b>,3 x 10-8,(African),0.0193,'-,5.547 z score increase,'-,"LINC02837, SRP72P1",Opioid dependence,opioid dependence,GCST009853,18:49498978
"rs9319617-<b>?</b>, rs9912789-<b>?</b>, rs12939525-<b>?</b>, rs969413-<b>?</b>, rs8073077-<b>?</b>, rs2255166-<b>?</b>, rs906175-<b>?</b>, rs2659005-<b>?</b>, rs2725391-<b>?</b>, rs1048775-<b>?</b>, rs9896850-<b>?</b>, rs2659030-<b>?</b>",7 x 10-6,,NR,1.44,'-,[1.22-1.69],CEP131; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes; No mapped genes,Frontotemporal dementia,Frontotemporal dementia,GCST002960,17:81218646
rs12546767-<b>?</b>,1 x 10-7,,0.9,1.22,'-,[NR],WASHC5,Amyotrophic lateral sclerosis or frontotemporal dementia,"amyotrophic lateral sclerosis, Frontotemporal dementia",GCST002510,8:125070323
rs429358-<b>C</b>,3 x 10-64,,0.14,2.46,'-,[2.22-2.74],'-,Dementia with Lewy bodies,Lewy body dementia,GCST005276,Mapping not available
rs7681440-<b>?</b>,9 x 10-13,,0.52,1.369863,'-,[1.27-1.49],SNCA,Dementia with Lewy bodies,Lewy body dementia,GCST005276,4:89835399
rs35749011-<b>G</b>,7 x 10-10,,0.014,2.27,'-,[1.75-2.95],'-,Dementia with Lewy bodies,Lewy body dementia,GCST005276,Mapping not available
rs897984-<b>?</b>,1 x 10-8,,0.6,1.2987013,'-,[1.18-1.41],"MIR4519, MIR762HG, BCL7C",Dementia with Lewy bodies,Lewy body dementia,GCST005276,16:30875322
rs4951043-<b>C</b>,7 x 10-7,,0.46,'-,0.44 unit decrease,[0.26-0.62],SOX13,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,1:204105737
rs11059336-<b>C</b>,8 x 10-7,,0.14,'-,0.63 unit increase,[0.38-0.88],'-,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,12:127745489
rs1192553-<b>G</b>,1 x 10-6,,0.25,'-,0.49 unit increase,[0.29-0.69],LINC01654,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,1:17967858
rs12060257-<b>A</b>,2 x 10-6,,0.21,'-,0.51 unit increase,[0.29-0.73],"PLPPR5, SNX7",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,1:98811303
rs10777553-<b>A</b>,2 x 10-6,,0.05,'-,0.93 unit increase,[0.54-1.32],"CRADD, RN7SKP263",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,12:93916977
rs7076862-<b>A</b>,4 x 10-6,,0.36,'-,0.44 unit increase,[0.26-0.62],DCLRE1C,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,10:14934415
rs10072948-<b>G</b>,4 x 10-6,,0.19,'-,0.51 unit decrease,[0.29-0.73],"TCERG1, POU4F3",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,5:146440541
rs5018014-<b>T</b>,7 x 10-6,,0.15,'-,0.58 unit decrease,[0.33-0.83],"RYBP, LINC00877",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,3:72370075
rs115339319-<b>C</b>,7 x 10-6,,0.14,'-,0.57 unit decrease,[0.32-0.82],"GYPA, GYPB",Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,4:144029633
rs11122565-<b>T</b>,8 x 10-6,,0.21,'-,0.49 unit decrease,[0.27-0.71],COG2,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008359,1:230643520
rs34516333-<b>T</b>,1 x 10-6,,0.27,'-,0.24 unit increase,[0.14-0.34],ZFHX3,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008360,16:73114768
rs7818243-<b>C</b>,4 x 10-6,,0.28,'-,0.22 unit increase,[0.12-0.32],DLGAP2,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008360,8:1181480
rs72733034-<b>A</b>,4 x 10-6,,0.11,'-,0.34 unit increase,[0.2-0.48],TMC1,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008360,9:72703151
rs73164463-<b>C</b>,4 x 10-6,,0.1,'-,0.34 unit decrease,[0.2-0.48],SYPL1P1,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008360,3:154556181
rs34724549-<b>A</b>,6 x 10-6,,0.07,'-,0.39 unit increase,[0.21-0.57],TRA2B,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008360,3:118668737
rs6455972-<b>T</b>,7 x 10-6,,0.17,'-,0.26 unit decrease,[0.14-0.38],'-,Response to cognitive-behavioural therapy in anxiety disorder,"anxiety disorder, cognitive behavioural therapy",GCST008360,6:164927680
rs147650109-<b>G</b>,7 x 10-7,,0.026,1.5724013,'-,[NR],ADGRE1,Bipolar II disorder,bipolar II disorder,GCST008116,19:6908884
rs72761817-<b>G</b>,3 x 10-7,,0.025,1.5387928,'-,[NR],OXCT1,Bipolar II disorder,bipolar II disorder,GCST008116,5:41654144
chr21_26773583_D-<b>?</b>,9 x 10-8,,0.034,1.5260652,'-,[NR],'-,Bipolar II disorder,bipolar II disorder,GCST008116,Mapping not available
rs111444407-<b>T</b>,4 x 10-6,,0.144,1.18685,'-,[NR],NCAN,Bipolar II disorder,bipolar II disorder,GCST008116,19:19247398
rs79143696-<b>C</b>,9 x 10-8,,0.0212,1.66496,'-,[NR],"KRTAP5-11, KRTAP5-10",Bipolar II disorder,bipolar II disorder,GCST008116,11:71576909
rs4675502-<b>?</b>,4 x 10-7,"(Strict, all)",NR,1.28,'-,[1.16-1.41],PARD3B,Autism,autism,GCST001619,2:205221447
rs7711337-<b>?</b>,8 x 10-7,"(Spectrum, all)",NR,1.22,'-,[1.12-1.32],'-,Autism,autism,GCST001619,5:162656512
rs7834018-<b>?</b>,8 x 10-7,"(Strict, EA)",NR,1.56,'-,[1.3-1.89],EYA1,Autism,autism,GCST001619,8:71649507
rs4150167-<b>?</b>,3 x 10-7,"(Spectrum, all)",NR,1.96,'-,[1.52-2.56],TAF1C,Autism,autism,GCST001619,16:84180078
rs12388359-<b>T</b>,4 x 10-6,,0.11,1.61,'-,[1.32-2.00],CLCN4,Alcohol dependence,alcohol dependence,GCST000432,X:10263651
rs7590720-<b>G</b>,1 x 10-8,,0.29,1.35,'-,[1.22-1.49],"PECR, MREG",Alcohol dependence,alcohol dependence,GCST000432,2:216033935
rs13160562-<b>G</b>,7 x 10-6,,0.68,1.27,'-,[1.14-1.41],"ERAP1, CAST",Alcohol dependence,alcohol dependence,GCST000432,5:96775667
rs1864982-<b>A</b>,3 x 10-6,,0.13,1.36,'-,[1.20-1.55],PPP2R2B,Alcohol dependence,alcohol dependence,GCST000432,5:146941260
rs6902771-<b>C</b>,8 x 10-6,,0.51,1.24,'-,[1.13-1.36],ESR1,Alcohol dependence,alcohol dependence,GCST000432,6:151836746
rs36563-<b>A</b>,5 x 10-6,,0.15,1.33,'-,[1.18-1.50],"PCNX1, MAP3K9",Alcohol dependence,alcohol dependence,GCST000432,14:70885931
rs117354149-<b>C</b>,3 x 10-6,,0.085,'-,'-,'-,SETD5,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010221,3:9464601
rs61913097-<b>C</b>,3 x 10-6,,0.182,'-,'-,'-,ERC1,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST010220,12:1340033
rs117059665-<b>T</b>,5 x 10-6,,0.048,'-,'-,'-,FGFR2,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST010220,10:121570923
rs609728-<b>T</b>,6 x 10-6,,0.164,'-,'-,'-,ANO4,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST010220,12:100981868
rs6699651-<b>T</b>,8 x 10-7,,0.106,'-,'-,'-,CAMTA1,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,1:7592327
rs2817619-<b>T</b>,6 x 10-7,,0.442,'-,'-,'-,"DISP3, LINC01647",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,1:11543006
rs214220-<b>C</b>,1 x 10-6,,0.5,'-,'-,'-,SKINT1L,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,1:48156510
rs10800919-<b>C</b>,4 x 10-7,,0.371,'-,'-,'-,"LARP7P1, FMOD",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,1:203367680
rs11119570-<b>A</b>,1 x 10-7,,0.396,'-,'-,'-,IL19,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,1:206794890
rs16823921-<b>G</b>,6 x 10-7,,0.333,'-,'-,'-,"TEX41, LINC01412",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,2:144618549
rs7684645-<b>A</b>,1 x 10-8,,0.387,'-,'-,'-,"APELA, SMIM31",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,4:164874994
rs6796-<b>C</b>,3 x 10-7,,0.491,'-,'-,'-,"KDELR2, DAGLB",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,7:6462736
rs12538843-<b>A</b>,2 x 10-8,,0.287,'-,'-,'-,"POU6F2, YAE1",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,7:39560498
rs6954881-<b>G</b>,2 x 10-7,,0.472,'-,'-,'-,"RNU6-1335P, CCNJP1",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,7:56302123
rs10868138-<b>C</b>,7 x 10-7,,0.093,'-,'-,'-,SLC28A3,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,9:84302386
rs74120710-<b>T</b>,3 x 10-7,,0.157,'-,'-,'-,"CCDC3, CAMK1D",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,10:12895634
rs4945333-<b>G</b>,9 x 10-7,,0.245,'-,'-,'-,TENM4,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,11:79209774
rs9316596-<b>A</b>,8 x 10-7,,0.343,'-,'-,'-,LINC00424,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,13:21895101
rs1239704-<b>G</b>,8 x 10-8,,0.324,'-,'-,'-,"DLEU1, DLEU7",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,13:50578475
rs11074258-<b>C</b>,4 x 10-8,,0.17,'-,'-,'-,"H3P40, MCTP2",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,15:94227570
rs34396552-<b>G</b>,5 x 10-8,,0.359,'-,'-,'-,"CIDEA, RNU6-170P",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,18:12286114
rs35493881-<b>?</b>,8 x 10-8,,0.359,'-,'-,'-,"RPS2P6, RN7SL795P",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,18:70486327
rs6073330-<b>A</b>,3 x 10-7,,0.481,'-,'-,'-,JPH2,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,20:44108854
rs62214554-<b>G</b>,3 x 10-7,,0.25,'-,'-,'-,"PFDN4, CYP24A1",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,20:54190723
rs6015071-<b>A</b>,2 x 10-7,,0.274,'-,'-,'-,NKILA,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,20:57739583
rs9464011-<b>C</b>,7 x 10-7,,0.102,'-,'-,'-,"MLIP, MLIP-IT1, MLIP-AS1",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST010218,6:54001468
rs34442475-<b>C</b>,2 x 10-6,,0.412,2.3,'-,[1.41-3.78],UBBP1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010222,2:136306815
rs2238652-<b>T</b>,3 x 10-6,,0.289,4.79,'-,[2.28-10.0],"COMP, UPF1",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010222,19:18831750
rs11906570-<b>A</b>,7 x 10-7,,0.0212,2.91276,'-,[NR],MYT1,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,20:64131898
rs140724264-<b>G</b>,2 x 10-7,,0.025,2.0680385,'-,[NR],PTCH1,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,9:95602990
rs3851101-<b>G</b>,4 x 10-7,,0.136,1.4237511,'-,[NR],SCN3B,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,11:123653388
rs1990042-<b>C</b>,1 x 10-6,,0.724,1.405936,'-,[NR],"MYO1G, PURB",Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,7:44936750
rs62198555-<b>G</b>,7 x 10-7,,0.576,1.3027787,'-,[NR],'-,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,2:185171397
rs703610-<b>G</b>,7 x 10-7,,0.528,1.2964116,'-,[NR],STAB2,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,12:103617146
rs10954695-<b>A</b>,3 x 10-7,,0.373,1.30591,'-,[NR],PCLO,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,7:82927912
rs12405527-<b>A</b>,6 x 10-7,,0.0702,1.71343,'-,[NR],S1PR1,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,1:101217609
rs11849937-<b>T</b>,8 x 10-7,,0.034,1.80273,'-,[NR],NRXN3,Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,14:78645876
rs10098598-<b>T</b>,6 x 10-7,,0.0302,1.94507,'-,[NR],"UTP23, RAD21",Schizoaffective disorder-bipolar type,Schizoaffective disorder-bipolar type,GCST008117,8:116848536
rs3914502-<b>A</b>,4 x 10-6,,0.38,1.4,'-,[1.20-1.60],NAALADL2,Autism spectrum disorder,autism spectrum disorder,GCST003130,3:174846812
rs12543592-<b>G</b>,3 x 10-6,,0.5,1.43,'-,[1.25-1.67],LINC01151,Autism spectrum disorder,autism spectrum disorder,GCST003130,8:122499413
rs10888329-<b>?</b>,8 x 10-6,,0.804,1.82,'-,[1.39-2.33],OR2M4,Autism spectrum disorder,autism spectrum disorder,GCST003130,1:248241352
rs2447097-<b>A</b>,9 x 10-6,,0.261,1.53,'-,[1.27-1.85],SGSM2,Autism spectrum disorder,autism spectrum disorder,GCST003130,17:2374770
rs118045675-<b>G</b>,3 x 10-6,,0.9682542,1.4084507,'-,[1.22-1.64],SMIM21,Autism spectrum disorder,autism spectrum disorder,GCST010515,18:75424019
rs60527016-<b>T</b>,5 x 10-8,,0.792283,1.1904762,'-,[1.11-1.27],FGFR1,Autism spectrum disorder,autism spectrum disorder,GCST010515,8:38442106
rs405182-<b>G</b>,2 x 10-6,,0.692795,1.1764705,'-,[1.1-1.25],SSUH2,Autism spectrum disorder,autism spectrum disorder,GCST010515,3:8678265
rs60624745-<b>C</b>,6 x 10-6,,0.721586,1.1627907,'-,[1.09-1.23],NLRP4,Autism spectrum disorder,autism spectrum disorder,GCST010515,19:55856118
rs1046041-<b>T</b>,6 x 10-6,,0.518174,1.1235955,'-,[1.06-1.18],POLR2E,Autism spectrum disorder,autism spectrum disorder,GCST010515,19:1095337
rs11184553-<b>A</b>,6 x 10-6,,0.460644,1.12,'-,[1.07-1.18],CDK4P1,Autism spectrum disorder,autism spectrum disorder,GCST010515,1:105395840
rs11188360-<b>A</b>,3 x 10-6,,0.149671,1.19,'-,[1.1-1.27],SORBS1,Autism spectrum disorder,autism spectrum disorder,GCST010515,10:95558200
rs77230196-<b>C</b>,3 x 10-6,,0.0706573,1.29,'-,[1.16-1.43],LUZP2,Autism spectrum disorder,autism spectrum disorder,GCST010515,11:24997823
rs10742763-<b>T</b>,4 x 10-6,,0.063043,1.31,'-,[1.17-1.46],"MIR7154, CHST1",Autism spectrum disorder,autism spectrum disorder,GCST010515,11:45672434
rs9598562-<b>T</b>,4 x 10-6,,0.212546,1.15,'-,[1.09-1.23],LINC00376,Autism spectrum disorder,autism spectrum disorder,GCST010515,13:63231583
rs72646783-<b>T</b>,6 x 10-6,,0.0377415,1.35,'-,[1.19-1.55],"HSP90AB6P, HS6ST3",Autism spectrum disorder,autism spectrum disorder,GCST010515,13:96859683
rs77562299-<b>C</b>,4 x 10-6,,0.06984,1.26,'-,[1.14-1.39],LINC00922,Autism spectrum disorder,autism spectrum disorder,GCST010515,16:65377873
rs632349-<b>G</b>,3 x 10-6,,0.362939,1.13,'-,[1.08-1.2],'-,Autism spectrum disorder,autism spectrum disorder,GCST010515,18:69268412
rs2638592-<b>C</b>,7 x 10-6,,0.235119,1.14,'-,[1.08-1.21],"GPR156, LRRC58",Autism spectrum disorder,autism spectrum disorder,GCST010515,3:120312093
rs56027323-<b>A</b>,9 x 10-6,,0.093149,1.22,'-,[1.12-1.33],"AACSP1, ZNF354A",Autism spectrum disorder,autism spectrum disorder,GCST010515,5:178734176
rs145570843-<b>A</b>,4 x 10-6,,0.98923,2.1276596,'-,[1.54-2.94],SPTLC1P2,Autism spectrum disorder,autism spectrum disorder,GCST010514,6:23777604
rs405182-<b>G</b>,5 x 10-6,,0.692795,1.1904762,'-,[1.1-1.28],SSUH2,Autism spectrum disorder,autism spectrum disorder,GCST010514,3:8678265
rs60527016-<b>T</b>,3 x 10-6,,0.792283,1.0752687,'-,[1.04-1.1],FGFR1,Autism spectrum disorder,autism spectrum disorder,GCST010514,8:38442106
rs36059156-<b>G</b>,8 x 10-6,,0.696869,1.0638298,'-,[1.04-1.1],"RPL10P19, RNU6-682P",Autism spectrum disorder,autism spectrum disorder,GCST010514,8:8924057
rs61925919-<b>A</b>,5 x 10-6,,0.195114,1.08,'-,[1.05-1.12],"LINC02827, LINC02404",Autism spectrum disorder,autism spectrum disorder,GCST010514,12:91843377
rs143634450-<b>A</b>,1 x 10-6,,0.0394467,1.39,'-,[1.22-1.58],MPPED1,Autism spectrum disorder,autism spectrum disorder,GCST010515,22:43499322
rs7627815-<b>T</b>,8 x 10-6,,0.0343502,1.38,'-,[1.2-1.58],"PBX2P1, SLC9A9",Autism spectrum disorder,autism spectrum disorder,GCST010515,3:143236587
rs10099100-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"RP1L1, SOX7",Autism spectrum disorder,autism spectrum disorder,GCST010648,8:10719265
rs71190156-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,MACROD2,Autism spectrum disorder,autism spectrum disorder,GCST010648,20:14855598
rs910805-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"XRN2, ZNF877P",Autism spectrum disorder,autism spectrum disorder,GCST010648,20:21267478
rs1589526-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,RSRC1,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,3:158138357
rs416223-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,'-,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,5:104655775
rs34509057-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,GALNT10,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,5:154221702
rs6461809-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,RNU6-1103P,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,7:24486420
rs10099100-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"RP1L1, SOX7",Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,8:10719265
rs6584649-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,SORCS3,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,10:104985346
rs6500768-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,RBFOX1,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,16:6292640
rs6508210-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,DCC,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,18:53220821
rs71190156-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,MACROD2,Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,20:14855598
rs910805-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,"XRN2, ZNF877P",Autism spectrum disorder (MTAG),autism spectrum disorder,GCST010643,20:21267478
rs4141463-<b>?</b>,4 x 10-8,(Str),0.57,1.37,'-,[1.22-1.52],MACROD2,Autism,autism,GCST000740,20:14766825
rs7142002-<b>?</b>,3 x 10-6,(Spc),0.94,1.56,'-,[1.28-1.89],PPP2R5C,Autism,autism,GCST000740,14:101894408
rs73191662-<b>C</b>,2 x 10-6,,0.72,2.7027025,'-,[1.28-25],"DLD, PIGCP2",Behavioural changes in frontotemporal lobe dementia,"Frontotemporal dementia, behavior",GCST006146,7:107837310
rs1455740-<b>G</b>,7 x 10-6,,0.68,2.4390244,'-,[1.25-50],TRMT11,Behavioural changes in frontotemporal lobe dementia,"Frontotemporal dementia, behavior",GCST006146,6:126184256
rs4888280-<b>A</b>,7 x 10-6,,0.33,2,'-,[1.71-2.29],"LINC01568, ZFHX3",Behavioural changes in frontotemporal lobe dementia,"Frontotemporal dementia, behavior",GCST006146,16:73431477
rs6809184-<b>T</b>,1 x 10-6,,0.09,'-,5.46 unit decrease,'-,TNIK,Frontotemporal dementia (age at onset),"age at onset, Frontotemporal dementia",GCST006147,3:171170409
rs6962939-<b>A</b>,8 x 10-7,,0.06,'-,6.04 unit decrease,'-,COL28A1,Frontotemporal dementia (age at onset),"age at onset, Frontotemporal dementia",GCST006147,7:7484595
rs9792144-<b>G</b>,8 x 10-7,,0.18,'-,3.78 unit increase,'-,ST18,Frontotemporal dementia (age at onset),"age at onset, Frontotemporal dementia",GCST006147,8:52168991
rs6108746-<b>C</b>,3 x 10-7,,0.25,'-,3.19 unit increase,'-,"FAT1P1, LINC02871",Frontotemporal dementia (age at onset),"age at onset, Frontotemporal dementia",GCST006147,20:10922123
rs6111609-<b>A</b>,1 x 10-6,,0.22,'-,2.86 unit increase,'-,"RRBP1, BANF2",Frontotemporal dementia (age at onset),"age at onset, Frontotemporal dementia",GCST006147,20:17683901
rs10816848-<b>T</b>,5 x 10-6,,0.51,1.4285715,'-,[1.22-1.67],PALM2AKAP2,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,9:109659155
rs79095029-<b>C</b>,4 x 10-6,,0.92,2.564103,'-,[1.69-3.7],KRT18P42,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,5:109519605
rs13393316-<b>A</b>,1 x 10-6,,0.86,1.8867927,'-,[1.47-2.44],NDUFS1,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,2:206134615
rs7791726-<b>G</b>,2 x 10-14,,0.58,2,'-,[1.67-2.38],"VWDE, TMEM106B",Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,7:12243703
rs10101195-<b>C</b>,1 x 10-6,,0.77,1.6129031,'-,[1.33-1.96],"GATA4, NEIL2",Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,8:11765703
rs36196656-<b>A</b>,1 x 10-7,,0.65,1.55,'-,[1.32-1.82],GFRA2,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,8:21763735
rs13072484-<b>A</b>,1 x 10-6,,0.78,1.51,'-,[1.28-1.78],LINC02012,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,3:197409951
rs62443267-<b>C</b>,6 x 10-6,,0.75,1.54,'-,[1.28-4.35],"SFRP4, STARD3NL",Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,7:38113711
rs10791882-<b>A</b>,5 x 10-6,,0.39,1.43,'-,[1.23-1.67],ACTN3,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,11:66551842
rs10860097-<b>T</b>,2 x 10-6,,0.02,3.04,'-,[1.92-4.81],CFAP54,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,12:96805878
rs7240419-<b>A</b>,1 x 10-6,,0.23,1.52,'-,[1.28-1.79],ATP9B,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,18:79168989
rs6076187-<b>A</b>,9 x 10-6,,0.04,2.27,'-,[1.58-3.26],LINC01721,Frontotemporal dementia with GRN mutation,Frontotemporal dementia,GCST006148,20:24101942
rs6962939-<b>A</b>,5 x 10-6,,0.05,'-,5.76 unit decrease,[8.22-3.29],COL28A1,Frontotemporal dementia with GRN mutation (age at onset),"age at onset, Frontotemporal dementia",GCST006149,7:7484595
rs2922921-<b>A</b>,2 x 10-6,,0.03,'-,9.5 unit increase,[5.6-13.39],"SEM1, MARK2P10",Frontotemporal dementia with GRN mutation (age at onset),"age at onset, Frontotemporal dementia",GCST006149,7:96768767
rs9792144-<b>G</b>,9 x 10-6,,0.14,'-,3.62 unit increase,[2.03-5.22],ST18,Frontotemporal dementia with GRN mutation (age at onset),"age at onset, Frontotemporal dementia",GCST006149,8:52168991
rs3922636-<b>A</b>,4 x 10-6,,0.37,'-,2.98 unit increase,[1.71-4.25],RPL3P9,Frontotemporal dementia with GRN mutation (age at onset),"age at onset, Frontotemporal dementia",GCST006149,8:79471267
rs6108746-<b>C</b>,7 x 10-7,,0.22,'-,3.24 unit increase,[1.96-4.52],"FAT1P1, LINC02871",Frontotemporal dementia with GRN mutation (age at onset),"age at onset, Frontotemporal dementia",GCST006149,20:10922123
rs6111609-<b>A</b>,5 x 10-6,,0.28,'-,2.78 unit increase,[1.59-3.97],"RRBP1, BANF2",Frontotemporal dementia with GRN mutation (age at onset),"age at onset, Frontotemporal dementia",GCST006149,20:17683901
rs2732260-<b>A</b>,1 x 10-6,,0.03,5.64,'-,[4.93-6.35],FUT10,Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,8:33431749
rs1034797-<b>G</b>,5 x 10-6,,0.08,3.84,'-,[3.27-4.41],"NUP35P2, MAGI2-AS3",Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,7:79474577
rs28649357-<b>G</b>,8 x 10-6,,0.14,2.61,'-,[2.20-3.02],"LRRC37B, SH3GL1P1",Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,17:32040171
rs13012521-<b>T</b>,8 x 10-6,,0.09,2.99,'-,[2.50-3.48],PRPF40A,Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,2:152703130
rs6010061-<b>T</b>,8 x 10-6,,0.36,2.173913,'-,[1.25-9.09],SHANK3,Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,22:50713296
rs10084892-<b>C</b>,9 x 10-6,,0.1,2.94,'-,[2.47-3.41],FAT4,Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,4:125446831
rs3773384-<b>C</b>,4 x 10-6,,0.58,2.3255813,'-,[1.28-12.5],"CHL1, CHL1-AS1",Parkinsonism in frontotemporal lobe dementia,"Parkinson's disease, Frontotemporal dementia",GCST006153,3:374758
rs34656641-<b>C</b>,8 x 10-6,,0.08,3.26,'-,[2.75-3.77],SP1,Parkinsonism in frontotemporal lobe dementia,"Parkinson's disease, Frontotemporal dementia",GCST006153,12:53403452
rs17833740-<b>T</b>,9 x 10-6,,0.29,2.17,'-,[1.84-2.50],LINC01500,Parkinsonism in frontotemporal lobe dementia,"Parkinson's disease, Frontotemporal dementia",GCST006153,14:59154251
rs7791726-<b>G</b>,4 x 10-16,,0.58,1.8518518,'-,[1.59-2.17],"VWDE, TMEM106B",Frontotemporal dementia,Frontotemporal dementia,GCST006154,7:12243703
rs10101195-<b>C</b>,4 x 10-6,,0.77,1.4705882,'-,[1.25-1.72],"GATA4, NEIL2",Frontotemporal dementia,Frontotemporal dementia,GCST006154,8:11765703
rs10816848-<b>T</b>,6 x 10-6,,0.51,1.4492754,'-,[1.18-1.54],PALM2AKAP2,Frontotemporal dementia,Frontotemporal dementia,GCST006154,9:109659155
rs36196656-<b>A</b>,2 x 10-8,,0.37,1.49,'-,[1.30-1.71],GFRA2,Frontotemporal dementia,Frontotemporal dementia,GCST006154,8:21763735
rs10860097-<b>T</b>,5 x 10-6,,0.02,2.38,'-,[1.64-3.45],CFAP54,Frontotemporal dementia,Frontotemporal dementia,GCST006154,12:96805878
rs7240419-<b>A</b>,6 x 10-6,,0.22,1.41,'-,[1.21-1.63],ATP9B,Frontotemporal dementia,Frontotemporal dementia,GCST006154,18:79168989
rs2708146-<b>A</b>,8 x 10-7,,0.545,1.1293023,'-,'-,LINC01122,Tourette syndrome,Tourette syndrome,GCST007277,2:58728818
rs1865896-<b>G</b>,3 x 10-6,,0.5052,1.1227713,'-,'-,SGPP2,Tourette syndrome,Tourette syndrome,GCST007277,2:222469223
rs6445765-<b>C</b>,3 x 10-6,,0.6279,1.1271586,'-,'-,ERC2,Tourette syndrome,Tourette syndrome,GCST007277,3:56058870
rs73205493-<b>T</b>,2 x 10-6,,0.3436,1.1509641,'-,'-,CFAP99,Tourette syndrome,Tourette syndrome,GCST007277,4:2458844
rs4047771-<b>A</b>,4 x 10-7,,0.6764,1.154076,'-,'-,RNA5SP172,Tourette syndrome,Tourette syndrome,GCST007277,4:177549744
rs147208935-<b>T</b>,2 x 10-6,,0.01,1.8606018,'-,'-,TENM2,Tourette syndrome,Tourette syndrome,GCST007277,5:167853450
rs1906252-<b>C</b>,3 x 10-7,,0.5087,1.1348494,'-,'-,"MIR2113, EIF4EBP2P3",Tourette syndrome,Tourette syndrome,GCST007277,6:98102413
rs72673503-<b>A</b>,7 x 10-6,,0.1451,1.1701126,'-,'-,'-,Tourette syndrome,Tourette syndrome,GCST007277,8:92205896
rs117780640-<b>C</b>,3 x 10-6,,0.8639,1.2153109,'-,'-,"SNORD3H, TSPYL5",Tourette syndrome,Tourette syndrome,GCST007277,8:97308702
rs117648881-<b>G</b>,6 x 10-7,,0.9762,1.6571512,'-,'-,CSMD3,Tourette syndrome,Tourette syndrome,GCST007277,8:112569669
rs72734943-<b>A</b>,4 x 10-6,,0.014,1.9006578,'-,'-,RNU6-1228P,Tourette syndrome,Tourette syndrome,GCST007277,9:75215240
rs191044310-<b>T</b>,6 x 10-7,,0.9778,1.7931969,'-,'-,"OTUD1, C10orf67",Tourette syndrome,Tourette syndrome,GCST007277,10:23416522
rs10846381-<b>T</b>,1 x 10-6,,0.5897,1.1308845,'-,'-,"LMO3, MGST1",Tourette syndrome,Tourette syndrome,GCST007277,12:16599165
rs2504235-<b>A</b>,2 x 10-7,,0.3848,1.1403098,'-,'-,FLT3,Tourette syndrome,Tourette syndrome,GCST007277,13:28038749
rs66489957-<b>T</b>,4 x 10-6,,0.7692,1.1447657,'-,'-,TSHR,Tourette syndrome,Tourette syndrome,GCST007277,14:81133860
rs74772983-<b>A</b>,9 x 10-6,,0.9281,1.2448313,'-,'-,XYLT1,Tourette syndrome,Tourette syndrome,GCST007277,16:17399267
rs150975336-<b>G</b>,4 x 10-7,,0.0269,1.5866106,'-,'-,"MUC16, BOLA3P2",Tourette syndrome,Tourette syndrome,GCST007277,19:8995481
rs1979398-<b>?</b>,3 x 10-6,,NR,1.23,'-,[NR],ITGA1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST004778,5:52898497
rs852004-<b>A</b>,3 x 10-8,,0.08,'-,11.84 unit decrease,[-15.94--7.734],"CCDC170, ESR1",Executive function in ADHD,"attention deficit hyperactivity disorder, executive function measurement",GCST006219,6:151639281
rs13328379-<b>T</b>,8 x 10-7,(Commissions),0.14,'-,3.41 unit decrease,[2.06-4.76],'-,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,8:20777239
rs7936591-<b>T</b>,8 x 10-6,(Commissions),0.499,'-,2.08 unit decrease,[1.18-2.98],RN7SKP279,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,11:127427559
rs7642644-<b>T</b>,6 x 10-6,(Commissions),0.144,'-,3.15 unit decrease,[1.78-4.52],LINC00971,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,3:84871217
rs4689642-<b>G</b>,4 x 10-7,(HRTSE),0.254,'-,1.01 unit increase,[0.62-1.4],SORCS2,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,4:7213595
rs12095069-<b>T</b>,9 x 10-7,(HRTSE),0.107,'-,1.36 unit decrease,[0.81-1.91],"ST6GALNAC3, ASB17",Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,1:75997387
rs17058466-<b>G</b>,1 x 10-6,(HRTSE),0.013,'-,3.73 unit decrease,[2.22-5.24],'-,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,18:75893390
rs34892827-<b>T</b>,2 x 10-6,(HRTSE),0.015,'-,3.45 unit increase,[2.04-4.86],DST,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,6:56477338
rs2341917-<b>G</b>,2 x 10-6,(HRTSE),0.145,'-,1.17 unit increase,[0.68-1.66],ACOXL,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,2:110953512
rs259991-<b>G</b>,3 x 10-6,(HRTSE),0.05,'-,1.78 unit decrease,[1.04-2.52],ZNF831,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,20:59153293
rs6539247-<b>T</b>,3 x 10-6,(HRTSE),0.429,'-,0.82 unit decrease,[0.49-1.15],NUAK1,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,12:106066124
rs6893207-<b>G</b>,3 x 10-6,(HRTSE),0.021,'-,2.88 unit decrease,[1.66-4.1],LINC02150,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,5:16367529
rs1144333-<b>G</b>,4 x 10-6,(HRTSE),0.096,'-,1.32 unit decrease,[0.75-1.89],MSH4,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,1:75809415
SNP6-38440872-<b>C</b>,4 x 10-6,(HRTSE),0.016,'-,3.2 unit increase,[1.83-4.57],'-,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,Mapping not available
rs17147674-<b>T</b>,5 x 10-6,(HRTSE),0.032,'-,2.2 unit decrease,[1.26-3.14],DLG2,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,11:84878878
rs10511779-<b>T</b>,6 x 10-6,(HRTSE),0.144,'-,1.1 unit increase,[0.63-1.57],'-,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,9:26725704
rs16878196-<b>T</b>,7 x 10-6,(HRTSE),0.052,'-,1.71 unit decrease,[0.97-2.45],'-,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,4:11114241
rs28498503-<b>T</b>,7 x 10-6,(HRTSE),0.158,'-,1.03 unit increase,[0.58-1.48],LINC01896,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,18:78902955
rs2341917-<b>G</b>,3 x 10-7,(IIV),0.145,'-,0.29 unit increase,[0.17-0.41],ACOXL,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,2:110953512
rs6539247-<b>T</b>,6 x 10-7,(IIV),0.451,'-,0.2 unit decrease,[0.12-0.28],NUAK1,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,12:106066124
rs12914008-<b>G</b>,6 x 10-6,(IIV),0.302,'-,0.6 unit increase,[0.35-0.85],CHRNB4,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,15:78631163
rs7122488-<b>T</b>,7 x 10-6,(IIV),0.238,'-,0.2 unit decrease,[0.1-0.3],ANO5,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,11:21852707
rs4681767-<b>T</b>,8 x 10-6,(IIV),0.429,'-,0.18 unit decrease,[0.1-0.26],"TASOR, ARHGEF3",Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,3:56725664
rs1422110-<b>G</b>,8 x 10-6,(IIV),0.46,'-,0.19 unit decrease,[0.11-0.27],PTP4A1P4,Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,5:86170322
rs9513794-<b>T</b>,8 x 10-6,,0.326,'-,'-,'-,NALCN-AS1,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010221,13:100749970
rs11917999-<b>G</b>,4 x 10-6,,0.222,'-,'-,'-,SOX2-OT,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST010220,3:181538459
rs74490514-<b>T</b>,9 x 10-6,,0.038,'-,'-,'-,"MTND5P15, LINC01208",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST010220,3:176923607
rs3116816-<b>A</b>,2 x 10-7,,0.398,'-,'-,'-,OR2J4P,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST010219,6:29181665
rs6584649-<b>?</b>,1 x 10-11,,'-,'-,'-,'-,SORCS3,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,10:104985346
rs7952220-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"METTL15, LINC02758",Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,11:28585698
rs35928531-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"POC1B, DUSP6",Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,12:89354807
rs2243517-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,OBI1-AS1,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,13:78330662
rs281297-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,SEMA6D,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,15:47393307
rs12596294-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LINC01572,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,16:72553194
rs8084351-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,DCC,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,18:53200189
rs35947542-<b>?</b>,9 x 10-9,,'-,'-,'-,'-,"HYI-AS1, PTPRF",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,1:43518009
rs11420276-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,"ST3GAL3, ST3GAL3-AS1",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,1:43718522
rs1222063-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,RNU1-130P,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,1:96136884
rs2391769-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,"RN7SL831P, EEF1A1P11",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,1:96513405
rs9677504-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,SPAG16,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,2:214317165
rs4858241-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,SGO1-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,3:20627579
rs28411770-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"LINC02497, PCDH7",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,4:31149834
rs4916723-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LINC00461,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,5:88558577
rs304132-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,MEF2C-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,5:88919777
rs5886709-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,FOXP2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,7:114446079
rs74760947-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,8:34495092
rs11591402-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,SORCS3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,10:104987596
rs1427829-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"DUSP6, POC1B",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,12:89366967
rs281324-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,SEMA6D,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,15:47461821
rs212178-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,LINC01572,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010649,16:72544232
rs12410155-<b>?</b>,8 x 10-14,,'-,'-,'-,'-,"ST3GAL3-AS1, ST3GAL3",Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,1:43722794
rs3952787-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,ST3GAL3,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,1:43857572
rs10789368-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,LINC01360,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,1:73348476
rs1222063-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,RNU1-130P,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,1:96136884
rs7585730-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,RNA5SP87,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,2:22316866
rs9677504-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,SPAG16,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,2:214317165
rs1021938-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,SGO1-AS1,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,3:20531976
rs28411770-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"LINC02497, PCDH7",Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,4:31149834
rs56022653-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LINC00461,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,5:88588020
rs12658032-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,'-,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,5:104568525
rs9969232-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,FOXP2,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,7:114518899
rs74760947-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,'-,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,8:34495092
rs1334561-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,'-,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,10:8778125
rs11192193-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,SORCS3,Attention deficit hyperactivity disorder (MTAG),attention deficit hyperactivity disorder,GCST010644,10:104809495
rs17232800-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"MTL3P, TMX3",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST002048,18:68625022
rs6453417-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,ARSB,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST002048,5:78814709
rs4245040-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,GRIK4,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST002048,11:120649920
rs16828074-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,NCL,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST002048,2:231454043
rs9627183-<b>C</b>,3 x 10-6,,0.03,'-,'-,'-,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000235,22:47888765
rs11134178-<b>T</b>,3 x 10-6,,0.05,'-,'-,'-,"LINC02196, LINC02236",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000235,5:6834054
rs12575642-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,FERMT3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,11:64212171
rs11607165-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,STIP1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,11:64196475
rs11778329-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,UBE2V2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,8:48140605
rs10858396-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"SOCS5P2, C9orf62",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,9:135383930
rs1059440-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,TRPT1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,11:64224329
rs12037173-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,LRRC7,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,1:69890298
rs797820-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,SEMA3A,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001154,7:83979723
rs2823819-<b>C</b>,7 x 10-7,,0.18,1.65,'-,[NR],MIR99AHG,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,21:16455971
rs1859156-<b>?</b>,2 x 10-6,,0.79,1.54,'-,[NR],BMPR1B,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,4:94912883
rs438259-<b>?</b>,4 x 10-6,,0.28,1.49,'-,[NR],HULC,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,6:9030103
rs9810857-<b>T</b>,6 x 10-6,,0.49,1.41,'-,[NR],"SLC9A9, PBX2P1",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,3:143264057
rs11074889-<b>A</b>,7 x 10-7,,0.16,1.68,'-,[NR],EMP2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,16:10539308
rs8074751-<b>?</b>,1 x 10-6,,0.61,1.45,'-,[NR],CEP112,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,17:65646424
rs4923705-<b>C</b>,2 x 10-6,,0.27,1.51,'-,[NR],LINC02853,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,15:36001404
rs2602381-<b>A</b>,4 x 10-6,,0.48,1.42,'-,[NR],"UGT1A10, UGT1A8, UGT1A9",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,2:233675678
rs10487524-<b>T</b>,9 x 10-6,,0.15,1.6,'-,[NR],'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,7:145144438
rs10011926-<b>?</b>,8 x 10-6,,0.78,1.49,'-,[NR],ELOVL6,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000684,4:110105771
rs11243897-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,AK8,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,9:132742896
rs2587695-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,CFAP221,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,2:119564241
rs864643-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,MOBP,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,3:39514089
rs2677744-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,MAN2A2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,15:90907211
rs10983238-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ASTN2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,9:116571404
rs515910-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,CFAP43,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,10:104206646
rs4964805-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,NT5DC3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,12:103799046
rs2242073-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,CRYGC,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,2:208129321
rs7164335-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ITGA11,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,15:68422693
rs7995215-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,GPC6,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,13:93756253
rs2241685-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,MYT1L,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,2:1922221
rs10786284-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,TLL2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,10:96375748
rs2237349-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,CREB5,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,7:28723346
rs10514604-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,ATP2C2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,16:84412778
rs11646411-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,CDH13,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,16:82713332
rs2842643-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"NPM1P51, TFEB",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,6:41682998
rs469727-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,REEP5,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,5:112907271
rs3799977-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,SUPT3H,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,6:44869619
rs16928529-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,UNC5B,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,10:71223228
rs2199161-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,MAP1B,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,5:72114529
rs7175404-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,SEPHS1P2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,15:93493459
rs2502731-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,DNM1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,9:128214278
rs220470-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,ITGAE,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,17:3761681
rs1555322-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"MMP24OS, MMP24",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,20:35261376
rs2281597-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,CSMD2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,1:33894257
rs412050-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,PPM1F-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000246,22:21953147
rs4402823-<b>T</b>,3 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:48461279
rs13043694-<b>A</b>,3 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:48459908
rs17123726-<b>A</b>,5 x 10-6,,'-,'-,'-,'-,EFCAB8,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32859562
rs12613775-<b>T</b>,4 x 10-6,,'-,'-,'-,'-,LINC01965,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,2:103964045
rs7722425-<b>T</b>,5 x 10-6,,'-,'-,'-,'-,CCDC192,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127790070
rs11681930-<b>A</b>,5 x 10-6,,'-,'-,'-,'-,PARD3B,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,2:205198574
rs2110267-<b>C</b>,6 x 10-6,,'-,'-,'-,'-,DPP6,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,7:153838604
rs11994034-<b>T</b>,7 x 10-6,,'-,'-,'-,'-,MSC-AS1,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,8:72158500
rs9364220-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,FRMD1,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,6:168089888
rs4458264-<b>T</b>,3 x 10-6,,'-,'-,'-,'-,"LINC00494, RNU7-144P",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:48461291
rs4402823-<b>T</b>,3 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:48461279
rs4810796-<b>A</b>,3 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:48459954
rs4810796-<b>A</b>,3 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:48459954
rs6057648-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,DNMT3B,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32797074
rs6119285-<b>T</b>,4 x 10-6,,'-,'-,'-,'-,DNMT3B,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32789189
rs6057651-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,MAPRE1,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32822531
rs6057652-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,MAPRE1,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32832003
rs10463833-<b>A</b>,5 x 10-6,,'-,'-,'-,'-,"CCDC192, CUL1P1",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127786620
rs8123073-<b>A</b>,5 x 10-6,,'-,'-,'-,'-,EFCAB8,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32859052
rs10153620-<b>C</b>,6 x 10-6,,'-,'-,'-,'-,PARD3B,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,2:205195913
rs6983777-<b>A</b>,8 x 10-6,,'-,'-,'-,'-,"LINC01181, MTCO2P4",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,8:103106338
rs6758152-<b>T</b>,3 x 10-6,,'-,'-,'-,'-,LINC01965,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,2:104051280
rs7164923-<b>T</b>,5 x 10-6,,'-,'-,'-,'-,"RNU6-741P, PWRN4",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,15:23817768
rs6947495-<b>A</b>,1 x 10-6,,'-,'-,'-,'-,DPP6,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,7:153855979
rs4458264-<b>T</b>,3 x 10-6,,'-,'-,'-,'-,"LINC00494, RNU7-144P",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:48461291
rs6119286-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,DNMT3B,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32807671
rs6057659-<b>A</b>,5 x 10-6,,'-,'-,'-,'-,"EFCAB8, MAPRE1",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32857341
rs11903187-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,LINC01965,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,2:103972680
rs4708431-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,FRMD1,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,6:168083405
rs910191-<b>A</b>,2 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:48460486
rs12523164-<b>T</b>,6 x 10-6,,'-,'-,'-,'-,CCDC192,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127726279
rs4835929-<b>T</b>,7 x 10-6,,'-,'-,'-,'-,CCDC192,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127718586
rs6057651-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,MAPRE1,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:32822531
rs2110267-<b>C</b>,5 x 10-7,,'-,'-,'-,'-,DPP6,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,7:153838604
rs910191-<b>A</b>,2 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:48460486
rs1515641-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,CCDC192,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127803924
rs2192271-<b>T</b>,1 x 10-6,,'-,'-,'-,'-,DPP6,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,7:153852211
rs12671878-<b>A</b>,1 x 10-6,,'-,'-,'-,'-,DPP6,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,7:153861864
rs13043694-<b>A</b>,3 x 10-6,,'-,'-,'-,'-,"RNU7-144P, LINC00494",Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:48459908
rs2119507-<b>T</b>,4 x 10-6,,'-,'-,'-,'-,LINC01965,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,2:103956547
rs10193430-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,LINC01965,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,2:103970893
rs1036736-<b>T</b>,4 x 10-6,,'-,'-,'-,'-,LINC01965,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,2:103962075
rs7270085-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,MAPRE1,Attention deficit hyperactivity disorder (combined symptoms),attention deficit hyperactivity disorder,GCST001931,20:32849801
rs10463832-<b>A</b>,5 x 10-6,,'-,'-,'-,'-,CCDC192,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127774794
rs12513840-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,CCDC192,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,5:127724250
rs6057652-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,MAPRE1,Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms),attention deficit hyperactivity disorder,GCST001944,20:32832003
rs12919130-<b>A</b>,2 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20115652
rs11687420-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,"RPL6P5, TEX41",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,2:145287997
rs9364220-<b>A</b>,6 x 10-6,,'-,'-,'-,'-,FRMD1,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,6:168089888
rs12596252-<b>A</b>,3 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20045671
rs1902813-<b>C</b>,3 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20046339
rs12926725-<b>T</b>,3 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20048355
rs1822881-<b>A</b>,4 x 10-6,,'-,'-,'-,'-,"RPL6P5, TEX41",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,2:145286484
rs12931939-<b>T</b>,6 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20049508
rs6497436-<b>T</b>,6 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20112193
rs2608200-<b>A</b>,6 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20110968
rs11642377-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20098331
rs7448069-<b>T</b>,1 x 10-6,,'-,'-,'-,'-,CPLX2,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,5:175817031
rs12926729-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20089048
rs11647507-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20084306
rs10180522-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,"TEX41, RPL6P5",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,2:145314285
rs12924103-<b>T</b>,7 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20083224
rs10521115-<b>A</b>,8 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20079323
rs13407123-<b>T</b>,8 x 10-6,,'-,'-,'-,'-,"TEX41, RPL6P5",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,2:145335188
rs7185264-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20083564
rs7201408-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20082732
rs10521114-<b>A</b>,8 x 10-6,,'-,'-,'-,'-,GPR139,Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,16:20078432
rs13006237-<b>A</b>,9 x 10-6,,'-,'-,'-,'-,"PSMD14P1, ELOAP1",Attention deficit hyperactivity disorder (inattention symptoms),attention deficit hyperactivity disorder,GCST001943,2:123757465
rs243034-<b>C</b>,1 x 10-6,,0.394,1.521,'-,[1.28-1.76],MIR4432HG,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,2:60375757
rs1353581-<b>?</b>,5 x 10-6,,0.234,1.5384616,'-,[1.43-1.65],'-,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,4:189068835
rs10968750-<b>T</b>,2 x 10-6,,0.941,2.633,'-,[1.77-3.5],LINGO2,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,9:28753984
rs2666895-<b>?</b>,4 x 10-7,,0.092,1.992032,'-,[1.87-2.11],"MIR7154, CHST1",Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,11:45689480
rs3814837-<b>?</b>,3 x 10-6,,0.247,1.55521,'-,[1.45-1.66],CATSPERB,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,14:91725006
rs11909995-<b>?</b>,4 x 10-6,,0.176,1.6207455,'-,[1.51-1.74],ATP5PF,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,21:25725147
rs429358-<b>?</b>,2 x 10-30,,0.21,5.24,'-,[5.19-5.29],'-,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,Mapping not available
rs10405693-<b>?</b>,3 x 10-14,,NR,1.3981868,'-,'-,"NECTIN2, BCAM",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44823407
rs10402271-<b>?</b>,7 x 10-14,,NR,1.3904976,'-,'-,"BCAM, NECTIN2",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44825957
rs8103315-<b>?</b>,4 x 10-6,,NR,1.3527919,'-,'-,BCL3,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44750911
rs2298369-<b>?</b>,3 x 10-7,(females),NR,1.3267368,'-,'-,"MIR155HG, MRPL39",Alzheimer's disease,Alzheimer's disease,GCST007600,21:25583969
rs10953322-<b>?</b>,5 x 10-6,,NR,1.3187115,'-,'-,"SERPINE1, TRIM56",Alzheimer's disease,Alzheimer's disease,GCST007600,7:101103377
rs6838792-<b>?</b>,2 x 10-6,(females),NR,1.2961394,'-,'-,STK32B,Alzheimer's disease,Alzheimer's disease,GCST007600,4:5096839
rs2298369-<b>?</b>,4 x 10-7,,NR,1.2475969,'-,'-,"MIR155HG, MRPL39",Alzheimer's disease,Alzheimer's disease,GCST007600,21:25583969
rs4961664-<b>?</b>,4 x 10-6,,NR,1.2335871,'-,'-,"CCDC171, C9orf92",Alzheimer's disease,Alzheimer's disease,GCST007600,9:16161235
rs10794342-<b>?</b>,4 x 10-6,,NR,1.2132727,'-,'-,AP2A2,Alzheimer's disease,Alzheimer's disease,GCST007600,11:924904
rs6859-<b>A</b>,6 x 10-13,(females),0.42469,1.570301,'-,[1.39-1.75],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44878777
rs7259620-<b>G</b>,6 x 10-16,(females),0.568643,1.665856,'-,[1.47-1.86],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44904531
rs1160985-<b>C</b>,4 x 10-16,(females),0.564781,1.669499,'-,[1.48-1.86],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44900155
rs1172922-<b>A</b>,5 x 10-6,(females),0.117523,1.407788,'-,[1.22-1.6],"OR7E109P, DIRAS2",Alzheimer's disease,Alzheimer's disease,GCST007600,9:90726252
rs405509-<b>T</b>,4 x 10-14,(females),0.49585,1.596079,'-,[1.41-1.78],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44905579
rs769450-<b>G</b>,3 x 10-13,(females),0.614728,1.604012,'-,[1.41-1.79],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44907187
rs8106922-<b>A</b>,6 x 10-14,(females),0.618134,1.62673,'-,[1.43-1.82],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44898409
rs7412-<b>C</b>,1 x 10-7,(females),0.9279,2.065872,'-,[1.58-2.55],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44908822
rs1160985-<b>C</b>,3 x 10-8,(males),0.563262,1.629703,'-,[1.37-1.89],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44900155
rs405509-<b>T</b>,1 x 10-8,(males),0.498083,1.640389,'-,[1.38-1.9],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44905579
rs6859-<b>A</b>,1 x 10-9,(males),0.433641,1.677747,'-,[1.42-1.94],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44878777
rs7259620-<b>G</b>,2 x 10-9,(males),0.567196,1.700015,'-,[1.43-1.97],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44904531
rs5969117-<b>C</b>,1 x 10-6,(males),0.295488,1.490488,'-,[1.27-1.71],'-,Alzheimer's disease,Alzheimer's disease,GCST007600,X:87181248
rs769450-<b>G</b>,2 x 10-7,(males),0.610827,1.600702,'-,[1.34-1.86],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44907187
rs8106922-<b>A</b>,6 x 10-8,(males),0.611921,1.6359,'-,[1.37-1.9],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44898409
rs10426423-<b>C</b>,3 x 10-6,,0.620314,1.265674,'-,[1.15-1.38],"NECTIN2, BCAM",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44844996
rs1871047-<b>A</b>,2 x 10-6,,0.619781,1.270037,'-,[1.15-1.39],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44848489
rs440277-<b>G</b>,2 x 10-7,,0.691681,1.321105,'-,[1.19-1.45],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44857967
rs769450-<b>G</b>,6 x 10-19,,0.61311,1.59501,'-,[1.44-1.75],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44907187
rs6859-<b>A</b>,2 x 10-21,,0.428373,1.599071,'-,[1.45-1.75],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44878777
rs405509-<b>T</b>,2 x 10-21,,0.496776,1.613847,'-,[1.46-1.77],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44905579
rs8106922-<b>A</b>,2 x 10-20,,0.615581,1.624312,'-,[1.47-1.78],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44898409
rs1160985-<b>C</b>,1 x 10-22,,0.564132,1.653124,'-,[1.49-1.81],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44900155
rs7259620-<b>G</b>,2 x 10-23,,0.568042,1.6754,'-,[1.51-1.84],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44904531
rs7412-<b>C</b>,4 x 10-13,,0.928632,2.214072,'-,[1.79-2.64],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44908822
rs35242772-<b>C</b>,1 x 10-6,,0.356238,1.230973,'-,[1.13-1.33],MIR302F,Alzheimer's disease,Alzheimer's disease,GCST007600,18:30214382
rs912322-<b>A</b>,1 x 10-6,,0.73251,1.259729,'-,[1.15-1.37],MYO16,Alzheimer's disease,Alzheimer's disease,GCST007600,13:109155938
rs283814-<b>G</b>,9 x 10-6,,0.933446,1.588872,'-,[1.3-1.88],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44885967
rs77657034-<b>G</b>,5 x 10-6,,0.9924,6.912992,'-,[3.02-10.81],MAP4K4,Alzheimer's disease,Alzheimer's disease,GCST007600,2:101857264
rs483082-<b>?</b>,1 x 10-37,(females),0.734105,2.6149259,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44912921
rs283815-<b>?</b>,9 x 10-23,(males),0.753336,2.794014,'-,'-,NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44887076
rs483082-<b>?</b>,1 x 10-62,,0.738441,2.6436493,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44912921
rs2233083-<b>?</b>,1 x 10-6,,NR,7.2292986,'-,'-,MAPK7,Alzheimer's disease,Alzheimer's disease,GCST007600,17:19383150
rs12450778-<b>?</b>,2 x 10-6,(females),NR,2.4201357,'-,'-,"EPOP, SRCIN1",Alzheimer's disease,Alzheimer's disease,GCST007600,17:38658216
rs429358-<b>?</b>,2 x 10-91,,NR,3.9972339,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,Mapping not available
rs429358-<b>?</b>,1 x 10-53,(females),NR,3.921738,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,Mapping not available
rs157580-<b>?</b>,4 x 10-9,(males),NR,1.7230357,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892009
rs769449-<b>?</b>,2 x 10-83,,NR,3.8717523,'-,'-,APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44906745
rs429358-<b>?</b>,3 x 10-31,(males),NR,3.8628085,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,Mapping not available
rs769449-<b>?</b>,6 x 10-47,(females),NR,3.7354689,'-,'-,APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44906745
rs73165159-<b>?</b>,3 x 10-6,(males),NR,3.3545792,'-,'-,"CENPM, LINC00634",Alzheimer's disease,Alzheimer's disease,GCST007600,22:41950038
rs4420638-<b>?</b>,2 x 10-24,(males),NR,3.3425252,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919689
rs56131196-<b>?</b>,3 x 10-24,(males),NR,3.3117516,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919589
rs71352238-<b>?</b>,2 x 10-25,(males),NR,3.295186,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44891079
rs2075650-<b>?</b>,8 x 10-26,(males),NR,3.2904043,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892362
rs11969759-<b>?</b>,2 x 10-6,(females),NR,1.6222337,'-,'-,TNXB,Alzheimer's disease,Alzheimer's disease,GCST007600,6:32053353
rs405697-<b>?</b>,1 x 10-13,,NR,1.5548013,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44901434
rs405697-<b>?</b>,1 x 10-8,(females),NR,1.5508373,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44901434
rs584007-<b>?</b>,2 x 10-9,(females),NR,1.5096664,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44913221
rs439401-<b>?</b>,3 x 10-9,(females),NR,1.5058857,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44911194
rs1497197-<b>?</b>,3 x 10-6,,NR,1.4972146,'-,'-,LHX1-DT,Alzheimer's disease,Alzheimer's disease,GCST007600,17:36819274
rs2075650-<b>?</b>,1 x 10-39,(females),NR,3.1072497,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892362
rs439401-<b>?</b>,6 x 10-14,,NR,1.486781,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44911194
rs116593898-<b>?</b>,3 x 10-6,,NR,3.0120482,'-,'-,SFT2D2,Alzheimer's disease,Alzheimer's disease,GCST007600,1:168232648
rs7963314-<b>?</b>,3 x 10-6,(females),NR,1.4279574,'-,'-,LINC02414,Alzheimer's disease,Alzheimer's disease,GCST007600,12:131573284
rs157582-<b>?</b>,1 x 10-23,(males),NR,2.8279662,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892962
rs10402271-<b>?</b>,2 x 10-9,(females),NR,1.4007349,'-,'-,"BCAM, NECTIN2",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44825957
rs157582-<b>?</b>,2 x 10-35,(females),NR,2.6219604,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892962
rs77104831-<b>?</b>,2 x 10-6,(males),NR,4.27716,'-,'-,FBXL13,Alzheimer's disease,Alzheimer's disease,GCST007600,7:102911421
rs7561207-<b>?</b>,4 x 10-6,(females),NR,2.1267998,'-,'-,ANTXR1,Alzheimer's disease,Alzheimer's disease,GCST007600,2:69138666
rs12450778-<b>?</b>,2 x 10-6,,NR,2.0929258,'-,'-,"EPOP, SRCIN1",Alzheimer's disease,Alzheimer's disease,GCST007600,17:38658216
rs769449-<b>?</b>,7 x 10-30,(males),NR,3.921353,'-,'-,APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44906745
rs157580-<b>?</b>,4 x 10-23,,NR,1.7063565,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892009
rs157580-<b>?</b>,6 x 10-14,(females),NR,1.6891578,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892009
rs76252969-<b>?</b>,5 x 10-6,,NR,1.68319,'-,'-,"RPL13AP7, RNA5SP489",Alzheimer's disease,Alzheimer's disease,GCST007600,21:25277446
rs2282079-<b>?</b>,4 x 10-6,,NR,1.6799409,'-,'-,"PAX5, RPL32P21",Alzheimer's disease,Alzheimer's disease,GCST007600,9:37036250
rs8103315-<b>?</b>,2 x 10-6,(males),NR,1.6666555,'-,'-,BCL3,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44750911
rs9862849-<b>?</b>,3 x 10-6,(males),NR,1.6597484,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,3:66855351
rs62402815-<b>?</b>,4 x 10-7,(females),NR,1.6387721,'-,'-,LNC-LBCS,Alzheimer's disease,Alzheimer's disease,GCST007600,6:19350484
rs111436800-<b>?</b>,5 x 10-6,,NR,1.6282058,'-,'-,Y_RNA,Alzheimer's disease,Alzheimer's disease,GCST007600,21:23456358
rs56131196-<b>?</b>,6 x 10-77,,NR,3.2625577,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919589
rs4420638-<b>?</b>,9 x 10-77,,NR,3.2591338,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919689
rs2075650-<b>?</b>,2 x 10-71,,NR,3.2239969,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892362
rs56131196-<b>?</b>,4 x 10-48,(females),NR,3.2052002,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919589
rs4420638-<b>?</b>,8 x 10-48,(females),NR,3.1868043,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919689
rs71352238-<b>?</b>,7 x 10-69,,NR,3.181876,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44891079
rs584007-<b>?</b>,3 x 10-14,,NR,1.4945852,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44913221
rs71352238-<b>?</b>,6 x 10-38,(females),NR,3.0343766,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44891079
rs62402815-<b>?</b>,2 x 10-6,,NR,1.4489708,'-,'-,LNC-LBCS,Alzheimer's disease,Alzheimer's disease,GCST007600,6:19350484
rs10405693-<b>?</b>,1 x 10-9,(females),NR,1.4069744,'-,'-,"NECTIN2, BCAM",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44823407
rs157582-<b>?</b>,4 x 10-63,,NR,2.7341528,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892962
rs34925435-<b>?</b>,5 x 10-6,(males),NR,2.7270248,'-,'-,"TMCC1-DT, TRH",Alzheimer's disease,Alzheimer's disease,GCST007600,3:129947221
rs302668-<b>T</b>,2 x 10-7,(Behavioural variant FTD),0.708,1.23,'-,[1.09-1.41],RAB38,Frontotemporal dementia,Frontotemporal dementia,GCST002516,11:88143743
rs9268856-<b>C</b>,6 x 10-9,(All Frontotemporal dementia),0.748,1.24,'-,[1.16-1.32],HLA-DRB9,Frontotemporal dementia,Frontotemporal dementia,GCST002516,6:32461942
rs16976358-<b>C</b>,6 x 10-7,(Japanese),'-,2.0506,'-,[NR],LINC00907,Autism spectrum disorder,autism spectrum disorder,GCST003104,18:42611606
rs1867503-<b>?</b>,4 x 10-7,(ASD paternal model),NR,1.55,'-,[1.30-1.84],INHCAP,Autism spectrum disorder-related traits,autism spectrum disorder,GCST002639,3:133691804
rs1409313-<b>?</b>,4 x 10-7,(ASD paternal model),NR,1.75,'-,[1.40-2.18],CUEDC2,Autism spectrum disorder-related traits,autism spectrum disorder,GCST002639,10:102431844
rs4773054-<b>?</b>,5 x 10-8,(ASD paternal model),NR,2.66,'-,[1.83-3.86],'-,Autism spectrum disorder-related traits,autism spectrum disorder,GCST002639,13:109501681
rs1558477-<b>?</b>,3 x 10-7,,'-,'-,'-,'-,ADCYAP1R1,Major depressive disorder,unipolar depression,GCST001083,7:31115733
rs8023445-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,SHC4,Major depressive disorder,unipolar depression,GCST001083,15:48900594
rs7565124-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,"LAPTM4A-DT, RPS16P2",Major depressive disorder,unipolar depression,GCST001083,2:20061924
rs1780436-<b>?</b>,3 x 10-6,,'-,'-,'-,'-,LINC02629,Major depressive disorder,unipolar depression,GCST001083,10:33968684
rs2715148-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,PCLO,Major depressive disorder,unipolar depression,GCST001083,7:82820719
rs12938916-<b>?</b>,5 x 10-7,(dominant),NR,'-,'-,'-,"RN7SKP94, CCDC182",Bipolar disorder,bipolar disorder,GCST000961,17:57788926
rs420259-<b>?</b>,9 x 10-9,(recessive),NR,'-,'-,'-,PALB2,Bipolar disorder,bipolar disorder,GCST000961,16:23622705
rs3761218-<b>?</b>,1 x 10-6,(dominant),NR,'-,'-,'-,CDC25B,Bipolar disorder,bipolar disorder,GCST000961,20:3795528
rs2989476-<b>?</b>,2 x 10-6,(dominant),NR,'-,'-,'-,LINC01748,Bipolar disorder,bipolar disorder,GCST000961,1:60593587
rs4027132-<b>?</b>,3 x 10-6,(recessive),NR,'-,'-,'-,MIR3681HG,Bipolar disorder,bipolar disorder,GCST000961,2:11897366
rs7570682-<b>?</b>,3 x 10-6,(addtive),NR,'-,'-,'-,"TCF23, AHCYP3",Bipolar disorder,bipolar disorder,GCST000961,2:104366809
rs1375144-<b>?</b>,2 x 10-6,(addtive),NR,'-,'-,'-,DPP10,Bipolar disorder,bipolar disorder,GCST000961,2:115483610
rs2953174-<b>?</b>,6 x 10-6,(addtive),NR,'-,'-,'-,CAPN10-DT,Bipolar disorder,bipolar disorder,GCST000961,2:240582850
rs4627791-<b>?</b>,2 x 10-6,(addtive),NR,'-,'-,'-,CMTM8,Bipolar disorder,bipolar disorder,GCST000961,3:32306332
rs514636-<b>?</b>,7 x 10-7,(dominant),NR,'-,'-,'-,LAMP3,Bipolar disorder,bipolar disorder,GCST000961,3:183152648
rs6844851-<b>?</b>,9 x 10-7,(dominant),NR,'-,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST000961,4:179766847
rs2286492-<b>?</b>,8 x 10-6,(recessive),NR,'-,'-,'-,FAM126A,Bipolar disorder,bipolar disorder,GCST000961,7:22945391
rs2609653-<b>?</b>,7 x 10-6,(addtive),NR,'-,'-,'-,RPL10AP3,Bipolar disorder,bipolar disorder,GCST000961,8:34379474
rs4739466-<b>?</b>,4 x 10-6,(recessive),NR,'-,'-,'-,SMARCE1P4,Bipolar disorder,bipolar disorder,GCST000961,8:37084024
rs914715-<b>?</b>,1 x 10-6,(dominant),NR,'-,'-,'-,TLE4,Bipolar disorder,bipolar disorder,GCST000961,9:79695983
rs10982256-<b>?</b>,9 x 10-6,(addtive),NR,'-,'-,'-,WHRN,Bipolar disorder,bipolar disorder,GCST000961,9:114498554
rs17600642-<b>?</b>,5 x 10-6,(addtive),NR,'-,'-,'-,ADAMTS14,Bipolar disorder,bipolar disorder,GCST000961,10:70703238
rs1568889-<b>?</b>,2 x 10-6,(recessive),NR,'-,'-,'-,"HSP90AA2P, KIF18A",Bipolar disorder,bipolar disorder,GCST000961,11:27987916
rs10134944-<b>?</b>,1 x 10-6,(dominant),NR,'-,'-,'-,SLC35F4,Bipolar disorder,bipolar disorder,GCST000961,14:57652478
rs6574988-<b>?</b>,4 x 10-6,(dominant),NR,'-,'-,'-,LINC01146,Bipolar disorder,bipolar disorder,GCST000961,14:88093648
rs11622475-<b>?</b>,2 x 10-6,(addtive),NR,'-,'-,'-,TDRD9,Bipolar disorder,bipolar disorder,GCST000961,14:104042739
rs1344484-<b>?</b>,2 x 10-6,(addtive),NR,'-,'-,'-,PHBP21,Bipolar disorder,bipolar disorder,GCST000961,16:52878387
rs7247513-<b>?</b>,2 x 10-6,(addtive),NR,'-,'-,'-,ZNF490,Bipolar disorder,bipolar disorder,GCST000961,19:12580371
rs74760947-<b>G</b>,2 x 10-10,,NR,1.1904762,'-,[1.14-1.27],'-,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,8:34495092
rs76545266-<b>C</b>,2 x 10-8,,NR,1.1764705,'-,[1.11-1.25],RPL10AP3,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,8:34224003
rs113551349-<b>C</b>,5 x 10-10,,NR,1.098901,'-,[1.08-1.14],SLC6A9,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,1:44009451
rs797267-<b>G</b>,4 x 10-9,,NR,1.098901,'-,[1.06-1.12],"DUSP6, POC1B",Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,12:89373460
rs11210887-<b>G</b>,3 x 10-11,,NR,1.0869565,'-,[1.06-1.11],PTPRF,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,1:43610348
rs56319043-<b>C</b>,4 x 10-9,,NR,1.0869565,'-,[1.05-1.11],KDM4A-AS1,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,1:43705540
rs2782639-<b>G</b>,2 x 10-8,,NR,1.0752687,'-,[1.05-1.1],PTPRF,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,1:43540668
rs4916723-<b>C</b>,2 x 10-9,,NR,1.0752687,'-,[1.05-1.1],LINC00461,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,5:88558577
rs4259397-<b>G</b>,5 x 10-8,,NR,1.0752687,'-,[1.04-1.1],'-,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,8:92354062
rs8039398-<b>C</b>,4 x 10-11,,NR,1.0752687,'-,[1.05-1.1],SEMA6D,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,15:47438673
rs2391769-<b>G</b>,3 x 10-8,,NR,1.0638298,'-,[1.04-1.09],"RN7SL831P, EEF1A1P11",Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,1:96513405
rs4858253-<b>C</b>,2 x 10-8,,NR,1.0638298,'-,[1.04-1.09],SGO1-AS1,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,3:20687599
rs1476535-<b>T</b>,6 x 10-10,,NR,1.07,'-,[1.05-1.1],FOXP2,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,7:114430980
rs2189012-<b>A</b>,1 x 10-8,,NR,1.07,'-,[1.05-1.1],FOXP2,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,7:114571857
rs145108385-<b>A</b>,3 x 10-8,,NR,1.08,'-,[1.05-1.1],"ZNF131, ANXA2R",Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,5:43054645
rs139868495-<b>T</b>,8 x 10-9,,NR,1.19,'-,[1.12-1.26],LINC01288,Attention deficit hyperactivity disorder or cannabis use,"attention deficit hyperactivity disorder, Cannabis use",GCST006983,8:34805452
rs2025758-<b>?</b>,5 x 10-18,,NR,'-,'-,'-,LINC02676,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,10:8799706
rs7094182-<b>?</b>,5 x 10-12,,NR,'-,'-,'-,KRT8P37,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,10:8484656
rs325485-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,5:104659667
rs227283-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MANBA,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,4:102686096
rs6736411-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,WDPCP,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,2:63446926
rs71565398-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ITPR3,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,6:33633953
rs12653396-<b>A</b>,1 x 10-9,,NR,'-,5.38 z score increase,NR,LINC00461,Attention deficit hyperactivity disorder or caudate nucleus volume (pleiotropy),"attention deficit hyperactivity disorder, caudate nucleus volume",GCST007591,5:88551455
rs281320-<b>T</b>,1 x 10-10,,NR,'-,6.46553 z score decrease,NR,SEMA6D,Attention deficit hyperactivity disorder or intracranial volume (pleiotropy),"attention deficit hyperactivity disorder, intracranial volume measurement",GCST007586,15:47477227
rs13332522-<b>C</b>,7 x 10-9,,NR,'-,5.784743 z score increase,NR,RBFOX1,Attention deficit hyperactivity disorder or intracranial volume (pleiotropy),"attention deficit hyperactivity disorder, intracranial volume measurement",GCST007586,16:5779203
rs12596294-<b>?</b>,1 x 10-8,,NR,'-,5.673685 z score increase,NR,LINC01572,Attention deficit hyperactivity disorder or intracranial volume (pleiotropy),"attention deficit hyperactivity disorder, intracranial volume measurement",GCST007586,16:72553194
rs114181198-<b>A</b>,4 x 10-9,,NR,'-,5.13 z score increase,NR,"CACYBPP2, DIRC3",Attention deficit hyperactivity disorder or putamen volume (pleiotropy),"attention deficit hyperactivity disorder, putamen volume",GCST007582,2:183618431
rs281323-<b>A</b>,4 x 10-9,,NR,'-,5.9 z score increase,NR,SEMA6D,Attention deficit hyperactivity disorder or putamen volume (pleiotropy),"attention deficit hyperactivity disorder, putamen volume",GCST007582,15:47461830
rs56135409-<b>A</b>,2 x 10-9,,NR,'-,6.01 z score decrease,NR,SGO1-AS1,Attention deficit hyperactivity disorder or amygdala volume (pleiotropy),"attention deficit hyperactivity disorder, amygdala volume",GCST007588,3:20683524
rs9822411-<b>?</b>,5 x 10-6,(multivariate),NR,'-,'-,'-,RARB,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,3:25322452
rs4500123-<b>?</b>,6 x 10-6,(multivariate),NR,'-,'-,'-,RUNX1T1,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,8:91957925
rs1278352-<b>?</b>,1 x 10-6,(multivariate),NR,'-,'-,'-,ADAM12,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,10:126084807
rs4758132-<b>?</b>,3 x 10-6,(multivariate),NR,'-,'-,'-,"OR2AG2, GVINP2",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,11:6762170
rs17399946-<b>?</b>,7 x 10-6,(multivariate),NR,'-,'-,'-,SOX5,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,12:23924575
rs12370275-<b>?</b>,2 x 10-6,(multivariate),NR,'-,'-,'-,DUX4L52,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,12:61513241
rs11844114-<b>?</b>,5 x 10-6,(multivariate),NR,'-,'-,'-,CCDC197,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,14:93994183
rs7204436-<b>?</b>,2 x 10-7,(multivariate),NR,'-,'-,'-,"RBFOX1, LINC02164",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,16:5233490
rs6060821-<b>?</b>,4 x 10-6,(multivariate),NR,'-,'-,'-,"BCL2L1-AS1, BCL2L1",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,20:31706231
rs6060960-<b>?</b>,3 x 10-6,(multivariate),NR,'-,'-,'-,"MYLK2, TPX2",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003030,20:31806714
rs1521365-<b>T</b>,4 x 10-6,(HRT),0.06,'-,41.3 unit decrease,[23.84-58.76],"RNU6-1151P, RN7SL474P",Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,8:16858839
rs16982689-<b>T</b>,6 x 10-6,(HRTSE),0.022,'-,2.67 unit increase,[1.51-3.83],"IGLVI-63, IGLV1-62",Attention function in attention deficit hyperactive disorder,"attention deficit hyperactivity disorder, attention function measurement",GCST003025,22:22081907
rs11514810-<b>T</b>,5 x 10-9,(Stroop WIT),NR,'-,9.31 unit increase,'-,MICALL2,Executive inhibition (Stroop WIT and CIT) in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, cognitive inhibition measurement",GCST004336,7:1388840
rs10826548-<b>A</b>,1 x 10-6,,'-,'-,1.6612 unit decrease,[0.99-2.33],LINC01517,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28966665
rs35974940-<b>T</b>,1 x 10-6,,'-,'-,3.2303 unit increase,[1.92-4.54],NTM,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,11:131375192
rs188370812-<b>A</b>,2 x 10-6,,'-,'-,1.7787 unit decrease,[1.05-2.51],LINC01517,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28957320
rs78030545-<b>T</b>,2 x 10-6,,'-,'-,3.7706 unit decrease,[2.22-5.32],LINC02380,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,4:57505757
rs192649950-<b>A</b>,2 x 10-6,,'-,'-,1.7727 unit increase,[1.04-2.5],LINC01517,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28957321
rs138850252-<b>C</b>,2 x 10-6,,'-,'-,2.9016 unit decrease,[1.71-4.1],"LINC02826, LINC02359",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,12:126082700
rs80113388-<b>T</b>,3 x 10-6,,'-,'-,4.3626 unit decrease,[2.54-6.18],CSMD1,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,8:3610121
rs76037120-<b>C</b>,3 x 10-6,,'-,'-,3.224 unit increase,[1.87-4.57],"MAN2A1-DT, KRT18P42",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,5:109597780
rs12600304-<b>T</b>,3 x 10-6,,'-,'-,1.6231 unit increase,[0.94-2.3],"ZNF319, TEPP",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,16:57988232
rs77206607-<b>T</b>,4 x 10-6,,'-,'-,2.759 unit decrease,[1.58-3.93],"LINC02826, LINC02359",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,12:126069817
rs3893429-<b>A</b>,4 x 10-6,,'-,'-,1.5454 unit decrease,[0.89-2.2],CPNE4,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,3:132160302
rs10831734-<b>A</b>,5 x 10-6,,'-,'-,1.336 unit decrease,[0.77-1.91],MICAL2,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,11:12101674
rs10826546-<b>A</b>,5 x 10-6,,'-,'-,1.5444 unit increase,[0.88-2.21],LINC01517,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28948533
rs117352156-<b>T</b>,5 x 10-6,,'-,'-,1.5494 unit decrease,[0.88-2.22],LINC01517,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28957276
rs10826545-<b>A</b>,6 x 10-6,,'-,'-,1.5399 unit decrease,[0.88-2.2],LINC01517,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28947466
rs11058518-<b>T</b>,6 x 10-6,,'-,'-,2.79 unit increase,[1.58-4],LINC02359,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,12:126098067
rs72664414-<b>C</b>,6 x 10-6,,'-,'-,4.4025 unit decrease,[2.5-6.31],MIR4422HG,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,1:55274411
rs72796654-<b>A</b>,6 x 10-6,,'-,'-,3.157 unit increase,[1.79-4.53],'-,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:57596184
rs12737863-<b>T</b>,6 x 10-6,,'-,'-,2.362 unit increase,[1.34-3.39],"SDE2, H3-3A-DT",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,1:226044737
rs11058488-<b>T</b>,7 x 10-6,,'-,'-,2.7151 unit increase,[1.53-3.9],"LINC02826, LINC02359",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,12:126066659
rs34674354-<b>A</b>,7 x 10-6,,'-,'-,3.1479 unit decrease,[1.78-4.52],'-,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:57607636
rs140265971-<b>A</b>,7 x 10-6,,'-,'-,3.1539 unit increase,[1.78-4.53],'-,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:57552143
rs12752329-<b>C</b>,7 x 10-6,,'-,'-,2.3339 unit increase,[1.31-3.35],"ACBD3, LINC01703",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,1:226130363
rs10750165-<b>A</b>,7 x 10-6,,'-,'-,1.5241 unit increase,[0.86-2.19],NECTIN1,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,11:119767379
rs117063229-<b>T</b>,7 x 10-6,,'-,'-,3.5443 unit increase,[1.99-5.1],LINC02652,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:28466333
rs10128443-<b>T</b>,8 x 10-6,,'-,'-,2.6274 unit increase,[1.52-3.83],'-,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,10:57662667
rs72752681-<b>A</b>,8 x 10-6,,'-,'-,3.1736 unit decrease,[1.78-4.56],CAPZA1,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,1:239270572
rs9326778-<b>T</b>,8 x 10-6,,'-,'-,3.6559 unit increase,[2.05-5.26],"MAN2A1-DT, KRT18P42",Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,5:109593896
rs2195588-<b>A</b>,8 x 10-6,,'-,'-,2.7004 unit increase,[1.52-3.88],ZMAT4,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,8:40499181
rs114439515-<b>A</b>,9 x 10-6,,'-,'-,3.8041 unit decrease,[2.13-5.48],SPINK2,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,4:56810237
rs692916-<b>T</b>,9 x 10-6,,'-,'-,1.492 unit increase,[0.84-2.15],PHLPP1,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,18:62858159
rs61947646-<b>T</b>,9 x 10-6,,'-,'-,3.4562 unit decrease,[1.93-4.98],UFM1,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,13:38359940
rs10483554-<b>G</b>,5 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.482 unit decrease,[0.85-2.11],ATP5MC2P2,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,14:49364377
rs1330598-<b>C</b>,1 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.172 unit decrease,[0.7-1.64],PCDH20,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,13:61358998
rs9367214-<b>G</b>,8 x 10-6,(Defiant/Vindictive dimension),NR,'-,0.9467 unit decrease,[0.54-1.36],SUPT3H,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,6:45058175
rs12036759-<b>G</b>,5 x 10-7,(Irritable dimension),NR,'-,0.7084 unit decrease,[0.44-0.98],"LINC01744, MAP10",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,1:232789695
rs12042052-<b>G</b>,4 x 10-7,(Irritable dimension),NR,'-,0.7052 unit decrease,[0.44-0.98],"MAP10, LINC01744",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,1:232799973
rs10910623-<b>A</b>,3 x 10-7,(Irritable dimension),NR,'-,0.7022 unit decrease,[0.44-0.97],"LINC01744, MAP10",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,1:232802953
rs3787069-<b>G</b>,5 x 10-6,(Irritable dimension),NR,'-,0.6959 unit decrease,[0.4-0.99],MLLT1,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,19:6221876
rs9559203-<b>C</b>,8 x 10-6,(Irritable dimension),NR,'-,0.3784 unit decrease,[0.21-0.54],'-,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,13:108012406
rs6127978-<b>G</b>,5 x 10-6,(Irritable dimension),NR,'-,0.2907 unit decrease,[0.17-0.41],BMP7,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,20:57244117
rs6892228-<b>C</b>,2 x 10-6,(Irritable dimension),NR,'-,0.2236 unit increase,[0.13-0.32],CDH6,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,5:31179064
rs10075707-<b>G</b>,2 x 10-6,(Irritable dimension),NR,'-,0.2236 unit increase,[0.13-0.32],CDH6,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,5:31179621
rs13184157-<b>A</b>,2 x 10-6,(Irritable dimension),NR,'-,0.2236 unit increase,[0.13-0.32],CDH6,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,5:31180684
rs6869294-<b>A</b>,2 x 10-6,(Irritable dimension),NR,'-,0.2236 unit increase,[0.13-0.32],CDH6,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,5:31182306
rs1278352-<b>A</b>,9 x 10-7,(Irritable dimension),NR,'-,0.2377 unit increase,[0.14-0.33],ADAM12,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,10:126084807
rs2447961-<b>T</b>,8 x 10-6,(Irritable dimension),NR,'-,0.3281 unit increase,[0.18-0.47],"GRHL2, RN7SL563P",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,8:101469080
rs137887-<b>G</b>,7 x 10-6,(Defiant/Vindictive dimension),NR,'-,0.9683 unit increase,[0.55-1.39],TTLL8,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,22:50026010
rs9463078-<b>A</b>,3 x 10-6,(Defiant/Vindictive dimension),NR,'-,0.9733 unit increase,[0.57-1.38],SUPT3H,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,6:45213603
rs11791652-<b>T</b>,3 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.017 unit increase,[0.59-1.44],"PCNPP2, S1PR3",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,9:88987881
rs7043095-<b>T</b>,3 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.018 unit increase,[0.6-1.44],"S1PR3, PCNPP2",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,9:88989090
rs9380938-<b>G</b>,7 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.036 unit increase,[0.59-1.48],"EDN1, HIVEP1",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,6:12241592
rs4075163-<b>A</b>,1 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.065 unit increase,[0.64-1.49],"S1PR3, PCNPP2",Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,9:88984188
rs3849811-<b>C</b>,3 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.079 unit increase,[0.63-1.53],ST18,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,8:52097592
rs3892512-<b>G</b>,3 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.079 unit increase,[0.63-1.53],ST18,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,8:52097603
rs1895885-<b>C</b>,3 x 10-6,(Defiant/Vindictive dimension),NR,'-,1.079 unit increase,[0.63-1.53],ST18,Oppositional defiant disorder dimensions in attention-deficit hyperactivity disorder,"attention deficit hyperactivity disorder, oppositional defiant disorder measurement",GCST003472,8:52097970
rs7181782-<b>C</b>,9 x 10-8,(females),NR,'-,0.17 unit decrease,[0.11-0.23],"ARNT2, LINC00927",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,15:80394651
rs4984687-<b>T</b>,2 x 10-7,(females),NR,'-,0.168 unit decrease,[0.11-0.23],FBXL16,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,16:704314
rs28600876-<b>C</b>,7 x 10-7,(females),NR,'-,0.134 unit increase,[0.081-0.187],"FGF3, NCAM1",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,11:69890712
rs114247285-<b>A</b>,8 x 10-7,(females),NR,'-,0.339 unit increase,[0.2-0.47],SAP18P1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,5:76044157
rs9941217-<b>C</b>,9 x 10-7,(females),NR,'-,0.128 unit increase,[0.077-0.179],RPL7P47,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,16:17957069
rs142295881-<b>A</b>,1 x 10-6,(females),NR,'-,0.465 unit decrease,[0.28-0.65],"MLIP-AS1, MLIP",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,6:54034290
rs79891548-<b>T</b>,1 x 10-6,(females),NR,'-,0.216 unit decrease,[0.13-0.3],CSRNP3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,2:165481308
rs150844750-<b>T</b>,2 x 10-6,(females),NR,'-,0.25 unit decrease,[0.15-0.35],RANBP2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,2:108742827
rs71450738-<b>T</b>,2 x 10-6,(females),NR,'-,0.118 unit decrease,[0.069-0.167],SOX5,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,12:24045898
rs770082-<b>A</b>,2 x 10-6,(females),NR,'-,0.12 unit increase,[0.071-0.169],"POC1B, DUSP6",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,12:89382708
rs3047819-<b>T</b>,2 x 10-8,(males),NR,'-,0.097 unit decrease,[0.064-0.13],MEF2C,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,5:88879383
rs8039398-<b>T</b>,3 x 10-8,(males),NR,'-,0.094 unit decrease,[0.061-0.127],SEMA6D,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,15:47438673
rs200508662-<b>T</b>,3 x 10-8,(males),NR,'-,0.131 unit increase,[0.084-0.178],'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,5:121055487
rs145108385-<b>A</b>,2 x 10-7,(males),NR,'-,0.098 unit increase,[0.061-0.135],"ZNF131, ANXA2R",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,5:43054645
rs112984125-<b>A</b>,2 x 10-7,(males),NR,'-,0.097 unit decrease,[0.06-0.134],"KDM4A-AS1, ST3GAL3",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,1:43707752
rs142458453-<b>T</b>,5 x 10-7,(males),NR,'-,0.104 unit increase,[0.063-0.145],"DENND5B, LINC02387",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,12:31377392
rs56135409-<b>A</b>,6 x 10-7,(males),NR,'-,0.087 unit decrease,[0.054-0.12],SGO1-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,3:20683524
rs11317767-<b>G</b>,6 x 10-7,(males),NR,'-,0.087 unit increase,[0.054-0.12],"MFSD6L, SPDYE4",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,17:8770824
rs9746958-<b>A</b>,7 x 10-7,(males),NR,'-,0.311 unit increase,[0.19-0.43],GNPATP,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,16:60584735
rs74129883-<b>A</b>,7 x 10-7,(males),NR,'-,0.218 unit decrease,[0.13-0.3],"ZNF488, ANXA8",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST005362,10:47411236
rs2015560-<b>?</b>,2 x 10-6,,NR,2.7808676,'-,[1.83-4.23],'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,21:24656576
rs6686722-<b>?</b>,3 x 10-8,,NR,2.399808,'-,[1.76-3.27],TNR,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,1:175764827
rs28609353-<b>?</b>,4 x 10-6,,NR,2.1285653,'-,[1.55-2.93],TRIM51,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,11:55884182
rs61975260-<b>?</b>,6 x 10-7,,NR,2.0242915,'-,[1.53-2.67],SPATA7,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,14:88429597
rs2410116-<b>?</b>,4 x 10-7,,NR,2.0036066,'-,[1.53-2.62],'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,8:13815938
rs4778174-<b>?</b>,1 x 10-6,,NR,1.8681113,'-,[1.45-2.4],OCA2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,15:27724420
rs28612433-<b>?</b>,1 x 10-6,,NR,1.8570102,'-,[1.45-2.38],PI4K2B,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,4:25262751
rs4673294-<b>?</b>,5 x 10-6,,NR,1.8308313,'-,[1.41-2.38],DSTNP5,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,2:204324360
rs35624673-<b>?</b>,2 x 10-6,,NR,1.819174,'-,[1.42-2.33],FBN3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,19:8069732
rs9545903-<b>C</b>,7 x 10-6,,NR,1.747,'-,[1.37-2.228],'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,13:81872778
rs10767556-<b>G</b>,3 x 10-6,,NR,2.029,'-,[1.509-2.728],ANO3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,11:26602166
rs13439086-<b>C</b>,6 x 10-6,,NR,2.162,'-,[1.549-3.018],RN7SL178P,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,8:8516736
rs112686226-<b>G</b>,6 x 10-6,,NR,2.903,'-,[1.831-4.602],"OLIG1, LINC01548",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,21:33155073
rs77224013-<b>A</b>,1 x 10-6,,NR,3.869,'-,[2.252-6.647],"LINC01548, IFNAR2",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST006916,21:33171540
rs2360997-<b>C</b>,8 x 10-6,(maternal warmth),0.86,'-,1.3 unit decrease,[NR],ESRRB,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,14:76346148
rs2212361-<b>C</b>,9 x 10-7,(maternal warmth),0.26,'-,0.97 unit decrease,[NR],PIWIL4,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,11:94579157
rs4875598-<b>G</b>,9 x 10-6,(maternal warmth),0.34,'-,0.94 unit decrease,[NR],'-,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,8:5604231
rs1161463-<b>C</b>,2 x 10-6,(maternal warmth),0.79,'-,1.72 unit decrease,[NR],MTUS2,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,13:28857201
rs4714261-<b>T</b>,2 x 10-6,(maternal warmth),0.17,'-,0.95 unit increase,[NR],KIF6,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,6:39571431
rs2825388-<b>A</b>,8 x 10-6,(maternal criticism),0.4,'-,1.06 unit increase,[NR],SLC6A6P1,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,21:19164331
rs10049246-<b>G</b>,8 x 10-6,(maternal warmth),0.59,'-,0.6 unit increase,[NR],NMRAL2P,Attention deficit hyperactivity disorder symptoms (maternal expressed emotions interaction),"attention deficit hyperactivity disorder, parental emotion expression measurmement",GCST000247,3:185968952
rs930421-<b>?</b>,6 x 10-6,(binary),NR,'-,'-,'-,MTA3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,2:42754099
rs7577925-<b>?</b>,3 x 10-6,(binary),NR,'-,'-,'-,"NCKAP5, NCKAP5-AS2",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,2:133282947
rs272000-<b>?</b>,9 x 10-6,(count),NR,'-,'-,'-,DPP10,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,2:115898219
rs6791644-<b>?</b>,8 x 10-6,(count),NR,'-,'-,'-,FHIT,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,3:60785375
rs17651978-<b>?</b>,6 x 10-6,(count),NR,'-,'-,'-,FOXP1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,3:70971339
rs8047014-<b>?</b>,4 x 10-6,(binary),NR,'-,'-,'-,"HAS3, TANGO6",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,16:69101146
rs260461-<b>?</b>,8 x 10-6,(binary),NR,'-,'-,'-,"ZNF8-DT, ZNF544",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,19:58259517
rs17367118-<b>?</b>,9 x 10-6,(count),NR,'-,'-,'-,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,2:122884035
rs1918172-<b>?</b>,5 x 10-6,(count),NR,'-,'-,'-,LINC01876,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,2:156031988
rs2290416-<b>?</b>,9 x 10-6,(count),NR,'-,'-,'-,NAPRT,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,8:143575430
rs7992643-<b>?</b>,5 x 10-6,(count),NR,'-,'-,'-,"ZIC5, CLYBL",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,13:99902784
rs10767942-<b>?</b>,8 x 10-6,(count),NR,'-,'-,'-,"EIF3M, WT1-AS",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,11:32500461
rs130575-<b>?</b>,5 x 10-6,(binary),NR,'-,'-,'-,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,22:34463801
rs1514928-<b>?</b>,3 x 10-6,(binary),NR,'-,'-,'-,LINC00644,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,14:62211585
rs1018040-<b>?</b>,5 x 10-6,(binary),NR,'-,'-,'-,"LINC02869, U3",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,1:218532472
rs11719664-<b>?</b>,2 x 10-6,(count),NR,'-,'-,'-,ZNF385D,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,3:21913706
rs4147141-<b>?</b>,6 x 10-6,(count),NR,'-,'-,'-,LINC01707,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,1:69113569
rs522958-<b>?</b>,1 x 10-6,(binary),NR,'-,'-,'-,CCDC91,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,12:28075634
rs1350666-<b>?</b>,8 x 10-6,(binary),NR,'-,'-,'-,"EPGN, EREG",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000281,4:74358873
rs6968385-<b>T</b>,2 x 10-6,(earlier onset),NR,'-,'-,'-,'-,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,7:110407414
rs874426-<b>C</b>,4 x 10-6,(earlier onset),NR,'-,'-,'-,NAV2,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,11:19548016
rs17658378-<b>A</b>,9 x 10-6,(later onset),NR,'-,'-,'-,TRPS1,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,8:115381846
rs1335515-<b>C</b>,8 x 10-6,(earlier onset),NR,'-,'-,'-,SLC35F4,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,14:57918647
rs4810685-<b>C</b>,7 x 10-6,(earlier onset),NR,'-,'-,'-,SULF2,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,20:47771969
rs1517484-<b>C</b>,5 x 10-7,(earlier onset),NR,'-,'-,'-,NYAP2,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,2:225373194
rs9845475-<b>G</b>,4 x 10-6,(later onset),NR,'-,'-,'-,"RPL23AP43, TRIM71",Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,3:32800609
rs3892715-<b>C</b>,6 x 10-6,(earlier onset),NR,'-,'-,'-,"MIR1263, XXYLT1",Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,3:195037281
rs1325154-<b>C</b>,5 x 10-6,(later onset),NR,'-,'-,'-,'-,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,9:12582565
rs806276-<b>A</b>,3 x 10-7,(later onset),NR,'-,'-,'-,MAP3K7,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,6:90497632
rs10039254-<b>A</b>,8 x 10-6,(later onset),NR,'-,'-,'-,ADAMTS2,Attention deficit hyperactivity disorder (time to onset),attention deficit hyperactivity disorder,GCST000280,5:179143913
rs7442317-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,RPS3AP17,Attention deficit hyperactivity disorder motor coordination,attention deficit hyperactivity disorder,GCST001030,4:29901430
rs78210707-<b>?</b>,4 x 10-6,,0.011,2.67,'-,[2.54-2.80],GRIN2B,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,12:13763366
rs28868104-<b>?</b>,4 x 10-7,,0.131,1.4534883,'-,[1.36-1.55],'-,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,3:104241993
rs1925458-<b>?</b>,1 x 10-6,,0.117,1.552795,'-,[1.45-1.66],'-,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,6:23378723
rs75036080-<b>?</b>,3 x 10-6,,0.02,2.0576131,'-,[1.93-2.19],"C12orf40, SLC2A13",Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,12:39882501
rs429358-<b>?</b>,6 x 10-43,,0.147,3.26,'-,[3.21-3.31],'-,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,Mapping not available
rs11967676-<b>G</b>,9 x 10-8,,0.08,'-,1.07 unit decrease,[0.7-1.44],'-,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST006990,6:48747159
rs4955783-<b>G</b>,5 x 10-7,,0.49,'-,0.61 unit decrease,[0.39-0.83],GOLIM4,Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, t-tau measurement",GCST006991,3:168031109
rs181850653-<b>T</b>,9 x 10-7,,0.03,'-,1.59 unit decrease,[0.98-2.2],"RNU6-363P, C5orf22",Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, t-tau measurement",GCST006991,5:31575350
rs80011616-<b>A</b>,2 x 10-7,,0.14,'-,0.92 unit decrease,[0.61-1.23],RNF165,Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, t-tau measurement",GCST006991,18:46404184
rs114090132-<b>T</b>,8 x 10-7,,0.02,'-,2.46 unit decrease,[1.54-3.38],SLC25A48,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,5:135810905
rs117556552-<b>T</b>,5 x 10-7,,0.05,'-,2.21 unit decrease,[1.41-3.01],ANO3,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,11:26498505
rs117908734-<b>T</b>,1 x 10-6,,0.02,'-,3.03 unit decrease,[1.89-4.17],'-,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,14:98492717
rs8039237-<b>C</b>,1 x 10-7,,0.03,'-,0.79 unit increase,[0.52-1.06],'-,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,15:94845722
rs186911969-<b>T</b>,3 x 10-7,,0.02,'-,3.65 unit increase,[2.32-4.98],"ACTL8, ERICH3",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,1:17877570
rs137929838-<b>T</b>,3 x 10-7,,0.03,'-,1.59 unit increase,[1.02-2.16],COLGALT2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,1:183941302
rs7576531-<b>T</b>,1 x 10-6,,0.04,'-,1.64 unit increase,[1.01-2.27],ABCB11,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,2:168969959
rs140442947-<b>C</b>,1 x 10-7,,0.01,'-,2.83 unit increase,[1.85-3.81],GSK3B,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,3:119865430
rs116105213-<b>C</b>,4 x 10-7,,0.02,'-,2.73 unit increase,[1.73-3.73],ARAP2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,4:36187535
rs17488073-<b>G</b>,2 x 10-7,,0.16,'-,0.83 unit increase,[0.54-1.12],IRF2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,4:184407819
rs182645021-<b>C</b>,5 x 10-7,,0.01,'-,2.69 unit increase,[1.69-3.69],"RN7SL221P, FARS2",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,6:5877202
rs10455152-<b>C</b>,8 x 10-7,,0.23,'-,0.69 unit increase,[0.44-0.94],"KRT18P64, LINC02535",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,6:85308630
rs79846291-<b>T</b>,2 x 10-8,,0.02,'-,1.85 unit increase,[1.24-2.46],LINC00271,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,6:135756791
rs149454736-<b>T</b>,2 x 10-7,,0.03,'-,1.72 unit increase,[1.11-2.33],AKAP9,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,7:92101277
rs139934868-<b>G</b>,1 x 10-7,,0.06,'-,1.53 unit increase,[1-2.06],DSCAML1,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,11:117780161
rs78927322-<b>G</b>,1 x 10-7,,0.01,'-,2.85 unit increase,[1.85-3.85],IL34,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,16:70602635
rs146446983-<b>C</b>,7 x 10-7,,0.02,'-,2.59 unit increase,[1.61-3.57],GPR160P2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,17:31761101
rs62125664-<b>A</b>,6 x 10-7,,0.02,'-,2.23 unit increase,[1.39-3.07],"LINC01838, ZNF30-AS1",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,19:34915156
rs75627662-<b>T</b>,8 x 10-7,,0.27,'-,0.51 unit decrease,[0.31-0.71],"APOC1, APOE",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,19:44910319
rs147906088-<b>T</b>,8 x 10-8,,0.02,'-,1.76 unit decrease,[1.15-2.37],"LINC01445, VSTM2A",Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,7:54496119
rs56214552-<b>G</b>,4 x 10-7,,0.26,'-,0.44 unit increase,[0.28-0.6],TRIQK,Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,8:93011994
rs6479525-<b>A</b>,9 x 10-7,,0.34,'-,0.39 unit decrease,[0.23-0.55],LINC01508,Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,9:90331096
rs62187521-<b>T</b>,5 x 10-7,,0.03,'-,1.33 unit decrease,[0.84-1.82],RSPO4,Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,20:959154
rs72639058-<b>T</b>,5 x 10-7,,0.17,'-,0.47 unit decrease,[0.29-0.65],KAZN,Logical memory (delayed recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006995,1:13913797
rs117905930-<b>T</b>,7 x 10-8,,0.02,'-,1.59 unit decrease,[1.04-2.14],"PCNPP2, S1PR3",Logical memory (delayed recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006995,9:88973603
rs429358-<b>C</b>,4 x 10-43,,0.126,2.39,'-,[2.11-2.70],'-,Alzheimer's disease (onset at age over 80),Alzheimer's disease,GCST009497,Mapping not available
rs7412-<b>C</b>,6 x 10-12,,0.93,1.8518518,'-,[1.54-2.22],APOE,Alzheimer's disease (onset at age over 80),Alzheimer's disease,GCST009497,19:44908822
rs7412-<b>C</b>,3 x 10-33,,0.947,2.173913,'-,[1.89-2.44],APOE,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44908822
rs111371860-<b>A</b>,1 x 10-12,,0.961,1.6949153,'-,[1.45-1.92],"BCAM, NECTIN2",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44842530
rs440446-<b>G</b>,9 x 10-59,,0.686,1.6393442,'-,[1.56-1.75],APOE,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44905910
rs449647-<b>A</b>,9 x 10-22,,0.887,1.6129031,'-,[1.45-1.79],"APOE, TOMM40",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44905307
rs78986976-<b>G</b>,5 x 10-8,,0.968,1.5384616,'-,[1.32-1.79],"NECTIN2, BCAM",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44826181
rs35568738-<b>G</b>,9 x 10-10,,0.953,1.4925373,'-,[1.32-1.69],TOMM40,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44899461
rs71352239-<b>C</b>,3 x 10-14,,0.807,1.4492754,'-,[1.32-1.59],"APOC1P1, APOC1",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44926286
rs2967668-<b>A</b>,3 x 10-11,,0.913,1.4084507,'-,[1.28-1.56],CBLC,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44799694
rs76692773-<b>C</b>,4 x 10-9,,0.937,1.4084507,'-,[1.27-1.59],TOMM40,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44890954
rs4803748-<b>C</b>,3 x 10-16,,0.617,1.2820514,'-,[1.22-1.37],"CEACAM16-AS1, BCL3",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44743791
rs3851179-<b>C</b>,1 x 10-8,,0.648,1.1764705,'-,[1.11-1.23],"RNU6-560P, LINC02695",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,11:86157598
rs13025717-<b>T</b>,8 x 10-10,,0.295,1.2,'-,[1.13-1.28],"NIFKP9, BIN1",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,2:127128582
rs3818361-<b>A</b>,5 x 10-9,,0.204,1.21,'-,[1.14-1.29],CR1,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,1:207611623
rs35336243-<b>T</b>,2 x 10-9,,0.293,1.24,'-,[1.15-1.33],"APOC1P1, APOC4",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44939262
rs7561528-<b>A</b>,2 x 10-15,,0.37,1.26,'-,[1.19-1.33],"BIN1, NIFKP9",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,2:127132061
rs79638902-<b>T</b>,1 x 10-10,,0.127,1.33,'-,[1.22-1.45],CEACAM16-AS1,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44718495
rs74846209-<b>T</b>,9 x 10-16,,0.101,1.43,'-,[1.31-1.56],"PPP1R37, MARK4",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:45146841
rs6859-<b>A</b>,7 x 10-39,,0.47,1.44,'-,[1.36-1.52],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44878777
rs4803764-<b>C</b>,1 x 10-34,,0.282,1.52,'-,[1.42-1.63],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44854120
rs192775394-<b>C</b>,8 x 10-9,,0.018,1.88,'-,[1.52-2.33],"MARK4, TRAPPC6A",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:45168224
rs60049679-<b>C</b>,1 x 10-17,,0.038,2.07,'-,[1.75-2.44],"APOC1P1, APOC1",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44926451
rs144261139-<b>A</b>,1 x 10-10,,0.012,2.37,'-,[1.82-3.09],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44882099
rs141441332-<b>A</b>,1 x 10-11,,0.012,2.57,'-,[1.96-3.38],"APOC1P1, APOC4",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44935318
rs28399664-<b>G</b>,6 x 10-16,,0.017,2.59,'-,[2.06-3.26],"NECTIN2, BCAM",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44821499
rs138607350-<b>G</b>,6 x 10-14,,0.014,2.66,'-,[2.06-3.43],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44860563
rs79701229-<b>A</b>,2 x 10-9,,0.006,3.35,'-,[2.26-4.95],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44881674
rs429358-<b>C</b>,5 x 10-286,,0.248,3.93,'-,[3.65-4.23],'-,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,Mapping not available
rs78194510-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,SCARB1,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,12:124853790
rs759819-<b>?</b>,6 x 10-12,,'-,'-,'-,'-,"LILRA5, MIR4752",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:54304302
rs12805422-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,"CRY2, SLC35C1",Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,11:45818338
rs1483121-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,"OR4C3, OR4S1",Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,11:48311808
rs17747324-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,TCF7L2,Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,10:112992744
rs10501320-<b>?</b>,3 x 10-16,,'-,'-,'-,'-,MADD,Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,11:47272248
rs6656401-<b>?</b>,4 x 10-15,,'-,'-,'-,'-,CR1,Alzheimer's disease or fasting insulin levels (pleiotropy),"Alzheimer's disease, fasting blood insulin measurement",GCST007826,1:207518704
rs4803750-<b>?</b>,7 x 10-13,,'-,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or fasting insulin levels (pleiotropy),"Alzheimer's disease, fasting blood insulin measurement",GCST007826,19:44744370
rs2279590-<b>?</b>,1 x 10-17,,'-,'-,'-,'-,CLU,Alzheimer's disease or fasting insulin levels (pleiotropy),"Alzheimer's disease, fasting blood insulin measurement",GCST007826,8:27598736
rs157595-<b>?</b>,1 x 10-97,,'-,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44922203
rs261291-<b>?</b>,4 x 10-84,,'-,'-,'-,'-,ALDH1A2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,15:58387979
rs77301115-<b>?</b>,7 x 10-74,,'-,'-,'-,'-,TOMM40,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44893716
rs58826447-<b>?</b>,7 x 10-54,,'-,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44825122
rs406315-<b>?</b>,5 x 10-50,,'-,'-,'-,'-,NECTIN2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44880859
rs41290120-<b>?</b>,3 x 10-36,,'-,'-,'-,'-,NECTIN2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44879418
rs2740488-<b>?</b>,9 x 10-33,,'-,'-,'-,'-,ABCA1,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,9:104899461
rs6733839-<b>?</b>,3 x 10-25,,'-,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,2:127135234
rs141622900-<b>?</b>,3 x 10-24,,'-,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44923535
rs12148780-<b>?</b>,1 x 10-22,,'-,'-,'-,'-,ALDH1A2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,15:58289090
rs7254723-<b>?</b>,7 x 10-22,,'-,'-,'-,'-,"CLPTM1, APOC4-APOC2",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44952664
rs2678379-<b>?</b>,1 x 10-19,,'-,'-,'-,'-,APOB,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,2:21003688
rs10792832-<b>?</b>,1 x 10-14,,'-,'-,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,11:86156833
rs35816125-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,LIPG,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,18:49562460
rs10401176-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,BCL3,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44750234
rs5754166-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,UBE2L3,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,22:21576488
rs10426401-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,"CEACAM16-AS1, PVR",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44644419
rs10808026-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,EPHA1,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,7:143402040
rs189590409-<b>A</b>,2 x 10-7,(between families),NR,'-,5.243 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:113715373
rs149038799-<b>A</b>,7 x 10-8,(between families),NR,'-,5.382 unit increase,'-,"LINC01151, SMILR",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:122446223
rs118152978-<b>A</b>,2 x 10-10,(between families),NR,'-,6.359 unit decrease,'-,LINC00861,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:126341293
rs10975167-<b>T</b>,8 x 10-7,(between families),NR,'-,4.928 unit increase,'-,PDCD1LG2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:5538407
rs147338646-<b>A</b>,5 x 10-7,(within families),NR,'-,5.009 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:11812813
rs78496360-<b>A</b>,5 x 10-7,(between families),NR,'-,5.026 unit decrease,'-,MTATP6P30,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:31499715
rs147213018-<b>A</b>,2 x 10-7,(between families),NR,'-,5.213 unit increase,'-,"ATP5MFP3, RFC5P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:77060964
rs7047415-<b>T</b>,3 x 10-7,(between families),NR,'-,5.096 unit increase,'-,LINC00476,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:95778950
rs12378800-<b>A</b>,2 x 10-7,(between families),NR,'-,5.218 unit increase,'-,"FOXE1, TRMO",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:97869538
rs1774093-<b>A</b>,7 x 10-7,(between families),NR,'-,4.956 unit decrease,'-,MTND3P4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:101884874
rs139090762-<b>A</b>,8 x 10-8,(between families),NR,'-,5.358 unit increase,'-,PNPLA7,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:137522127
rs181666690-<b>T</b>,1 x 10-7,(within families),NR,'-,5.289 unit decrease,'-,WAC,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:28563093
rs146650065-<b>A</b>,4 x 10-8,(between families),NR,'-,5.471 unit decrease,'-,JCAD,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:29940940
rs211257-<b>C</b>,2 x 10-8,(between families),NR,'-,5.641 unit decrease,'-,"RN7SL825P, RPL34P19",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:31991363
rs117850870-<b>C</b>,1 x 10-6,(between families),NR,'-,4.893 unit decrease,'-,C10orf71,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:49315703
rs61860854-<b>T</b>,3 x 10-11,(between families),NR,'-,6.651 unit decrease,'-,"MRPL50P4, SLC16A9",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:59580135
rs79538733-<b>A</b>,5 x 10-7,(between families),NR,'-,5.015 unit increase,'-,"LINC02651, RPL5P26",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:69741141
rs190780914-<b>T</b>,5 x 10-8,(between families),NR,'-,5.452 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:83190139
rs73320584-<b>A</b>,7 x 10-7,(between families),NR,'-,4.96 unit decrease,'-,LINC02653,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:90473719
rs73310256-<b>T</b>,3 x 10-7,(between families),NR,'-,5.123 unit decrease,'-,"HTR7, LINC02653",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:90679092
rs117792039-<b>A</b>,2 x 10-7,(between families),NR,'-,5.158 unit increase,'-,SORCS3,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:105050857
rs188188267-<b>T</b>,5 x 10-7,(between families),NR,'-,5.024 unit increase,'-,"LINC02752, ZBED5-AS1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:10951303
rs117250828-<b>A</b>,3 x 10-7,(between families),NR,'-,5.134 unit decrease,'-,MICAL2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:12171710
rs115514216-<b>T</b>,3 x 10-9,(between families),NR,'-,5.958 unit decrease,'-,LINC02699,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:25871035
rs139675748-<b>T</b>,2 x 10-9,(between families),NR,'-,6.022 unit increase,'-,"HSD17B12, MIR129-2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:43611658
rs56146971-<b>A</b>,8 x 10-7,(between families),NR,'-,4.941 unit decrease,'-,"CCDC88C, PPP4R3A",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:91453757
rs117161928-<b>A</b>,1 x 10-7,(between families),NR,'-,5.294 unit decrease,'-,"FAM181A-AS1, FAM181A",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:93925359
rs57602116-<b>A</b>,3 x 10-7,(between families),NR,'-,5.136 unit increase,'-,RPL15P2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:94816883
rs150511909-<b>T</b>,4 x 10-9,(between families),NR,'-,5.892 unit decrease,'-,LINC02325,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:97442349
rs8033755-<b>A</b>,1 x 10-7,(between families),NR,'-,5.299 unit decrease,'-,HERC2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:28136400
rs149916999-<b>A</b>,1 x 10-7,(between families),NR,'-,5.334 unit increase,'-,TRPM1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:31116066
rs142200609-<b>T</b>,3 x 10-7,(within families),NR,'-,5.118 unit increase,'-,THSD4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:71449755
rs62013859-<b>T</b>,4 x 10-7,(between families),NR,'-,5.094 unit increase,'-,AGBL1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:86283609
rs189794920-<b>A</b>,6 x 10-7,(between families),NR,'-,4.999 unit decrease,'-,"PDPK1, PDPK2P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:2608384
rs118099348-<b>T</b>,1 x 10-9,(between families),NR,'-,6.05 unit increase,'-,TMC5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:19423707
rs145049847-<b>C</b>,8 x 10-9,(between families),NR,'-,5.771 unit decrease,'-,SDR42E2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:22190681
rs77414823-<b>T</b>,2 x 10-7,(between families),NR,'-,5.24 unit decrease,'-,"NCOA5LP, RPL34P29",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:49948846
rs150252171-<b>A</b>,2 x 10-7,(between families),NR,'-,5.224 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:62536445
rs79358781-<b>A</b>,1 x 10-7,(between families),NR,'-,5.268 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:80264653
rs137967137-<b>A</b>,1 x 10-7,(between families),NR,'-,5.331 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:80433296
rs77894924-<b>A</b>,2 x 10-7,(between families),NR,'-,5.208 unit increase,'-,CDH13,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:83521415
rs78910009-<b>T</b>,5 x 10-7,(between families),NR,'-,5.024 unit increase,'-,"FENDRR, LINC00917",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:86374577
rs111816999-<b>T</b>,7 x 10-7,(between families),NR,'-,4.967 unit decrease,'-,ALOX12-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:6979124
rs139471609-<b>A</b>,6 x 10-8,(between families),NR,'-,5.433 unit increase,'-,COX10-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:13791198
rs56176358-<b>T</b>,6 x 10-7,(between families),NR,'-,5.004 unit increase,'-,"MPP3, CD300LG",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:43843285
rs79480822-<b>T</b>,7 x 10-7,(between families),NR,'-,4.952 unit increase,'-,DCAF7,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:63576864
rs34111070-<b>T</b>,1 x 10-6,(between families),NR,'-,4.892 unit decrease,'-,STRADA,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:63716838
rs71377714-<b>T</b>,3 x 10-7,(between families),NR,'-,5.128 unit increase,'-,TCAM1P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:63852268
rs16973424-<b>A</b>,3 x 10-7,(between families),NR,'-,5.144 unit decrease,'-,ABCA8,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:68907860
rs149464898-<b>T</b>,3 x 10-7,(between families),NR,'-,5.136 unit increase,'-,"RPL12P37, RPTOR",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:80973533
rs62076840-<b>A</b>,8 x 10-7,(between families),NR,'-,4.927 unit increase,'-,L3MBTL4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:5958062
rs183708309-<b>T</b>,6 x 10-7,(between families),NR,'-,5.001 unit decrease,'-,LAMA1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:6974460
rs142176337-<b>T</b>,8 x 10-8,(between families),NR,'-,5.36 unit decrease,'-,"NFE2L3P1, PMAIP1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:59914255
rs138098194-<b>A</b>,4 x 10-7,(between families),NR,'-,5.084 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:66840171
rs148273964-<b>A</b>,8 x 10-7,(between families),NR,'-,4.936 unit decrease,'-,"RAB3D, TSPAN16",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:11323255
rs9304861-<b>A</b>,4 x 10-7,(between families),NR,'-,5.082 unit decrease,'-,"LINC01801, ZNF599",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:34780984
rs2927694-<b>C</b>,8 x 10-7,(between families),NR,'-,4.928 unit increase,'-,ZNF813,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:53470531
rs113118940-<b>T</b>,1 x 10-8,(between families),NR,'-,5.733 unit increase,'-,"CST8, CST13P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:23514209
rs147525344-<b>T</b>,5 x 10-9,(between families),NR,'-,5.856 unit decrease,'-,"CSTP2, CST1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:23762403
rs115786578-<b>A</b>,6 x 10-7,(between families),NR,'-,4.992 unit increase,'-,"RPS2P1, ASIP",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:34149795
rs147775533-<b>T</b>,6 x 10-7,(between families),NR,'-,4.993 unit increase,'-,"LINC01271, RN7SL636P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:50382958
rs2409317-<b>T</b>,4 x 10-7,(between families),NR,'-,5.088 unit decrease,'-,U6,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:28702102
rs147991290-<b>T</b>,3 x 10-9,(between families),NR,'-,5.943 unit decrease,'-,SYNJ1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:32716160
rs189677472-<b>A</b>,1 x 10-7,(between families),NR,'-,5.324 unit decrease,'-,"PDE9A, LINC01671",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:42641102
rs857551-<b>A</b>,7 x 10-7,(between families),NR,'-,4.949 unit increase,'-,"LINC01679, SIK1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:43410112
rs79985863-<b>T</b>,8 x 10-7,(between families),NR,'-,4.925 unit increase,'-,COL18A1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:45486796
rs141503849-<b>T</b>,5 x 10-7,(between families),NR,'-,5.042 unit increase,'-,SEPTIN5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:19704370
rs117496069-<b>T</b>,5 x 10-7,(between families),NR,'-,5.043 unit increase,'-,"TEX33, TST",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:37009621
rs150927461-<b>T</b>,4 x 10-7,(between families),NR,'-,5.08 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:48098836
rs4420638-<b>A</b>,2 x 10-16,(between families),NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:44919689
rs17639982-<b>C</b>,8 x 10-9,(between families),NR,'-,5.774 unit decrease,'-,LINC01117,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:176778182
rs1347297-<b>T</b>,5 x 10-8,(within families),NR,'-,5.469 unit increase,'-,OSBPL6,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:178380259
rs6927354-<b>T</b>,5 x 10-8,(between families),NR,'-,5.44 unit decrease,'-,F13A1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:6316080
rs16887604-<b>T</b>,3 x 10-8,(between families),NR,'-,5.544 unit increase,'-,RNU6-261P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:76439941
rs183826639-<b>T</b>,1 x 10-12,(within families),NR,'-,7.098 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:75905029
rs11961710-<b>A</b>,7 x 10-7,(between families),NR,'-,4.95 unit increase,'-,LINC02518,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:113399037
rs190204665-<b>T</b>,1 x 10-7,(between families),NR,'-,5.259 unit increase,'-,"F2R, F2RL1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:76793184
rs116300850-<b>T</b>,7 x 10-7,(between families),NR,'-,4.963 unit increase,'-,WDR41,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:77556409
rs17069431-<b>T</b>,6 x 10-7,(between families),NR,'-,4.994 unit increase,'-,FILNC1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:139874946
rs34804891-<b>T</b>,6 x 10-8,(between families),NR,'-,5.425 unit increase,'-,SNX9,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:157844754
rs9293513-<b>A</b>,5 x 10-7,(between families),NR,'-,5.035 unit increase,'-,MEF2C-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:89337967
rs77780208-<b>A</b>,9 x 10-7,(between families),NR,'-,4.917 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:105543433
rs4705644-<b>A</b>,9 x 10-7,(between families),NR,'-,4.905 unit decrease,'-,KCNN2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:114241467
rs56357845-<b>A</b>,7 x 10-7,(between families),NR,'-,4.958 unit increase,'-,CHN2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:29210652
rs190338033-<b>A</b>,2 x 10-7,(between families),NR,'-,5.167 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:119985478
rs7702102-<b>A</b>,5 x 10-7,(between families),NR,'-,5.034 unit decrease,'-,"ZCCHC10, Y_RNA",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:132994460
rs188951355-<b>T</b>,9 x 10-7,(between families),NR,'-,4.911 unit increase,'-,RNU7-156P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:143553786
rs2962508-<b>T</b>,4 x 10-8,(between families),NR,'-,5.499 unit increase,'-,LARS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:146158952
rs186127414-<b>A</b>,2 x 10-7,(between families),NR,'-,5.17 unit increase,'-,G3BP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:151801825
rs143766413-<b>C</b>,5 x 10-7,(between families),NR,'-,5.024 unit increase,'-,"HAND1, CIR1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:154557919
rs61142792-<b>T</b>,4 x 10-7,(between families),NR,'-,5.083 unit increase,'-,"TMED9, FAM193B-DT",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:177556462
rs188911996-<b>A</b>,2 x 10-8,(between families),NR,'-,5.578 unit increase,'-,KDM1B,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:18173684
rs62400067-<b>T</b>,4 x 10-7,(between families),NR,'-,5.092 unit increase,'-,CDKAL1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:20592753
rs543844-<b>A</b>,1 x 10-7,(between families),NR,'-,5.323 unit decrease,'-,CDC5L,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:44457063
rs61510607-<b>T</b>,5 x 10-7,(between families),NR,'-,5.012 unit decrease,'-,"EN2, BLACE",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:155432020
rs188420713-<b>T</b>,2 x 10-10,(between families),NR,'-,6.328 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:37276671
rs4557697-<b>A</b>,8 x 10-9,(between families),NR,'-,5.761 unit decrease,'-,NKAIN3,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:62931072
rs6908580-<b>T</b>,3 x 10-7,(between families),NR,'-,5.099 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:91867653
rs182838111-<b>T</b>,2 x 10-7,(between families),NR,'-,5.233 unit increase,'-,PPP1R42,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:66977235
rs847012-<b>C</b>,3 x 10-7,(within families),NR,'-,5.096 unit increase,'-,"SOBP, SCML4",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:107689329
rs11742761-<b>A</b>,3 x 10-7,(between families),NR,'-,5.107 unit decrease,'-,FGF10,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:44301065
rs17062407-<b>A</b>,2 x 10-7,(between families),NR,'-,5.2 unit increase,'-,EYA4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:133383011
rs4896030-<b>A</b>,6 x 10-7,(between families),NR,'-,4.988 unit increase,'-,SGK1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:134242215
rs186292051-<b>T</b>,2 x 10-7,(between families),NR,'-,5.17 unit increase,'-,MEF2C-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:89030013
rs141568462-<b>T</b>,2 x 10-7,(between families),NR,'-,5.183 unit decrease,'-,MEF2C-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:89179048
rs116886320-<b>A</b>,3 x 10-7,(between families),NR,'-,5.116 unit increase,'-,TULP4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:158508928
rs183600932-<b>T</b>,1 x 10-8,(between families),NR,'-,5.706 unit increase,'-,PHF14,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:11018769
rs12374991-<b>T</b>,5 x 10-7,(between families),NR,'-,5.046 unit increase,'-,"NPM1P11, PHF14",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:11188315
rs77296444-<b>A</b>,2 x 10-7,(between families),NR,'-,5.183 unit increase,'-,"LINC02214, RPS17P2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:116719736
rs138090874-<b>A</b>,4 x 10-8,(between families),NR,'-,5.511 unit increase,'-,NEUROD6,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:31262777
rs11773349-<b>A</b>,6 x 10-7,(between families),NR,'-,4.991 unit decrease,'-,"MTDHP1, ZNF117",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:64946786
rs118071777-<b>A</b>,7 x 10-7,(between families),NR,'-,4.951 unit increase,'-,"EEF1A1P28, PQLC1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:88614935
rs75290158-<b>A</b>,8 x 10-7,(between families),NR,'-,4.943 unit increase,'-,DLX5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:97023147
rs62496419-<b>A</b>,5 x 10-7,(between families),NR,'-,5.027 unit increase,'-,AP1S2P1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:97350347
rs12706411-<b>T</b>,8 x 10-7,(between families),NR,'-,4.928 unit increase,'-,CADPS2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:122425165
rs71574743-<b>T</b>,1 x 10-7,(between families),NR,'-,5.329 unit increase,'-,IQUB,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:123404453
rs116932763-<b>A</b>,2 x 10-7,(between families),NR,'-,5.171 unit increase,'-,ZNF862,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:149851920
rs191603973-<b>C</b>,7 x 10-7,(between families),NR,'-,4.962 unit decrease,'-,INSIG1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:155309976
rs185968827-<b>A</b>,2 x 10-7,(between families),NR,'-,5.158 unit increase,'-,DST,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:56843712
rs140996952-<b>T</b>,9 x 10-7,(between families),NR,'-,4.912 unit decrease,'-,KHDRBS2-OT1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:61662196
rs36099249-<b>T</b>,7 x 10-8,(between families),NR,'-,5.39 unit decrease,'-,COL12A1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:75180632
rs191342285-<b>A</b>,2 x 10-7,(between families),NR,'-,5.233 unit decrease,'-,"C8orf44-SGK3, SGK3",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:66786417
rs140633572-<b>A</b>,5 x 10-7,(between families),NR,'-,5.03 unit decrease,'-,LINC02532,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:106832060
rs192093332-<b>A</b>,2 x 10-7,(between families),NR,'-,5.179 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:83267319
rs76070545-<b>T</b>,1 x 10-7,(between families),NR,'-,5.262 unit decrease,'-,"FZD6, CTHRC1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:103359219
rs11062987-<b>A</b>,7 x 10-7,(between families),NR,'-,4.964 unit decrease,'-,HSPA8P5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:4063960
rs116938548-<b>T</b>,2 x 10-7,(between families),NR,'-,5.24 unit increase,'-,"GAU1, NDUFA9",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:4699085
rs3794318-<b>A</b>,5 x 10-7,(between families),NR,'-,5.043 unit decrease,'-,AICDA,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:8605947
rs117154046-<b>A</b>,6 x 10-7,(between families),NR,'-,5.001 unit increase,'-,OVCH1-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:29389844
rs79335261-<b>T</b>,7 x 10-8,(between families),NR,'-,5.399 unit increase,'-,"PA2G4, ERBB3",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:56103857
rs187293782-<b>T</b>,7 x 10-9,(between families),NR,'-,5.78 unit increase,'-,SNORA70,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:75763576
rs190909796-<b>T</b>,5 x 10-7,(between families),NR,'-,5.038 unit increase,'-,"RNU7-106P, OTOGL",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:80080902
rs117483990-<b>T</b>,1 x 10-9,(between families),NR,'-,6.07 unit decrease,'-,"BRWD1P2, RNU6-148P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:89830937
rs185806653-<b>A</b>,8 x 10-7,(between families),NR,'-,4.932 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:127489593
rs144288546-<b>A</b>,2 x 10-8,(between families),NR,'-,5.634 unit increase,'-,TMEM132C,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:128585137
rs61960582-<b>A</b>,8 x 10-7,(between families),NR,'-,4.927 unit increase,'-,"MRPS31P4, LINC00345",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:52557892
rs61956285-<b>T</b>,1 x 10-6,(between families),NR,'-,4.902 unit increase,'-,RABEPKP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:71297394
rs189465671-<b>T</b>,2 x 10-7,(between families),NR,'-,5.246 unit increase,'-,"ARF4P4, LINC00377",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:80962230
rs9546312-<b>T</b>,9 x 10-7,(between families),NR,'-,4.92 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:83172816
rs6491411-<b>A</b>,9 x 10-7,(between families),NR,'-,4.911 unit decrease,'-,FARP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:98252314
rs117969561-<b>T</b>,9 x 10-7,(between families),NR,'-,4.909 unit increase,'-,GGACT,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:100558935
rs115694210-<b>A</b>,1 x 10-7,(between families),NR,'-,5.336 unit decrease,'-,LINC00343,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:105740230
rs150813880-<b>A</b>,1 x 10-6,(between families),NR,'-,4.895 unit increase,'-,MYO16,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:109140829
rs3850930-<b>A</b>,6 x 10-7,(between families),NR,'-,4.991 unit increase,'-,TRIM51CP,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:48948392
rs2313143-<b>A</b>,2 x 10-7,(between families),NR,'-,5.224 unit increase,'-,GTF2IP11,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:50114007
rs141218484-<b>T</b>,9 x 10-8,(between families),NR,'-,5.336 unit decrease,'-,AHNAK,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:62481191
rs117983694-<b>A</b>,7 x 10-8,(between families),NR,'-,5.399 unit decrease,'-,CCDC89,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:85685837
rs3911569-<b>A</b>,3 x 10-7,(between families),NR,'-,5.145 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:95362871
rs188168326-<b>T</b>,9 x 10-8,(between families),NR,'-,5.352 unit increase,'-,"LINC02763, LINC02762",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:112392241
rs11220271-<b>A</b>,5 x 10-7,(between families),NR,'-,5.033 unit increase,'-,DDX25,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:125907477
rs76930906-<b>A</b>,3 x 10-11,(between families),NR,'-,6.631 unit decrease,'-,LINC02268,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:174174724
rs75718659-<b>T</b>,4 x 10-7,(between families),NR,'-,5.052 unit increase,'-,"MRPS36P2, FAT1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:186821932
rs11749176-<b>A</b>,2 x 10-7,(between families),NR,'-,5.218 unit increase,'-,RNU6-381P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:44145829
rs79781504-<b>A</b>,2 x 10-8,(between families),NR,'-,5.603 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:83837822
rs146168866-<b>A</b>,9 x 10-8,(within families),NR,'-,5.348 unit increase,'-,LAMP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:113312674
rs75885813-<b>A</b>,4 x 10-10,(within families),NR,'-,6.258 unit decrease,'-,RBFOX1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:7091262
rs56131196-<b>A</b>,3 x 10-24,(within families),NR,'-,10.157 unit increase,'-,"APOC1, APOC1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:44919589
rs144191434-<b>A</b>,2 x 10-7,(between families),NR,'-,5.189 unit increase,'-,ARVCF,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:20016577
rs2445130-<b>A</b>,8 x 10-7,(between families),NR,'-,4.933 unit increase,'-,HSPG2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:21911229
rs56039743-<b>T</b>,3 x 10-7,(between families),NR,'-,5.112 unit decrease,'-,UBXN11,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:26294315
rs12041233-<b>A</b>,6 x 10-9,(between families),NR,'-,5.825 unit increase,'-,"RPS29P6, RNA5SP43",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:37287106
rs182798940-<b>T</b>,7 x 10-7,(between families),NR,'-,4.971 unit increase,'-,"HYI, SZT2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:43453815
rs143083071-<b>A</b>,1 x 10-8,(between families),NR,'-,5.734 unit increase,'-,PLPPR4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:99242198
rs11588387-<b>T</b>,1 x 10-6,(between families),NR,'-,4.893 unit increase,'-,AHCYL1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:109995242
rs79036927-<b>A</b>,1 x 10-6,(between families),NR,'-,4.896 unit decrease,'-,NMNAT1P2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:164275038
rs181424343-<b>A</b>,8 x 10-8,(within families),NR,'-,5.375 unit increase,'-,TGFB2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:218421142
rs36060340-<b>A</b>,7 x 10-7,(between families),NR,'-,4.975 unit increase,'-,RNU4-77P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:233487182
rs148822902-<b>C</b>,1 x 10-6,(between families),NR,'-,4.901 unit decrease,'-,RNU6-649P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:4989398
rs75009721-<b>T</b>,2 x 10-8,(between families),NR,'-,5.66 unit increase,'-,ITSN2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:24254185
rs183562580-<b>A</b>,6 x 10-7,(within families),NR,'-,4.996 unit decrease,'-,OTOF,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:26471784
rs186552003-<b>A</b>,8 x 10-7,(within families),NR,'-,4.943 unit increase,'-,MSH2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:47443115
rs186166314-<b>A</b>,9 x 10-8,(between families),NR,'-,5.355 unit decrease,'-,"PPP1R21-DT, FOXN2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:48435898
rs191975838-<b>T</b>,5 x 10-8,(between families),NR,'-,5.467 unit decrease,'-,CCDC12P1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:51894529
rs115291397-<b>A</b>,2 x 10-9,(between families),NR,'-,6.033 unit decrease,'-,LINC01185,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:60832908
rs182928794-<b>T</b>,8 x 10-7,(between families),NR,'-,4.927 unit increase,'-,"RAB1A, SNORA74",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:65140292
rs140661185-<b>A</b>,1 x 10-6,(between families),NR,'-,4.893 unit decrease,'-,SPRED2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:65382753
rs2970989-<b>T</b>,4 x 10-8,(between families),NR,'-,5.479 unit decrease,'-,LINC01868,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:100697607
rs186971130-<b>A</b>,1 x 10-7,(between families),NR,'-,5.311 unit increase,'-,LINC01965,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:104003000
rs181319480-<b>T</b>,4 x 10-7,(between families),NR,'-,5.086 unit decrease,'-,CFAP20DC,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:58807331
rs7609954-<b>T</b>,4 x 10-8,(between families),NR,'-,5.492 unit increase,'-,PTPRG,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:61650482
rs58920042-<b>T</b>,8 x 10-7,(between families),NR,'-,4.931 unit increase,'-,LINC00877,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:71931938
rs142710255-<b>A</b>,3 x 10-7,(between families),NR,'-,5.135 unit decrease,'-,LINC02008,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:82012036
rs190500289-<b>A</b>,8 x 10-7,(between families),NR,'-,4.934 unit increase,'-,INHCAP,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:133712051
rs28582745-<b>A</b>,9 x 10-7,(between families),NR,'-,4.912 unit increase,'-,"RNU6-637P, TERC",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:169741537
rs189421534-<b>A</b>,2 x 10-8,(between families),NR,'-,5.646 unit increase,'-,"SNRPCP13, ENPP7P11",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:9590409
rs147028191-<b>A</b>,1 x 10-9,(between families),NR,'-,6.062 unit increase,'-,GABRA2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:46412095
rs183757472-<b>A</b>,1 x 10-9,(between families),NR,'-,6.062 unit decrease,'-,RAC1P2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:46689227
rs115809613-<b>A</b>,1 x 10-8,(between families),NR,'-,5.688 unit decrease,'-,"NDUFS5P4, RNU7-149P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:98971324
rs115641191-<b>T</b>,2 x 10-7,(between families),NR,'-,5.237 unit increase,'-,BANK1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:102133052
rs72728723-<b>A</b>,2 x 10-7,(between families),NR,'-,5.201 unit increase,'-,SETD7,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:139599374
rs143638193-<b>T</b>,4 x 10-9,(between families),NR,'-,5.895 unit increase,'-,"RN7SL152P, TBC1D9",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:140579551
rs3931397-<b>T</b>,6 x 10-7,(between families),NR,'-,4.984 unit increase,'-,NR3C2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:148158346
rs13133687-<b>A</b>,7 x 10-7,(between families),NR,'-,4.966 unit increase,'-,ANXA10,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:168062923
rs9994441-<b>C</b>,6 x 10-7,(between families),NR,'-,4.99 unit increase,'-,SH3RF1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:169173411
rs982100-<b>A</b>,4 x 10-7,(between families),NR,'-,5.08 unit increase,'-,DDX18,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:117717968
rs140009341-<b>A</b>,2 x 10-7,(between families),NR,'-,5.186 unit increase,'-,RN7SKP141,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:136433314
rs116677506-<b>A</b>,7 x 10-7,(between families),NR,'-,4.955 unit decrease,'-,"CTAGE14P, B3GALT1-AS1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:167746937
rs75286889-<b>A</b>,7 x 10-8,(between families),NR,'-,5.379 unit increase,'-,"Y_RNA, LRRC2P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:174268728
rs1443024-<b>A</b>,6 x 10-7,(between families),NR,'-,4.999 unit increase,'-,"FAM228B, ZNF804A",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:184511570
rs187402274-<b>C</b>,1 x 10-7,(between families),NR,'-,5.264 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:220047457
rs59904869-<b>C</b>,4 x 10-7,(between families),NR,'-,5.054 unit decrease,'-,COL4A4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:227138926
rs148471206-<b>T</b>,5 x 10-7,(between families),NR,'-,5.023 unit increase,'-,"RANP7, SALL4P5",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:22933695
rs7374058-<b>T</b>,3 x 10-7,(between families),NR,'-,5.137 unit increase,'-,HMGB3P12,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:26205084
rs75002042-<b>T</b>,5 x 10-8,(adjusted for APOE),0.92,1.59,'-,[1.33-1.85],FBXL7,Alzheimer's disease (late onset),Alzheimer's disease,GCST002983,5:15669858
rs7431992-<b>A</b>,2 x 10-6,(adjusted for APOE),0.1,1.46,'-,[1.25-1.71],CACNA2D3,Alzheimer's disease (late onset),Alzheimer's disease,GCST002983,3:54319213
rs394819-<b>T</b>,8 x 10-11,,0.07,1.89,'-,[1.55-2.3],TOMM40,Alzheimer's disease (late onset),Alzheimer's disease,GCST002983,19:44901322
rs271066-<b>?</b>,3 x 10-6,,NR,'-,0.6491 unit decrease,'-,'-,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,3:6336008
rs704454-<b>?</b>,3 x 10-6,,NR,'-,0.5038 unit increase,'-,ADAMTS9-AS2,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,3:64941350
rs1466662-<b>?</b>,5 x 10-7,,NR,'-,0.9595 unit decrease,'-,DCHS2,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,4:154426241
rs2034764-<b>?</b>,4 x 10-6,,NR,'-,0.879 unit increase,'-,PUM3,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,9:2742771
rs17429217-<b>?</b>,3 x 10-6,,NR,'-,2.436 unit increase,'-,HRK,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,12:116857528
rs3743162-<b>?</b>,9 x 10-6,,NR,'-,0.8828 unit decrease,'-,SLC28A1,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,15:84887738
rs4420638-<b>?</b>,1 x 10-12,,NR,'-,2.2018 unit increase,'-,"APOC1, APOC1P1",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,19:44919689
rs10517270-<b>?</b>,4 x 10-6,,NR,'-,3.3056 unit decrease,'-,'-,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,4:33201518
rs2104362-<b>?</b>,7 x 10-6,,NR,'-,0.8441 unit increase,'-,"LINC01016, MLN",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,6:33857581
rs12933233-<b>?</b>,8 x 10-6,,NR,'-,0.7869 unit increase,'-,'-,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,Mapping not available
rs1037757-<b>?</b>,8 x 10-6,,NR,'-,4.5618 unit decrease,'-,"OACYLP, SEC11C",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,18:59084822
rs3743162-<b>?</b>,9 x 10-6,,NR,'-,0.88 unit decrease,'-,SLC28A1,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,15:84887738
rs12816806-<b>?</b>,9 x 10-6,,NR,'-,0.8384 unit increase,'-,"RBM19, DYNLL1P4",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,12:113810386
rs4937314-<b>C</b>,7 x 10-6,,0.17,'-,'-,'-,LINC02098,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,11:128319206
rs11848070-<b>C</b>,6 x 10-6,,0.25,'-,'-,'-,PCNX1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,14:71040884
rs6085820-<b>A</b>,9 x 10-6,,0.09,'-,'-,'-,'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,20:6999988
rs4145462-<b>T</b>,1 x 10-6,,0.05,'-,'-,'-,MPZL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,1:167749262
rs41458646-<b>G</b>,8 x 10-6,,0.17,'-,'-,'-,'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,2:23016071
rs6738181-<b>A</b>,5 x 10-6,,0.19,'-,'-,'-,DSTNP5,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,2:204263298
rs7638995-<b>A</b>,2 x 10-6,,0.11,'-,'-,'-,"FRMD4B, LMOD3",Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,3:69124224
rs11983798-<b>T</b>,1 x 10-6,,0.08,'-,'-,'-,ATXN7L1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,7:105640741
rs6468852-<b>G</b>,1 x 10-6,,0.13,'-,'-,'-,MAILR,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,8:102963761
rs9969729-<b>A</b>,2 x 10-6,,0.08,'-,'-,'-,SLC25A6P5,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,9:105869669
rs12361953-<b>C</b>,8 x 10-7,,0.15,'-,'-,'-,LUZP2,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,11:24589584
rs472926-<b>C</b>,3 x 10-6,,0.15,'-,'-,'-,CDON,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,11:126035363
rs17767225-<b>T</b>,8 x 10-6,,0.2,'-,'-,'-,"FOXN3, PCNX1",Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,14:71199580
rs2075650-<b>G</b>,9 x 10-116,,'-,4.48,'-,[NR],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST002422,19:44892362
rs249153-<b>C</b>,4 x 10-7,,'-,1.41,'-,[NR],NDUFA12,Alzheimer's disease,Alzheimer's disease,GCST002422,12:94930613
rs13178362-<b>T</b>,7 x 10-7,,'-,1.3333,'-,[NR],HPRT1P2,Alzheimer's disease,Alzheimer's disease,GCST002422,5:30178906
rs474951-<b>T</b>,1 x 10-6,,'-,1.2658,'-,[NR],"MS4A2, MS4A3",Alzheimer's disease,Alzheimer's disease,GCST002422,11:60071148
rs1552244-<b>A</b>,2 x 10-6,,'-,1.32,'-,[NR],"FANCD2OS, FANCD2",Alzheimer's disease,Alzheimer's disease,GCST002422,3:10093893
rs157580-<b>?</b>,1 x 10-40,,NR,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000313,19:44892009
rs4298437-<b>A</b>,2 x 10-6,,0.26,'-,'-,'-,RELN,Alzheimer's disease,Alzheimer's disease,GCST000676,7:103985430
rs11782819-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,LINCR-0001,Alzheimer's disease,Alzheimer's disease,GCST000676,8:10477271
APOE-<b>E3</b>,4 x 10-9,,NR,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST001372,Mapping not available
APOE-<b>E4</b>,7 x 10-16,,NR,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST001372,Mapping not available
rs2243170-<b>?</b>,7 x 10-7,,'-,1.65,'-,[NR],IL19,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,1:206836565
rs7588354-<b>?</b>,1 x 10-6,,'-,1.5151515,'-,[NR],"NCKAP5, RN7SKP93",Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,2:133575190
rs2400749-<b>?</b>,2 x 10-6,,'-,1.3888888,'-,[NR],CCDC85C,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,14:99570681
rs840163-<b>?</b>,2 x 10-6,,'-,1.4,'-,[NR],SDR9C7,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,12:56926927
rs4474465-<b>?</b>,3 x 10-6,,'-,1.44,'-,[NR],NARS2,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,11:78493334
rs6695033-<b>?</b>,3 x 10-6,,'-,2.71,'-,[NR],ALDH4A1,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,1:18875425
rs11601321-<b>?</b>,8 x 10-6,,'-,1.63,'-,[NR],PKNOX2,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,11:125323700
rs4420638-<b>?</b>,1 x 10-39,,NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST000121,19:44919689
rs4509693-<b>?</b>,6 x 10-6,,0.18,'-,'-,'-,PAX2,Alzheimer's disease,Alzheimer's disease,GCST000484,10:100741814
rs7539409-<b>?</b>,1 x 10-6,,0.18,'-,'-,'-,LINC01725,Alzheimer's disease,Alzheimer's disease,GCST000484,1:83789052
rs9390537-<b>?</b>,8 x 10-6,,0.22,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST000484,6:148102235
rs690705-<b>?</b>,6 x 10-7,,0.25,'-,'-,'-,VDAC1P12,Alzheimer's disease,Alzheimer's disease,GCST000484,13:34080781
rs2075650-<b>?</b>,3 x 10-11,,0.15,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000484,19:44892362
rs2573905-<b>?</b>,2 x 10-7,,0.46,1.29,'-,[1.17-1.42],PCDH11X,Alzheimer's disease,Alzheimer's disease,GCST000315,X:92147221
rs6859-<b>A</b>,6 x 10-14,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST000237,19:44878777
rs727153-<b>C</b>,3 x 10-6,,0.52,1.63,'-,[1.37-1.95],LRAT,Alzheimer's disease,Alzheimer's disease,GCST000237,4:154733269
rs4420638-<b>?</b>,1 x 10-39,,NR,4.01,'-,[NR],"APOC1, APOC1P1",Alzheimer's disease (late onset),Alzheimer's disease,GCST000018,19:44919689
rs4676049-<b>A</b>,4 x 10-8,,0.08,1.76,'-,[1.44-2.15],EDAR,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,2:109018801
rs2075650-<b>G</b>,5 x 10-36,,0.2,2.94,'-,[2.48-3.47],TOMM40,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,19:44892362
rs6859-<b>A</b>,1 x 10-7,,0.46,1.41,'-,[1.24-1.60],NECTIN2,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,19:44878777
rs11754661-<b>A</b>,2 x 10-10,,0.07,2.1,'-,[1.67-2.64],MTHFD1L,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,6:150885942
rs17006206-<b>G</b>,2 x 10-6,,0.1,2.05,'-,[1.52-2.76],SLC4A1AP,Alzheimer's disease,Alzheimer's disease,GCST001342,2:27684606
rs956225-<b>A</b>,9 x 10-6,,NR,3.33,'-,[1.96-5.56],HAS2-AS1,Alzheimer's disease,Alzheimer's disease,GCST001342,8:121897448
rs340849-<b>?</b>,8 x 10-6,,NR,1.69,'-,[1.33-2.13],PROX1-AS1,Alzheimer's disease,Alzheimer's disease,GCST001342,1:213944747
rs11889338-<b>A</b>,9 x 10-6,,0.26,1.55,'-,[1.28-1.88],ZFYVE9P2,Alzheimer's disease,Alzheimer's disease,GCST001342,2:17246318
rs2221154-<b>?</b>,3 x 10-6,,NR,1.75,'-,[1.39-2.22],RBMS3,Alzheimer's disease,Alzheimer's disease,GCST001342,3:28887369
rs1923775-<b>T</b>,6 x 10-6,,0.25,1.6,'-,[1.30-1.95],"POLN, HAUS3",Alzheimer's disease,Alzheimer's disease,GCST001342,4:2101369
rs10273775-<b>G</b>,9 x 10-6,,0.42,1.52,'-,[1.27-1.84],CNTNAP2,Alzheimer's disease,Alzheimer's disease,GCST001342,7:147200311
rs10850408-<b>?</b>,9 x 10-7,,NR,1.59,'-,[1.32-1.92],'-,Alzheimer's disease,Alzheimer's disease,GCST001342,12:114942588
rs912330-<b>?</b>,4 x 10-6,,NR,1.85,'-,[1.43-2.44],STK24,Alzheimer's disease,Alzheimer's disease,GCST001342,13:98479040
rs6859-<b>A</b>,5 x 10-7,,NR,1.58,'-,[NR],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST001342,19:44878777
rs17511627-<b>C</b>,5 x 10-6,,0.17,1.75,'-,[1.37-2.22],"ATP8A2P3, RNF6",Alzheimer's disease,Alzheimer's disease,GCST001342,13:26150190
rs12989701-<b>?</b>,3 x 10-10,,NR,1.23,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST000986,2:127130409
rs744373-<b>?</b>,1 x 10-10,,NR,1.19,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST000986,2:127137039
rs2061333-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"ZNF225, ZNF224",Alzheimer's disease,Alzheimer's disease,GCST000310,19:44110055
rs11610206-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,"PCED1B, PPIAP45",Alzheimer's disease,Alzheimer's disease,GCST000310,12:47245743
rs12044355-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,"TSNAX-DISC1, DISC1",Alzheimer's disease,Alzheimer's disease,GCST000310,1:231708601
rs11023139-<b>?</b>,7 x 10-11,,0.05,'-,0.31 unit decrease,'-,SPON1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,11:14202800
rs326946-<b>?</b>,7 x 10-7,,0.17,'-,0.16 unit decrease,'-,ARHGAP20,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,11:110628530
rs147845115-<b>?</b>,3 x 10-7,,0.03,'-,0.29 unit decrease,'-,SLC4A8,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,12:51484976
rs61144803-<b>?</b>,5 x 10-8,,0.04,'-,0.16 unit decrease,'-,CRADD,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,12:93841389
rs1399439-<b>?</b>,4 x 10-7,,0.04,'-,0.2 unit decrease,'-,ANO4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,12:100827461
rs143258881-<b>?</b>,7 x 10-8,,0.03,'-,0.29 unit decrease,'-,GPC6,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,13:93293605
rs17393344-<b>?</b>,2 x 10-8,,0.06,'-,0.26 unit decrease,'-,MYO16,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,13:108821598
rs115102486-<b>?</b>,2 x 10-8,,0.03,'-,0.31 unit decrease,'-,CLMN,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,14:95298227
rs74006954-<b>?</b>,3 x 10-7,,0.03,'-,0.28 unit decrease,'-,GABRG3,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,15:27467498
rs17301739-<b>?</b>,2 x 10-6,,0.07,'-,0.28 unit decrease,'-,"LIPC-AS1, LIPC, ALDH1A2",Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,15:58438440
rs8045064-<b>?</b>,4 x 10-8,,0.05,'-,0.21 unit decrease,'-,"LINC01567, TNRC6A",Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,16:24664268
rs9934540-<b>?</b>,4 x 10-7,,0.03,'-,0.25 unit decrease,'-,VAT1L,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,16:77842866
rs4794202-<b>?</b>,8 x 10-8,,0.08,'-,0.19 unit decrease,'-,SP6,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,17:47853173
rs117964204-<b>?</b>,1 x 10-9,,0.04,'-,0.28 unit decrease,'-,CACNA1G,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,17:50614721
rs72832584-<b>?</b>,1 x 10-11,,0.05,'-,0.3 unit decrease,'-,BCAS3,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,17:61215075
rs7245858-<b>?</b>,2 x 10-6,,0.04,'-,0.28 unit decrease,'-,PPIAP59,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,19:50927340
rs34972666-<b>?</b>,3 x 10-8,,0.11,'-,0.23 unit decrease,'-,TGM6,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,20:2404326
rs75617873-<b>?</b>,5 x 10-7,,0.03,'-,0.17 unit decrease,'-,PARVB,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,22:44130225
rs17172199-<b>?</b>,1 x 10-6,,0.08,'-,0.28 unit decrease,'-,HECW1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:43337677
rs2421847-<b>?</b>,9 x 10-7,,0.04,'-,0.26 unit decrease,'-,PRRC2C,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,1:171588461
rs12091371-<b>?</b>,7 x 10-8,,0.07,'-,0.17 unit decrease,'-,FMN2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,1:240441752
rs6738962-<b>?</b>,1 x 10-8,,0.04,'-,0.18 unit decrease,'-,CTNNA2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,2:80054047
rs78022502-<b>?</b>,2 x 10-6,,0.06,'-,0.23 unit decrease,'-,LIMS2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,2:127638592
rs538867-<b>?</b>,1 x 10-7,,0.03,'-,0.26 unit decrease,'-,MOBP,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,3:39471787
rs78647349-<b>?</b>,5 x 10-7,,0.04,'-,0.3 unit decrease,'-,STK32B,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,4:5235426
rs340635-<b>?</b>,2 x 10-7,,0.03,'-,0.23 unit decrease,'-,AFF1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,4:87010252
rs4700060-<b>?</b>,1 x 10-8,,0.1,'-,0.21 unit decrease,'-,ANKRD55,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:56214829
rs112724034-<b>?</b>,9 x 10-13,,0.03,'-,0.31 unit decrease,'-,PGAM5P1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:109885325
rs77636885-<b>?</b>,2 x 10-6,,0.03,'-,0.3 unit decrease,'-,CAMK4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:111383489
rs116348108-<b>?</b>,9 x 10-7,,0.04,'-,0.28 unit decrease,'-,DMXL1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:119099432
rs143954261-<b>?</b>,8 x 10-7,,0.04,'-,0.29 unit decrease,'-,MEGF10,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:127393758
rs146579248-<b>?</b>,4 x 10-7,,0.04,'-,0.21 unit decrease,'-,LINC01184,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:128046610
rs148763909-<b>?</b>,1 x 10-8,,0.03,'-,0.15 unit decrease,'-,SAP30L,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:154457546
rs117780815-<b>?</b>,6 x 10-7,,0.03,'-,0.31 unit decrease,'-,NKAIN2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,6:124005082
rs11154851-<b>?</b>,1 x 10-8,,0.04,'-,0.25 unit decrease,'-,PDE7B,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,6:136046867
rs75253868-<b>?</b>,2 x 10-6,,0.03,'-,0.26 unit decrease,'-,PLEKHG1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,6:150781694
rs58370486-<b>?</b>,6 x 10-11,,0.03,'-,0.36 unit decrease,'-,BZW2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:16668236
rs1861525-<b>?</b>,2 x 10-7,,0.03,'-,0.25 unit decrease,'-,CYCS,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:25121983
rs2392492-<b>?</b>,1 x 10-6,,0.04,'-,0.32 unit decrease,'-,ELMO1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:37325592
rs11770757-<b>?</b>,5 x 10-7,,0.04,'-,0.16 unit decrease,'-,EXOC4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:134063193
rs73660619-<b>?</b>,8 x 10-7,,0.06,'-,0.26 unit decrease,'-,CSMD1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,8:3230651
rs7009219-<b>?</b>,5 x 10-7,,0.06,'-,0.16 unit decrease,'-,ST18,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,8:52301705
rs4836694-<b>?</b>,7 x 10-7,,0.11,'-,0.21 unit decrease,'-,NCS1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,9:130177513
rs118048115-<b>?</b>,6 x 10-7,,0.04,'-,0.34 unit decrease,'-,PLPP4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,10:120519964
rs6670211-<b>C</b>,2 x 10-6,,0.5347,1.1276096,'-,'-,PTPRU,Tourette syndrome,Tourette syndrome,GCST007277,1:29250272
rs13407215-<b>T</b>,2 x 10-7,,0.017,2.2106795,'-,'-,'-,Tourette syndrome,Tourette syndrome,GCST007277,2:160688380
rs17137210-<b>C</b>,5 x 10-6,,0.0117,1.747699,'-,'-,TENM4,Tourette syndrome,Tourette syndrome,GCST007277,11:78822066
rs1619561-<b>C</b>,2 x 10-6,,0.7659,1.1511943,'-,'-,PITPNM2,Tourette syndrome,Tourette syndrome,GCST007277,12:123135721
rs4886520-<b>C</b>,7 x 10-6,,0.5532,1.1175066,'-,'-,"INSYN1, CD276",Tourette syndrome,Tourette syndrome,GCST007277,15:73724281
rs66904072-<b>G</b>,7 x 10-6,,0.0363,1.3617901,'-,'-,EFL1,Tourette syndrome,Tourette syndrome,GCST007277,15:82133524
rs12459560-<b>T</b>,9 x 10-7,,0.1535,1.1823453,'-,'-,"ZNF577, FPR3",Tourette syndrome,Tourette syndrome,GCST007277,19:51815127
rs7868992-<b>G</b>,3 x 10-8,,0.28,1.29,'-,[NR],COL27A1,Tourette syndrome,Tourette syndrome,GCST001635,9:114228791
rs6539267-<b>T</b>,6 x 10-6,,0.69,1.27,'-,[NR],POLR3B,Tourette syndrome,Tourette syndrome,GCST001635,12:106391776
rs621942-<b>A</b>,9 x 10-6,,0.24,1.22,'-,[NR],"RNU6-560P, PICALM",Tourette syndrome,Tourette syndrome,GCST001635,11:86072696
rs9393366-<b>A</b>,8 x 10-6,,0.28,1.27,'-,[NR],RNU6-1060P,Tourette syndrome,Tourette syndrome,GCST001635,6:23077083
rs5951698-<b>G</b>,6 x 10-6,,0.0032,5.65,'-,[NR],PHEX,Tourette syndrome,Tourette syndrome,GCST001635,X:22116540
rs10990268-<b>C</b>,5 x 10-6,,0.12,1.29,'-,[NR],LINC00587,Tourette syndrome,Tourette syndrome,GCST001635,9:102740216
rs769111-<b>T</b>,6 x 10-6,,0.62,1.23,'-,[NR],FZD9,Tourette syndrome,Tourette syndrome,GCST001635,7:12020180
rs9834970-<b>C</b>,4 x 10-14,,0.491,1.1213151,'-,[NR],"LINC02033, HSPD1P6",Bipolar I disorder,bipolar I disorder,GCST008115,3:36814539
rs111444407-<b>T</b>,3 x 10-9,,0.147,1.13032,'-,'-,NCAN,Bipolar I disorder,bipolar I disorder,GCST008115,19:19247398
rs10950456-<b>A</b>,6 x 10-9,,0.572,1.0945,'-,'-,MAD1L1,Bipolar I disorder,bipolar I disorder,GCST008115,7:1940114
chr5_7587236_D-<b>?</b>,7 x 10-9,,0.178,1.123444,'-,[NR],'-,Bipolar I disorder,bipolar I disorder,GCST008115,Mapping not available
rs10744560-<b>T</b>,8 x 10-9,,0.336,1.09483,'-,'-,"CACNA1C, CACNA1C-IT3",Bipolar I disorder,bipolar I disorder,GCST008115,12:2277933
rs35958438-<b>G</b>,1 x 10-8,,0.776,1.1116052,'-,[NR],LINC02694,Bipolar I disorder,bipolar I disorder,GCST008115,15:38681592
rs10994318-<b>C</b>,2 x 10-8,,0.0574,1.19339,'-,'-,ANK3,Bipolar I disorder,bipolar I disorder,GCST008115,10:60366098
rs57957974-<b>A</b>,2 x 10-8,,0.351,1.09582,'-,'-,PARP10,Bipolar I disorder,bipolar I disorder,GCST008115,8:144002361
rs2305929-<b>G</b>,2 x 10-8,,0.176,1.1169441,'-,[NR],"BABAM2, MRPL33",Bipolar I disorder,bipolar I disorder,GCST008115,2:27891044
rs489337-<b>G</b>,2 x 10-8,,0.765,1.1068313,'-,[NR],PACS1,Bipolar I disorder,bipolar I disorder,GCST008115,11:66087090
rs12226877-<b>A</b>,3 x 10-8,,0.293,1.10429,'-,'-,"FADS1, FADS2",Bipolar I disorder,bipolar I disorder,GCST008115,11:61824435
rs112968809-<b>A</b>,3 x 10-8,,0.229,1.10362,'-,'-,"CDAN1, TTBK2",Bipolar I disorder,bipolar I disorder,GCST008115,15:42738205
rs71395455-<b>A</b>,4 x 10-8,,0.684,1.09461,'-,'-,ZSCAN2,Bipolar I disorder,bipolar I disorder,GCST008115,15:84610573
rs2240917-<b>T</b>,5 x 10-8,,0.613,1.08872,'-,'-,ITIH4,Bipolar I disorder,bipolar I disorder,GCST008115,3:52817121
rs1850-<b>C</b>,6 x 10-8,,0.347,1.0911194,'-,[NR],KCNG1,Bipolar I disorder,bipolar I disorder,GCST008115,20:51003734
rs9295358-<b>A</b>,7 x 10-8,,0.719,1.09527,'-,'-,RPS6KA2,Bipolar I disorder,bipolar I disorder,GCST008115,6:166646138
rs4794820-<b>G</b>,1 x 10-7,,0.55,1.0867556,'-,[NR],LRRC3C,Bipolar I disorder,bipolar I disorder,GCST008115,17:39933091
rs6848834-<b>T</b>,1 x 10-7,,0.328,1.08839,'-,'-,IL21,Bipolar I disorder,bipolar I disorder,GCST008115,4:122588558
rs10147900-<b>T</b>,2 x 10-7,,0.138,1.16137,'-,'-,"LINC02280, TMEM179",Bipolar I disorder,bipolar I disorder,GCST008115,14:104625694
rs57681866-<b>G</b>,2 x 10-7,,0.9384,1.1913697,'-,[NR],ACTG1P22,Bipolar I disorder,bipolar I disorder,GCST008115,2:57748579
rs10092482-<b>T</b>,2 x 10-7,,0.178,1.1055,'-,'-,RRS1-AS1,Bipolar I disorder,bipolar I disorder,GCST008115,8:66342488
rs2052387-<b>A</b>,2 x 10-7,,0.357,1.08546,'-,'-,"RPSAP12, LINC02384",Bipolar I disorder,bipolar I disorder,GCST008115,12:68483007
rs10058613-<b>C</b>,2 x 10-7,,0.316,1.0936253,'-,[NR],KDM3B,Bipolar I disorder,bipolar I disorder,GCST008115,5:138358306
rs11972012-<b>G</b>,2 x 10-7,,0.75,1.1122727,'-,[NR],"MYO1G, PURB",Bipolar I disorder,bipolar I disorder,GCST008115,7:44946070
rs13231398-<b>G</b>,2 x 10-7,,0.889,1.1363249,'-,[NR],'-,Bipolar I disorder,bipolar I disorder,GCST008115,7:110557355
rs960145-<b>A</b>,2 x 10-7,,0.47,1.08166,'-,'-,RPS6KA2,Bipolar I disorder,bipolar I disorder,GCST008115,6:166583503
rs181957530-<b>C</b>,3 x 10-7,,0.016,1.3703886,'-,[NR],FSTL5,Bipolar I disorder,bipolar I disorder,GCST008115,4:161420812
rs6090435-<b>G</b>,3 x 10-7,,0.497,1.0910003,'-,[NR],"EEF1A2, PPDPF",Bipolar I disorder,bipolar I disorder,GCST008115,20:63501358
rs17395886-<b>C</b>,3 x 10-7,,0.836,1.1139331,'-,[NR],FSTL5,Bipolar I disorder,bipolar I disorder,GCST008115,4:161358233
rs6065777-<b>T</b>,3 x 10-7,,0.697,1.08904,'-,'-,STK4,Bipolar I disorder,bipolar I disorder,GCST008115,20:45041000
rs2388334-<b>G</b>,3 x 10-7,,0.481,1.0800419,'-,[NR],"EIF4EBP2P3, HLA-DRB5",Bipolar I disorder,bipolar I disorder,GCST008115,6:98143746
rs73222936-<b>A</b>,3 x 10-7,,0.0441,1.25986,'-,'-,"MESTP3, LINC02364",Bipolar I disorder,bipolar I disorder,GCST008115,4:28921093
chr2_181742430_D-<b>?</b>,3 x 10-7,,0.055,1.1793983,'-,[NR],'-,Bipolar I disorder,bipolar I disorder,GCST008115,Mapping not available
rs12754946-<b>T</b>,3 x 10-7,,0.575,1.0835,'-,'-,AK5,Bipolar I disorder,bipolar I disorder,GCST008115,1:77524238
rs138321-<b>A</b>,3 x 10-7,,0.502,1.08091,'-,'-,SLC25A17,Bipolar I disorder,bipolar I disorder,GCST008115,22:40813300
rs73496688-<b>A</b>,4 x 10-7,,0.144,1.11483,'-,'-,TENM4,Bipolar I disorder,bipolar I disorder,GCST008115,11:79445704
rs60960031-<b>G</b>,4 x 10-7,,0.592,1.0815605,'-,[NR],NUTF2P8,Bipolar I disorder,bipolar I disorder,GCST008115,2:21307787
rs4301023-<b>T</b>,4 x 10-7,,0.474,1.0795,'-,'-,'-,Bipolar I disorder,bipolar I disorder,GCST008115,Mapping not available
rs35755081-<b>A</b>,4 x 10-7,,0.481,1.08643,'-,'-,"RNU4-74P, TMEM178B",Bipolar I disorder,bipolar I disorder,GCST008115,7:141068359
rs56158970-<b>G</b>,4 x 10-7,,0.014,1.3937476,'-,[NR],LINC01392,Bipolar I disorder,bipolar I disorder,GCST008115,7:115282097
rs546671-<b>A</b>,4 x 10-7,,0.447,1.07929,'-,'-,LINC01748,Bipolar I disorder,bipolar I disorder,GCST008115,1:60628168
rs1331621-<b>T</b>,4 x 10-7,,0.351,1.08318,'-,'-,BRINP1,Bipolar I disorder,bipolar I disorder,GCST008115,9:119412084
rs78014668-<b>C</b>,5 x 10-7,,0.0818,1.15189,'-,'-,MAPK8IP1,Bipolar I disorder,bipolar I disorder,GCST008115,11:45892443
rs78381888-<b>A</b>,5 x 10-7,,0.815,1.12165,'-,'-,"ANKRD23, CNNM3",Bipolar I disorder,bipolar I disorder,GCST008115,2:96835038
rs8047469-<b>G</b>,5 x 10-7,,0.878,1.1792731,'-,[NR],PRSS36,Bipolar I disorder,bipolar I disorder,GCST008115,16:31140200
rs10745843-<b>A</b>,5 x 10-7,,0.621,1.08091,'-,'-,ANKS1B,Bipolar I disorder,bipolar I disorder,GCST008115,12:99102252
rs11647445-<b>G</b>,5 x 10-7,,0.346,1.0834001,'-,[NR],GRIN2A,Bipolar I disorder,bipolar I disorder,GCST008115,16:9833109
rs7314975-<b>A</b>,5 x 10-7,,0.427,1.08101,'-,'-,"DHH, RHEBL1",Bipolar I disorder,bipolar I disorder,GCST008115,12:49083734
rs3026433-<b>G</b>,6 x 10-7,,0.225,1.0986717,'-,[NR],ATP2A2,Bipolar I disorder,bipolar I disorder,GCST008115,12:110281387
rs55648125-<b>G</b>,6 x 10-7,,0.105,1.1280571,'-,[NR],"RPS17P5, TFAP2B",Bipolar I disorder,bipolar I disorder,GCST008115,6:50849005
rs1948223-<b>C</b>,6 x 10-7,,0.339,1.0842576,'-,[NR],LINC01378,Bipolar I disorder,bipolar I disorder,GCST008115,4:117624232
rs7613933-<b>G</b>,7 x 10-7,,0.507,1.0792842,'-,[NR],WDR49,Bipolar I disorder,bipolar I disorder,GCST008115,3:167586401
rs6079463-<b>G</b>,8 x 10-7,,0.195,1.0970205,'-,[NR],MACROD2,Bipolar I disorder,bipolar I disorder,GCST008115,20:14495111
rs998817-<b>T</b>,8 x 10-7,,0.507,1.07735,'-,'-,LINC01378,Bipolar I disorder,bipolar I disorder,GCST008115,4:117548415
rs115858175-<b>G</b>,8 x 10-7,,0.165,1.1046184,'-,[NR],LINC01221,Bipolar I disorder,bipolar I disorder,GCST008115,1:199032122
rs111998037-<b>C</b>,8 x 10-7,,0.248,1.0910003,'-,[NR],"ANKHD1-EIF4EBP3, ANKHD1",Bipolar I disorder,bipolar I disorder,GCST008115,5:140418422
rs9521159-<b>G</b>,8 x 10-7,,0.604,1.0793891,'-,[NR],MYO16,Bipolar I disorder,bipolar I disorder,GCST008115,13:109076822
rs11917269-<b>G</b>,9 x 10-7,,0.738,1.0916554,'-,[NR],CACNA2D2,Bipolar I disorder,bipolar I disorder,GCST008115,3:50443604
rs7858026-<b>T</b>,1 x 10-6,,0.476,1.0790745,'-,[NR],ASTN2,Bipolar I disorder,bipolar I disorder,GCST008115,9:117186184
rs143685090-<b>C</b>,1 x 10-6,,0.009,1.56816,'-,[NR],RPSAP74,Bipolar I disorder,bipolar I disorder,GCST008115,8:89152810
rs9371601-<b>T</b>,1 x 10-6,,0.349,1.07983,'-,'-,SYNE1,Bipolar I disorder,bipolar I disorder,GCST008115,6:152469438
rs297941-<b>?</b>,5 x 10-7,,NR,1.23,'-,NR,LINC02395,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST001636,12:49925303
rs9499708-<b>?</b>,3 x 10-6,,NR,1.2,'-,NR,R3HDM2P2,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST001636,6:103997492
rs9652236-<b>?</b>,5 x 10-6,,NR,1.4,'-,NR,'-,Obsessive-compulsive disorder,obsessive-compulsive disorder,GCST001636,13:72114636
rs115539978-<b>T</b>,3 x 10-8,(African),NR,1.33,'-,[1.20-1.47],MIR5007,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,13:55185074
rs142174523-<b>G</b>,4 x 10-8,"(African, male)",NR,1.3157895,'-,[1.19-1.45],"LINC02571, HLA-B",Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,6:31326513
rs148757321-<b>CTGTG</b>,4 x 10-8,"(EA, male)",NR,1.18,'-,[1.11-1.26],KAZN,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,1:15109728
rs34517852-<b>A</b>,3 x 10-9,(EA),NR,1.12,'-,[1.08-1.16],"TMEM242-DT, ZDHHC14",Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,6:157368301
rs518152-<b>G</b>,3 x 10-7,"(EA, male)",NR,1.1627907,'-,NR,KAZN,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,1:15107763
rs571848662-<b>TATAC</b>,3 x 10-6,(EA),NR,1.0869565,'-,NR,ZNF813,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,19:53485588
rs9364611-<b>C</b>,4 x 10-8,(EA),NR,1.1363636,'-,[1.09-1.18],PRKN,Post-traumatic stress disorder,post-traumatic stress disorder,GCST009315,6:161742474
rs41310573-<b>?</b>,4 x 10-20,,NR,'-,'-,'-,OR2T12,Major depressive disorder,unipolar depression,GCST005547,1:248295464
rs201935337-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,TMEM150B,Major depressive disorder,unipolar depression,GCST005547,19:55320451
rs140395831-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,"ARHGAP8, PRR5-ARHGAP8",Major depressive disorder,unipolar depression,GCST005547,22:44859739
rs56293203-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,MUC5B,Major depressive disorder,unipolar depression,GCST005547,11:1226857
rs78562453-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,MAB21L4,Major depressive disorder,unipolar depression,GCST005547,2:240891738
rs115054458-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,TRIO,Major depressive disorder,unipolar depression,GCST005547,5:14488019
rs143696449-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,ANO8,Major depressive disorder,unipolar depression,GCST005547,19:17324842
rs748441912-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,KRBA1,Major depressive disorder,unipolar depression,GCST005547,7:149733387
rs62001028-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,BCAR3,Major depressive disorder,unipolar depression,GCST005547,1:93589086
rs150952348-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,UNC13D,Major depressive disorder,unipolar depression,GCST005547,17:75828078
rs782472239-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,ORAI1,Major depressive disorder,unipolar depression,GCST005547,12:121641369
rs112610420-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,ADGRE2,Major depressive disorder,unipolar depression,GCST005547,19:14765351
rs142029931-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,CNTNAP1,Major depressive disorder,unipolar depression,GCST005547,17:42691962
rs201483250-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,LILRA1,Major depressive disorder,unipolar depression,GCST005547,19:54595276
rs200897153-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,FASN,Major depressive disorder,unipolar depression,GCST005547,17:82082645
rs3744550-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,MYH13,Major depressive disorder,unipolar depression,GCST005547,17:10303278
rs115668237-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,SLC2A8,Major depressive disorder,unipolar depression,GCST005547,9:127405508
SLC22A8-<b>?</b>,2 x 10-6,(bupropion + escitalopram),NR,'-,'-,'-,'-,Response to antidepressants in depression,"unipolar depression, response to antidepressant",GCST006817,Mapping not available
rs10769025-<b>?</b>,1 x 10-7,(escitalopram + placebo),NR,'-,'-,'-,ALX4,Response to antidepressants in depression,"unipolar depression, response to antidepressant",GCST006817,11:44267885
LYPD6B-<b>?</b>,5 x 10-6,(escitalopram + placebo),NR,'-,'-,'-,'-,Response to antidepressants in depression,"unipolar depression, response to antidepressant",GCST006817,Mapping not available
downstreamRASGEF1B-<b>?</b>,2 x 10-6,(venlafaxine + mirtazapine),NR,'-,'-,'-,'-,Response to antidepressants in depression,"unipolar depression, response to antidepressant",GCST006817,Mapping not available
PPP5C-<b>?</b>,5 x 10-6,(venlafaxine + mirtazapine),NR,'-,'-,'-,'-,Response to antidepressants in depression,"unipolar depression, response to antidepressant",GCST006817,Mapping not available
rs950893-<b>G</b>,2 x 10-6,,0.28,'-,4.76 z score decrease,'-,"SLC25A37, RNU4-71P",Major depressive disorder,unipolar depression,GCST005691,8:23592997
rs12415800-<b>A</b>,5 x 10-7,,0.46,'-,5.02 z score increase,'-,"RNU6-523P, RPL12P8",Major depressive disorder,unipolar depression,GCST005691,10:67864422
rs35936514-<b>T</b>,2 x 10-6,,0.26,'-,4.78 z score decrease,'-,LHPP,Major depressive disorder,unipolar depression,GCST005691,10:124556401
rs7526682-<b>G</b>,3 x 10-8,,0.13,'-,5.54 z score increase,'-,LPGAT1,Major depressive disorder (unexposed to adversity),unipolar depression,GCST005689,1:211800608
rs11577545-<b>T</b>,3 x 10-8,,0.21,'-,5.54 z score increase,'-,"ITPKB, STUM",Major depressive disorder (unexposed to adversity),unipolar depression,GCST005689,1:226611382
rs950893-<b>G</b>,7 x 10-9,,0.28,'-,5.79 z score decrease,'-,"SLC25A37, RNU4-71P",Major depressive disorder (unexposed to adversity),unipolar depression,GCST005689,8:23592997
rs12415800-<b>A</b>,3 x 10-6,,0.46,'-,4.66 z score increase,'-,"RNU6-523P, RPL12P8",Major depressive disorder (unexposed to adversity),unipolar depression,GCST005689,10:67864422
rs10510908-<b>A</b>,2 x 10-6,,NR,'-,0.23672 unit increase,NR,"C3orf49, SNTN",Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,3:63777318
rs7934698-<b>A</b>,2 x 10-6,,NR,'-,0.2774 unit increase,NR,B3GAT1-DT,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,11:134542845
rs7606549-<b>A</b>,2 x 10-6,,NR,'-,0.17774 unit decrease,NR,DPP10,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,2:114732621
rs6851779-<b>A</b>,3 x 10-6,,NR,'-,0.31734 unit decrease,NR,RNU6-931P,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,4:45485662
rs319858-<b>G</b>,4 x 10-6,,NR,'-,0.17288 unit decrease,NR,DPP10,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,2:114773264
rs13098181-<b>A</b>,7 x 10-6,,NR,'-,0.22507 unit increase,NR,"SNTN, C3orf49",Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,3:63763729
rs12108177-<b>G</b>,8 x 10-6,,NR,'-,0.21682 unit increase,NR,SNTN,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,3:63688119
rs6063840-<b>G</b>,8 x 10-6,,NR,'-,0.17969 unit decrease,NR,LINC01524,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,20:52592410
rs4765723-<b>C</b>,8 x 10-6,,NR,'-,0.19597 unit increase,NR,TSPAN9,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,12:3243377
rs6068235-<b>A</b>,8 x 10-6,,NR,'-,0.18046 unit decrease,NR,LINC01524,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008506,20:52550630
rs2221540-<b>G</b>,4 x 10-7,,NR,'-,0.6395 unit increase,NR,OPCML,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008507,11:132846474
rs4783107-<b>T</b>,2 x 10-6,,NR,'-,0.4538 unit increase,NR,"ZDHHC7, LINC02176",Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008507,16:84962841
rs4575282-<b>C</b>,3 x 10-6,,NR,'-,0.5776 unit increase,NR,OPCML,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008507,11:132849751
rs246565-<b>A</b>,3 x 10-6,,NR,'-,4.684 z score decrease,NR,"LINC02056, ZNF366",Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,5:72513420
rs319924-<b>A</b>,5 x 10-7,,NR,'-,5.024 z score increase,NR,"PHF3, EYS",Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,6:63777354
rs10485358-<b>A</b>,5 x 10-6,,NR,'-,4.546 z score decrease,NR,PHF3,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,6:63676159
rs10987199-<b>A</b>,9 x 10-6,,NR,'-,4.442 z score decrease,NR,'-,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,9:126206708
rs2265265-<b>A</b>,4 x 10-6,,NR,'-,4.604 z score increase,NR,"ARHGAP21, KIAA1217",Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,10:24565947
rs3762096-<b>A</b>,6 x 10-6,,NR,'-,4.521 z score decrease,NR,TLL2,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,10:96376493
rs2221540-<b>A</b>,7 x 10-6,,NR,'-,4.492 z score decrease,NR,OPCML,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,11:132846474
rs10778077-<b>A</b>,6 x 10-6,,NR,'-,4.54 z score increase,NR,ANO4,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,12:100800210
rs7199110-<b>A</b>,5 x 10-6,,NR,'-,4.553 z score decrease,NR,WWOX,Stress sensitivity (neuroticism score x major depressive disorder status interaction),"unipolar depression, neuroticism measurement",GCST008508,16:78756868
undefined,3 x 10-6,,'-,1.306,'-,[NR],'-,Depression,unipolar depression,GCST009978,Mapping not available
rs78355601-<b>?</b>,1 x 10-8,,NR,'-,0.237 unit decrease,[0.16-0.31],SCIRT,Vascular endothelial growth factor levels in major depressive disorder,"unipolar depression, vascular endothelial growth factor measurement",GCST010036,6:43957026
rs17156280-<b>C</b>,2 x 10-7,,0.142,'-,'-,'-,CACNA2D1,Major depressive disorder (stressful life events interaction),"unipolar depression, self rated health, stressful life event measurement",GCST003319,7:82414674
rs6055685-<b>A</b>,8 x 10-7,,0.18,'-,3.568 Suicidal ideation score increase,'-,PLCB1,Suicide ideation score in major depressive disorder,"suicide ideation measurement, unipolar depression",GCST002974,20:8233139
rs2419374-<b>A</b>,1 x 10-6,,0.19,'-,3.456 Suicidal ideation score increase,'-,BRINP3,Suicide ideation score in major depressive disorder,"suicide ideation measurement, unipolar depression",GCST002974,1:190088550
rs13358904-<b>G</b>,5 x 10-6,,0.21,'-,3.049 Suicidal ideation score increase,'-,EPB41L4A,Suicide ideation score in major depressive disorder,"suicide ideation measurement, unipolar depression",GCST002974,5:112267016
rs4308128-<b>A</b>,4 x 10-6,,0.43,1.795,'-,[1.401-2.300],DPP10,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST002972,2:115733670
rs17662598-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,"LINC01526, LINC02542",Cognitive function in depression,"unipolar depression, cognitive function measurement",GCST011069,6:81842817
rs79966641-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,DMXL1,Cognitive impairment in depression,"unipolar depression, Cognitive impairment",GCST011068,5:119241160
rs73240021-<b>?</b>,1 x 10-6,,'-,'-,'-,'-,GRXCR1,Cognitive decline in depression,"unipolar depression, cognitive decline measurement",GCST011067,4:42920686
rs2017305-<b>A</b>,9 x 10-6,,0.92,'-,0.22 unit decrease,[NR],"DDX21, DDX50",Depression (quantitative trait),unipolar depression,GCST000779,10:68952306
rs12912233-<b>T</b>,6 x 10-7,,0.46,'-,0.15 unit increase,[NR],RORA,Depression (quantitative trait),unipolar depression,GCST000779,15:60974897
rs1927745-<b>A</b>,5 x 10-6,,0.24,'-,0.16 unit decrease,[NR],"FAM155A, KLF12",Depression (quantitative trait),unipolar depression,GCST000779,13:107127968
rs349475-<b>T</b>,2 x 10-6,,0.29,'-,0.18 unit increase,[NR],CDH18,Depression (quantitative trait),unipolar depression,GCST000779,5:19440059
rs8070473-<b>T</b>,2 x 10-6,,0.32,'-,0.16 unit decrease,[NR],SLFN12L,Depression (quantitative trait),unipolar depression,GCST000779,17:35516493
rs11009175-<b>A</b>,5 x 10-6,,0.17,'-,0.16 unit increase,[NR],ITGB1-DT,Depression (quantitative trait),unipolar depression,GCST000779,10:33005847
rs1449984-<b>A</b>,7 x 10-6,,0.72,'-,0.15 unit decrease,[NR],'-,Depression (quantitative trait),unipolar depression,GCST000779,2:23191780
rs12420464-<b>T</b>,3 x 10-6,,0.04,'-,0.38 unit decrease,[NR],EIF3F,Depression (quantitative trait),unipolar depression,GCST000779,11:7993230
rs10514585-<b>A</b>,5 x 10-6,,0.31,'-,0.15 unit increase,[NR],CDH13,Depression (quantitative trait),unipolar depression,GCST000779,16:83250733
rs17864092-<b>T</b>,6 x 10-6,,0.9,'-,0.17 unit decrease,[NR],GRM8,Depression (quantitative trait),unipolar depression,GCST000779,7:126999550
rs10744304-<b>A</b>,9 x 10-6,,0.63,'-,0.15 unit decrease,[NR],LINC02375,Depression (quantitative trait),unipolar depression,GCST000779,12:127329196
rs1133152-<b>A</b>,1 x 10-7,,0.132,1.0460252,'-,[NR],TMEM161B,Major depressive disorder,unipolar depression,GCST005907,5:88189247
rs6065333-<b>C</b>,9 x 10-8,,0.15,1.0438414,'-,[NR],"ZHX3, ADI1P1",Major depressive disorder,unipolar depression,GCST005907,20:41329322
rs9623320-<b>A</b>,4 x 10-8,,0.304,1.0362694,'-,[NR],"ACTBP15, MIR1281",Major depressive disorder,unipolar depression,GCST005907,22:41082478
rs1867368-<b>C</b>,5 x 10-8,,0.317,1.0330578,'-,[NR],"ZNF646P1, RN7SL618P",Major depressive disorder,unipolar depression,GCST005907,13:53329376
rs1210358-<b>A</b>,9 x 10-8,,0.615,1.0319917,'-,[NR],RSRC1,Major depressive disorder,unipolar depression,GCST005907,3:158310697
rs1413573-<b>A</b>,2 x 10-8,,0.492,1.0319917,'-,[NR],PCDH9,Major depressive disorder,unipolar depression,GCST005907,13:66377697
rs4339373-<b>T</b>,2 x 10-7,,0.51,1.03,'-,[NR],'-,Major depressive disorder,unipolar depression,GCST005907,5:165056066
rs2717046-<b>T</b>,1 x 10-8,,0.367,1.034,'-,[NR],"ACTG1P22, VRK2",Major depressive disorder,unipolar depression,GCST005907,2:57814801
rs6687024-<b>T</b>,4 x 10-8,,0.623,1.034,'-,[NR],RPL31P12,Major depressive disorder,unipolar depression,GCST005907,1:72359177
rs1457257-<b>G</b>,1 x 10-8,,0.366,1.035,'-,[NR],'-,Major depressive disorder,unipolar depression,GCST005907,15:37455148
rs3785234-<b>T</b>,2 x 10-8,,0.624,1.035,'-,[NR],RBFOX1,Major depressive disorder,unipolar depression,GCST005907,16:7617390
rs4289855-<b>T</b>,2 x 10-7,,0.228,1.036,'-,[NR],CHD7,Major depressive disorder,unipolar depression,GCST005907,8:60799811
rs2956278-<b>G</b>,2 x 10-7,,0.234,1.037,'-,[NR],'-,Major depressive disorder,unipolar depression,GCST005907,12:84304455
rs6978272-<b>?</b>,7 x 10-6,,NR,3.448276,'-,[2-5.88],EXOC4,Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST006267,7:133403285
rs7954376-<b>?</b>,4 x 10-6,,NR,3.448276,'-,[2.04-5.88],GRIN2B,Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST006267,12:13481181
rs4810894-<b>?</b>,3 x 10-6,,NR,2.7,'-,[1.78-4.10],"ARFGEF2, PREX1",Response to selective serotonin reuptake inhibitors in depression,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST006267,20:48916462
rs77554113-<b>?</b>,1 x 10-6,,NR,4.81,'-,[2.54-9.13],TSHZ3,Remission after SSRI treatment in major depression,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST006266,19:31140034
rs1518395-<b>G</b>,4 x 10-12,,0.61298,'-,0.032 unit increase,[0.02-0.044],VRK2,Major depressive disorder,unipolar depression,GCST006041,2:57980939
rs2179744-<b>G</b>,6 x 10-11,,0.718312,'-,0.0354 unit decrease,[0.022-0.049],"L3MBTL2-AS1, L3MBTL2",Major depressive disorder,unipolar depression,GCST006041,22:41225710
rs11209948-<b>T</b>,8 x 10-11,,0.638888,'-,0.0357 unit increase,[0.024-0.047],RPL31P12,Major depressive disorder,unipolar depression,GCST006041,1:72346221
rs454214-<b>T</b>,1 x 10-9,,0.568054,'-,0.0337 unit decrease,[0.022-0.045],MEF2C-AS2,Major depressive disorder,unipolar depression,GCST006041,5:88707586
rs301806-<b>T</b>,2 x 10-9,,0.551911,'-,0.0271 unit decrease,[0.015-0.039],RERE,Major depressive disorder,unipolar depression,GCST006041,1:8422018
rs1475120-<b>G</b>,4 x 10-9,,0.452458,'-,0.0292 unit decrease,[0.017-0.041],LIN28B,Major depressive disorder,unipolar depression,GCST006041,6:104942078
rs10786831-<b>G</b>,8 x 10-9,,0.600689,'-,0.0297 unit decrease,[0.018-0.041],SORCS3,Major depressive disorder,unipolar depression,GCST006041,10:104854813
rs12552-<b>G</b>,8 x 10-9,,0.554993,'-,0.0433 unit decrease,[0.032-0.055],OLFM4,Major depressive disorder,unipolar depression,GCST006041,13:53051646
rs6476606-<b>G</b>,1 x 10-8,,0.637191,'-,0.0277 unit decrease,[0.016-0.039],PAX5,Major depressive disorder,unipolar depression,GCST006041,9:37005564
rs8025231-<b>C</b>,1 x 10-8,,0.427531,'-,0.0355 unit increase,[0.024-0.047],'-,Major depressive disorder,unipolar depression,GCST006041,15:37356201
rs12065553-<b>G</b>,1 x 10-8,,0.279676,'-,0.0309 unit increase,[0.017-0.045],HMGB1P18,Major depressive disorder,unipolar depression,GCST006041,1:80327433
rs1656369-<b>T</b>,1 x 10-8,,0.670312,'-,0.0346 unit increase,[0.023-0.046],"MLF1, RSRC1",Major depressive disorder,unipolar depression,GCST006041,3:158562296
rs4543289-<b>T</b>,1 x 10-8,,0.480069,'-,0.0322 unit decrease,[0.02-0.044],'-,Major depressive disorder,unipolar depression,GCST006041,5:165057942
rs2125716-<b>G</b>,3 x 10-8,,0.765477,'-,0.0345 unit decrease,[0.021-0.048],'-,Major depressive disorder,unipolar depression,GCST006041,12:84547650
rs2422321-<b>G</b>,3 x 10-8,,0.441006,'-,0.0308 unit increase,[0.019-0.043],LINC02797,Major depressive disorder,unipolar depression,GCST006041,1:72827710
rs7044150-<b>T</b>,4 x 10-8,,0.384543,'-,0.0299 unit decrease,[0.018-0.042],CARM1P1,Major depressive disorder,unipolar depression,GCST006041,9:2982931
rs9838374-<b>T</b>,6 x 10-8,,0.182843,'-,0.0373 unit increase,[0.022-0.053],OPA1,Major depressive disorder,unipolar depression,GCST006041,3:193598916
rs17792983-<b>T</b>,6 x 10-8,,0.305209,'-,0.03 unit decrease,[0.016-0.044],SIM1,Major depressive disorder,unipolar depression,GCST006041,6:100363657
rs620339-<b>T</b>,8 x 10-8,,0.592561,'-,0.0299 unit decrease,[0.018-0.042],DCDC1,Major depressive disorder,unipolar depression,GCST006041,11:30830509
rs736840-<b>G</b>,8 x 10-8,,0.094915,'-,0.0491 unit increase,[0.03-0.069],LINC01645,Major depressive disorder,unipolar depression,GCST006041,1:177393877
rs3806843-<b>T</b>,9 x 10-8,,0.448516,'-,0.0291 unit decrease,[0.017-0.041],"PCDHA5, PCDHA6, PCDHA1, PCDHA2, PCDHA4, PCDHA3",Major depressive disorder,unipolar depression,GCST006041,5:140832953
rs9298467-<b>T</b>,2 x 10-7,,0.808561,'-,0.0383 unit decrease,[0.023-0.054],PCMTD1,Major depressive disorder,unipolar depression,GCST006041,8:51894122
rs3897746-<b>G</b>,2 x 10-7,,0.483057,'-,0.0292 unit increase,[0.017-0.041],SPPL3,Major depressive disorder,unipolar depression,GCST006041,12:120886924
rs10521261-<b>T</b>,3 x 10-7,,0.801142,'-,0.0339 unit increase,[0.018-0.05],CASC22,Major depressive disorder,unipolar depression,GCST006041,16:52266343
rs2228246-<b>G</b>,3 x 10-7,,0.162703,'-,0.042 unit increase,[0.026-0.058],PLCG1,Major depressive disorder,unipolar depression,GCST006041,20:41163423
rs1806152-<b>T</b>,4 x 10-7,,0.172277,'-,0.0415 unit increase,[0.026-0.057],PAUPAR,Major depressive disorder,unipolar depression,GCST006041,11:31829493
rs16841842-<b>C</b>,5 x 10-7,,0.783416,'-,0.0322 unit increase,[0.018-0.046],DENND1B,Major depressive disorder,unipolar depression,GCST006041,1:197642552
rs272440-<b>G</b>,6 x 10-7,,0.998687,'-,0.4807 unit decrease,[0.27-0.69],MGAT4B,Major depressive disorder,unipolar depression,GCST006041,5:179801623
rs3785236-<b>C</b>,9 x 10-7,,0.754871,'-,0.0365 unit increase,[0.023-0.05],RBFOX1,Major depressive disorder,unipolar depression,GCST006041,16:7617197
rs9540720-<b>G</b>,9 x 10-7,,0.499908,'-,0.0305 unit increase,[0.019-0.042],PCDH9,Major depressive disorder,unipolar depression,GCST006041,13:66348573
rs2524222-<b>T</b>,1 x 10-6,,0.219809,'-,0.0335 unit increase,[0.02-0.047],GNL1,Major depressive disorder,unipolar depression,GCST006041,6:30543393
rs1935881-<b>T</b>,1 x 10-6,,0.643387,'-,0.0283 unit decrease,[0.017-0.04],BRINP3,Major depressive disorder,unipolar depression,GCST006041,1:190097256
rs5754682-<b>T</b>,1 x 10-6,,0.873545,'-,0.0421 unit decrease,[0.024-0.06],LARGE1,Major depressive disorder,unipolar depression,GCST006041,22:33806297
rs10505997-<b>T</b>,2 x 10-6,,0.881516,'-,0.0448 unit increase,[0.027-0.062],ITPR2,Major depressive disorder,unipolar depression,GCST006041,12:26376309
rs699319-<b>C</b>,2 x 10-6,,0.318762,'-,0.0318 unit increase,[0.02-0.044],SF3B1,Major depressive disorder,unipolar depression,GCST006041,2:197417052
rs2163544-<b>C</b>,2 x 10-6,,0.420291,'-,0.031 unit decrease,[0.019-0.043],MIR924HG,Major depressive disorder,unipolar depression,GCST006041,18:39305111
rs12115299-<b>G</b>,2 x 10-6,,0.0693957,'-,0.0522 unit increase,[0.029-0.076],DENND1A,Major depressive disorder,unipolar depression,GCST006041,9:123923619
rs33435-<b>G</b>,2 x 10-6,,0.4133,'-,0.0271 unit decrease,[0.015-0.039],ZNF536,Major depressive disorder,unipolar depression,GCST006041,19:30452548
rs2042772-<b>T</b>,3 x 10-6,,0.254914,'-,0.0334 unit decrease,[0.02-0.047],"LY75-CD302, LY75",Major depressive disorder,unipolar depression,GCST006041,2:159805547
rs4356032-<b>C</b>,3 x 10-6,,0.374977,'-,0.0291 unit decrease,[0.017-0.041],RNU6-695P,Major depressive disorder,unipolar depression,GCST006041,1:90330554
rs4660091-<b>T</b>,3 x 10-6,,0.662341,'-,0.0285 unit decrease,[0.017-0.04],FH,Major depressive disorder,unipolar depression,GCST006041,1:241465130
rs2012485-<b>T</b>,3 x 10-6,,0.033314,'-,0.0769 unit increase,[0.046-0.108],CDCA2,Major depressive disorder,unipolar depression,GCST006041,8:25517394
rs8066520-<b>G</b>,4 x 10-6,,0.849656,'-,0.038 unit decrease,[0.022-0.054],PIPOX,Major depressive disorder,unipolar depression,GCST006041,17:29049573
rs10806805-<b>G</b>,6 x 10-6,,0.539686,'-,0.0266 unit increase,[0.015-0.038],'-,Major depressive disorder,unipolar depression,GCST006041,6:164732581
rs10457592-<b>G</b>,6 x 10-6,,0.760869,'-,0.0372 unit decrease,[0.023-0.051],MIR548AI,Major depressive disorder,unipolar depression,GCST006041,6:99104094
rs5771109-<b>T</b>,7 x 10-6,,0.599435,'-,0.0269 unit decrease,[0.015-0.039],TUBGCP6,Major depressive disorder,unipolar depression,GCST006041,22:50240142
rs10514299-<b>T</b>,1 x 10-15,,0.240584,'-,0.0449 unit increase,[0.031-0.059],TMEM161B-AS1,Major depressive disorder,unipolar depression,GCST006041,5:88367793
rs114034759-<b>A</b>,6 x 10-7,,NR,1.83,'-,[NR],MKLN1,Bipolar disorder (early onset),bipolar disorder,GCST003742,7:131128204
rs10168049-<b>G</b>,1 x 10-6,,0.465,'-,'-,'-,"CLASP1, RPS17P7",Bipolar disorder,bipolar disorder,GCST008905,2:121320830
rs1516725-<b>T</b>,1 x 10-24,,NR,'-,0.046 unit decrease,[0.038-0.054],"DGKG, ETV5",Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,3:186106215
rs3888190-<b>A</b>,1 x 10-24,,NR,'-,0.031 unit increase,[0.025-0.037],"ATP2A1, SH2B1",Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,16:28878165
rs151181-<b>T</b>,3 x 10-19,,NR,'-,0.027 unit decrease,[0.021-0.033],CLN3,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,16:28479196
rs10968576-<b>A</b>,3 x 10-15,,NR,'-,0.025 unit decrease,[0.019-0.031],LINGO2,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,9:28414341
rs1620977-<b>A</b>,9 x 10-13,,NR,'-,0.024 unit increase,[0.018-0.03],NEGR1,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,1:72263459
rs2968487-<b>T</b>,3 x 10-12,,NR,'-,0.025 unit increase,[0.017-0.033],"EEF1A1P11, UBE2WP1",Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,1:96421814
rs2127162-<b>A</b>,5 x 10-11,,NR,'-,0.023 unit decrease,[0.015-0.031],MAP2K5,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,15:67798486
rs4141973-<b>T</b>,2 x 10-9,,NR,'-,0.029 unit increase,[0.019-0.039],FTH1P5,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,6:50978808
rs1477199-<b>A</b>,6 x 10-9,,NR,'-,0.025 unit decrease,[0.017-0.033],RPGRIP1L,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,16:53678223
rs17203016-<b>A</b>,1 x 10-8,,NR,'-,0.022 unit decrease,[0.014-0.03],'-,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,2:207390794
rs6671342-<b>T</b>,2 x 10-8,,NR,'-,0.023 unit decrease,[0.015-0.031],"RN7SL831P, EEF1A1P11",Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,1:96535401
rs4729098-<b>A</b>,3 x 10-8,,NR,'-,0.037 unit decrease,[0.023-0.051],DTX2P1-UPK3BP1-PMS2P11,Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,7:77007753
rs2814944-<b>A</b>,4 x 10-8,,NR,'-,0.023 unit increase,[0.015-0.031],"IFITM3P3, ILRUN",Bipolar disorder or body mass index,"bipolar disorder, body mass index",GCST009371,6:34585020
rs17099448-<b>?</b>,3 x 10-6,(externalizing vs. non-externalizing),'-,2.1584287,'-,[NR],"TPI1P1, ST6GALNAC3",Bipolar disorder,bipolar disorder,GCST002809,1:76682734
rs17622252-<b>?</b>,4 x 10-6,(externalizing vs. non-externalizing),'-,1.658,'-,[NR],CDKAL1,Bipolar disorder,bipolar disorder,GCST002809,6:21331676
rs9359856-<b>?</b>,5 x 10-6,(early-onset vs. non-externalizing),'-,1.6417665,'-,[NR],"LYRM2, ANKRD6",Bipolar disorder,bipolar disorder,GCST002809,6:89598266
rs4761053-<b>?</b>,7 x 10-6,(early-onset vs. non-externalizing),'-,1.525,'-,[NR],"LINC00508, LINC02441",Bipolar disorder,bipolar disorder,GCST002809,12:128021656
rs16865916-<b>?</b>,6 x 10-6,,NR,3.621,'-,[2.073-6.324],"RN7SKP112, RNF144A",Manic episodes in bipolar disorder,"manic or hypomanic episode, bipolar disorder",GCST003089,2:7077341
rs3101942-<b>?</b>,7 x 10-6,,NR,1.733,'-,[1.365-2.201],"HLA-Z, HLA-DMB",Manic episodes in bipolar disorder,"manic or hypomanic episode, bipolar disorder",GCST003089,6:32902280
rs2485892-<b>?</b>,7 x 10-6,,NR,1.844,'-,[1.412-2.409],"SERTAD4-AS1, SYT14",Manic episodes in bipolar disorder,"manic or hypomanic episode, bipolar disorder",GCST003089,1:210174645
rs10513249-<b>?</b>,9 x 10-9,,NR,'-,0.18 unit increase,[NR],"ATP6V1G1, WHRN",Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,9:114541631
rs2190547-<b>?</b>,9 x 10-7,,NR,'-,0.08 unit increase,[NR],'-,Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,17:70933294
rs6993270-<b>?</b>,1 x 10-6,,NR,'-,0.12 unit increase,[NR],DEPTOR,Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,8:119929476
rs9362426-<b>?</b>,1 x 10-6,,NR,'-,0.08 unit increase,[NR],SMIM8,Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,6:87380156
rs6568686-<b>?</b>,2 x 10-6,,NR,'-,0.08 unit increase,[NR],TRAF3IP2-AS1,Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,6:111551279
rs7123770-<b>?</b>,3 x 10-6,,NR,'-,0.14 unit increase,[NR],'-,Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,11:127688543
rs1528010-<b>?</b>,9 x 10-6,,NR,'-,0.06 unit increase,[NR],BTF3P13,Depressive episodes in bipolar disorder,"depressive episode measurement, bipolar disorder",GCST003091,4:98747312
rs6568686-<b>?</b>,4 x 10-8,,NR,'-,0.11 unit increase,[NR],TRAF3IP2-AS1,Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,6:111551279
rs1359582-<b>?</b>,1 x 10-7,,NR,'-,0.09 unit increase,[NR],RNLS,Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,10:88570726
rs10513249-<b>?</b>,5 x 10-7,,NR,'-,0.18 unit increase,[NR],"ATP6V1G1, WHRN",Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,9:114541631
rs10489167-<b>?</b>,6 x 10-7,,NR,'-,0.16 unit increase,[NR],NFYC,Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,1:40710794
rs6993270-<b>?</b>,9 x 10-7,,NR,'-,0.14 unit increase,[NR],DEPTOR,Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,8:119929476
rs16840900-<b>?</b>,4 x 10-6,,NR,'-,0.09 unit increase,[NR],SORCS2,Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,4:7715902
rs7123770-<b>?</b>,7 x 10-6,,NR,'-,0.15 unit increase,[NR],'-,Depressive and manic episodes in bipolar disorder,"manic episode measurement, depressive episode measurement, bipolar disorder",GCST003090,11:127688543
rs144447022-<b>?</b>,7 x 10-20,,'-,'-,'-,'-,"OR2U2P, OR14J1",Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:29276442
rs169738-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,GGNBP1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:33569769
rs60730-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,SNAP91,Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:83663339
rs9320913-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,EIF4EBP2P3,Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:98136857
rs58120505-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,MAD1L1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,7:1990232
rs80195870-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,GSDME,Bipolar disorder (MTAG),bipolar disorder,GCST010641,7:24734849
rs12704290-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"GRM3-AS1, GRM3",Bipolar disorder (MTAG),bipolar disorder,GCST010641,7:86798310
rs2966422-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,'-,Bipolar disorder (MTAG),bipolar disorder,GCST010641,7:110538893
rs13236223-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"BRAF, CCT4P1",Bipolar disorder (MTAG),bipolar disorder,GCST010641,7:140967165
rs75836205-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,'-,Bipolar disorder (MTAG),bipolar disorder,GCST010641,8:34163620
rs6984358-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,FGFR1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,8:38427063
rs11167136-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,TSNARE1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,8:142229454
rs10764493-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,CACNB2,Bipolar disorder (MTAG),bipolar disorder,GCST010641,10:18439070
rs7098825-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,"BORCS7-ASMT, U6",Bipolar disorder (MTAG),bipolar disorder,GCST010641,10:102868477
rs72830427-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"MXI1, SNRPGP12",Bipolar disorder (MTAG),bipolar disorder,GCST010641,10:110175792
rs12805133-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,SPTBN2,Bipolar disorder (MTAG),bipolar disorder,GCST010641,11:66715794
rs2514218-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,DRD2,Bipolar disorder (MTAG),bipolar disorder,GCST010641,11:113522272
rs4298967-<b>?</b>,3 x 10-16,,'-,'-,'-,'-,CACNA1C,Bipolar disorder (MTAG),bipolar disorder,GCST010641,12:2299028
rs4762559-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,ANKS1B,Bipolar disorder (MTAG),bipolar disorder,GCST010641,12:99104862
rs10149407-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,PRKD1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,14:29718199
rs7161596-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,RGS6,Bipolar disorder (MTAG),bipolar disorder,GCST010641,14:71975895
rs11624408-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,BCL11B,Bipolar disorder (MTAG),bipolar disorder,GCST010641,14:99246608
rs722637-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,PPP1R13B,Bipolar disorder (MTAG),bipolar disorder,GCST010641,14:103795386
rs28681284-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,CHRNA3,Bipolar disorder (MTAG),bipolar disorder,GCST010641,15:78616223
rs12906474-<b>?</b>,5 x 10-12,,'-,'-,'-,'-,UBE2Q2P1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,15:84566006
rs78835388-<b>G</b>,7 x 10-9,,0.021,'-,6.6 unit decrease,NR,THSD7A,Response to antiepileptic mood-stabilizing treatment in bipolar disorder,"bipolar disorder, response to anticonvulsant",GCST010579,7:11774419
rs114872993-<b>G</b>,3 x 10-8,,0.029,'-,4.5 unit decrease,NR,"SLC35F3, COA6-AS1",Response to antiepileptic mood-stabilizing treatment in bipolar disorder,"bipolar disorder, response to anticonvulsant",GCST010579,1:234346906
rs34701716-<b>C</b>,2 x 10-6,,0.14,'-,1.8 unit increase,NR,DISP1,Response to antiepileptic mood-stabilizing treatment in bipolar disorder,"bipolar disorder, response to anticonvulsant",GCST010579,1:222940467
rs13353016-<b>T</b>,2 x 10-6,,0.028,'-,4.7 unit decrease,NR,VAV3,Response to antiepileptic mood-stabilizing treatment in bipolar disorder,"bipolar disorder, response to anticonvulsant",GCST010579,1:107856873
rs875740-<b>C</b>,2 x 10-6,,0.34,'-,1.3 unit decrease,NR,ABCC1,Response to antiepileptic mood-stabilizing treatment in bipolar disorder,"bipolar disorder, response to anticonvulsant",GCST010579,16:16029191
rs8179328-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,'-,Bipolar disorder (MTAG),bipolar disorder,GCST010641,1:163783451
rs2339519-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,LINC01830,Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:22381268
rs12474906-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,"MRPL33, RBKS",Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:27810671
rs80256351-<b>?</b>,9 x 10-11,,'-,'-,'-,'-,"ACTG1P22, VRK2",Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:57844458
rs4619651-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"LMAN2L, CNNM4",Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:96750416
rs10497655-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"ZNF804A, LINC01812",Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:184597314
rs4380187-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,ZNF804A,Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:184947213
rs59979824-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,'-,Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:192983614
rs2439202-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,'-,Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:193513924
rs6434928-<b>?</b>,8 x 10-10,,'-,'-,'-,'-,"RNU6-1029P, SF3B1",Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:197439853
rs769950-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,"FTCDNL1, RN7SL717P",Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:199865305
rs778353-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,NGEF,Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:232923640
rs35346733-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,CNTN4,Bipolar disorder (MTAG),bipolar disorder,GCST010641,3:2479638
rs9834970-<b>?</b>,6 x 10-16,,'-,'-,'-,'-,"LINC02033, HSPD1P6",Bipolar disorder (MTAG),bipolar disorder,GCST010641,3:36814539
rs2710323-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,ITIH1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,3:52781889
rs13135092-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,SLC39A8,Bipolar disorder (MTAG),bipolar disorder,GCST010641,4:102276925
rs4604142-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,ZSWIM6,Bipolar disorder (MTAG),bipolar disorder,GCST010641,5:61346768
rs329319-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,JADE2,Bipolar disorder (MTAG),bipolar disorder,GCST010641,5:134570919
rs10043984-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,KDM3B,Bipolar disorder (MTAG),bipolar disorder,GCST010641,5:138376432
rs72799190-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,LINC01470,Bipolar disorder (MTAG),bipolar disorder,GCST010641,5:152807563
rs2910032-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,LINC01470,Bipolar disorder (MTAG),bipolar disorder,GCST010641,5:153160794
rs215011-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,"CMAHP, CARMIL1",Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:25384133
rs75782365-<b>?</b>,3 x 10-18,,'-,'-,'-,'-,BTN3A1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:26408323
rs6922815-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"ZNF204P, VN1R10P",Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:27343879
rs34706883-<b>?</b>,7 x 10-20,,'-,'-,'-,'-,"H2BC15, H4C12",Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:27837477
rs4702-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,FURIN,Bipolar disorder (MTAG),bipolar disorder,GCST010641,15:90883330
rs11647445-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,GRIN2A,Bipolar disorder (MTAG),bipolar disorder,GCST010641,16:9833109
rs12691307-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"TMEM219, KCTD13",Bipolar disorder (MTAG),bipolar disorder,GCST010641,16:29928556
rs10423874-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,NCAN,Bipolar disorder (MTAG),bipolar disorder,GCST010641,19:19248691
rs2068756-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,MACROD2,Bipolar disorder (MTAG),bipolar disorder,GCST010641,20:14512564
rs6125656-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,KCNB1,Bipolar disorder (MTAG),bipolar disorder,GCST010641,20:49474242
rs6519227-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,"SLC25A17, MCHR1",Bipolar disorder (MTAG),bipolar disorder,GCST010641,22:40723895
rs760648-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,TCF20,Bipolar disorder (MTAG),bipolar disorder,GCST010641,22:42175022
rs11682175-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,ACTG1P22,Bipolar disorder (MTAG),bipolar disorder,GCST010641,2:57760458
rs10946817-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"BTN3A2, H3C9P",Bipolar disorder (MTAG),bipolar disorder,GCST010641,6:26363828
rs740417-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,CACNA1C,Bipolar disorder (MTAG),bipolar disorder,GCST010641,12:2390683
rs2439202-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST010646,2:193513924
rs9834970-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST010646,3:36814539
rs329319-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,JADE2,Bipolar disorder,bipolar disorder,GCST010646,5:134570919
rs72830427-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"MXI1, SNRPGP12",Bipolar disorder,bipolar disorder,GCST010646,10:110175792
rs10744560-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,"CACNA1C, CACNA1C-IT3",Bipolar disorder,bipolar disorder,GCST010646,12:2277933
rs111444407-<b>?</b>,9 x 10-10,,'-,'-,'-,'-,NCAN,Bipolar disorder,bipolar disorder,GCST010646,19:19247398
rs6079463-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,MACROD2,Bipolar disorder,bipolar disorder,GCST010646,20:14495111
rs6519227-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,"SLC25A17, MCHR1",Bipolar disorder,bipolar disorder,GCST010646,22:40723895
rs1023330-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"TLCD4-RWDD3, TLCD4",Bipolar disorder (MTAG),bipolar disorder,GCST010641,1:95121217
rs78676616-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,"RN7SL480P, PLEKHO1",Bipolar disorder (MTAG),bipolar disorder,GCST010641,1:150171103
rs17079247-<b>T</b>,8 x 10-6,(IM vs. EM),NR,1.75,'-,'-,LINC00375,Bipolar disorder (mania),bipolar disorder,GCST001811,13:85091744
rs79436609-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,TRIM42,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,3:140698604
rs74619861-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,NAALADL2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,3:175506108
rs118174081-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,TSHZ2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,20:53161584
rs4814920-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,RIN2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,20:19885312
rs72795979-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,FBXL17,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:107946647
rs11957407-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,PDZD2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:31917136
rs116951791-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,8:92207493
rs150404479-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,"CFAP57, EBNA1BP2",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,1:43222879
rs62110082-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,ZNF577,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,19:51835388
rs6963495-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,"RINT1, PUS7",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,7:105526406
rs113508841-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"MTFR2, PDE7B",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,6:136224135
rs10782174-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,6:112813274
rs74789784-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,DSEL-AS1,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,18:67804281
rs391760-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:144031781
rs409220-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,RN7SL87P,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:144043380
rs116075389-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"Metazoa_SRP, RPSAP12",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,12:68563384
rs75687134-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,DSEL-AS1,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,18:67804806
rs72795980-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,FBXL17,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:107946648
rs114588203-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"RPSAP12, Metazoa_SRP",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,12:68562405
rs58873874-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,ADAM19,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:157518140
rs17541406-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,SEPHS1P2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,15:93346230
rs12772424-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,TCF7L2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,10:113120792
rs11150078-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,WWOX,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,16:78432807
rs1043607-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,TMEM132B,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,12:125658800
rs1625975-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,CDH23,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,10:71662527
rs7690204-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,4:144275053
rs6934970-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,6:112803099
rs2699783-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,2:66031567
rs10070308-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,FBXL17,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:107945920
rs114535501-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,DSEL-AS1,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,18:67803512
rs116896199-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,CDH4,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,20:61531817
rs290475-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,TCF7L2,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,10:113114260
rs12300899-<b>?</b>,5 x 10-7,,NR,'-,'-,'-,"BRI3BP, AACS",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,12:125062029
rs58630086-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,"ALOX12-AS1, ALOX12P2",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,17:6878094
rs150888153-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,SLC25A36,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,3:140963071
rs141220432-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,SLC25A36,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,3:140957958
rs117982730-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,7:126256694
rs191753171-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"IGKV1OR2-118, IGKV3D-7",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,2:90296917
rs62421103-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,6:112839142
rs147721431-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,"SH3PXD2B, LINC02058",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:93007488
rs183418565-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"GOLGA8S, HERC2P6",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,15:23402602
rs7588591-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,CLHC1,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,2:55191799
rs11660238-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,DSEL-AS1,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,18:67802897
rs6921059-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,'-,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,6:50384423
rs150516896-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"RPSAP12, Metazoa_SRP",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,12:68561792
rs116979167-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,EFCAB10,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,7:105582004
rs34975147-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,JPH3,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,16:87644970
rs80088139-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,TAFA5,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,22:48527647
rs11661646-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,DSEL-AS1,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,18:67816575
rs72977016-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"TRIM42, CLSTN2",Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,3:140651170
rs77372450-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,ADAM19,Bipolar disorder (body mass index interaction),"bipolar disorder, body mass index",GCST002306,5:157543136
rs17190927-<b>?</b>,8 x 10-7,(SPTLC3),NR,'-,'-,'-,SPTLC3,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,20:13143086
rs10479334-<b>?</b>,2 x 10-9,(TCI-C1),0.078,'-,'-,'-,'-,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,5:105618627
rs13080594-<b>?</b>,8 x 10-7,(ZKPQ-neuroticism anxiety),NR,'-,'-,'-,GRM7,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,3:7361959
rs9419788-<b>?</b>,4 x 10-8,(TCI-ST1),0.354,'-,'-,'-,PLCE1,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,10:94253948
rs9846232-<b>?</b>,1 x 10-8,(TCI-C3),NR,'-,'-,'-,LINC00620,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,3:13701633
rs411174-<b>?</b>,1 x 10-6,(ZKPQ-neuroticism anxiety),NR,'-,'-,'-,ITK,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,5:157181989
rs285480-<b>?</b>,4 x 10-7,(ZKPQ-sensation seeking),NR,'-,'-,'-,RXRG,Personality traits in bipolar disorder,"personality trait, bipolar disorder",GCST000995,1:165434666
rs6479352-<b>?</b>,8 x 10-6,(anti-CMV),'-,'-,'-,'-,"ROR2, NFIL3",Bipolar disorder (inflammation and infection response interaction),"bipolar disorder, cytomegalovirus seropositivity",GCST002815,9:91519428
rs9910816-<b>?</b>,2 x 10-6,(anti-CMV),'-,'-,'-,'-,ARSG,Bipolar disorder (inflammation and infection response interaction),"bipolar disorder, cytomegalovirus seropositivity",GCST002815,17:68348562
rs885553-<b>?</b>,8 x 10-7,(anti-HSV1),'-,'-,'-,'-,LINC01121,Bipolar disorder (inflammation and infection response interaction),"HSV1 seropositivity, bipolar disorder",GCST002815,2:45229251
rs4234848-<b>?</b>,4 x 10-6,(anti-HSV1),'-,'-,'-,'-,ANTXR2,Bipolar disorder (inflammation and infection response interaction),"HSV1 seropositivity, bipolar disorder",GCST002815,4:79929651
rs3736986-<b>?</b>,6 x 10-6,(anti-HSV1),'-,'-,'-,'-,CLTA,Bipolar disorder (inflammation and infection response interaction),"HSV1 seropositivity, bipolar disorder",GCST002815,9:36194572
"rs12568010-<b>A</b>, rs1125777-<b>C</b>, rs41453448-<b>G</b>",2 x 10-7,,NR,2.5,'-,[NR],NFIA; No mapped genes; No mapped genes,Bipolar disorder,bipolar disorder,GCST001647,1:61366266
"rs12568010-<b>A</b>, rs1125777-<b>C</b>",2 x 10-7,,NR,2.34,'-,[NR],NFIA; No mapped genes,Bipolar disorder,bipolar disorder,GCST001647,1:61366266
"rs7556462-<b>C</b>, rs17121983-<b>C</b>",4 x 10-7,,NR,2.26,'-,[NR],NFIA; No mapped genes,Bipolar disorder,bipolar disorder,GCST001647,1:61356147
"rs7556462-<b>C</b>, rs4915737-<b>C</b>",4 x 10-7,,NR,2.26,'-,[NR],NFIA; No mapped genes,Bipolar disorder,bipolar disorder,GCST001647,1:61356147
rs10237317-<b>?</b>,5 x 10-6,(SM vs. Control),NR,1.775,'-,[NR],AUTS2,Bipolar disorder,bipolar disorder,GCST001647,7:70580955
rs2245641-<b>?</b>,2 x 10-6,(SM vs. Control),NR,1.896,'-,[NR],"TTC39B, RPL7P33",Bipolar disorder,bipolar disorder,GCST001647,9:15309930
rs9995093-<b>?</b>,7 x 10-6,(NSM vs. Control),NR,2.067,'-,[NR],PPM1K-DT,Bipolar disorder,bipolar disorder,GCST001647,4:88299792
rs3750552-<b>?</b>,5 x 10-6,(NSM vs. Control),NR,1.679,'-,[NR],FAM189A2,Bipolar disorder,bipolar disorder,GCST001647,9:69328086
rs7897194-<b>?</b>,8 x 10-6,(NSM vs. Control),NR,2.91,'-,[NR],MIR4675,Bipolar disorder,bipolar disorder,GCST001647,10:20503405
rs312273-<b>?</b>,9 x 10-6,(NSM vs. Control),NR,1.566,'-,[NR],CNTN1,Bipolar disorder,bipolar disorder,GCST001647,12:40853940
rs4467006-<b>?</b>,7 x 10-6,(NSM vs. Control),NR,1.593,'-,[NR],TMEM63C,Bipolar disorder,bipolar disorder,GCST001647,14:77218327
rs2287375-<b>?</b>,5 x 10-6,(NSM vs. Control),NR,1.606,'-,[NR],TMEM63C,Bipolar disorder,bipolar disorder,GCST001647,14:77218499
rs6510489-<b>?</b>,8 x 10-6,(NSM vs. Control),NR,1.92,'-,[NR],"KRTDAP, FFAR2",Bipolar disorder,bipolar disorder,GCST001647,19:35482387
rs41350144-<b>T</b>,3 x 10-7,(SM vs. NSM),0.477,2.269,'-,[1.66-3.11],NFIA,Bipolar disorder,bipolar disorder,GCST001647,1:61350127
rs6124684-<b>?</b>,9 x 10-6,(NSM vs. Control),NR,1.73,'-,[NR],KCNS1,Bipolar disorder,bipolar disorder,GCST001647,20:45092852
rs1171113-<b>C</b>,1 x 10-7,,NR,1.23,'-,[NR],PRSS35,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,6:83516876
rs11710433-<b>?</b>,1 x 10-6,,NR,1.23,'-,[NR],'-,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,3:5663365
rs9834970-<b>?</b>,1 x 10-7,,NR,1.22,'-,[NR],"LINC02033, HSPD1P6",Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,3:36814539
rs2333194-<b>?</b>,7 x 10-7,,NR,1.2,'-,[NR],NUMB,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,14:73300506
rs4450798-<b>T</b>,2 x 10-6,,NR,1.26,'-,[NR],LINC00620,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,3:13695501
rs11773966-<b>A</b>,2 x 10-6,,NR,2.17,'-,[NR],ATP6V1H,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,8:53642640
rs10865974-<b>?</b>,2 x 10-6,,NR,1.19,'-,[NR],"PBRM1, GNL3",Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,3:52684264
rs3744728-<b>C</b>,3 x 10-6,,NR,1.51,'-,[NR],"WSCD1, RNU6-1264P",Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,17:6190631
rs2860031-<b>?</b>,3 x 10-6,,NR,1.22,'-,[NR],LINC01648,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,1:30052867
rs3934861-<b>?</b>,4 x 10-6,,NR,1.25,'-,[NR],MYOM3,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,1:24105466
rs10255295-<b>G</b>,5 x 10-6,,NR,1.31,'-,[NR],"RCC2P3, Y_RNA",Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,7:138174020
rs1775715-<b>G</b>,5 x 10-6,,NR,1.18,'-,[NR],KIF5B,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,10:32020077
rs2962370-<b>G</b>,5 x 10-6,,NR,1.19,'-,[NR],"BASP1-AS1, BASP1",Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,5:17215335
rs1680005-<b>A</b>,7 x 10-6,,NR,1.18,'-,[NR],"PIM1, TMEM217",Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,6:37206969
rs12617721-<b>C</b>,7 x 10-6,,NR,1.2,'-,[NR],INPP4A,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,2:98467429
rs1930961-<b>?</b>,9 x 10-6,,NR,1.39,'-,[NR],CRYBB2P1,Bipolar disorder with mood-incongruent psychosis,bipolar disorder,GCST001715,22:25479298
rs1039002-<b>?</b>,2 x 10-8,(Latent Class 1),NR,'-,'-,'-,PDE10A,Bipolar disorder,bipolar disorder,GCST001359,6:165741969
rs12563333-<b>?</b>,6 x 10-8,(Latent Class 1),NR,'-,'-,'-,"LINC02779, PRELID3BP1",Bipolar disorder,bipolar disorder,GCST001359,1:220484892
rs2727943-<b>?</b>,3 x 10-8,(Latent Class 2),NR,'-,'-,'-,RPL21P17,Bipolar disorder,bipolar disorder,GCST001359,3:1856289
rs17371334-<b>?</b>,2 x 10-6,(Cyclothymic),NR,'-,1.05 unit decrease,[NR],MTND4P1,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,13:84458192
rs4075511-<b>?</b>,3 x 10-6,(Irritable),NR,'-,0.93 unit decrease,[NR],KCNS3,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,2:18062268
rs4698169-<b>?</b>,2 x 10-6,(Anxious),NR,'-,2.11 unit increase,[NR],"MTND5P4, LINC02493",Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,4:17133720
rs7313402-<b>?</b>,8 x 10-6,(Anxious),NR,'-,1.13 unit increase,[NR],WSCD2,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,12:108209193
rs1985671-<b>?</b>,2 x 10-8,(Hyperthymic),NR,'-,1.06 unit decrease,[NR],FBLN1,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,22:45566024
rs17018311-<b>?</b>,2 x 10-8,(Irritable),NR,'-,4.21 unit increase,[NR],INTS7,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,1:211981666
rs6767049-<b>?</b>,2 x 10-6,(Dysthymic),NR,'-,0.77 unit decrease,[NR],"SGO1-AS1, SGO1",Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,3:20179220
rs17599018-<b>?</b>,2 x 10-6,(Dysthymic),NR,'-,0.98 unit increase,[NR],GPM6A,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,4:175740936
rs11035577-<b>?</b>,6 x 10-6,(Dysthymic),NR,'-,1.03 unit decrease,[NR],'-,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,11:39887112
rs17121944-<b>?</b>,4 x 10-6,(Dysthymic),NR,'-,2.66 unit increase,[NR],RPS6P22,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,12:59046451
rs2155929-<b>?</b>,5 x 10-6,(Dysthymic),NR,'-,1.01 unit increase,[NR],RNU6-408P,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,18:29026683
rs2150410-<b>?</b>,4 x 10-6,(Hyperthymic),NR,'-,1.69 unit decrease,[NR],BRWD1,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,21:39197853
rs416350-<b>?</b>,4 x 10-8,(Hyperthymic),NR,'-,2.1 unit increase,[NR],LINC02384,Temperament (bipolar disorder),"behavior or behavioral disorder measurement, personality trait, bipolar disorder",GCST001419,12:68385633
rs9378249-<b>?</b>,1 x 10-8,(addtive),NR,'-,'-,'-,"DHFRP2, HLA-B",Bipolar disorder,bipolar disorder,GCST000961,6:31359924
rs10078434-<b>T</b>,7 x 10-8,,0.09,'-,1.1 unit decrease,[0.73-1.47],"RPL7P19, ETF1",Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST006990,5:138496342
rs283812-<b>C</b>,3 x 10-7,,0.29,'-,0.55 unit decrease,[0.35-0.75],NECTIN2,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST006990,19:44885311
rs11670070-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,IGSF23,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44628686
rs2919845-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CEACAM19, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44677956
rs118104581-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44557839
rs79638902-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44718495
rs2965162-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44695666
rs2965164-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44698782
rs76670936-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44693311
rs62117160-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44728895
rs73037426-<b>?</b>,4 x 10-22,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44719517
rs150820726-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44723891
rs2965169-<b>?</b>,1 x 10-49,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44747899
rs112450640-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44793107
rs28399657-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44815094
rs41290100-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44867684
rs28399637-<b>?</b>,7 x 10-120,,NR,'-,'-,'-,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44820881
rs2889414-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44794671
rs1786140-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"LINC02705, MS4A2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60141154
rs4939338-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MS4A6E,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60331752
rs11666329-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44851039
rs4803764-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44854120
rs55840414-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44840322
rs56394238-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44832419
rs111371860-<b>?</b>,5 x 10-24,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44842530
rs41289512-<b>?</b>,5 x 10-175,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44848259
rs28399664-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44821499
rs11605427-<b>?</b>,8 x 10-17,,NR,'-,'-,'-,"MS4A6A, LINC02705",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60161199
rs501945-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MS4A2, MS4A3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60076769
rs580064-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MS4A2, LINC02705",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60101646
rs7108879-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MS4A4A,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60313801
rs56157503-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86152038
rs7114401-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86128893
rs10792832-<b>?</b>,6 x 10-33,,NR,1.1004289,'-,[1.08330873363297- 1.1178195976052],"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86156833
rs527162-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,PICALM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86004693
rs17745409-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PICALM, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86101743
rs7129687-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86160142
rs61904266-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, LINC02695",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86160172
rs11218343-<b>?</b>,1 x 10-9,,NR,1.0624738,'-,'-,SORL1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:121564878
rs17125924-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,FERMT2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:52924962
rs8008388-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:92470346
rs593742-<b>?</b>,6 x 10-11,,NR,1.06,'-,[1.04- 1.07],"ADAM10, SNORD3P1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,15:58753575
rs889555-<b>?</b>,3 x 10-8,,NR,1.0526316,'-,'-,BCKDK,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,16:31111250
rs73976310-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ZNF232,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:5110917
rs6504163-<b>?</b>,5 x 10-9,,NR,1.05,'-,[1.03- 1.07],"PPIAP55, CYB561",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:63468418
rs3752231-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:1043639
rs3795065-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"ABCA7, CNN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:1039445
rs80257887-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,CEACAM20,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44516798
rs142034848-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CEACAM19, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44673285
rs73046410-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44549809
rs143459034-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44854769
rs56261258-<b>?</b>,1 x 10-21,,NR,'-,'-,'-,"PVR, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44646342
rs4802240-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44849547
rs283814-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44885967
rs61679753-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44897490
rs148601586-<b>?</b>,2 x 10-43,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44843409
rs112380717-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45019803
rs2927468-<b>?</b>,4 x 10-108,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44854682
rs4803760-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44830577
rs11668738-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44844304
rs2972558-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44852884
rs73050293-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44876489
rs375972689-<b>?</b>,1 x 10-32,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44857231
rs8112526-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44857505
rs406456-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879460
rs35568738-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44899461
rs157580-<b>?</b>,2 x 10-208,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44892009
rs11669338-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879727
rs760136-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44900601
rs405697-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44901434
rs157595-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44922203
rs8106813-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,APOC1P1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44928401
rs141864196-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44902242
rs150639620-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44878035
rs41290120-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879418
rs138235833-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44912028
rs283810-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44884984
rs346758-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45222481
rs346763-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"EXOC3L2, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45226017
rs12461144-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45220448
rs62118504-<b>?</b>,5 x 10-14,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45231493
rs11667829-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45236417
rs6069736-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"CSTF1, CASS4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,20:56408019
rs9271192-<b>?</b>,7 x 10-10,,NR,1.0530598,'-,'-,"HLA-DRB1, HLA-DQA1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:32610753
rs2718058-<b>?</b>,2 x 10-6,,NR,1.0383158,'-,'-,"GPR141, EPDR1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:37801932
rs10838725-<b>?</b>,2 x 10-6,,NR,1.0392507,'-,[1.02288186365195- 1.05588153898494],CELF1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:47536319
rs769446-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, TOMM40",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44905371
rs12721109-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC4, APOC4-APOC2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44943964
rs1081105-<b>?</b>,1 x 10-162,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44909698
rs7254133-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC4, APOC1P1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44935297
rs60049679-<b>?</b>,2 x 10-70,,NR,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44926451
rs4263041-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,"APOC1P1, APOC4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44935386
rs2376866-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CLPTM1, RELB",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44997454
rs35194383-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45012792
rs4803791-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,Mapping not available
rs117612135-<b>?</b>,9 x 10-31,,NR,'-,'-,'-,"RELB, CLPTM1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45001269
rs76856627-<b>?</b>,9 x 10-11,,NR,'-,'-,'-,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45040497
rs78620885-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, GEMIN7, GEMIN7-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45087826
rs112481437-<b>?</b>,6 x 10-15,,NR,'-,'-,'-,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45045877
rs7251911-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45079144
rs145903417-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PPP1R37, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45125846
rs149495476-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BLOC1S3, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45193381
rs138137383-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,"MARK4, PPP1R37",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45098343
rs12461065-<b>?</b>,1 x 10-17,,NR,'-,'-,'-,"PPP1R37, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45102050
rs8100183-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, GEMIN7-AS1, GEMIN7",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45081434
rs17643262-<b>?</b>,2 x 10-30,,NR,'-,'-,'-,"MARK4, PPP1R37",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45128558
rs10408847-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, PPP1R37",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45131424
rs12463049-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45187692
rs111243475-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45188312
rs595290-<b>?</b>,7 x 10-21,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45205150
rs620807-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BLOC1S3, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45203694
rs75161053-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44544863
rs2965156-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44685157
rs73035597-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44696254
rs8103315-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44750911
rs203709-<b>?</b>,7 x 10-17,,NR,'-,'-,'-,"CEACAM16-AS1, PVR",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44658298
rs2965163-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44697256
rs12150984-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44698757
rs11881756-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44717621
rs10401176-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44750234
rs62117205-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44752009
rs2927437-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44738381
rs12459810-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44746404
rs7254776-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44724478
rs8100197-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44750325
rs2967668-<b>?</b>,4 x 10-18,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44799694
rs112262807-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44828429
rs1466435-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44839558
rs140824606-<b>?</b>,4 x 10-26,,NR,'-,'-,'-,"BCAM, CBLC",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44807827
rs186110295-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44730236
rs1135062-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44819487
rs10412413-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44824052
rs12974942-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44849230
rs78986976-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44826181
rs77241309-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44845920
rs12978931-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44860443
rs10407439-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44838691
rs2972562-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44840407
rs393584-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44874077
rs117310449-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"TOMM40, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44890259
rs412776-<b>?</b>,5 x 10-15,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44876259
rs6859-<b>?</b>,1 x 10-155,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44878777
rs3852860-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879709
rs11668327-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44895376
rs1081106-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44910109
rs59325138-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44913034
rs449647-<b>?</b>,2 x 10-58,,NR,'-,'-,'-,"APOE, TOMM40",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44905307
rs365653-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44858389
rs7412-<b>?</b>,2 x 10-76,,NR,'-,'-,'-,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44908822
rs148933445-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44799247
rs144311893-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44920687
rs3925681-<b>?</b>,7 x 10-162,,NR,'-,'-,'-,APOC1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44917843
rs71352239-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44926286
rs73045691-<b>?</b>,2 x 10-19,,NR,'-,'-,'-,"APOC1P1, APOC4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44937272
rs9304644-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC2, APOC4-APOC2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44946776
rs34874378-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45013623
rs57270598-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44982891
rs114248186-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45020861
rs147188206-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45049329
rs60239918-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45077114
rs536518226-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PPP1R37, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45137507
rs73566293-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45209421
rs6701713-<b>?</b>,9 x 10-24,,NR,'-,'-,'-,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,1:207612944
rs12036785-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,1:207619564
rs11118328-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CR1L,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,1:207677194
rs17014873-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127072643
rs1060743-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127068957
rs6733839-<b>?</b>,2 x 10-64,,NR,1.1470575,'-,[1.12899064608461-1.16541354700668],"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127135234
rs10194375-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127082205
rs72838215-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127104478
rs6431219-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127104557
rs4663099-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127120856
rs35103166-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127124606
rs7575209-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127126547
rs58682665-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127127671
rs13025765-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127128657
rs13031703-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127129099
rs745717-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127136321
rs730482-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127136908
rs35349669-<b>?</b>,2 x 10-10,,NR,1.0525334,'-,[1.03595530394875-1.06937674771915],INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:233159830
rs10933431-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:233117202
rs9381563-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47464901
rs9395255-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47424807
rs9395288-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CD2AP, ADGRF2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47630389
rs10948374-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ADGRF2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47679485
rs1859788-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,PILRA,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100374211
rs7480193-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86150377
rs7113976-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86158695
rs580887-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86120391
rs7938634-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PICALM, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86134431
rs11603136-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, LINC02695",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86163280
rs12881735-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:92466484
rs12590654-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:92472511
rs7225151-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"SCIMP, ZNF594-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:5233752
rs3845261-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"ZFP3, ZNF232",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:5104941
rs4311-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ACE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:63483402
rs4147929-<b>?</b>,3 x 10-8,,NR,1.0491707,'-,[1.03-1.07],ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:1063444
rs11083742-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44567824
rs2734897-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,AGFG2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100561944
rs2293479-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,AP4M1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100106335
rs866500-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CASTOR3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100242838
rs858502-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CASTOR3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100245730
rs35305377-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"STAG3L5P, STAG3L5P-PVRIG2P-PILRB",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100341332
rs7810606-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143411065
rs56402156-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143406388
rs3935067-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143407238
rs62472729-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143418968
rs11771145-<b>?</b>,4 x 10-11,,NR,1.0548515,'-,[1.04-1.07],EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143413669
rs7805776-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143427203
rs9640386-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143435090
rs28834970-<b>?</b>,6 x 10-16,,NR,1.0666256,'-,[1.05003132808944-1.08348207689744],PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27337604
rs10109834-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27354759
rs2741342-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CHRNA2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27472579
rs79145239-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,CHRNA2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27462330
rs2269461-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHX2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27541103
rs4236673-<b>?</b>,4 x 10-25,,NR,'-,'-,'-,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27607412
rs4732728-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,GULOP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27584004
rs9331908-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27606101
rs576748-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CLU, SCARA3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27629399
rs485902-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"SCARA3, CLU",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27632442
rs7920721-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"ECHDC3, USP6NL-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,10:11678309
rs12292911-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"PSMC3, RAPSN",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:47427521
rs3740688-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SPI1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:47358789
rs640345-<b>T</b>,8 x 10-9,,0.824,1.3157895,'-,[1.19-1.45],KIR3DL2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:54851404
rs9899728-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"RNU6-362P, MRPL58",Alzheimer's disease or small vessel stroke,"Alzheimer's disease, small vessel stroke",GCST003423,17:75022679
rs17774966-<b>?</b>,8 x 10-6,,NR,'-,0.153 unit increase,[NR],'-,Entorhinal cortical thickness (Alzheimer's disease interaction),"Alzheimer's disease, cortical thickness",GCST000889,9:25551359
rs1925690-<b>?</b>,3 x 10-8,,NR,'-,0.0003 unit increase,[NR],ZNF292,Entorhinal cortical volume (Alzheimer's disease interaction),"Alzheimer's disease, entorhinal cortical volume",GCST000893,6:87157345
rs4670766-<b>?</b>,2 x 10-6,,NR,'-,0.005 unit decrease,[NR],CDC42EP3,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,2:37713399
rs10937470-<b>?</b>,9 x 10-6,,NR,'-,0.004 unit decrease,[NR],UTS2B,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,3:191283019
rs2084385-<b>?</b>,5 x 10-6,,NR,'-,0.006 unit increase,[NR],PAK2,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,3:196826996
rs7805803-<b>?</b>,9 x 10-6,,NR,'-,0.004 unit decrease,[NR],SPATA48,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,7:50185795
rs263238-<b>?</b>,2 x 10-6,,NR,'-,0.006 unit increase,[NR],ADCY8,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,8:130799787
rs12555345-<b>?</b>,5 x 10-6,,NR,'-,0.004 unit decrease,[NR],CTAGE12P,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,9:27630564
rs10512049-<b>?</b>,3 x 10-6,,NR,'-,0.007 unit decrease,[NR],OTX2P1,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,9:75661759
rs990324-<b>?</b>,5 x 10-6,,NR,'-,0.006 unit decrease,'-,"LINC00423, PDS5B",Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,13:32813108
rs9574199-<b>?</b>,7 x 10-6,,NR,'-,0.004 unit increase,[NR],OBI1-AS1,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,13:78234779
rs4318070-<b>?</b>,7 x 10-6,,NR,'-,0.004 unit decrease,[NR],FARP1,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,13:98308508
rs3784609-<b>?</b>,3 x 10-6,,NR,'-,0.005 unit decrease,[NR],"RORA-AS1, RORA",Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,15:60618351
rs1857353-<b>?</b>,2 x 10-6,,NR,'-,0.016 unit decrease,[NR],SLC44A5,Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,1:75448141
rs9846480-<b>?</b>,8 x 10-6,,NR,'-,0.009 unit increase,[NR],NME9,Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,3:138306554
rs3905000-<b>?</b>,9 x 10-6,,NR,'-,0.013 unit increase,[NR],ABCA1,Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,9:104894789
rs2852894-<b>?</b>,1 x 10-6,,NR,'-,0.016 unit decrease,[NR],"RNU6-952P, YAP1",Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,11:102284743
rs1992269-<b>A</b>,1 x 10-6,,0.076,1.66,'-,[1.35-2.03],AIDAP3,Alzheimer's disease (late onset),Alzheimer's disease,GCST002954,18:1872316
rs802571-<b>T</b>,1 x 10-6,(noncarrier),0.916,1.923077,'-,[1.47-2.50],CNTNAP2,Alzheimer's disease (late onset),Alzheimer's disease,GCST002954,7:146265094
rs11613092-<b>G</b>,7 x 10-6,(noncarrier),0.093,1.64,'-,[1.32-2.04],SUDS3,Alzheimer's disease (late onset),Alzheimer's disease,GCST002954,12:118455443
rs1800795-<b>?</b>,7 x 10-8,,'-,'-,0.375 unit increase,[NR],"IL6, STEAP1B, IL6-AS1",Cerebrospinal fluid clusterin levels in APOEe4- carriers,"Alzheimer's disease, cerebrospinal fluid clusterin measurement",GCST003137,7:22727026
rs56755606-<b>A</b>,1 x 10-7,(GEE model),NR,'-,1.1021 unit decrease,[0.7-1.51],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:179046443
rs11723502-<b>T</b>,9 x 10-6,(GEE model),NR,'-,0.51405 unit decrease,[0.29-0.74],"LINC01093, MIR3945HG",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:184883166
rs72712682-<b>G</b>,6 x 10-6,(GEE model),NR,'-,0.58942 unit decrease,[0.33-0.85],F11-AS1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:186419433
rs150052082-<b>T</b>,2 x 10-6,(GEE model),NR,'-,1.1459 unit decrease,[0.68-1.62],SLC6A3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:1418892
rs149799089-<b>T</b>,1 x 10-6,(GEE model),NR,'-,0.91021 unit decrease,[0.55-1.28],PDE4D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:59464462
rs148373370-<b>A</b>,5 x 10-6,(GEE model),NR,'-,1.1872 unit decrease,[0.68-1.7],TMEM174,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:73210437
rs71654380-<b>C</b>,3 x 10-6,(GEE model),NR,'-,0.93659 unit decrease,[0.54-1.33],"LIX1-AS1, LINC01340",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:97450102
rs13435934-<b>A</b>,5 x 10-6,(GEE model),NR,'-,0.65998 unit decrease,[0.38-0.94],PJA2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:109410936
rs77152330-<b>A</b>,7 x 10-6,(GEE model),NR,'-,1.1042 unit decrease,[0.62-1.58],LINC02208,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:118294256
rs4895368-<b>T</b>,4 x 10-6,(GEE model),NR,'-,0.87692 unit decrease,[0.5-1.25],TNFAIP8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:119351201
chr5:124938416-<b>C</b>,6 x 10-7,(GEE model),NR,'-,1.1527 unit decrease,[0.7-1.61],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs78049001-<b>A</b>,3 x 10-8,(GEE model),NR,'-,0.8685 unit decrease,[0.56-1.17],"LINC02039, GRAMD2B",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:126272219
rs6596201-<b>A</b>,8 x 10-6,(GEE model),NR,'-,0.82968 unit decrease,[0.47-1.19],C5orf66,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:135155460
rs150117434-<b>T</b>,6 x 10-6,(GEE model),NR,'-,1.1035 unit decrease,[0.62-1.58],COL23A1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:178502420
rs145578678-<b>C</b>,3 x 10-6,(GEE model),NR,'-,1.1492 unit increase,[0.67-1.63],DEK,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:18229415
rs9380681-<b>T</b>,1 x 10-6,(GEE model),NR,'-,0.46432 unit increase,[0.28-0.65],"MIR4462, MDGA1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:37562679
rs73449416-<b>A</b>,4 x 10-7,(GEE model),NR,'-,1.0698 unit increase,[0.65-1.49],"RNA5SP208, RNU6-280P",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:67513240
rs76190283-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.87975 unit decrease,[0.52-1.24],TENT5A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:81540046
rs185296986-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.95756 unit decrease,[0.57-1.35],CYCSP17,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:95466536
rs182244165-<b>C</b>,9 x 10-6,(GEE model),NR,'-,0.89476 unit decrease,[0.5-1.29],HSF2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:122379209
rs79102053-<b>A</b>,3 x 10-7,(GEE model),NR,'-,1.004 unit decrease,[0.62-1.39],PLEKHG1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:150814249
rs7787594-<b>T</b>,4 x 10-6,(GEE model),NR,'-,0.40398 unit decrease,[0.23-0.58],PER3P1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:9676532
rs73084930-<b>G</b>,1 x 10-6,(GEE model),NR,'-,0.69382 unit decrease,[0.41-0.97],RNU6-1103P,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:24490721
rs39447-<b>C</b>,2 x 10-6,(GEE model),NR,'-,0.52406 unit increase,[0.31-0.74],CYCS,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:25089373
rs13228275-<b>T</b>,4 x 10-7,(GEE model),NR,'-,0.93231 unit decrease,[0.57-1.29],AMPH,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:38422579
chr7:48804308-<b>C</b>,9 x 10-10,(GEE model),NR,'-,1.5803 unit decrease,[1.07-2.09],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs10234213-<b>G</b>,1 x 10-7,(GEE model),NR,'-,1.1717 unit decrease,[0.74-1.6],"HGF, DDX43P3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:81631105
rs28381924-<b>A</b>,5 x 10-8,(GEE model),NR,'-,1.0778 unit decrease,[0.69-1.46],ABCB1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:87543786
rs76542556-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.84971 unit decrease,[0.5-1.2],"BET1, GNG11",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:93933243
chr7:102553128-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.95805 unit increase,[0.54-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs180725393-<b>C</b>,4 x 10-7,(GEE model),NR,'-,1.0867 unit increase,[0.67-1.51],NAPEPLD,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:103145984
rs147874219-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.96543 unit increase,[0.54-1.39],DPY19L2P2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:103263955
chr7:103017132-<b>CAGA</b>,6 x 10-7,(GEE model),NR,'-,1.0651 unit increase,[0.65-1.48],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs10953388-<b>T</b>,8 x 10-6,(GEE model),NR,'-,0.43339 unit decrease,[0.24-0.62],RELN,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:103545824
rs62489373-<b>G</b>,4 x 10-6,(GEE model),NR,'-,1.0309 unit decrease,[0.59-1.47],ZP3P2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:136467453
rs28491578-<b>T</b>,8 x 10-7,(GEE model),NR,'-,0.82735 unit increase,[0.5-1.16],DGKI,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:137828192
rs60465337-<b>C</b>,9 x 10-7,(GEE model),NR,'-,1.028 unit increase,[0.62-1.44],CNTNAP2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:148107001
rs189842957-<b>T</b>,6 x 10-6,(GEE model),NR,'-,0.51509 unit decrease,[0.29-0.74],"XRCC2, 5S_rRNA",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:152641544
chr8:14944492-<b>CAA</b>,4 x 10-6,(GEE model),NR,'-,0.87757 unit increase,[0.5-1.25],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs6985143-<b>C</b>,3 x 10-8,(GEE model),NR,'-,1.1407 unit decrease,[0.74-1.55],MSR1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:16108576
rs77048708-<b>G</b>,6 x 10-6,(GEE model),NR,'-,0.67354 unit decrease,[0.38-0.97],STC1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:23939348
rs17357035-<b>A</b>,8 x 10-6,(GEE model),NR,'-,1.0025 unit decrease,[0.56-1.44],UNC5D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:35746651
rs72637528-<b>G</b>,1 x 10-7,(GEE model),NR,'-,1.1324 unit decrease,[0.72-1.55],UNC5D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:35848592
rs142214173-<b>G</b>,1 x 10-8,(GEE model),NR,'-,1.2016 unit decrease,[0.79-1.62],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36006420
rs138297249-<b>G</b>,5 x 10-7,(GEE model),NR,'-,1.128 unit decrease,[0.69-1.57],MTCYBP19,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36187530
rs187649623-<b>T</b>,4 x 10-7,(GEE model),NR,'-,1.3596 unit decrease,[0.83-1.89],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36471595
rs151108108-<b>T</b>,2 x 10-6,(GEE model),NR,'-,1.2808 unit decrease,[0.75-1.81],RPL23P10,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36613876
rs74972376-<b>G</b>,5 x 10-6,(GEE model),NR,'-,1.1597 unit increase,[0.66-1.66],ANXA13,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:123708021
rs6992906-<b>G</b>,3 x 10-6,(GEE model),NR,'-,0.86346 unit increase,[0.5-1.23],PVT1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:127857208
rs16904657-<b>A</b>,6 x 10-6,(GEE model),NR,'-,0.64115 unit decrease,[0.36-0.92],KCNQ3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:132318791
rs7560412-<b>C</b>,2 x 10-6,(GEE model),NR,'-,0.68478 unit decrease,[0.4-0.97],"UBXN4, R3HDM1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:135727526
rs12070360-<b>C</b>,5 x 10-6,(GEE model),NR,'-,0.75133 unit decrease,[0.43-1.07],RPSAP20,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:56296719
rs11689493-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.4526 unit decrease,[0.27-0.64],"CDCA7, JPT1P1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:173394711
rs141385851-<b>G</b>,3 x 10-6,(GEE model),NR,'-,0.85234 unit decrease,[0.49-1.21],"RNU7-62P, UBE2U",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:64352304
rs62192855-<b>G</b>,5 x 10-6,(GEE model),NR,'-,0.70881 unit decrease,[0.41-1.01],"CRYGD, CRYGC",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:208128047
rs74567324-<b>T</b>,5 x 10-7,(GEE model),NR,'-,1.3319 unit decrease,[0.81-1.85],"Y_RNA, NRBF2P3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:110784619
rs76119111-<b>G</b>,6 x 10-7,(GEE model),NR,'-,1.4893 unit increase,[0.9-2.08],FARSB,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:222619881
rs9814965-<b>A</b>,3 x 10-6,(GEE model),NR,'-,0.8509 unit decrease,[0.5-1.21],LMCD1-AS1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:7994605
rs16844046-<b>A</b>,2 x 10-7,(GEE model),NR,'-,1.2387 unit decrease,[0.77-1.71],"LINC01222, MIR181A1HG",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:199004936
rs79379488-<b>A</b>,1 x 10-6,(GEE model),NR,'-,1.3364 unit increase,[0.8-1.88],"ST13P19, HHAT",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:210306349
rs12137733-<b>C</b>,2 x 10-8,(GEE model),NR,'-,0.83305 unit decrease,[0.54-1.12],U3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:221521649
rs1764346-<b>T</b>,1 x 10-6,(GEE model),NR,'-,0.72017 unit decrease,[0.43-1.01],ENAH,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:225494483
rs116233900-<b>T</b>,1 x 10-7,(GEE model),NR,'-,1.0543 unit decrease,[0.67-1.44],KRT18P32,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:238566133
rs9833127-<b>G</b>,3 x 10-6,(GEE model),NR,'-,0.78263 unit decrease,[0.45-1.11],GPR156,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:120222474
rs34166650-<b>A</b>,6 x 10-7,(GEE model),NR,'-,0.44474 unit decrease,[0.27-0.62],RPL21P71,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:147275608
chr3:159754413-<b>CA</b>,4 x 10-6,(GEE model),NR,'-,1.3097 unit increase,[0.75-1.87],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs79221325-<b>G</b>,7 x 10-8,(GEE model),NR,'-,1.4982 unit increase,[0.95-2.04],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:162297342
rs4857800-<b>T</b>,8 x 10-6,(GEE model),NR,'-,0.40043 unit decrease,[0.22-0.58],LINC01208,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:176900051
rs13121626-<b>A</b>,2 x 10-6,(GEE model),NR,'-,0.51147 unit decrease,[0.3-0.72],CLNK,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:10489927
rs184621768-<b>A</b>,2 x 10-8,(GEE model),NR,'-,1.2709 unit decrease,[0.82-1.72],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:65977824
rs6850546-<b>A</b>,3 x 10-6,(GEE model),NR,'-,1.2771 unit increase,[0.74-1.82],ENOPH1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:82449681
rs17034334-<b>T</b>,2 x 10-7,(GEE model),NR,'-,0.54164 unit increase,[0.34-0.75],LINC02503,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:104132856
rs76098257-<b>T</b>,2 x 10-7,(GEE model),NR,'-,0.87288 unit decrease,[0.55-1.2],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:160150870
rs6546173-<b>C</b>,2 x 10-6,(GEE model),NR,'-,0.75928 unit decrease,[0.45-1.07],KRT18P33,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:65672385
rs58170570-<b>G</b>,9 x 10-6,(GEE model),NR,'-,1.0055 unit increase,[0.56-1.45],"RPL27AP4, ILRUNP1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:106342796
rs79784973-<b>G</b>,1 x 10-6,(GEE model),NR,'-,0.97698 unit decrease,[0.58-1.37],ANAPC1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:111620617
rs80178823-<b>C</b>,3 x 10-6,(GEE model),NR,'-,1.1552 unit decrease,[0.67-1.64],"CZIB, MAGOH",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:53223405
rs111535588-<b>G</b>,5 x 10-8,(GEE model),NR,'-,0.83287 unit decrease,[0.53-1.13],SCN2A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:165296141
rs76600213-<b>T</b>,8 x 10-6,(GEE model),NR,'-,0.99358 unit increase,[0.56-1.43],LINC01748,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:60526484
rs147710719-<b>C</b>,2 x 10-6,(GEE model),NR,'-,1.0539 unit decrease,[0.62-1.49],"ARHGAP15, SCHLAP1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:180605464
rs7523405-<b>A</b>,3 x 10-6,(GEE model),NR,'-,1.0999 unit decrease,[0.64-1.56],NEGR1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:71880109
rs1525608-<b>A</b>,6 x 10-6,(GEE model),NR,'-,0.40478 unit decrease,[0.23-0.58],"PSMB3P2, IGFBP2",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:216629032
rs17033324-<b>C</b>,2 x 10-12,(GEE model),NR,'-,1.2284 unit decrease,[0.89-1.57],LINC01765,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:115169958
rs2265081-<b>C</b>,5 x 10-8,(GEE model),NR,'-,1.054 unit increase,[0.68-1.43],"RN7SL44P, S100A6",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:153527732
rs192099504-<b>C</b>,7 x 10-7,(GEE model),NR,'-,0.90541 unit decrease,[0.55-1.26],SNRK,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:43305720
chr3:44643004-<b>GA</b>,6 x 10-6,(GEE model),NR,'-,0.74072 unit decrease,[0.42-1.06],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs952365-<b>A</b>,5 x 10-7,(GEE model),NR,'-,0.8233 unit decrease,[0.5-1.14],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:105262407
rs13101183-<b>T</b>,6 x 10-7,(GEE model),NR,'-,0.99061 unit decrease,[0.6-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:117260229
rs9812918-<b>C</b>,7 x 10-7,(GEE model),NR,'-,0.49768 unit decrease,[0.3-0.69],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:118331871
chr3:118177672-<b>A</b>,8 x 10-6,(GEE model),NR,'-,0.45133 unit decrease,[0.25-0.65],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr1:239050971-<b>A</b>,2 x 10-6,(GEE model),NR,'-,1.0635 unit increase,[0.62-1.5],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs16837642-<b>T</b>,1 x 10-7,(GEE model),NR,'-,0.88226 unit decrease,[0.56-1.21],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:238994295
rs78401062-<b>C</b>,5 x 10-6,(GEE model),NR,'-,0.71892 unit decrease,[0.41-1.03],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:5450224
chr2:9046230-<b>AGG</b>,3 x 10-6,(GEE model),NR,'-,1.0132 unit decrease,[0.59-1.44],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr2:9156797-<b>CA</b>,7 x 10-6,(GEE model),NR,'-,0.95779 unit decrease,[0.54-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr2:35083087-<b>G</b>,3 x 10-7,(GEE model),NR,'-,0.46041 unit decrease,[0.28-0.64],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs75207608-<b>G</b>,5 x 10-6,(GEE model),NR,'-,0.99573 unit decrease,[0.57-1.42],CCDC85A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:56441694
rs17048196-<b>A</b>,1 x 10-7,(GEE model),NR,'-,1.0356 unit decrease,[0.65-1.42],LLPHP3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:56583247
rs78144564-<b>A</b>,3 x 10-7,(GEE model),NR,'-,0.92865 unit decrease,[0.57-1.29],"LINC02245, LINC02576",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:65037716
rs115101230-<b>C</b>,4 x 10-7,(GEE model),NR,'-,1.066 unit decrease,[0.65-1.48],RNA5SP173,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:178408010
rs73026046-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.7973 unit decrease,[0.45-1.15],PATE3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:125791197
rs78356676-<b>C</b>,8 x 10-7,(GEE model),NR,'-,0.98241 unit increase,[0.59-1.37],SLC2A14,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:7824330
rs12303711-<b>A</b>,7 x 10-6,(GEE model),NR,'-,0.82933 unit increase,[0.47-1.19],LINC00477,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:24581194
rs34528337-<b>C</b>,3 x 10-6,(GEE model),NR,'-,1.2485 unit decrease,[0.72-1.77],LINC01479,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:67926217
chr12:102082121-<b>CG</b>,2 x 10-7,(GEE model),NR,'-,0.92584 unit increase,[0.58-1.27],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs80086666-<b>T</b>,7 x 10-6,(GEE model),NR,'-,0.88148 unit decrease,[0.5-1.27],"LINC00424, RN7SL766P",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:21809886
rs1590594-<b>C</b>,3 x 10-8,(GEE model),NR,'-,1.1951 unit increase,[0.77-1.62],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:47612501
rs36180537-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.88672 unit decrease,[0.52-1.26],LINC02335,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:55131671
rs11620044-<b>G</b>,7 x 10-6,(GEE model),NR,'-,0.98684 unit decrease,[0.56-1.42],DNAJA1P1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:58831133
rs118102991-<b>A</b>,5 x 10-6,(GEE model),NR,'-,1.0582 unit decrease,[0.6-1.51],HMGN2P39,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:59005492
rs9599110-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.8945 unit decrease,[0.53-1.26],PCDH9,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:66405989
rs79538982-<b>G</b>,2 x 10-9,(GEE model),NR,'-,1.4337 unit decrease,[0.96-1.9],"LINC00348, MTCL1P1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:70946701
rs7985509-<b>G</b>,1 x 10-8,(GEE model),NR,'-,0.81664 unit increase,[0.54-1.1],"LINC00564, DPPA3P3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:81170245
chr13:93655779-<b>AACTC</b>,1 x 10-6,(GEE model),NR,'-,1.2061 unit increase,[0.72-1.7],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs9559817-<b>A</b>,1 x 10-6,(GEE model),NR,'-,0.45677 unit decrease,[0.27-0.64],COL4A2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:110472624
rs57611377-<b>T</b>,1 x 10-7,(GEE model),NR,'-,0.95611 unit increase,[0.6-1.31],STXBP6,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:24804695
rs950010-<b>G</b>,2 x 10-7,(GEE model),NR,'-,0.96362 unit decrease,[0.6-1.33],GNG2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:51970017
rs138656381-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.93839 unit decrease,[0.55-1.33],FUT8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:65495566
rs79666627-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.89637 unit decrease,[0.5-1.29],FUT8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:65755293
rs117045930-<b>C</b>,1 x 10-7,(GEE model),NR,'-,1.273 unit decrease,[0.8-1.75],"SERPINA9, SERPINA11",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:94454310
rs2899492-<b>C</b>,6 x 10-7,(GEE model),NR,'-,0.62012 unit increase,[0.38-0.86],FAM214A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:52641065
rs150550955-<b>G</b>,2 x 10-7,(GEE model),NR,'-,1.2447 unit decrease,[0.78-1.71],PRTG,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:55719171
chr15:68055986-<b>A</b>,2 x 10-6,(GEE model),NR,'-,0.72052 unit decrease,[0.42-1.02],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs58226358-<b>T</b>,2 x 10-6,(GEE model),NR,'-,1.0128 unit decrease,[0.6-1.43],ADAMTS7P3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:77983053
rs186706570-<b>C</b>,4 x 10-7,(GEE model),NR,'-,1.0482 unit decrease,[0.64-1.45],LINC01579,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:93798258
rs79116212-<b>G</b>,5 x 10-7,(GEE model),NR,'-,0.87308 unit decrease,[0.53-1.21],VLDLR-AS1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:2448654
rs10122329-<b>G</b>,2 x 10-8,(GEE model),NR,'-,1.0368 unit increase,[0.67-1.4],"PUM3, GPS2P1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:2844360
chr9:17646666-<b>T</b>,3 x 10-6,(GEE model),NR,'-,1.0588 unit decrease,[0.61-1.51],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs10963978-<b>G</b>,2 x 10-6,(GEE model),NR,'-,1.1215 unit decrease,[0.66-1.58],PLIN2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:19139572
rs3731249-<b>C</b>,6 x 10-6,(GEE model),NR,'-,1.2609 unit decrease,[0.71-1.81],CDKN2A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:21970917
chr9:72111879-<b>AC</b>,8 x 10-7,(GEE model),NR,'-,0.67226 unit decrease,[0.4-0.94],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr9:75841708-<b>AT</b>,6 x 10-7,(GEE model),NR,'-,0.87695 unit increase,[0.53-1.22],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr9:80358202-<b>C</b>,3 x 10-7,(GEE model),NR,'-,0.99635 unit decrease,[0.62-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs7028759-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.67689 unit increase,[0.4-0.96],TRMO,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:97915601
rs3824497-<b>A</b>,4 x 10-6,(GEE model),NR,'-,0.72886 unit decrease,[0.42-1.04],GABBR2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:98453701
rs12686004-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.60571 unit increase,[0.36-0.86],ABCA1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:104891145
rs79523756-<b>C</b>,2 x 10-9,(GEE model),NR,'-,0.75083 unit decrease,[0.5-1],"KIF12, COL27A1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:114127254
rs10819287-<b>C</b>,3 x 10-9,(GEE model),NR,'-,1.1125 unit increase,[0.75-1.48],SLC2A8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:127404103
rs11250601-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.82215 unit decrease,[0.46-1.18],"ADARB2-AS1, ADARB2",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:1537583
rs148405458-<b>C</b>,4 x 10-8,(GEE model),NR,'-,1.0014 unit decrease,[0.64-1.36],LINC02668,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:3254357
rs181259817-<b>C</b>,4 x 10-6,(GEE model),NR,'-,0.92002 unit decrease,[0.53-1.31],PRKG1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:51756590
rs61851911-<b>G</b>,1 x 10-6,(GEE model),NR,'-,0.88856 unit decrease,[0.53-1.24],MRPS35P3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:58077561
rs11195365-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.67448 unit decrease,[0.4-0.95],PDCD4,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:110883279
chr10:112774958-<b>A</b>,9 x 10-7,(GEE model),NR,'-,0.75765 unit decrease,[0.45-1.06],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs182768834-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.87088 unit decrease,[0.52-1.23],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:129071311
rs72957958-<b>C</b>,7 x 10-6,(GEE model),NR,'-,0.84577 unit increase,[0.48-1.21],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:38108548
rs188620244-<b>G</b>,5 x 10-7,(GEE model),NR,'-,1.0576 unit increase,[0.65-1.47],"RNA5SP349, SNORD39",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:109218136
rs185433085-<b>C</b>,7 x 10-6,(GEE model),NR,'-,0.8837 unit decrease,[0.5-1.27],RNF214,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:117235353
rs74498740-<b>C</b>,5 x 10-7,(GEE model),NR,'-,1.228 unit increase,[0.75-1.71],DSCAML1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:117659180
rs73017762-<b>C</b>,1 x 10-6,(GEE model),NR,'-,1.0541 unit decrease,[0.63-1.48],FEZ1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:125560085
rs641615-<b>G</b>,4 x 10-7,(LME model),NR,'-,0.53685 unit decrease,[0.33-0.74],KRT5,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:52519125
rs10785192-<b>T</b>,2 x 10-6,(LME model),NR,'-,0.79444 unit decrease,[0.47-1.12],"KRR1, GLIPR1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:75491985
rs58107565-<b>G</b>,9 x 10-6,(LME model),NR,'-,0.47969 unit decrease,[0.27-0.69],TMEM132D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:129673196
rs80187936-<b>C</b>,7 x 10-6,(LME model),NR,'-,1.0617 unit decrease,[0.6-1.53],ATP8A2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:25959811
rs4534807-<b>C</b>,3 x 10-6,(LME model),NR,'-,0.47135 unit increase,[0.27-0.67],"TMCO5B, RYR3-DT",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:33283306
rs4776063-<b>C</b>,6 x 10-6,(LME model),NR,'-,0.5229 unit increase,[0.3-0.75],FAM214A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:52611849
rs12913603-<b>A</b>,7 x 10-6,(LME model),NR,'-,0.4172 unit decrease,[0.24-0.6],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:70376485
rs3176205-<b>T</b>,1 x 10-7,(LME model),NR,'-,0.4721 unit decrease,[0.3-0.65],POLG,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:89322461
rs138299341-<b>A</b>,2 x 10-6,(LME model),NR,'-,1.2753 unit increase,[0.75-1.81],RNU1-23P,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,20:24272354
rs12924820-<b>A</b>,2 x 10-6,(GEE model),NR,'-,0.47702 unit decrease,[0.28-0.67],"ATF7IP2, RN7SL493P",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:10274092
rs62030649-<b>G</b>,7 x 10-8,(GEE model),NR,'-,1.0277 unit decrease,[0.65-1.4],PRKCB,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:23860811
rs4949142-<b>A</b>,6 x 10-7,(GEE model),NR,'-,0.59647 unit decrease,[0.36-0.83],LINC02165,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:63720296
rs59395068-<b>T</b>,4 x 10-6,(GEE model),NR,'-,1.1214 unit increase,[0.64-1.6],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:79447990
chr17:9322274-<b>CCT</b>,4 x 10-6,(GEE model),NR,'-,0.44997 unit decrease,[0.26-0.64],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs79343067-<b>T</b>,4 x 10-6,(GEE model),NR,'-,1.2663 unit increase,[0.73-1.81],HDAC5,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:44119096
rs74592000-<b>C</b>,1 x 10-6,(GEE model),NR,'-,0.96807 unit increase,[0.57-1.36],LINC01982,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:52478681
chr17:56010692-<b>CCT</b>,4 x 10-6,(GEE model),NR,'-,0.45109 unit increase,[0.26-0.64],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs55994995-<b>A</b>,1 x 10-6,(GEE model),NR,'-,0.96571 unit decrease,[0.57-1.36],"GRB2, SLC25A19",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:75313351
rs2650243-<b>A</b>,1 x 10-6,(GEE model),NR,'-,0.81205 unit increase,[0.48-1.14],TBC1D16,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:79935540
rs1994558-<b>A</b>,7 x 10-6,(GEE model),NR,'-,0.41538 unit decrease,[0.23-0.6],CTIF,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,18:48806024
rs594284-<b>T</b>,1 x 10-8,(GEE model),NR,'-,0.90559 unit decrease,[0.59-1.22],LINC01916,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,18:65373686
rs73620745-<b>G</b>,6 x 10-6,(GEE model),NR,'-,1.2914 unit decrease,[0.73-1.85],"PIEZO1P1, EDN3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,20:59377140
rs742720-<b>T</b>,6 x 10-6,(GEE model),NR,'-,0.73415 unit decrease,[0.42-1.05],PPIAP1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,21:20862645
rs35108539-<b>T</b>,7 x 10-6,(GEE model),NR,'-,0.40059 unit increase,[0.23-0.58],"KRTAP7-1, KRTAP11-1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,21:30864151
chr2:19395907-<b>T</b>,9 x 10-6,(LME model),NR,'-,0.72481 unit increase,[0.41-1.04],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs192269070-<b>A</b>,4 x 10-6,(LME model),NR,'-,1.2594 unit increase,[0.73-1.79],"ANAPC1P3, MIR4771-1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:87124603
rs10182651-<b>A</b>,1 x 10-9,(LME model),NR,'-,0.63574 unit decrease,[0.43-0.84],"UGT1A12P, USP40",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:233575317
rs111747604-<b>C</b>,9 x 10-6,(LME model),NR,'-,0.85339 unit increase,[0.48-1.23],MBOAT1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:20177687
rs45604140-<b>C</b>,7 x 10-6,(LME model),NR,'-,0.65899 unit decrease,[0.37-0.95],PTK7,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:43131869
rs77801015-<b>A</b>,1 x 10-6,(LME model),NR,'-,0.82996 unit decrease,[0.5-1.16],MIR4643,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:91471198
rs4897203-<b>T</b>,1 x 10-6,(LME model),NR,'-,0.75243 unit increase,[0.45-1.05],TRDN,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:123371601
rs34919929-<b>G</b>,7 x 10-7,(LME model),NR,'-,0.48295 unit increase,[0.29-0.67],ZCWPW1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:100414711
rs117754360-<b>C</b>,6 x 10-6,(LME model),NR,'-,0.98912 unit decrease,[0.56-1.42],LINC00587,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:102673902
rs1545045-<b>A</b>,2 x 10-6,(LME model),NR,'-,0.5362 unit increase,[0.32-0.76],"TEX36-AS1, RPS27P18",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:125501459
rs12151021-<b>?</b>,2 x 10-13,,NR,'-,0.0772974 unit increase,'-,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:1050875
rs4147918-<b>?</b>,8 x 10-7,,NR,'-,0.120111 unit decrease,'-,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:1058177
rs4311-<b>?</b>,1 x 10-8,,NR,'-,0.0542811 unit decrease,'-,ACE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,17:63483402
rs3730025-<b>?</b>,3 x 10-7,,NR,'-,0.199405 unit increase,'-,ACE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,17:63480412
rs4775044-<b>?</b>,4 x 10-6,,NR,'-,0.0438743 unit decrease,'-,ALDH1A2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,15:58392768
rs442495-<b>?</b>,3 x 10-11,,NR,'-,0.0675868 unit decrease,'-,ADAM10,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,15:58730416
rs4817090-<b>?</b>,1 x 10-7,,NR,'-,0.0530908 unit increase,'-,APP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,21:26161943
rs2830489-<b>?</b>,3 x 10-8,,NR,'-,0.0589648 unit decrease,'-,ADAMTS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,21:26775872
rs7412-<b>?</b>,4 x 10-123,,NR,'-,0.435261 unit decrease,'-,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44908822
rs111358663-<b>?</b>,3 x 10-16,,NR,'-,0.353882 unit decrease,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44693688
rs4803774-<b>?</b>,5 x 10-15,,NR,'-,0.0747163 unit increase,'-,"APOC4-APOC2, APOC2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44947615
rs3112440-<b>?</b>,2 x 10-14,,NR,'-,0.102341 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44864753
rs71171301-<b>?</b>,5 x 10-29,,NR,'-,0.171993 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44879835
rs35194062-<b>?</b>,8 x 10-18,,NR,'-,0.198766 unit increase,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:45001919
rs283813-<b>?</b>,8 x 10-28,,NR,'-,0.20705 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44885917
rs138607350-<b>?</b>,4 x 10-102,,NR,'-,1.03437 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44860563
rs146275714-<b>?</b>,1 x 10-300,,NR,'-,1.11415 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44862190
rs429358-<b>?</b>,1 x 10-300,,NR,'-,1.17924 unit increase,'-,'-,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,Mapping not available
rs12691088-<b>?</b>,1 x 10-300,,NR,'-,1.18305 unit increase,'-,APOC1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44915229
rs7584040-<b>?</b>,2 x 10-6,,NR,'-,0.0537322 unit increase,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:127105648
rs6733839-<b>?</b>,1 x 10-54,,NR,'-,0.155615 unit increase,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:127135234
rs867230-<b>?</b>,8 x 10-26,,NR,'-,0.105124 unit decrease,'-,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,8:27610986
rs73223431-<b>?</b>,2 x 10-15,,NR,'-,0.0790484 unit increase,'-,PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,8:27362470
rs12703526-<b>?</b>,1 x 10-11,,NR,'-,0.0654321 unit decrease,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,7:143410495
rs10265814-<b>?</b>,3 x 10-10,,NR,'-,0.0607201 unit increase,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,7:143424528
rs143080277-<b>?</b>,1 x 10-12,,NR,'-,0.520528 unit increase,'-,NCK2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:105749599
rs116038905-<b>?</b>,3 x 10-6,,NR,'-,0.150266 unit decrease,'-,NCK2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:105805908
rs3857580-<b>?</b>,1 x 10-7,,NR,'-,0.0503548 unit decrease,'-,TREML5P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,6:41248596
rs114812713-<b>?</b>,1 x 10-12,,NR,'-,0.208485 unit increase,'-,OARD1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,6:41066261
rs187370608-<b>?</b>,2 x 10-23,,NR,'-,0.796876 unit increase,'-,UNC5CL,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,6:40974457
rs56131196-<b>A</b>,4 x 10-12,(Cortical Ab),0.29,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,19:44919589
rs6857-<b>T</b>,1 x 10-10,(Cortical Ab),0.28,'-,'-,'-,NECTIN2,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,19:44888997
rs59007384-<b>T</b>,7 x 10-9,(Cortical Ab),0.32,'-,'-,'-,TOMM40,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,19:44893408
rs7702276-<b>T</b>,1 x 10-6,(Cortical Ab),0.36,'-,'-,'-,MFSD4BP1,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,5:52509908
rs24449894-<b>A</b>,2 x 10-6,(Cortical Ab),0.17,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,Mapping not available
rs7039300-<b>G</b>,2 x 10-6,(Cortical Ab),0.23,'-,'-,'-,"RPL3P11, ATP5PDP3",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,9:14064742
rs9384488-<b>A</b>,3 x 10-6,(Cortical Ab),0.35,'-,'-,'-,"H3P28, ARID1B",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,6:156688247
rs10219670-<b>C</b>,4 x 10-6,(Cortical Ab),0.42,'-,'-,'-,CASC18,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,12:105714941
Position173336636-<b>A</b>,6 x 10-7,(Cortical Ab),0.43,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,Mapping not available
rs509208-<b>G</b>,3 x 10-8,(Cortical Ab),0.16,'-,'-,'-,CCDC66,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,3:166296681
rs113524839-<b>T</b>,8 x 10-7,(Cortical Ab),0.11,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,5:84788958
rs1422438-<b>G</b>,6 x 10-7,(Cortical Ab),0.3,'-,'-,'-,"RN7SL782P, RN7SKP122",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,5:107775475
rs429358-<b>C</b>,5 x 10-14,(Cortical Ab),0.28,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,Mapping not available
rs62209-<b>C</b>,2 x 10-7,(APOE E4 homozygotes),NR,2.04,'-,[1.56-2.67],CELF2,Alzheimer's disease (late onset),Alzheimer's disease,GCST000980,10:10958376
rs4968782-<b>G</b>,4 x 10-12,(Angiotensin-converting enzyme),NR,'-,'-,'-,"PPIAP55, CYB561",Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"angiotensin-converting enzyme measurement, Alzheimer's disease, Alzheimer's disease biomarker measurement",GCST002665,17:63471115
rs61812598-<b>G</b>,6 x 10-63,(Interleukin-6 receptor),NR,'-,'-,'-,IL6R,Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"Alzheimer's disease, interleukin-6 measurement, Alzheimer's disease biomarker measurement",GCST002665,1:154447611
rs6808835-<b>G</b>,2 x 10-13,(Macrophage Inflammatory protein-1 beta),NR,'-,'-,'-,CCRL2,Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"Alzheimer's disease, CCL4 measurement, Alzheimer's disease biomarker measurement",GCST002665,3:46408373
rs573521-<b>A</b>,2 x 10-44,(Matrix metalloproteinase-3),NR,'-,'-,'-,"MMP3, MMP12",Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"matrix metalloproteinase measurement, Alzheimer's disease, Alzheimer's disease biomarker measurement",GCST002665,11:102846249
rs2228467-<b>G</b>,4 x 10-18,(Monocyte chemotactic protein 1),NR,'-,'-,'-,"ACKR2, KRBOX1, CYP8B1",Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"Alzheimer's disease, Alzheimer's disease biomarker measurement, CCL2 measurement",GCST002665,3:42864624
rs75932628-<b>T</b>,2 x 10-12,,0.0063,2.9,'-,[2.16-3.91],TREM2,Alzheimer's disease,Alzheimer's disease,GCST001743,6:41161514
rs2373115-<b>G</b>,1 x 10-10,,0.7,4.06,'-,[2.81-14.69],GAB2,Alzheimer's disease (late onset),Alzheimer's disease,GCST000046,11:78380104
rs2121433-<b>?</b>,1 x 10-6,(t-tau),NR,'-,'-,'-,"EPC2, RNU2-9P",Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST000900,2:148800291
rs157580-<b>?</b>,1 x 10-6,(AB1-42),NR,'-,'-,'-,TOMM40,Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST000900,19:44892009
rs7364180-<b>?</b>,1 x 10-6,(AB1-42),NR,'-,'-,'-,CCDC134,Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST000900,22:41822852
rs4499362-<b>?</b>,1 x 10-6,(t-tau/AB1-42),NR,'-,'-,'-,"RNU2-9P, EPC2",Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement, t-tau measurement",GCST000900,2:148810827
rs2075650-<b>?</b>,1 x 10-6,"(p-tau181p/AB1-42, t-tau/AB1-42)",NR,'-,'-,'-,TOMM40,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement",GCST000900,19:44892362
rs429358-<b>?</b>,1 x 10-6,"(AB1-42, p-tau181p, p-tau181p/AB1-42, t-tau/AB1-42)",NR,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement",GCST000900,Mapping not available
rs439401-<b>?</b>,1 x 10-6,(AB1-42),NR,'-,'-,'-,"APOC1, APOE",Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST000900,19:44911194
rs4420638-<b>?</b>,8 x 10-149,,NR,3.45,'-,[NR],"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST001529,19:44919689
rs11738335-<b>?</b>,5 x 10-6,,NR,1.2,'-,[NR],C5orf64,Alzheimer's disease,Alzheimer's disease,GCST001529,5:61654384
rs12808148-<b>?</b>,1 x 10-6,,NR,1.23,'-,[NR],"MMP12, MMP3",Alzheimer's disease,Alzheimer's disease,GCST001529,11:102862432
rs1357692-<b>?</b>,9 x 10-6,,NR,1.16,'-,[NR],DHFRP3,Alzheimer's disease,Alzheimer's disease,GCST001529,2:107062032
rs7561528-<b>?</b>,6 x 10-11,,NR,1.25,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease,Alzheimer's disease,GCST001529,2:127132061
rs17817600-<b>?</b>,2 x 10-8,,NR,1.33,'-,[NR],PICALM,Alzheimer's disease,Alzheimer's disease,GCST001529,11:85966428
rs3748140-<b>?</b>,3 x 10-7,,NR,2.43,'-,[NR],PPP1R3B,Alzheimer's disease,Alzheimer's disease,GCST001529,8:9141509
rs6856768-<b>?</b>,5 x 10-6,,NR,1.18,'-,[NR],RN7SKP199,Alzheimer's disease,Alzheimer's disease,GCST001529,4:30466544
rs9832461-<b>A</b>,4 x 10-6,,0.24,'-,3785.6 unit increase,[NR],NFU1P1,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,3:39708102
rs1448284-<b>T</b>,2 x 10-6,,0.03,'-,9939.9 unit increase,[NR],MAPRE1P2,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,4:33078033
rs11055612-<b>C</b>,3 x 10-6,,0.5,'-,3371.6 unit decrease,[NR],GRIN2B,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,12:13770394
rs7155434-<b>A</b>,8 x 10-6,,0.27,'-,3643 unit increase,[NR],NRXN3,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,14:78308963
rs2456930-<b>G</b>,3 x 10-7,,0.38,'-,3843.9 unit increase,[NR],TLN2,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,15:62395140
rs17636071-<b>G</b>,2 x 10-6,(MMSE),0.09,'-,4.74 unit decrease,[NR],'-,Response to cholinesterase inhibitors in Alzheimer's disease,"response to cholinesterase inhibitor, Alzheimer's disease",GCST001835,Mapping not available
rs2270875-<b>G</b>,9 x 10-6,(MMSE),0.16,'-,2.84 unit decrease,[NR],EFR3A,Response to cholinesterase inhibitors in Alzheimer's disease,"response to cholinesterase inhibitor, Alzheimer's disease",GCST001835,8:131987689
rs17798800-<b>?</b>,7 x 10-6,(cases vs. controls),0.71,2.63,'-,[1.72-4],LINC02343,Response to cholinesterase inhibitors in Alzheimer's disease,"response to cholinesterase inhibitor, Alzheimer's disease",GCST001835,13:34376390
rs11159647-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST000255,14:84308865
rs3826656-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"CD33, SIGLEC22P",Alzheimer's disease,Alzheimer's disease,GCST000255,19:51223357
rs3117006-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,HLA-DPB2,Asthma and attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, asthma",GCST008919,6:33128931
rs183882582-<b>T</b>,2 x 10-8,,0.98,1.43,'-,[1.26-1.60],"RSPH3, RNU6-293P",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,6:158963192
rs3958046-<b>T</b>,2 x 10-8,,0.4,1.09,'-,[1.06-1.10],"FEZF1, CADPS2",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,7:122315274
rs200721207-<b>T</b>,4 x 10-8,,0.66,1.1,'-,[1.06-1.13],"LINC02497, PCDH7",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,4:31149844
rs1920644-<b>T</b>,5 x 10-8,,0.52,1.09,'-,[1.05-1.12],"ARL14, RPL6P8",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,3:160595566
rs4858241-<b>T</b>,5 x 10-7,,NR,1.08,'-,[1.05-1.12],SGO1-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,3:20627579
rs1427829-<b>A</b>,6 x 10-7,,NR,1.08,'-,[1.05-1.11],"DUSP6, POC1B",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,12:89366967
rs281324-<b>?</b>,7 x 10-7,,NR,1.0752687,'-,[1.04-1.11],SEMA6D,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST010291,15:47461821
rs28768443-<b>?</b>,6 x 10-7,,0.81,1.1494253,'-,[1.09-1.22],'-,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,14:29285390
rs3923931-<b>A</b>,2 x 10-7,,0.11,1.2,'-,[1.12-1.28],CNBD1,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,8:87401743
rs10962864-<b>T</b>,5 x 10-7,,0.16,1.16,'-,[1.09-1.23],"RN7SL720P, RPS29P33",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,9:17091466
rs4836899-<b>T</b>,3 x 10-7,,0.52,1.12,'-,[1.07-1.17],ASTN2,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,9:116894150
rs74030106-<b>?</b>,2 x 10-6,,0.05,1.2820514,'-,[1.16-1.43],TMC3-AS1,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,15:81525290
rs113773212-<b>?</b>,2 x 10-6,,0.05,1.2820514,'-,[1.16-1.41],LINC00917,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,16:86361158
rs57422381-<b>?</b>,3 x 10-6,,0.07,1.2195122,'-,[1.12-1.33],"MBNL2, LINC00456",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,13:97205239
rs35835615-<b>?</b>,1 x 10-6,,0.09,1.2048193,'-,[1.11-1.3],"ERLIN1, SPCS2P2",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,10:100145181
rs75311156-<b>?</b>,4 x 10-6,,0.82,1.1627907,'-,[1.09-1.23],"OR5H5P, OR5H3P",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,3:98198801
rs2832008-<b>?</b>,4 x 10-6,,0.14,1.1494253,'-,[1.09-1.23],U6,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,21:28737676
rs876538-<b>?</b>,2 x 10-6,,0.79,1.1363636,'-,[1.09-1.2],"CRP, CRPP1",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,1:159705927
rs296884-<b>?</b>,1 x 10-6,,0.74,1.1235955,'-,[1.08-1.19],"C9orf64, HNRNPK",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,9:83968008
rs145190003-<b>?</b>,3 x 10-6,,0.26,1.1235955,'-,[1.06-1.18],CNTLN,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,9:17263750
rs9661242-<b>?</b>,2 x 10-6,,0.48,1.1111112,'-,[1.06-1.16],'-,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,1:29615908
rs393488-<b>?</b>,3 x 10-6,,0.53,1.1111112,'-,[1.06-1.16],RN7SL720P,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,9:17044973
rs6540899-<b>A</b>,2 x 10-6,,0.12,1.21,'-,[1.12-1.31],KCTD3,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,1:215479116
rs13019774-<b>T</b>,1 x 10-6,,0.39,1.12,'-,[1.07-1.17],"RNA5SP107, GALNT13",Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,2:154505440
rs13088735-<b>T</b>,3 x 10-6,,0.02,1.48,'-,[1.25-1.75],LMCD1-AS1,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,3:8123815
rs895614-<b>A</b>,4 x 10-6,,0.29,1.13,'-,[1.07-1.19],RNU6-276P,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,4:55792612
rs34846424-<b>T</b>,4 x 10-6,,0.36,1.11,'-,[1.06-1.16],LINC02374,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,4:187244864
rs35854754-<b>CT</b>,3 x 10-6,,0.94,1.27,'-,[1.15-1.40],'-,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,6:91356930
rs6475111-<b>T</b>,5 x 10-6,,0.26,1.13,'-,[1.07-1.18],CNTLN,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,9:17162415
rs1537617-<b>A</b>,2 x 10-6,,0.84,1.17,'-,[1.10-1.25],'-,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,10:2740611
rs55654452-<b>G</b>,2 x 10-6,,0.56,1.11,'-,[1.06-1.16],ZNF521,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,18:25064312
rs35782676-<b>T</b>,4 x 10-6,,0.77,1.13,'-,[1.07-1.19],ZNF584,Attention deficit hyperactivity disorder (persistent),attention deficit hyperactivity disorder,GCST010290,19:58414978
rs138596453-<b>?</b>,6 x 10-7,,0.98,1.4925373,'-,[1.27-1.75],GAB4,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,22:17006586
rs1610098-<b>?</b>,8 x 10-7,,0.37,1.1111112,'-,[1.06-1.15],SEMA6D,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,15:47513815
rs191624305-<b>T</b>,2 x 10-7,,0.9,1.21,'-,[1.13-1.30],TNR,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,1:175353170
rs55686778-<b>T</b>,2 x 10-7,,0.19,1.15,'-,[1.09-1.21],TMEM114,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,16:8458589
rs11255938-<b>?</b>,2 x 10-6,,0.54,1.098901,'-,[1.06-1.15],LINC02676,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,10:8808772
rs79221481-<b>T</b>,3 x 10-6,,0.03,1.39,'-,[1.21-1.60],EPCAM-DT,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,2:47277861
rs795989-<b>A</b>,2 x 10-6,,0.68,1.11,'-,[1.07-1.17],MAML3,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,4:139808192
rs526318-<b>T</b>,3 x 10-6,,0.54,1.1,'-,[1.06-1.15],RNA5SP214,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,6:117070716
rs536749404-<b>T</b>,3 x 10-6,,0.14,1.17,'-,[1.10-1.25],'-,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,8:13806960
rs1858800-<b>T</b>,1 x 10-6,,0.35,1.12,'-,[1.07-1.17],'-,Attention deficit hyperactivity disorder (childhood),attention deficit hyperactivity disorder,GCST010289,Mapping not available
rs7463256-<b>T</b>,3 x 10-6,,NR,'-,'-,'-,CHMP7,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000751,8:23244107
rs1027730-<b>A</b>,7 x 10-6,,NR,'-,'-,'-,"C8orf87, MIR8084",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000751,8:93073310
rs1464807-<b>T</b>,1 x 10-6,,NR,'-,'-,'-,SEM1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000751,7:96733032
rs12680109-<b>T</b>,7 x 10-6,,NR,'-,'-,'-,"Metazoa_SRP, RN7SL675P",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000751,8:69897026
rs10485813-<b>A</b>,8 x 10-6,,NR,'-,'-,'-,"TSHZ2, RPL36P1",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST000751,20:52967444
rs5016282-<b>A</b>,1 x 10-6,,NR,'-,'-,'-,GRM5,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001287,11:89008492
rs2556378-<b>T</b>,7 x 10-6,,NR,'-,'-,'-,BCL11A,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST001287,2:60535367
rs9839776-<b>T</b>,3 x 10-7,,0.27,1.158,'-,[1.095-1.225],SOX2-OT,Anorexia nervosa,anorexia nervosa,GCST002354,3:181593779
rs17030795-<b>G</b>,6 x 10-6,,0.192,1.149,'-,[1.082-1.220],PPP3CA,Anorexia nervosa,anorexia nervosa,GCST002354,4:101126919
rs2422320-<b>T</b>,2 x 10-11,,0.43,'-,'-,'-,LINC02797,Broad depression or major depressive disorder (self-reported),unipolar depression,GCST007254,1:72827649
rs7714851-<b>T</b>,8 x 10-16,,0.52,'-,'-,'-,'-,Broad depression or major depressive disorder (self-reported),unipolar depression,GCST007254,5:165048768
rs9368649-<b>A</b>,1 x 10-8,,0.14,'-,'-,'-,"MUC21, NAPGP2",Broad depression or major depressive disorder (self-reported),unipolar depression,GCST007254,6:30971106
rs9323497-<b>T</b>,4 x 10-9,,0.05,'-,'-,'-,PLEK2,Broad depression or major depressive disorder (recurrent),unipolar depression,GCST007256,14:67406411
rs396755-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,RNU6-334P,Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,5:104686538
rs301817-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,RERE,Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,1:8443319
rs10789340-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,'-,Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,1:72474590
rs7775835-<b>T</b>,2 x 10-8,,NR,'-,5.588 z score decrease,'-,"LINC00533, RPSAP2",Depression,unipolar depression,GCST006477,6:28710580
rs8089865-<b>A</b>,3 x 10-11,,NR,'-,6.624 z score increase,'-,DCC,Depression,unipolar depression,GCST006477,18:53431552
rs8099160-<b>A</b>,2 x 10-14,,NR,'-,7.638 z score increase,'-,DCC,Depression,unipolar depression,GCST006477,18:53226240
rs8181889-<b>A</b>,4 x 10-8,,NR,'-,5.489 z score decrease,'-,OLFM4,Depression,unipolar depression,GCST006477,13:53039855
rs848293-<b>A</b>,2 x 10-8,,NR,'-,5.644 z score decrease,'-,VRK2,Depression,unipolar depression,GCST006477,2:58155355
rs9592461-<b>A</b>,2 x 10-12,,NR,'-,7.062 z score increase,'-,PCDH9,Depression,unipolar depression,GCST006477,13:66367660
rs9611460-<b>T</b>,2 x 10-8,,NR,'-,5.596 z score decrease,'-,"RBX1, Y_RNA",Depression,unipolar depression,GCST006477,22:41022293
rs4846314-<b>A</b>,6 x 10-6,,0.25004333,'-,0.14602003 unit increase,[0.083-0.209],XRCC6P3,Menstruation quality of life impact (depression),"quality of life during menstruation measurement, unipolar depression",GCST006644,1:220325294
rs454214-<b>T</b>,4 x 10-8,,NR,'-,5.486 z score decrease,'-,MEF2C-AS2,Depression,unipolar depression,GCST006477,5:88707586
rs4543289-<b>T</b>,4 x 10-8,,NR,'-,5.502 z score decrease,'-,'-,Depression,unipolar depression,GCST006477,5:165057942
rs4799936-<b>A</b>,2 x 10-8,,NR,'-,5.638 z score decrease,'-,CELF4,Depression,unipolar depression,GCST006477,18:37524865
rs4801157-<b>T</b>,4 x 10-8,,NR,'-,5.495 z score increase,'-,TCF4,Depression,unipolar depression,GCST006477,18:55497462
rs4883777-<b>T</b>,1 x 10-8,,NR,'-,5.712 z score increase,'-,PCDH9,Depression,unipolar depression,GCST006477,13:66400574
rs55748329-<b>A</b>,1 x 10-9,,NR,'-,6.101 z score increase,'-,BAIAP2,Depression,unipolar depression,GCST006477,17:81071973
rs586533-<b>T</b>,2 x 10-9,,NR,'-,6.029 z score decrease,'-,CNTN5,Depression,unipolar depression,GCST006477,11:99649777
rs6019826-<b>T</b>,9 x 10-9,,NR,'-,5.744 z score increase,'-,KCNB1,Depression,unipolar depression,GCST006477,20:49426433
rs6066975-<b>A</b>,4 x 10-8,,NR,'-,5.471 z score decrease,'-,STAU1,Depression,unipolar depression,GCST006477,20:49133840
rs62097899-<b>T</b>,8 x 10-10,,NR,'-,6.145 z score increase,'-,DCC,Depression,unipolar depression,GCST006477,18:52991139
rs6441175-<b>A</b>,2 x 10-9,,NR,'-,6.039 z score decrease,'-,RSRC1,Depression,unipolar depression,GCST006477,3:158139321
rs935526-<b>T</b>,5 x 10-8,,NR,'-,5.452 z score decrease,'-,ROBO2,Depression,unipolar depression,GCST006477,3:77510866
rs6442260-<b>A</b>,5 x 10-8,,NR,'-,5.455 z score decrease,'-,ATG7,Depression,unipolar depression,GCST006477,3:11549277
rs645592-<b>T</b>,3 x 10-8,,NR,'-,5.571 z score decrease,'-,TYR,Depression,unipolar depression,GCST006477,11:89271726
rs6562505-<b>A</b>,5 x 10-8,,NR,'-,5.467 z score decrease,'-,'-,Depression,unipolar depression,GCST006477,13:67627955
rs6695867-<b>A</b>,5 x 10-9,,NR,'-,5.855 z score decrease,'-,RERE,Depression,unipolar depression,GCST006477,1:8670720
rs6882046-<b>A</b>,1 x 10-8,,NR,'-,5.663 z score decrease,'-,LINC00461,Depression,unipolar depression,GCST006477,5:88673046
rs7170398-<b>T</b>,2 x 10-8,,NR,'-,5.618 z score increase,'-,LINGO1,Depression,unipolar depression,GCST006477,15:77775291
rs7193263-<b>A</b>,9 x 10-11,,NR,'-,6.478 z score decrease,'-,RBFOX1,Depression,unipolar depression,GCST006477,16:6265879
rs72733826-<b>A</b>,3 x 10-9,,NR,'-,5.911 z score increase,'-,SEMA6D,Depression,unipolar depression,GCST006477,15:47424966
rs73117594-<b>T</b>,2 x 10-8,,NR,'-,5.659 z score increase,'-,"MRPS17P3, ROBO1",Depression,unipolar depression,GCST006477,3:78544763
rs7505145-<b>A</b>,2 x 10-8,,NR,'-,5.622 z score decrease,'-,DCC,Depression,unipolar depression,GCST006477,18:53185406
rs77087420-<b>A</b>,2 x 10-10,,NR,'-,6.399 z score increase,'-,KIAA1109,Depression,unipolar depression,GCST006477,4:122201701
rs775766-<b>A</b>,2 x 10-8,,NR,'-,5.659 z score increase,'-,ROBO2,Depression,unipolar depression,GCST006477,3:77542041
rs77741769-<b>T</b>,8 x 10-9,,NR,'-,5.775 z score increase,'-,"RPL12P33, HNF1A-AS1",Depression,unipolar depression,GCST006477,12:120926032
rs1656369-<b>A</b>,5 x 10-9,,NR,'-,5.844 z score decrease,'-,"MLF1, RSRC1",Depression,unipolar depression,GCST006477,3:158562296
rs1706497-<b>T</b>,3 x 10-8,,NR,'-,5.54 z score increase,'-,LINC02824,Depression,unipolar depression,GCST006477,12:126713136
rs17487383-<b>C</b>,4 x 10-8,,NR,'-,5.502 z score decrease,'-,SOX5,Depression,unipolar depression,GCST006477,12:24126651
rs17828731-<b>T</b>,1 x 10-8,,NR,'-,5.668 z score increase,'-,LINC02882,Depression,unipolar depression,GCST006477,12:73941576
rs1946473-<b>A</b>,3 x 10-8,,NR,'-,5.548 z score decrease,'-,CDH9,Depression,unipolar depression,GCST006477,5:26972576
rs1961639-<b>A</b>,4 x 10-9,,NR,'-,5.891 z score decrease,'-,SORCS3,Depression,unipolar depression,GCST006477,10:104876239
rs200990-<b>T</b>,4 x 10-10,,NR,'-,6.256 z score increase,'-,H2BC15,Depression,unipolar depression,GCST006477,6:27848045
rs2056477-<b>C</b>,4 x 10-8,,NR,'-,5.472 z score decrease,'-,MAD1L1,Depression,unipolar depression,GCST006477,7:2040109
rs2064219-<b>A</b>,8 x 10-10,,NR,'-,6.152 z score increase,'-,"ZNF184, MCFD2P1",Depression,unipolar depression,GCST006477,6:27408222
rs2098651-<b>C</b>,2 x 10-10,,NR,'-,6.344 z score increase,'-,TENM2,Depression,unipolar depression,GCST006477,5:167564265
rs2149351-<b>T</b>,3 x 10-8,,NR,'-,5.553 z score increase,'-,TLR4,Depression,unipolar depression,GCST006477,9:117739366
rs2191130-<b>T</b>,1 x 10-9,,NR,'-,6.099 z score increase,'-,RBFOX1,Depression,unipolar depression,GCST006477,16:7617795
rs2304607-<b>A</b>,1 x 10-9,,NR,'-,6.059 z score decrease,'-,MEF2C-AS2,Depression,unipolar depression,GCST006477,5:88692916
rs2721811-<b>A</b>,4 x 10-8,,NR,'-,5.502 z score decrease,'-,GSDME,Depression,unipolar depression,GCST006477,7:24709810
rs2806985-<b>C</b>,2 x 10-8,,NR,'-,5.631 z score increase,'-,LINC01065,Depression,unipolar depression,GCST006477,13:53103588
rs2956287-<b>A</b>,5 x 10-11,,NR,'-,6.573 z score decrease,'-,'-,Depression,unipolar depression,GCST006477,12:84315437
rs301795-<b>A</b>,8 x 10-9,,NR,'-,5.774 z score decrease,'-,RERE,Depression,unipolar depression,GCST006477,1:8407293
rs301807-<b>A</b>,1 x 10-10,,NR,'-,6.407 z score increase,'-,"RERE-AS1, RERE",Depression,unipolar depression,GCST006477,1:8424763
rs3787317-<b>T</b>,9 x 10-10,,NR,'-,6.119 z score increase,'-,KCNB1,Depression,unipolar depression,GCST006477,20:49424674
rs3793577-<b>A</b>,3 x 10-12,,NR,'-,6.992 z score decrease,'-,ELAVL2,Depression,unipolar depression,GCST006477,9:23737629
rs3799380-<b>T</b>,8 x 10-9,,NR,'-,5.773 z score increase,'-,BTN2A1,Depression,unipolar depression,GCST006477,6:26466954
rs3806843-<b>T</b>,1 x 10-9,,NR,'-,6.049 z score decrease,'-,"PCDHA5, PCDHA6, PCDHA1, PCDHA2, PCDHA4, PCDHA3",Depression,unipolar depression,GCST006477,5:140832953
rs3823612-<b>C</b>,5 x 10-11,,NR,'-,6.582 z score increase,'-,TMEM106B,Depression,unipolar depression,GCST006477,7:12219129
rs4277413-<b>A</b>,1 x 10-11,,NR,'-,6.77 z score decrease,'-,DCC,Depression,unipolar depression,GCST006477,18:53172556
rs4480613-<b>T</b>,3 x 10-9,,NR,'-,5.925 z score increase,'-,'-,Depression,unipolar depression,GCST006477,12:84099287
rs10274968-<b>T</b>,1 x 10-8,,NR,'-,5.711 z score increase,'-,VPS41,Depression,unipolar depression,GCST006477,7:38899654
rs10811965-<b>T</b>,2 x 10-8,,NR,'-,5.629 z score decrease,'-,ELAVL2,Depression,unipolar depression,GCST006477,9:23741280
rs10830220-<b>C</b>,1 x 10-9,,NR,'-,6.096 z score decrease,'-,"TYR, GRM5",Depression,unipolar depression,GCST006477,11:89140984
rs10896636-<b>C</b>,3 x 10-9,,NR,'-,5.958 z score decrease,'-,ZDHHC5,Depression,unipolar depression,GCST006477,11:57680560
rs11124319-<b>A</b>,2 x 10-8,,NR,'-,5.618 z score decrease,'-,'-,Depression,unipolar depression,GCST006477,2:22212484
rs1150313-<b>A</b>,1 x 10-9,,NR,'-,6.09 z score increase,'-,GRM5,Depression,unipolar depression,GCST006477,11:88962678
rs1151849-<b>A</b>,2 x 10-8,,NR,'-,5.6 z score decrease,'-,SPPL3,Depression,unipolar depression,GCST006477,12:120902796
rs11629621-<b>C</b>,4 x 10-8,,NR,'-,5.48 z score decrease,'-,LINGO1,Depression,unipolar depression,GCST006477,15:77788395
rs11665070-<b>A</b>,2 x 10-9,,NR,'-,6.036 z score decrease,'-,"MIR4318, CELF4",Depression,unipolar depression,GCST006477,18:37572600
rs11688767-<b>A</b>,3 x 10-8,,NR,'-,5.533 z score decrease,'-,ACTG1P22,Depression,unipolar depression,GCST006477,2:57761059
rs117319730-<b>C</b>,3 x 10-8,,NR,'-,5.539 z score decrease,'-,SEMA6D,Depression,unipolar depression,GCST006477,15:47400457
rs12073845-<b>T</b>,3 x 10-8,,NR,'-,5.524 z score decrease,'-,HMGB1P18,Depression,unipolar depression,GCST006477,1:80332225
rs12376738-<b>T</b>,2 x 10-8,,NR,'-,5.651 z score increase,'-,FAM120A,Depression,unipolar depression,GCST006477,9:93539518
rs12552-<b>A</b>,2 x 10-10,,NR,'-,6.366 z score increase,'-,OLFM4,Depression,unipolar depression,GCST006477,13:53051646
rs1261070-<b>A</b>,1 x 10-8,,NR,'-,5.701 z score decrease,'-,TCF4,Depression,unipolar depression,GCST006477,18:55235854
rs12713370-<b>A</b>,2 x 10-9,,NR,'-,6.035 z score decrease,'-,VRK2,Depression,unipolar depression,GCST006477,2:57973613
rs12963231-<b>A</b>,3 x 10-8,,NR,'-,5.525 z score increase,'-,LINC01929,Depression,unipolar depression,GCST006477,18:55100746
rs12968428-<b>A</b>,2 x 10-12,,NR,'-,7.065 z score increase,'-,DCC,Depression,unipolar depression,GCST006477,18:53223855
rs13218591-<b>T</b>,2 x 10-8,,NR,'-,5.608 z score increase,'-,BTN3A2,Depression,unipolar depression,GCST006477,6:26376604
rs1322944-<b>A</b>,2 x 10-9,,NR,'-,5.979 z score increase,'-,LINC01065,Depression,unipolar depression,GCST006477,13:53109028
rs1427027-<b>T</b>,2 x 10-8,,NR,'-,5.627 z score increase,'-,"RPL12P40, MIR4318",Depression,unipolar depression,GCST006477,18:37666359
rs1431181-<b>A</b>,3 x 10-12,,NR,'-,6.958 z score increase,'-,DCC,Depression,unipolar depression,GCST006477,18:53253042
rs1452788-<b>A</b>,5 x 10-8,,NR,'-,5.454 z score decrease,'-,TCF4,Depression,unipolar depression,GCST006477,18:55450073
rs149389640-<b>A</b>,7 x 10-10,,NR,'-,6.175 z score increase,'-,CCDC170,Depression,unipolar depression,GCST006477,6:151604372
rs149735550-<b>T</b>,3 x 10-8,,NR,'-,5.529 z score increase,'-,DCC,Depression,unipolar depression,GCST006477,18:52866733
rs6666516-<b>A</b>,6 x 10-6,,0.492379,1.071,'-,[1.04-1.1],RN7SL299P,Major depressive disorder,unipolar depression,GCST009979,1:232192655
rs4501813-<b>G</b>,8 x 10-6,,0.939503,1.071,'-,[1.04-1.1],"KLHDC7A, DYNLL1P3",Major depressive disorder,unipolar depression,GCST009979,1:18490385
rs10247376-<b>C</b>,8 x 10-6,,0.0276479,1.071,'-,[1.04-1.1],RAPGEF5,Major depressive disorder,unipolar depression,GCST009979,7:22085200
rs141208948-<b>G</b>,3 x 10-6,,0.0205973,1.072,'-,[1.04-1.1],'-,Major depressive disorder,unipolar depression,GCST009979,11:103612982
rs1504721-<b>C</b>,4 x 10-6,,0.397784,1.072,'-,[1.04-1.1],CNTN5,Major depressive disorder,unipolar depression,GCST009979,11:99397886
rs35864932-<b>C</b>,4 x 10-6,,0.474933,1.072,'-,[1.04-1.1],RNF213,Major depressive disorder,unipolar depression,GCST009979,17:80308082
rs10476497-<b>A</b>,5 x 10-6,,0.534226,1.072,'-,[1.04-1.1],LINC01938,Major depressive disorder,unipolar depression,GCST009979,5:165161811
rs116100277-<b>T</b>,1 x 10-6,,0.0144628,1.073,'-,[1.04-1.1],'-,Major depressive disorder,unipolar depression,GCST009979,6:51300739
rs1676905-<b>G</b>,3 x 10-6,,0.92639,1.073,'-,[1.04-1.1],"RNY4, RNY3",Major depressive disorder,unipolar depression,GCST009979,7:148974185
rs116842147-<b>T</b>,6 x 10-7,,0.0105958,1.075,'-,[1.05-1.1],UFL1-AS1,Major depressive disorder,unipolar depression,GCST009979,6:96479972
rs7568777-<b>A</b>,1 x 10-6,,0.1858,1.075,'-,[1.04-1.11],"RTN4, CLHC1",Major depressive disorder,unipolar depression,GCST009979,2:55156291
rs2466882-<b>A</b>,1 x 10-6,,0.582441,1.076,'-,[1.05-1.11],'-,Major depressive disorder,unipolar depression,GCST009979,12:22903786
rs34071114-<b>T</b>,4 x 10-7,,0.046004,1.077,'-,[1.05-1.11],"SLC25A5P1, WBP2NL",Major depressive disorder,unipolar depression,GCST009979,22:42000886
rs30266-<b>A</b>,2 x 10-7,,0.333712,1.082,'-,[1.05-1.11],'-,Major depressive disorder,unipolar depression,GCST009979,5:104636656
rs3807866-<b>A</b>,1 x 10-7,,0.398234,1.084,'-,[1.05-1.11],TMEM106B,Major depressive disorder,unipolar depression,GCST009979,7:12210752
rs35514087-<b>G</b>,2 x 10-7,,0.0476509,1.086,'-,[1.05-1.12],'-,Major depressive disorder,unipolar depression,GCST009979,5:136696864
rs11515172-<b>T</b>,4 x 10-8,,0.784243,1.0869565,'-,[1.06-1.12],'-,Major depressive disorder,unipolar depression,GCST009979,9:11256041
rs144213213-<b>C</b>,2 x 10-7,,0.9809848,1.0857763,'-,[1.05-1.12],'-,Major depressive disorder,unipolar depression,GCST009979,14:84015812
rs138879850-<b>T</b>,2 x 10-7,,0.99147537,1.0822511,'-,[1.05-1.11],TMEM229A,Major depressive disorder,unipolar depression,GCST009979,7:124043151
rs3788338-<b>G</b>,3 x 10-7,,0.746028,1.081081,'-,[1.05-1.11],RSPH14,Major depressive disorder,unipolar depression,GCST009979,22:23069879
rs10070411-<b>A</b>,7 x 10-7,,0.778321,1.0787487,'-,[1.05-1.11],FER,Major depressive disorder,unipolar depression,GCST009979,5:109111647
rs1343607-<b>A</b>,1 x 10-6,,0.374666,1.0764263,'-,[1.05-1.11],"OLFM4, LINC01065",Major depressive disorder,unipolar depression,GCST009979,13:53071313
rs143864773-<b>T</b>,1 x 10-6,,0.9307518,1.0764263,'-,[1.05-1.11],CCDC73,Major depressive disorder,unipolar depression,GCST009979,11:32744320
rs1811320-<b>A</b>,1 x 10-6,,0.581533,1.0764263,'-,[1.05-1.11],RBFOX1,Major depressive disorder,unipolar depression,GCST009979,16:6074205
rs78643921-<b>C</b>,1 x 10-6,,0.896425,1.0764263,'-,[1.05-1.11],PCDH9,Major depressive disorder,unipolar depression,GCST009979,13:66647244
rs10947863-<b>T</b>,2 x 10-6,,0.746556,1.0764263,'-,[1.05-1.11],TDRG1,Major depressive disorder,unipolar depression,GCST009979,6:40244840
rs186555608-<b>C</b>,1 x 10-6,,0.984715,1.0752687,'-,[1.04-1.11],KCNQ3,Major depressive disorder,unipolar depression,GCST009979,8:132216505
rs60225398-<b>T</b>,2 x 10-6,,0.761321,1.0752687,'-,[1.04-1.11],EGLN3,Major depressive disorder,unipolar depression,GCST009979,14:34024218
rs61909191-<b>A</b>,3 x 10-6,,0.9342475,1.0752687,'-,[1.04-1.11],CCND2-AS1,Major depressive disorder,unipolar depression,GCST009979,12:4241124
rs6995581-<b>G</b>,3 x 10-6,,0.209451,1.0741138,'-,[1.04-1.11],'-,Major depressive disorder,unipolar depression,GCST009979,8:137616924
rs4565433-<b>G</b>,2 x 10-6,,0.159273,1.0729614,'-,[1.04-1.1],ZFPM2,Major depressive disorder,unipolar depression,GCST009979,8:105485315
rs2414116-<b>A</b>,3 x 10-6,,0.461564,1.0729614,'-,[1.04-1.1],LYSMD2,Major depressive disorder,unipolar depression,GCST009979,15:51725148
rs2977608-<b>A</b>,8 x 10-6,,0.259029,1.0729614,'-,[1.04-1.1],LINC01128,Major depressive disorder,unipolar depression,GCST009979,1:832873
rs78825642-<b>C</b>,4 x 10-6,,0.8699,1.0718113,'-,[1.04-1.1],"MTCO3P27, MTCYBP16",Major depressive disorder,unipolar depression,GCST009979,4:64607622
rs114098943-<b>G</b>,4 x 10-6,,0.9582778,1.0718113,'-,[1.04-1.1],"TRIM63, SLC30A2",Major depressive disorder,unipolar depression,GCST009979,1:26049538
rs147643734-<b>A</b>,6 x 10-6,,0.9601256,1.0706638,'-,[1.04-1.1],EPHA7,Major depressive disorder,unipolar depression,GCST009979,6:93481026
rs6922076-<b>C</b>,7 x 10-6,,0.545976,1.0706638,'-,[1.04-1.1],"LINC01016, MLN",Major depressive disorder,unipolar depression,GCST009979,6:33839788
rs143445914-<b>C</b>,8 x 10-6,,0.9717484,1.0706638,'-,[1.04-1.1],"ZNF80, TIGIT",Major depressive disorder,unipolar depression,GCST009979,3:114265592
rs972697-<b>G</b>,8 x 10-6,,0.205631,1.0695187,'-,[1.04-1.1],'-,Major depressive disorder,unipolar depression,GCST009979,18:30530053
rs13186198-<b>G</b>,9 x 10-6,,0.536186,1.0695187,'-,[1.04-1.1],"CYSTM1, PFDN1",Major depressive disorder,unipolar depression,GCST009979,5:140272472
rs2781093-<b>G</b>,9 x 10-6,,0.723417,1.0695187,'-,[1.04-1.1],'-,Major depressive disorder,unipolar depression,GCST009979,9:119806336
rs117183159-<b>T</b>,9 x 10-6,,0.9493536,1.0695187,'-,[1.04-1.1],RN7SL601P,Major depressive disorder,unipolar depression,GCST009979,17:11149061
rs71560357-<b>T</b>,8 x 10-6,,0.0102767,1.066,'-,[1.04-1.1],KRT18P50,Major depressive disorder,unipolar depression,GCST009979,6:95893891
rs112904378-<b>A</b>,9 x 10-6,,0.0353645,1.067,'-,[1.04-1.1],GRIK2,Major depressive disorder,unipolar depression,GCST009979,6:101595927
rs79696139-<b>A</b>,9 x 10-6,,0.0514137,1.067,'-,[1.04-1.1],CATSPERD,Major depressive disorder,unipolar depression,GCST009979,19:5756634
rs116215823-<b>T</b>,7 x 10-6,,0.0105559,1.068,'-,[1.04-1.1],KCNH8,Major depressive disorder,unipolar depression,GCST009979,3:19322024
rs188386326-<b>G</b>,8 x 10-6,,0.0137242,1.068,'-,[1.04-1.1],TRPM3,Major depressive disorder,unipolar depression,GCST009979,9:70634117
rs111796550-<b>A</b>,8 x 10-6,,0.0373333,1.068,'-,[1.04-1.1],"Y_RNA, ZMYM4",Major depressive disorder,unipolar depression,GCST009979,1:35200179
rs140992857-<b>A</b>,8 x 10-6,,0.0306898,1.068,'-,[1.04-1.1],'-,Major depressive disorder,unipolar depression,GCST009979,6:67951517
rs139146062-<b>T</b>,9 x 10-6,,0.0241839,1.068,'-,[1.04-1.1],"STK17B, DNAH7",Major depressive disorder,unipolar depression,GCST009979,2:196094898
rs144356690-<b>A</b>,5 x 10-6,,0.00834446,1.069,'-,[1.04-1.1],LINC00276,Major depressive disorder,unipolar depression,GCST009979,2:13707862
rs11223270-<b>A</b>,8 x 10-6,,0.3137,1.069,'-,[1.04-1.1],OPCML,Major depressive disorder,unipolar depression,GCST009979,11:132898896
rs113416614-<b>T</b>,8 x 10-6,,0.0678518,1.069,'-,[1.04-1.1],MCMBP,Major depressive disorder,unipolar depression,GCST009979,10:119869536
rs4903685-<b>G</b>,8 x 10-6,,0.274613,1.069,'-,[1.04-1.1],"ADCK1, FXNP1",Major depressive disorder,unipolar depression,GCST009979,14:78009678
rs8008104-<b>G</b>,6 x 10-6,,0.0948978,1.07,'-,[1.04-1.1],PRIMA1,Major depressive disorder,unipolar depression,GCST009979,14:93720026
rs1575671-<b>G</b>,7 x 10-6,,0.138985,1.07,'-,[1.04-1.1],FTH1P5,Major depressive disorder,unipolar depression,GCST009979,6:51007388
rs139340185-<b>A</b>,7 x 10-6,,0.0102598,1.07,'-,[1.04-1.1],LINC01288,Major depressive disorder,unipolar depression,GCST009979,8:34718769
rs10460050-<b>T</b>,9 x 10-6,,0.420586,1.07,'-,[1.04-1.1],"NOL4, ASXL3",Major depressive disorder,unipolar depression,GCST009979,18:33833707
rs1841556-<b>T</b>,9 x 10-6,,0.634608,1.07,'-,[1.04-1.1],"MIR7515HG, LINC00487",Major depressive disorder,unipolar depression,GCST009979,2:6674345
rs1496089-<b>T</b>,9 x 10-6,,0.736326,1.07,'-,[1.04-1.1],LINC01036,Major depressive disorder,unipolar depression,GCST009979,1:187322087
rs111747875-<b>T</b>,3 x 10-6,,0.0192821,1.071,'-,[1.04-1.1],"SEMA3C, CD36",Major depressive disorder,unipolar depression,GCST009979,7:80708697
rs116071213-<b>G</b>,4 x 10-6,,0.0403872,1.071,'-,[1.04-1.1],'-,Major depressive disorder,unipolar depression,GCST009979,1:102234129
rs2342343-<b>A</b>,6 x 10-6,,0.305863,1.071,'-,[1.04-1.1],MON1B,Major depressive disorder,unipolar depression,GCST009979,16:77134353
rs34534607-<b>T</b>,6 x 10-6,,0.201176,1.071,'-,[1.04-1.1],TSPAN33,Major depressive disorder,unipolar depression,GCST009979,7:129150350
rs10485715-<b>C</b>,8 x 10-9,,0.144,'-,'-,'-,"LINC01751, LINC01428",Major depressive disorder (stressful life events interaction),"unipolar depression, self rated health, stressful life event measurement",GCST003319,20:7279278
rs7785360-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,AUTS2,Response to serotonin reuptake inhibitors in non-psychotic unipolar depression,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST003118,7:69944392
rs10924309-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,KIF26B,Response to serotonin reuptake inhibitors in non-psychotic unipolar depression,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST003118,1:245699920
rs3135296-<b>?</b>,5 x 10-7,,NR,1.1049724,'-,[1.06-1.15],"LINC01623, NOP56P1",Major depressive disorder (lifetime),unipolar depression,GCST010009,6:28828079
rs3129120-<b>?</b>,4 x 10-7,,NR,1.1049724,'-,[1.06-1.15],"OR2J2, OR2J3",Major depressive disorder (lifetime),unipolar depression,GCST010009,6:29143998
rs926552-<b>G</b>,4 x 10-8,,0.86,1.1074197,'-,[1.07-1.14],GABBR1,Major depressive disorder (lifetime),unipolar depression,GCST010009,6:29580312
rs3115631-<b>?</b>,4 x 10-7,,NR,1.1037527,'-,[1.06-1.15],ZNRD1ASP,Major depressive disorder (lifetime),unipolar depression,GCST010009,6:30018547
rs3115631-<b>T</b>,3 x 10-13,,0.874,1.059322,'-,[1.04-1.08],ZNRD1ASP,Help-seeking from a GP,unipolar depression,GCST010011,6:30018547
rs236346-<b>T</b>,1 x 10-8,,0.905,1.0526316,'-,[1.03-1.07],PPIL1,Help-seeking from a GP,unipolar depression,GCST010011,6:36864327
rs75782365-<b>T</b>,1 x 10-9,,0.89,1.0515248,'-,[1.04-1.07],BTN3A1,Help-seeking from a GP,unipolar depression,GCST010011,6:26408323
rs12057031-<b>C</b>,5 x 10-9,,0.892,1.0504202,'-,[1.03-1.07],'-,Help-seeking from a GP,unipolar depression,GCST010011,9:25235065
rs578174-<b>A</b>,2 x 10-8,,0.898,1.049318,'-,[1.03-1.07],"CHORDC1, DISC1FP1",Help-seeking from a GP,unipolar depression,GCST010011,11:90226469
rs6699744-<b>T</b>,7 x 10-14,,0.612,1.0416667,'-,[1.03-1.05],RPL31P12,Help-seeking from a GP,unipolar depression,GCST010011,1:72359461
rs1625792-<b>G</b>,5 x 10-8,,0.853,1.0405828,'-,[1.03-1.05],"HLA-B, LINC02571",Help-seeking from a GP,unipolar depression,GCST010011,6:31338643
rs7772160-<b>T</b>,3 x 10-12,,0.522,1.0362694,'-,[1.03-1.05],"ZNF184, MCFD2P1",Help-seeking from a GP,unipolar depression,GCST010011,6:27444607
rs535777-<b>?</b>,5 x 10-6,,NR,1.0362694,'-,[1.02-1.05],"HLA-DRB1, HLA-DQA1",Help-seeking from a GP,unipolar depression,GCST010011,6:32609856
rs393488-<b>T</b>,2 x 10-10,,0.531,1.0341262,'-,[1.02-1.04],RN7SL720P,Help-seeking from a GP,unipolar depression,GCST010011,9:17044973
rs9345737-<b>A</b>,3 x 10-9,,0.561,1.0319917,'-,[1.02-1.04],'-,Help-seeking from a GP,unipolar depression,GCST010011,6:65967045
rs4713145-<b>?</b>,2 x 10-7,,NR,1.0319917,'-,[1.02-1.04],"ZKSCAN8, ZSCAN16-AS1",Help-seeking from a GP,unipolar depression,GCST010011,6:28139049
rs11599236-<b>T</b>,3 x 10-8,,0.592,1.0298661,'-,[1.02-1.04],SORCS3,Help-seeking from a GP,unipolar depression,GCST010011,10:104694914
rs12889665-<b>G</b>,3 x 10-8,,0.538,1.0288066,'-,[1.02-1.04],YLPM1,Help-seeking from a GP,unipolar depression,GCST010011,14:74768127
rs4543289-<b>?</b>,7 x 10-6,,NR,1.0235415,'-,[1.01-1.03],'-,Help-seeking from a GP,unipolar depression,GCST010011,5:165057942
rs3807866-<b>A</b>,5 x 10-13,,0.41,1.039,'-,[1.03-1.05],TMEM106B,Help-seeking from a GP,unipolar depression,GCST010011,7:12210752
rs30266-<b>A</b>,4 x 10-12,,0.328,1.039,'-,[1.03-1.05],'-,Help-seeking from a GP,unipolar depression,GCST010011,5:104636656
rs537635-<b>T</b>,6 x 10-10,,0.484,1.033,'-,[1.02-1.04],GRM5,Help-seeking from a GP,unipolar depression,GCST010011,11:88972067
rs12205083-<b>G</b>,6 x 10-10,,0.104,1.053,'-,[1.04-1.07],DCDC2,Help-seeking from a GP,unipolar depression,GCST010011,6:24275255
rs11123030-<b>T</b>,1 x 10-9,,0.491,1.032,'-,[1.02-1.04],CNTNAP5,Help-seeking from a GP,unipolar depression,GCST010011,2:124218586
rs12967855-<b>A</b>,2 x 10-9,,0.329,1.034,'-,[1.02-1.05],CELF4,Help-seeking from a GP,unipolar depression,GCST010011,18:37558282
rs6697602-<b>G</b>,6 x 10-9,,0.083,1.056,'-,[1.04-1.07],ASTN1,Help-seeking from a GP,unipolar depression,GCST010011,1:177070236
rs11646401-<b>G</b>,4 x 10-8,,0.442,1.029,'-,[1.02-1.04],METTL9,Help-seeking from a GP,unipolar depression,GCST010011,16:21598657
rs8097498-<b>G</b>,1 x 10-8,,0.387,1.031,'-,[1.02-1.04],"LINC01415, LINC01416",Help-seeking from a GP,unipolar depression,GCST010011,18:55782436
rs66511648-<b>C</b>,2 x 10-8,,0.284,1.033,'-,[1.02-1.04],'-,Help-seeking from a GP,unipolar depression,GCST010011,3:117796672
rs61997596-<b>A</b>,4 x 10-8,,0.191,1.037,'-,[1.02-1.05],TDRD9,Help-seeking from a GP,unipolar depression,GCST010011,14:104044869
rs10786831-<b>A</b>,2 x 10-6,,NR,1.026,'-,[1.015-1.036],SORCS3,Help-seeking from a GP,unipolar depression,GCST010011,10:104854813
rs4713145-<b>T</b>,5 x 10-11,,0.756,1.0626993,'-,NR,"ZKSCAN8, ZSCAN16-AS1",Help-seeking from a psychiatrist,unipolar depression,GCST010012,6:28139049
rs66975207-<b>A</b>,1 x 10-9,,0.889,1.081081,'-,NR,LINC00240,Help-seeking from a psychiatrist,unipolar depression,GCST010012,6:26974367
rs535777-<b>G</b>,1 x 10-9,,0.862,1.0752687,'-,NR,"HLA-DRB1, HLA-DQA1",Help-seeking from a psychiatrist,unipolar depression,GCST010012,6:32609856
rs465787-<b>?</b>,1 x 10-6,(dominant),'-,'-,'-,'-,'-,Depression x herpes simplex 1 infection interaction,"unipolar depression, herpes virus seropositivity",GCST010561,5:2388741
rs377094-<b>?</b>,2 x 10-6,(dominant),'-,'-,'-,'-,'-,Depression x herpes simplex 1 infection interaction,"unipolar depression, herpes virus seropositivity",GCST010561,5:2391248
rs414421-<b>?</b>,2 x 10-6,(dominant),'-,'-,'-,'-,'-,Depression x herpes simplex 1 infection interaction,"unipolar depression, herpes virus seropositivity",GCST010561,5:2391247
rs113444436-<b>?</b>,2 x 10-6,(additive),'-,'-,'-,'-,"CLPSL2, ARMC12",Depression x herpes simplex 1 infection interaction,"unipolar depression, herpes virus seropositivity",GCST010561,6:35749084
rs160730-<b>?</b>,2 x 10-6,(dominant),'-,'-,'-,'-,'-,Depression x herpes simplex 1 infection interaction,"unipolar depression, herpes virus seropositivity",GCST010561,5:2392717
rs528732638-<b>GAA</b>,1 x 10-10,,0.13,3.62,'-,[2.38-5.5],"AQP4-AS1, CHST9",Severe depressive disorders in coronary artery disease,"unipolar depression, coronary artery disease",GCST007230,18:26940224
rs11054833-<b>A</b>,3 x 10-6,,0.13,2.47,'-,[1.6-3.8],"MANSC1, LOH12CR2",Severe depressive disorders in coronary artery disease,"unipolar depression, coronary artery disease",GCST007230,12:12350535
rs11835646-<b>T</b>,4 x 10-6,,0.44,2.12,'-,[1.47-3.06],ACSS3,Severe depressive disorders in coronary artery disease,"unipolar depression, coronary artery disease",GCST007230,12:81158559
rs7148335-<b>G</b>,5 x 10-6,,0.08,2.9411764,'-,[1.79-5],BRMS1L,Severe depressive disorders in coronary artery disease,"unipolar depression, coronary artery disease",GCST007230,14:35913595
rs60466238-<b>T</b>,9 x 10-6,,0.12,2.58,'-,[1.65-4.03],"KIAA0087, LINC02860",Severe depressive disorders in coronary artery disease,"unipolar depression, coronary artery disease",GCST007230,7:26612673
rs12049330-<b>G</b>,6 x 10-6,,0.14,1.44,'-,'-,ATXN7L2,Major depressive disorder,unipolar depression,GCST000578,1:109488566
rs2828520-<b>G</b>,4 x 10-7,,0.31,1.35,'-,'-,'-,Major depressive disorder,unipolar depression,GCST000578,21:23770802
rs6537837-<b>T</b>,1 x 10-6,,0.17,1.43,'-,'-,GNAI3,Major depressive disorder,unipolar depression,GCST000578,1:109577110
rs882632-<b>T</b>,2 x 10-6,,0.29,1.34,'-,'-,"PCARE, TOGARAM2",Major depressive disorder,unipolar depression,GCST000578,2:29057895
rs10514718-<b>C</b>,4 x 10-6,,0.94,2.12,'-,'-,'-,Major depressive disorder,unipolar depression,GCST000578,3:61428140
rs9572423-<b>G</b>,9 x 10-6,,0.88,1.54,'-,'-,LINC00540,Major depressive disorder,unipolar depression,GCST000578,13:70272071
rs270545-<b>G</b>,1 x 10-6,,0.69,1.37,'-,'-,LINC02119,Major depressive disorder,unipolar depression,GCST000578,5:38051491
rs17077540-<b>G</b>,2 x 10-7,,0.11,1.61,'-,'-,DSEL-AS1,Major depressive disorder,unipolar depression,GCST000578,18:67618042
rs17144465-<b>G</b>,6 x 10-6,,0.04,1.82,'-,'-,SP4,Major depressive disorder,unipolar depression,GCST000578,7:21464809
rs1074145-<b>?</b>,2 x 10-16,(S-DCT/S-CT ratio),0.162,'-,'-,'-,"CYP2C9, RPL7AP52",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,10:94922089
rs1074145-<b>?</b>,4 x 10-9,(S-CT concentration),0.162,'-,'-,'-,"CYP2C9, RPL7AP52",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,10:94922089
rs9747992-<b>?</b>,2 x 10-7,(S-DCT concentration),0.086,'-,'-,'-,"LINC01977, CBX4",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,17:79831041
rs2059865-<b>?</b>,3 x 10-7,(S-DCT concentration),0.235,'-,'-,'-,PDZD2,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,5:31766326
rs55734731-<b>?</b>,4 x 10-7,"(S-CT concentration, adjusted for CYP2C19)",0.124,'-,'-,'-,"HSPE1P1, LINC01370",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,20:39943772
rs71607999-<b>?</b>,7 x 10-9,"(S-DCT/S-CT ratio, adjusted for CYP2C19)",0.165,'-,'-,'-,'-,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,4:188269957
rs11934750-<b>?</b>,1 x 10-7,"(S-DCT/S-CT ratio, adjusted for CYP2C19)",0.16,'-,'-,'-,'-,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,4:27962783
rs77724872-<b>?</b>,7 x 10-7,"(S-DCT concentration, adjusted for CYP2C19)",0.047,'-,'-,'-,"CHST11, TXNRD1",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,12:104360722
rs8102150-<b>?</b>,7 x 10-7,"(S-DCT concentration, adjusted for CYP2C19)",0.028,'-,'-,'-,"CPT1C, TSKS",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,19:49727070
rs1722229-<b>?</b>,1 x 10-6,"(S-CT concentration, adjusted for CYP2C19)",0.034,'-,'-,'-,MYL10,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,7:101642897
rs117020818-<b>?</b>,7 x 10-7,(S-DCT concentration),0.046,'-,'-,'-,RASSF10,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,11:13107616
rs1058172-<b>?</b>,2 x 10-16,(S-DDCT concentration),0.155,'-,'-,'-,SEPTIN3,Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,22:41996807
rs1058172-<b>?</b>,8 x 10-16,(S-DDCT/S-DCT ratio),0.155,'-,'-,'-,"NDUFA6-DT, CYP2D6",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,22:42127526
rs1065852-<b>?</b>,2 x 10-16,(S-DDCT concentration),0.215,'-,'-,'-,"NDUFA6-DT, CYP2D6",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,22:42130692
rs1065852-<b>?</b>,8 x 10-16,(S-DDCT/S-DCT ratio),0.215,'-,'-,'-,"NDUFA6-DT, CYP2D6",Response to serotonin reuptake inhibitors in major depressive disorder (plasma drug and metabolite levels),"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002549,22:42130692
rs6889896-<b>?</b>,5 x 10-7,(% Change in score),NR,'-,0.17 unit decrease,[NR],LINC02240,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,5:125363546
rs35806662-<b>?</b>,6 x 10-7,(% Change in score),NR,'-,0.2 unit decrease,[NR],UPP2,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,2:157933913
rs73069924-<b>?</b>,8 x 10-7,(% Change in score),NR,'-,0.44 unit decrease,[NR],MTMR12,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,5:32278127
rs4615376-<b>?</b>,1 x 10-6,(% Change in score),NR,'-,0.16 unit decrease,[NR],PHACTR1,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,6:13070841
rs2566255-<b>?</b>,2 x 10-6,(% Change in score),NR,'-,0.26 unit increase,[NR],OR52I2,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,11:4583965
rs910039-<b>?</b>,2 x 10-6,(% Change in score),NR,'-,0.13 unit increase,[NR],CAP2,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,6:17505713
rs17068112-<b>?</b>,3 x 10-6,(% Change in score),NR,'-,0.26 unit increase,[NR],REPS1,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,6:138928988
rs7485210-<b>?</b>,3 x 10-6,(% Change in score),NR,'-,0.14 unit increase,[NR],"ADGRD1, LINC01257",Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,12:131154308
rs74378198-<b>?</b>,4 x 10-6,(% Change in score),NR,'-,0.43 unit decrease,[NR],OSMR,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,5:38870806
rs4236420-<b>?</b>,4 x 10-6,(% Change in score),NR,'-,0.13 unit increase,[NR],PER3P1,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,7:9648479
rs2456568-<b>?</b>,5 x 10-8,(Response),NR,1.36,'-,[NR],HPRT1P3,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,11:93958166
rs113889867-<b>?</b>,9 x 10-7,(Response),NR,1.96,'-,[NR],STMN2,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,8:79644265
rs10954808-<b>?</b>,1 x 10-6,(Response),NR,1.37,'-,[NR],"NRG1, RNA5SP261",Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,8:31622107
rs506546-<b>?</b>,1 x 10-6,(Response),NR,1.32,'-,[NR],CSMD2,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,1:33973693
rs74546197-<b>?</b>,3 x 10-6,(Response),NR,2.17,'-,[NR],"PM20D1, SLC26A9",Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,1:205911051
rs72772787-<b>?</b>,4 x 10-6,(Response),NR,2.34,'-,[NR],"TRIM58, OR11L1",Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,1:247853076
rs2043144-<b>?</b>,4 x 10-6,(Response),NR,2.63,'-,[NR],TRPM3,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,9:71336039
rs291028-<b>?</b>,5 x 10-6,(Response),NR,1.64,'-,[NR],'-,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,15:95072557
rs7051085-<b>?</b>,6 x 10-6,(Response),NR,1.59,'-,[NR],PTCHD1,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,X:23356860
rs1210638-<b>?</b>,6 x 10-6,(Response),NR,1.33,'-,[NR],DGCR5,Response to serotonin reuptake inhibitors in major depressive disorder,"unipolar depression, response to selective serotonin reuptake inhibitor",GCST002868,22:18994050
rs8050326-<b>A</b>,3 x 10-7,,0.44,1.45,'-,[1.26-1.76],'-,Major depressive disorder,unipolar depression,GCST002095,16:86070536
rs11152166-<b>?</b>,3 x 10-6,,0.58,1.41,'-,[1.22-1.61],CCBE1,Major depressive disorder,unipolar depression,GCST002095,18:59647575
rs644695-<b>A</b>,5 x 10-6,,0.88,1.35,'-,[NR],LINC00578,Major depressive disorder (broad),unipolar depression,GCST000551,3:177573909
rs5990417-<b>T</b>,6 x 10-6,,0.83,1.23,'-,[NR],'-,Major depressive disorder (broad),unipolar depression,GCST000551,X:95824871
rs1106634-<b>A</b>,7 x 10-7,,0.14,1.3,'-,[NR],ATP6V1B2,Major depressive disorder (broad),unipolar depression,GCST000551,8:20208538
rs17144465-<b>G</b>,8 x 10-7,,0.03,1.56,'-,[NR],SP4,Major depressive disorder (broad),unipolar depression,GCST000551,7:21464809
rs9870680-<b>T</b>,1 x 10-6,,0.44,1.19,'-,[NR],GRM7,Major depressive disorder (broad),unipolar depression,GCST000551,3:7487868
rs2326810-<b>G</b>,7 x 10-6,,0.92,1.41,'-,[NR],"LY86-AS1, LY86",Major depressive disorder (broad),unipolar depression,GCST000551,6:6612234
rs1612122-<b>T</b>,7 x 10-6,,0.48,1.17,'-,[NR],LINC01517,Major depressive disorder (broad),unipolar depression,GCST000551,10:29002969
rs10265216-<b>A</b>,3 x 10-6,,0.28,1.19,'-,[NR],MKLN1,Major depressive disorder (broad),unipolar depression,GCST000551,7:131215362
rs724568-<b>C</b>,5 x 10-6,,0.36,1.17,'-,[NR],"LINC02831, LINC01812",Major depressive disorder (broad),unipolar depression,GCST000551,2:67715348
rs4238010-<b>G</b>,6 x 10-6,,0.02,1.72,'-,'-,"PARP11-AS1, HSPA8P5",Major depressive disorder,unipolar depression,GCST000304,12:4009151
rs17651119-<b>C</b>,2 x 10-8,(% improvement - 12 weeks),0.99,3.1807,'-,[2.77-3.59],MYO10,Major depressive disorder,unipolar depression,GCST001850,5:16812529
rs1525293-<b>C</b>,2 x 10-6,(remission - SSRI treated - 12 weeks),0.66,1.7041,'-,[1.48-1.92],'-,Major depressive disorder,unipolar depression,GCST001850,7:71008019
rs12410462-<b>A</b>,4 x 10-7,(% improvement - 12 weeks),0.122,1.259,'-,[1.16-1.36],"BTF3P9, TUBB8P10",Major depressive disorder,unipolar depression,GCST001850,1:227480089
rs8012941-<b>G</b>,4 x 10-6,(remission - SSRI treated - 12 weeks),0.4975174,1.5387,'-,[1.35-1.72],KCNH5,Major depressive disorder,unipolar depression,GCST001850,14:62855629
rs264272-<b>G</b>,4 x 10-6,(% improvement - 12 weeks),0.52,1.144,'-,[1.09-1.2],PIEZO2,Major depressive disorder,unipolar depression,GCST001850,18:10923810
rs12054895-<b>T</b>,3 x 10-8,(% improvement - SSRI treated - 2 weeks),0.275456,'-,0.2428 unit increase,[0.16-0.33],EDIL3,Major depressive disorder,unipolar depression,GCST001850,5:27611324
rs7174755-<b>C</b>,3 x 10-7,(% improvement - SSRI treated - 2 weeks),0.3690476,'-,0.2048 unit decrease,[0.13-0.28],ITGA11,Major depressive disorder,unipolar depression,GCST001850,15:68304789
rs17692896-<b>A</b>,7 x 10-7,(% improvement - SSRI treated - 2 weeks),0.0739179,'-,0.4395 unit decrease,[0.27-0.61],ANKRD27,Major depressive disorder,unipolar depression,GCST001850,19:32598525
rs9466930-<b>C</b>,4 x 10-6,(remission - 12 weeks),0.215,1.501,'-,[1.32-1.68],SPTLC1P2,Major depressive disorder,unipolar depression,GCST001850,6:23840904
rs1457614-<b>C</b>,8 x 10-6,(remission - 12 weeks),0.181,1.4652,'-,[1.29-1.64],GRIN2B,Major depressive disorder,unipolar depression,GCST001850,12:13488772
rs7174755-<b>T</b>,9 x 10-7,(% improvement - 2 weeks),0.63,1.168,'-,[1.11-1.23],ITGA11,Major depressive disorder,unipolar depression,GCST001850,15:68304789
rs10065906-<b>C</b>,2 x 10-6,(% improvement - 2 weeks),0.332,1.1655,'-,[1.11-1.22],'-,Major depressive disorder,unipolar depression,GCST001850,5:159580770
rs12513663-<b>T</b>,2 x 10-6,(% improvement - 2 weeks),0.268,1.184,'-,[1.11-1.26],LINC01170,Major depressive disorder,unipolar depression,GCST001850,5:124496959
rs4585146-<b>G</b>,6 x 10-6,(% improvement - 2 weeks),0.65,1.1643,'-,[1.11-1.22],"FGF12, RN7SKP222",Major depressive disorder,unipolar depression,GCST001850,3:192100853
rs974379-<b>C</b>,8 x 10-6,(% improvement - 2 weeks),0.075,1.2872,'-,[1.17-1.4],"FMN1, TMCO5B",Major depressive disorder,unipolar depression,GCST001850,15:33212866
rs7742824-<b>A</b>,9 x 10-6,(% improvement - 2 weeks),0.224,1.185,'-,[1.11-1.26],"SCIRT, MRPL14",Major depressive disorder,unipolar depression,GCST001850,6:44097574
rs10065906-<b>C</b>,5 x 10-8,(partial response - 2 weeks),0.308,1.4712,'-,[1.33-1.61],'-,Major depressive disorder,unipolar depression,GCST001850,5:159580770
rs10174573-<b>T</b>,2 x 10-6,(partial response - 2 weeks),0.57,1.564,'-,[1.39-1.74],'-,Major depressive disorder,unipolar depression,GCST001850,2:192877447
rs1706631-<b>T</b>,6 x 10-6,(partial response - 2 weeks),0.408,1.3548,'-,[1.22-1.49],LINC02378,Major depressive disorder,unipolar depression,GCST001850,12:17509301
rs12500612-<b>G</b>,7 x 10-6,(partial response - 2 weeks),0.85,1.7665,'-,[1.51-2.02],"HNRNPA1P65, LINC02473",Major depressive disorder,unipolar depression,GCST001850,4:24739335
rs1034394-<b>G</b>,2 x 10-6,(% improvement - SSRI treated - 12 weeks),0.3390146,'-,0.2107 unit increase,[0.12-0.3],'-,Major depressive disorder,unipolar depression,GCST001850,22:34427837
rs264272-<b>T</b>,3 x 10-6,(% improvement - SSRI treated - 12 weeks),0.4874733,'-,0.1712 unit decrease,[0.099-0.243],PIEZO2,Major depressive disorder,unipolar depression,GCST001850,18:10923810
rs398426-<b>T</b>,5 x 10-6,(% improvement - SSRI treated - 12 weeks),0.2588456,'-,0.2513 unit decrease,[0.14-0.36],"RN7SL150P, KCTD15",Major depressive disorder,unipolar depression,GCST001850,19:33830353
rs17634917-<b>G</b>,6 x 10-6,(% improvement - SSRI treated - 12 weeks),0.0573945,'-,0.3761 unit decrease,[0.21-0.54],"RFPL4A, NLRP9",Major depressive disorder,unipolar depression,GCST001850,19:55754298
rs6534441-<b>C</b>,7 x 10-6,(% improvement - SSRI treated - 12 weeks),0.3328325,'-,0.1801 unit decrease,[0.1-0.26],"LINC02516, TECRP2",Major depressive disorder,unipolar depression,GCST001850,4:124494379
rs4625554-<b>G</b>,9 x 10-6,(% improvement - SSRI treated - 12 weeks),0.2996789,'-,0.1927 unit increase,[0.11-0.28],"TIGAR, CCND2",Major depressive disorder,unipolar depression,GCST001850,12:4307138
rs2546057-<b>A</b>,3 x 10-7,(% improvement - 12 weeks),0.52,1.183,'-,[1.12-1.24],"RN7SL150P, KCTD15",Major depressive disorder,unipolar depression,GCST001850,19:33829949
rs364477-<b>C</b>,4 x 10-6,(remission - SSRI treated - 12 weeks),0.2154931,1.6925,'-,[1.47-1.92],DMRT1,Major depressive disorder,unipolar depression,GCST001850,9:955794
rs17634917-<b>A</b>,3 x 10-6,(% improvement - 12 weeks),0.94,1.371,'-,[1.23-1.51],"RFPL4A, NLRP9",Major depressive disorder,unipolar depression,GCST001850,19:55754298
rs2377360-<b>G</b>,9 x 10-6,(remission - SSRI treated - 12 weeks),0.2632403,1.6,'-,[1.39-1.81],ESRRG,Major depressive disorder,unipolar depression,GCST001850,1:217027541
rs9601248-<b>C</b>,2 x 10-6,(remission - 12 weeks),0.498,1.3841,'-,[1.25-1.52],LINC01068,Major depressive disorder,unipolar depression,GCST001850,13:79594869
rs2125000-<b>T</b>,3 x 10-6,(remission - 12 weeks),0.307,1.425,'-,[1.27-1.58],TUBAP10,Major depressive disorder,unipolar depression,GCST001850,4:124344158
rs17710780-<b>T</b>,4 x 10-6,(remission - 12 weeks),0.86,1.662,'-,[1.45-1.88],"U3, ARHGEF37",Major depressive disorder,unipolar depression,GCST001850,5:149657413
rs10484358-<b>T</b>,1 x 10-6,(% improvement - SSRI treated - 2 weeks),0.0827112,'-,0.4258 unit decrease,[0.25-0.6],GMPR,Major depressive disorder,unipolar depression,GCST001850,6:16255812
rs1673101-<b>A</b>,4 x 10-6,(% improvement - SSRI treated - 2 weeks),0.3312154,'-,0.1877 unit decrease,[0.11-0.27],LINC02144,Major depressive disorder,unipolar depression,GCST001850,5:87738535
rs912988-<b>T</b>,6 x 10-6,(% improvement - SSRI treated - 2 weeks),0.3630374,'-,0.1825 unit increase,[0.1-0.26],'-,Major depressive disorder,unipolar depression,GCST001850,1:5294784
rs604222-<b>A</b>,7 x 10-6,(% improvement - SSRI treated - 2 weeks),0.1915251,'-,0.2173 unit increase,[0.12-0.31],"LINC02038, LINC02026",Major depressive disorder,unipolar depression,GCST001850,3:193865921
rs6799788-<b>G</b>,1 x 10-6,(partial response - SSRI treated - 2 weeks),0.2476976,1.6268,'-,[1.43-1.82],IL12A-AS1,Major depressive disorder,unipolar depression,GCST001850,3:159926508
rs10065906-<b>C</b>,2 x 10-6,(partial response - SSRI treated - 2 weeks),0.3622876,1.5298,'-,[1.36-1.7],'-,Major depressive disorder,unipolar depression,GCST001850,5:159580770
rs1822818-<b>T</b>,6 x 10-6,(partial response - SSRI treated - 2 weeks),0.87,1.7737,'-,[1.53-2.02],RASGEF1B,Major depressive disorder,unipolar depression,GCST001850,4:81541443
rs12210761-<b>A</b>,6 x 10-6,(partial response - SSRI treated - 2 weeks),0.0676606,2.4458,'-,[2.06-2.83],OFCC1,Major depressive disorder,unipolar depression,GCST001850,6:10175803
rs2462686-<b>C</b>,9 x 10-6,(partial response - SSRI treated - 2 weeks),0.3509068,1.4872,'-,[1.31-1.66],"FTLP15, IGFBP3",Major depressive disorder,unipolar depression,GCST001850,7:45942861
rs12552369-<b>A</b>,8 x 10-6,(% improvement - 2 weeks),0.494,1.155,'-,[1.1-1.21],AK8,Major depressive disorder,unipolar depression,GCST001850,9:132757106
rs166040-<b>G</b>,5 x 10-6,(partial response - 2 weeks),0.87,1.6054,'-,[1.41-1.8],PCDH1,Major depressive disorder,unipolar depression,GCST001850,5:141831188
rs17538444-<b>T</b>,4 x 10-7,(% improvement - SSRI treated - 12 weeks),0.0698752,'-,0.3905 unit decrease,[0.24-0.54],ENOX1,Major depressive disorder,unipolar depression,GCST001850,13:43260134
rs6598266-<b>A</b>,3 x 10-6,(% improvement - SSRI treated - 12 weeks),0.1427493,'-,0.2543 unit increase,[0.15-0.36],"DNM1P46, LYSMD4",Major depressive disorder,unipolar depression,GCST001850,15:99759034
rs11149178-<b>A</b>,7 x 10-6,(% improvement - SSRI treated - 12 weeks),0.3560899,'-,0.1777 unit decrease,[0.1-0.26],'-,Major depressive disorder,unipolar depression,GCST001850,13:80783536
rs11055387-<b>C</b>,8 x 10-6,(remission - SSRI treated - 12 weeks),0.0895145,2.1853,'-,[1.84-2.53],LINC01559,Major depressive disorder,unipolar depression,GCST001850,12:13367062
rs4585146-<b>A</b>,3 x 10-7,(% improvement - SSRI treated - 2 weeks),0.362271,'-,0.2208 unit decrease,[0.14-0.31],"FGF12, RN7SKP222",Major depressive disorder,unipolar depression,GCST001850,3:192100853
rs13074924-<b>?</b>,9 x 10-6,,0.36,1.18,'-,[NR],ANAPC15P2,Major depressive disorder,unipolar depression,GCST000689,3:174311255
rs606149-<b>?</b>,3 x 10-6,,0.46,1.25,'-,[NR],DDAH1,Major depressive disorder,unipolar depression,GCST000689,1:193952418
rs4709845-<b>?</b>,9 x 10-6,,0.85,1.21,'-,[NR],'-,Major depressive disorder,unipolar depression,GCST000689,6:164479565
rs17420782-<b>G</b>,9 x 10-6,(Quantitative),0.16,'-,0.55 unit increase,[NR],ATP6V0E1P4,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,1:47553550
rs17221829-<b>A</b>,5 x 10-6,(Quantitative),0.38,'-,0.4408 unit decrease,[NR],'-,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,Mapping not available
rs921896-<b>C</b>,4 x 10-6,(Quantitative),0.47,'-,0.47 unit increase,[NR],DMD,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,X:32195845
rs17374749-<b>?</b>,7 x 10-6,(Dichotomous),0.78,1.54,'-,[NR],IL20RB,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,3:137049168
rs3798943-<b>?</b>,8 x 10-6,(Dichotomous),0.53,1.45,'-,[NR],AGPAT4,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,6:161254459
rs10238623-<b>A</b>,5 x 10-6,(Dichotomous),0.28,1.545,'-,[NR],CREB5,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,7:28772876
rs7867155-<b>?</b>,9 x 10-7,(Dichotomous),0.88,1.84,'-,[NR],ERCC6L2,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,9:96065532
rs9980603-<b>?</b>,3 x 10-7,(Dichotomous),0.58,1.53,'-,[NR],DSCAM,Anxiety in major depressive disorder,"unipolar depression, anxiety",GCST002202,21:40514656
rs3950186-<b>T</b>,8 x 10-6,,0.338,1.319,'-,[NR],"ADTRP, AMD1P4",Anxiety and major depressive disorder,"unipolar depression, anxiety",GCST002200,6:11811081
rs294856-<b>?</b>,2 x 10-6,,0.58,1.34,'-,[NR],PTPRD,Anxiety and major depressive disorder,"unipolar depression, anxiety",GCST002200,9:10192290
rs4796827-<b>A</b>,2 x 10-6,,0.409,1.326,'-,[NR],"CYTH1, SCAT1",Anxiety and major depressive disorder,"unipolar depression, anxiety",GCST002200,17:78637883
rs11579964-<b>C</b>,4 x 10-6,,0.84,1.19,'-,[NR],"NVL, CNIH4",Major depressive disorder,unipolar depression,GCST000856,1:224351238
rs12446956-<b>C</b>,1 x 10-6,,0.13,1.22,'-,[NR],"ZFHX3, LINC01568",Major depressive disorder,unipolar depression,GCST000856,16:73467637
rs7647854-<b>G</b>,5 x 10-6,,0.16,1.19,'-,[NR],"C3orf70, EHHADH-AS1",Major depressive disorder,unipolar depression,GCST000856,3:185158995
rs12457996-<b>T</b>,6 x 10-6,,0.77,1.15,'-,[NR],SYT4,Major depressive disorder,unipolar depression,GCST000856,18:43292308
rs45527431-<b>G</b>,2 x 10-9,,0.1052,'-,0.0115 unit decrease,[0.0078-0.0152],ABT1,Depression (broad),unipolar depression,GCST005902,6:26599281
rs35144506-<b>G</b>,5 x 10-9,,0.1183,'-,0.0114 unit decrease,[0.0077-0.0151],'-,Depression (broad),unipolar depression,GCST005902,6:26762393
rs66975207-<b>C</b>,7 x 10-9,,0.1059,'-,0.0111 unit decrease,[0.0074-0.0148],LINC00240,Depression (broad),unipolar depression,GCST005902,6:26974367
rs55834529-<b>G</b>,3 x 10-9,,0.1059,'-,0.0114 unit decrease,[0.0077-0.0151],"RNU2-62P, VN1R11P",Depression (broad),unipolar depression,GCST005902,6:27104763
rs7749305-<b>C</b>,4 x 10-11,,0.1209,'-,0.0119 unit decrease,[0.0084-0.0154],"ZNF184, HNRNPA1P1",Depression (broad),unipolar depression,GCST005902,6:27478787
rs35715914-<b>T</b>,8 x 10-11,,0.1076,'-,0.0125 unit decrease,[0.0088-0.0162],"RPL8P1, RNU6-471P",Depression (broad),unipolar depression,GCST005902,6:27624224
rs483143-<b>C</b>,8 x 10-12,,0.1277,'-,0.0121 unit decrease,[0.0086-0.0156],"H4C13, H3C12",Depression (broad),unipolar depression,GCST005902,6:27878966
rs13197574-<b>C</b>,1 x 10-11,,0.1103,'-,0.0128 unit decrease,[0.0091-0.0165],"ZSCAN12P1, ZSCAN16-AS1",Depression (broad),unipolar depression,GCST005902,6:28092461
rs35017208-<b>T</b>,1 x 10-12,,0.1109,'-,0.0133 unit decrease,[0.0096-0.017],"ZKSCAN3, ZSCAN12",Depression (broad),unipolar depression,GCST005902,6:28377505
rs13191038-<b>C</b>,4 x 10-12,,0.1101,'-,0.0131 unit decrease,[0.0094-0.0168],GPX6,Depression (broad),unipolar depression,GCST005902,6:28515140
rs13194504-<b>A</b>,1 x 10-11,,0.1122,'-,0.0127 unit decrease,[0.009-0.0164],"RPSAP2, LINC00533",Depression (broad),unipolar depression,GCST005902,6:28662914
rs9257248-<b>T</b>,4 x 10-11,,0.114,'-,0.0123 unit decrease,[0.0086-0.016],"LINC01623, NOP56P1",Depression (broad),unipolar depression,GCST005902,6:28835514
rs3129791-<b>A</b>,2 x 10-11,,0.1148,'-,0.0125 unit decrease,[0.0088-0.0162],HCG15,Depression (broad),unipolar depression,GCST005902,6:28986516
rs4947263-<b>T</b>,3 x 10-12,,0.1178,'-,0.0127 unit decrease,[0.0092-0.0162],"OR2J2, OR2J3",Depression (broad),unipolar depression,GCST005902,6:29165865
rs9257681-<b>G</b>,2 x 10-12,,0.1151,'-,0.0131 unit decrease,[0.0094-0.0168],"OR2U2P, OR14J1",Depression (broad),unipolar depression,GCST005902,6:29287205
rs2523443-<b>A</b>,1 x 10-12,,0.1188,'-,0.013 unit decrease,[0.0095-0.0165],OR11A1,Depression (broad),unipolar depression,GCST005902,6:29447687
rs1233393-<b>G</b>,8 x 10-13,,0.1223,'-,0.0129 unit decrease,[0.0094-0.0164],GABBR1,Depression (broad),unipolar depression,GCST005902,6:29581876
rs9258375-<b>G</b>,1 x 10-12,,0.122,'-,0.0131 unit decrease,[0.0094-0.0168],"HLA-V, IFITM4P",Depression (broad),unipolar depression,GCST005902,6:29785031
rs3132685-<b>A</b>,2 x 10-13,,0.1302,'-,0.0131 unit decrease,[0.0096-0.0166],HCG9,Depression (broad),unipolar depression,GCST005902,6:29978172
rs2517601-<b>C</b>,5 x 10-13,,0.1326,'-,0.0126 unit decrease,[0.0093-0.0159],"TRIM31-AS1, TRIM31",Depression (broad),unipolar depression,GCST005902,6:30106295
rs3130116-<b>C</b>,6 x 10-13,,0.1391,'-,0.0124 unit decrease,[0.0091-0.0157],"UBQLN1P1, MICC",Depression (broad),unipolar depression,GCST005902,6:30397671
rs28894081-<b>A</b>,1 x 10-7,,0.0655,'-,0.0126 unit increase,[0.0079-0.0173],"HLA-E, LINC02569",Depression (broad),unipolar depression,GCST005902,6:30514699
rs2284174-<b>C</b>,1 x 10-12,,0.2189,'-,0.0102 unit decrease,[0.0075-0.0129],HCG20,Depression (broad),unipolar depression,GCST005902,6:30745803
rs3131781-<b>G</b>,9 x 10-9,,0.1445,'-,0.0097 unit decrease,[0.0064-0.013],"NAPGP2, MUC21",Depression (broad),unipolar depression,GCST005902,6:30969955
rs28732092-<b>T</b>,5 x 10-7,,0.0787,'-,0.011 unit increase,[0.0067-0.0153],"RNU6-1133P, C6orf15",Depression (broad),unipolar depression,GCST005902,6:31084855
rs2596505-<b>T</b>,1 x 10-8,,0.1681,'-,0.009 unit decrease,[0.0059-0.0121],"HLA-B, LINC02571",Depression (broad),unipolar depression,GCST005902,6:31351008
rs2736155-<b>C</b>,6 x 10-7,,0.478,'-,0.0059 unit increase,[0.0035-0.0083],PRRC2A,Depression (broad),unipolar depression,GCST005902,6:31637422
rs537160-<b>G</b>,3 x 10-7,,0.6394,'-,0.0063 unit increase,[0.0039-0.0087],CFB,Depression (broad),unipolar depression,GCST005902,6:31948623
rs56366527-<b>A</b>,2 x 10-7,,0.3855,'-,0.0062 unit decrease,[0.0038-0.0086],"LINC01016, MLN",Depression (broad),unipolar depression,GCST005902,6:33838164
rs76736233-<b>C</b>,3 x 10-7,,0.1338,'-,0.009 unit increase,[0.0055-0.0125],ADH5P4,Depression (broad),unipolar depression,GCST005902,6:65936845
rs112348907-<b>G</b>,2 x 10-8,,0.2959,'-,0.0073 unit increase,[0.0048-0.0098],KCNQ5,Depression (broad),unipolar depression,GCST005902,6:72878230
rs10447426-<b>A</b>,3 x 10-7,,0.0428,'-,0.0153 unit decrease,[0.0094-0.0212],DDO,Depression (broad),unipolar depression,GCST005902,6:110400547
rs2876520-<b>G</b>,2 x 10-7,,0.4665,'-,0.0062 unit increase,[0.0038-0.0086],HIVEP2,Depression (broad),unipolar depression,GCST005902,6:142675481
rs3807865-<b>A</b>,7 x 10-12,,0.4117,'-,0.0082 unit increase,[0.0058-0.0106],TMEM106B,Depression (broad),unipolar depression,GCST005902,7:12210776
rs6466512-<b>A</b>,8 x 10-7,,0.4172,'-,0.0059 unit decrease,[0.0035-0.0083],LINC01392,Depression (broad),unipolar depression,GCST005902,7:115202520
rs2402273-<b>C</b>,2 x 10-9,,0.4094,'-,0.0072 unit increase,[0.0048-0.0096],CTTNBP2,Depression (broad),unipolar depression,GCST005902,7:117960370
rs144369419-<b>T</b>,5 x 10-7,,0.0114,'-,0.0301 unit decrease,[0.018-0.042],'-,Depression (broad),unipolar depression,GCST005902,7:153124547
rs10809385-<b>A</b>,6 x 10-8,,0.4042,'-,0.0065 unit decrease,[0.0041-0.0089],'-,Depression (broad),unipolar depression,GCST005902,9:11208995
rs56116032-<b>G</b>,8 x 10-8,,0.2215,'-,0.0076 unit decrease,[0.0049-0.0103],'-,Depression (broad),unipolar depression,GCST005902,9:11453149
rs10959926-<b>C</b>,6 x 10-8,,0.2175,'-,0.0078 unit decrease,[0.0051-0.0105],'-,Depression (broad),unipolar depression,GCST005902,9:11553382
rs10960103-<b>G</b>,5 x 10-8,,0.2273,'-,0.0076 unit decrease,[0.0049-0.0103],'-,Depression (broad),unipolar depression,GCST005902,9:11699270
rs263575-<b>A</b>,2 x 10-8,,0.4601,'-,0.0066 unit decrease,[0.0042-0.009],RN7SL720P,Depression (broad),unipolar depression,GCST005902,9:17033842
rs73474148-<b>C</b>,7 x 10-8,,0.1095,'-,0.0102 unit decrease,[0.0065-0.0139],'-,Depression (broad),unipolar depression,GCST005902,9:25236861
rs7030813-<b>T</b>,4 x 10-7,,0.3739,'-,0.0062 unit increase,[0.0038-0.0086],PAX5,Depression (broad),unipolar depression,GCST005902,9:36999372
rs6131010-<b>G</b>,7 x 10-8,,0.7402,'-,0.0073 unit decrease,[0.0048-0.0098],"RPL13P2, NCOA5",Depression (broad),unipolar depression,GCST005902,20:46095666
rs143502921-<b>C</b>,1 x 10-7,,0.1807,'-,0.009 unit increase,[0.0057-0.0123],CDH4,Depression (broad),unipolar depression,GCST005902,20:61252175
rs10762080-<b>G</b>,6 x 10-7,,0.5858,'-,0.006 unit decrease,[0.0036-0.0084],CTNNA3,Depression (broad),unipolar depression,GCST005902,10:66637687
rs11599236-<b>C</b>,8 x 10-8,,0.4091,'-,0.0065 unit decrease,[0.0041-0.0089],SORCS3,Depression (broad),unipolar depression,GCST005902,10:104694914
rs1021363-<b>G</b>,1 x 10-8,,0.6422,'-,0.007 unit decrease,[0.0046-0.0094],SORCS3,Depression (broad),unipolar depression,GCST005902,10:104851081
rs1765516-<b>A</b>,5 x 10-7,,0.5425,'-,0.0059 unit decrease,[0.0035-0.0083],"DPT, LINC00626",Depression (broad),unipolar depression,GCST005902,1:168736051
rs7548151-<b>A</b>,4 x 10-9,,0.0836,'-,0.0125 unit increase,[0.0084-0.0166],ASTN1,Depression (broad),unipolar depression,GCST005902,1:177057847
rs568799986-<b>T</b>,2 x 10-7,,0.0869,'-,0.0109 unit increase,[0.0068-0.015],LINC01645,Depression (broad),unipolar depression,GCST005902,1:177469985
rs2759663-<b>G</b>,1 x 10-7,,0.2186,'-,0.0075 unit decrease,[0.0048-0.0102],CRB1,Depression (broad),unipolar depression,GCST005902,1:197415296
rs12118513-<b>A</b>,1 x 10-7,,0.2148,'-,0.0076 unit decrease,[0.0049-0.0103],DENND1B,Depression (broad),unipolar depression,GCST005902,1:197547956
rs17641524-<b>T</b>,2 x 10-7,,0.2086,'-,0.0075 unit decrease,[0.0048-0.0102],DENND1B,Depression (broad),unipolar depression,GCST005902,1:197735587
rs10175979-<b>T</b>,8 x 10-7,,0.6506,'-,0.0061 unit increase,[0.0037-0.0085],'-,Depression (broad),unipolar depression,GCST005902,2:57586038
rs2945451-<b>T</b>,1 x 10-7,,0.2388,'-,0.0073 unit decrease,[0.0046-0.01],LINC01965,Depression (broad),unipolar depression,GCST005902,2:103852954
rs111945524-<b>T</b>,9 x 10-8,,0.0453,'-,0.0151 unit decrease,[0.0096-0.0206],FHL2,Depression (broad),unipolar depression,GCST005902,2:105482561
rs11123030-<b>C</b>,3 x 10-7,,0.5098,'-,0.006 unit decrease,[0.0036-0.0084],CNTNAP5,Depression (broad),unipolar depression,GCST005902,2:124218586
rs4455170-<b>T</b>,5 x 10-7,,0.2843,'-,0.0066 unit increase,[0.0041-0.0091],'-,Depression (broad),unipolar depression,GCST005902,2:160633619
rs72948529-<b>C</b>,2 x 10-7,,0.2161,'-,0.0075 unit increase,[0.0048-0.0102],"MTND2P23, ERBB4",Depression (broad),unipolar depression,GCST005902,2:211777265
rs7635184-<b>A</b>,2 x 10-7,,0.6015,'-,0.0063 unit decrease,[0.0039-0.0087],ERC2,Depression (broad),unipolar depression,GCST005902,3:56192013
rs66511648-<b>C</b>,1 x 10-7,,0.2855,'-,0.007 unit increase,[0.0045-0.0095],'-,Depression (broad),unipolar depression,GCST005902,3:117796672
rs6818069-<b>G</b>,4 x 10-7,,0.2526,'-,0.0069 unit increase,[0.0042-0.0096],'-,Depression (broad),unipolar depression,GCST005902,4:130232015
rs4475190-<b>C</b>,5 x 10-7,,0.2681,'-,0.0068 unit decrease,[0.0043-0.0093],LINC00499,Depression (broad),unipolar depression,GCST005902,4:138715045
rs2028526-<b>C</b>,5 x 10-7,,0.349,'-,0.0062 unit increase,[0.0038-0.0086],LINC02163,Depression (broad),unipolar depression,GCST005902,5:104430453
rs40465-<b>G</b>,4 x 10-10,,0.3319,'-,0.0078 unit increase,[0.0053-0.0103],'-,Depression (broad),unipolar depression,GCST005902,5:104646025
rs323509-<b>C</b>,3 x 10-9,,0.6771,'-,0.0074 unit decrease,[0.0049-0.0099],RNU6-334P,Depression (broad),unipolar depression,GCST005902,5:104746478
rs10035449-<b>C</b>,2 x 10-7,,0.5358,'-,0.0061 unit increase,[0.0037-0.0085],'-,Depression (broad),unipolar depression,GCST005902,5:165059061
rs564483817-<b>C</b>,3 x 10-7,,0.3761,'-,0.0062 unit decrease,[0.0038-0.0086],LINC01938,Depression (broad),unipolar depression,GCST005902,5:165239475
rs62383381-<b>C</b>,9 x 10-7,,0.1644,'-,0.0078 unit increase,[0.0047-0.0109],TENM2,Depression (broad),unipolar depression,GCST005902,5:168029174
rs12189861-<b>A</b>,7 x 10-7,,0.1053,'-,0.0095 unit increase,[0.0058-0.0132],DCDC2,Depression (broad),unipolar depression,GCST005902,6:24274224
rs68006638-<b>A</b>,6 x 10-7,,0.0938,'-,0.0102 unit decrease,[0.0063-0.0141],"H2AC1, SCGN",Depression (broad),unipolar depression,GCST005902,6:25710343
rs75782365-<b>G</b>,6 x 10-9,,0.1045,'-,0.0112 unit decrease,[0.0075-0.0149],BTN3A1,Depression (broad),unipolar depression,GCST005902,6:26408323
rs1900599-<b>A</b>,6 x 10-7,,0.2782,'-,0.0065 unit increase,[0.004-0.009],LRFN5,Depression (broad),unipolar depression,GCST005902,14:41671998
rs10148293-<b>G</b>,1 x 10-7,,0.5385,'-,0.0062 unit increase,[0.0038-0.0086],YLPM1,Depression (broad),unipolar depression,GCST005902,14:74830128
rs4906349-<b>G</b>,5 x 10-7,,0.3108,'-,0.0064 unit decrease,[0.0039-0.0089],KLC1,Depression (broad),unipolar depression,GCST005902,14:103624778
rs28541419-<b>G</b>,3 x 10-8,,0.231,'-,0.0078 unit decrease,[0.0051-0.0105],MRPL46,Depression (broad),unipolar depression,GCST005902,15:88402647
rs830716-<b>C</b>,5 x 10-7,,0.7135,'-,0.0066 unit increase,[0.0041-0.0091],SNX29,Depression (broad),unipolar depression,GCST005902,16:12229652
rs12932870-<b>T</b>,7 x 10-8,,0.1868,'-,0.0082 unit increase,[0.0053-0.0111],'-,Depression (broad),unipolar depression,GCST005902,16:13696499
rs1478461-<b>T</b>,1 x 10-7,,0.6618,'-,0.0066 unit increase,[0.0042-0.009],METTL9,Depression (broad),unipolar depression,GCST005902,16:21599483
rs34187563-<b>T</b>,3 x 10-7,,0.4051,'-,0.0064 unit decrease,[0.004-0.0088],ASIC2,Depression (broad),unipolar depression,GCST005902,17:33399144
rs12943181-<b>C</b>,6 x 10-8,,0.2798,'-,0.0071 unit decrease,[0.0046-0.0096],WIPI1,Depression (broad),unipolar depression,GCST005902,17:68428200
rs11877758-<b>G</b>,1 x 10-7,,0.3114,'-,0.0067 unit increase,[0.0042-0.0092],CELF4,Depression (broad),unipolar depression,GCST005902,18:37558147
rs57679688-<b>T</b>,3 x 10-7,,0.2633,'-,0.0069 unit increase,[0.0044-0.0094],RNU6-706P,Depression (broad),unipolar depression,GCST005902,18:39041098
rs17410557-<b>C</b>,8 x 10-7,,0.3907,'-,0.0059 unit increase,[0.0035-0.0083],DCC,Depression (broad),unipolar depression,GCST005902,18:53250021
rs4801146-<b>C</b>,1 x 10-7,,0.4922,'-,0.0063 unit increase,[0.0039-0.0087],"TCF4, RNA5SP459",Depression (broad),unipolar depression,GCST005902,18:55173694
rs12967143-<b>C</b>,6 x 10-8,,0.7016,'-,0.007 unit decrease,[0.0045-0.0095],TCF4,Depression (broad),unipolar depression,GCST005902,18:55431781
rs1452787-<b>G</b>,2 x 10-7,,0.2744,'-,0.0068 unit increase,[0.0043-0.0093],TCF4,Depression (broad),unipolar depression,GCST005902,18:55539976
rs4653218-<b>C</b>,1 x 10-7,,0.579,'-,0.0063 unit decrease,[0.0039-0.0087],GRIK3,Depression (broad),unipolar depression,GCST005902,1:36731718
rs10127497-<b>T</b>,1 x 10-8,,0.1382,'-,0.0097 unit increase,[0.0064-0.013],SGIP1,Depression (broad),unipolar depression,GCST005902,1:66584461
rs6679379-<b>T</b>,3 x 10-8,,0.2875,'-,0.0072 unit increase,[0.0047-0.0097],SGIP1,Depression (broad),unipolar depression,GCST005902,1:66733473
rs6699744-<b>T</b>,2 x 10-13,,0.612,'-,0.0089 unit increase,[0.0065-0.0113],RPL31P12,Depression (broad),unipolar depression,GCST005902,1:72359461
rs10789340-<b>G</b>,2 x 10-12,,0.6236,'-,0.0086 unit increase,[0.0062-0.011],'-,Depression (broad),unipolar depression,GCST005902,1:72474590
rs12129942-<b>T</b>,2 x 10-7,,0.5146,'-,0.0061 unit increase,[0.0037-0.0085],LINC02797,Depression (broad),unipolar depression,GCST005902,1:72843399
rs11210111-<b>A</b>,5 x 10-8,,0.4617,'-,0.0064 unit decrease,[0.004-0.0088],KRT8P21,Depression (broad),unipolar depression,GCST005902,1:73050889
rs6424532-<b>A</b>,4 x 10-8,,0.4856,'-,0.0065 unit increase,[0.0041-0.0089],RN7SKP19,Depression (broad),unipolar depression,GCST005902,1:73198339
rs10890045-<b>C</b>,7 x 10-7,,0.7042,'-,0.0064 unit decrease,[0.0039-0.0089],'-,Depression (broad),unipolar depression,GCST005902,1:73531941
rs4971040-<b>C</b>,2 x 10-7,,0.8411,'-,0.0084 unit increase,[0.0053-0.0115],"PSMB4, SELENBP1",Depression (broad),unipolar depression,GCST005902,1:151394018
rs9885896-<b>A</b>,4 x 10-9,,'-,'-,0.0241602 unit decrease,[0.016-0.032],ADH5P4,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:65886038
rs12206488-<b>T</b>,2 x 10-9,,'-,'-,0.0302724 unit increase,[0.02-0.04],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:66290024
rs2328370-<b>A</b>,3 x 10-8,,'-,'-,0.0231486 unit increase,[0.015-0.031],HIVEP2,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:142685569
rs9347896-<b>A</b>,1 x 10-8,,'-,'-,0.0281251 unit increase,[0.018-0.038],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,6:164656716
rs11561993-<b>T</b>,2 x 10-9,,'-,'-,0.0244869 unit increase,[0.016-0.033],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,7:109462798
rs11784932-<b>A</b>,3 x 10-8,,'-,'-,0.0258772 unit increase,[0.017-0.035],CCDC26,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,8:129083232
rs1931391-<b>A</b>,8 x 10-9,,'-,'-,0.0235744 unit increase,[0.016-0.032],'-,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,9:11213674
rs62553458-<b>A</b>,9 x 10-9,,'-,'-,0.0499565 unit decrease,[0.033-0.067],KLF9,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,9:11695224
rs13299293-<b>A</b>,2 x 10-8,,'-,'-,0.0241789 unit decrease,[0.016-0.033],SLC25A6P2,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,9:31234707
rs2212333-<b>A</b>,8 x 10-9,,'-,'-,0.0242113 unit increase,[0.016-0.032],GRM5,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,11:89035729
rs7358418-<b>T</b>,6 x 10-9,,'-,'-,0.0260823 unit decrease,[0.017-0.035],TYR,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,11:89236970
rs9538160-<b>A</b>,3 x 10-8,,'-,'-,0.0238311 unit decrease,[0.015-0.032],DNAJA1P1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,13:58680025
rs35625885-<b>A</b>,1 x 10-8,,'-,'-,0.0357605 unit decrease,[0.023-0.048],"PGAM1P12, TUBAP12",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,15:96414739
rs1395455-<b>A</b>,4 x 10-8,,'-,'-,0.0245324 unit increase,[0.016-0.033],"FTLP18, GRIK3",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:36719589
rs1620977-<b>A</b>,1 x 10-8,,'-,'-,0.02653 unit increase,[0.017-0.036],NEGR1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:72263459
rs6680839-<b>T</b>,9 x 10-10,,'-,'-,0.025214 unit decrease,[0.017-0.033],"COP1, RPS29P5",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:175933460
rs2175177-<b>A</b>,1 x 10-8,,'-,'-,0.0234815 unit decrease,[0.015-0.032],"COP1, U7",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:176214920
rs11809140-<b>T</b>,2 x 10-8,,'-,'-,0.0229278 unit decrease,[0.015-0.031],MORF4L1P7,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:176349468
rs72740410-<b>T</b>,1 x 10-8,,'-,'-,0.0465852 unit increase,[0.031-0.063],"HNRNPA1P46, UBE2V1P8",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:191145969
rs78108344-<b>T</b>,2 x 10-9,,'-,'-,0.0299671 unit decrease,[0.02-0.04],CRB1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197419740
rs12118913-<b>T</b>,2 x 10-9,,'-,'-,0.0292513 unit increase,[0.02-0.039],DENND1B,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197543274
rs2224873-<b>A</b>,1 x 10-9,,'-,'-,0.0300135 unit decrease,[0.02-0.04],DENND1B,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197676319
rs12121863-<b>A</b>,4 x 10-10,,'-,'-,0.0328269 unit increase,[0.023-0.043],"DENND1B, C1orf53",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,1:197816290
rs9586-<b>T</b>,2 x 10-10,,'-,'-,0.0313868 unit decrease,[0.022-0.041],KLHDC8B,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49176204
rs6778080-<b>T</b>,3 x 10-9,,'-,'-,0.0271179 unit increase,[0.018-0.036],USP4,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49279905
rs13118306-<b>C</b>,4 x 10-8,,'-,'-,0.0231304 unit decrease,[0.015-0.031],CC2D2A,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,4:15476188
rs2134025-<b>A</b>,1 x 10-8,,'-,'-,0.0282905 unit increase,[0.019-0.038],LINC02503,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,4:104011140
rs12512642-<b>T</b>,5 x 10-8,,'-,'-,0.0274113 unit increase,[0.018-0.037],LINC02479,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,4:130288732
rs57273516-<b>A</b>,5 x 10-8,,'-,'-,0.0255575 unit increase,[0.016-0.035],"RNA5SP130, NICN1",Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49445641
rs13164188-<b>T</b>,9 x 10-9,,'-,'-,0.0242283 unit increase,[0.016-0.032],LINC02147,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,5:104578822
rs9835157-<b>A</b>,4 x 10-10,,'-,'-,0.0334667 unit increase,[0.023-0.044],IP6K1,Endometriosis or depression (pleiotropy),"endometriosis, unipolar depression",GCST010859,3:49760336
rs614288-<b>T</b>,2 x 10-8,,NR,'-,0.05 unit increase,[0.030-0.070],"ALDOAP1, POC1A",Bipolar disorder or type 2 diabetes,"bipolar disorder, type II diabetes mellitus",GCST009372,3:52186187
rs6091248-<b>A</b>,4 x 10-8,,NR,'-,0.05 unit increase,[0.030-0.070],KCNG1,Bipolar disorder or type 2 diabetes,"bipolar disorder, type II diabetes mellitus",GCST009372,20:51014081
rs12334475-<b>T</b>,3 x 10-7,,NR,1.3733491,'-,[1.21714766313734-1.54959718221248],'-,Bipolar disorder,bipolar disorder,GCST004139,8:142064186
rs174576-<b>A</b>,1 x 10-10,,NR,1.1258574,'-,[1.085854143728-1.16733516060197],FADS2,Bipolar disorder,bipolar disorder,GCST004139,11:61836038
rs10896135-<b>G</b>,1 x 10-7,,NR,1.12427,'-,[1.0763-1.17437],C11orf80,Bipolar disorder,bipolar disorder,GCST004139,11:66783531
rs12576775-<b>G</b>,3 x 10-9,,NR,1.1829699,'-,[1.11890240150022-1.25070508499166],'-,Bipolar disorder,bipolar disorder,GCST004139,Mapping not available
rs1842329-<b>T</b>,4 x 10-7,,NR,1.1168443,'-,[1.07016653931685-1.1655568622743],'-,Bipolar disorder,bipolar disorder,GCST004139,12:98170438
rs4926298-<b>G</b>,6 x 10-10,,NR,1.1321515,'-,[1.08856333588057-1.17748461027614],NFIX,Bipolar disorder,bipolar disorder,GCST004139,19:13042221
rs186197500-<b>A</b>,7 x 10-7,(Japanese),NR,1.8491876,'-,[1.45126296159233-2.35622325686603],RASAL2,Bipolar disorder,bipolar disorder,GCST004139,1:178131084
rs72874541-<b>G</b>,2 x 10-7,(Japanese),NR,1.23368,'-,[1.13997-1.33509],"LINC00698, UBL5P3",Bipolar disorder,bipolar disorder,GCST004139,3:63148173
rs115769866-<b>A</b>,8 x 10-7,(Japanese),NR,1.18655,'-,[1.1087-1.26988],"ZBED9, GPX5",Bipolar disorder,bipolar disorder,GCST004139,6:28545105
rs3931398-<b>A</b>,4 x 10-7,(Japanese),NR,1.34919,'-,[1.20176-1.51471],MAD1L1,Bipolar disorder,bipolar disorder,GCST004139,7:1991957
rs35425515-<b>C</b>,7 x 10-7,(Japanese),NR,1.5163853,'-,[1.28695491024776-1.78671931532916],SLIT1,Bipolar disorder,bipolar disorder,GCST004139,10:97119904
rs78089757-<b>A</b>,4 x 10-7,(Japanese),NR,1.406913,'-,[1.23294984483326-1.6054224749514],RPS27P18,Bipolar disorder,bipolar disorder,GCST004139,10:125424260
rs329674-<b>A</b>,1 x 10-7,(Japanese),NR,1.2155114,'-,[1.13140218066456-1.30587513221986],IGSF9B,Bipolar disorder,bipolar disorder,GCST004139,11:133907053
rs185880008-<b>T</b>,4 x 10-7,(Japanese),NR,1.18733,'-,[1.11096-1.26895],CPNE8,Bipolar disorder,bipolar disorder,GCST004139,12:38807668
rs76317718-<b>G</b>,2 x 10-7,(Japanese),NR,1.19429,'-,[1.11666-1.27731],ARHGEF15,Bipolar disorder,bipolar disorder,GCST004139,17:8319459
rs61580878-<b>A</b>,9 x 10-7,(Japanese),NR,1.19373,'-,[1.11231-1.2811],LINC01643,Bipolar disorder,bipolar disorder,GCST004139,22:34102046
rs9834970-<b>C</b>,2 x 10-9,,NR,1.11554,'-,[1.07634-1.15616],"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST004139,3:36814539
rs9393813-<b>A</b>,5 x 10-7,,NR,1.09431,'-,[1.05655-1.13342],"ZNF204P, ZNF391",Bipolar disorder,bipolar disorder,GCST004139,6:27363817
rs2205829-<b>G</b>,4 x 10-7,,NR,1.09434,'-,[1.05685-1.13317],"ZNF184, HNRNPA1P1",Bipolar disorder,bipolar disorder,GCST004139,6:27512448
rs4523096-<b>A</b>,7 x 10-8,,NR,1.15455,'-,[1.09573-1.21652],SYNE1,Bipolar disorder,bipolar disorder,GCST004139,6:152472277
rs4332037-<b>T</b>,2 x 10-9,,NR,1.1659197,'-,[1.10894251242016-1.22582369222999],MAD1L1,Bipolar disorder,bipolar disorder,GCST004139,7:1911173
rs28456-<b>G</b>,6 x 10-9,(Japanese),NR,1.18,'-,[1.11-1.24],"FADS2, FADS1",Bipolar disorder,bipolar disorder,GCST004139,11:61822009
rs10875914-<b>G</b>,6 x 10-8,,NR,1.11,'-,[1.07-1.15],KMT2D,Bipolar disorder,bipolar disorder,GCST004139,12:49028311
rs9863544-<b>T</b>,2 x 10-8,,0.058,0.65,'-,[0.559-0.756],NPHP3-AS1,Bipolar disorder,bipolar disorder,GCST011101,3:132893820
rs4245147-<b>C</b>,4 x 10-7,,0.161,0.789,'-,[0.720-0.865],DRD2,Bipolar disorder,bipolar disorder,GCST011101,11:113447285
rs41335055-<b>T</b>,5 x 10-9,,NR,0.849,'-,[0.804-0.897],ACTG1P22,Bipolar disorder,bipolar disorder,GCST011102,2:57734094
rs17183814-<b>A</b>,2 x 10-9,,NR,0.883,'-,[0.848-0.919],SCN2A,Bipolar disorder,bipolar disorder,GCST011102,2:165295879
chr2:194465711-<b>?</b>,9 x 10-10,,NR,0.935,'-,[0.915-0.955],'-,Bipolar disorder,bipolar disorder,GCST011102,Mapping not available
rs9834970-<b>T</b>,4 x 10-12,,NR,0.928,'-,[0.909-0.948],"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST011102,3:36814539
rs2302417-<b>A</b>,6 x 10-11,,NR,0.932,'-,[0.913-0.952],ITIH1,Bipolar disorder,bipolar disorder,GCST011102,3:52780240
rs3804640-<b>A</b>,2 x 10-9,,NR,1.068,'-,[1.045-1.091],CD47,Bipolar disorder,bipolar disorder,GCST011102,3:108074862
rs10035291-<b>T</b>,3 x 10-8,,NR,1.068,'-,[1.044-1.093],SSBP2,Bipolar disorder,bipolar disorder,GCST011102,5:81500549
chr6:72519394-<b>?</b>,2 x 10-8,,NR,1.063,'-,[1.041-1.086],'-,Bipolar disorder,bipolar disorder,GCST011102,Mapping not available
rs2388334-<b>A</b>,4 x 10-9,,NR,0.939,'-,[0.920-0.959],"EIF4EBP2P3, HLA-DRB5",Bipolar disorder,bipolar disorder,GCST011102,6:98143746
rs12672003-<b>A</b>,3 x 10-8,,NR,0.893,'-,[0.858-0.929],MPP6,Bipolar disorder,bipolar disorder,GCST011102,7:24607603
rs10994318-<b>C</b>,1 x 10-8,,NR,1.134,'-,[1.086-1.184],ANK3,Bipolar disorder,bipolar disorder,GCST011102,10:60366098
chr10:111745562-<b>?</b>,2 x 10-9,,NR,1.089,'-,[1.059-1.120],'-,Bipolar disorder,bipolar disorder,GCST011102,Mapping not available
rs10896090-<b>A</b>,2 x 10-8,,NR,1.079,'-,[1.051-1.108],PACS1,Bipolar disorder,bipolar disorder,GCST011102,11:66177715
rs968369-<b>T</b>,2 x 10-8,,NR,1.124,'-,[1.079-1.171],TENM4,Bipolar disorder,bipolar disorder,GCST011102,11:79442036
rs10744560-<b>T</b>,5 x 10-10,,NR,1.075,'-,[1.051-1.100],"CACNA1C, CACNA1C-IT3",Bipolar disorder,bipolar disorder,GCST011102,12:2277933
rs7969091-<b>A</b>,3 x 10-8,,NR,0.932,'-,[0.909-0.956],"DHH, RHEBL1",Bipolar disorder,bipolar disorder,GCST011102,12:49070666
rs12902052-<b>A</b>,7 x 10-9,,NR,1.088,'-,[1.057-1.120],"ZSCAN2, LINC00933",Bipolar disorder,bipolar disorder,GCST011102,15:84582607
rs11647445-<b>T</b>,9 x 10-11,,NR,0.928,'-,[0.907-0.949],GRIN2A,Bipolar disorder,bipolar disorder,GCST011102,16:9833109
rs112114764-<b>T</b>,3 x 10-8,,NR,0.937,'-,[0.916-0.959],HDAC5,Bipolar disorder,bipolar disorder,GCST011102,17:44123673
rs884303-<b>A</b>,6 x 10-10,,NR,0.921,'-,[0.897-0.945],HLF,Bipolar disorder,bipolar disorder,GCST011102,17:55289939
rs11557713-<b>A</b>,1 x 10-8,,NR,1.069,'-,[1.045-1.094],ZCCHC2,Bipolar disorder,bipolar disorder,GCST011102,18:62576643
rs111444407-<b>T</b>,5 x 10-10,,NR,1.097,'-,[1.065-1.130],NCAN,Bipolar disorder,bipolar disorder,GCST011102,19:19247398
rs6130764-<b>T</b>,6 x 10-9,,NR,1.067,'-,[1.044-1.091],"WFDC12, WFDC5",Bipolar disorder,bipolar disorder,GCST011102,20:45121769
rs8099939-<b>T</b>,2 x 10-6,,0.39,1.95,'-,[1.43-2.67],GRIK5,Bipolar disorder,bipolar disorder,GCST001164,19:42016956
rs6122972-<b>A</b>,3 x 10-6,,0.82,2.02,'-,[1.46-2.80],"PARD6B, BCAS4",Bipolar disorder,bipolar disorder,GCST001164,20:50758705
rs2289700-<b>A</b>,9 x 10-6,,0.07,2.13,'-,[1.53-2.95],CTSH,Bipolar disorder,bipolar disorder,GCST001164,15:78932341
rs8040009-<b>C</b>,6 x 10-6,,0.11,1.4,'-,[1.21-1.61],C15orf32,Bipolar I disorder,bipolar disorder,GCST000654,15:92501109
rs2709736-<b>G</b>,5 x 10-7,,NR,1.44,'-,[1.25-1.66],"SP8, RPL23P8",Bipolar I disorder,bipolar disorder,GCST000654,7:20822683
rs9834970-<b>?</b>,4 x 10-7,(BP vs. controls),NR,'-,'-,'-,"LINC02033, HSPD1P6",Schizophrenia or bipolar disorder,bipolar disorder,GCST002295,3:36814539
rs1006737-<b>?</b>,7 x 10-8,(BP vs. controls),NR,'-,'-,'-,CACNA1C,Schizophrenia or bipolar disorder,bipolar disorder,GCST002295,12:2236129
rs2610025-<b>A</b>,5 x 10-6,(suicide behaviour severity),'-,'-,0.02332 unit decrease,[0.0069-0.0397],RPL37P6,Suicide in bipolar disorder,"suicide behaviour measurement, bipolar disorder",GCST002699,8:56592754
rs7079041-<b>A</b>,2 x 10-6,(suicide behaviour severity),'-,'-,0.02383 unit increase,[0.0067-0.0409],CCDC7,Suicide in bipolar disorder,"suicide behaviour measurement, bipolar disorder",GCST002699,10:32704340
rs10448044-<b>C</b>,3 x 10-6,(suicide attempt),'-,'-,4.685 z score increase,'-,'-,Suicide in bipolar disorder,"bipolar disorder, attempted suicide",GCST002699,8:79191197
rs7244261-<b>T</b>,4 x 10-6,(suicide attempt),'-,'-,4.606 z score increase,'-,MTL3P,Suicide in bipolar disorder,"bipolar disorder, attempted suicide",GCST002699,18:68547459
rs472913-<b>C</b>,2 x 10-7,,0.5,1.18,'-,[1.11-1.25],LINC01748,Bipolar disorder,bipolar disorder,GCST000387,1:60629886
rs6990255-<b>T</b>,6 x 10-6,,0.95,1.33,'-,[1.18-1.51],"PPP1R3B, RPL10AP3",Bipolar disorder,bipolar disorder,GCST000387,8:34269430
rs2905072-<b>A</b>,6 x 10-6,,0.77,1.21,'-,[1.11-1.32],GFI1B,Bipolar disorder,bipolar disorder,GCST000387,9:132969648
rs1035050-<b>T</b>,9 x 10-6,,0.4,1.17,'-,[1.09-1.25],"NGFR, LINC02075",Bipolar disorder,bipolar disorder,GCST000387,17:49486650
rs7250872-<b>T</b>,2 x 10-6,,0.69,1.21,'-,[1.12-1.31],ATP8B3,Bipolar disorder,bipolar disorder,GCST000387,19:1811604
rs6733011-<b>G</b>,3 x 10-6,,0.46,1.17,'-,[1.10-1.25],CRACDL,Bipolar disorder,bipolar disorder,GCST000387,2:98849039
rs1042779-<b>A</b>,2 x 10-7,,0.63,1.19,'-,[1.11-1.27],ITIH1,Bipolar disorder,bipolar disorder,GCST000387,3:52786995
rs7427021-<b>G</b>,5 x 10-6,,0.56,1.16,'-,[1.09-1.24],'-,Bipolar disorder,bipolar disorder,GCST000387,3:164044176
rs17418283-<b>C</b>,1 x 10-7,,0.28,1.21,'-,[1.13-1.30],MCTP1,Bipolar disorder,bipolar disorder,GCST000387,5:94818883
rs6494849-<b>A</b>,7 x 10-6,,0.12,1.23,'-,[1.13-1.35],"RNU6-745P, TLE3",Bipolar disorder,bipolar disorder,GCST000387,15:70188275
rs13409348-<b>G</b>,3 x 10-6,,0.24,1.2,'-,[1.11-1.29],CTNNA2,Bipolar disorder,bipolar disorder,GCST000387,2:79312862
rs2537859-<b>T</b>,4 x 10-6,,0.6,1.16,'-,[1.09-1.24],"KIT, LINC02260",Bipolar disorder,bipolar disorder,GCST000387,4:54616651
rs2242663-<b>T</b>,1 x 10-6,,0.25,1.2,'-,[1.11-1.29],CTSF,Bipolar disorder,bipolar disorder,GCST000387,11:66567837
rs4650608-<b>T</b>,8 x 10-9,,NR,'-,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST001358,1:78772330
rs2271893-<b>G</b>,2 x 10-10,,NR,'-,'-,'-,LMAN2L,Bipolar disorder,bipolar disorder,GCST001358,2:96739703
rs7618915-<b>G</b>,3 x 10-10,,NR,'-,'-,'-,TWF2,Bipolar disorder,bipolar disorder,GCST001358,3:52245578
rs9834970-<b>C</b>,1 x 10-12,,NR,'-,'-,'-,"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST001358,3:36814539
rs4948418-<b>T</b>,4 x 10-10,,NR,'-,'-,'-,ANK3,Bipolar disorder,bipolar disorder,GCST001358,10:60425736
rs2314398-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"CNNM4, LMAN2L",Bipolar disorder,bipolar disorder,GCST006865,2:96747751
rs3821396-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,ZNF385D,Bipolar disorder,bipolar disorder,GCST006865,3:21664877
rs17082664-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,SYNE1,Bipolar disorder,bipolar disorder,GCST006865,6:152417619
rs7041940-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,GARNL3,Bipolar disorder,bipolar disorder,GCST006865,9:127347467
rs109944336-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,ANK3,Bipolar disorder,bipolar disorder,GCST006865,10:60420054
rs1938526-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ANK3,Bipolar disorder,bipolar disorder,GCST006865,10:60540625
rs12290811-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,TENM4,Bipolar disorder,bipolar disorder,GCST006865,11:79372576
rs544368-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,SIAE,Bipolar disorder,bipolar disorder,GCST006865,11:124668099
rs1006737-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,CACNA1C,Bipolar disorder,bipolar disorder,GCST006865,12:2236129
rs12436436-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,LINC00596,Bipolar disorder,bipolar disorder,GCST006865,14:23912306
rs12899449-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,LINC02694,Bipolar disorder,bipolar disorder,GCST006865,15:38703290
rs722667-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,"SEPTIN7P14, PDE5A",Bipolar disorder,bipolar disorder,GCST006865,4:119514966
rs216345-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,UBE2R2-AS1,Bipolar disorder,bipolar disorder,GCST006865,9:33799372
rs2278702-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"LINC00927, ARNT2",Bipolar disorder,bipolar disorder,GCST006865,15:80402580
rs1419103-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,LINC01307,Bipolar disorder,bipolar disorder,GCST006865,1:101475100
rs1601875-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,SUMF1,Bipolar disorder,bipolar disorder,GCST006865,3:3617156
rs307660-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,UBAP2,Bipolar disorder,bipolar disorder,GCST006865,9:33942932
rs7042161-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,SVEP1,Bipolar disorder,bipolar disorder,GCST006865,9:110434983
rs16966460-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,SPRED1,Bipolar disorder,bipolar disorder,GCST006865,15:38219782
rs703965-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,ZMIZ1,Bipolar disorder,bipolar disorder,GCST006865,10:79195310
rs7226677-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,"COLEC12, THOC1-DT",Bipolar disorder,bipolar disorder,GCST006865,18:278796
rs17746001-<b>T</b>,3 x 10-7,,NR,2.03,'-,[NR],'-,Bipolar disorder,bipolar disorder,GCST001569,4:179734472
rs17040430-<b>T</b>,9 x 10-7,,NR,1.89,'-,[NR],"CMKLR1, LINC01498",Bipolar disorder,bipolar disorder,GCST001569,12:108349043
rs271738-<b>A</b>,5 x 10-6,,NR,1.32,'-,[NR],"LINC01354, TARBP1",Bipolar disorder,bipolar disorder,GCST001569,1:234527144
rs289585-<b>?</b>,5 x 10-6,,NR,1.45,'-,[NR],DLC1,Bipolar disorder,bipolar disorder,GCST001569,8:13403027
rs1012053-<b>A</b>,2 x 10-8,,0.84,1.59,'-,[1.35-1.87],DGKH,Bipolar disorder,bipolar disorder,GCST000033,13:42079301
rs2111504-<b>T</b>,2 x 10-6,(AA),0.23,1.74,'-,[NR],DPY19L3,Bipolar disorder,bipolar disorder,GCST000417,19:32426549
rs2934442-<b>?</b>,1 x 10-6,(age of onset),NR,'-,1.022 unit decrease,[NR],CGNL1,Bipolar disorder (age of onset and psychotic symptoms),"age at onset, bipolar disorder",GCST000969,15:57470595
rs7795096-<b>?</b>,2 x 10-6,(psychotic symptoms),NR,1.2,'-,[NR],PRKAG2,Bipolar disorder (age of onset and psychotic symptoms),"psychotic symptoms, bipolar disorder",GCST000969,7:151849504
rs300774-<b>A</b>,5 x 10-8,,0.18,1.22,'-,[NR],FAM110C,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST001015,2:112496
rs10437629-<b>?</b>,4 x 10-6,,NR,1.34,'-,[NR],KIAA1549L,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST001015,11:33566664
rs7296262-<b>T</b>,1 x 10-6,,0.51,1.22,'-,[NR],TMEM132C,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST001015,12:128610527
rs2989476-<b>C</b>,3 x 10-6,,NR,1.16,'-,[NR],LINC01748,Bipolar disorder,bipolar disorder,GCST001135,1:60593587
rs12618769-<b>T</b>,1 x 10-6,,NR,1.25,'-,[NR],MGAT4A,Bipolar disorder,bipolar disorder,GCST001135,2:98623468
rs7747960-<b>A</b>,9 x 10-6,,NR,1.23,'-,[NR],SYNE1,Bipolar disorder,bipolar disorder,GCST001135,6:152470339
rs4770394-<b>A</b>,9 x 10-6,,NR,1.59,'-,[NR],HMGA1P6,Bipolar disorder,bipolar disorder,GCST001135,13:23118839
rs17197037-<b>A</b>,2 x 10-6,,NR,1.17,'-,[NR],HNRNPC,Bipolar disorder,bipolar disorder,GCST001135,14:21257495
rs1038094-<b>G</b>,9 x 10-6,,NR,1.27,'-,[NR],"INSYN1, CD276",Bipolar disorder,bipolar disorder,GCST001135,15:73720096
rs994280-<b>A</b>,3 x 10-8,,NR,1.07,'-,[1.05-1.09],SPATS2L,Bipolar disorder,bipolar disorder,GCST011767,2:200375363
rs1440518-<b>A</b>,3 x 10-8,,NR,1.06,'-,[1.04-1.08],RBMS3,Bipolar disorder,bipolar disorder,GCST011767,3:29707867
rs1948246-<b>G</b>,5 x 10-9,,NR,1.07,'-,[1.05-1.09],LINC01378,Bipolar disorder,bipolar disorder,GCST011767,4:117534962
rs113799727-<b>G</b>,5 x 10-9,,NR,1.08,'-,[1.06-1.1],LINC01470,Bipolar disorder,bipolar disorder,GCST011767,5:152698812
rs11742527-<b>G</b>,2 x 10-8,,NR,1.06,'-,[1.04-1.08],"DOCK2, INSYN2B",Bipolar disorder,bipolar disorder,GCST011767,5:169916213
rs1180221-<b>T</b>,3 x 10-9,,NR,1.09,'-,[1.07-1.11],ME1,Bipolar disorder,bipolar disorder,GCST011767,6:83243557
rs62533709-<b>T</b>,3 x 10-9,,NR,1.11,'-,[1.07-1.15],PAX5,Bipolar disorder,bipolar disorder,GCST011767,9:37003707
rs12921204-<b>T</b>,3 x 10-9,,NR,1.08,'-,[1.06-1.1],"C16orf72, RPL21P119",Bipolar disorder,bipolar disorder,GCST011767,16:9133864
rs6079469-<b>A</b>,1 x 10-9,,NR,1.09,'-,[1.07-1.11],MACROD2,Bipolar disorder,bipolar disorder,GCST011767,20:14520495
rs8118905-<b>C</b>,2 x 10-8,,NR,1.07,'-,[1.05-1.09],"KCNG1, MOCS3",Bipolar disorder,bipolar disorder,GCST011767,20:50994060
rs8063446-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,SLC7A6OS,Schizophrenia,schizophrenia,GCST008906,16:68310460
rs112845369-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,LINC01579,Schizophrenia,schizophrenia,GCST008906,15:93627884
rs2693698-<b>?</b>,9 x 10-10,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,Mapping not available
rs12190758-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,6:92438623
rs74804370-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,8:34141053
rs7819570-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,8:88576397
rs59979824-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,2:192983614
rs6748251-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,2:193603800
rs13107325-<b>?</b>,8 x 10-11,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,Mapping not available
rs12190758-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010645,6:92438623
rs13107325-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010645,Mapping not available
rs7185124-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010645,16:13656837
rs7521492-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,1:163758686
rs72769124-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010640,1:239046758
rs7819570-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST010645,8:88576397
rs2188177-<b>?</b>,8 x 10-6,,NR,2.4207213,'-,NR,"RN7SL7P, SAMD9",Physical aggression in schizophrenia,"schizophrenia, aggressive behavior",GCST010467,7:93029846
rs1446296-<b>C</b>,3 x 10-6,,NR,3.023,'-,NR,"RMDN2, RMDN2-AS1",Verbal aggression in schizophrenia,"schizophrenia, aggressive behavior",GCST010466,2:37989273
rs4253405-<b>G</b>,5 x 10-6,,NR,2.809,'-,NR,F11,Verbal aggression in schizophrenia,"schizophrenia, aggressive behavior",GCST010466,4:186269656
rs1412115-<b>?</b>,6 x 10-6,,0.37,'-,'-,'-,"RPL23P11, LINC00838",Schizophrenia,schizophrenia,GCST001119,10:33799125
rs17039583-<b>?</b>,4 x 10-6,,NR,'-,2.431 unit increase,[NR],COL25A1,Schizophrenia (age at onset),"schizophrenia, age at onset",GCST001115,4:108959574
rs17407555-<b>?</b>,5 x 10-6,,'-,'-,1.501 unit decrease,[NR],RAF1P1,Schizophrenia (age at onset),"schizophrenia, age at onset",GCST001115,4:10273370
rs7017212-<b>?</b>,4 x 10-6,,0.41,'-,'-,'-,MSRA,Schizophrenia,schizophrenia,GCST001110,8:10165428
rs4129148-<b>C</b>,4 x 10-7,,NR,3.23,'-,[2.04-5.15],RPL14P5,Schizophrenia,schizophrenia,GCST000016,X:1029445
rs17594526-<b>T</b>,1 x 10-7,,0.03,1.44,'-,'-,TCF4,Schizophrenia,schizophrenia,GCST000434,18:55391007
rs13194053-<b>T</b>,1 x 10-8,,0.86,1.22,'-,'-,"MIR3143, RPL10P2",Schizophrenia,schizophrenia,GCST000434,6:27176104
rs7544736-<b>G</b>,6 x 10-7,,0.18,1.25,'-,'-,"PTBP2, RN7SKP270",Schizophrenia,schizophrenia,GCST000434,1:96698787
rs6782299-<b>T</b>,1 x 10-7,,0.73,1.1,'-,'-,'-,Schizophrenia,schizophrenia,GCST000434,Mapping not available
rs11064768-<b>A</b>,1 x 10-6,,0.91,'-,'-,'-,CCDC60,Schizophrenia,schizophrenia,GCST000163,12:119380704
rs1490191-<b>?</b>,7 x 10-9,,NR,'-,0.1379 unit decrease,'-,"THEM4, KRT8P28",Eye movement in schizophrenia (horizontal position gain),"eye movement measurement, schizophrenia",GCST006448,1:151944275
rs6964854-<b>?</b>,4 x 10-8,,NR,'-,0.182 unit decrease,'-,"RN7SKP218, LINC01446",Eye movement in schizophrenia (horizontal position gain),"eye movement measurement, schizophrenia",GCST006448,7:53559913
rs6104543-<b>?</b>,2 x 10-8,,NR,'-,0.1984 unit decrease,'-,"SLC35C2, CDH22",Eye movement in schizophrenia (horizontal position gain),"eye movement measurement, schizophrenia",GCST006448,20:46311139
rs4736253-<b>?</b>,5 x 10-8,(EA),NR,'-,5.448 z score increase,'-,'-,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,8:139342742
rs10895475-<b>A</b>,2 x 10-7,(EA),0.357,'-,5.167 z score decrease,'-,'-,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,11:103593113
rs10180106-<b>A</b>,5 x 10-7,(EA),0.2813,'-,5.03 z score increase,'-,CTNNA2,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,2:79994772
rs511841-<b>C</b>,2 x 10-7,(AA),NR,'-,5.185 z score decrease,'-,"STXBP5L, LINC02049",Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,3:120896668
rs7620938-<b>?</b>,3 x 10-7,(AA),NR,'-,5.116 z score decrease,'-,STXBP5L,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,3:121172743
rs4736253-<b>?</b>,2 x 10-6,,NR,'-,4.718 z score increase,'-,'-,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,8:139342742
rs10180106-<b>A</b>,2 x 10-6,,NR,'-,4.719 z score increase,'-,CTNNA2,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,2:79994772
rs642516-<b>A</b>,2 x 10-6,,0.6926,'-,4.803 z score increase,'-,TENM4,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,11:79289084
rs4507566-<b>A</b>,2 x 10-6,,0.5584,'-,4.756 z score decrease,'-,EYS,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,6:65552163
rs60354593-<b>T</b>,5 x 10-6,,0.1435,'-,4.557 z score decrease,'-,"ATP5MGP4, TET2",Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,4:148673270
rs26193-<b>A</b>,8 x 10-6,,0.3048,'-,4.475 z score increase,'-,U3,Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,5:35363807
rs12857574-<b>A</b>,9 x 10-6,,0.3397,'-,4.441 z score increase,'-,"LINC00460, RPL35P9",Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,13:106409080
rs524045-<b>A</b>,9 x 10-7,,0.1151,'-,4.918 z score increase,'-,"RNU6-210P, RN7SKP123",Response to lurasidone in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006248,1:93024470
rs10099100-<b>C</b>,1 x 10-8,,0.331,1.08,'-,[NR],"RP1L1, SOX7",Autism spectrum disorder,autism spectrum disorder,GCST007556,8:10719265
rs183563276-<b>G</b>,4 x 10-6,,0.011,1.4265335,'-,[NR],"RN7SKP32, RNU6-819P",Autism spectrum disorder,autism spectrum disorder,GCST007556,8:47124851
rs10110094-<b>A</b>,8 x 10-7,,0.163,1.091,'-,[NR],ASAP1,Autism spectrum disorder,autism spectrum disorder,GCST007556,8:130459801
rs11787216-<b>C</b>,4 x 10-6,,0.636,1.0638298,'-,[NR],MROH5,Autism spectrum disorder,autism spectrum disorder,GCST007556,8:141605122
rs45595836-<b>T</b>,3 x 10-6,,0.067,1.126,'-,[NR],RSU1,Autism spectrum disorder,autism spectrum disorder,GCST007556,10:16649400
rs113764414-<b>A</b>,5 x 10-7,,0.672,1.078,'-,[NR],EGR2,Autism spectrum disorder,autism spectrum disorder,GCST007556,10:62889636
rs141319505-<b>A</b>,4 x 10-6,,0.98,1.308,'-,[NR],MRPL35P2,Autism spectrum disorder,autism spectrum disorder,GCST007556,10:63661682
undefined,8 x 10-6,,0.037,1.1641443,'-,[NR],'-,Autism spectrum disorder,autism spectrum disorder,GCST007556,Mapping not available
rs117603308-<b>T</b>,9 x 10-6,,0.026,1.229,'-,[NR],GUCY1A2,Autism spectrum disorder,autism spectrum disorder,GCST007556,11:106957251
rs77691144-<b>C</b>,6 x 10-7,,0.025,1.2330457,'-,[NR],PCDH9,Autism spectrum disorder,autism spectrum disorder,GCST007556,13:66396080
rs201369005-<b>G</b>,9 x 10-6,,0.051,1.155,'-,[NR],ESRRB,Autism spectrum disorder,autism spectrum disorder,GCST007556,14:76369281
rs112635299-<b>T</b>,2 x 10-7,,0.025,1.245,'-,[NR],"SERPINA1, SERPINA2",Autism spectrum disorder,autism spectrum disorder,GCST007556,14:94371805
rs12942300-<b>T</b>,2 x 10-6,,0.829,1.0893246,'-,[NR],LINC02210-CRHR1,Autism spectrum disorder,autism spectrum disorder,GCST007556,17:45782039
rs141455452-<b>T</b>,6 x 10-7,,0.525,1.078,'-,[NR],MAPT,Autism spectrum disorder,autism spectrum disorder,GCST007556,17:45941717
rs142920272-<b>C</b>,9 x 10-7,,0.187,1.0881393,'-,[NR],KANSL1,Autism spectrum disorder,autism spectrum disorder,GCST007556,17:46224474
rs143609523-<b>G</b>,1 x 10-6,,0.012,1.3513513,'-,[NR],GALNT1,Autism spectrum disorder,autism spectrum disorder,GCST007556,18:35685266
rs292441-<b>G</b>,3 x 10-6,,0.324,1.0672358,'-,[NR],NEDD4L,Autism spectrum disorder,autism spectrum disorder,GCST007556,18:58205326
rs138867053-<b>A</b>,4 x 10-7,,0.017,1.285,'-,[NR],ZNF568,Autism spectrum disorder,autism spectrum disorder,GCST007556,19:36948739
rs71190156-<b>G</b>,4 x 10-8,,0.519,1.0741138,'-,[NR],MACROD2,Autism spectrum disorder,autism spectrum disorder,GCST007556,20:14855598
rs6047270-<b>T</b>,8 x 10-7,,0.319,1.071,'-,[NR],KIZ,Autism spectrum disorder,autism spectrum disorder,GCST007556,20:21141571
rs910805-<b>G</b>,3 x 10-7,,0.24,1.0787487,'-,[NR],"XRN2, ZNF877P",Autism spectrum disorder,autism spectrum disorder,GCST007556,20:21267478
rs201910565-<b>AT</b>,4 x 10-8,,0.311,1.0787487,'-,[NR],LINC02790,Autism spectrum disorder,autism spectrum disorder,GCST007556,1:96096246
rs2391769-<b>G</b>,5 x 10-7,,0.631,1.0695187,'-,[NR],"RN7SL831P, EEF1A1P11",Autism spectrum disorder,autism spectrum disorder,GCST007556,1:96513405
rs6701243-<b>A</b>,1 x 10-6,,0.609,1.067,'-,[NR],SNX7,Autism spectrum disorder,autism spectrum disorder,GCST007556,1:98627228
rs11185408-<b>G</b>,1 x 10-6,,0.477,1.0649627,'-,[NR],FTLP17,Autism spectrum disorder,autism spectrum disorder,GCST007556,1:104249635
rs6692705-<b>A</b>,1 x 10-6,,0.4,1.066,'-,[NR],CAMSAP2,Autism spectrum disorder,autism spectrum disorder,GCST007556,1:193533479
rs59566011-<b>GA</b>,1 x 10-6,,0.569,1.068,'-,[NR],PKP4,Autism spectrum disorder,autism spectrum disorder,GCST007556,2:158528670
rs148587110-<b>C</b>,1 x 10-6,,0.011,1.3927578,'-,[NR],SGO1-AS1,Autism spectrum disorder,autism spectrum disorder,GCST007556,3:20600474
rs1452075-<b>T</b>,6 x 10-7,,0.721,1.074,'-,[NR],CADPS,Autism spectrum disorder,autism spectrum disorder,GCST007556,3:62495388
rs200332011-<b>C</b>,6 x 10-6,,0.769,1.0775862,'-,[NR],RSRC1,Autism spectrum disorder,autism spectrum disorder,GCST007556,3:158283895
rs79940520-<b>G</b>,9 x 10-6,,0.141,1.0893246,'-,[NR],"RN7SKP222, FGF12",Autism spectrum disorder,autism spectrum disorder,GCST007556,3:192120380
rs56054767-<b>C</b>,4 x 10-6,,0.113,1.11,'-,[NR],Y_RNA,Autism spectrum disorder,autism spectrum disorder,GCST007556,4:83700165
rs4916723-<b>C</b>,3 x 10-6,,0.428,1.0626993,'-,[NR],LINC00461,Autism spectrum disorder,autism spectrum disorder,GCST007556,5:88558577
rs2635182-<b>T</b>,5 x 10-7,,0.466,1.067,'-,[NR],LINC02058,Autism spectrum disorder,autism spectrum disorder,GCST007556,5:92919459
rs325485-<b>A</b>,2 x 10-6,,0.378,1.066,'-,[NR],'-,Autism spectrum disorder,autism spectrum disorder,GCST007556,5:104659667
rs13188074-<b>A</b>,2 x 10-6,,0.391,1.064,'-,[NR],KCNN2,Autism spectrum disorder,autism spectrum disorder,GCST007556,5:114465726
rs34509057-<b>A</b>,6 x 10-6,,0.226,1.071,'-,[NR],GALNT10,Autism spectrum disorder,autism spectrum disorder,GCST007556,5:154221702
chr5:168173526-<b>A</b>,2 x 10-7,,0.016,1.332,'-,[NR],'-,Autism spectrum disorder,autism spectrum disorder,GCST007556,Mapping not available
rs210894-<b>T</b>,4 x 10-7,,0.548,1.068,'-,[NR],ADTRP,Autism spectrum disorder,autism spectrum disorder,GCST007556,6:11731766
rs12203328-<b>C</b>,2 x 10-6,,0.278,1.069,'-,[NR],SPTLC1P2,Autism spectrum disorder,autism spectrum disorder,GCST007556,6:23766810
rs34739626-<b>T</b>,8 x 10-6,,0.617,1.067,'-,[NR],SPTLC1P2,Autism spectrum disorder,autism spectrum disorder,GCST007556,6:23870548
rs740883-<b>T</b>,1 x 10-6,,0.088,1.1160713,'-,[NR],GABBR1,Autism spectrum disorder,autism spectrum disorder,GCST007556,6:29607628
chr6:96509180-<b>D</b>,8 x 10-6,,0.641,1.072,'-,[NR],'-,Autism spectrum disorder,autism spectrum disorder,GCST007556,Mapping not available
rs72934503-<b>G</b>,2 x 10-7,,0.463,1.0718113,'-,[NR],EIF4EBP2P3,Autism spectrum disorder,autism spectrum disorder,GCST007556,6:98135612
rs111931861-<b>G</b>,3 x 10-8,,0.034,1.242236,'-,[NR],KMT2E,Autism spectrum disorder,autism spectrum disorder,GCST007556,7:105103772
chr7:105064665-<b>T</b>,3 x 10-6,,0.25,1.076,'-,[NR],'-,Autism spectrum disorder,autism spectrum disorder,GCST007556,Mapping not available
rs2388334-<b>A</b>,3 x 10-12,,0.517,'-,0.065 unit decrease,[0.047-0.083],"EIF4EBP2P3, HLA-DRB5",Autism and educational attainment (MTAG),"autism spectrum disorder, self reported educational attainment",GCST007554,6:98143746
rs1452075-<b>T</b>,3 x 10-9,,0.721,'-,0.061 unit increase,[0.041-0.081],CADPS,Autism and educational attainment (MTAG),"autism spectrum disorder, self reported educational attainment",GCST007554,3:62495388
rs11787216-<b>T</b>,2 x 10-9,,0.364,'-,0.058 unit decrease,[0.038-0.078],MROH5,Autism and educational attainment (MTAG),"autism spectrum disorder, self reported educational attainment",GCST007554,8:141605122
rs13294439-<b>A</b>,3 x 10-7,,0.596,'-,0.048 unit decrease,[0.03-0.066],'-,Autism and educational attainment (MTAG),"autism spectrum disorder, self reported educational attainment",GCST007554,9:23358877
rs7225151-<b>?</b>,1 x 10-8,,NR,1.1,'-,[1.06-1.14],"SCIMP, ZNF594-DT",Alzheimer's disease,Alzheimer's disease,GCST009021,17:5233752
rs429358-<b>C</b>,1 x 10-62,,0.17,2.27,'-,[2.5-2.06],'-,Alzheimer's disease,Alzheimer's disease,GCST009020,Mapping not available
rs429358-<b>C</b>,1 x 10-64,,0.17,2.39,'-,[2.64-2.17],'-,Alzheimer’s disease (clinical subgroup AD+),Alzheimer's disease,GCST009022,Mapping not available
rs429358-<b>C</b>,1 x 10-76,,0.17,2.71,'-,[3.01-2.44],'-,Alzheimer’s disease (clinical subgroup AD++),Alzheimer's disease,GCST009023,Mapping not available
rs429358-<b>C</b>,1 x 10-75,,0.17,2.92,'-,[3.27-2.6],'-,Alzheimer’s disease (clinical subgroup AD+++),Alzheimer's disease,GCST009024,Mapping not available
rs6733839-<b>?</b>,5 x 10-20,,NR,1.23,'-,[1.18 – 1.28],"NIFKP9, BIN1",Alzheimer's disease,Alzheimer's disease,GCST009019,2:127135234
rs983392-<b>?</b>,5 x 10-8,,NR,1.1235955,'-,'-,"LINC02705, MS4A2",Alzheimer's disease,Alzheimer's disease,GCST009019,11:60156035
rs10792832-<b>?</b>,2 x 10-11,,NR,1.1627907,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease,Alzheimer's disease,GCST009019,11:86156833
rs429358-<b>?</b>,2 x 10-303,,NR,3.21,'-,[3.02 – 3.41],'-,Alzheimer's disease,Alzheimer's disease,GCST009019,Mapping not available
rs3865444-<b>?</b>,7 x 10-6,,NR,1.1111112,'-,'-,"CD33, SIGLEC22P",Alzheimer's disease,Alzheimer's disease,GCST009019,19:51224706
rs4704171-<b>?</b>,1 x 10-8,,NR,1.18,'-,[1.11-1.24],ANKRD31,Alzheimer's disease,Alzheimer's disease,GCST009019,5:75072429
rs11218343-<b>?</b>,1 x 10-10,,NR,1.2820514,'-,[1.37-1.19],SORL1,Alzheimer's disease,Alzheimer's disease,GCST009021,11:121564878
rs2732703-<b>?</b>,1 x 10-7,,NR,1.1627907,'-,[1.23-1.1],ARL17B,Alzheimer's disease,Alzheimer's disease,GCST009021,17:46275856
rs9331896-<b>?</b>,6 x 10-15,,NR,1.1363636,'-,[1.16-1.1],CLU,Alzheimer's disease,Alzheimer's disease,GCST009021,8:27610169
rs10792832-<b>?</b>,4 x 10-18,,NR,1.1363636,'-,[1.1-1.16],"LINC02695, RNU6-560P",Alzheimer's disease,Alzheimer's disease,GCST009021,11:86156833
rs983392-<b>?</b>,9 x 10-13,,NR,1.1111112,'-,[1.08-1.15],"LINC02705, MS4A2",Alzheimer's disease,Alzheimer's disease,GCST009021,11:60156035
rs11771145-<b>?</b>,5 x 10-10,,NR,1.098901,'-,[1.06-1.14],EPHA1-AS1,Alzheimer's disease,Alzheimer's disease,GCST009021,7:143413669
rs10498633-<b>?</b>,1 x 10-6,,NR,1.0869565,'-,[1.05-1.14],SLC24A4,Alzheimer's disease,Alzheimer's disease,GCST009021,14:92460608
rs3865444-<b>?</b>,4 x 10-8,,NR,1.0869565,'-,[1.05-1.12],"CD33, SIGLEC22P",Alzheimer's disease,Alzheimer's disease,GCST009021,19:51224706
rs190982-<b>?</b>,4 x 10-6,,NR,1.0752687,'-,[1.11-1.04],MEF2C-AS1,Alzheimer's disease,Alzheimer's disease,GCST009021,5:88927603
rs1476679-<b>?</b>,2 x 10-6,,NR,1.0752687,'-,[1.11-1.04],ZCWPW1,Alzheimer's disease,Alzheimer's disease,GCST009021,7:100406823
rs2718058-<b>?</b>,2 x 10-6,,NR,1.0638298,'-,[1.10-1.03],"GPR141, EPDR1",Alzheimer's disease,Alzheimer's disease,GCST009021,7:37801932
rs10838725-<b>?</b>,3 x 10-6,,NR,1.07,'-,[1.04-1.10],CELF1,Alzheimer's disease,Alzheimer's disease,GCST009021,11:47536319
rs9271192-<b>?</b>,5 x 10-7,,NR,1.09,'-,[1.13-1.05],"HLA-DRB1, HLA-DQA1",Alzheimer's disease,Alzheimer's disease,GCST009021,6:32610753
rs28834970-<b>?</b>,6 x 10-9,,NR,1.09,'-,[1.12-1.06],PTK2B,Alzheimer's disease,Alzheimer's disease,GCST009021,8:27337604
rs10948363-<b>?</b>,5 x 10-9,,NR,1.1,'-,[1.13-1.06],CD2AP,Alzheimer's disease,Alzheimer's disease,GCST009021,6:47520026
rs4147929-<b>?</b>,3 x 10-9,,NR,1.12,'-,[1.08-1.17],ABCA7,Alzheimer's disease,Alzheimer's disease,GCST009021,19:1063444
rs6656401-<b>?</b>,2 x 10-14,,NR,1.15,'-,[1.11-1.19],CR1,Alzheimer's disease,Alzheimer's disease,GCST009021,1:207518704
rs6733839-<b>?</b>,3 x 10-30,,NR,1.2,'-,[1.16-1.23],"NIFKP9, BIN1",Alzheimer's disease,Alzheimer's disease,GCST009021,2:127135234
rs10098778-<b>?</b>,2 x 10-8,,NR,1.0638298,'-,[1.04-1.09],NDUFAF6,Alzheimer's disease,Alzheimer's disease,GCST009021,8:94979792
rs7274581-<b>C</b>,3 x 10-8,,0.084,'-,5.53 z-unit decrease,NR,CASS4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,20:56443204
rs9331896-<b>C</b>,7 x 10-17,,0.4107,'-,8.35 z-unit decrease,NR,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27610169
rs983392-<b>G</b>,2 x 10-11,,0.4083,'-,6.71 z-unit decrease,NR,"LINC02705, MS4A2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:60156035
rs114360492-<b>T</b>,2 x 10-9,,2.59E-04,'-,5.99 z-unit increase,NR,CNTNAP2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:146252937
rs184384746-<b>T</b>,1 x 10-8,,0.002,'-,5.69 z-unit increase,NR,"HESX1, IL17RD",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,3:57192122
rs187370608-<b>A</b>,1 x 10-16,,0.002,'-,8.26 z-unit increase,NR,UNC5CL,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:40974457
rs76726049-<b>C</b>,3 x 10-8,,0.014,'-,5.52 z-unit increase,NR,ALPK2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,18:58522227
rs41289512-<b>G</b>,6 x 10-276,,0.039,'-,35.5 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44848259
rs76320948-<b>T</b>,5 x 10-8,,0.046,'-,5.46 z-unit increase,NR,MEIOSIN,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45738583
rs6014724-<b>G</b>,7 x 10-10,,0.089,'-,6.18 z-unit decrease,NR,CASS4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,20:56423488
rs113260531-<b>A</b>,9 x 10-10,,0.12,'-,6.12 z-unit increase,NR,ZNF594-DT,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,17:5235685
rs117618017-<b>T</b>,3 x 10-8,,0.132,'-,5.52 z-unit increase,NR,APH1B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,15:63277703
rs111278892-<b>G</b>,8 x 10-11,,0.161,'-,6.5 z-unit increase,NR,"CNN2, ABCA7",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:1039324
rs2093760-<b>A</b>,1 x 10-18,,0.205,'-,8.82 z-unit increase,NR,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,1:207613483
rs10933431-<b>G</b>,9 x 10-10,,0.235,'-,6.13 z-unit decrease,NR,INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:233117202
rs4575098-<b>A</b>,2 x 10-10,,0.24,'-,6.36 z-unit increase,NR,ADAMTS4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,1:161185602
rs6448453-<b>A</b>,2 x 10-9,,0.252,'-,6 z-unit increase,NR,'-,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,4:11024404
rs59735493-<b>A</b>,4 x 10-8,,0.3,'-,5.49 z-unit decrease,NR,KAT8,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,16:31121779
rs1859788-<b>A</b>,2 x 10-15,,0.31,'-,7.93 z-unit decrease,NR,PILRA,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:100374211
rs867611-<b>G</b>,2 x 10-18,,0.314,'-,8.75 z-unit decrease,NR,PICALM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:86065502
rs3865444-<b>A</b>,6 x 10-9,,0.32,'-,5.81 z-unit decrease,NR,"CD33, SIGLEC22P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:51224706
rs442495-<b>C</b>,1 x 10-9,,0.32,'-,6.07 z-unit decrease,NR,ADAM10,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,15:58730416
rs12590654-<b>A</b>,2 x 10-10,,0.344,'-,6.39 z-unit decrease,NR,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,14:92472511
rs41289512-<b>G</b>,3 x 10-194,,NR,'-,29.735075 z-score increase,NR,NECTIN2,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,19:44848259
rs4663105-<b>C</b>,4 x 10-29,,NR,'-,11.21158 z-score increase,NR,"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:127133851
rs2632516-<b>C</b>,1 x 10-9,,NR,'-,6.0526648 z-score decrease,NR,TSPOAP1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,17:58331728
rs6014724-<b>G</b>,9 x 10-8,,NR,'-,5.351533 z-score decrease,NR,CASS4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,20:56423488
rs9381563-<b>C</b>,5 x 10-9,,NR,'-,5.835869 z-score increase,NR,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:47464901
rs3865444-<b>A</b>,4 x 10-8,,NR,'-,5.4802556 z-score decrease,NR,"CD33, SIGLEC22P",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,19:51224706
rs4236673-<b>A</b>,6 x 10-20,,NR,'-,9.13808 z-score decrease,NR,CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,8:27607412
rs11257242-<b>C</b>,2 x 10-8,,NR,'-,5.5817 z-score decrease,NR,"ECHDC3, USP6NL-AS1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,10:11679120
rs11763230-<b>T</b>,3 x 10-11,,NR,'-,6.6686625 z-score decrease,NR,EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:143411748
rs9269853-<b>A</b>,3 x 10-8,,NR,'-,5.5623274 z-score increase,NR,HLA-DRB1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:32582545
rs7657553-<b>A</b>,2 x 10-8,,NR,'-,5.5982833 z-score increase,NR,LINC02360,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,4:11721611
rs10933431-<b>G</b>,2 x 10-6,,NR,'-,4.7898254 z-score decrease,NR,INPP5D,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:233117202
rs7935829-<b>G</b>,8 x 10-13,,NR,'-,7.1575665 z-score decrease,NR,MS4A6A,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:60175342
rs113260531-<b>A</b>,3 x 10-6,,NR,'-,4.6568017 z-score increase,NR,ZNF594-DT,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,17:5235685
rs12590654-<b>A</b>,2 x 10-8,,NR,'-,5.614125 z-score decrease,NR,SLC24A4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,14:92472511
rs8093731-<b>T</b>,5 x 10-8,,NR,'-,5.4649644 z-score decrease,NR,DSG2,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,18:31508995
rs1859788-<b>A</b>,6 x 10-9,,NR,'-,5.8154516 z-score decrease,NR,PILRA,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:100374211
rs6656401-<b>A</b>,1 x 10-17,,NR,'-,8.54 z-score increase,NR,CR1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,1:207518704
rs6733839-<b>T</b>,1 x 10-29,,NR,'-,11.3 z-score increase,NR,"NIFKP9, BIN1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:127135234
rs35349669-<b>T</b>,8 x 10-6,,NR,'-,4.46 z-score increase,NR,INPP5D,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:233159830
rs9271192-<b>C</b>,5 x 10-7,,NR,'-,5.02 z-score increase,NR,"HLA-DRB1, HLA-DQA1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:32610753
rs10948363-<b>G</b>,7 x 10-8,,NR,'-,5.39 z-score increase,NR,CD2AP,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:47520026
rs2718058-<b>G</b>,1 x 10-6,,NR,'-,4.87 z-score decrease,NR,"GPR141, EPDR1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:37801932
rs1476679-<b>C</b>,2 x 10-7,,NR,'-,5.21 z-score decrease,NR,ZCWPW1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:100406823
rs11771145-<b>A</b>,4 x 10-8,,NR,'-,5.49 z-score decrease,NR,EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:143413669
rs28399637-<b>A</b>,2 x 10-143,,0.3156,'-,25.508192 z-unit increase,NR,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44820881
rs11218343-<b>C</b>,1 x 10-11,,0.03743,'-,6.79 z-unit decrease,NR,SORL1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:121564878
rs11771145-<b>A</b>,1 x 10-6,,0.3085,'-,4.88 z-unit decrease,NR,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:143413669
rs1476679-<b>C</b>,6 x 10-14,,0.3085,'-,7.51 z-unit decrease,NR,ZCWPW1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:100406823
rs28834970-<b>C</b>,1 x 10-11,,0.3644,'-,6.8 z-unit increase,NR,PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27337604
rs35349669-<b>T</b>,5 x 10-9,,0.4983,'-,5.85 z-unit increase,NR,INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:233159830
rs4147929-<b>A</b>,6 x 10-7,,NR,'-,5.01 z-unit increase,NR,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:1063444
rs6656401-<b>A</b>,4 x 10-18,,0.1782,'-,8.67 z-unit increase,NR,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,1:207518704
rs6733839-<b>T</b>,1 x 10-29,,0.3797,'-,11.3 z-unit increase,NR,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:127135234
rs28834970-<b>C</b>,7 x 10-8,,NR,'-,5.39 z-score increase,NR,PTK2B,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,8:27337604
rs9331896-<b>C</b>,1 x 10-18,,NR,'-,8.82 z-score decrease,NR,CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,8:27610169
rs983392-<b>G</b>,5 x 10-11,,NR,'-,6.56 z-score decrease,NR,"LINC02705, MS4A2",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:60156035
rs10792832-<b>A</b>,1 x 10-17,,NR,'-,8.56 z-score decrease,NR,"LINC02695, RNU6-560P",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:86156833
rs11218343-<b>C</b>,6 x 10-11,,NR,'-,6.55 z-score decrease,NR,SORL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:121564878
rs10498633-<b>T</b>,1 x 10-7,,NR,'-,5.3 z-score decrease,NR,SLC24A4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,14:92460608
rs4147929-<b>A</b>,9 x 10-9,,NR,'-,5.76 z-score increase,NR,ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,19:1063444
rs7274581-<b>C</b>,2 x 10-7,,NR,'-,5.21 z-score decrease,NR,CASS4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,20:56443204
rs9381563-<b>C</b>,3 x 10-10,,0.355,'-,6.33 z-unit increase,NR,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:47464901
rs11257238-<b>C</b>,1 x 10-8,,0.375,'-,5.69 z-unit increase,NR,"ECHDC3, USP6NL-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,10:11675398
rs2081545-<b>A</b>,2 x 10-15,,0.381,'-,7.97 z-unit decrease,NR,MS4A4A,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:60190907
rs4236673-<b>A</b>,3 x 10-19,,0.391,'-,8.98 z-unit decrease,NR,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27607412
rs4663105-<b>C</b>,3 x 10-44,,0.415,'-,13.94 z-unit increase,NR,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:127133851
rs2632516-<b>C</b>,1 x 10-6,,0.455,'-,4.9 z-unit decrease,NR,TSPOAP1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,17:58331728
rs28394864-<b>A</b>,2 x 10-8,,0.473,'-,5.62 z-unit increase,NR,"PHB, ZNF652",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,17:49373413
rs7810606-<b>T</b>,4 x 10-11,,0.5,'-,6.62 z-unit decrease,NR,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:143411065
rs7412-<b>T</b>,1 x 10-99,,0.07994,'-,21.199877 z-unit decrease,NR,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44908822
rs138607350-<b>G</b>,3 x 10-65,,0.00629,'-,17.060017 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44860563
rs79701229-<b>A</b>,1 x 10-64,,0.01276,'-,16.990263 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44881674
rs10407439-<b>A</b>,1 x 10-58,,0.296,'-,16.138115 z-unit decrease,NR,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44838691
rs2965169-<b>C</b>,3 x 10-57,,0.3883,'-,15.944032 z-unit decrease,NR,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44747899
rs116949436-<b>A</b>,7 x 10-50,,0.01073,'-,14.848961 z-unit increase,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44960129
rs55923289-<b>C</b>,3 x 10-44,,0.13,'-,13.958599 z-unit increase,NR,"CEACAM16-AS1, BCL3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44737327
rs28469095-<b>C</b>,2 x 10-38,,0.09149,'-,12.963469 z-unit increase,NR,"MARK4, NKPD1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45152075
rs111371860-<b>T</b>,6 x 10-35,,0.06009,'-,12.327317 z-unit decrease,NR,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44842530
rs2967668-<b>G</b>,7 x 10-25,,0.1098,'-,10.3022 z-unit decrease,NR,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44799694
rs76692773-<b>T</b>,9 x 10-24,,0.07319,'-,10.04716 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44890954
rs11672748-<b>G</b>,1 x 10-23,,0.3171,'-,10.028075 z-unit increase,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44986934
rs595290-<b>C</b>,7 x 10-23,,0.1582,'-,9.847612 z-unit increase,NR,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45205150
rs346757-<b>C</b>,2 x 10-22,,0.08386,'-,9.756002 z-unit increase,NR,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45222190
rs34874378-<b>A</b>,9 x 10-22,,0.04366,'-,9.593067 z-unit increase,NR,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45013623
rs183427010-<b>A</b>,3 x 10-21,,0.004629,'-,9.459884 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44863241
rs111740474-<b>A</b>,5 x 10-21,,0.01165,'-,9.402366 z-unit increase,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44720227
rs1160984-<b>T</b>,2 x 10-20,,0.05762,'-,9.292308 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44900667
rs11665676-<b>T</b>,1 x 10-19,,0.05183,'-,9.089448 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44875462
rs561654715-<b>A</b>,9 x 10-19,,0.002832,'-,8.842536 z-unit increase,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44890947
rs55840414-<b>A</b>,5 x 10-18,,0.1183,'-,8.655959 z-unit decrease,NR,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44840322
rs112481437-<b>A</b>,1 x 10-17,,0.02337,'-,8.578216 z-unit increase,NR,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45045877
rs203709-<b>A</b>,4 x 10-17,,0.2645,'-,8.408471 z-unit decrease,NR,"CEACAM16-AS1, PVR",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44658298
rs11881756-<b>C</b>,5 x 10-17,,0.1138,'-,8.381871 z-unit decrease,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44717621
rs76856627-<b>G</b>,1 x 10-16,,0.0329,'-,8.306043 z-unit increase,NR,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45040497
rs60239918-<b>T</b>,2 x 10-15,,0.03999,'-,7.945099 z-unit increase,NR,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45077114
rs41290100-<b>T</b>,2 x 10-15,,0.02432,'-,7.9216814 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44867684
rs846876-<b>C</b>,1 x 10-14,,0.3755,'-,7.715924 z-unit decrease,NR,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44576817
rs147188206-<b>C</b>,3 x 10-14,,0.008636,'-,7.5976734 z-unit increase,NR,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45049329
rs2965164-<b>T</b>,1 x 10-13,,0.3456,'-,7.438834 z-unit decrease,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44698782
rs41290108-<b>C</b>,3 x 10-13,,0.03803,'-,7.317556 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44874585
rs547509922-<b>T</b>,3 x 10-13,,0.003614,'-,7.314314 z-unit increase,NR,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44828004
rs62118504-<b>G</b>,5 x 10-13,,0.3957,'-,7.2163415 z-unit decrease,NR,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45231493
rs35194383-<b>T</b>,8 x 10-13,,0.4234,'-,7.1647267 z-unit increase,NR,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45012792
rs80257887-<b>A</b>,1 x 10-12,,0.03562,'-,7.089606 z-unit increase,NR,CEACAM20,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44516798
rs75161053-<b>A</b>,2 x 10-12,,0.04757,'-,7.0672655 z-unit increase,NR,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44544863
rs142412517-<b>T</b>,2 x 10-12,,0.001157,'-,7.033927 z-unit increase,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44900801
rs12461144-<b>T</b>,4 x 10-12,,0.1266,'-,6.9530225 z-unit increase,NR,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45220448
rs142092405-<b>G</b>,6 x 10-12,,0.00433,'-,6.8754373 z-unit increase,NR,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44820087
rs150820726-<b>T</b>,1 x 10-11,,0.008836,'-,6.80423 z-unit increase,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44723891
rs183321458-<b>A</b>,2 x 10-11,,0.003582,'-,6.7473207 z-unit increase,NR,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45077818
rs539159088-<b>C</b>,2 x 10-11,,0.01086,'-,6.705168 z-unit increase,NR,"CEACAM16-AS1, IGSF23",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44634022
rs576651896-<b>G</b>,2 x 10-11,,0.004649,'-,6.6975107 z-unit increase,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44960141
rs186110295-<b>T</b>,4 x 10-11,,0.01273,'-,6.5884266 z-unit increase,NR,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44730236
rs78986976-<b>A</b>,8 x 10-11,,0.05489,'-,6.508301 z-unit decrease,NR,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44826181
rs204907-<b>G</b>,9 x 10-11,,0.049,'-,6.482148 z-unit decrease,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44958739
rs141864196-<b>A</b>,3 x 10-10,,0.02628,'-,6.313068 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44902242
rs114036675-<b>A</b>,3 x 10-10,,0.002756,'-,6.2855 z-unit increase,NR,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44759439
rs3752241-<b>G</b>,4 x 10-10,,0.1656,'-,6.273173 z-unit decrease,NR,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:1053525
rs11083743-<b>C</b>,1 x 10-9,,0.2682,'-,6.0971603 z-unit increase,NR,IGSF23,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44621921
rs34181358-<b>A</b>,3 x 10-9,,0.1063,'-,5.9258137 z-unit decrease,NR,CHRNA2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27465457
rs204480-<b>T</b>,6 x 10-9,,0.2501,'-,5.81275 z-unit decrease,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44973854
rs10421247-<b>C</b>,7 x 10-9,,0.4994,'-,5.801472 z-unit decrease,NR,"NKPD1, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45154228
rs419010-<b>C</b>,8 x 10-9,,0.4477,'-,5.773656 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44865063
rs9653111-<b>T</b>,1 x 10-8,,0.1298,'-,5.6693845 z-unit decrease,NR,"GEMIN7-AS1, MARK4, GEMIN7",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45089217
rs769452-<b>C</b>,2 x 10-8,,0.001629,'-,5.5855217 z-unit increase,NR,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44907853
rs143332484-<b>T</b>,3 x 10-8,,0.009954,'-,5.5406914 z-unit increase,NR,TREM2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:41161469
rs4727449-<b>T</b>,3 x 10-8,,0.1607,'-,5.5144157 z-unit increase,NR,STAG3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:100188127
rs123187-<b>A</b>,4 x 10-8,,0.3694,'-,5.504638 z-unit decrease,NR,"RPS16P9, CKM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45327689
rs10498633-<b>T</b>,2 x 10-7,,NR,'-,5.17 z-unit decrease,NR,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,14:92460608
rs10792832-<b>A</b>,7 x 10-18,,0.3702,'-,8.61 z-unit decrease,NR,"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:86156833
rs10948363-<b>G</b>,1 x 10-8,,0.2754,'-,5.72 z-unit increase,NR,CD2AP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:47520026
rs1081105-<b>C</b>,1 x 10-231,,0.02756,'-,32.50298 z-unit increase,NR,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44909698
rs157580-<b>G</b>,8 x 10-220,,0.3949,'-,31.6502 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44892009
rs6859-<b>A</b>,1 x 10-152,,0.4218,'-,26.320562 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44878777
rs11168036-<b>T</b>,7 x 10-9,,0.5,1.08,'-,[1.06-1.10],"HBEGF, PFDN1",Alzheimer's disease,Alzheimer's disease,GCST004246,5:140327854
rs7920721-<b>G</b>,3 x 10-8,,0.4,1.08,'-,[1.06-1.10],"ECHDC3, USP6NL-AS1",Alzheimer's disease,Alzheimer's disease,GCST004246,10:11678309
rs2632516-<b>?</b>,4 x 10-8,,0.6,1.0869565,'-,[1.06-1.1],TSPOAP1-AS1,Alzheimer's disease,Alzheimer's disease,GCST004246,17:58331728
rs283811-<b>G</b>,7 x 10-9,(AA),NR,1.34,'-,[1.21-1.47],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44885243
rs6857-<b>T</b>,6 x 10-7,(AA),NR,1.27,'-,[1.15-1.40],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44888997
rs283811-<b>G</b>,1 x 10-15,(Japanese),NR,2.56,'-,[2.02-3.24],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44885243
rs6857-<b>T</b>,7 x 10-18,(Japanese),NR,3.22,'-,[2.45-4.24],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44888997
rs483082-<b>T</b>,1 x 10-15,(Japanese),NR,2.8,'-,[2.17-3.61],"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST004246,19:44912921
rs11168036-<b>T</b>,7 x 10-9,,NR,1.08,'-,[1.06-1.10],"HBEGF, PFDN1",Alzheimer's disease,Alzheimer's disease,GCST004246,5:140327854
rs12358692-<b>T</b>,3 x 10-8,,NR,1.0869565,'-,[1.04-1.12],"ECHDC3, USP6NL-AS1",Alzheimer's disease,Alzheimer's disease,GCST004246,10:11679103
rs2632516-<b>G</b>,4 x 10-8,,NR,1.0869565,'-,[1.06-1.1],TSPOAP1-AS1,Alzheimer's disease,Alzheimer's disease,GCST004246,17:58331728
rs9749589-<b>T</b>,2 x 10-8,,'-,1.3157895,'-,[1.2-1.45],NFIC,Alzheimer's disease (APOE e4 interaction),Alzheimer's disease,GCST004247,19:3405594
rs11168036-<b>T</b>,1 x 10-6,,NR,1.11,'-,[1.06-1.15],"HBEGF, PFDN1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST004249,5:140327854
rs11257238-<b>T</b>,5 x 10-9,,NR,1.14,'-,[1.10-1.18],"ECHDC3, USP6NL-AS1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST004249,10:11675398
rs2632516-<b>G</b>,4 x 10-6,,NR,1.098901,'-,[1.05-1.14],TSPOAP1-AS1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST004249,17:58331728
rs429358-<b>C</b>,3 x 10-7,,0.2968,2.256,'-,[1.6552-3.0749],'-,Alzheimer's disease,Alzheimer's disease,GCST90013665,Mapping not available
rs2075650-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST002429,19:44892362
rs17169634-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,BMPER,Alzheimer's disease,Alzheimer's disease,GCST002429,7:34054385
rs75847378-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,SLC8A1-AS1,Alzheimer's disease,Alzheimer's disease,GCST002429,2:39954377
rs62256378-<b>A</b>,3 x 10-12,,0.061,'-,0.71 unit increase,[0.51-0.91],SUCLG2,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST002531,3:67406609
rs429358-<b>?</b>,4 x 10-17,,0.442,'-,0.4 unit decrease,[0.30-0.50],'-,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST002531,Mapping not available
rs2075650-<b>G</b>,1 x 10-295,,0.14,2.53,'-,[2.41-2.66],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000682,19:44892362
rs1562990-<b>?</b>,4 x 10-11,,0.58,1.14,'-,[1.10-1.18],MS4A4A,Alzheimer's disease,Alzheimer's disease,GCST001087,11:60255614
rs157580-<b>?</b>,8 x 10-89,,NR,1.69,'-,[NR],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST001087,19:44892009
rs536841-<b>?</b>,3 x 10-9,,NR,1.16,'-,[NR],"PICALM, RNU6-560P",Alzheimer's disease,Alzheimer's disease,GCST001087,11:86076782
rs569214-<b>?</b>,4 x 10-8,,NR,1.14,'-,[NR],"CLU, SCARA3",Alzheimer's disease,Alzheimer's disease,GCST001087,8:27630273
rs744373-<b>?</b>,2 x 10-9,,NR,1.18,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease,Alzheimer's disease,GCST001087,2:127137039
"rs9331888-<b>G</b>, rs2279590-<b>C</b>, rs11136000-<b>C</b>",6 x 10-10,,0.26,1.22,'-,[1.14-1.29],CLU; CLU; No mapped genes,Alzheimer's disease,Alzheimer's disease,GCST000480,8:27611345|8:27598736
"rs6656401-<b>A</b>, rs3818361-<b>A</b>",3 x 10-10,(AA),0.18,1.22,'-,[1.15-1.30],CR1; CR1,Alzheimer's disease,Alzheimer's disease,GCST000480,1:207518704|1:207611623
rs2075650-<b>?</b>,2 x 10-16,,0.9,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000480,19:44892362
rs4420638-<b>?</b>,2 x 10-44,,NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST000124,19:44919689
rs11218343-<b>?</b>,2 x 10-9,,0.96,1.23,'-,[1.15-1.33],SORL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001947,11:121564878
rs519113-<b>G</b>,5 x 10-39,(Japanese),0.29,2.09,'-,[1.87-2.34],NECTIN2,Alzheimer's disease (late onset),Alzheimer's disease,GCST001947,19:44873027
rs9877502-<b>A</b>,5 x 10-9,(tau),NR,'-,0.052 unit increase,[NR],GMNC,Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST001951,3:190951729
rs769449-<b>A</b>,2 x 10-16,(tau),NR,'-,0.082 unit increase,[NR],APOE,Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST001951,19:44906745
rs769449-<b>A</b>,2 x 10-18,(ptau),NR,'-,0.091 unit increase,[NR],APOE,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement",GCST001951,19:44906745
rs514716-<b>G</b>,1 x 10-8,(tau),NR,'-,0.071 unit decrease,[NR],GLIS3,Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST001951,9:3929424
rs514716-<b>G</b>,3 x 10-9,(ptau),NR,'-,0.072 unit decrease,[NR],GLIS3,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement",GCST001951,9:3929424
rs6922617-<b>A</b>,4 x 10-8,(ptau),NR,'-,0.094 unit decrease,[NR],NCR2,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement",GCST001951,6:41368363
rs115550680-<b>G</b>,2 x 10-9,,0.07,1.79,'-,[1.47-2.12],ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST001963,19:1050421
rs145848414-<b>A</b>,7 x 10-8,,0.04,2.29,'-,[1.69-3.09],"HIGD1AP3, SUMO2P6",Alzheimer's disease (late onset),Alzheimer's disease,GCST001963,5:174587111
rs4746003-<b>?</b>,6 x 10-6,,0.25,1.3,'-,[NR],"LINC02651, RPL5P26",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,10:69778536
rs4576506-<b>?</b>,1 x 10-6,,0.06,1.66,'-,[NR],"HMGB3P23, MTCO3P30",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,9:31546474
rs733175-<b>?</b>,5 x 10-6,,0.18,1.37,'-,[NR],SLC2A9,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,4:10048517
rs10792830-<b>?</b>,6 x 10-6,,0.44,1.25,'-,[NR],"RNU6-560P, PICALM",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,11:86127766
rs16970672-<b>?</b>,2 x 10-6,,0.29,1.29,'-,[NR],"RNU1-80P, TNRC6C",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,17:77948568
rs4038131-<b>?</b>,6 x 10-7,,0.93,1.5384616,'-,[NR],VSNL1,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,2:17593765
rs10207628-<b>?</b>,1 x 10-6,,0.81,1.4084507,'-,[NR],BIN1,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,2:127094445
rs9811423-<b>?</b>,4 x 10-6,,0.47,1.28,'-,[NR],"NEPRO, LINC02044",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,3:113103475
rs1464108-<b>?</b>,8 x 10-6,,0.32,1.28,'-,[NR],RIMBP2,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,12:130537465
rs11006923-<b>?</b>,9 x 10-6,,0.95,1.5873016,'-,[NR],MPP7,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,10:28216015
rs157582-<b>?</b>,9 x 10-52,,0.26,2.3,'-,[NR],TOMM40,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,19:44892962
rs753129-<b>?</b>,3 x 10-7,,0.76,1.5151515,'-,[NR],"RNU6-276P, EXOC1L",Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,4:55802265
rs257016-<b>?</b>,4 x 10-6,,0.63,1.4285715,'-,[NR],'-,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,5:123821728
rs6509701-<b>?</b>,5 x 10-6,,0.7,1.4084507,'-,[NR],ZNF320,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,19:52880932
rs3764640-<b>?</b>,8 x 10-6,,0.79,1.4705882,'-,[NR],STK11,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,19:1207239
rs11252926-<b>?</b>,8 x 10-6,,0.64,1.3888888,'-,[NR],DIP2C,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,10:520439
rs2969775-<b>?</b>,2 x 10-6,,0.63,1.4705882,'-,[NR],MSH2,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,2:47658337
rs16922670-<b>?</b>,7 x 10-6,,0.14,1.63,'-,[NR],LINC01492,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,9:103261938
rs17716202-<b>?</b>,8 x 10-6,,0.94,2.2222223,'-,[NR],C5orf67,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,5:56609071
rs7175766-<b>?</b> x rs3733980-<b>?</b>,7 x 10-10,(men),NR,'-,'-,'-,No mapped genes x WWC1,Alzheimer's disease (SNP x SNP interaction),Alzheimer's disease,GCST008056,5:168441804
rs1477307-<b>?</b> x rs4077746-<b>?</b>,2 x 10-6,(men),NR,'-,'-,'-,No mapped genes x TLN2,Alzheimer's disease (SNP x SNP interaction),Alzheimer's disease,GCST008056,15:62623147
rs9821797-<b>A</b>,7 x 10-15,,0.12,1.17,'-,[1.13-1.21],NCKIPSD,Anorexia nervosa,anorexia nervosa,GCST008465,3:48680820
rs6589488-<b>A</b>,6 x 10-11,,0.13,1.14,'-,[1.1-1.18],CADM1,Anorexia nervosa,anorexia nervosa,GCST008465,11:115226236
rs2287348-<b>T</b>,6 x 10-9,,0.16,1.11,'-,[1.07-1.15],"ASB3, ERLEC1",Anorexia nervosa,anorexia nervosa,GCST008465,2:53812676
rs2008387-<b>A</b>,2 x 10-8,,0.33,1.08,'-,[1.06-1.1],MGMT,Anorexia nervosa,anorexia nervosa,GCST008465,10:129650500
rs9874207-<b>C</b>,2 x 10-8,,0.49,1.08,'-,[1.06-1.1],FOXP1,Anorexia nervosa,anorexia nervosa,GCST008465,3:70970599
rs10747478-<b>T</b>,3 x 10-8,,0.41,1.08,'-,[1.06-1.1],"UBE2WP1, EEF1A1P11",Anorexia nervosa,anorexia nervosa,GCST008465,1:96435899
rs370838138-<b>G</b>,3 x 10-8,,0.56,1.08,'-,[1.06-1.1],LINC02228,Anorexia nervosa,anorexia nervosa,GCST008465,5:25081736
rs13100344-<b>T</b>,4 x 10-8,,0.54,1.08,'-,[1.06-1.1],WDR82P1,Anorexia nervosa,anorexia nervosa,GCST008465,3:94886263
rs9677504-<b>G</b>,9 x 10-7,,NR,1.066098,'-,NR,SPAG16,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,2:214317165
rs11591402-<b>T</b>,4 x 10-9,,NR,1.0471205,'-,NR,SORCS3,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,10:104987596
rs2243517-<b>C</b>,4 x 10-8,,NR,1.035,'-,NR,OBI1-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,13:78330662
rs56135409-<b>C</b>,5 x 10-8,,NR,1.0309278,'-,NR,SGO1-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,3:20683524
rs4916723-<b>C</b>,7 x 10-7,,NR,1.025,'-,NR,LINC00461,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,5:88558577
rs74760947-<b>G</b>,5 x 10-6,,NR,1.004,'-,NR,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,8:34495092
rs2391769-<b>A</b>,5 x 10-7,,NR,1.013,'-,NR,"RN7SL831P, EEF1A1P11",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,1:96513405
rs4858241-<b>T</b>,1 x 10-6,,NR,1.017294,'-,NR,SGO1-AS1,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,3:20627579
rs1427829-<b>A</b>,7 x 10-9,,NR,1.021,'-,NR,"DUSP6, POC1B",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,12:89366967
rs28452470-<b>A</b>,3 x 10-6,,NR,1.042,'-,NR,"CADPS2, FEZF1",Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,7:122317528
rs5886709-<b>G</b>,4 x 10-10,,NR,1.049,'-,NR,FOXP2,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,7:114446079
rs1592757-<b>C</b>,1 x 10-9,,NR,1.062,'-,NR,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,5:104554297
rs10956838-<b>A</b>,1 x 10-6,,NR,1.0626992,'-,NR,'-,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,8:92392214
rs3001723-<b>A</b>,1 x 10-8,,NR,1.075,'-,NR,PTPRF,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,1:43572014
rs4275621-<b>A</b>,3 x 10-9,,NR,1.081081,'-,NR,LINC02758,Attention deficit hyperactivity disorder,attention deficit hyperactivity disorder,GCST007543,11:28631449
rs2855812-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,MICB,Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:31504943
rs2854275-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,"HLA-DQB1-AS1, HLA-DQB1",Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:32660651
rs150814685-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"RPSAP2, LINC00533",Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:28728995
rs149702363-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,"OR2U1P, OR2G1P",Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:29257248
rs493161-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"H4C13, H3C12",Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:27882936
rs148696809-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"LINC01556, KRT18P1",Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:28966575
rs147121091-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,POM121L2,Asthma and major depressive disorder,"unipolar depression, asthma",GCST008921,6:27303811
rs6976860-<b>T</b>,7 x 10-6,,0.666711,1.1235955,'-,[1.07-1.18],PHTF2,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,7:77822829
rs612711-<b>T</b>,9 x 10-6,,0.414926,1.1223345,'-,[1.07-1.17],MRPL37,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:54220701
rs325502-<b>G</b>,8 x 10-6,,0.422234,1.1223345,'-,[1.07-1.18],'-,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,5:104672432
rs73133999-<b>G</b>,7 x 10-6,,0.9644714,1.1210762,'-,[1.07-1.17],ST3GAL6-AS1,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,3:98715123
rs145189127-<b>G</b>,7 x 10-6,,0.0228545,1.117,'-,[1.07-1.17],"MIR557, QRSL1P1",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:168405362
rs78994374-<b>A</b>,9 x 10-6,,0.0200533,1.118,'-,[1.07-1.17],MAP3K5,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,6:136623641
rs17526879-<b>G</b>,9 x 10-6,,0.019323,1.121,'-,[1.07-1.17],LINC01742,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,20:57976061
rs142592479-<b>A</b>,4 x 10-6,,0.0226635,1.122,'-,[1.07-1.17],'-,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,2:49555287
rs111629393-<b>G</b>,8 x 10-6,,0.329171,1.123,'-,[1.07-1.18],NELL1,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,11:21292600
rs1390496-<b>G</b>,5 x 10-6,,0.743567,1.126,'-,[1.07-1.18],LINC01036,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:187307421
rs17676433-<b>T</b>,2 x 10-6,,0.031546,1.127,'-,[1.08-1.18],GRK5,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,10:119348012
rs147542932-<b>C</b>,3 x 10-6,,0.0605838,1.128,'-,[1.08-1.18],KCNT2,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:196204734
rs4312987-<b>T</b>,2 x 10-6,,0.592484,1.13,'-,[1.08-1.18],"KLHL31, LRRC1",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,6:53720234
rs535355-<b>G</b>,7 x 10-7,,0.377677,1.1547344,'-,[1.1-1.21],MAGI2,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,7:78841329
rs11708664-<b>A</b>,1 x 10-6,,0.711729,1.1520737,'-,[1.09-1.21],TBC1D5,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,3:17749535
rs55940619-<b>C</b>,4 x 10-6,,0.9228412,1.150748,'-,[1.09-1.21],GRID1,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,10:86126629
rs6497642-<b>A</b>,4 x 10-6,,0.679059,1.1454753,'-,[1.09-1.21],USP31,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,16:23047129
rs5766499-<b>A</b>,8 x 10-6,,0.661674,1.1402508,'-,[1.08-1.2],LINC01656,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,22:44427215
rs17534846-<b>A</b>,8 x 10-6,,0.655753,1.1389521,'-,[1.08-1.2],FER,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,5:109115513
rs4973321-<b>G</b>,6 x 10-6,,0.013128,1.1325028,'-,[1.08-1.19],SP140L,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,2:230387764
rs111275535-<b>A</b>,5 x 10-6,,0.060316,1.133,'-,[1.08-1.19],LINC02366,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,12:10760728
rs116200762-<b>C</b>,9 x 10-6,,0.0673603,1.129,'-,[1.07-1.18],"OR9S24P, OR6B3",Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,2:240079088
rs117225626-<b>T</b>,5 x 10-7,,0.0148587,1.148,'-,[1.09-1.2],NPAP1L,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,16:60321124
rs138272922-<b>C</b>,5 x 10-8,,0.0107319,1.16,'-,[1.11-1.21],THRB,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,3:24256536
rs139146062-<b>T</b>,7 x 10-7,,0.0241839,1.147,'-,[1.09-1.2],"STK17B, DNAH7",Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,2:196094898
rs9964540-<b>A</b>,3 x 10-6,,0.00879648,1.075,'-,[1.04-1.11],"RNU6-340P, Y_RNA",Major depressive disorder,unipolar depression,GCST009979,18:2643559
rs13214628-<b>G</b>,1 x 10-6,,0.9730667,1.1337868,'-,[1.08-1.19],"VNN2, VNN3",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,6:132741777
rs73176142-<b>C</b>,3 x 10-6,,0.982012,1.1273957,'-,[1.08-1.18],"RNU6-348P, PLD1",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,3:171542960
rs10468608-<b>C</b>,5 x 10-6,,0.627944,1.126126,'-,[1.07-1.18],"MAP2K3, EIF1P5",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,17:21283048
rs35099409-<b>T</b>,5 x 10-6,,0.9511414,1.1248593,'-,[1.07-1.18],INTS9,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,8:28876569
rs2498010-<b>A</b>,6 x 10-6,,0.372037,1.1248593,'-,[1.07-1.18],'-,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,10:84826084
rs10892733-<b>T</b>,6 x 10-6,,0.706353,1.1235955,'-,[1.07-1.18],"SC5D, BMPR1AP2",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,11:121344415
rs79954464-<b>G</b>,7 x 10-6,,0.9710358,1.1235955,'-,[1.07-1.18],"ZNF683, LIN28A",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:26402358
rs138567168-<b>C</b>,5 x 10-6,,0.9811409,1.1235955,'-,[1.07-1.18],TRIM44,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,11:35778692
rs3131115-<b>C</b>,1 x 10-7,,0.671942,1.0845987,'-,[1.05-1.12],"LINC02569, HLA-E",Major depressive disorder,unipolar depression,GCST009979,6:30501014
rs7222143-<b>A</b>,7 x 10-6,,0.444808,1.07,'-,[1.04-1.1],"SUPT4H1, TSPOAP1-AS1",Major depressive disorder,unipolar depression,GCST009979,17:58349957
rs3135296-<b>A</b>,4 x 10-12,,0.88,1.0570824,'-,[1.04-1.07],"LINC01623, NOP56P1",Help-seeking from a GP,unipolar depression,GCST010011,6:28828079
rs2517622-<b>G</b>,4 x 10-11,,0.863,1.0799136,'-,NR,"TRIM26, PAIP1P1",Help-seeking from a psychiatrist,unipolar depression,GCST010012,6:30187372
rs3129120-<b>T</b>,1 x 10-10,,0.876,1.081081,'-,NR,"OR2J2, OR2J3",Help-seeking from a psychiatrist,unipolar depression,GCST010012,6:29143998
rs3094146-<b>G</b>,5 x 10-8,,0.87,1.1494253,'-,[1.10-1.20],ZNRD1ASP,Help-seeking from a GP (without major depressive disorder symptoms),unipolar depression,GCST010014,6:30003183
rs3135296-<b>?</b>,1 x 10-6,,NR,1.1350738,'-,[1.08-1.19],"LINC01623, NOP56P1",Help-seeking from a GP (without major depressive disorder symptoms),unipolar depression,GCST010014,6:28828079
rs2517622-<b>?</b>,3 x 10-6,,NR,1.1223345,'-,[1.07-1.18],"TRIM26, PAIP1P1",Help-seeking from a GP (without major depressive disorder symptoms),unipolar depression,GCST010014,6:30187372
rs7931589-<b>T</b>,1 x 10-6,,0.796356,1.1415524,'-,[1.09-1.2],"DCDC1, CADM1",Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,11:115133290
rs4875590-<b>T</b>,1 x 10-6,,0.483964,1.1402508,'-,[1.09-1.19],'-,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,8:5578168
rs11027560-<b>T</b>,2 x 10-6,,0.187934,1.1389521,'-,[1.08-1.19],"FAM86GP, SNRPCP5",Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,11:3477645
rs12191873-<b>A</b>,2 x 10-6,,0.865092,1.1376565,'-,[1.08-1.19],"SCIRT, MRPL14",Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,6:44092839
rs8849-<b>A</b>,2 x 10-6,,0.9204773,1.1363636,'-,[1.08-1.19],LRATD1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,2:14640007
rs116949162-<b>G</b>,1 x 10-6,,0.9857409,1.1350738,'-,[1.08-1.19],KCNQ1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,11:2495782
rs113712920-<b>A</b>,2 x 10-6,,0.9647906,1.1350738,'-,[1.08-1.19],"ZNF571-AS1, ZNF540, ZNF571",Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,19:37577358
rs164241-<b>C</b>,3 x 10-6,,0.9107834,1.1350738,'-,[1.08-1.19],LINC00856,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,10:78574404
rs41279358-<b>C</b>,3 x 10-6,,0.844772,1.1337868,'-,[1.08-1.19],PCMTD2,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,20:64274498
rs57434630-<b>A</b>,5 x 10-6,,0.833311,1.1312217,'-,[1.08-1.19],MIR3144,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,6:120017462
rs115706669-<b>G</b>,7 x 10-6,,0.9508678,1.1273957,'-,[1.07-1.18],"OR2M4, OR2T33",Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,1:248251128
rs2949947-<b>A</b>,8 x 10-6,,0.77975,1.1273957,'-,[1.07-1.18],PITPNC1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,17:67450445
rs73064535-<b>T</b>,6 x 10-6,,0.9804157,1.126126,'-,[1.07-1.18],AGMO,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,7:15339805
rs7605669-<b>G</b>,9 x 10-6,,0.831855,1.126126,'-,[1.07-1.18],"LTBP1, H2ACP2",Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,2:33060517
rs118133708-<b>T</b>,7 x 10-6,,0.0131438,1.127,'-,[1.07-1.18],ZNF295-AS1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,21:42049461
rs11575858-<b>T</b>,2 x 10-6,,0.0189106,1.135,'-,[1.08-1.19],OPRM1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,6:154118730
rs146419710-<b>A</b>,3 x 10-6,,0.0225273,1.135,'-,[1.08-1.19],LINC01845,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,5:159436452
rs4151636-<b>G</b>,4 x 10-6,,0.0438058,1.136,'-,[1.08-1.19],RB1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,13:48482598
rs112103252-<b>G</b>,8 x 10-8,,0.0106596,1.157,'-,[1.1-1.21],SRGAP1,Trauma exposure in major depressive disorder,"unipolar depression, trauma exposure measurement",GCST009983,12:63896282
rs139388380-<b>T</b>,5 x 10-6,,0.0193939,1.135,'-,[1.08-1.19],SOX2-OT,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,3:181738428
rs150406602-<b>A</b>,1 x 10-6,,0.0289884,1.144,'-,[1.09-1.2],"TNFAIP8L3, MIR4713HG",Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,15:51097433
rs1504722-<b>G</b>,9 x 10-6,,0.397333,1.137,'-,[1.08-1.2],CNTN5,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,11:99397985
rs164241-<b>T</b>,2 x 10-6,,0.0892166,1.143,'-,[1.09-1.2],LINC00856,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,10:78574404
rs17377987-<b>G</b>,3 x 10-7,,0.0632337,1.15,'-,[1.09-1.21],MEI1,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,22:41774931
rs1957408-<b>G</b>,2 x 10-6,,0.491191,1.148,'-,[1.09-1.21],DAAM1,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,14:59333603
rs28672333-<b>A</b>,2 x 10-7,,0.0727552,1.161,'-,[1.1-1.22],"PIP, OR6W1P",Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,7:143129705
rs35693458-<b>A</b>,8 x 10-6,,0.147982,1.135,'-,[1.08-1.19],PANK3,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,5:168558454
rs56039004-<b>A</b>,8 x 10-7,,0.0703749,1.146,'-,[1.09-1.2],'-,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,18:2427956
rs56294834-<b>A</b>,8 x 10-6,,0.0210005,1.127,'-,[1.07-1.18],"KRTAP4-17P, KRTAP9-1",Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,17:41188621
rs6096232-<b>G</b>,5 x 10-6,,0.060598,1.139,'-,[1.08-1.2],KCNG1,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,20:51021437
rs6567380-<b>T</b>,2 x 10-6,,0.0225261,1.137,'-,[1.08-1.19],SERPINB13,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,18:63600273
rs67917624-<b>A</b>,1 x 10-6,,0.0273652,1.162,'-,[1.1-1.22],RASA3,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,13:114043625
rs72717793-<b>A</b>,6 x 10-6,,0.228085,1.137,'-,[1.08-1.19],TBPL2,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,14:55454152
rs9991694-<b>C</b>,5 x 10-7,,0.766787,1.161,'-,[1.1-1.22],"PLAC8, COPS4",Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,4:83078972
rs1933802-<b>G</b>,1 x 10-19,,0.5464,1.0204082,'-,[1.02-1.02],LIN28B-AS1,Depression,unipolar depression,GCST007342,6:104918016
rs2876520-<b>G</b>,3 x 10-17,,0.4729,1.0193679,'-,[1.01-1.02],HIVEP2,Depression,unipolar depression,GCST007342,6:142675481
rs725616-<b>T</b>,1 x 10-9,,0.3644,1.014,'-,[1.009-1.018],SAMD5,Depression,unipolar depression,GCST007342,6:147629286
rs2029865-<b>T</b>,4 x 10-17,,0.5466,1.01833,'-,[1.01-1.02],'-,Depression,unipolar depression,GCST007342,6:164700811
rs3823624-<b>T</b>,2 x 10-26,,0.8067,1.03,'-,[1.024-1.036],MAD1L1,Depression,unipolar depression,GCST007342,7:2070711
rs2043539-<b>A</b>,8 x 10-24,,0.4177,1.022,'-,[1.018-1.027],TMEM106B,Depression,unipolar depression,GCST007342,7:12214254
rs2247523-<b>G</b>,9 x 10-14,,0.4681,1.0162601,'-,[1.01-1.02],PCLO,Depression,unipolar depression,GCST007342,7:82825088
rs16887442-<b>T</b>,1 x 10-11,,0.4347,1.015,'-,[1.011-1.019],SEMA3E,Depression,unipolar depression,GCST007342,7:83307593
rs58104186-<b>A</b>,4 x 10-18,,0.4689,1.019,'-,[1.015-1.024],'-,Depression,unipolar depression,GCST007342,7:109459862
rs7807677-<b>T</b>,5 x 10-22,,0.5505,1.021,'-,[1.017-1.026],CTTNBP2,Depression,unipolar depression,GCST007342,7:117862520
rs7837935-<b>G</b>,1 x 10-13,,0.8478,1.0224949,'-,[1.02-1.03],CYP7B1,Depression,unipolar depression,GCST007342,8:64649462
rs67436663-<b>G</b>,3 x 10-8,,0.7598,1.0141988,'-,[1.01-1.02],"NCOA2, RN7SL203P",Depression,unipolar depression,GCST007342,8:70435391
rs1354115-<b>A</b>,4 x 10-17,,0.6243,1.019,'-,[1.014-1.023],CARM1P1,Depression,unipolar depression,GCST007342,9:2983774
rs1982277-<b>T</b>,1 x 10-15,,0.7594,1.021,'-,[1.016-1.026],'-,Depression,unipolar depression,GCST007342,9:11513019
rs263645-<b>A</b>,7 x 10-16,,0.5438,1.018,'-,[1.013-1.022],RN7SL720P,Depression,unipolar depression,GCST007342,9:17016505
rs3793577-<b>G</b>,6 x 10-22,,0.5335,1.0214505,'-,[1.02-1.03],ELAVL2,Depression,unipolar depression,GCST007342,9:23737629
rs59283172-<b>G</b>,1 x 10-6,,0.8931,1.017294,'-,[1.01-1.02],'-,Depression,unipolar depression,GCST007342,9:25232980
rs34653192-<b>G</b>,3 x 10-16,,0.6804,1.0193679,'-,[1.02-1.02],'-,Depression,unipolar depression,GCST007342,9:31124454
rs7030813-<b>T</b>,9 x 10-30,,0.3736,1.025,'-,[1.021-1.03],PAX5,Depression,unipolar depression,GCST007342,9:36999372
rs10817969-<b>T</b>,1 x 10-12,,0.7173,1.017,'-,[1.012-1.022],ASTN2,Depression,unipolar depression,GCST007342,9:116968766
rs913930-<b>G</b>,1 x 10-21,,0.3567,1.0224949,'-,[1.02-1.03],TLR4,Depression,unipolar depression,GCST007342,9:117721731
rs2670139-<b>C</b>,2 x 10-12,,0.2391,1.01833,'-,[1.01-1.02],DENND1A,Depression,unipolar depression,GCST007342,9:123871976
rs997934-<b>T</b>,5 x 10-13,,0.3795,1.016,'-,[1.012-1.021],ADARB2,Depression,unipolar depression,GCST007342,10:1753000
rs72710803-<b>C</b>,1 x 10-10,,0.0879,1.0245901,'-,[1.02-1.03],LINC01645,Depression,unipolar depression,GCST007342,1:177458882
rs169235-<b>G</b>,2 x 10-11,,0.247,1.017294,'-,[1.01-1.02],CACNA1E,Depression,unipolar depression,GCST007342,1:181771788
rs17641524-<b>C</b>,8 x 10-20,,0.7909,1.0245901,'-,[1.02-1.03],DENND1B,Depression,unipolar depression,GCST007342,1:197735587
rs12052908-<b>T</b>,4 x 10-22,,0.4675,1.0214505,'-,[1.02-1.03],RNA5SP87,Depression,unipolar depression,GCST007342,2:22280172
rs1568452-<b>T</b>,3 x 10-40,,0.3851,1.03,'-,[1.025-1.034],ACTG1P22,Depression,unipolar depression,GCST007342,2:57785698
rs7585722-<b>C</b>,5 x 10-13,,0.1542,1.0214505,'-,[1.02-1.03],RNF103-CHMP3,Depression,unipolar depression,GCST007342,2:86592005
rs1226412-<b>T</b>,3 x 10-18,,0.7917,1.023,'-,[1.018-1.029],LINC01876,Depression,unipolar depression,GCST007342,2:156254801
rs62188629-<b>A</b>,5 x 10-13,,0.3136,1.017,'-,[1.012-1.022],MYOSLID,Depression,unipolar depression,GCST007342,2:207179746
rs4346585-<b>C</b>,5 x 10-12,,0.304,1.0162601,'-,[1.01-1.02],"ZKSCAN7-AS1, SOCS5P3",Depression,unipolar depression,GCST007342,3:44695001
rs13084037-<b>G</b>,2 x 10-17,,0.226,1.0214505,'-,[1.02-1.03],"C3orf84, KLHDC8B",Depression,unipolar depression,GCST007342,3:49176633
rs141954845-<b>A</b>,1 x 10-15,,0.388,1.018,'-,[1.014-1.022],FHIT,Depression,unipolar depression,GCST007342,3:61207237
rs6783233-<b>T</b>,1 x 10-13,,0.2833,1.018,'-,[1.013-1.023],'-,Depression,unipolar depression,GCST007342,3:117791137
rs1095626-<b>C</b>,6 x 10-39,,0.4201,1.0288066,'-,[1.02-1.03],RSRC1,Depression,unipolar depression,GCST007342,3:158260173
rs7685686-<b>A</b>,6 x 10-15,,0.5753,1.017,'-,[1.013-1.022],HTT,Depression,unipolar depression,GCST007342,4:3205415
rs34937911-<b>T</b>,5 x 10-13,,0.8838,1.025,'-,[1.018-1.032],"BEND4, SLC30A9",Depression,unipolar depression,GCST007342,4:42108336
rs45510091-<b>A</b>,8 x 10-21,,0.9472,1.047,'-,[1.037-1.057],KIAA1109,Depression,unipolar depression,GCST007342,4:122265238
rs35553410-<b>C</b>,2 x 10-10,,0.2538,1.0162601,'-,[1.01-1.02],LINC02479,Depression,unipolar depression,GCST007342,4:130316226
rs60157091-<b>T</b>,6 x 10-21,,0.515,1.021,'-,[1.016-1.025],"RN7SKP157, KIF2A",Depression,unipolar depression,GCST007342,5:62213828
rs3099439-<b>C</b>,2 x 10-21,,0.4712,1.0214505,'-,[1.02-1.03],TMEM161B,Depression,unipolar depression,GCST007342,5:88249501
rs10061069-<b>G</b>,5 x 10-22,,0.7788,1.025641,'-,[1.02-1.03],"FAM172A, POU5F2",Depression,unipolar depression,GCST007342,5:93735924
rs30266-<b>A</b>,2 x 10-45,,0.3296,1.033,'-,[1.028-1.037],'-,Depression,unipolar depression,GCST007342,5:104636656
rs11135349-<b>C</b>,2 x 10-30,,0.5287,1.025641,'-,[1.02-1.03],'-,Depression,unipolar depression,GCST007342,5:165096466
rs200949-<b>A</b>,2 x 10-37,,0.8744,1.044,'-,[1.037-1.051],"H3C11, H1-5",Depression,unipolar depression,GCST007342,6:27867657
rs9363467-<b>T</b>,3 x 10-12,,0.6035,1.016,'-,[1.011-1.021],ADH5P4,Depression,unipolar depression,GCST007342,6:65855810
rs7758630-<b>T</b>,8 x 10-14,,0.5949,1.0162601,'-,[1.01-1.02],"GRIK2, ASCC3",Depression,unipolar depression,GCST007342,6:100939428
rs12967855-<b>A</b>,1 x 10-19,,0.3295,1.021,'-,[1.016-1.026],CELF4,Depression,unipolar depression,GCST007342,18:37558282
rs7227069-<b>A</b>,2 x 10-28,,0.4326,1.024,'-,[1.02-1.029],DCC,Depression,unipolar depression,GCST007342,18:53205432
rs62091461-<b>C</b>,2 x 10-14,,0.7726,1.0204082,'-,[1.02-1.03],RAB27B,Depression,unipolar depression,GCST007342,18:54821441
rs12966052-<b>G</b>,4 x 10-11,,0.8195,1.0193679,'-,[1.01-1.02],LINC01929,Depression,unipolar depression,GCST007342,18:55084408
rs12967143-<b>G</b>,2 x 10-27,,0.3016,1.025641,'-,[1.02-1.03],TCF4,Depression,unipolar depression,GCST007342,18:55431781
rs7241572-<b>A</b>,3 x 10-13,,0.201,1.02,'-,[1.015-1.026],"CTDP1, KCNG2",Depression,unipolar depression,GCST007342,18:79820712
rs33431-<b>T</b>,5 x 10-8,,0.6144,1.012,'-,[1.008-1.016],ZNF536,Depression,unipolar depression,GCST007342,19:30449082
rs143186028-<b>T</b>,7 x 10-18,,0.1778,1.025,'-,[1.019-1.03],"CHD6, EMILIN3",Depression,unipolar depression,GCST007342,20:41368764
rs12624433-<b>A</b>,2 x 10-14,,0.2584,1.019,'-,[1.014-1.024],SLC12A5,Depression,unipolar depression,GCST007342,20:46052214
rs5995992-<b>C</b>,3 x 10-35,,0.2845,1.0309278,'-,[1.03-1.04],"ACTBP15, MIR1281",Depression,unipolar depression,GCST007342,22:41091214
rs9592461-<b>A</b>,1 x 10-28,,0.4874,1.025,'-,[1.02-1.029],PCDH9,Depression,unipolar depression,GCST007342,13:66367660
rs61990288-<b>G</b>,2 x 10-31,,0.4917,1.025641,'-,[1.02-1.03],LRFN5,Depression,unipolar depression,GCST007342,14:41605523
rs1045430-<b>G</b>,4 x 10-25,,0.5208,1.0224949,'-,[1.02-1.03],AREL1,Depression,unipolar depression,GCST007342,14:74663532
rs7193263-<b>G</b>,4 x 10-19,,0.3321,1.0204082,'-,[1.02-1.03],RBFOX1,Depression,unipolar depression,GCST007342,16:6265879
rs12923444-<b>C</b>,2 x 10-24,,0.4375,1.0235415,'-,[1.02-1.03],METTL9,Depression,unipolar depression,GCST007342,16:21628389
rs301799-<b>C</b>,4 x 10-31,,0.4306,1.025641,'-,[1.02-1.03],"RERE, RERE-AS1",Depression,unipolar depression,GCST007342,1:8429242
rs1002656-<b>C</b>,5 x 10-19,,0.2967,1.0214505,'-,[1.02-1.03],"GRIK3, FTLP18",Depression,unipolar depression,GCST007342,1:36727140
rs1466887-<b>C</b>,1 x 10-8,,0.4489,1.0121458,'-,[1.01-1.02],"RNA5SP43, RNU6-636P",Depression,unipolar depression,GCST007342,1:37243727
rs11579246-<b>A</b>,9 x 10-18,,0.9067,1.033,'-,[1.025-1.04],ELAVL4,Depression,unipolar depression,GCST007342,1:50093490
rs1890946-<b>C</b>,9 x 10-19,,0.5329,1.0193679,'-,[1.02-1.02],NRDC,Depression,unipolar depression,GCST007342,1:51876755
rs10789214-<b>T</b>,4 x 10-10,,0.5661,1.014,'-,[1.009-1.018],SGIP1,Depression,unipolar depression,GCST007342,1:66681134
rs2568958-<b>A</b>,4 x 10-52,,0.6156,1.034,'-,[1.03-1.039],"NEGR1, RPL31P12",Depression,unipolar depression,GCST007342,1:72299433
rs10890020-<b>G</b>,3 x 10-34,,0.4844,1.026694,'-,[1.02-1.03],RN7SKP19,Depression,unipolar depression,GCST007342,1:73203153
rs113188507-<b>A</b>,3 x 10-21,,0.2838,1.024,'-,[1.019-1.029],HMGB1P18,Depression,unipolar depression,GCST007342,1:80343951
rs10913112-<b>C</b>,2 x 10-20,,0.6233,1.0214505,'-,[1.02-1.03],"RPS29P5, COP1",Depression,unipolar depression,GCST007342,1:175944692
rs1021363-<b>A</b>,4 x 10-23,,0.3547,1.023,'-,[1.018-1.027],SORCS3,Depression,unipolar depression,GCST007342,10:104851081
rs1448938-<b>A</b>,4 x 10-15,,0.4171,1.017,'-,[1.013-1.022],DCDC1,Depression,unipolar depression,GCST007342,11:30871277
rs2509805-<b>T</b>,5 x 10-16,,0.3209,1.019,'-,[1.015-1.024],"OR5BA1P, OR5AZ1P",Depression,unipolar depression,GCST007342,11:57883324
rs198457-<b>C</b>,5 x 10-14,,0.8075,1.0214505,'-,[1.02-1.03],DAGLA,Depression,unipolar depression,GCST007342,11:61704206
rs58621819-<b>T</b>,2 x 10-10,,0.2097,1.017294,'-,[1.01-1.02],LTBP3,Depression,unipolar depression,GCST007342,11:65547359
rs7117514-<b>G</b>,4 x 10-14,,0.4583,1.0162601,'-,[1.01-1.02],SHANK2,Depression,unipolar depression,GCST007342,11:70698832
rs7932640-<b>T</b>,3 x 10-25,,0.4417,1.023,'-,[1.019-1.027],GRM5,Depression,unipolar depression,GCST007342,11:89011257
rs61902811-<b>G</b>,4 x 10-39,,0.6318,1.0288066,'-,[1.02-1.03],DRD2,Depression,unipolar depression,GCST007342,11:113500036
rs57344483-<b>G</b>,5 x 10-9,,0.0741,1.0245901,'-,[1.02-1.03],'-,Depression,unipolar depression,GCST007342,11:127152665
rs78337797-<b>T</b>,1 x 10-11,,0.8781,1.023,'-,[1.016-1.03],SOX5,Depression,unipolar depression,GCST007342,12:23834991
rs56314503-<b>G</b>,1 x 10-16,,0.2513,1.0204082,'-,[1.02-1.03],'-,Depression,unipolar depression,GCST007342,12:84071243
rs3213572-<b>A</b>,6 x 10-20,,0.4745,1.02,'-,[1.016-1.024],SPPL3,Depression,unipolar depression,GCST007342,12:120767275
rs1409379-<b>T</b>,8 x 10-11,,0.7641,1.017,'-,[1.012-1.022],B3GLCT,Depression,unipolar depression,GCST007342,13:31333604
rs1343605-<b>A</b>,2 x 10-25,,0.384,1.023,'-,[1.019-1.028],"LINC01065, OLFM4",Depression,unipolar depression,GCST007342,13:53072913
rs9545360-<b>C</b>,7 x 10-9,,0.8193,1.017294,'-,[1.01-1.02],SPRY2,Depression,unipolar depression,GCST007342,13:80252238
rs4772087-<b>T</b>,2 x 10-20,,0.3732,1.021,'-,[1.017-1.026],STK24,Depression,unipolar depression,GCST007342,13:98462787
rs1956373-<b>G</b>,6 x 10-12,,0.2564,1.017294,'-,[1.01-1.02],RTN1,Depression,unipolar depression,GCST007342,14:59675104
rs1152578-<b>C</b>,4 x 10-12,,0.5643,1.0152284,'-,[1.01-1.02],ESR2,Depression,unipolar depression,GCST007342,14:64230319
rs10149470-<b>G</b>,7 x 10-22,,0.5131,1.0204082,'-,[1.02-1.02],"RNU7-160P, BAG5",Depression,unipolar depression,GCST007342,14:103551616
rs8037355-<b>C</b>,2 x 10-18,,0.4444,1.0193679,'-,[1.02-1.02],'-,Depression,unipolar depression,GCST007342,15:37351630
rs34488670-<b>C</b>,5 x 10-13,,0.2113,1.0193679,'-,[1.01-1.02],SEMA6D,Depression,unipolar depression,GCST007342,15:47392739
rs7198928-<b>T</b>,4 x 10-23,,0.6159,1.022,'-,[1.018-1.027],RBFOX1,Depression,unipolar depression,GCST007342,16:7616400
rs7200826-<b>T</b>,3 x 10-28,,0.2551,1.027,'-,[1.022-1.032],SHISA9,Depression,unipolar depression,GCST007342,16:12972976
rs56887639-<b>G</b>,6 x 10-13,,0.2736,1.017294,'-,[1.01-1.02],'-,Depression,unipolar depression,GCST007342,16:13661673
rs75581564-<b>A</b>,3 x 10-13,,0.1165,1.025,'-,[1.018-1.032],PIPOX,Depression,unipolar depression,GCST007342,17:29036732
rs1481631-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"RNU6-1263P, LINC00973",Major depressive disorder,unipolar depression,GCST006582,3:98969178
rs2247523-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,PCLO,Major depressive disorder,unipolar depression,GCST006582,7:82825088
rs1780436-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,LINC02629,Major depressive disorder,unipolar depression,GCST006582,10:33968684
rs9943849-<b>T</b>,3 x 10-6,,0.73,1.37,'-,[1.20-1.56],CPM,Major depressive disorder,unipolar depression,GCST000743,12:68976976
rs7713917-<b>G</b>,1 x 10-6,,0.6,1.33,'-,[1.19-1.49],"HOMER1, Y_RNA",Major depressive disorder,unipolar depression,GCST000743,5:79533426
rs10520045-<b>T</b>,7 x 10-6,,0.27,1.32,'-,[1.17-1.50],LINC02853,Major depressive disorder,unipolar depression,GCST000743,15:36021764
rs310501-<b>?</b>,7 x 10-6,,0.33,1.16,'-,[NR],"HAPLN1, VCAN",Major depressive disorder,unipolar depression,GCST000689,5:83594091
rs77044609-<b>C</b>,1 x 10-6,,0.05,'-,0.55 unit increase,[0.33-0.77],COL22A1,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,8:138632440
rs7894240-<b>T</b>,2 x 10-6,,0.45,'-,0.24 unit increase,[0.14-0.34],NT5C2,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,10:103240612
rs73218483-<b>T</b>,2 x 10-6,,0.08,'-,0.46 unit decrease,[0.26-0.66],ABLIM2,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,4:8135871
rs12953784-<b>A</b>,3 x 10-6,,0.13,'-,0.37 unit increase,[0.21-0.53],'-,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,18:2334694
rs145698325-<b>T</b>,3 x 10-6,,0.08,'-,0.45 unit decrease,[0.25-0.65],HULC,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,6:9207484
rs11816901-<b>A</b>,4 x 10-6,,0.21,'-,0.3 unit increase,[0.16-0.44],BTF3P15,Response to cognitive-behavioural therapy in major depressive disorder,"unipolar depression, cognitive behavioural therapy",GCST008361,10:109576103
rs17616243-<b>T</b>,3 x 10-9,,0.16,2.03,'-,[1.79-2.27],BMPR1B,Schizophrenia,schizophrenia,GCST007219,4:94871365
rs2461451-<b>A</b>,3 x 10-7,,NR,'-,7320 unit decrease,'-,"SAP130, AMMECR1L",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,2:127927687
rs4662592-<b>T</b>,3 x 10-7,,NR,'-,8370 unit decrease,'-,"UGGT1, Y_RNA",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,2:128076730
rs737191-<b>T</b>,3 x 10-7,,NR,'-,9050 unit decrease,'-,HS6ST1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,2:128259316
rs7924197-<b>C</b>,3 x 10-7,,NR,'-,6160 unit decrease,'-,JAKMIP3,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,10:132100221
rs10829461-<b>A</b>,7 x 10-7,,NR,'-,1600 unit decrease,'-,'-,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,10:128646955
rs12625774-<b>T</b>,9 x 10-7,,NR,'-,4550 unit increase,'-,"RBM38, HMGB1P1",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,20:57412108
rs7793239-<b>C</b>,9 x 10-7,,NR,'-,1960 unit increase,'-,CEP41,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,7:130394854
rs17454013-<b>A</b>,2 x 10-6,,NR,'-,3710 unit decrease,'-,GPR12,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,13:26774997
rs7229439-<b>T</b>,2 x 10-6,,NR,'-,2660 unit increase,'-,SLC14A2,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,18:45380719
rs12039371-<b>C</b>,2 x 10-6,,NR,'-,3500 unit decrease,'-,COLGALT2,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,1:184016669
rs9425326-<b>C</b>,2 x 10-6,,NR,'-,3340 unit decrease,'-,RGL1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,1:183869871
rs1163825-<b>A</b>,2 x 10-6,,NR,'-,29700 unit increase,'-,'-,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,13:111491360
rs11025109-<b>A</b>,3 x 10-6,,NR,'-,2720 unit decrease,'-,"NAV2-IT1, NAV2",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,11:19383945
rs10105578-<b>A</b>,3 x 10-6,,NR,'-,4280 unit decrease,'-,CSMD1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,8:3658097
rs11025120-<b>T</b>,3 x 10-6,,NR,'-,3630 unit decrease,'-,NAV2,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,11:19403687
rs1423688-<b>G</b>,3 x 10-6,,NR,'-,6110 unit decrease,'-,RICTOR,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,5:39072514
rs2278326-<b>C</b>,3 x 10-6,,NR,'-,6610 unit decrease,'-,OSMR,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,5:38881251
rs2914244-<b>T</b>,3 x 10-6,,NR,'-,7650 unit decrease,'-,LIFR-AS1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,5:38655151
rs9293983-<b>G</b>,4 x 10-6,,NR,'-,6730 unit decrease,'-,'-,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,6:74851875
rs4337869-<b>A</b>,4 x 10-6,,NR,'-,4990 unit decrease,'-,OSMR-AS1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,5:38728116
rs777948-<b>C</b>,4 x 10-6,,NR,'-,3180 unit decrease,'-,'-,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,3:104732323
rs10829470-<b>A</b>,4 x 10-6,,NR,'-,1800 unit decrease,'-,'-,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,10:128678844
rs9642793-<b>A</b>,4 x 10-6,,NR,'-,531 unit decrease,'-,"ADI1P2, GASAL1",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,8:102721404
rs793278-<b>T</b>,5 x 10-6,,NR,'-,2480 unit decrease,'-,"CSRP3-AS1, E2F8",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,11:19224307
rs515103-<b>T</b>,5 x 10-6,,NR,'-,2260 unit decrease,'-,COL12A1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,6:75100605
rs2491441-<b>C</b>,5 x 10-6,,NR,'-,5060 unit decrease,'-,RGL1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,1:183833125
rs1190460-<b>C</b>,6 x 10-6,,NR,'-,6260 unit decrease,'-,"PRSS56, ECEL1",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,2:232502030
rs11132911-<b>T</b>,7 x 10-6,,NR,'-,4500 unit decrease,'-,LINC02174,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,4:171565714
rs17834760-<b>G</b>,7 x 10-6,,NR,'-,1520 unit decrease,'-,KHDRBS2-OT1,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,6:61668740
rs9542550-<b>C</b>,7 x 10-6,,NR,'-,2730 unit decrease,'-,"LINC00348, MTCL1P1",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,13:70973380
rs9378078-<b>T</b>,7 x 10-6,,NR,'-,6700 unit decrease,'-,'-,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,6:61213337
rs1928480-<b>A</b>,7 x 10-6,,NR,'-,2500 unit decrease,'-,"RFC5P1, ATP5MFP3",Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,9:77071521
rs9363882-<b>T</b>,7 x 10-6,,NR,'-,5350 unit decrease,'-,KHDRBS2,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,6:62150634
rs998808-<b>A</b>,7 x 10-6,,NR,'-,6910 unit decrease,'-,KHDRBS2,Antipsychotic drug-induced QTc interval change in schizophrenia,"schizophrenia, heart rate variability measurement, response to antipsychotic drug",GCST004987,6:61997852
rs4320241-<b>C</b>,1 x 10-6,,NR,'-,20.0689 unit increase,[12.16-27.98],"RPL27AP5, GCNT4",Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,5:75003319
rs183547317-<b>T</b>,1 x 10-6,,NR,'-,24.2758 unit increase,[14.58-33.97],'-,Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,4:11562007
rs3862662-<b>A</b>,3 x 10-6,,NR,'-,9.0566 unit increase,[5.34-12.77],ZP1,Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,11:60868357
rs59730210-<b>G</b>,3 x 10-6,,NR,'-,34.625 unit increase,[20.37-48.88],GRXCR1,Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,4:138789275
rs56080959-<b>A</b>,3 x 10-6,,NR,'-,8.8291 unit decrease,[5.17-12.49],"LINC00303, SOX13",Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,1:204053289
rs150634721-<b>C</b>,4 x 10-7,,NR,'-,26.0032 unit increase,[16.13-35.88],IGF1,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,12:102492363
rs2802383-<b>G</b>,8 x 10-7,,NR,'-,9.507 unit decrease,[5.8-13.21],"SYF2P2, C9orf131",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,9:35020439
rs9554958-<b>A</b>,1 x 10-6,,NR,'-,8.9266 unit decrease,[5.4-12.46],"ATP6V1G1P7, LINC00343",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,13:103448176
rs76694263-<b>G</b>,1 x 10-6,,NR,'-,12.474 unit decrease,[7.49-17.46],GALNT10,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,5:154286206
rs16834649-<b>T</b>,2 x 10-6,,NR,'-,16.6214 unit increase,[9.85-23.4],"RGS13, RPS27AP5",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,1:192698757
rs642296-<b>T</b>,3 x 10-6,,NR,'-,9.0135 unit decrease,[5.31-12.72],"RN7SL338P, VCP",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,9:35051272
rs7088969-<b>T</b>,3 x 10-6,,NR,'-,8.7002 unit decrease,[5.11-12.29],LINC02674,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,10:117774246
rs34624213-<b>A</b>,4 x 10-6,,NR,'-,16.2055 unit increase,[9.46-22.95],"RPS27AP5, RGS2",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,1:192734842
rs28533249-<b>G</b>,4 x 10-6,,NR,'-,8.8627 unit decrease,[5.16-12.56],LINC01310,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,22:48894738
rs3753947-<b>T</b>,5 x 10-6,,NR,'-,16.0195 unit increase,[9.27-22.77],"RGS2, RPS27AP5",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,1:192745941
rs30419-<b>T</b>,6 x 10-6,,NR,'-,14.8543 unit increase,[8.53-21.18],"LINC01949, MIR4280HG",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,5:87168783
rs4879848-<b>T</b>,6 x 10-6,,NR,'-,8.8412 unit decrease,[5.07-12.61],DNAJB5,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,9:34992077
rs986359-<b>A</b>,7 x 10-6,,NR,'-,16.4643 unit decrease,[9.37-23.56],SPOCK1,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,5:137311415
rs568300-<b>T</b>,9 x 10-6,,NR,'-,8.421 unit decrease,[4.76-12.08],PIGO,Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,9:35093023
rs630961-<b>C</b>,9 x 10-6,,NR,'-,8.3966 unit decrease,[4.74-12.05],"FAM214B, STOML2",Response to quetiapine in schizophrenia,"schizophrenia, response to quetiapine",GCST006295,9:35103725
rs17022006-<b>G</b>,3 x 10-8,,NR,'-,7.16 unit decrease,[4.63-9.69],CNTN4,Response to aripiprazole in schizophrenia,"schizophrenia, response to aripiprazole, response to antipsychotic drug",GCST006285,3:2897050
rs68057166-<b>G</b>,4 x 10-7,,NR,'-,6.15 unit decrease,[3.76-8.54],TENM2,Response to aripiprazole in schizophrenia,"schizophrenia, response to aripiprazole, response to antipsychotic drug",GCST006285,5:167805815
rs16921385-<b>A</b>,4 x 10-8,,NR,'-,6.8 unit increase,[4.37-9.23],SLC1A1,Response to risperidone in schizophrenia,"schizophrenia, response to risperidone",GCST006294,9:4507513
rs2239063-<b>A</b>,1 x 10-8,,NR,'-,7.04 unit increase,[4.63-9.45],CACNA1C,Response to olanzapine in schizophrenia,"schizophrenia, response to olanzapine",GCST006293,12:2402665
rs1731240-<b>A</b>,3 x 10-6,,NR,'-,6.9 unit increase,[4.02-9.78],CIB4,Response to olanzapine in schizophrenia,"schizophrenia, response to olanzapine",GCST006293,2:26614527
rs72790443-<b>T</b>,1 x 10-9,,0.09,'-,5.64 unit decrease,[3.82-7.46],MEGF10,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,5:127455149
rs1471786-<b>G</b>,2 x 10-9,,0.42,'-,3.35 unit decrease,[2.25-4.45],"SPATA6L, SLC1A1",Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,9:4576774
rs9291547-<b>A</b>,3 x 10-9,,0.48,'-,3.18 unit decrease,[2.12-4.24],PCDH7,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,4:30748032
rs12711680-<b>G</b>,2 x 10-8,,0.36,'-,3.18 unit increase,[2.06-4.3],CNTNAP5,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,2:124546458
rs6444970-<b>T</b>,5 x 10-8,,0.11,'-,4.8 unit decrease,[3.08-6.52],TNIK,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,3:171192653
rs77685948-<b>G</b>,7 x 10-8,,0.32,'-,3.14 unit decrease,[2-4.28],PCDH7,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,4:30653520
rs301440-<b>C</b>,2 x 10-7,,0.35,'-,3.07 unit decrease,[1.91-4.23],SPATA6L,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,9:4590305
rs150192045-<b>C</b>,2 x 10-6,,0.04,'-,6.64 unit decrease,[3.92-9.36],"MEGF10, HNRNPKP1",Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,5:127477772
rs4848939-<b>G</b>,4 x 10-6,,0.3,'-,2.75 unit increase,[1.57-3.93],CNTNAP5,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,2:124558127
rs9544382-<b>C</b>,9 x 10-6,,0.34,'-,2.52 unit increase,[1.4-3.64],NBEA,Response to antipsychotic treatment in schizophrenia,"schizophrenia, response to antipsychotic drug",GCST006292,13:35449873
rs760816-<b>A</b>,1 x 10-7,,NR,'-,13.7849 unit decrease,[8.92-18.65],"MROH9, AJAP1",Response to haloperidol in schizophrenia,"schizophrenia, response to haloperidol",GCST006298,1:4796871
rs929255-<b>C</b>,8 x 10-7,,NR,'-,14.7695 unit increase,[9.11-20.43],"NPVF, U3",Response to haloperidol in schizophrenia,"schizophrenia, response to haloperidol",GCST006298,7:25233001
rs13338060-<b>G</b>,6 x 10-6,,NR,'-,11.0966 unit decrease,[6.43-15.76],CNTNAP4,Response to haloperidol in schizophrenia,"schizophrenia, response to haloperidol",GCST006298,16:76494737
rs73770737-<b>G</b>,6 x 10-6,,NR,'-,13.4294 unit increase,[7.78-19.08],MIR3660,Response to haloperidol in schizophrenia,"schizophrenia, response to haloperidol",GCST006298,5:89917211
rs138126300-<b>A</b>,7 x 10-6,,NR,'-,11.6948 unit increase,[6.75-16.63],ZNF665,Response to haloperidol in schizophrenia,"schizophrenia, response to haloperidol",GCST006298,19:53167698
rs1885572-<b>A</b>,9 x 10-6,,NR,'-,12.6252 unit decrease,[7.2-18.05],"Y_RNA, SNRPB2",Response to haloperidol in schizophrenia,"schizophrenia, response to haloperidol",GCST006298,20:16679517
rs13239071-<b>G</b>,2 x 10-6,,NR,'-,16.8758 unit decrease,[10.21-23.54],"TFAMP1, ELFN1",Response to perphenazine in schizophrenia,"schizophrenia, response to perphenazine",GCST006297,7:1624714
rs7116879-<b>T</b>,3 x 10-6,,NR,'-,14.6983 unit decrease,[8.72-20.68],DKK3,Response to perphenazine in schizophrenia,"schizophrenia, response to perphenazine",GCST006297,11:11992266
rs75953396-<b>A</b>,5 x 10-6,,NR,'-,16.3291 unit increase,[9.52-23.13],"LGI1, FRA10AC1",Response to perphenazine in schizophrenia,"schizophrenia, response to perphenazine",GCST006297,10:93748796
rs77989818-<b>G</b>,7 x 10-6,,NR,'-,26.962 unit decrease,[15.57-38.36],'-,Response to perphenazine in schizophrenia,"schizophrenia, response to perphenazine",GCST006297,5:44968962
rs7358476-<b>A</b>,9 x 10-6,,NR,'-,11.4794 unit decrease,[6.55-16.41],'-,Response to perphenazine in schizophrenia,"schizophrenia, response to perphenazine",GCST006297,11:87481582
rs12567918-<b>T</b>,7 x 10-7,,NR,'-,9.2903 unit decrease,[5.67-12.91],"SOX13, LINC00303",Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,1:204057325
rs737724-<b>G</b>,2 x 10-7,,NR,'-,10.6228 unit decrease,[6.68-14.56],LINC01656,Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,22:44437202
rs10012947-<b>C</b>,8 x 10-7,,NR,'-,9.1431 unit decrease,[5.56-12.73],'-,Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,4:30491805
rs12133007-<b>T</b>,9 x 10-7,,NR,'-,9.2915 unit decrease,[5.64-12.94],LINC00303,Response to ziprazidone in schizophrenia,"schizophrenia, response to ziprasidone",GCST006296,1:204039811
rs3849046-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ETF1,Schizophrenia,schizophrenia,GCST008459,5:138515503
rs2053079-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,ZNF536,Schizophrenia,schizophrenia,GCST008459,19:30496516
rs6430095-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,2:145682377
rs4523957-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,SRR,Schizophrenia,schizophrenia,GCST008459,17:2305605
rs11139497-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,DDX10P2,Schizophrenia,schizophrenia,GCST008459,9:82125026
rs12363019-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,LINC02686,Schizophrenia,schizophrenia,GCST008459,11:24352999
rs12325245-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"CNOT1, SLC38A7",Schizophrenia,schizophrenia,GCST008459,16:58647489
rs4648845-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,PLCH2,Schizophrenia,schizophrenia,GCST008459,1:2455662
rs4908972-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,TBC1D5,Schizophrenia,schizophrenia,GCST008459,3:17754700
rs1106568-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,GPM6A,Schizophrenia,schizophrenia,GCST008459,4:175940150
rs62378245-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,MEF2C-AS1,Schizophrenia,schizophrenia,GCST008459,5:89448145
rs7235891-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"LINC01415, LINC01416",Schizophrenia,schizophrenia,GCST008459,18:55787543
rs11685299-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,CUL3,Schizophrenia,schizophrenia,GCST008459,2:224526579
rs7191183-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,GRIN2A,Schizophrenia,schizophrenia,GCST008459,16:9806200
rs7927176-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,GRAMD1B,Schizophrenia,schizophrenia,GCST008459,11:123525156
rs6990941-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,8:88632202
rs7299943-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,PITPNM2,Schizophrenia,schizophrenia,GCST008459,12:123108938
rs10803138-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SDCCAG8,Schizophrenia,schizophrenia,GCST008459,1:243391917
rs8082590-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,GID4,Schizophrenia,schizophrenia,GCST008459,17:18055088
rs12647126-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,NEK1,Schizophrenia,schizophrenia,GCST008459,4:169455554
rs6704641-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,SATB2,Schizophrenia,schizophrenia,GCST008459,2:199299529
rs679087-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,TMTC1,Schizophrenia,schizophrenia,GCST008459,12:29764332
rs2693698-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,Mapping not available
rs7801375-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,CAPZA1P4,Schizophrenia,schizophrenia,GCST008459,7:131882504
rs215411-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,RFPL4AP3,Schizophrenia,schizophrenia,GCST008459,4:23421980
rs13168670-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,"VTRNA1-3, PCDHA1",Schizophrenia,schizophrenia,GCST008459,5:140767314
rs9292918-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,HCN1,Schizophrenia,schizophrenia,GCST008459,5:45300933
rs1355585-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,15:70294278
rs9928653-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,NFATC3,Schizophrenia,schizophrenia,GCST008459,16:68218176
rs7523273-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,MIR29B2CHG,Schizophrenia,schizophrenia,GCST008459,1:207803738
rs704364-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,ATXN7,Schizophrenia,schizophrenia,GCST008459,3:63889058
rs9420-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,SELENOH,Schizophrenia,schizophrenia,GCST008459,11:57742822
rs59724122-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,GULOP,Schizophrenia,schizophrenia,GCST008459,8:27567179
rs10046758-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,CSMD1,Schizophrenia,schizophrenia,GCST008459,8:4326648
rs3735025-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,DGKI,Schizophrenia,schizophrenia,GCST008459,7:137390098
rs6019879-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,PTGIS,Schizophrenia,schizophrenia,GCST008459,20:49514091
rs3858402-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,LINC02715,Schizophrenia,schizophrenia,GCST008459,11:109685112
rs2909457-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,"SLC4A10, DPP4",Schizophrenia,schizophrenia,GCST008459,2:161989345
rs6864084-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,GALNT10,Schizophrenia,schizophrenia,GCST008459,5:154305966
rs71575306-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,MAN2A1,Schizophrenia,schizophrenia,GCST008459,5:109710509
rs1339227-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,RIMS1,Schizophrenia,schizophrenia,GCST008459,6:72445999
rs16851048-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST008459,1:177306870
rs56282503-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,PAK6,Schizophrenia,schizophrenia,GCST008459,15:40274558
rs2068012-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,PRKD1,Schizophrenia,schizophrenia,GCST008459,14:29721110
rs56873913-<b>?</b>,4 x 10-7,,NR,'-,'-,'-,"NOSIP, PRRG2",Schizophrenia,schizophrenia,GCST008459,19:49587942
rs12154597-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,GSDME,Schizophrenia,schizophrenia,GCST008459,7:24746263
rs502834-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,IGSF9B,Schizophrenia,schizophrenia,GCST008459,11:133947438
rs9656169-<b>?</b>,8 x 10-7,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,7:110434219
rs5936660-<b>?</b>,9 x 10-7,,NR,'-,'-,'-,PJA1,Schizophrenia,schizophrenia,GCST008459,X:69158094
rs10860965-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,C12orf42,Schizophrenia,schizophrenia,GCST008459,12:103211559
rs73627050-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,NLGN4X,Schizophrenia,schizophrenia,GCST008459,X:6094587
rs4702-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,FURIN,Schizophrenia,schizophrenia,GCST008459,15:90883330
rs4873803-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,MROH6,Schizophrenia,schizophrenia,GCST008459,8:143572424
rs926231-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,CACNA1I,Schizophrenia,schizophrenia,GCST008459,22:39610981
rs11693094-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,ZNF804A,Schizophrenia,schizophrenia,GCST008459,2:184736693
rs66486766-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,"EFL1P1, DNM1P41",Schizophrenia,schizophrenia,GCST008459,15:84137308
rs17194490-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,CNTN4,Schizophrenia,schizophrenia,GCST008459,3:2506102
rs17691888-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,CACNB2,Schizophrenia,schizophrenia,GCST008459,10:18445599
rs4642619-<b>?</b>,8 x 10-11,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,8:110475239
rs2535627-<b>?</b>,8 x 10-11,,NR,'-,'-,'-,"ITIH3, ITIH4",Schizophrenia,schizophrenia,GCST008459,3:52811089
rs4391122-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,LINC02057,Schizophrenia,schizophrenia,GCST008459,5:61302716
rs3798869-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,SNAP91,Schizophrenia,schizophrenia,GCST008459,6:83618941
rs75968099-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,"LINC02033, HSPD1P6",Schizophrenia,schizophrenia,GCST008459,3:36817092
rs9607782-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,EP300-AS1,Schizophrenia,schizophrenia,GCST008459,22:41191552
rs10750450-<b>?</b>,7 x 10-13,,NR,'-,'-,'-,LINC02551,Schizophrenia,schizophrenia,GCST008459,11:130849166
rs4129585-<b>?</b>,7 x 10-13,,NR,'-,'-,'-,TSNARE1,Schizophrenia,schizophrenia,GCST008459,8:142231572
rs9636107-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,TCF4,Schizophrenia,schizophrenia,GCST008459,18:55532886
rs11210892-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"PTPRF, KDM4A",Schizophrenia,schizophrenia,GCST008459,1:43634413
rs7766356-<b>?</b>,3 x 10-21,,NR,'-,'-,'-,ZSCAN23,Schizophrenia,schizophrenia,GCST008459,6:28432761
rs12244388-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,"AS3MT, BORCS7-ASMT",Schizophrenia,schizophrenia,GCST008459,10:102880295
rs2007044-<b>?</b>,9 x 10-18,,NR,'-,'-,'-,CACNA1C,Schizophrenia,schizophrenia,GCST008459,12:2235794
rs1702294-<b>?</b>,1 x 10-17,,NR,'-,'-,'-,MIR137HG,Schizophrenia,schizophrenia,GCST008459,1:98036428
rs11693528-<b>?</b>,3 x 10-14,,NR,'-,'-,'-,"FTCDNL1, RN7SL717P",Schizophrenia,schizophrenia,GCST008459,2:199871784
rs58120505-<b>?</b>,8 x 10-14,,NR,'-,'-,'-,MAD1L1,Schizophrenia,schizophrenia,GCST008459,7:1990232
rs7951870-<b>?</b>,9 x 10-11,,NR,'-,'-,'-,DGKZ,Schizophrenia,schizophrenia,GCST008459,11:46351761
rs12887734-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,"KLC1, COA8",Schizophrenia,schizophrenia,GCST008459,14:103580497
rs34796896-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,FXR1,Schizophrenia,schizophrenia,GCST008459,3:180905467
rs59979824-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,2:192983614
rs12691307-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,"TMEM219, KCTD13",Schizophrenia,schizophrenia,GCST008459,16:29928556
rs7405404-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,16:13656002
rs35225048-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,15:61564064
rs12129573-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,LINC01360,Schizophrenia,schizophrenia,GCST008459,1:73302683
rs2514218-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,DRD2,Schizophrenia,schizophrenia,GCST008459,11:113522272
rs2905426-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,"MAU2, GATAD2A",Schizophrenia,schizophrenia,GCST008459,19:19367213
rs6984242-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,'-,Schizophrenia,schizophrenia,GCST008459,8:59787910
rs1498232-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,LINC01648,Schizophrenia,schizophrenia,GCST008459,1:29961104
rs2332700-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,RGS6,Schizophrenia,schizophrenia,GCST008459,14:71950609
rs6466055-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,SRPK2,Schizophrenia,schizophrenia,GCST008459,7:105288617
rs2910032-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,LINC01470,Schizophrenia,schizophrenia,GCST008459,5:153160794
rs301797-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,"RERE-AS1, RERE",Schizophrenia,schizophrenia,GCST008459,1:8427263
rs8043009-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,CHRNA3,Schizophrenia,schizophrenia,GCST008459,15:78615812
rs11682175-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,ACTG1P22,Schizophrenia,schizophrenia,GCST008459,2:57760458
rs55661361-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,NRGN,Schizophrenia,schizophrenia,GCST008459,11:124744061
rs778371-<b>?</b>,5 x 10-12,,NR,'-,'-,'-,SNORC,Schizophrenia,schizophrenia,GCST008459,2:232878399
rs6065094-<b>?</b>,5 x 10-12,,NR,'-,'-,'-,PPP1R16B,Schizophrenia,schizophrenia,GCST008459,20:38824551
rs7427564-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,STAG1,Schizophrenia,schizophrenia,GCST008459,3:136555593
rs12704290-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST008459,7:86798310
rs2565164-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,COQ10B,Schizophrenia,schizophrenia,GCST008459,2:197472796
rs13240464-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,IMMP2L,Schizophrenia,schizophrenia,GCST008459,7:111258859
rs7720513-<b>?</b>,1 x 10-6,(EA),'-,'-,0.406 unit increase,'-,RNU6-500P,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,5:173402299
rs117433199-<b>?</b>,2 x 10-6,(EA),'-,'-,0.397 unit increase,'-,OBI1-AS1,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,13:78393555
rs78129933-<b>?</b>,3 x 10-6,(EA),'-,'-,0.398 unit increase,'-,"LINC00299, LINC00298",Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,2:8241153
rs62097526-<b>?</b>,4 x 10-6,(EA),'-,'-,0.387 unit increase,'-,"RNU6-170P, CIDEA",Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,18:12291681
rs62344853-<b>?</b>,4 x 10-6,(EA),'-,'-,0.397 unit decrease,'-,'-,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,4:177607660
rs74820080-<b>?</b>,5 x 10-6,(EA),'-,'-,0.383 unit increase,'-,ZNF883,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,9:112966650
rs7938982-<b>?</b>,6 x 10-6,(EA),'-,'-,0.381 unit increase,'-,LUZP2,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,11:24708480
rs191168-<b>?</b>,8 x 10-6,(EA),'-,'-,0.39 unit increase,'-,'-,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,5:3036482
rs60232573-<b>?</b>,1 x 10-6,(EA),'-,'-,0.3788 unit increase,'-,IL17B,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,5:149400276
rs1525085-<b>?</b>,2 x 10-6,,NR,'-,4.789 z-score increase,'-,DGKB,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,7:14600073
rs1052990-<b>?</b>,2 x 10-6,,NR,'-,4.764 z-score increase,'-,CAV2,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,7:116508316
rs10114227-<b>?</b>,3 x 10-6,,NR,'-,4.642 z-score decrease,'-,'-,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,9:75600670
rs3779511-<b>?</b>,4 x 10-6,,NR,'-,4.605 z-score increase,'-,CAV2,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,7:116501724
rs73909111-<b>?</b>,4 x 10-6,,NR,'-,4.595 z-score increase,'-,RNA5SP484,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,20:40920595
rs7938982-<b>?</b>,5 x 10-6,,NR,'-,4.58 z-score increase,'-,LUZP2,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,11:24708480
rs12460932-<b>?</b>,6 x 10-6,,NR,'-,4.517 z-score increase,'-,DMKN,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,19:35513269
rs56910685-<b>?</b>,6 x 10-6,,NR,'-,4.512 z-score increase,'-,OBI1-AS1,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,13:78424804
rs1411552-<b>?</b>,7 x 10-6,,NR,'-,4.491 z-score increase,'-,LINC00676,Antipsychotic drug-induced weight gain in schizophrenia,"schizophrenia, antipsychotic drug related weight gain",GCST009302,13:109718917
rs10252923-<b>A</b>,2 x 10-6,,0.29,1.82,'-,[1.42-2.33],"NIPA2P1, FZD1",Schizophrenia,schizophrenia,GCST009603,7:91275726
rs17018359-<b>?</b>,2 x 10-6,(MTAG including spine BMD data),NR,'-,0.102 unit decrease,'-,CTNNA2,Schizophrenia (MTAG),schizophrenia,GCST009891,2:79989050
rs16945898-<b>?</b>,4 x 10-6,(MTAG including spine BMD data),NR,'-,0.14 unit decrease,'-,'-,Schizophrenia (MTAG),schizophrenia,GCST009891,17:12322858
rs1561296-<b>?</b>,7 x 10-6,(MTAG including spine BMD data),NR,'-,0.092 unit decrease,'-,SPATS2L,Schizophrenia (MTAG),schizophrenia,GCST009891,2:200443394
rs1791244-<b>?</b>,7 x 10-6,(MTAG including spine BMD data),NR,'-,0.083 unit decrease,'-,MIR924HG,Schizophrenia (MTAG),schizophrenia,GCST009891,18:39489348
rs2959223-<b>A</b>,4 x 10-7,,0.3,5.55,'-,[1.44-21.26],SIX2,Clozapine-induced myocarditis in schizophrenia,"myocarditis, schizophrenia, response to clozapine",GCST009817,2:45018026
rs9463787-<b>G</b>,8 x 10-7,,0.13,7.67,'-,[2.63-22.36],EFHC1,Clozapine-induced myocarditis in schizophrenia,"myocarditis, schizophrenia, response to clozapine",GCST009817,6:52431785
rs117188076-<b>T</b>,3 x 10-7,,0.03,13.74,'-,[3.68-51.22],ADAM7,Clozapine-induced myocarditis in schizophrenia,"myocarditis, schizophrenia, response to clozapine",GCST009817,8:24543885
rs74675399-<b>A</b>,1 x 10-7,,0.07,6.36,'-,[2.28-17.8],"GNA15, GNA15-DT",Clozapine-induced myocarditis in schizophrenia,"myocarditis, schizophrenia, response to clozapine",GCST009817,19:3148871
rs6424555-<b>T</b>,3 x 10-6,,NR,1.05,'-,[NR],LINC02238,Schizophrenia,schizophrenia,GCST003048,1:73616692
rs6430491-<b>G</b>,2 x 10-6,,NR,1.0638298,'-,[NR],MGAT5,Schizophrenia,schizophrenia,GCST003048,2:134083396
rs6434928-<b>G</b>,5 x 10-11,,NR,1.0752687,'-,[NR],"RNU6-1029P, SF3B1",Schizophrenia,schizophrenia,GCST003048,2:197439853
rs6466055-<b>A</b>,1 x 10-9,,NR,1.07,'-,[NR],SRPK2,Schizophrenia,schizophrenia,GCST003048,7:105288617
rs6468049-<b>T</b>,2 x 10-6,,NR,1.05,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,8:31484951
rs648516-<b>T</b>,1 x 10-6,,NR,1.06,'-,[NR],LINC00571,Schizophrenia,schizophrenia,GCST003048,13:38255485
rs6500602-<b>T</b>,3 x 10-7,,NR,1.06,'-,[NR],DNAJA3,Schizophrenia,schizophrenia,GCST003048,16:4447450
rs6517329-<b>A</b>,8 x 10-6,,NR,1.05,'-,[NR],"MEMO1P1, SETD4",Schizophrenia,schizophrenia,GCST003048,21:36109179
rs6549358-<b>G</b>,5 x 10-6,,NR,1.0526316,'-,[NR],"HMGB1P36, RNU6-281P",Schizophrenia,schizophrenia,GCST003048,3:70803555
rs6568685-<b>A</b>,7 x 10-7,,NR,1.07,'-,[NR],TRAF3IP2-AS1,Schizophrenia,schizophrenia,GCST003048,6:111499910
rs66691851-<b>C</b>,2 x 10-11,,NR,1.0752687,'-,[NR],STAG1,Schizophrenia,schizophrenia,GCST003048,3:136435986
rs6670165-<b>T</b>,5 x 10-8,,NR,1.08,'-,[NR],"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST003048,1:177310985
rs6678676-<b>C</b>,2 x 10-6,,NR,1.0638298,'-,[NR],LINC00862,Schizophrenia,schizophrenia,GCST003048,1:200297375
rs6704641-<b>A</b>,2 x 10-8,,NR,1.08,'-,[NR],SATB2,Schizophrenia,schizophrenia,GCST003048,2:199299529
rs6707588-<b>T</b>,9 x 10-7,,NR,1.06,'-,[NR],ZFAND2B,Schizophrenia,schizophrenia,GCST003048,2:219196879
rs6716963-<b>A</b>,6 x 10-8,,NR,1.06,'-,[NR],NAB1,Schizophrenia,schizophrenia,GCST003048,2:193502815
rs6736848-<b>T</b>,5 x 10-6,,NR,1.05,'-,[NR],"RNU6-1001P, CBX3P6",Schizophrenia,schizophrenia,GCST003048,2:155012155
rs67478160-<b>C</b>,6 x 10-6,,NR,1.0526316,'-,[NR],PPP1R13B,Schizophrenia,schizophrenia,GCST003048,14:103824337
rs67682613-<b>G</b>,7 x 10-19,,NR,1.1494253,'-,[NR],NEU1,Schizophrenia,schizophrenia,GCST003048,6:31858928
rs679087-<b>C</b>,3 x 10-8,,NR,1.0638298,'-,[NR],TMTC1,Schizophrenia,schizophrenia,GCST003048,12:29764332
rs67981189-<b>G</b>,2 x 10-7,,NR,1.0638298,'-,[NR],PCNX1,Schizophrenia,schizophrenia,GCST003048,14:71005509
rs6800435-<b>A</b>,5 x 10-7,,NR,1.08,'-,[NR],LINC00606,Schizophrenia,schizophrenia,GCST003048,3:10762866
rs6825268-<b>G</b>,4 x 10-7,,NR,1.0526316,'-,[NR],"TBC1D19, STIM2",Schizophrenia,schizophrenia,GCST003048,4:26781831
rs6868545-<b>C</b>,7 x 10-7,,NR,1.1235955,'-,[NR],LINC01470,Schizophrenia,schizophrenia,GCST003048,5:153115323
rs6878284-<b>C</b>,2 x 10-7,,NR,1.0638298,'-,[NR],SLCO6A1,Schizophrenia,schizophrenia,GCST003048,5:102434022
rs6083-<b>A</b>,5 x 10-6,,NR,1.29,'-,[NR],LIPC,Schizophrenia,schizophrenia,GCST003050,15:58545811
rs67900830-<b>A</b>,4 x 10-6,,NR,1.4705882,'-,[NR],CRYAA,Schizophrenia,schizophrenia,GCST003050,21:43195762
rs76569837-<b>G</b>,3 x 10-6,,NR,2.7,'-,[NR],U6,Schizophrenia,schizophrenia,GCST003050,12:45565980
rs66831316-<b>?</b>,3 x 10-6,,NR,1.2820514,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003050,Mapping not available
rs189918-<b>C</b>,4 x 10-6,,NR,1.0526316,'-,[NR],DNAJC11,Schizophrenia,schizophrenia,GCST003048,1:6677152
rs190474885-<b>C</b>,1 x 10-6,,NR,1.2048193,'-,[NR],NT5C2,Schizophrenia,schizophrenia,GCST003048,10:103213560
rs55661361-<b>G</b>,1 x 10-12,,NR,1.0869565,'-,[NR],NRGN,Schizophrenia,schizophrenia,GCST003048,11:124744061
rs55675132-<b>C</b>,2 x 10-6,,NR,1.0638298,'-,[NR],TSPAN2,Schizophrenia,schizophrenia,GCST003048,1:115077013
rs55833108-<b>T</b>,1 x 10-8,,NR,1.08,'-,[NR],CNNM2,Schizophrenia,schizophrenia,GCST003048,10:102981826
rs55834529-<b>A</b>,9 x 10-27,,NR,1.24,'-,[NR],"RNU2-62P, VN1R11P",Schizophrenia,schizophrenia,GCST003048,6:27104763
rs56038139-<b>G</b>,2 x 10-7,,NR,1.1111112,'-,[NR],ARHGEF26,Schizophrenia,schizophrenia,GCST003048,3:154245185
rs56145559-<b>T</b>,1 x 10-7,,NR,1.07,'-,[NR],ALMS1,Schizophrenia,schizophrenia,GCST003048,2:73396311
rs56205728-<b>A</b>,9 x 10-8,,NR,1.07,'-,[NR],PAK6,Schizophrenia,schizophrenia,GCST003048,15:40275036
rs56775891-<b>T</b>,9 x 10-8,,NR,1.06,'-,[NR],"KCNG2, CTDP1",Schizophrenia,schizophrenia,GCST003048,18:79815613
rs56873913-<b>T</b>,3 x 10-7,,NR,1.07,'-,[NR],"NOSIP, PRRG2",Schizophrenia,schizophrenia,GCST003048,19:49587942
rs5749696-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],YPEL1,Schizophrenia,schizophrenia,GCST003048,22:21709048
rs57549656-<b>G</b>,5 x 10-7,,NR,1.0638298,'-,[NR],GNG7,Schizophrenia,schizophrenia,GCST003048,19:2687653
rs5757717-<b>C</b>,6 x 10-10,,NR,1.0752687,'-,[NR],"CACNA1I, RPS19BP1",Schizophrenia,schizophrenia,GCST003048,22:39546229
rs5769765-<b>G</b>,2 x 10-7,,NR,1.0638298,'-,[NR],ZBED4,Schizophrenia,schizophrenia,GCST003048,22:49877528
rs582580-<b>G</b>,3 x 10-6,,NR,1.0526316,'-,[NR],"ARL2, BATF2",Schizophrenia,schizophrenia,GCST003048,11:65004475
rs58605417-<b>G</b>,6 x 10-7,,NR,1.0638298,'-,[NR],MMP16,Schizophrenia,schizophrenia,GCST003048,8:88282093
rs58950470-<b>T</b>,3 x 10-6,,NR,1.05,'-,[NR],PCNX3,Schizophrenia,schizophrenia,GCST003048,11:65616284
rs59888335-<b>T</b>,5 x 10-6,,NR,1.05,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:80610899
rs59979824-<b>C</b>,2 x 10-8,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,2:192983614
rs6002655-<b>T</b>,6 x 10-10,,NR,1.07,'-,[NR],TCF20,Schizophrenia,schizophrenia,GCST003048,22:42207808
rs60037734-<b>G</b>,7 x 10-6,,NR,1.0869565,'-,[NR],"ZMYM4, Y_RNA",Schizophrenia,schizophrenia,GCST003048,1:35213586
rs6019826-<b>T</b>,2 x 10-6,,NR,1.08,'-,[NR],KCNB1,Schizophrenia,schizophrenia,GCST003048,20:49426433
rs6035684-<b>C</b>,3 x 10-7,,NR,1.0638298,'-,[NR],"MRPS11P1, RN7SL607P",Schizophrenia,schizophrenia,GCST003048,20:20754934
rs6065094-<b>G</b>,3 x 10-11,,NR,1.0752687,'-,[NR],PPP1R16B,Schizophrenia,schizophrenia,GCST003048,20:38824551
rs6065777-<b>T</b>,2 x 10-6,,NR,1.06,'-,[NR],STK4,Schizophrenia,schizophrenia,GCST003048,20:45041000
rs6095357-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],"ARFGEF2, PREX1",Schizophrenia,schizophrenia,GCST003048,20:48907328
rs61021925-<b>T</b>,2 x 10-6,,NR,1.05,'-,[NR],CLIP1,Schizophrenia,schizophrenia,GCST003048,12:122379112
rs61712019-<b>T</b>,1 x 10-6,,NR,1.06,'-,[NR],LRRTM4,Schizophrenia,schizophrenia,GCST003048,2:77477763
rs61747867-<b>T</b>,2 x 10-7,,NR,1.07,'-,[NR],H2AC10P,Schizophrenia,schizophrenia,GCST003048,6:26272320
rs61765555-<b>C</b>,9 x 10-7,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,1:73492132
rs61826828-<b>A</b>,9 x 10-6,,NR,1.07,'-,[NR],"RPL30P1, LINC02776",Schizophrenia,schizophrenia,GCST003048,1:174046123
rs61847307-<b>C</b>,4 x 10-7,,NR,1.0638298,'-,[NR],PRKG1,Schizophrenia,schizophrenia,GCST003048,10:52184682
rs61867294-<b>A</b>,2 x 10-6,,NR,1.07,'-,[NR],SORCS3,Schizophrenia,schizophrenia,GCST003048,10:104809449
rs61903125-<b>G</b>,8 x 10-6,,NR,1.098901,'-,[NR],GUCY1A2,Schizophrenia,schizophrenia,GCST003048,11:106620055
rs61935443-<b>C</b>,7 x 10-6,,NR,1.06,'-,[NR],"KRT19P2, NDUFA12",Schizophrenia,schizophrenia,GCST003048,12:94855988
rs62055045-<b>G</b>,1 x 10-6,,NR,1.0752687,'-,[NR],CALB2,Schizophrenia,schizophrenia,GCST003048,16:71362758
rs62064224-<b>G</b>,7 x 10-6,,NR,1.0526316,'-,[NR],RHBDL3,Schizophrenia,schizophrenia,GCST003048,17:32308096
rs62200787-<b>T</b>,2 x 10-8,,NR,1.098901,'-,[NR],ZNF804A,Schizophrenia,schizophrenia,GCST003048,2:184862626
rs62244881-<b>T</b>,3 x 10-7,,NR,1.09,'-,[NR],FOXP1,Schizophrenia,schizophrenia,GCST003048,3:71519926
rs62296447-<b>T</b>,6 x 10-6,,NR,1.0752687,'-,[NR],LINC02438,Schizophrenia,schizophrenia,GCST003048,4:19361370
rs62355986-<b>C</b>,2 x 10-6,,NR,1.06,'-,[NR],PIK3R1,Schizophrenia,schizophrenia,GCST003048,5:68360793
rs62378245-<b>C</b>,1 x 10-8,,NR,1.0752687,'-,[NR],MEF2C-AS1,Schizophrenia,schizophrenia,GCST003048,5:89448145
rs62392365-<b>A</b>,4 x 10-15,,NR,1.22,'-,[NR],"CMAHP, CARMIL1",Schizophrenia,schizophrenia,GCST003048,6:25371141
rs62402013-<b>G</b>,4 x 10-11,,NR,1.0752687,'-,[NR],GUSBP2,Schizophrenia,schizophrenia,GCST003048,6:26947221
rs62544595-<b>G</b>,6 x 10-6,,NR,1.1235955,'-,[NR],TEK,Schizophrenia,schizophrenia,GCST003048,9:27135720
rs72934570-<b>C</b>,7 x 10-13,,NR,1.1627907,'-,[NR],"LINC01416, LINC01415",Schizophrenia,schizophrenia,GCST003048,18:55865958
rs72963233-<b>C</b>,4 x 10-6,,NR,1.1235955,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,18:34349283
rs72975629-<b>C</b>,4 x 10-6,,NR,1.0869565,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:135767692
rs72986630-<b>T</b>,2 x 10-8,,NR,1.16,'-,[NR],ZNF823,Schizophrenia,schizophrenia,GCST003048,19:11738921
rs7303433-<b>G</b>,3 x 10-6,,NR,1.1111112,'-,[NR],SOX5,Schizophrenia,schizophrenia,GCST003048,12:23487545
rs73044404-<b>G</b>,5 x 10-6,,NR,1.0752687,'-,[NR],CACNA1C,Schizophrenia,schizophrenia,GCST003048,12:2026283
rs73060317-<b>T</b>,8 x 10-7,,NR,1.06,'-,[NR],SP4,Schizophrenia,schizophrenia,GCST003048,7:21480594
rs7314326-<b>A</b>,1 x 10-6,,NR,1.06,'-,[NR],SOX5,Schizophrenia,schizophrenia,GCST003048,12:23954663
rs73191547-<b>T</b>,4 x 10-8,,NR,1.0638298,'-,[NR],MSRA,Schizophrenia,schizophrenia,GCST003048,8:10175915
rs73201076-<b>C</b>,1 x 10-6,,NR,1.0869565,'-,[NR],IMMP2L,Schizophrenia,schizophrenia,GCST003048,7:111135343
rs73229090-<b>C</b>,2 x 10-8,,NR,1.098901,'-,[NR],GULOP,Schizophrenia,schizophrenia,GCST003048,8:27584610
rs73388146-<b>G</b>,7 x 10-9,,NR,1.1494253,'-,[NR],CMAHP,Schizophrenia,schizophrenia,GCST003048,6:25170440
rs73396800-<b>G</b>,4 x 10-16,,NR,1.1904762,'-,[NR],"HLA-DMA, HLA-DMB",Schizophrenia,schizophrenia,GCST003048,6:32946949
rs73405966-<b>T</b>,9 x 10-6,,NR,1.06,'-,[NR],CUX1,Schizophrenia,schizophrenia,GCST003048,7:102032019
rs7372960-<b>T</b>,7 x 10-8,,NR,1.07,'-,[NR],FOXP1,Schizophrenia,schizophrenia,GCST003048,3:71205600
rs7383287-<b>A</b>,1 x 10-7,,NR,1.07,'-,[NR],HLA-DOB,Schizophrenia,schizophrenia,GCST003048,6:32815309
rs7405404-<b>T</b>,1 x 10-10,,NR,1.08,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,16:13656002
rs74338693-<b>G</b>,7 x 10-6,,NR,1.0638298,'-,[NR],SCN1A-AS1,Schizophrenia,schizophrenia,GCST003048,2:165957215
rs74804370-<b>C</b>,2 x 10-7,,NR,1.1494253,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,8:34141053
rs75059851-<b>A</b>,7 x 10-12,,NR,1.1,'-,[NR],IGSF9B,Schizophrenia,schizophrenia,GCST003048,11:133952674
rs75080020-<b>T</b>,6 x 10-6,,NR,1.13,'-,[NR],EIF4E2P2,Schizophrenia,schizophrenia,GCST003048,3:115264809
rs7521492-<b>A</b>,4 x 10-7,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,1:163758686
rs7521837-<b>T</b>,9 x 10-6,,NR,1.06,'-,[NR],"HAX1, RNU6-239P",Schizophrenia,schizophrenia,GCST003048,1:154280384
rs7523273-<b>A</b>,4 x 10-7,,NR,1.06,'-,[NR],MIR29B2CHG,Schizophrenia,schizophrenia,GCST003048,1:207803738
rs7529073-<b>C</b>,6 x 10-7,,NR,1.0526316,'-,[NR],PROX1-AS1,Schizophrenia,schizophrenia,GCST003048,1:213974546
rs7531932-<b>A</b>,4 x 10-6,,NR,1.05,'-,[NR],NEGR1,Schizophrenia,schizophrenia,GCST003048,1:71668902
rs7537052-<b>G</b>,3 x 10-7,,NR,1.0638298,'-,[NR],TRAPPC3,Schizophrenia,schizophrenia,GCST003048,1:36151340
rs7539624-<b>A</b>,8 x 10-6,,NR,1.06,'-,[NR],CAPN2,Schizophrenia,schizophrenia,GCST003048,1:223719125
rs7551222-<b>A</b>,5 x 10-6,,NR,1.06,'-,[NR],LRRN2,Schizophrenia,schizophrenia,GCST003048,1:204630167
rs7551345-<b>A</b>,4 x 10-6,,NR,1.07,'-,[NR],ZCCHC17,Schizophrenia,schizophrenia,GCST003048,1:31359023
rs75575209-<b>T</b>,1 x 10-8,,NR,1.1111112,'-,[NR],VRK2,Schizophrenia,schizophrenia,GCST003048,2:57911057
rs75608493-<b>C</b>,3 x 10-7,,NR,1.09,'-,[NR],LINC01741,Schizophrenia,schizophrenia,GCST003048,1:177796886
rs7562618-<b>C</b>,5 x 10-7,,NR,1.0526316,'-,[NR],RNA5SP87,Schizophrenia,schizophrenia,GCST003048,2:22307927
rs7577463-<b>G</b>,5 x 10-7,,NR,1.0638298,'-,[NR],SPHKAP,Schizophrenia,schizophrenia,GCST003048,2:228130066
rs75968099-<b>T</b>,2 x 10-12,,NR,1.08,'-,[NR],"LINC02033, HSPD1P6",Schizophrenia,schizophrenia,GCST003048,3:36817092
rs7599488-<b>C</b>,6 x 10-7,,NR,1.0526316,'-,[NR],BCL11A,Schizophrenia,schizophrenia,GCST003048,2:60491212
rs7601312-<b>G</b>,4 x 10-8,,NR,1.0638298,'-,[NR],LINC01807,Schizophrenia,schizophrenia,GCST003048,2:228455377
rs76049629-<b>G</b>,3 x 10-6,,NR,1.0869565,'-,[NR],ATOH1,Schizophrenia,schizophrenia,GCST003048,4:93837884
rs7610761-<b>A</b>,5 x 10-6,,NR,1.05,'-,[NR],LPP,Schizophrenia,schizophrenia,GCST003048,3:188467141
rs7617937-<b>A</b>,7 x 10-6,,NR,1.05,'-,[NR],SATB1-AS1,Schizophrenia,schizophrenia,GCST003048,3:18846493
rs7619427-<b>G</b>,9 x 10-7,,NR,1.0869565,'-,[NR],RNU6-367P,Schizophrenia,schizophrenia,GCST003048,3:44035549
rs76329678-<b>A</b>,6 x 10-7,,NR,1.05,'-,[NR],EMB,Schizophrenia,schizophrenia,GCST003048,5:50534452
rs76355118-<b>G</b>,3 x 10-8,,NR,1.1627907,'-,[NR],EPC2,Schizophrenia,schizophrenia,GCST003048,2:148654436
rs76405237-<b>G</b>,4 x 10-6,,NR,1.1494253,'-,[NR],TMEM178B,Schizophrenia,schizophrenia,GCST003048,7:141271019
rs7641070-<b>G</b>,6 x 10-6,,NR,1.0526316,'-,[NR],PPP2R3A,Schizophrenia,schizophrenia,GCST003048,3:135979287
rs76432012-<b>T</b>,2 x 10-7,,NR,1.16,'-,[NR],LINC01877,Schizophrenia,schizophrenia,GCST003048,2:199712044
rs76456399-<b>A</b>,6 x 10-6,,NR,1.2,'-,[NR],"LINC01394, FOXF2-DT",Schizophrenia,schizophrenia,GCST003048,6:1371322
rs7648449-<b>C</b>,8 x 10-6,,NR,1.0752687,'-,[NR],FRMD4B,Schizophrenia,schizophrenia,GCST003048,3:69391700
rs76503615-<b>A</b>,8 x 10-6,,NR,1.11,'-,[NR],RN7SL18P,Schizophrenia,schizophrenia,GCST003048,2:62452374
rs76832595-<b>A</b>,2 x 10-6,,NR,1.08,'-,[NR],KLHL29,Schizophrenia,schizophrenia,GCST003048,2:23503849
rs6917512-<b>C</b>,2 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,6:40860546
rs6918586-<b>T</b>,6 x 10-10,,NR,1.07,'-,[NR],HFE,Schizophrenia,schizophrenia,GCST003048,6:26097156
rs6919939-<b>A</b>,7 x 10-6,,NR,1.05,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,6:164553981
rs6953837-<b>A</b>,7 x 10-6,,NR,1.06,'-,[NR],"INSIG1-DT, RN7SKP280",Schizophrenia,schizophrenia,GCST003048,7:155227220
rs6981717-<b>C</b>,9 x 10-6,,NR,1.0526316,'-,[NR],MMP16,Schizophrenia,schizophrenia,GCST003048,8:88176225
rs6984242-<b>G</b>,7 x 10-10,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,8:59787910
rs7002619-<b>T</b>,4 x 10-6,,NR,1.1,'-,[NR],MSR1,Schizophrenia,schizophrenia,GCST003048,8:16208048
rs7008026-<b>C</b>,6 x 10-6,,NR,1.0638298,'-,[NR],"PRDM14, SUMO2P20",Schizophrenia,schizophrenia,GCST003048,8:70038045
rs7020830-<b>T</b>,8 x 10-6,,NR,1.0526316,'-,[NR],EBLN3P,Schizophrenia,schizophrenia,GCST003048,9:37085187
rs7099380-<b>A</b>,1 x 10-6,,NR,1.05,'-,[NR],CACNB2,Schizophrenia,schizophrenia,GCST003048,10:18260087
rs710369-<b>C</b>,7 x 10-7,,NR,1.1363636,'-,[NR],LINC02144,Schizophrenia,schizophrenia,GCST003048,5:87799433
rs7122181-<b>T</b>,2 x 10-7,,NR,1.0526316,'-,[NR],MTND4LP18,Schizophrenia,schizophrenia,GCST003048,11:81491868
rs7127399-<b>G</b>,6 x 10-6,,NR,1.0526316,'-,[NR],"OR8Q1P, OR8A1",Schizophrenia,schizophrenia,GCST003048,11:124591378
rs71391092-<b>C</b>,8 x 10-6,,NR,1.07,'-,[NR],GLG1,Schizophrenia,schizophrenia,GCST003048,16:74533177
rs715170-<b>C</b>,1 x 10-8,,NR,1.0752687,'-,[NR],"LINC01539, LINC01905",Schizophrenia,schizophrenia,GCST003048,18:56128283
rs7194676-<b>C</b>,2 x 10-6,,NR,1.0638298,'-,[NR],ZCCHC14,Schizophrenia,schizophrenia,GCST003048,16:87456285
rs7266699-<b>C</b>,4 x 10-6,,NR,1.0638298,'-,[NR],PHACTR3,Schizophrenia,schizophrenia,GCST003048,20:59678383
rs7267348-<b>C</b>,5 x 10-8,,NR,1.0638298,'-,[NR],PTGIS,Schizophrenia,schizophrenia,GCST003048,20:49514499
rs72697068-<b>A</b>,8 x 10-6,,NR,1.11,'-,[NR],NPY1R,Schizophrenia,schizophrenia,GCST003048,4:163272521
rs72700829-<b>C</b>,3 x 10-8,,NR,1.1363636,'-,[NR],MCL1,Schizophrenia,schizophrenia,GCST003048,1:150567705
rs72749142-<b>G</b>,3 x 10-6,,NR,1.0752687,'-,[NR],KIF21B,Schizophrenia,schizophrenia,GCST003048,1:200982179
rs72793138-<b>A</b>,4 x 10-6,,NR,1.14,'-,[NR],PCDH15,Schizophrenia,schizophrenia,GCST003048,10:53721128
rs72882854-<b>A</b>,6 x 10-6,,NR,1.06,'-,[NR],"SCN1A-AS1, SCN9A",Schizophrenia,schizophrenia,GCST003048,2:166304860
rs72925918-<b>G</b>,7 x 10-6,,NR,1.0752687,'-,[NR],HNRNPA1P47,Schizophrenia,schizophrenia,GCST003048,2:194215175
rs72926932-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],TCF4,Schizophrenia,schizophrenia,GCST003048,18:55383415
rs76869799-<b>G</b>,1 x 10-7,,NR,1.1764705,'-,[NR],DPYD,Schizophrenia,schizophrenia,GCST003048,1:97368969
rs7688014-<b>C</b>,3 x 10-6,,NR,1.0526316,'-,[NR],SLC9B2,Schizophrenia,schizophrenia,GCST003048,4:103053903
rs76939711-<b>A</b>,3 x 10-6,,NR,1.2,'-,[NR],DNAJB8-AS1,Schizophrenia,schizophrenia,GCST003048,3:128468391
rs7712671-<b>G</b>,1 x 10-6,,NR,1.0526316,'-,[NR],RPL35AP15,Schizophrenia,schizophrenia,GCST003048,5:117201554
rs77149735-<b>A</b>,6 x 10-9,,NR,1.32,'-,[NR],SDCCAG8,Schizophrenia,schizophrenia,GCST003048,1:243391803
rs77221366-<b>C</b>,8 x 10-7,,NR,1.1627907,'-,[NR],SHISA9,Schizophrenia,schizophrenia,GCST003048,16:13018138
rs77421486-<b>C</b>,5 x 10-6,,NR,1.1235955,'-,[NR],RN7SKP60,Schizophrenia,schizophrenia,GCST003048,5:165690456
rs7742212-<b>A</b>,9 x 10-6,,NR,1.05,'-,[NR],PTPRK,Schizophrenia,schizophrenia,GCST003048,6:128007688
rs77502336-<b>C</b>,4 x 10-10,,NR,1.07,'-,[NR],GRAMD1B,Schizophrenia,schizophrenia,GCST003048,11:123523928
rs7779018-<b>A</b>,1 x 10-7,,NR,1.06,'-,[NR],"CADPS2, FEZF1",Schizophrenia,schizophrenia,GCST003048,7:122310911
rs778371-<b>G</b>,2 x 10-12,,NR,1.0869565,'-,[NR],SNORC,Schizophrenia,schizophrenia,GCST003048,2:232878399
rs77868089-<b>A</b>,3 x 10-6,,NR,1.19,'-,[NR],"AZU1P1, CDKN2AIPNLP3",Schizophrenia,schizophrenia,GCST003048,13:39822000
rs7786896-<b>T</b>,8 x 10-6,,NR,1.05,'-,[NR],POU6F2,Schizophrenia,schizophrenia,GCST003048,7:39054328
rs7801375-<b>G</b>,9 x 10-9,,NR,1.0869565,'-,[NR],CAPZA1P4,Schizophrenia,schizophrenia,GCST003048,7:131882504
rs78037194-<b>G</b>,3 x 10-6,,NR,1.0869565,'-,[NR],FMN2,Schizophrenia,schizophrenia,GCST003048,1:240059390
rs7811528-<b>G</b>,4 x 10-6,,NR,1.0752687,'-,[NR],TTYH3,Schizophrenia,schizophrenia,GCST003048,7:2663182
rs78177980-<b>G</b>,8 x 10-6,,NR,1.1235955,'-,[NR],CHD2,Schizophrenia,schizophrenia,GCST003048,15:92937233
rs7819570-<b>T</b>,2 x 10-8,,NR,1.08,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,8:88576397
rs78226650-<b>A</b>,8 x 10-6,,NR,1.13,'-,[NR],LINC01122,Schizophrenia,schizophrenia,GCST003048,2:58925919
rs783540-<b>G</b>,7 x 10-8,,NR,1.0638298,'-,[NR],CPEB1,Schizophrenia,schizophrenia,GCST003048,15:82585958
rs78381888-<b>A</b>,2 x 10-7,,NR,1.09,'-,[NR],"ANKRD23, CNNM3",Schizophrenia,schizophrenia,GCST003048,2:96835038
rs78392994-<b>T</b>,5 x 10-6,,NR,1.09,'-,[NR],FER,Schizophrenia,schizophrenia,GCST003048,5:108953202
rs7875611-<b>T</b>,6 x 10-6,,NR,1.05,'-,[NR],ALOX15P2,Schizophrenia,schizophrenia,GCST003048,9:92916727
rs78901727-<b>A</b>,9 x 10-6,,NR,1.11,'-,[NR],SEC61GP1,Schizophrenia,schizophrenia,GCST003048,2:193755470
rs7893279-<b>T</b>,6 x 10-11,,NR,1.12,'-,[NR],CACNB2,Schizophrenia,schizophrenia,GCST003048,10:18456176
rs1587409-<b>T</b>,2 x 10-7,,'-,'-,0.572 unit decrease,[NR],SLC30A8,Left superior temporal gyrus thickness (schizophrenia interaction),"schizophrenia, left superior temporal gyrus thickness measurement",GCST003069,8:117251493
rs1466921-<b>T</b>,9 x 10-7,,'-,'-,0.353 unit decrease,[NR],LINC01583,Left superior temporal gyrus thickness (schizophrenia interaction),"schizophrenia, left superior temporal gyrus thickness measurement",GCST003069,15:82092316
rs1973985-<b>A</b>,1 x 10-6,,'-,'-,0.443 unit decrease,[NR],"EFNB2, RPL35P9",Left superior temporal gyrus thickness (schizophrenia interaction),"schizophrenia, left superior temporal gyrus thickness measurement",GCST003069,13:106430556
rs2802493-<b>C</b>,2 x 10-6,,'-,'-,0.275 unit decrease,[NR],LINC00841,Left superior temporal gyrus thickness (schizophrenia interaction),"schizophrenia, left superior temporal gyrus thickness measurement",GCST003069,10:44058135
rs17338034-<b>A</b>,6 x 10-6,,'-,'-,0.351 unit increase,[NR],UNGP1,Left superior temporal gyrus thickness (schizophrenia interaction),"schizophrenia, left superior temporal gyrus thickness measurement",GCST003069,16:51323571
rs9359762-<b>T</b>,9 x 10-6,,'-,'-,0.265 unit decrease,[NR],RN7SL183P,Left superior temporal gyrus thickness (schizophrenia interaction),"schizophrenia, left superior temporal gyrus thickness measurement",GCST003069,6:87939728
rs10123671-<b>G</b>,8 x 10-6,,NR,1.3513513,'-,[NR],DMRT1,Schizophrenia,schizophrenia,GCST003050,9:29161220
rs114333818-<b>A</b>,7 x 10-6,,NR,1.3513513,'-,[NR],PLA2G4A,Schizophrenia,schizophrenia,GCST003050,1:186856584
rs11592657-<b>A</b>,7 x 10-6,,NR,1.27,'-,[NR],DOCK1,Schizophrenia,schizophrenia,GCST003050,10:126992179
rs13020137-<b>A</b>,5 x 10-6,,NR,1.26,'-,[NR],"RAB6C, ARHGAP42P2",Schizophrenia,schizophrenia,GCST003050,2:129999731
rs146641304-<b>AC</b>,9 x 10-6,,NR,1.5625,'-,[NR],"RUFY1, U4",Schizophrenia,schizophrenia,GCST003050,5:179493202
rs200610334-<b>AT</b>,8 x 10-6,,NR,1.34,'-,[NR],"MCHR1, SLC25A17",Schizophrenia,schizophrenia,GCST003050,22:40728162
rs2455601-<b>A</b>,7 x 10-6,,NR,1.34,'-,[NR],DENND2B,Schizophrenia,schizophrenia,GCST003050,11:8877853
rs3131888-<b>C</b>,7 x 10-6,,NR,1.2820514,'-,[NR],"ZFP57, ZDHHC20P1",Schizophrenia,schizophrenia,GCST003050,6:29696112
rs35553880-<b>T</b>,8 x 10-6,,NR,1.25,'-,[NR],LINC01378,Schizophrenia,schizophrenia,GCST003050,4:117723666
rs4129575-<b>A</b>,8 x 10-6,,NR,1.31,'-,[NR],HS3ST4,Schizophrenia,schizophrenia,GCST003050,16:26118462
rs4646312-<b>C</b>,8 x 10-6,,NR,1.25,'-,[NR],COMT,Schizophrenia,schizophrenia,GCST003050,22:19960814
rs61841072-<b>G</b>,7 x 10-6,,NR,1.3157895,'-,[NR],SEPTIN14P21,Schizophrenia,schizophrenia,GCST003050,1:242966101
rs75094680-<b>A</b>,7 x 10-6,,NR,3.5714285,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003050,5:30558030
rs10812882-<b>T</b>,1 x 10-6,,NR,1.3,'-,[NR],MIR873,Schizophrenia,schizophrenia,GCST003050,9:28891819
rs11211309-<b>A</b>,2 x 10-6,,NR,1.41,'-,[NR],MKNK1,Schizophrenia,schizophrenia,GCST003050,1:46579541
rs11345859-<b>A</b>,5 x 10-7,,NR,1.2987013,'-,[NR],KIT,Schizophrenia,schizophrenia,GCST003050,4:54669212
rs11864208-<b>C</b>,4 x 10-6,,NR,1.27,'-,[NR],"ADCY7, TENT4B",Schizophrenia,schizophrenia,GCST003050,16:50243303
rs12412942-<b>A</b>,8 x 10-7,,NR,1.2820514,'-,[NR],"LINC02645, LINC00701",Schizophrenia,schizophrenia,GCST003050,10:2315508
rs144759648-<b>A</b>,4 x 10-6,,NR,1.79,'-,[NR],"NOM1, LMBR1",Schizophrenia,schizophrenia,GCST003050,7:156943329
rs2144051-<b>G</b>,4 x 10-6,,NR,3.56,'-,[NR],LINC02304,Schizophrenia,schizophrenia,GCST003050,14:97078236
rs369019574-<b>A</b>,4 x 10-6,,NR,1.4925373,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003050,9:79271833
rs41297816-<b>G</b>,1 x 10-7,,NR,1.3513513,'-,[NR],TBX1,Schizophrenia,schizophrenia,GCST003050,22:19776455
rs4685495-<b>A</b>,3 x 10-6,,NR,1.29,'-,[NR],CNTN4,Schizophrenia,schizophrenia,GCST003050,3:2195173
rs55970365-<b>C</b>,4 x 10-6,,NR,1.923077,'-,[NR],LINC01370,Schizophrenia,schizophrenia,GCST003050,20:40096545
rs58880514-<b>A</b>,2 x 10-6,,NR,1.2987013,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003050,7:70939851
rs78944489-<b>C</b>,2 x 10-6,,NR,1.1111112,'-,[NR],"NOTO, RAB11FIP5",Schizophrenia,schizophrenia,GCST003048,2:73191915
rs7901794-<b>C</b>,7 x 10-6,,NR,1.1235955,'-,[NR],"NRBF2, RNU6-543P",Schizophrenia,schizophrenia,GCST003048,10:63118178
rs79090407-<b>A</b>,2 x 10-6,,NR,1.12,'-,[NR],LINC02195,Schizophrenia,schizophrenia,GCST003048,16:26505812
rs79169085-<b>C</b>,4 x 10-6,,NR,1.2195122,'-,[NR],SKAP1,Schizophrenia,schizophrenia,GCST003048,17:48220153
rs79193624-<b>T</b>,9 x 10-8,,NR,1.22,'-,[NR],RTKN2,Schizophrenia,schizophrenia,GCST003048,10:62240577
rs79212538-<b>T</b>,3 x 10-8,,NR,1.15,'-,[NR],LINC01470,Schizophrenia,schizophrenia,GCST003048,5:152613544
rs79258494-<b>A</b>,7 x 10-6,,NR,1.06,'-,[NR],SUMO2P2,Schizophrenia,schizophrenia,GCST003048,9:23576502
rs793571-<b>A</b>,2 x 10-6,,NR,1.06,'-,[NR],MINDY2,Schizophrenia,schizophrenia,GCST003048,15:58849507
rs7951870-<b>C</b>,4 x 10-11,,NR,1.098901,'-,[NR],DGKZ,Schizophrenia,schizophrenia,GCST003048,11:46351761
rs79844775-<b>C</b>,9 x 10-6,,NR,1.2048193,'-,[NR],"CRYGFP, MEAF6P1",Schizophrenia,schizophrenia,GCST003048,2:209176663
rs79947808-<b>G</b>,8 x 10-6,,NR,1.1363636,'-,[NR],"LEP, MIR129-1",Schizophrenia,schizophrenia,GCST003048,7:128227402
rs80021942-<b>C</b>,1 x 10-7,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:161738174
rs8012642-<b>C</b>,2 x 10-6,,NR,1.06,'-,[NR],MTCYBP27,Schizophrenia,schizophrenia,GCST003048,14:84203137
rs8016982-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],"GTF2A1, DYNLL1P1",Schizophrenia,schizophrenia,GCST003048,14:81240713
rs8025470-<b>A</b>,8 x 10-6,,NR,1.1,'-,[NR],TMCO5B,Schizophrenia,schizophrenia,GCST003048,15:33236067
rs80353807-<b>G</b>,4 x 10-6,,NR,1.0869565,'-,[NR],ZNF365,Schizophrenia,schizophrenia,GCST003048,10:62559780
rs8042374-<b>A</b>,1 x 10-12,,NR,1.09,'-,[NR],CHRNA3,Schizophrenia,schizophrenia,GCST003048,15:78615690
rs8044995-<b>A</b>,4 x 10-8,,NR,1.08,'-,[NR],NFATC3,Schizophrenia,schizophrenia,GCST003048,16:68155437
rs8054347-<b>A</b>,1 x 10-7,,NR,1.06,'-,[NR],RBFOX1,Schizophrenia,schizophrenia,GCST003048,16:6667756
rs8066384-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],RPTOR,Schizophrenia,schizophrenia,GCST003048,17:80651956
rs8067545-<b>C</b>,1 x 10-6,,NR,1.0526316,'-,[NR],SPECC1,Schizophrenia,schizophrenia,GCST003048,17:20009397
rs8082590-<b>G</b>,2 x 10-8,,NR,1.0638298,'-,[NR],GID4,Schizophrenia,schizophrenia,GCST003048,17:18055088
rs8099121-<b>A</b>,2 x 10-6,,NR,1.06,'-,[NR],PPIAP14,Schizophrenia,schizophrenia,GCST003048,18:4980409
rs8133932-<b>C</b>,3 x 10-6,,NR,1.0638298,'-,[NR],PCBP3,Schizophrenia,schizophrenia,GCST003048,21:45791171
rs832190-<b>C</b>,3 x 10-8,,NR,1.0638298,'-,[NR],THOC7,Schizophrenia,schizophrenia,GCST003048,3:63856953
rs79533578-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.5676763 unit increase,[0.33-0.81],RNF135,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,17:30998606
rs142996120-<b>?</b>,3 x 10-6,(MLM),NR,'-,0.702981 unit increase,[0.41-1],POMT2,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,14:77289119
rs2429928-<b>?</b>,4 x 10-6,(MLM),NR,'-,0.7148641 unit increase,[0.41-1.02],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,17:71726064
rs76131026-<b>G</b>,1 x 10-8,(GLM),NR,'-,10.692 unit decrease,[NR],"KCNIP1, LINC01366",Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,5:170352321
rs200868329-<b>AT</b>,3 x 10-6,(GLM),NR,'-,7.5455 unit decrease,[NR],CTNNA3,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,10:66162055
chr12:106657179-<b>A</b>,5 x 10-6,(GLM),NR,'-,7.002 unit decrease,[NR],'-,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,Mapping not available
rs191581512-<b>G</b>,6 x 10-8,(GLM),NR,'-,6.736 unit decrease,[NR],LINC00390,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,13:44105194
rs117325373-<b>G</b>,2 x 10-6,(GLM),NR,'-,6.3469 unit decrease,[NR],PIM3,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,22:49963977
rs115449435-<b>T</b>,7 x 10-6,(GLM),NR,'-,6.1478 unit decrease,[NR],EGFEM1P,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:168747556
rs113353280-<b>A</b>,8 x 10-6,(GLM),NR,'-,5.8417 unit decrease,[NR],USP24,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,1:55180186
rs76540759-<b>G</b>,9 x 10-6,(GLM),NR,'-,5.6127 unit decrease,[NR],ACTN4P1,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,4:116607403
rs146460178-<b>C</b>,7 x 10-6,(GLM),NR,'-,5.2383 unit decrease,[NR],ZNF326,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,1:90109901
rs76289741-<b>A</b>,8 x 10-6,(GLM),NR,'-,5.1717 unit decrease,[NR],EGFEM1P,Response to paliperidone in schizophrenia (positive Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004040,3:168633460
rs6545747-<b>?</b>,6 x 10-6,(MLM),NR,'-,0.1756764 unit increase,[0.1-0.251],RNA5SP94,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,2:59725711
rs7859245-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.1832648 unit decrease,[0.1-0.26],"PAEPP1, GLT6D1",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,9:135598751
rs10827221-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.1877251 unit decrease,[0.11-0.27],NRP1,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:33256536
rs2634458-<b>?</b>,7 x 10-6,(MLM),NR,'-,0.4892784 unit decrease,[0.28-0.7],PSD3,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:18600936
rs61857276-<b>?</b>,1 x 10-7,(MLM),NR,'-,0.7002314 unit increase,[0.44-0.96],ZWINT,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:56434080
rs61854820-<b>?</b>,6 x 10-8,(MLM),NR,'-,0.724535 unit increase,[0.46-0.99],ZWINT,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:56294881
rs77217161-<b>?</b>,9 x 10-7,(MLM),NR,'-,0.6896701 unit increase,[0.42-0.96],'-,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,10:56074184
rs923806-<b>?</b>,8 x 10-6,(MLM),NR,'-,0.6283593 unit increase,[0.35-0.9],"DKK3, LINC02547",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,11:12026851
rs78547569-<b>?</b>,5 x 10-6,(MLM),NR,'-,0.6972073 unit increase,[0.4-1],CCDC122,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,13:43866062
rs117752187-<b>G</b>,6 x 10-11,(GLM),NR,'-,7.9991 unit decrease,[NR],MIR100HG,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,11:122490175
rs76830538-<b>C</b>,2 x 10-8,(GLM),NR,'-,4.4144 unit decrease,[NR],TUSC3,Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:15615416
rs117019455-<b>G</b>,2 x 10-7,(GLM),NR,'-,4.0451 unit decrease,[NR],"TUSC3, PPM1AP1",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,8:15796634
rs75070487-<b>G</b>,2 x 10-7,(GLM),NR,'-,4.4176 unit decrease,[NR],"KCNIP1, KCNIP1-OT1",Response to paliperidone in schizophrenia (negative Marder score),"schizophrenia, response to paliperidone, schizophrenia symptom severity measurement",GCST004041,5:170389767
rs876983-<b>T</b>,9 x 10-8,,NR,1.06,'-,[NR],PSD3,Schizophrenia,schizophrenia,GCST003048,8:18550348
rs893949-<b>C</b>,5 x 10-7,,NR,1.0526316,'-,[NR],B3GAT1-DT,Schizophrenia,schizophrenia,GCST003048,11:134426490
rs9274623-<b>G</b>,6 x 10-19,,NR,1.1363636,'-,[NR],HLA-DQB1,Schizophrenia,schizophrenia,GCST003048,6:32668221
rs9293741-<b>A</b>,1 x 10-6,,NR,1.06,'-,[NR],"SCAMP1-AS1, Y_RNA",Schizophrenia,schizophrenia,GCST003048,5:78328190
rs9310732-<b>A</b>,3 x 10-6,,NR,1.05,'-,[NR],THRB,Schizophrenia,schizophrenia,GCST003048,3:24174066
rs9316337-<b>G</b>,2 x 10-6,,NR,1.0526316,'-,[NR],ZDHHC20,Schizophrenia,schizophrenia,GCST003048,13:21388068
rs9317639-<b>C</b>,5 x 10-6,,NR,1.098901,'-,[NR],PCDH9,Schizophrenia,schizophrenia,GCST003048,13:67112708
rs9330316-<b>A</b>,5 x 10-8,,NR,1.06,'-,[NR],"SH3RF3, SEPTIN10",Schizophrenia,schizophrenia,GCST003048,2:109526659
rs9341835-<b>C</b>,4 x 10-6,,NR,1.0526316,'-,[NR],"EEF1B2P5, LGSN",Schizophrenia,schizophrenia,GCST003048,6:63416275
rs9362395-<b>T</b>,7 x 10-7,,NR,1.12,'-,[NR],"RCN1P1, ZNF292",Schizophrenia,schizophrenia,GCST003048,6:87144623
rs9398171-<b>C</b>,4 x 10-8,,NR,1.0638298,'-,[NR],FOXO3,Schizophrenia,schizophrenia,GCST003048,6:108662324
rs9403484-<b>T</b>,6 x 10-6,,NR,1.06,'-,[NR],AIG1,Schizophrenia,schizophrenia,GCST003048,6:143330832
rs9420-<b>A</b>,2 x 10-8,,NR,1.06,'-,[NR],SELENOH,Schizophrenia,schizophrenia,GCST003048,11:57742822
rs9461856-<b>A</b>,4 x 10-12,,NR,1.08,'-,[NR],SYNGAP1,Schizophrenia,schizophrenia,GCST003048,6:33427422
rs950169-<b>C</b>,3 x 10-11,,NR,1.0869565,'-,[NR],ADAMTSL3,Schizophrenia,schizophrenia,GCST003048,15:84037709
rs9545047-<b>A</b>,3 x 10-6,,NR,1.05,'-,[NR],RBM26,Schizophrenia,schizophrenia,GCST003048,13:79285321
rs9554348-<b>T</b>,3 x 10-6,,NR,1.0752687,'-,[NR],HS6ST3,Schizophrenia,schizophrenia,GCST003048,13:96360101
rs956096-<b>A</b>,8 x 10-6,,NR,1.07,'-,[NR],RNU7-152P,Schizophrenia,schizophrenia,GCST003048,6:155683529
rs9584154-<b>A</b>,3 x 10-7,,NR,1.06,'-,[NR],GPC6,Schizophrenia,schizophrenia,GCST003048,13:93774100
rs9595066-<b>T</b>,4 x 10-6,,NR,1.07,'-,[NR],"LINC00390, SMIM2-AS1",Schizophrenia,schizophrenia,GCST003048,13:44132132
rs9607782-<b>A</b>,2 x 10-11,,NR,1.09,'-,[NR],EP300-AS1,Schizophrenia,schizophrenia,GCST003048,22:41191552
rs9607791-<b>A</b>,7 x 10-7,,NR,1.17,'-,[NR],"RANGAP1, ZC3H7B",Schizophrenia,schizophrenia,GCST003048,22:41298384
rs9611177-<b>C</b>,6 x 10-7,,NR,1.0638298,'-,[NR],"TAB1, MGAT3",Schizophrenia,schizophrenia,GCST003048,22:39444125
rs9631085-<b>A</b>,2 x 10-6,,NR,1.13,'-,[NR],ANKRD36,Schizophrenia,schizophrenia,GCST003048,2:97220558
rs9636107-<b>G</b>,1 x 10-12,,NR,1.0752687,'-,[NR],TCF4,Schizophrenia,schizophrenia,GCST003048,18:55532886
rs10262624-<b>C</b>,2 x 10-6,,NR,1.0526316,'-,[NR],STK31,Schizophrenia,schizophrenia,GCST003048,7:23876057
rs1033023-<b>A</b>,2 x 10-7,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,1:239045834
rs1033394-<b>C</b>,1 x 10-6,,NR,1.0638298,'-,[NR],HDAC2-AS2,Schizophrenia,schizophrenia,GCST003048,6:114392159
rs1040393-<b>C</b>,7 x 10-6,,NR,1.0638298,'-,[NR],"ILDR2, TADA1",Schizophrenia,schizophrenia,GCST003048,1:166892359
rs10425465-<b>T</b>,3 x 10-8,,NR,1.07,'-,[NR],PEPD,Schizophrenia,schizophrenia,GCST003048,19:33407028
rs1042992-<b>T</b>,2 x 10-7,,NR,1.07,'-,[NR],BNIP3L,Schizophrenia,schizophrenia,GCST003048,8:26411675
rs10446497-<b>G</b>,9 x 10-6,,NR,1.0526316,'-,[NR],PAK2,Schizophrenia,schizophrenia,GCST003048,3:196819658
rs10503253-<b>A</b>,1 x 10-8,,NR,1.07,'-,[NR],CSMD1,Schizophrenia,schizophrenia,GCST003048,8:4323322
rs10520163-<b>T</b>,1 x 10-8,,NR,1.06,'-,[NR],CLCN3,Schizophrenia,schizophrenia,GCST003048,4:169705401
rs10745841-<b>C</b>,1 x 10-6,,NR,1.05,'-,[NR],ANKS1B,Schizophrenia,schizophrenia,GCST003048,12:99099957
rs10777165-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],POC1B,Schizophrenia,schizophrenia,GCST003048,12:89447088
rs10783624-<b>C</b>,2 x 10-6,,NR,1.0526316,'-,[NR],LINC02406,Schizophrenia,schizophrenia,GCST003048,12:39129105
rs10788251-<b>C</b>,4 x 10-6,,NR,1.0869565,'-,[NR],TACC2,Schizophrenia,schizophrenia,GCST003048,10:122142449
rs10791097-<b>T</b>,2 x 10-12,,NR,1.08,'-,[NR],LINC02551,Schizophrenia,schizophrenia,GCST003048,11:130848735
rs10838634-<b>A</b>,5 x 10-8,,NR,1.1,'-,[NR],LRP4,Schizophrenia,schizophrenia,GCST003048,11:46908403
rs10849689-<b>A</b>,6 x 10-6,,NR,1.07,'-,[NR],C12orf76,Schizophrenia,schizophrenia,GCST003048,12:110055417
rs10853575-<b>T</b>,3 x 10-6,,NR,1.05,'-,[NR],"SMAD7, DYM",Schizophrenia,schizophrenia,GCST003048,18:49033349
rs10860964-<b>T</b>,9 x 10-8,,NR,1.06,'-,[NR],C12orf42,Schizophrenia,schizophrenia,GCST003048,12:103202677
rs10862476-<b>G</b>,8 x 10-6,,NR,1.0526316,'-,[NR],"RPL7P43, ZDHHC17",Schizophrenia,schizophrenia,GCST003048,12:76740025
rs1108252-<b>T</b>,3 x 10-7,,NR,1.08,'-,[NR],"EFHD1, GIGYF2",Schizophrenia,schizophrenia,GCST003048,2:232688857
rs11104379-<b>G</b>,5 x 10-7,,NR,1.0638298,'-,[NR],RPL23AP68,Schizophrenia,schizophrenia,GCST003048,12:87266212
rs111294930-<b>A</b>,4 x 10-9,,NR,1.09,'-,[NR],LINC01470,Schizophrenia,schizophrenia,GCST003048,5:152797561
rs11139497-<b>A</b>,2 x 10-9,,NR,1.07,'-,[NR],DDX10P2,Schizophrenia,schizophrenia,GCST003048,9:82125026
rs111547017-<b>A</b>,1 x 10-6,,NR,1.1,'-,[NR],"ZNF318, ABCC10",Schizophrenia,schizophrenia,GCST003048,6:43373951
rs11156875-<b>A</b>,3 x 10-7,,NR,1.07,'-,[NR],PRORP,Schizophrenia,schizophrenia,GCST003048,14:35150610
rs111803315-<b>G</b>,3 x 10-6,,NR,1.1111112,'-,[NR],JKAMP,Schizophrenia,schizophrenia,GCST003048,14:59498575
rs11191419-<b>T</b>,3 x 10-18,,NR,1.098901,'-,[NR],"BORCS7, PTGES3P4",Schizophrenia,schizophrenia,GCST003048,10:102852578
rs11215609-<b>T</b>,9 x 10-6,,NR,1.26,'-,[NR],"LINC02698, RPL12P46",Schizophrenia,schizophrenia,GCST003048,11:115593028
rs11231629-<b>C</b>,1 x 10-6,,NR,1.0526316,'-,[NR],MARK2,Schizophrenia,schizophrenia,GCST003048,11:63881101
rs112509803-<b>C</b>,7 x 10-7,,NR,1.09,'-,[NR],"GSDME, MPP6",Schizophrenia,schizophrenia,GCST003048,7:24695385
rs112537273-<b>T</b>,2 x 10-7,,NR,1.07,'-,[NR],LETM2,Schizophrenia,schizophrenia,GCST003048,8:38390788
rs112627313-<b>A</b>,4 x 10-6,,NR,1.07,'-,[NR],U3,Schizophrenia,schizophrenia,GCST003048,3:45288559
rs11264213-<b>A</b>,3 x 10-6,,NR,1.09,'-,[NR],AGO4,Schizophrenia,schizophrenia,GCST003048,1:35818353
rs112973353-<b>T</b>,1 x 10-8,,NR,1.11,'-,[NR],"ASPG, TDRD9",Schizophrenia,schizophrenia,GCST003048,14:104071343
rs113731670-<b>C</b>,2 x 10-6,,NR,1.1627907,'-,[NR],LINC02828,Schizophrenia,schizophrenia,GCST003048,6:24738159
rs114042773-<b>C</b>,9 x 10-7,,NR,1.1904762,'-,[NR],LINC02240,Schizophrenia,schizophrenia,GCST003048,5:125639572
rs10967586-<b>G</b>,5 x 10-7,,NR,1.0869565,'-,[NR],RN7SL100P,Schizophrenia,schizophrenia,GCST003048,9:26895810
rs11004008-<b>G</b>,2 x 10-6,,NR,1.0526316,'-,[NR],PCDH15,Schizophrenia,schizophrenia,GCST003048,10:54025428
rs11006253-<b>A</b>,2 x 10-6,,NR,1.06,'-,[NR],BICC1,Schizophrenia,schizophrenia,GCST003048,10:58759688
rs11039131-<b>C</b>,4 x 10-6,,NR,1.0526316,'-,[NR],"DDB2, PACSIN3",Schizophrenia,schizophrenia,GCST003048,11:47210487
rs11044946-<b>T</b>,8 x 10-6,,NR,1.1,'-,[NR],TCP1P3,Schizophrenia,schizophrenia,GCST003048,12:19928401
rs11063421-<b>T</b>,5 x 10-6,,NR,1.08,'-,[NR],"KCNA1, KCNA5",Schizophrenia,schizophrenia,GCST003048,12:4949227
rs11064837-<b>A</b>,7 x 10-6,,NR,1.06,'-,[NR],"TMEM233, CCDC60",Schizophrenia,schizophrenia,GCST003048,12:119579901
rs1106568-<b>G</b>,7 x 10-9,,NR,1.0752687,'-,[NR],GPM6A,Schizophrenia,schizophrenia,GCST003048,4:175940150
rs10878577-<b>A</b>,6 x 10-7,,NR,1.06,'-,[NR],"GGTA2P, RAB11AP2",Schizophrenia,schizophrenia,GCST003048,12:67200061
rs10883832-<b>T</b>,2 x 10-16,,NR,1.16,'-,[NR],NT5C2,Schizophrenia,schizophrenia,GCST003048,10:103111522
rs10890032-<b>T</b>,7 x 10-11,,NR,1.07,'-,[NR],LINC01360,Schizophrenia,schizophrenia,GCST003048,1:73323641
rs10891354-<b>C</b>,8 x 10-6,,NR,1.0526316,'-,[NR],"LINC02762, LINC02763",Schizophrenia,schizophrenia,GCST003048,11:112392780
rs10932194-<b>G</b>,4 x 10-6,,NR,1.0526316,'-,[NR],CREB1,Schizophrenia,schizophrenia,GCST003048,2:207465706
rs10967505-<b>A</b>,4 x 10-7,,NR,1.09,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,9:26737658
rs12432904-<b>G</b>,4 x 10-6,,NR,1.0526316,'-,[NR],"EIF5, HMGB3P26",Schizophrenia,schizophrenia,GCST003048,14:103345983
rs12446487-<b>C</b>,1 x 10-8,,NR,1.0869565,'-,[NR],"CNOT1, SLC38A7",Schizophrenia,schizophrenia,GCST003048,16:58637911
rs12447542-<b>A</b>,7 x 10-7,,NR,1.08,'-,[NR],RBFOX1,Schizophrenia,schizophrenia,GCST003048,16:7694178
rs12449000-<b>T</b>,5 x 10-6,,NR,1.05,'-,[NR],FANCA,Schizophrenia,schizophrenia,GCST003048,16:89806562
rs12474906-<b>A</b>,4 x 10-8,,NR,1.07,'-,[NR],"MRPL33, RBKS",Schizophrenia,schizophrenia,GCST003048,2:27810671
rs12478234-<b>A</b>,1 x 10-6,,NR,1.09,'-,[NR],ZNF385B,Schizophrenia,schizophrenia,GCST003048,2:179470242
rs12487279-<b>C</b>,8 x 10-6,,NR,1.11,'-,[NR],LINC02050,Schizophrenia,schizophrenia,GCST003048,3:80865258
rs12498839-<b>A</b>,2 x 10-6,,NR,1.11,'-,[NR],GPM6A,Schizophrenia,schizophrenia,GCST003048,4:175810250
rs12510251-<b>A</b>,1 x 10-7,,NR,1.07,'-,[NR],TENM3,Schizophrenia,schizophrenia,GCST003048,4:182693431
rs1251350-<b>C</b>,4 x 10-6,,NR,1.0526316,'-,[NR],"RN7SL825P, KIF5B",Schizophrenia,schizophrenia,GCST003048,10:32004006
rs12519062-<b>C</b>,5 x 10-6,,NR,1.0869565,'-,[NR],MIR583HG,Schizophrenia,schizophrenia,GCST003048,5:96170382
rs12522290-<b>C</b>,5 x 10-8,,NR,1.08,'-,[NR],GRIA1,Schizophrenia,schizophrenia,GCST003048,5:153418096
rs12540205-<b>C</b>,5 x 10-6,,NR,1.0526316,'-,[NR],ATXN7L1,Schizophrenia,schizophrenia,GCST003048,7:105670146
rs12541491-<b>T</b>,3 x 10-7,,NR,1.06,'-,[NR],MSRA,Schizophrenia,schizophrenia,GCST003048,8:10392538
rs12554020-<b>C</b>,6 x 10-6,,NR,1.07,'-,[NR],FAM120A,Schizophrenia,schizophrenia,GCST003048,9:93507955
rs12595305-<b>T</b>,4 x 10-6,,NR,1.05,'-,[NR],"MIR9-3HG, POLG-DT",Schizophrenia,schizophrenia,GCST003048,15:89356393
rs12652777-<b>T</b>,9 x 10-6,,NR,1.05,'-,[NR],SGCD,Schizophrenia,schizophrenia,GCST003048,5:156348065
rs12668848-<b>G</b>,1 x 10-13,,NR,1.0869565,'-,[NR],MAD1L1,Schizophrenia,schizophrenia,GCST003048,7:1981360
rs12681288-<b>A</b>,2 x 10-6,,NR,1.05,'-,[NR],DLGAP2,Schizophrenia,schizophrenia,GCST003048,8:1085152
rs12682527-<b>C</b>,5 x 10-6,,NR,1.0869565,'-,[NR],ASH2L,Schizophrenia,schizophrenia,GCST003048,8:21463493
rs12691307-<b>A</b>,2 x 10-10,,NR,1.07,'-,[NR],"TMEM219, KCTD13",Schizophrenia,schizophrenia,GCST003048,16:29928556
rs12693217-<b>G</b>,7 x 10-6,,NR,1.0752687,'-,[NR],CWC22,Schizophrenia,schizophrenia,GCST003048,2:179977187
rs12704290-<b>G</b>,7 x 10-11,,NR,1.1111112,'-,[NR],"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST003048,7:86798310
rs12723316-<b>G</b>,4 x 10-6,,NR,1.0752687,'-,[NR],LINC01725,Schizophrenia,schizophrenia,GCST003048,1:83848587
rs12755164-<b>A</b>,4 x 10-7,,NR,1.06,'-,[NR],"KRT8P21, RN7SKP19",Schizophrenia,schizophrenia,GCST003048,1:73170208
rs12823424-<b>A</b>,5 x 10-9,,NR,1.07,'-,[NR],CACNA1C,Schizophrenia,schizophrenia,GCST003048,12:2404946
rs12826178-<b>G</b>,1 x 10-11,,NR,1.1764705,'-,[NR],"NXPH4, SHMT2",Schizophrenia,schizophrenia,GCST003048,12:57228588
rs12877581-<b>C</b>,4 x 10-7,,NR,1.07,'-,[NR],KLF12,Schizophrenia,schizophrenia,GCST003048,13:73751362
rs12883788-<b>T</b>,3 x 10-7,,NR,1.06,'-,[NR],AKAP6,Schizophrenia,schizophrenia,GCST003048,14:32834334
rs12887386-<b>A</b>,7 x 10-6,,NR,1.1,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,14:85099583
rs12887734-<b>T</b>,2 x 10-13,,NR,1.09,'-,[NR],"KLC1, COA8",Schizophrenia,schizophrenia,GCST003048,14:103580497
rs12903146-<b>A</b>,4 x 10-10,,NR,1.07,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,15:61562464
rs12908161-<b>A</b>,5 x 10-10,,NR,1.08,'-,[NR],"SEC11A, NMB",Schizophrenia,schizophrenia,GCST003048,15:84664594
rs12914626-<b>C</b>,1 x 10-6,,NR,1.0526316,'-,[NR],"LIPC, ALDH1A2, LIPC-AS1",Schizophrenia,schizophrenia,GCST003048,15:58446224
rs12938078-<b>A</b>,2 x 10-6,,NR,1.07,'-,[NR],MSI2,Schizophrenia,schizophrenia,GCST003048,17:57665916
rs12991836-<b>C</b>,4 x 10-7,,NR,1.0526316,'-,[NR],ZEB2,Schizophrenia,schizophrenia,GCST003048,2:144383974
rs12997796-<b>A</b>,2 x 10-6,,NR,1.07,'-,[NR],RMND5A,Schizophrenia,schizophrenia,GCST003048,2:86747195
rs13004237-<b>G</b>,4 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,Mapping not available
rs13017997-<b>T</b>,4 x 10-6,,NR,1.0526316,'-,[NR],LINC01876,Schizophrenia,schizophrenia,GCST003048,2:155988248
rs13027106-<b>C</b>,3 x 10-7,,NR,1.0752687,'-,[NR],"PNPP1, TDRD15",Schizophrenia,schizophrenia,GCST003048,2:76228042
rs13096210-<b>C</b>,4 x 10-11,,NR,1.1363636,'-,[NR],FXR1,Schizophrenia,schizophrenia,GCST003048,3:180881530
rs13107325-<b>T</b>,2 x 10-12,,NR,1.16,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,Mapping not available
rs13110633-<b>C</b>,5 x 10-6,,NR,1.06,'-,[NR],"SLAIN2, SLC10A4",Schizophrenia,schizophrenia,GCST003048,4:48468279
rs13119516-<b>A</b>,5 x 10-6,,NR,1.07,'-,[NR],BANK1,Schizophrenia,schizophrenia,GCST003048,4:101920448
rs13168670-<b>T</b>,4 x 10-7,,NR,1.05,'-,[NR],"VTRNA1-3, PCDHA1",Schizophrenia,schizophrenia,GCST003048,5:140767314
rs13170232-<b>T</b>,5 x 10-8,,NR,1.098901,'-,[NR],GRIA1,Schizophrenia,schizophrenia,GCST003048,5:153519972
rs13176547-<b>T</b>,1 x 10-6,,NR,1.14,'-,[NR],RANBP3L,Schizophrenia,schizophrenia,GCST003048,5:36370194
rs13198474-<b>G</b>,3 x 10-20,,NR,1.2195122,'-,[NR],SLC17A3,Schizophrenia,schizophrenia,GCST003048,6:25874195
rs13217239-<b>T</b>,4 x 10-15,,NR,1.09,'-,[NR],POM121L2,Schizophrenia,schizophrenia,GCST003048,6:27287188
rs13217619-<b>T</b>,2 x 10-29,,NR,1.25,'-,[NR],ZSCAN31,Schizophrenia,schizophrenia,GCST003048,6:28338894
rs2205299-<b>T</b>,6 x 10-6,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,21:16834310
rs2219089-<b>T</b>,8 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,2:122473221
rs2237436-<b>C</b>,5 x 10-7,,NR,1.06,'-,[NR],INHBA,Schizophrenia,schizophrenia,GCST003048,7:41691333
rs2242194-<b>G</b>,2 x 10-6,,NR,1.0526316,'-,[NR],ZBTB7B,Schizophrenia,schizophrenia,GCST003048,1:155017821
rs2247419-<b>G</b>,6 x 10-7,,NR,1.0526316,'-,[NR],ADGRV1,Schizophrenia,schizophrenia,GCST003048,5:90859597
rs227932-<b>G</b>,9 x 10-7,,NR,1.0869565,'-,[NR],"TRA2A, CLK2P1",Schizophrenia,schizophrenia,GCST003048,7:23584856
rs2293052-<b>G</b>,7 x 10-7,,NR,1.0526316,'-,[NR],NOS1,Schizophrenia,schizophrenia,GCST003048,12:117277815
rs2298450-<b>C</b>,5 x 10-6,,NR,1.0526316,'-,[NR],DOP1B,Schizophrenia,schizophrenia,GCST003048,21:36251149
rs2306864-<b>G</b>,1 x 10-6,,NR,1.0869565,'-,[NR],DNAH1,Schizophrenia,schizophrenia,GCST003048,3:52359426
rs2332700-<b>C</b>,1 x 10-9,,NR,1.08,'-,[NR],RGS6,Schizophrenia,schizophrenia,GCST003048,14:71950609
rs2358740-<b>G</b>,5 x 10-7,,NR,1.0526316,'-,[NR],CACNA1D,Schizophrenia,schizophrenia,GCST003048,3:53421542
rs2381759-<b>T</b>,1 x 10-8,,NR,1.0869565,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,2:145670463
rs2391672-<b>A</b>,2 x 10-7,,NR,1.06,'-,[NR],LINC01761,Schizophrenia,schizophrenia,GCST003048,1:95456141
rs2413045-<b>A</b>,9 x 10-6,,NR,1.07,'-,[NR],LIMK2,Schizophrenia,schizophrenia,GCST003048,22:31269876
rs2429030-<b>T</b>,3 x 10-6,,NR,1.05,'-,[NR],KIFBP,Schizophrenia,schizophrenia,GCST003048,10:68991917
rs2470578-<b>G</b>,3 x 10-7,,NR,1.0526316,'-,[NR],TBC1D5,Schizophrenia,schizophrenia,GCST003048,3:17288600
rs2514218-<b>C</b>,2 x 10-10,,NR,1.0752687,'-,[NR],DRD2,Schizophrenia,schizophrenia,GCST003048,11:113522272
rs2535627-<b>T</b>,2 x 10-11,,NR,1.07,'-,[NR],"ITIH3, ITIH4",Schizophrenia,schizophrenia,GCST003048,3:52811089
rs2540277-<b>C</b>,7 x 10-6,,NR,1.098901,'-,[NR],TMEM182,Schizophrenia,schizophrenia,GCST003048,2:102809718
rs2565065-<b>A</b>,2 x 10-7,,NR,1.06,'-,[NR],CHRNA2,Schizophrenia,schizophrenia,GCST003048,8:27470504
rs2581794-<b>A</b>,3 x 10-7,,NR,1.06,'-,[NR],SFMBT1,Schizophrenia,schizophrenia,GCST003048,3:53002190
rs2596500-<b>A</b>,8 x 10-20,,NR,1.18,'-,[NR],"HLA-B, LINC02571",Schizophrenia,schizophrenia,GCST003048,6:31353490
rs2660304-<b>T</b>,1 x 10-17,,NR,1.12,'-,[NR],MIR137HG,Schizophrenia,schizophrenia,GCST003048,1:98046571
rs2693698-<b>G</b>,1 x 10-8,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,Mapping not available
rs270776-<b>G</b>,9 x 10-7,,NR,1.0638298,'-,[NR],LILRP2,Schizophrenia,schizophrenia,GCST003048,19:54711025
rs27419-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],MOCS2,Schizophrenia,schizophrenia,GCST003048,5:53125108
rs2796441-<b>G</b>,2 x 10-7,,NR,1.0638298,'-,[NR],"TLE1, RNU6-1035P",Schizophrenia,schizophrenia,GCST003048,9:81694033
rs2811474-<b>G</b>,9 x 10-6,,NR,1.0638298,'-,[NR],EEFSEC,Schizophrenia,schizophrenia,GCST003048,3:128174008
rs281768-<b>A</b>,2 x 10-14,,NR,1.11,'-,[NR],MAIP1,Schizophrenia,schizophrenia,GCST003048,2:199960517
rs2828478-<b>A</b>,4 x 10-7,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,21:23732894
rs28375034-<b>G</b>,9 x 10-7,,NR,1.0752687,'-,[NR],"EXOC4, ST13P7",Schizophrenia,schizophrenia,GCST003048,7:133201294
rs28587833-<b>G</b>,8 x 10-6,,NR,1.0638298,'-,[NR],"RPL32P31, NPTX1",Schizophrenia,schizophrenia,GCST003048,17:80537527
rs28669119-<b>G</b>,4 x 10-6,,NR,1.0752687,'-,[NR],MEF2C-AS1,Schizophrenia,schizophrenia,GCST003048,5:88909036
rs2868985-<b>A</b>,3 x 10-7,,NR,1.07,'-,[NR],MIR217HG,Schizophrenia,schizophrenia,GCST003048,2:55964335
rs28730912-<b>T</b>,5 x 10-8,,NR,1.07,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:162062168
rs2905426-<b>G</b>,5 x 10-9,,NR,1.0638298,'-,[NR],"MAU2, GATAD2A",Schizophrenia,schizophrenia,GCST003048,19:19367213
rs2905627-<b>T</b>,5 x 10-7,,NR,1.06,'-,[NR],CXXC4-AS1,Schizophrenia,schizophrenia,GCST003048,4:104528928
rs2909457-<b>G</b>,6 x 10-8,,NR,1.0638298,'-,[NR],"SLC4A10, DPP4",Schizophrenia,schizophrenia,GCST003048,2:161989345
rs2917569-<b>T</b>,4 x 10-7,,NR,1.06,'-,[NR],OPCML,Schizophrenia,schizophrenia,GCST003048,11:132698360
rs2929278-<b>C</b>,6 x 10-6,,NR,1.0638298,'-,[NR],FRMD5,Schizophrenia,schizophrenia,GCST003048,15:43958115
rs2945232-<b>C</b>,2 x 10-8,,NR,1.0638298,'-,[NR],"ALG1L13P, FAM86B3P",Schizophrenia,schizophrenia,GCST003048,8:8240516
rs2957613-<b>T</b>,5 x 10-6,,NR,1.09,'-,[NR],SCAPER,Schizophrenia,schizophrenia,GCST003048,15:76408248
rs2973155-<b>C</b>,1 x 10-9,,NR,1.0638298,'-,[NR],LINC01470,Schizophrenia,schizophrenia,GCST003048,5:153229059
rs2977125-<b>T</b>,4 x 10-6,,NR,1.0638298,'-,[NR],"TRMT9B, LINC00681",Schizophrenia,schizophrenia,GCST003048,8:12915747
rs2977993-<b>A</b>,2 x 10-6,,NR,1.06,'-,[NR],KYAT1,Schizophrenia,schizophrenia,GCST003048,9:128846507
rs3001723-<b>A</b>,3 x 10-9,,NR,1.07,'-,[NR],PTPRF,Schizophrenia,schizophrenia,GCST003048,1:43572014
rs301797-<b>A</b>,5 x 10-9,,NR,1.07,'-,[NR],"RERE-AS1, RERE",Schizophrenia,schizophrenia,GCST003048,1:8427263
rs302010-<b>G</b>,2 x 10-6,,NR,1.0638298,'-,[NR],ATXN8OS,Schizophrenia,schizophrenia,GCST003048,13:70145330
rs3132565-<b>A</b>,1 x 10-9,,NR,1.07,'-,[NR],PSORS1C1,Schizophrenia,schizophrenia,GCST003048,6:31135187
rs314272-<b>G</b>,1 x 10-6,,NR,1.0526316,'-,[NR],LIN28B,Schizophrenia,schizophrenia,GCST003048,6:105014129
rs114200269-<b>T</b>,2 x 10-19,,NR,1.23,'-,[NR],"MICC, UBQLN1P1",Schizophrenia,schizophrenia,GCST003048,6:30368886
rs1144403-<b>A</b>,8 x 10-6,,NR,1.05,'-,[NR],CASP12,Schizophrenia,schizophrenia,GCST003048,11:104807143
rs114473235-<b>A</b>,8 x 10-7,,NR,1.07,'-,[NR],"TSBP1-AS1, TSBP1",Schizophrenia,schizophrenia,GCST003048,6:32317765
rs114540395-<b>T</b>,1 x 10-6,,NR,1.1,'-,[NR],"FGF8, FBXW4",Schizophrenia,schizophrenia,GCST003048,10:101719305
rs114726755-<b>T</b>,3 x 10-6,,NR,1.1627907,'-,[NR],CRB1,Schizophrenia,schizophrenia,GCST003048,1:197324293
rs11597473-<b>G</b>,1 x 10-6,,NR,1.0638298,'-,[NR],NEURL1,Schizophrenia,schizophrenia,GCST003048,10:103559284
rs11599218-<b>G</b>,4 x 10-6,,NR,1.0638298,'-,[NR],CFAP58,Schizophrenia,schizophrenia,GCST003048,10:104445317
rs11603151-<b>A</b>,7 x 10-6,,NR,1.05,'-,[NR],LINC02706,Schizophrenia,schizophrenia,GCST003048,11:134654555
rs11616416-<b>A</b>,7 x 10-6,,NR,1.06,'-,[NR],MTUS2,Schizophrenia,schizophrenia,GCST003048,13:29262114
rs11617058-<b>T</b>,1 x 10-6,,NR,1.07,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,13:84718977
rs11625793-<b>G</b>,5 x 10-7,,NR,1.0526316,'-,[NR],NCOA4P1,Schizophrenia,schizophrenia,GCST003048,14:65849165
rs11680328-<b>T</b>,1 x 10-6,,NR,1.0752687,'-,[NR],"KCNS3, MSGN1",Schizophrenia,schizophrenia,GCST003048,2:17856540
rs11682175-<b>C</b>,1 x 10-12,,NR,1.0752687,'-,[NR],ACTG1P22,Schizophrenia,schizophrenia,GCST003048,2:57760458
rs11685299-<b>C</b>,4 x 10-8,,NR,1.0638298,'-,[NR],CUL3,Schizophrenia,schizophrenia,GCST003048,2:224526579
rs11690935-<b>G</b>,6 x 10-6,,NR,1.0526316,'-,[NR],"RPL21P38, DYNC1I2",Schizophrenia,schizophrenia,GCST003048,2:171676795
rs11693094-<b>C</b>,4 x 10-12,,NR,1.0752687,'-,[NR],ZNF804A,Schizophrenia,schizophrenia,GCST003048,2:184736693
rs117074560-<b>C</b>,5 x 10-9,,NR,1.1764705,'-,[NR],"FUT9, KRT18P50",Schizophrenia,schizophrenia,GCST003048,6:96011775
rs11712112-<b>A</b>,4 x 10-6,,NR,1.08,'-,[NR],MGLL,Schizophrenia,schizophrenia,GCST003048,3:128023522
rs11717383-<b>G</b>,3 x 10-9,,NR,1.0638298,'-,[NR],"PPM1M, WDR82",Schizophrenia,schizophrenia,GCST003048,3:52253452
rs11730701-<b>G</b>,1 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,4:24130930
rs117358016-<b>A</b>,8 x 10-6,,NR,1.16,'-,[NR],HS6ST3,Schizophrenia,schizophrenia,GCST003048,13:96514229
rs11740474-<b>T</b>,5 x 10-8,,NR,1.0638298,'-,[NR],GALNT10,Schizophrenia,schizophrenia,GCST003048,5:154301187
rs117488988-<b>A</b>,5 x 10-6,,NR,1.08,'-,[NR],KRT18P50,Schizophrenia,schizophrenia,GCST003048,6:95898699
rs117509195-<b>G</b>,5 x 10-6,,NR,1.1764705,'-,[NR],LINC00301,Schizophrenia,schizophrenia,GCST003048,11:60619545
rs117578877-<b>T</b>,9 x 10-7,,NR,1.15,'-,[NR],GRIN2B,Schizophrenia,schizophrenia,GCST003048,12:13528544
rs144223816-<b>G</b>,5 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,5:45835157
rs144373461-<b>C</b>,6 x 10-16,,NR,1.1494253,'-,[NR],"HLA-V, IFITM4P",Schizophrenia,schizophrenia,GCST003048,6:29783228
rs144447022-<b>G</b>,2 x 10-28,,NR,1.25,'-,[NR],"OR2U2P, OR14J1",Schizophrenia,schizophrenia,GCST003048,6:29276442
rs144960271-<b>T</b>,1 x 10-6,,NR,1.14,'-,[NR],"RBX1, Y_RNA",Schizophrenia,schizophrenia,GCST003048,22:40993781
rs1451488-<b>G</b>,6 x 10-8,,NR,1.0638298,'-,[NR],RNU7-147P,Schizophrenia,schizophrenia,GCST003048,2:199125384
rs146797905-<b>A</b>,4 x 10-7,,NR,1.15,'-,[NR],NTRK3,Schizophrenia,schizophrenia,GCST003048,15:88215343
rs147897924-<b>C</b>,2 x 10-6,,NR,1.0638298,'-,[NR],LINC02264,Schizophrenia,schizophrenia,GCST003048,4:117923644
rs148114321-<b>T</b>,9 x 10-6,,NR,1.2,'-,[NR],RALGAPA1,Schizophrenia,schizophrenia,GCST003048,14:35744236
rs1482292-<b>C</b>,2 x 10-6,,NR,1.0869565,'-,[NR],TMEM132D,Schizophrenia,schizophrenia,GCST003048,12:129333701
rs1483242-<b>G</b>,7 x 10-8,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,2:185179900
rs149110600-<b>A</b>,6 x 10-6,,NR,1.11,'-,[NR],CIR1,Schizophrenia,schizophrenia,GCST003048,2:174376730
rs1498232-<b>T</b>,7 x 10-10,,NR,1.07,'-,[NR],LINC01648,Schizophrenia,schizophrenia,GCST003048,1:29961104
rs1499972-<b>C</b>,3 x 10-6,,NR,1.0869565,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:118000691
rs1501357-<b>C</b>,1 x 10-8,,NR,1.0752687,'-,[NR],HCN1,Schizophrenia,schizophrenia,GCST003048,5:45364773
rs1506297-<b>T</b>,7 x 10-7,,NR,1.06,'-,[NR],RBMS3,Schizophrenia,schizophrenia,GCST003048,3:30030816
rs1509378-<b>A</b>,2 x 10-7,,NR,1.06,'-,[NR],LINC01884,Schizophrenia,schizophrenia,GCST003048,2:22531594
rs1516570-<b>A</b>,5 x 10-6,,NR,1.06,'-,[NR],GRM7,Schizophrenia,schizophrenia,GCST003048,3:6963334
rs1521470-<b>A</b>,9 x 10-6,,NR,1.07,'-,[NR],ADCY1,Schizophrenia,schizophrenia,GCST003048,7:45607253
rs1524480-<b>G</b>,2 x 10-6,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,2:5322854
rs1546044-<b>A</b>,5 x 10-6,,NR,1.05,'-,[NR],NR3C2,Schizophrenia,schizophrenia,GCST003048,4:148411792
rs1561296-<b>T</b>,5 x 10-6,,NR,1.05,'-,[NR],SPATS2L,Schizophrenia,schizophrenia,GCST003048,2:200443394
rs1565411-<b>G</b>,9 x 10-6,,NR,1.0752687,'-,[NR],"LINC02710, FBLIM1P2",Schizophrenia,schizophrenia,GCST003048,11:46207098
rs1682361-<b>G</b>,8 x 10-7,,NR,1.0526316,'-,[NR],IL20RB,Schizophrenia,schizophrenia,GCST003048,3:137015172
rs16831047-<b>A</b>,4 x 10-6,,NR,1.07,'-,[NR],RNU7-147P,Schizophrenia,schizophrenia,GCST003048,2:199145752
rs16863064-<b>G</b>,9 x 10-6,,NR,1.0638298,'-,[NR],LPP,Schizophrenia,schizophrenia,GCST003048,3:188169789
rs13217797-<b>T</b>,6 x 10-6,,NR,1.06,'-,[NR],CARMIL1,Schizophrenia,schizophrenia,GCST003048,6:25485786
rs13233308-<b>C</b>,3 x 10-7,,NR,1.0526316,'-,[NR],ABCB1,Schizophrenia,schizophrenia,GCST003048,7:87615644
rs13240464-<b>T</b>,3 x 10-13,,NR,1.08,'-,[NR],IMMP2L,Schizophrenia,schizophrenia,GCST003048,7:111258859
rs13247936-<b>G</b>,1 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,7:8921233
rs13276960-<b>G</b>,5 x 10-6,,NR,1.0638298,'-,[NR],MAILR,Schizophrenia,schizophrenia,GCST003048,8:102895776
rs1329313-<b>T</b>,3 x 10-7,,NR,1.06,'-,[NR],LINC00457,Schizophrenia,schizophrenia,GCST003048,13:34619885
rs13301469-<b>C</b>,8 x 10-7,,NR,1.08,'-,[NR],GLIS3,Schizophrenia,schizophrenia,GCST003048,9:3911353
rs133047-<b>T</b>,7 x 10-10,,NR,1.12,'-,[NR],MRTFA,Schizophrenia,schizophrenia,GCST003048,22:40631815
rs1335882-<b>T</b>,4 x 10-6,,NR,1.0526316,'-,[NR],SPATA2P1,Schizophrenia,schizophrenia,GCST003048,13:56258138
rs13358908-<b>C</b>,5 x 10-7,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,5:46349602
rs13376709-<b>C</b>,6 x 10-8,,NR,1.0638298,'-,[NR],AKT3,Schizophrenia,schizophrenia,GCST003048,1:243527189
rs1339227-<b>C</b>,2 x 10-7,,NR,1.0638298,'-,[NR],RIMS1,Schizophrenia,schizophrenia,GCST003048,6:72445999
rs13424309-<b>T</b>,6 x 10-6,,NR,1.05,'-,[NR],PCGEM1,Schizophrenia,schizophrenia,GCST003048,2:192861321
rs1351356-<b>T</b>,4 x 10-6,,NR,1.06,'-,[NR],MED30,Schizophrenia,schizophrenia,GCST003048,8:117587883
rs1353545-<b>C</b>,5 x 10-8,,NR,1.06,'-,[NR],FHIT,Schizophrenia,schizophrenia,GCST003048,3:60302116
rs1360695-<b>A</b>,3 x 10-7,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,9:119786808
rs1367858-<b>T</b>,3 x 10-8,,NR,1.06,'-,[NR],SPATS2L,Schizophrenia,schizophrenia,GCST003048,2:200296048
rs1389724-<b>T</b>,4 x 10-6,,NR,1.05,'-,[NR],"NRBF2P3, Y_RNA",Schizophrenia,schizophrenia,GCST003048,1:110814219
rs139283246-<b>G</b>,9 x 10-6,,NR,1.0638298,'-,[NR],"NDUFS5P2, RPL7P9",Schizophrenia,schizophrenia,GCST003048,1:96655051
rs140130327-<b>T</b>,8 x 10-7,,NR,1.27,'-,[NR],Y_RNA,Schizophrenia,schizophrenia,GCST003048,3:191623790
rs140505938-<b>C</b>,4 x 10-10,,NR,1.098901,'-,[NR],"OTUD7B, VPS45",Schizophrenia,schizophrenia,GCST003048,1:150059494
rs141216273-<b>A</b>,5 x 10-6,,NR,1.14,'-,[NR],"ARNILA, DTNB",Schizophrenia,schizophrenia,GCST003048,2:25376303
rs141308780-<b>G</b>,3 x 10-6,,NR,1.2987013,'-,[NR],SH3GL3,Schizophrenia,schizophrenia,GCST003048,15:83591790
rs142089946-<b>G</b>,5 x 10-7,,NR,1.1363636,'-,[NR],ZSWIM6,Schizophrenia,schizophrenia,GCST003048,5:61495766
rs142453246-<b>T</b>,9 x 10-6,,NR,1.25,'-,[NR],SHC4,Schizophrenia,schizophrenia,GCST003048,15:48862521
rs3770752-<b>A</b>,3 x 10-6,,NR,1.05,'-,[NR],QPCT,Schizophrenia,schizophrenia,GCST003048,2:37348993
rs3788567-<b>T</b>,2 x 10-11,,NR,1.08,'-,[NR],CACNA1I,Schizophrenia,schizophrenia,GCST003048,22:39610030
rs3798869-<b>G</b>,9 x 10-10,,NR,1.0638298,'-,[NR],SNAP91,Schizophrenia,schizophrenia,GCST003048,6:83618941
rs3812831-<b>C</b>,1 x 10-6,,NR,1.0526316,'-,[NR],"RASA3, CFAP97D2",Schizophrenia,schizophrenia,GCST003048,13:114134675
rs3818802-<b>A</b>,2 x 10-7,,NR,1.06,'-,[NR],SDCCAG8,Schizophrenia,schizophrenia,GCST003048,1:243286579
rs3849046-<b>T</b>,6 x 10-9,,NR,1.06,'-,[NR],ETF1,Schizophrenia,schizophrenia,GCST003048,5:138515503
rs385492-<b>T</b>,1 x 10-8,,NR,1.06,'-,[NR],"ZFP57, ZDHHC20P1",Schizophrenia,schizophrenia,GCST003048,6:29681770
rs3856261-<b>G</b>,3 x 10-6,,NR,1.0526316,'-,[NR],RIT1,Schizophrenia,schizophrenia,GCST003048,1:155906822
rs4084594-<b>T</b>,4 x 10-6,,NR,1.05,'-,[NR],NT5ELP,Schizophrenia,schizophrenia,GCST003048,5:64418618
rs41266839-<b>G</b>,7 x 10-27,,NR,1.25,'-,[NR],BTN3A1,Schizophrenia,schizophrenia,GCST003048,6:26409662
rs41268902-<b>A</b>,5 x 10-6,,NR,1.09,'-,[NR],TNXB,Schizophrenia,schizophrenia,GCST003048,6:32103231
rs4129585-<b>A</b>,8 x 10-14,,NR,1.08,'-,[NR],TSNARE1,Schizophrenia,schizophrenia,GCST003048,8:142231572
rs41314284-<b>T</b>,2 x 10-6,,NR,1.09,'-,[NR],STUM,Schizophrenia,schizophrenia,GCST003048,1:226602300
rs4240624-<b>G</b>,8 x 10-6,,NR,1.0869565,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,Mapping not available
rs4240748-<b>G</b>,2 x 10-7,,NR,1.0638298,'-,[NR],LINC02404,Schizophrenia,schizophrenia,GCST003048,12:91853010
rs4246774-<b>C</b>,9 x 10-6,,NR,1.2345679,'-,[NR],LINC02219,Schizophrenia,schizophrenia,GCST003048,5:68196284
rs427230-<b>T</b>,4 x 10-8,,NR,1.12,'-,[NR],"PPDPF, PTK6",Schizophrenia,schizophrenia,GCST003048,20:63523758
rs4273100-<b>T</b>,5 x 10-7,,NR,1.1,'-,[NR],EPN2,Schizophrenia,schizophrenia,GCST003048,17:19250104
rs4330281-<b>C</b>,3 x 10-8,,NR,1.0638298,'-,[NR],TBC1D5,Schizophrenia,schizophrenia,GCST003048,3:17817874
rs4388249-<b>T</b>,2 x 10-7,,NR,1.07,'-,[NR],MAN2A1,Schizophrenia,schizophrenia,GCST003048,5:109700365
rs4391122-<b>G</b>,2 x 10-13,,NR,1.0869565,'-,[NR],LINC02057,Schizophrenia,schizophrenia,GCST003048,5:61302716
rs4459386-<b>A</b>,5 x 10-6,,NR,1.05,'-,[NR],LIMA1,Schizophrenia,schizophrenia,GCST003048,12:50201164
rs4470825-<b>G</b>,3 x 10-7,,NR,1.0526316,'-,[NR],DOP1A,Schizophrenia,schizophrenia,GCST003048,6:83080079
rs4523957-<b>T</b>,1 x 10-9,,NR,1.07,'-,[NR],SRR,Schizophrenia,schizophrenia,GCST003048,17:2305605
rs4626214-<b>G</b>,7 x 10-7,,NR,1.0526316,'-,[NR],LINC02267,Schizophrenia,schizophrenia,GCST003048,4:96805918
rs324017-<b>C</b>,3 x 10-7,,NR,1.0638298,'-,[NR],NAB2,Schizophrenia,schizophrenia,GCST003048,12:57094031
rs337718-<b>T</b>,4 x 10-6,,NR,1.05,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,18:72107043
rs34102591-<b>G</b>,3 x 10-7,,NR,1.0752687,'-,[NR],"ZNF664, RFLNA",Schizophrenia,schizophrenia,GCST003048,12:123996254
rs34232444-<b>T</b>,9 x 10-6,,NR,1.05,'-,[NR],"KDM4B, UHRF1",Schizophrenia,schizophrenia,GCST003048,19:4965393
rs34411452-<b>T</b>,4 x 10-6,,NR,1.06,'-,[NR],"UBLCP1, LINC01932",Schizophrenia,schizophrenia,GCST003048,5:159261655
rs34626435-<b>A</b>,9 x 10-8,,NR,1.1,'-,[NR],NLGN1,Schizophrenia,schizophrenia,GCST003048,3:173786357
rs34706883-<b>A</b>,5 x 10-27,,NR,1.24,'-,[NR],"H2BC15, H4C12",Schizophrenia,schizophrenia,GCST003048,6:27837477
rs34753377-<b>T</b>,9 x 10-8,,NR,1.07,'-,[NR],SPG7,Schizophrenia,schizophrenia,GCST003048,16:89543010
rs34777351-<b>C</b>,4 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,18:25526259
rs35058679-<b>T</b>,2 x 10-6,,NR,1.06,'-,[NR],"CLDN10, CLDN10-AS1",Schizophrenia,schizophrenia,GCST003048,13:95493125
rs35094601-<b>G</b>,7 x 10-6,,NR,1.0526316,'-,[NR],"RNF14P1, SPOPL",Schizophrenia,schizophrenia,GCST003048,2:138454920
rs35123781-<b>G</b>,4 x 10-6,,NR,1.0526316,'-,[NR],"RNU6-236P, CXXC5",Schizophrenia,schizophrenia,GCST003048,5:139685595
rs35245641-<b>C</b>,2 x 10-6,,NR,1.0869565,'-,[NR],MIRLET7BHG,Schizophrenia,schizophrenia,GCST003048,22:46077965
rs35261864-<b>C</b>,6 x 10-6,,NR,1.0526316,'-,[NR],ROBO2,Schizophrenia,schizophrenia,GCST003048,3:76220735
rs354225-<b>G</b>,3 x 10-6,,NR,1.0526316,'-,[NR],"EML6, SPTBN1",Schizophrenia,schizophrenia,GCST003048,2:54696629
rs35659386-<b>A</b>,9 x 10-6,,NR,1.07,'-,[NR],NTM,Schizophrenia,schizophrenia,GCST003048,11:131430474
rs35662245-<b>A</b>,1 x 10-6,,NR,1.06,'-,[NR],LINC01911,Schizophrenia,schizophrenia,GCST003048,2:146825619
rs35998080-<b>T</b>,8 x 10-11,,NR,1.07,'-,[NR],LINC02797,Schizophrenia,schizophrenia,GCST003048,1:72812932
rs36059107-<b>A</b>,7 x 10-6,,NR,1.06,'-,[NR],NPAS3,Schizophrenia,schizophrenia,GCST003048,14:33768747
rs36104021-<b>C</b>,6 x 10-6,,NR,1.08,'-,[NR],ASCL1,Schizophrenia,schizophrenia,GCST003048,12:102967334
rs36109662-<b>G</b>,4 x 10-6,,NR,1.0869565,'-,[NR],LHFPL3,Schizophrenia,schizophrenia,GCST003048,7:104443254
rs367543-<b>T</b>,8 x 10-6,,NR,1.05,'-,[NR],PPP1R3B,Schizophrenia,schizophrenia,GCST003048,8:9176638
rs3735025-<b>T</b>,2 x 10-9,,NR,1.07,'-,[NR],DGKI,Schizophrenia,schizophrenia,GCST003048,7:137390098
rs3756766-<b>A</b>,2 x 10-8,,NR,1.07,'-,[NR],"FAM53C, CDC25C",Schizophrenia,schizophrenia,GCST003048,5:138337478
rs3768644-<b>G</b>,1 x 10-7,,NR,1.098901,'-,[NR],CYP26B1,Schizophrenia,schizophrenia,GCST003048,2:72134376
rs12738007-<b>?</b>,2 x 10-6,,0.056,1.9,'-,[1.44-2.46],MECR,Schizophrenia,schizophrenia,GCST003190,1:29195193
rs9650682-<b>G</b>,9 x 10-6,,NR,1.0638298,'-,[NR],SNAPC3,Schizophrenia,schizophrenia,GCST003048,9:15457779
rs9665626-<b>G</b>,5 x 10-9,,NR,1.1111112,'-,[NR],SUFU,Schizophrenia,schizophrenia,GCST003048,10:102540881
rs9677260-<b>T</b>,9 x 10-7,,NR,1.07,'-,[NR],HECW2,Schizophrenia,schizophrenia,GCST003048,2:196463011
rs9695226-<b>G</b>,4 x 10-7,,NR,1.0638298,'-,[NR],LINC01239,Schizophrenia,schizophrenia,GCST003048,9:22759397
rs975752-<b>A</b>,5 x 10-6,,NR,1.09,'-,[NR],"ERLIN1, SPCS2P2",Schizophrenia,schizophrenia,GCST003048,10:100146576
rs9789483-<b>A</b>,1 x 10-6,,NR,1.05,'-,[NR],"EIF3FP3, LINC01795",Schizophrenia,schizophrenia,GCST003048,2:58265210
rs9841616-<b>T</b>,3 x 10-8,,NR,1.0869565,'-,[NR],SOX2-OT,Schizophrenia,schizophrenia,GCST003048,3:181449797
rs9879311-<b>T</b>,5 x 10-6,,NR,1.05,'-,[NR],ATP2B2,Schizophrenia,schizophrenia,GCST003048,3:10373659
rs9881798-<b>C</b>,7 x 10-6,,NR,1.0526316,'-,[NR],PLCL2,Schizophrenia,schizophrenia,GCST003048,3:16805459
rs9883949-<b>C</b>,9 x 10-6,,NR,1.0869565,'-,[NR],"ZBTB20, ZBTB20-AS5",Schizophrenia,schizophrenia,GCST003048,3:114452543
rs989197-<b>T</b>,7 x 10-6,,NR,1.05,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:162197124
rs9908102-<b>T</b>,2 x 10-6,,NR,1.05,'-,[NR],ELAC2,Schizophrenia,schizophrenia,GCST003048,17:12993236
rs9908552-<b>T</b>,3 x 10-6,,NR,1.05,'-,[NR],YWHAE,Schizophrenia,schizophrenia,GCST003048,17:1394697
rs9922678-<b>A</b>,2 x 10-9,,NR,1.07,'-,[NR],GRIN2A,Schizophrenia,schizophrenia,GCST003048,16:9852462
rs9924758-<b>C</b>,2 x 10-6,,NR,1.06,'-,[NR],TMF1P1,Schizophrenia,schizophrenia,GCST003048,16:13522627
rs9990395-<b>G</b>,8 x 10-6,,NR,1.0526316,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,3:80420359
rs9267119-<b>C</b>,1 x 10-6,,NR,1.098901,'-,[NR],"LINC01149, HCP5",Schizophrenia,schizophrenia,GCST003048,6:31456808
rs2296342-<b>A</b>,2 x 10-6,,NR,1.05,'-,[NR],ITPR3,Schizophrenia,schizophrenia,GCST003048,6:33659300
rs1267813-<b>G</b>,4 x 10-6,,NR,1.0526316,'-,[NR],JAM3,Schizophrenia,schizophrenia,GCST003048,11:134111180
rs1001780-<b>G</b>,8 x 10-6,,NR,1.0752687,'-,[NR],DLX2-DT,Schizophrenia,schizophrenia,GCST003048,2:172107630
rs10106298-<b>G</b>,9 x 10-6,,NR,1.0526316,'-,[NR],"ADI1P2, KLF10",Schizophrenia,schizophrenia,GCST003048,8:102676153
rs10124101-<b>G</b>,1 x 10-6,,NR,1.0526316,'-,[NR],"HMGB3P24, RNF38",Schizophrenia,schizophrenia,GCST003048,9:36308830
rs10148671-<b>C</b>,2 x 10-6,,NR,1.0526316,'-,[NR],LINC02326,Schizophrenia,schizophrenia,GCST003048,14:29000167
rs10218712-<b>T</b>,4 x 10-6,,NR,1.06,'-,[NR],FOXO6,Schizophrenia,schizophrenia,GCST003048,1:41366625
rs1023500-<b>T</b>,3 x 10-8,,NR,1.08,'-,[NR],CENPM,Schizophrenia,schizophrenia,GCST003048,22:41944840
rs117799466-<b>C</b>,2 x 10-6,,NR,1.06,'-,[NR],"LPCAT4, ACTG1P15",Schizophrenia,schizophrenia,GCST003048,15:34367316
rs11784536-<b>A</b>,5 x 10-6,,NR,1.06,'-,[NR],IQANK1,Schizophrenia,schizophrenia,GCST003048,8:143756977
rs11785400-<b>T</b>,8 x 10-7,,NR,1.06,'-,[NR],"JRK, ARC",Schizophrenia,schizophrenia,GCST003048,8:142649072
rs11790388-<b>G</b>,2 x 10-6,,NR,1.0752687,'-,[NR],RALGPS1,Schizophrenia,schizophrenia,GCST003048,9:126978004
rs11807834-<b>A</b>,8 x 10-7,,NR,1.06,'-,[NR],GALNT2,Schizophrenia,schizophrenia,GCST003048,1:230136877
rs118162387-<b>G</b>,9 x 10-6,,NR,1.1627907,'-,[NR],"HTR3B, HTR3A",Schizophrenia,schizophrenia,GCST003048,11:113949306
rs11874716-<b>T</b>,6 x 10-11,,NR,1.07,'-,[NR],LINC01929,Schizophrenia,schizophrenia,GCST003048,18:55083457
rs1191551-<b>T</b>,8 x 10-8,,NR,1.07,'-,[NR],"RNU11-5P, PRKD1",Schizophrenia,schizophrenia,GCST003048,14:29531199
rs11982256-<b>T</b>,1 x 10-7,,NR,1.1627907,'-,[NR],DMTF1,Schizophrenia,schizophrenia,GCST003048,7:87170125
rs12069356-<b>A</b>,2 x 10-6,,NR,1.05,'-,[NR],"PMVK, KCNN3",Schizophrenia,schizophrenia,GCST003048,1:154877295
rs1210898-<b>T</b>,3 x 10-6,,NR,1.1,'-,[NR],EBNA1BP2,Schizophrenia,schizophrenia,GCST003048,1:43259573
rs12129719-<b>A</b>,1 x 10-6,,NR,1.05,'-,[NR],PDE4B,Schizophrenia,schizophrenia,GCST003048,1:65858829
rs12129731-<b>T</b>,6 x 10-6,,NR,1.06,'-,[NR],LINC01776,Schizophrenia,schizophrenia,GCST003048,1:98222135
rs12138061-<b>A</b>,6 x 10-6,,NR,1.06,'-,[NR],ELAVL4,Schizophrenia,schizophrenia,GCST003048,1:50106424
rs12139672-<b>G</b>,4 x 10-7,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,1:190971497
rs12142465-<b>C</b>,2 x 10-7,,NR,1.0638298,'-,[NR],SLC45A1,Schizophrenia,schizophrenia,GCST003048,1:8329994
rs12148337-<b>T</b>,3 x 10-8,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,15:70296933
rs12190758-<b>G</b>,3 x 10-7,,NR,1.0638298,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,6:92438623
rs12193070-<b>A</b>,7 x 10-6,,NR,1.06,'-,[NR],LINC02549,Schizophrenia,schizophrenia,GCST003048,6:68309831
rs12195417-<b>C</b>,5 x 10-6,,NR,1.0526316,'-,[NR],"PRSS35, ME1",Schizophrenia,schizophrenia,GCST003048,6:83463309
rs12332385-<b>T</b>,2 x 10-6,,NR,1.0526316,'-,[NR],CCDC192,Schizophrenia,schizophrenia,GCST003048,5:127878652
rs12360997-<b>G</b>,2 x 10-8,,NR,1.0638298,'-,[NR],Y_RNA,Schizophrenia,schizophrenia,GCST003048,11:24364023
rs12421382-<b>C</b>,4 x 10-8,,NR,1.0638298,'-,[NR],C11orf87,Schizophrenia,schizophrenia,GCST003048,11:109507345
rs12431204-<b>A</b>,4 x 10-6,,NR,1.05,'-,[NR],"TRPC4, LINC02334",Schizophrenia,schizophrenia,GCST003048,13:37876098
rs12431410-<b>C</b>,6 x 10-7,,NR,1.0526316,'-,[NR],RTN1,Schizophrenia,schizophrenia,GCST003048,14:59699304
rs16914811-<b>A</b>,6 x 10-7,,NR,1.08,'-,[NR],GABBR2,Schizophrenia,schizophrenia,GCST003048,9:98314345
rs16937-<b>A</b>,5 x 10-7,,NR,1.06,'-,[NR],CNTN2,Schizophrenia,schizophrenia,GCST003048,1:205066327
rs17194490-<b>T</b>,1 x 10-11,,NR,1.1,'-,[NR],CNTN4,Schizophrenia,schizophrenia,GCST003048,3:2506102
rs16971465-<b>C</b>,6 x 10-6,,NR,1.08,'-,[NR],ZFHX3,Schizophrenia,schizophrenia,GCST003048,16:72983162
rs1734907-<b>A</b>,4 x 10-6,,NR,1.07,'-,[NR],"POP7, EPO",Schizophrenia,schizophrenia,GCST003048,7:100717894
rs17396122-<b>G</b>,1 x 10-6,,NR,1.0869565,'-,[NR],VN1R18P,Schizophrenia,schizophrenia,GCST003048,2:47993197
rs1765142-<b>A</b>,2 x 10-6,,NR,1.05,'-,[NR],"ARL14EP, RPL12P30",Schizophrenia,schizophrenia,GCST003048,11:30357012
rs17684571-<b>C</b>,4 x 10-6,,NR,1.0638298,'-,[NR],DST,Schizophrenia,schizophrenia,GCST003048,6:56710873
rs17687067-<b>C</b>,2 x 10-7,,NR,1.0752687,'-,[NR],ZDHHC2,Schizophrenia,schizophrenia,GCST003048,8:17178692
rs17731-<b>A</b>,2 x 10-6,,NR,1.05,'-,[NR],KLF6,Schizophrenia,schizophrenia,GCST003048,10:3779369
rs17766408-<b>T</b>,4 x 10-6,,NR,1.08,'-,[NR],RPSAP52,Schizophrenia,schizophrenia,GCST003048,12:65791310
rs1805203-<b>G</b>,7 x 10-6,,NR,1.0869565,'-,[NR],SOX2-OT,Schizophrenia,schizophrenia,GCST003048,3:181056092
rs181900-<b>C</b>,6 x 10-8,,NR,1.1494253,'-,[NR],MEF2C-AS2,Schizophrenia,schizophrenia,GCST003048,5:88709751
rs1837495-<b>G</b>,7 x 10-8,,NR,1.0638298,'-,[NR],PLCL1,Schizophrenia,schizophrenia,GCST003048,2:198056477
rs183823891-<b>T</b>,1 x 10-7,,NR,1.07,'-,[NR],EFR3B,Schizophrenia,schizophrenia,GCST003048,2:25129331
rs185572712-<b>G</b>,1 x 10-6,,NR,1.1764705,'-,[NR],ERCC8,Schizophrenia,schizophrenia,GCST003048,5:60877688
rs1858740-<b>C</b>,5 x 10-6,,NR,1.0526316,'-,[NR],XYLB,Schizophrenia,schizophrenia,GCST003048,3:38396881
rs1863824-<b>G</b>,5 x 10-6,,NR,1.0526316,'-,[NR],GRID1,Schizophrenia,schizophrenia,GCST003048,10:86353182
rs1864774-<b>C</b>,9 x 10-7,,NR,1.0526316,'-,[NR],DLG2,Schizophrenia,schizophrenia,GCST003048,11:83488233
rs187696124-<b>T</b>,7 x 10-17,,NR,1.14,'-,[NR],HLA-DRB9,Schizophrenia,schizophrenia,GCST003048,6:32469754
rs1878874-<b>T</b>,1 x 10-7,,NR,1.0638298,'-,[NR],SOX2-OT,Schizophrenia,schizophrenia,GCST003048,3:181317582
rs1914395-<b>A</b>,4 x 10-7,,NR,1.11,'-,[NR],CALN1,Schizophrenia,schizophrenia,GCST003048,7:72374423
rs1941342-<b>A</b>,1 x 10-7,,NR,1.06,'-,[NR],NOL4,Schizophrenia,schizophrenia,GCST003048,18:34015569
rs1962636-<b>C</b>,8 x 10-6,,NR,1.0526316,'-,[NR],MOSMO,Schizophrenia,schizophrenia,GCST003048,16:22053074
rs1974653-<b>A</b>,8 x 10-6,,NR,1.06,'-,[NR],ZDHHC8,Schizophrenia,schizophrenia,GCST003048,22:20146827
rs198160-<b>G</b>,3 x 10-6,,NR,1.0526316,'-,[NR],"LINC02194, PRKCB",Schizophrenia,schizophrenia,GCST003048,16:24229404
rs1986112-<b>A</b>,2 x 10-6,,NR,1.05,'-,[NR],RAB8B,Schizophrenia,schizophrenia,GCST003048,15:63248373
rs1987778-<b>T</b>,2 x 10-6,,NR,1.06,'-,[NR],SIPA1L1,Schizophrenia,schizophrenia,GCST003048,14:71249146
rs2007044-<b>G</b>,1 x 10-17,,NR,1.098901,'-,[NR],CACNA1C,Schizophrenia,schizophrenia,GCST003048,12:2235794
rs2008905-<b>T</b>,8 x 10-6,,NR,1.05,'-,[NR],PIK3C2A,Schizophrenia,schizophrenia,GCST003048,11:17163076
rs2018916-<b>C</b>,7 x 10-9,,NR,1.0638298,'-,[NR],LINC02165,Schizophrenia,schizophrenia,GCST003048,16:63666604
rs2019872-<b>C</b>,7 x 10-6,,NR,1.0752687,'-,[NR],SMG6,Schizophrenia,schizophrenia,GCST003048,17:2107024
rs2026714-<b>G</b>,4 x 10-7,,NR,1.0526316,'-,[NR],KDM4C,Schizophrenia,schizophrenia,GCST003048,9:7177284
rs2048656-<b>A</b>,1 x 10-7,,NR,1.06,'-,[NR],TNKS,Schizophrenia,schizophrenia,GCST003048,8:9787149
rs2053079-<b>G</b>,2 x 10-9,,NR,1.0752687,'-,[NR],ZNF536,Schizophrenia,schizophrenia,GCST003048,19:30496516
rs2068012-<b>C</b>,2 x 10-7,,NR,1.0638298,'-,[NR],PRKD1,Schizophrenia,schizophrenia,GCST003048,14:29721110
rs207282-<b>T</b>,3 x 10-6,,NR,1.05,'-,[NR],"LINC02438, FAM184B",Schizophrenia,schizophrenia,GCST003048,4:19107261
rs2072883-<b>A</b>,6 x 10-6,,NR,1.05,'-,[NR],"TTLL1, TTLL1-AS1",Schizophrenia,schizophrenia,GCST003048,22:43039662
rs2077586-<b>A</b>,2 x 10-7,,NR,1.07,'-,[NR],EMX1,Schizophrenia,schizophrenia,GCST003048,2:72934422
rs2094900-<b>A</b>,3 x 10-6,,NR,1.05,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,13:109614902
rs210152-<b>A</b>,9 x 10-10,,NR,1.09,'-,[NR],GGNBP1,Schizophrenia,schizophrenia,GCST003048,6:33547743
rs2102949-<b>G</b>,2 x 10-14,,NR,1.098901,'-,[NR],MPHOSPH9,Schizophrenia,schizophrenia,GCST003048,12:123192216
rs211829-<b>T</b>,7 x 10-7,,NR,1.06,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,7:110408836
rs215411-<b>A</b>,7 x 10-9,,NR,1.07,'-,[NR],RFPL4AP3,Schizophrenia,schizophrenia,GCST003048,4:23421980
rs2159292-<b>C</b>,2 x 10-6,,NR,1.098901,'-,[NR],SHISA6,Schizophrenia,schizophrenia,GCST003048,17:11259875
rs2161300-<b>T</b>,6 x 10-6,,NR,1.07,'-,[NR],"CTB-178M22.2, TENM2",Schizophrenia,schizophrenia,GCST003048,5:168234157
rs216452-<b>T</b>,9 x 10-6,,NR,1.05,'-,[NR],TBC1D29P,Schizophrenia,schizophrenia,GCST003048,17:30556723
rs2185077-<b>T</b>,3 x 10-6,,NR,1.07,'-,[NR],"LINC02812, SLC25A3P1",Schizophrenia,schizophrenia,GCST003048,1:53379768
rs2189246-<b>A</b>,5 x 10-6,,NR,1.05,'-,[NR],PCLO,Schizophrenia,schizophrenia,GCST003048,7:82815056
rs220519-<b>T</b>,5 x 10-6,,NR,1.05,'-,[NR],ARHGAP40,Schizophrenia,schizophrenia,GCST003048,20:38650612
rs4629607-<b>G</b>,1 x 10-6,,NR,1.0526316,'-,[NR],MRPS30,Schizophrenia,schizophrenia,GCST003048,5:44857365
rs4632195-<b>T</b>,4 x 10-6,,NR,1.05,'-,[NR],DCC,Schizophrenia,schizophrenia,GCST003048,18:53220378
rs4642619-<b>A</b>,8 x 10-11,,NR,1.09,'-,[NR],'-,Schizophrenia,schizophrenia,GCST003048,8:110475239
rs4648845-<b>T</b>,2 x 10-9,,NR,1.07,'-,[NR],PLCH2,Schizophrenia,schizophrenia,GCST003048,1:2455662
rs4669297-<b>T</b>,5 x 10-6,,NR,1.17,'-,[NR],"LINC01814, SNRPEP5",Schizophrenia,schizophrenia,GCST003048,2:8598773
rs4702-<b>G</b>,3 x 10-12,,NR,1.0752687,'-,[NR],FURIN,Schizophrenia,schizophrenia,GCST003048,15:90883330
rs4711350-<b>G</b>,9 x 10-9,,NR,1.0869565,'-,[NR],LEMD2,Schizophrenia,schizophrenia,GCST003048,6:33773939
rs4727751-<b>T</b>,1 x 10-6,,NR,1.05,'-,[NR],MAGI2,Schizophrenia,schizophrenia,GCST003048,7:78707618
rs4733770-<b>G</b>,8 x 10-7,,NR,1.0526316,'-,[NR],ASAP1,Schizophrenia,schizophrenia,GCST003048,8:130140419
rs4740446-<b>T</b>,7 x 10-6,,NR,1.05,'-,[NR],PTPRD,Schizophrenia,schizophrenia,GCST003048,9:10255540
rs4744901-<b>C</b>,8 x 10-6,,NR,1.098901,'-,[NR],APBA1,Schizophrenia,schizophrenia,GCST003048,9:69472320
rs4766428-<b>T</b>,2 x 10-10,,NR,1.07,'-,[NR],ATP2A2,Schizophrenia,schizophrenia,GCST003048,12:110285440
rs4776059-<b>T</b>,4 x 10-6,,NR,1.06,'-,[NR],FAM214A,Schizophrenia,schizophrenia,GCST003048,15:52594765
rs4879901-<b>C</b>,8 x 10-6,,NR,1.0526316,'-,[NR],RUSC2,Schizophrenia,schizophrenia,GCST003048,9:35519000
rs4955124-<b>T</b>,8 x 10-6,,NR,1.08,'-,[NR],OSBPL10,Schizophrenia,schizophrenia,GCST003048,3:32021149
rs4968361-<b>A</b>,9 x 10-6,,NR,1.08,'-,[NR],LINC01476,Schizophrenia,schizophrenia,GCST003048,17:59425467
rs498154-<b>G</b>,9 x 10-6,,NR,1.0526316,'-,[NR],"RNU1-130P, LINC01787",Schizophrenia,schizophrenia,GCST003048,1:96246965
rs4987094-<b>A</b>,6 x 10-7,,NR,1.09,'-,[NR],TTC12,Schizophrenia,schizophrenia,GCST003048,11:113345201
rs504918-<b>C</b>,2 x 10-6,,NR,1.0526316,'-,[NR],KALRN,Schizophrenia,schizophrenia,GCST003048,3:124364323
rs513088-<b>G</b>,7 x 10-6,,NR,1.0526316,'-,[NR],"RPL4P2, FMO10P",Schizophrenia,schizophrenia,GCST003048,1:166700699
rs514209-<b>C</b>,5 x 10-7,,NR,1.06,'-,[NR],TRPM6,Schizophrenia,schizophrenia,GCST003048,9:74727899
rs524732-<b>A</b>,1 x 10-6,,NR,1.06,'-,[NR],MTHFD1L,Schizophrenia,schizophrenia,GCST003048,6:150993705
rs533123-<b>A</b>,2 x 10-7,,NR,1.08,'-,[NR],OPRD1,Schizophrenia,schizophrenia,GCST003048,1:28814643
rs540425-<b>T</b>,3 x 10-7,,NR,1.0638298,'-,[NR],"DDX56, NPC1L1",Schizophrenia,schizophrenia,GCST003048,7:44552473
rs7085104-<b>?</b>,2 x 10-16,,'-,'-,'-,'-,BORCS7-ASMT,Schizophrenia (MTAG),schizophrenia,GCST010640,10:102869116
rs79780963-<b>?</b>,3 x 10-14,,'-,'-,'-,'-,NT5C2,Schizophrenia (MTAG),schizophrenia,GCST010640,10:103192742
rs61867294-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,SORCS3,Schizophrenia (MTAG),schizophrenia,GCST010640,10:104809449
rs12363019-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,LINC02686,Schizophrenia (MTAG),schizophrenia,GCST010640,11:24352999
rs61882743-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,AMBRA1,Schizophrenia (MTAG),schizophrenia,GCST010640,11:46527204
rs3858402-<b>?</b>,9 x 10-9,,'-,'-,'-,'-,LINC02715,Schizophrenia (MTAG),schizophrenia,GCST010640,11:109685112
rs2514218-<b>?</b>,7 x 10-11,,'-,'-,'-,'-,DRD2,Schizophrenia (MTAG),schizophrenia,GCST010640,11:113522272
rs55661361-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,NRGN,Schizophrenia (MTAG),schizophrenia,GCST010640,11:124744061
rs73022874-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,LINC02551,Schizophrenia (MTAG),schizophrenia,GCST010640,11:130861542
rs11223656-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"IGSF9B, LINC02730",Schizophrenia (MTAG),schizophrenia,GCST010640,11:133973078
rs4298967-<b>?</b>,3 x 10-17,,'-,'-,'-,'-,CACNA1C,Schizophrenia (MTAG),schizophrenia,GCST010640,12:2299028
rs672107-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,TMTC1,Schizophrenia (MTAG),schizophrenia,GCST010640,12:29764333
rs3741434-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,RARG,Schizophrenia (MTAG),schizophrenia,GCST010640,12:53211560
rs12826178-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"NXPH4, SHMT2",Schizophrenia (MTAG),schizophrenia,GCST010640,12:57228588
rs10735362-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,ANKS1B,Schizophrenia (MTAG),schizophrenia,GCST010640,12:99101208
rs10860964-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,C12orf42,Schizophrenia (MTAG),schizophrenia,GCST010640,12:103202677
rs2851447-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,MPHOSPH9,Schizophrenia (MTAG),schizophrenia,GCST010640,12:123180566
rs10149407-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,PRKD1,Schizophrenia (MTAG),schizophrenia,GCST010640,14:29718199
rs34542576-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,PCNX1,Schizophrenia (MTAG),schizophrenia,GCST010640,14:71068776
rs7143919-<b>?</b>,9 x 10-10,,'-,'-,'-,'-,RGS6,Schizophrenia (MTAG),schizophrenia,GCST010640,14:71967285
rs61637848-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,KLC1,Schizophrenia (MTAG),schizophrenia,GCST010640,14:103629694
rs3743078-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,CHRNA3,Schizophrenia (MTAG),schizophrenia,GCST010640,15:78602417
rs748455-<b>?</b>,6 x 10-13,,'-,'-,'-,'-,ZSCAN2,Schizophrenia (MTAG),schizophrenia,GCST010640,15:84606344
rs4702-<b>?</b>,8 x 10-14,,'-,'-,'-,'-,FURIN,Schizophrenia (MTAG),schizophrenia,GCST010640,15:90883330
rs6922815-<b>?</b>,3 x 10-10,,'-,'-,'-,'-,"ZNF204P, VN1R10P",Schizophrenia (MTAG),schizophrenia,GCST010640,6:27343879
rs34706883-<b>?</b>,2 x 10-26,,'-,'-,'-,'-,"H2BC15, H4C12",Schizophrenia (MTAG),schizophrenia,GCST010640,6:27837477
rs144478515-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,ZBED9,Schizophrenia (MTAG),schizophrenia,GCST010640,6:28593450
rs185053056-<b>?</b>,1 x 10-13,,'-,'-,'-,'-,"RPSAP2, LINC00533",Schizophrenia (MTAG),schizophrenia,GCST010640,6:28712999
rs144447022-<b>?</b>,9 x 10-28,,'-,'-,'-,'-,"OR2U2P, OR14J1",Schizophrenia (MTAG),schizophrenia,GCST010640,6:29276442
rs114187207-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,OR5V1,Schizophrenia (MTAG),schizophrenia,GCST010640,6:29388810
rs115374247-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,"SUMO2P1, MOG",Schizophrenia (MTAG),schizophrenia,GCST010640,6:29642504
rs114460660-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"ZNF70P1, HTATSF1P1",Schizophrenia (MTAG),schizophrenia,GCST010640,6:33227606
rs169738-<b>?</b>,8 x 10-12,,'-,'-,'-,'-,GGNBP1,Schizophrenia (MTAG),schizophrenia,GCST010640,6:33569769
rs2016358-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,SNAP91,Schizophrenia (MTAG),schizophrenia,GCST010640,6:83574014
rs111611027-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,MAD1L1,Schizophrenia (MTAG),schizophrenia,GCST010640,7:2105994
rs73060317-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,SP4,Schizophrenia (MTAG),schizophrenia,GCST010640,7:21480594
rs79210963-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,MPP6,Schizophrenia (MTAG),schizophrenia,GCST010640,7:24678350
rs12704290-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,"GRM3-AS1, GRM3",Schizophrenia (MTAG),schizophrenia,GCST010640,7:86798310
rs13233308-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,ABCB1,Schizophrenia (MTAG),schizophrenia,GCST010640,7:87615644
rs7776707-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,LINC01004,Schizophrenia (MTAG),schizophrenia,GCST010640,7:104965083
rs12668724-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,IMMP2L,Schizophrenia (MTAG),schizophrenia,GCST010640,7:111494001
rs7785663-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,DGKI,Schizophrenia (MTAG),schizophrenia,GCST010640,7:137385552
rs13236223-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"BRAF, CCT4P1",Schizophrenia (MTAG),schizophrenia,GCST010640,7:140967165
rs4647903-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,FGFR1,Schizophrenia (MTAG),schizophrenia,GCST010640,8:38415064
rs4129585-<b>?</b>,1 x 10-11,,'-,'-,'-,'-,TSNARE1,Schizophrenia (MTAG),schizophrenia,GCST010640,8:142231572
rs7893279-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,CACNB2,Schizophrenia (MTAG),schizophrenia,GCST010640,10:18456176
rs11693094-<b>?</b>,4 x 10-11,,'-,'-,'-,'-,ZNF804A,Schizophrenia (MTAG),schizophrenia,GCST010640,2:184736693
rs6434928-<b>?</b>,8 x 10-12,,'-,'-,'-,'-,"RNU6-1029P, SF3B1",Schizophrenia (MTAG),schizophrenia,GCST010640,2:197439853
rs796364-<b>?</b>,3 x 10-13,,'-,'-,'-,'-,"RN7SL717P, FTCDNL1",Schizophrenia (MTAG),schizophrenia,GCST010640,2:199851396
rs747462-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,NGEF,Schizophrenia (MTAG),schizophrenia,GCST010640,2:232925461
rs17194490-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,CNTN4,Schizophrenia (MTAG),schizophrenia,GCST010640,3:2506102
rs9834970-<b>?</b>,4 x 10-14,,'-,'-,'-,'-,"LINC02033, HSPD1P6",Schizophrenia (MTAG),schizophrenia,GCST010640,3:36814539
rs4481150-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,ITIH3,Schizophrenia (MTAG),schizophrenia,GCST010640,3:52803777
rs832187-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,"THOC7, C3orf49",Schizophrenia (MTAG),schizophrenia,GCST010640,3:63847374
rs7636341-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,ROBO2,Schizophrenia (MTAG),schizophrenia,GCST010640,3:76172528
rs10935185-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,STAG1,Schizophrenia (MTAG),schizophrenia,GCST010640,3:136571687
rs13097727-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,FXR1,Schizophrenia (MTAG),schizophrenia,GCST010640,3:180934082
rs7653924-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,SH3RF1,Schizophrenia (MTAG),schizophrenia,GCST010640,4:169281711
rs62366215-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,LINC02057,Schizophrenia (MTAG),schizophrenia,GCST010640,5:61253693
rs454822-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,TMEM161B,Schizophrenia (MTAG),schizophrenia,GCST010640,5:88254278
rs10043984-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,KDM3B,Schizophrenia (MTAG),schizophrenia,GCST010640,5:138376432
rs4835691-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,"CTNNA1, HSPA9",Schizophrenia (MTAG),schizophrenia,GCST010640,5:138602884
rs72799198-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,LINC01470,Schizophrenia (MTAG),schizophrenia,GCST010640,5:152811145
rs2910032-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,LINC01470,Schizophrenia (MTAG),schizophrenia,GCST010640,5:153160794
rs11740474-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,GALNT10,Schizophrenia (MTAG),schizophrenia,GCST010640,5:154301187
rs215011-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,"CMAHP, CARMIL1",Schizophrenia (MTAG),schizophrenia,GCST010640,6:25384133
rs9358912-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"H2BC8, H4C5",Schizophrenia (MTAG),schizophrenia,GCST010640,6:26210918
rs75782365-<b>?</b>,3 x 10-25,,'-,'-,'-,'-,BTN3A1,Schizophrenia (MTAG),schizophrenia,GCST010640,6:26408323
rs7653924-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,SH3RF1,Schizophrenia (MTAG),schizophrenia,GCST010645,4:169281711
rs6868457-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,LINC02057,Schizophrenia (MTAG),schizophrenia,GCST010645,5:61254214
rs35017470-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,"LINC02060, TMEM161B-AS1",Schizophrenia (MTAG),schizophrenia,GCST010645,5:88431287
rs16867576-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,MEF2C-AS1,Schizophrenia (MTAG),schizophrenia,GCST010645,5:89450514
rs3849046-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,ETF1,Schizophrenia (MTAG),schizophrenia,GCST010645,5:138515503
rs13361438-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,LINC01470,Schizophrenia (MTAG),schizophrenia,GCST010645,5:152627515
rs13176930-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,LINC01470,Schizophrenia (MTAG),schizophrenia,GCST010645,5:153285161
rs11740474-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,GALNT10,Schizophrenia (MTAG),schizophrenia,GCST010645,5:154301187
rs73388146-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,CMAHP,Schizophrenia (MTAG),schizophrenia,GCST010645,6:25170440
rs6918354-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"CARMIL1, CMAHP",Schizophrenia (MTAG),schizophrenia,GCST010645,6:25444386
rs34661691-<b>?</b>,6 x 10-22,,'-,'-,'-,'-,H2BC6,Schizophrenia (MTAG),schizophrenia,GCST010645,6:26173250
rs13218591-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,BTN3A2,Schizophrenia (MTAG),schizophrenia,GCST010645,6:26376604
rs2022272-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,"H2AC11, H4C9",Schizophrenia (MTAG),schizophrenia,GCST010645,6:27135801
rs7746199-<b>?</b>,7 x 10-23,,'-,'-,'-,'-,POM121L2,Schizophrenia (MTAG),schizophrenia,GCST010645,6:27293545
rs144478515-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,ZBED9,Schizophrenia (MTAG),schizophrenia,GCST010645,6:28593450
rs115329265-<b>?</b>,1 x 10-27,,'-,'-,'-,'-,"NOP56P1, RPSAP2",Schizophrenia (MTAG),schizophrenia,GCST010645,6:28744470
rs145501595-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,OR11A1,Schizophrenia (MTAG),schizophrenia,GCST010645,6:29445191
rs115374247-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,"SUMO2P1, MOG",Schizophrenia (MTAG),schizophrenia,GCST010645,6:29642504
rs114460660-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"ZNF70P1, HTATSF1P1",Schizophrenia (MTAG),schizophrenia,GCST010645,6:33227606
rs210155-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,GGNBP1,Schizophrenia (MTAG),schizophrenia,GCST010645,6:33549254
rs111611027-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,MAD1L1,Schizophrenia (MTAG),schizophrenia,GCST010645,7:2105994
rs12704290-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,"GRM3-AS1, GRM3",Schizophrenia (MTAG),schizophrenia,GCST010645,7:86798310
rs13233308-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,ABCB1,Schizophrenia (MTAG),schizophrenia,GCST010645,7:87615644
rs67575965-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,H1-12P,Schizophrenia (MTAG),schizophrenia,GCST010645,6:26196365
rs72936314-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,LINC01416,Schizophrenia (MTAG),schizophrenia,GCST010645,18:55913446
rs1789567-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,"LINC01539, LINC01905",Schizophrenia (MTAG),schizophrenia,GCST010645,18:56123888
rs2103655-<b>?</b>,5 x 10-12,,'-,'-,'-,'-,"PPP1R16B, ACTR5",Schizophrenia (MTAG),schizophrenia,GCST010645,20:38797315
rs8139773-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,CACNA1I,Schizophrenia (MTAG),schizophrenia,GCST010645,22:39579686
rs9607782-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,EP300-AS1,Schizophrenia (MTAG),schizophrenia,GCST010645,22:41191552
rs1023500-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,CENPM,Schizophrenia (MTAG),schizophrenia,GCST010645,22:41944840
rs760648-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,TCF20,Schizophrenia (MTAG),schizophrenia,GCST010645,22:42175022
rs11210892-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,"PTPRF, KDM4A",Schizophrenia (MTAG),schizophrenia,GCST010645,1:43634413
rs1198588-<b>?</b>,4 x 10-16,,'-,'-,'-,'-,NFU1P2,Schizophrenia (MTAG),schizophrenia,GCST010645,1:98087276
rs9428966-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,AKT3,Schizophrenia (MTAG),schizophrenia,GCST010645,1:243504598
rs13011472-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,ACTG1P22,Schizophrenia (MTAG),schizophrenia,GCST010645,2:57734467
rs7599488-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,BCL11A,Schizophrenia (MTAG),schizophrenia,GCST010645,2:60491212
rs9330316-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,"SH3RF3, SEPTIN10",Schizophrenia (MTAG),schizophrenia,GCST010645,2:109526659
rs11693094-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,ZNF804A,Schizophrenia (MTAG),schizophrenia,GCST010645,2:184736693
rs6434928-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,"RNU6-1029P, SF3B1",Schizophrenia (MTAG),schizophrenia,GCST010645,2:197439853
rs281768-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,MAIP1,Schizophrenia (MTAG),schizophrenia,GCST010645,2:199960517
rs7577690-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,RETREG2,Schizophrenia (MTAG),schizophrenia,GCST010645,2:219180313
rs6704768-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,GIGYF2,Schizophrenia (MTAG),schizophrenia,GCST010645,2:232727791
rs17620999-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,CNTN4,Schizophrenia (MTAG),schizophrenia,GCST010645,3:2519872
rs75968099-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,"LINC02033, HSPD1P6",Schizophrenia (MTAG),schizophrenia,GCST010645,3:36817092
rs2535627-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,"ITIH3, ITIH4",Schizophrenia (MTAG),schizophrenia,GCST010645,3:52811089
rs832190-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,THOC7,Schizophrenia (MTAG),schizophrenia,GCST010645,3:63856953
rs940174-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,STAG1,Schizophrenia (MTAG),schizophrenia,GCST010645,3:136590868
rs34312605-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,FXR1,Schizophrenia (MTAG),schizophrenia,GCST010645,3:180872509
rs61882743-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,AMBRA1,Schizophrenia (MTAG),schizophrenia,GCST010645,11:46527204
rs12421382-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,C11orf87,Schizophrenia (MTAG),schizophrenia,GCST010645,11:109507345
rs2514218-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,DRD2,Schizophrenia (MTAG),schizophrenia,GCST010645,11:113522272
rs55661361-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,NRGN,Schizophrenia (MTAG),schizophrenia,GCST010645,11:124744061
rs35274053-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,LINC02551,Schizophrenia (MTAG),schizophrenia,GCST010645,11:130848319
rs75059851-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,IGSF9B,Schizophrenia (MTAG),schizophrenia,GCST010645,11:133952674
rs1024582-<b>?</b>,1 x 10-13,,'-,'-,'-,'-,CACNA1C,Schizophrenia (MTAG),schizophrenia,GCST010645,12:2293080
rs2239063-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,CACNA1C,Schizophrenia (MTAG),schizophrenia,GCST010645,12:2402665
rs679087-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,TMTC1,Schizophrenia (MTAG),schizophrenia,GCST010645,12:29764332
rs3741434-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,RARG,Schizophrenia (MTAG),schizophrenia,GCST010645,12:53211560
rs12826178-<b>?</b>,6 x 10-11,,'-,'-,'-,'-,"NXPH4, SHMT2",Schizophrenia (MTAG),schizophrenia,GCST010645,12:57228588
rs4766428-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,ATP2A2,Schizophrenia (MTAG),schizophrenia,GCST010645,12:110285440
rs2851447-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,MPHOSPH9,Schizophrenia (MTAG),schizophrenia,GCST010645,12:123180566
rs2068012-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,PRKD1,Schizophrenia (MTAG),schizophrenia,GCST010645,14:29721110
rs34542576-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,PCNX1,Schizophrenia (MTAG),schizophrenia,GCST010645,14:71068776
rs2332700-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,RGS6,Schizophrenia (MTAG),schizophrenia,GCST010645,14:71950609
rs34053174-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,BCL11B,Schizophrenia (MTAG),schizophrenia,GCST010645,14:99255953
rs4906364-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,PPP1R13B,Schizophrenia (MTAG),schizophrenia,GCST010645,14:103748005
rs3743078-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,CHRNA3,Schizophrenia (MTAG),schizophrenia,GCST010645,15:78602417
rs12902973-<b>?</b>,4 x 10-10,,'-,'-,'-,'-,UBE2Q2P1,Schizophrenia (MTAG),schizophrenia,GCST010645,15:84562751
rs4702-<b>?</b>,5 x 10-12,,'-,'-,'-,'-,FURIN,Schizophrenia (MTAG),schizophrenia,GCST010645,15:90883330
rs11874716-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,LINC01929,Schizophrenia (MTAG),schizophrenia,GCST010645,18:55083457
rs76641465-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,TCF4,Schizophrenia (MTAG),schizophrenia,GCST010645,18:55319930
rs9636107-<b>?</b>,8 x 10-11,,'-,'-,'-,'-,TCF4,Schizophrenia (MTAG),schizophrenia,GCST010645,18:55532886
rs185053056-<b>?</b>,1 x 10-13,,'-,'-,'-,'-,"RPSAP2, LINC00533",Schizophrenia (MTAG),schizophrenia,GCST010645,6:28712999
rs185071033-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,"RPSAP2, NOP56P1",Schizophrenia (MTAG),schizophrenia,GCST010645,6:28746191
rs3740393-<b>?</b>,2 x 10-8,,'-,'-,'-,'-,"AS3MT, BORCS7-ASMT",Schizophrenia (MTAG),schizophrenia,GCST010645,10:102876898
rs7312955-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,CDK2AP1,Schizophrenia (MTAG),schizophrenia,GCST010645,12:123263236
rs6694545-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,LINC01648,Schizophrenia (MTAG),schizophrenia,GCST010640,1:29964421
rs11210892-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,"PTPRF, KDM4A",Schizophrenia (MTAG),schizophrenia,GCST010640,1:43634413
rs35998080-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,LINC02797,Schizophrenia (MTAG),schizophrenia,GCST010640,1:72812932
rs1023330-<b>?</b>,9 x 10-9,,'-,'-,'-,'-,"TLCD4-RWDD3, TLCD4",Schizophrenia (MTAG),schizophrenia,GCST010640,1:95121217
rs1198588-<b>?</b>,4 x 10-16,,'-,'-,'-,'-,NFU1P2,Schizophrenia (MTAG),schizophrenia,GCST010640,1:98087276
rs140505938-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,"OTUD7B, VPS45",Schizophrenia (MTAG),schizophrenia,GCST010640,1:150059494
rs12691548-<b>?</b>,7 x 10-9,,'-,'-,'-,'-,AKT3,Schizophrenia (MTAG),schizophrenia,GCST010640,1:243656826
rs11903391-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,LINC01830,Schizophrenia (MTAG),schizophrenia,GCST010640,2:22418280
rs12474906-<b>?</b>,9 x 10-9,,'-,'-,'-,'-,"MRPL33, RBKS",Schizophrenia (MTAG),schizophrenia,GCST010640,2:27810671
rs11682175-<b>?</b>,5 x 10-12,,'-,'-,'-,'-,ACTG1P22,Schizophrenia (MTAG),schizophrenia,GCST010640,2:57760458
rs11899902-<b>?</b>,5 x 10-8,,'-,'-,'-,'-,ALMS1,Schizophrenia (MTAG),schizophrenia,GCST010640,2:73404436
rs4619651-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,"LMAN2L, CNNM4",Schizophrenia (MTAG),schizophrenia,GCST010640,2:96750416
rs2192932-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,LINC01004,Schizophrenia (MTAG),schizophrenia,GCST010645,7:105012818
rs12532143-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,IMMP2L,Schizophrenia (MTAG),schizophrenia,GCST010645,7:111385892
rs13262595-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,TSNARE1,Schizophrenia (MTAG),schizophrenia,GCST010645,8:142235609
rs7893279-<b>?</b>,8 x 10-9,,'-,'-,'-,'-,CACNB2,Schizophrenia (MTAG),schizophrenia,GCST010645,10:18456176
rs7085104-<b>?</b>,3 x 10-15,,'-,'-,'-,'-,BORCS7-ASMT,Schizophrenia (MTAG),schizophrenia,GCST010645,10:102869116
rs79780963-<b>?</b>,3 x 10-14,,'-,'-,'-,'-,NT5C2,Schizophrenia (MTAG),schizophrenia,GCST010645,10:103192742
rs11027827-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,LINC02686,Schizophrenia (MTAG),schizophrenia,GCST010645,11:24353633
rs9922678-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,GRIN2A,Schizophrenia (MTAG),schizophrenia,GCST010640,16:9852462
rs8055219-<b>?</b>,5 x 10-11,,'-,'-,'-,'-,MIR4719,Schizophrenia (MTAG),schizophrenia,GCST010640,16:13659527
rs12691307-<b>?</b>,5 x 10-10,,'-,'-,'-,'-,"TMEM219, KCTD13",Schizophrenia (MTAG),schizophrenia,GCST010640,16:29928556
rs4632195-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,DCC,Schizophrenia (MTAG),schizophrenia,GCST010640,18:53220378
rs11874716-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,LINC01929,Schizophrenia (MTAG),schizophrenia,GCST010640,18:55083457
rs76641465-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,TCF4,Schizophrenia (MTAG),schizophrenia,GCST010640,18:55319930
rs9636107-<b>?</b>,1 x 10-11,,'-,'-,'-,'-,TCF4,Schizophrenia (MTAG),schizophrenia,GCST010640,18:55532886
rs144158419-<b>?</b>,9 x 10-11,,'-,'-,'-,'-,LINC01416,Schizophrenia (MTAG),schizophrenia,GCST010640,18:55887502
rs1789567-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,"LINC01539, LINC01905",Schizophrenia (MTAG),schizophrenia,GCST010640,18:56123888
rs4812322-<b>?</b>,7 x 10-11,,'-,'-,'-,'-,PPP1R16B,Schizophrenia (MTAG),schizophrenia,GCST010640,20:38854787
rs7267348-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,PTGIS,Schizophrenia (MTAG),schizophrenia,GCST010640,20:49514499
rs5995756-<b>?</b>,2 x 10-9,,'-,'-,'-,'-,CACNA1I,Schizophrenia (MTAG),schizophrenia,GCST010640,22:39604308
rs133047-<b>?</b>,3 x 10-9,,'-,'-,'-,'-,MRTFA,Schizophrenia (MTAG),schizophrenia,GCST010640,22:40631815
rs5758265-<b>?</b>,8 x 10-10,,'-,'-,'-,'-,"L3MBTL2, L3MBTL2-AS1",Schizophrenia (MTAG),schizophrenia,GCST010640,22:41221893
rs1023497-<b>?</b>,9 x 10-9,,'-,'-,'-,'-,CENPM,Schizophrenia (MTAG),schizophrenia,GCST010640,22:41944504
rs760648-<b>?</b>,1 x 10-11,,'-,'-,'-,'-,TCF20,Schizophrenia (MTAG),schizophrenia,GCST010640,22:42175022
rs80256351-<b>?</b>,2 x 10-10,,'-,'-,'-,'-,"ACTG1P22, VRK2",Schizophrenia (MTAG),schizophrenia,GCST010640,2:57844458
rs10491964-<b>?</b>,1 x 10-9,,'-,'-,'-,'-,CACNA1C,Schizophrenia (MTAG),schizophrenia,GCST010640,12:2391265
rs10946817-<b>?</b>,2 x 10-11,,'-,'-,'-,'-,"BTN3A2, H3C9P",Schizophrenia (MTAG),schizophrenia,GCST010640,6:26363828
rs72841270-<b>?</b>,6 x 10-9,,'-,'-,'-,'-,"BORCS7-ASMT, AS3MT",Schizophrenia (MTAG),schizophrenia,GCST010640,10:102882480
rs7312955-<b>?</b>,4 x 10-8,,'-,'-,'-,'-,CDK2AP1,Schizophrenia (MTAG),schizophrenia,GCST010640,12:123263236
rs2472297-<b>T</b>,4 x 10-10,,NR,'-,0.073 unit increase,[0.049-0.097],"CYP1A2, CYP1A1",Clozapine concentration in schizophrenia,"schizophrenia, response to clozapine",GCST010565,15:74735539
rs3732218-<b>A</b>,7 x 10-9,,NR,'-,0.095 unit increase,[0.064-0.126],"UGT1A9, UGT1A10, UGT1A6, UGT1A7, UGT1A5, UGT1A8",N-desmethylclozapine concentration in schizophrenia,"schizophrenia, response to clozapine",GCST010564,2:233718658
rs10000284-<b>T</b>,4 x 10-20,,NR,'-,0.14 unit decrease,[0.11-0.17],UGT2B10,N-desmethylclozapine concentration in schizophrenia,"schizophrenia, response to clozapine",GCST010564,4:68803465
rs10023464-<b>T</b>,2 x 10-91,,NR,'-,0.177 unit decrease,[0.16-0.19],UGT2B10,Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia,"schizophrenia, response to clozapine",GCST010563,4:68794020
rs12767583-<b>T</b>,1 x 10-16,,NR,'-,0.063 unit decrease,[0.047-0.079],CYP2C19,Clozapine-to-N-desmethylclozapine metabolic ratio in schizophrenia,"schizophrenia, response to clozapine",GCST010563,10:94787706
rs4757144-<b>G</b>,5 x 10-6,,0.418,1.154,'-,'-,ARNTL,Schizophrenia,schizophrenia,GCST001839,11:13309679
rs8057927-<b>C</b>,1 x 10-6,,0.069,1.342,'-,'-,CDH13,Schizophrenia,schizophrenia,GCST001839,16:82659207
rs12922317-<b>G</b>,9 x 10-7,,0.339,1.174,'-,'-,SNX29,Schizophrenia,schizophrenia,GCST001839,16:11983775
rs2159767-<b>?</b>,7 x 10-6,,0.62,1.33,'-,[NR],'-,Schizophrenia,schizophrenia,GCST000164,X:148299501
rs9512730-<b>?</b>,5 x 10-6,,0.26,1.52,'-,[NR],"RNU6-63P, LNX2",Schizophrenia,schizophrenia,GCST000164,13:27503007
rs151222-<b>?</b>,6 x 10-6,,0.08,2.1,'-,[NR],"ACSM1, ACSM3",Schizophrenia,schizophrenia,GCST000164,16:20663170
rs16977195-<b>?</b>,2 x 10-6,,0.03,6.01,'-,[NR],AGBL1,Schizophrenia,schizophrenia,GCST000164,15:86441009
rs4846033-<b>?</b>,4 x 10-6,,0.01,2.87,'-,[NR],"AGTRAP, DRAXIN",Schizophrenia,schizophrenia,GCST000164,1:11728507
rs10911902-<b>?</b>,2 x 10-6,,0.17,1.79,'-,[NR],"PTGS2, SSBP3",Schizophrenia,schizophrenia,GCST000164,1:186663185
rs7233060-<b>?</b>,3 x 10-7,(Positive symptoms),NR,'-,0.1225 unit increase,[NR],CTDP1,Schizophrenia,schizophrenia,GCST001757,18:79632379
rs17206232-<b>?</b>,1 x 10-6,(Positive symptoms),NR,'-,0.135 unit increase,[NR],"ADAMTS6, Y_RNA",Schizophrenia,schizophrenia,GCST001757,5:65137573
rs2323266-<b>?</b>,3 x 10-6,(Positive symptoms),NR,'-,0.1032 unit decrease,[NR],PCDH20,Schizophrenia,schizophrenia,GCST001757,13:61391170
rs10900020-<b>?</b>,3 x 10-6,(Positive symptoms),NR,'-,0.1536 unit decrease,[NR],"LINC02881, CXCL12",Schizophrenia,schizophrenia,GCST001757,10:44331749
rs10052004-<b>?</b>,4 x 10-6,(Positive symptoms),NR,'-,0.0921 unit decrease,[NR],SALL4P1,Schizophrenia,schizophrenia,GCST001757,5:57370673
rs959770-<b>?</b>,9 x 10-6,(Positive symptoms),NR,'-,0.1198 unit decrease,[NR],ZFYVE28,Schizophrenia,schizophrenia,GCST001757,4:2393570
rs11699237-<b>?</b>,3 x 10-6,(Negative/disorganized symptoms),NR,'-,0.1221 unit increase,[NR],BMP7,Schizophrenia,schizophrenia,GCST001757,20:57108940
rs1455244-<b>?</b>,3 x 10-6,(Negative/disorganized symptoms),NR,'-,0.0605 unit decrease,[NR],LINC01255,Schizophrenia,schizophrenia,GCST001757,18:11494200
rs7172342-<b>?</b>,4 x 10-6,(Negative/disorganized symptoms),NR,'-,0.0795 unit decrease,[NR],RORA,Schizophrenia,schizophrenia,GCST001757,15:61044243
rs4530903-<b>?</b>,5 x 10-6,(Negative/disorganized symptoms),NR,'-,0.0919 unit increase,[NR],'-,Schizophrenia,schizophrenia,GCST001757,Mapping not available
rs1920592-<b>?</b>,1 x 10-6,(Mood symptoms),NR,'-,0.1125 unit decrease,[NR],"TBX5, LINC02459",Schizophrenia,schizophrenia,GCST001757,12:114267781
rs4798896-<b>?</b>,4 x 10-6,(Mood symptoms),NR,'-,0.0917 unit increase,[NR],'-,Schizophrenia,schizophrenia,GCST001757,18:78152922
rs489332-<b>?</b>,6 x 10-6,(Mood symptoms),NR,'-,0.1097 unit decrease,[NR],'-,Schizophrenia,schizophrenia,GCST001757,9:75413430
rs10924245-<b>?</b>,7 x 10-6,(Mood symptoms),NR,'-,0.1661 unit decrease,[NR],KIF26B,Schizophrenia,schizophrenia,GCST001757,1:245570306
rs17290922-<b>?</b>,8 x 10-6,(Mood symptoms),NR,'-,0.1338 unit decrease,[NR],NLRC5,Schizophrenia,schizophrenia,GCST001757,16:56990405
rs1351267-<b>?</b>,7 x 10-6,(Mood symptoms),NR,'-,0.0882 unit increase,[NR],'-,Schizophrenia,schizophrenia,GCST001757,3:152045912
rs7341475-<b>G</b>,9 x 10-7,,0.62,1.58,'-,[1.31-1.89],RELN,Schizophrenia,schizophrenia,GCST000155,7:103764368
rs11098403-<b>G</b>,3 x 10-8,,NR,1.15,'-,[1.08-1.21],LINC01378,Schizophrenia,schizophrenia,GCST002277,4:117725752
rs11871847-<b>?</b>,6 x 10-6,(anti-CMV),'-,'-,'-,'-,"CASC17, RNU7-155P",Schizophrenia (inflammation and infection response interaction),"schizophrenia, cytomegalovirus seropositivity",GCST002812,17:71285625
rs10170846-<b>?</b>,2 x 10-6,(anti-HSV1),'-,'-,'-,'-,FARSB,Schizophrenia (inflammation and infection response interaction),"schizophrenia, HSV1 seropositivity",GCST002812,2:222652986
rs12369635-<b>?</b>,8 x 10-6,(anti-HSV1),'-,'-,'-,'-,'-,Schizophrenia (inflammation and infection response interaction),"schizophrenia, HSV1 seropositivity",GCST002812,Mapping not available
rs1009840-<b>?</b>,8 x 10-6,(anti-TOXO),'-,'-,'-,'-,SGK1,Schizophrenia (inflammation and infection response interaction),"schizophrenia, Toxoplasma gondii seropositivity",GCST002812,6:134225547
rs7527939-<b>C</b>,6 x 10-9,,NR,2.63,'-,[1.89-3.66],HHAT,Schizophrenia,schizophrenia,GCST001733,1:210362681
rs4803480-<b>A</b>,1 x 10-7,,0.13,'-,'-,'-,CEACAM21,Schizophrenia,schizophrenia,GCST001119,19:41559909
rs2269372-<b>A</b>,4 x 10-8,,NR,1.313,'-,[NR],RENBP,Schizophrenia,schizophrenia,GCST002190,X:153942092
rs138880-<b>C</b>,2 x 10-7,,0.78,1.1,'-,[NR],BRD1,Schizophrenia,schizophrenia,GCST001851,22:49824963
rs4381823-<b>?</b>,6 x 10-6,(EA),0.93,1.43,'-,[NR],FBXO11,Schizophrenia,schizophrenia,GCST001851,2:47820196
rs17203055-<b>?</b>,5 x 10-6,(EA),0.87,1.43,'-,[NR],ARHGAP31,Schizophrenia,schizophrenia,GCST001851,3:119365484
rs433598-<b>T</b>,3 x 10-6,,NR,1.13,'-,[NR],"ACSM1, ACSM3",Schizophrenia,schizophrenia,GCST000607,16:20668884
rs7045881-<b>?</b>,2 x 10-6,,NR,1.16,'-,[NR],PLAA,Schizophrenia,schizophrenia,GCST000607,9:26935998
rs10761482-<b>?</b>,8 x 10-6,,NR,1.16,'-,[NR],ANK3,Schizophrenia,schizophrenia,GCST000607,10:60325579
rs13194053-<b>T</b>,1 x 10-8,(EA),0.82,1.28,'-,[NR],"MIR3143, RPL10P2",Schizophrenia,schizophrenia,GCST000433,6:27176104
rs9272219-<b>G</b>,7 x 10-8,(EA),0.72,1.14,'-,[NR],HLA-DQA1,Schizophrenia,schizophrenia,GCST000433,6:32634492
rs13025591-<b>?</b>,8 x 10-8,,NR,1.11,'-,[NR],AGAP1,Schizophrenia,schizophrenia,GCST001565,2:235886699
rs17597926-<b>?</b>,1 x 10-7,,NR,1.36,'-,[NR],CACNA1C,Schizophrenia,schizophrenia,GCST001565,12:2240418
rs4765905-<b>?</b>,2 x 10-7,,NR,1.11,'-,[NR],CACNA1C,Schizophrenia,schizophrenia,GCST001565,12:2240418
rs11191580-<b>?</b>,2 x 10-9,,NR,1.23,'-,[NR],NT5C2,Schizophrenia,schizophrenia,GCST001565,10:103146454
rs12592967-<b>?</b>,3 x 10-7,,NR,1.1,'-,[NR],'-,Schizophrenia,schizophrenia,GCST001565,15:61578744
rs10894294-<b>?</b>,3 x 10-7,,NR,1.1,'-,[NR],"SNX19, RN7SL167P",Schizophrenia,schizophrenia,GCST001565,11:130960853
rs1198588-<b>?</b>,5 x 10-7,,NR,1.12,'-,[NR],NFU1P2,Schizophrenia,schizophrenia,GCST001565,1:98087276
rs12071951-<b>?</b>,5 x 10-7,,NR,1.14,'-,[NR],"RPL7P9, NDUFS5P2",Schizophrenia,schizophrenia,GCST001565,1:96648359
rs12666575-<b>?</b>,2 x 10-9,,NR,1.12,'-,[NR],MAD1L1,Schizophrenia,schizophrenia,GCST001565,7:1964786
rs7709645-<b>?</b>,4 x 10-8,,NR,1.11,'-,[NR],ZSWIM6,Schizophrenia,schizophrenia,GCST001565,5:61435631
rs7004633-<b>?</b>,6 x 10-8,,NR,1.15,'-,[NR],'-,Schizophrenia,schizophrenia,GCST001565,8:88748082
rs11220082-<b>?</b>,7 x 10-7,,NR,1.1,'-,[NR],FEZ1,Schizophrenia,schizophrenia,GCST001565,11:125454069
rs16915157-<b>?</b>,7 x 10-7,,NR,1.13,'-,[NR],ANK3,Schizophrenia,schizophrenia,GCST001565,10:60586880
rs10503256-<b>?</b>,9 x 10-7,,NR,1.1,'-,[NR],CSMD1,Schizophrenia,schizophrenia,GCST001565,8:4356657
rs17693963-<b>?</b>,3 x 10-11,,NR,1.24,'-,[NR],"GPR89P, RSL24D1P1",Schizophrenia,schizophrenia,GCST001565,6:27742386
rs643410-<b>A</b>,1 x 10-6,,0.05,1.6,'-,[NR],TMEM245,Schizophrenia (negative symptoms),schizophrenia,GCST001836,9:109037283
rs583583-<b>A</b>,6 x 10-7,,0.28,1.3,'-,[NR],BCL9,Schizophrenia (negative symptoms),schizophrenia,GCST001836,1:147611315
rs2860223-<b>C</b>,2 x 10-6,,0.35,1.26,'-,[NR],"Metazoa_SRP, ST3GAL1-DT",Schizophrenia (negative symptoms),schizophrenia,GCST001836,8:133656434
rs4427170-<b>T</b>,4 x 10-6,,0.3947,1.629,'-,[NR],SGCZ,Methamphetamine dependence,schizophrenia,GCST001972,8:14996272
rs245201-<b>?</b>,9 x 10-8,,0.32,'-,'-,'-,CCDC192,Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction),"schizophrenia, dorsolateral prefrontal cortex functional measurement, brain measurement",GCST000271,5:127833520
rs10133111-<b>?</b>,5 x 10-6,,0.2,'-,'-,'-,TRAF3,Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction),"schizophrenia, dorsolateral prefrontal cortex functional measurement, brain measurement",GCST000271,14:102910984
rs9491640-<b>?</b>,9 x 10-6,,0.06,'-,'-,'-,'-,Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction),"schizophrenia, dorsolateral prefrontal cortex functional measurement, brain measurement",GCST000271,6:98471388
rs2088885-<b>?</b>,6 x 10-6,,0.47,'-,'-,'-,TNIK,Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction),"schizophrenia, dorsolateral prefrontal cortex functional measurement, brain measurement",GCST000271,3:171253502
rs9836484-<b>?</b>,4 x 10-6,,0.32,'-,'-,'-,LINC02077,Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction),"schizophrenia, dorsolateral prefrontal cortex functional measurement, brain measurement",GCST000271,3:77995538
rs1574192-<b>?</b>,4 x 10-6,,0.38,'-,'-,'-,"U3, GPC1",Brain imaging in schizophrenia (dorsolateral prefrontal cortex interaction),"schizophrenia, dorsolateral prefrontal cortex functional measurement, brain measurement",GCST000271,2:240369088
rs10204933-<b>G</b>,4 x 10-10,,NR,1.3,'-,[1.213-1.386],SPHKAP,Schizophrenia,schizophrenia,GCST007205,2:228206898
rs12928842-<b>C</b>,6 x 10-10,,NR,1.14,'-,[1.098-1.181],"SLC38A8, MBTPS1",Schizophrenia,schizophrenia,GCST007205,16:84044382
rs78885399-<b>C</b>,1 x 10-8,,NR,1.1547344,'-,[1.09-1.22],"SPPL3, ACADS",Schizophrenia,schizophrenia,GCST007205,12:120741095
rs10085567-<b>A</b>,2 x 10-7,,NR,1.1086475,'-,[1.06-1.16],GTF2IP7,Schizophrenia,schizophrenia,GCST007205,7:76104888
rs6946310-<b>T</b>,3 x 10-7,,NR,1.1074197,'-,[1.06-1.16],"YWHAG, HSPB1",Schizophrenia,schizophrenia,GCST007205,7:76306782
rs196590-<b>C</b>,1 x 10-6,,NR,1.118,'-,[1.073-1.163],EEPD1,Schizophrenia,schizophrenia,GCST007205,7:36285952
rs2357066-<b>T</b>,1 x 10-6,,NR,1.1185683,'-,[1.06-1.18],SIPA1L2,Schizophrenia,schizophrenia,GCST007205,1:232419607
rs11685323-<b>C</b>,5 x 10-6,,NR,1.1299435,'-,[1.07-1.2],SPAG16,Schizophrenia,schizophrenia,GCST007205,2:213848854
rs6935231-<b>A</b>,5 x 10-6,,NR,1.1560693,'-,[1.08-1.25],COL21A1,Schizophrenia,schizophrenia,GCST007205,6:56339106
rs6834681-<b>A</b>,6 x 10-6,,NR,1.126,'-,[1.075-1.178],RASGEF1B,Schizophrenia,schizophrenia,GCST007205,4:81713656
rs4621267-<b>T</b>,7 x 10-6,,NR,1.092,'-,[1.051-1.134],RPL35P8,Schizophrenia,schizophrenia,GCST007205,22:49179065
rs1275572-<b>C</b>,8 x 10-6,,NR,1.098,'-,[1.057-1.139],SNORA70,Schizophrenia,schizophrenia,GCST007205,12:75740477
rs2015748-<b>A</b>,9 x 10-6,,NR,1.1013216,'-,[1.04-1.17],"ETS2, SNORA62",Schizophrenia,schizophrenia,GCST007205,21:38831045
rs359260-<b>G</b>,1 x 10-8,(East Asian),NR,1.126,'-,[1.08-1.17],MIR4432HG,Schizophrenia,schizophrenia,GCST007201,2:60259801
rs12052801-<b>A</b>,6 x 10-6,(East Asian),NR,1.0799136,'-,[1.05-1.11],PPP3R1,Schizophrenia,schizophrenia,GCST007201,2:68196086
rs12620761-<b>C</b>,2 x 10-6,(East Asian),NR,1.0905125,'-,[1.06-1.13],MGAT5,Schizophrenia,schizophrenia,GCST007201,2:134096560
rs78681500-<b>C</b>,6 x 10-9,(East Asian),NR,1.25,'-,[1.17-1.33],SPATS2L,Schizophrenia,schizophrenia,GCST007201,2:200322593
rs2073499-<b>G</b>,3 x 10-8,(East Asian),NR,1.098901,'-,[1.07-1.13],RASSF1,Schizophrenia,schizophrenia,GCST007201,3:50336862
rs1021487-<b>C</b>,1 x 10-6,(East Asian),NR,1.086,'-,[1.05-1.12],LINC02494,Schizophrenia,schizophrenia,GCST007201,4:58590920
rs41464545-<b>G</b>,4 x 10-6,(East Asian),NR,1.125,'-,[1.07-1.18],LINC02232,Schizophrenia,schizophrenia,GCST007201,4:64952689
rs2962250-<b>G</b>,1 x 10-7,(East Asian),NR,1.164,'-,[1.11-1.22],"RNU6-1296P, RNU6-480P",Schizophrenia,schizophrenia,GCST007201,5:51094157
rs7757969-<b>C</b>,8 x 10-9,(East Asian),NR,1.107,'-,[1.07-1.14],FYN,Schizophrenia,schizophrenia,GCST007201,6:111810829
rs2961033-<b>C</b>,5 x 10-7,(East Asian),NR,1.082,'-,[1.05-1.12],YWHAG,Schizophrenia,schizophrenia,GCST007201,7:76335026
rs323167-<b>C</b>,3 x 10-6,(East Asian),NR,1.103,'-,[1.06-1.14],MAGI2,Schizophrenia,schizophrenia,GCST007201,7:78707361
rs11534004-<b>A</b>,5 x 10-7,(East Asian),NR,1.0893246,'-,[1.05-1.13],PPP1R3A,Schizophrenia,schizophrenia,GCST007201,7:113827389
rs11685299-<b>C</b>,4 x 10-11,,NR,1.0683761,'-,[1.05-1.09],CUL3,Schizophrenia,schizophrenia,GCST007201,2:224526579
rs2194545-<b>G</b>,3 x 10-6,,NR,1.0471205,'-,[1.03-1.07],"SNF8P1, LINC01807",Schizophrenia,schizophrenia,GCST007201,2:228418495
rs778371-<b>G</b>,2 x 10-13,,NR,1.0752687,'-,[1.05-1.1],SNORC,Schizophrenia,schizophrenia,GCST007201,2:232878399
rs7529073-<b>C</b>,1 x 10-7,,NR,1.0504202,'-,[1.03-1.07],PROX1-AS1,Schizophrenia,schizophrenia,GCST007201,1:213974546
rs12543645-<b>C</b>,3 x 10-7,,NR,1.055,'-,[1.03-1.08],MSRA,Schizophrenia,schizophrenia,GCST007201,8:10388815
rs17687067-<b>C</b>,2 x 10-10,,NR,1.0741138,'-,[1.05-1.1],ZDHHC2,Schizophrenia,schizophrenia,GCST007201,8:17178692
rs13259407-<b>C</b>,1 x 10-8,,NR,1.0548522,'-,[1.04-1.07],PSD3,Schizophrenia,schizophrenia,GCST007201,8:18565413
rs73219805-<b>A</b>,2 x 10-12,,NR,1.083,'-,[1.06-1.11],BNIP3L,Schizophrenia,schizophrenia,GCST007201,8:26415252
rs11778040-<b>C</b>,1 x 10-8,,NR,1.0729614,'-,[1.05-1.1],GULOP,Schizophrenia,schizophrenia,GCST007201,8:27562290
rs112537273-<b>T</b>,1 x 10-12,,NR,1.081,'-,[1.06-1.1],LETM2,Schizophrenia,schizophrenia,GCST007201,8:38390788
rs867743-<b>G</b>,2 x 10-9,,NR,1.0615711,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,8:59782088
rs7012816-<b>A</b>,2 x 10-8,,NR,1.072,'-,[1.05-1.1],PRDM14,Schizophrenia,schizophrenia,GCST007201,8:70052508
rs7010876-<b>T</b>,3 x 10-8,,NR,1.0638298,'-,[1.04-1.09],MMP16,Schizophrenia,schizophrenia,GCST007201,8:88252522
rs1460583-<b>C</b>,2 x 10-7,,NR,1.0515248,'-,[1.03-1.07],ZFPM2,Schizophrenia,schizophrenia,GCST007201,8:105096365
rs16880831-<b>G</b>,2 x 10-10,,NR,1.0775862,'-,[1.05-1.1],STAU2,Schizophrenia,schizophrenia,GCST007201,8:110549276
rs13266463-<b>G</b>,9 x 10-9,,NR,1.059322,'-,[1.04-1.08],TSNARE1,Schizophrenia,schizophrenia,GCST007201,8:142322332
rs7022054-<b>G</b>,6 x 10-8,,NR,1.0537407,'-,[1.03-1.07],KDM4C,Schizophrenia,schizophrenia,GCST007201,9:7173500
rs9695226-<b>G</b>,9 x 10-8,,NR,1.059322,'-,[1.04-1.08],LINC01239,Schizophrenia,schizophrenia,GCST007201,9:22759397
rs10124101-<b>G</b>,8 x 10-7,,NR,1.049318,'-,[1.03-1.07],"HMGB3P24, RNF38",Schizophrenia,schizophrenia,GCST007201,9:36308830
rs2767713-<b>C</b>,1 x 10-10,,NR,1.0729614,'-,[1.05-1.09],DDX10P2,Schizophrenia,schizophrenia,GCST007201,9:82184622
rs3824451-<b>C</b>,2 x 10-7,,NR,1.066098,'-,[1.04-1.09],GABBR2,Schizophrenia,schizophrenia,GCST007201,9:98309240
rs11790388-<b>G</b>,1 x 10-7,,NR,1.0706638,'-,[1.05-1.1],RALGPS1,Schizophrenia,schizophrenia,GCST007201,9:126978004
rs7099380-<b>A</b>,2 x 10-6,,NR,1.047,'-,[1.03-1.07],CACNB2,Schizophrenia,schizophrenia,GCST007201,10:18260087
rs7893279-<b>T</b>,9 x 10-14,,NR,1.122,'-,[1.09-1.15],CACNB2,Schizophrenia,schizophrenia,GCST007201,10:18456176
rs61847307-<b>C</b>,5 x 10-7,,NR,1.0604454,'-,[1.04-1.08],PRKG1,Schizophrenia,schizophrenia,GCST007201,10:52184682
rs8012642-<b>C</b>,7 x 10-8,,NR,1.056,'-,[1.04-1.08],MTCYBP27,Schizophrenia,schizophrenia,GCST007201,14:84203137
rs2693698-<b>G</b>,5 x 10-8,,NR,1.0615711,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,Mapping not available
rs12887734-<b>T</b>,1 x 10-12,,NR,1.078,'-,[1.06-1.1],"KLC1, COA8",Schizophrenia,schizophrenia,GCST007201,14:103580497
rs12911832-<b>A</b>,4 x 10-8,,NR,1.061,'-,[1.04-1.08],ADAM10,Schizophrenia,schizophrenia,GCST007201,15:58693705
rs35225048-<b>C</b>,4 x 10-13,,NR,1.0706638,'-,[1.05-1.09],'-,Schizophrenia,schizophrenia,GCST007201,15:61564064
rs12148337-<b>T</b>,6 x 10-10,,NR,1.059,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,15:70296933
rs3825845-<b>C</b>,4 x 10-10,,NR,1.0729614,'-,[1.05-1.1],CHRNA3,Schizophrenia,schizophrenia,GCST007201,15:78617916
rs783540-<b>G</b>,9 x 10-9,,NR,1.0548522,'-,[1.04-1.07],CPEB1,Schizophrenia,schizophrenia,GCST007201,15:82585958
rs950169-<b>C</b>,2 x 10-11,,NR,1.0822511,'-,[1.06-1.11],ADAMTSL3,Schizophrenia,schizophrenia,GCST007201,15:84037709
rs758129-<b>G</b>,3 x 10-7,,NR,1.0537407,'-,[1.03-1.07],"POLG-DT, MIR9-3HG",Schizophrenia,schizophrenia,GCST007201,15:89357656
rs11539637-<b>T</b>,4 x 10-9,,NR,1.063,'-,[1.04-1.08],FES,Schizophrenia,schizophrenia,GCST007201,15:90885060
rs6500596-<b>G</b>,2 x 10-7,,NR,1.0582011,'-,[1.04-1.08],"CORO7-PAM16, CORO7",Schizophrenia,schizophrenia,GCST007201,16:4420026
rs9922678-<b>A</b>,2 x 10-8,,NR,1.062,'-,[1.04-1.08],GRIN2A,Schizophrenia,schizophrenia,GCST007201,16:9852462
rs7405404-<b>T</b>,7 x 10-9,,NR,1.07,'-,[1.05-1.09],'-,Schizophrenia,schizophrenia,GCST007201,16:13656002
rs3814881-<b>G</b>,4 x 10-12,,NR,1.0672358,'-,[1.05-1.09],TAOK2,Schizophrenia,schizophrenia,GCST007201,16:29989580
rs12325245-<b>T</b>,2 x 10-7,,NR,1.0729614,'-,[1.05-1.1],"CNOT1, SLC38A7",Schizophrenia,schizophrenia,GCST007201,16:58647489
rs7193419-<b>T</b>,2 x 10-7,,NR,1.05,'-,[1.03-1.07],"LINC02858, LINC02165",Schizophrenia,schizophrenia,GCST007201,16:63663230
rs8058130-<b>G</b>,5 x 10-8,,NR,1.0559661,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,16:64337259
rs55757091-<b>A</b>,3 x 10-7,,NR,1.07,'-,[1.04-1.1],"SLC7A6, SLC7A6OS",Schizophrenia,schizophrenia,GCST007201,16:68289751
rs2514218-<b>C</b>,5 x 10-10,(EA),NR,1.075,'-,[1.05-1.1],DRD2,Schizophrenia,schizophrenia,GCST007201,11:113522272
rs832190-<b>C</b>,6 x 10-10,(EA),NR,1.072,'-,[1.05-1.09],THOC7,Schizophrenia,schizophrenia,GCST007201,3:63856953
rs4766428-<b>T</b>,6 x 10-10,(EA),NR,1.0719,'-,[1.05-1.09],ATP2A2,Schizophrenia,schizophrenia,GCST007201,12:110285440
rs2577831-<b>A</b>,9 x 10-10,(EA),NR,1.0689,'-,[1.05-1.09],PBRM1,Schizophrenia,schizophrenia,GCST007201,3:52594040
rs210152-<b>A</b>,9 x 10-10,(EA),NR,1.094,'-,[1.07-1.12],GGNBP1,Schizophrenia,schizophrenia,GCST007201,6:33547743
rs202904-<b>C</b>,1 x 10-9,(EA),NR,1.08,'-,[1.06-1.1],ZSCAN16-AS1,Schizophrenia,schizophrenia,GCST007201,6:28050847
rs12139672-<b>G</b>,4 x 10-8,,NR,1.0626993,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,1:190971497
rs11240341-<b>T</b>,9 x 10-7,,NR,1.052,'-,[1.03-1.07],CNTN2,Schizophrenia,schizophrenia,GCST007201,1:205046156
rs7523273-<b>A</b>,3 x 10-7,,NR,1.057,'-,[1.04-1.08],MIR29B2CHG,Schizophrenia,schizophrenia,GCST007201,1:207803738
rs11127668-<b>C</b>,8 x 10-7,,NR,1.0504202,'-,[1.03-1.07],"HMGB1P38, ROBO1",Schizophrenia,schizophrenia,GCST007201,3:79866620
rs12623170-<b>C</b>,5 x 10-8,,NR,1.0604454,'-,[1.04-1.08],"RBKS, MRPL33",Schizophrenia,schizophrenia,GCST007201,2:27797290
rs2372993-<b>C</b>,5 x 10-7,,NR,1.0504202,'-,[1.03-1.07],"QPCT, RNU6-939P",Schizophrenia,schizophrenia,GCST007201,2:37334786
rs75575209-<b>T</b>,8 x 10-9,,NR,1.1098778,'-,[1.07-1.15],VRK2,Schizophrenia,schizophrenia,GCST007201,2:57911057
rs7596038-<b>C</b>,1 x 10-13,,NR,1.0764263,'-,[1.06-1.1],VRK2,Schizophrenia,schizophrenia,GCST007201,2:58156685
rs999494-<b>C</b>,1 x 10-8,,NR,1.0729614,'-,[1.05-1.1],EMX1,Schizophrenia,schizophrenia,GCST007201,2:72930266
rs7560272-<b>T</b>,1 x 10-7,,NR,1.0570824,'-,[1.04-1.08],"RNU6-111P, RPSAP28",Schizophrenia,schizophrenia,GCST007201,2:73334357
rs35430959-<b>C</b>,1 x 10-7,,NR,1.0706638,'-,[1.04-1.1],PNPP1,Schizophrenia,schizophrenia,GCST007201,2:76238162
rs61712019-<b>T</b>,1 x 10-7,,NR,1.062,'-,[1.04-1.08],LRRTM4,Schizophrenia,schizophrenia,GCST007201,2:77477763
rs62152284-<b>T</b>,6 x 10-7,,NR,1.057,'-,[1.04-1.08],AHCYP3,Schizophrenia,schizophrenia,GCST007201,2:104367929
rs6430491-<b>G</b>,5 x 10-10,,NR,1.0706638,'-,[1.05-1.09],MGAT5,Schizophrenia,schizophrenia,GCST007201,2:134083396
rs2381759-<b>A</b>,7 x 10-8,,NR,1.072,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST007201,2:145670463
rs35662245-<b>A</b>,5 x 10-6,,NR,1.045,'-,[1.03-1.06],LINC01911,Schizophrenia,schizophrenia,GCST007201,2:146825619
rs12622667-<b>C</b>,8 x 10-9,,NR,1.0845987,'-,[1.06-1.11],EPC2,Schizophrenia,schizophrenia,GCST007201,2:148762617
rs3845702-<b>A</b>,1 x 10-6,,NR,1.058,'-,[1.04-1.08],CWC22,Schizophrenia,schizophrenia,GCST007201,2:179983761
rs7597593-<b>T</b>,2 x 10-11,,NR,1.069,'-,[1.05-1.09],ZNF804A,Schizophrenia,schizophrenia,GCST007201,2:184668853
rs12619354-<b>T</b>,3 x 10-8,,NR,1.058,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,2:193138056
rs10204454-<b>T</b>,3 x 10-8,,NR,1.057,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,2:193481559
rs6434928-<b>G</b>,2 x 10-10,,NR,1.0672358,'-,[1.05-1.09],"RNU6-1029P, SF3B1",Schizophrenia,schizophrenia,GCST007201,2:197439853
rs895526-<b>C</b>,3 x 10-10,,NR,1.0718113,'-,[1.05-1.09],SATB2,Schizophrenia,schizophrenia,GCST007201,2:199297702
rs796364-<b>C</b>,1 x 10-14,,NR,1.0928961,'-,[1.07-1.12],"RN7SL717P, FTCDNL1",Schizophrenia,schizophrenia,GCST007201,2:199851396
rs17630293-<b>T</b>,4 x 10-9,,NR,1.107,'-,[1.07-1.14],SPATS2L,Schizophrenia,schizophrenia,GCST007201,2:200282053
rs2944823-<b>A</b>,4 x 10-8,,NR,1.059,'-,[1.04-1.08],CALN1,Schizophrenia,schizophrenia,GCST007201,7:72330485
rs12704290-<b>G</b>,4 x 10-10,,NR,1.1013216,'-,[1.07-1.13],"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST007201,7:86798310
rs11982256-<b>T</b>,3 x 10-8,,NR,1.1376565,'-,[1.09-1.18],DMTF1,Schizophrenia,schizophrenia,GCST007201,7:87170125
rs221780-<b>G</b>,1 x 10-7,,NR,1.0752687,'-,[1.05-1.1],"POP7, GIGYF1",Schizophrenia,schizophrenia,GCST007201,7:100699412
rs2057884-<b>T</b>,3 x 10-12,,NR,1.07,'-,[1.05-1.09],SRPK2,Schizophrenia,schizophrenia,GCST007201,7:105289803
rs7807720-<b>A</b>,2 x 10-8,,NR,1.058,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST007201,7:110433698
rs214467-<b>A</b>,5 x 10-11,,NR,1.068,'-,[1.05-1.09],IMMP2L,Schizophrenia,schizophrenia,GCST007201,7:111218212
rs7801375-<b>G</b>,3 x 10-8,,NR,1.0822511,'-,[1.05-1.11],CAPZA1P4,Schizophrenia,schizophrenia,GCST007201,7:131882504
rs3735025-<b>T</b>,1 x 10-9,,NR,1.062,'-,[1.04-1.08],DGKI,Schizophrenia,schizophrenia,GCST007201,7:137390098
rs13261217-<b>G</b>,4 x 10-9,,NR,1.0706638,'-,[1.05-1.09],CSMD1,Schizophrenia,schizophrenia,GCST007201,8:4325535
rs12541020-<b>T</b>,6 x 10-9,,NR,1.061,'-,[1.04-1.08],CSMD1,Schizophrenia,schizophrenia,GCST007201,8:4960070
rs2980436-<b>A</b>,4 x 10-7,,NR,1.052,'-,[1.03-1.07],FAM86B3P,Schizophrenia,schizophrenia,GCST007201,8:8234503
rs11102159-<b>T</b>,1 x 10-6,,NR,1.05,'-,[1.03-1.07],"NRBF2P3, Y_RNA",Schizophrenia,schizophrenia,GCST007201,1:110782105
rs7523654-<b>T</b>,4 x 10-7,,NR,1.053,'-,[1.03-1.07],"NGF-AS1, NGF",Schizophrenia,schizophrenia,GCST007201,1:115318644
rs12129037-<b>T</b>,1 x 10-8,,NR,1.094,'-,[1.06-1.12],"FALEC, ADAMTSL4-AS2",Schizophrenia,schizophrenia,GCST007201,1:150519638
rs6670165-<b>T</b>,4 x 10-11,,NR,1.081,'-,[1.06-1.1],"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST007201,1:177310985
rs9970077-<b>A</b>,5 x 10-8,,NR,1.068,'-,[1.04-1.09],LINC01741,Schizophrenia,schizophrenia,GCST007201,1:177791783
rs160593-<b>G</b>,2 x 10-9,,NR,1.059322,'-,[1.04-1.08],LIN28B,Schizophrenia,schizophrenia,GCST007201,6:105018457
rs9398171-<b>C</b>,2 x 10-11,,NR,1.0695187,'-,[1.05-1.09],FOXO3,Schizophrenia,schizophrenia,GCST007201,6:108662324
rs9384900-<b>T</b>,7 x 10-7,,NR,1.058,'-,[1.04-1.08],HDAC2-AS2,Schizophrenia,schizophrenia,GCST007201,6:114389931
rs12664251-<b>A</b>,2 x 10-7,,NR,1.052,'-,[1.03-1.07],FAM184A,Schizophrenia,schizophrenia,GCST007201,6:119023381
rs12668848-<b>G</b>,2 x 10-15,,NR,1.0799136,'-,[1.06-1.1],MAD1L1,Schizophrenia,schizophrenia,GCST007201,7:1981360
rs7811417-<b>T</b>,3 x 10-7,,NR,1.05,'-,[1.03-1.07],SP4,Schizophrenia,schizophrenia,GCST007201,7:21494534
rs112509803-<b>C</b>,1 x 10-7,,NR,1.088,'-,[1.06-1.12],"GSDME, MPP6",Schizophrenia,schizophrenia,GCST007201,7:24695385
rs217331-<b>G</b>,3 x 10-12,,NR,1.0672358,'-,[1.05-1.09],SNAP91,Schizophrenia,schizophrenia,GCST007201,6:83634970
rs3798869-<b>G</b>,1 x 10-9,(EA),NR,1.069,'-,[1.05-1.09],SNAP91,Schizophrenia,schizophrenia,GCST007201,6:83618941
rs34796896-<b>G</b>,1 x 10-9,(EA),NR,1.086,'-,[1.06-1.11],FXR1,Schizophrenia,schizophrenia,GCST007201,3:180905467
rs7719676-<b>G</b>,1 x 10-9,(EA),NR,1.077,'-,[1.05-1.1],ZSWIM6,Schizophrenia,schizophrenia,GCST007201,5:61441122
rs4523957-<b>T</b>,1 x 10-9,(EA),NR,1.0722,'-,[1.05-1.09],SRR,Schizophrenia,schizophrenia,GCST007201,17:2305605
rs215411-<b>A</b>,2 x 10-9,(EA),NR,1.0717,'-,[1.05-1.09],RFPL4AP3,Schizophrenia,schizophrenia,GCST007201,4:23421980
rs2057884-<b>T</b>,2 x 10-9,(EA),NR,1.0709,'-,[1.05-1.09],SRPK2,Schizophrenia,schizophrenia,GCST007201,7:105289803
rs67575965-<b>A</b>,2 x 10-9,(EA),NR,1.083,'-,[1.06-1.11],H1-12P,Schizophrenia,schizophrenia,GCST007201,6:26196365
rs59979824-<b>C</b>,3 x 10-9,(EA),NR,1.074,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST007201,2:192983614
rs2970610-<b>T</b>,4 x 10-9,(EA),NR,1.0703,'-,[1.05-1.09],"KDM4A, PTPRF",Schizophrenia,schizophrenia,GCST007201,1:43631859
rs67981189-<b>G</b>,4 x 10-9,(EA),NR,1.072,'-,[1.05-1.1],PCNX1,Schizophrenia,schizophrenia,GCST007201,14:71005509
rs113897692-<b>A</b>,5 x 10-9,(EA),NR,1.075,'-,[1.05-1.1],LINC01470,Schizophrenia,schizophrenia,GCST007201,5:152797226
rs72804786-<b>G</b>,5 x 10-9,(EA),NR,1.073,'-,[1.05-1.1],LINC01470,Schizophrenia,schizophrenia,GCST007201,5:152938239
rs1509378-<b>A</b>,5 x 10-9,(EA),NR,1.072,'-,[1.05-1.1],LINC01884,Schizophrenia,schizophrenia,GCST007201,2:22531594
rs9922678-<b>A</b>,6 x 10-9,(EA),NR,1.0708,'-,[1.05-1.09],GRIN2A,Schizophrenia,schizophrenia,GCST007201,16:9852462
rs1837495-<b>G</b>,6 x 10-9,(EA),NR,1.07,'-,[1.05-1.09],PLCL1,Schizophrenia,schizophrenia,GCST007201,2:198056477
rs60005721-<b>A</b>,8 x 10-9,(EA),NR,1.116,'-,[1.08-1.15],CMAHP,Schizophrenia,schizophrenia,GCST007201,6:25262991
rs11658257-<b>G</b>,8 x 10-9,(EA),NR,1.068,'-,[1.05-1.09],GID4,Schizophrenia,schizophrenia,GCST007201,17:18053145
rs9859557-<b>A</b>,9 x 10-9,(EA),NR,1.0805,'-,[1.05-1.11],SOX2-OT,Schizophrenia,schizophrenia,GCST007201,3:181113122
rs10803138-<b>G</b>,1 x 10-8,(EA),NR,1.075,'-,[1.05-1.1],SDCCAG8,Schizophrenia,schizophrenia,GCST007201,1:243391917
rs9859557-<b>A</b>,2 x 10-11,,NR,1.085,'-,[1.06-1.11],SOX2-OT,Schizophrenia,schizophrenia,GCST007201,3:181113122
rs10786736-<b>G</b>,5 x 10-11,(EA),NR,1.1234692,'-,[1.09-1.16],"CNNM2, NT5C2",Schizophrenia,schizophrenia,GCST007201,10:103089359
rs2163548-<b>G</b>,9 x 10-11,(EA),NR,1.1098778,'-,[1.08-1.14],SPATS2L,Schizophrenia,schizophrenia,GCST007201,2:200362139
rs950169-<b>C</b>,1 x 10-10,(EA),NR,1.0818998,'-,[1.06-1.11],ADAMTSL3,Schizophrenia,schizophrenia,GCST007201,15:84037709
rs66691851-<b>C</b>,2 x 10-10,(EA),NR,1.0729614,'-,[1.05-1.09],STAG1,Schizophrenia,schizophrenia,GCST007201,3:136435986
rs7427564-<b>G</b>,2 x 10-10,(EA),NR,1.0729614,'-,[1.05-1.09],STAG1,Schizophrenia,schizophrenia,GCST007201,3:136555593
rs13261217-<b>G</b>,1 x 10-7,(EA),NR,1.0729614,'-,[1.05-1.1],CSMD1,Schizophrenia,schizophrenia,GCST007201,8:4325535
rs34321714-<b>G</b>,1 x 10-7,(EA),NR,1.0592098,'-,[1.04-1.08],RIMS1,Schizophrenia,schizophrenia,GCST007201,6:72454442
rs1878561-<b>A</b>,1 x 10-7,(EA),NR,1.059322,'-,[1.04-1.08],FAM86B3P,Schizophrenia,schizophrenia,GCST007201,8:8234883
rs7267348-<b>C</b>,1 x 10-7,(EA),NR,1.0680337,'-,[1.04-1.09],PTGIS,Schizophrenia,schizophrenia,GCST007201,20:49514499
rs7438-<b>G</b>,1 x 10-7,(EA),NR,1.0594343,'-,[1.04-1.08],CLCN3,Schizophrenia,schizophrenia,GCST007201,4:169721095
rs35430959-<b>C</b>,2 x 10-7,(EA),NR,1.0729614,'-,[1.05-1.1],PNPP1,Schizophrenia,schizophrenia,GCST007201,2:76238162
rs11982256-<b>T</b>,2 x 10-7,(EA),NR,1.1731582,'-,[1.11-1.23],DMTF1,Schizophrenia,schizophrenia,GCST007201,7:87170125
rs62148129-<b>A</b>,2 x 10-7,(EA),NR,1.0857763,'-,[1.05-1.12],SFXN5,Schizophrenia,schizophrenia,GCST007201,2:72977074
rs35978510-<b>C</b>,2 x 10-7,(EA),NR,1.0645093,'-,[1.04-1.09],AKT3,Schizophrenia,schizophrenia,GCST007201,1:243612815
rs9398171-<b>C</b>,3 x 10-7,(EA),NR,1.0631511,'-,[1.04-1.09],FOXO3,Schizophrenia,schizophrenia,GCST007201,6:108662324
rs2734325-<b>T</b>,3 x 10-7,(EA),NR,1.0615711,'-,[1.04-1.08],STK19,Schizophrenia,schizophrenia,GCST007201,6:31977869
rs6990941-<b>C</b>,3 x 10-7,(EA),NR,1.0752687,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST007201,8:88632202
rs7022054-<b>G</b>,3 x 10-7,(EA),NR,1.0576415,'-,[1.04-1.08],KDM4C,Schizophrenia,schizophrenia,GCST007201,9:7173500
rs6434928-<b>G</b>,1 x 10-11,(EA),NR,1.0818998,'-,[1.06-1.1],"RNU6-1029P, SF3B1",Schizophrenia,schizophrenia,GCST007201,2:197439853
rs314272-<b>G</b>,3 x 10-7,(EA),NR,1.0570824,'-,[1.04-1.08],LIN28B,Schizophrenia,schizophrenia,GCST007201,6:105014129
rs7727515-<b>G</b>,3 x 10-7,(EA),NR,1.0956502,'-,[1.06-1.13],GRIA1,Schizophrenia,schizophrenia,GCST007201,5:153512744
rs7934083-<b>C</b>,4 x 10-7,(EA),NR,1.0575297,'-,[1.04-1.08],MTND4LP18,Schizophrenia,schizophrenia,GCST007201,11:81492479
rs9841616-<b>T</b>,4 x 10-7,(EA),NR,1.077122,'-,[1.05-1.11],SOX2-OT,Schizophrenia,schizophrenia,GCST007201,3:181449797
rs4240748-<b>G</b>,4 x 10-7,(EA),NR,1.0589855,'-,[1.04-1.08],LINC02404,Schizophrenia,schizophrenia,GCST007201,12:91853010
rs12327082-<b>T</b>,5 x 10-7,(EA),NR,1.0559661,'-,[1.03-1.08],NOL4,Schizophrenia,schizophrenia,GCST007201,18:34011495
rs34102591-<b>G</b>,5 x 10-7,(EA),NR,1.0718113,'-,[1.04-1.1],"ZNF664, RFLNA",Schizophrenia,schizophrenia,GCST007201,12:123996254
rs7445192-<b>G</b>,5 x 10-7,(EA),NR,1.0559661,'-,[1.03-1.08],"VTRNA1-3, PCDHA1",Schizophrenia,schizophrenia,GCST007201,5:140759116
rs895526-<b>C</b>,6 x 10-7,(EA),NR,1.0742292,'-,[1.05-1.1],SATB2,Schizophrenia,schizophrenia,GCST007201,2:199297702
rs7010876-<b>T</b>,7 x 10-7,(EA),NR,1.0615711,'-,[1.04-1.09],MMP16,Schizophrenia,schizophrenia,GCST007201,8:88252522
rs12190758-<b>G</b>,7 x 10-7,(EA),NR,1.0638298,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST007201,6:92438623
rs56873913-<b>T</b>,2 x 10-8,,NR,1.069,'-,[1.05-1.09],"NOSIP, PRRG2",Schizophrenia,schizophrenia,GCST007201,19:49587942
rs2103655-<b>A</b>,6 x 10-11,,NR,1.068,'-,[1.05-1.09],"PPP1R16B, ACTR5",Schizophrenia,schizophrenia,GCST007201,20:38797315
rs7267348-<b>C</b>,8 x 10-9,,NR,1.0638298,'-,[1.04-1.08],PTGIS,Schizophrenia,schizophrenia,GCST007201,20:49514499
rs7273691-<b>T</b>,3 x 10-6,,NR,1.061,'-,[1.04-1.09],PHACTR3,Schizophrenia,schizophrenia,GCST007201,20:59678449
rs5757730-<b>G</b>,2 x 10-10,,NR,1.0729614,'-,[1.05-1.09],CACNA1I,Schizophrenia,schizophrenia,GCST007201,22:39571425
rs714031-<b>C</b>,3 x 10-7,,NR,1.0559661,'-,[1.03-1.08],CACNA1I,Schizophrenia,schizophrenia,GCST007201,22:39674229
rs17002069-<b>C</b>,1 x 10-8,,NR,1.07,'-,[1.05-1.09],"MRTFA, GAPDHP37",Schizophrenia,schizophrenia,GCST007201,22:40654982
rs9607782-<b>A</b>,4 x 10-13,,NR,1.093,'-,[1.07-1.12],EP300-AS1,Schizophrenia,schizophrenia,GCST007201,22:41191552
rs6002655-<b>T</b>,1 x 10-8,,NR,1.059,'-,[1.04-1.08],TCF20,Schizophrenia,schizophrenia,GCST007201,22:42207808
rs1024582-<b>A</b>,6 x 10-18,(EA),NR,1.1037527,'-,[1.08-1.13],CACNA1C,Schizophrenia,schizophrenia,GCST007201,12:2293080
rs7085104-<b>A</b>,1 x 10-17,(EA),NR,1.1025358,'-,[1.08-1.12],BORCS7-ASMT,Schizophrenia,schizophrenia,GCST007201,10:102869116
rs796364-<b>C</b>,5 x 10-14,(EA),NR,1.1088934,'-,[1.08-1.14],"RN7SL717P, FTCDNL1",Schizophrenia,schizophrenia,GCST007201,2:199851396
rs12668848-<b>G</b>,1 x 10-13,(EA),NR,1.0855407,'-,[1.06-1.11],MAD1L1,Schizophrenia,schizophrenia,GCST007201,7:1981360
rs4129585-<b>A</b>,4 x 10-13,(EA),NR,1.0822511,'-,[1.06-1.1],TSNARE1,Schizophrenia,schizophrenia,GCST007201,8:142231572
rs10791098-<b>T</b>,2 x 10-12,(EA),NR,1.0799136,'-,[1.06-1.1],LINC02551,Schizophrenia,schizophrenia,GCST007201,11:130848816
rs75968099-<b>T</b>,2 x 10-12,(EA),NR,1.0834236,'-,[1.06-1.11],"LINC02033, HSPD1P6",Schizophrenia,schizophrenia,GCST007201,3:36817092
rs1615350-<b>C</b>,4 x 10-12,(EA),NR,1.0888501,'-,[1.06-1.11],MPHOSPH9,Schizophrenia,schizophrenia,GCST007201,12:123165788
rs38752-<b>T</b>,5 x 10-12,(EA),NR,1.0822511,'-,[1.06-1.1],IMMP2L,Schizophrenia,schizophrenia,GCST007201,7:111438856
rs9461856-<b>A</b>,7 x 10-12,(EA),NR,1.0775862,'-,[1.06-1.1],SYNGAP1,Schizophrenia,schizophrenia,GCST007201,6:33427422
rs778371-<b>G</b>,8 x 10-12,(EA),NR,1.0854228,'-,[1.06-1.11],SNORC,Schizophrenia,schizophrenia,GCST007201,2:232878399
rs2905426-<b>G</b>,4 x 10-9,(EA),NR,1.0695187,'-,[1.05-1.09],"MAU2, GATAD2A",Schizophrenia,schizophrenia,GCST007201,19:19367213
rs2910032-<b>C</b>,5 x 10-9,(EA),NR,1.0650761,'-,[1.04-1.09],LINC01470,Schizophrenia,schizophrenia,GCST007201,5:153160794
rs6738529-<b>G</b>,6 x 10-9,(EA),NR,1.0706638,'-,[1.05-1.09],"EFHD1, GIGYF2",Schizophrenia,schizophrenia,GCST007201,2:232686251
rs73191547-<b>T</b>,6 x 10-9,(EA),NR,1.0695187,'-,[1.05-1.09],MSRA,Schizophrenia,schizophrenia,GCST007201,8:10175915
rs75575209-<b>T</b>,9 x 10-9,(EA),NR,1.118068,'-,[1.08-1.16],VRK2,Schizophrenia,schizophrenia,GCST007201,2:57911057
rs10940346-<b>G</b>,2 x 10-7,,NR,1.049318,'-,[1.03-1.07],EMB,Schizophrenia,schizophrenia,GCST007201,5:50510208
rs4391122-<b>A</b>,5 x 10-13,,NR,1.074,'-,[1.05-1.09],LINC02057,Schizophrenia,schizophrenia,GCST007201,5:61302716
rs1065861-<b>T</b>,3 x 10-7,,NR,1.0928961,'-,[1.06-1.13],MEF2C,Schizophrenia,schizophrenia,GCST007201,5:88796133
rs2247870-<b>A</b>,5 x 10-7,,NR,1.047,'-,[1.03-1.07],ADGRV1,Schizophrenia,schizophrenia,GCST007201,5:90855772
rs4388249-<b>T</b>,2 x 10-8,,NR,1.065,'-,[1.04-1.09],MAN2A1,Schizophrenia,schizophrenia,GCST007201,5:109700365
rs248083-<b>A</b>,2 x 10-7,,NR,1.054,'-,[1.03-1.07],"MRPS5P3, SELENOTP2",Schizophrenia,schizophrenia,GCST007201,5:127174476
rs2764766-<b>C</b>,2 x 10-8,,NR,1.055,'-,[1.04-1.07],CCDC192,Schizophrenia,schizophrenia,GCST007201,5:127877933
rs146300688-<b>C</b>,4 x 10-6,(East Asian),NR,1.2468828,'-,[1.09-1.4],LINC01320,Schizophrenia,schizophrenia,GCST007201,2:34062217
rs820970-<b>G</b>,5 x 10-6,(East Asian),NR,1.123,'-,[1.07-1.18],'-,Schizophrenia,schizophrenia,GCST007201,2:57513953
rs1518395-<b>G</b>,1 x 10-12,(East Asian),NR,1.1376565,'-,[1.1-1.17],VRK2,Schizophrenia,schizophrenia,GCST007201,2:57980939
rs10994415-<b>C</b>,7 x 10-11,,NR,1.27,'-,[NR],ANK3,Bipolar disorder,bipolar disorder,GCST002385,10:60562276
rs2011503-<b>?</b>,9 x 10-8,,NR,1.15,'-,[NR],MAU2,Bipolar disorder,bipolar disorder,GCST002385,19:19333177
rs12290811-<b>A</b>,1 x 10-9,,NR,1.19,'-,[NR],TENM4,Bipolar disorder,bipolar disorder,GCST002385,11:79372576
rs17826816-<b>G</b>,1 x 10-8,,NR,1.14,'-,[NR],ADCY2,Bipolar disorder,bipolar disorder,GCST002385,5:7519185
rs12202969-<b>A</b>,1 x 10-8,,NR,1.12,'-,[NR],EIF4EBP2P3,Bipolar disorder,bipolar disorder,GCST002385,6:98128347
rs6550435-<b>G</b>,2 x 10-8,,NR,1.13,'-,[NR],"TRANK1, LINC02033",Bipolar disorder,bipolar disorder,GCST002385,3:36822998
rs12290811-<b>A</b>,4 x 10-6,,0.15,1.2,'-,[NR],TENM4,Bipolar disorder,bipolar disorder,GCST000220,11:79372576
rs10994336-<b>T</b>,9 x 10-9,,0.05,1.45,'-,[NR],ANK3,Bipolar disorder,bipolar disorder,GCST000220,10:60420054
rs2314398-<b>?</b>,3 x 10-6,,0.69,1.17,'-,[NR],"CNNM4, LMAN2L",Bipolar disorder,bipolar disorder,GCST000220,2:96747751
rs11720452-<b>?</b>,5 x 10-6,,0.58,1.15,'-,[NR],SGO1-AS1,Bipolar disorder,bipolar disorder,GCST000220,3:21207150
rs12899449-<b>?</b>,4 x 10-7,,0.72,1.2,'-,[NR],LINC02694,Bipolar disorder,bipolar disorder,GCST000220,15:38703290
rs8015959-<b>T</b>,5 x 10-6,,0.02,1.59,'-,[NR],NPAS3,Bipolar disorder,bipolar disorder,GCST000220,14:33011716
rs1601875-<b>?</b>,7 x 10-6,,0.5,1.14,'-,[NR],SUMF1,Bipolar disorder,bipolar disorder,GCST000220,3:3617156
rs4130590-<b>?</b>,3 x 10-6,,0.56,1.16,'-,[NR],GARNL3,Bipolar disorder,bipolar disorder,GCST000220,9:127345685
rs16966460-<b>G</b>,4 x 10-6,,0.1,1.26,'-,[NR],SPRED1,Bipolar disorder,bipolar disorder,GCST000220,15:38219782
rs12436436-<b>C</b>,5 x 10-6,,0.08,1.3,'-,[NR],LINC00596,Bipolar disorder,bipolar disorder,GCST000220,14:23912306
rs4380451-<b>?</b>,4 x 10-6,,0.73,1.18,'-,[NR],CMTM8,Bipolar disorder,bipolar disorder,GCST000220,3:32288005
rs216345-<b>T</b>,4 x 10-6,,0.37,1.15,'-,[NR],UBE2R2-AS1,Bipolar disorder,bipolar disorder,GCST000220,9:33799372
rs3821396-<b>A</b>,5 x 10-6,,0.11,1.23,'-,[NR],ZNF385D,Bipolar disorder,bipolar disorder,GCST000220,3:21664877
rs1948368-<b>?</b>,6 x 10-6,,0.51,1.15,'-,[NR],LINC01307,Bipolar disorder,bipolar disorder,GCST000220,1:101472921
rs544368-<b>T</b>,6 x 10-6,,0.12,1.22,'-,[NR],SIAE,Bipolar disorder,bipolar disorder,GCST000220,11:124668099
rs2278702-<b>?</b>,6 x 10-6,,0.83,1.21,'-,[NR],"LINC00927, ARNT2",Bipolar disorder,bipolar disorder,GCST000220,15:80402580
rs7226677-<b>G</b>,7 x 10-6,,0.12,1.24,'-,[NR],"COLEC12, THOC1-DT",Bipolar disorder,bipolar disorder,GCST000220,18:278796
rs703965-<b>?</b>,8 x 10-6,,0.54,1.15,'-,[NR],ZMIZ1,Bipolar disorder,bipolar disorder,GCST000220,10:79195310
rs1006737-<b>A</b>,7 x 10-8,,0.32,1.18,'-,[NR],CACNA1C,Bipolar disorder,bipolar disorder,GCST000220,12:2236129
rs17082664-<b>G</b>,4 x 10-6,,0.13,1.22,'-,[NR],SYNE1,Bipolar disorder,bipolar disorder,GCST000220,6:152417619
rs7042161-<b>?</b>,6 x 10-6,,0.65,1.15,'-,[NR],SVEP1,Bipolar disorder,bipolar disorder,GCST000220,9:110434983
rs1064395-<b>A</b>,2 x 10-9,,0.16,1.17,'-,[NR],NCAN,Bipolar disorder,bipolar disorder,GCST000985,19:19250926
rs9271192-<b>C</b>,4 x 10-8,,0.2751,'-,5.49 z-unit increase,NR,"HLA-DRB1, HLA-DQA1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:32610753
rs6931277-<b>T</b>,8 x 10-11,,0.153,'-,6.49 z-unit decrease,NR,"HLA-DQA1, HLA-DRB1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:32615580
rs9469112-<b>T</b>,1 x 10-10,,0.1734,'-,6.4424515 z-unit increase,NR,"HLA-DRA, HLA-DRB9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:32447376
rs16830122-<b>A</b>,2 x 10-6,,0.13,1.17,'-,[1.10-1.25],KCNN3,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,1:154713065
rs4663105-<b>C</b>,2 x 10-12,,0.43,1.19,'-,[1.13-1.24],"BIN1, NIFKP9",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,2:127133851
rs16847609-<b>A</b>,5 x 10-7,,0.09,1.19,'-,[1.11-1.28],"HSPA8P9, CLDN18",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,3:137931894
rs13146780-<b>C</b>,3 x 10-6,,0.05,1.23,'-,[1.13-1.34],RN7SL193P,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,4:43849075
rs78538083-<b>C</b>,8 x 10-6,,0.06,1.32,'-,[1.17-1.48],IL21-AS1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,4:122647254
rs71636213-<b>G</b>,9 x 10-6,,0.1,1.18,'-,[1.10-1.27],"SERINC5, KRT18P45",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:80285949
rs382216-<b>C</b>,2 x 10-7,,0.64,1.1494253,'-,[1.09-1.22],CDC42SE2,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131351444
rs6890695-<b>G</b>,6 x 10-7,,0.79,1.1494253,'-,[1.09-1.22],RAPGEF6,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131552731
rs758324-<b>T</b>,4 x 10-7,,0.81,1.1627907,'-,[1.1-1.22],FNIP1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131773852
rs142958719-<b>G</b>,3 x 10-7,,0.82,1.1627907,'-,[1.1-1.23],MEIKIN,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131897266
rs476428-<b>G</b>,2 x 10-7,,0.81,1.1627907,'-,[1.1-1.23],ACSL6,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131965922
rs11168036-<b>T</b>,3 x 10-7,,0.5,1.12,'-,[1.07-1.17],"HBEGF, PFDN1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:140327854
rs11761441-<b>G</b>,2 x 10-6,,0.46,1.12,'-,[1.07-1.17],'-,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,7:82377
rs10807828-<b>C</b>,7 x 10-6,,0.51,1.098901,'-,[1.05-1.15],'-,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,7:25528235
rs75045569-<b>T</b>,8 x 10-6,,0.83,1.1494253,'-,[1.08-1.22],EPHA1-AS1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,7:143412115
rs2279590-<b>C</b>,2 x 10-6,,0.6,1.1235955,'-,[1.08-1.18],CLU,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,8:27598736
rs7920721-<b>G</b>,3 x 10-6,,0.38,1.12,'-,[1.07-1.17],"ECHDC3, USP6NL-AS1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,10:11678309
rs59616746-<b>C</b>,1 x 10-6,,0.85,1.2987013,'-,[1.18-1.45],SH2D4B,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,10:80629227
rs61310603-<b>T</b>,8 x 10-6,,0.84,1.1904762,'-,[1.11-1.3],'-,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,10:128547890
rs1582763-<b>G</b>,2 x 10-9,,0.63,1.1494253,'-,[1.1-1.2],MS4A4A,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,11:60254475
rs3851179-<b>C</b>,2 x 10-6,,0.65,1.1235955,'-,[1.06-1.18],"RNU6-560P, LINC02695",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,11:86157598
rs10498633-<b>G</b>,4 x 10-7,,0.78,1.1494253,'-,[1.09-1.22],SLC24A4,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,14:92460608
rs7207400-<b>T</b>,5 x 10-6,,0.75,1.1363636,'-,[1.08-1.2],LINC02210-CRHR1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:45746994
rs2732703-<b>T</b>,6 x 10-9,,0.87,1.369863,'-,[1.23-1.54],ARL17B,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:46275856
rs199499-<b>C</b>,6 x 10-6,,0.81,1.1627907,'-,[1.09-1.23],WNT3,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:46788132
rs71380849-<b>A</b>,9 x 10-7,,0.05,1.47,'-,[1.26-1.71],"CDR2L, HID1-AS1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:74979653
rs6110969-<b>T</b>,3 x 10-6,,0.08,1.2,'-,[1.11-1.29],PPIAP17,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,20:16216865
rs59043219-<b>A</b>,9 x 10-6,,0.37,1.19,'-,[1.10-1.28],IRF6,Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,1:209797265
rs1936246-<b>T</b>,2 x 10-13,,0.43,1.04,'-,[1.03-1.05],"RBBP4P4, GAPDHP15",Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,6:58045670
rs116139393-<b>C</b>,3 x 10-8,,0.84,1.098901,'-,[1.06-1.12],PMS2CL,Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,7:6732029
rs1595014-<b>T</b>,4 x 10-6,,0.72,1.1904762,'-,[1.11-1.28],TMEM106B,Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,7:12148903
rs10792832-<b>G</b>,4 x 10-6,,0.65,1.14,'-,[1.08-1.19],"LINC02695, RNU6-560P",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,11:86156833
rs679515-<b>T</b>,4 x 10-9,,0.21,1.22,'-,[1.14-1.30],CR1,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,1:207577223
rs6733839-<b>T</b>,1 x 10-9,,0.41,1.2,'-,[1.13-1.27],"NIFKP9, BIN1",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:127135234
rs1125355-<b>A</b>,4 x 10-6,,0.26,1.16,'-,[1.09-1.23],DAPL1,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:158844068
rs17366218-<b>A</b>,2 x 10-6,,0.95,1.5384616,'-,[1.28-1.85],PDE1A,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:182154019
rs178585-<b>C</b>,4 x 10-6,,0.47,1.13,'-,[1.07-1.19],'-,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:211107743
rs71316816-<b>C</b>,9 x 10-6,,0.92,1.25,'-,[1.14-1.37],CADM2,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,3:85855884
rs9869689-<b>T</b>,3 x 10-6,,0.1,1.21,'-,[1.12-1.31],FBXO40,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,3:121607829
rs10018288-<b>G</b>,4 x 10-6,,0.19,1.16,'-,[1.09-1.24],"LINC00290, LINC02500",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,4:181180536
rs2876189-<b>G</b>,6 x 10-6,,0.31,1.14,'-,[1.08-1.21],OFCC1,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,6:10101984
rs1129187-<b>T</b>,7 x 10-6,,0.45,1.13,'-,[1.07-1.19],PEX6,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,6:42964462
rs59406683-<b>A</b>,6 x 10-6,,0.89,1.2048193,'-,[1.11-1.3],'-,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,7:110142514
rs9331896-<b>T</b>,3 x 10-9,,0.62,1.1904762,'-,[1.12-1.25],CLU,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,8:27610169
rs639012-<b>G</b>,1 x 10-7,,0.7,1.1627907,'-,[1.1-1.22],PICALM,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,11:85970540
rs471470-<b>A</b>,3 x 10-8,,0.68,1.1627907,'-,[1.1-1.23],"RNU6-560P, PICALM",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,11:86120499
rs2854437-<b>G</b>,2 x 10-6,,0.87,1.2345679,'-,[1.14-1.35],SORD,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,15:45065212
rs721146-<b>A</b>,4 x 10-6,,0.21,1.17,'-,[1.09-1.25],LINC01684,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,21:24540925
rs2271920-<b>A</b>,8 x 10-6,,0.39,1.11,'-,[1.06-1.16],PTK2B,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,8:27458600
rs11218343-<b>T</b>,9 x 10-6,,0.96,1.3,'-,[1.16-1.45],SORL1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,11:121564878
rs11136000-<b>?</b>,9 x 10-10,,0.6,1.16,'-,[1.11-1.22],'-,Alzheimer's disease,Alzheimer's disease,GCST000479,Mapping not available
rs3851179-<b>?</b>,1 x 10-9,,0.63,1.16,'-,[1.11-1.22],"RNU6-560P, LINC02695",Alzheimer's disease,Alzheimer's disease,GCST000479,11:86157598
rs2075650-<b>?</b>,2 x 10-157,,0.15,2.53,'-,[2.37-2.71],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000479,19:44892362
"rs7081208-<b>A</b>, rs17314229-<b>C</b>, rs2446581-<b>A</b>",1 x 10-10,,0.028,1.68,'-,[1.43-1.96],FRMD4A; No mapped genes; No mapped genes,Alzheimer's disease,Alzheimer's disease,GCST001449,10:13949865
rs1060743-<b>?</b>,5 x 10-8,,NR,1.1066935,'-,'-,BIN1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,2:127068957
rs1532278-<b>?</b>,6 x 10-10,,NR,1.1177499,'-,'-,CLU,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,8:27608798
rs3865444-<b>?</b>,2 x 10-6,,NR,1.0942049,'-,'-,"CD33, SIGLEC22P",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,19:51224706
rs6656401-<b>?</b>,7 x 10-11,,NR,1.1725225,'-,'-,CR1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,1:207518704
rs7232-<b>?</b>,6 x 10-7,,NR,1.0942651,'-,'-,MS4A6A,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:60173126
rs7412-<b>?</b>,3 x 10-105,,NR,2.3065467,'-,'-,APOE,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,19:44908822
rs143332484-<b>T</b>,2 x 10-14,,NR,1.6665556,'-,[1.46-1.90],TREM2,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,6:41161469
rs616338-<b>T</b>,5 x 10-10,,NR,1.4296066,'-,[1.3-1.6],ABI3,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,17:49219935
rs72824905-<b>?</b>,5 x 10-10,,NR,1.4756235,'-,[1.25-1.67],PLCG2,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,16:81908423
rs75932628-<b>T</b>,5 x 10-24,,NR,2.4557426,'-,[2.06-2.92],TREM2,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,6:41161514
rs78541046-<b>?</b>,2 x 10-6,(adjusted),NR,6.2228026,'-,[2.94-12.5],RHBDF1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,16:63029
rs11828907-<b>C</b>,2 x 10-7,,NR,4.4935546,'-,[2.55-7.92],AHNAK,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:62521506
rs139967528-<b>G</b>,6 x 10-10,,NR,6.119662,'-,[3.45-10.9],ATP5F1C,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,10:7799848
rs201850688-<b>G</b>,9 x 10-6,,NR,1.804889,'-,[1.39-2.34],BSG,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,19:572671
rs201879533-<b>?</b>,4 x 10-6,(adjusted),NR,5.6306844,'-,[2.7-12.5],THSD4,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,15:71746912
rs56009889-<b>?</b>,6 x 10-7,,NR,3.0578122,'-,[1.96-4.76],"ATM, C11orf65",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:108326169
rs148619105-<b>?</b>,1 x 10-7,,NR,1.8587084,'-,[1.47-2.33],TECTA,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:121146015
rs7185636-<b>T</b>,2 x 10-8,,0.82,1.0869565,'-,[1.05-1.12],IQCK,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,16:19796841
rs593742-<b>A</b>,7 x 10-9,,0.705,1.0752687,'-,[1.05-1.1],"ADAM10, SNORD3P1",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,15:58753575
rs2830500-<b>C</b>,3 x 10-8,,0.692,1.0752687,'-,[1.04-1.1],ADAMTS1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,21:26784537
rs4735340-<b>T</b>,9 x 10-8,,0.524,1.0638298,'-,[1.04-1.09],NDUFAF6,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,8:94964023
rs10467994-<b>T</b>,4 x 10-7,,0.667,1.0638298,'-,[1.04-1.09],SPPL2A,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,15:50716490
rs2632516-<b>G</b>,5 x 10-8,,0.56,1.0638298,'-,[1.04-1.1],TSPOAP1-AS1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,17:58331728
rs7295246-<b>G</b>,4 x 10-7,,0.413,1.06,'-,[1.04-1.08],"ADAMTS20, EEF1A1P17",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,12:43573874
rs7920721-<b>G</b>,2 x 10-11,,0.39,1.08,'-,[1.06-1.11],"ECHDC3, USP6NL-AS1",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,10:11678309
rs138190086-<b>A</b>,5 x 10-9,,0.02,1.3,'-,[1.19-1.42],"PPIAP55, CYB561",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,17:63460787
rs114812713-<b>C</b>,2 x 10-13,,0.03,1.32,'-,[1.22-1.42],OARD1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,6:41066261
rs62039712-<b>A</b>,4 x 10-8,,0.116,1.16,'-,[1.10-1.23],RNA5SP431,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,16:79321960
rs35868327-<b>T</b>,3 x 10-7,,0.987,1.4705882,'-,[1.27-1.69],'-,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,5:53369400
rs71618613-<b>A</b>,3 x 10-7,,0.99,1.4084507,'-,[1.23-1.59],LINC02109,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,5:29005878
rs190094306-<b>?</b>,4 x 10-6,,NR,1.62,'-,[1.32-1.99],NHLRC3,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,13:39050685
rs187857322-<b>?</b>,2 x 10-6,,NR,1.63,'-,[1.33-2.00],"OR7E59P, OR7E136P",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,7:6869229
rs192326911-<b>?</b>,3 x 10-6,,NR,1.65,'-,[1.34-2.04],"STAU2-AS1, RDH10-AS1",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,8:73378103
rs192098867-<b>?</b>,7 x 10-6,,NR,1.2987013,'-,[1.16-1.47],TRPM1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,15:31149558
rs35833468-<b>?</b>,3 x 10-6,,NR,1.0869565,'-,[1.04-1.12],EGLN3,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,14:33974720
rs190217640-<b>?</b>,7 x 10-6,,NR,1.4492754,'-,[1.23-1.69],NEGR1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,1:71755908
rs19213255-<b>?</b>,4 x 10-6,,NR,1.3333333,'-,[1.18-1.49],'-,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,Mapping not available
rs182921547-<b>?</b>,8 x 10-7,,NR,1.38,'-,[1.21-1.56],'-,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,4:32832588
rs8111708-<b>?</b>,2 x 10-6,,NR,1.06,'-,[1.03-1.09],ELL,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,19:18448066
rs11038990-<b>?</b>,6 x 10-6,,NR,1.09,'-,[1.05-1.13],CKAP5,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,11:46783211
rs6806784-<b>?</b>,4 x 10-6,,NR,1.53,'-,[1.28-1.83],SENP7,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,3:101508591
rs7647854-<b>G</b>,5 x 10-11,(50% oldest-onset cases),0.16,1.16,'-,[1.11-1.21],"C3orf70, EHHADH-AS1",Major depressive disorder,unipolar depression,GCST003558,3:185158995
rs9323497-<b>?</b>,4 x 10-6,(European),NR,'-,4.61 Z score increase,'-,PLEK2,Depressive symptom measurement or major depressive disorder,"unipolar depression, depressive symptom measurement",GCST004024,14:67406411
rs9825823-<b>?</b>,7 x 10-10,,NR,'-,6.2 Z score increase,'-,FHIT,Depressive symptom measurement or major depressive disorder,"unipolar depression, depressive symptom measurement",GCST004024,3:61096480
rs111625585-<b>T</b>,7 x 10-8,,0.06,1.57,'-,1.33-1.84,Metazoa_SRP,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,14:82337988
rs116428372-<b>A</b>,2 x 10-7,,0.06,1.74,'-,1.41-2.14,CAPN15,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,16:539359
rs77033326-<b>A</b>,2 x 10-7,,0.02,2.24,'-,1.65-3.03,FAM13A,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,4:88856467
rs183414028-<b>C</b>,2 x 10-7,,0.01,2.564103,'-,[1.79-3.7],"MFSD2A, CAP1",Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,1:39976354
rs113330417-<b>G</b>,2 x 10-7,,0.02,1.754386,'-,[1.41-2.17],GPHN,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,14:66782703
rs111367251-<b>G</b>,3 x 10-7,,0.01,2.2222223,'-,[1.64-3.03],CTTNBP2,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,7:145271196
rs62460873-<b>C</b>,5 x 10-7,,0.01,2.7027025,'-,[1.85-4],DYNLL1P7,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,7:85348650
rs186736781-<b>T</b>,6 x 10-7,,0.02,2.27,'-,1.64-3.13,C2orf69,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,2:239551396
chr15_24344805-I-<b>?</b>,7 x 10-7,,0.59,1.2658228,'-,[1.15-1.37],'-,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,Mapping not available
rs111326206-<b>C</b>,7 x 10-7,,0.03,1.6129031,'-,[1.33-1.96],"TRPC1, PLS1",Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,3:142719589
chr6_128178230-I-<b>?</b>,8 x 10-7,,0.06,1.58,'-,1.32-1.90,'-,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,Mapping not available
rs184924771-<b>C</b>,9 x 10-7,,0.01,2.564103,'-,[1.75-3.7],LINC02699,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,11:25863658
rs113386487-<b>T</b>,1 x 10-6,,0.02,2.1276596,'-,[1.56-2.86],"RBISP1, SEPHS1",Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,10:13316583
rs13137453-<b>G</b>,1 x 10-6,,0.02,2.173913,'-,[1.59-2.94],FHDC1,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,4:152986727
rs9972552-<b>A</b>,1 x 10-6,,0.02,2.18,'-,1.59-2.98,PGBD4,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,15:34104712
rs191852465-<b>C</b>,1 x 10-6,,0.03,2.173913,'-,[1.59-2.94],"CICP24, MIR4283-2",Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,7:63703764
chr13_46256859-D-<b>?</b>,1 x 10-6,,0.01,2.27,'-,1.63-3.16,'-,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,Mapping not available
rs145440507-<b>T</b>,1 x 10-6,,0.01,2.7027025,'-,[1.82-4],"LINC02515, LINC02492",Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,4:187479383
rs76347430-<b>G</b>,1 x 10-6,,0.02,2,'-,[1.52-2.63],KAZN,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,1:14069324
rs45593736-<b>A</b>,3 x 10-8,,0.02,2.38,'-,[1.75-3.23],ARL5B,Suicide attempts in major depressive disorder,"unipolar depression, attempted suicide",GCST008118,10:18666008
rs161645-<b>A</b>,8 x 10-8,,0.34,'-,'-,'-,RNU6-334P,Depression (quantitative trait),unipolar depression,GCST001802,5:104734216
rs8020095-<b>A</b>,3 x 10-6,,0.17,'-,'-,'-,GPHN,Depression (quantitative trait),unipolar depression,GCST001802,14:66987141
rs1969253-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,DVL3,Major depressive disorder,unipolar depression,GCST001469,3:184158724
rs2173763-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,PARP15,Major depressive disorder,unipolar depression,GCST001469,3:122610313
rs2721937-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,TRPS1,Major depressive disorder,unipolar depression,GCST001469,8:115621472
rs4478239-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,LINC02374,Major depressive disorder,unipolar depression,GCST001469,4:187270152
rs9646303-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,ZCCHC14,Major depressive disorder,unipolar depression,GCST001469,16:87428363
rs56055643-<b>A</b>,5 x 10-8,,0.4,'-,10.75 unit increase,[7.0-14.5],"MOBP, RPSA",Dentate gyrus volume x schizophrenia interaction,"schizophrenia, dentate gyrus volume measurement",GCST008557,3:39431138
rs7903146-<b>C</b>,1 x 10-9,,0.61,1.53,'-,[1.39-1.67],TCF7L2,Schizophrenia vs type 2 diabetes,"schizophrenia, type II diabetes mellitus",GCST007223,10:112998590
chr6:163319442-<b>G</b>,5 x 10-9,,0.91,3.81,'-,[3.32-4.29],'-,Schizophrenia and type 2 diabetes,"schizophrenia, type II diabetes mellitus",GCST007220,Mapping not available
rs1449245-<b>A</b>,3 x 10-8,,0.79,1.96,'-,[1.71-2.20],'-,Schizophrenia and type 2 diabetes,"schizophrenia, type II diabetes mellitus",GCST007220,8:92576112
rs2159100-<b>T</b>,3 x 10-19,,NR,1.102,'-,[1.08-1.12],CACNA1C,Schizophrenia,schizophrenia,GCST004946,12:2237227
rs7893279-<b>T</b>,3 x 10-13,,NR,1.117,'-,[1.09-1.15],CACNB2,Schizophrenia,schizophrenia,GCST004946,10:18456176
rs17630293-<b>T</b>,3 x 10-12,,NR,1.124,'-,[1.09-1.16],SPATS2L,Schizophrenia,schizophrenia,GCST004946,2:200282053
rs76091702-<b>T</b>,1 x 10-7,,NR,1.124,'-,[1.08-1.17],LINC01470,Schizophrenia,schizophrenia,GCST004946,5:153103403
rs115329265-<b>A</b>,5 x 10-36,,NR,1.21,'-,[1.18-1.24],"NOP56P1, RPSAP2",Schizophrenia,schizophrenia,GCST004946,6:28744470
rs61041384-<b>C</b>,6 x 10-13,,NR,1.1223345,'-,[1.09-1.15],MPHOSPH9,Schizophrenia,schizophrenia,GCST004946,12:123159496
rs10786736-<b>G</b>,4 x 10-17,,NR,1.1148272,'-,[1.09-1.14],"CNNM2, NT5C2",Schizophrenia,schizophrenia,GCST004946,10:103089359
rs80256351-<b>C</b>,5 x 10-8,,NR,1.1135857,'-,[1.07-1.15],"ACTG1P22, VRK2",Schizophrenia,schizophrenia,GCST004946,2:57844458
rs75575209-<b>T</b>,1 x 10-8,,NR,1.1086475,'-,[1.07-1.14],VRK2,Schizophrenia,schizophrenia,GCST004946,2:57911057
rs111364339-<b>C</b>,5 x 10-9,,NR,1.1037527,'-,[1.07-1.14],RNU6-543P,Schizophrenia,schizophrenia,GCST004946,10:63098112
rs1198589-<b>C</b>,1 x 10-13,,NR,1.1025358,'-,[1.08-1.13],NFU1P2,Schizophrenia,schizophrenia,GCST004946,1:98084855
rs12704290-<b>G</b>,3 x 10-10,,NR,1.1013216,'-,[1.07-1.13],"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST004946,7:86798310
rs796364-<b>C</b>,2 x 10-16,,NR,1.0964912,'-,[1.07-1.12],"RN7SL717P, FTCDNL1",Schizophrenia,schizophrenia,GCST004946,2:199851396
rs61882743-<b>G</b>,7 x 10-12,,NR,1.0940919,'-,[1.07-1.12],AMBRA1,Schizophrenia,schizophrenia,GCST004946,11:46527204
rs1615350-<b>C</b>,6 x 10-18,,NR,1.091703,'-,[1.07-1.11],MPHOSPH9,Schizophrenia,schizophrenia,GCST004946,12:123165788
rs11191424-<b>G</b>,4 x 10-20,,NR,1.0905125,'-,[1.07-1.11],BORCS7-ASMT,Schizophrenia,schizophrenia,GCST004946,10:102866129
rs7619427-<b>G</b>,2 x 10-7,,NR,1.0857763,'-,[1.05-1.12],RNU6-367P,Schizophrenia,schizophrenia,GCST004946,3:44035549
rs12668848-<b>G</b>,4 x 10-17,,NR,1.0834236,'-,[1.06-1.1],MAD1L1,Schizophrenia,schizophrenia,GCST004946,7:1981360
rs778371-<b>G</b>,2 x 10-13,,NR,1.0834236,'-,[1.06-1.1],SNORC,Schizophrenia,schizophrenia,GCST004946,2:232878399
rs950169-<b>C</b>,5 x 10-12,,NR,1.0834236,'-,[1.06-1.11],ADAMTSL3,Schizophrenia,schizophrenia,GCST004946,15:84037709
rs999494-<b>C</b>,2 x 10-10,,NR,1.0822511,'-,[1.06-1.11],EMX1,Schizophrenia,schizophrenia,GCST004946,2:72930266
rs11708578-<b>G</b>,7 x 10-11,,NR,1.081081,'-,[1.06-1.1],CNTN4,Schizophrenia,schizophrenia,GCST004946,3:2474210
rs17687067-<b>C</b>,3 x 10-12,,NR,1.081081,'-,[1.06-1.1],ZDHHC2,Schizophrenia,schizophrenia,GCST004946,8:17178692
rs66691851-<b>C</b>,4 x 10-15,,NR,1.0799136,'-,[1.06-1.1],STAG1,Schizophrenia,schizophrenia,GCST004946,3:136435986
rs7801375-<b>G</b>,6 x 10-8,,NR,1.0799136,'-,[1.05-1.11],CAPZA1P4,Schizophrenia,schizophrenia,GCST004946,7:131882504
rs1792709-<b>A</b>,6 x 10-8,(Chinese),NR,1.1494253,'-,[1.1-1.2],"LINC01905, LINC01539",Schizophrenia,schizophrenia,GCST004946,18:56101744
rs4479915-<b>G</b>,5 x 10-9,(Chinese),NR,1.1415524,'-,[1.1-1.19],'-,Schizophrenia,schizophrenia,GCST004946,6:164654568
rs11534004-<b>G</b>,2 x 10-8,(Chinese),NR,1.1235955,'-,[1.08-1.16],PPP1R3A,Schizophrenia,schizophrenia,GCST004946,7:113827389
rs2073499-<b>A</b>,3 x 10-8,(Chinese),NR,1.112347,'-,[1.08-1.15],RASSF1,Schizophrenia,schizophrenia,GCST004946,3:50336862
rs5891007-<b>?</b>,1 x 10-7,(Chinese),NR,1.1086475,'-,[1.07-1.15],LSM1,Schizophrenia,schizophrenia,GCST004946,8:38163493
rs187568-<b>A</b>,3 x 10-6,(Chinese),NR,1.1025358,'-,[1.06-1.14],EDIL3,Schizophrenia,schizophrenia,GCST004946,5:84019804
rs12052801-<b>G</b>,9 x 10-7,(Chinese),NR,1.1013216,'-,[1.06-1.14],PPP3R1,Schizophrenia,schizophrenia,GCST004946,2:68196086
rs12620761-<b>T</b>,6 x 10-6,(Chinese),NR,1.098901,'-,[1.06-1.14],MGAT5,Schizophrenia,schizophrenia,GCST004946,2:134096560
rs10928112-<b>C</b>,2 x 10-6,(Chinese),NR,1.0964912,'-,[1.06-1.13],LRP1B,Schizophrenia,schizophrenia,GCST004946,2:141573400
rs259282-<b>T</b>,5 x 10-6,(Chinese),NR,1.0964912,'-,[1.06-1.14],ANKRD27,Schizophrenia,schizophrenia,GCST004946,19:32672137
rs3013169-<b>T</b>,3 x 10-6,(Chinese),NR,1.091703,'-,[1.05-1.13],EYS,Schizophrenia,schizophrenia,GCST004946,6:64133067
rs10744422-<b>C</b>,5 x 10-6,(Chinese),NR,1.092,'-,[1.05-1.13],HIP1R,Schizophrenia,schizophrenia,GCST004946,12:122852242
rs950394-<b>G</b>,1 x 10-6,(Chinese),NR,1.096,'-,[1.06-1.13],AHCYP3,Schizophrenia,schizophrenia,GCST004946,2:104353789
rs1021487-<b>T</b>,1 x 10-7,(Chinese),NR,1.105,'-,[1.07-1.14],LINC02494,Schizophrenia,schizophrenia,GCST004946,4:58590920
rs12660387-<b>A</b>,9 x 10-6,(Chinese),NR,1.106,'-,[1.06-1.15],EYS,Schizophrenia,schizophrenia,GCST004946,6:64581751
rs7757969-<b>T</b>,5 x 10-8,(Chinese),NR,1.11,'-,[1.07-1.15],FYN,Schizophrenia,schizophrenia,GCST004946,6:111810829
rs359260-<b>T</b>,7 x 10-7,(Chinese),NR,1.12,'-,[1.07-1.17],MIR4432HG,Schizophrenia,schizophrenia,GCST004946,2:60259801
rs3759413-<b>C</b>,2 x 10-7,(Chinese),NR,1.127,'-,[1.08-1.17],CLSTN3,Schizophrenia,schizophrenia,GCST004946,12:7138610
rs61990820-<b>G</b>,7 x 10-7,(Chinese),NR,1.133,'-,[1.08-1.18],NRXN3,Schizophrenia,schizophrenia,GCST004946,14:79899927
rs41464545-<b>A</b>,1 x 10-6,(Chinese),NR,1.15,'-,[1.09-1.21],LINC02232,Schizophrenia,schizophrenia,GCST004946,4:64952689
rs820970-<b>T</b>,6 x 10-6,(Chinese),NR,1.156,'-,[1.09-1.22],'-,Schizophrenia,schizophrenia,GCST004946,2:57513953
rs2962250-<b>A</b>,2 x 10-7,(Chinese),NR,1.178,'-,[1.12-1.24],"RNU6-1296P, RNU6-480P",Schizophrenia,schizophrenia,GCST004946,5:51094157
rs2514218-<b>C</b>,5 x 10-11,,NR,1.0775862,'-,[1.06-1.1],DRD2,Schizophrenia,schizophrenia,GCST004946,11:113522272
rs715170-<b>C</b>,5 x 10-12,,NR,1.0775862,'-,[1.06-1.1],"LINC01539, LINC01905",Schizophrenia,schizophrenia,GCST004946,18:56128283
rs9841616-<b>T</b>,5 x 10-9,,NR,1.0775862,'-,[1.05-1.1],SOX2-OT,Schizophrenia,schizophrenia,GCST004946,3:181449797
rs2381759-<b>T</b>,9 x 10-9,,NR,1.0764263,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST004946,2:145670463
rs16880831-<b>G</b>,4 x 10-10,,NR,1.0752687,'-,[1.05-1.1],STAU2,Schizophrenia,schizophrenia,GCST004946,8:110549276
rs172531-<b>G</b>,5 x 10-11,,NR,1.0741138,'-,[1.05-1.1],RERE,Schizophrenia,schizophrenia,GCST004946,1:8435530
rs35430959-<b>C</b>,6 x 10-8,,NR,1.0729614,'-,[1.05-1.1],PNPP1,Schizophrenia,schizophrenia,GCST004946,2:76238162
rs3825845-<b>C</b>,2 x 10-10,,NR,1.0729614,'-,[1.05-1.09],CHRNA3,Schizophrenia,schizophrenia,GCST004946,15:78617916
rs55661361-<b>G</b>,1 x 10-12,,NR,1.0729614,'-,[1.05-1.09],NRGN,Schizophrenia,schizophrenia,GCST004946,11:124744061
rs9292918-<b>G</b>,4 x 10-11,,NR,1.0729614,'-,[1.05-1.09],HCN1,Schizophrenia,schizophrenia,GCST004946,5:45300933
rs221780-<b>G</b>,3 x 10-7,,NR,1.0718113,'-,[1.05-1.1],"POP7, GIGYF1",Schizophrenia,schizophrenia,GCST004946,7:100699412
rs5757730-<b>G</b>,2 x 10-10,,NR,1.0718113,'-,[1.05-1.09],CACNA1I,Schizophrenia,schizophrenia,GCST004946,22:39571425
rs11685299-<b>C</b>,5 x 10-12,,NR,1.0706638,'-,[1.05-1.09],CUL3,Schizophrenia,schizophrenia,GCST004946,2:224526579
rs11790388-<b>G</b>,8 x 10-8,,NR,1.0706638,'-,[1.05-1.1],RALGPS1,Schizophrenia,schizophrenia,GCST004946,9:126978004
rs13261217-<b>G</b>,2 x 10-9,,NR,1.0706638,'-,[1.05-1.09],CSMD1,Schizophrenia,schizophrenia,GCST004946,8:4325535
rs217331-<b>G</b>,2 x 10-13,,NR,1.0706638,'-,[1.05-1.09],SNAP91,Schizophrenia,schizophrenia,GCST004946,6:83634970
rs34102591-<b>G</b>,5 x 10-8,,NR,1.0706638,'-,[1.05-1.09],"ZNF664, RFLNA",Schizophrenia,schizophrenia,GCST004946,12:123996254
rs12622667-<b>C</b>,1 x 10-6,,NR,1.0695187,'-,[1.04-1.1],EPC2,Schizophrenia,schizophrenia,GCST004946,2:148762617
rs35225048-<b>C</b>,8 x 10-13,,NR,1.0695187,'-,[1.05-1.09],'-,Schizophrenia,schizophrenia,GCST004946,15:61564064
rs9398171-<b>C</b>,2 x 10-11,,NR,1.0695187,'-,[1.05-1.09],FOXO3,Schizophrenia,schizophrenia,GCST004946,6:108662324
rs2577831-<b>C</b>,5 x 10-13,,NR,1.0683761,'-,[1.05-1.09],PBRM1,Schizophrenia,schizophrenia,GCST004946,3:52594040
rs3814881-<b>G</b>,8 x 10-13,,NR,1.0683761,'-,[1.05-1.09],TAOK2,Schizophrenia,schizophrenia,GCST004946,16:29989580
rs6430491-<b>G</b>,1 x 10-9,,NR,1.0683761,'-,[1.05-1.09],MGAT5,Schizophrenia,schizophrenia,GCST004946,2:134083396
rs8082590-<b>G</b>,7 x 10-10,,NR,1.0683761,'-,[1.05-1.09],GID4,Schizophrenia,schizophrenia,GCST004946,17:18055088
rs895526-<b>C</b>,9 x 10-10,,NR,1.0683761,'-,[1.05-1.09],SATB2,Schizophrenia,schizophrenia,GCST004946,2:199297702
rs319204-<b>T</b>,4 x 10-7,,NR,1.051,'-,[1.03-1.07],PPP2R2B,Schizophrenia,schizophrenia,GCST004946,5:146882926
rs4632195-<b>T</b>,2 x 10-6,,NR,1.051,'-,[1.03-1.07],DCC,Schizophrenia,schizophrenia,GCST004946,18:53220378
rs10199182-<b>A</b>,7 x 10-7,,NR,1.052,'-,[1.03-1.07],LINC01884,Schizophrenia,schizophrenia,GCST004946,2:22524252
rs12541020-<b>T</b>,4 x 10-7,,NR,1.052,'-,[1.03-1.07],CSMD1,Schizophrenia,schizophrenia,GCST004946,8:4960070
rs13074132-<b>T</b>,2 x 10-6,,NR,1.052,'-,[1.03-1.07],FHIT,Schizophrenia,schizophrenia,GCST004946,3:60335351
rs2247870-<b>A</b>,3 x 10-8,,NR,1.052,'-,[1.03-1.07],ADGRV1,Schizophrenia,schizophrenia,GCST004946,5:90855772
rs7733403-<b>A</b>,2 x 10-8,,NR,1.052,'-,[1.03-1.07],"PCDHA1, VTRNA1-3",Schizophrenia,schizophrenia,GCST004946,5:140774630
rs1411740-<b>A</b>,2 x 10-7,,NR,1.053,'-,[1.03-1.07],LINC00571,Schizophrenia,schizophrenia,GCST004946,13:38256005
rs7099380-<b>A</b>,7 x 10-8,,NR,1.054,'-,[1.03-1.07],CACNB2,Schizophrenia,schizophrenia,GCST004946,10:18260087
rs7807720-<b>A</b>,1 x 10-7,,NR,1.054,'-,[1.03-1.07],'-,Schizophrenia,schizophrenia,GCST004946,7:110433698
rs248083-<b>A</b>,6 x 10-8,,NR,1.055,'-,[1.04-1.07],"MRPS5P3, SELENOTP2",Schizophrenia,schizophrenia,GCST004946,5:127174476
rs2764766-<b>C</b>,2 x 10-8,,NR,1.055,'-,[1.04-1.07],CCDC192,Schizophrenia,schizophrenia,GCST004946,5:127877933
rs7523273-<b>A</b>,6 x 10-7,,NR,1.055,'-,[1.03-1.08],MIR29B2CHG,Schizophrenia,schizophrenia,GCST004946,1:207803738
rs8012642-<b>C</b>,5 x 10-8,,NR,1.055,'-,[1.04-1.07],MTCYBP27,Schizophrenia,schizophrenia,GCST004946,14:84203137
rs9384900-<b>T</b>,1 x 10-6,,NR,1.055,'-,[1.03-1.08],HDAC2-AS2,Schizophrenia,schizophrenia,GCST004946,6:114389931
rs12619354-<b>T</b>,4 x 10-8,,NR,1.056,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST004946,2:193138056
rs61712019-<b>T</b>,1 x 10-6,,NR,1.056,'-,[1.03-1.08],LRRTM4,Schizophrenia,schizophrenia,GCST004946,2:77477763
rs12138061-<b>A</b>,1 x 10-7,,NR,1.057,'-,[1.04-1.08],ELAVL4,Schizophrenia,schizophrenia,GCST004946,1:50106424
rs1353545-<b>C</b>,2 x 10-7,,NR,1.057,'-,[1.04-1.08],FHIT,Schizophrenia,schizophrenia,GCST004946,3:60302116
rs2980436-<b>A</b>,2 x 10-8,,NR,1.057,'-,[1.04-1.08],FAM86B3P,Schizophrenia,schizophrenia,GCST004946,8:8234503
rs146300688-<b>T</b>,8 x 10-7,(Chinese),NR,1.633987,'-,[1.44-1.83],LINC01320,Schizophrenia,schizophrenia,GCST004946,2:34062217
rs78681500-<b>T</b>,3 x 10-10,(Chinese),NR,1.3315579,'-,[1.24-1.42],SPATS2L,Schizophrenia,schizophrenia,GCST004946,2:200322593
rs111782145-<b>C</b>,2 x 10-8,(Chinese),NR,1.2300123,'-,[1.16-1.3],"GTF2H4, DDR1",Schizophrenia,schizophrenia,GCST004946,6:30905731
rs7989524-<b>A</b>,3 x 10-6,(Chinese),NR,1.1627907,'-,[1.1-1.23],PHF2P2,Schizophrenia,schizophrenia,GCST004946,13:19057017
rs1518395-<b>A</b>,4 x 10-13,(Chinese),NR,1.1600928,'-,[1.12-1.2],VRK2,Schizophrenia,schizophrenia,GCST004946,2:57980939
rs36025579-<b>G</b>,5 x 10-7,,NR,1.0515248,'-,[1.03-1.07],DPYD,Schizophrenia,schizophrenia,GCST004946,1:97337068
rs7022054-<b>G</b>,1 x 10-7,,NR,1.0515248,'-,[1.03-1.07],KDM4C,Schizophrenia,schizophrenia,GCST004946,9:7173500
rs10124101-<b>G</b>,2 x 10-7,,NR,1.0504202,'-,[1.03-1.07],"HMGB3P24, RNF38",Schizophrenia,schizophrenia,GCST004946,9:36308830
rs11127668-<b>C</b>,5 x 10-7,,NR,1.0504202,'-,[1.03-1.07],"HMGB1P38, ROBO1",Schizophrenia,schizophrenia,GCST004946,3:79866620
rs12431410-<b>C</b>,5 x 10-7,,NR,1.0504202,'-,[1.03-1.07],RTN1,Schizophrenia,schizophrenia,GCST004946,14:59699304
rs34321714-<b>G</b>,3 x 10-7,,NR,1.0504202,'-,[1.03-1.07],RIMS1,Schizophrenia,schizophrenia,GCST004946,6:72454442
rs4626214-<b>G</b>,5 x 10-7,,NR,1.0504202,'-,[1.03-1.07],LINC02267,Schizophrenia,schizophrenia,GCST004946,4:96805918
rs1864774-<b>C</b>,2 x 10-7,,NR,1.049318,'-,[1.03-1.07],DLG2,Schizophrenia,schizophrenia,GCST004946,11:83488233
rs2372993-<b>C</b>,7 x 10-7,,NR,1.049318,'-,[1.03-1.07],"QPCT, RNU6-939P",Schizophrenia,schizophrenia,GCST004946,2:37334786
rs2194545-<b>G</b>,2 x 10-6,,NR,1.048218,'-,[1.03-1.07],"SNF8P1, LINC01807",Schizophrenia,schizophrenia,GCST004946,2:228418495
rs2526882-<b>G</b>,1 x 10-6,,NR,1.048218,'-,[1.03-1.07],PCNX1,Schizophrenia,schizophrenia,GCST004946,14:70907985
rs7529073-<b>C</b>,3 x 10-7,,NR,1.048218,'-,[1.03-1.07],PROX1-AS1,Schizophrenia,schizophrenia,GCST004946,1:213974546
rs7915131-<b>C</b>,6 x 10-7,,NR,1.048218,'-,[1.03-1.07],ALDH7A1P4,Schizophrenia,schizophrenia,GCST004946,10:62658896
rs4833558-<b>C</b>,3 x 10-6,,NR,1.0471205,'-,[1.03-1.07],NDST3,Schizophrenia,schizophrenia,GCST004946,4:117998342
rs13259407-<b>C</b>,2 x 10-6,,NR,1.0449321,'-,[1.03-1.06],PSD3,Schizophrenia,schizophrenia,GCST004946,8:18565413
rs1460583-<b>C</b>,4 x 10-6,,NR,1.0449321,'-,[1.03-1.06],ZFPM2,Schizophrenia,schizophrenia,GCST004946,8:105096365
rs11102159-<b>T</b>,3 x 10-6,,NR,1.048,'-,[1.03-1.07],"NRBF2P3, Y_RNA",Schizophrenia,schizophrenia,GCST004946,1:110782105
rs11240341-<b>T</b>,3 x 10-6,,NR,1.049,'-,[1.03-1.07],CNTN2,Schizophrenia,schizophrenia,GCST004946,1:205046156
rs12664251-<b>A</b>,7 x 10-7,,NR,1.049,'-,[1.03-1.07],FAM184A,Schizophrenia,schizophrenia,GCST004946,6:119023381
rs4347184-<b>T</b>,2 x 10-7,,NR,1.049,'-,[1.03-1.07],PDE4B,Schizophrenia,schizophrenia,GCST004946,1:65848311
rs7523654-<b>T</b>,2 x 10-6,,NR,1.049,'-,[1.03-1.07],"NGF-AS1, NGF",Schizophrenia,schizophrenia,GCST004946,1:115318644
rs12148337-<b>T</b>,6 x 10-8,,NR,1.05,'-,[1.03-1.07],'-,Schizophrenia,schizophrenia,GCST004946,15:70296933
rs2905627-<b>T</b>,3 x 10-6,,NR,1.05,'-,[1.03-1.07],CXXC4-AS1,Schizophrenia,schizophrenia,GCST004946,4:104528928
rs35662245-<b>A</b>,5 x 10-7,,NR,1.05,'-,[1.03-1.07],LINC01911,Schizophrenia,schizophrenia,GCST004946,2:146825619
rs7811417-<b>T</b>,2 x 10-7,,NR,1.05,'-,[1.03-1.07],SP4,Schizophrenia,schizophrenia,GCST004946,7:21494534
rs10803138-<b>G</b>,8 x 10-8,,NR,1.0672358,'-,[1.04-1.09],SDCCAG8,Schizophrenia,schizophrenia,GCST004946,1:243391917
rs302321-<b>C</b>,2 x 10-11,,NR,1.0672358,'-,[1.05-1.09],TMTC1,Schizophrenia,schizophrenia,GCST004946,12:29775455
rs2053079-<b>G</b>,5 x 10-9,,NR,1.066098,'-,[1.04-1.09],ZNF536,Schizophrenia,schizophrenia,GCST004946,19:30496516
rs11778040-<b>C</b>,8 x 10-7,,NR,1.0649627,'-,[1.04-1.09],GULOP,Schizophrenia,schizophrenia,GCST004946,8:27562290
rs12190758-<b>G</b>,4 x 10-7,,NR,1.0649627,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST004946,6:92438623
rs6500596-<b>G</b>,5 x 10-9,,NR,1.0649627,'-,[1.04-1.09],"CORO7-PAM16, CORO7",Schizophrenia,schizophrenia,GCST004946,16:4420026
rs7010876-<b>T</b>,1 x 10-8,,NR,1.0649627,'-,[1.04-1.09],MMP16,Schizophrenia,schizophrenia,GCST004946,8:88252522
rs11740474-<b>T</b>,2 x 10-8,,NR,1.0626993,'-,[1.04-1.08],GALNT10,Schizophrenia,schizophrenia,GCST004946,5:154301187
rs2693698-<b>G</b>,2 x 10-8,,NR,1.0626993,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST004946,Mapping not available
rs2767713-<b>C</b>,2 x 10-8,,NR,1.0626993,'-,[1.04-1.08],DDX10P2,Schizophrenia,schizophrenia,GCST004946,9:82184622
rs28735056-<b>G</b>,5 x 10-10,,NR,1.0626993,'-,[1.04-1.08],KCNG2,Schizophrenia,schizophrenia,GCST004946,18:79862879
rs35978510-<b>C</b>,7 x 10-10,,NR,1.0626993,'-,[1.04-1.08],AKT3,Schizophrenia,schizophrenia,GCST004946,1:243612815
rs758117-<b>C</b>,2 x 10-8,,NR,1.0626993,'-,[1.04-1.08],CACNA1C,Schizophrenia,schizophrenia,GCST004946,12:2404143
rs4330281-<b>C</b>,3 x 10-8,,NR,1.0615711,'-,[1.04-1.08],TBC1D5,Schizophrenia,schizophrenia,GCST004946,3:17817874
rs11210195-<b>C</b>,2 x 10-9,,NR,1.0604454,'-,[1.04-1.08],"RN7SKP19, LINC01360",Schizophrenia,schizophrenia,GCST004946,1:73283600
rs12623170-<b>C</b>,3 x 10-8,,NR,1.0604454,'-,[1.04-1.08],"RBKS, MRPL33",Schizophrenia,schizophrenia,GCST004946,2:27797290
rs13164092-<b>G</b>,1 x 10-9,,NR,1.0604454,'-,[1.04-1.08],"ETF1, RPL7P19",Schizophrenia,schizophrenia,GCST004946,5:138505171
rs17234749-<b>G</b>,5 x 10-9,,NR,1.0604454,'-,[1.04-1.08],"Y_RNA, LINC02686",Schizophrenia,schizophrenia,GCST004946,11:24360352
rs2910032-<b>C</b>,1 x 10-9,,NR,1.0604454,'-,[1.04-1.08],LINC01470,Schizophrenia,schizophrenia,GCST004946,5:153160794
rs3824451-<b>C</b>,2 x 10-6,,NR,1.0604454,'-,[1.04-1.08],GABBR2,Schizophrenia,schizophrenia,GCST004946,9:98309240
rs61847307-<b>C</b>,4 x 10-7,,NR,1.0604454,'-,[1.04-1.08],PRKG1,Schizophrenia,schizophrenia,GCST004946,10:52184682
rs6804239-<b>C</b>,8 x 10-10,,NR,1.0604454,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST004946,3:162062700
rs714031-<b>C</b>,8 x 10-8,,NR,1.059322,'-,[1.04-1.08],CACNA1I,Schizophrenia,schizophrenia,GCST004946,22:39674229
rs12421382-<b>C</b>,2 x 10-8,,NR,1.0582011,'-,[1.04-1.08],C11orf87,Schizophrenia,schizophrenia,GCST004946,11:109507345
rs758129-<b>G</b>,3 x 10-8,,NR,1.0582011,'-,[1.04-1.08],"POLG-DT, MIR9-3HG",Schizophrenia,schizophrenia,GCST004946,15:89357656
rs867743-<b>G</b>,5 x 10-9,,NR,1.0582011,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST004946,8:59782088
rs9695226-<b>G</b>,2 x 10-7,,NR,1.0582011,'-,[1.04-1.08],LINC01239,Schizophrenia,schizophrenia,GCST004946,9:22759397
rs12139672-<b>G</b>,3 x 10-7,,NR,1.0570824,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST004946,1:190971497
rs12327082-<b>T</b>,7 x 10-8,,NR,1.0570824,'-,[1.04-1.08],NOL4,Schizophrenia,schizophrenia,GCST004946,18:34011495
rs28607014-<b>C</b>,2 x 10-8,,NR,1.0570824,'-,[1.04-1.08],NOS1,Schizophrenia,schizophrenia,GCST004946,12:117270806
rs323167-<b>C</b>,4 x 10-8,,NR,1.0570824,'-,[1.04-1.08],MAGI2,Schizophrenia,schizophrenia,GCST004946,7:78707361
rs10148671-<b>C</b>,4 x 10-8,,NR,1.0559661,'-,[1.04-1.08],LINC02326,Schizophrenia,schizophrenia,GCST004946,14:29000167
rs10894308-<b>G</b>,2 x 10-8,,NR,1.0559661,'-,[1.04-1.08],RN7SL167P,Schizophrenia,schizophrenia,GCST004946,11:131022000
rs13266463-<b>G</b>,2 x 10-8,,NR,1.0559661,'-,[1.04-1.08],TSNARE1,Schizophrenia,schizophrenia,GCST004946,8:142322332
rs160593-<b>G</b>,8 x 10-9,,NR,1.0559661,'-,[1.04-1.07],LIN28B,Schizophrenia,schizophrenia,GCST004946,6:105018457
rs619091-<b>T</b>,6 x 10-9,,NR,1.0559661,'-,[1.04-1.07],LINC02730,Schizophrenia,schizophrenia,GCST004946,11:134014242
rs6903570-<b>C</b>,3 x 10-8,,NR,1.0559661,'-,[1.04-1.08],EYS,Schizophrenia,schizophrenia,GCST004946,6:64156964
rs7267348-<b>C</b>,3 x 10-7,,NR,1.0559661,'-,[1.03-1.08],PTGIS,Schizophrenia,schizophrenia,GCST004946,20:49514499
rs1838472-<b>C</b>,2 x 10-7,,NR,1.0548522,'-,[1.04-1.07],KALRN,Schizophrenia,schizophrenia,GCST004946,3:124332814
rs4240748-<b>G</b>,5 x 10-8,,NR,1.0548522,'-,[1.04-1.07],LINC02404,Schizophrenia,schizophrenia,GCST004946,12:91853010
rs7934083-<b>C</b>,2 x 10-7,,NR,1.0548522,'-,[1.04-1.07],MTND4LP18,Schizophrenia,schizophrenia,GCST004946,11:81492479
rs8058130-<b>G</b>,5 x 10-8,,NR,1.0548522,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST004946,16:64337259
rs832190-<b>C</b>,4 x 10-8,,NR,1.0548522,'-,[1.04-1.07],THOC7,Schizophrenia,schizophrenia,GCST004946,3:63856953
rs10940346-<b>G</b>,1 x 10-8,,NR,1.0537407,'-,[1.04-1.07],EMB,Schizophrenia,schizophrenia,GCST004946,5:50510208
rs192812-<b>C</b>,9 x 10-8,,NR,1.0537407,'-,[1.03-1.07],'-,Schizophrenia,schizophrenia,GCST004946,3:161774043
rs2358740-<b>G</b>,7 x 10-8,,NR,1.0537407,'-,[1.03-1.07],CACNA1D,Schizophrenia,schizophrenia,GCST004946,3:53421542
rs7560272-<b>T</b>,6 x 10-7,,NR,1.0537407,'-,[1.03-1.07],"RNU6-111P, RPSAP28",Schizophrenia,schizophrenia,GCST004946,2:73334357
rs11625793-<b>G</b>,2 x 10-7,,NR,1.0526316,'-,[1.03-1.07],NCOA4P1,Schizophrenia,schizophrenia,GCST004946,14:65849165
rs783540-<b>G</b>,3 x 10-8,,NR,1.0526316,'-,[1.03-1.07],CPEB1,Schizophrenia,schizophrenia,GCST004946,15:82585958
rs11722779-<b>G</b>,3 x 10-8,,NR,1.0515248,'-,[1.03-1.07],SLC9B1,Schizophrenia,schizophrenia,GCST004946,4:102906331
rs7597593-<b>T</b>,9 x 10-11,,NR,1.066,'-,[1.05-1.09],ZNF804A,Schizophrenia,schizophrenia,GCST004946,2:184668853
rs6846161-<b>A</b>,1 x 10-9,,NR,1.067,'-,[1.05-1.09],GPM6A,Schizophrenia,schizophrenia,GCST004946,4:175945308
rs3735025-<b>T</b>,4 x 10-12,,NR,1.068,'-,[1.05-1.09],DGKI,Schizophrenia,schizophrenia,GCST004946,7:137390098
rs2057884-<b>T</b>,2 x 10-12,,NR,1.069,'-,[1.05-1.09],SRPK2,Schizophrenia,schizophrenia,GCST004946,7:105289803
rs215411-<b>A</b>,6 x 10-10,,NR,1.069,'-,[1.05-1.09],RFPL4AP3,Schizophrenia,schizophrenia,GCST004946,4:23421980
rs7273691-<b>T</b>,8 x 10-8,,NR,1.069,'-,[1.05-1.09],PHACTR3,Schizophrenia,schizophrenia,GCST004946,20:59678449
rs72843506-<b>A</b>,4 x 10-8,,NR,1.07,'-,[1.05-1.09],SPECC1,Schizophrenia,schizophrenia,GCST004946,17:20042974
rs55757091-<b>A</b>,2 x 10-7,,NR,1.071,'-,[1.05-1.1],"SLC7A6, SLC7A6OS",Schizophrenia,schizophrenia,GCST004946,16:68289751
rs2970610-<b>T</b>,1 x 10-12,,NR,1.072,'-,[1.05-1.09],"KDM4A, PTPRF",Schizophrenia,schizophrenia,GCST004946,1:43631859
rs214467-<b>A</b>,8 x 10-13,,NR,1.073,'-,[1.05-1.09],IMMP2L,Schizophrenia,schizophrenia,GCST004946,7:111218212
rs6670165-<b>T</b>,3 x 10-9,,NR,1.073,'-,[1.05-1.1],"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST004946,1:177310985
rs7405404-<b>T</b>,8 x 10-10,,NR,1.073,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST004946,16:13656002
rs10510653-<b>A</b>,3 x 10-8,,NR,1.074,'-,[1.05-1.1],OSBPL10,Schizophrenia,schizophrenia,GCST004946,3:32017067
rs1191551-<b>T</b>,2 x 10-8,,NR,1.074,'-,[1.05-1.1],"RNU11-5P, PRKD1",Schizophrenia,schizophrenia,GCST004946,14:29531199
rs3732386-<b>T</b>,3 x 10-11,,NR,1.075,'-,[1.05-1.1],TRANK1,Schizophrenia,schizophrenia,GCST004946,3:36830502
rs112537273-<b>T</b>,1 x 10-11,,NR,1.077,'-,[1.06-1.1],LETM2,Schizophrenia,schizophrenia,GCST004946,8:38390788
rs73219805-<b>A</b>,2 x 10-11,,NR,1.078,'-,[1.06-1.1],BNIP3L,Schizophrenia,schizophrenia,GCST004946,8:26415252
rs2383377-<b>A</b>,2 x 10-8,,NR,1.081,'-,[1.05-1.11],AKAP6,Schizophrenia,schizophrenia,GCST004946,14:32788708
rs112509803-<b>C</b>,5 x 10-8,,NR,1.09,'-,[1.06-1.12],"GSDME, MPP6",Schizophrenia,schizophrenia,GCST004946,7:24695385
rs9607782-<b>A</b>,1 x 10-12,,NR,1.09,'-,[1.07-1.11],EP300-AS1,Schizophrenia,schizophrenia,GCST004946,22:41191552
rs35607894-<b>A</b>,5 x 10-11,,NR,1.094,'-,[1.07-1.12],RGS6,Schizophrenia,schizophrenia,GCST004946,14:71941921
rs9859557-<b>A</b>,6 x 10-14,,NR,1.094,'-,[1.07-1.12],SOX2-OT,Schizophrenia,schizophrenia,GCST004946,3:181113122
rs9882618-<b>T</b>,1 x 10-6,,NR,1.095,'-,[1.06-1.13],"SLC38A3, GNAT1",Schizophrenia,schizophrenia,GCST004946,3:50200112
rs12129037-<b>T</b>,5 x 10-9,,NR,1.096,'-,[1.06-1.13],"FALEC, ADAMTSL4-AS2",Schizophrenia,schizophrenia,GCST004946,1:150519638
rs75059851-<b>A</b>,9 x 10-13,,NR,1.098,'-,[1.07-1.12],IGSF9B,Schizophrenia,schizophrenia,GCST004946,11:133952674
rs1075195-<b>T</b>,9 x 10-7,,NR,1.062,'-,[1.04-1.09],"Metazoa_SRP, SLC32A1",Schizophrenia,schizophrenia,GCST004946,20:38718108
rs17002069-<b>C</b>,2 x 10-7,,NR,1.062,'-,[1.04-1.09],"MRTFA, GAPDHP37",Schizophrenia,schizophrenia,GCST004946,22:40654982
rs3756766-<b>A</b>,8 x 10-8,,NR,1.062,'-,[1.04-1.08],"FAM53C, CDC25C",Schizophrenia,schizophrenia,GCST004946,5:138337478
rs3845702-<b>A</b>,6 x 10-8,,NR,1.063,'-,[1.04-1.08],CWC22,Schizophrenia,schizophrenia,GCST004946,2:179983761
rs77502336-<b>C</b>,1 x 10-9,,NR,1.063,'-,[1.04-1.08],GRAMD1B,Schizophrenia,schizophrenia,GCST004946,11:123523928
rs113568682-<b>A</b>,4 x 10-8,,NR,1.064,'-,[1.04-1.09],LINC01470,Schizophrenia,schizophrenia,GCST004946,5:152920194
rs7012816-<b>A</b>,4 x 10-7,,NR,1.064,'-,[1.04-1.09],PRDM14,Schizophrenia,schizophrenia,GCST004946,8:70052508
rs7372960-<b>T</b>,3 x 10-7,,NR,1.064,'-,[1.04-1.09],FOXP1,Schizophrenia,schizophrenia,GCST004946,3:71205600
rs4766428-<b>T</b>,3 x 10-9,,NR,1.065,'-,[1.04-1.09],ATP2A2,Schizophrenia,schizophrenia,GCST004946,12:110285440
rs4949526-<b>T</b>,3 x 10-10,,NR,1.065,'-,[1.05-1.08],LINC01648,Schizophrenia,schizophrenia,GCST004946,1:29959372
rs62152284-<b>T</b>,6 x 10-9,,NR,1.065,'-,[1.04-1.09],AHCYP3,Schizophrenia,schizophrenia,GCST004946,2:104367929
rs9922678-<b>A</b>,3 x 10-9,,NR,1.065,'-,[1.04-1.09],GRIN2A,Schizophrenia,schizophrenia,GCST004946,16:9852462
rs35065479-<b>A</b>,2 x 10-8,,NR,1.066,'-,[1.04-1.09],MSI2,Schizophrenia,schizophrenia,GCST004946,17:57659374
rs4388249-<b>T</b>,8 x 10-9,,NR,1.066,'-,[1.04-1.09],MAN2A1,Schizophrenia,schizophrenia,GCST004946,5:109700365
rs7438-<b>A</b>,7 x 10-11,,NR,1.066,'-,[1.05-1.09],CLCN3,Schizophrenia,schizophrenia,GCST004946,4:169721095
rs12543645-<b>C</b>,3 x 10-8,,NR,1.058,'-,[1.04-1.08],MSRA,Schizophrenia,schizophrenia,GCST004946,8:10388815
rs1506297-<b>T</b>,8 x 10-7,,NR,1.058,'-,[1.04-1.08],RBMS3,Schizophrenia,schizophrenia,GCST004946,3:30030816
rs56775891-<b>T</b>,2 x 10-8,,NR,1.058,'-,[1.04-1.08],"KCNG2, CTDP1",Schizophrenia,schizophrenia,GCST004946,18:79815613
rs9970077-<b>A</b>,2 x 10-6,,NR,1.058,'-,[1.03-1.08],LINC01741,Schizophrenia,schizophrenia,GCST004946,1:177791783
rs10878577-<b>A</b>,9 x 10-7,,NR,1.059,'-,[1.04-1.08],"GGTA2P, RAB11AP2",Schizophrenia,schizophrenia,GCST004946,12:67200061
rs12911832-<b>A</b>,8 x 10-8,,NR,1.059,'-,[1.04-1.08],ADAM10,Schizophrenia,schizophrenia,GCST004946,15:58693705
rs2944823-<b>A</b>,3 x 10-8,,NR,1.059,'-,[1.04-1.08],CALN1,Schizophrenia,schizophrenia,GCST004946,7:72330485
rs56007784-<b>C</b>,1 x 10-9,,NR,1.059,'-,[1.04-1.08],YWHAE,Schizophrenia,schizophrenia,GCST004946,17:1387656
rs56873913-<b>T</b>,4 x 10-7,,NR,1.061,'-,[1.04-1.08],"NOSIP, PRRG2",Schizophrenia,schizophrenia,GCST004946,19:49587942
rs9420-<b>A</b>,9 x 10-9,,NR,1.061,'-,[1.04-1.08],SELENOH,Schizophrenia,schizophrenia,GCST004946,11:57742822
rs10866912-<b>A</b>,4 x 10-8,(South Asian),0.72,1.27,'-,[1.17-1.38],"MROH6, NAPRT",Schizophrenia,schizophrenia,GCST008459,8:143573145
rs6002655-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,TCF20,Schizophrenia,schizophrenia,GCST008459,22:42207808
rs10515678-<b>?</b>,8 x 10-9,,NR,1.0711111,'-,[1.05-1.09],LINC01470,Schizophrenia,schizophrenia,GCST009337,5:152943676
rs2927176-<b>?</b>,4 x 10-10,,NR,1.06109,'-,[1.04-1.08],LINC01470,Schizophrenia,schizophrenia,GCST009337,5:153222354
rs76262184-<b>?</b>,3 x 10-8,,NR,1.08524,'-,[1.06-1.11],GRIA1,Schizophrenia,schizophrenia,GCST009337,5:153415751
rs6864084-<b>?</b>,4 x 10-8,,NR,1.07638,'-,[1.05-1.1],GALNT10,Schizophrenia,schizophrenia,GCST009337,5:154305966
rs6938026-<b>?</b>,5 x 10-9,,NR,1.06046,'-,[1.04-1.08],CUL9,Schizophrenia,schizophrenia,GCST009337,6:43217995
rs9342117-<b>?</b>,9 x 10-10,,NR,1.0582347,'-,[1.04-1.08],EYS,Schizophrenia,schizophrenia,GCST009337,6:64081515
rs217289-<b>?</b>,1 x 10-13,,NR,1.066735,'-,[1.05-1.08],SNAP91,Schizophrenia,schizophrenia,GCST009337,6:83692088
rs160593-<b>?</b>,3 x 10-10,,NR,1.0564348,'-,[1.04-1.07],LIN28B,Schizophrenia,schizophrenia,GCST009337,6:105018457
rs2153960-<b>?</b>,1 x 10-12,,NR,1.0680109,'-,[1.05-1.09],FOXO3,Schizophrenia,schizophrenia,GCST009337,6:108666981
rs4479913-<b>?</b>,6 x 10-9,,NR,1.06162,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST009337,6:164654177
rs58120505-<b>?</b>,1 x 10-18,,NR,1.08101,'-,[1.06-1.1],MAD1L1,Schizophrenia,schizophrenia,GCST009337,7:1990232
rs7811417-<b>?</b>,2 x 10-8,,NR,1.05022,'-,[1.03-1.07],SP4,Schizophrenia,schizophrenia,GCST009337,7:21494534
rs112316332-<b>?</b>,3 x 10-8,,NR,1.0751879,'-,[1.05-1.1],IGF2BP3,Schizophrenia,schizophrenia,GCST009337,7:23453994
rs79210963-<b>?</b>,6 x 10-9,,NR,1.0912265,'-,[1.06-1.12],MPP6,Schizophrenia,schizophrenia,GCST009337,7:24678350
rs79527984-<b>?</b>,9 x 10-9,,NR,1.0522218,'-,[1.03-1.07],CALN1,Schizophrenia,schizophrenia,GCST009337,7:72387188
rs323169-<b>?</b>,3 x 10-8,,NR,1.054641,'-,[1.04-1.07],MAGI2,Schizophrenia,schizophrenia,GCST009337,7:78708384
rs1357318-<b>?</b>,1 x 10-8,,NR,1.06599,'-,[1.04-1.09],SGCE,Schizophrenia,schizophrenia,GCST009337,7:94638550
rs2057884-<b>?</b>,1 x 10-11,,NR,1.06109,'-,[1.04-1.08],SRPK2,Schizophrenia,schizophrenia,GCST009337,7:105289803
rs9656169-<b>?</b>,3 x 10-8,,NR,1.0536964,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST009337,7:110434219
rs214475-<b>?</b>,4 x 10-14,,NR,1.0703658,'-,[1.05-1.09],IMMP2L,Schizophrenia,schizophrenia,GCST009337,7:111227479
rs7785663-<b>?</b>,4 x 10-15,,NR,1.0754075,'-,[1.06-1.09],DGKI,Schizophrenia,schizophrenia,GCST009337,7:137385552
rs58146172-<b>?</b>,1 x 10-10,,NR,1.0653484,'-,[1.05-1.08],SMG6,Schizophrenia,schizophrenia,GCST009337,17:2210774
rs72639203-<b>?</b>,5 x 10-10,,NR,1.090572,'-,[1.06-1.12],SNORD3A,Schizophrenia,schizophrenia,GCST009337,17:19188139
rs61257528-<b>?</b>,1 x 10-8,,NR,1.07326,'-,[1.05-1.1],SPECC1,Schizophrenia,schizophrenia,GCST009337,17:20028279
rs4793885-<b>?</b>,1 x 10-9,,NR,1.06354,'-,[1.04-1.08],MSI2,Schizophrenia,schizophrenia,GCST009337,17:57650863
rs1440849-<b>?</b>,5 x 10-8,,NR,1.0574961,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST009337,18:29921527
rs12969453-<b>?</b>,3 x 10-8,,NR,1.05012,'-,[1.03-1.07],LINC01929,Schizophrenia,schizophrenia,GCST009337,18:55084477
rs73477270-<b>?</b>,8 x 10-9,,NR,1.1941154,'-,[1.13-1.25],TCF4,Schizophrenia,schizophrenia,GCST009337,18:55425653
rs9636107-<b>?</b>,2 x 10-9,,NR,1.0583354,'-,[1.04-1.08],TCF4,Schizophrenia,schizophrenia,GCST009337,18:55532886
rs337718-<b>?</b>,1 x 10-8,,NR,1.0538,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST009337,18:72107043
rs28735056-<b>?</b>,1 x 10-12,,NR,1.0655642,'-,[1.05-1.08],KCNG2,Schizophrenia,schizophrenia,GCST009337,18:79862879
rs11878180-<b>?</b>,3 x 10-8,,NR,1.0595,'-,[1.04-1.08],GNG7,Schizophrenia,schizophrenia,GCST009337,19:2686463
rs72986630-<b>?</b>,1 x 10-9,,NR,1.15558,'-,[1.11-1.2],ZNF823,Schizophrenia,schizophrenia,GCST009337,19:11738921
rs3810449-<b>?</b>,2 x 10-8,,NR,1.090572,'-,[1.06-1.12],THAP8,Schizophrenia,schizophrenia,GCST009337,19:36040011
rs12104272-<b>?</b>,1 x 10-8,,NR,1.0578094,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST009337,Mapping not available
rs7271624-<b>?</b>,3 x 10-8,,NR,1.0596138,'-,[1.04-1.08],PTGIS,Schizophrenia,schizophrenia,GCST009337,20:49512632
rs9975024-<b>?</b>,4 x 10-8,,NR,1.0520115,'-,[1.03-1.07],NRIP1,Schizophrenia,schizophrenia,GCST009337,21:15067562
rs5757730-<b>?</b>,8 x 10-11,,NR,1.0732608,'-,[1.05-1.09],CACNA1I,Schizophrenia,schizophrenia,GCST009337,22:39571425
rs6633421-<b>?</b>,1 x 10-11,,NR,1.0767,'-,[1.06-1.1],CNKSR2,Schizophrenia,schizophrenia,GCST009337,X:21551802
rs5943630-<b>?</b>,2 x 10-9,,NR,1.05243,'-,[1.04-1.07],IL1RAPL1,Schizophrenia,schizophrenia,GCST009337,X:29258095
rs7067170-<b>?</b>,3 x 10-10,,NR,1.07047,'-,[1.05-1.09],PJA1,Schizophrenia,schizophrenia,GCST009337,X:69162993
rs4660761-<b>?</b>,5 x 10-9,,NR,1.098901,'-,'-,"ATP6V0B, DPH2",Schizophrenia,schizophrenia,GCST009336,1:43974474
rs848293-<b>?</b>,9 x 10-17,,NR,1.1235955,'-,'-,VRK2,Schizophrenia,schizophrenia,GCST009336,2:58155355
rs17592552-<b>?</b>,2 x 10-13,,NR,1.1363636,'-,'-,SPATS2L,Schizophrenia,schizophrenia,GCST009336,2:200311348
rs2073499-<b>?</b>,1 x 10-13,,NR,1.1111112,'-,'-,RASSF1,Schizophrenia,schizophrenia,GCST009336,3:50336862
rs76442143-<b>?</b>,6 x 10-10,,NR,1.12,'-,'-,DOCK3,Schizophrenia,schizophrenia,GCST009336,3:51006168
rs10935182-<b>?</b>,7 x 10-10,,NR,1.1111112,'-,'-,STAG1,Schizophrenia,schizophrenia,GCST009336,3:136418580
rs4856763-<b>?</b>,2 x 10-10,,NR,1.0869565,'-,'-,'-,Schizophrenia,schizophrenia,GCST009336,3:162113887
rs13096176-<b>?</b>,3 x 10-9,,NR,1.1235955,'-,'-,SOX2-OT,Schizophrenia,schizophrenia,GCST009336,3:181034350
rs6832165-<b>?</b>,3 x 10-8,,NR,1.12,'-,'-,'-,Schizophrenia,schizophrenia,GCST009336,4:24268587
rs13142920-<b>?</b>,5 x 10-9,,NR,1.0869565,'-,'-,GPM6A,Schizophrenia,schizophrenia,GCST009336,4:175807463
rs4479913-<b>?</b>,2 x 10-10,,NR,1.12,'-,'-,'-,Schizophrenia,schizophrenia,GCST009336,6:164654177
rs320696-<b>?</b>,3 x 10-9,,NR,1.098901,'-,'-,"PTN, DGKI",Schizophrenia,schizophrenia,GCST009336,7:137362391
rs11986274-<b>?</b>,1 x 10-8,,NR,1.08,'-,'-,"FGFR1, LETM2",Schizophrenia,schizophrenia,GCST009336,8:38401963
rs2612614-<b>?</b>,2 x 10-8,,NR,1.11,'-,'-,MIR124-2HG,Schizophrenia,schizophrenia,GCST009336,8:64398279
rs4147157-<b>?</b>,1 x 10-15,,NR,1.1235955,'-,'-,WBP1L,Schizophrenia,schizophrenia,GCST009336,10:102776603
rs10861879-<b>?</b>,1 x 10-8,,NR,1.08,'-,'-,WSCD2,Schizophrenia,schizophrenia,GCST009336,12:108215857
rs1984658-<b>?</b>,9 x 10-14,,NR,1.1111112,'-,'-,PITPNM2,Schizophrenia,schizophrenia,GCST009336,12:122998879
rs9567393-<b>?</b>,1 x 10-9,,NR,1.09,'-,'-,FRY,Schizophrenia,schizophrenia,GCST009336,13:32189620
rs9890128-<b>?</b>,3 x 10-9,,NR,1.1111112,'-,'-,YWHAE,Schizophrenia,schizophrenia,GCST009336,17:1370352
rs11665111-<b>?</b>,1 x 10-8,,NR,1.09,'-,'-,KCNG2,Schizophrenia,schizophrenia,GCST009336,18:79862996
rs55642704-<b>?</b>,4 x 10-11,,NR,1.09,'-,'-,SLC66A2,Schizophrenia,schizophrenia,GCST009336,18:79928124
rs942820-<b>?</b>,3 x 10-9,,NR,1.0645999,'-,[1.04-1.09],PLCH2,Schizophrenia,schizophrenia,GCST009337,1:2448266
rs172531-<b>?</b>,5 x 10-12,,NR,1.0746564,'-,[1.05-1.1],RERE,Schizophrenia,schizophrenia,GCST009337,1:8435530
rs533123-<b>?</b>,2 x 10-8,,NR,1.08264,'-,[1.05-1.11],OPRD1,Schizophrenia,schizophrenia,GCST009337,1:28814643
rs6694545-<b>?</b>,8 x 10-14,,NR,1.07918,'-,[1.06-1.1],LINC01648,Schizophrenia,schizophrenia,GCST009337,1:29964421
rs12083902-<b>?</b>,4 x 10-8,,NR,1.0718688,'-,[1.05-1.1],AGO4,Schizophrenia,schizophrenia,GCST009337,1:35809511
rs2801578-<b>?</b>,2 x 10-10,,NR,1.06184,'-,[1.04-1.08],PDE4B,Schizophrenia,schizophrenia,GCST009337,1:65866972
rs1198588-<b>?</b>,1 x 10-16,,NR,1.1092623,'-,[1.08-1.13],NFU1P2,Schizophrenia,schizophrenia,GCST009337,1:98087276
rs975025-<b>?</b>,2 x 10-9,,NR,1.0735834,'-,[1.05-1.1],AXDND1,Schizophrenia,schizophrenia,GCST009337,1:179369192
rs11587347-<b>?</b>,3 x 10-10,,NR,1.1161711,'-,[1.08-1.15],'-,Schizophrenia,schizophrenia,GCST009337,1:239035659
rs59159185-<b>?</b>,1 x 10-8,,NR,1.10916,'-,[1.07-1.14],VRK2,Schizophrenia,schizophrenia,GCST009337,2:57874972
rs7596038-<b>?</b>,7 x 10-22,,NR,1.088613,'-,[1.07-1.11],VRK2,Schizophrenia,schizophrenia,GCST009337,2:58156685
rs7599488-<b>?</b>,3 x 10-8,,NR,1.0519007,'-,[1.03-1.07],BCL11A,Schizophrenia,schizophrenia,GCST009337,2:60491212
rs999494-<b>?</b>,3 x 10-10,,NR,1.0760556,'-,[1.05-1.1],EMX1,Schizophrenia,schizophrenia,GCST009337,2:72930266
rs62152284-<b>?</b>,1 x 10-9,,NR,1.06184,'-,[1.04-1.08],AHCYP3,Schizophrenia,schizophrenia,GCST009337,2:104367929
rs6721549-<b>?</b>,6 x 10-10,,NR,1.06237,'-,[1.04-1.08],MGAT5,Schizophrenia,schizophrenia,GCST009337,2:134084736
rs2381760-<b>?</b>,4 x 10-10,,NR,1.0828488,'-,[1.06-1.11],'-,Schizophrenia,schizophrenia,GCST009337,2:145683104
rs13004237-<b>?</b>,1 x 10-8,,NR,1.0564348,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST009337,Mapping not available
rs4666990-<b>?</b>,2 x 10-15,,NR,1.07401,'-,[1.06-1.09],ZNF804A,Schizophrenia,schizophrenia,GCST009337,2:184798577
rs1716180-<b>?</b>,2 x 10-23,,NR,1.0989977,'-,[1.08-1.12],MPHOSPH9,Schizophrenia,schizophrenia,GCST009337,12:123197534
rs9567393-<b>?</b>,7 x 10-10,,NR,1.08318,'-,[1.06-1.11],FRY,Schizophrenia,schizophrenia,GCST009337,13:32189620
rs71428218-<b>?</b>,6 x 10-10,,NR,1.0711111,'-,[1.05-1.09],'-,Schizophrenia,schizophrenia,GCST009337,13:56374126
rs9569820-<b>?</b>,3 x 10-8,,NR,1.0662,'-,[1.04-1.09],LINC02338,Schizophrenia,schizophrenia,GCST009337,13:58128612
rs75365967-<b>?</b>,8 x 10-9,,NR,1.0550637,'-,[1.04-1.07],LINC02326,Schizophrenia,schizophrenia,GCST009337,14:29004453
rs4243617-<b>?</b>,6 x 10-9,,NR,1.05432,'-,[1.04-1.07],RTN1,Schizophrenia,schizophrenia,GCST009337,14:59698352
rs2189806-<b>?</b>,5 x 10-10,,NR,1.0609854,'-,[1.04-1.08],PCNX1,Schizophrenia,schizophrenia,GCST009337,14:70921681
rs2190864-<b>?</b>,1 x 10-12,,NR,1.06556,'-,[1.05-1.08],RGS6,Schizophrenia,schizophrenia,GCST009337,14:71949502
rs1676062-<b>?</b>,8 x 10-9,,NR,1.054741,'-,[1.04-1.07],MTCYBP27,Schizophrenia,schizophrenia,GCST009337,14:84178478
rs10873538-<b>?</b>,6 x 10-14,,NR,1.0731571,'-,[1.05-1.09],PPP1R13B,Schizophrenia,schizophrenia,GCST009337,14:103789232
rs2957582-<b>?</b>,2 x 10-8,,NR,1.0588622,'-,[1.04-1.08],FRMD5,Schizophrenia,schizophrenia,GCST009337,15:43965756
rs793571-<b>?</b>,3 x 10-8,,NR,1.05443,'-,[1.04-1.07],MINDY2,Schizophrenia,schizophrenia,GCST009337,15:58849507
rs35225048-<b>?</b>,5 x 10-12,,NR,1.062688,'-,[1.05-1.08],'-,Schizophrenia,schizophrenia,GCST009337,15:61564064
rs28681284-<b>?</b>,3 x 10-12,,NR,1.0848105,'-,[1.06-1.11],CHRNA3,Schizophrenia,schizophrenia,GCST009337,15:78616223
rs4702-<b>?</b>,2 x 10-15,,NR,1.077238,'-,[1.06-1.1],FURIN,Schizophrenia,schizophrenia,GCST009337,15:90883330
rs41356645-<b>?</b>,1 x 10-10,,NR,1.07283,'-,[1.05-1.09],GRIN2A,Schizophrenia,schizophrenia,GCST009337,16:9852062
rs7499362-<b>?</b>,1 x 10-10,,NR,1.0769131,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST009337,16:13655059
rs3814881-<b>?</b>,7 x 10-12,,NR,1.0604566,'-,[1.04-1.08],TAOK2,Schizophrenia,schizophrenia,GCST009337,16:29989580
rs2010476-<b>?</b>,2 x 10-9,,NR,1.05982,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST009337,16:64339990
rs75970938-<b>?</b>,2 x 10-25,,NR,1.1336,'-,[1.11-1.16],CNNM2,Schizophrenia,schizophrenia,GCST009337,10:103033891
rs12363019-<b>?</b>,5 x 10-10,,NR,1.06375,'-,[1.04-1.08],LINC02686,Schizophrenia,schizophrenia,GCST009337,11:24352999
rs7926389-<b>?</b>,2 x 10-12,,NR,1.0901321,'-,[1.07-1.11],ARHGAP1,Schizophrenia,schizophrenia,GCST009337,11:46690304
rs9420-<b>?</b>,7 x 10-9,,NR,1.05834,'-,[1.04-1.08],SELENOH,Schizophrenia,schizophrenia,GCST009337,11:57742822
rs11230827-<b>?</b>,5 x 10-8,,NR,1.10816,'-,[1.07-1.15],RAB3IL1,Schizophrenia,schizophrenia,GCST009337,11:61919982
rs7951609-<b>?</b>,5 x 10-8,,NR,1.0552753,'-,[1.04-1.07],TENM4,Schizophrenia,schizophrenia,GCST009337,11:79519877
rs12421382-<b>?</b>,2 x 10-8,,NR,1.0530639,'-,[1.03-1.07],C11orf87,Schizophrenia,schizophrenia,GCST009337,11:109507345
rs2514218-<b>?</b>,2 x 10-11,,NR,1.0771335,'-,[1.06-1.1],DRD2,Schizophrenia,schizophrenia,GCST009337,11:113522272
rs77502336-<b>?</b>,6 x 10-10,,NR,1.06194,'-,[1.04-1.08],GRAMD1B,Schizophrenia,schizophrenia,GCST009337,11:123523928
rs55661361-<b>?</b>,5 x 10-11,,NR,1.0624734,'-,[1.04-1.08],NRGN,Schizophrenia,schizophrenia,GCST009337,11:124744061
rs10791099-<b>?</b>,1 x 10-8,,NR,1.0535854,'-,[1.04-1.07],LINC02551,Schizophrenia,schizophrenia,GCST009337,11:130848918
rs2917568-<b>?</b>,1 x 10-8,,NR,1.05285,'-,[1.04-1.07],OPCML,Schizophrenia,schizophrenia,GCST009337,11:132698359
rs302321-<b>?</b>,1 x 10-13,,NR,1.0701482,'-,[1.05-1.09],TMTC1,Schizophrenia,schizophrenia,GCST009337,12:29775455
rs61937595-<b>?</b>,6 x 10-12,,NR,1.1514238,'-,[1.11-1.19],R3HDM2,Schizophrenia,schizophrenia,GCST009337,12:57289173
rs10777342-<b>?</b>,2 x 10-8,,NR,1.0531636,'-,[1.03-1.07],LINC02404,Schizophrenia,schizophrenia,GCST009337,12:91863357
rs10861879-<b>?</b>,2 x 10-10,,NR,1.05929,'-,[1.04-1.08],WSCD2,Schizophrenia,schizophrenia,GCST009337,12:108215857
rs4766428-<b>?</b>,2 x 10-8,,NR,1.05855,'-,[1.04-1.08],ATP2A2,Schizophrenia,schizophrenia,GCST009337,12:110285440
rs28607014-<b>?</b>,5 x 10-8,,NR,1.051381,'-,[1.03-1.07],NOS1,Schizophrenia,schizophrenia,GCST009337,12:117270806
rs13261217-<b>?</b>,1 x 10-9,,NR,1.0621574,'-,[1.04-1.08],CSMD1,Schizophrenia,schizophrenia,GCST009337,8:4325535
rs6986895-<b>?</b>,6 x 10-10,,NR,1.0590752,'-,[1.04-1.08],CSMD1,Schizophrenia,schizophrenia,GCST009337,8:4959350
rs17687067-<b>?</b>,7 x 10-10,,NR,1.0647019,'-,[1.04-1.08],ZDHHC2,Schizophrenia,schizophrenia,GCST009337,8:17178692
rs2634447-<b>?</b>,2 x 10-8,,NR,1.0654505,'-,[1.04-1.09],PSD3,Schizophrenia,schizophrenia,GCST009337,8:18584841
rs117325001-<b>?</b>,2 x 10-13,,NR,1.07605,'-,[1.06-1.1],BNIP3L,Schizophrenia,schizophrenia,GCST009337,8:26384756
rs73229090-<b>?</b>,1 x 10-8,,NR,1.1088196,'-,[1.07-1.14],GULOP,Schizophrenia,schizophrenia,GCST009337,8:27584610
rs78895722-<b>?</b>,7 x 10-9,,NR,1.2021399,'-,[1.14-1.26],RPL10AP3,Schizophrenia,schizophrenia,GCST009337,8:34223067
rs6983764-<b>?</b>,4 x 10-8,,NR,1.0518,'-,[1.03-1.07],RP1,Schizophrenia,schizophrenia,GCST009337,8:54828373
rs867743-<b>?</b>,2 x 10-9,,NR,1.0536964,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST009337,8:59782088
rs6994019-<b>?</b>,4 x 10-10,,NR,1.06833,'-,[1.05-1.09],MMP16,Schizophrenia,schizophrenia,GCST009337,8:88256314
rs6995307-<b>?</b>,5 x 10-11,,NR,1.0787487,'-,[1.06-1.1],'-,Schizophrenia,schizophrenia,GCST009337,8:110494336
rs13262595-<b>?</b>,3 x 10-14,,NR,1.06983,'-,[1.05-1.09],TSNARE1,Schizophrenia,schizophrenia,GCST009337,8:142235609
rs2767713-<b>?</b>,2 x 10-9,,NR,1.0586604,'-,[1.04-1.08],DDX10P2,Schizophrenia,schizophrenia,GCST009337,9:82184622
rs13284900-<b>?</b>,1 x 10-9,,NR,1.07283,'-,[1.05-1.1],RALGPS1,Schizophrenia,schizophrenia,GCST009337,9:126943228
rs1043009-<b>?</b>,2 x 10-9,,NR,1.05675,'-,[1.04-1.07],KLF6,Schizophrenia,schizophrenia,GCST009337,10:3777522
rs1926026-<b>?</b>,4 x 10-14,,NR,1.12524,'-,[1.09-1.16],CACNB2,Schizophrenia,schizophrenia,GCST009337,10:18436730
rs61847303-<b>?</b>,2 x 10-8,,NR,1.0630043,'-,[1.04-1.08],PRKG1,Schizophrenia,schizophrenia,GCST009337,10:52180766
rs1483245-<b>?</b>,1 x 10-8,,NR,1.05169,'-,[1.03-1.07],BCL11A,Schizophrenia,schizophrenia,GCST009337,2:185182339
rs13019859-<b>?</b>,7 x 10-9,,NR,1.05348,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST009337,2:193062410
rs76432012-<b>?</b>,4 x 10-8,,NR,1.14843,'-,[1.1-1.2],LINC01877,Schizophrenia,schizophrenia,GCST009337,2:199712044
rs2949006-<b>?</b>,3 x 10-18,,NR,1.09615,'-,[1.08-1.12],FTCDNL1,Schizophrenia,schizophrenia,GCST009337,2:199850665
rs17592552-<b>?</b>,1 x 10-17,,NR,1.1353058,'-,[1.11-1.16],SPATS2L,Schizophrenia,schizophrenia,GCST009337,2:200311348
rs11685299-<b>?</b>,3 x 10-11,,NR,1.0621574,'-,[1.04-1.08],CUL3,Schizophrenia,schizophrenia,GCST009337,2:224526579
rs17164-<b>?</b>,5 x 10-12,,NR,1.0700451,'-,[1.05-1.09],GIGYF2,Schizophrenia,schizophrenia,GCST009337,2:232728789
rs17194490-<b>?</b>,2 x 10-11,,NR,1.10385,'-,[1.08-1.13],CNTN4,Schizophrenia,schizophrenia,GCST009337,3:2506102
rs6797774-<b>?</b>,3 x 10-8,,NR,1.0519,'-,[1.03-1.07],U3,Schizophrenia,schizophrenia,GCST009337,3:30262715
rs59721702-<b>?</b>,9 x 10-9,,NR,1.07616,'-,[1.05-1.1],OSBPL10,Schizophrenia,schizophrenia,GCST009337,3:32021957
rs3732386-<b>?</b>,3 x 10-11,,NR,1.07326,'-,[1.05-1.09],TRANK1,Schizophrenia,schizophrenia,GCST009337,3:36830502
rs17635239-<b>?</b>,5 x 10-8,,NR,1.07304,'-,[1.05-1.1],U3,Schizophrenia,schizophrenia,GCST009337,3:45265142
rs2236989-<b>?</b>,9 x 10-9,,NR,1.0611993,'-,[1.04-1.08],CACNA2D2,Schizophrenia,schizophrenia,GCST009337,3:50467964
rs138636117-<b>?</b>,3 x 10-8,,NR,1.134623,'-,[1.09-1.18],MAPKAPK3,Schizophrenia,schizophrenia,GCST009337,3:50636095
rs76442143-<b>?</b>,6 x 10-10,,NR,1.1184,'-,[1.08-1.15],DOCK3,Schizophrenia,schizophrenia,GCST009337,3:51006168
rs117465168-<b>?</b>,3 x 10-8,,NR,1.1345072,'-,[1.09-1.18],DOCK3,Schizophrenia,schizophrenia,GCST009337,3:51263988
rs2577831-<b>?</b>,3 x 10-14,,NR,1.0662004,'-,[1.05-1.08],PBRM1,Schizophrenia,schizophrenia,GCST009337,3:52594040
rs2358740-<b>?</b>,4 x 10-8,,NR,1.0510604,'-,[1.03-1.07],CACNA1D,Schizophrenia,schizophrenia,GCST009337,3:53421542
rs832190-<b>?</b>,4 x 10-8,,NR,1.0499018,'-,[1.03-1.07],THOC7,Schizophrenia,schizophrenia,GCST009337,3:63856953
rs62244881-<b>?</b>,1 x 10-8,,NR,1.0968,'-,[1.07-1.13],FOXP1,Schizophrenia,schizophrenia,GCST009337,3:71519926
rs3849490-<b>?</b>,2 x 10-8,,NR,1.049274,'-,[1.03-1.07],ROBO2,Schizophrenia,schizophrenia,GCST009337,3:76420223
rs66691851-<b>?</b>,4 x 10-18,,NR,1.0832828,'-,[1.07-1.1],STAG1,Schizophrenia,schizophrenia,GCST009337,3:136435986
rs28886334-<b>?</b>,4 x 10-8,,NR,1.05411,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST009337,3:161749343
rs6804239-<b>?</b>,1 x 10-13,,NR,1.066735,'-,[1.05-1.08],'-,Schizophrenia,schizophrenia,GCST009337,3:162062700
rs215412-<b>?</b>,6 x 10-9,,NR,1.06258,'-,[1.04-1.08],RFPL4AP3,Schizophrenia,schizophrenia,GCST009337,4:23421963
rs4697446-<b>?</b>,4 x 10-8,,NR,1.05096,'-,[1.03-1.07],'-,Schizophrenia,schizophrenia,GCST009337,4:24267999
rs10517289-<b>?</b>,3 x 10-9,,NR,1.0771335,'-,[1.05-1.1],'-,Schizophrenia,schizophrenia,GCST009337,4:33645261
rs13107325-<b>?</b>,4 x 10-13,,NR,1.16637,'-,[1.12-1.21],'-,Schizophrenia,schizophrenia,GCST009337,Mapping not available
rs7676765-<b>?</b>,3 x 10-10,,NR,1.0544297,'-,[1.04-1.07],SLC9B1,Schizophrenia,schizophrenia,GCST009337,4:103016776
rs28419375-<b>?</b>,8 x 10-9,,NR,1.054641,'-,[1.04-1.07],LINC02264,Schizophrenia,schizophrenia,GCST009337,4:117906596
rs57346805-<b>?</b>,6 x 10-11,,NR,1.059816,'-,[1.04-1.08],NEK1,Schizophrenia,schizophrenia,GCST009337,4:169382833
rs7673823-<b>?</b>,5 x 10-9,,NR,1.10263,'-,[1.07-1.14],GPM6A,Schizophrenia,schizophrenia,GCST009337,4:175804069
rs13142920-<b>?</b>,2 x 10-10,,NR,1.0712258,'-,[1.05-1.09],GPM6A,Schizophrenia,schizophrenia,GCST009337,4:175807463
rs2333321-<b>?</b>,2 x 10-10,,NR,1.07412,'-,[1.05-1.1],GPM6A,Schizophrenia,schizophrenia,GCST009337,4:175938841
rs6874127-<b>?</b>,9 x 10-13,,NR,1.0710077,'-,[1.05-1.09],HCN1,Schizophrenia,schizophrenia,GCST009337,5:45305513
rs13355485-<b>?</b>,5 x 10-10,,NR,1.0641807,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST009337,5:45904032
rs8188203-<b>?</b>,8 x 10-11,,NR,1.05665,'-,[1.04-1.07],'-,Schizophrenia,schizophrenia,GCST009337,5:50161448
rs11958187-<b>?</b>,9 x 10-9,,NR,1.05454,'-,[1.04-1.07],PPP2R2B,Schizophrenia,schizophrenia,GCST009337,5:147055600
rs200528994-<b>?</b>,3 x 10-8,,NR,1.15189,'-,[1.1-1.2],LINC01470,Schizophrenia,schizophrenia,GCST009337,5:152599547
rs10883795-<b>?</b>,8 x 10-10,,'-,1.15,'-,[1.10-1.20],"AS3MT, BORCS7-ASMT",Schizophrenia,schizophrenia,GCST003880,10:102894820
rs13268772-<b>?</b>,9 x 10-6,,'-,1.13,'-,[1.08-1.18],CSMD1,Schizophrenia,schizophrenia,GCST003880,8:3362037
rs4073405-<b>?</b>,1 x 10-6,,'-,1.01,'-,[0.96-1.04],"SYT13, LINC02696",Schizophrenia,schizophrenia,GCST003880,11:45302302
rs12561919-<b>?</b>,2 x 10-7,,'-,1.22,'-,[1.13-1.31],C1orf167,Schizophrenia,schizophrenia,GCST003880,1:11779866
rs1051061-<b>?</b>,1 x 10-10,,'-,1.17,'-,[1.12-1.22],VRK2,Schizophrenia,schizophrenia,GCST003880,2:58089679
rs10077591-<b>?</b>,6 x 10-7,,'-,1.09,'-,[1.16-1.22],"PGAM1P1, RPL7P20",Schizophrenia,schizophrenia,GCST003880,5:165935005
rs115070292-<b>?</b>,5 x 10-10,,'-,1.3,'-,[1.22-1.38],GABBR1,Schizophrenia,schizophrenia,GCST003880,6:29563197
rs12949688-<b>?</b>,7 x 10-6,,'-,1.07,'-,[1.04-1.10],"RN7SKP94, CCDC182",Schizophrenia,schizophrenia,GCST003880,17:57748340
rs10883765-<b>?</b>,3 x 10-9,,'-,1.0869565,'-,[1.04-1.13],ARL3,Schizophrenia,schizophrenia,GCST003880,10:102696929
rs7902091-<b>A</b>,7 x 10-7,,NR,5.331,'-,[NR],CTNNA3,Schizophrenia (cytomegalovirus infection interaction),"schizophrenia, cytomegalovirus infection",GCST001833,10:66838534
rs1006737-<b>?</b>,2 x 10-6,(SCZ vs. controls),NR,'-,'-,'-,CACNA1C,Schizophrenia or bipolar disorder,schizophrenia,GCST002295,12:2236129
rs17693963-<b>?</b>,3 x 10-9,(SCZ vs. controls),NR,'-,'-,'-,"GPR89P, RSL24D1P1",Schizophrenia or bipolar disorder,schizophrenia,GCST002295,6:27742386
rs10275045-<b>?</b>,2 x 10-6,(SCZ vs. controls),NR,'-,'-,'-,MAD1L1,Schizophrenia or bipolar disorder,schizophrenia,GCST002295,7:1881190
rs1635-<b>?</b>,7 x 10-12,,NR,1.28,'-,[1.22-1.37],NKAPL,Schizophrenia,schizophrenia,GCST001299,6:28259826
rs11038167-<b>?</b>,1 x 10-11,,NR,1.29,'-,[1.23-1.36],TSPAN18,Schizophrenia,schizophrenia,GCST001299,11:44821583
rs7192086-<b>T</b>,6 x 10-6,,0.24,1.12,'-,[NR],SHISA9,Schizophrenia,schizophrenia,GCST000215,16:12967754
rs1602565-<b>C</b>,3 x 10-6,,0.11,1.16,'-,[NR],"MYBPC3, LINC02742",Schizophrenia,schizophrenia,GCST000215,11:29140589
rs1344706-<b>T</b>,2 x 10-7,,0.59,1.12,'-,[NR],ZNF804A,Schizophrenia,schizophrenia,GCST000215,2:184913701
rs589249-<b>G</b>,3 x 10-7,,0.64,1.2,'-,[NR],"GRIK3, FTLP18",Schizophrenia,schizophrenia,GCST001851,1:36696751
rs3132935-<b>?</b>,5 x 10-7,(EA),0.82,1.25,'-,[NR],NOTCH4,Schizophrenia,schizophrenia,GCST001851,6:32203298
rs6917824-<b>G</b>,4 x 10-6,(EA),0.83,1.3,'-,[NR],NKAIN2,Schizophrenia,schizophrenia,GCST001851,6:124021518
rs1261117-<b>T</b>,3 x 10-10,(EA),0.06,1.6,'-,[NR],TCF4,Schizophrenia,schizophrenia,GCST001851,18:55282426
rs12611334-<b>G</b>,2 x 10-6,(EA),0.7,1.4,'-,[NR],"CLC, LEUTX",Schizophrenia,schizophrenia,GCST001851,19:39738769
rs7930295-<b>G</b>,3 x 10-6,(EA),0.86,1.3,'-,[NR],FEZ1,Schizophrenia,schizophrenia,GCST001851,11:125443703
rs1046089-<b>G</b>,4 x 10-6,(EA),0.34,1.3,'-,[NR],PRRC2A,Schizophrenia,schizophrenia,GCST001851,6:31635190
rs3132935-<b>?</b>,3 x 10-7,,0.82,1.25,'-,[NR],NOTCH4,Schizophrenia,schizophrenia,GCST001851,6:32203298
rs7897654-<b>T</b>,3 x 10-7,,0.3,1.2,'-,[NR],"CNNM2, BORCS7-ASMT",Schizophrenia,schizophrenia,GCST001851,10:102902701
rs12140439-<b>C</b>,1 x 10-6,(EA),0.31,1.3,'-,[NR],LINC01741,Schizophrenia,schizophrenia,GCST001851,1:177753772
rs16897515-<b>C</b>,4 x 10-7,(EA),0.16,1.3,'-,[NR],POM121L2,Schizophrenia,schizophrenia,GCST001851,6:27310241
rs3847375-<b>?</b>,1 x 10-6,(EA),NR,1.46,'-,[NR],NEBL,Schizophrenia,schizophrenia,GCST001657,10:21278636
rs12210050-<b>?</b>,3 x 10-6,(EA),NR,1.197,'-,[NR],"IRF4, EXOC2",Schizophrenia,schizophrenia,GCST001657,6:475489
rs12426725-<b>?</b>,4 x 10-6,(EA),NR,1.37,'-,[NR],PPFIA2,Schizophrenia,schizophrenia,GCST001657,12:81449349
rs16869652-<b>?</b>,5 x 10-6,(EA),NR,1.448,'-,[NR],LINC01016,Schizophrenia,schizophrenia,GCST001657,6:33883396
rs1170612-<b>?</b>,6 x 10-6,(EA),NR,1.4,'-,[NR],CNTNAP5,Schizophrenia,schizophrenia,GCST001657,2:124225479
rs2726807-<b>?</b>,6 x 10-6,(EA),NR,1.291,'-,[NR],TENM3,Schizophrenia,schizophrenia,GCST001657,4:182216245
rs16934812-<b>?</b>,7 x 10-6,(EA),NR,1.339,'-,[NR],TMTC1,Schizophrenia,schizophrenia,GCST001657,12:29719385
rs2048485-<b>?</b>,8 x 10-6,(EA),NR,1.4,'-,[NR],LINC01478,Schizophrenia,schizophrenia,GCST001657,18:44510702
rs10429924-<b>?</b>,1 x 10-6,(EA),NR,1.61,'-,[NR],'-,Schizophrenia,schizophrenia,GCST001657,1:244227262
rs12210050-<b>?</b>,4 x 10-6,(All),NR,1.18,'-,[NR],"IRF4, EXOC2",Schizophrenia,schizophrenia,GCST001657,6:475489
rs1170612-<b>?</b>,9 x 10-6,(All),NR,1.37,'-,[NR],CNTNAP5,Schizophrenia,schizophrenia,GCST001657,2:124225479
rs10489202-<b>A</b>,1 x 10-8,,0.141,1.23,'-,[1.15-1.32],'-,Schizophrenia,schizophrenia,GCST001301,Mapping not available
rs16887244-<b>?</b>,1 x 10-10,,0.683,1.19,'-,[1.14-1.27],LSM1,Schizophrenia,schizophrenia,GCST001301,8:38173827
rs2439202-<b>C</b>,3 x 10-8,,NR,1.06,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST011768,2:193513924
rs7584565-<b>T</b>,9 x 10-9,,NR,1.05,'-,[1.03-1.07],PRKD3,Schizophrenia,schizophrenia,GCST011769,2:37323760
rs12475492-<b>G</b>,6 x 10-9,,NR,1.09,'-,[1.07-1.11],RN7SKP224,Schizophrenia,schizophrenia,GCST011769,2:48153579
rs13416544-<b>G</b>,1 x 10-8,,NR,1.05,'-,[1.03-1.07],"TMEM17, RN7SL18P",Schizophrenia,schizophrenia,GCST011769,2:62494761
rs13017997-<b>T</b>,6 x 10-9,,NR,1.06,'-,[1.04-1.08],LINC01876,Schizophrenia,schizophrenia,GCST011769,2:155988248
rs9332466-<b>T</b>,2 x 10-9,,NR,1.06,'-,[1.04-1.08],PCGF3,Schizophrenia,schizophrenia,GCST011769,4:750310
rs1132998-<b>C</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],GSX2,Schizophrenia,schizophrenia,GCST011769,4:54100752
rs12652777-<b>T</b>,3 x 10-8,,NR,1.05,'-,[1.03-1.07],SGCD,Schizophrenia,schizophrenia,GCST011769,5:156348065
rs6467912-<b>C</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],PCLO,Schizophrenia,schizophrenia,GCST011769,7:82804512
rs4146645-<b>A</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],PCDH15,Schizophrenia,schizophrenia,GCST011768,10:54023386
rs1137522-<b>C</b>,5 x 10-9,,NR,1.05,'-,[1.03-1.07],JRK,Schizophrenia,schizophrenia,GCST011769,8:142657606
rs4937935-<b>T</b>,3 x 10-9,,NR,1.05,'-,[1.03-1.07],"LINC02873, LINC02706",Schizophrenia,schizophrenia,GCST011768,11:134710697
rs11169294-<b>G</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],"CERS5, LIMA1",Schizophrenia,schizophrenia,GCST011768,12:50168215
rs7900775-<b>T</b>,4 x 10-9,,NR,1.05,'-,[1.03-1.07],SORCS3,Schizophrenia,schizophrenia,GCST011769,10:104840585
rs11226509-<b>C</b>,3 x 10-8,,NR,1.05,'-,[1.03-1.07],CASP12,Schizophrenia,schizophrenia,GCST011769,11:104802933
rs4937935-<b>T</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],"LINC02873, LINC02706",Schizophrenia,schizophrenia,GCST011769,11:134710697
rs3742658-<b>C</b>,6 x 10-9,,NR,1.08,'-,[1.06-1.1],TTC7B,Schizophrenia,schizophrenia,GCST011768,14:90657500
rs1635298-<b>A</b>,3 x 10-8,,NR,1.07,'-,[1.05-1.09],LINC02210-CRHR1,Schizophrenia,schizophrenia,GCST011768,17:45666978
rs200450-<b>G</b>,8 x 10-9,,NR,1.05,'-,[1.03-1.07],DNAJC11,Schizophrenia,schizophrenia,GCST011769,1:6665170
rs9849438-<b>A</b>,2 x 10-9,,NR,1.06,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST011768,3:80506314
rs9998799-<b>T</b>,3 x 10-9,,NR,1.05,'-,[1.03-1.07],"NAA11, LINC01088",Schizophrenia,schizophrenia,GCST011768,4:79297258
rs2868134-<b>A</b>,3 x 10-8,,NR,1.06,'-,[1.04-1.08],PRKG2,Schizophrenia,schizophrenia,GCST011768,4:81095067
rs35751669-<b>A</b>,5 x 10-8,,NR,1.05,'-,[1.03-1.07],TENM3,Schizophrenia,schizophrenia,GCST011768,4:182716504
rs156089-<b>C</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],"CYSTM1, IGIP",Schizophrenia,schizophrenia,GCST011768,5:140142743
rs303739-<b>C</b>,7 x 10-9,,NR,1.06,'-,[1.04-1.08],CDCA4P1,Schizophrenia,schizophrenia,GCST011768,9:14505994
rs505061-<b>A</b>,2 x 10-9,,NR,1.05,'-,[1.03-1.07],LINC01239,Schizophrenia,schizophrenia,GCST011768,9:22767165
rs6479495-<b>C</b>,4 x 10-9,,NR,1.06,'-,[1.04-1.08],"PHF2, FAM120A",Schizophrenia,schizophrenia,GCST011768,9:93572320
rs890235-<b>G</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],"LINC01289, LINC01414",Schizophrenia,schizophrenia,GCST011769,8:63803912
rs11226509-<b>C</b>,1 x 10-8,,NR,1.05,'-,[1.03-1.07],CASP12,Schizophrenia,schizophrenia,GCST011768,11:104802933
rs4615688-<b>G</b>,1 x 10-9,,NR,1.07,'-,[1.05-1.09],CDCA4P1,Schizophrenia,schizophrenia,GCST011769,9:14505863
rs505061-<b>A</b>,5 x 10-9,,NR,1.05,'-,[1.03-1.07],LINC01239,Schizophrenia,schizophrenia,GCST011769,9:22767165
rs1907719-<b>T</b>,1 x 10-7,,NR,1.05,'-,[1.03-1.07],KCNMA1,Schizophrenia,schizophrenia,GCST011769,10:77003539
rs7309031-<b>C</b>,3 x 10-8,,NR,1.04,'-,[1.02-1.06],LINC02882,Schizophrenia,schizophrenia,GCST011768,12:74103016
rs2088911-<b>G</b>,3 x 10-8,,NR,1.05,'-,[1.03-1.07],LINC00571,Schizophrenia,schizophrenia,GCST011768,13:38270302
rs11147928-<b>G</b>,5 x 10-9,,NR,1.05,'-,[1.03-1.07],ENOX1,Schizophrenia,schizophrenia,GCST011768,13:43777097
rs7322886-<b>T</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],"RCBTB1, ARL11",Schizophrenia,schizophrenia,GCST011768,13:49605318
rs11104379-<b>G</b>,2 x 10-8,,NR,1.06,'-,[1.04-1.08],RPL23AP68,Schizophrenia,schizophrenia,GCST011769,12:87266212
rs9595066-<b>T</b>,1 x 10-8,,NR,1.06,'-,[1.04-1.08],"LINC00390, SMIM2-AS1",Schizophrenia,schizophrenia,GCST011769,13:44132132
rs7494766-<b>G</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],NIN,Schizophrenia,schizophrenia,GCST011769,14:50752053
rs76664468-<b>T</b>,3 x 10-8,,NR,1.07,'-,[1.05-1.09],PPP2R5E,Schizophrenia,schizophrenia,GCST011769,14:63530992
rs62065467-<b>C</b>,1 x 10-8,,NR,1.05,'-,[1.03-1.07],"ZNF207, PSMD11",Schizophrenia,schizophrenia,GCST011769,17:32433299
rs11665242-<b>G</b>,9 x 10-10,,NR,1.06,'-,[1.04-1.08],DCC,Schizophrenia,schizophrenia,GCST011769,18:53380757
rs281377-<b>C</b>,2 x 10-8,,NR,1.05,'-,[1.03-1.07],FUT2,Schizophrenia,schizophrenia,GCST011769,19:48703346
rs2143757-<b>G</b>,9 x 10-9,,NR,1.07,'-,[1.05-1.09],LINC01725,Schizophrenia,schizophrenia,GCST011768,1:83801108
rs7982251-<b>C</b>,3 x 10-6,,0.13,1.2658228,'-,[1.15-1.39],FLT1,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,13:28335698
rs1052873-<b>C</b>,2 x 10-6,,0.78,1.2048193,'-,[1.12-1.32],"PBK, ESCO2",Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,8:27810276
rs6428588-<b>C</b>,3 x 10-6,,0.66,1.1764705,'-,[1.1-1.27],KCNK1,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,1:90359648
rs7979008-<b>C</b>,4 x 10-6,,0.66,1.1764705,'-,[1.1-1.27],PCED1B,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,12:47085745
rs5016373-<b>C</b>,6 x 10-6,,0.35,1.1627907,'-,[1.09-1.25],"AVEN, CHRM5",Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,15:34021840
rs67658161-<b>A</b>,3 x 10-6,,0.48,1.16,'-,1.09-1.24,CSMD1,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,8:3429211
rs165774-<b>A</b>,9 x 10-6,,0.33,1.18,'-,1.1-1.27,COMT,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,22:19965038
rs12639760-<b>A</b>,9 x 10-6,,0.22,1.21,'-,1.11-1.31,LINC02485,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,4:135037116
chr10_7228436-I-<b>?</b>,9 x 10-6,,0.14,1.31,'-,1.16-1.47,'-,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,Mapping not available
rs190572487-<b>T</b>,7 x 10-6,,0.75,1.35,'-,1.18-1.54,"DUXAP10, BMS1P17",Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,14:19312355
rs3847511-<b>T</b>,8 x 10-6,,0.08,1.36,'-,1.19-1.55,LINC02756,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,11:91720868
rs55893662-<b>T</b>,5 x 10-6,,0.11,1.46,'-,1.24-1.73,"ZNF77, TLE6",Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,19:2955761
rs118167891-<b>T</b>,2 x 10-6,,0.02,1.93,'-,1.47-2.53,CCDC7,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,10:32657081
rs141199126-<b>T</b>,9 x 10-6,,0.02,2.05,'-,1.49-2.83,LINC02755,Suicide attempts in bipolar disorder,"bipolar disorder, attempted suicide",GCST008119,11:29739727
rs1487441-<b>G</b>,3 x 10-8,,0.51,1.12,'-,[1.08-1.15],"MIR2113, EIF4EBP2P3",Bipolar disorder,bipolar disorder,GCST003724,6:98106018
rs9834970-<b>T</b>,5 x 10-10,,0.5,1.14,'-,[1.09-1.18],"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST003724,3:36814539
rs4236274-<b>G</b>,8 x 10-12,,0.39,1.15,'-,[1.10-1.20],MAD1L1,Bipolar disorder,bipolar disorder,GCST003724,7:1856777
rs12553324-<b>C</b>,6 x 10-9,,0.59,1.12,'-,[1.07-1.16],'-,Bipolar disorder,bipolar disorder,GCST003724,9:23347867
rs1054442-<b>A</b>,1 x 10-8,,0.62,1.13,'-,[1.09-1.17],DDN,Bipolar disorder,bipolar disorder,GCST003724,12:48995537
rs2517959-<b>T</b>,5 x 10-9,,0.67,1.13,'-,[1.09-1.17],"ERBB2, PGAP3",Bipolar disorder,bipolar disorder,GCST003724,17:39690259
rs7561528-<b>A</b>,4 x 10-14,,0.35,1.17,'-,[1.13-1.22],"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,2:127132061
rs4938933-<b>?</b>,8 x 10-12,,0.61,1.12,'-,[1.09-1.15],MS4A4A,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,11:60266956
rs6701713-<b>A</b>,5 x 10-10,,0.2,1.16,'-,[1.11-1.22],CR1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,1:207612944
rs1532278-<b>?</b>,8 x 10-8,,0.64,1.12,'-,[1.08-1.18],CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,8:27608798
rs561655-<b>?</b>,7 x 10-11,,0.66,1.15,'-,[1.10-1.19],"PICALM, RNU6-560P",Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,11:86089237
rs3752246-<b>G</b>,6 x 10-7,,0.19,1.15,'-,[1.09-1.21],ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,19:1056493
rs9349407-<b>C</b>,9 x 10-9,,0.27,1.11,'-,[1.07-1.15],CD2AP,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,6:47485642
rs3865444-<b>?</b>,2 x 10-9,,0.7,1.1,'-,[1.08-1.14],"CD33, SIGLEC22P",Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,19:51224706
rs11767557-<b>?</b>,6 x 10-10,,0.81,1.11,'-,[1.08-1.16],EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,7:143412046
rs3764650-<b>?</b>,5 x 10-17,,0.1,1.23,'-,[1.18-1.30],ABCA7,Alzheimer's disease,Alzheimer's disease,GCST001025,19:1046521
rs3818361-<b>?</b>,4 x 10-14,,0.19,1.18,'-,[1.13-1.24],CR1,Alzheimer's disease,Alzheimer's disease,GCST001025,1:207611623
rs2070615-<b>G</b>,1 x 10-6,,NR,1.1,'-,[NR],CACNB3,Bipolar disorder,bipolar disorder,GCST001241,12:48824388
rs12576775-<b>G</b>,4 x 10-8,,NR,1.14,'-,[NR],'-,Bipolar disorder,bipolar disorder,GCST001241,Mapping not available
rs3845817-<b>T</b>,2 x 10-6,,NR,1.1,'-,[NR],"RPS15AP15, RN7SL635P",Bipolar disorder,bipolar disorder,GCST001241,2:65531391
rs2176528-<b>C</b>,4 x 10-6,,NR,1.12,'-,[NR],'-,Bipolar disorder,bipolar disorder,GCST001241,2:194007459
rs4660531-<b>T</b>,3 x 10-6,,NR,1.1,'-,[NR],FOXO6,Bipolar disorder,bipolar disorder,GCST001241,1:41374150
rs2287921-<b>C</b>,3 x 10-6,,NR,1.1,'-,[NR],RASIP1,Bipolar disorder,bipolar disorder,GCST001241,19:48725015
rs7827290-<b>G</b>,9 x 10-6,,NR,1.1,'-,[NR],SLC45A4,Bipolar disorder,bipolar disorder,GCST001241,8:141290216
rs12730292-<b>C</b>,5 x 10-6,,NR,1.1,'-,[NR],'-,Bipolar disorder,bipolar disorder,GCST001241,1:78789077
rs6746896-<b>A</b>,2 x 10-6,,NR,1.1,'-,[NR],"CNNM4, LMAN2L",Bipolar disorder,bipolar disorder,GCST001241,2:96745212
rs10994397-<b>T</b>,3 x 10-7,,NR,1.22,'-,[NR],ANK3,Bipolar disorder,bipolar disorder,GCST001241,10:60519366
rs4765913-<b>A</b>,2 x 10-8,,NR,1.14,'-,[NR],CACNA1C,Bipolar disorder,bipolar disorder,GCST001241,12:2310730
rs10896135-<b>G</b>,2 x 10-7,,NR,1.12,'-,[NR],C11orf80,Bipolar disorder,bipolar disorder,GCST001241,11:66783531
rs7578035-<b>G</b>,3 x 10-6,,NR,1.09,'-,[NR],LINC02611,Bipolar disorder,bipolar disorder,GCST001241,2:98766429
rs9371601-<b>T</b>,7 x 10-7,,NR,1.1,'-,[NR],SYNE1,Bipolar disorder,bipolar disorder,GCST001241,6:152469438
rs736408-<b>C</b>,2 x 10-6,,NR,1.1,'-,[NR],ITIH3,Bipolar disorder,bipolar disorder,GCST001241,3:52801338
rs12912251-<b>G</b>,3 x 10-6,,NR,1.1,'-,[NR],LINC02694,Bipolar disorder,bipolar disorder,GCST001241,15:38694167
rs4332037-<b>T</b>,7 x 10-6,,NR,1.11,'-,[NR],MAD1L1,Bipolar disorder,bipolar disorder,GCST001241,7:1911173
rs6550435-<b>G</b>,9 x 10-6,,NR,1.09,'-,[NR],"TRANK1, LINC02033",Bipolar disorder,bipolar disorder,GCST001241,3:36822998
rs610932-<b>?</b>,2 x 10-14,,0.58,1.11,'-,[1.09-1.15],"MS4A6A, LINC02705",Alzheimer's disease,Alzheimer's disease,GCST001025,11:60171834
rs744373-<b>?</b>,3 x 10-14,,0.29,1.17,'-,[1.12-1.21],"BIN1, NIFKP9",Alzheimer's disease,Alzheimer's disease,GCST001025,2:127137039
rs7920721-<b>G</b>,3 x 10-7,,0.387,1.07,'-,[1.04-1.10],"ECHDC3, USP6NL-AS1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,10:11678309
rs10751667-<b>T</b>,6 x 10-7,,0.634,1.0753,'-,[1.04-1.1],AP2A2,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:941941
rs7295246-<b>G</b>,3 x 10-7,,0.406,1.07,'-,[1.04-1.10],"ADAMTS20, EEF1A1P17",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,12:43573874
rs2337406-<b>C</b>,3 x 10-7,,0.897,1.1494,'-,[1.09-1.2],"IGHV3-71, IGHV2-70",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,14:106772332
rs8035452-<b>T</b>,3 x 10-7,,0.661,1.0753,'-,[1.04-1.1],SPPL2A,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,15:50748601
rs74615166-<b>C</b>,4 x 10-7,,0.02,1.29,'-,[1.17-1.42],TRIP4,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,15:64433291
rs7225151-<b>A</b>,4 x 10-7,,0.121,1.1,'-,[1.06-1.15],"SCIMP, ZNF594-DT",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,17:5233752
chr17:61538148-<b>A</b>,3 x 10-7,,0.018,1.34,'-,[1.20-1.50],'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,Mapping not available
rs3865444-<b>C</b>,3 x 10-6,,0.693,1.06,'-,[1.04-1.1],"CD33, SIGLEC22P",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,19:51224706
rs2718058-<b>A</b>,5 x 10-9,,0.627,1.0753,'-,[1.05-1.11],"GPR141, EPDR1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,7:37801932
rs7274581-<b>T</b>,3 x 10-8,,0.917,1.1364,'-,[1.09-1.19],CASS4,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,20:56443204
rs11218343-<b>T</b>,1 x 10-14,,0.961,1.2987,'-,[1.22-1.39],SORL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:121564878
rs6656401-<b>A</b>,6 x 10-24,,0.197,1.18,'-,[1.14-1.22],CR1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,1:207518704
rs6733839-<b>T</b>,7 x 10-44,,0.409,1.22,'-,[1.18-1.25],"NIFKP9, BIN1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,2:127135234
rs10948363-<b>G</b>,5 x 10-11,,0.266,1.1,'-,[1.07-1.13],CD2AP,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,6:47520026
rs11771145-<b>G</b>,1 x 10-13,,0.662,1.1111,'-,[1.08-1.14],EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,7:143413669
rs9331896-<b>T</b>,3 x 10-25,,0.621,1.1628,'-,[1.12-1.19],CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,8:27610169
rs983392-<b>A</b>,6 x 10-16,,0.597,1.1111,'-,[1.09-1.15],"LINC02705, MS4A2",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:60156035
rs10792832-<b>G</b>,9 x 10-26,,0.642,1.1494,'-,[1.12-1.18],"LINC02695, RNU6-560P",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:86156833
rs4147929-<b>A</b>,1 x 10-15,,0.19,1.15,'-,[1.11-1.19],ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,19:1063444
rs35349669-<b>T</b>,3 x 10-8,,0.488,1.08,'-,[1.05-1.11],INPP5D,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,2:233159830
rs190982-<b>A</b>,3 x 10-8,,0.592,1.0753,'-,[1.05-1.11],MEF2C-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,5:88927603
rs1476679-<b>T</b>,6 x 10-10,,0.713,1.0989,'-,[1.06-1.12],ZCWPW1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,7:100406823
rs10838725-<b>C</b>,1 x 10-8,,0.316,1.08,'-,[1.05-1.11],CELF1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:47536319
rs17125944-<b>C</b>,8 x 10-9,,0.092,1.14,'-,[1.09-1.19],FERMT2,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,14:52933911
rs9271192-<b>C</b>,3 x 10-12,,0.276,1.11,'-,[1.08-1.18],"HLA-DRB1, HLA-DQA1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,6:32610753
rs28834970-<b>C</b>,7 x 10-14,,0.366,1.1,'-,[1.08-1.13],PTK2B,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,8:27337604
rs10498633-<b>G</b>,6 x 10-9,,0.783,1.0989,'-,[1.06-1.14],SLC24A4,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,14:92460608
rs6678275-<b>C</b>,3 x 10-7,,0.169,1.09,'-,[1.05-1.13],'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,1:193656103
rs6448799-<b>T</b>,7 x 10-8,,0.3,1.08,'-,[1.05-1.11],'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,4:11628425
rs72807343-<b>T</b>,7 x 10-7,,0.016,1.35,'-,[1.20-1.52],SQSTM1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,5:179811261
rs9381040-<b>C</b>,6 x 10-7,,0.703,1.0753,'-,[1.04-1.1],"TREML2, TREM2",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,6:41186912
rs7818382-<b>T</b>,8 x 10-8,,0.469,1.07,'-,[1.04-1.10],NDUFAF6,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,8:95041772
rs73650494-<b>C</b>,5 x 10-6,,0.02,1.7857143,'-,[1.39-2.33],PCSK5,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,9:76216527
rs72756712-<b>G</b>,3 x 10-6,,0.05,1.6666665,'-,[1.35-2.04],'-,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,9:126140627
rs13198361-<b>C</b>,9 x 10-6,,0.86,1.5384616,'-,[1.27-1.85],'-,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,6:90963695
rs73215273-<b>C</b>,9 x 10-6,,0.1,1.5151515,'-,[1.27-1.85],DACH1,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,13:71829118
rs2739958-<b>C</b>,8 x 10-6,,0.4,1.4705882,'-,[1.25-1.75],FAM66A,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,8:12375025
rs191312301-<b>C</b>,3 x 10-6,,0.11,1.4084507,'-,[1.22-1.61],DNAH8,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,6:39007951
rs57729539-<b>G</b>,6 x 10-6,,0.17,1.3157895,'-,[1.16-1.47],ACSBG1,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,15:78231857
rs875777-<b>C</b>,7 x 10-6,,0.8,1.3157895,'-,[1.16-1.49],"DMTF1, ELAPOR2",Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,7:87116064
chr2_188481671-I-<b>?</b>,4 x 10-6,,0.62,1.2658228,'-,[1.15-1.41],'-,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,Mapping not available
rs4494728-<b>C</b>,8 x 10-6,,0.45,1.2195122,'-,[1.12-1.33],SPRED2,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,2:65362379
rs6497871-<b>A</b>,7 x 10-6,,0.6,1.24,'-,1.13-1.37,"RN7SL493P, ATF7IP2",Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,16:10270306
rs4843180-<b>T</b>,1 x 10-6,,0.39,1.25,'-,1.14-1.36,LINC02188,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,16:86719464
chr11_133764404-I-<b>?</b>,6 x 10-6,,0.75,1.29,'-,1.15-1.43,'-,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,Mapping not available
rs180697792-<b>A</b>,1 x 10-6,,0.2,1.34,'-,1.19-1.50,ABCA5,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,17:69298289
rs75305337-<b>A</b>,6 x 10-6,,0.09,1.39,'-,1.20-1.60,'-,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,3:84283982
rs3858375-<b>T</b>,9 x 10-7,,0.05,1.6,'-,1.33-1.94,FTH1,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,11:95344003
rs6114731-<b>A</b>,5 x 10-6,,0.03,1.78,'-,1.39-2.27,"GAPDHP53, SYNDIG1",Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,20:24446544
rs151336980-<b>T</b>,8 x 10-6,,0.03,1.78,'-,1.38-2.29,GRIK4,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,11:120600028
rs11739808-<b>A</b>,9 x 10-6,,0.02,2.3,'-,1.59-3.31,"LINC01385, FOXD1",Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,5:73449216
rs482039-<b>T</b>,4 x 10-7,,0.02,2.37,'-,1.70-3.31,LINC01720,Suicide attempts in schizophrenia,"schizophrenia, attempted suicide",GCST008120,1:190808437
rs9257566-<b>?</b>,7 x 10-30,,NR,1.2277772,'-,[1.19-1.26],"OR2J2, OR2J4P",Schizophrenia,schizophrenia,GCST009337,6:29176755
rs117074560-<b>?</b>,5 x 10-10,,NR,1.180331,'-,[1.13-1.23],"FUT9, KRT18P50",Schizophrenia,schizophrenia,GCST009337,6:96011775
rs13230421-<b>?</b>,2 x 10-11,,NR,1.10584,'-,[1.08-1.14],"GRM3, GRM3-AS1",Schizophrenia,schizophrenia,GCST009337,7:86790810
rs74912003-<b>?</b>,5 x 10-8,,NR,1.2416036,'-,[1.16-1.32],"TP53TG1, TMEM243",Schizophrenia,schizophrenia,GCST009337,7:87252657
rs4365348-<b>?</b>,7 x 10-9,,NR,1.06141,'-,[1.04-1.08],"ATPAF2, DRC3",Schizophrenia,schizophrenia,GCST009337,17:18009234
rs72934570-<b>?</b>,3 x 10-12,,NR,1.1558021,'-,[1.12-1.2],"LINC01416, LINC01415",Schizophrenia,schizophrenia,GCST009337,18:55865958
rs11663602-<b>?</b>,1 x 10-10,,NR,1.06056,'-,[1.04-1.08],"KCNG2, CTDP1",Schizophrenia,schizophrenia,GCST009337,18:79818191
rs1792709-<b>?</b>,3 x 10-11,,NR,1.0703658,'-,[1.05-1.09],"LINC01905, LINC01539",Schizophrenia,schizophrenia,GCST009337,18:56101744
rs1075195-<b>?</b>,4 x 10-9,,NR,1.06567,'-,[1.04-1.09],"Metazoa_SRP, SLC32A1",Schizophrenia,schizophrenia,GCST009337,20:38718108
rs6128857-<b>?</b>,2 x 10-9,,NR,1.06588,'-,[1.05-1.09],"ACTR5, SLC32A1",Schizophrenia,schizophrenia,GCST009337,20:38738094
rs5757773-<b>?</b>,3 x 10-8,,NR,1.06226,'-,[1.04-1.08],"ENTHD1, CACNA1I",Schizophrenia,schizophrenia,GCST009337,22:39691384
rs9607782-<b>?</b>,2 x 10-11,,NR,1.08405,'-,[1.06-1.11],EP300-AS1,Schizophrenia,schizophrenia,GCST009337,22:41191552
rs77441740-<b>?</b>,3 x 10-8,,NR,1.1770383,'-,[1.12-1.23],"TNFRSF13C, CENPM",Schizophrenia,schizophrenia,GCST009337,22:41933271
rs11210892-<b>?</b>,1 x 10-15,,NR,1.0749799,'-,[1.06-1.09],"PTPRF, KDM4A",Schizophrenia,schizophrenia,GCST009337,1:43634413
rs946106-<b>?</b>,7 x 10-9,,NR,1.055799,'-,[1.04-1.07],"AGBL4, AGBL4-IT1",Schizophrenia,schizophrenia,GCST009337,1:49462817
rs12031518-<b>?</b>,6 x 10-11,,NR,1.0726161,'-,[1.05-1.09],"PTBP2, RN7SKP270",Schizophrenia,schizophrenia,GCST009337,1:96708350
rs1999512-<b>?</b>,4 x 10-8,,NR,1.0526427,'-,[1.03-1.07],"Y_RNA, NRBF2P3",Schizophrenia,schizophrenia,GCST009337,1:110779397
rs2319280-<b>?</b>,1 x 10-9,,NR,1.0947267,'-,[1.07-1.12],"OTUD7B, VPS45",Schizophrenia,schizophrenia,GCST009337,1:150042041
rs61826793-<b>?</b>,4 x 10-8,,NR,1.0697247,'-,[1.05-1.09],"ANKRD45, KLHL20",Schizophrenia,schizophrenia,GCST009337,1:173677634
rs6670165-<b>?</b>,2 x 10-9,,NR,1.06833,'-,[1.05-1.09],"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST009337,1:177310985
rs6703335-<b>?</b>,1 x 10-8,,NR,1.0526427,'-,[1.04-1.07],SDCCAG8,Schizophrenia,schizophrenia,GCST009337,1:243445665
rs13376709-<b>?</b>,9 x 10-11,,NR,1.0590752,'-,[1.04-1.08],AKT3,Schizophrenia,schizophrenia,GCST009337,1:243527189
rs4632296-<b>?</b>,1 x 10-12,,NR,1.0738,'-,[1.05-1.09],"RBKS, MRPL33",Schizophrenia,schizophrenia,GCST009337,2:27802117
rs12328348-<b>?</b>,1 x 10-9,,NR,1.06067,'-,[1.04-1.08],"RN7SL361P, BCL11A",Schizophrenia,schizophrenia,GCST009337,2:60558802
rs1191551-<b>?</b>,3 x 10-8,,NR,1.07251,'-,[1.05-1.1],"RNU11-5P, PRKD1",Schizophrenia,schizophrenia,GCST009337,14:29531199
rs783540-<b>?</b>,2 x 10-8,,NR,1.049274,'-,[1.03-1.07],CPEB1,Schizophrenia,schizophrenia,GCST009337,15:82585958
rs11633534-<b>?</b>,8 x 10-14,,NR,1.0806956,'-,[1.06-1.1],"LINC00933, ZSCAN2",Schizophrenia,schizophrenia,GCST009337,15:84581411
rs758129-<b>?</b>,8 x 10-10,,NR,1.0597149,'-,[1.04-1.08],"POLG-DT, MIR9-3HG",Schizophrenia,schizophrenia,GCST009337,15:89357656
rs13335685-<b>?</b>,6 x 10-10,,NR,1.0612,'-,[1.04-1.08],"CORO7-PAM16, CORO7",Schizophrenia,schizophrenia,GCST009337,16:4419283
rs9890128-<b>?</b>,1 x 10-12,,NR,1.0713291,'-,[1.05-1.09],YWHAE,Schizophrenia,schizophrenia,GCST009337,17:1370352
rs11038391-<b>?</b>,8 x 10-9,,NR,1.0643846,'-,[1.04-1.09],"LINC02696, SYT13",Schizophrenia,schizophrenia,GCST009337,11:45308670
rs7127399-<b>?</b>,4 x 10-9,,NR,1.0561223,'-,[1.04-1.07],"OR8Q1P, OR8A1",Schizophrenia,schizophrenia,GCST009337,11:124591378
rs3802924-<b>?</b>,2 x 10-12,,NR,1.09428,'-,[1.07-1.12],"IGSF9B, LINC02730",Schizophrenia,schizophrenia,GCST009337,11:133957838
rs2159100-<b>?</b>,1 x 10-19,,NR,1.10076,'-,[1.08-1.12],CACNA1C,Schizophrenia,schizophrenia,GCST009337,12:2237227
rs11615992-<b>?</b>,3 x 10-8,,NR,1.068125,'-,[1.04-1.09],"P2RX4, P2RX7",Schizophrenia,schizophrenia,GCST009337,12:121189465
rs147786161-<b>?</b>,3 x 10-9,,NR,1.0524322,'-,[1.04-1.07],MLXIP,Schizophrenia,schizophrenia,GCST009337,12:122099234
rs111589530-<b>?</b>,3 x 10-9,,NR,1.08199,'-,[1.06-1.11],"CCDC62, HIP1R",Schizophrenia,schizophrenia,GCST009337,12:122830405
rs3088186-<b>?</b>,4 x 10-9,,NR,1.05802,'-,[1.04-1.08],MSRA,Schizophrenia,schizophrenia,GCST009337,8:10368845
rs7001340-<b>?</b>,2 x 10-13,,NR,1.07412,'-,[1.06-1.09],"FGFR1, LETM2",Schizophrenia,schizophrenia,GCST009337,8:38404715
rs148415900-<b>?</b>,4 x 10-10,,NR,1.0848105,'-,[1.06-1.11],MIR124-2HG,Schizophrenia,schizophrenia,GCST009337,8:64405112
rs4734654-<b>?</b>,2 x 10-8,,NR,1.05443,'-,[1.04-1.07],"KLF10, ADI1P2",Schizophrenia,schizophrenia,GCST009337,8:102657763
rs72829007-<b>?</b>,6 x 10-9,,NR,1.18495,'-,[1.13-1.24],"RN7SL591P, LINC02621",Schizophrenia,schizophrenia,GCST009337,10:62328196
rs112222723-<b>?</b>,1 x 10-9,,NR,1.0919892,'-,[1.06-1.12],RNU6-543P,Schizophrenia,schizophrenia,GCST009337,10:63102717
rs3929747-<b>?</b>,5 x 10-15,,NR,1.0851283,'-,[1.06-1.11],C10orf95-AS1,Schizophrenia,schizophrenia,GCST009337,10:102454510
rs7476192-<b>?</b>,9 x 10-19,,NR,1.08893,'-,[1.07-1.11],"AS3MT, BORCS7-ASMT",Schizophrenia,schizophrenia,GCST009337,10:102889618
rs7605813-<b>?</b>,5 x 10-12,,NR,1.06791,'-,[1.05-1.09],"HSPE1-MOB4, HSPD1",Schizophrenia,schizophrenia,GCST009337,2:197510605
rs1451488-<b>?</b>,3 x 10-9,,NR,1.0560108,'-,[1.04-1.07],RNU7-147P,Schizophrenia,schizophrenia,GCST009337,2:199125384
rs2293018-<b>?</b>,4 x 10-9,,NR,1.13553,'-,[1.09-1.18],"MST1R, MON1A",Schizophrenia,schizophrenia,GCST009337,3:49906323
rs374528934-<b>?</b>,4 x 10-11,,NR,1.130544,'-,[1.09-1.17],"HYAL2, HYAL1",Schizophrenia,schizophrenia,GCST009337,3:50312945
rs4855019-<b>?</b>,6 x 10-15,,NR,1.0927528,'-,[1.07-1.12],SOX2-OT,Schizophrenia,schizophrenia,GCST009337,3:181120856
rs9841616-<b>?</b>,5 x 10-10,,NR,1.0818764,'-,[1.06-1.11],SOX2-OT,Schizophrenia,schizophrenia,GCST009337,3:181449797
rs1997529-<b>?</b>,4 x 10-8,,NR,1.0523214,'-,[1.03-1.07],"COX7A2P2, LINC02267",Schizophrenia,schizophrenia,GCST009337,4:96819992
rs4132385-<b>?</b>,6 x 10-12,,NR,1.06727,'-,[1.05-1.09],"ZSWIM6, LINC02057",Schizophrenia,schizophrenia,GCST009337,5:61319052
rs419677-<b>?</b>,5 x 10-9,,NR,1.0548522,'-,[1.04-1.07],"KRT18P42, MAN2A1-DT",Schizophrenia,schizophrenia,GCST009337,5:109676609
rs13164092-<b>?</b>,1 x 10-9,,NR,1.0572836,'-,[1.04-1.08],"ETF1, RPL7P19",Schizophrenia,schizophrenia,GCST009337,5:138505171
rs7733403-<b>?</b>,9 x 10-11,,NR,1.05622,'-,[1.04-1.07],"PCDHA1, VTRNA1-3",Schizophrenia,schizophrenia,GCST009337,5:140774630
rs4561819-<b>?</b>,3 x 10-11,,NR,'-,0.017707828 unit decrease,[0.013-0.023],CNTN4,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:2485619
rs9846711-<b>?</b>,4 x 10-12,,NR,'-,0.014301584 unit decrease,[0.01-0.018],PLCL2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:16821370
rs6801153-<b>?</b>,6 x 10-12,,NR,'-,0.016061356 unit decrease,[0.011-0.021],"LINC00691, NR1D2","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:24072206
rs4678552-<b>?</b>,2 x 10-13,,NR,'-,0.015579467 unit decrease,[0.011-0.02],"LINC02033, HSPD1P6","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:36803031
rs7429990-<b>?</b>,3 x 10-9,,NR,'-,0.01354075 unit decrease,[0.0091-0.018],MAP4,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:47860313
rs4688756-<b>?</b>,2 x 10-17,,NR,'-,0.017151818 unit decrease,[0.013-0.021],RBM6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:50002761
rs35971989-<b>?</b>,3 x 10-8,,NR,'-,0.014847553 unit increase,[0.0096-0.0201],DCAF1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:51431798
rs2710323-<b>?</b>,9 x 10-10,,NR,'-,0.012100469 unit decrease,[0.0082-0.016],ITIH1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:52781889
rs832187-<b>?</b>,2 x 10-8,,NR,'-,0.011610742 unit increase,[0.0076-0.0156],"THOC7, C3orf49","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:63847374
rs6779258-<b>?</b>,9 x 10-10,,NR,'-,0.012331557 unit decrease,[0.0084-0.0163],FOXP1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:71500488
rs62263923-<b>?</b>,9 x 10-11,,NR,'-,0.013731798 unit decrease,[0.0096-0.0179],CADM2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:85625640
rs9868075-<b>?</b>,3 x 10-8,,NR,'-,0.014295965 unit decrease,[0.0092-0.0194],BBX,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:107549762
rs2866466-<b>?</b>,4 x 10-8,,NR,'-,0.0148022 unit decrease,[0.0095-0.0201],IGSF11,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:119038184
rs9289296-<b>?</b>,8 x 10-9,,NR,'-,0.01547775 unit increase,[0.01-0.021],"LINC01471, LINC02016","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:127425764
rs7432375-<b>?</b>,6 x 10-10,,NR,'-,0.012484669 unit increase,[0.0085-0.0164],STAG1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:136569563
rs13076861-<b>?</b>,8 x 10-9,,NR,'-,0.014693938 unit increase,[0.0097-0.0197],FXR1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,3:180969810
rs3095075-<b>?</b>,1 x 10-8,,NR,'-,0.011685019 unit decrease,[0.0077-0.0157],MSANTD1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:3251456
rs207338-<b>?</b>,5 x 10-8,,NR,'-,0.01078371 unit decrease,[0.0069-0.0147],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:19052136
rs215412-<b>?</b>,3 x 10-8,,NR,'-,0.011997007 unit decrease,[0.0078-0.0162],RFPL4AP3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:23421963
rs6844280-<b>?</b>,4 x 10-8,,NR,'-,0.011314505 unit increase,[0.0073-0.0153],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:31385522
rs13145146-<b>?</b>,2 x 10-9,,NR,'-,0.028579967 unit decrease,[0.019-0.038],EPHA5,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:65564907
rs11725618-<b>?</b>,1 x 10-8,,NR,'-,0.012540856 unit increase,[0.0082-0.0169],"MIR1269A, IFITM3P1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:66188051
rs35225200-<b>?</b>,4 x 10-13,,NR,'-,0.023882955 unit increase,[0.017-0.03],SLC39A8,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:102225731
rs7674220-<b>?</b>,1 x 10-11,,NR,'-,0.013915018 unit decrease,[0.0099-0.0179],TET2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:105227601
rs10006235-<b>?</b>,3 x 10-11,,NR,'-,0.015006348 unit decrease,[0.011-0.019],LINC02466,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:129748953
rs4493682-<b>?</b>,3 x 10-10,,NR,'-,0.015637161 unit increase,[0.011-0.021],HCN1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:45187922
rs13157551-<b>?</b>,2 x 10-9,,NR,'-,0.012148838 unit increase,[0.0082-0.0161],SALL4P1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:57368769
rs2434582-<b>?</b>,7 x 10-11,,NR,'-,0.013207105 unit increase,[0.0092-0.0172],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:58304690
rs1526896-<b>?</b>,2 x 10-15,,NR,'-,0.016284786 unit decrease,[0.012-0.02],NDUFAF2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:61063883
rs10061788-<b>?</b>,4 x 10-14,,NR,'-,0.018549735 unit increase,[0.014-0.023],LINC00461,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:88638889
rs62378245-<b>?</b>,7 x 10-9,,NR,'-,0.014030106 unit increase,[0.0093-0.0188],MEF2C-AS1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:89448145
rs1560208-<b>?</b>,1 x 10-8,,NR,'-,0.014982785 unit decrease,[0.0098-0.0202],MIR3660,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:89990437
rs2283-<b>?</b>,1 x 10-9,,NR,'-,0.012567089 unit decrease,[0.0085-0.0166],EFNA5,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:107437922
rs12189452-<b>?</b>,6 x 10-9,,NR,'-,0.015964694 unit decrease,[0.011-0.021],"FBXL17, RN7SKP122","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:107837492
rs73260443-<b>?</b>,6 x 10-9,,NR,'-,0.014660899 unit decrease,[0.0097-0.0196],KCNN2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:114119850
rs406204-<b>?</b>,3 x 10-13,,NR,'-,0.01769974 unit decrease,[0.013-0.022],"LINC01957, KCNN2","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:114539463
rs2531360-<b>?</b>,2 x 10-10,,NR,'-,0.0126121985 unit decrease,[0.0087-0.0165],"VTRNA1-3, PCDHA1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:140737079
rs7444191-<b>?</b>,2 x 10-10,,NR,'-,0.01334298 unit decrease,[0.0092-0.0175],LINC01470,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:152871873
rs11740474-<b>?</b>,2 x 10-8,,NR,'-,0.011435834 unit increase,[0.0074-0.0155],GALNT10,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,5:154301187
rs2144683-<b>?</b>,7 x 10-13,,NR,'-,0.017740319 unit increase,[0.013-0.023],RNU6-793P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:14717284
rs6459480-<b>?</b>,2 x 10-10,,NR,'-,0.012876417 unit decrease,[0.0089-0.0169],ATXN1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:16663232
rs7774567-<b>?</b>,1 x 10-15,,NR,'-,0.03166287 unit increase,[0.024-0.039],"CARMIL1, CMAHP","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:25425298
rs482786-<b>?</b>,2 x 10-12,,NR,'-,0.015925342 unit increase,[0.011-0.02],IP6K3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:33739822
rs91894-<b>?</b>,7 x 10-9,,NR,'-,0.011890353 unit decrease,[0.0079-0.0159],SNAP91,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:83678186
rs117074560-<b>?</b>,4 x 10-9,,NR,'-,0.028000625 unit increase,[0.019-0.037],"FUT9, KRT18P50","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,6:96011775
rs11100307-<b>?</b>,5 x 10-14,,NR,'-,0.016192827 unit decrease,[0.012-0.02],MAML3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:139846549
rs7683893-<b>?</b>,4 x 10-9,,NR,'-,0.01163537 unit increase,[0.0078-0.0155],SH3RF1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:169282216
rs13136968-<b>?</b>,2 x 10-8,,NR,'-,0.01358445 unit decrease,[0.0089-0.0183],GPM6A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:175713861
rs71615297-<b>?</b>,2 x 10-8,,NR,'-,0.011505666 unit decrease,[0.0075-0.0155],"LINC01098, RNU1-45P","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:178095326
rs28600726-<b>?</b>,2 x 10-8,,NR,'-,0.011445643 unit increase,[0.0074-0.0154],"PPID, FNIP2","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,4:158730723
rs302719-<b>?</b>,3 x 10-10,,NR,'-,0.013391206 unit increase,[0.0092-0.0176],"RERE-AS1, RERE","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:8430260
rs2143103-<b>?</b>,3 x 10-9,,NR,'-,0.016323835 unit increase,[0.011-0.022],"CDC42, WNT4","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:22103576
rs2015244-<b>?</b>,3 x 10-9,,NR,'-,0.013036855 unit decrease,[0.0087-0.0174],LINC01648,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:29956096
rs11209970-<b>?</b>,1 x 10-8,,NR,'-,0.012434894 unit increase,[0.0081-0.0167],FOXO6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:41377768
rs12410444-<b>?</b>,7 x 10-12,,NR,'-,0.01519143 unit decrease,[0.011-0.02],"ST3GAL3-AS1, ST3GAL3","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:43723048
rs12124523-<b>?</b>,2 x 10-12,,NR,'-,0.022796417 unit increase,[0.016-0.029],NEGR1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:72155780
rs4130548-<b>?</b>,2 x 10-9,,NR,'-,0.012752418 unit increase,[0.0086-0.0169],"GIPC2, DNAJB4","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:77998184
rs1008078-<b>?</b>,3 x 10-13,,NR,'-,0.015171385 unit decrease,[0.011-0.019],"BARHL2, LINC02609","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:90724174
rs236318-<b>?</b>,9 x 10-9,,NR,'-,0.013588152 unit decrease,[0.009-0.0182],BCAR3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:93584664
rs6685859-<b>?</b>,1 x 10-9,,NR,'-,0.012283642 unit increase,[0.0083-0.0163],DPYD,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:97357213
rs80289781-<b>?</b>,1 x 10-21,,NR,'-,0.026779253 unit decrease,[0.021-0.032],"MIR137HG, DPYD","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:97980274
rs2297797-<b>?</b>,3 x 10-8,,NR,'-,0.011191746 unit decrease,[0.0072-0.0151],CYB561D1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:109498058
rs2477432-<b>?</b>,3 x 10-8,,NR,'-,0.011372222 unit increase,[0.0074-0.0154],RAP1A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:111642655
rs72694951-<b>?</b>,7 x 10-9,,NR,'-,0.015576103 unit increase,[0.01-0.021],"VPS45, PLEKHO1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:150146987
rs3027001-<b>?</b>,2 x 10-8,,NR,'-,0.013022569 unit decrease,[0.0085-0.0176],"CADM3-AS1, CADM3","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:159199673
rs12139351-<b>?</b>,5 x 10-11,,NR,'-,0.013982416 unit increase,[0.0098-0.0182],LINC02789,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:199471855
rs3747631-<b>?</b>,1 x 10-16,,NR,'-,0.020482434 unit increase,[0.016-0.025],LRRN2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:204618441
rs35771425-<b>?</b>,5 x 10-12,,NR,'-,0.017222868 unit increase,[0.012-0.022],"ARPC3P2, LINC00467","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:211436426
rs9441956-<b>?</b>,2 x 10-8,,NR,'-,0.011435131 unit increase,[0.0075-0.0154],"LINC01655, DUSP10","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:221783857
rs2256126-<b>?</b>,4 x 10-16,,NR,'-,0.01773371 unit increase,[0.013-0.022],SDCCAG8,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,1:243340806
rs76076331-<b>?</b>,2 x 10-8,,NR,'-,0.01779352 unit increase,[0.012-0.024],PDIA6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:10837459
rs10490175-<b>?</b>,2 x 10-8,,NR,'-,0.014611234 unit decrease,[0.0095-0.0197],NRXN1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:50855616
rs72807818-<b>?</b>,1 x 10-8,,NR,'-,0.017506748 unit increase,[0.011-0.024],KNOP1P3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:51591881
rs11688767-<b>?</b>,2 x 10-12,,NR,'-,0.014326841 unit increase,[0.01-0.018],ACTG1P22,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:57761059
rs7599488-<b>?</b>,4 x 10-16,,NR,'-,0.016694613 unit decrease,[0.013-0.021],BCL11A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:60491212
rs268134-<b>?</b>,2 x 10-8,,NR,'-,0.012981593 unit increase,[0.0084-0.0175],SPRED2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:65381229
rs7557781-<b>?</b>,5 x 10-12,,NR,'-,0.013778182 unit decrease,[0.0099-0.0177],ZNF638,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:71386784
rs7602651-<b>?</b>,3 x 10-8,,NR,'-,0.013407344 unit increase,[0.0087-0.0181],RAB11FIP5,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:73109679
rs6712515-<b>?</b>,2 x 10-15,,NR,'-,0.016002202 unit decrease,[0.012-0.02],AFF3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:100190052
rs72906060-<b>?</b>,3 x 10-8,,NR,'-,0.017926758 unit increase,[0.012-0.024],LINC01876,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:156053895
rs6723841-<b>?</b>,1 x 10-10,,NR,'-,0.013711477 unit decrease,[0.0095-0.0179],TANK-AS1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:161023105
rs4664442-<b>?</b>,1 x 10-13,,NR,'-,0.014770402 unit decrease,[0.011-0.019],SLC4A10,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:161971491
rs9784123-<b>?</b>,3 x 10-8,,NR,'-,0.012116563 unit decrease,[0.0078-0.0164],"HAT1, SLC25A12","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:171928495
rs3769309-<b>?</b>,2 x 10-9,,NR,'-,0.012022352 unit increase,[0.0081-0.0159],RAPGEF4,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:172815054
rs4666990-<b>?</b>,5 x 10-11,,NR,'-,0.013381981 unit decrease,[0.0094-0.0174],ZNF804A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:184798577
rs17656017-<b>?</b>,1 x 10-13,,NR,'-,0.015048835 unit decrease,[0.011-0.019],SESTD1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:192981548
rs788021-<b>?</b>,1 x 10-9,,NR,'-,0.013781111 unit decrease,[0.0093-0.0182],SF3B1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:197428967
rs1451488-<b>?</b>,4 x 10-8,,NR,'-,0.010893398 unit increase,[0.007-0.0148],RNU7-147P,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:199125384
rs2949006-<b>?</b>,3 x 10-13,,NR,'-,0.019905087 unit decrease,[0.015-0.025],FTCDNL1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:199850665
rs13010104-<b>?</b>,9 x 10-9,,NR,'-,0.014770379 unit decrease,[0.0097-0.0198],"LRP1B, CREB1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:207504489
rs35559831-<b>?</b>,1 x 10-10,,NR,'-,0.022093302 unit increase,[0.015-0.029],CRLF3P1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:103486682
rs62154720-<b>?</b>,7 x 10-9,,NR,'-,0.01816122 unit decrease,[0.012-0.024],TGFBRAP1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:105306623
rs77609760-<b>?</b>,1 x 10-12,,NR,'-,0.027236994 unit increase,[0.02-0.035],LRP1B,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:141601381
rs4273169-<b>?</b>,3 x 10-12,,NR,'-,0.014703349 unit increase,[0.011-0.019],ARHGAP15,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:143473740
rs12991836-<b>?</b>,7 x 10-10,,NR,'-,0.012876864 unit decrease,[0.0088-0.017],ZEB2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:144383974
rs4398228-<b>?</b>,3 x 10-8,,NR,'-,0.011238307 unit increase,[0.0073-0.0152],"KCNJ3, RNA5SP107","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:154674692
rs7558283-<b>?</b>,5 x 10-8,,NR,'-,0.010967125 unit decrease,[0.007-0.0149],VWC2L,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:214424561
rs67890737-<b>?</b>,4 x 10-8,,NR,'-,0.0116704665 unit increase,[0.0075-0.0158],SPHKAP,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:228119928
rs6704768-<b>?</b>,1 x 10-14,,NR,'-,0.015298749 unit increase,[0.011-0.019],GIGYF2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:232727791
rs56236451-<b>?</b>,7 x 10-11,,NR,'-,0.017760335 unit increase,[0.012-0.023],"Y_RNA, AGAP1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,2:236148196
rs11617058-<b>?</b>,3 x 10-11,,NR,'-,0.018343437 unit increase,[0.013-0.024],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,13:84718977
rs9634624-<b>?</b>,3 x 10-8,,NR,'-,0.01409095 unit decrease,[0.0091-0.019],"GPC5, MIR17HG","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,13:91376987
rs9556958-<b>?</b>,8 x 10-10,,NR,'-,0.012444864 unit decrease,[0.0085-0.0164],"FARP1, STK24","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,13:98447792
rs2251499-<b>?</b>,6 x 10-9,,NR,'-,0.013049886 unit increase,[0.0086-0.0175],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,13:105987507
rs9989230-<b>?</b>,4 x 10-12,,NR,'-,0.014386957 unit increase,[0.01-0.018],RBM23,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:22912771
rs12897763-<b>?</b>,3 x 10-9,,NR,'-,0.015836988 unit increase,[0.011-0.021],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:29169732
rs1959440-<b>?</b>,4 x 10-10,,NR,'-,0.012606909 unit decrease,[0.0086-0.0166],PRKD1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:29739424
rs2239647-<b>?</b>,3 x 10-11,,NR,'-,0.013295427 unit decrease,[0.0094-0.0172],AKAP6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:32823537
rs67652508-<b>?</b>,3 x 10-8,,NR,'-,0.014017323 unit decrease,[0.0091-0.019],"LGALS3, MAPK1IP1L","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:55088650
rs7146434-<b>?</b>,3 x 10-11,,NR,'-,0.013552505 unit decrease,[0.0096-0.0176],ESR2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:64259785
rs989501-<b>?</b>,1 x 10-11,,NR,'-,0.0138115985 unit increase,[0.0098-0.0178],"MAP3K9, PCNX1","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:70894697
rs34328930-<b>?</b>,5 x 10-11,,NR,'-,0.017342182 unit decrease,[0.012-0.023],RGS6,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:71971007
rs58694847-<b>?</b>,1 x 10-13,,NR,'-,0.016648613 unit decrease,[0.012-0.021],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:84450167
rs35229468-<b>?</b>,2 x 10-13,,NR,'-,0.01667109 unit decrease,[0.012-0.021],"KLC1, COA8","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,14:103585720
rs117799466-<b>?</b>,8 x 10-10,,NR,'-,0.013453722 unit decrease,[0.0092-0.0177],"LPCAT4, ACTG1P15","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:34367316
rs1813760-<b>?</b>,5 x 10-13,,NR,'-,0.014986361 unit increase,[0.011-0.019],SEMA6D,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:47270920
rs2414718-<b>?</b>,2 x 10-9,,NR,'-,0.012107124 unit decrease,[0.0082-0.0161],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:61570934
rs28513670-<b>?</b>,1 x 10-9,,NR,'-,0.016429868 unit decrease,[0.011-0.022],DENND4A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:65690339
rs4468571-<b>?</b>,1 x 10-10,,NR,'-,0.013117198 unit decrease,[0.0091-0.0171],LINGO1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:77727790
rs28669908-<b>?</b>,5 x 10-12,,NR,'-,0.017219163 unit increase,[0.012-0.022],CHRNA3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:78617925
rs17507216-<b>?</b>,4 x 10-10,,NR,'-,0.01446739 unit increase,[0.0099-0.019],CPEB1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:82558175
rs11638445-<b>?</b>,3 x 10-10,,NR,'-,0.014086767 unit increase,[0.0097-0.0185],"LINC00933, ZSCAN2","Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:84594463
rs4702-<b>?</b>,3 x 10-11,,NR,'-,0.01349165 unit increase,[0.0095-0.0175],FURIN,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,15:90883330
rs117304774-<b>?</b>,4 x 10-9,,NR,'-,0.04517018 unit decrease,[0.03-0.06],GRIN2A,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:10057377
rs1035578-<b>?</b>,3 x 10-9,,NR,'-,0.011777017 unit decrease,[0.0079-0.0157],SNX29,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,16:12437508
rs6065094-<b>?</b>,9 x 10-11,,NR,'-,0.013549915 unit increase,[0.0095-0.0176],PPP1R16B,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,20:38824551
rs348276-<b>?</b>,5 x 10-9,,NR,'-,0.012520961 unit increase,[0.0083-0.0167],STAU1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,20:49169653
rs1810868-<b>?</b>,6 x 10-9,,NR,'-,0.011782898 unit decrease,[0.0078-0.0158],BACE2,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,21:41279554
rs132570-<b>?</b>,1 x 10-11,,NR,'-,0.013624602 unit increase,[0.0097-0.0176],CACNA1I,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:39580123
rs133047-<b>?</b>,2 x 10-8,,NR,'-,0.018239945 unit decrease,[0.012-0.025],MRTFA,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:40631815
rs9607782-<b>?</b>,9 x 10-11,,NR,'-,0.015108941 unit decrease,[0.011-0.02],EP300-AS1,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:41191552
rs1800754-<b>?</b>,2 x 10-15,,NR,'-,0.016218908 unit increase,[0.012-0.02],CYP2D7,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:42141587
rs5767976-<b>?</b>,8 x 10-10,,NR,'-,0.0125027755 unit decrease,[0.0085-0.0165],'-,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:47763237
rs68178377-<b>?</b>,4 x 10-8,,NR,'-,0.01223199 unit increase,[0.0079-0.0166],DENND6B,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:50313721
rs9616914-<b>?</b>,3 x 10-9,,NR,'-,0.012076274 unit increase,[0.0081-0.0161],SHANK3,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,22:50678709
rs3131296-<b>G</b>,2 x 10-10,,0.87,1.19,'-,[NR],NOTCH4,Schizophrenia,schizophrenia,GCST000435,6:32205216
rs2312147-<b>C</b>,3 x 10-7,,NR,1.09,'-,[NR],VRK2,Schizophrenia,schizophrenia,GCST000435,2:57995793
rs9960767-<b>C</b>,4 x 10-9,,0.06,1.23,'-,[NR],TCF4,Schizophrenia,schizophrenia,GCST000435,18:55487771
rs1502844-<b>C</b>,1 x 10-6,,NR,1.09,'-,[NR],"LINC00492, SLCO6A1",Schizophrenia,schizophrenia,GCST000435,5:102523613
rs6932590-<b>T</b>,1 x 10-12,,0.78,1.16,'-,[NR],"POM121L2, PRSS16",Schizophrenia,schizophrenia,GCST000435,6:27281152
rs1572299-<b>A</b>,4 x 10-6,,NR,1.08,'-,[NR],'-,Schizophrenia,schizophrenia,GCST000435,9:118584139
rs12807809-<b>T</b>,2 x 10-9,,0.83,1.15,'-,[NR],'-,Schizophrenia,schizophrenia,GCST000435,Mapping not available
rs2523722-<b>G</b>,1 x 10-16,,0.737,1.25,'-,[1.12-1.39],TRIM26,Schizophrenia,schizophrenia,GCST001631,6:30197496
rs9611198-<b>C</b>,8 x 10-6,,0.458,1.22,'-,[1.11-1.34],"RPS19BP1, CACNA1I",Schizophrenia,schizophrenia,GCST001631,22:39559868
rs7074335-<b>T</b>,2 x 10-6,,NR,'-,4.758858 z score increase,[NR],SORCS3,Depression,"unipolar depression, depressive symptom measurement",GCST003769,10:104940636
rs7973260-<b>A</b>,2 x 10-8,,NR,'-,5.6011147 z score increase,[NR],KSR2,Depression,"unipolar depression, depressive symptom measurement",GCST003769,12:117937681
rs6828666-<b>A</b>,3 x 10-6,,NR,'-,4.6532216 z score decrease,[NR],FNIP2,Depression,"unipolar depression, depressive symptom measurement",GCST003769,4:158858089
rs4810896-<b>A</b>,4 x 10-9,,NR,'-,5.8794484 z score decrease,[NR],"PREX1, ARFGEF2",Depression,"unipolar depression, depressive symptom measurement",GCST003769,20:48918761
rs59659806-<b>T</b>,5 x 10-6,,NR,'-,4.563033 z score decrease,[NR],"RASGRP1, LINC02694",Depression,"unipolar depression, depressive symptom measurement",GCST003769,15:38627763
rs10884216-<b>T</b>,6 x 10-7,,NR,'-,4.994715 z score decrease,[NR],YWHAZP5,Depression,"unipolar depression, depressive symptom measurement",GCST003769,10:105701367
rs10809520-<b>T</b>,6 x 10-9,,NR,'-,5.8197784 z score decrease,[NR],'-,Depression,"unipolar depression, depressive symptom measurement",GCST003769,9:11557797
rs1690818-<b>T</b>,6 x 10-8,,NR,'-,5.4051075 z score decrease,[NR],CNTN5,Depression,"unipolar depression, depressive symptom measurement",GCST003769,11:99625823
rs1961982-<b>A</b>,7 x 10-7,,NR,'-,4.971417 z score decrease,[NR],C12orf42,Depression,"unipolar depression, depressive symptom measurement",GCST003769,12:103218955
rs782212-<b>T</b>,7 x 10-11,,NR,'-,6.516477 z score decrease,[NR],'-,Depression,"unipolar depression, depressive symptom measurement",GCST003769,1:72479983
rs10233018-<b>A</b>,9 x 10-8,,NR,'-,5.3463354 z score decrease,[NR],CTTNBP2,Depression,"unipolar depression, depressive symptom measurement",GCST003769,7:117883655
rs853679-<b>A</b>,1 x 10-7,,NR,'-,5.298256 z score decrease,[NR],ZSCAN31,Depression,"unipolar depression, depressive symptom measurement",GCST003769,6:28329086
rs62100776-<b>A</b>,1 x 10-8,,NR,'-,5.6640935 z score decrease,[NR],DCC,Depression,"unipolar depression, depressive symptom measurement",GCST003769,18:53228263
rs2017122-<b>T</b>,1 x 10-6,,NR,'-,4.811745 z score increase,[NR],KMT2A,Depression,"unipolar depression, depressive symptom measurement",GCST003769,11:118444134
rs1877075-<b>A</b>,2 x 10-6,,NR,'-,4.810405 z score decrease,[NR],MAML3,Depression,"unipolar depression, depressive symptom measurement",GCST003769,4:140004716
rs68093531-<b>C</b>,3 x 10-6,,0.878,1.0846928,'-,'-,"SLAMF9, LINC01133",Bipolar disorder,bipolar disorder,GCST008103,1:159954778
rs79032349-<b>T</b>,3 x 10-6,,0.958,1.17457,'-,[1.11-1.24],HIVEP2,Bipolar disorder,bipolar disorder,GCST008103,6:142872951
rs17073012-<b>G</b>,3 x 10-6,,0.14,1.0755116,'-,'-,FYN,Bipolar disorder,bipolar disorder,GCST008103,6:111858435
rs436129-<b>G</b>,4 x 10-6,,0.795,1.0694042,'-,'-,VAV3-AS1,Bipolar disorder,bipolar disorder,GCST008103,1:107969525
rs77516904-<b>G</b>,4 x 10-6,,0.037,1.1497028,'-,'-,NRF1,Bipolar disorder,bipolar disorder,GCST008103,7:129627460
rs58377812-<b>T</b>,4 x 10-6,,0.0505,1.12266,'-,[1.07-1.17],KPNA4,Bipolar disorder,bipolar disorder,GCST008103,3:160530034
rs113123846-<b>G</b>,4 x 10-6,,0.011,1.2811971,'-,'-,LINC00970,Bipolar disorder,bipolar disorder,GCST008103,1:168967834
rs78785751-<b>C</b>,4 x 10-6,,0.028,1.1793983,'-,'-,SRPK2,Bipolar disorder,bipolar disorder,GCST008103,7:105230141
rs1889339-<b>G</b>,4 x 10-6,,0.199,1.065235,'-,'-,WNK2,Bipolar disorder,bipolar disorder,GCST008103,9:93291646
chr12_49463279_D-<b>?</b>,4 x 10-6,,0.434,1.05317,'-,[1.03-1.08],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs17730333-<b>G</b>,4 x 10-6,,0.017,1.2032247,'-,'-,"RNA5SP272, MMP16",Bipolar disorder,bipolar disorder,GCST008103,8:88364075
rs1850-<b>C</b>,4 x 10-6,,0.347,1.055799,'-,'-,KCNG1,Bipolar disorder,bipolar disorder,GCST008103,20:51003734
rs12468729-<b>G</b>,4 x 10-6,,0.689,1.0668374,'-,'-,SLC4A10,Bipolar disorder,bipolar disorder,GCST008103,2:161476919
rs7210415-<b>G</b>,4 x 10-6,,0.474,1.0535854,'-,'-,"KCTD2, ATP5PD, RN7SL573P",Bipolar disorder,bipolar disorder,GCST008103,17:75041773
rs2117096-<b>T</b>,5 x 10-6,,0.772,1.06386,'-,[1.04-1.09],MIR378C,Bipolar disorder,bipolar disorder,GCST008103,10:130881981
rs7015455-<b>C</b>,5 x 10-6,,0.585,1.0533745,'-,'-,MSRA,Bipolar disorder,bipolar disorder,GCST008103,8:10367649
rs10492859-<b>A</b>,5 x 10-6,,0.758,1.06269,'-,[1.04-1.09],CDH13,Bipolar disorder,bipolar disorder,GCST008103,16:82828209
rs13231398-<b>G</b>,5 x 10-6,,0.889,1.0863189,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,7:110557355
rs7581349-<b>G</b>,5 x 10-6,,0.492,1.0528532,'-,'-,LINC02611,Bipolar disorder,bipolar disorder,GCST008103,2:98773244
rs3843751-<b>T</b>,5 x 10-6,,0.676,1.05622,'-,[1.03-1.08],SLC44A2,Bipolar disorder,bipolar disorder,GCST008103,19:10637445
rs75677206-<b>C</b>,5 x 10-6,,0.017,1.2618774,'-,'-,IL12A-AS1,Bipolar disorder,bipolar disorder,GCST008103,3:160083194
rs2339519-<b>A</b>,5 x 10-6,,0.449,1.05285,'-,[1.03-1.07],LINC01830,Bipolar disorder,bipolar disorder,GCST008103,2:22381268
chr2_186025770_D-<b>?</b>,5 x 10-6,,0.12,1.0857763,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs1013191-<b>T</b>,5 x 10-6,,0.44,1.052953,'-,'-,"LINC02096, CDRT7",Bipolar disorder,bipolar disorder,GCST008103,17:15025416
rs942516-<b>A</b>,5 x 10-6,,0.148,1.07412,'-,[1.04-1.1],BRINP1,Bipolar disorder,bipolar disorder,GCST008103,9:119363076
chr15_85357857_I-<b>?</b>,3 x 10-8,,0.719,1.0726161,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs10035291-<b>T</b>,3 x 10-8,,0.675,1.07015,'-,[1.05-1.09],SSBP2,Bipolar disorder,bipolar disorder,GCST008103,5:81500549
rs6130764-<b>T</b>,3 x 10-8,,0.569,1.06439,'-,[1.04-1.09],"WFDC12, WFDC5",Bipolar disorder,bipolar disorder,GCST008103,20:45121769
chr6_72519394_D-<b>?</b>,3 x 10-8,,0.443,1.06439,'-,[1.04-1.09],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs11557713-<b>A</b>,4 x 10-8,,0.285,1.0694,'-,[1.05-1.09],ZCCHC2,Bipolar disorder,bipolar disorder,GCST008103,18:62576643
rs7122539-<b>G</b>,4 x 10-8,,0.652,1.066735,'-,'-,PC,Bipolar disorder,bipolar disorder,GCST008103,11:66895260
rs10455979-<b>G</b>,4 x 10-8,,0.466,1.0640675,'-,'-,RPS6KA2,Bipolar disorder,bipolar disorder,GCST008103,6:166581772
rs7544145-<b>T</b>,5 x 10-8,,0.812,1.08535,'-,[1.06-1.11],"PLEKHO1, RN7SL480P",Bipolar disorder,bipolar disorder,GCST008103,1:150166501
rs11624408-<b>A</b>,5 x 10-8,,0.558,1.06407,'-,[1.04-1.09],BCL11B,Bipolar disorder,bipolar disorder,GCST008103,14:99246608
rs11231677-<b>G</b>,6 x 10-8,,0.505,1.0649173,'-,'-,MACROD1,Bipolar disorder,bipolar disorder,GCST008103,11:64017876
rs62535709-<b>T</b>,8 x 10-8,,0.0586,1.13633,'-,[1.09-1.18],ZCCHC7,Bipolar disorder,bipolar disorder,GCST008103,9:37166192
rs55648125-<b>G</b>,8 x 10-8,,0.105,1.1005337,'-,'-,"RPS17P5, TFAP2B",Bipolar disorder,bipolar disorder,GCST008103,6:50849005
rs17150022-<b>C</b>,9 x 10-8,,0.116,1.0944991,'-,'-,GSDME,Bipolar disorder,bipolar disorder,GCST008103,7:24732158
rs74446114-<b>C</b>,1 x 10-7,,0.185,1.0801469,'-,'-,"MRPL33, RBKS",Bipolar disorder,bipolar disorder,GCST008103,2:27843255
rs9371601-<b>T</b>,1 x 10-7,,0.349,1.06258,'-,[1.04-1.09],SYNE1,Bipolar disorder,bipolar disorder,GCST008103,6:152469438
rs2635253-<b>T</b>,1 x 10-7,,0.491,1.06099,'-,[1.04-1.08],LINC01378,Bipolar disorder,bipolar disorder,GCST008103,4:117551578
rs72745470-<b>G</b>,1 x 10-7,,0.374,1.066098,'-,'-,"IQCH, IQCH-AS1",Bipolar disorder,bipolar disorder,GCST008103,15:67361344
rs138321-<b>A</b>,2 x 10-7,,0.502,1.06003,'-,[1.04-1.08],SLC25A17,Bipolar disorder,bipolar disorder,GCST008103,22:40813300
rs12594483-<b>A</b>,2 x 10-7,,0.115,1.09516,'-,[1.06-1.13],CDAN1,Bipolar disorder,bipolar disorder,GCST008103,15:42729788
rs329319-<b>A</b>,2 x 10-7,,0.428,1.0612,'-,[1.04-1.08],JADE2,Bipolar disorder,bipolar disorder,GCST008103,5:134570919
rs884301-<b>T</b>,2 x 10-7,,0.374,1.06131,'-,[1.04-1.08],HLF,Bipolar disorder,bipolar disorder,GCST008103,17:55290103
rs4301023-<b>T</b>,2 x 10-7,,0.474,1.05929,'-,[1.04-1.08],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs2463709-<b>T</b>,2 x 10-7,,0.428,1.06279,'-,[1.04-1.09],RIMS1,Bipolar disorder,bipolar disorder,GCST008103,6:72155201
rs10745843-<b>A</b>,2 x 10-7,,0.621,1.06099,'-,[1.04-1.08],ANKS1B,Bipolar disorder,bipolar disorder,GCST008103,12:99102252
rs62085738-<b>A</b>,3 x 10-7,,0.228,1.06983,'-,[1.04-1.1],ARIH2P1,Bipolar disorder,bipolar disorder,GCST008103,18:28736659
rs181957530-<b>?</b>,2 x 10-6,(Conditioned on rs11724116),NR,'-,'-,'-,FSTL5,Bipolar disorder,bipolar disorder,GCST008103,4:161420812
rs9834970-<b>C</b>,6 x 10-12,,0.491,1.0803686,'-,'-,"LINC02033, HSPD1P6",Bipolar disorder,bipolar disorder,GCST008103,3:36814539
rs2302417-<b>T</b>,7 x 10-11,,0.51,1.07616,'-,'-,ITIH1,Bipolar disorder,bipolar disorder,GCST008103,3:52780240
rs11647445-<b>G</b>,1 x 10-10,,0.346,1.0785276,'-,'-,GRIN2A,Bipolar disorder,bipolar disorder,GCST008103,16:9833109
rs10744560-<b>T</b>,4 x 10-10,,0.336,1.07595,'-,[1.05-1.1],"CACNA1C, CACNA1C-IT3",Bipolar disorder,bipolar disorder,GCST008103,12:2277933
chr7_140700006_I-<b>?</b>,6 x 10-10,,0.748,1.088388,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
chr2_194465711_D-<b>?</b>,8 x 10-10,,0.586,1.0727197,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs12226877-<b>A</b>,1 x 10-9,,0.293,1.08502,'-,[1.06-1.11],"FADS1, FADS2",Bipolar disorder,bipolar disorder,GCST008103,11:61824435
rs73188321-<b>C</b>,1 x 10-9,,0.667,1.0811278,'-,'-,"SRPK2, PUS7",Bipolar disorder,bipolar disorder,GCST008103,7:105407711
rs111444407-<b>T</b>,1 x 10-9,,0.148,1.09702,'-,[1.07-1.13],NCAN,Bipolar disorder,bipolar disorder,GCST008103,19:19247398
rs17183814-<b>G</b>,2 x 10-9,,0.9251,1.1416829,'-,'-,SCN2A,Bipolar disorder,bipolar disorder,GCST008103,2:165295879
rs113779084-<b>A</b>,3 x 10-9,,0.304,1.07562,'-,[1.05-1.1],THSD7A,Bipolar disorder,bipolar disorder,GCST008103,7:11832161
chr2_97376407_I-<b>?</b>,4 x 10-9,,0.658,1.0736871,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs2388334-<b>G</b>,4 x 10-9,,0.481,1.0671562,'-,'-,"EIF4EBP2P3, HLA-DRB5",Bipolar disorder,bipolar disorder,GCST008103,6:98143746
rs10994318-<b>C</b>,7 x 10-9,,0.0574,1.14488,'-,[1.1-1.19],ANK3,Bipolar disorder,bipolar disorder,GCST008103,10:60366098
rs12575685-<b>A</b>,8 x 10-9,,0.314,1.07272,'-,[1.05-1.1],SHANK2,Bipolar disorder,bipolar disorder,GCST008103,11:70671822
rs4447398-<b>A</b>,9 x 10-9,,0.123,1.09878,'-,[1.07-1.13],STARD9,Bipolar disorder,bipolar disorder,GCST008103,15:42612706
chr20_43682549_I-<b>?</b>,1 x 10-8,,0.719,1.0759515,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
chr10_111745562_I-<b>?</b>,1 x 10-8,,0.164,1.09013,'-,[1.06-1.12],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
chr5_7587236_D-<b>?</b>,1 x 10-8,,0.178,1.088388,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs10896090-<b>A</b>,2 x 10-8,,0.809,1.08372,'-,[1.06-1.11],PACS1,Bipolar disorder,bipolar disorder,GCST008103,11:66177715
rs3804640-<b>A</b>,2 x 10-8,,0.533,1.06481,'-,[1.04-1.09],CD47,Bipolar disorder,bipolar disorder,GCST008103,3:108074862
rs11724116-<b>C</b>,2 x 10-8,,0.84,1.0887198,'-,'-,FSTL5,Bipolar disorder,bipolar disorder,GCST008103,4:161372886
rs112114764-<b>G</b>,2 x 10-8,,0.311,1.0702628,'-,'-,HDAC5,Bipolar disorder,bipolar disorder,GCST008103,17:44123673
rs7567409-<b>A</b>,3 x 10-7,,0.155,1.08058,'-,[1.05-1.11],BABAM2,Bipolar disorder,bipolar disorder,GCST008103,2:28293404
rs12898460-<b>C</b>,3 x 10-7,,0.69,1.0639656,'-,'-,LINC02694,Bipolar disorder,bipolar disorder,GCST008103,15:38694612
rs63722863-<b>G</b>,3 x 10-7,,0.474,1.0619432,'-,'-,KIF15,Bipolar disorder,bipolar disorder,GCST008103,3:44780094
rs66752127-<b>G</b>,4 x 10-7,,0.381,1.0613008,'-,'-,PDE3B,Bipolar disorder,bipolar disorder,GCST008103,11:14767417
rs1477143-<b>T</b>,4 x 10-7,,0.259,1.06812,'-,[1.04-1.09],"HLF, STXBP4",Bipolar disorder,bipolar disorder,GCST008103,17:55258467
chr17_49345320_D-<b>?</b>,4 x 10-7,,0.552,1.05855,'-,[1.04-1.08],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs73496688-<b>A</b>,4 x 10-7,,0.144,1.08307,'-,[1.05-1.11],TENM4,Bipolar disorder,bipolar disorder,GCST008103,11:79445704
rs6954854-<b>G</b>,4 x 10-7,,0.426,1.0583354,'-,'-,SP4,Bipolar disorder,bipolar disorder,GCST008103,7:21452971
rs12833856-<b>G</b>,4 x 10-7,,0.357,1.0670536,'-,'-,"RPL29P25, PPP1CC",Bipolar disorder,bipolar disorder,GCST008103,12:110824378
rs7222752-<b>G</b>,5 x 10-7,,0.173,1.0842576,'-,'-,"NPTX1, RPL32P31",Bipolar disorder,bipolar disorder,GCST008103,17:80489926
chr11_47580062_D-<b>?</b>,5 x 10-7,,0.0881,1.12705,'-,[1.08-1.17],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs8067817-<b>T</b>,6 x 10-7,,0.557,1.05781,'-,[1.04-1.08],"PSMD3, CSF3",Bipolar disorder,bipolar disorder,GCST008103,17:40007683
rs72966520-<b>C</b>,6 x 10-7,,0.9361,1.1261388,'-,'-,"TLCD4-RWDD3, TLCD4",Bipolar disorder,bipolar disorder,GCST008103,1:95142777
rs11709009-<b>A</b>,6 x 10-7,,0.194,1.0724,'-,[1.04-1.1],"VIPR1, RPL35AP8",Bipolar disorder,bipolar disorder,GCST008103,3:42473630
rs5754941-<b>C</b>,6 x 10-7,,0.437,1.05792,'-,[1.04-1.08],"MAPK1, YPEL1",Bipolar disorder,bipolar disorder,GCST008103,22:21747706
rs74577022-<b>A</b>,7 x 10-7,,0.738,1.06823,'-,[1.04-1.09],"BICRA, RN7SL322P",Bipolar disorder,bipolar disorder,GCST008103,19:47601390
rs116403057-<b>A</b>,7 x 10-7,,0.111,1.09166,'-,[1.06-1.13],"TSBP1-AS1, TSBP1",Bipolar disorder,bipolar disorder,GCST008103,6:32335895
rs778433-<b>A</b>,7 x 10-7,,0.435,1.05802,'-,[1.04-1.08],STARP1,Bipolar disorder,bipolar disorder,GCST008103,13:65233151
rs10878840-<b>G</b>,7 x 10-7,,0.381,1.0585483,'-,'-,"LINC02384, RPSAP12",Bipolar disorder,bipolar disorder,GCST008103,12:68487269
rs907162-<b>C</b>,8 x 10-7,,0.401,1.0597149,'-,'-,ASAP2,Bipolar disorder,bipolar disorder,GCST008103,2:9270500
rs13411201-<b>A</b>,8 x 10-7,,0.131,1.08589,'-,[1.05-1.12],"IFITM3P9, RN7SL361P",Bipolar disorder,bipolar disorder,GCST008103,2:60680195
rs2956395-<b>C</b>,8 x 10-7,,0.692,1.06396,'-,[1.04-1.09],MYRF-AS1,Bipolar disorder,bipolar disorder,GCST008103,11:61752514
rs17680579-<b>A</b>,8 x 10-7,,0.877,1.08806,'-,[1.05-1.12],LAMA4-AS1,Bipolar disorder,bipolar disorder,GCST008103,6:112269480
rs10058613-<b>C</b>,8 x 10-7,,0.315,1.0643846,'-,'-,KDM3B,Bipolar disorder,bipolar disorder,GCST008103,5:138358306
rs6090435-<b>G</b>,8 x 10-7,,0.497,1.0613008,'-,'-,"EEF1A2, PPDPF",Bipolar disorder,bipolar disorder,GCST008103,20:63501358
rs735931-<b>A</b>,9 x 10-7,,0.488,1.05844,'-,[1.04-1.08],ATP2B2,Bipolar disorder,bipolar disorder,GCST008103,3:10483412
rs4380187-<b>A</b>,9 x 10-7,,0.53,1.05643,'-,[1.03-1.08],ZNF804A,Bipolar disorder,bipolar disorder,GCST008103,2:184947213
rs62433108-<b>G</b>,9 x 10-7,,0.281,1.0620446,'-,'-,DCBLD1,Bipolar disorder,bipolar disorder,GCST008103,6:117483634
rs1819204-<b>A</b>,1 x 10-6,,0.731,1.06823,'-,[1.04-1.09],CUL4A,Bipolar disorder,bipolar disorder,GCST008103,13:113229001
rs184148144-<b>T</b>,1 x 10-6,,0.833,1.08058,'-,[1.05-1.11],"SLAIN2, SLC10A4",Bipolar disorder,bipolar disorder,GCST008103,4:48443799
rs143577122-<b>C</b>,1 x 10-6,,0.9538,1.1713991,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,7:145943513
rs4845399-<b>T</b>,1 x 10-6,,0.358,1.05823,'-,[1.04-1.08],"KCNN3, PMVK",Bipolar disorder,bipolar disorder,GCST008103,1:154893617
rs57681866-<b>G</b>,1 x 10-6,,0.9385,1.1236713,'-,'-,ACTG1P22,Bipolar disorder,bipolar disorder,GCST008103,2:57748579
rs35955717-<b>T</b>,1 x 10-6,,0.851,1.08134,'-,[1.05-1.11],"AKAP6, NPAS3",Bipolar disorder,bipolar disorder,GCST008103,14:32925854
chr1_95580645_I-<b>?</b>,1 x 10-6,,0.345,1.05844,'-,[1.04-1.08],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs2345964-<b>A</b>,1 x 10-6,,0.458,1.05538,'-,[1.03-1.08],'-,Bipolar disorder,bipolar disorder,GCST008103,1:163781667
rs57957974-<b>A</b>,1 x 10-6,,0.351,1.05919,'-,[1.04-1.08],PARP10,Bipolar disorder,bipolar disorder,GCST008103,8:144002361
rs206949-<b>A</b>,1 x 10-6,,0.268,1.06343,'-,[1.04-1.09],"COX6A1, RPS27P25",Bipolar disorder,bipolar disorder,GCST008103,12:120384246
rs6529693-<b>G</b>,1 x 10-6,,0.535,1.0524322,'-,'-,HUWE1,Bipolar disorder,bipolar disorder,GCST008103,X:53707621
rs976498-<b>T</b>,1 x 10-6,,0.829,1.07691,'-,[1.05-1.11],PPIAP48,Bipolar disorder,bipolar disorder,GCST008103,16:64687040
rs3911862-<b>A</b>,1 x 10-6,,0.446,1.05506,'-,[1.03-1.08],"RPS15AP15, RN7SL635P",Bipolar disorder,bipolar disorder,GCST008103,2:65532537
rs12153740-<b>C</b>,1 x 10-6,,0.636,1.066735,'-,'-,LINC01470,Bipolar disorder,bipolar disorder,GCST008103,5:152697204
chr12_110877946_I-<b>?</b>,1 x 10-6,,0.0257,1.22507,'-,[1.14-1.31],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs142370491-<b>C</b>,1 x 10-6,,0.018,1.2743075,'-,'-,AKAP6,Bipolar disorder,bipolar disorder,GCST008103,14:32749087
rs75580062-<b>T</b>,2 x 10-6,,0.0257,1.18994,'-,[1.12-1.26],CFAP221,Bipolar disorder,bipolar disorder,GCST008103,2:119565915
rs5990908-<b>C</b>,2 x 10-6,,0.875,1.0835057,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,X:20638387
rs13006127-<b>C</b>,2 x 10-6,,0.543,1.055164,'-,'-,CERS6,Bipolar disorder,bipolar disorder,GCST008103,2:168535393
rs62002181-<b>C</b>,2 x 10-6,,0.14,1.07972,'-,[1.05-1.11],KRT8P2,Bipolar disorder,bipolar disorder,GCST008103,14:43505794
rs4906364-<b>G</b>,2 x 10-6,,0.324,1.0587612,'-,'-,PPP1R13B,Bipolar disorder,bipolar disorder,GCST008103,14:103748005
rs77626951-<b>G</b>,2 x 10-6,,0.01,1.3078734,'-,'-,LINC02149,Bipolar disorder,bipolar disorder,GCST008103,5:15113630
rs11162556-<b>A</b>,5 x 10-6,,0.665,1.05929,'-,[1.03-1.08],ADGRL4,Bipolar disorder,bipolar disorder,GCST008103,1:78795698
rs188076915-<b>G</b>,5 x 10-6,,0.015,1.2708741,'-,'-,AIFM1,Bipolar disorder,bipolar disorder,GCST008103,X:130151035
rs7707252-<b>G</b>,5 x 10-6,,0.275,1.0581226,'-,'-,Y_RNA,Bipolar disorder,bipolar disorder,GCST008103,5:79544787
rs6829845-<b>A</b>,5 x 10-6,,0.328,1.05538,'-,[1.03-1.08],IL21,Bipolar disorder,bipolar disorder,GCST008103,4:122589611
chr6_84351889_I-<b>?</b>,6 x 10-6,,0.444,1.05707,'-,[1.03-1.08],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs72673100-<b>C</b>,6 x 10-6,,0.544,1.0574961,'-,'-,LINC00641,Bipolar disorder,bipolar disorder,GCST008103,14:21205210
rs12392936-<b>A</b>,6 x 10-6,,0.911,1.11193,'-,[1.07-1.16],"RNU6-133P, CNKSR2",Bipolar disorder,bipolar disorder,GCST008103,X:21304805
rs7971456-<b>C</b>,6 x 10-6,,0.486,1.0526427,'-,'-,WSCD2,Bipolar disorder,bipolar disorder,GCST008103,12:108202622
rs8066384-<b>C</b>,6 x 10-6,,0.704,1.0587612,'-,'-,RPTOR,Bipolar disorder,bipolar disorder,GCST008103,17:80651956
rs10005422-<b>T</b>,6 x 10-6,,0.397,1.0564348,'-,'-,"LINC02264, LINC01378",Bipolar disorder,bipolar disorder,GCST008103,4:117740497
rs142920219-<b>C</b>,6 x 10-6,,0.9219,1.1018555,'-,'-,CAMK1D,Bipolar disorder,bipolar disorder,GCST008103,10:12489159
chr6_18802039_I-<b>?</b>,6 x 10-6,,0.9774,1.1953001,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs189574365-<b>A</b>,6 x 10-6,,0.0243,1.18175,'-,[1.11-1.25],"GNA14, GNAQ",Bipolar disorder,bipolar disorder,GCST008103,9:77685834
rs77015885-<b>A</b>,7 x 10-6,,0.0365,1.14993,'-,[1.09-1.21],LINC02751,Bipolar disorder,bipolar disorder,GCST008103,11:15509462
rs117450257-<b>G</b>,7 x 10-6,,0.041,1.1336069,'-,'-,"SLC12A9, SLC12A9-AS1",Bipolar disorder,bipolar disorder,GCST008103,7:100848615
rs9895770-<b>T</b>,7 x 10-6,,0.236,1.06014,'-,[1.03-1.09],PRKCA,Bipolar disorder,bipolar disorder,GCST008103,17:66538700
rs1378559-<b>T</b>,7 x 10-6,,0.834,1.07369,'-,[1.04-1.1],CNKSR2,Bipolar disorder,bipolar disorder,GCST008103,X:21362148
chr16_60146407_D-<b>?</b>,7 x 10-6,,0.014,1.2433326,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs115858175-<b>G</b>,7 x 10-6,,0.165,1.06865,'-,'-,LINC01221,Bipolar disorder,bipolar disorder,GCST008103,1:199032122
rs10092482-<b>T</b>,7 x 10-6,,0.178,1.06577,'-,[1.04-1.09],RRS1-AS1,Bipolar disorder,bipolar disorder,GCST008103,8:66342488
rs1552246-<b>G</b>,7 x 10-6,,0.572,1.0521111,'-,'-,U2,Bipolar disorder,bipolar disorder,GCST008103,8:109796715
rs12677998-<b>G</b>,7 x 10-6,,0.891,1.090679,'-,'-,LETM2,Bipolar disorder,bipolar disorder,GCST008103,8:38391683
rs7307046-<b>G</b>,7 x 10-6,,0.582,1.0527425,'-,'-,HDAC7,Bipolar disorder,bipolar disorder,GCST008103,12:47784411
chr12_57483523_I-<b>?</b>,7 x 10-6,,0.647,1.0567473,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs66506713-<b>T</b>,8 x 10-6,,0.369,1.05897,'-,[1.03-1.08],"RPA1, RTN4RL1",Bipolar disorder,bipolar disorder,GCST008103,17:1916217
rs8047469-<b>G</b>,8 x 10-6,,0.879,1.133029,'-,'-,PRSS36,Bipolar disorder,bipolar disorder,GCST008103,16:31140200
rs7550853-<b>C</b>,8 x 10-6,,0.251,1.0582347,'-,'-,SMYD3,Bipolar disorder,bipolar disorder,GCST008103,1:246455643
rs255353-<b>A</b>,8 x 10-6,,0.375,1.05264,'-,[1.03-1.08],MCTP1,Bipolar disorder,bipolar disorder,GCST008103,5:94785878
rs73068042-<b>G</b>,8 x 10-6,,0.9396,1.1203101,'-,'-,TRANK1,Bipolar disorder,bipolar disorder,GCST008103,3:36876910
rs16842765-<b>G</b>,8 x 10-6,,0.681,1.054641,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,2:209292126
rs111998037-<b>C</b>,9 x 10-6,,0.248,1.0592884,'-,'-,"ANKHD1-EIF4EBP3, ANKHD1",Bipolar disorder,bipolar disorder,GCST008103,5:140418422
chr15_96034210_I-<b>?</b>,9 x 10-6,,0.9346,1.1355249,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
chr7_130876812_D-<b>?</b>,9 x 10-6,,0.892,1.0862126,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs111930716-<b>A</b>,9 x 10-6,,0.0282,1.1587,'-,[1.09-1.22],LINC01505,Bipolar disorder,bipolar disorder,GCST008103,9:105992588
rs6788153-<b>T</b>,9 x 10-6,,0.921,1.09604,'-,[1.06-1.14],FGF12,Bipolar disorder,bipolar disorder,GCST008103,3:192499942
rs115462819-<b>C</b>,2 x 10-6,,0.9527,1.1660312,'-,'-,"RNU6-239P, HAX1",Bipolar disorder,bipolar disorder,GCST008103,1:154293485
rs76420936-<b>A</b>,2 x 10-6,,0.0137,1.26314,'-,[1.17-1.36],KCNN2,Bipolar disorder,bipolar disorder,GCST008103,5:114086246
rs191580074-<b>A</b>,2 x 10-6,,0.0154,1.32287,'-,[1.21-1.44],"RNA5SP149, PEX5L",Bipolar disorder,bipolar disorder,GCST008103,3:180084126
rs56397913-<b>C</b>,2 x 10-6,,0.9054,1.1094838,'-,'-,TMEM131,Bipolar disorder,bipolar disorder,GCST008103,2:97983036
rs6902652-<b>G</b>,2 x 10-6,,0.9546,1.1421393,'-,'-,OFCC1,Bipolar disorder,bipolar disorder,GCST008103,6:10167324
rs9295358-<b>A</b>,2 x 10-6,,0.718,1.06056,'-,[1.04-1.08],RPS6KA2,Bipolar disorder,bipolar disorder,GCST008103,6:166646138
rs10860416-<b>G</b>,2 x 10-6,,0.305,1.0613008,'-,'-,ANKS1B,Bipolar disorder,bipolar disorder,GCST008103,12:99298229
rs3004668-<b>G</b>,2 x 10-6,,0.369,1.070469,'-,'-,IL9RP1,Bipolar disorder,bipolar disorder,GCST008103,9:138141056
rs10122788-<b>G</b>,2 x 10-6,,0.436,1.0540073,'-,'-,MVB12B,Bipolar disorder,bipolar disorder,GCST008103,9:126444553
rs6714647-<b>A</b>,2 x 10-6,,0.756,1.06599,'-,[1.04-1.09],LYARP1,Bipolar disorder,bipolar disorder,GCST008103,2:82237883
rs814197-<b>G</b>,2 x 10-6,,0.448,1.0537963,'-,'-,LINC01748,Bipolar disorder,bipolar disorder,GCST008103,1:60626784
rs10136228-<b>G</b>,2 x 10-6,,0.46,1.0539074,'-,'-,SLC8A3,Bipolar disorder,bipolar disorder,GCST008103,14:70118552
rs10147900-<b>T</b>,2 x 10-6,,0.138,1.10054,'-,[1.06-1.14],"LINC02280, TMEM179",Bipolar disorder,bipolar disorder,GCST008103,14:104625694
rs28627084-<b>C</b>,2 x 10-6,,0.888,1.0879499,'-,'-,"INSYN1, CD276",Bipolar disorder,bipolar disorder,GCST008103,15:73731297
rs140643378-<b>G</b>,3 x 10-6,,0.62,1.0589743,'-,'-,"PABPC1L2B, PABPC1L2A",Bipolar disorder,bipolar disorder,GCST008103,X:73035874
rs59811079-<b>G</b>,3 x 10-6,,0.716,1.0640675,'-,'-,DLGAP2,Bipolar disorder,bipolar disorder,GCST008103,8:1677566
chr7_131863813_D-<b>?</b>,3 x 10-6,,0.471,1.05791,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
chr10_116615129_I-<b>?</b>,3 x 10-6,,0.0148,1.33309,'-,[1.21-1.45],'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs190905111-<b>A</b>,3 x 10-6,,0.949,1.15004,'-,[1.09-1.21],"SEMG1, SEMG2",Bipolar disorder,bipolar disorder,GCST008103,20:45212068
rs142204301-<b>A</b>,3 x 10-6,,0.0169,1.23491,'-,[1.15-1.32],LINC01203,Bipolar disorder,bipolar disorder,GCST008103,X:13358691
rs78781559-<b>A</b>,3 x 10-6,,0.083,1.10583,'-,[1.06-1.15],"C12orf76, IFT81",Bipolar disorder,bipolar disorder,GCST008103,12:110075511
rs4938784-<b>T</b>,3 x 10-6,,0.321,1.05823,'-,[1.03-1.08],LAYN,Bipolar disorder,bipolar disorder,GCST008103,11:111542740
rs56662938-<b>A</b>,3 x 10-6,,0.132,1.07853,'-,[1.05-1.11],"TNKS, MIR124-1HG",Bipolar disorder,bipolar disorder,GCST008103,8:9836046
rs2592118-<b>T</b>,3 x 10-6,,0.444,1.05432,'-,[1.03-1.08],NGEF,Bipolar disorder,bipolar disorder,GCST008103,2:232927715
chr20_33361359_I-<b>?</b>,3 x 10-6,,0.823,1.0727197,'-,'-,'-,Bipolar disorder,bipolar disorder,GCST008103,Mapping not available
rs2953145-<b>C</b>,7 x 10-6,,0.23,1.84,'-,[1.31-2.58],RNPEPL1,Bipolar disorder,bipolar disorder,GCST000044,2:240576179
rs3761218-<b>C</b>,7 x 10-6,,0.64,1.03,'-,[1.15-1.23],CDC25B,Bipolar disorder,bipolar disorder,GCST000044,20:3795528
rs420259-<b>A</b>,6 x 10-8,,0.72,2.08,'-,[1.60-2.71],PALB2,Bipolar disorder,bipolar disorder,GCST000044,16:23622705
rs10134944-<b>T</b>,7 x 10-6,,0.09,1.45,'-,[1.24-1.68],SLC35F4,Bipolar disorder,bipolar disorder,GCST000044,14:57652478
rs11622475-<b>C</b>,8 x 10-6,,0.7,1.13,'-,[0.89-1.44],TDRD9,Bipolar disorder,bipolar disorder,GCST000044,14:104042739
rs6458307-<b>?</b>,4 x 10-6,,0.69,1.19,'-,[1.04-1.33],BICRAL,Bipolar disorder,bipolar disorder,GCST000044,6:42763377
rs683395-<b>G</b>,5 x 10-6,,0.08,1.47,'-,[1.26-1.71],LAMP3,Bipolar disorder,bipolar disorder,GCST000044,3:183152030
rs1538774-<b>G</b>,3 x 10-8,,0.74,1.09,'-,[1.06-1.12],SDCCAG8,Schizophrenia,schizophrenia,GCST002149,1:243381525
rs2910032-<b>C</b>,4 x 10-8,,0.469,1.08,'-,[1.05-1.11],LINC01470,Schizophrenia,schizophrenia,GCST002149,5:153160794
rs4356203-<b>?</b>,1 x 10-7,,NR,1.09,'-,[1.06-1.12],PIK3C2A,Schizophrenia,schizophrenia,GCST001242,11:17138601
rs1009080-<b>?</b>,3 x 10-6,,NR,1.09,'-,[1.05-1.13],LINC01648,Schizophrenia,schizophrenia,GCST001242,1:29958713
rs11130874-<b>?</b>,2 x 10-6,,NR,1.1,'-,[1.06-1.14],PTPRG,Schizophrenia,schizophrenia,GCST001242,3:62079095
rs6703335-<b>?</b>,5 x 10-8,,NR,1.09,'-,[1.06-1.13],SDCCAG8,Schizophrenia,schizophrenia,GCST001242,1:243445665
rs13025591-<b>?</b>,6 x 10-6,,NR,1.07,'-,[1.04-1.11],AGAP1,Schizophrenia,schizophrenia,GCST001242,2:235886699
rs2239547-<b>?</b>,6 x 10-8,,NR,1.1,'-,[1.06-1.14],ITIH4,Schizophrenia,schizophrenia,GCST001242,3:52821213
rs4624519-<b>?</b>,2 x 10-7,,NR,1.09,'-,[1.05-1.12],LINC02033,Schizophrenia,schizophrenia,GCST001242,3:36821489
rs1869901-<b>?</b>,3 x 10-6,,NR,1.07,'-,[1.04-1.09],PLCB2,Schizophrenia,schizophrenia,GCST001242,15:40303426
rs17512836-<b>C</b>,1 x 10-6,,0.02,1.23,'-,[1.14-1.31],TCF4,Schizophrenia,schizophrenia,GCST001242,18:55527730
rs12699131-<b>?</b>,2 x 10-6,,NR,1.08,'-,[1.04-1.11],CALN1,Schizophrenia,schizophrenia,GCST001242,7:72286331
rs10503253-<b>A</b>,2 x 10-8,,0.19,1.16,'-,[1.11-1.21],CSMD1,Schizophrenia,schizophrenia,GCST001242,8:4323322
rs7004633-<b>A</b>,2 x 10-7,,0.18,1.11,'-,[1.07-1.15],'-,Schizophrenia,schizophrenia,GCST001242,8:88748082
rs2021722-<b>C</b>,2 x 10-12,,0.78,1.15,'-,[1.11-1.19],TRIM26,Schizophrenia,schizophrenia,GCST001242,6:30206354
rs10894294-<b>?</b>,3 x 10-6,,NR,1.08,'-,[1.05-1.12],"SNX19, RN7SL167P",Schizophrenia,schizophrenia,GCST001242,11:130960853
rs16915157-<b>?</b>,5 x 10-6,,NR,1.1,'-,[1.06-1.14],ANK3,Schizophrenia,schizophrenia,GCST001242,10:60586880
rs7914558-<b>G</b>,2 x 10-8,,0.59,1.22,'-,[1.15-1.29],CNNM2,Schizophrenia,schizophrenia,GCST001242,10:103016151
rs11191580-<b>T</b>,3 x 10-8,,0.91,1.2,'-,[1.13-1.26],NT5C2,Schizophrenia,schizophrenia,GCST001242,10:103146454
rs548181-<b>G</b>,1 x 10-6,,0.88,1.1,'-,[1.06-1.14],"FEZ1, STT3A",Schizophrenia,schizophrenia,GCST001242,11:125591814
rs4765905-<b>?</b>,2 x 10-6,,NR,1.08,'-,[1.05-1.11],CACNA1C,Schizophrenia,schizophrenia,GCST001242,12:2240418
rs4775413-<b>?</b>,2 x 10-6,,NR,1.08,'-,[1.04-1.11],'-,Schizophrenia,schizophrenia,GCST001242,15:61547904
rs12966547-<b>G</b>,3 x 10-8,,0.58,1.4,'-,[1.28-1.52],LINC01929,Schizophrenia,schizophrenia,GCST001242,18:55084786
rs2252865-<b>?</b>,3 x 10-6,,NR,1.08,'-,[1.04-1.11],RERE,Schizophrenia,schizophrenia,GCST001242,1:8362616
rs1625579-<b>T</b>,2 x 10-11,,0.8,1.12,'-,[1.09-1.16],MIR137HG,Schizophrenia,schizophrenia,GCST001242,1:98037378
rs17662626-<b>A</b>,5 x 10-8,,0.91,1.2,'-,[1.13-1.26],'-,Schizophrenia,schizophrenia,GCST001242,2:193119895
rs1879248-<b>?</b>,7 x 10-6,,NR,1.07,'-,[1.04-1.11],CCDC39,Schizophrenia,schizophrenia,GCST001242,3:180833426
rs114002140-<b>A</b>,9 x 10-14,,0.763,1.67,'-,[1.63-1.71],HLA-DRB9,Schizophrenia,schizophrenia,GCST002149,6:32464185
rs7085104-<b>A</b>,4 x 10-13,,0.645,1.11,'-,[1.08-1.14],BORCS7-ASMT,Schizophrenia,schizophrenia,GCST002149,10:102869116
rs6461049-<b>T</b>,6 x 10-13,,0.571,1.107,'-,[1.08-1.13],MAD1L1,Schizophrenia,schizophrenia,GCST002149,7:1977810
rs1198588-<b>T</b>,2 x 10-12,,0.786,1.1249,'-,[1.09-1.16],NFU1P2,Schizophrenia,schizophrenia,GCST002149,1:98087276
rs1006737-<b>A</b>,5 x 10-12,,0.332,1.103,'-,[1.08-1.13],CACNA1C,Schizophrenia,schizophrenia,GCST002149,12:2236129
rs17691888-<b>G</b>,1 x 10-10,,0.886,1.16,'-,[1.11-1.21],CACNB2,Schizophrenia,schizophrenia,GCST002149,10:18445599
rs4129585-<b>A</b>,2 x 10-10,,0.439,1.091,'-,[1.06-1.12],TSNARE1,Schizophrenia,schizophrenia,GCST002149,8:142231572
rs10789369-<b>A</b>,4 x 10-10,,0.383,1.095,'-,[1.07-1.12],LINC01360,Schizophrenia,schizophrenia,GCST002149,1:73359226
rs7940866-<b>T</b>,2 x 10-9,,0.487,1.09,'-,[1.06-1.12],"SNX19, RN7SL167P",Schizophrenia,schizophrenia,GCST002149,11:130947684
rs17504622-<b>T</b>,3 x 10-9,,0.05,1.238,'-,[1.17-1.31],LINC01470,Schizophrenia,schizophrenia,GCST002149,5:153274919
rs2905424-<b>T</b>,3 x 10-9,,0.348,1.092,'-,[1.06-1.12],"GATAD2A, MAU2",Schizophrenia,schizophrenia,GCST002149,19:19362636
rs2373000-<b>T</b>,7 x 10-9,,0.402,1.087,'-,[1.06-1.11],QPCT,Schizophrenia,schizophrenia,GCST002149,2:37365485
rs6878284-<b>C</b>,9 x 10-9,,0.363,1.09,'-,[1.06-1.12],SLCO6A1,Schizophrenia,schizophrenia,GCST002149,5:102434022
rs4687552-<b>T</b>,1 x 10-8,,0.641,1.086,'-,[1.06-1.11],ITIH3,Schizophrenia,schizophrenia,GCST002149,3:52804386
rs12991836-<b>C</b>,1 x 10-8,,0.348,1.08,'-,[1.05-1.11],ZEB2,Schizophrenia,schizophrenia,GCST002149,2:144383974
rs2949006-<b>T</b>,1 x 10-8,,0.192,1.102,'-,[1.07-1.14],FTCDNL1,Schizophrenia,schizophrenia,GCST002149,2:199850665
rs4801131-<b>C</b>,1 x 10-8,,0.582,1.08,'-,[1.05-1.11],LINC01929,Schizophrenia,schizophrenia,GCST002149,18:55085469
rs778371-<b>G</b>,2 x 10-8,,0.281,1.09,'-,[1.06-1.12],SNORC,Schizophrenia,schizophrenia,GCST002149,2:232878399
rs14403-<b>C</b>,2 x 10-8,,0.773,1.1,'-,[1.07-1.13],AKT3,Schizophrenia,schizophrenia,GCST002149,1:243500591
rs11532322-<b>A</b>,2 x 10-8,,0.318,1.094,'-,[1.06-1.13],C12orf65,Schizophrenia,schizophrenia,GCST002149,12:123246876
rs11995572-<b>T</b>,3 x 10-8,,0.135,1.12,'-,[1.08-1.16],SLC45A4,Schizophrenia,schizophrenia,GCST002149,8:88579854
rs171748-<b>A</b>,4 x 10-8,,0.471,1.078,'-,[1.05-1.11],"SMIM15-AS1, LINC02057",Schizophrenia,schizophrenia,GCST002149,5:61203304
rs4380187-<b>A</b>,6 x 10-8,,0.529,1.078,'-,[1.05-1.11],ZNF804A,Schizophrenia,schizophrenia,GCST002149,2:184947213
rs4523957-<b>T</b>,6 x 10-8,,0.616,1.083,'-,[1.05-1.11],SRR,Schizophrenia,schizophrenia,GCST002149,17:2305605
rs6550435-<b>G</b>,6 x 10-8,,0.344,1.08,'-,[1.05-1.11],"TRANK1, LINC02033",Schizophrenia,schizophrenia,GCST002149,3:36822998
rs211829-<b>T</b>,4 x 10-8,,0.628,1.061,'-,[1.039-1.083],'-,Schizophrenia,schizophrenia,GCST002539,7:110408836
rs215411-<b>A</b>,3 x 10-8,,0.314,1.064,'-,[1.041-1.087],RFPL4AP3,Schizophrenia,schizophrenia,GCST002539,4:23421980
rs35518360-<b>T</b>,8 x 10-15,,0.078,1.166861,'-,[1.12-1.21],"SLC39A8, LINC02498",Schizophrenia,schizophrenia,GCST002539,4:102225733
rs10520163-<b>T</b>,1 x 10-9,,0.47,1.065,'-,[1.043-1.086],CLCN3,Schizophrenia,schizophrenia,GCST002539,4:169705401
rs11210892-<b>A</b>,3 x 10-10,,0.323,1.0706638,'-,[1.05-1.09],"PTPRF, KDM4A",Schizophrenia,schizophrenia,GCST002539,1:43634413
rs12129573-<b>A</b>,2 x 10-12,,0.358,1.078,'-,[1.056-1.101],LINC01360,Schizophrenia,schizophrenia,GCST002539,1:73302683
rs1702294-<b>C</b>,3 x 10-19,,0.809,1.1273957,'-,[1.1-1.16],MIR137HG,Schizophrenia,schizophrenia,GCST002539,1:98036428
rs140505938-<b>T</b>,4 x 10-10,,0.836,1.0940919,'-,[1.06-1.13],"OTUD7B, VPS45",Schizophrenia,schizophrenia,GCST002539,1:150059494
rs6670165-<b>T</b>,4 x 10-8,,0.184,1.075,'-,[1.047-1.103],"BRINP2, LINC01645",Schizophrenia,schizophrenia,GCST002539,1:177310985
rs7523273-<b>A</b>,4 x 10-8,,0.685,1.063,'-,[1.040-1.087],MIR29B2CHG,Schizophrenia,schizophrenia,GCST002539,1:207803738
rs77149735-<b>A</b>,4 x 10-9,,0.0191,1.317,'-,[1.202-1.444],SDCCAG8,Schizophrenia,schizophrenia,GCST002539,1:243391803
rs11682175-<b>C</b>,1 x 10-11,,0.458,1.0718113,'-,[1.05-1.09],ACTG1P22,Schizophrenia,schizophrenia,GCST002539,2:57760458
rs3768644-<b>G</b>,7 x 10-9,,0.899,1.1061947,'-,[1.07-1.14],CYP26B1,Schizophrenia,schizophrenia,GCST002539,2:72134376
rs117074560-<b>C</b>,2 x 10-9,,0.9524,1.1778563,'-,[1.12-1.24],"FUT9, KRT18P50",Schizophrenia,schizophrenia,GCST002539,6:96011775
rs12704290-<b>G</b>,3 x 10-10,,0.877,1.1061947,'-,[1.07-1.14],"GRM3-AS1, GRM3",Schizophrenia,schizophrenia,GCST002539,7:86798310
rs6466055-<b>A</b>,1 x 10-9,,0.332,1.068,'-,[1.046-1.091],SRPK2,Schizophrenia,schizophrenia,GCST002539,7:105288617
rs13240464-<b>T</b>,3 x 10-13,,0.647,1.083,'-,[1.060-1.106],IMMP2L,Schizophrenia,schizophrenia,GCST002539,7:111258859
rs7801375-<b>G</b>,4 x 10-8,,0.848,1.0822511,'-,[1.05-1.11],CAPZA1P4,Schizophrenia,schizophrenia,GCST002539,7:131882504
rs3735025-<b>T</b>,3 x 10-9,,0.642,1.066,'-,[1.043-1.089],DGKI,Schizophrenia,schizophrenia,GCST002539,7:137390098
rs10503253-<b>A</b>,1 x 10-8,,0.219,1.073,'-,[1.048-1.100],CSMD1,Schizophrenia,schizophrenia,GCST002539,8:4323322
rs73229090-<b>C</b>,2 x 10-8,,0.884,1.1013216,'-,[1.06-1.14],GULOP,Schizophrenia,schizophrenia,GCST002539,8:27584610
rs6984242-<b>G</b>,6 x 10-9,,0.4,1.0626993,'-,[1.04-1.08],'-,Schizophrenia,schizophrenia,GCST002539,8:59787910
rs7819570-<b>T</b>,1 x 10-8,,0.174,1.079,'-,[1.051-1.108],'-,Schizophrenia,schizophrenia,GCST002539,8:88576397
rs6704768-<b>G</b>,2 x 10-12,,0.448,1.0752687,'-,[1.05-1.1],GIGYF2,Schizophrenia,schizophrenia,GCST002539,2:232727791
rs17194490-<b>T</b>,3 x 10-11,,0.156,1.101,'-,[1.070-1.132],CNTN4,Schizophrenia,schizophrenia,GCST002539,3:2506102
rs4330281-<b>C</b>,5 x 10-9,,0.52,1.0638298,'-,[1.04-1.09],TBC1D5,Schizophrenia,schizophrenia,GCST002539,3:17817874
rs75968099-<b>T</b>,1 x 10-13,,0.324,1.085,'-,[1.062-1.109],"LINC02033, HSPD1P6",Schizophrenia,schizophrenia,GCST002539,3:36817092
rs2535627-<b>T</b>,4 x 10-11,,0.529,1.071,'-,[1.049-1.092],"ITIH3, ITIH4",Schizophrenia,schizophrenia,GCST002539,3:52811089
rs832187-<b>C</b>,1 x 10-8,,0.385,1.0626993,'-,[1.04-1.08],"THOC7, C3orf49",Schizophrenia,schizophrenia,GCST002539,3:63847374
rs7432375-<b>G</b>,7 x 10-11,,0.551,1.0718113,'-,[1.05-1.09],STAG1,Schizophrenia,schizophrenia,GCST002539,3:136569563
rs4129585-<b>A</b>,2 x 10-15,,0.424,1.087,'-,[1.065-1.109],TSNARE1,Schizophrenia,schizophrenia,GCST002539,8:142231572
rs11139497-<b>A</b>,4 x 10-9,,0.337,1.069,'-,[1.045-1.093],DDX10P2,Schizophrenia,schizophrenia,GCST002539,9:82125026
rs7893279-<b>T</b>,2 x 10-12,,0.889,1.125,'-,[1.088-1.162],CACNB2,Schizophrenia,schizophrenia,GCST002539,10:18456176
rs11191419-<b>T</b>,6 x 10-19,,0.64,1.1037527,'-,[1.08-1.13],"BORCS7, PTGES3P4",Schizophrenia,schizophrenia,GCST002539,10:102852578
rs11027857-<b>A</b>,3 x 10-9,,0.499,1.064,'-,[1.042-1.085],Y_RNA,Schizophrenia,schizophrenia,GCST002539,11:24382074
rs9420-<b>A</b>,2 x 10-9,,0.311,1.068,'-,[1.045-1.092],SELENOH,Schizophrenia,schizophrenia,GCST002539,11:57742822
rs12421382-<b>C</b>,4 x 10-8,,0.666,1.0626993,'-,[1.04-1.09],C11orf87,Schizophrenia,schizophrenia,GCST002539,11:109507345
rs2514218-<b>C</b>,3 x 10-11,,0.686,1.0787487,'-,[1.05-1.1],DRD2,Schizophrenia,schizophrenia,GCST002539,11:113522272
rs77502336-<b>C</b>,8 x 10-9,,0.322,1.066,'-,[1.043-1.090],GRAMD1B,Schizophrenia,schizophrenia,GCST002539,11:123523928
rs55661361-<b>G</b>,3 x 10-12,,0.665,1.0799136,'-,[1.06-1.1],NRGN,Schizophrenia,schizophrenia,GCST002539,11:124744061
rs10791097-<b>T</b>,1 x 10-12,,0.46,1.076,'-,[1.055-1.098],LINC02551,Schizophrenia,schizophrenia,GCST002539,11:130848735
rs75059851-<b>A</b>,4 x 10-11,,0.797,1.091,'-,[1.063-1.119],IGSF9B,Schizophrenia,schizophrenia,GCST002539,11:133952674
rs2007044-<b>G</b>,3 x 10-18,,0.376,1.0964912,'-,[1.07-1.12],CACNA1C,Schizophrenia,schizophrenia,GCST002539,12:2235794
rs679087-<b>C</b>,4 x 10-8,,0.663,1.0626993,'-,[1.04-1.09],TMTC1,Schizophrenia,schizophrenia,GCST002539,12:29764332
rs12826178-<b>G</b>,2 x 10-12,,0.929,1.1820331,'-,[1.13-1.24],"NXPH4, SHMT2",Schizophrenia,schizophrenia,GCST002539,12:57228588
rs4240748-<b>G</b>,5 x 10-8,,0.634,1.0604454,'-,[1.04-1.08],LINC02404,Schizophrenia,schizophrenia,GCST002539,12:91853010
rs10860964-<b>T</b>,5 x 10-8,,0.646,1.06,'-,[1.038-1.083],C12orf42,Schizophrenia,schizophrenia,GCST002539,12:103202677
rs4766428-<b>T</b>,1 x 10-9,,0.474,1.068,'-,[1.045-1.091],ATP2A2,Schizophrenia,schizophrenia,GCST002539,12:110285440
rs2851447-<b>G</b>,2 x 10-14,,0.259,1.0928961,'-,[1.07-1.12],MPHOSPH9,Schizophrenia,schizophrenia,GCST002539,12:123180566
rs2068012-<b>C</b>,1 x 10-8,,0.229,1.0718113,'-,[1.05-1.1],PRKD1,Schizophrenia,schizophrenia,GCST002539,14:29721110
rs2332700-<b>C</b>,5 x 10-9,,0.249,1.073,'-,[1.048-1.098],RGS6,Schizophrenia,schizophrenia,GCST002539,14:71950609
rs2693698-<b>G</b>,5 x 10-9,,0.582,1.0649627,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST002539,Mapping not available
rs12887734-<b>T</b>,1 x 10-13,,0.287,1.088,'-,[1.064-1.113],"KLC1, COA8",Schizophrenia,schizophrenia,GCST002539,14:103580497
rs56205728-<b>A</b>,4 x 10-9,,0.274,1.074,'-,[1.048-1.099],PAK6,Schizophrenia,schizophrenia,GCST002539,15:40275036
rs12903146-<b>A</b>,3 x 10-10,,0.52,1.067,'-,[1.046-1.089],'-,Schizophrenia,schizophrenia,GCST002539,15:61562464
rs4702-<b>G</b>,8 x 10-14,,0.438,1.0845987,'-,[1.06-1.11],FURIN,Schizophrenia,schizophrenia,GCST002539,15:90883330
rs9922678-<b>A</b>,1 x 10-8,,0.281,1.067,'-,[1.043-1.091],GRIN2A,Schizophrenia,schizophrenia,GCST002539,16:9852462
rs7405404-<b>T</b>,1 x 10-9,,0.223,1.077,'-,[1.052-1.103],'-,Schizophrenia,schizophrenia,GCST002539,16:13656002
rs12691307-<b>A</b>,5 x 10-11,,0.51,1.073,'-,[1.051-1.096],"TMEM219, KCTD13",Schizophrenia,schizophrenia,GCST002539,16:29928556
rs12325245-<b>T</b>,2 x 10-8,,0.141,1.0869565,'-,[1.06-1.12],"CNOT1, SLC38A7",Schizophrenia,schizophrenia,GCST002539,16:58647489
rs8044995-<b>A</b>,2 x 10-8,,0.162,1.081,'-,[1.052-1.111],NFATC3,Schizophrenia,schizophrenia,GCST002539,16:68155437
rs4523957-<b>T</b>,3 x 10-10,,0.627,1.071,'-,[1.049-1.094],SRR,Schizophrenia,schizophrenia,GCST002539,17:2305605
rs8082590-<b>G</b>,2 x 10-8,,0.386,1.0649627,'-,[1.04-1.09],GID4,Schizophrenia,schizophrenia,GCST002539,17:18055088
rs9636107-<b>G</b>,3 x 10-12,,0.497,1.0752687,'-,[1.05-1.1],TCF4,Schizophrenia,schizophrenia,GCST002539,18:55532886
rs72934570-<b>C</b>,2 x 10-11,,0.9203,1.1454753,'-,[1.1-1.19],"LINC01416, LINC01415",Schizophrenia,schizophrenia,GCST002539,18:55865958
rs2905426-<b>G</b>,4 x 10-10,,0.372,1.0706638,'-,[1.05-1.09],"MAU2, GATAD2A",Schizophrenia,schizophrenia,GCST002539,19:19367213
rs2053079-<b>G</b>,4 x 10-9,,0.231,1.0741138,'-,[1.05-1.1],ZNF536,Schizophrenia,schizophrenia,GCST002539,19:30496516
rs56873913-<b>T</b>,5 x 10-8,,0.766,1.071,'-,[1.045-1.098],"NOSIP, PRRG2",Schizophrenia,schizophrenia,GCST002539,19:49587942
rs6065094-<b>G</b>,1 x 10-11,,0.678,1.0775862,'-,[1.05-1.1],PPP1R16B,Schizophrenia,schizophrenia,GCST002539,20:38824551
rs7267348-<b>C</b>,5 x 10-8,,0.246,1.0672358,'-,[1.04-1.09],PTGIS,Schizophrenia,schizophrenia,GCST002539,20:49514499
rs9607782-<b>A</b>,2 x 10-11,,0.232,1.087,'-,[1.060-1.113],EP300-AS1,Schizophrenia,schizophrenia,GCST002539,22:41191552
rs6002655-<b>T</b>,2 x 10-9,,0.443,1.066,'-,[1.044-1.088],TCF20,Schizophrenia,schizophrenia,GCST002539,22:42207808
rs12845396-<b>T</b>,2 x 10-8,,0.247,1.0559661,'-,[1.04-1.08],NLGN4X,Schizophrenia,schizophrenia,GCST002539,X:6111492
rs1378559-<b>T</b>,2 x 10-12,,0.831,1.09,'-,[1.064-1.116],CNKSR2,Schizophrenia,schizophrenia,GCST002539,X:21362148
rs5937157-<b>G</b>,2 x 10-10,,0.241,1.066098,'-,[1.05-1.09],PJA1,Schizophrenia,schizophrenia,GCST002539,X:69157283
rs9841616-<b>T</b>,2 x 10-8,,0.833,1.081081,'-,[1.05-1.11],SOX2-OT,Schizophrenia,schizophrenia,GCST002539,3:181449797
rs4648845-<b>T</b>,9 x 10-10,,0.527,1.072,'-,[1.049-1.097],PLCH2,Schizophrenia,schizophrenia,GCST002539,1:2455662
rs1498232-<b>T</b>,3 x 10-9,,0.296,1.069,'-,[1.046-1.093],LINC01648,Schizophrenia,schizophrenia,GCST002539,1:29961104
rs1106568-<b>G</b>,9 x 10-9,,0.239,1.0706638,'-,[1.05-1.1],GPM6A,Schizophrenia,schizophrenia,GCST002539,4:175940150
rs1501357-<b>C</b>,5 x 10-9,,0.198,1.0799136,'-,[1.05-1.11],HCN1,Schizophrenia,schizophrenia,GCST002539,5:45364773
rs4391122-<b>G</b>,1 x 10-14,,0.468,1.0845987,'-,[1.06-1.11],LINC02057,Schizophrenia,schizophrenia,GCST002539,5:61302716
rs16867576-<b>A</b>,5 x 10-9,,0.883,1.101,'-,[1.066-1.138],MEF2C-AS1,Schizophrenia,schizophrenia,GCST002539,5:89450514
rs4388249-<b>T</b>,3 x 10-8,,0.213,1.076,'-,[1.048-1.104],MAN2A1,Schizophrenia,schizophrenia,GCST002539,5:109700365
rs3849046-<b>T</b>,5 x 10-9,,0.523,1.063,'-,[1.042-1.085],ETF1,Schizophrenia,schizophrenia,GCST002539,5:138515503
rs111294930-<b>A</b>,1 x 10-10,,0.782,1.094,'-,[1.064-1.124],LINC01470,Schizophrenia,schizophrenia,GCST002539,5:152797561
rs11740474-<b>T</b>,3 x 10-8,,0.379,1.0615711,'-,[1.04-1.08],GALNT10,Schizophrenia,schizophrenia,GCST002539,5:154301187
rs115329265-<b>A</b>,3 x 10-31,,0.85,1.205,'-,[1.168-1.244],"NOP56P1, RPSAP2",Schizophrenia,schizophrenia,GCST002539,6:28744470
rs1339227-<b>C</b>,3 x 10-8,,0.632,1.0615711,'-,[1.04-1.08],RIMS1,Schizophrenia,schizophrenia,GCST002539,6:72445999
rs2909457-<b>G</b>,5 x 10-8,,0.407,1.059322,'-,[1.04-1.08],"SLC4A10, DPP4",Schizophrenia,schizophrenia,GCST002539,2:161989345
rs11693094-<b>C</b>,2 x 10-12,,0.542,1.0764263,'-,[1.05-1.1],ZNF804A,Schizophrenia,schizophrenia,GCST002539,2:184736693
rs59979824-<b>C</b>,8 x 10-9,,0.663,1.0672358,'-,[1.04-1.09],'-,Schizophrenia,schizophrenia,GCST002539,2:192983614
rs6434928-<b>G</b>,2 x 10-11,,0.357,1.0764263,'-,[1.05-1.1],"RNU6-1029P, SF3B1",Schizophrenia,schizophrenia,GCST002539,2:197439853
rs6704641-<b>A</b>,8 x 10-9,,0.805,1.081,'-,[1.053-1.110],SATB2,Schizophrenia,schizophrenia,GCST002539,2:199299529
rs11685299-<b>C</b>,1 x 10-8,,0.674,1.0649627,'-,[1.04-1.09],CUL3,Schizophrenia,schizophrenia,GCST002539,2:224526579
rs36068923-<b>G</b>,3 x 10-11,,0.197,1.0881393,'-,[1.06-1.12],SINHCAFP3,Schizophrenia,schizophrenia,GCST002539,8:110473532
rs12148337-<b>T</b>,2 x 10-8,,0.465,1.06,'-,[1.038-1.081],'-,Schizophrenia,schizophrenia,GCST002539,15:70296933
rs8042374-<b>A</b>,2 x 10-13,,0.725,1.093,'-,[1.067-1.119],CHRNA3,Schizophrenia,schizophrenia,GCST002539,15:78615690
rs950169-<b>C</b>,2 x 10-11,,0.743,1.0834236,'-,[1.06-1.11],ADAMTSL3,Schizophrenia,schizophrenia,GCST002539,15:84037709
rs10075092-<b>A</b>,9 x 10-6,,NR,1.22755,'-,[1.1216-1.34351],"PRRC1, CTXN3",Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,5:127632898
rs62082533-<b>T</b>,8 x 10-6,,NR,1.28381,'-,[1.15038-1.43273],'-,Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,18:4856891
rs140751744-<b>C</b>,6 x 10-6,,NR,1.40963,'-,[1.2154-1.63489],PLCB4,Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,20:9165604
rs77191500-<b>G</b>,1 x 10-6,,NR,'-,0.689274 unit decrease,[0.41-0.97],CABYRP1,Chronotype (sMEQ score),chronotype measurement,GCST010576,3:54047780
rs79036472-<b>T</b>,7 x 10-6,,NR,'-,0.551993 unit increase,[0.31-0.79],'-,Chronotype (sMEQ score),chronotype measurement,GCST010576,5:155722238
rs7764996-<b>G</b>,8 x 10-7,,NR,'-,0.348817 unit decrease,[0.21-0.49],IPCEF1,Chronotype (sMEQ score),chronotype measurement,GCST010576,6:154312725
rs7814838-<b>C</b>,1 x 10-6,,NR,'-,0.616986 unit decrease,[0.37-0.87],"RN7SL685P, FLJ42969",Chronotype (sMEQ score),chronotype measurement,GCST010576,8:101002364
rs4742419-<b>T</b>,2 x 10-6,,NR,'-,0.339957 unit increase,[0.2-0.48],"KANK1, DMRT1",Chronotype (sMEQ score),chronotype measurement,GCST010576,9:804436
rs10750135-<b>G</b>,2 x 10-6,,NR,'-,0.674313 unit increase,[0.39-0.95],'-,Chronotype (sMEQ score),chronotype measurement,GCST010576,11:98814768
rs7131148-<b>A</b>,2 x 10-6,,NR,'-,0.428939 unit decrease,[0.25-0.6],"MMP7, TMEM123",Chronotype (sMEQ score),chronotype measurement,GCST010576,11:102503236
rs1366235-<b>G</b>,9 x 10-6,,NR,'-,0.323262 unit increase,[0.18-0.47],INSR,Chronotype (sMEQ score),chronotype measurement,GCST010576,19:7167704
rs79036472-<b>?</b>,3 x 10-7,,NR,1.4286346,'-,[1.25-1.64],'-,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,5:155722238
rs9314082-<b>?</b>,2 x 10-6,,NR,1.3954787,'-,[1.21-1.6],"RNA5SP199, SGCD",Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,5:155863201
rs7071256-<b>?</b>,5 x 10-6,,NR,1.2338673,'-,[1.13-1.35],VTI1A,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,10:112769266
rs1608147-<b>?</b>,2 x 10-6,,NR,1.2305315,'-,[1.13-1.34],PTPRG,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,3:61725482
rs10108002-<b>?</b>,5 x 10-6,,NR,1.2062494,'-,[1.11-1.31],SULF1,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,8:69577780
rs4971864-<b>?</b>,7 x 10-6,,NR,1.1791577,'-,[1.1-1.27],'-,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,2:49510496
rs11721971-<b>G</b>,9 x 10-6,,NR,1.18662,'-,[1.10028-1.27972],'-,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,4:134886000
rs6501006-<b>G</b>,2 x 10-6,,NR,1.19247,'-,[1.10881-1.28243],RBFOX1,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,16:7659968
rs7683928-<b>G</b>,8 x 10-6,,NR,1.19645,'-,[1.10589-1.29442],ARHGAP24,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,4:85577344
rs13087217-<b>G</b>,9 x 10-7,,NR,1.28313,'-,[1.16177-1.41718],LPP,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,3:188790116
rs6990182-<b>G</b>,6 x 10-7,,NR,1.39354,'-,[1.2235-1.58721],'-,Evening vs. morning chronotype (sMEQ score),chronotype measurement,GCST010575,8:139266592
rs17826722-<b>?</b>,8 x 10-6,,NR,1.4228597,'-,[1.22-1.66],"LINC01994, NMD3",Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,3:182437274
rs4653454-<b>?</b>,2 x 10-7,,NR,1.194084,'-,[1.12-1.28],"STUM, ITPKB",Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,1:226617423
rs208626-<b>?</b>,1 x 10-6,,NR,1.1735656,'-,[1.1-1.25],HS3ST2,Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,16:22916566
rs12412747-<b>?</b>,9 x 10-6,,NR,1.1713264,'-,[1.09-1.26],CRTAC1,Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,10:97889774
rs56149312-<b>?</b>,9 x 10-6,,NR,1.1532881,'-,[1.08-1.23],RNU6-420P,Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,4:22216527
rs10029061-<b>T</b>,1 x 10-6,,NR,1.18016,'-,[1.1039-1.26168],TTC29,Evening vs. morning chronotype (self-assessed),chronotype measurement,GCST010574,4:146843235
rs76626729-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,CAMTA1,Morning person,chronotype measurement,GCST007083,1:7684499
rs17374439-<b>?</b>,5 x 10-24,,NR,'-,'-,'-,PER3,Morning person,chronotype measurement,GCST007083,1:7828378
rs17448682-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,DDI2,Morning person,chronotype measurement,GCST007083,1:15640218
rs4912144-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,TMCO4,Morning person,chronotype measurement,GCST007083,1:19685219
rs3767240-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,EIF4G3,Morning person,chronotype measurement,GCST007083,1:20837428
rs12140153-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,PATJ,Morning person,chronotype measurement,GCST007083,1:62114219
rs7547493-<b>?</b>,2 x 10-23,,NR,'-,'-,'-,AK5,Morning person,chronotype measurement,GCST007083,1:77309548
rs11588913-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ADH5P2,Morning person,chronotype measurement,GCST007083,1:79498131
rs72720396-<b>?</b>,3 x 10-16,,NR,'-,'-,'-,"BARHL2, LINC02609",Morning person,chronotype measurement,GCST007083,1:90726025
rs11164855-<b>?</b>,9 x 10-8,,NR,'-,'-,'-,"RN7SL692P, RNU6-210P",Morning person,chronotype measurement,GCST007083,1:93001403
rs11165655-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"RN7SL831P, EEF1A1P11",Morning person,chronotype measurement,GCST007083,1:96493548
rs12047910-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"DPYD-AS1, DPYD",Morning person,chronotype measurement,GCST007083,1:97134483
rs17575798-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,GPR61,Morning person,chronotype measurement,GCST007083,1:109543829
rs9429539-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,TRIM33,Morning person,chronotype measurement,GCST007083,1:114381014
rs2072727-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,PABPC1L,Morning person,chronotype measurement,GCST007083,20:44910092
rs9613630-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,TTC28,Morning person,chronotype measurement,GCST007083,22:28475582
rs139911-<b>?</b>,7 x 10-17,,NR,'-,'-,'-,TNRC6B,Morning person,chronotype measurement,GCST007083,22:40308048
rs4822107-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,TCF20,Morning person,chronotype measurement,GCST007083,22:42308828
rs10148448-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BEGAIN,Morning person,chronotype measurement,GCST007083,14:100559811
rs59986227-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SEMA6D,Morning person,chronotype measurement,GCST007083,15:47717066
rs8023703-<b>?</b>,2 x 10-7,,NR,'-,'-,'-,PKM,Morning person,chronotype measurement,GCST007083,15:72211718
rs12927162-<b>?</b>,7 x 10-21,,NR,'-,'-,'-,CASC16,Morning person,chronotype measurement,GCST007083,16:52651004
rs1421085-<b>?</b>,8 x 10-21,,NR,'-,'-,'-,FTO,Morning person,chronotype measurement,GCST007083,16:53767042
rs2398144-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,GNAO1,Morning person,chronotype measurement,GCST007083,16:56318942
rs8063159-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,GNPATP,Morning person,chronotype measurement,GCST007083,16:60593587
rs35746112-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"PMFBP1, LINC01572",Morning person,chronotype measurement,GCST007083,16:72181248
rs2518022-<b>?</b>,5 x 10-15,,NR,'-,'-,'-,PER1,Morning person,chronotype measurement,GCST007083,17:8154049
rs3760185-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,"PEMT, RASD1",Morning person,chronotype measurement,GCST007083,17:17498422
rs226090-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,AP2B1,Morning person,chronotype measurement,GCST007083,17:35707040
rs35653190-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,"CDK5RAP3, COPZ2",Morning person,chronotype measurement,GCST007083,17:48000601
rs117987711-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,TRIM37,Morning person,chronotype measurement,GCST007083,17:59033908
rs17682747-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,TANC2,Morning person,chronotype measurement,GCST007083,17:63103751
rs2364972-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,PITPNC1,Morning person,chronotype measurement,GCST007083,17:67479216
rs2580160-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,18:1816035
rs62082401-<b>?</b>,6 x 10-14,,NR,'-,'-,'-,AKAIN1,Morning person,chronotype measurement,GCST007083,18:5186020
rs1013987-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"ZNF521, WBP2P1",Morning person,chronotype measurement,GCST007083,18:25050872
rs4239386-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,NOL4,Morning person,chronotype measurement,GCST007083,18:34084746
rs12969848-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,18:40572871
rs9962650-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,LINC01416,Morning person,chronotype measurement,GCST007083,18:55906812
rs9964420-<b>?</b>,2 x 10-16,,NR,'-,'-,'-,SEC11C,Morning person,chronotype measurement,GCST007083,18:59156809
rs56076457-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,ZCCHC2,Morning person,chronotype measurement,GCST007083,18:62571435
rs11670534-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,PPP5D1,Morning person,chronotype measurement,GCST007083,19:46500649
rs78095690-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,"KIF16B, PPIAP17",Morning person,chronotype measurement,GCST007083,20:16259038
rs11587758-<b>?</b>,4 x 10-15,,NR,'-,'-,'-,"RPRD2, PRPF3",Morning person,chronotype measurement,GCST007083,1:150354630
rs11587444-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CTSS,Morning person,chronotype measurement,GCST007083,1:150750368
rs75650221-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RABGAP1L,Morning person,chronotype measurement,GCST007083,1:174452856
rs11580135-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"HNRNPA1P54, AXDND1",Morning person,chronotype measurement,GCST007083,1:179448645
rs1144566-<b>?</b>,8 x 10-40,,NR,'-,'-,'-,RGS16,Morning person,chronotype measurement,GCST007083,1:182600491
rs10196909-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,"NPM1P48, LINC01249",Morning person,chronotype measurement,GCST007083,2:4603609
rs848552-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CRIM1,Morning person,chronotype measurement,GCST007083,2:36473437
rs75120545-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,LRPPRC,Morning person,chronotype measurement,GCST007083,2:44044357
rs786406-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,CAMKMT,Morning person,chronotype measurement,GCST007083,2:44508814
rs6751138-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"LHCGR, STON1-GTF2A1L",Morning person,chronotype measurement,GCST007083,2:48734502
rs10495976-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,2:49523560
rs7602425-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,NRXN1,Morning person,chronotype measurement,GCST007083,2:50233342
rs11691214-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LINC01793,Morning person,chronotype measurement,GCST007083,2:59208484
rs778138-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,USP34,Morning person,chronotype measurement,GCST007083,2:61460079
rs6744983-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,SUCLA2P2,Morning person,chronotype measurement,GCST007083,2:76119259
rs10520176-<b>?</b>,9 x 10-14,,NR,'-,'-,'-,"LRRTM4-AS1, LRRTM4",Morning person,chronotype measurement,GCST007083,2:76990184
rs28380327-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,ARHGAP15,Morning person,chronotype measurement,GCST007083,2:143474922
rs1947198-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"EPC2, RPS29P8",Morning person,chronotype measurement,GCST007083,2:148632866
rs1064213-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,PLCL1,Morning person,chronotype measurement,GCST007083,2:198085516
rs184033703-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,"NDUFS1, INO80D",Morning person,chronotype measurement,GCST007083,2:206091414
rs960783-<b>?</b>,6 x 10-18,,NR,'-,'-,'-,"PER2, HES6",Morning person,chronotype measurement,GCST007083,2:238240929
rs80271258-<b>?</b>,7 x 10-26,,NR,'-,'-,'-,"RNU6-234P, TRAF3IP1",Morning person,chronotype measurement,GCST007083,2:238402864
rs62182135-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,HDAC4,Morning person,chronotype measurement,GCST007083,2:239345610
rs34581681-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,CNTN4,Morning person,chronotype measurement,GCST007083,3:2393963
rs149611468-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"CAV3, RAD18",Morning person,chronotype measurement,GCST007083,3:8775737
rs9853258-<b>?</b>,8 x 10-11,,NR,'-,'-,'-,TBC1D5,Morning person,chronotype measurement,GCST007083,3:18113027
rs7428484-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,UBE2E2,Morning person,chronotype measurement,GCST007083,3:23288610
rs13059636-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,3:24894299
rs115774037-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"HSPD1P6, LINC02033",Morning person,chronotype measurement,GCST007083,3:36793177
rs11712056-<b>?</b>,7 x 10-12,,NR,'-,'-,'-,ACTL11P,Morning person,chronotype measurement,GCST007083,3:49876964
rs60194061-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,ROBO2,Morning person,chronotype measurement,GCST007083,3:77251970
rs957501-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,CADM2,Morning person,chronotype measurement,GCST007083,3:85742507
rs13065394-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"TMEM108-AS1, TMEM108",Morning person,chronotype measurement,GCST007083,3:133252483
rs2102506-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,"TIPARP-AS1, SSR3",Morning person,chronotype measurement,GCST007083,3:156625060
rs9831488-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,PPM1L,Morning person,chronotype measurement,GCST007083,3:161037274
rs3850174-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,NCEH1,Morning person,chronotype measurement,GCST007083,3:172646303
rs1906508-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,LINC01994,Morning person,chronotype measurement,GCST007083,3:182406713
rs2239626-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,DGKG,Morning person,chronotype measurement,GCST007083,3:186281095
rs231398-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,SH3BP2,Morning person,chronotype measurement,GCST007083,4:2830462
rs12498561-<b>?</b>,8 x 10-8,,NR,'-,'-,'-,KCNIP4,Morning person,chronotype measurement,GCST007083,4:21859140
rs28634184-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,ADGRL3,Morning person,chronotype measurement,GCST007083,4:62007701
rs7691121-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,HNRNPD,Morning person,chronotype measurement,GCST007083,4:82353055
rs4339281-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,LINC02263,Morning person,chronotype measurement,GCST007083,4:117394404
rs4241964-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,4:136132804
rs4992300-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"CD14, RNU4-43P",Morning person,chronotype measurement,GCST007083,5:26029438
rs7701529-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,RGS7BP,Morning person,chronotype measurement,GCST007083,5:64565648
rs12657776-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,TMEM161B-AS1,Morning person,chronotype measurement,GCST007083,5:88365776
rs34875688-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"MEF2C, MEF2C-AS1",Morning person,chronotype measurement,GCST007083,5:88886209
rs12055234-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,RNU6-334P,Morning person,chronotype measurement,GCST007083,5:104702059
rs1027742-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,SEMA6A,Morning person,chronotype measurement,GCST007083,5:116568714
rs1480152-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,PPP2R2B,Morning person,chronotype measurement,GCST007083,5:147062083
rs4246036-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,LINC01470,Morning person,chronotype measurement,GCST007083,5:152825870
rs7735794-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"THOC3, CPLX2",Morning person,chronotype measurement,GCST007083,5:175912981
rs9369915-<b>?</b>,9 x 10-15,,NR,'-,'-,'-,PHACTR1,Morning person,chronotype measurement,GCST007083,6:13191215
rs2842638-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,"MDFI, FOXP4",Morning person,chronotype measurement,GCST007083,6:41615838
rs6904450-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,FTH1P5,Morning person,chronotype measurement,GCST007083,6:50953889
rs2653343-<b>?</b>,4 x 10-30,,NR,'-,'-,'-,HCRTR2,Morning person,chronotype measurement,GCST007083,6:55268528
rs1931814-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,KHDRBS2,Morning person,chronotype measurement,GCST007083,6:61879262
rs60616179-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"GPR6, FIG4",Morning person,chronotype measurement,GCST007083,6:109923562
rs520954-<b>?</b>,1 x 10-19,,NR,'-,'-,'-,LINC02840,Morning person,chronotype measurement,GCST007083,6:152814243
rs3877930-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,RNA5SP224,Morning person,chronotype measurement,GCST007083,6:153252968
rs9365769-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,6:164765930
rs9348050-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,PDE10A,Morning person,chronotype measurement,GCST007083,6:165850000
rs28479767-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,7:24027086
rs17161045-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,PDE1C,Morning person,chronotype measurement,GCST007083,7:32221846
rs56049037-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RP9P, KBTBD2",Morning person,chronotype measurement,GCST007083,7:32907589
rs6967481-<b>?</b>,5 x 10-11,,NR,'-,'-,'-,"DDC, GRB10",Morning person,chronotype measurement,GCST007083,7:50575004
rs4729303-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,MARK2P10,Morning person,chronotype measurement,GCST007083,7:96845566
rs202157-<b>?</b>,8 x 10-15,,NR,'-,'-,'-,CUX1,Morning person,chronotype measurement,GCST007083,7:101994473
rs6960360-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,ORAI2,Morning person,chronotype measurement,GCST007083,7:102442785
rs4729854-<b>?</b>,3 x 10-23,,NR,'-,'-,'-,"RASA4DP, FAM185A",Morning person,chronotype measurement,GCST007083,7:102743216
rs117430989-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,"SLC26A5, PSMC2",Morning person,chronotype measurement,GCST007083,7:103366166
rs2189008-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,FOXP2,Morning person,chronotype measurement,GCST007083,7:114483253
rs1113295-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,TFEC,Morning person,chronotype measurement,GCST007083,7:116038592
rs35524253-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,CSMD1,Morning person,chronotype measurement,GCST007083,8:4966086
rs640245-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"MPPED2, RPL12P30",Morning person,chronotype measurement,GCST007083,11:30371813
rs11032362-<b>?</b>,5 x 10-17,,NR,'-,'-,'-,"CD59, FBXO3",Morning person,chronotype measurement,GCST007083,11:33737546
rs12787765-<b>?</b>,6 x 10-12,,NR,'-,'-,'-,"CNTF, GLYAT",Morning person,chronotype measurement,GCST007083,11:58633213
rs17577073-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CNTN5,Morning person,chronotype measurement,GCST007083,11:99282070
rs10891630-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,ZBTB16,Morning person,chronotype measurement,GCST007083,11:114140943
rs7130530-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CADM1,Morning person,chronotype measurement,GCST007083,11:115279008
rs73606718-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,JHY,Morning person,chronotype measurement,GCST007083,11:122943766
rs7943634-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,KIRREL3,Morning person,chronotype measurement,GCST007083,11:126864424
rs1601409-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,SKP1P2,Morning person,chronotype measurement,GCST007083,12:16913835
rs2467109-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,12:22911104
rs12811046-<b>?</b>,5 x 10-13,,NR,'-,'-,'-,SOX5,Morning person,chronotype measurement,GCST007083,12:23914003
rs1906136-<b>?</b>,1 x 10-19,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,12:33752358
rs7313852-<b>?</b>,9 x 10-29,,NR,'-,'-,'-,KITLG,Morning person,chronotype measurement,GCST007083,12:38514587
rs11183201-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ARID2,Morning person,chronotype measurement,GCST007083,12:45777199
rs11174781-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,"AVPR1A, RSL24D1P5",Morning person,chronotype measurement,GCST007083,12:63122346
rs7959983-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,12:90059201
rs7304278-<b>?</b>,4 x 10-10,,NR,'-,'-,'-,RFX4,Morning person,chronotype measurement,GCST007083,12:106596137
rs7298532-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,NAA25,Morning person,chronotype measurement,GCST007083,12:112072600
rs9597241-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,13:55707137
rs9573971-<b>?</b>,9 x 10-18,,NR,'-,'-,'-,"CLN5, FBXL3",Morning person,chronotype measurement,GCST007083,13:76994597
rs61963491-<b>?</b>,5 x 10-15,,NR,'-,'-,'-,MYCBP2,Morning person,chronotype measurement,GCST007083,13:77370501
rs4270038-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,GPC6,Morning person,chronotype measurement,GCST007083,13:93446964
rs112306229-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,NRXN3,Morning person,chronotype measurement,GCST007083,14:78289738
rs10149448-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,RNU6ATAC28P,Morning person,chronotype measurement,GCST007083,14:83786927
rs1014894-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,TTC8,Morning person,chronotype measurement,GCST007083,14:88889377
rs13255030-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,NRG1,Morning person,chronotype measurement,GCST007083,8:31813814
rs7001604-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,TRPS1,Morning person,chronotype measurement,GCST007083,8:33823461
rs2590466-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,RPL10AP3,Morning person,chronotype measurement,GCST007083,8:34407252
rs769066-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ST18,Morning person,chronotype measurement,GCST007083,8:52233138
rs16939162-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,8:75740921
rs1470764-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,YWHAZ,Morning person,chronotype measurement,GCST007083,8:100937810
rs12682033-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,TRPS1,Morning person,chronotype measurement,GCST007083,8:115688903
rs34340407-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,9:8147423
rs10976942-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,PTPRD,Morning person,chronotype measurement,GCST007083,9:8310813
rs12377175-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,PTPRD,Morning person,chronotype measurement,GCST007083,9:8417501
rs308521-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,"ZCCHC7, LINC01627",Morning person,chronotype measurement,GCST007083,9:37367097
rs62550819-<b>?</b>,6 x 10-12,,NR,'-,'-,'-,'-,Morning person,chronotype measurement,GCST007083,9:74054330
rs295268-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,GKAP1,Morning person,chronotype measurement,GCST007083,9:83814390
rs10123584-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"HSDL2, C9orf147",Morning person,chronotype measurement,GCST007083,9:112440330
rs10818834-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,DENND1A,Morning person,chronotype measurement,GCST007083,9:123555045
rs3780204-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,NEK6,Morning person,chronotype measurement,GCST007083,9:124330608
rs13289026-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,IER5L,Morning person,chronotype measurement,GCST007083,9:129202541
rs34619169-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,INPP5E,Morning person,chronotype measurement,GCST007083,9:136432825
rs28458909-<b>?</b>,3 x 10-23,,NR,'-,'-,'-,EXD3,Morning person,chronotype measurement,GCST007083,9:137362737
rs2893787-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,BICC1,Morning person,chronotype measurement,GCST007083,10:58808937
rs4752593-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,ATE1,Morning person,chronotype measurement,GCST007083,10:121776975
rs6599694-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,LINC02641,Morning person,chronotype measurement,GCST007083,10:123365368
rs9664044-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,CTBP2,Morning person,chronotype measurement,GCST007083,10:125022222
rs72632979-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,SOX6,Morning person,chronotype measurement,GCST007083,11:16594336
rs10501087-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,BDNF-AS,Morning person,chronotype measurement,GCST007083,11:27648561
rs1144566-<b>C</b>,3 x 10-8,,0.03,'-,0.066 unit decrease,[0.042-0.09],RGS16,Ease of getting up in the morning,chronotype measurement,GCST004697,1:182600491
rs569778919-<b>C</b>,4 x 10-8,,0.28,'-,0.027 unit increase,[0.018-0.036],"KCNF1, LINC01954",Ease of getting up in the morning,chronotype measurement,GCST004697,2:10886120
rs9382484-<b>G</b>,1 x 10-8,,0.24,'-,0.028 unit decrease,[0.019-0.037],"GFRAL, HCRTR2",Ease of getting up in the morning,chronotype measurement,GCST004697,6:55318062
rs28458909-<b>T</b>,6 x 10-9,,0.12,'-,0.036 unit decrease,[0.024-0.048],EXD3,Ease of getting up in the morning,chronotype measurement,GCST004697,9:137362737
rs72827839-<b>A</b>,9 x 10-10,,0.22,'-,0.03 unit increase,[0.02-0.04],SKAP1,Ease of getting up in the morning,chronotype measurement,GCST004697,17:48343634
rs61773374-<b>G</b>,3 x 10-14,,0.195,'-,0.0164 unit increase,[0.012-0.021],PER3,Ease of getting up in the morning,chronotype measurement,GCST007986,1:7798048
rs148173313-<b>A</b>,9 x 10-11,,0.005527,'-,0.0164 unit increase,[0.012-0.021],PER3,Ease of getting up in the morning,chronotype measurement,GCST007986,1:7833451
rs301806-<b>C</b>,5 x 10-8,,0.4208,'-,0.0095 unit decrease,[0.0062-0.0128],RERE,Ease of getting up in the morning,chronotype measurement,GCST007986,1:8422018
rs77576965-<b>T</b>,2 x 10-8,,0.2727,'-,0.0109 unit increase,[0.0072-0.0146],DNAJC16,Ease of getting up in the morning,chronotype measurement,GCST007986,1:15590239
rs12752290-<b>C</b>,1 x 10-12,,0.4421,'-,0.0124 unit increase,[0.0091-0.0157],"EIF4G3, ECE1",Ease of getting up in the morning,chronotype measurement,GCST007986,1:21208837
rs113240734-<b>A</b>,2 x 10-16,,0.1601,'-,0.0192 unit increase,[0.015-0.024],"AK5, PIGK",Ease of getting up in the morning,chronotype measurement,GCST007986,1:77233386
rs148137538-<b>G</b>,1 x 10-11,,0.02314,'-,0.0389 unit increase,[0.03-0.048],PRDX6-AS1,Ease of getting up in the morning,chronotype measurement,GCST007986,1:173430538
rs6691053-<b>T</b>,3 x 10-8,,0.2144,'-,0.0389 unit increase,[0.03-0.048],ZBTB37,Ease of getting up in the morning,chronotype measurement,GCST007986,1:173899817
rs75650221-<b>T</b>,4 x 10-18,,0.03814,'-,0.0389 unit increase,[0.03-0.048],RABGAP1L,Ease of getting up in the morning,chronotype measurement,GCST007986,1:174452856
rs695459-<b>T</b>,7 x 10-9,,0.3886,'-,0.013 unit decrease,[0.0091-0.0169],TTC28,Morningness,chronotype measurement,GCST007983,22:28452290
rs28580373-<b>A</b>,3 x 10-8,,0.2317,'-,0.014 unit increase,[0.0081-0.0199],"RASD2, MCM5",Morningness,chronotype measurement,GCST007983,22:35451295
rs11705370-<b>A</b>,3 x 10-15,,0.5981,'-,0.019 unit decrease,[0.015-0.023],TNRC6B,Morningness,chronotype measurement,GCST007983,22:40159989
rs9611302-<b>A</b>,8 x 10-9,,0.1142,'-,0.019 unit decrease,[0.013-0.025],TNRC6B,Morningness,chronotype measurement,GCST007983,22:40254280
rs55715427-<b>C</b>,1 x 10-9,,0.09697,'-,0.022 unit decrease,[0.014-0.03],NAGA,Morningness,chronotype measurement,GCST007983,22:42062823
rs4822107-<b>A</b>,2 x 10-8,,0.5065,'-,0.012 unit increase,[0.0081-0.0159],TCF20,Morningness,chronotype measurement,GCST007983,22:42308828
rs2294203-<b>A</b>,3 x 10-8,,0.6796,'-,0.013 unit increase,[0.0091-0.0169],"FAM118A, SMC1B",Morningness,chronotype measurement,GCST007983,22:45342606
rs196973-<b>A</b>,6 x 10-9,,0.5395,'-,0.015 unit decrease,[0.011-0.019],IL1RAPL1,Morningness,chronotype measurement,GCST007983,X:28702019
rs12844850-<b>A</b>,4 x 10-20,,0.3614,'-,0.013 unit decrease,[0.0091-0.0169],"FAM155B, EDA",Morningness,chronotype measurement,GCST007983,X:69534894
rs213443-<b>C</b>,6 x 10-10,,0.4522,'-,0.013 unit increase,[0.0091-0.0169],POU3F4,Morningness,chronotype measurement,GCST007983,X:83456934
rs4375148-<b>T</b>,2 x 10-12,,0.769,'-,0.015 unit increase,[0.0091-0.0209],CYLC1,Morningness,chronotype measurement,GCST007983,X:83901556
rs6621219-<b>T</b>,1 x 10-10,,0.1754,'-,0.026 unit increase,[0.02-0.032],NXF5,Morningness,chronotype measurement,GCST007983,X:101835980
rs5987510-<b>A</b>,2 x 10-9,,0.3743,'-,0.014 unit increase,[0.01-0.018],"RPSAP59, NXF3",Morningness,chronotype measurement,GCST007983,X:103176064
rs10758971-<b>T</b>,5 x 10-8,,0.652,'-,0.012 unit increase,[0.0081-0.0159],PTPRD,Morningness,chronotype measurement,GCST007983,9:8418837
rs1323591-<b>T</b>,2 x 10-12,,0.3243,'-,0.016 unit decrease,[0.012-0.02],PTPRD,Morningness,chronotype measurement,GCST007983,9:8456020
rs1936637-<b>T</b>,9 x 10-9,,0.6601,'-,0.013 unit increase,[0.0091-0.0169],PAX5,Morningness,chronotype measurement,GCST007983,9:36901164
rs10973160-<b>T</b>,2 x 10-8,,0.3195,'-,0.013 unit decrease,[0.0091-0.0169],PAX5,Morningness,chronotype measurement,GCST007983,9:36994972
rs2291589-<b>T</b>,2 x 10-16,,0.6226,'-,0.018 unit increase,[0.014-0.022],EBLN3P,Morningness,chronotype measurement,GCST007983,9:37079664
rs66507804-<b>T</b>,1 x 10-10,,0.7946,'-,0.017 unit decrease,[0.011-0.023],"CCNH, RASA1",Morningness,chronotype measurement,GCST007983,5:87334467
rs78146603-<b>T</b>,3 x 10-9,,0.96175,'-,0.033 unit increase,[0.021-0.045],ZCCHC7,Morningness,chronotype measurement,GCST007983,9:37233861
rs77598468-<b>A</b>,1 x 10-12,,0.03428,'-,0.042 unit decrease,[0.03-0.054],'-,Morningness,chronotype measurement,GCST007983,9:73869352
rs72742394-<b>T</b>,7 x 10-9,,0.9017,'-,0.021 unit increase,[0.013-0.029],INIP,Morningness,chronotype measurement,GCST007983,9:74114787
rs4565536-<b>A</b>,5 x 10-8,,0.4993,'-,0.012 unit decrease,[0.0081-0.0159],'-,Morningness,chronotype measurement,GCST007983,9:82574173
rs10797119-<b>T</b>,3 x 10-9,,0.4633,'-,0.013 unit decrease,[0.0091-0.0169],"SEMA4D, GADD45G",Morningness,chronotype measurement,GCST007983,9:89587580
rs10818834-<b>T</b>,5 x 10-9,,0.7344,'-,0.014 unit increase,[0.01-0.018],DENND1A,Morningness,chronotype measurement,GCST007983,9:123555045
rs28365587-<b>A</b>,4 x 10-9,,0.5141,'-,0.013 unit decrease,[0.0091-0.0169],IER5L,Morningness,chronotype measurement,GCST007983,9:129197336
rs10448340-<b>T</b>,9 x 10-9,,0.6806,'-,0.013 unit decrease,[0.0091-0.0169],"INPP5E, PMPCA",Morningness,chronotype measurement,GCST007983,9:136425617
rs28458909-<b>T</b>,2 x 10-16,,0.1224,'-,0.03 unit decrease,[0.022-0.038],EXD3,Morningness,chronotype measurement,GCST007983,9:137362737
rs1750785-<b>A</b>,4 x 10-9,,0.2638,'-,0.014 unit increase,[0.01-0.018],"LARP4B, DIP2C",Morningness,chronotype measurement,GCST007983,10:730210
rs9416744-<b>A</b>,1 x 10-12,,0.2561,'-,0.017 unit increase,[0.013-0.021],BICC1,Morningness,chronotype measurement,GCST007983,10:58808177
rs7910164-<b>A</b>,5 x 10-8,,0.6423,'-,0.012 unit increase,[0.0081-0.0159],'-,Morningness,chronotype measurement,GCST007983,Mapping not available
rs76518095-<b>T</b>,1 x 10-8,,0.07513,'-,0.023 unit increase,[0.015-0.031],'-,Morningness,chronotype measurement,GCST007983,10:129351712
rs9795439-<b>A</b>,7 x 10-9,,0.1963,'-,0.018 unit increase,[0.012-0.024],BRSK2,Morningness,chronotype measurement,GCST007983,11:1462313
rs925947-<b>T</b>,1 x 10-9,,0.2016,'-,0.016 unit increase,[0.01-0.022],BDNF-AS,Morningness,chronotype measurement,GCST007983,11:27645820
rs605765-<b>T</b>,3 x 10-8,,0.6107,'-,0.012 unit decrease,[0.0081-0.0159],FSHB,Morningness,chronotype measurement,GCST007983,11:30195956
rs12799529-<b>T</b>,5 x 10-13,,0.7583,'-,0.018 unit increase,[0.012-0.024],MPPED2,Morningness,chronotype measurement,GCST007983,11:30387005
rs11032362-<b>A</b>,3 x 10-17,,0.09112,'-,0.031 unit increase,[0.023-0.039],"CD59, FBXO3",Morningness,chronotype measurement,GCST007983,11:33737546
rs34239319-<b>T</b>,6 x 10-12,,0.1018,'-,0.024 unit increase,[0.016-0.032],ALKBH3,Morningness,chronotype measurement,GCST007983,11:43881131
rs10495976-<b>A</b>,1 x 10-13,,0.6114,'-,0.017 unit decrease,[0.013-0.021],'-,Morningness,chronotype measurement,GCST007983,2:49523560
rs10173945-<b>T</b>,3 x 10-9,,0.6185,'-,0.013 unit increase,[0.0091-0.0169],'-,Morningness,chronotype measurement,GCST007983,2:49581894
rs72831198-<b>T</b>,5 x 10-8,,0.8235,'-,0.016 unit decrease,[0.01-0.022],RPL7P13,Morningness,chronotype measurement,GCST007983,2:49838742
rs1520524-<b>T</b>,3 x 10-12,,0.1006,'-,0.025 unit increase,[0.017-0.033],NRXN1,Morningness,chronotype measurement,GCST007983,2:50298490
rs10193431-<b>T</b>,4 x 10-9,,0.5255,'-,0.013 unit increase,[0.0091-0.0169],ASB3,Morningness,chronotype measurement,GCST007983,2:53498629
rs17049270-<b>T</b>,2 x 10-8,,0.09593,'-,0.02 unit decrease,[0.012-0.028],VRK2,Morningness,chronotype measurement,GCST007983,2:57965770
rs10175975-<b>T</b>,2 x 10-10,,0.179,'-,0.018 unit increase,[0.012-0.024],LINC01793,Morningness,chronotype measurement,GCST007983,2:59202672
rs359237-<b>T</b>,9 x 10-12,,0.4678,'-,0.015 unit decrease,[0.011-0.019],MIR4432HG,Morningness,chronotype measurement,GCST007983,2:60245959
rs4672440-<b>T</b>,5 x 10-13,,0.3465,'-,0.016 unit increase,[0.012-0.02],USP34,Morningness,chronotype measurement,GCST007983,2:61389518
rs113851554-<b>T</b>,1 x 10-8,,0.05058,'-,0.028 unit decrease,[0.018-0.038],MEIS1,Morningness,chronotype measurement,GCST007983,2:66523432
rs28362672-<b>A</b>,3 x 10-8,,0.7406,'-,0.014 unit decrease,[0.01-0.018],GMCL1,Morningness,chronotype measurement,GCST007983,2:69829734
rs1800828-<b>C</b>,5 x 10-9,,0.7473,'-,0.014 unit increase,[0.01-0.018],DRD3,Morningness,chronotype measurement,GCST007983,3:114172702
rs2706762-<b>T</b>,3 x 10-10,,0.15,'-,0.019 unit decrease,[0.013-0.025],PCYOX1,Morningness,chronotype measurement,GCST007983,2:70261338
rs7586062-<b>C</b>,3 x 10-24,,0.4717,'-,0.022 unit decrease,[0.018-0.026],LRRTM4,Morningness,chronotype measurement,GCST007983,2:77078034
rs10190053-<b>A</b>,7 x 10-9,,0.3695,'-,0.013 unit decrease,[0.0091-0.0169],"RPL38P2, LRRTM4",Morningness,chronotype measurement,GCST007983,2:77689636
rs6799356-<b>A</b>,4 x 10-8,,0.7538,'-,0.014 unit increase,[0.0081-0.0199],ADCY5,Morningness,chronotype measurement,GCST007983,3:123429515
rs75863239-<b>T</b>,3 x 10-8,,0.90976,'-,0.023 unit decrease,[0.015-0.031],"SNORA72, RPL23AP27",Morningness,chronotype measurement,GCST007983,2:104696517
rs62172117-<b>A</b>,1 x 10-17,,0.3572,'-,0.019 unit decrease,[0.015-0.023],ARHGAP15,Morningness,chronotype measurement,GCST007983,2:143411098
rs2699869-<b>A</b>,5 x 10-9,,0.454,'-,0.013 unit increase,[0.0091-0.0169],TMEM108,Morningness,chronotype measurement,GCST007983,3:133314048
rs2731553-<b>A</b>,1 x 10-10,,0.7544,'-,0.016 unit decrease,[0.012-0.02],ARHGAP15,Morningness,chronotype measurement,GCST007983,2:143616372
rs7579662-<b>A</b>,2 x 10-8,,0.3919,'-,0.012 unit decrease,[0.0081-0.0159],TANK-AS1,Morningness,chronotype measurement,GCST007983,2:161059299
rs13004345-<b>T</b>,4 x 10-8,,0.6523,'-,0.012 unit decrease,[0.0081-0.0159],"MAP3K20-AS1, MAP3K20",Morningness,chronotype measurement,GCST007983,2:173172619
rs1109088-<b>A</b>,3 x 10-9,,0.5738,'-,0.013 unit increase,[0.0091-0.0169],ESYT3,Morningness,chronotype measurement,GCST007983,3:138435953
rs11677484-<b>T</b>,6 x 10-10,,0.2531,'-,0.015 unit increase,[0.011-0.019],NAB1,Morningness,chronotype measurement,GCST007983,2:190713446
rs4850712-<b>T</b>,9 x 10-9,,0.3221,'-,0.013 unit increase,[0.0091-0.0169],HECW2,Morningness,chronotype measurement,GCST007983,2:196436701
rs4319473-<b>A</b>,9 x 10-9,,0.1573,'-,0.017 unit increase,[0.011-0.023],ARHGAP1,Morningness,chronotype measurement,GCST007983,11:46681141
rs6485751-<b>C</b>,1 x 10-9,,0.2097,'-,0.016 unit decrease,[0.01-0.022],MADD,Morningness,chronotype measurement,GCST007983,11:47314891
rs11039308-<b>A</b>,5 x 10-11,,0.4083,'-,0.014 unit increase,[0.01-0.018],"C1QTNF4, MTCH2",Morningness,chronotype measurement,GCST007983,11:47600860
rs11605681-<b>A</b>,1 x 10-8,,0.05632,'-,0.027 unit increase,[0.017-0.037],FNBP4,Morningness,chronotype measurement,GCST007983,11:47726467
rs3168135-<b>A</b>,4 x 10-12,,0.2408,'-,0.017 unit decrease,[0.011-0.023],"ZFP91-CNTF, ZFP91",Morningness,chronotype measurement,GCST007983,11:58618704
rs4008953-<b>A</b>,3 x 10-11,,0.7123,'-,0.016 unit decrease,[0.012-0.02],PC,Morningness,chronotype measurement,GCST007983,11:66893478
rs4237555-<b>T</b>,4 x 10-8,,0.5272,'-,0.012 unit increase,[0.0081-0.0159],"RPL26P31, MTNR1B",Morningness,chronotype measurement,GCST007983,11:92992637
rs4936290-<b>A</b>,1 x 10-8,,0.6508,'-,0.013 unit decrease,[0.0091-0.0169],ZBTB16,Morningness,chronotype measurement,GCST007983,11:114138533
rs577924-<b>T</b>,2 x 10-8,,0.5342,'-,0.012 unit increase,[0.0081-0.0159],MIR100HG,Morningness,chronotype measurement,GCST007983,11:122264399
rs1174510-<b>A</b>,5 x 10-8,,0.6244,'-,0.012 unit increase,[0.0081-0.0159],SKP1P2,Morningness,chronotype measurement,GCST007983,12:16940383
rs11611435-<b>T</b>,4 x 10-8,,0.5528,'-,0.012 unit increase,[0.0081-0.0159],SOX5,Morningness,chronotype measurement,GCST007983,12:23936388
rs13377754-<b>T</b>,8 x 10-27,,0.6123,'-,0.024 unit increase,[0.02-0.028],RNU6-472P,Morningness,chronotype measurement,GCST007983,12:33898830
rs11610973-<b>T</b>,3 x 10-11,,0.8737,'-,0.024 unit decrease,[0.016-0.032],'-,Morningness,chronotype measurement,GCST007983,12:34674017
rs7313852-<b>A</b>,1 x 10-29,,0.435,'-,0.025 unit decrease,[0.021-0.029],KITLG,Morningness,chronotype measurement,GCST007983,12:38514587
rs117554039-<b>A</b>,5 x 10-8,,0.9121,'-,0.021 unit increase,[0.013-0.029],LINC02406,Morningness,chronotype measurement,GCST007983,12:39050701
rs12828063-<b>T</b>,5 x 10-9,,0.691,'-,0.014 unit decrease,[0.01-0.018],"KIF21A, LINC02406",Morningness,chronotype measurement,GCST007983,12:39194520
rs11183201-<b>T</b>,2 x 10-14,,0.4925,'-,0.017 unit decrease,[0.013-0.021],ARID2,Morningness,chronotype measurement,GCST007983,12:45777199
rs671255-<b>A</b>,1 x 10-8,,0.7505,'-,0.014 unit decrease,[0.01-0.018],SCN8A,Morningness,chronotype measurement,GCST007983,12:51795782
rs7299922-<b>A</b>,9 x 10-9,,0.6334,'-,0.013 unit increase,[0.0091-0.0169],COPZ1,Morningness,chronotype measurement,GCST007983,12:54308735
rs225289-<b>T</b>,1 x 10-8,,0.1693,'-,0.016 unit increase,[0.01-0.022],AP2B1,Morningness,chronotype measurement,GCST007983,17:35601926
rs72828815-<b>T</b>,6 x 10-9,,0.1849,'-,0.016 unit increase,[0.01-0.022],"KIF18B, GFAP",Morningness,chronotype measurement,GCST007983,17:44917426
rs117974417-<b>C</b>,2 x 10-9,,0.8477,'-,0.018 unit decrease,[0.012-0.024],CBX1,Morningness,chronotype measurement,GCST007983,17:48079148
rs6504758-<b>A</b>,1 x 10-10,,0.4645,'-,0.014 unit decrease,[0.01-0.018],CA10,Morningness,chronotype measurement,GCST007983,17:52131006
rs9898091-<b>T</b>,7 x 10-12,,0.9604,'-,0.038 unit increase,[0.026-0.05],ANKFN1,Morningness,chronotype measurement,GCST007983,17:56096238
rs8072058-<b>A</b>,1 x 10-8,,0.7822,'-,0.015 unit decrease,[0.0091-0.0209],MSI2,Morningness,chronotype measurement,GCST007983,17:57656837
rs17682747-<b>A</b>,5 x 10-8,,0.2312,'-,0.014 unit increase,[0.0081-0.0199],TANC2,Morningness,chronotype measurement,GCST007983,17:63103751
rs2916142-<b>T</b>,8 x 10-12,,0.4565,'-,0.015 unit increase,[0.011-0.019],PITPNC1,Morningness,chronotype measurement,GCST007983,17:67485948
rs10491171-<b>C</b>,4 x 10-9,,0.865,'-,0.019 unit increase,[0.013-0.025],'-,Morningness,chronotype measurement,GCST007983,17:70418854
rs487952-<b>A</b>,4 x 10-9,,0.5656,'-,0.013 unit increase,[0.0091-0.0169],MGAT5B,Morningness,chronotype measurement,GCST007983,17:76902218
rs974552-<b>A</b>,1 x 10-15,,0.8085,'-,0.022 unit decrease,[0.016-0.028],AKAIN1,Morningness,chronotype measurement,GCST007983,18:5186165
rs1013987-<b>T</b>,1 x 10-11,,0.4042,'-,0.015 unit decrease,[0.011-0.019],"ZNF521, WBP2P1",Morningness,chronotype measurement,GCST007983,18:25050872
rs4239386-<b>A</b>,2 x 10-17,,0.3342,'-,0.019 unit decrease,[0.015-0.023],NOL4,Morningness,chronotype measurement,GCST007983,18:34084746
rs12969848-<b>T</b>,2 x 10-15,,0.5294,'-,0.017 unit increase,[0.013-0.021],'-,Morningness,chronotype measurement,GCST007983,18:40572871
rs989885-<b>A</b>,4 x 10-8,,0.93675,'-,0.024 unit decrease,[0.016-0.032],'-,Morningness,chronotype measurement,GCST007983,18:40884891
rs9956387-<b>A</b>,1 x 10-10,,0.4963,'-,0.014 unit decrease,[0.01-0.018],SKOR2,Morningness,chronotype measurement,GCST007983,18:47247011
rs17596722-<b>T</b>,3 x 10-11,,0.2006,'-,0.018 unit decrease,[0.012-0.024],TCF4,Morningness,chronotype measurement,GCST007983,18:55486936
rs66791238-<b>T</b>,3 x 10-8,,0.7917,'-,0.015 unit decrease,[0.0091-0.0209],TCF4,Morningness,chronotype measurement,GCST007983,18:55563419
rs12959908-<b>T</b>,1 x 10-8,,0.5776,'-,0.012 unit decrease,[0.0081-0.0159],LINC01416,Morningness,chronotype measurement,GCST007983,18:55908718
rs8094095-<b>A</b>,6 x 10-9,,0.1496,'-,0.018 unit increase,[0.012-0.024],SEC11C,Morningness,chronotype measurement,GCST007983,18:59156767
rs9964420-<b>A</b>,4 x 10-21,,0.301,'-,0.022 unit decrease,[0.018-0.026],SEC11C,Morningness,chronotype measurement,GCST007983,18:59156809
rs11152350-<b>A</b>,1 x 10-12,,0.4704,'-,0.015 unit decrease,[0.011-0.019],ZCCHC2,Morningness,chronotype measurement,GCST007983,18:62573119
rs9958145-<b>A</b>,4 x 10-8,,0.2009,'-,0.015 unit decrease,[0.0091-0.0209],CDH19,Morningness,chronotype measurement,GCST007983,18:66696563
rs10402849-<b>T</b>,7 x 10-9,,0.2008,'-,0.016 unit increase,[0.01-0.022],GNG7,Morningness,chronotype measurement,GCST007983,19:2695663
rs3843751-<b>T</b>,6 x 10-9,,0.6642,'-,0.013 unit increase,[0.0091-0.0169],SLC44A2,Morningness,chronotype measurement,GCST007983,19:10637445
rs9636202-<b>A</b>,4 x 10-8,,0.2653,'-,0.013 unit decrease,[0.0091-0.0169],"RN7SL513P, PGPEP1",Morningness,chronotype measurement,GCST007983,19:18338428
rs12481462-<b>T</b>,4 x 10-8,,0.3727,'-,0.012 unit increase,[0.0081-0.0159],MACROD2,Morningness,chronotype measurement,GCST007983,20:14748326
rs78095690-<b>T</b>,6 x 10-9,,0.5635,'-,0.013 unit decrease,[0.0091-0.0169],"KIF16B, PPIAP17",Morningness,chronotype measurement,GCST007983,20:16259038
rs6131942-<b>A</b>,8 x 10-12,,0.4196,'-,0.015 unit decrease,[0.011-0.019],PCSK2,Morningness,chronotype measurement,GCST007983,20:17367963
rs1737893-<b>T</b>,1 x 10-9,,0.3779,'-,0.014 unit decrease,[0.01-0.018],NOL4L,Morningness,chronotype measurement,GCST007983,20:32463896
rs2072727-<b>T</b>,3 x 10-8,,0.4359,'-,0.012 unit increase,[0.0081-0.0159],PABPC1L,Morningness,chronotype measurement,GCST007983,20:44910092
rs17416934-<b>T</b>,6 x 10-9,,0.616,'-,0.013 unit increase,[0.0091-0.0169],LINC02792,Morningness,chronotype measurement,GCST007983,1:79409126
rs74802342-<b>A</b>,2 x 10-8,,0.1125,'-,0.019 unit decrease,[0.013-0.025],"SNORD3G, LINC02787",Morningness,chronotype measurement,GCST007983,1:90612489
rs72720396-<b>A</b>,3 x 10-18,,0.7706,'-,0.022 unit decrease,[0.016-0.028],"BARHL2, LINC02609",Morningness,chronotype measurement,GCST007983,1:90726025
rs7522677-<b>T</b>,8 x 10-9,,0.2099,'-,0.015 unit increase,[0.0091-0.0209],LINC02790,Morningness,chronotype measurement,GCST007983,1:96004705
rs9437742-<b>C</b>,4 x 10-8,,0.526,'-,0.012 unit decrease,[0.0081-0.0159],"EEF1A1P11, RN7SL831P",Morningness,chronotype measurement,GCST007983,1:96495427
rs12139650-<b>T</b>,2 x 10-8,,0.8131,'-,0.015 unit increase,[0.0091-0.0209],"DPYD-AS1, DPYD",Morningness,chronotype measurement,GCST007983,1:97132544
rs10494041-<b>C</b>,1 x 10-12,,0.8269,'-,0.02 unit increase,[0.014-0.026],ATXN7L2,Morningness,chronotype measurement,GCST007983,1:109489368
rs35461065-<b>T</b>,8 x 10-9,,0.5397,'-,0.012 unit decrease,[0.0081-0.0159],"TRIM33, PKMP1",Morningness,chronotype measurement,GCST007983,1:114518205
rs956796-<b>A</b>,2 x 10-8,,0.1092,'-,0.019 unit decrease,[0.013-0.025],"ANP32E, RN7SL480P",Morningness,chronotype measurement,GCST007983,1:150213795
rs12401456-<b>A</b>,8 x 10-10,,0.1667,'-,0.018 unit decrease,[0.012-0.024],ANP32E,Morningness,chronotype measurement,GCST007983,1:150232067
rs2794682-<b>T</b>,4 x 10-22,,0.396,'-,0.021 unit increase,[0.017-0.025],PRPF3,Morningness,chronotype measurement,GCST007983,1:150348371
rs2055975-<b>A</b>,4 x 10-12,,0.2895,'-,0.016 unit increase,[0.012-0.02],"ENSA, GOLPH3L",Morningness,chronotype measurement,GCST007983,1:150646156
rs148137538-<b>A</b>,6 x 10-9,,0.97686,'-,0.041 unit decrease,[0.027-0.055],PRDX6-AS1,Morningness,chronotype measurement,GCST007983,1:173430538
rs75650221-<b>T</b>,9 x 10-10,,0.03814,'-,0.034 unit increase,[0.022-0.046],RABGAP1L,Morningness,chronotype measurement,GCST007983,1:174452856
rs13306728-<b>A</b>,6 x 10-14,,0.92388,'-,0.03 unit increase,[0.022-0.038],SOAT1,Morningness,chronotype measurement,GCST007983,1:179343424
rs7534480-<b>T</b>,3 x 10-15,,0.385,'-,0.017 unit increase,[0.013-0.021],"RGS16, RNASEL",Morningness,chronotype measurement,GCST007983,1:182590218
rs509476-<b>T</b>,7 x 10-56,,0.02995,'-,0.099 unit increase,[0.087-0.111],RGS16,Morningness,chronotype measurement,GCST007983,1:182604092
rs12746073-<b>T</b>,2 x 10-8,,0.5259,'-,0.012 unit increase,[0.0081-0.0159],RGL1,Morningness,chronotype measurement,GCST007983,1:183710777
rs12025393-<b>A</b>,2 x 10-8,,0.2653,'-,0.014 unit decrease,[0.01-0.018],LINC01031,Morningness,chronotype measurement,GCST007983,1:193371988
rs16839841-<b>T</b>,3 x 10-8,,0.9188,'-,0.022 unit increase,[0.014-0.03],KCNT2,Morningness,chronotype measurement,GCST007983,1:196384254
rs13011556-<b>C</b>,8 x 10-11,,0.7622,'-,0.016 unit decrease,[0.01-0.022],"LINC01249, NPM1P48",Morningness,chronotype measurement,GCST007983,2:4604333
rs2712056-<b>T</b>,2 x 10-10,,0.1845,'-,0.018 unit increase,[0.012-0.024],"ATAD2B, KLHL29",Morningness,chronotype measurement,GCST007983,2:23736261
rs848552-<b>C</b>,1 x 10-9,,0.4724,'-,0.013 unit decrease,[0.0091-0.0169],CRIM1,Morningness,chronotype measurement,GCST007983,2:36473437
rs62135536-<b>T</b>,1 x 10-8,,0.03132,'-,0.035 unit increase,[0.023-0.047],RNU6-566P,Morningness,chronotype measurement,GCST007983,2:44098889
rs2592199-<b>C</b>,1 x 10-14,,0.7693,'-,0.022 unit increase,[0.016-0.028],CAMKMT,Morningness,chronotype measurement,GCST007983,2:44483030
rs6769642-<b>A</b>,3 x 10-13,,0.4815,'-,0.016 unit increase,[0.012-0.02],PPM1L,Morningness,chronotype measurement,GCST007983,3:161045681
rs6716898-<b>A</b>,2 x 10-22,,0.4838,'-,0.021 unit increase,[0.017-0.025],PLCL1,Morningness,chronotype measurement,GCST007983,2:198079547
rs184033703-<b>A</b>,1 x 10-9,,0.05762,'-,0.032 unit increase,[0.022-0.042],"NDUFS1, INO80D",Morningness,chronotype measurement,GCST007983,2:206091414
rs35333999-<b>T</b>,5 x 10-19,,0.04295,'-,0.047 unit decrease,[0.037-0.057],PER2,Morningness,chronotype measurement,GCST007983,2:238253316
rs3850174-<b>A</b>,9 x 10-9,,0.2541,'-,0.014 unit decrease,[0.01-0.018],NCEH1,Morningness,chronotype measurement,GCST007983,3:172646303
rs77942338-<b>T</b>,1 x 10-16,,0.97369,'-,0.056 unit decrease,[0.042-0.07],PER2,Morningness,chronotype measurement,GCST007983,2:238286052
rs12477345-<b>T</b>,2 x 10-9,,0.6316,'-,0.013 unit decrease,[0.0091-0.0169],TRAF3IP1,Morningness,chronotype measurement,GCST007983,2:238334326
rs11900963-<b>A</b>,3 x 10-32,,0.91376,'-,0.045 unit increase,[0.037-0.053],TRAF3IP1,Morningness,chronotype measurement,GCST007983,2:238399408
rs6443788-<b>A</b>,1 x 10-9,,0.2886,'-,0.015 unit decrease,[0.011-0.019],'-,Morningness,chronotype measurement,GCST007983,3:182248402
rs62182135-<b>A</b>,8 x 10-9,,0.3305,'-,0.013 unit decrease,[0.0091-0.0169],HDAC4,Morningness,chronotype measurement,GCST007983,2:239345610
rs17786957-<b>C</b>,6 x 10-10,,0.1633,'-,0.018 unit decrease,[0.012-0.024],CNTN4,Morningness,chronotype measurement,GCST007983,3:2508409
rs6443810-<b>C</b>,2 x 10-10,,0.6856,'-,0.015 unit increase,[0.011-0.019],"LINC01995, RPL7L1P8",Morningness,chronotype measurement,GCST007983,3:182544884
rs7428484-<b>A</b>,2 x 10-8,,0.6734,'-,0.013 unit increase,[0.0091-0.0169],UBE2E2,Morningness,chronotype measurement,GCST007983,3:23288610
rs6778003-<b>T</b>,5 x 10-12,,0.2941,'-,0.016 unit increase,[0.012-0.02],DGKG,Morningness,chronotype measurement,GCST007983,3:186274181
rs7617588-<b>T</b>,3 x 10-11,,0.8605,'-,0.021 unit decrease,[0.015-0.027],DGKG,Morningness,chronotype measurement,GCST007983,3:186362201
rs9683585-<b>C</b>,2 x 10-8,,0.5608,'-,0.012 unit decrease,[0.0081-0.0159],FAM193A,Morningness,chronotype measurement,GCST007983,4:2701077
rs56040212-<b>A</b>,2 x 10-8,,0.2421,'-,0.014 unit decrease,[0.0081-0.0199],"LDB2, ZEB2P1",Morningness,chronotype measurement,GCST007983,4:16433461
rs28634184-<b>T</b>,2 x 10-8,,0.251,'-,0.014 unit decrease,[0.01-0.018],ADGRL3,Morningness,chronotype measurement,GCST007983,4:62007701
rs57180764-<b>A</b>,3 x 10-11,,0.7676,'-,0.017 unit increase,[0.011-0.023],VAMP9P,Morningness,chronotype measurement,GCST007983,4:82318620
rs4241964-<b>T</b>,4 x 10-12,,0.5248,'-,0.015 unit decrease,[0.011-0.019],'-,Morningness,chronotype measurement,GCST007983,4:136132804
rs7449161-<b>T</b>,2 x 10-9,,0.5226,'-,0.013 unit increase,[0.0091-0.0169],LINC02196,Morningness,chronotype measurement,GCST007983,5:7213927
rs3797051-<b>T</b>,1 x 10-9,,0.7613,'-,0.015 unit increase,[0.0091-0.0209],RGS7BP,Morningness,chronotype measurement,GCST007983,5:64564314
rs56411893-<b>A</b>,2 x 10-12,,0.8413,'-,0.021 unit decrease,[0.015-0.027],IP6K2,Morningness,chronotype measurement,GCST007983,3:48732422
rs62263597-<b>A</b>,5 x 10-13,,0.08451,'-,0.028 unit increase,[0.02-0.036],"RBM6, RBM5",Morningness,chronotype measurement,GCST007983,3:50094258
rs11714286-<b>A</b>,9 x 10-11,,0.5372,'-,0.014 unit increase,[0.01-0.018],SEMA3F-AS1,Morningness,chronotype measurement,GCST007983,3:50148075
rs150812083-<b>C</b>,4 x 10-22,,0.995398,'-,0.153 unit decrease,[0.12-0.18],PER3,Morningness,chronotype measurement,GCST007983,1:7809893
rs61773390-<b>T</b>,3 x 10-27,,0.1955,'-,0.029 unit increase,[0.023-0.035],PER3,Morningness,chronotype measurement,GCST007983,1:7824465
rs228654-<b>A</b>,3 x 10-16,,0.09752,'-,0.03 unit decrease,[0.022-0.038],PER3,Morningness,chronotype measurement,GCST007983,1:7837168
rs12065331-<b>T</b>,2 x 10-10,,0.3068,'-,0.015 unit decrease,[0.011-0.019],KAZN,Morningness,chronotype measurement,GCST007983,1:14181336
rs17448682-<b>T</b>,4 x 10-13,,0.2315,'-,0.018 unit increase,[0.012-0.024],DDI2,Morningness,chronotype measurement,GCST007983,1:15640218
rs7543480-<b>T</b>,7 x 10-13,,0.3447,'-,0.016 unit increase,[0.012-0.02],TMCO4,Morningness,chronotype measurement,GCST007983,1:19688334
rs10916866-<b>A</b>,2 x 10-14,,0.5887,'-,0.017 unit decrease,[0.013-0.021],EIF4G3,Morningness,chronotype measurement,GCST007983,1:20811275
rs12140153-<b>T</b>,5 x 10-12,,0.0877,'-,0.027 unit decrease,[0.019-0.035],PATJ,Morningness,chronotype measurement,GCST007983,1:62114219
rs11208844-<b>A</b>,3 x 10-8,,0.1379,'-,0.017 unit decrease,[0.011-0.023],PDE4B,Morningness,chronotype measurement,GCST007983,1:66385464
rs11162296-<b>C</b>,1 x 10-34,,0.16,'-,0.036 unit increase,[0.03-0.042],"AK5, PIGK",Morningness,chronotype measurement,GCST007983,1:77234511
rs10873936-<b>A</b>,9 x 10-9,,0.3098,'-,0.013 unit decrease,[0.0091-0.0169],AK5,Morningness,chronotype measurement,GCST007983,1:77396290
rs7652260-<b>C</b>,2 x 10-8,,0.8411,'-,0.017 unit increase,[0.011-0.023],"CACNA2D2, C3orf18",Morningness,chronotype measurement,GCST007983,3:50534154
rs67000219-<b>T</b>,3 x 10-8,,0.1137,'-,0.019 unit decrease,[0.013-0.025],FOXP1,Morningness,chronotype measurement,GCST007983,3:71508430
rs9876864-<b>A</b>,9 x 10-14,,0.4128,'-,0.016 unit increase,[0.012-0.02],ROBO2,Morningness,chronotype measurement,GCST007983,3:77159370
rs55753638-<b>T</b>,3 x 10-11,,0.8786,'-,0.022 unit decrease,[0.016-0.028],CADM2,Morningness,chronotype measurement,GCST007983,3:85595332
rs542867945-<b>A</b>,4 x 10-8,,0.9998192,'-,0.49 unit increase,[0.32-0.66],LINC02229,Morningness,chronotype measurement,GCST007983,5:66447878
rs9788226-<b>C</b>,1 x 10-11,,0.8781,'-,0.022 unit increase,[0.016-0.028],"AVPR1A, RSL24D1P5",Morningness,chronotype measurement,GCST007983,12:63123576
rs7138306-<b>A</b>,9 x 10-10,,0.4693,'-,0.013 unit increase,[0.0091-0.0169],"AVPR1A, HNRNPA1P69",Morningness,chronotype measurement,GCST007983,12:63240707
rs7488974-<b>A</b>,2 x 10-13,,0.3976,'-,0.016 unit increase,[0.012-0.02],LINC02399,Morningness,chronotype measurement,GCST007983,12:90048224
rs10861694-<b>T</b>,3 x 10-10,,0.5641,'-,0.014 unit increase,[0.01-0.018],CRY1,Morningness,chronotype measurement,GCST007983,12:107012144
rs77531286-<b>T</b>,1 x 10-8,,0.8517,'-,0.017 unit decrease,[0.011-0.023],RBM19,Morningness,chronotype measurement,GCST007983,12:113861743
rs4102203-<b>T</b>,8 x 10-12,,0.8936,'-,0.024 unit increase,[0.018-0.03],RNF10,Morningness,chronotype measurement,GCST007983,12:120538568
rs61963123-<b>T</b>,2 x 10-10,,0.7847,'-,0.017 unit increase,[0.011-0.023],VWA8,Morningness,chronotype measurement,GCST007983,13:41938503
rs9597250-<b>A</b>,3 x 10-12,,0.188,'-,0.019 unit decrease,[0.013-0.025],DCLK1,Morningness,chronotype measurement,GCST007983,13:55729575
rs2321993-<b>A</b>,3 x 10-11,,0.5691,'-,0.014 unit decrease,[0.01-0.018],POLR3KP1,Morningness,chronotype measurement,GCST007983,13:59107012
rs2593487-<b>A</b>,3 x 10-10,,0.3388,'-,0.014 unit decrease,[0.01-0.018],"LINC00383, SRSF1P1",Morningness,chronotype measurement,GCST007983,13:69328926
rs9565309-<b>T</b>,1 x 10-28,,0.96619,'-,0.066 unit increase,[0.054-0.078],"FBXL3, CLN5",Morningness,chronotype measurement,GCST007983,13:77002892
rs61963491-<b>A</b>,2 x 10-12,,0.994247,'-,0.112 unit increase,[0.081-0.143],MYCBP2,Morningness,chronotype measurement,GCST007983,13:77370501
rs7337911-<b>A</b>,1 x 10-9,,0.7471,'-,0.015 unit increase,[0.011-0.019],GPC6,Morningness,chronotype measurement,GCST007983,13:93459590
rs9521184-<b>T</b>,8 x 10-10,,0.4871,'-,0.013 unit increase,[0.0091-0.0169],MYO16,Morningness,chronotype measurement,GCST007983,13:109130220
rs11157143-<b>A</b>,8 x 10-10,,0.7264,'-,0.015 unit decrease,[0.011-0.019],'-,Morningness,chronotype measurement,GCST007983,14:40541351
rs56376592-<b>A</b>,1 x 10-9,,0.8217,'-,0.017 unit increase,[0.011-0.023],OTX2-AS1,Morningness,chronotype measurement,GCST007983,14:56912194
rs4899502-<b>A</b>,2 x 10-11,,0.6869,'-,0.016 unit decrease,[0.012-0.02],"VSX2, LIN52",Morningness,chronotype measurement,GCST007983,14:74203190
rs12432176-<b>A</b>,1 x 10-8,,0.3781,'-,0.013 unit increase,[0.0091-0.0169],BEGAIN,Morningness,chronotype measurement,GCST007983,14:100554881
rs2701524-<b>T</b>,5 x 10-9,,0.5871,'-,0.013 unit increase,[0.0091-0.0169],MEIS2,Morningness,chronotype measurement,GCST007983,15:37091487
rs59986227-<b>C</b>,5 x 10-9,,0.7456,'-,0.015 unit decrease,[0.011-0.019],SEMA6D,Morningness,chronotype measurement,GCST007983,15:47717066
rs4652514-<b>C</b>,1 x 10-8,,0.3018,'-,0.0107 unit decrease,[0.007-0.0144],OVAAL,Ease of getting up in the morning,chronotype measurement,GCST007986,1:180560406
rs12736689-<b>C</b>,2 x 10-24,,0.02967,'-,0.0518 unit increase,[0.042-0.062],RNASEL,Ease of getting up in the morning,chronotype measurement,GCST007986,1:182580594
rs76048411-<b>T</b>,9 x 10-10,,0.4833,'-,0.0106 unit increase,[0.0073-0.0139],"NPM1P48, LINC01249",Ease of getting up in the morning,chronotype measurement,GCST007986,2:4602489
rs2053457-<b>C</b>,1 x 10-15,,0.2465,'-,0.016 unit decrease,[0.012-0.02],PREPL,Ease of getting up in the morning,chronotype measurement,GCST007986,2:44345025
rs1402121-<b>C</b>,7 x 10-11,,0.1998,'-,0.014 unit increase,[0.0097-0.0183],NRXN1,Ease of getting up in the morning,chronotype measurement,GCST007986,2:50369469
rs10180284-<b>T</b>,5 x 10-8,,0.4834,'-,0.014 unit increase,[0.0097-0.0183],NRXN1,Ease of getting up in the morning,chronotype measurement,GCST007986,2:50488878
rs4671328-<b>T</b>,1 x 10-9,,0.4478,'-,0.0107 unit increase,[0.0072-0.0142],LINC01122,Ease of getting up in the morning,chronotype measurement,GCST007986,2:58708147
rs10175975-<b>T</b>,3 x 10-9,,0.179,'-,0.0134 unit increase,[0.0089-0.0179],LINC01793,Ease of getting up in the morning,chronotype measurement,GCST007986,2:59202672
rs13393656-<b>A</b>,2 x 10-8,,0.2426,'-,0.0113 unit increase,[0.0074-0.0152],"SNRNP27, GMCL1",Ease of getting up in the morning,chronotype measurement,GCST007986,2:69892123
rs406952-<b>C</b>,1 x 10-8,,0.3765,'-,0.0101 unit increase,[0.0066-0.0136],SUCLA2P2,Ease of getting up in the morning,chronotype measurement,GCST007986,2:76080219
rs4853283-<b>G</b>,2 x 10-16,,0.4401,'-,0.0143 unit decrease,[0.011-0.018],LRRTM4,Ease of getting up in the morning,chronotype measurement,GCST007986,2:76929276
rs1606803-<b>T</b>,3 x 10-10,,0.2871,'-,0.0119 unit increase,[0.0082-0.0156],EIF2AK3,Ease of getting up in the morning,chronotype measurement,GCST007986,2:88633798
rs35333999-<b>T</b>,3 x 10-9,,0.04295,'-,0.0172 unit decrease,[0.012-0.022],PER2,Ease of getting up in the morning,chronotype measurement,GCST007986,2:238253316
rs116298301-<b>T</b>,2 x 10-11,,0.02567,'-,0.0172 unit decrease,[0.012-0.022],PER2,Ease of getting up in the morning,chronotype measurement,GCST007986,2:238269045
rs4483990-<b>C</b>,6 x 10-13,,0.1549,'-,0.0172 unit decrease,[0.012-0.022],LINC01107,Ease of getting up in the morning,chronotype measurement,GCST007986,2:238514457
rs13116306-<b>T</b>,2 x 10-8,,0.42,'-,0.0099 unit decrease,[0.0064-0.0134],"LINC02498, CLNK",Ease of getting up in the morning,chronotype measurement,GCST007986,4:10726073
rs10470887-<b>G</b>,4 x 10-8,,0.4874,'-,0.0095 unit decrease,[0.0062-0.0128],CCSER1,Ease of getting up in the morning,chronotype measurement,GCST007986,4:91646291
rs9995419-<b>A</b>,2 x 10-8,,0.2369,'-,0.0114 unit increase,[0.0075-0.0153],Y_RNA,Ease of getting up in the morning,chronotype measurement,GCST007986,4:157686231
rs79751662-<b>C</b>,2 x 10-8,,0.1067,'-,0.0156 unit decrease,[0.01-0.021],"APOBEC3AP1, AADAT",Ease of getting up in the morning,chronotype measurement,GCST007986,4:170093504
rs1459192-<b>T</b>,2 x 10-8,,0.3288,'-,0.0102 unit decrease,[0.0067-0.0137],"MRPL49P1, RGS7BP",Ease of getting up in the morning,chronotype measurement,GCST007986,5:64648692
rs12515274-<b>A</b>,5 x 10-10,,0.2523,'-,0.0123 unit decrease,[0.0084-0.0162],TMEM161B-AS1,Ease of getting up in the morning,chronotype measurement,GCST007986,5:88359845
rs4958316-<b>A</b>,4 x 10-15,,0.2883,'-,0.015 unit increase,[0.011-0.019],LINC01470,Ease of getting up in the morning,chronotype measurement,GCST007986,5:152562690
rs553108-<b>A</b>,3 x 10-8,,0.4159,'-,0.0097 unit increase,[0.0062-0.0132],SLC44A4,Ease of getting up in the morning,chronotype measurement,GCST007986,6:31872678
rs2653349-<b>A</b>,8 x 10-29,,0.213,'-,0.0234 unit increase,[0.019-0.028],HCRTR2,Ease of getting up in the morning,chronotype measurement,GCST007986,6:55277539
rs9399613-<b>T</b>,1 x 10-8,,0.2861,'-,0.0109 unit decrease,[0.0072-0.0146],SAMD5,Ease of getting up in the morning,chronotype measurement,GCST007986,6:147664888
rs3735478-<b>T</b>,2 x 10-8,,0.2908,'-,0.0107 unit decrease,[0.007-0.0144],ZMIZ2,Ease of getting up in the morning,chronotype measurement,GCST007986,7:44760577
rs2944822-<b>T</b>,4 x 10-9,,0.4452,'-,0.0101 unit increase,[0.0068-0.0134],CALN1,Ease of getting up in the morning,chronotype measurement,GCST007986,7:72330607
rs16917522-<b>C</b>,1 x 10-9,,0.1827,'-,0.0136 unit increase,[0.0093-0.0179],ST18,Ease of getting up in the morning,chronotype measurement,GCST007986,8:52223882
rs72663537-<b>G</b>,3 x 10-8,,0.1295,'-,0.0143 unit decrease,[0.0092-0.0194],'-,Ease of getting up in the morning,chronotype measurement,GCST007986,8:75788383
rs77641763-<b>T</b>,2 x 10-11,,0.122,'-,0.0176 unit decrease,[0.013-0.023],EXD3,Ease of getting up in the morning,chronotype measurement,GCST007986,9:137371330
rs4962716-<b>T</b>,2 x 10-9,,0.1258,'-,0.0156 unit decrease,[0.011-0.021],CTBP2,Ease of getting up in the morning,chronotype measurement,GCST007986,10:124997298
rs11229264-<b>A</b>,1 x 10-10,,0.2982,'-,0.0122 unit decrease,[0.0085-0.0159],OR9Q1,Ease of getting up in the morning,chronotype measurement,GCST007986,11:58141614
rs7297799-<b>T</b>,1 x 10-12,,0.3989,'-,0.0128 unit decrease,[0.0093-0.0163],"TUBB8P4, ALG10",Ease of getting up in the morning,chronotype measurement,GCST007986,12:34107207
rs11520042-<b>C</b>,8 x 10-9,,0.3455,'-,0.0123 unit increase,[0.0088-0.0158],ZNF970P,Ease of getting up in the morning,chronotype measurement,GCST007986,12:37651543
rs17464772-<b>A</b>,1 x 10-11,,0.3508,'-,0.0123 unit increase,[0.0088-0.0158],CPNE8,Ease of getting up in the morning,chronotype measurement,GCST007986,12:38853975
rs2193749-<b>T</b>,2 x 10-8,,0.4947,'-,0.0097 unit decrease,[0.0064-0.013],ARID2,Ease of getting up in the morning,chronotype measurement,GCST007986,12:45741029
rs6581138-<b>A</b>,2 x 10-10,,0.2434,'-,0.0127 unit increase,[0.0088-0.0166],R3HDM2,Ease of getting up in the morning,chronotype measurement,GCST007986,12:57351081
rs1017168-<b>A</b>,3 x 10-8,,0.3551,'-,0.0101 unit decrease,[0.0066-0.0136],CRY1,Ease of getting up in the morning,chronotype measurement,GCST007986,12:107041627
rs74643199-<b>T</b>,1 x 10-8,,0.1538,'-,0.0137 unit decrease,[0.009-0.0184],"MIR4472-2, MED13L",Ease of getting up in the morning,chronotype measurement,GCST007986,12:116335086
rs4884166-<b>A</b>,1 x 10-8,,0.1984,'-,0.0123 unit decrease,[0.008-0.0166],MIR5007,Ease of getting up in the morning,chronotype measurement,GCST007986,13:55195010
rs7332608-<b>G</b>,5 x 10-11,,0.03381,'-,0.0313 unit decrease,[0.022-0.041],"FBXL3, CLN5",Ease of getting up in the morning,chronotype measurement,GCST007986,13:76996542
rs61963491-<b>G</b>,5 x 10-9,,0.005753,'-,0.0313 unit decrease,[0.022-0.041],MYCBP2,Ease of getting up in the morning,chronotype measurement,GCST007986,13:77370501
rs6575012-<b>A</b>,3 x 10-8,,0.4819,'-,0.0096 unit decrease,[0.0063-0.0129],ZC3H14,Ease of getting up in the morning,chronotype measurement,GCST007986,14:88590355
rs3935182-<b>G</b>,7 x 10-12,,0.4207,'-,0.012 unit increase,[0.0085-0.0155],LINGO1,Ease of getting up in the morning,chronotype measurement,GCST007986,15:77802465
rs1420607-<b>A</b>,2 x 10-11,,0.2713,'-,0.0131 unit increase,[0.0094-0.0168],MTND4LP25,Ease of getting up in the morning,chronotype measurement,GCST007986,16:49115280
rs11642015-<b>T</b>,6 x 10-11,,0.4041,'-,0.0114 unit increase,[0.0079-0.0149],FTO,Ease of getting up in the morning,chronotype measurement,GCST007986,16:53768582
rs1949072-<b>A</b>,2 x 10-8,,0.4342,'-,0.0097 unit increase,[0.0064-0.013],CES5A,Ease of getting up in the morning,chronotype measurement,GCST007986,16:55972196
rs17822102-<b>G</b>,9 x 10-10,,0.3437,'-,0.0111 unit increase,[0.0076-0.0146],GNPATP,Ease of getting up in the morning,chronotype measurement,GCST007986,16:60616239
rs11643192-<b>A</b>,1 x 10-9,,0.3893,'-,0.0107 unit decrease,[0.0072-0.0142],"LINC01572, PMFBP1",Ease of getting up in the morning,chronotype measurement,GCST007986,16:72180377
rs4790352-<b>G</b>,9 x 10-9,,0.08119,'-,0.0181 unit decrease,[0.012-0.024],PAFAH1B1,Ease of getting up in the morning,chronotype measurement,GCST007986,17:2675256
rs3760185-<b>T</b>,5 x 10-8,,0.2433,'-,0.0111 unit decrease,[0.0072-0.015],"PEMT, RASD1",Ease of getting up in the morning,chronotype measurement,GCST007986,17:17498422
rs7222039-<b>T</b>,3 x 10-8,,0.4467,'-,0.0095 unit increase,[0.0062-0.0128],"CSF3, PSMD3",Ease of getting up in the morning,chronotype measurement,GCST007986,17:40009288
rs12150229-<b>G</b>,4 x 10-9,,0.2236,'-,0.0122 unit increase,[0.0081-0.0163],MAPT,Ease of getting up in the morning,chronotype measurement,GCST007986,17:45938080
rs77556405-<b>A</b>,2 x 10-13,,0.1727,'-,0.0168 unit increase,[0.012-0.021],SKAP1,Ease of getting up in the morning,chronotype measurement,GCST007986,17:48386547
rs12601968-<b>T</b>,1 x 10-9,,0.3261,'-,0.0112 unit decrease,[0.0077-0.0147],CA10,Ease of getting up in the morning,chronotype measurement,GCST007986,17:52219099
rs4395148-<b>T</b>,2 x 10-8,,0.308,'-,0.0104 unit decrease,[0.0067-0.0141],NOL4,Ease of getting up in the morning,chronotype measurement,GCST007986,18:34110704
rs8182491-<b>T</b>,1 x 10-9,,0.1005,'-,0.0174 unit decrease,[0.012-0.023],DEDD2,Ease of getting up in the morning,chronotype measurement,GCST007986,19:42207872
rs3746601-<b>C</b>,3 x 10-8,,0.3603,'-,0.01 unit increase,[0.0065-0.0135],HCK,Ease of getting up in the morning,chronotype measurement,GCST007986,20:32075002
rs11697690-<b>C</b>,2 x 10-8,,0.469,'-,0.0097 unit increase,[0.0064-0.013],EFCAB8,Ease of getting up in the morning,chronotype measurement,GCST007986,20:32890175
rs74555583-<b>A</b>,3 x 10-8,,0.08551,'-,0.017 unit decrease,[0.011-0.023],LINC01524,Ease of getting up in the morning,chronotype measurement,GCST007986,20:52715729
rs4634827-<b>G</b>,9 x 10-10,,0.3412,'-,0.0127 unit increase,[0.0086-0.0168],RN7SL91P,Ease of getting up in the morning,chronotype measurement,GCST007986,X:25071113
rs139757732-<b>T</b>,3 x 10-8,,0.95599,'-,0.029 unit decrease,[0.019-0.039],ZSCAN16-AS1,Morningness,chronotype measurement,GCST007983,6:28116838
rs9295795-<b>T</b>,2 x 10-8,,0.94311,'-,0.026 unit decrease,[0.016-0.036],"OR2J2, OR2J4P",Morningness,chronotype measurement,GCST007983,6:29177846
rs486416-<b>A</b>,6 x 10-9,,0.6376,'-,0.013 unit decrease,[0.0091-0.0169],EHMT2,Morningness,chronotype measurement,GCST007983,6:31888293
rs734597-<b>A</b>,2 x 10-8,,0.1696,'-,0.016 unit increase,[0.01-0.022],"RPS17P5, FTH1P5",Morningness,chronotype measurement,GCST007983,6:50868566
rs11969918-<b>A</b>,2 x 10-9,,0.431,'-,0.013 unit decrease,[0.0091-0.0169],FAM83B,Morningness,chronotype measurement,GCST007983,6:54883421
rs144870624-<b>T</b>,2 x 10-8,,0.97588,'-,0.039 unit decrease,[0.025-0.053],HCRTR2,Morningness,chronotype measurement,GCST007983,6:55170886
rs2653349-<b>A</b>,1 x 10-32,,0.213,'-,0.031 unit increase,[0.025-0.037],HCRTR2,Morningness,chronotype measurement,GCST007983,6:55277539
rs9396083-<b>A</b>,2 x 10-15,,0.4077,'-,0.017 unit decrease,[0.013-0.021],GFRAL,Morningness,chronotype measurement,GCST007983,6:55352748
rs2881955-<b>T</b>,6 x 10-11,,0.2777,'-,0.016 unit increase,[0.012-0.02],'-,Morningness,chronotype measurement,GCST007983,6:71769560
rs9375352-<b>A</b>,2 x 10-8,,0.2672,'-,0.014 unit increase,[0.01-0.018],'-,Morningness,chronotype measurement,GCST007983,6:98292062
rs4557564-<b>A</b>,2 x 10-9,,0.92961,'-,0.025 unit increase,[0.017-0.033],"GPR6, FIG4",Morningness,chronotype measurement,GCST007983,6:109910848
rs6935086-<b>T</b>,6 x 10-9,,0.8871,'-,0.02 unit increase,[0.014-0.026],Y_RNA,Morningness,chronotype measurement,GCST007983,6:128623532
rs827751-<b>A</b>,2 x 10-17,,0.3281,'-,0.019 unit increase,[0.015-0.023],LINC02840,Morningness,chronotype measurement,GCST007983,6:152808480
rs9479402-<b>T</b>,1 x 10-22,,0.9893,'-,0.102 unit decrease,[0.082-0.122],LINC02840,Morningness,chronotype measurement,GCST007983,6:152814204
rs62436127-<b>C</b>,1 x 10-18,,0.1596,'-,0.026 unit increase,[0.02-0.032],MTRF1L,Morningness,chronotype measurement,GCST007983,6:152999483
rs9348050-<b>T</b>,2 x 10-9,,0.4891,'-,0.013 unit increase,[0.0091-0.0169],PDE10A,Morningness,chronotype measurement,GCST007983,6:165850000
rs16873715-<b>A</b>,4 x 10-8,,0.7564,'-,0.015 unit decrease,[0.0091-0.0209],NXPH1,Morningness,chronotype measurement,GCST007983,7:8520824
rs56382918-<b>T</b>,1 x 10-12,,0.7436,'-,0.018 unit increase,[0.014-0.022],'-,Morningness,chronotype measurement,GCST007983,7:24028374
rs10236197-<b>T</b>,2 x 10-10,,0.6303,'-,0.014 unit increase,[0.01-0.018],PDE1C,Morningness,chronotype measurement,GCST007983,7:32252149
rs56049037-<b>A</b>,2 x 10-12,,0.2874,'-,0.017 unit decrease,[0.013-0.021],"RP9P, KBTBD2",Morningness,chronotype measurement,GCST007983,7:32907589
rs4245555-<b>T</b>,2 x 10-15,,0.5872,'-,0.018 unit decrease,[0.014-0.022],GRB10,Morningness,chronotype measurement,GCST007983,7:50593712
rs2190500-<b>C</b>,2 x 10-10,,0.1025,'-,0.022 unit decrease,[0.014-0.03],GRB10,Morningness,chronotype measurement,GCST007983,7:50618411
rs2138759-<b>A</b>,2 x 10-9,,0.297,'-,0.014 unit increase,[0.01-0.018],CALN1,Morningness,chronotype measurement,GCST007983,7:72358451
rs2922966-<b>A</b>,1 x 10-17,,0.8357,'-,0.025 unit increase,[0.019-0.031],MARK2P10,Morningness,chronotype measurement,GCST007983,7:96826286
rs202157-<b>T</b>,1 x 10-14,,0.7019,'-,0.018 unit decrease,[0.014-0.022],CUX1,Morningness,chronotype measurement,GCST007983,7:101994473
rs12442008-<b>T</b>,3 x 10-8,,0.2521,'-,0.014 unit increase,[0.01-0.018],WDR72,Morningness,chronotype measurement,GCST007983,15:53432915
rs11852820-<b>C</b>,6 x 10-10,,0.6589,'-,0.014 unit decrease,[0.01-0.018],ASB7,Morningness,chronotype measurement,GCST007983,15:100610230
rs2304467-<b>C</b>,4 x 10-8,,0.6026,'-,0.012 unit decrease,[0.0081-0.0159],USP7,Morningness,chronotype measurement,GCST007983,16:8894920
rs7196720-<b>T</b>,4 x 10-9,,0.486,'-,0.013 unit increase,[0.0091-0.0169],RBBP6,Morningness,chronotype measurement,GCST007983,16:24523341
rs12927162-<b>A</b>,2 x 10-32,,0.7237,'-,0.028 unit increase,[0.024-0.032],CASC16,Morningness,chronotype measurement,GCST007983,16:52651004
rs1421085-<b>T</b>,1 x 10-25,,0.5961,'-,0.023 unit decrease,[0.019-0.027],FTO,Morningness,chronotype measurement,GCST007983,16:53767042
rs1110698-<b>A</b>,3 x 10-8,,0.07882,'-,0.022 unit decrease,[0.014-0.03],GNAO1,Morningness,chronotype measurement,GCST007983,16:56123141
rs2398144-<b>A</b>,2 x 10-21,,0.3947,'-,0.021 unit decrease,[0.017-0.025],GNAO1,Morningness,chronotype measurement,GCST007983,16:56318942
rs8044054-<b>T</b>,4 x 10-12,,0.3889,'-,0.015 unit increase,[0.011-0.019],GNPATP,Morningness,chronotype measurement,GCST007983,16:60594532
rs11641811-<b>A</b>,6 x 10-10,,0.5218,'-,0.013 unit decrease,[0.0091-0.0169],"TAT-AS1, MARVELD3",Morningness,chronotype measurement,GCST007983,16:71601933
rs17604349-<b>A</b>,1 x 10-15,,0.1792,'-,0.022 unit decrease,[0.016-0.028],"LINC01572, PMFBP1",Morningness,chronotype measurement,GCST007983,16:72176966
rs58356259-<b>T</b>,2 x 10-9,,0.4687,'-,0.013 unit decrease,[0.0091-0.0169],"HES7, PER1",Morningness,chronotype measurement,GCST007983,17:8136833
rs2518022-<b>T</b>,2 x 10-16,,0.08555,'-,0.032 unit increase,[0.024-0.04],PER1,Morningness,chronotype measurement,GCST007983,17:8154049
rs1242490-<b>C</b>,7 x 10-14,,0.7456,'-,0.018 unit decrease,[0.014-0.022],MED9,Morningness,chronotype measurement,GCST007983,17:17489922
rs2232839-<b>T</b>,2 x 10-21,,0.2113,'-,0.025 unit decrease,[0.019-0.031],RASD1,Morningness,chronotype measurement,GCST007983,17:17496321
rs9915731-<b>A</b>,3 x 10-8,,0.2703,'-,0.013 unit decrease,[0.0091-0.0169],RHBDL3,Morningness,chronotype measurement,GCST007983,17:32272536
rs12657776-<b>A</b>,4 x 10-14,,0.7482,'-,0.019 unit increase,[0.015-0.023],TMEM161B-AS1,Morningness,chronotype measurement,GCST007983,5:88365776
rs304137-<b>A</b>,3 x 10-14,,0.5225,'-,0.016 unit increase,[0.012-0.02],MEF2C,Morningness,chronotype measurement,GCST007983,5:88873835
rs40465-<b>T</b>,2 x 10-8,,0.6702,'-,0.013 unit decrease,[0.0091-0.0169],'-,Morningness,chronotype measurement,GCST007983,5:104646025
rs286808-<b>T</b>,4 x 10-9,,0.4746,'-,0.013 unit increase,[0.0091-0.0169],FBXL17,Morningness,chronotype measurement,GCST007983,5:108123675
rs10052000-<b>C</b>,8 x 10-19,,0.3226,'-,0.02 unit increase,[0.016-0.024],LINC01470,Morningness,chronotype measurement,GCST007983,5:152919330
rs2910032-<b>T</b>,6 x 10-18,,0.5184,'-,0.019 unit increase,[0.015-0.023],LINC01470,Morningness,chronotype measurement,GCST007983,5:153160794
rs42210-<b>C</b>,4 x 10-9,,0.7134,'-,0.014 unit decrease,[0.01-0.018],LINC01947,Morningness,chronotype measurement,GCST007983,5:166981783
rs335433-<b>T</b>,2 x 10-9,,0.4568,'-,0.013 unit decrease,[0.0091-0.0169],"GRK6, PRR7-AS1",Morningness,chronotype measurement,GCST007983,5:177440206
rs9395520-<b>T</b>,2 x 10-18,,0.3042,'-,0.02 unit increase,[0.016-0.024],PHACTR1,Morningness,chronotype measurement,GCST007983,6:13183291
rs73405966-<b>T</b>,4 x 10-9,,0.8233,'-,0.019 unit increase,[0.013-0.025],CUX1,Morningness,chronotype measurement,GCST007983,7:102032019
rs1047998-<b>T</b>,3 x 10-9,,0.2527,'-,0.015 unit increase,[0.011-0.019],PRKRIP1,Morningness,chronotype measurement,GCST007983,7:102425204
rs77655131-<b>T</b>,5 x 10-11,,0.1223,'-,0.022 unit decrease,[0.016-0.028],ORAI2,Morningness,chronotype measurement,GCST007983,7:102446105
rs60984271-<b>A</b>,3 x 10-10,,0.8144,'-,0.02 unit decrease,[0.014-0.026],"FAM185A, RASA4DP",Morningness,chronotype measurement,GCST007983,7:102708677
rs112613078-<b>A</b>,2 x 10-20,,0.81,'-,0.025 unit decrease,[0.019-0.031],FAM185A,Morningness,chronotype measurement,GCST007983,7:102793231
rs17474942-<b>T</b>,4 x 10-17,,0.02161,'-,0.062 unit increase,[0.048-0.076],FBXL13,Morningness,chronotype measurement,GCST007983,7:102842634
rs148266530-<b>T</b>,1 x 10-8,,0.02025,'-,0.044 unit increase,[0.028-0.06],FBXL13,Morningness,chronotype measurement,GCST007983,7:102898955
rs79055896-<b>A</b>,5 x 10-10,,0.94261,'-,0.033 unit increase,[0.023-0.043],FBXL13,Morningness,chronotype measurement,GCST007983,7:103004605
rs6944123-<b>T</b>,2 x 10-15,,0.3146,'-,0.018 unit increase,[0.014-0.022],RELN,Morningness,chronotype measurement,GCST007983,7:103488377
rs10262462-<b>A</b>,3 x 10-12,,0.3974,'-,0.015 unit decrease,[0.011-0.019],FOXP2,Morningness,chronotype measurement,GCST007983,7:114540007
rs6978514-<b>T</b>,5 x 10-8,,0.559,'-,0.013 unit decrease,[0.0091-0.0169],TFEC,Morningness,chronotype measurement,GCST007983,7:116044355
rs2971970-<b>T</b>,2 x 10-11,,0.2177,'-,0.017 unit increase,[0.011-0.023],EXOC4,Morningness,chronotype measurement,GCST007983,7:133959025
rs35748596-<b>T</b>,2 x 10-12,,0.6423,'-,0.016 unit decrease,[0.012-0.02],CSMD1,Morningness,chronotype measurement,GCST007983,8:4967921
rs34344642-<b>T</b>,3 x 10-9,,0.07832,'-,0.024 unit decrease,[0.016-0.032],NRG1,Morningness,chronotype measurement,GCST007983,8:31908070
rs12541362-<b>A</b>,6 x 10-15,,0.6511,'-,0.018 unit decrease,[0.014-0.022],VENTXP5,Morningness,chronotype measurement,GCST007983,8:33727143
rs1996866-<b>A</b>,2 x 10-8,,0.7498,'-,0.016 unit decrease,[0.01-0.022],LINC01288,Morningness,chronotype measurement,GCST007983,8:34722310
rs1919346-<b>A</b>,1 x 10-8,,0.5251,'-,0.012 unit increase,[0.0081-0.0159],UNC5D,Morningness,chronotype measurement,GCST007983,8:35353939
rs11988076-<b>A</b>,2 x 10-11,,0.8359,'-,0.019 unit decrease,[0.013-0.025],ST18,Morningness,chronotype measurement,GCST007983,8:52216069
rs6472936-<b>T</b>,5 x 10-12,,0.7788,'-,0.018 unit increase,[0.012-0.024],'-,Morningness,chronotype measurement,GCST007983,8:75727524
rs1110275-<b>T</b>,4 x 10-8,,0.90582,'-,0.02 unit increase,[0.012-0.028],"REXO1L6P, LINC02849",Morningness,chronotype measurement,GCST007983,8:85842103
rs34578339-<b>A</b>,3 x 10-8,,0.843,'-,0.016 unit decrease,[0.01-0.022],RNA5SP272,Morningness,chronotype measurement,GCST007983,8:88428613
rs17748165-<b>A</b>,3 x 10-8,,0.7422,'-,0.014 unit increase,[0.01-0.018],'-,Morningness,chronotype measurement,GCST007983,8:92274499
rs72673588-<b>C</b>,1 x 10-9,,0.8152,'-,0.017 unit decrease,[0.011-0.023],'-,Morningness,chronotype measurement,GCST007983,8:92344162
rs3100052-<b>A</b>,1 x 10-8,,0.3874,'-,0.013 unit increase,[0.0091-0.0169],"YWHAZ, RN7SL685P",Morningness,chronotype measurement,GCST007983,8:100954911
rs2737245-<b>T</b>,3 x 10-14,,0.2779,'-,0.018 unit increase,[0.014-0.022],TRPS1,Morningness,chronotype measurement,GCST007983,8:115646356
rs28380327-<b>A</b>,5 x 10-25,,0.6317,1.0378,'-,'-,ARHGAP15,Morning person,chronotype measurement,GCST007565,2:143474922
rs10788872-<b>A</b>,8 x 10-26,,0.582,1.0382,'-,'-,"RNU2-17P, CA14",Morning person,chronotype measurement,GCST007565,1:150239384
rs4800998-<b>A</b>,5 x 10-14,,0.1827,1.0384,'-,'-,"TCF4, LINC01415",Morning person,chronotype measurement,GCST007565,18:55762424
rs6465876-<b>T</b>,4 x 10-24,,0.3565,1.0401,'-,'-,FBXL13,Morning person,chronotype measurement,GCST007565,7:102857122
rs2794681-<b>T</b>,8 x 10-30,,0.3986,1.0404,'-,'-,PRPF3,Morning person,chronotype measurement,GCST007565,1:150349475
rs12472359-<b>T</b>,1 x 10-27,,0.4767,1.0407,'-,'-,"BOLL, MARS2",Morning person,chronotype measurement,GCST007565,2:197723141
rs9436119-<b>A</b>,6 x 10-30,,0.3842,1.041,'-,'-,TARS2,Morning person,chronotype measurement,GCST007565,1:150495277
rs1400283-<b>C</b>,6 x 10-29,,0.4402,1.0423,'-,'-,CPNE8-AS1,Morning person,chronotype measurement,GCST007565,12:38970794
rs11495590-<b>T</b>,8 x 10-28,,0.3842,1.0424,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:37716007
rs1064213-<b>A</b>,4 x 10-31,,0.4826,1.0425,'-,'-,PLCL1,Morning person,chronotype measurement,GCST007565,2:198085516
rs9739706-<b>T</b>,8 x 10-28,,0.4051,1.0425,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:34640786
rs1405024-<b>A</b>,7 x 10-31,,0.506,1.0431,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:33785004
rs12456222-<b>T</b>,9 x 10-23,,0.7345,1.0433,'-,'-,NOL4,Morning person,chronotype measurement,GCST007565,18:34187721
rs4419127-<b>A</b>,8 x 10-30,,0.6622,1.0446,'-,'-,NOL4,Morning person,chronotype measurement,GCST007565,18:34083690
rs7314457-<b>A</b>,1 x 10-33,,0.5264,1.0457,'-,'-,AK6P1,Morning person,chronotype measurement,GCST007565,12:34301366
rs1705773-<b>A</b>,3 x 10-35,,0.6062,1.0476,'-,'-,"Y_RNA, ALG10",Morning person,chronotype measurement,GCST007565,12:34016940
rs62082402-<b>T</b>,7 x 10-19,,0.1936,1.048,'-,'-,AKAIN1,Morning person,chronotype measurement,GCST007565,18:5186567
rs11833948-<b>T</b>,3 x 10-35,,0.6035,1.0482,'-,'-,"TUBB8P4, ALG10",Morning person,chronotype measurement,GCST007565,12:34124007
rs7314227-<b>A</b>,2 x 10-39,,0.499,1.0491,'-,'-,CPNE8,Morning person,chronotype measurement,GCST007565,12:38863966
rs35833281-<b>C</b>,2 x 10-31,,0.2296,1.0501,'-,'-,HCRTR2,Morning person,chronotype measurement,GCST007565,6:55156763
rs78440618-<b>A</b>,3 x 10-18,,0.8935,1.0504,'-,'-,LINC01937,Morning person,chronotype measurement,GCST007565,2:238608454
rs35817541-<b>T</b>,1 x 10-40,,0.5526,1.0507,'-,'-,CPNE8,Morning person,chronotype measurement,GCST007565,12:38581199
rs11182930-<b>A</b>,8 x 10-41,,0.539,1.0509,'-,'-,"Y_RNA, NF1P12",Morning person,chronotype measurement,GCST007565,12:38239891
rs13377754-<b>T</b>,3 x 10-40,,0.6104,1.0511,'-,'-,RNU6-472P,Morning person,chronotype measurement,GCST007565,12:33898830
rs12470914-<b>A</b>,3 x 10-17,,0.1005,1.0513,'-,'-,NRXN1,Morning person,chronotype measurement,GCST007565,2:50305702
rs2433634-<b>C</b>,5 x 10-10,,0.2759,1.0271623,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,12:22907429
rs2979139-<b>G</b>,4 x 10-14,,0.4952,1.0270597,'-,'-,PRAG1,Chronotype,chronotype measurement,GCST007576,8:8410803
rs4775086-<b>G</b>,1 x 10-8,,0.7637,1.0270597,'-,'-,ADAM10,Chronotype,chronotype measurement,GCST007576,15:58677093
rs12051-<b>G</b>,5 x 10-13,,0.3881,1.0267515,'-,'-,COPZ2,Chronotype,chronotype measurement,GCST007576,17:48026394
rs6131942-<b>G</b>,7 x 10-16,,0.582,1.0266489,'-,'-,PCSK2,Chronotype,chronotype measurement,GCST007576,20:17367963
rs9636202-<b>G</b>,4 x 10-11,,0.7338,1.026341,'-,'-,"RN7SL513P, PGPEP1",Chronotype,chronotype measurement,GCST007576,19:18338428
rs4027217-<b>C</b>,4 x 10-8,,0.783,1.0261357,'-,'-,"Y_RNA, RPL6P21",Chronotype,chronotype measurement,GCST007576,7:14054289
rs4666682-<b>G</b>,4 x 10-9,,0.8203,1.0257254,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,2:185339016
rs9997394-<b>G</b>,1 x 10-9,,0.7134,1.0257254,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,4:162782931
rs6433478-<b>C</b>,1 x 10-11,,0.5399,1.0256228,'-,'-,CIR1,Chronotype,chronotype measurement,GCST007576,2:174376754
rs1737893-<b>C</b>,9 x 10-11,,0.6195,1.0256228,'-,'-,NOL4L,Chronotype,chronotype measurement,GCST007576,20:32463896
rs4657983-<b>G</b>,8 x 10-11,,0.3489,1.0255202,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,1:195485427
rs13203140-<b>C</b>,2 x 10-9,,0.3647,1.0255202,'-,'-,MDGA1,Chronotype,chronotype measurement,GCST007576,6:37662357
rs6007594-<b>G</b>,6 x 10-10,,0.7356,1.025315,'-,'-,FAM118A,Chronotype,chronotype measurement,GCST007576,22:45332489
rs555784-<b>T</b>,3 x 10-10,,0.6197,1.0252126,'-,'-,RPS6P12,Chronotype,chronotype measurement,GCST007576,9:82703789
rs10759208-<b>C</b>,4 x 10-10,,0.3862,1.0251101,'-,'-,ZNF462,Chronotype,chronotype measurement,GCST007576,9:107043918
rs6690292-<b>C</b>,2 x 10-8,,0.2715,1.0250076,'-,'-,CAPZA1,Chronotype,chronotype measurement,GCST007576,1:112645797
rs17712705-<b>G</b>,3 x 10-9,,0.6735,1.0250076,'-,'-,"RPL12P8, RNU6-523P",Chronotype,chronotype measurement,GCST007576,10:67863513
rs12065331-<b>C</b>,2 x 10-11,,0.6875,1.0247,'-,'-,KAZN,Chronotype,chronotype measurement,GCST007576,1:14181336
rs62182135-<b>C</b>,1 x 10-12,,0.6715,1.0244951,'-,'-,HDAC4,Chronotype,chronotype measurement,GCST007576,2:239345610
rs4236237-<b>C</b>,1 x 10-10,,0.4008,1.0244951,'-,'-,AUTS2,Chronotype,chronotype measurement,GCST007576,7:70471491
rs5016898-<b>C</b>,5 x 10-10,,0.5762,1.0243927,'-,'-,RN7SKP247,Chronotype,chronotype measurement,GCST007576,1:81206328
rs11597421-<b>G</b>,2 x 10-8,,0.5027,1.0240855,'-,'-,ANK3,Chronotype,chronotype measurement,GCST007576,10:60034388
rs2648721-<b>G</b>,2 x 10-8,,0.2961,1.0240855,'-,'-,PCGF5,Chronotype,chronotype measurement,GCST007576,10:91267239
rs301218-<b>G</b>,1 x 10-10,,0.6084,1.0239831,'-,'-,LINC01208,Chronotype,chronotype measurement,GCST007576,3:176379131
rs42210-<b>G</b>,5 x 10-10,,0.2876,1.0295275,'-,'-,LINC01947,Chronotype,chronotype measurement,GCST007576,5:166981783
rs7304278-<b>G</b>,2 x 10-14,,0.7173,1.0295275,'-,'-,RFX4,Chronotype,chronotype measurement,GCST007576,12:106596137
rs1013987-<b>C</b>,6 x 10-13,,0.5967,1.0295275,'-,'-,"ZNF521, WBP2P1",Chronotype,chronotype measurement,GCST007576,18:25050872
rs11208844-<b>G</b>,5 x 10-9,,0.8592,1.0294245,'-,'-,PDE4B,Chronotype,chronotype measurement,GCST007576,1:66385464
rs4241964-<b>G</b>,9 x 10-16,,0.4783,1.0291158,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,4:136132804
rs1163628-<b>C</b>,4 x 10-9,,0.1428,1.0291158,'-,'-,LINC02337,Chronotype,chronotype measurement,GCST007576,13:111574073
rs7626335-<b>C</b>,6 x 10-12,,0.6695,1.0290129,'-,'-,FOXP1,Chronotype,chronotype measurement,GCST007576,3:71526026
rs13011556-<b>G</b>,1 x 10-13,,0.2376,1.02891,'-,'-,"LINC01249, NPM1P48",Chronotype,chronotype measurement,GCST007576,2:4604333
rs17140201-<b>G</b>,1 x 10-8,,0.828,1.02891,'-,'-,SEMA6A-AS2,Chronotype,chronotype measurement,GCST007576,5:116604200
rs2593487-<b>G</b>,2 x 10-12,,0.6639,1.02891,'-,'-,"LINC00383, SRSF1P1",Chronotype,chronotype measurement,GCST007576,13:69328926
rs848552-<b>G</b>,5 x 10-14,,0.5245,1.0286014,'-,'-,CRIM1,Chronotype,chronotype measurement,GCST007576,2:36473437
rs11165655-<b>G</b>,5 x 10-13,,0.4719,1.0284985,'-,'-,"RN7SL831P, EEF1A1P11",Chronotype,chronotype measurement,GCST007576,1:96493548
rs8072058-<b>T</b>,9 x 10-9,,0.2188,1.0284985,'-,'-,MSI2,Chronotype,chronotype measurement,GCST007576,17:57656837
rs11152350-<b>C</b>,1 x 10-13,,0.533,1.0284985,'-,'-,ZCCHC2,Chronotype,chronotype measurement,GCST007576,18:62573119
rs111261826-<b>C</b>,4 x 10-11,,0.321,1.0283957,'-,'-,GRM7,Chronotype,chronotype measurement,GCST007576,3:7147930
rs9836621-<b>C</b>,2 x 10-13,,0.4783,1.0282929,'-,'-,LINC01994,Chronotype,chronotype measurement,GCST007576,3:182378523
rs11678584-<b>T</b>,4 x 10-9,,0.1401,1.02819,'-,'-,"BIRC6, YIPF4",Chronotype,chronotype measurement,GCST007576,2:32338357
rs359248-<b>G</b>,2 x 10-16,,0.5436,1.0278816,'-,'-,MIR4432HG,Chronotype,chronotype measurement,GCST007576,2:60250326
rs13065394-<b>G</b>,4 x 10-11,,0.714,1.0277789,'-,'-,"TMEM108-AS1, TMEM108",Chronotype,chronotype measurement,GCST007576,3:133252483
rs62465218-<b>C</b>,1 x 10-8,,0.8544,1.0277789,'-,'-,PLXNA4,Chronotype,chronotype measurement,GCST007576,7:132609553
rs11845599-<b>G</b>,5 x 10-13,,0.3647,1.0277789,'-,'-,BEGAIN,Chronotype,chronotype measurement,GCST007576,14:100550487
rs621421-<b>C</b>,2 x 10-14,,0.3744,1.0276761,'-,'-,"MPPED2, RPL12P30",Chronotype,chronotype measurement,GCST007576,11:30384367
rs1788784-<b>G</b>,4 x 10-10,,0.6558,1.0276761,'-,'-,NPC1,Chronotype,chronotype measurement,GCST007576,18:23579666
rs9571526-<b>G</b>,5 x 10-9,,0.2294,1.0275733,'-,'-,MIR548X2,Chronotype,chronotype measurement,GCST007576,13:66016736
rs9664044-<b>C</b>,2 x 10-9,,0.7681,1.0271623,'-,'-,CTBP2,Chronotype,chronotype measurement,GCST007576,10:125022222
rs2194316-<b>C</b>,3 x 10-15,,0.7429,1.0307153,'-,'-,LINC01572,Morning person,chronotype measurement,GCST007565,16:72295611
rs812925-<b>G</b>,7 x 10-17,,0.3542,1.030609,'-,'-,USP34,Morning person,chronotype measurement,GCST007565,2:61453858
rs10917513-<b>C</b>,3 x 10-15,,0.3524,1.0305029,'-,'-,HTR6,Morning person,chronotype measurement,GCST007565,1:19680394
rs1017168-<b>C</b>,1 x 10-13,,0.6423,1.029548,'-,'-,CRY1,Morning person,chronotype measurement,GCST007565,12:107041627
rs10495976-<b>T</b>,5 x 10-14,,0.391,1.0279605,'-,'-,'-,Morning person,chronotype measurement,GCST007565,2:49523560
rs4241964-<b>G</b>,9 x 10-16,,0.4783,1.029442,'-,'-,'-,Morning person,chronotype measurement,GCST007565,4:136132804
rs2600667-<b>T</b>,9 x 10-14,,0.2963,1.0291243,'-,'-,AHSA2P,Morning person,chronotype measurement,GCST007565,2:61177796
rs202157-<b>C</b>,5 x 10-14,,0.3008,1.0291243,'-,'-,CUX1,Morning person,chronotype measurement,GCST007565,7:101994473
rs11052689-<b>C</b>,2 x 10-14,,0.5394,1.0290183,'-,'-,SYT10,Morning person,chronotype measurement,GCST007565,12:33415968
rs11152350-<b>C</b>,1 x 10-13,,0.533,1.0288066,'-,'-,ZCCHC2,Morning person,chronotype measurement,GCST007565,18:62573119
rs12554976-<b>G</b>,1 x 10-16,,0.6204,1.0287007,'-,'-,ZCCHC7,Morning person,chronotype measurement,GCST007565,9:37244508
rs11183201-<b>C</b>,8 x 10-17,,0.51,1.0287007,'-,'-,ARID2,Morning person,chronotype measurement,GCST007565,12:45777199
rs11641811-<b>C</b>,1 x 10-15,,0.4861,1.0287007,'-,'-,"TAT-AS1, MARVELD3",Morning person,chronotype measurement,GCST007565,16:71601933
rs848552-<b>G</b>,5 x 10-14,,0.5245,1.0277493,'-,'-,CRIM1,Morning person,chronotype measurement,GCST007565,2:36473437
rs621421-<b>C</b>,2 x 10-14,,0.3744,1.0277493,'-,'-,"MPPED2, RPL12P30",Morning person,chronotype measurement,GCST007565,11:30384367
rs11992186-<b>G</b>,6 x 10-14,,0.5073,1.0274324,'-,'-,"RN7SL178P, CLDN23",Morning person,chronotype measurement,GCST007565,8:8666964
rs7970129-<b>C</b>,1 x 10-15,,0.508,1.0274324,'-,'-,SCAF11,Morning person,chronotype measurement,GCST007565,12:46011267
rs6131942-<b>G</b>,7 x 10-16,,0.582,1.0274324,'-,'-,PCSK2,Morning person,chronotype measurement,GCST007565,20:17367963
rs2979139-<b>G</b>,4 x 10-14,,0.4952,1.0272213,'-,'-,PRAG1,Morning person,chronotype measurement,GCST007565,8:8410803
rs359248-<b>G</b>,2 x 10-16,,0.5436,1.0270104,'-,'-,MIR4432HG,Morning person,chronotype measurement,GCST007565,2:60250326
rs2404340-<b>C</b>,2 x 10-14,,0.5046,1.0270104,'-,'-,"EEF1GP4, NMD3",Morning person,chronotype measurement,GCST007565,3:161280514
rs13403127-<b>G</b>,1 x 10-14,,0.6319,1.025641,'-,'-,CAMKMT,Morning person,chronotype measurement,GCST007565,2:44489932
rs10070734-<b>C</b>,5 x 10-14,,0.7089,1.025536,'-,'-,LINC00461,Morning person,chronotype measurement,GCST007565,5:88644208
rs1579641-<b>A</b>,7 x 10-15,,0.6595,1.0252,'-,'-,CAMKMT,Morning person,chronotype measurement,GCST007565,2:44635000
rs2306061-<b>T</b>,8 x 10-14,,0.496,1.0269,'-,'-,PPM1L,Morning person,chronotype measurement,GCST007565,3:161069714
rs4729854-<b>T</b>,4 x 10-36,,0.5299,1.0490978,'-,'-,"RASA4DP, FAM185A",Morning person,chronotype measurement,GCST007565,7:102743216
rs975025-<b>C</b>,7 x 10-14,,0.9242,1.0487677,'-,'-,AXDND1,Morning person,chronotype measurement,GCST007565,1:179369192
rs4882315-<b>C</b>,7 x 10-36,,0.4929,1.0472301,'-,'-,AK6P2,Morning person,chronotype measurement,GCST007565,12:38065104
rs11180986-<b>G</b>,2 x 10-33,,0.4829,1.0454783,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:37870684
rs11526064-<b>T</b>,1 x 10-31,,0.5254,1.0450413,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:34530740
rs8189580-<b>C</b>,5 x 10-31,,0.45,1.0444955,'-,'-,ZNF970P,Morning person,chronotype measurement,GCST007565,12:37639662
rs56411893-<b>G</b>,6 x 10-17,,0.1586,1.0441684,'-,'-,IP6K2,Morning person,chronotype measurement,GCST007565,3:48732422
rs1283298-<b>G</b>,2 x 10-31,,0.4501,1.0439503,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:37753828
rs1421085-<b>C</b>,5 x 10-32,,0.4065,1.0432968,'-,'-,FTO,Morning person,chronotype measurement,GCST007565,16:53767042
rs7845620-<b>C</b>,8 x 10-19,,0.1656,1.0425354,'-,'-,ST18,Morning person,chronotype measurement,GCST007565,8:52216509
rs2048061-<b>C</b>,4 x 10-28,,0.4062,1.0424267,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:37473973
rs9705901-<b>C</b>,7 x 10-28,,0.4081,1.0423181,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:34423425
rs72720396-<b>G</b>,4 x 10-21,,0.2259,1.0416667,'-,'-,"BARHL2, LINC02609",Morning person,chronotype measurement,GCST007565,1:90726025
rs57862683-<b>G</b>,1 x 10-27,,0.5072,1.0409076,'-,'-,PLCL1,Morning person,chronotype measurement,GCST007565,2:197882813
rs2236950-<b>C</b>,2 x 10-16,,0.8258,1.0407994,'-,'-,CACNA2D2,Morning person,chronotype measurement,GCST007565,3:50383123
rs7111582-<b>G</b>,4 x 10-14,,0.1044,1.0403662,'-,'-,"ALKBH3, HSD17B12",Morning person,chronotype measurement,GCST007565,11:43871672
rs4394914-<b>G</b>,1 x 10-27,,0.5054,1.0399334,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:33684853
rs17604349-<b>G</b>,3 x 10-19,,0.8152,1.0385294,'-,'-,"LINC01572, PMFBP1",Morning person,chronotype measurement,GCST007565,16:72176966
rs2550298-<b>C</b>,6 x 10-26,,0.6189,1.0384216,'-,'-,GNAO1,Morning person,chronotype measurement,GCST007565,16:56334057
rs17575798-<b>G</b>,4 x 10-14,,0.8082,1.0379905,'-,'-,GPR61,Morning person,chronotype measurement,GCST007565,1:109543829
rs267733-<b>G</b>,2 x 10-14,,0.1591,1.0375596,'-,'-,ANXA9,Morning person,chronotype measurement,GCST007565,1:150986360
rs2340688-<b>C</b>,6 x 10-23,,0.4732,1.0369141,'-,'-,RFTN2,Morning person,chronotype measurement,GCST007565,2:197573701
rs1468945-<b>G</b>,6 x 10-16,,0.2148,1.0369141,'-,'-,DGKG,Morning person,chronotype measurement,GCST007565,3:186272603
rs735459-<b>C</b>,7 x 10-22,,0.3609,1.0369141,'-,'-,SLC26A5,Morning person,chronotype measurement,GCST007565,7:103424359
rs79864120-<b>G</b>,1 x 10-17,,0.7648,1.036162,'-,'-,MEF2C-AS1,Morning person,chronotype measurement,GCST007565,5:88908895
rs787988-<b>C</b>,8 x 10-21,,0.4423,1.0357327,'-,'-,"NPM1P46, ANKRD44",Morning person,chronotype measurement,GCST007565,2:197336078
rs3850174-<b>T</b>,3 x 10-15,,0.7425,1.0348753,'-,'-,NCEH1,Morning person,chronotype measurement,GCST007565,3:172646303
rs4269995-<b>C</b>,6 x 10-20,,0.749,1.0345541,'-,'-,TMEM161B-AS1,Morning person,chronotype measurement,GCST007565,5:88405406
rs72799142-<b>C</b>,2 x 10-17,,0.2877,1.0345541,'-,'-,LINC01470,Morning person,chronotype measurement,GCST007565,5:152721172
rs67988891-<b>G</b>,2 x 10-18,,0.3179,1.0344471,'-,'-,LINC01470,Morning person,chronotype measurement,GCST007565,5:152825181
rs12808544-<b>C</b>,3 x 10-15,,0.7591,1.0344471,'-,'-,"ZFP91-CNTF, ZFP91",Morning person,chronotype measurement,GCST007565,11:58605748
rs2706762-<b>C</b>,4 x 10-14,,0.8504,1.0341262,'-,'-,PCYOX1,Morning person,chronotype measurement,GCST007565,2:70261338
rs6993892-<b>C</b>,5 x 10-20,,0.3838,1.0339123,'-,'-,'-,Morning person,chronotype measurement,GCST007565,8:33871682
rs7736377-<b>G</b>,4 x 10-18,,0.3215,1.0338055,'-,'-,LINC01470,Morning person,chronotype measurement,GCST007565,5:152930241
rs12541362-<b>T</b>,4 x 10-19,,0.3405,1.0338055,'-,'-,VENTXP5,Morning person,chronotype measurement,GCST007565,8:33727143
rs10916892-<b>C</b>,5 x 10-19,,0.3797,1.0335917,'-,'-,EIF4G3,Morning person,chronotype measurement,GCST007565,1:20874832
rs139911-<b>C</b>,1 x 10-18,,0.4278,1.0333781,'-,'-,TNRC6B,Morning person,chronotype measurement,GCST007565,22:40308048
rs4715491-<b>G</b>,2 x 10-14,,0.2246,1.0332713,'-,'-,FAM83B,Morning person,chronotype measurement,GCST007565,6:54899522
rs5467-<b>C</b>,2 x 10-15,,0.7852,1.0331646,'-,'-,TXNL4B,Morning person,chronotype measurement,GCST007565,16:72054381
rs1456038-<b>G</b>,2 x 10-16,,0.469,1.0329511,'-,'-,"AVPR1A, HNRNPA1P69",Morning person,chronotype measurement,GCST007565,12:63236717
rs6846730-<b>C</b>,3 x 10-14,,0.7647,1.0326312,'-,'-,HNRNPD,Morning person,chronotype measurement,GCST007565,4:82357888
rs7925560-<b>G</b>,1 x 10-13,,0.7688,1.0326312,'-,'-,"OR5B21, OR5B12",Morning person,chronotype measurement,GCST007565,11:58495563
rs7304278-<b>G</b>,2 x 10-14,,0.7173,1.0320983,'-,'-,RFX4,Morning person,chronotype measurement,GCST007565,12:106596137
rs12404954-<b>G</b>,1 x 10-17,,0.3903,1.0314595,'-,'-,HP1BP3,Morning person,chronotype measurement,GCST007565,1:20748234
rs6680486-<b>C</b>,1 x 10-17,,0.4005,1.0313531,'-,'-,EIF4G3,Morning person,chronotype measurement,GCST007565,1:20976281
rs6001817-<b>G</b>,7 x 10-17,,0.4062,1.0313531,'-,'-,TNRC6B,Morning person,chronotype measurement,GCST007565,22:40165755
rs12752290-<b>C</b>,3 x 10-18,,0.4444,1.0311404,'-,'-,"EIF4G3, ECE1",Morning person,chronotype measurement,GCST007565,1:21208837
rs13011556-<b>G</b>,1 x 10-13,,0.2376,1.0310341,'-,'-,"LINC01249, NPM1P48",Morning person,chronotype measurement,GCST007565,2:4604333
rs2731553-<b>C</b>,2 x 10-14,,0.2435,1.0310341,'-,'-,ARHGAP15,Morning person,chronotype measurement,GCST007565,2:143616372
rs7959983-<b>C</b>,5 x 10-16,,0.4045,1.0310341,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:90059201
rs9574021-<b>A</b>,8 x 10-19,,0.98,1.1135,'-,'-,MYCBP2,Morning person,chronotype measurement,GCST007565,13:77239199
rs9573980-<b>A</b>,5 x 10-36,,0.9659,1.1311,'-,'-,"FBXL3, CLN5",Morning person,chronotype measurement,GCST007565,13:77016606
rs114769095-<b>C</b>,1 x 10-27,,0.0242,1.1441,'-,'-,LINC02610,Morning person,chronotype measurement,GCST007565,2:238231384
rs149611468-<b>T</b>,6 x 10-15,,0.9888,1.146,'-,'-,"CAV3, RAD18",Morning person,chronotype measurement,GCST007565,3:8775737
rs112289739-<b>T</b>,3 x 10-15,,0.0081,1.1503,'-,'-,RGS17,Morning person,chronotype measurement,GCST007565,6:153129930
rs115807391-<b>A</b>,2 x 10-14,,0.0067,1.1807,'-,'-,NMNAT2,Morning person,chronotype measurement,GCST007565,1:183357633
rs183708046-<b>A</b>,1 x 10-19,,0.0079,1.2066,'-,'-,LAMC2,Morning person,chronotype measurement,GCST007565,1:183208749
rs76626729-<b>A</b>,9 x 10-22,,0.0071,1.2286,'-,'-,CAMTA1,Morning person,chronotype measurement,GCST007565,1:7684499
rs1144566-<b>T</b>,2 x 10-95,,0.029,1.2442,'-,'-,RGS16,Morning person,chronotype measurement,GCST007565,1:182600491
rs78743131-<b>T</b>,1 x 10-28,,0.0084,1.2526,'-,'-,"LINC01688, NPL",Morning person,chronotype measurement,GCST007565,1:182752764
rs61963491-<b>A</b>,4 x 10-19,,0.9931,1.254,'-,'-,MYCBP2,Morning person,chronotype measurement,GCST007565,13:77370501
rs74340015-<b>T</b>,7 x 10-30,,0.009,1.2624,'-,'-,RGSL1,Morning person,chronotype measurement,GCST007565,1:182454446
rs142872577-<b>A</b>,1 x 10-14,,0.0032,1.7468,'-,'-,CAMTA1,Morning person,chronotype measurement,GCST007565,1:7562399
rs9479402-<b>C</b>,4 x 10-33,,0.0117,1.2443334,'-,'-,LINC02840,Chronotype,chronotype measurement,GCST007576,6:152814204
rs80271258-<b>C</b>,4 x 10-43,,0.9156,1.0935179,'-,'-,"RNU6-234P, TRAF3IP1",Chronotype,chronotype measurement,GCST007576,2:238402864
rs112201801-<b>C</b>,1 x 10-10,,0.0709,1.0889279,'-,'-,LINC02008,Chronotype,chronotype measurement,GCST007576,3:82542228
rs114848860-<b>T</b>,1 x 10-13,,0.0263,1.0798261,'-,'-,"LINC02033, HSPD1P6",Chronotype,chronotype measurement,GCST007576,3:36818003
rs115073088-<b>G</b>,4 x 10-12,,0.025,1.0784233,'-,'-,RABGAP1L,Chronotype,chronotype measurement,GCST007576,1:174246720
rs28458909-<b>C</b>,1 x 10-33,,0.8775,1.0727227,'-,'-,EXD3,Chronotype,chronotype measurement,GCST007576,9:137362737
rs62553781-<b>C</b>,1 x 10-12,,0.9671,1.0713291,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,9:74064861
rs12140153-<b>G</b>,7 x 10-19,,0.9108,1.0622613,'-,'-,PATJ,Chronotype,chronotype measurement,GCST007576,1:62114219
rs10254050-<b>G</b>,4 x 10-29,,0.8095,1.0593971,'-,'-,MARK2P10,Chronotype,chronotype measurement,GCST007576,7:96838765
rs113851554-<b>G</b>,2 x 10-13,,0.9433,1.0554847,'-,'-,MEIS1,Chronotype,chronotype measurement,GCST007576,2:66523432
rs71523448-<b>G</b>,2 x 10-13,,0.9212,1.051166,'-,'-,NRG1,Chronotype,chronotype measurement,GCST007576,8:31959977
rs11545787-<b>G</b>,4 x 10-30,,0.7518,1.0510609,'-,'-,RASD1,Chronotype,chronotype measurement,GCST007576,17:17494964
rs2055975-<b>A</b>,6 x 10-15,,0.2912,1.0328,'-,'-,"ENSA, GOLPH3L",Morning person,chronotype measurement,GCST007565,1:150646156
rs10951325-<b>T</b>,8 x 10-20,,0.6319,1.0328,'-,'-,PDE1C,Morning person,chronotype measurement,GCST007565,7:32225933
rs12195792-<b>A</b>,5 x 10-15,,0.2717,1.0329,'-,'-,EIF4EBP2P3,Morning person,chronotype measurement,GCST007565,6:98257419
rs13208701-<b>A</b>,6 x 10-19,,0.3534,1.0334,'-,'-,"FAM83B, HCRTR2",Morning person,chronotype measurement,GCST007565,6:55015670
rs2860457-<b>T</b>,1 x 10-13,,0.7895,1.0336,'-,'-,'-,Morning person,chronotype measurement,GCST007565,13:55435759
rs7429614-<b>T</b>,2 x 10-19,,0.416,1.0337,'-,'-,ROBO2,Morning person,chronotype measurement,GCST007565,3:77156287
rs1367233-<b>A</b>,3 x 10-19,,0.7486,1.0339,'-,'-,TMEM161B-AS1,Morning person,chronotype measurement,GCST007565,5:88301195
rs9381653-<b>A</b>,2 x 10-15,,0.3003,1.0339,'-,'-,PHACTR1,Morning person,chronotype measurement,GCST007565,6:13064164
rs35524253-<b>A</b>,3 x 10-18,,0.3539,1.0339,'-,'-,CSMD1,Morning person,chronotype measurement,GCST007565,8:4966086
rs4527088-<b>A</b>,7 x 10-19,,0.5899,1.0341,'-,'-,'-,Morning person,chronotype measurement,GCST007565,18:40439032
rs10742179-<b>A</b>,3 x 10-15,,0.2627,1.0344,'-,'-,"BDNF-AS, LINC00678",Morning person,chronotype measurement,GCST007565,11:27628977
rs9597241-<b>A</b>,9 x 10-14,,0.8106,1.0344,'-,'-,'-,Morning person,chronotype measurement,GCST007565,13:55707137
rs7315607-<b>A</b>,1 x 10-17,,0.3439,1.0346,'-,'-,LINC02406,Morning person,chronotype measurement,GCST007565,12:39071889
rs2736208-<b>T</b>,4 x 10-16,,0.239,1.035,'-,'-,TRPS1,Morning person,chronotype measurement,GCST007565,8:115814018
rs9416744-<b>A</b>,7 x 10-17,,0.2595,1.0351,'-,'-,BICC1,Morning person,chronotype measurement,GCST007565,10:58808177
rs723427-<b>A</b>,9 x 10-14,,0.182,1.0352,'-,'-,"NMUR2, LINC01933",Morning person,chronotype measurement,GCST007565,5:152316208
rs11924337-<b>C</b>,3 x 10-16,,0.2707,1.0353,'-,'-,ROBO2,Morning person,chronotype measurement,GCST007565,3:77272419
rs16939162-<b>A</b>,1 x 10-14,,0.8304,1.0354,'-,'-,'-,Morning person,chronotype measurement,GCST007565,8:75740921
rs10877962-<b>T</b>,4 x 10-18,,0.4083,1.0354,'-,'-,"RSL24D1P5, AVPR1A",Morning person,chronotype measurement,GCST007565,12:63127132
rs10520176-<b>T</b>,5 x 10-24,,0.4926,1.0358,'-,'-,"LRRTM4-AS1, LRRTM4",Morning person,chronotype measurement,GCST007565,2:76990184
rs7314943-<b>A</b>,4 x 10-22,,0.5785,1.0359,'-,'-,"RNU6-400P, SYT10",Morning person,chronotype measurement,GCST007565,12:33523772
rs4958318-<b>T</b>,7 x 10-18,,0.2853,1.036,'-,'-,LINC01470,Morning person,chronotype measurement,GCST007565,5:152563493
rs10237162-<b>T</b>,2 x 10-18,,0.7232,1.037,'-,'-,RNA5SP228,Morning person,chronotype measurement,GCST007565,7:24045786
rs12969848-<b>T</b>,1 x 10-21,,0.5313,1.037,'-,'-,'-,Morning person,chronotype measurement,GCST007565,18:40572871
rs3731570-<b>T</b>,3 x 10-23,,0.4737,1.0373,'-,'-,"RNU6-1029P, COQ10B",Morning person,chronotype measurement,GCST007565,2:197453059
rs712255-<b>A</b>,1 x 10-13,,0.6212,1.0275,'-,'-,"FAM86B3P, PRAG1",Morning person,chronotype measurement,GCST007565,8:8262194
rs2979256-<b>T</b>,9 x 10-14,,0.4476,1.0279,'-,'-,ERI1,Morning person,chronotype measurement,GCST007565,8:9014200
rs1873958-<b>A</b>,2 x 10-15,,0.4088,1.0279,'-,'-,ASB7,Morning person,chronotype measurement,GCST007565,15:100607521
rs9347926-<b>A</b>,1 x 10-13,,0.4407,1.0281,'-,'-,'-,Morning person,chronotype measurement,GCST007565,6:164774517
rs1599374-<b>A</b>,3 x 10-15,,0.5163,1.0285,'-,'-,NMD3,Morning person,chronotype measurement,GCST007565,3:161173939
rs215639-<b>T</b>,2 x 10-15,,0.6544,1.0287,'-,'-,PDE1C,Morning person,chronotype measurement,GCST007565,7:32334027
rs2291589-<b>T</b>,2 x 10-16,,0.6252,1.0288,'-,'-,EBLN3P,Morning person,chronotype measurement,GCST007565,9:37079664
rs247929-<b>C</b>,5 x 10-17,,0.5081,1.0291,'-,'-,ARID2,Morning person,chronotype measurement,GCST007565,12:45901125
rs10953388-<b>T</b>,2 x 10-14,,0.3726,1.0292,'-,'-,RELN,Morning person,chronotype measurement,GCST007565,7:103545824
rs2553100-<b>A</b>,3 x 10-14,,0.4115,1.0292,'-,'-,BRWD1P2,Morning person,chronotype measurement,GCST007565,12:89879521
rs2916148-<b>A</b>,3 x 10-14,,0.4522,1.0292,'-,'-,PITPNC1,Morning person,chronotype measurement,GCST007565,17:67485993
rs308521-<b>T</b>,4 x 10-17,,0.6039,1.0293,'-,'-,"ZCCHC7, LINC01627",Morning person,chronotype measurement,GCST007565,9:37367097
rs2910032-<b>T</b>,6 x 10-14,,0.5185,1.0294,'-,'-,LINC01470,Morning person,chronotype measurement,GCST007565,5:153160794
rs4842509-<b>T</b>,1 x 10-14,,0.3976,1.0295,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:90168240
rs6477309-<b>T</b>,5 x 10-15,,0.6661,1.0301,'-,'-,PTPRD,Morning person,chronotype measurement,GCST007565,9:8450638
rs2072727-<b>T</b>,4 x 10-15,,0.4327,1.0302,'-,'-,PABPC1L,Morning person,chronotype measurement,GCST007565,20:44910092
rs4739403-<b>A</b>,2 x 10-16,,0.359,1.0304,'-,'-,'-,Morning person,chronotype measurement,GCST007565,8:34089439
rs7459675-<b>A</b>,2 x 10-16,,0.3789,1.0305,'-,'-,'-,Morning person,chronotype measurement,GCST007565,8:33979579
rs1886205-<b>A</b>,6 x 10-14,,0.7604,1.0307,'-,'-,GPC6,Morning person,chronotype measurement,GCST007565,13:93409842
rs8044054-<b>T</b>,7 x 10-17,,0.3878,1.0315,'-,'-,GNPATP,Morning person,chronotype measurement,GCST007565,16:60594532
rs957163-<b>T</b>,9 x 10-18,,0.3999,1.0316,'-,'-,EIF4G3,Morning person,chronotype measurement,GCST007565,1:21089688
rs1929447-<b>A</b>,6 x 10-19,,0.569,1.0317,'-,'-,LRRTM4,Morning person,chronotype measurement,GCST007565,2:76881187
rs17448682-<b>T</b>,3 x 10-16,,0.2339,1.0326,'-,'-,DDI2,Morning person,chronotype measurement,GCST007565,1:15640218
rs6967481-<b>T</b>,8 x 10-21,,0.5011,1.0326,'-,'-,"DDC, GRB10",Morning person,chronotype measurement,GCST007565,7:50575004
rs2737245-<b>T</b>,3 x 10-17,,0.2748,1.0327,'-,'-,TRPS1,Morning person,chronotype measurement,GCST007565,8:115646356
rs1843888-<b>A</b>,2 x 10-43,,0.5433,1.052,'-,'-,ALG10B,Morning person,chronotype measurement,GCST007565,12:38343508
rs62260798-<b>T</b>,2 x 10-16,,0.0813,1.0527,'-,'-,GNAI2,Morning person,chronotype measurement,GCST007565,3:50236846
rs12427164-<b>A</b>,4 x 10-43,,0.5416,1.053,'-,'-,'-,Morning person,chronotype measurement,GCST007565,12:38474975
rs79821347-<b>A</b>,4 x 10-14,,0.0677,1.0539,'-,'-,CACNA2D2,Morning person,chronotype measurement,GCST007565,3:50494404
rs116131939-<b>T</b>,6 x 10-16,,0.0833,1.0543,'-,'-,NRXN1,Morning person,chronotype measurement,GCST007565,2:50033268
rs12927162-<b>A</b>,6 x 10-38,,0.7276,1.0544,'-,'-,CASC16,Morning person,chronotype measurement,GCST007565,16:52651004
rs62261468-<b>T</b>,5 x 10-14,,0.0715,1.0547,'-,'-,PFKFB4,Morning person,chronotype measurement,GCST007565,3:48548762
rs62262466-<b>A</b>,1 x 10-16,,0.0794,1.0555,'-,'-,ARIH2,Morning person,chronotype measurement,GCST007565,3:48952211
rs62436127-<b>C</b>,3 x 10-27,,0.162,1.0556,'-,'-,MTRF1L,Morning person,chronotype measurement,GCST007565,6:152999483
rs17040190-<b>C</b>,2 x 10-14,,0.0742,1.057,'-,'-,NRXN1,Morning person,chronotype measurement,GCST007565,2:50203415
rs62260125-<b>T</b>,1 x 10-13,,0.0617,1.0572,'-,'-,DOCK3,Morning person,chronotype measurement,GCST007565,3:50688763
rs6797500-<b>A</b>,3 x 10-18,,0.082,1.0577,'-,'-,CAMKV,Morning person,chronotype measurement,GCST007565,3:49859185
rs62260771-<b>C</b>,7 x 10-19,,0.0821,1.0585,'-,'-,SEMA3F-AS1,Morning person,chronotype measurement,GCST007565,3:50128130
rs62259941-<b>A</b>,1 x 10-17,,0.076,1.0594,'-,'-,RHOA,Morning person,chronotype measurement,GCST007565,3:49377868
rs12636669-<b>T</b>,5 x 10-19,,0.0801,1.0596,'-,'-,RBM6,Morning person,chronotype measurement,GCST007565,3:49965890
rs184033703-<b>A</b>,1 x 10-13,,0.0585,1.0607,'-,'-,"NDUFS1, INO80D",Morning person,chronotype measurement,GCST007565,2:206091414
rs35982802-<b>A</b>,6 x 10-14,,0.0553,1.0607,'-,'-,"RNU6-1023P, KRASP1",Morning person,chronotype measurement,GCST007565,6:54781755
rs1061032-<b>T</b>,2 x 10-23,,0.094,1.0634,'-,'-,VAMP2,Morning person,chronotype measurement,GCST007565,17:8160765
rs12030598-<b>A</b>,4 x 10-40,,0.1777,1.0635,'-,'-,AK5,Morning person,chronotype measurement,GCST007565,1:77354442
rs77181415-<b>C</b>,6 x 10-20,,0.0784,1.0642,'-,'-,PIGK,Morning person,chronotype measurement,GCST007565,1:77124675
rs61773390-<b>T</b>,5 x 10-41,,0.1931,1.065,'-,'-,PER3,Morning person,chronotype measurement,GCST007565,1:7824465
rs2653349-<b>A</b>,3 x 10-48,,0.2073,1.0679,'-,'-,HCRTR2,Morning person,chronotype measurement,GCST007565,6:55277539
rs12040629-<b>A</b>,5 x 10-45,,0.16,1.0713,'-,'-,"PIGK, AK5",Morning person,chronotype measurement,GCST007565,1:77239680
rs11032362-<b>A</b>,1 x 10-27,,0.0937,1.0743,'-,'-,"CD59, FBXO3",Morning person,chronotype measurement,GCST007565,11:33737546
rs75120545-<b>T</b>,7 x 10-17,,0.0319,1.0972,'-,'-,LRPPRC,Morning person,chronotype measurement,GCST007565,2:44044357
rs138267314-<b>T</b>,6 x 10-26,,0.0045,1.3460763,'-,'-,"ERRFI1, U8",Morning person,chronotype measurement,GCST007565,1:8065431
rs141498473-<b>G</b>,2 x 10-25,,0.0086,1.2434717,'-,'-,"LINC01344, RNU6-152P",Morning person,chronotype measurement,GCST007565,1:182325137
rs9479402-<b>C</b>,4 x 10-33,,0.0117,1.2335019,'-,'-,LINC02840,Morning person,chronotype measurement,GCST007565,6:152814204
rs186768855-<b>G</b>,2 x 10-24,,0.0086,1.225941,'-,'-,SHCBP1L,Morning person,chronotype measurement,GCST007565,1:182910881
rs191268001-<b>G</b>,3 x 10-16,,0.007,1.1954573,'-,'-,LINC01344,Morning person,chronotype measurement,GCST007565,1:182123821
rs9573999-<b>C</b>,1 x 10-18,,0.9802,1.1128422,'-,'-,"MYCBP2-AS1, MYCBP2",Morning person,chronotype measurement,GCST007565,13:77122121
rs140647239-<b>C</b>,1 x 10-13,,0.0175,1.1053388,'-,'-,FBXL13,Morning person,chronotype measurement,GCST007565,7:102995330
rs7795180-<b>C</b>,3 x 10-23,,0.954,1.0938525,'-,'-,ALKBH4,Morning person,chronotype measurement,GCST007565,7:102460731
rs80271258-<b>C</b>,4 x 10-43,,0.9156,1.0913455,'-,'-,"RNU6-234P, TRAF3IP1",Morning person,chronotype measurement,GCST007565,2:238402864
rs114848860-<b>T</b>,1 x 10-13,,0.0263,1.0876659,'-,'-,"LINC02033, HSPD1P6",Morning person,chronotype measurement,GCST007565,3:36818003
rs28458909-<b>C</b>,1 x 10-33,,0.8775,1.0713521,'-,'-,EXD3,Morning person,chronotype measurement,GCST007565,9:137362737
rs72993073-<b>G</b>,8 x 10-36,,0.874,1.0690614,'-,'-,"ASB1, LINC01107",Morning person,chronotype measurement,GCST007565,2:238504284
rs11539148-<b>C</b>,4 x 10-17,,0.0665,1.0623606,'-,'-,QARS1,Morning person,chronotype measurement,GCST007565,3:49101377
rs112017743-<b>C</b>,3 x 10-18,,0.0747,1.0608954,'-,'-,RNF123,Morning person,chronotype measurement,GCST007565,3:49709137
rs62262670-<b>T</b>,1 x 10-17,,0.0777,1.0590976,'-,'-,BSN,Morning person,chronotype measurement,GCST007565,3:49608773
rs73228360-<b>C</b>,1 x 10-13,,0.9258,1.0574179,'-,'-,SEM1,Morning person,chronotype measurement,GCST007565,7:96736111
rs113851554-<b>G</b>,2 x 10-13,,0.9433,1.0566356,'-,'-,MEIS1,Morning person,chronotype measurement,GCST007565,2:66523432
rs10254050-<b>G</b>,4 x 10-29,,0.8095,1.0563009,'-,'-,MARK2P10,Morning person,chronotype measurement,GCST007565,7:96838765
rs12140153-<b>G</b>,7 x 10-19,,0.9108,1.0558547,'-,'-,PATJ,Morning person,chronotype measurement,GCST007565,1:62114219
rs7312879-<b>G</b>,5 x 10-43,,0.5495,1.0521885,'-,'-,CPNE8,Morning person,chronotype measurement,GCST007565,12:38756950
rs71523448-<b>G</b>,2 x 10-13,,0.9212,1.0518565,'-,'-,NRG1,Morning person,chronotype measurement,GCST007565,8:31959977
rs9964420-<b>C</b>,2 x 10-37,,0.7017,1.049979,'-,'-,SEC11C,Morning person,chronotype measurement,GCST007565,18:59156809
rs9381812-<b>G</b>,1 x 10-33,,0.2949,1.0497586,'-,'-,PHACTR1,Morning person,chronotype measurement,GCST007565,6:13183766
rs13203948-<b>C</b>,8 x 10-16,,0.1102,1.0496484,'-,'-,"HMGCLL1, GFRAL",Morning person,chronotype measurement,GCST007565,6:55407146
rs11545787-<b>G</b>,4 x 10-30,,0.7518,1.0495381,'-,'-,RASD1,Morning person,chronotype measurement,GCST007565,17:17494964
rs9381812-<b>G</b>,1 x 10-33,,0.2949,1.0507456,'-,'-,PHACTR1,Chronotype,chronotype measurement,GCST007576,6:13183766
rs975025-<b>C</b>,7 x 10-14,,0.9242,1.0502204,'-,'-,AXDND1,Chronotype,chronotype measurement,GCST007576,1:179369192
rs9964420-<b>C</b>,2 x 10-37,,0.7017,1.0500103,'-,'-,SEC11C,Chronotype,chronotype measurement,GCST007576,18:59156809
rs4729854-<b>T</b>,4 x 10-36,,0.5299,1.0496954,'-,'-,"RASA4DP, FAM185A",Chronotype,chronotype measurement,GCST007576,7:102743216
rs7060620-<b>T</b>,1 x 10-11,,0.1857,1.0458744,'-,'-,"GK4P, RNU6-587P",Chronotype,chronotype measurement,GCST007576,X:101757875
rs62124718-<b>G</b>,3 x 10-13,,0.105,1.0457141,'-,'-,MIR3681HG,Chronotype,chronotype measurement,GCST007576,2:12682869
rs7845620-<b>C</b>,8 x 10-19,,0.1656,1.043416,'-,'-,ST18,Chronotype,chronotype measurement,GCST007576,8:52216509
rs1421085-<b>C</b>,5 x 10-32,,0.4065,1.0427902,'-,'-,FTO,Chronotype,chronotype measurement,GCST007576,16:53767042
rs72720396-<b>G</b>,4 x 10-21,,0.2259,1.0424774,'-,'-,"BARHL2, LINC02609",Chronotype,chronotype measurement,GCST007576,1:90726025
rs2550298-<b>C</b>,6 x 10-26,,0.6189,1.0408108,'-,'-,GNAO1,Chronotype,chronotype measurement,GCST007576,16:56334057
rs146820337-<b>I</b>,2 x 10-10,,0.5249,1.0405612,'-,'-,BRINP3,Chronotype,chronotype measurement,GCST007576,1:190125997
rs7111582-<b>G</b>,4 x 10-14,,0.1044,1.0395626,'-,'-,"ALKBH3, HSD17B12",Chronotype,chronotype measurement,GCST007576,11:43871672
rs17604349-<b>G</b>,3 x 10-19,,0.8152,1.0381081,'-,'-,"LINC01572, PMFBP1",Chronotype,chronotype measurement,GCST007576,16:72176966
rs2706762-<b>C</b>,4 x 10-14,,0.8504,1.037693,'-,'-,PCYOX1,Chronotype,chronotype measurement,GCST007576,2:70261338
rs213462-<b>C</b>,5 x 10-12,,0.45,1.0369687,'-,'-,POU3F4,Chronotype,chronotype measurement,GCST007576,X:83449447
rs1468945-<b>G</b>,6 x 10-16,,0.2148,1.0369669,'-,'-,DGKG,Chronotype,chronotype measurement,GCST007576,3:186272603
rs67988891-<b>G</b>,2 x 10-18,,0.3179,1.0369669,'-,'-,LINC01470,Chronotype,chronotype measurement,GCST007576,5:152825181
rs36055559-<b>G</b>,7 x 10-12,,0.834,1.0366558,'-,'-,"NRTN, DUS3L",Chronotype,chronotype measurement,GCST007576,19:5799422
rs80097534-<b>G</b>,3 x 10-9,,0.9034,1.0363449,'-,'-,"POP5, RPL11P5",Chronotype,chronotype measurement,GCST007576,12:120591801
rs67169439-<b>I</b>,3 x 10-8,,0.3986,1.0359389,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,Mapping not available
rs12808544-<b>C</b>,3 x 10-15,,0.7591,1.0354125,'-,'-,"ZFP91-CNTF, ZFP91",Chronotype,chronotype measurement,GCST007576,11:58605748
rs6993892-<b>C</b>,5 x 10-20,,0.3838,1.0353091,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,8:33871682
rs3850174-<b>T</b>,3 x 10-15,,0.7425,1.0352055,'-,'-,NCEH1,Chronotype,chronotype measurement,GCST007576,3:172646303
rs10916892-<b>C</b>,5 x 10-19,,0.3797,1.035102,'-,'-,EIF4G3,Chronotype,chronotype measurement,GCST007576,1:20874832
rs4269995-<b>C</b>,6 x 10-20,,0.749,1.0344812,'-,'-,TMEM161B-AS1,Chronotype,chronotype measurement,GCST007576,5:88405406
rs12249410-<b>G</b>,3 x 10-9,,0.8923,1.0342742,'-,'-,ZNF365,Chronotype,chronotype measurement,GCST007576,10:62542182
rs17575798-<b>G</b>,4 x 10-14,,0.8082,1.0341709,'-,'-,GPR61,Chronotype,chronotype measurement,GCST007576,1:109543829
rs139911-<b>C</b>,1 x 10-18,,0.4278,1.0341709,'-,'-,TNRC6B,Chronotype,chronotype measurement,GCST007576,22:40308048
rs73026775-<b>G</b>,2 x 10-8,,0.8754,1.0340675,'-,'-,ZNF536,Chronotype,chronotype measurement,GCST007576,19:30562047
rs77248969-<b>G</b>,5 x 10-9,,0.8884,1.0338607,'-,'-,"UBXN4, R3HDM1",Chronotype,chronotype measurement,GCST007576,2:135733161
rs4761989-<b>C</b>,7 x 10-10,,0.132,1.0338607,'-,'-,SCN8A,Chronotype,chronotype measurement,GCST007576,12:51648358
rs2166559-<b>C</b>,2 x 10-9,,0.1389,1.0334471,'-,'-,"EPC2, RNU2-9P",Chronotype,chronotype measurement,GCST007576,2:148794089
rs2011528-<b>C</b>,3 x 10-11,,0.1746,1.0334471,'-,'-,AP2B1,Chronotype,chronotype measurement,GCST007576,17:35653547
rs6846730-<b>C</b>,3 x 10-14,,0.7647,1.0328273,'-,'-,HNRNPD,Chronotype,chronotype measurement,GCST007576,4:82357888
rs66507804-<b>C</b>,4 x 10-11,,0.201,1.032724,'-,'-,"CCNH, RASA1",Chronotype,chronotype measurement,GCST007576,5:87334467
rs111867612-<b>C</b>,4 x 10-8,,0.8979,1.0325176,'-,'-,"SHOX2, RN7SKP46",Chronotype,chronotype measurement,GCST007576,3:158004030
rs34329963-<b>C</b>,1 x 10-8,,0.887,1.032311,'-,'-,RNU6-1037P,Chronotype,chronotype measurement,GCST007576,18:66858996
rs35346733-<b>G</b>,4 x 10-10,,0.8058,1.0321046,'-,'-,CNTN4,Chronotype,chronotype measurement,GCST007576,3:2479638
rs3747463-<b>C</b>,3 x 10-9,,0.6391,1.0320705,'-,'-,FAM155B,Chronotype,chronotype measurement,GCST007576,X:69531878
rs10832648-<b>C</b>,7 x 10-12,,0.8011,1.0318981,'-,'-,SOX6,Chronotype,chronotype measurement,GCST007576,11:16596760
rs10917513-<b>C</b>,3 x 10-15,,0.3524,1.0313823,'-,'-,HTR6,Chronotype,chronotype measurement,GCST007576,1:19680394
rs295268-<b>C</b>,2 x 10-10,,0.2597,1.0312792,'-,'-,GKAP1,Chronotype,chronotype measurement,GCST007576,9:83814390
rs59986227-<b>G</b>,1 x 10-11,,0.2507,1.0311761,'-,'-,SEMA6D,Chronotype,chronotype measurement,GCST007576,15:47717066
rs812925-<b>G</b>,7 x 10-17,,0.3542,1.031073,'-,'-,USP34,Chronotype,chronotype measurement,GCST007576,2:61453858
rs11670534-<b>C</b>,5 x 10-10,,0.8386,1.0309699,'-,'-,PPP5D1,Chronotype,chronotype measurement,GCST007576,19:46500649
rs72729847-<b>C</b>,1 x 10-10,,0.1995,1.0307637,'-,'-,SLC10A7,Chronotype,chronotype measurement,GCST007576,4:146375778
rs72841368-<b>T</b>,2 x 10-11,,0.1896,1.0305576,'-,'-,TANC2,Chronotype,chronotype measurement,GCST007576,17:63313753
rs7959983-<b>C</b>,5 x 10-16,,0.4045,1.0303515,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,12:90059201
rs1811899-<b>C</b>,1 x 10-9,,0.2105,1.0302485,'-,'-,HNRNPA1P58,Chronotype,chronotype measurement,GCST007576,6:14877829
rs7701529-<b>T</b>,5 x 10-12,,0.7607,1.0299394,'-,'-,RGS7BP,Chronotype,chronotype measurement,GCST007576,5:64565648
rs6816922-<b>C</b>,4 x 10-8,,0.4623,1.0202013,'-,'-,"LINC01088, NAA11",Chronotype,chronotype measurement,GCST007576,4:79285118
rs1799464-<b>G</b>,3 x 10-8,,0.7132,1.0202013,'-,'-,"DERA, SLC15A5",Chronotype,chronotype measurement,GCST007576,12:16133148
rs9956387-<b>T</b>,3 x 10-8,,0.5047,1.0199974,'-,'-,SKOR2,Chronotype,chronotype measurement,GCST007576,18:47247011
rs6468316-<b>C</b>,3 x 10-8,,0.5292,1.0198953,'-,'-,UNC5D,Chronotype,chronotype measurement,GCST007576,8:35380270
rs7203707-<b>C</b>,5 x 10-10,,0.4807,1.0198953,'-,'-,RBBP6,Chronotype,chronotype measurement,GCST007576,16:24507248
rs6665637-<b>G</b>,2 x 10-9,,0.7196,1.0197933,'-,'-,"Y_RNA, SLC27A3",Chronotype,chronotype measurement,GCST007576,1:153783607
rs4365329-<b>T</b>,3 x 10-8,,0.4617,1.0195894,'-,'-,ASIC2,Chronotype,chronotype measurement,GCST007576,17:33298869
rs4690085-<b>G</b>,2 x 10-8,,0.4652,1.0194875,'-,'-,FAM193A,Chronotype,chronotype measurement,GCST007576,4:2695573
rs9558942-<b>C</b>,4 x 10-8,,0.3278,1.0193856,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,13:107047870
rs13004345-<b>C</b>,2 x 10-9,,0.3525,1.0190797,'-,'-,"MAP3K20-AS1, MAP3K20",Chronotype,chronotype measurement,GCST007576,2:173172619
rs7900191-<b>C</b>,5 x 10-8,,0.5965,1.018876,'-,'-,"EMX2OS, PDZD8",Chronotype,chronotype measurement,GCST007576,10:117386263
rs7225002-<b>G</b>,5 x 10-8,,0.4084,1.0180612,'-,'-,KANSL1,Chronotype,chronotype measurement,GCST007576,17:46111701
rs1502249-<b>A</b>,3 x 10-8,,0.5223,1.0174506,'-,'-,"SORCS2, IGBP1P5",Chronotype,chronotype measurement,GCST007576,4:27493757
rs66617308-<b>T</b>,4 x 10-8,,0.6713,1.0185703,'-,'-,PCDH15,Chronotype,chronotype measurement,GCST007576,10:54939578
rs4860734-<b>A</b>,3 x 10-8,,0.2897,1.0196913,'-,'-,MIR1269A,Chronotype,chronotype measurement,GCST007576,4:66231186
rs747003-<b>T</b>,3 x 10-8,,0.6088,1.0197934,'-,'-,TANK-AS1,Chronotype,chronotype measurement,GCST007576,2:161059898
rs909757-<b>T</b>,1 x 10-8,,0.63,1.0198953,'-,'-,AJAP1,Chronotype,chronotype measurement,GCST007576,1:4790763
rs1221502-<b>A</b>,1 x 10-8,,0.7386,1.0198953,'-,'-,LINC01031,Chronotype,chronotype measurement,GCST007576,1:193307845
rs11788633-<b>C</b>,7 x 10-9,,0.6547,1.0198953,'-,'-,ZNF618,Chronotype,chronotype measurement,GCST007576,9:114005376
rs2506089-<b>T</b>,3 x 10-8,,0.5682,1.0199974,'-,'-,"SRSF10, MYOM3",Chronotype,chronotype measurement,GCST007576,1:23995445
rs34967119-<b>A</b>,1 x 10-8,,0.4958,1.0202013,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,3:105059586
rs3808964-<b>T</b>,1 x 10-8,,0.6326,1.0202013,'-,'-,GPR26,Chronotype,chronotype measurement,GCST007576,10:123667111
rs6429233-<b>A</b>,1 x 10-8,,0.4574,1.0204054,'-,'-,RGS7,Chronotype,chronotype measurement,GCST007576,1:240973733
rs7721608-<b>T</b>,2 x 10-9,,0.4648,1.0206095,'-,'-,PDE8B,Chronotype,chronotype measurement,GCST007576,5:77285433
rs6718511-<b>A</b>,1 x 10-8,,0.557,1.02112,'-,'-,ADCY3,Chronotype,chronotype measurement,GCST007576,2:24899455
rs7298532-<b>T</b>,1 x 10-10,,0.7213,1.0273678,'-,'-,NAA25,Chronotype,chronotype measurement,GCST007576,12:112072600
rs2881955-<b>T</b>,5 x 10-11,,0.2788,1.0274706,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,6:71769560
rs497338-<b>T</b>,2 x 10-10,,0.2881,1.0274706,'-,'-,"LARP4B, DIP2C",Chronotype,chronotype measurement,GCST007576,10:758375
rs487722-<b>T</b>,2 x 10-9,,0.2084,1.0276761,'-,'-,R3HDM2,Chronotype,chronotype measurement,GCST007576,12:57430382
rs3760381-<b>A</b>,4 x 10-10,,0.2544,1.0277789,'-,'-,NMT1,Chronotype,chronotype measurement,GCST007576,17:44969715
rs12631477-<b>T</b>,3 x 10-9,,0.7982,1.0280873,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,3:83755410
rs11611435-<b>T</b>,7 x 10-11,,0.5561,1.02819,'-,'-,SOX5,Chronotype,chronotype measurement,GCST007576,12:23936388
rs1873958-<b>A</b>,2 x 10-15,,0.4088,1.0282929,'-,'-,ASB7,Chronotype,chronotype measurement,GCST007576,15:100607521
rs2916148-<b>A</b>,3 x 10-14,,0.4522,1.0282929,'-,'-,PITPNC1,Chronotype,chronotype measurement,GCST007576,17:67485993
rs1508608-<b>A</b>,8 x 10-13,,0.3199,1.0283957,'-,'-,SLC36A4,Chronotype,chronotype measurement,GCST007576,11:93160659
rs1278402-<b>A</b>,2 x 10-9,,0.736,1.0284985,'-,'-,CCDC90B,Chronotype,chronotype measurement,GCST007576,11:83261055
rs4550782-<b>T</b>,5 x 10-12,,0.6655,1.0286014,'-,'-,"MRAS, ESYT3",Chronotype,chronotype measurement,GCST007576,3:138413551
rs662094-<b>A</b>,5 x 10-13,,0.4944,1.0286014,'-,'-,"CTSF, CCDC87",Chronotype,chronotype measurement,GCST007576,11:66575220
rs2072727-<b>T</b>,4 x 10-15,,0.4327,1.0286014,'-,'-,PABPC1L,Chronotype,chronotype measurement,GCST007576,20:44910092
rs308521-<b>T</b>,4 x 10-17,,0.6039,1.0287043,'-,'-,"ZCCHC7, LINC01627",Chronotype,chronotype measurement,GCST007576,9:37367097
rs10830107-<b>A</b>,5 x 10-9,,0.7922,1.0287043,'-,'-,"NPS, DOCK1",Chronotype,chronotype measurement,GCST007576,10:127505811
rs2580160-<b>A</b>,4 x 10-11,,0.5554,1.0287043,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,18:1816035
rs12442008-<b>T</b>,5 x 10-11,,0.2593,1.02891,'-,'-,WDR72,Chronotype,chronotype measurement,GCST007576,15:53432915
rs1886205-<b>A</b>,6 x 10-14,,0.7604,1.0297334,'-,'-,GPC6,Chronotype,chronotype measurement,GCST007576,13:93409842
rs72773411-<b>A</b>,3 x 10-8,,0.1529,1.0297334,'-,'-,LINC02867,Chronotype,chronotype measurement,GCST007576,16:678514
rs73050286-<b>T</b>,4 x 10-11,,0.7817,1.0301454,'-,'-,"UBE2E2-AS1, RPL24P7",Chronotype,chronotype measurement,GCST007576,3:23183193
rs7006885-<b>A</b>,9 x 10-12,,0.2878,1.0305576,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,8:92271350
rs10818834-<b>T</b>,5 x 10-12,,0.7297,1.0306606,'-,'-,DENND1A,Chronotype,chronotype measurement,GCST007576,9:123555045
rs4698678-<b>C</b>,1 x 10-11,,0.2786,1.0311761,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,4:18259153
rs17455138-<b>T</b>,1 x 10-10,,0.7655,1.0311761,'-,'-,LINC02465,Chronotype,chronotype measurement,GCST007576,4:129982356
rs3782860-<b>T</b>,6 x 10-11,,0.543,1.0253152,'-,'-,SLC6A13,Chronotype,chronotype measurement,GCST007576,12:252830
rs10175975-<b>T</b>,1 x 10-9,,0.1853,1.0255202,'-,'-,LINC01793,Chronotype,chronotype measurement,GCST007576,2:59202672
rs6794796-<b>A</b>,3 x 10-10,,0.2897,1.0256227,'-,'-,LINC01267,Chronotype,chronotype measurement,GCST007576,3:14342132
rs6047481-<b>A</b>,3 x 10-9,,0.6709,1.0256227,'-,'-,"NKX2-2, LINC01727",Chronotype,chronotype measurement,GCST007576,20:21558926
rs12206814-<b>C</b>,1 x 10-8,,0.4869,1.0257254,'-,'-,FOXP4,Chronotype,chronotype measurement,GCST007576,6:41549719
rs12600452-<b>A</b>,2 x 10-9,,0.2015,1.0258279,'-,'-,"GOSR2, RPRML",Chronotype,chronotype measurement,GCST007576,17:46977198
rs6727752-<b>A</b>,2 x 10-10,,0.3569,1.0259305,'-,'-,SUCLA2P2,Chronotype,chronotype measurement,GCST007576,2:76134657
rs1800828-<b>C</b>,2 x 10-8,,0.7508,1.026033,'-,'-,DRD3,Chronotype,chronotype measurement,GCST007576,3:114172702
rs6131805-<b>T</b>,2 x 10-11,,0.4022,1.026033,'-,'-,"PPIAP17, KIF16B",Chronotype,chronotype measurement,GCST007576,20:16241448
rs1398346-<b>T</b>,4 x 10-8,,0.8668,1.0262383,'-,'-,RNU6ATAC15P,Chronotype,chronotype measurement,GCST007576,3:110553096
rs61875203-<b>T</b>,2 x 10-9,,0.2773,1.0262383,'-,'-,CPEB3,Chronotype,chronotype measurement,GCST007576,10:92129053
rs10402849-<b>T</b>,3 x 10-9,,0.2002,1.0262383,'-,'-,GNG7,Chronotype,chronotype measurement,GCST007576,19:2695663
rs3955311-<b>T</b>,3 x 10-8,,0.1491,1.026341,'-,'-,RBM19,Chronotype,chronotype measurement,GCST007576,12:113906013
rs6958557-<b>T</b>,4 x 10-12,,0.6067,1.0264436,'-,'-,EXOC4,Chronotype,chronotype measurement,GCST007576,7:133901041
rs3867239-<b>A</b>,2 x 10-11,,0.3762,1.0265462,'-,'-,MIR100HG,Chronotype,chronotype measurement,GCST007576,11:122222382
rs9476310-<b>T</b>,8 x 10-13,,0.5104,1.0266489,'-,'-,"RBBP4P3, GAPDHP41",Chronotype,chronotype measurement,GCST007576,6:60799829
rs1931814-<b>A</b>,3 x 10-13,,0.4787,1.0267515,'-,'-,KHDRBS2,Chronotype,chronotype measurement,GCST007576,6:61879262
rs9347926-<b>A</b>,1 x 10-13,,0.4407,1.0267515,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,6:164774517
rs4785296-<b>C</b>,1 x 10-9,,0.231,1.0267515,'-,'-,"C16orf78, LINC02179",Chronotype,chronotype measurement,GCST007576,16:49433323
rs2844016-<b>T</b>,2 x 10-9,,0.2935,1.0269569,'-,'-,IZUMO3,Chronotype,chronotype measurement,GCST007576,9:24582749
rs28459838-<b>T</b>,1 x 10-9,,0.2369,1.0269569,'-,'-,"RASD2, MCM5",Chronotype,chronotype measurement,GCST007576,22:35450175
rs7248205-<b>T</b>,1 x 10-12,,0.6003,1.0270597,'-,'-,ILF3,Chronotype,chronotype measurement,GCST007576,19:10659629
rs12871550-<b>A</b>,1 x 10-12,,0.3229,1.0271623,'-,'-,"PCDH17, HMGN2P39",Chronotype,chronotype measurement,GCST007576,13:59002231
rs57236847-<b>C</b>,4 x 10-9,,0.6029,1.0272651,'-,'-,SLC12A5,Chronotype,chronotype measurement,GCST007576,20:46039762
rs2514214-<b>A</b>,2 x 10-9,,0.2691,1.0273678,'-,'-,DRD2,Chronotype,chronotype measurement,GCST007576,11:113524607
rs12927162-<b>A</b>,6 x 10-38,,0.7276,1.0577035,'-,'-,CASC16,Chronotype,chronotype measurement,GCST007576,16:52651004
rs72829706-<b>A</b>,1 x 10-10,,0.96,1.057915,'-,'-,ANKFN1,Chronotype,chronotype measurement,GCST007576,17:56096372
rs12636669-<b>T</b>,5 x 10-19,,0.0801,1.0586559,'-,'-,RBM6,Chronotype,chronotype measurement,GCST007576,3:49965890
rs184033703-<b>A</b>,1 x 10-13,,0.0585,1.0593971,'-,'-,"NDUFS1, INO80D",Chronotype,chronotype measurement,GCST007576,2:206091414
rs72790386-<b>T</b>,2 x 10-8,,0.0338,1.0622613,'-,'-,NFATC3,Chronotype,chronotype measurement,GCST007576,16:68103029
rs1061032-<b>T</b>,2 x 10-23,,0.094,1.0665189,'-,'-,VAMP2,Chronotype,chronotype measurement,GCST007576,17:8160765
rs61773390-<b>T</b>,5 x 10-41,,0.1931,1.0681199,'-,'-,PER3,Chronotype,chronotype measurement,GCST007576,1:7824465
rs2653349-<b>A</b>,3 x 10-48,,0.2073,1.0681199,'-,'-,HCRTR2,Chronotype,chronotype measurement,GCST007576,6:55277539
rs11032362-<b>A</b>,1 x 10-27,,0.0937,1.0729373,'-,'-,"CD59, FBXO3",Chronotype,chronotype measurement,GCST007576,11:33737546
rs12040629-<b>A</b>,5 x 10-45,,0.16,1.0754079,'-,'-,"PIGK, AK5",Chronotype,chronotype measurement,GCST007576,1:77239680
rs75120545-<b>T</b>,7 x 10-17,,0.0319,1.0900244,'-,'-,LRPPRC,Chronotype,chronotype measurement,GCST007576,2:44044357
rs9573980-<b>A</b>,5 x 10-36,,0.9659,1.1348494,'-,'-,"FBXL3, CLN5",Chronotype,chronotype measurement,GCST007576,13:77016606
rs149611468-<b>T</b>,6 x 10-15,,0.9888,1.1539606,'-,'-,"CAV3, RAD18",Chronotype,chronotype measurement,GCST007576,3:8775737
rs1144566-<b>T</b>,2 x 10-95,,0.029,1.2593554,'-,'-,RGS16,Chronotype,chronotype measurement,GCST007576,1:182600491
rs228726-<b>A</b>,3 x 10-26,,0.1001,'-,0.0299295 unit decrease,[0.024-0.035],PER3,Chronotype,chronotype measurement,GCST007576,1:7788883
rs150812083-<b>C</b>,7 x 10-40,,0.995,'-,0.15862 unit decrease,[0.14-0.18],PER3,Chronotype,chronotype measurement,GCST007576,1:7809893
rs6702412-<b>T</b>,7 x 10-9,,0.4517,'-,0.00984452 unit increase,[0.0065-0.0132],LINC01761,Chronotype,chronotype measurement,GCST007576,1:95463751
rs2256459-<b>A</b>,5 x 10-13,,0.7847,'-,0.0148723 unit increase,[0.011-0.019],"EEF1A1P11, RN7SL831P",Chronotype,chronotype measurement,GCST007576,1:96519483
rs1760217-<b>A</b>,2 x 10-11,,0.7981,'-,0.0141847 unit increase,[0.01-0.018],"DPYD, DPYD-AS1",Chronotype,chronotype measurement,GCST007576,1:97137438
rs41279738-<b>T</b>,1 x 10-7,,0.9731,'-,0.0275818 unit increase,[0.017-0.038],GPR61,Chronotype,chronotype measurement,GCST007576,1:109539929
rs6537747-<b>T</b>,2 x 10-8,,0.7286,'-,0.0107681 unit decrease,[0.007-0.0145],CAPZA1,Chronotype,chronotype measurement,GCST007576,1:112636975
rs7524620-<b>A</b>,3 x 10-10,,0.5935,'-,0.0108808 unit increase,[0.0075-0.0143],"GOLPH3L, ENSA",Chronotype,chronotype measurement,GCST007576,1:150644223
rs2378824-<b>T</b>,1 x 10-8,,0.5685,'-,0.00976017 unit increase,[0.0064-0.0131],Y_RNA,Chronotype,chronotype measurement,GCST007576,1:184220881
rs34580810-<b>A</b>,6 x 10-10,,0.3376,'-,0.0110672 unit decrease,[0.0076-0.0146],BRINP3,Chronotype,chronotype measurement,GCST007576,1:190038476
rs10754194-<b>C</b>,1 x 10-7,,0.0867,'-,0.0159938 unit decrease,[0.01-0.022],KCNT2,Chronotype,chronotype measurement,GCST007576,1:196560738
rs11676272-<b>A</b>,1 x 10-8,,0.5217,'-,0.00967895 unit increase,[0.0064-0.013],ADCY3,Chronotype,chronotype measurement,GCST007576,2:24918669
rs6725031-<b>T</b>,4 x 10-8,,0.6477,'-,0.00976359 unit decrease,[0.0063-0.0132],HNRNPA1P57,Chronotype,chronotype measurement,GCST007576,2:41161708
rs12998046-<b>A</b>,1 x 10-9,,0.6167,'-,0.0105904 unit increase,[0.0072-0.014],CAMKMT,Chronotype,chronotype measurement,GCST007576,2:44653786
rs66888174-<b>A</b>,1 x 10-7,,0.6716,'-,0.00960485 unit increase,[0.0061-0.0131],"STON1, STON1-GTF2A1L",Chronotype,chronotype measurement,GCST007576,2:48577637
rs972557-<b>T</b>,2 x 10-8,,0.5018,'-,0.00947014 unit increase,[0.0062-0.0128],"FSHR, RNU6-439P",Chronotype,chronotype measurement,GCST007576,2:49174063
rs10495976-<b>A</b>,5 x 10-14,,0.609,'-,0.0130441 unit decrease,[0.0096-0.0164],'-,Chronotype,chronotype measurement,GCST007576,2:49523560
rs4254526-<b>T</b>,5 x 10-11,,0.3706,'-,0.0115233 unit decrease,[0.0081-0.015],LRRTM4,Chronotype,chronotype measurement,GCST007576,2:77659381
rs1593205-<b>A</b>,4 x 10-9,,0.8199,'-,0.0129873 unit increase,[0.0087-0.0173],'-,Chronotype,chronotype measurement,GCST007576,2:185329131
rs57690685-<b>A</b>,4 x 10-10,,0.9895,'-,0.0517931 unit decrease,[0.036-0.068],"LINC02610, HES6",Chronotype,chronotype measurement,GCST007576,2:238235960
rs960783-<b>T</b>,1 x 10-26,,0.0442,'-,0.0440497 unit decrease,[0.036-0.052],"PER2, HES6",Chronotype,chronotype measurement,GCST007576,2:238240929
rs80261926-<b>T</b>,4 x 10-27,,0.0188,'-,0.0672728 unit increase,[0.055-0.079],PER2,Chronotype,chronotype measurement,GCST007576,2:238244229
rs58574366-<b>A</b>,1 x 10-8,,0.0498,'-,0.0221134 unit decrease,[0.014-0.03],PER2,Chronotype,chronotype measurement,GCST007576,2:238286196
rs188004381-<b>A</b>,9 x 10-14,,0.0423,'-,0.0313766 unit decrease,[0.023-0.04],"ASB1, RNU6-234P",Chronotype,chronotype measurement,GCST007576,2:238414218
rs13059636-<b>A</b>,6 x 10-9,,0.5356,'-,0.00987093 unit decrease,[0.0065-0.0132],'-,Chronotype,chronotype measurement,GCST007576,3:24894299
rs2236950-<b>A</b>,2 x 10-16,,0.1742,'-,0.0184224 unit decrease,[0.014-0.023],CACNA2D2,Chronotype,chronotype measurement,GCST007576,3:50383123
rs56357549-<b>T</b>,3 x 10-12,,0.8224,'-,0.0154127 unit increase,[0.011-0.02],DNAH1,Chronotype,chronotype measurement,GCST007576,3:52340500
rs17655548-<b>A</b>,1 x 10-8,,0.2143,'-,0.0118261 unit decrease,[0.0078-0.0159],FOXP1,Chronotype,chronotype measurement,GCST007576,3:71316514
rs116291712-<b>A</b>,6 x 10-6,,0.0127,'-,0.034198 unit decrease,[0.019-0.049],ROBO2,Chronotype,chronotype measurement,GCST007576,3:77392675
rs4324483-<b>T</b>,2 x 10-8,,0.559,'-,0.00950261 unit decrease,[0.0062-0.0128],LINC02008,Chronotype,chronotype measurement,GCST007576,3:81942898
rs56242353-<b>T</b>,4 x 10-10,,0.1167,'-,0.0164642 unit increase,[0.011-0.022],LINC02008,Chronotype,chronotype measurement,GCST007576,3:82532680
rs79402305-<b>A</b>,2 x 10-10,,0.9232,'-,0.0203097 unit increase,[0.014-0.027],LSAMP,Chronotype,chronotype measurement,GCST007576,3:116322521
rs2102506-<b>A</b>,6 x 10-8,,0.6413,'-,0.00957602 unit decrease,[0.0061-0.013],"TIPARP-AS1, SSR3",Chronotype,chronotype measurement,GCST007576,3:156625060
rs482204-<b>A</b>,1 x 10-10,,0.7433,'-,0.0125335 unit decrease,[0.0087-0.0163],GHSR,Chronotype,chronotype measurement,GCST007576,3:172445039
rs4859215-<b>T</b>,2 x 10-13,,0.4776,'-,0.0124602 unit increase,[0.0091-0.0158],'-,Chronotype,chronotype measurement,GCST007576,3:182320542
rs4484214-<b>A</b>,7 x 10-10,,0.6819,'-,0.0112208 unit increase,[0.0077-0.0148],"RPL7L1P8, LINC01995",Chronotype,chronotype measurement,GCST007576,3:182539798
rs73182221-<b>A</b>,4 x 10-12,,0.1116,'-,0.0186748 unit increase,[0.013-0.024],DGKG,Chronotype,chronotype measurement,GCST007576,3:186361472
rs4834311-<b>A</b>,1 x 10-8,,0.5831,'-,0.00978561 unit decrease,[0.0064-0.0132],"ANK2-AS1, ANK2",Chronotype,chronotype measurement,GCST007576,4:113069787
rs1458146-<b>A</b>,1 x 10-9,,0.2866,'-,0.0114226 unit decrease,[0.0078-0.0151],'-,Chronotype,chronotype measurement,GCST007576,4:162782487
rs32897-<b>T</b>,1 x 10-7,,0.8406,'-,0.0122696 unit increase,[0.0077-0.0168],CRHBP,Chronotype,chronotype measurement,GCST007576,5:76955147
rs388340-<b>A</b>,5 x 10-10,,0.5593,'-,0.0106183 unit decrease,[0.0073-0.014],RASA1,Chronotype,chronotype measurement,GCST007576,5:87289003
rs79864120-<b>A</b>,1 x 10-17,,0.2352,'-,0.0170852 unit decrease,[0.013-0.021],MEF2C-AS1,Chronotype,chronotype measurement,GCST007576,5:88908895
rs62378355-<b>A</b>,1 x 10-8,,0.634,'-,0.0100352 unit decrease,[0.0066-0.0135],LINC01950,Chronotype,chronotype measurement,GCST007576,5:106976175
rs72834074-<b>A</b>,2 x 10-8,,0.1172,'-,0.0148128 unit increase,[0.0097-0.02],'-,Chronotype,chronotype measurement,GCST007576,5:166725517
rs2742986-<b>T</b>,3 x 10-9,,0.6335,'-,0.0103924 unit decrease,[0.0069-0.0138],'-,Chronotype,chronotype measurement,GCST007576,6:19079960
rs56402621-<b>T</b>,2 x 10-7,,0.0181,'-,0.0330166 unit increase,[0.021-0.045],"MICD, HLA-W",Chronotype,chronotype measurement,GCST007576,6:29967944
rs827749-<b>T</b>,9 x 10-30,,0.6682,'-,0.0203698 unit decrease,[0.017-0.024],LINC02840,Chronotype,chronotype measurement,GCST007576,6:152808528
rs62436127-<b>C</b>,3 x 10-27,,0.162,'-,0.024844 unit increase,[0.02-0.029],MTRF1L,Chronotype,chronotype measurement,GCST007576,6:152999483
rs12701263-<b>T</b>,2 x 10-12,,0.4035,'-,0.0121911 unit decrease,[0.0088-0.0156],RP9P,Chronotype,chronotype measurement,GCST007576,7:32922477
rs202157-<b>T</b>,5 x 10-14,,0.6992,'-,0.0138831 unit decrease,[0.01-0.018],CUX1,Chronotype,chronotype measurement,GCST007576,7:101994473
rs6960360-<b>A</b>,1 x 10-12,,0.4004,'-,0.0122393 unit decrease,[0.0089-0.0156],ORAI2,Chronotype,chronotype measurement,GCST007576,7:102442785
rs1131359-<b>T</b>,3 x 10-13,,0.9746,'-,0.039267 unit increase,[0.029-0.05],POLR2J,Chronotype,chronotype measurement,GCST007576,7:102473643
rs73406288-<b>T</b>,2 x 10-6,,0.0505,'-,0.0185662 unit increase,[0.011-0.026],FBXL13,Chronotype,chronotype measurement,GCST007576,7:102862758
rs76187115-<b>T</b>,2 x 10-19,,0.9798,'-,0.0542925 unit decrease,[0.043-0.066],FBXL13,Chronotype,chronotype measurement,GCST007576,7:102884388
rs148266530-<b>T</b>,2 x 10-12,,0.0286,'-,0.0358219 unit increase,[0.026-0.046],FBXL13,Chronotype,chronotype measurement,GCST007576,7:102898955
rs4909296-<b>T</b>,3 x 10-8,,0.4839,'-,0.00935643 unit decrease,[0.006-0.0127],ZFAT,Chronotype,chronotype measurement,GCST007576,8:134578267
rs3780204-<b>C</b>,1 x 10-9,,0.3389,'-,0.0108315 unit decrease,[0.0073-0.0143],NEK6,Chronotype,chronotype measurement,GCST007576,9:124330608
rs4838192-<b>T</b>,7 x 10-8,,0.5128,'-,0.00912265 unit increase,[0.0058-0.0124],NR5A1,Chronotype,chronotype measurement,GCST007576,9:124488222
rs1630848-<b>A</b>,4 x 10-8,,0.5407,'-,0.00929779 unit increase,[0.006-0.0126],PCDH15,Chronotype,chronotype measurement,GCST007576,10:54934462
rs10999667-<b>A</b>,1 x 10-7,,0.6351,'-,0.00937 unit increase,[0.0059-0.0128],'-,Chronotype,chronotype measurement,GCST007576,10:71088697
rs2173244-<b>T</b>,4 x 10-9,,0.655,'-,0.0104665 unit decrease,[0.007-0.014],ATE1,Chronotype,chronotype measurement,GCST007576,10:121793750
rs2760545-<b>T</b>,1 x 10-10,,0.5064,'-,0.0109403 unit increase,[0.0076-0.0143],"MACROD2, PPIAP17",Chronotype,chronotype measurement,GCST007576,20:16132030
rs947088-<b>T</b>,2 x 10-7,,0.7185,'-,0.00973438 unit increase,[0.006-0.0134],"RNU6-27P, RNU1-131P",Chronotype,chronotype measurement,GCST007576,20:17190728
rs762995-<b>A</b>,8 x 10-12,,0.467,'-,0.0115978 unit decrease,[0.0083-0.0149],"OGFRP1, TCF20",Chronotype,chronotype measurement,GCST007576,22:42276118
rs45597035-<b>G</b>,2 x 10-8,,0.3531,1.0224482,'-,'-,KLF5,Chronotype,chronotype measurement,GCST007576,13:73075014
rs3923809-<b>G</b>,3 x 10-8,,0.3053,1.0222439,'-,'-,BTBD9,Chronotype,chronotype measurement,GCST007576,6:38473194
rs695459-<b>C</b>,1 x 10-8,,0.6094,1.0222439,'-,'-,TTC28,Chronotype,chronotype measurement,GCST007576,22:28452290
rs11102807-<b>G</b>,8 x 10-9,,0.4639,1.0221416,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,Mapping not available
rs13414393-<b>C</b>,6 x 10-9,,0.4595,1.0221416,'-,'-,ACYP2,Chronotype,chronotype measurement,GCST007576,2:54048025
rs962961-<b>C</b>,4 x 10-11,,0.6692,1.0221416,'-,'-,"OTX2, OTX2-AS1",Chronotype,chronotype measurement,GCST007576,14:56814436
rs2362775-<b>C</b>,6 x 10-9,,0.4658,1.0220394,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,3:24882930
rs1025601-<b>C</b>,3 x 10-8,,0.6145,1.0220394,'-,'-,"SMIM21, TSHZ1",Chronotype,chronotype measurement,GCST007576,18:75344323
rs9394154-<b>G</b>,8 x 10-10,,0.564,1.0219371,'-,'-,TMEM170B,Chronotype,chronotype measurement,GCST007576,6:11574141
rs9817910-<b>G</b>,2 x 10-10,,0.4424,1.021835,'-,'-,TBC1D5,Chronotype,chronotype measurement,GCST007576,3:18205378
rs3815983-<b>C</b>,4 x 10-10,,0.6396,1.021835,'-,'-,MYO16,Chronotype,chronotype measurement,GCST007576,13:109127558
rs2322605-<b>G</b>,2 x 10-9,,0.5316,1.0217328,'-,'-,TRIM35,Chronotype,chronotype measurement,GCST007576,8:27306932
rs3743794-<b>G</b>,6 x 10-9,,0.3927,1.0217328,'-,'-,C16orf97,Chronotype,chronotype measurement,GCST007576,16:52078400
rs12464387-<b>G</b>,1 x 10-9,,0.5362,1.0216306,'-,'-,TACR1,Chronotype,chronotype measurement,GCST007576,2:75218418
rs1474754-<b>G</b>,2 x 10-8,,0.7364,1.0216306,'-,'-,CFAP61,Chronotype,chronotype measurement,GCST007576,20:20096534
rs6838677-<b>C</b>,3 x 10-8,,0.3311,1.0215285,'-,'-,EPHA5,Chronotype,chronotype measurement,GCST007576,4:65654949
rs10988239-<b>C</b>,3 x 10-11,,0.4883,1.0215285,'-,'-,IER5L,Chronotype,chronotype measurement,GCST007576,9:129181161
rs2878172-<b>G</b>,7 x 10-9,,0.4307,1.0215285,'-,'-,"GCH1, WDHD1",Chronotype,chronotype measurement,GCST007576,14:54906952
rs938836-<b>G</b>,1 x 10-9,,0.533,1.0214263,'-,'-,NOCT,Chronotype,chronotype measurement,GCST007576,4:139018499
rs12445235-<b>G</b>,1 x 10-8,,0.5902,1.0213243,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,16:8145276
rs55846845-<b>G</b>,5 x 10-11,,0.4823,1.0212221,'-,'-,CA10,Chronotype,chronotype measurement,GCST007576,17:52014841
rs2072413-<b>C</b>,5 x 10-8,,0.7376,1.0210178,'-,'-,KCNH2,Chronotype,chronotype measurement,GCST007576,7:150950881
rs10058356-<b>C</b>,2 x 10-9,,0.3042,1.0209157,'-,'-,PRLR,Chronotype,chronotype measurement,GCST007576,5:35220302
rs12380242-<b>C</b>,8 x 10-10,,0.4942,1.0208136,'-,'-,PMPCA,Chronotype,chronotype measurement,GCST007576,9:136415735
rs486416-<b>G</b>,1 x 10-9,,0.3473,1.0203034,'-,'-,EHMT2,Chronotype,chronotype measurement,GCST007576,6:31888293
rs34125199-<b>D</b>,1 x 10-8,,0.3497,1.0377898,'-,'-,HIVEP1,Chronotype,chronotype measurement,GCST007576,6:12154882
rs9611597-<b>A</b>,3 x 10-12,,0.8371,1.0381082,'-,'-,"ACO2, PHF5A",Chronotype,chronotype measurement,GCST007576,22:41468186
rs10520176-<b>T</b>,5 x 10-24,,0.4926,1.0384196,'-,'-,"LRRTM4-AS1, LRRTM4",Chronotype,chronotype measurement,GCST007576,2:76990184
rs16939162-<b>A</b>,1 x 10-14,,0.8304,1.0387312,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,8:75740921
rs4800998-<b>A</b>,5 x 10-14,,0.1827,1.0401865,'-,'-,"TCF4, LINC01415",Chronotype,chronotype measurement,GCST007576,18:55762424
rs10610420-<b>D</b>,1 x 10-8,,0.7138,1.0402169,'-,'-,"CXXC4, STK32B",Chronotype,chronotype measurement,GCST007576,4:104396839
rs9436119-<b>A</b>,6 x 10-30,,0.3842,1.0402905,'-,'-,TARS2,Chronotype,chronotype measurement,GCST007576,1:150495277
rs34509802-<b>A</b>,1 x 10-12,,0.1785,1.0403945,'-,'-,"NPAS2, NPAS2-AS1",Chronotype,chronotype measurement,GCST007576,2:100975248
rs76518095-<b>T</b>,8 x 10-9,,0.0772,1.0406027,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,10:129351712
rs28380327-<b>A</b>,5 x 10-25,,0.6317,1.0408108,'-,'-,ARHGAP15,Chronotype,chronotype measurement,GCST007576,2:143474922
rs78580841-<b>T</b>,3 x 10-11,,0.0694,1.0433117,'-,'-,CCDC12,Chronotype,chronotype measurement,GCST007576,3:46944962
rs1449403-<b>A</b>,6 x 10-13,,0.1226,1.0433117,'-,'-,CADM2,Chronotype,chronotype measurement,GCST007576,3:85542317
rs60521023-<b>D</b>,5 x 10-10,,0.2965,1.0438432,'-,'-,ARNTL,Chronotype,chronotype measurement,GCST007576,11:13292556
rs113161209-<b>A</b>,4 x 10-8,,0.077,1.0451914,'-,'-,EZH2,Chronotype,chronotype measurement,GCST007576,7:148867275
rs1064213-<b>A</b>,4 x 10-31,,0.4826,1.0454004,'-,'-,PLCL1,Chronotype,chronotype measurement,GCST007576,2:198085516
rs4419127-<b>A</b>,8 x 10-30,,0.6622,1.0454004,'-,'-,NOL4,Chronotype,chronotype measurement,GCST007576,18:34083690
rs72950188-<b>T</b>,2 x 10-10,,0.9238,1.0457141,'-,'-,LSAMP,Chronotype,chronotype measurement,GCST007576,3:116384428
rs9991917-<b>A</b>,1 x 10-8,,0.19,1.0463107,'-,'-,LINC02377,Chronotype,chronotype measurement,GCST007576,4:131590963
rs58876439-<b>A</b>,3 x 10-11,,0.0674,1.0485413,'-,'-,POU2F2,Chronotype,chronotype measurement,GCST007576,19:42096832
rs13377754-<b>T</b>,3 x 10-40,,0.6104,1.0496954,'-,'-,RNU6-472P,Chronotype,chronotype measurement,GCST007576,12:33898830
rs62082402-<b>T</b>,7 x 10-19,,0.1936,1.0512711,'-,'-,AKAIN1,Chronotype,chronotype measurement,GCST007576,18:5186567
rs60616179-<b>A</b>,3 x 10-10,,0.9443,1.0522177,'-,'-,"GPR6, FIG4",Chronotype,chronotype measurement,GCST007576,6:109923562
rs1843888-<b>A</b>,2 x 10-43,,0.5433,1.0526386,'-,'-,ALG10B,Chronotype,chronotype measurement,GCST007576,12:38343508
rs7975791-<b>T</b>,5 x 10-9,,0.0384,1.0526386,'-,'-,KMT2D,Chronotype,chronotype measurement,GCST007576,12:49019703
rs12470914-<b>A</b>,3 x 10-17,,0.1005,1.0544297,'-,'-,NRXN1,Chronotype,chronotype measurement,GCST007576,2:50305702
rs7949336-<b>A</b>,9 x 10-9,,0.7414,'-,0.0111271 unit decrease,[0.0073-0.0149],ARNTL,Chronotype,chronotype measurement,GCST007576,11:13298347
rs297343-<b>T</b>,7 x 10-8,,0.364,'-,0.00948928 unit decrease,[0.006-0.0129],SOX6,Chronotype,chronotype measurement,GCST007576,11:16333107
rs35233100-<b>T</b>,4 x 10-12,,0.0617,'-,0.0243579 unit decrease,[0.017-0.031],MADD,Chronotype,chronotype measurement,GCST007576,11:47285079
rs271043-<b>A</b>,3 x 10-10,,0.5261,'-,0.0107238 unit increase,[0.0074-0.014],"RPL26P31, MTNR1B",Chronotype,chronotype measurement,GCST007576,11:92993923
rs7108229-<b>A</b>,6 x 10-8,,0.5725,'-,0.00929064 unit increase,[0.0059-0.0126],NXPE2,Chronotype,chronotype measurement,GCST007576,11:114783125
rs4436614-<b>A</b>,1 x 10-10,,0.5335,'-,0.0136065 unit increase,[0.0095-0.0177],'-,Chronotype,chronotype measurement,GCST007576,12:37891210
rs10735836-<b>A</b>,7 x 10-10,,0.8679,'-,0.015389 unit decrease,[0.01-0.02],SCN8A,Chronotype,chronotype measurement,GCST007576,12:51641864
rs11174782-<b>T</b>,1 x 10-17,,0.1306,'-,0.0214393 unit decrease,[0.017-0.026],"RSL24D1P5, AVPR1A",Chronotype,chronotype measurement,GCST007576,12:63123270
rs7964138-<b>A</b>,7 x 10-8,,0.2576,'-,0.0104521 unit increase,[0.0067-0.0142],"ZCCHC8, CLIP1",Chronotype,chronotype measurement,GCST007576,12:122465828
rs2321993-<b>A</b>,3 x 10-12,,0.567,'-,0.0119341 unit decrease,[0.0086-0.0153],POLR3KP1,Chronotype,chronotype measurement,GCST007576,13:59107012
rs61963491-<b>A</b>,4 x 10-19,,0.9931,'-,0.100919 unit increase,[0.079-0.123],MYCBP2,Chronotype,chronotype measurement,GCST007576,13:77370501
rs9523817-<b>A</b>,3 x 10-9,,0.7239,'-,0.0112048 unit decrease,[0.0075-0.0149],GPC5,Chronotype,chronotype measurement,GCST007576,13:92864367
rs12594634-<b>T</b>,9 x 10-7,,0.7356,'-,0.00941244 unit decrease,[0.0057-0.0132],"TUBAP12, NR2F2",Chronotype,chronotype measurement,GCST007576,15:96354777
rs35888008-<b>A</b>,1 x 10-9,,0.7694,'-,0.0121717 unit decrease,[0.0082-0.0161],"C16orf78, LINC02179",Chronotype,chronotype measurement,GCST007576,16:49443361
rs1344490-<b>T</b>,4 x 10-8,,0.4025,'-,0.00951045 unit decrease,[0.0061-0.0129],LINC02180,Chronotype,chronotype measurement,GCST007576,16:52132795
rs6499821-<b>A</b>,2 x 10-10,,0.9011,'-,0.0180586 unit increase,[0.013-0.024],GNAO1,Chronotype,chronotype measurement,GCST007576,16:56113734
rs8063159-<b>A</b>,7 x 10-17,,0.3878,'-,0.0144983 unit increase,[0.011-0.018],GNPATP,Chronotype,chronotype measurement,GCST007576,16:60593587
rs11641811-<b>A</b>,1 x 10-15,,0.5139,'-,0.0135583 unit decrease,[0.01-0.017],"TAT-AS1, MARVELD3",Chronotype,chronotype measurement,GCST007576,16:71601933
rs2232831-<b>A</b>,2 x 10-21,,0.2589,'-,0.0183454 unit increase,[0.015-0.022],"PEMT, RASD1",Chronotype,chronotype measurement,GCST007576,17:17496735
rs12938235-<b>T</b>,3 x 10-8,,0.4618,'-,0.00944011 unit increase,[0.0061-0.0128],ASIC2,Chronotype,chronotype measurement,GCST007576,17:33298182
rs612720-<b>A</b>,2 x 10-8,,0.5287,'-,0.00946707 unit increase,[0.0061-0.0128],CALCOCO2,Chronotype,chronotype measurement,GCST007576,17:48840842
rs17643207-<b>A</b>,3 x 10-9,,0.9185,'-,0.0184417 unit increase,[0.012-0.025],DTNA,Chronotype,chronotype measurement,GCST007576,18:34729882
rs75457814-<b>A</b>,2 x 10-8,,0.8024,'-,0.0119233 unit decrease,[0.0078-0.0161],'-,Chronotype,chronotype measurement,GCST007576,18:38748131
rs28602385-<b>A</b>,6 x 10-10,,0.3892,'-,0.0107271 unit increase,[0.0073-0.0141],TCF4,Chronotype,chronotype measurement,GCST007576,18:55392089
rs1007204-<b>A</b>,2 x 10-8,,0.314,'-,0.0102898 unit decrease,[0.0067-0.0139],"CCDC61, NOVA2",Chronotype,chronotype measurement,GCST007576,19:45976897
rs1163238-<b>G</b>,3 x 10-8,,0.6115,1.0239831,'-,'-,NT5C2,Chronotype,chronotype measurement,GCST007576,10:103184236
rs2304467-<b>G</b>,7 x 10-9,,0.3934,1.0239831,'-,'-,USP7,Chronotype,chronotype measurement,GCST007576,16:8894920
rs11588913-<b>G</b>,3 x 10-10,,0.5963,1.0238807,'-,'-,ADH5P2,Chronotype,chronotype measurement,GCST007576,1:79498131
rs12518401-<b>G</b>,2 x 10-10,,0.6156,1.0238807,'-,'-,NSG2,Chronotype,chronotype measurement,GCST007576,5:174112585
rs766406-<b>G</b>,7 x 10-10,,0.3591,1.0238807,'-,'-,"H4C8, H3C9P",Chronotype,chronotype measurement,GCST007576,6:26319360
rs9496623-<b>G</b>,3 x 10-8,,0.2672,1.0237783,'-,'-,ADAT2,Chronotype,chronotype measurement,GCST007576,6:143430488
rs7943634-<b>C</b>,9 x 10-10,,0.6925,1.0237783,'-,'-,KIRREL3,Chronotype,chronotype measurement,GCST007576,11:126864424
rs9950528-<b>G</b>,4 x 10-9,,0.3495,1.0237783,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,18:38182497
rs72966564-<b>C</b>,7 x 10-9,,0.7493,1.0236759,'-,'-,ADCY5,Chronotype,chronotype measurement,GCST007576,3:123430969
rs2850979-<b>C</b>,3 x 10-9,,0.2397,1.0236759,'-,'-,PPP3CA,Chronotype,chronotype measurement,GCST007576,4:101173607
rs11200159-<b>C</b>,4 x 10-9,,0.3449,1.0236759,'-,'-,ATE1,Chronotype,chronotype measurement,GCST007576,10:121793877
rs12298405-<b>C</b>,2 x 10-10,,0.6699,1.0236759,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,12:16862333
rs11154718-<b>C</b>,1 x 10-9,,0.57,1.0235735,'-,'-,"MIR548AI, BDH2P1",Chronotype,chronotype measurement,GCST007576,6:99144528
rs12378543-<b>C</b>,5 x 10-9,,0.6159,1.0235735,'-,'-,MTND2P9,Chronotype,chronotype measurement,GCST007576,9:80581182
rs1871729-<b>G</b>,8 x 10-9,,0.3184,1.0234712,'-,'-,"LINC01591, OSGIN2",Chronotype,chronotype measurement,GCST007576,8:135211459
rs3796618-<b>T</b>,1 x 10-8,,0.4707,1.0231643,'-,'-,UVSSA,Chronotype,chronotype measurement,GCST007576,4:1355814
rs4936290-<b>C</b>,1 x 10-10,,0.3416,1.0231643,'-,'-,ZBTB16,Chronotype,chronotype measurement,GCST007576,11:114138533
rs56113850-<b>C</b>,2 x 10-10,,0.5769,1.0231643,'-,'-,CYP2A6,Chronotype,chronotype measurement,GCST007576,19:40847202
rs2298117-<b>C</b>,4 x 10-9,,0.552,1.022755,'-,'-,TET1,Chronotype,chronotype measurement,GCST007576,10:68586983
rs4672458-<b>C</b>,2 x 10-10,,0.5236,1.0226527,'-,'-,ASB3,Chronotype,chronotype measurement,GCST007576,2:53509224
rs6560218-<b>C</b>,1 x 10-8,,0.4817,1.0226527,'-,'-,"RPL35AP21, CEMIP2",Chronotype,chronotype measurement,GCST007576,9:71630510
rs412000-<b>G</b>,2 x 10-9,,0.445,1.0226527,'-,'-,"U3, TEX14",Chronotype,chronotype measurement,GCST007576,17:58631697
rs12771973-<b>G</b>,2 x 10-8,,0.7525,1.0225505,'-,'-,PPP2R2D,Chronotype,chronotype measurement,GCST007576,10:131935790
rs10109566-<b>G</b>,9 x 10-9,,0.5151,1.0224482,'-,'-,TOX,Chronotype,chronotype measurement,GCST007576,8:58887887
rs187028-<b>T</b>,2 x 10-10,,0.6854,1.0224482,'-,'-,KCNB2,Chronotype,chronotype measurement,GCST007576,8:72547278
rs2978382-<b>T</b>,6 x 10-9,,0.5852,1.0234712,'-,'-,ESR2,Chronotype,chronotype measurement,GCST007576,14:64302356
rs6544906-<b>A</b>,6 x 10-10,,0.5616,1.0235735,'-,'-,"CRIPT, LINC01118",Chronotype,chronotype measurement,GCST007576,2:46636733
rs12950382-<b>A</b>,5 x 10-8,,0.7198,1.0236759,'-,'-,RHBDL3,Chronotype,chronotype measurement,GCST007576,17:32276975
rs4804951-<b>A</b>,4 x 10-9,,0.3306,1.0236759,'-,'-,"LINC01791, TSHZ3",Chronotype,chronotype measurement,GCST007576,19:31182482
rs3138490-<b>A</b>,7 x 10-10,,0.515,1.0237783,'-,'-,GADD45G,Chronotype,chronotype measurement,GCST007576,9:89604085
rs118047999-<b>C</b>,2 x 10-8,,0.2459,1.0238807,'-,'-,"KDELR3, KCNJ4",Chronotype,chronotype measurement,GCST007576,22:38455669
rs11681299-<b>T</b>,6 x 10-9,,0.2835,1.0239831,'-,'-,EIF2AK3,Chronotype,chronotype measurement,GCST007576,2:88602214
rs4550384-<b>T</b>,2 x 10-9,,0.758,1.0239831,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,14:84883798
rs7299922-<b>A</b>,5 x 10-11,,0.6388,1.0241879,'-,'-,COPZ1,Chronotype,chronotype measurement,GCST007576,12:54308735
rs465670-<b>T</b>,3 x 10-10,,0.5404,1.0243927,'-,'-,PRR7,Chronotype,chronotype measurement,GCST007576,5:177450623
rs7700110-<b>A</b>,4 x 10-9,,0.2566,1.0244952,'-,'-,CAMK2D,Chronotype,chronotype measurement,GCST007576,4:113518738
rs62479736-<b>T</b>,4 x 10-10,,0.2915,1.0245976,'-,'-,CSMD1,Chronotype,chronotype measurement,GCST007576,8:3796798
rs72796401-<b>A</b>,7 x 10-13,,0.1903,1.0249051,'-,'-,UBXN2A,Chronotype,chronotype measurement,GCST007576,2:23957208
rs2901796-<b>A</b>,6 x 10-10,,0.3983,1.0249051,'-,'-,LSM1P2,Chronotype,chronotype measurement,GCST007576,5:163903702
rs3807651-<b>A</b>,9 x 10-9,,0.4938,1.0249051,'-,'-,MAGI2,Chronotype,chronotype measurement,GCST007576,7:78194454
rs3100052-<b>A</b>,3 x 10-11,,0.3886,1.0249051,'-,'-,"YWHAZ, RN7SL685P",Chronotype,chronotype measurement,GCST007576,8:100954911
rs17577073-<b>A</b>,2 x 10-10,,0.5636,1.0249051,'-,'-,CNTN5,Chronotype,chronotype measurement,GCST007576,11:99282070
rs7143933-<b>T</b>,7 x 10-9,,0.2615,1.0249051,'-,'-,SYT16,Chronotype,chronotype measurement,GCST007576,14:61993501
rs4923541-<b>T</b>,6 x 10-10,,0.5104,1.0250076,'-,'-,METTL15,Chronotype,chronotype measurement,GCST007576,11:28457988
rs4903203-<b>A</b>,2 x 10-10,,0.3237,1.0250076,'-,'-,LIN52,Chronotype,chronotype measurement,GCST007576,14:74193805
rs61990287-<b>A</b>,6 x 10-9,,0.2742,1.0251101,'-,'-,LRFN5,Chronotype,chronotype measurement,GCST007576,14:41600686
rs6573308-<b>T</b>,1 x 10-8,,0.3941,1.0251101,'-,'-,"LINC02322, C14orf39",Chronotype,chronotype measurement,GCST007576,14:60340258
rs34054660-<b>A</b>,4 x 10-8,,0.5747,1.0252126,'-,'-,LINC01414,Chronotype,chronotype measurement,GCST007576,8:64103102
rs10762434-<b>C</b>,2 x 10-8,,0.7752,1.0252126,'-,'-,UNC5B,Chronotype,chronotype measurement,GCST007576,10:71284656
rs2944831-<b>A</b>,9 x 10-11,,0.2946,1.0253152,'-,'-,CALN1,Chronotype,chronotype measurement,GCST007576,7:72314650
rs6440833-<b>A</b>,9 x 10-10,,0.4638,1.021222,'-,'-,P2RY1,Chronotype,chronotype measurement,GCST007576,3:152928455
rs17396357-<b>T</b>,2 x 10-8,,0.3818,1.0213242,'-,'-,"VN1R18P, FARP2",Chronotype,chronotype measurement,GCST007576,2:48025172
rs7649164-<b>T</b>,6 x 10-9,,0.5745,1.0213242,'-,'-,CLRN1-AS1,Chronotype,chronotype measurement,GCST007576,3:151070245
rs4535583-<b>T</b>,4 x 10-8,,0.6991,1.0214263,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,6:115378116
rs2396004-<b>A</b>,3 x 10-9,,0.4354,1.0216306,'-,'-,"ZNF318, ABCC10",Chronotype,chronotype measurement,GCST007576,6:43388113
rs6968240-<b>A</b>,3 x 10-10,,0.4171,1.021835,'-,'-,FEZF1,Chronotype,chronotype measurement,GCST007576,7:122302620
rs1559253-<b>A</b>,5 x 10-9,,0.3588,1.0219371,'-,'-,EFNA5,Chronotype,chronotype measurement,GCST007576,5:107321314
rs13172141-<b>A</b>,2 x 10-9,,0.5694,1.0219371,'-,'-,KRT18P16,Chronotype,chronotype measurement,GCST007576,5:123655208
rs2050185-<b>A</b>,7 x 10-9,,0.6245,1.0219371,'-,'-,SAMD5,Chronotype,chronotype measurement,GCST007576,6:147615645
rs711098-<b>A</b>,6 x 10-9,,0.3979,1.0219371,'-,'-,NAV3,Chronotype,chronotype measurement,GCST007576,12:77582779
rs4878734-<b>A</b>,5 x 10-8,,0.5114,1.0220394,'-,'-,SHB,Chronotype,chronotype measurement,GCST007576,9:38010088
rs4121878-<b>C</b>,8 x 10-9,,0.5008,1.0221416,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,11:95387208
rs17302081-<b>T</b>,8 x 10-9,,0.4414,1.0222437,'-,'-,TFEC,Chronotype,chronotype measurement,GCST007576,7:116033025
rs710284-<b>T</b>,2 x 10-8,,0.5797,1.0222437,'-,'-,"LINC01550, LINC02295",Chronotype,chronotype measurement,GCST007576,14:98066203
rs77960-<b>A</b>,8 x 10-11,,0.3304,1.022346,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,5:104628884
rs9348050-<b>T</b>,7 x 10-11,,0.4864,1.022346,'-,'-,PDE10A,Chronotype,chronotype measurement,GCST007576,6:165850000
rs7602499-<b>T</b>,4 x 10-8,,0.3536,1.0225505,'-,'-,HNRNPA1P57,Chronotype,chronotype measurement,GCST007576,2:41158227
rs495593-<b>A</b>,4 x 10-9,,0.7383,1.0228573,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,13:72345662
rs11677484-<b>T</b>,1 x 10-9,,0.2574,1.0231643,'-,'-,NAB1,Chronotype,chronotype measurement,GCST007576,2:190713446
rs6988733-<b>T</b>,3 x 10-8,,0.3491,1.0231643,'-,'-,LINC00534,Chronotype,chronotype measurement,GCST007576,8:90523458
rs12442674-<b>A</b>,8 x 10-9,,0.7296,1.0231643,'-,'-,"NR2F2, TUBAP12",Chronotype,chronotype measurement,GCST007576,15:96364590
rs11641239-<b>T</b>,5 x 10-9,,0.2854,1.0231643,'-,'-,USP31,Chronotype,chronotype measurement,GCST007576,16:23112872
rs9465253-<b>T</b>,3 x 10-9,,0.2801,1.0232666,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,6:19102016
rs17007397-<b>C</b>,5 x 10-8,,0.5801,1.0233688,'-,'-,SAMMSON,Chronotype,chronotype measurement,GCST007576,3:70545824
rs481214-<b>A</b>,2 x 10-8,,0.6063,1.0234712,'-,'-,"RNU6-210P, RN7SL692P",Chronotype,chronotype measurement,GCST007576,1:93004308
rs8044054-<b>T</b>,7 x 10-17,,0.3878,1.0311761,'-,'-,GNPATP,Chronotype,chronotype measurement,GCST007576,16:60594532
rs1599374-<b>A</b>,3 x 10-15,,0.5163,1.0313823,'-,'-,NMD3,Chronotype,chronotype measurement,GCST007576,3:161173939
rs6477309-<b>T</b>,5 x 10-15,,0.6661,1.0313823,'-,'-,PTPRD,Chronotype,chronotype measurement,GCST007576,9:8450638
rs247929-<b>C</b>,5 x 10-17,,0.5081,1.0314856,'-,'-,ARID2,Chronotype,chronotype measurement,GCST007576,12:45901125
rs74357745-<b>A</b>,4 x 10-10,,0.8803,1.0316918,'-,'-,JHY,Chronotype,chronotype measurement,GCST007576,11:122941114
rs6967481-<b>T</b>,8 x 10-21,,0.5011,1.0326208,'-,'-,"DDC, GRB10",Chronotype,chronotype measurement,GCST007576,7:50575004
rs3857599-<b>A</b>,2 x 10-9,,0.1659,1.032724,'-,'-,FTH1P5,Chronotype,chronotype measurement,GCST007576,6:50970534
rs2396719-<b>A</b>,1 x 10-12,,0.239,1.0336539,'-,'-,FOXP2,Chronotype,chronotype measurement,GCST007576,7:114253829
rs9597241-<b>A</b>,9 x 10-14,,0.8106,1.0337573,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,13:55707137
rs12436039-<b>T</b>,3 x 10-8,,0.8801,1.0337573,'-,'-,NRXN3,Chronotype,chronotype measurement,GCST007576,14:78985676
rs2737245-<b>T</b>,3 x 10-17,,0.2748,1.0340674,'-,'-,TRPS1,Chronotype,chronotype measurement,GCST007576,8:115646356
rs10951325-<b>T</b>,8 x 10-20,,0.6319,1.0341709,'-,'-,PDE1C,Chronotype,chronotype measurement,GCST007576,7:32225933
rs76064513-<b>T</b>,3 x 10-8,,0.1342,1.0343777,'-,'-,CNTNAP5,Chronotype,chronotype measurement,GCST007576,2:124681064
rs12195792-<b>A</b>,5 x 10-15,,0.2717,1.0345846,'-,'-,EIF4EBP2P3,Chronotype,chronotype measurement,GCST007576,6:98257419
rs35524253-<b>A</b>,3 x 10-18,,0.3539,1.0347916,'-,'-,CSMD1,Chronotype,chronotype measurement,GCST007576,8:4966086
rs7735794-<b>A</b>,2 x 10-8,,0.2241,1.0349985,'-,'-,"THOC3, CPLX2",Chronotype,chronotype measurement,GCST007576,5:175912981
rs9416744-<b>A</b>,7 x 10-17,,0.2595,1.0349985,'-,'-,BICC1,Chronotype,chronotype measurement,GCST007576,10:58808177
rs10838687-<b>T</b>,2 x 10-13,,0.7918,1.035102,'-,'-,MADD,Chronotype,chronotype measurement,GCST007576,11:47291341
rs17448682-<b>T</b>,3 x 10-16,,0.2339,1.0354125,'-,'-,DDI2,Chronotype,chronotype measurement,GCST007576,1:15640218
rs7429614-<b>T</b>,2 x 10-19,,0.416,1.0355161,'-,'-,ROBO2,Chronotype,chronotype measurement,GCST007576,3:77156287
rs10742179-<b>A</b>,3 x 10-15,,0.2627,1.0358268,'-,'-,"BDNF-AS, LINC00678",Chronotype,chronotype measurement,GCST007576,11:27628977
rs58681483-<b>A</b>,1 x 10-9,,0.918,1.0358268,'-,'-,"RNU6-450P, TUBD1",Chronotype,chronotype measurement,GCST007576,17:59857293
rs12969848-<b>T</b>,1 x 10-21,,0.5313,1.0361377,'-,'-,'-,Chronotype,chronotype measurement,GCST007576,18:40572871
rs10877962-<b>T</b>,4 x 10-18,,0.4083,1.0365522,'-,'-,"RSL24D1P5, AVPR1A",Chronotype,chronotype measurement,GCST007576,12:63127132
rs10237162-<b>T</b>,2 x 10-18,,0.7232,1.0374855,'-,'-,RNA5SP228,Chronotype,chronotype measurement,GCST007576,7:24045786
rs11205668-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,AGBL4,Reaction time,reaction time measurement,GCST90011294,1:49951158
rs61789318-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"NDUFS5P2, RPL7P9",Reaction time,reaction time measurement,GCST90011294,1:96633485
rs10911301-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,NMNAT2,Reaction time,reaction time measurement,GCST90011294,1:183313440
rs12713315-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,CCDC85A,Reaction time,reaction time measurement,GCST90011294,2:56231374
rs13028903-<b>?</b>,2 x 10-14,,NR,'-,'-,'-,RNA5SP94,Reaction time,reaction time measurement,GCST90011294,2:59724330
rs4852256-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,ZNF638,Reaction time,reaction time measurement,GCST90011294,2:71404215
rs35066740-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,PNPP1,Reaction time,reaction time measurement,GCST90011294,2:76232404
rs264979-<b>?</b>,6 x 10-13,,NR,'-,'-,'-,CAPZBP1,Reaction time,reaction time measurement,GCST90011294,2:103652804
rs10804171-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"KCNJ3, CBX3P6",Reaction time,reaction time measurement,GCST90011294,2:154921126
rs16822665-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,DPP4,Reaction time,reaction time measurement,GCST90011294,2:162044817
rs7598246-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,METAP1D,Reaction time,reaction time measurement,GCST90011294,2:172001452
rs77998199-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"RPSAP24, OLA1",Reaction time,reaction time measurement,GCST90011294,2:174064024
rs4673905-<b>?</b>,4 x 10-12,,NR,'-,'-,'-,SPATS2L,Reaction time,reaction time measurement,GCST90011294,2:200299060
rs1032501-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,UBE2E2-AS1,Reaction time,reaction time measurement,GCST90011294,3:23199180
rs7684366-<b>?</b>,9 x 10-9,,NR,'-,'-,'-,GATB,Reaction time,reaction time measurement,GCST90011294,4:151816704
rs77917390-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,NREP,Reaction time,reaction time measurement,GCST90011294,5:111798361
rs56335290-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"LINC02200, APC",Reaction time,reaction time measurement,GCST90011294,5:112700937
rs6870103-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"PFDN1, HBEGF",Reaction time,reaction time measurement,GCST90011294,5:140312930
rs3800228-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,FOXO3,Reaction time,reaction time measurement,GCST90011294,6:108675545
rs13219424-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,PTPRK,Reaction time,reaction time measurement,GCST90011294,6:128010939
rs2040879-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"PURB, MYO1G",Reaction time,reaction time measurement,GCST90011294,7:44906642
rs80054135-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,'-,Reaction time,reaction time measurement,GCST90011294,7:110137741
rs7783359-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,TMEM229A,Reaction time,reaction time measurement,GCST90011294,7:124049140
rs2604268-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,'-,Reaction time,reaction time measurement,GCST90011294,9:74294470
rs10125715-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,KIF27,Reaction time,reaction time measurement,GCST90011294,9:83913943
rs7075591-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ARID5B,Reaction time,reaction time measurement,GCST90011294,10:61911055
rs73464507-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,PRDM11,Reaction time,reaction time measurement,GCST90011294,11:45102380
rs7936413-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,DGKZ,Reaction time,reaction time measurement,GCST90011294,11:46372408
rs1054442-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,DDN,Reaction time,reaction time measurement,GCST90011294,12:48995537
rs936414-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,KCNC2,Reaction time,reaction time measurement,GCST90011294,12:75154686
rs648997-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,ATXN2,Reaction time,reaction time measurement,GCST90011294,12:111538972
rs58984824-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"MED13L, MIR4472-2",Reaction time,reaction time measurement,GCST90011294,12:116333266
rs7399616-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,'-,Reaction time,reaction time measurement,GCST90011294,13:57844772
rs16959783-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SEMA6D,Reaction time,reaction time measurement,GCST90011294,15:47604353
rs1734197-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,GNAO1,Reaction time,reaction time measurement,GCST90011294,16:56182024
rs7209589-<b>?</b>,9 x 10-24,,NR,'-,'-,'-,ARL17B,Reaction time,reaction time measurement,GCST90011294,17:46292054
rs1503043-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CA10,Reaction time,reaction time measurement,GCST90011294,17:52217005
rs323299-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,KIAA1328,Reaction time,reaction time measurement,GCST90011294,18:37088184
rs66534382-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,ZBTB7A,Reaction time,reaction time measurement,GCST90011294,19:4056368
rs7296313-<b>?</b>,1 x 10-8,,NR,'-,0.0296961 unit decrease,[NR],SH2B3,Reaction time,reaction time measurement,GCST003499,12:111440722
rs10931898-<b>?</b>,3 x 10-8,,NR,'-,0.0241142 unit increase,[NR],SPATS2L,Reaction time,reaction time measurement,GCST003499,2:200306468
rs150943874-<b>?</b>,5 x 10-6,,NR,'-,0.019601 unit increase,[0.011-0.028],'-,Reaction time,reaction time measurement,GCST006268,2:162961035
rs9789538-<b>?</b>,3 x 10-7,,NR,'-,0.0090409 unit increase,[0.0056-0.0125],"DYNC1I2, SLC25A12",Reaction time,reaction time measurement,GCST006268,2:171761964
rs59844139-<b>?</b>,2 x 10-7,,NR,'-,0.0091096 unit increase,[0.0057-0.0125],SLC25A12,Reaction time,reaction time measurement,GCST006268,2:171875473
rs11686160-<b>?</b>,7 x 10-7,,NR,'-,0.0085913 unit increase,[0.0052-0.012],GPR155,Reaction time,reaction time measurement,GCST006268,2:174450579
rs3828186-<b>?</b>,3 x 10-6,,NR,'-,0.0079218 unit decrease,[0.0046-0.0113],SATB2,Reaction time,reaction time measurement,GCST006268,2:199349550
rs56155997-<b>?</b>,7 x 10-7,,NR,'-,0.008509 unit increase,[0.0051-0.0119],"RN7SL717P, C2orf69",Reaction time,reaction time measurement,GCST006268,2:199903768
rs7605374-<b>?</b>,3 x 10-6,,NR,'-,0.0081324 unit decrease,[0.0047-0.0116],SPATS2L,Reaction time,reaction time measurement,GCST006268,2:200405533
rs7606468-<b>?</b>,3 x 10-6,,NR,'-,0.0082564 unit decrease,[0.0048-0.0117],PARD3B,Reaction time,reaction time measurement,GCST006268,2:205280109
rs568420197-<b>?</b>,6 x 10-6,,NR,'-,0.007558 unit decrease,[0.0043-0.0108],PID1,Reaction time,reaction time measurement,GCST006268,2:228961785
rs10209575-<b>?</b>,5 x 10-6,,NR,'-,0.0079021 unit decrease,[0.0045-0.0113],"GIGYF2, EFHD1",Reaction time,reaction time measurement,GCST006268,2:232693280
rs73102769-<b>?</b>,7 x 10-7,,NR,'-,0.0086284 unit increase,[0.0052-0.012],NGEF,Reaction time,reaction time measurement,GCST006268,2:232928501
rs115659367-<b>?</b>,6 x 10-6,,NR,'-,0.041847 unit increase,[0.024-0.06],'-,Reaction time,reaction time measurement,GCST006268,2:236808252
rs140870884-<b>?</b>,5 x 10-7,,NR,'-,0.0084947 unit increase,[0.0052-0.0118],GPC1,Reaction time,reaction time measurement,GCST006268,2:240425252
rs115620538-<b>?</b>,7 x 10-6,,NR,'-,0.0075536 unit increase,[0.0043-0.0109],ANO7,Reaction time,reaction time measurement,GCST006268,2:241224123
rs6780194-<b>?</b>,9 x 10-6,,NR,'-,0.044417 unit increase,[0.025-0.064],LMCD1-AS1,Reaction time,reaction time measurement,GCST006268,3:7959844
rs143759286-<b>?</b>,2 x 10-6,,NR,'-,0.0081588 unit increase,[0.0048-0.0115],SRGAP3,Reaction time,reaction time measurement,GCST006268,3:9230433
rs4858496-<b>?</b>,5 x 10-7,,NR,'-,0.0087329 unit decrease,[0.0053-0.0121],UBE2E2,Reaction time,reaction time measurement,GCST006268,3:23308005
rs9862557-<b>?</b>,1 x 10-7,,NR,'-,0.0092597 unit increase,[0.0058-0.0127],UBE2E2,Reaction time,reaction time measurement,GCST006268,3:23479570
rs17787217-<b>?</b>,5 x 10-6,,NR,'-,0.0079376 unit decrease,[0.0045-0.0113],UBE2E1,Reaction time,reaction time measurement,GCST006268,3:23866284
rs4682718-<b>?</b>,5 x 10-6,,NR,'-,0.0080821 unit increase,[0.0046-0.0116],"MIR138-1, TOPAZ1",Reaction time,reaction time measurement,GCST006268,3:44184840
rs11719795-<b>?</b>,2 x 10-7,,NR,'-,0.0090456 unit increase,[0.0056-0.0125],"PTH1R, CCDC12",Reaction time,reaction time measurement,GCST006268,3:46910445
rs12631730-<b>?</b>,2 x 10-6,,NR,'-,0.0083757 unit increase,[0.0049-0.0118],SETD2,Reaction time,reaction time measurement,GCST006268,3:47088413
rs13059519-<b>?</b>,2 x 10-6,,NR,'-,0.0084444 unit increase,[0.005-0.0119],ELP6,Reaction time,reaction time measurement,GCST006268,3:47498479
rs7618684-<b>?</b>,6 x 10-7,,NR,'-,0.0087343 unit decrease,[0.0053-0.0122],PDE12,Reaction time,reaction time measurement,GCST006268,3:57560266
rs6795439-<b>?</b>,4 x 10-6,,NR,'-,0.0079976 unit increase,[0.0046-0.0114],"DENND6A-DT, SLMAP",Reaction time,reaction time measurement,GCST006268,3:57717983
rs141854496-<b>?</b>,6 x 10-7,,NR,'-,0.028313 unit increase,[0.017-0.039],"CCKAR, TBC1D19",Reaction time,reaction time measurement,GCST006268,4:26518645
rs116171472-<b>?</b>,6 x 10-6,,NR,'-,0.03465 unit increase,[0.02-0.05],LINC02261,Reaction time,reaction time measurement,GCST006268,4:27210339
chr4:37670836-<b>?</b>,7 x 10-6,,NR,'-,0.008989 unit increase,[0.0051-0.0129],'-,Reaction time,reaction time measurement,GCST006268,Mapping not available
rs115965110-<b>?</b>,3 x 10-6,,NR,'-,0.069001 unit increase,[0.04-0.098],TBC1D1,Reaction time,reaction time measurement,GCST006268,4:37906729
rs28519512-<b>?</b>,3 x 10-6,,NR,'-,0.0081748 unit decrease,[0.0048-0.0116],N4BP2,Reaction time,reaction time measurement,GCST006268,4:40085132
rs527577433-<b>?</b>,7 x 10-7,,NR,'-,0.013623 unit decrease,[0.0082-0.019],PHOX2B-AS1,Reaction time,reaction time measurement,GCST006268,4:41800412
rs7672100-<b>?</b>,3 x 10-6,,NR,'-,0.0081376 unit decrease,[0.0047-0.0115],GABRB1,Reaction time,reaction time measurement,GCST006268,4:47263573
rs145895560-<b>?</b>,8 x 10-6,,NR,'-,0.0083175 unit decrease,[0.0047-0.012],RNU6-1325P,Reaction time,reaction time measurement,GCST006268,4:59848499
rs144257849-<b>?</b>,9 x 10-6,,NR,'-,0.0075416 unit decrease,[0.0042-0.0109],'-,Reaction time,reaction time measurement,GCST006268,4:60164258
rs145025545-<b>?</b>,3 x 10-6,,NR,'-,0.0082439 unit decrease,[0.0048-0.0117],"LINC02483, RCHY1",Reaction time,reaction time measurement,GCST006268,4:75451860
rs141033168-<b>?</b>,2 x 10-6,,NR,'-,0.0081738 unit decrease,[0.0048-0.0115],RASGEF1B,Reaction time,reaction time measurement,GCST006268,4:81815398
rs116663439-<b>?</b>,2 x 10-7,,NR,'-,0.12419 unit increase,[0.077-0.171],COQ2,Reaction time,reaction time measurement,GCST006268,4:83284309
rs11932693-<b>?</b>,2 x 10-7,,NR,'-,0.0091307 unit increase,[0.0057-0.0125],"PIGY-DT, RN7SKP244",Reaction time,reaction time measurement,GCST006268,4:88545184
rs3017917-<b>?</b>,3 x 10-6,,NR,'-,0.0082995 unit increase,[0.0048-0.0118],HERC3,Reaction time,reaction time measurement,GCST006268,4:88679669
rs553205008-<b>?</b>,2 x 10-6,,NR,'-,0.0078587 unit increase,[0.0046-0.0111],BANK1,Reaction time,reaction time measurement,GCST006268,4:101429340
rs13123752-<b>?</b>,2 x 10-6,,NR,'-,0.0082518 unit increase,[0.0048-0.0117],TET2,Reaction time,reaction time measurement,GCST006268,4:105160963
rs9991319-<b>?</b>,4 x 10-6,,NR,'-,0.0082749 unit decrease,[0.0048-0.0118],COL25A1,Reaction time,reaction time measurement,GCST006268,4:109249480
rs1448818-<b>?</b>,1 x 10-6,,NR,'-,0.0084108 unit decrease,[0.005-0.0118],PITX2,Reaction time,reaction time measurement,GCST006268,4:110649067
rs17861885-<b>?</b>,2 x 10-7,,NR,'-,0.008905 unit decrease,[0.0055-0.0123],LINC01378,Reaction time,reaction time measurement,GCST006268,4:117419552
rs113318338-<b>?</b>,1 x 10-7,,NR,'-,0.0090911 unit increase,[0.0057-0.0125],INPP4B,Reaction time,reaction time measurement,GCST006268,4:142417326
rs6843300-<b>?</b>,1 x 10-6,,NR,'-,0.0088596 unit decrease,[0.0053-0.0124],LINC02273,Reaction time,reaction time measurement,GCST006268,4:152110897
rs748053358-<b>?</b>,9 x 10-6,,NR,'-,0.0073472 unit increase,[0.0041-0.0106],'-,Reaction time,reaction time measurement,GCST006268,4:179414414
rs760278682-<b>?</b>,1 x 10-6,,NR,'-,0.0080594 unit increase,[0.0048-0.0113],'-,Reaction time,reaction time measurement,GCST006268,4:179552483
rs74553517-<b>?</b>,1 x 10-6,,NR,'-,0.0083835 unit decrease,[0.005-0.0118],"CEP72, TPPP",Reaction time,reaction time measurement,GCST006268,5:665556
rs76718060-<b>?</b>,5 x 10-6,,NR,'-,0.0077685 unit decrease,[0.0044-0.0111],RNU6-1232P,Reaction time,reaction time measurement,GCST006268,5:68108820
rs7650936-<b>?</b>,8 x 10-7,,NR,'-,0.008589 unit decrease,[0.0052-0.012],ARL6IP5,Reaction time,reaction time measurement,GCST006268,3:69103442
rs17008195-<b>?</b>,6 x 10-7,,NR,'-,0.0087606 unit increase,[0.0053-0.0122],FOXP1,Reaction time,reaction time measurement,GCST006268,3:71080728
rs143551942-<b>?</b>,8 x 10-6,,NR,'-,0.0079423 unit increase,[0.0045-0.0114],LINC00877,Reaction time,reaction time measurement,GCST006268,3:72224210
rs13095389-<b>?</b>,9 x 10-6,,NR,'-,0.0076379 unit increase,[0.0043-0.011],GBE1,Reaction time,reaction time measurement,GCST006268,3:81726884
rs34671460-<b>?</b>,3 x 10-6,,NR,'-,0.008004 unit increase,[0.0046-0.0114],'-,Reaction time,reaction time measurement,GCST006268,3:81874076
rs2034718-<b>?</b>,2 x 10-7,,NR,'-,0.0090619 unit decrease,[0.0056-0.0125],LINC00971,Reaction time,reaction time measurement,GCST006268,3:84737828
rs62122-<b>?</b>,5 x 10-7,,NR,'-,0.0088325 unit increase,[0.0054-0.0123],LINC00971,Reaction time,reaction time measurement,GCST006268,3:84851726
rs424029-<b>?</b>,5 x 10-6,,NR,'-,0.0079726 unit increase,[0.0046-0.0114],CADM2,Reaction time,reaction time measurement,GCST006268,3:84960888
rs6549016-<b>?</b>,2 x 10-6,,NR,'-,0.008369 unit decrease,[0.0049-0.0118],CADM2,Reaction time,reaction time measurement,GCST006268,3:85131120
rs4855621-<b>?</b>,9 x 10-7,,NR,'-,0.0083956 unit decrease,[0.005-0.0117],"LINC01215, CD47",Reaction time,reaction time measurement,GCST006268,3:108110959
rs7635040-<b>?</b>,4 x 10-7,,NR,'-,0.0087215 unit decrease,[0.0054-0.0121],MYH15,Reaction time,reaction time measurement,GCST006268,3:108381013
rs76462595-<b>?</b>,5 x 10-6,,NR,'-,0.0078258 unit increase,[0.0045-0.0112],"FSTL1, NDUFB4",Reaction time,reaction time measurement,GCST006268,3:120515118
rs1457546-<b>?</b>,2 x 10-6,,NR,'-,0.0083875 unit increase,[0.005-0.0118],PFN2,Reaction time,reaction time measurement,GCST006268,3:149974810
rs1711079-<b>?</b>,8 x 10-6,,NR,'-,0.0077687 unit decrease,[0.0044-0.0112],MECOM,Reaction time,reaction time measurement,GCST006268,3:169212636
rs6444974-<b>?</b>,3 x 10-7,,NR,'-,0.0089509 unit increase,[0.0055-0.0124],TNIK,Reaction time,reaction time measurement,GCST006268,3:171268622
rs11705870-<b>?</b>,3 x 10-7,,NR,'-,0.0088756 unit increase,[0.0055-0.0123],LINC00578,Reaction time,reaction time measurement,GCST006268,3:177472205
rs7643043-<b>?</b>,8 x 10-6,,NR,'-,0.0079836 unit decrease,[0.0045-0.0115],LINC02053,Reaction time,reaction time measurement,GCST006268,3:180418798
rs768882952-<b>?</b>,7 x 10-6,,NR,'-,0.0075016 unit decrease,[0.0042-0.0108],FXR1,Reaction time,reaction time measurement,GCST006268,3:180940263
rs12632136-<b>?</b>,9 x 10-6,,NR,'-,0.007727 unit decrease,[0.0043-0.0111],SOX2-OT,Reaction time,reaction time measurement,GCST006268,3:181275636
rs141542299-<b>?</b>,2 x 10-7,,NR,'-,0.09187 unit increase,[0.057-0.126],LINC02052,Reaction time,reaction time measurement,GCST006268,3:186474657
rs4687530-<b>?</b>,1 x 10-6,,NR,'-,0.0084154 unit decrease,[0.005-0.0118],LINC02036,Reaction time,reaction time measurement,GCST006268,3:194203771
rs4504245-<b>?</b>,3 x 10-6,,NR,'-,0.0080472 unit increase,[0.0046-0.0114],'-,Reaction time,reaction time measurement,GCST006268,4:11013198
rs190680301-<b>?</b>,9 x 10-6,,NR,'-,0.0077478 unit decrease,[0.0043-0.0112],CC2D2A,Reaction time,reaction time measurement,GCST006268,4:15529227
rs768695-<b>?</b>,6 x 10-6,,NR,'-,0.0078592 unit decrease,[0.0044-0.0113],PPARGC1A,Reaction time,reaction time measurement,GCST006268,4:23797195
rs73810222-<b>?</b>,2 x 10-6,,NR,'-,0.019531 unit increase,[0.012-0.028],RBPJ,Reaction time,reaction time measurement,GCST006268,4:26390517
rs33415-<b>?</b>,3 x 10-6,,NR,'-,0.0082402 unit increase,[0.0048-0.0117],"ZNF366, LINC02056",Reaction time,reaction time measurement,GCST006268,5:72567509
rs10077289-<b>?</b>,9 x 10-7,,NR,'-,0.0085837 unit increase,[0.0052-0.012],IQGAP2,Reaction time,reaction time measurement,GCST006268,5:76602072
rs192426480-<b>?</b>,3 x 10-6,,NR,'-,0.0077842 unit decrease,[0.0045-0.011],"AP3B1, TBCA",Reaction time,reaction time measurement,GCST006268,5:77925191
rs145129667-<b>?</b>,2 x 10-6,,NR,'-,0.0081115 unit increase,[0.0048-0.0115],ARSB,Reaction time,reaction time measurement,GCST006268,5:78977363
rs1650697-<b>?</b>,8 x 10-6,,NR,'-,0.0077569 unit decrease,[0.0043-0.0112],"DHFR, MSH3",Reaction time,reaction time measurement,GCST006268,5:80654962
rs115449331-<b>?</b>,9 x 10-6,,NR,'-,0.0076759 unit decrease,[0.0043-0.0111],'-,Reaction time,reaction time measurement,GCST006268,5:82668365
rs17446201-<b>?</b>,9 x 10-6,,NR,'-,0.0077758 unit decrease,[0.0043-0.0112],MIR4280HG,Reaction time,reaction time measurement,GCST006268,5:87132009
rs13355146-<b>?</b>,5 x 10-6,,NR,'-,0.0079453 unit increase,[0.0045-0.0114],'-,Reaction time,reaction time measurement,GCST006268,5:92687954
rs62366053-<b>?</b>,9 x 10-7,,NR,'-,0.0085001 unit decrease,[0.0051-0.0119],FAM172A,Reaction time,reaction time measurement,GCST006268,5:94053622
rs293058-<b>?</b>,4 x 10-7,,NR,'-,0.008771 unit decrease,[0.0054-0.0122],MCTP1,Reaction time,reaction time measurement,GCST006268,5:94870685
rs79219208-<b>?</b>,8 x 10-6,,NR,'-,0.0076999 unit increase,[0.0043-0.0111],MCTP1,Reaction time,reaction time measurement,GCST006268,5:95226029
rs759425971-<b>?</b>,8 x 10-6,,NR,'-,0.0072504 unit increase,[0.0041-0.0104],RNU6-334P,Reaction time,reaction time measurement,GCST006268,5:104742117
rs55754532-<b>?</b>,5 x 10-6,,NR,'-,0.0079808 unit decrease,[0.0046-0.0114],EFNA5,Reaction time,reaction time measurement,GCST006268,5:107629612
rs11741087-<b>?</b>,4 x 10-6,,NR,'-,0.0080344 unit increase,[0.0046-0.0115],PJA2,Reaction time,reaction time measurement,GCST006268,5:109472059
rs757231047-<b>?</b>,9 x 10-6,,NR,'-,0.0076533 unit increase,[0.0043-0.011],STARD4-AS1,Reaction time,reaction time measurement,GCST006268,5:111538465
rs112316630-<b>?</b>,1 x 10-6,,NR,'-,0.0082247 unit decrease,[0.0049-0.0115],"EPB41L4A, NREP-AS1",Reaction time,reaction time measurement,GCST006268,5:112086876
rs72803246-<b>?</b>,5 x 10-8,,NR,'-,0.009474 unit increase,[0.0061-0.0129],MCC,Reaction time,reaction time measurement,GCST006268,5:113103140
rs189809079-<b>?</b>,8 x 10-6,,NR,'-,0.0086838 unit increase,[0.0049-0.0125],PRRC1,Reaction time,reaction time measurement,GCST006268,5:127533964
rs155949-<b>?</b>,1 x 10-6,,NR,'-,0.0084385 unit decrease,[0.005-0.0119],"IGIP, CYSTM1",Reaction time,reaction time measurement,GCST006268,5:140144099
rs372085168-<b>?</b>,6 x 10-6,,NR,'-,0.012255 unit increase,[0.0069-0.0176],PPP2R2B,Reaction time,reaction time measurement,GCST006268,5:147068032
rs2915820-<b>?</b>,3 x 10-6,,NR,'-,0.0080527 unit decrease,[0.0047-0.0115],"CLMAT3, ATOX1",Reaction time,reaction time measurement,GCST006268,5:151734774
rs3792766-<b>?</b>,5 x 10-6,,NR,'-,0.0078739 unit increase,[0.0045-0.0113],GRIA1,Reaction time,reaction time measurement,GCST006268,5:153490064
rs76964760-<b>?</b>,6 x 10-6,,NR,'-,0.0075548 unit increase,[0.0043-0.0108],FAXDC2,Reaction time,reaction time measurement,GCST006268,5:154849367
rs2909797-<b>?</b>,9 x 10-7,,NR,'-,0.0089384 unit increase,[0.0054-0.0125],TENM2,Reaction time,reaction time measurement,GCST006268,5:167848944
rs10057481-<b>?</b>,6 x 10-7,,NR,'-,0.0086854 unit decrease,[0.0053-0.0121],ARL2BPP6,Reaction time,reaction time measurement,GCST006268,5:175260479
rs139778071-<b>?</b>,5 x 10-6,,NR,'-,0.0076115 unit increase,[0.0043-0.0109],TMEM168,Reaction time,reaction time measurement,GCST006268,7:112772226
rs549993043-<b>?</b>,5 x 10-6,,NR,'-,0.0075106 unit decrease,[0.0043-0.0107],FOXP2,Reaction time,reaction time measurement,GCST006268,7:114513582
rs13234003-<b>?</b>,5 x 10-6,,NR,'-,0.0078284 unit decrease,[0.0045-0.0112],PTPRZ1,Reaction time,reaction time measurement,GCST006268,7:121927229
rs17716738-<b>?</b>,6 x 10-6,,NR,'-,0.007904 unit decrease,[0.0045-0.0113],"PAX4, SND1",Reaction time,reaction time measurement,GCST006268,7:127635395
rs17718395-<b>?</b>,4 x 10-6,,NR,'-,0.0080441 unit decrease,[0.0046-0.0115],SND1,Reaction time,reaction time measurement,GCST006268,7:127738598
rs1362267-<b>?</b>,2 x 10-7,,NR,'-,0.009122 unit increase,[0.0057-0.0126],SND1,Reaction time,reaction time measurement,GCST006268,7:127961201
rs4731401-<b>?</b>,2 x 10-6,,NR,'-,0.0085134 unit decrease,[0.005-0.012],"MIR129-1, SND1",Reaction time,reaction time measurement,GCST006268,7:128138460
rs141082647-<b>?</b>,1 x 10-6,,NR,'-,0.075267 unit increase,[0.045-0.106],'-,Reaction time,reaction time measurement,GCST006268,7:136385479
rs28590034-<b>?</b>,8 x 10-7,,NR,'-,0.0088043 unit decrease,[0.0053-0.0123],CHRM2,Reaction time,reaction time measurement,GCST006268,7:137108024
rs1376609-<b>?</b>,2 x 10-6,,NR,'-,0.0084892 unit increase,[0.005-0.012],DGKI,Reaction time,reaction time measurement,GCST006268,7:137401234
rs144684241-<b>?</b>,6 x 10-6,,NR,'-,0.0075889 unit increase,[0.0043-0.0109],DGKI,Reaction time,reaction time measurement,GCST006268,7:137790351
rs566321594-<b>?</b>,1 x 10-7,,NR,'-,0.0087543 unit increase,[0.0055-0.012],TPK1,Reaction time,reaction time measurement,GCST006268,7:144464943
rs73160311-<b>?</b>,6 x 10-6,,NR,'-,0.007707 unit increase,[0.0044-0.011],"RNY4, RNY3",Reaction time,reaction time measurement,GCST006268,7:148976002
rs142037757-<b>?</b>,3 x 10-6,,NR,'-,0.0079541 unit increase,[0.0046-0.0113],PTPRN2,Reaction time,reaction time measurement,GCST006268,7:157897424
rs4317600-<b>?</b>,9 x 10-8,,NR,'-,0.0093042 unit increase,[0.0059-0.0127],CSMD1,Reaction time,reaction time measurement,GCST006268,8:4964327
rs371069475-<b>?</b>,2 x 10-6,,NR,'-,0.0082027 unit decrease,[0.0048-0.0116],RPL23AP54,Reaction time,reaction time measurement,GCST006268,8:5418663
rs78157579-<b>?</b>,7 x 10-7,,NR,'-,0.067345 unit increase,[0.041-0.094],"LONRF1, LINC00681",Reaction time,reaction time measurement,GCST006268,8:12779073
rs190324086-<b>?</b>,5 x 10-6,,NR,'-,0.0079173 unit decrease,[0.0045-0.0113],PPP2R2A,Reaction time,reaction time measurement,GCST006268,8:26312674
rs28414044-<b>?</b>,2 x 10-6,,NR,'-,0.022735 unit increase,[0.013-0.032],"DPYSL2, ADRA1A",Reaction time,reaction time measurement,GCST006268,8:26729520
rs344201-<b>?</b>,4 x 10-6,,NR,'-,0.0082515 unit decrease,[0.0047-0.0118],"NARS1P2, LINC02842",Reaction time,reaction time measurement,GCST006268,8:62032464
rs6472945-<b>?</b>,7 x 10-7,,NR,'-,0.0086897 unit decrease,[0.0053-0.0121],'-,Reaction time,reaction time measurement,GCST006268,8:75938847
rs189271369-<b>?</b>,8 x 10-6,,NR,'-,0.0076126 unit decrease,[0.0043-0.011],EIF3H,Reaction time,reaction time measurement,GCST006268,8:116595430
rs10107133-<b>?</b>,2 x 10-6,,NR,'-,0.008343 unit increase,[0.0049-0.0118],"EFR3A, OC90",Reaction time,reaction time measurement,GCST006268,8:132016986
rs74545339-<b>?</b>,6 x 10-6,,NR,'-,0.0077942 unit decrease,[0.0044-0.0112],"ZFAT, FAM110B",Reaction time,reaction time measurement,GCST006268,8:134428365
rs117619771-<b>?</b>,2 x 10-6,,NR,'-,0.008002 unit decrease,[0.0047-0.0113],LINC02055,Reaction time,reaction time measurement,GCST006268,8:136664307
rs11686001-<b>?</b>,4 x 10-6,,NR,'-,0.0079224 unit decrease,[0.0046-0.0113],"RBKS, MRPL33",Reaction time,reaction time measurement,GCST006268,2:27800195
rs13021775-<b>?</b>,3 x 10-6,,NR,'-,0.008115 unit decrease,[0.0047-0.0115],"STRN, VIT",Reaction time,reaction time measurement,GCST006268,2:36832414
rs12995492-<b>?</b>,8 x 10-6,,NR,'-,0.0077523 unit decrease,[0.0043-0.0112],EML4,Reaction time,reaction time measurement,GCST006268,2:42227321
rs698796-<b>?</b>,7 x 10-7,,NR,'-,0.008722 unit increase,[0.0053-0.0122],CAMKMT,Reaction time,reaction time measurement,GCST006268,2:44462530
rs4953152-<b>?</b>,1 x 10-6,,NR,'-,0.0085471 unit decrease,[0.0051-0.012],SIX3,Reaction time,reaction time measurement,GCST006268,2:44943014
rs72874349-<b>?</b>,5 x 10-6,,NR,'-,0.031822 unit decrease,[0.018-0.045],PRKCE,Reaction time,reaction time measurement,GCST006268,2:45960699
rs10187482-<b>?</b>,4 x 10-6,,NR,'-,0.0079349 unit decrease,[0.0045-0.0113],NRXN1,Reaction time,reaction time measurement,GCST006268,2:51312095
rs2251081-<b>?</b>,6 x 10-6,,NR,'-,0.0078461 unit decrease,[0.0044-0.0113],RNU6-508P,Reaction time,reaction time measurement,GCST006268,2:59605504
rs62143603-<b>?</b>,2 x 10-6,,NR,'-,0.0081377 unit decrease,[0.0048-0.0115],'-,Reaction time,reaction time measurement,GCST006268,2:59858710
rs560576410-<b>?</b>,7 x 10-7,,NR,'-,0.0084106 unit increase,[0.0051-0.0117],"OR7E62P, NAGK",Reaction time,reaction time measurement,GCST006268,2:71062086
rs4241246-<b>?</b>,5 x 10-8,,NR,'-,0.0095654 unit decrease,[0.0061-0.013],"DYSF, ZNF638",Reaction time,reaction time measurement,GCST006268,2:71449236
rs72820790-<b>?</b>,5 x 10-8,,NR,'-,0.0094152 unit increase,[0.006-0.0128],SUCLA2P2,Reaction time,reaction time measurement,GCST006268,2:76033590
rs4430958-<b>?</b>,7 x 10-6,,NR,'-,0.0078346 unit increase,[0.0044-0.0113],REEP1,Reaction time,reaction time measurement,GCST006268,2:86335779
rs1441102-<b>?</b>,5 x 10-8,,NR,'-,0.0095365 unit increase,[0.0061-0.013],LINC01965,Reaction time,reaction time measurement,GCST006268,2:103863404
rs4241120-<b>?</b>,8 x 10-6,,NR,'-,0.0081179 unit decrease,[0.0046-0.0117],TMEM87B,Reaction time,reaction time measurement,GCST006268,2:112095141
rs187907266-<b>?</b>,4 x 10-6,,NR,'-,0.0078936 unit decrease,[0.0046-0.0112],'-,Reaction time,reaction time measurement,GCST006268,2:123263594
rs1368091-<b>?</b>,7 x 10-6,,NR,'-,0.0077884 unit decrease,[0.0044-0.0112],'-,Reaction time,reaction time measurement,GCST006268,Mapping not available
rs186733086-<b>?</b>,8 x 10-6,,NR,'-,0.0076902 unit increase,[0.0043-0.0111],TEX41,Reaction time,reaction time measurement,GCST006268,2:144932535
rs10928298-<b>?</b>,8 x 10-6,,NR,'-,0.0077952 unit increase,[0.0044-0.0112],OTX2P2,Reaction time,reaction time measurement,GCST006268,2:146484191
rs4662486-<b>?</b>,2 x 10-6,,NR,'-,0.0084562 unit decrease,[0.005-0.0119],MYT1L,Reaction time,reaction time measurement,GCST006268,2:147078365
rs544533597-<b>?</b>,2 x 10-6,,NR,'-,0.0079451 unit increase,[0.0047-0.0112],GALNT13,Reaction time,reaction time measurement,GCST006268,2:154000180
rs116267997-<b>?</b>,2 x 10-6,,NR,'-,0.0080595 unit increase,[0.0047-0.0114],RNU6-1001P,Reaction time,reaction time measurement,GCST006268,2:155066911
rs1948731-<b>?</b>,1 x 10-6,,NR,'-,0.0086966 unit decrease,[0.0052-0.0122],"MTND4P28, ATP5F1AP2",Reaction time,reaction time measurement,GCST006268,2:155294876
rs1505729-<b>?</b>,1 x 10-6,,NR,'-,0.0087606 unit decrease,[0.0052-0.0123],'-,Reaction time,reaction time measurement,GCST006268,2:155453957
rs76868064-<b>?</b>,7 x 10-6,,NR,'-,0.0076231 unit increase,[0.0043-0.011],CDK7P1,Reaction time,reaction time measurement,GCST006268,2:157117929
rs340122-<b>?</b>,6 x 10-6,,NR,'-,0.0081266 unit decrease,[0.0046-0.0116],ADAMTS2,Reaction time,reaction time measurement,GCST006268,5:179260682
rs3778555-<b>?</b>,3 x 10-6,,NR,'-,0.0081918 unit increase,[0.0048-0.0116],GMDS,Reaction time,reaction time measurement,GCST006268,6:1917455
rs536247550-<b>?</b>,7 x 10-6,,NR,'-,0.0077195 unit decrease,[0.0044-0.0111],ECI2-DT,Reaction time,reaction time measurement,GCST006268,6:4160061
rs1150602-<b>?</b>,6 x 10-6,,NR,'-,0.0078994 unit increase,[0.0045-0.0113],PHACTR1,Reaction time,reaction time measurement,GCST006268,6:13190980
rs2299048-<b>?</b>,7 x 10-6,,NR,'-,0.0078252 unit decrease,[0.0044-0.0112],JARID2,Reaction time,reaction time measurement,GCST006268,6:15438337
rs7760870-<b>?</b>,4 x 10-7,,NR,'-,0.0090011 unit decrease,[0.0055-0.0125],CAP2,Reaction time,reaction time measurement,GCST006268,6:17522755
rs6929812-<b>?</b>,5 x 10-7,,NR,'-,0.0087708 unit increase,[0.0053-0.0122],"ZNF184, MCFD2P1",Reaction time,reaction time measurement,GCST006268,6:27416741
rs116628042-<b>?</b>,6 x 10-6,,NR,'-,0.0075805 unit increase,[0.0043-0.0109],"GPX6, OR2E1P",Reaction time,reaction time measurement,GCST006268,6:28474553
rs114416898-<b>?</b>,6 x 10-6,,NR,'-,0.0076225 unit increase,[0.0043-0.0109],ZBED9,Reaction time,reaction time measurement,GCST006268,6:28589372
rs185008237-<b>?</b>,4 x 10-6,,NR,'-,0.0077326 unit increase,[0.0045-0.011],"OR2G1P, OR2J4P",Reaction time,reaction time measurement,GCST006268,6:29190807
rs1269556-<b>?</b>,2 x 10-6,,NR,'-,0.0083093 unit decrease,[0.0049-0.0117],"TMPOP1, MICC",Reaction time,reaction time measurement,GCST006268,6:30441010
rs73437885-<b>?</b>,8 x 10-6,,NR,'-,0.0081424 unit increase,[0.0046-0.0117],LINC00243,Reaction time,reaction time measurement,GCST006268,6:30810506
rs11965885-<b>?</b>,2 x 10-6,,NR,'-,0.0083895 unit decrease,[0.0049-0.0118],"MRPS18A, VEGFA",Reaction time,reaction time measurement,GCST006268,6:43725357
rs3756920-<b>?</b>,6 x 10-6,,NR,'-,0.0081704 unit decrease,[0.0046-0.0117],"TFAP2B, TFAP2D",Reaction time,reaction time measurement,GCST006268,6:50817586
rs9367420-<b>?</b>,7 x 10-6,,NR,'-,0.007971 unit decrease,[0.0045-0.0115],FTH1P5,Reaction time,reaction time measurement,GCST006268,6:50941485
rs116251883-<b>?</b>,4 x 10-6,,NR,'-,0.0079029 unit decrease,[0.0046-0.0112],"CLNS1AP1, RPL10P10",Reaction time,reaction time measurement,GCST006268,6:54523322
rs36086007-<b>?</b>,6 x 10-6,,NR,'-,0.0076989 unit decrease,[0.0044-0.011],"VARS2, KRASP1",Reaction time,reaction time measurement,GCST006268,6:54730547
rs115663989-<b>?</b>,8 x 10-6,,NR,'-,0.031227 unit increase,[0.018-0.045],'-,Reaction time,reaction time measurement,GCST006268,6:68514383
rs531467446-<b>?</b>,5 x 10-6,,NR,'-,0.0079799 unit decrease,[0.0045-0.0114],RIMS1,Reaction time,reaction time measurement,GCST006268,6:71965157
rs118038155-<b>?</b>,6 x 10-6,,NR,'-,0.0078176 unit decrease,[0.0044-0.0112],RIMS1,Reaction time,reaction time measurement,GCST006268,6:72253437
rs2224195-<b>?</b>,3 x 10-6,,NR,'-,0.0081575 unit decrease,[0.0047-0.0116],SNAP91,Reaction time,reaction time measurement,GCST006268,6:83598007
rs116122500-<b>?</b>,3 x 10-6,,NR,'-,0.038724 unit increase,[0.023-0.055],BACH2,Reaction time,reaction time measurement,GCST006268,6:90112008
rs12207304-<b>?</b>,9 x 10-6,,NR,'-,0.0077361 unit decrease,[0.0043-0.0112],MMS22L,Reaction time,reaction time measurement,GCST006268,6:97197059
rs10499014-<b>?</b>,1 x 10-7,,NR,'-,0.0092283 unit decrease,[0.0058-0.0126],'-,Reaction time,reaction time measurement,GCST006268,6:97499879
rs74704950-<b>?</b>,7 x 10-7,,NR,'-,0.0084743 unit increase,[0.0051-0.0118],ATF1P1,Reaction time,reaction time measurement,GCST006268,6:97605732
rs112706601-<b>?</b>,3 x 10-6,,NR,'-,0.0079946 unit increase,[0.0047-0.0113],'-,Reaction time,reaction time measurement,GCST006268,6:97712657
rs139063082-<b>?</b>,1 x 10-6,,NR,'-,0.0084 unit decrease,[0.005-0.0118],'-,Reaction time,reaction time measurement,GCST006268,6:97918057
rs17813462-<b>?</b>,8 x 10-6,,NR,'-,0.0077658 unit decrease,[0.0044-0.0112],MIR2113,Reaction time,reaction time measurement,GCST006268,6:98022357
rs217526-<b>?</b>,6 x 10-6,,NR,'-,0.0078978 unit increase,[0.0045-0.0113],NR2E1,Reaction time,reaction time measurement,GCST006268,6:108178521
rs113125045-<b>?</b>,3 x 10-6,,NR,'-,0.038792 unit increase,[0.023-0.055],CDK19,Reaction time,reaction time measurement,GCST006268,6:110628557
rs6937866-<b>?</b>,7 x 10-8,,NR,'-,0.009434 unit decrease,[0.006-0.0129],SAMD3,Reaction time,reaction time measurement,GCST006268,6:130301595
rs11154580-<b>?</b>,5 x 10-7,,NR,'-,0.0089948 unit decrease,[0.0055-0.0125],TMEM200A,Reaction time,reaction time measurement,GCST006268,6:130432443
rs7766061-<b>?</b>,5 x 10-6,,NR,'-,0.0081433 unit decrease,[0.0047-0.0116],ENPP3,Reaction time,reaction time measurement,GCST006268,6:131645893
rs9376390-<b>?</b>,7 x 10-6,,NR,'-,0.0079142 unit increase,[0.0045-0.0114],REPS1,Reaction time,reaction time measurement,GCST006268,6:138971546
rs74935095-<b>?</b>,4 x 10-6,,NR,'-,0.0077738 unit decrease,[0.0045-0.0111],'-,Reaction time,reaction time measurement,GCST006268,6:140436557
rs139486976-<b>?</b>,4 x 10-6,,NR,'-,0.0078404 unit decrease,[0.0045-0.0112],"MIR4465, RPS3AP24",Reaction time,reaction time measurement,GCST006268,6:140737106
rs12194480-<b>?</b>,2 x 10-6,,NR,'-,0.0080787 unit decrease,[0.0048-0.0114],PIM1,Reaction time,reaction time measurement,GCST006268,6:141270656
rs45490997-<b>?</b>,8 x 10-6,,NR,'-,0.0075637 unit increase,[0.0043-0.0109],UST,Reaction time,reaction time measurement,GCST006268,6:148747642
rs185618594-<b>?</b>,9 x 10-6,,NR,'-,0.0076377 unit decrease,[0.0043-0.011],"PACRG, PACRG-AS1",Reaction time,reaction time measurement,GCST006268,6:163308318
rs6979438-<b>?</b>,6 x 10-6,,NR,'-,0.0082021 unit decrease,[0.0047-0.0118],STK31,Reaction time,reaction time measurement,GCST006268,7:23799377
rs7788070-<b>?</b>,2 x 10-7,,NR,'-,0.009074 unit decrease,[0.0057-0.0125],RP9P,Reaction time,reaction time measurement,GCST006268,7:32932226
rs565177611-<b>?</b>,1 x 10-6,,NR,'-,0.0080231 unit decrease,[0.0048-0.0113],RNU6-832P,Reaction time,reaction time measurement,GCST006268,7:69144725
rs10279237-<b>?</b>,3 x 10-7,,NR,'-,0.009048 unit increase,[0.0056-0.0125],AUTS2,Reaction time,reaction time measurement,GCST006268,7:70403503
rs183571045-<b>?</b>,8 x 10-6,,NR,'-,0.024021 unit increase,[0.013-0.035],POM121,Reaction time,reaction time measurement,GCST006268,7:72886134
rs185522560-<b>?</b>,5 x 10-6,,NR,'-,0.0078938 unit decrease,[0.0045-0.0113],"MLXIPL, VPS37D",Reaction time,reaction time measurement,GCST006268,7:73659090
rs4728514-<b>?</b>,2 x 10-6,,NR,'-,0.0082051 unit increase,[0.0048-0.0116],CACNA2D1,Reaction time,reaction time measurement,GCST006268,7:82468608
rs777583985-<b>?</b>,2 x 10-6,,NR,'-,0.0077314 unit increase,[0.0045-0.0109],"PPP1R9A, ARF1P1",Reaction time,reaction time measurement,GCST006268,7:94873152
rs140513734-<b>?</b>,2 x 10-6,,NR,'-,0.0081053 unit decrease,[0.0048-0.0114],"LHFPL3-AS1, LHFPL3",Reaction time,reaction time measurement,GCST006268,7:104782957
rs37658-<b>?</b>,4 x 10-6,,NR,'-,0.008109 unit decrease,[0.0047-0.0115],IMMP2L,Reaction time,reaction time measurement,GCST006268,7:111359447
rs143759156-<b>?</b>,5 x 10-7,,NR,'-,0.0084299 unit increase,[0.0051-0.0117],NPM1P14,Reaction time,reaction time measurement,GCST006268,7:112544508
rs4925825-<b>?</b>,1 x 10-6,,NR,'-,0.0084098 unit increase,[0.005-0.0118],"PPP1R16A, FOXH1",Reaction time,reaction time measurement,GCST006268,8:144477389
rs150417221-<b>?</b>,5 x 10-6,,NR,'-,0.023694 unit increase,[0.013-0.034],CCDC171,Reaction time,reaction time measurement,GCST006268,9:15600100
rs7874842-<b>?</b>,8 x 10-6,,NR,'-,0.007939 unit decrease,[0.0045-0.0114],BNC2,Reaction time,reaction time measurement,GCST006268,9:16476973
rs4413866-<b>?</b>,8 x 10-6,,NR,'-,0.0077956 unit decrease,[0.0044-0.0112],MLLT3,Reaction time,reaction time measurement,GCST006268,9:20572182
rs76476250-<b>?</b>,3 x 10-6,,NR,'-,0.007842 unit decrease,[0.0045-0.0111],'-,Reaction time,reaction time measurement,GCST006268,9:31960710
rs191353623-<b>?</b>,7 x 10-6,,NR,'-,0.0075605 unit decrease,[0.0043-0.0109],'-,Reaction time,reaction time measurement,GCST006268,9:32063616
rs10868082-<b>?</b>,6 x 10-8,,NR,'-,0.0095779 unit decrease,[0.0061-0.013],RMI1,Reaction time,reaction time measurement,GCST006268,9:84024194
rs76076355-<b>?</b>,2 x 10-6,,NR,'-,0.033955 unit increase,[0.02-0.048],"ANKRD19P, BICD2",Reaction time,reaction time measurement,GCST006268,9:92765319
rs35572409-<b>?</b>,3 x 10-6,,NR,'-,0.0080604 unit increase,[0.0047-0.0114],GRIN3A,Reaction time,reaction time measurement,GCST006268,9:101601141
rs374016619-<b>?</b>,2 x 10-7,,NR,'-,0.0088503 unit increase,[0.0055-0.0122],RNU6-329P,Reaction time,reaction time measurement,GCST006268,9:102156624
rs552101601-<b>?</b>,2 x 10-6,,NR,'-,0.0077538 unit increase,[0.0046-0.011],RXRA,Reaction time,reaction time measurement,GCST006268,9:134424138
rs570706529-<b>?</b>,4 x 10-6,,NR,'-,0.0078742 unit increase,[0.0045-0.0112],"TMEM250, LHX3",Reaction time,reaction time measurement,GCST006268,9:136195403
rs548404876-<b>?</b>,9 x 10-6,,NR,'-,0.0074071 unit increase,[0.0041-0.0107],BPI,Reaction time,reaction time measurement,GCST006268,20:38304865
rs117629411-<b>?</b>,4 x 10-6,,NR,'-,0.007845 unit decrease,[0.0045-0.0112],CHD6,Reaction time,reaction time measurement,GCST006268,20:41462727
rs79122751-<b>?</b>,7 x 10-6,,NR,'-,0.0078518 unit decrease,[0.0044-0.0113],CHD6,Reaction time,reaction time measurement,GCST006268,20:41569174
rs3848711-<b>?</b>,3 x 10-6,,NR,'-,0.0081758 unit increase,[0.0047-0.0116],"UBE2C, TNNC2",Reaction time,reaction time measurement,GCST006268,20:45817461
rs6073984-<b>?</b>,2 x 10-6,,NR,'-,0.0084168 unit decrease,[0.005-0.0119],"MMP9, FTLP1",Reaction time,reaction time measurement,GCST006268,20:46002014
rs6019624-<b>?</b>,1 x 10-6,,NR,'-,0.0085344 unit increase,[0.0051-0.012],CSE1L,Reaction time,reaction time measurement,GCST006268,20:49069278
rs8118105-<b>?</b>,4 x 10-6,,NR,'-,0.0080467 unit decrease,[0.0046-0.0115],STAU1,Reaction time,reaction time measurement,GCST006268,20:49182127
rs10432728-<b>?</b>,2 x 10-6,,NR,'-,0.0082699 unit increase,[0.0049-0.0117],SUMO1P1,Reaction time,reaction time measurement,GCST006268,20:53849561
rs62205791-<b>?</b>,7 x 10-6,,NR,'-,0.0076957 unit decrease,[0.0043-0.0111],NKILA,Reaction time,reaction time measurement,GCST006268,20:57750396
rs7270007-<b>?</b>,7 x 10-7,,NR,'-,0.008623 unit decrease,[0.0052-0.012],"GATA5, MIR1-1HG-AS1",Reaction time,reaction time measurement,GCST006268,20:62496697
rs111174523-<b>?</b>,7 x 10-6,,NR,'-,0.0077048 unit decrease,[0.0043-0.0111],LINC01749,Reaction time,reaction time measurement,GCST006268,20:63061572
rs143876314-<b>?</b>,4 x 10-6,,NR,'-,0.0078478 unit decrease,[0.0045-0.0112],MIR99AHG,Reaction time,reaction time measurement,GCST006268,21:16005052
rs551606218-<b>?</b>,7 x 10-6,,NR,'-,0.0075676 unit decrease,[0.0043-0.0109],NEK4P1,Reaction time,reaction time measurement,GCST006268,21:17278870
rs2321388-<b>?</b>,3 x 10-8,,NR,'-,0.0096873 unit decrease,[0.0063-0.0131],LINC02338,Reaction time,reaction time measurement,GCST006268,13:58117474
rs4627212-<b>?</b>,2 x 10-9,,NR,'-,0.01047 unit increase,[0.0071-0.0139],LINC00374,Reaction time,reaction time measurement,GCST006268,13:58247917
rs16959783-<b>?</b>,2 x 10-8,,NR,'-,0.0097198 unit increase,[0.0063-0.0131],SEMA6D,Reaction time,reaction time measurement,GCST006268,15:47604353
rs1734197-<b>?</b>,2 x 10-8,,NR,'-,0.0097447 unit increase,[0.0063-0.0132],GNAO1,Reaction time,reaction time measurement,GCST006268,16:56182024
rs75543711-<b>?</b>,5 x 10-8,,NR,'-,0.009456 unit decrease,[0.0061-0.0128],YWHAE,Reaction time,reaction time measurement,GCST006268,17:1352780
rs10775404-<b>?</b>,3 x 10-21,,NR,'-,0.01638 unit decrease,[0.013-0.02],KANSL1,Reaction time,reaction time measurement,GCST006268,17:46090000
rs2532345-<b>?</b>,3 x 10-15,,NR,'-,0.013842 unit decrease,[0.01-0.017],"MAPK8IP1P1, ARL17B",Reaction time,reaction time measurement,GCST006268,17:46266536
rs1863115-<b>?</b>,7 x 10-21,,NR,'-,0.016585 unit increase,[0.013-0.02],"ARL17A, LRRC37A2",Reaction time,reaction time measurement,GCST006268,17:46548562
rs35937770-<b>?</b>,1 x 10-16,,NR,'-,0.014359 unit decrease,[0.011-0.018],NSF,Reaction time,reaction time measurement,GCST006268,17:46730994
rs1503043-<b>?</b>,2 x 10-8,,NR,'-,0.0097248 unit increase,[0.0063-0.0131],CA10,Reaction time,reaction time measurement,GCST006268,17:52217005
rs323299-<b>?</b>,1 x 10-8,,NR,'-,0.0099819 unit decrease,[0.0065-0.0134],KIAA1328,Reaction time,reaction time measurement,GCST006268,18:37088184
rs66534382-<b>?</b>,2 x 10-10,,NR,'-,0.011182 unit decrease,[0.0078-0.0146],ZBTB7A,Reaction time,reaction time measurement,GCST006268,19:4056368
rs11205668-<b>?</b>,3 x 10-8,,NR,'-,0.0097948 unit increase,[0.0063-0.0132],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49951158
rs61789318-<b>?</b>,2 x 10-8,,NR,'-,0.0098512 unit increase,[0.0064-0.0133],"NDUFS5P2, RPL7P9",Reaction time,reaction time measurement,GCST006268,1:96633485
rs61786416-<b>?</b>,2 x 10-8,,NR,'-,0.0098016 unit increase,[0.0064-0.0132],PTBP2,Reaction time,reaction time measurement,GCST006268,1:96817982
rs10911301-<b>?</b>,2 x 10-9,,NR,'-,0.01049 unit decrease,[0.0071-0.0139],NMNAT2,Reaction time,reaction time measurement,GCST006268,1:183313440
rs925229-<b>?</b>,5 x 10-8,,NR,'-,0.0095239 unit increase,[0.0061-0.0129],MFSD2B,Reaction time,reaction time measurement,GCST006268,2:24011570
rs2869529-<b>?</b>,2 x 10-9,,NR,'-,0.010448 unit decrease,[0.007-0.0139],CCDC85A,Reaction time,reaction time measurement,GCST006268,2:56245024
rs13028903-<b>?</b>,2 x 10-14,,NR,'-,0.013329 unit increase,[0.0099-0.0167],RNA5SP94,Reaction time,reaction time measurement,GCST006268,2:59724330
rs4852778-<b>?</b>,4 x 10-8,,NR,'-,0.0096549 unit decrease,[0.0062-0.0131],ZNF638,Reaction time,reaction time measurement,GCST006268,2:71317824
rs35066740-<b>?</b>,4 x 10-9,,NR,'-,0.010193 unit increase,[0.0068-0.0136],PNPP1,Reaction time,reaction time measurement,GCST006268,2:76232404
rs266067-<b>?</b>,3 x 10-9,,NR,'-,0.010444 unit increase,[0.007-0.0139],CRLF3P1,Reaction time,reaction time measurement,GCST006268,2:103453326
rs264979-<b>?</b>,6 x 10-13,,NR,'-,0.012573 unit increase,[0.0092-0.016],CAPZBP1,Reaction time,reaction time measurement,GCST006268,2:103652804
rs10804171-<b>?</b>,4 x 10-8,,NR,'-,0.0096283 unit decrease,[0.0062-0.0131],"KCNJ3, CBX3P6",Reaction time,reaction time measurement,GCST006268,2:154921126
rs16822665-<b>?</b>,5 x 10-9,,NR,'-,0.01021 unit decrease,[0.0068-0.0136],DPP4,Reaction time,reaction time measurement,GCST006268,2:162044817
rs7598246-<b>?</b>,4 x 10-8,,NR,'-,0.0096707 unit increase,[0.0062-0.0131],METAP1D,Reaction time,reaction time measurement,GCST006268,2:172001452
rs77998199-<b>?</b>,2 x 10-10,,NR,'-,0.010943 unit increase,[0.0076-0.0143],"RPSAP24, OLA1",Reaction time,reaction time measurement,GCST006268,2:174064024
rs4131583-<b>?</b>,5 x 10-9,,NR,'-,0.010374 unit increase,[0.0069-0.0138],OLA1,Reaction time,reaction time measurement,GCST006268,2:174217580
rs4673905-<b>?</b>,4 x 10-12,,NR,'-,0.012099 unit increase,[0.0087-0.0155],SPATS2L,Reaction time,reaction time measurement,GCST006268,2:200299060
rs1032501-<b>?</b>,1 x 10-8,,NR,'-,0.010036 unit increase,[0.0066-0.0135],UBE2E2-AS1,Reaction time,reaction time measurement,GCST006268,3:23199180
rs1385253-<b>?</b>,2 x 10-8,,NR,'-,0.0098623 unit decrease,[0.0064-0.0133],GATB,Reaction time,reaction time measurement,GCST006268,4:151828443
rs77917390-<b>?</b>,2 x 10-8,,NR,'-,0.0095862 unit decrease,[0.0063-0.0129],NREP,Reaction time,reaction time measurement,GCST006268,5:111798361
rs56335290-<b>?</b>,2 x 10-12,,NR,'-,0.012204 unit increase,[0.0088-0.0156],"LINC02200, APC",Reaction time,reaction time measurement,GCST006268,5:112700937
rs2952615-<b>?</b>,1 x 10-9,,NR,'-,0.010585 unit decrease,[0.0072-0.014],APC,Reaction time,reaction time measurement,GCST006268,5:112803191
rs151980-<b>?</b>,3 x 10-8,,NR,'-,0.0096693 unit increase,[0.0062-0.0131],REEP5,Reaction time,reaction time measurement,GCST006268,5:112921894
rs6870103-<b>?</b>,2 x 10-9,,NR,'-,0.010484 unit increase,[0.0071-0.0139],"PFDN1, HBEGF",Reaction time,reaction time measurement,GCST006268,5:140312930
rs1575676-<b>?</b>,2 x 10-10,,NR,'-,0.011183 unit increase,[0.0077-0.0146],"AFG1L, FOXO3",Reaction time,reaction time measurement,GCST006268,6:108540061
rs4946935-<b>?</b>,8 x 10-12,,NR,'-,0.012285 unit decrease,[0.0088-0.0158],FOXO3,Reaction time,reaction time measurement,GCST006268,6:108679539
rs13219424-<b>?</b>,1 x 10-8,,NR,'-,0.0098881 unit decrease,[0.0065-0.0133],PTPRK,Reaction time,reaction time measurement,GCST006268,6:128010939
rs2040879-<b>?</b>,3 x 10-10,,NR,'-,0.01121 unit increase,[0.0077-0.0147],"PURB, MYO1G",Reaction time,reaction time measurement,GCST006268,7:44906642
rs80054135-<b>?</b>,2 x 10-8,,NR,'-,0.009888 unit decrease,[0.0064-0.0134],'-,Reaction time,reaction time measurement,GCST006268,7:110137741
rs7783359-<b>?</b>,3 x 10-8,,NR,'-,0.009673 unit increase,[0.0063-0.0131],TMEM229A,Reaction time,reaction time measurement,GCST006268,7:124049140
rs2604268-<b>?</b>,9 x 10-12,,NR,'-,0.011798 unit increase,[0.0084-0.0152],'-,Reaction time,reaction time measurement,GCST006268,9:74294470
rs10125715-<b>?</b>,1 x 10-8,,NR,'-,0.009979 unit increase,[0.0065-0.0134],KIF27,Reaction time,reaction time measurement,GCST006268,9:83913943
rs7075591-<b>?</b>,1 x 10-8,,NR,'-,0.0098564 unit increase,[0.0065-0.0133],ARID5B,Reaction time,reaction time measurement,GCST006268,10:61911055
rs1484399-<b>?</b>,2 x 10-9,,NR,'-,0.010408 unit increase,[0.007-0.0138],"PRDM11, LINC02685",Reaction time,reaction time measurement,GCST006268,11:45039120
rs7937459-<b>?</b>,1 x 10-9,,NR,'-,0.010596 unit increase,[0.0072-0.014],"PRDM11, LINC02685",Reaction time,reaction time measurement,GCST006268,11:45047020
rs34937552-<b>?</b>,1 x 10-9,,NR,'-,0.010677 unit decrease,[0.0072-0.0141],PRDM11,Reaction time,reaction time measurement,GCST006268,11:45102247
rs73464507-<b>?</b>,1 x 10-9,,NR,'-,0.010586 unit decrease,[0.0072-0.014],PRDM11,Reaction time,reaction time measurement,GCST006268,11:45102380
rs4606447-<b>?</b>,7 x 10-9,,NR,'-,0.010443 unit decrease,[0.0069-0.014],ATG13,Reaction time,reaction time measurement,GCST006268,11:46670187
rs115898021-<b>?</b>,4 x 10-7,,NR,'-,0.14149 unit increase,[0.087-0.196],'-,Reaction time,reaction time measurement,GCST006268,21:22916527
rs35741360-<b>?</b>,5 x 10-7,,NR,'-,0.0086824 unit increase,[0.0053-0.0121],CCDC3,Reaction time,reaction time measurement,GCST006268,10:12903180
rs11259645-<b>?</b>,8 x 10-6,,NR,'-,0.0078181 unit decrease,[0.0044-0.0112],"FAM171A1, DBF4P1",Reaction time,reaction time measurement,GCST006268,10:15403489
rs11813260-<b>?</b>,2 x 10-6,,NR,'-,0.0837 unit increase,[0.049-0.118],"U3, ZNF101P1",Reaction time,reaction time measurement,GCST006268,10:28395402
rs551170370-<b>?</b>,3 x 10-7,,NR,'-,0.0087676 unit increase,[0.0054-0.0121],FAM13C,Reaction time,reaction time measurement,GCST006268,10:59418215
rs76326634-<b>?</b>,4 x 10-6,,NR,'-,0.0079245 unit increase,[0.0046-0.0113],CTNNA3,Reaction time,reaction time measurement,GCST006268,10:66824220
rs10998279-<b>?</b>,5 x 10-7,,NR,'-,0.0087989 unit increase,[0.0054-0.0122],TET1,Reaction time,reaction time measurement,GCST006268,10:68564691
rs12777271-<b>?</b>,5 x 10-6,,NR,'-,0.0079172 unit increase,[0.0045-0.0113],"TET1, CCAR1",Reaction time,reaction time measurement,GCST006268,10:68705121
rs2265309-<b>?</b>,9 x 10-6,,NR,'-,0.0077467 unit increase,[0.0043-0.0112],SFXN2,Reaction time,reaction time measurement,GCST006268,10:102728114
rs771652991-<b>?</b>,8 x 10-6,,NR,'-,0.0077649 unit increase,[0.0044-0.0112],SORCS3,Reaction time,reaction time measurement,GCST006268,10:105305161
rs149186070-<b>?</b>,5 x 10-6,,NR,'-,0.0077331 unit increase,[0.0044-0.0111],'-,Reaction time,reaction time measurement,GCST006268,10:105920482
rs561635855-<b>?</b>,4 x 10-6,,NR,'-,0.0076482 unit increase,[0.0044-0.0109],TACC2,Reaction time,reaction time measurement,GCST006268,10:122018042
rs574316709-<b>?</b>,7 x 10-7,,NR,'-,0.022702 unit increase,[0.014-0.032],"CHST15, YBX2P1",Reaction time,reaction time measurement,GCST006268,10:123995560
rs1351848-<b>?</b>,9 x 10-10,,NR,'-,0.010752 unit increase,[0.0073-0.0142],"PRDM11, LINC02685",Reaction time,reaction time measurement,GCST006268,11:45052307
rs7936413-<b>?</b>,2 x 10-9,,NR,'-,0.010629 unit increase,[0.0072-0.0141],DGKZ,Reaction time,reaction time measurement,GCST006268,11:46372408
rs10838613-<b>?</b>,7 x 10-9,,NR,'-,0.010043 unit decrease,[0.0066-0.0134],ARHGAP1,Reaction time,reaction time measurement,GCST006268,11:46690228
rs9667108-<b>?</b>,2 x 10-8,,NR,'-,0.010319 unit increase,[0.0067-0.0139],LRP4,Reaction time,reaction time measurement,GCST006268,11:46913634
rs1054442-<b>?</b>,2 x 10-12,,NR,'-,0.012305 unit increase,[0.0089-0.0157],DDN,Reaction time,reaction time measurement,GCST006268,12:48995537
rs936414-<b>?</b>,5 x 10-8,,NR,'-,0.0096594 unit increase,[0.0062-0.0131],KCNC2,Reaction time,reaction time measurement,GCST006268,12:75154686
rs141885450-<b>?</b>,2 x 10-8,,NR,'-,0.0094375 unit increase,[0.0062-0.0127],LIMA1,Reaction time,reaction time measurement,GCST006268,12:90165345
rs648997-<b>?</b>,2 x 10-12,,NR,'-,0.012891 unit decrease,[0.0093-0.0165],ATXN2,Reaction time,reaction time measurement,GCST006268,12:111538972
rs10850031-<b>?</b>,8 x 10-10,,NR,'-,0.011109 unit decrease,[0.0076-0.0147],HECTD4,Reaction time,reaction time measurement,GCST006268,12:112333259
rs11066320-<b>?</b>,2 x 10-9,,NR,'-,0.010513 unit decrease,[0.0071-0.0139],PTPN11,Reaction time,reaction time measurement,GCST006268,12:112468611
rs58984824-<b>?</b>,2 x 10-8,,NR,'-,0.0096194 unit increase,[0.0063-0.013],"MED13L, MIR4472-2",Reaction time,reaction time measurement,GCST006268,12:116333266
rs1595217-<b>?</b>,2 x 10-9,,NR,'-,0.010425 unit increase,[0.007-0.0138],'-,Reaction time,reaction time measurement,GCST006268,13:57881394
rs11168839-<b>?</b>,9 x 10-9,,NR,'-,0.010043 unit increase,[0.0066-0.0135],"RHEBL1, KMT2D",Reaction time,reaction time measurement,GCST006268,12:49063852
rs4766578-<b>?</b>,1 x 10-8,,NR,'-,0.010036 unit decrease,[0.0066-0.0135],ATXN2,Reaction time,reaction time measurement,GCST006268,12:111466567
rs1029388-<b>?</b>,3 x 10-11,,NR,'-,0.012157 unit decrease,[0.0086-0.0157],ATXN2,Reaction time,reaction time measurement,GCST006268,12:111489097
rs7978851-<b>?</b>,5 x 10-8,,NR,'-,0.010062 unit decrease,[0.0064-0.0137],PTPN11,Reaction time,reaction time measurement,GCST006268,12:112490647
rs11079727-<b>?</b>,2 x 10-9,,NR,'-,0.010276 unit decrease,[0.0069-0.0136],MAPT,Reaction time,reaction time measurement,GCST006268,17:45899447
rs242562-<b>?</b>,2 x 10-9,,NR,'-,0.01038 unit decrease,[0.007-0.0138],MAPT,Reaction time,reaction time measurement,GCST006268,17:45949373
rs6503453-<b>?</b>,3 x 10-9,,NR,'-,0.010352 unit decrease,[0.0069-0.0138],MAPT,Reaction time,reaction time measurement,GCST006268,17:45985237
rs8079215-<b>?</b>,1 x 10-9,,NR,'-,0.01063 unit decrease,[0.0072-0.014],MAPT,Reaction time,reaction time measurement,GCST006268,17:45987485
rs2471738-<b>?</b>,6 x 10-15,,NR,'-,0.013463 unit decrease,[0.01-0.017],MAPT,Reaction time,reaction time measurement,GCST006268,17:45998697
rs117754181-<b>?</b>,2 x 10-9,,NR,'-,0.010104 unit decrease,[0.0068-0.0134],KANSL1,Reaction time,reaction time measurement,GCST006268,17:46109112
rs4988900-<b>?</b>,3 x 10-9,,NR,'-,0.010394 unit increase,[0.007-0.0138],"ARL17B, MAPK8IP1P1",Reaction time,reaction time measurement,GCST006268,17:46265012
rs3874943-<b>?</b>,7 x 10-14,,NR,'-,0.01303 unit increase,[0.0096-0.0164],"RDM1P2, NSFP1",Reaction time,reaction time measurement,GCST006268,17:46494702
rs568039055-<b>?</b>,2 x 10-16,,NR,'-,0.014099 unit decrease,[0.011-0.017],"LRRC37A2, ARL17A",Reaction time,reaction time measurement,GCST006268,17:46555097
rs62074125-<b>?</b>,5 x 10-12,,NR,'-,0.012092 unit increase,[0.0087-0.0155],WNT3,Reaction time,reaction time measurement,GCST006268,17:46775246
rs7351050-<b>?</b>,6 x 10-10,,NR,'-,0.010809 unit decrease,[0.0074-0.0142],ZBTB7A,Reaction time,reaction time measurement,GCST006268,19:4044581
rs12748895-<b>?</b>,2 x 10-9,,NR,'-,0.010456 unit decrease,[0.007-0.0139],NMNAT2,Reaction time,reaction time measurement,GCST006268,1:183303351
rs12713315-<b>?</b>,2 x 10-9,,NR,'-,0.010344 unit decrease,[0.0069-0.0137],CCDC85A,Reaction time,reaction time measurement,GCST006268,2:56231374
rs12612590-<b>?</b>,4 x 10-8,,NR,'-,0.0095557 unit increase,[0.0061-0.013],CCDC85A,Reaction time,reaction time measurement,GCST006268,2:56233947
rs1442883-<b>?</b>,2 x 10-10,,NR,'-,0.011064 unit increase,[0.0077-0.0145],RNA5SP94,Reaction time,reaction time measurement,GCST006268,2:59743525
rs10168190-<b>?</b>,2 x 10-9,,NR,'-,0.010523 unit increase,[0.0071-0.0139],RNA5SP94,Reaction time,reaction time measurement,GCST006268,2:59756769
rs12474507-<b>?</b>,6 x 10-11,,NR,'-,0.011352 unit increase,[0.0079-0.0148],RNA5SP94,Reaction time,reaction time measurement,GCST006268,2:59761123
rs13027159-<b>?</b>,6 x 10-9,,NR,'-,0.010097 unit decrease,[0.0067-0.0135],SUCLA2P2,Reaction time,reaction time measurement,GCST006268,2:76156463
rs1433309-<b>?</b>,6 x 10-9,,NR,'-,0.010155 unit increase,[0.0067-0.0136],CRLF3P1,Reaction time,reaction time measurement,GCST006268,2:103442825
rs12712181-<b>?</b>,5 x 10-9,,NR,'-,0.010198 unit increase,[0.0068-0.0136],'-,Reaction time,reaction time measurement,GCST006268,2:103737774
rs9636259-<b>?</b>,4 x 10-8,,NR,'-,0.0095128 unit increase,[0.0061-0.0129],OLA1,Reaction time,reaction time measurement,GCST006268,2:174093068
rs1729412-<b>?</b>,2 x 10-10,,NR,'-,0.011091 unit decrease,[0.0077-0.0145],SPATS2L,Reaction time,reaction time measurement,GCST006268,2:200218875
rs4673912-<b>?</b>,5 x 10-9,,NR,'-,0.010264 unit increase,[0.0068-0.0137],SPATS2L,Reaction time,reaction time measurement,GCST006268,2:200304270
rs296790-<b>?</b>,9 x 10-11,,NR,'-,0.011305 unit decrease,[0.0079-0.0147],SPATS2L,Reaction time,reaction time measurement,GCST006268,2:200368139
rs361212-<b>?</b>,2 x 10-8,,NR,'-,0.0098301 unit decrease,[0.0064-0.0133],GATB,Reaction time,reaction time measurement,GCST006268,4:151847799
rs72791200-<b>?</b>,1 x 10-9,,NR,'-,0.010417 unit increase,[0.007-0.0138],"APC, LINC02200",Reaction time,reaction time measurement,GCST006268,5:112648837
rs7727738-<b>?</b>,4 x 10-12,,NR,'-,0.012139 unit decrease,[0.0087-0.0156],"APC, LINC02200",Reaction time,reaction time measurement,GCST006268,5:112685702
rs154346-<b>?</b>,4 x 10-8,,NR,'-,0.0095484 unit increase,[0.0061-0.013],"DCP2, REEP5",Reaction time,reaction time measurement,GCST006268,5:112929796
rs479744-<b>?</b>,4 x 10-9,,NR,'-,0.010506 unit increase,[0.007-0.014],"FOXO3, LINC00222",Reaction time,reaction time measurement,GCST006268,6:108698829
rs557544-<b>?</b>,7 x 10-9,,NR,'-,0.010194 unit increase,[0.0067-0.0136],"LINC00222, FOXO3",Reaction time,reaction time measurement,GCST006268,6:108699129
rs55738054-<b>?</b>,2 x 10-9,,NR,'-,0.01042 unit decrease,[0.007-0.0138],"PURB, MYO1G",Reaction time,reaction time measurement,GCST006268,7:44921738
rs2604271-<b>?</b>,2 x 10-10,,NR,'-,0.010993 unit increase,[0.0076-0.0144],'-,Reaction time,reaction time measurement,GCST006268,9:74276496
rs9608667-<b>?</b>,3 x 10-6,,NR,'-,0.0081765 unit decrease,[0.0048-0.0116],TTC28,Reaction time,reaction time measurement,GCST006268,22:28144504
rs738199-<b>?</b>,4 x 10-6,,NR,'-,0.0080527 unit decrease,[0.0046-0.0115],TTC28,Reaction time,reaction time measurement,GCST006268,22:28360593
rs695267-<b>?</b>,3 x 10-6,,NR,'-,0.0081812 unit decrease,[0.0048-0.0116],TTC28,Reaction time,reaction time measurement,GCST006268,22:28503760
rs2413029-<b>?</b>,3 x 10-6,,NR,'-,0.0081001 unit decrease,[0.0047-0.0115],"PLA2G3, MIR3928",Reaction time,reaction time measurement,GCST006268,22:31146151
rs4820043-<b>?</b>,9 x 10-6,,NR,'-,0.0076614 unit decrease,[0.0043-0.0111],LIMK2,Reaction time,reaction time measurement,GCST006268,22:31251108
rs28578592-<b>?</b>,6 x 10-7,,NR,'-,0.045585 unit increase,[0.028-0.063],"SLC5A4-AS1, RFPL3",Reaction time,reaction time measurement,GCST006268,22:32345932
rs60504186-<b>?</b>,1 x 10-6,,NR,'-,0.0085648 unit increase,[0.0051-0.012],ELFN2,Reaction time,reaction time measurement,GCST006268,22:37345011
rs4528309-<b>?</b>,3 x 10-6,,NR,'-,0.0083035 unit increase,[0.0048-0.0118],ARNTL,Reaction time,reaction time measurement,GCST006268,11:13262509
rs182674159-<b>?</b>,6 x 10-6,,NR,'-,0.0078002 unit decrease,[0.0044-0.0112],SPON1,Reaction time,reaction time measurement,GCST006268,11:14247288
rs117129545-<b>?</b>,9 x 10-6,,NR,'-,0.0077156 unit decrease,[0.0043-0.0111],PSMA1,Reaction time,reaction time measurement,GCST006268,11:14548716
rs588470-<b>?</b>,2 x 10-6,,NR,'-,0.0082902 unit decrease,[0.0049-0.0117],SOX6,Reaction time,reaction time measurement,GCST006268,11:16359208
rs35891966-<b>?</b>,2 x 10-6,,NR,'-,0.0081298 unit increase,[0.0048-0.0115],NAV2,Reaction time,reaction time measurement,GCST006268,11:20107765
rs143665171-<b>?</b>,5 x 10-6,,NR,'-,0.0078112 unit increase,[0.0045-0.0112],FIBIN,Reaction time,reaction time measurement,GCST006268,11:26987780
rs7396827-<b>?</b>,3 x 10-6,,NR,'-,0.008096 unit decrease,[0.0047-0.0115],METTL15,Reaction time,reaction time measurement,GCST006268,11:28556320
rs1013608-<b>?</b>,8 x 10-6,,NR,'-,0.0077915 unit decrease,[0.0044-0.0112],KIAA1549L,Reaction time,reaction time measurement,GCST006268,11:33515079
chr11:38884261-<b>?</b>,7 x 10-6,,NR,'-,0.0075628 unit increase,[0.0043-0.0109],'-,Reaction time,reaction time measurement,GCST006268,Mapping not available
chr11:39334955-<b>?</b>,4 x 10-6,,NR,'-,0.0077831 unit increase,[0.0045-0.0111],'-,Reaction time,reaction time measurement,GCST006268,Mapping not available
rs10768562-<b>?</b>,4 x 10-6,,NR,'-,0.0080552 unit increase,[0.0046-0.0115],'-,Reaction time,reaction time measurement,GCST006268,11:39934248
rs61882549-<b>?</b>,5 x 10-7,,NR,'-,0.0085934 unit increase,[0.0052-0.0119],PHF21A,Reaction time,reaction time measurement,GCST006268,11:46049384
rs61884130-<b>?</b>,8 x 10-7,,NR,'-,0.0084332 unit increase,[0.0051-0.0118],LINC02710,Reaction time,reaction time measurement,GCST006268,11:46220206
rs61897848-<b>?</b>,6 x 10-8,,NR,'-,0.0093358 unit increase,[0.006-0.0127],ARFGAP2,Reaction time,reaction time measurement,GCST006268,11:47177087
rs184694846-<b>?</b>,3 x 10-6,,NR,'-,0.0079054 unit increase,[0.0046-0.0112],'-,Reaction time,reaction time measurement,GCST006268,11:50599094
rs567071568-<b>?</b>,3 x 10-6,,NR,'-,0.0078824 unit increase,[0.0046-0.0112],'-,Reaction time,reaction time measurement,GCST006268,11:50719050
rs139411693-<b>?</b>,3 x 10-6,,NR,'-,0.0078996 unit increase,[0.0046-0.0112],OPCML,Reaction time,reaction time measurement,GCST006268,11:54852811
rs117084494-<b>?</b>,6 x 10-6,,NR,'-,0.0076009 unit increase,[0.0043-0.0109],LRRC55,Reaction time,reaction time measurement,GCST006268,11:57179994
rs2236647-<b>?</b>,2 x 10-7,,NR,'-,0.0091312 unit increase,[0.0057-0.0126],STIP1,Reaction time,reaction time measurement,GCST006268,11:64197133
rs80181608-<b>?</b>,4 x 10-6,,NR,'-,0.007804 unit increase,[0.0045-0.0111],CCDC88B,Reaction time,reaction time measurement,GCST006268,11:64353328
rs9971487-<b>?</b>,2 x 10-6,,NR,'-,0.0083168 unit increase,[0.0049-0.0117],PC,Reaction time,reaction time measurement,GCST006268,11:66899525
rs2186739-<b>?</b>,9 x 10-6,,NR,'-,0.0077138 unit decrease,[0.0043-0.0111],DBX1,Reaction time,reaction time measurement,GCST006268,11:95594210
rs11218881-<b>?</b>,5 x 10-7,,NR,'-,0.008681 unit increase,[0.0053-0.0121],CNTN5,Reaction time,reaction time measurement,GCST006268,11:99215777
rs55743104-<b>?</b>,8 x 10-6,,NR,'-,0.0076254 unit increase,[0.0043-0.011],CASP4,Reaction time,reaction time measurement,GCST006268,11:104943811
rs12541-<b>?</b>,4 x 10-6,,NR,'-,0.0082185 unit decrease,[0.0047-0.0117],ESAM,Reaction time,reaction time measurement,GCST006268,11:124753596
rs148837593-<b>?</b>,7 x 10-6,,NR,'-,0.0077708 unit increase,[0.0044-0.0112],NTM,Reaction time,reaction time measurement,GCST006268,11:131859504
rs11061991-<b>?</b>,2 x 10-6,,NR,'-,0.0082129 unit decrease,[0.0048-0.0116],"LRTM2, CACNA2D4",Reaction time,reaction time measurement,GCST006268,12:1827909
rs10845202-<b>?</b>,1 x 10-7,,NR,'-,0.0091664 unit decrease,[0.0058-0.0126],"YBX3, STYK1",Reaction time,reaction time measurement,GCST006268,12:10682266
rs3925523-<b>?</b>,2 x 10-7,,NR,'-,0.0090871 unit increase,[0.0057-0.0125],EMP1,Reaction time,reaction time measurement,GCST006268,12:13238357
rs11055406-<b>?</b>,3 x 10-6,,NR,'-,0.008086 unit decrease,[0.0047-0.0115],"LINC01559, GRIN2B",Reaction time,reaction time measurement,GCST006268,12:13391307
rs10846170-<b>?</b>,1 x 10-6,,NR,'-,0.008692 unit increase,[0.0052-0.0122],PTPRO,Reaction time,reaction time measurement,GCST006268,12:15380197
rs997479-<b>?</b>,4 x 10-6,,NR,'-,0.0080841 unit decrease,[0.0046-0.0115],"SOX5, SOX5-AS1",Reaction time,reaction time measurement,GCST006268,12:24248266
rs186888141-<b>?</b>,6 x 10-6,,NR,'-,0.013553 unit increase,[0.0077-0.0194],'-,Reaction time,reaction time measurement,GCST006268,16:62644386
rs4888921-<b>?</b>,4 x 10-6,,NR,'-,0.0081513 unit increase,[0.0047-0.0116],ZFHX3,Reaction time,reaction time measurement,GCST006268,16:73866095
rs549245859-<b>?</b>,6 x 10-7,,NR,'-,0.0084364 unit increase,[0.0051-0.0117],WWOX,Reaction time,reaction time measurement,GCST006268,16:78536985
rs117294751-<b>?</b>,3 x 10-6,,NR,'-,0.0080083 unit increase,[0.0047-0.0114],CDH13,Reaction time,reaction time measurement,GCST006268,16:83281774
rs12938775-<b>?</b>,1 x 10-6,,NR,'-,0.0084126 unit increase,[0.005-0.0118],PAFAH1B1,Reaction time,reaction time measurement,GCST006268,17:2671527
rs113133947-<b>?</b>,1 x 10-6,,NR,'-,0.0082398 unit increase,[0.0049-0.0116],RAP1GAP2,Reaction time,reaction time measurement,GCST006268,17:2784397
rs8079518-<b>?</b>,6 x 10-6,,NR,'-,0.0078902 unit increase,[0.0045-0.0113],"MIS12, NLRP1",Reaction time,reaction time measurement,GCST006268,17:5496857
rs4796330-<b>?</b>,2 x 10-7,,NR,'-,0.0090999 unit increase,[0.0057-0.0125],PITPNM3,Reaction time,reaction time measurement,GCST006268,17:6453498
rs57508443-<b>?</b>,2 x 10-7,,NR,'-,0.0088757 unit decrease,[0.0055-0.0122],"CLDN7, Y_RNA",Reaction time,reaction time measurement,GCST006268,17:7264457
rs7210683-<b>?</b>,4 x 10-6,,NR,'-,0.0080035 unit decrease,[0.0046-0.0114],LINC00670,Reaction time,reaction time measurement,GCST006268,17:12564778
rs142177012-<b>?</b>,2 x 10-7,,NR,'-,0.10155 unit increase,[0.063-0.14],TRIM16,Reaction time,reaction time measurement,GCST006268,17:15676134
rs11078398-<b>?</b>,1 x 10-6,,NR,'-,0.0088201 unit increase,[0.0053-0.0124],RAI1,Reaction time,reaction time measurement,GCST006268,17:17793785
rs12952704-<b>?</b>,3 x 10-6,,NR,'-,0.00806 unit decrease,[0.0047-0.0114],"RPL35AP35, NUFIP2",Reaction time,reaction time measurement,GCST006268,17:29305341
rs140016681-<b>?</b>,5 x 10-6,,NR,'-,0.0077347 unit increase,[0.0044-0.0111],ASIC2,Reaction time,reaction time measurement,GCST006268,17:33973273
rs72823860-<b>?</b>,1 x 10-6,,NR,'-,0.0083085 unit decrease,[0.005-0.0116],ARHGAP23,Reaction time,reaction time measurement,GCST006268,17:38470941
rs8077456-<b>?</b>,4 x 10-6,,NR,'-,0.0080599 unit decrease,[0.0046-0.0115],GSDMA,Reaction time,reaction time measurement,GCST006268,17:39972512
rs78505871-<b>?</b>,7 x 10-7,,NR,'-,0.0090629 unit decrease,[0.0055-0.0126],CDC27,Reaction time,reaction time measurement,GCST006268,17:47174947
rs9894188-<b>?</b>,3 x 10-6,,NR,'-,0.0081557 unit increase,[0.0047-0.0116],"PRR15L, CDK5RAP3",Reaction time,reaction time measurement,GCST006268,17:47966665
rs12453393-<b>?</b>,5 x 10-6,,NR,'-,0.0079571 unit decrease,[0.0046-0.0114],CA10,Reaction time,reaction time measurement,GCST006268,17:51795477
rs35775492-<b>?</b>,1 x 10-6,,NR,'-,0.0084988 unit increase,[0.0051-0.0119],"MMD, HLF",Reaction time,reaction time measurement,GCST006268,17:55390255
rs2680690-<b>?</b>,9 x 10-6,,NR,'-,0.0077118 unit decrease,[0.0043-0.0111],TSPOAP1-AS1,Reaction time,reaction time measurement,GCST006268,17:58342802
rs62081885-<b>?</b>,6 x 10-6,,NR,'-,0.0078797 unit decrease,[0.0045-0.0113],SKA2,Reaction time,reaction time measurement,GCST006268,17:59125280
rs12103754-<b>?</b>,1 x 10-7,,NR,'-,0.0092892 unit increase,[0.0058-0.0127],SLC39A11,Reaction time,reaction time measurement,GCST006268,17:72916200
rs7211963-<b>?</b>,4 x 10-7,,NR,'-,0.0088643 unit increase,[0.0054-0.0123],MXRA7,Reaction time,reaction time measurement,GCST006268,17:76700364
rs72892301-<b>?</b>,3 x 10-6,,NR,'-,0.0082028 unit increase,[0.0048-0.0117],"RNU1-80P, TNRC6C",Reaction time,reaction time measurement,GCST006268,17:77924040
rs35343344-<b>?</b>,4 x 10-6,,NR,'-,0.0080797 unit decrease,[0.0047-0.0115],PGPEP1,Reaction time,reaction time measurement,GCST006268,19:18360800
rs117315649-<b>?</b>,3 x 10-7,,NR,'-,0.0086584 unit decrease,[0.0053-0.012],GATAD2A,Reaction time,reaction time measurement,GCST006268,19:19466642
rs144193693-<b>?</b>,9 x 10-7,,NR,'-,0.0083633 unit decrease,[0.005-0.0117],ATP13A1,Reaction time,reaction time measurement,GCST006268,19:19656456
rs62104477-<b>?</b>,7 x 10-6,,NR,'-,0.0077834 unit decrease,[0.0044-0.0112],"CCNE1, C19orf12",Reaction time,reaction time measurement,GCST006268,19:29804084
rs142175722-<b>?</b>,7 x 10-6,,NR,'-,0.030003 unit increase,[0.017-0.043],"ACTN4, EIF3K",Reaction time,reaction time measurement,GCST006268,19:38640909
rs10915307-<b>?</b>,6 x 10-6,,NR,'-,0.0079179 unit decrease,[0.0045-0.0113],"LINC02781, LINC02782",Reaction time,reaction time measurement,GCST006268,1:5003233
rs11122155-<b>?</b>,4 x 10-7,,NR,'-,0.0088635 unit decrease,[0.0054-0.0123],CAMTA1,Reaction time,reaction time measurement,GCST006268,1:6803713
rs1064826-<b>?</b>,2 x 10-6,,NR,'-,0.0082815 unit decrease,[0.0049-0.0117],RERE,Reaction time,reaction time measurement,GCST006268,1:8352929
rs540859061-<b>?</b>,1 x 10-6,,NR,'-,0.0082092 unit increase,[0.0049-0.0115],EIF4G3,Reaction time,reaction time measurement,GCST006268,1:20887660
rs6687485-<b>?</b>,3 x 10-7,,NR,'-,0.0089822 unit increase,[0.0056-0.0124],GRIK3,Reaction time,reaction time measurement,GCST006268,1:37056337
rs7525929-<b>?</b>,3 x 10-6,,NR,'-,0.0080685 unit increase,[0.0047-0.0115],ERI3,Reaction time,reaction time measurement,GCST006268,1:44235605
rs12078192-<b>?</b>,3 x 10-6,,NR,'-,0.0080964 unit increase,[0.0047-0.0115],"RNU6-369P, ERI3",Reaction time,reaction time measurement,GCST006268,1:44360839
rs114026833-<b>?</b>,7 x 10-7,,NR,'-,0.031353 unit increase,[0.019-0.044],"LINC02794, TRABD2B",Reaction time,reaction time measurement,GCST006268,1:48015274
rs1079130-<b>?</b>,9 x 10-7,,NR,'-,0.0086086 unit increase,[0.0052-0.012],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49024756
rs354168-<b>?</b>,1 x 10-6,,NR,'-,0.0085554 unit increase,[0.0051-0.012],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49177026
rs6702977-<b>?</b>,7 x 10-8,,NR,'-,0.009493 unit increase,[0.006-0.0129],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49305436
rs4926814-<b>?</b>,5 x 10-8,,NR,'-,0.0096234 unit increase,[0.0062-0.0131],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49491464
rs1578800-<b>?</b>,9 x 10-8,,NR,'-,0.0094464 unit increase,[0.006-0.0129],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49644398
rs4926831-<b>?</b>,7 x 10-8,,NR,'-,0.0094827 unit increase,[0.006-0.0129],AGBL4,Reaction time,reaction time measurement,GCST006268,1:49824429
rs6685278-<b>?</b>,8 x 10-8,,NR,'-,0.0094725 unit increase,[0.006-0.0129],ELAVL4,Reaction time,reaction time measurement,GCST006268,1:50078144
rs1925409-<b>?</b>,6 x 10-7,,NR,'-,0.0087593 unit increase,[0.0053-0.0122],DNAI4,Reaction time,reaction time measurement,GCST006268,1:66899406
rs61780038-<b>?</b>,3 x 10-7,,NR,'-,0.0089881 unit increase,[0.0055-0.0124],SLC35D1,Reaction time,reaction time measurement,GCST006268,1:67021693
rs10873947-<b>?</b>,3 x 10-6,,NR,'-,0.0081359 unit increase,[0.0047-0.0115],AK5,Reaction time,reaction time measurement,GCST006268,1:77520831
rs668766-<b>?</b>,4 x 10-6,,NR,'-,0.0081333 unit increase,[0.0047-0.0116],GIPC2,Reaction time,reaction time measurement,GCST006268,1:78120284
rs563093-<b>?</b>,1 x 10-6,,NR,'-,0.0084359 unit decrease,[0.005-0.0119],LINC01362,Reaction time,reaction time measurement,GCST006268,1:82818879
rs4353386-<b>?</b>,5 x 10-8,,NR,'-,0.0094812 unit decrease,[0.0061-0.0129],PCDH17,Reaction time,reaction time measurement,GCST006268,13:57689156
rs1036449-<b>?</b>,5 x 10-8,,NR,'-,0.0095064 unit decrease,[0.0061-0.0129],RNA5SP30,Reaction time,reaction time measurement,GCST006268,13:57991742
rs183877724-<b>?</b>,3 x 10-6,,NR,'-,0.0080013 unit decrease,[0.0046-0.0114],CTAGE16P,Reaction time,reaction time measurement,GCST006268,13:58543552
rs11839321-<b>?</b>,3 x 10-6,,NR,'-,0.0081851 unit decrease,[0.0048-0.0116],RNU7-88P,Reaction time,reaction time measurement,GCST006268,13:59400305
rs117059932-<b>?</b>,3 x 10-6,,NR,'-,0.0078417 unit decrease,[0.0045-0.0111],KLF12,Reaction time,reaction time measurement,GCST006268,13:73786203
rs1335485-<b>?</b>,4 x 10-6,,NR,'-,0.0080051 unit increase,[0.0046-0.0114],'-,Reaction time,reaction time measurement,GCST006268,13:88363678
rs17568378-<b>?</b>,1 x 10-6,,NR,'-,0.0084297 unit decrease,[0.005-0.0118],FARP1,Reaction time,reaction time measurement,GCST006268,13:98349778
rs74690524-<b>?</b>,1 x 10-6,,NR,'-,0.020279 unit increase,[0.012-0.029],'-,Reaction time,reaction time measurement,GCST006268,13:105050913
rs9522155-<b>?</b>,9 x 10-6,,NR,'-,0.0077209 unit increase,[0.0043-0.0111],ARHGEF7,Reaction time,reaction time measurement,GCST006268,13:111196073
rs115080167-<b>?</b>,7 x 10-6,,NR,'-,0.051225 unit increase,[0.029-0.074],"OR5AU1, RNU6-252P",Reaction time,reaction time measurement,GCST006268,14:21120106
rs2877960-<b>?</b>,6 x 10-6,,NR,'-,0.0078933 unit decrease,[0.0045-0.0113],'-,Reaction time,reaction time measurement,GCST006268,14:29259797
rs189801708-<b>?</b>,2 x 10-6,,NR,'-,0.0080942 unit increase,[0.0048-0.0114],NUBPL,Reaction time,reaction time measurement,GCST006268,14:31779238
rs4647899-<b>?</b>,4 x 10-6,,NR,'-,0.0079713 unit decrease,[0.0046-0.0114],AKAP6,Reaction time,reaction time measurement,GCST006268,14:32824325
rs770642394-<b>?</b>,6 x 10-6,,NR,'-,0.0076763 unit increase,[0.0044-0.011],EAPP,Reaction time,reaction time measurement,GCST006268,14:34526569
rs2125249-<b>?</b>,9 x 10-6,,NR,'-,0.0077708 unit decrease,[0.0044-0.0112],TXNDC16,Reaction time,reaction time measurement,GCST006268,14:52430213
rs10148864-<b>?</b>,7 x 10-6,,NR,'-,0.0078352 unit decrease,[0.0044-0.0113],"PGF, RPS6KL1",Reaction time,reaction time measurement,GCST006268,14:74935311
rs79073669-<b>?</b>,8 x 10-6,,NR,'-,0.097767 unit increase,[0.055-0.141],"LINC01467, SEL1L",Reaction time,reaction time measurement,GCST006268,14:81573117
rs146639413-<b>?</b>,5 x 10-6,,NR,'-,0.0080135 unit increase,[0.0046-0.0115],"IGHVII-49-1, IGHV3-50",Reaction time,reaction time measurement,GCST006268,14:106564626
rs16959433-<b>?</b>,2 x 10-6,,NR,'-,0.0081988 unit increase,[0.0048-0.0116],SEMA6D,Reaction time,reaction time measurement,GCST006268,15:47416209
rs4775714-<b>?</b>,6 x 10-7,,NR,'-,0.0087445 unit decrease,[0.0053-0.0122],LINC01491,Reaction time,reaction time measurement,GCST006268,15:47785728
rs1452389-<b>?</b>,1 x 10-6,,NR,'-,0.0085268 unit decrease,[0.0051-0.012],"INSYN1-AS1, TBC1D21",Reaction time,reaction time measurement,GCST006268,15:73846481
rs2972272-<b>?</b>,5 x 10-6,,NR,'-,0.007882 unit increase,[0.0045-0.0113],NAGPA,Reaction time,reaction time measurement,GCST006268,16:5033482
rs72778533-<b>?</b>,5 x 10-7,,NR,'-,0.0086095 unit increase,[0.0053-0.012],RBFOX1,Reaction time,reaction time measurement,GCST006268,16:7711734
rs7206296-<b>?</b>,5 x 10-6,,NR,'-,0.0078588 unit decrease,[0.0045-0.0112],GRIN2A,Reaction time,reaction time measurement,GCST006268,16:10053621
rs41318749-<b>?</b>,3 x 10-7,,NR,'-,0.0088317 unit increase,[0.0054-0.0122],'-,Reaction time,reaction time measurement,GCST006268,16:51415632
rs10772116-<b>?</b>,1 x 10-6,,NR,'-,0.0084125 unit decrease,[0.005-0.0118],'-,Reaction time,reaction time measurement,GCST006268,12:33744860
rs9739724-<b>?</b>,7 x 10-7,,NR,'-,0.0086402 unit decrease,[0.0052-0.012],AK6P1,Reaction time,reaction time measurement,GCST006268,12:34304319
rs3924704-<b>?</b>,8 x 10-7,,NR,'-,0.0085755 unit decrease,[0.0052-0.012],WNK1,Reaction time,reaction time measurement,GCST006268,12:34404898
rs9739246-<b>?</b>,7 x 10-7,,NR,'-,0.0086772 unit decrease,[0.0052-0.0121],'-,Reaction time,reaction time measurement,GCST006268,12:34527073
rs9669269-<b>?</b>,2 x 10-6,,NR,'-,0.0083375 unit decrease,[0.0049-0.0118],'-,Reaction time,reaction time measurement,GCST006268,12:34687726
rs11520077-<b>?</b>,2 x 10-7,,NR,'-,0.0090058 unit decrease,[0.0056-0.0124],ZNF970P,Reaction time,reaction time measurement,GCST006268,12:37672469
rs11514048-<b>?</b>,4 x 10-6,,NR,'-,0.0080204 unit decrease,[0.0046-0.0114],'-,Reaction time,reaction time measurement,GCST006268,12:37833773
rs10880262-<b>?</b>,6 x 10-7,,NR,'-,0.0087256 unit decrease,[0.0053-0.0121],'-,Reaction time,reaction time measurement,GCST006268,12:37934894
rs7314177-<b>?</b>,7 x 10-6,,NR,'-,0.0078372 unit decrease,[0.0044-0.0112],AK6P2,Reaction time,reaction time measurement,GCST006268,12:38047377
rs1843892-<b>?</b>,9 x 10-7,,NR,'-,0.008566 unit decrease,[0.0051-0.012],"Y_RNA, NF1P12",Reaction time,reaction time measurement,GCST006268,12:38223163
rs7957367-<b>?</b>,8 x 10-6,,NR,'-,0.0077609 unit decrease,[0.0043-0.0112],"LRRK2, MUC19",Reaction time,reaction time measurement,GCST006268,12:40392930
rs139386226-<b>?</b>,8 x 10-6,,NR,'-,0.0076228 unit increase,[0.0043-0.011],CNTN1,Reaction time,reaction time measurement,GCST006268,12:41087721
rs11168936-<b>?</b>,5 x 10-7,,NR,'-,0.0089327 unit increase,[0.0054-0.0124],TUBA1C,Reaction time,reaction time measurement,GCST006268,12:49251457
rs77360222-<b>?</b>,1 x 10-6,,NR,'-,0.12307 unit increase,[0.073-0.173],"METTL7A, Y_RNA",Reaction time,reaction time measurement,GCST006268,12:50933800
rs113316657-<b>?</b>,1 x 10-6,,NR,'-,0.12873 unit increase,[0.076-0.181],CELA1,Reaction time,reaction time measurement,GCST006268,12:51342102
rs349885-<b>?</b>,3 x 10-6,,NR,'-,0.0083997 unit decrease,[0.0049-0.0119],TAFA2,Reaction time,reaction time measurement,GCST006268,12:61921140
rs12230740-<b>?</b>,4 x 10-6,,NR,'-,0.0080286 unit increase,[0.0046-0.0114],'-,Reaction time,reaction time measurement,GCST006268,12:98241212
rs3847952-<b>?</b>,5 x 10-8,,NR,'-,0.0099741 unit decrease,[0.0064-0.0136],CUX2,Reaction time,reaction time measurement,GCST006268,12:111308874
rs847895-<b>?</b>,5 x 10-8,,NR,'-,0.009541 unit decrease,[0.0061-0.013],BRAP,Reaction time,reaction time measurement,GCST006268,12:111680772
rs9971942-<b>?</b>,5 x 10-8,,NR,'-,0.0098147 unit decrease,[0.0063-0.0133],"ALDH2, MAPKAPK5-AS1",Reaction time,reaction time measurement,GCST006268,12:111818238
rs7978068-<b>?</b>,5 x 10-8,,NR,'-,0.010057 unit decrease,[0.0064-0.0137],NAA25,Reaction time,reaction time measurement,GCST006268,12:112063962
rs7956202-<b>?</b>,5 x 10-8,,NR,'-,0.010022 unit decrease,[0.0064-0.0136],HECTD4,Reaction time,reaction time measurement,GCST006268,12:112223459
rs232918-<b>?</b>,9 x 10-7,,NR,'-,0.0087532 unit increase,[0.0053-0.0122],RPH3A,Reaction time,reaction time measurement,GCST006268,12:112645027
rs7301953-<b>?</b>,3 x 10-6,,NR,'-,0.0081547 unit increase,[0.0048-0.0116],"DNAH10, CCDC92",Reaction time,reaction time measurement,GCST006268,12:123921324
rs549230195-<b>?</b>,2 x 10-6,,NR,'-,0.0079764 unit decrease,[0.0047-0.0113],FBRSL1,Reaction time,reaction time measurement,GCST006268,12:132566741
rs2311441-<b>?</b>,3 x 10-6,,NR,'-,0.0083029 unit increase,[0.0048-0.0118],TNRC6C,Reaction time,reaction time measurement,GCST006268,17:78061661
rs544749768-<b>?</b>,6 x 10-6,,NR,'-,0.0076692 unit increase,[0.0044-0.011],"LINC01970, CSNK1D",Reaction time,reaction time measurement,GCST006268,17:82287983
rs115915276-<b>?</b>,6 x 10-6,,NR,'-,0.064515 unit increase,[0.037-0.092],"CEP192, LDLRAD4",Reaction time,reaction time measurement,GCST006268,18:13128760
rs188885834-<b>?</b>,4 x 10-6,,NR,'-,0.0081264 unit increase,[0.0047-0.0116],ZNF521,Reaction time,reaction time measurement,GCST006268,18:25187295
rs150021505-<b>?</b>,2 x 10-6,,NR,'-,0.0082287 unit increase,[0.0048-0.0117],ZNF521,Reaction time,reaction time measurement,GCST006268,18:25331015
rs187347133-<b>?</b>,6 x 10-7,,NR,'-,0.0087181 unit increase,[0.0053-0.0122],CDH2,Reaction time,reaction time measurement,GCST006268,18:27902788
rs150440426-<b>?</b>,5 x 10-6,,NR,'-,0.0079734 unit increase,[0.0045-0.0114],CDH2,Reaction time,reaction time measurement,GCST006268,18:28045667
rs7234039-<b>?</b>,5 x 10-8,,NR,'-,0.0095566 unit increase,[0.0061-0.013],KIAA1328,Reaction time,reaction time measurement,GCST006268,18:36914684
rs1786064-<b>?</b>,8 x 10-8,,NR,'-,0.0094633 unit decrease,[0.006-0.0129],CELF4,Reaction time,reaction time measurement,GCST006268,18:37257085
rs111692872-<b>?</b>,1 x 10-6,,NR,'-,0.0081951 unit increase,[0.0049-0.0115],RIT2,Reaction time,reaction time measurement,GCST006268,18:42948342
rs55901120-<b>?</b>,4 x 10-6,,NR,'-,0.0078455 unit increase,[0.0045-0.0112],RIT2,Reaction time,reaction time measurement,GCST006268,18:43077938
rs16977484-<b>?</b>,1 x 10-7,,NR,'-,0.0092531 unit increase,[0.0058-0.0127],SYT4,Reaction time,reaction time measurement,GCST006268,18:43352041
rs138775024-<b>?</b>,3 x 10-6,,NR,'-,0.0079447 unit increase,[0.0046-0.0113],"LINC01478, SETBP1-DT",Reaction time,reaction time measurement,GCST006268,18:44672443
rs4940227-<b>?</b>,4 x 10-6,,NR,'-,0.0081162 unit decrease,[0.0046-0.0116],DCC,Reaction time,reaction time measurement,GCST006268,18:52960832
rs3730657-<b>?</b>,8 x 10-6,,NR,'-,0.0077161 unit increase,[0.0043-0.0111],"POLI, MBD2",Reaction time,reaction time measurement,GCST006268,18:54268184
rs4257287-<b>?</b>,1 x 10-6,,NR,'-,0.0084182 unit increase,[0.005-0.0118],LINC01929,Reaction time,reaction time measurement,GCST006268,18:55076600
rs756843594-<b>?</b>,5 x 10-6,,NR,'-,0.0075578 unit decrease,[0.0043-0.0108],WDR7,Reaction time,reaction time measurement,GCST006268,18:56948048
rs3810082-<b>?</b>,1 x 10-6,,NR,'-,0.0085794 unit increase,[0.0051-0.012],"TCF4, CDH7",Reaction time,reaction time measurement,GCST006268,18:65750073
rs4891744-<b>?</b>,1 x 10-6,,NR,'-,0.00853 unit increase,[0.0051-0.0119],DOK6,Reaction time,reaction time measurement,GCST006268,18:69338464
rs17793051-<b>?</b>,1 x 10-7,,NR,'-,0.0091055 unit increase,[0.0057-0.0125],DOK6,Reaction time,reaction time measurement,GCST006268,18:69524187
rs8087372-<b>?</b>,1 x 10-6,,NR,'-,0.0084531 unit increase,[0.0051-0.0119],"SMIM21, TSHZ1",Reaction time,reaction time measurement,GCST006268,18:75350123
rs10407127-<b>?</b>,7 x 10-6,,NR,'-,0.0078159 unit increase,[0.0044-0.0112],DNM2,Reaction time,reaction time measurement,GCST006268,19:10757176
rs149262789-<b>?</b>,7 x 10-6,,NR,'-,0.0076764 unit decrease,[0.0043-0.011],NFIX,Reaction time,reaction time measurement,GCST006268,19:13092810
rs138715897-<b>?</b>,7 x 10-7,,NR,'-,0.0084227 unit increase,[0.0051-0.0118],"BRD4, AKAP8",Reaction time,reaction time measurement,GCST006268,19:15337899
rs8106115-<b>?</b>,5 x 10-6,,NR,'-,0.0079575 unit decrease,[0.0045-0.0114],"GTPBP3, PLVAP",Reaction time,reaction time measurement,GCST006268,19:17349788
rs772322-<b>?</b>,7 x 10-6,,NR,'-,0.0078272 unit increase,[0.0044-0.0112],"LINC01871, RNU6ATAC37P",Reaction time,reaction time measurement,GCST006268,2:7630531
rs6751857-<b>?</b>,6 x 10-8,,NR,'-,0.0094529 unit increase,[0.006-0.0129],ATAD2B,Reaction time,reaction time measurement,GCST006268,2:23750929
rs7566727-<b>?</b>,9 x 10-8,,NR,'-,0.0093347 unit increase,[0.0059-0.0128],ATAD2B,Reaction time,reaction time measurement,GCST006268,2:23874519
rs12613951-<b>?</b>,2 x 10-7,,NR,'-,0.0090864 unit increase,[0.0057-0.0125],FAM228B,Reaction time,reaction time measurement,GCST006268,2:24139092
rs4665675-<b>?</b>,2 x 10-7,,NR,'-,0.0091034 unit increase,[0.0057-0.0125],ITSN2,Reaction time,reaction time measurement,GCST006268,2:24245263
rs11695528-<b>?</b>,1 x 10-7,,NR,'-,0.0092694 unit increase,[0.0059-0.0127],ITSN2,Reaction time,reaction time measurement,GCST006268,2:24382163
rs1470039-<b>?</b>,4 x 10-6,,NR,'-,0.0080758 unit increase,[0.0046-0.0115],DNAJC27,Reaction time,reaction time measurement,GCST006268,2:24970600
rs183687254-<b>?</b>,5 x 10-6,,NR,'-,0.056575 unit increase,[0.032-0.081],COL24A1,Reaction time,reaction time measurement,GCST006268,1:85908838
rs3867313-<b>?</b>,7 x 10-6,,NR,'-,0.0080305 unit decrease,[0.0045-0.0115],RNU1-130P,Reaction time,reaction time measurement,GCST006268,1:96211931
rs653958-<b>?</b>,4 x 10-7,,NR,'-,0.0088267 unit decrease,[0.0054-0.0122],"UBE2WP1, LINC01787",Reaction time,reaction time measurement,GCST006268,1:96418450
rs10493889-<b>?</b>,4 x 10-7,,NR,'-,0.0088073 unit increase,[0.0054-0.0122],DPYD,Reaction time,reaction time measurement,GCST006268,1:96981627
rs10875231-<b>?</b>,1 x 10-6,,NR,'-,0.0084973 unit decrease,[0.0051-0.0119],LINC01708,Reaction time,reaction time measurement,GCST006268,1:99534456
rs4915027-<b>?</b>,8 x 10-6,,NR,'-,0.041661 unit decrease,[0.023-0.06],NTNG1,Reaction time,reaction time measurement,GCST006268,1:107202134
rs12405062-<b>?</b>,9 x 10-6,,NR,'-,0.0076796 unit increase,[0.0043-0.0111],NR1H5P,Reaction time,reaction time measurement,GCST006268,1:114847395
rs79828990-<b>?</b>,7 x 10-6,,NR,'-,0.034045 unit increase,[0.019-0.049],"CRPP1, OR10J6P",Reaction time,reaction time measurement,GCST006268,1:159686009
rs10218696-<b>?</b>,8 x 10-6,,NR,'-,0.0078997 unit increase,[0.0044-0.0114],AIMP1P2,Reaction time,reaction time measurement,GCST006268,1:172854394
rs6658917-<b>?</b>,7 x 10-6,,NR,'-,0.0077653 unit increase,[0.0044-0.0112],RABGAP1L,Reaction time,reaction time measurement,GCST006268,1:174821673
rs78167602-<b>?</b>,8 x 10-6,,NR,'-,0.0077097 unit increase,[0.0043-0.0111],RABGAP1L,Reaction time,reaction time measurement,GCST006268,1:174926185
rs6663255-<b>?</b>,8 x 10-6,,NR,'-,0.0077667 unit decrease,[0.0043-0.0112],"RPS29P4, KIAA0040",Reaction time,reaction time measurement,GCST006268,1:175275967
rs75172530-<b>?</b>,7 x 10-6,,NR,'-,0.02773 unit increase,[0.016-0.04],ZNF648,Reaction time,reaction time measurement,GCST006268,1:182002053
rs73061369-<b>?</b>,3 x 10-6,,NR,'-,0.10845 unit increase,[0.063-0.154],"RGS16, LINC01686",Reaction time,reaction time measurement,GCST006268,1:182614911
rs4652800-<b>?</b>,6 x 10-8,,NR,'-,0.0094649 unit decrease,[0.006-0.0129],NMNAT2,Reaction time,reaction time measurement,GCST006268,1:183414508
rs789182-<b>?</b>,7 x 10-7,,NR,'-,0.0087639 unit increase,[0.0053-0.0122],"NCF2, SMG7",Reaction time,reaction time measurement,GCST006268,1:183557968
rs114078732-<b>?</b>,7 x 10-6,,NR,'-,0.083417 unit increase,[0.047-0.12],'-,Reaction time,reaction time measurement,GCST006268,1:191663557
rs538260231-<b>?</b>,5 x 10-6,,NR,'-,0.007651 unit increase,[0.0044-0.0109],BTG2,Reaction time,reaction time measurement,GCST006268,1:203308277
rs1772143-<b>?</b>,1 x 10-7,,NR,'-,0.0091791 unit increase,[0.0058-0.0126],PM20D1,Reaction time,reaction time measurement,GCST006268,1:205830859
rs71635159-<b>?</b>,8 x 10-8,,NR,'-,0.0091266 unit increase,[0.0058-0.0125],MIR29B2CHG,Reaction time,reaction time measurement,GCST006268,1:207843629
rs678294-<b>?</b>,7 x 10-6,,NR,'-,0.007683 unit increase,[0.0043-0.011],"PLXNA2, LINC02767",Reaction time,reaction time measurement,GCST006268,1:207996637
rs9429818-<b>?</b>,8 x 10-8,,NR,'-,0.0092965 unit increase,[0.0059-0.0127],CAMK1G,Reaction time,reaction time measurement,GCST006268,1:209594488
rs7546104-<b>?</b>,2 x 10-6,,NR,'-,0.0082005 unit increase,[0.0048-0.0116],UTP25,Reaction time,reaction time measurement,GCST006268,1:209854620
rs742690-<b>?</b>,4 x 10-6,,NR,'-,0.0080191 unit decrease,[0.0046-0.0114],"HHAT, ST13P19",Reaction time,reaction time measurement,GCST006268,1:210308795
rs116611025-<b>?</b>,3 x 10-6,,NR,'-,0.030717 unit increase,[0.018-0.044],MIR7515HG,Reaction time,reaction time measurement,GCST006268,2:6630327
rs2488397-<b>C</b>,2 x 10-8,,0.21,'-,0.04 cups per day increase,NR,DENND1B,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,1:197732149
rs1260326-<b>C</b>,2 x 10-8,,0.61,'-,0.033 cups per day increase,NR,'-,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,Mapping not available
rs1877723-<b>T</b>,3 x 10-10,,0.313,'-,0.04 cups per day decrease,NR,ADD1,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,4:2845072
rs1481012-<b>G</b>,2 x 10-12,,0.111,'-,0.066 cups per day decrease,NR,ABCG2,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,4:88117930
rs11766104-<b>T</b>,5 x 10-8,,0.167,'-,0.043 cups per day increase,NR,AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17152648
rs4410790-<b>C</b>,6 x 10-70,,0.64,'-,0.108 cups per day increase,NR,AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17244953
rs17645813-<b>A</b>,3 x 10-11,,0.077,'-,0.073 cups per day decrease,NR,LINC02888,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17380073
rs6461314-<b>G</b>,1 x 10-8,,0.112,'-,0.053 cups per day increase,NR,LINC02888,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17399985
rs6949509-<b>G</b>,2 x 10-12,,0.435,'-,0.042 cups per day decrease,NR,LINC02889,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17479637
rs17706320-<b>C</b>,5 x 10-16,,0.342,'-,0.05 cups per day decrease,NR,LINC02889,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17512278
rs13233604-<b>A</b>,5 x 10-12,,0.172,'-,0.058 cups per day decrease,NR,LINC02889,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17553862
rs17145750-<b>T</b>,2 x 10-10,,0.163,'-,0.05 cups per day increase,NR,MLXIPL,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:73612048
rs17685-<b>A</b>,8 x 10-20,,0.281,'-,0.059 cups per day increase,NR,POR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:75986787
rs351242-<b>A</b>,1 x 10-19,,0.757,'-,0.062 cups per day decrease,NR,STRA6,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:74180375
rs4886593-<b>A</b>,7 x 10-13,,0.2,'-,0.052 cups per day decrease,NR,CCDC33,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:74265737
rs8042558-<b>T</b>,1 x 10-10,,0.235,'-,0.044 cups per day decrease,NR,PPCDC,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:75028092
rs12917120-<b>C</b>,2 x 10-17,,0.665,'-,0.053 cups per day increase,NR,PPCDC,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:75036750
rs11722777-<b>A</b>,4 x 10-6,,0.819,'-,0.123 unit decrease,[0.07-0.176],SORCS2,Coffee consumption,coffee consumption measurement,GCST008487,4:7589092
rs10252701-<b>C</b>,1 x 10-14,,0.315,'-,0.171 unit decrease,[0.13-0.21],AHR,Coffee consumption,coffee consumption measurement,GCST008487,7:17240889
rs79105258-<b>A</b>,1 x 10-14,,0.283,'-,0.173 unit increase,[0.13-0.22],CUX2,Coffee consumption,coffee consumption measurement,GCST008487,12:111280427
rs1260326-<b>T</b>,4 x 10-22,,0.391852,'-,0.02297 unit decrease,[0.018-0.028],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
chr3:50895869-<b>ATAATAATAAT</b>,7 x 10-9,,0.915367,'-,0.028214 unit increase,[0.019-0.038],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
rs78456557-<b>C</b>,1 x 10-9,,0.900201,'-,0.02364 unit decrease,[0.016-0.031],HACD2,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,3:123581839
rs62332762-<b>C</b>,1 x 10-14,,0.597585,'-,0.01828 unit increase,[0.014-0.023],TET2,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,4:105222335
chr6:108876096-<b>CAAT</b>,2 x 10-9,,0.838739,'-,0.018991 unit increase,[0.013-0.025],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
rs4410790-<b>T</b>,2 x 10-249,,0.364122,'-,0.08137 unit decrease,[0.077-0.086],AHR,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,7:17244953
rs215601-<b>A</b>,6 x 10-10,,0.372618,'-,0.01488 unit increase,[0.01-0.02],PDE1C,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,7:32294309
chr7:73042302-<b>GCTTT</b>,7 x 10-26,,0.866226,'-,0.03591 unit decrease,[0.029-0.043],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
rs4240624-<b>G</b>,2 x 10-11,,0.092461,'-,0.02693 unit increase,[0.019-0.035],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
rs12785227-<b>A</b>,7 x 10-9,,0.685798,'-,0.014549 unit increase,[0.0096-0.0195],JMJD1C,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,10:63502925
rs117810762-<b>G</b>,1 x 10-14,,0.982023,'-,0.06827 unit decrease,[0.051-0.086],SCART1,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,10:133502291
rs376877108-<b>GTT</b>,9 x 10-10,,0.201051,'-,0.01783 unit increase,[0.012-0.024],ATXN2,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,12:111582989
rs4615895-<b>G</b>,9 x 10-11,,0.259574,'-,0.01705 unit decrease,[0.012-0.022],LINC02607,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,1:95809112
rs768283768-<b>A</b>,5 x 10-9,,0.419823,'-,0.014214 unit increase,[0.0094-0.019],"HORMAD1, CTSS",Caffeine consumption from coffee,coffee consumption measurement,GCST011125,1:150729035
rs7571970-<b>T</b>,9 x 10-12,,0.172823,'-,0.02076 unit decrease,[0.015-0.027],TMEM18,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,2:646849
rs11127048-<b>G</b>,8 x 10-17,,0.381191,'-,0.01997 unit decrease,[0.015-0.025],"GCKR, C2orf16",Caffeine consumption from coffee,coffee consumption measurement,GCST011125,2:27529596
rs35198275-<b>A</b>,8 x 10-10,,0.865693,'-,0.020797 unit increase,[0.014-0.027],CACNA2D2,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,3:50498661
rs2726513-<b>G</b>,7 x 10-11,,0.587077,'-,0.015301 unit increase,[0.011-0.02],"RN7SL89P, PPA2",Caffeine consumption from coffee,coffee consumption measurement,GCST011125,4:105296201
rs12514566-<b>G</b>,1 x 10-9,,0.664625,'-,0.014831 unit increase,[0.01-0.02],LINC02142,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,5:7391349
rs6893807-<b>A</b>,1 x 10-9,,0.843563,'-,0.01916 unit decrease,[0.013-0.025],LINC00461,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,5:88669203
rs1327259-<b>A</b>,3 x 10-11,,0.614152,'-,0.015707 unit increase,[0.011-0.02],'-,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,6:51313013
rs4410790-<b>T</b>,3 x 10-104,,0.364412,'-,0.05171 unit decrease,[0.047-0.056],AHR,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,7:17244953
rs34060476-<b>A</b>,7 x 10-14,,0.865581,'-,0.02519 unit decrease,[0.019-0.032],MLXIPL,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,7:73623626
rs1057868-<b>C</b>,6 x 10-22,,0.714413,'-,0.02445 unit decrease,[0.019-0.029],POR,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,7:75985688
rs76881016-<b>A</b>,7 x 10-9,,0.928496,'-,0.02584 unit decrease,[0.017-0.035],"LRRC27, PWWP2B",Caffeine consumption from coffee,coffee consumption measurement,GCST011125,10:132382782
rs117810762-<b>G</b>,1 x 10-8,,0.982047,'-,0.05011 unit decrease,[0.033-0.067],SCART1,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,10:133502291
rs2298527-<b>G</b>,2 x 10-10,,0.405568,'-,0.014947 unit increase,[0.01-0.02],NCAM1,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,11:112981239
rs2472297-<b>C</b>,3 x 10-140,,0.731859,'-,0.06521 unit decrease,[0.06-0.07],"CYP1A2, CYP1A1",Caffeine consumption from coffee,coffee consumption measurement,GCST011125,15:74735539
rs2521501-<b>A</b>,2 x 10-9,,0.677316,'-,0.014916 unit increase,[0.01-0.02],FES,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,15:90894158
rs201399553-<b>T</b>,3 x 10-21,,0.594033,'-,0.02253 unit decrease,[0.018-0.027],FTO,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,16:53796052
rs139937261-<b>C</b>,1 x 10-10,,0.487688,'-,0.01491 unit decrease,[0.01-0.019],RAI1,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,17:17681817
rs531431865-<b>C</b>,9 x 10-12,,0.678648,'-,0.0171 unit decrease,[0.012-0.022],CBX1,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,17:48087873
rs66723169-<b>C</b>,2 x 10-16,,0.769043,'-,0.02249 unit decrease,[0.017-0.028],"RPS3AP49, MIR4527HG",Caffeine consumption from coffee,coffee consumption measurement,GCST011125,18:60141746
rs56113850-<b>T</b>,5 x 10-19,,0.421821,'-,0.02071 unit decrease,[0.016-0.025],CYP2A6,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,19:40847202
rs6063085-<b>A</b>,3 x 10-11,,0.625251,'-,0.01571 unit decrease,[0.011-0.02],ZMYND8,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,20:47211814
rs181251778-<b>A</b>,2 x 10-13,,0.986146,'-,0.072648 unit increase,[0.053-0.092],UPB1,Caffeine consumption from coffee,coffee consumption measurement,GCST011125,22:24506000
chr16:18776851-<b>G</b>,2 x 10-10,,0.651439,'-,0.017366 unit increase,[0.012-0.023],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
rs531431865-<b>C</b>,3 x 10-13,,0.678686,'-,0.01854 unit decrease,[0.014-0.024],CBX1,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,17:48087873
rs56113850-<b>T</b>,2 x 10-29,,0.421755,'-,0.02649 unit decrease,[0.022-0.031],CYP2A6,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,19:40847202
chr20:35568001-<b>AAAAG</b>,5 x 10-9,,0.68498,'-,0.014682 unit increase,[0.0098-0.0196],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
chr1:174856749-<b>TG</b>,1 x 10-11,,0.538714,'-,0.016005 unit increase,[0.011-0.021],'-,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,Mapping not available
rs4233170-<b>G</b>,2 x 10-7,,0.0946,'-,0.0132 unit increase,[0.0083-0.0181],LINC01645,Coffee consumption,coffee consumption measurement,GCST008526,1:177365646
rs13088645-<b>A</b>,2 x 10-7,,0.4204,'-,0.0079 unit increase,[0.005-0.0108],"HMGB3P13, ANAPC13",Coffee consumption,coffee consumption measurement,GCST008526,3:134438421
rs13123752-<b>A</b>,2 x 10-7,,0.6161,'-,0.0079 unit increase,[0.005-0.0108],TET2,Coffee consumption,coffee consumption measurement,GCST008526,4:105160963
rs58203904-<b>C</b>,3 x 10-7,,0.7954,'-,0.0094 unit increase,[0.0059-0.0129],ARL15,Coffee consumption,coffee consumption measurement,GCST008526,5:54048522
rs3016390-<b>G</b>,3 x 10-7,,0.6194,'-,0.0079 unit increase,[0.005-0.0108],OPCML,Coffee consumption,coffee consumption measurement,GCST008526,11:132746178
rs56113850-<b>C</b>,8 x 10-16,,0.5776,'-,0.0121 unit increase,[0.0092-0.015],CYP2A6,Coffee consumption,coffee consumption measurement,GCST008526,19:40847202
rs2330783-<b>G</b>,2 x 10-12,,0.986,'-,0.0442 unit increase,[0.032-0.057],"SPECC1L, SPECC1L-ADORA2A",Coffee consumption,coffee consumption measurement,GCST008526,22:24351063
rs10127720-<b>C</b>,7 x 10-12,,0.7403,'-,0.0116 unit increase,[0.0083-0.0149],LINC02607,Coffee consumption,coffee consumption measurement,GCST008526,1:95808433
rs16903275-<b>A</b>,7 x 10-12,,0.1573,'-,0.0138 unit increase,[0.0099-0.0177],LINC00461,Coffee consumption,coffee consumption measurement,GCST008526,5:88654725
rs6062682-<b>T</b>,2 x 10-11,,0.4641,'-,0.01 unit increase,[0.0071-0.0129],PCMTD2,Coffee consumption,coffee consumption measurement,GCST008526,20:64260467
rs2465037-<b>C</b>,4 x 10-11,,0.656,'-,0.0103 unit increase,[0.0072-0.0134],'-,Coffee consumption,coffee consumption measurement,GCST008526,6:51314462
rs2199936-<b>G</b>,4 x 10-11,,0.8866,'-,0.0153 unit increase,[0.011-0.02],ABCG2,Coffee consumption,coffee consumption measurement,GCST008526,4:88124179
rs597045-<b>A</b>,6 x 10-11,,0.6945,'-,0.0106 unit increase,[0.0075-0.0137],"OR5M6P, OR5M7P",Coffee consumption,coffee consumption measurement,GCST008526,11:56504638
rs57918684-<b>A</b>,2 x 10-10,,0.1551,'-,0.0129 unit increase,[0.009-0.0168],"Y_RNA, MED13",Coffee consumption,coffee consumption measurement,GCST008526,17:62073022
rs117692895-<b>C</b>,4 x 10-10,,0.0129,'-,0.0421 unit increase,[0.029-0.055],AHR,Coffee consumption,coffee consumption measurement,GCST008526,7:17238068
rs574367-<b>T</b>,5 x 10-10,,0.2104,'-,0.0112 unit increase,[0.0077-0.0147],SEC16B,Coffee consumption,coffee consumption measurement,GCST008526,1:177904075
rs586346-<b>T</b>,7 x 10-10,,0.3648,'-,0.0095 unit increase,[0.0066-0.0124],C2,Coffee consumption,coffee consumption measurement,GCST008526,6:31907935
rs993885-<b>G</b>,2 x 10-9,,0.6326,'-,0.0092 unit increase,[0.0063-0.0121],LINC02142,Coffee consumption,coffee consumption measurement,GCST008526,5:7378890
rs2597979-<b>G</b>,3 x 10-9,,0.1964,'-,0.0111 unit increase,[0.0074-0.0148],"TAS2R14, PRH1",Coffee consumption,coffee consumption measurement,GCST008526,12:11037367
rs2297508-<b>G</b>,3 x 10-9,,0.6489,'-,0.0092 unit increase,[0.0063-0.0121],SREBF1,Coffee consumption,coffee consumption measurement,GCST008526,17:17812003
rs62104180-<b>G</b>,5 x 10-9,,0.95,'-,0.0199 unit increase,[0.013-0.027],LINC01874,Coffee consumption,coffee consumption measurement,GCST008526,2:466003
rs3810291-<b>A</b>,7 x 10-9,,0.6772,'-,0.0092 unit increase,[0.0061-0.0123],ZC3H4,Coffee consumption,coffee consumption measurement,GCST008526,19:47065746
rs6124969-<b>T</b>,9 x 10-9,,0.3642,'-,0.0088 unit increase,[0.0059-0.0117],EYA2,Coffee consumption,coffee consumption measurement,GCST008526,20:47187629
rs75347775-<b>A</b>,1 x 10-8,,0.2454,'-,0.0097 unit increase,[0.0064-0.013],GDF15,Coffee consumption,coffee consumption measurement,GCST008526,19:18385098
rs2613458-<b>C</b>,1 x 10-8,,0.719,'-,0.0093 unit increase,[0.0062-0.0124],"RPL12P46, LINC02698",Coffee consumption,coffee consumption measurement,GCST008526,11:115603863
rs1956218-<b>G</b>,2 x 10-8,,0.5587,'-,0.0084 unit increase,[0.0055-0.0113],AKAP6,Coffee consumption,coffee consumption measurement,GCST008526,14:32606037
rs4719497-<b>T</b>,2 x 10-8,,0.8652,'-,0.0121 unit increase,[0.0078-0.0164],AHR,Coffee consumption,coffee consumption measurement,GCST008526,7:17295275
rs10997940-<b>C</b>,3 x 10-8,,0.5979,'-,0.0083 unit increase,[0.0054-0.0112],MYPN,Coffee consumption,coffee consumption measurement,GCST008526,10:68127193
rs17687539-<b>A</b>,4 x 10-8,,0.792,'-,0.01 unit increase,[0.0065-0.0135],STEAP2-AS1,Coffee consumption,coffee consumption measurement,GCST008526,7:90033360
rs8056750-<b>T</b>,4 x 10-8,,0.3595,'-,0.0087 unit increase,[0.0056-0.0118],HYDIN,Coffee consumption,coffee consumption measurement,GCST008526,16:70893175
rs2521501-<b>A</b>,4 x 10-8,,0.6768,'-,0.0087 unit increase,[0.0056-0.0118],FES,Coffee consumption,coffee consumption measurement,GCST008526,15:90894158
rs13054099-<b>T</b>,5 x 10-8,,0.7399,'-,0.0091 unit increase,[0.0058-0.0124],"SLC25A17, ST13",Coffee consumption,coffee consumption measurement,GCST008526,22:40819668
rs4475789-<b>G</b>,1 x 10-7,,0.6547,'-,0.0083 unit increase,[0.0052-0.0114],"OR2M2, OR2M3",Coffee consumption,coffee consumption measurement,GCST008526,1:248189032
rs11518562-<b>T</b>,1 x 10-7,,0.0365,'-,0.022 unit increase,[0.014-0.03],"CD6, CD5",Coffee consumption,coffee consumption measurement,GCST008526,11:61095669
rs117810762-<b>A</b>,1 x 10-7,,0.018,'-,0.0298 unit increase,[0.019-0.041],SCART1,Coffee consumption,coffee consumption measurement,GCST008526,10:133502291
rs2027950-<b>C</b>,1 x 10-7,,0.4767,'-,0.0078 unit increase,[0.0049-0.0107],KRIT1,Coffee consumption,coffee consumption measurement,GCST008526,7:92234386
rs10119174-<b>G</b>,1 x 10-7,,0.4284,'-,0.0079 unit increase,[0.005-0.0108],LINGO2,Coffee consumption,coffee consumption measurement,GCST008526,9:27953726
rs7664424-<b>C</b>,3 x 10-6,,0.3788,'-,0.0071 unit increase,[0.0042-0.01],LINC01378,Coffee consumption,coffee consumption measurement,GCST008526,4:117421219
rs1503212-<b>A</b>,3 x 10-6,,0.4239,'-,0.007 unit increase,[0.0041-0.0099],GRID2,Coffee consumption,coffee consumption measurement,GCST008526,4:93154693
rs17144566-<b>C</b>,3 x 10-6,,0.8055,'-,0.0087 unit increase,[0.005-0.0124],RAB30-DT,Coffee consumption,coffee consumption measurement,GCST008526,11:83087184
rs149693390-<b>C</b>,3 x 10-6,,0.9879,'-,0.0336 unit increase,[0.019-0.048],'-,Coffee consumption,coffee consumption measurement,GCST008526,12:69072579
rs1401444-<b>A</b>,3 x 10-6,,0.6518,'-,0.0072 unit increase,[0.0041-0.0103],"MEIS1, MEIS1-AS2",Coffee consumption,coffee consumption measurement,GCST008526,2:66443844
rs2494995-<b>A</b>,4 x 10-6,,0.7822,'-,0.0082 unit increase,[0.0047-0.0117],PTPRF,Coffee consumption,coffee consumption measurement,GCST008526,1:43556632
rs12201974-<b>T</b>,4 x 10-6,,0.2039,'-,0.0086 unit increase,[0.0049-0.0123],"RPL35AP3, Y_RNA",Coffee consumption,coffee consumption measurement,GCST008526,6:136954746
rs144885044-<b>C</b>,4 x 10-6,,0.9851,'-,0.0286 unit increase,[0.016-0.041],ZMAT4,Coffee consumption,coffee consumption measurement,GCST008526,8:40541555
rs77936935-<b>G</b>,5 x 10-6,,0.9707,'-,0.0199 unit increase,[0.011-0.029],BRINP1,Coffee consumption,coffee consumption measurement,GCST008526,9:119277286
rs73102648-<b>C</b>,6 x 10-6,,0.0314,'-,0.0199 unit increase,[0.011-0.029],"OR8T1P, ANP32D",Coffee consumption,coffee consumption measurement,GCST008526,12:48448862
rs7774229-<b>G</b>,7 x 10-6,,0.9256,'-,0.0127 unit increase,[0.0072-0.0182],EYS,Coffee consumption,coffee consumption measurement,GCST008526,6:64772547
rs181624422-<b>C</b>,7 x 10-6,,0.9695,'-,0.0199 unit increase,[0.011-0.029],SND1,Coffee consumption,coffee consumption measurement,GCST008526,7:127766662
rs10802317-<b>C</b>,9 x 10-6,,0.3648,'-,0.0068 unit increase,[0.0039-0.0097],SMYD3,Coffee consumption,coffee consumption measurement,GCST008526,1:246003707
rs114908993-<b>C</b>,9 x 10-6,,0.9664,'-,0.0185 unit increase,[0.01-0.027],SETDB1,Coffee consumption,coffee consumption measurement,GCST008526,1:150958450
rs7580688-<b>G</b>,9 x 10-6,,0.2725,'-,0.0073 unit increase,[0.004-0.0106],"WDR33, LIMS2",Coffee consumption,coffee consumption measurement,GCST008526,2:127700367
rs2472297-<b>T</b>,9 x 10-157,,0.2641,'-,0.0447 unit increase,[0.041-0.048],"CYP1A2, CYP1A1",Coffee consumption,coffee consumption measurement,GCST008526,15:74735539
rs4410790-<b>C</b>,4 x 10-142,,0.633,'-,0.0387 unit increase,[0.036-0.042],AHR,Coffee consumption,coffee consumption measurement,GCST008526,7:17244953
rs1057868-<b>T</b>,1 x 10-33,,0.2851,'-,0.0197 unit increase,[0.017-0.023],POR,Coffee consumption,coffee consumption measurement,GCST008526,7:75985688
rs73073176-<b>C</b>,2 x 10-25,,0.8701,'-,0.023 unit increase,[0.019-0.027],LINC02889,Coffee consumption,coffee consumption measurement,GCST008526,7:17523328
rs9937053-<b>A</b>,2 x 10-21,,0.424,'-,0.0142 unit increase,[0.011-0.017],FTO,Coffee consumption,coffee consumption measurement,GCST008526,16:53765595
rs1260326-<b>C</b>,1 x 10-19,,0.6047,'-,0.0136 unit increase,[0.011-0.017],'-,Coffee consumption,coffee consumption measurement,GCST008526,Mapping not available
rs66723169-<b>A</b>,8 x 10-19,,0.232,'-,0.0155 unit increase,[0.012-0.019],"RPS3AP49, MIR4527HG",Coffee consumption,coffee consumption measurement,GCST008526,18:60141746
rs34060476-<b>G</b>,2 x 10-18,,0.1337,'-,0.019 unit increase,[0.015-0.023],MLXIPL,Coffee consumption,coffee consumption measurement,GCST008526,7:73623626
rs12699844-<b>C</b>,2 x 10-16,,0.468,'-,0.0122 unit increase,[0.0093-0.0151],LINC02888,Coffee consumption,coffee consumption measurement,GCST008526,7:17403575
rs10865548-<b>G</b>,2 x 10-16,,0.8276,'-,0.016 unit increase,[0.012-0.02],"LINC01875, TMEM18",Coffee consumption,coffee consumption measurement,GCST008526,2:631606
rs4877113-<b>G</b>,5 x 10-7,,0.3931,'-,0.0076 unit increase,[0.0047-0.0105],"UNQ6494, GADD45G",Coffee consumption,coffee consumption measurement,GCST008526,9:89630105
rs38319-<b>G</b>,6 x 10-7,,0.8211,'-,0.0096 unit increase,[0.0059-0.0133],AUTS2,Coffee consumption,coffee consumption measurement,GCST008526,7:70588120
rs2422370-<b>A</b>,6 x 10-7,,0.8205,'-,0.0104 unit increase,[0.0063-0.0145],'-,Coffee consumption,coffee consumption measurement,GCST008526,11:36846737
rs7947502-<b>C</b>,6 x 10-7,,0.4063,'-,0.0075 unit increase,[0.0046-0.0104],NCAM1,Coffee consumption,coffee consumption measurement,GCST008526,11:113038674
rs62579068-<b>A</b>,6 x 10-7,,0.1969,'-,0.0094 unit increase,[0.0057-0.0131],'-,Coffee consumption,coffee consumption measurement,GCST008526,9:82614839
rs395815-<b>C</b>,8 x 10-7,,0.7661,'-,0.0086 unit increase,[0.0053-0.0119],"AURKBP1, EIF3E",Coffee consumption,coffee consumption measurement,GCST008526,8:108144304
rs111994577-<b>G</b>,9 x 10-7,,0.0733,'-,0.014 unit increase,[0.0085-0.0195],BIRC6,Coffee consumption,coffee consumption measurement,GCST008526,2:32537414
rs4624274-<b>G</b>,1 x 10-6,,0.5677,'-,0.0073 unit increase,[0.0044-0.0102],SYT4,Coffee consumption,coffee consumption measurement,GCST008526,18:43261220
rs6593661-<b>A</b>,1 x 10-6,,0.8642,'-,0.0104 unit increase,[0.0063-0.0145],LINC02607,Coffee consumption,coffee consumption measurement,GCST008526,1:95523581
rs10193706-<b>C</b>,1 x 10-6,,0.5248,'-,0.0072 unit increase,[0.0043-0.0101],'-,Coffee consumption,coffee consumption measurement,GCST008526,2:145558751
rs116094457-<b>T</b>,2 x 10-6,,0.0293,'-,0.0212 unit increase,[0.013-0.03],RNF166,Coffee consumption,coffee consumption measurement,GCST008526,16:88704646
rs1153598-<b>G</b>,2 x 10-6,,0.1348,'-,0.0103 unit increase,[0.006-0.0146],RARB,Coffee consumption,coffee consumption measurement,GCST008526,3:25527552
rs115109216-<b>C</b>,2 x 10-6,,0.9444,'-,0.0155 unit increase,[0.0092-0.0218],EHBP1,Coffee consumption,coffee consumption measurement,GCST008526,2:62703068
rs10992783-<b>C</b>,2 x 10-6,,0.5831,'-,0.0071 unit increase,[0.0042-0.01],FAM120A,Coffee consumption,coffee consumption measurement,GCST008526,9:93548974
rs58867452-<b>T</b>,2 x 10-6,,0.0969,'-,0.0119 unit increase,[0.007-0.0168],'-,Coffee consumption,coffee consumption measurement,GCST008526,11:42526970
rs13378244-<b>A</b>,2 x 10-6,,0.4193,'-,0.0071 unit increase,[0.0042-0.01],LINC00598,Coffee consumption,coffee consumption measurement,GCST008526,13:40232218
rs6792502-<b>C</b>,2 x 10-6,,0.8548,'-,0.01 unit increase,[0.0059-0.0141],CACNA2D2,Coffee consumption,coffee consumption measurement,GCST008526,3:50493770
rs7159440-<b>G</b>,2 x 10-6,,0.3046,'-,0.0076 unit increase,[0.0045-0.0107],NPAS3,Coffee consumption,coffee consumption measurement,GCST008526,14:33350449
rs7801593-<b>A</b>,2 x 10-6,,0.7541,'-,0.0081 unit increase,[0.0048-0.0114],UMAD1,Coffee consumption,coffee consumption measurement,GCST008526,7:7864766
rs13064780-<b>G</b>,2 x 10-6,,0.623,'-,0.0072 unit increase,[0.0043-0.0101],IHO1,Coffee consumption,coffee consumption measurement,GCST008526,3:49237393
rs35189787-<b>T</b>,2 x 10-6,,0.1893,'-,0.0089 unit increase,[0.0052-0.0126],FNIP2,Coffee consumption,coffee consumption measurement,GCST008526,4:158881115
rs1906251-<b>A</b>,2 x 10-6,,0.643,'-,0.0073 unit increase,[0.0044-0.0102],"MIR2113, EIF4EBP2P3",Coffee consumption,coffee consumption measurement,GCST008526,6:98112950
rs329124-<b>A</b>,3 x 10-6,,0.5794,'-,0.007 unit increase,[0.0041-0.0099],JADE2,Coffee consumption,coffee consumption measurement,GCST008526,5:134529762
rs4697428-<b>T</b>,3 x 10-6,,0.9078,'-,0.012 unit increase,[0.0069-0.0171],PPARGC1A,Coffee consumption,coffee consumption measurement,GCST008526,4:23933430
rs11206378-<b>A</b>,4 x 10-7,,0.6433,'-,0.0078 unit increase,[0.0049-0.0107],"PABPC4, HEYL",Coffee consumption,coffee consumption measurement,GCST008526,1:39583512
rs2216084-<b>?</b>,9 x 10-9,,NR,'-,0.082 unit increase,[0.055-0.109],PDSS2,Coffee consumption,"coffee consumption, cups of coffee per day measurement",GCST003621,6:107232108
rs6942255-<b>?</b>,1 x 10-8,,NR,'-,0.082 unit increase,[0.055-0.109],PDSS2,Coffee consumption,"coffee consumption, cups of coffee per day measurement",GCST003621,6:107233814
rs7745311-<b>?</b>,1 x 10-8,,NR,'-,0.081 unit increase,[0.054-0.108],PDSS2,Coffee consumption,"coffee consumption, cups of coffee per day measurement",GCST003621,6:107243856
rs7754744-<b>?</b>,9 x 10-9,,NR,'-,0.082 unit increase,[0.055-0.109],"RPS24P12, PDSS2",Coffee consumption,"coffee consumption, cups of coffee per day measurement",GCST003621,6:107230077
rs9386630-<b>?</b>,1 x 10-8,,NR,'-,0.082 unit increase,[0.055-0.109],PDSS2,Coffee consumption,"coffee consumption, cups of coffee per day measurement",GCST003621,6:107241710
rs660550-<b>A</b>,8 x 10-9,,0.525,'-,0.034 cups per day decrease,NR,SLC44A4,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,6:31869500
rs9275576-<b>T</b>,6 x 10-9,,0.146,'-,0.048 cups per day increase,NR,"HLA-DQB3, MTCO3P1",Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,6:32711549
rs7791070-<b>C</b>,2 x 10-28,,0.234,'-,0.076 cups per day decrease,NR,"SNORA63, AHR",Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,7:17361403
rs11855112-<b>C</b>,3 x 10-8,,0.129,'-,0.049 cups per day increase,NR,"TBC1D21, INSYN1-AS1",Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:73841072
rs4077582-<b>T</b>,8 x 10-15,,0.706,'-,0.05 cups per day increase,NR,"LINC02255, CYP11A1",Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:74373281
rs4128436-<b>T</b>,2 x 10-8,,0.081,'-,0.06 cups per day decrease,NR,"EDC3, CLK3",Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:74643553
rs2472297-<b>T</b>,2 x 10-95,,0.272,'-,0.136 cups per day increase,NR,"CYP1A2, CYP1A1",Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,15:74735539
rs476828-<b>C</b>,2 x 10-10,,0.239,'-,0.043 cups per day increase,NR,RNU4-17P,Coffee consumption (cups per day),cups of coffee per day measurement,GCST010108,18:60185354
rs573194563-<b>CA</b>,5 x 10-7,,0.955,'-,0.2708 cups per day increase,[0.17-0.38],LINC02220,Coffee consumption,cups of coffee per day measurement,GCST005330,5:13076809
rs144504271-<b>A</b>,2 x 10-15,,0.265,'-,0.1887 cups per day increase,[0.14-0.24],HECTD4,Coffee consumption,cups of coffee per day measurement,GCST005330,12:112189546
rs6681426-<b>?</b>,1 x 10-10,,NR,'-,0.078 unit decrease,[0.055-0.101],ENSA,Coffee consumption,coffee consumption measurement,GCST009801,1:150614495
rs1260326-<b>?</b>,1 x 10-16,,NR,'-,0.096 unit increase,[0.074-0.118],'-,Coffee consumption,coffee consumption measurement,GCST009801,Mapping not available
rs4410790-<b>?</b>,8 x 10-68,,NR,'-,0.213 unit increase,[0.19-0.24],AHR,Coffee consumption,coffee consumption measurement,GCST009801,7:17244953
rs671-<b>?</b>,4 x 10-153,,NR,'-,0.354 unit increase,[0.33-0.38],ALDH2,Coffee consumption,coffee consumption measurement,GCST009801,12:111803962
rs58806801-<b>?</b>,2 x 10-9,,NR,'-,0.084 unit decrease,[0.057-0.111],"CYP1A2, CSK",Coffee consumption,coffee consumption measurement,GCST009801,15:74767205
rs5760444-<b>?</b>,4 x 10-10,,NR,'-,0.073 unit decrease,[0.051-0.095],ADORA2A-AS1,Coffee consumption,coffee consumption measurement,GCST009801,22:24482250
rs75544042-<b>?</b>,5 x 10-8,,NR,'-,0.069 unit increase,[0.045-0.093],ABCG2,Coffee consumption,coffee consumption measurement,GCST009801,4:88124179
rs12189679-<b>?</b>,3 x 10-8,,NR,'-,0.067 unit increase,[0.044-0.09],'-,Coffee consumption,coffee consumption measurement,GCST009801,6:97885533
rs13234378-<b>?</b>,2 x 10-8,,NR,'-,0.108 unit increase,[0.072-0.144],MLXIPL,Coffee consumption,coffee consumption measurement,GCST009801,7:73611821
rs3815455-<b>?</b>,1 x 10-8,,NR,'-,0.067 unit increase,[0.045-0.089],POR,Coffee consumption,coffee consumption measurement,GCST009801,7:75982438
rs662799-<b>?</b>,4 x 10-8,,NR,'-,0.066 unit increase,[0.043-0.089],"APOA5, APOA4",Coffee consumption,coffee consumption measurement,GCST009801,11:116792991
rs6265-<b>?</b>,3 x 10-6,,NR,'-,0.054 unit decrease,[0.032-0.076],"BDNF-AS, BDNF",Coffee consumption,coffee consumption measurement,GCST009801,11:27658369
rs72480748-<b>?</b>,9 x 10-8,,NR,'-,0.076 unit increase,[0.049-0.103],"CYP2G1P, CYP2A7P2",Coffee consumption,coffee consumption measurement,GCST009801,19:40908576
rs1349140-<b>?</b>,2 x 10-18,(conditioned on rs4410790),NR,'-,0.155 unit increase,[0.12-0.19],LINC02889,Coffee consumption,coffee consumption measurement,GCST009801,7:17523235
rs10259316-<b>?</b>,5 x 10-17,"(conditioned on rs4410790, rs1349140)",NR,'-,0.109 unit decrease,[0.084-0.134],"LINC02889, LINC02888",Coffee consumption,coffee consumption measurement,GCST009801,7:17406082
rs3779420-<b>?</b>,2 x 10-9,(conditioned on rs3815455),NR,'-,0.203 unit decrease,[0.14-0.27],MDH2,Coffee consumption,coffee consumption measurement,GCST009801,7:76053012
rs115454798-<b>A</b>,1 x 10-10,,0.871965,'-,0.02252 unit decrease,[0.016-0.029],XRN1,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,3:142373348
rs2231142-<b>G</b>,1 x 10-26,,0.886707,'-,0.03913 unit increase,[0.032-0.046],ABCG2,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,4:88131171
rs12514566-<b>G</b>,2 x 10-12,,0.664698,'-,0.017242 unit increase,[0.012-0.022],LINC02142,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,5:7391349
rs754177720-<b>CA</b>,4 x 10-9,,0.479652,'-,0.01384 unit decrease,[0.0092-0.0185],"EIF4EBP2P3, MIR2113",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,6:98107668
rs1490384-<b>C</b>,8 x 10-12,,0.501467,'-,0.01587 unit decrease,[0.011-0.02],"MIR588, RNU6-200P",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,6:126530014
rs139797380-<b>C</b>,4 x 10-15,,0.991601,'-,0.106741 unit increase,[0.08-0.133],SLC35D3,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,6:136923819
rs17685-<b>G</b>,4 x 10-56,,0.721471,'-,0.0408 unit decrease,[0.036-0.046],POR,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,7:75986787
rs4418728-<b>G</b>,7 x 10-10,,0.550788,'-,0.014384 unit increase,[0.0098-0.019],"CYP26A1, NIP7P1",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,10:93079967
rs6265-<b>C</b>,3 x 10-13,,0.810755,'-,0.021572 unit increase,[0.016-0.027],"BDNF-AS, BDNF",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,11:27658369
rs1228024-<b>C</b>,1 x 10-8,,0.340021,'-,0.013965 unit increase,[0.0092-0.0188],"NUP160, PTPRJ",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,11:47929801
rs7105462-<b>G</b>,2 x 10-9,,0.40559,'-,0.014163 unit increase,[0.0095-0.0188],NCAM1,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,11:113041326
rs12591786-<b>C</b>,4 x 10-10,,0.842038,'-,0.020213 unit increase,[0.014-0.027],"RORA-AS1, RORA",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,15:60610313
rs2472297-<b>C</b>,2 x 10-351,,0.731645,'-,0.10487 unit decrease,[0.1-0.11],"CYP1A2, CYP1A1",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,15:74735539
rs2667773-<b>A</b>,3 x 10-9,,0.686772,'-,0.014947 unit increase,[0.01-0.02],"LINGO1, HMG20A",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,15:77579849
rs489693-<b>C</b>,1 x 10-12,,0.67465,'-,0.01759 unit decrease,[0.013-0.022],RNU4-17P,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,18:60215554
rs61141867-<b>T</b>,1 x 10-11,,0.253635,'-,0.01842 unit decrease,[0.013-0.024],"TMEM160, ZC3H4",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,19:47053118
rs6062679-<b>T</b>,5 x 10-22,,0.534615,'-,0.02278 unit decrease,[0.018-0.027],PCMTD2,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,20:64258638
rs199612805-<b>T</b>,3 x 10-21,,0.986403,'-,0.095734 unit increase,[0.076-0.116],ADORA2A-AS1,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,22:24448024
rs9611527-<b>G</b>,1 x 10-15,,0.664286,'-,0.019792 unit increase,[0.015-0.025],RANGAP1,Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,22:41248424
rs768283768-<b>A</b>,1 x 10-23,,0.419751,'-,0.024685 unit increase,[0.02-0.03],"HORMAD1, CTSS",Caffeine consumption from coffee or tea,"coffee consumption measurement, tea consumption measurement",GCST011126,1:150729035
rs2074356-<b>A</b>,2 x 10-16,,0.24,'-,0.192 cups per day increase,[0.15-0.24],HECTD4,Coffee consumption,cups of coffee per day measurement,GCST005329,12:112207597
rs12094032-<b>G</b>,8 x 10-7,(adjusted for smoking status),0.057,'-,0.2139 cups per day increase,[0.13-0.3],"ATP1A1, U3",Coffee consumption,cups of coffee per day measurement,GCST005330,1:116348741
rs4410790-<b>C</b>,5 x 10-7,(adjusted for smoking status),0.375,'-,0.102 cups per day increase,[0.062-0.142],AHR,Coffee consumption,cups of coffee per day measurement,GCST005330,7:17244953
rs2106727-<b>?</b>,2 x 10-11,,NR,'-,0.02594639 unit increase,[0.018-0.034],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17248374
rs2892838-<b>?</b>,9 x 10-6,,NR,'-,0.01760686 unit increase,[0.0099-0.0254],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17285000
rs4410790-<b>?</b>,6 x 10-16,,NR,'-,0.03071323 unit increase,[0.023-0.038],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17244953
rs62234058-<b>?</b>,1 x 10-12,,NR,'-,0.047 unit decrease,[0.033-0.061],ADORA2A-AS1,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,22:24478555
rs62444550-<b>?</b>,6 x 10-6,,NR,'-,0.01761995 unit increase,[0.01-0.0253],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17290494
rs6968554-<b>?</b>,5 x 10-13,,NR,'-,0.0281684 unit increase,[0.021-0.036],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17247482
rs6968865-<b>?</b>,4 x 10-15,,NR,'-,0.02987925 unit increase,[0.022-0.037],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17247645
rs62234058-<b>?</b>,4 x 10-7,(AA),NR,'-,0.04113796 unit decrease,[0.025-0.057],ADORA2A-AS1,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,22:24478555
rs62234058-<b>?</b>,3 x 10-6,(Hispanic/Latino),NR,'-,0.05616214 unit decrease,[0.033-0.08],ADORA2A-AS1,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,22:24478555
rs10252701-<b>?</b>,4 x 10-10,,NR,'-,0.02918148 unit decrease,[0.02-0.038],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17240889
rs10275488-<b>?</b>,1 x 10-9,,NR,'-,0.02801235 unit decrease,[0.019-0.037],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17264154
rs10277582-<b>?</b>,2 x 10-10,,NR,'-,0.02923515 unit decrease,[0.02-0.038],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17245365
rs10281571-<b>?</b>,6 x 10-9,,NR,'-,0.02623358 unit decrease,[0.017-0.035],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17246243
rs10683220-<b>?</b>,1 x 10-7,,NR,'-,0.02023615 unit increase,[0.013-0.028],"SNORA63, AHR",Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17357123
rs11400459-<b>?</b>,1 x 10-6,,NR,'-,0.01887579 unit increase,[0.011-0.026],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17345883
rs12670403-<b>?</b>,4 x 10-9,,NR,'-,0.02280859 unit increase,[0.015-0.03],AHR,Coffee consumption (cups per day),cups of coffee per day measurement,GCST008028,7:17269655
rs1260326-<b>T</b>,7 x 10-8,,0.41,'-,0.04 unit decrease,[0.020-0.060],'-,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,Mapping not available
rs1481012-<b>A</b>,9 x 10-8,,0.89,'-,0.06 unit increase,[0.040-0.080],ABCG2,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,4:88117930
rs4410790-<b>T</b>,3 x 10-17,,0.37,'-,0.1 unit decrease,[0.08-0.12],AHR,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,7:17244953
rs17685-<b>A</b>,4 x 10-11,,0.29,'-,0.07 unit increase,[0.050-0.090],POR,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,7:75986787
rs12288512-<b>A</b>,6 x 10-7,,NR,'-,0.04 unit increase,[0.020-0.060],"BDNF, CBX3P1",Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,11:27726124
rs2472297-<b>T</b>,2 x 10-24,,0.24,'-,0.14 unit increase,[0.12-0.16],"CYP1A2, CYP1A1",Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,15:74735539
rs9902453-<b>A</b>,3 x 10-8,,0.54,'-,0.03 unit decrease,[0.01-0.05],EFCAB5,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,17:30022077
rs7800944-<b>T</b>,3 x 10-11,,0.72,'-,0.05 unit decrease,[0.030-0.070],MLXIPL,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,7:73621527
rs4245116-<b>T</b>,2 x 10-6,,NR,'-,0.03 unit increase,[0.010-0.050],OPCML,Coffee consumption (cups per day),"coffee consumption, cups of coffee per day measurement",GCST002650,11:133386666
rs12459249-<b>C</b>,1 x 10-39,,NR,'-,0.59 unit increase,[0.50-0.68],"CYP2F2P, CYP2A6",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST004976,19:40833991
rs111825958-<b>A</b>,6 x 10-26,,NR,'-,0.71 unit decrease,[0.58-0.84],CYP2F2P,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST004976,19:40825304
rs111645190-<b>A</b>,1 x 10-23,,NR,'-,0.62 unit decrease,[0.50-0.74],"CYP2A7, CYP2A6",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST004976,19:40855903
rs4720530-<b>?</b>,2 x 10-6,,'-,'-,'-,'-,WIPI2,Bone mineral density x blood lead interaction in current smokers (2df test),"smoking behavior, blood lead measurement, bone density",GCST006133,7:5212643
rs1032192-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,NAV2,Bone mineral density x blood lead interaction in current smokers (2df test),"smoking behavior, blood lead measurement, bone density",GCST006133,11:19495025
rs10748094-<b>?</b>,6 x 10-6,,'-,'-,'-,'-,IFNG-AS1,Bone mineral density x blood lead interaction in current smokers (2df test),"smoking behavior, blood lead measurement, bone density",GCST006133,12:68041536
rs4720530-<b>?</b>,4 x 10-7,,'-,'-,'-,'-,WIPI2,Bone mineral density x blood lead interaction in current smokers (1df test),"smoking behavior, blood lead measurement, bone density",GCST006132,7:5212643
rs117285774-<b>?</b>,6 x 10-6,(Native Hawaiian),NR,'-,1.5042 unit increase,[NR],LINC02726,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:23670881
rs117403524-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,1.3757 unit increase,[NR],"ZNF737, BNIP3P23",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:20452485
rs117933211-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,1.0044 unit increase,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:46331989
rs12209443-<b>?</b>,6 x 10-6,(Native Hawaiian),NR,'-,0.6219 unit increase,[NR],MCHR2-AS1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:100057472
rs12879264-<b>?</b>,9 x 10-6,(Native Hawaiian),NR,'-,0.2555 unit increase,[NR],FRMD6,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,14:51607489
rs1323612-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.6004 unit decrease,[NR],FAM216B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:42717153
rs139806220-<b>?</b>,5 x 10-8,(Native Hawaiian),NR,'-,1.187 unit increase,[NR],LILRB4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:54650073
rs142507408-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,1.6373 unit increase,[NR],ZFPM2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:105443330
rs143970033-<b>?</b>,9 x 10-8,(Native Hawaiian),NR,'-,1.0142 unit increase,[NR],PLEKHA5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:19368705
rs144460277-<b>?</b>,6 x 10-7,(Native Hawaiian),NR,'-,1.2032 unit increase,[NR],NTN1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:9172427
rs144606178-<b>?</b>,6 x 10-6,(Native Hawaiian),NR,'-,0.5584 unit decrease,[NR],DLGAP2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:1351712
rs144773862-<b>?</b>,6 x 10-6,(Native Hawaiian),NR,'-,1.1625 unit increase,[NR],TRPM6,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:74792899
rs146238395-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,1.1114 unit increase,[NR],"RFC5, KSR2",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:118006065
rs146383502-<b>?</b>,5 x 10-7,(Native Hawaiian),NR,'-,1.2123 unit increase,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:140517337
rs148386737-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,1.2238 unit increase,[NR],"RN7SL193P, NDUFB4P12",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:43888423
rs151011520-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,1.5544 unit increase,[NR],LINC00922,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:65627613
rs17643636-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,1.1347 unit increase,[NR],"TRPC3, RN7SL335P",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:121999890
rs180850064-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,1.3692 unit increase,[NR],UBAP2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:33995448
rs183026840-<b>?</b>,9 x 10-6,(Native Hawaiian),NR,'-,0.8436 unit increase,[NR],TMPRSS2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,21:41474608
rs184952719-<b>?</b>,7 x 10-6,(Native Hawaiian),NR,'-,1.2616 unit increase,[NR],TOPAZ1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:44285656
rs186826000-<b>?</b>,8 x 10-6,(Native Hawaiian),NR,'-,1.2102 unit increase,[NR],ATP5PBP4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:153086712
rs189370103-<b>?</b>,8 x 10-6,(Native Hawaiian),NR,'-,1.0607 unit increase,[NR],"DDX39BP1, HLA-T",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:29904733
rs191076832-<b>?</b>,6 x 10-6,(Native Hawaiian),NR,'-,1.1977 unit increase,[NR],RBFOX1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:5984142
rs191153365-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,1.2581 unit increase,[NR],PRKCI,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:170285775
rs1988399-<b>?</b>,7 x 10-6,(Native Hawaiian),NR,'-,0.2318 unit decrease,[NR],DYNC1I1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:95994998
rs71417845-<b>?</b>,1 x 10-6,,NR,'-,0.52 unit decrease,[NR],"LINC00605, RPL21P13",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,14:103210903
rs72904859-<b>?</b>,4 x 10-7,,NR,'-,0.4346 unit decrease,[NR],"LINC01799, LINC01828",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:67026490
rs72995528-<b>?</b>,6 x 10-7,,NR,'-,0.5172 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:147808253
rs73130949-<b>?</b>,2 x 10-6,,NR,'-,0.5089 unit decrease,[NR],LMCD1-AS1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:7878962
rs73869064-<b>?</b>,5 x 10-7,,NR,'-,0.3537 unit decrease,[NR],"MED12L, IGSF10",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:151426056
rs75764011-<b>?</b>,3 x 10-7,,NR,'-,0.2708 unit decrease,[NR],"RNA5SP166, ATP5MGP4",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:148653597
rs75778424-<b>?</b>,2 x 10-6,,NR,'-,0.3107 unit increase,[NR],LSINCT5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:2664364
rs77913157-<b>?</b>,6 x 10-7,,NR,'-,0.352 unit decrease,[NR],RPL30P9,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:20091687
rs7930114-<b>?</b>,2 x 10-6,,NR,'-,0.4242 unit decrease,[NR],PDGFD,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:104170883
rs79546472-<b>?</b>,1 x 10-6,,NR,'-,0.375 unit decrease,[NR],U2AF2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:55662011
rs79900979-<b>?</b>,7 x 10-8,,NR,'-,0.447 unit decrease,[NR],ACAP2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:195429768
rs80261602-<b>?</b>,1 x 10-6,,NR,'-,0.3507 unit decrease,[NR],CADPS2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:122631261
rs9925432-<b>?</b>,4 x 10-7,,NR,'-,0.1098 unit decrease,[NR],"PRSS22, FLYWCH2",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:2867326
rs11886159-<b>?</b>,4 x 10-7,,NR,'-,0.4335 unit decrease,[NR],"LINC01828, LINC01799",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:67015977
rs1003858-<b>?</b>,2 x 10-7,(AA),NR,'-,1.5177 unit decrease,[NR],PAPPA,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:116202676
rs10159528-<b>?</b>,8 x 10-6,(AA),NR,'-,0.3793 unit increase,[NR],GRID1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:85725660
rs111561475-<b>?</b>,2 x 10-6,(AA),NR,'-,1.3324 unit decrease,[NR],ANO5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:21935412
rs115299670-<b>?</b>,7 x 10-6,(AA),NR,'-,0.5975 unit decrease,[NR],RNU2-52P,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:40956071
rs117582141-<b>?</b>,1 x 10-6,(AA),NR,'-,1.4321 unit decrease,[NR],"EXOC6, Y_RNA",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:92804854
rs11919456-<b>?</b>,7 x 10-7,(AA),NR,'-,0.3125 unit decrease,[NR],BDH1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:197538563
rs139214349-<b>?</b>,6 x 10-8,(AA),NR,'-,1.3527 unit decrease,[NR],LINC02472,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:29168543
rs140436982-<b>?</b>,5 x 10-6,(AA),NR,'-,1.4246 unit decrease,[NR],DHRS4-AS1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,14:24034912
rs144073979-<b>?</b>,1 x 10-6,(AA),NR,'-,0.8925 unit decrease,[NR],"DGCR6, FAM230F",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,22:18899301
rs144363312-<b>?</b>,3 x 10-6,(AA),NR,'-,1.5622 unit decrease,[NR],"TWIST2, LINC01940",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:238918088
rs144850704-<b>?</b>,1 x 10-6,(AA),NR,'-,0.7013 unit decrease,[NR],KSR2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:117624269
rs146883444-<b>?</b>,6 x 10-6,(AA),NR,'-,1.4347 unit decrease,[NR],CNTNAP2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:147919701
rs16970670-<b>?</b>,4 x 10-6,(AA),NR,'-,1.0285 unit decrease,[NR],"LINC01572, PMFBP1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:72191288
rs17006842-<b>?</b>,4 x 10-6,(AA),NR,'-,0.9617 unit decrease,[NR],"MDFIC2, SAMMSON",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:70210551
rs182466621-<b>?</b>,8 x 10-7,(AA),NR,'-,1.3747 unit decrease,[NR],"LINC01868, NPAS2",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:100730839
rs183073101-<b>?</b>,6 x 10-6,(AA),NR,'-,0.8703 unit decrease,[NR],"ASB5, SPCS3-AS1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:176297102
rs191069440-<b>?</b>,6 x 10-7,(AA),NR,'-,0.9699 unit decrease,[NR],RN7SL776P,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:167451282
rs2309891-<b>?</b>,3 x 10-7,(AA),NR,'-,0.3754 unit decrease,[NR],TRPM3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:71226002
rs28452431-<b>?</b>,7 x 10-6,(AA),NR,'-,0.352 unit decrease,[NR],"RPS27AP1, GAS7",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:10208841
rs2945731-<b>?</b>,2 x 10-6,(AA),NR,'-,1.2332 unit decrease,[NR],"ST3GAL1-DT, Metazoa_SRP",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:133627845
rs311671-<b>?</b>,5 x 10-6,(AA),NR,'-,0.493 unit decrease,[NR],CGAS,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:73429655
rs34402840-<b>?</b>,9 x 10-7,(AA),NR,'-,1.5785 unit decrease,[NR],ANO5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:21687041
rs35493220-<b>?</b>,6 x 10-7,(AA),NR,'-,1.1798 unit decrease,[NR],"RN7SL292P, ROBO2P1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:51636695
rs35660623-<b>?</b>,5 x 10-6,(AA),NR,'-,0.5385 unit decrease,[NR],PINX1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:10829027
rs35757618-<b>?</b>,2 x 10-6,(AA),NR,'-,1.1564 unit decrease,[NR],ISOC1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:129188192
rs36032958-<b>?</b>,5 x 10-6,(AA),NR,'-,1.1962 unit decrease,[NR],ZNF460,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:57291543
rs3782464-<b>?</b>,7 x 10-6,(AA),NR,'-,0.3457 unit increase,[NR],TBX5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:114366775
rs454953-<b>?</b>,4 x 10-6,(AA),NR,'-,0.2799 unit decrease,[NR],EYA4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:133287530
rs4671400-<b>?</b>,5 x 10-6,(AA),NR,'-,0.805 unit increase,[NR],USP34,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:61245497
rs4797996-<b>?</b>,2 x 10-6,(AA),NR,'-,0.3058 unit increase,[NR],METTL4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:2507426
rs55904328-<b>?</b>,6 x 10-8,(AA),NR,'-,0.4203 unit decrease,[NR],"EMSY, LINC02757",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:76556433
rs55966191-<b>?</b>,5 x 10-7,(AA),NR,'-,1.042 unit decrease,[NR],PGAM1P1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:58227651
rs61731371-<b>?</b>,3 x 10-6,(AA),NR,'-,1.4609 unit decrease,[NR],SNX25,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:185351567
rs62195918-<b>?</b>,5 x 10-6,(AA),NR,'-,0.3458 unit decrease,[NR],PLCB1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:8294998
rs6714205-<b>?</b>,2 x 10-7,(AA),NR,'-,0.3626 unit decrease,[NR],"MIR1471, COPS7B",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:231879093
rs6931743-<b>?</b>,2 x 10-6,(AA),NR,'-,0.9262 unit decrease,[NR],LNC-LBCS,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:19235878
rs35295995-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.8108 unit increase,[NR],NELL1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:21024881
rs4812973-<b>?</b>,8 x 10-6,(Native Hawaiian),NR,'-,0.4476 unit increase,[NR],ZSWIM3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:45878897
rs6876032-<b>?</b>,8 x 10-6,(Native Hawaiian),NR,'-,0.4158 unit decrease,[NR],SPOCK1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:136997105
rs6895539-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.805 unit increase,[NR],"ACTBL2, LINCR-0003",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:57547358
rs71479994-<b>?</b>,9 x 10-6,(Native Hawaiian),NR,'-,0.8798 unit increase,[NR],LINC02098,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:128222597
rs74383458-<b>?</b>,9 x 10-6,(Native Hawaiian),NR,'-,0.9857 unit increase,[NR],PWWP2B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:132408041
rs74407240-<b>?</b>,9 x 10-6,(Native Hawaiian),NR,'-,0.705 unit decrease,[NR],GNG7,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:2522673
rs75000611-<b>?</b>,7 x 10-7,(Native Hawaiian),NR,'-,0.995 unit increase,[NR],NFATC1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:79568615
rs75327846-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.9315 unit increase,[NR],CLYBL,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:99804258
rs76720445-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.7911 unit increase,[NR],"ELFN1, MAD1L1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:1752760
rs76794758-<b>?</b>,8 x 10-7,(Native Hawaiian),NR,'-,1.1364 unit increase,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:46141196
rs76846186-<b>?</b>,2 x 10-8,(Native Hawaiian),NR,'-,1.4779 unit increase,[NR],"MIR3668, RNA5SP220",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:140195831
rs77206040-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,1.2408 unit increase,[NR],PARVB,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,22:44075243
rs77455689-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,1.1204 unit increase,[NR],LRP1B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:141257677
rs77464658-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.9525 unit increase,[NR],"ADAMTS20, EEF1A1P17",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:43590425
rs77583023-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,1.125 unit increase,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:46035004
rs77673554-<b>?</b>,8 x 10-6,(Native Hawaiian),NR,'-,0.9345 unit increase,[NR],LINC00877,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:71987769
rs77741790-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.3788 unit decrease,[NR],ARHGAP28,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:6894476
rs79987496-<b>?</b>,2 x 10-7,(Native Hawaiian),NR,'-,1.1521 unit increase,[NR],SPOCK1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:137107558
rs80127210-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.94 unit increase,[NR],"LINC02505, MIR1255B1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:36440352
rs11179118-<b>?</b>,2 x 10-6,,NR,'-,0.3063 unit increase,[NR],TRHDE,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:72224079
rs112226039-<b>?</b>,7 x 10-8,,NR,'-,0.1868 unit increase,[NR],LINC02434,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:188259805
rs113660214-<b>?</b>,2 x 10-6,,NR,'-,0.5166 unit decrease,[NR],DLGAP2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:1027436
rs114059891-<b>?</b>,2 x 10-6,,NR,'-,0.52 unit decrease,[NR],"LINC01833, CAMKMT",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:44833338
rs115205687-<b>?</b>,1 x 10-6,,NR,'-,0.4923 unit decrease,[NR],PLCB1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:8915129
rs116885154-<b>?</b>,4 x 10-7,,NR,'-,0.4672 unit decrease,[NR],"LINC02092, LINC00469",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:73788236
rs11980091-<b>?</b>,2 x 10-6,,NR,'-,0.4696 unit increase,[NR],RBMX2P4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:12935930
rs12375901-<b>?</b>,2 x 10-7,,NR,'-,0.5435 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:23035988
rs12710258-<b>?</b>,6 x 10-7,,NR,'-,0.1876 unit increase,[NR],CARM1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:10879653
rs139545172-<b>?</b>,3 x 10-7,,NR,'-,0.3328 unit decrease,[NR],ADGRG2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,X:19186106
rs139618469-<b>?</b>,4 x 10-7,,NR,'-,0.4553 unit decrease,[NR],"RN7SKP81, RN7SKP149",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,X:143165510
rs142980497-<b>?</b>,8 x 10-7,,NR,'-,0.143 unit decrease,[NR],PSPC1P1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:19216443
rs143362648-<b>?</b>,5 x 10-7,,NR,'-,0.5559 unit decrease,[NR],"RNMTL1P1, Metazoa_SRP",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:21405290
rs145880548-<b>?</b>,9 x 10-7,,NR,'-,0.4797 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:115097886
rs146559718-<b>?</b>,1 x 10-6,,NR,'-,0.2043 unit decrease,[NR],"EMC3, EMC3-AS1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:9988607
rs150394119-<b>?</b>,9 x 10-7,,NR,'-,0.3226 unit decrease,[NR],TNIK,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:171403444
rs150400940-<b>?</b>,7 x 10-7,,NR,'-,0.3888 unit decrease,[NR],GPAM,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:112050671
rs1741629-<b>?</b>,2 x 10-7,,NR,'-,0.389 unit increase,[NR],"CST5, CSTP1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:23918358
rs188493101-<b>?</b>,1 x 10-6,,NR,'-,0.6195 unit decrease,[NR],MYO9B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:17184193
rs191228972-<b>?</b>,1 x 10-6,,NR,'-,0.6347 unit decrease,[NR],SEC61GP1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:193827587
rs28456019-<b>?</b>,1 x 10-6,,NR,'-,0.1685 unit decrease,[NR],KRTAP19-8,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,21:31028811
rs2908197-<b>?</b>,2 x 10-6,,NR,'-,0.1227 unit increase,[NR],"YWHAG, HSPB1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:76307732
rs35815903-<b>?</b>,3 x 10-7,,NR,'-,0.3674 unit decrease,[NR],LINC01541,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:71607335
rs41427747-<b>?</b>,6 x 10-7,,NR,'-,0.3337 unit decrease,[NR],LINC02503,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:103999322
rs4954702-<b>?</b>,1 x 10-6,,NR,'-,0.1077 unit increase,[NR],LRP1B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:141414797
rs57514780-<b>?</b>,1 x 10-7,,NR,'-,0.3512 unit decrease,[NR],CPM,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:69004009
rs57827131-<b>?</b>,1 x 10-6,,NR,'-,0.2498 unit decrease,[NR],XXYLT1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:195192301
rs60188314-<b>?</b>,1 x 10-6,,NR,'-,0.4404 unit decrease,[NR],STK10,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:172111740
rs61496269-<b>?</b>,2 x 10-6,,NR,'-,0.397 unit increase,[NR],COL22A1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:138596475
rs6874604-<b>?</b>,2 x 10-7,,NR,'-,0.4952 unit decrease,[NR],"UGT3A2, ARL2BPP5",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:162680373
rs117178387-<b>?</b>,1 x 10-6,(Japanese),NR,'-,0.5797 unit decrease,[NR],CDK19,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:110815877
rs12423382-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.487 unit decrease,[NR],DERA,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,12:16026437
rs12440825-<b>?</b>,1 x 10-6,(Japanese),NR,'-,0.6862 unit decrease,[NR],SEC11A,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:84680172
rs12453524-<b>?</b>,4 x 10-6,(Japanese),NR,'-,0.6306 unit decrease,[NR],FAM20A,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:68578976
rs12996281-<b>?</b>,1 x 10-6,(Japanese),NR,'-,0.5723 unit decrease,[NR],PID1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:228861490
rs13098482-<b>?</b>,4 x 10-7,(Japanese),NR,'-,0.683 unit decrease,[NR],SYNPR,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:63251134
rs13406665-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.4538 unit decrease,[NR],LBH,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:30275787
rs139419907-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.762 unit decrease,[NR],"BCL2, KDSR",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:63326888
rs143050142-<b>?</b>,8 x 10-7,(Japanese),NR,'-,0.9785 unit decrease,[NR],"RNASET2, RPS6KA2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:166915656
rs143323161-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.6027 unit decrease,[NR],ARSG,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:68350415
rs147619472-<b>?</b>,4 x 10-6,(Japanese),NR,'-,0.6915 unit decrease,[NR],LAMA5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,20:62315753
rs147729365-<b>?</b>,4 x 10-7,(Japanese),NR,'-,0.7133 unit decrease,[NR],CAMK1D,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:12440908
rs148258131-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.7519 unit decrease,[NR],CPNE4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:132145292
rs150848999-<b>?</b>,4 x 10-6,(Japanese),NR,'-,0.2222 unit increase,[NR],"ABCB10P4, GOLGA8G",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:28515160
rs180858466-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.8521 unit decrease,[NR],CICP9,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:38472310
rs139429326-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.5905 unit decrease,[NR],CDK19,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:110625136
rs181104541-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.542 unit decrease,[NR],"TFRC, LINC00885",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:196101256
rs1820772-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.6803 unit decrease,[NR],"IGHV2OR16-5, BCAP31P2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:32866115
rs187025166-<b>?</b>,4 x 10-6,(Japanese),NR,'-,0.8255 unit decrease,[NR],CHD7,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:60680319
rs189798510-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.5677 unit decrease,[NR],LINC02096,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:14811500
rs2249382-<b>?</b>,1 x 10-7,(Japanese),NR,'-,0.298 unit increase,[NR],RN7SL554P,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:6911218
rs41475954-<b>?</b>,1 x 10-6,(Japanese),NR,'-,0.4614 unit decrease,[NR],CELF4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:37505770
rs55883249-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.6204 unit decrease,[NR],YWHAQ,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:9601406
rs58616815-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.3566 unit decrease,[NR],LINC02653,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:90392443
rs62097350-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.3644 unit decrease,[NR],LDLRAD4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:13298944
rs7177026-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.1442 unit increase,[NR],TFDP1P3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:79635252
rs72863877-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.7501 unit decrease,[NR],"CALM2P1, KCNJ2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:70210256
rs73197788-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.7369 unit decrease,[NR],"LINC00458, LINC00558",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:54019582
rs79797842-<b>?</b>,5 x 10-9,(Japanese),NR,'-,0.9475 unit decrease,[NR],ASB2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,14:93970393
rs80315173-<b>?</b>,4 x 10-7,(Japanese),NR,'-,0.6257 unit decrease,[NR],PRMT3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:20492179
rs8072599-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.7355 unit decrease,[NR],"LINC01970, CSNK1D",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:82284247
rs822203-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.1429 unit decrease,[NR],"RANP7, SALL4P5",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:22972467
rs891288-<b>?</b>,6 x 10-7,(Japanese),NR,'-,0.7142 unit decrease,[NR],ALPK3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:84833784
rs10031466-<b>?</b>,1 x 10-6,(Latino),NR,'-,0.2396 unit decrease,[NR],TRIML2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:188094248
rs111346824-<b>?</b>,3 x 10-6,(Latino),NR,'-,0.8801 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:106409915
rs111834582-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.2451 unit decrease,[NR],LINC00598,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:40214229
rs112208829-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.0368 unit decrease,[NR],"KCTD6, PDHB",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:58470270
rs112505062-<b>?</b>,4 x 10-6,(Latino),NR,'-,0.3738 unit decrease,[NR],C8orf37-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:95280875
rs112643338-<b>?</b>,4 x 10-6,(Latino),NR,'-,1.1442 unit decrease,[NR],MIR548XHG,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,21:18756591
rs115219852-<b>?</b>,7 x 10-7,(Latino),NR,'-,1.184 unit decrease,[NR],USP34,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:61424393
rs116571008-<b>?</b>,7 x 10-7,(Latino),NR,'-,1.0121 unit decrease,[NR],LINC00448,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:62709905
rs116989867-<b>?</b>,2 x 10-6,(Latino),NR,'-,1.4136 unit decrease,[NR],NFATC1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:79412316
rs11858486-<b>?</b>,4 x 10-6,(Latino),NR,'-,0.3081 unit increase,[NR],AGBL1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:86265638
rs137949660-<b>?</b>,1 x 10-6,(Latino),NR,'-,0.9133 unit decrease,[NR],KSR2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,12:117495695
rs137986605-<b>?</b>,8 x 10-8,(Latino),NR,'-,0.6545 unit decrease,[NR],"LINC02243, RNU6-616P",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:134944139
rs150889544-<b>?</b>,3 x 10-6,(Latino),NR,'-,0.8548 unit decrease,[NR],"SLC9A6, GAPDHP67",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:136051802
rs16855418-<b>?</b>,4 x 10-6,(Latino),NR,'-,0.8124 unit decrease,[NR],ETAA1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:146327302
rs16994935-<b>?</b>,2 x 10-6,(Latino),NR,'-,0.6174 unit decrease,[NR],"VPS26C, DYRK1A",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,21:37299116
rs184910283-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.0577 unit decrease,[NR],PHF12,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:28927882
rs185013096-<b>?</b>,2 x 10-6,(Latino),NR,'-,0.9424 unit decrease,[NR],WDR19,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:39250206
rs17657696-<b>?</b>,4 x 10-7,(AA),NR,'-,1.0923 unit decrease,[NR],"ZNF229, ZNF285",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,19:44401857
rs182466621-<b>?</b>,2 x 10-7,(AA),NR,'-,1.2926 unit decrease,[NR],"LINC01868, NPAS2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:100730839
rs1826411-<b>?</b>,2 x 10-7,(AA),NR,'-,1.4592 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:80930411
rs183369189-<b>?</b>,2 x 10-7,(AA),NR,'-,0.8502 unit decrease,[NR],CBX3P6,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:154955880
rs191792526-<b>?</b>,4 x 10-7,(AA),NR,'-,1.4223 unit decrease,[NR],"EFHC2, RBM39P1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:44070843
rs2463505-<b>?</b>,3 x 10-7,(AA),NR,'-,1.1143 unit decrease,[NR],SEMA5A,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:9356944
rs311671-<b>?</b>,4 x 10-7,(AA),NR,'-,0.4928 unit decrease,[NR],CGAS,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:73429655
rs35757618-<b>?</b>,3 x 10-7,(AA),NR,'-,1.1154 unit decrease,[NR],ISOC1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:129188192
rs61731371-<b>?</b>,5 x 10-7,(AA),NR,'-,1.4202 unit decrease,[NR],SNX25,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:185351567
rs62529502-<b>?</b>,2 x 10-7,(AA),NR,'-,1.2801 unit decrease,[NR],PTPRD,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:9142493
rs72690918-<b>?</b>,1 x 10-7,(AA),NR,'-,1.5694 unit decrease,[NR],"PSCA, JRK",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:142672278
rs72791114-<b>?</b>,2 x 10-7,(AA),NR,'-,1.1381 unit decrease,[NR],PMFBP1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:72171772
rs74249803-<b>?</b>,4 x 10-7,(AA),NR,'-,1.8701 unit decrease,[NR],TMC3-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:81413409
rs74657221-<b>?</b>,1 x 10-7,(AA),NR,'-,1.4229 unit decrease,[NR],MIPEP,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:23857670
rs75358501-<b>?</b>,3 x 10-7,(AA),NR,'-,0.8915 unit decrease,[NR],DYTN,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:206713131
rs79866052-<b>?</b>,2 x 10-7,(AA),NR,'-,0.6455 unit decrease,[NR],OPN1LW,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:154153041
rs10958852-<b>?</b>,2 x 10-6,(EA),NR,'-,0.6831 unit decrease,[NR],PTPRD,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:10060843
rs11019935-<b>?</b>,3 x 10-7,(EA),NR,'-,0.7379 unit decrease,[NR],"GAPDHP70, GRM5-AS1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:88441800
rs111873027-<b>?</b>,2 x 10-6,(EA),NR,'-,0.9778 unit decrease,[NR],NEK6,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:124191361
rs115944785-<b>?</b>,2 x 10-6,(EA),NR,'-,0.402 unit decrease,[NR],VDAC2P5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:128919841
rs11708245-<b>?</b>,1 x 10-7,(EA),NR,'-,0.1938 unit increase,[NR],TAFA4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:68747005
rs12218391-<b>?</b>,2 x 10-6,(EA),NR,'-,0.2158 unit decrease,[NR],PLXDC2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:20013643
rs140018268-<b>?</b>,2 x 10-6,(EA),NR,'-,0.6172 unit decrease,[NR],GFRA1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:116258452
rs147084229-<b>?</b>,8 x 10-7,(EA),NR,'-,0.7441 unit decrease,[NR],"ITGA4, LINC01934",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:181451520
rs149133508-<b>?</b>,5 x 10-7,(EA),NR,'-,1.4324 unit decrease,[NR],"KIF18BP1, C1QL1P1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:35616247
rs150734725-<b>?</b>,3 x 10-7,(EA),NR,'-,1.3024 unit decrease,[NR],"LINC01821, HNRNPA1P47",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:194286481
rs17041333-<b>?</b>,3 x 10-8,(EA),NR,'-,0.8959 unit decrease,[NR],"EGOT, ITPR1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:4751322
rs185203327-<b>?</b>,8 x 10-7,(EA),NR,'-,0.6381 unit decrease,[NR],PPIA,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:44809836
rs189962344-<b>?</b>,2 x 10-6,(EA),NR,'-,0.9147 unit decrease,[NR],"ADAMTS3, SEC24B",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:72634350
rs190542424-<b>?</b>,4 x 10-7,(EA),NR,'-,1.3492 unit decrease,[NR],"UBE2MP1, VN1R69P",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:35143453
rs192858301-<b>?</b>,5 x 10-7,(EA),NR,'-,1.1652 unit decrease,[NR],KIAA1217,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:23782077
rs193078978-<b>?</b>,2 x 10-6,(EA),NR,'-,0.3087 unit decrease,[NR],"FAM182A, NCOR1P1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,20:26102121
rs2497442-<b>?</b>,2 x 10-6,(EA),NR,'-,0.9057 unit increase,[NR],SFMBT2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:7175017
rs2696842-<b>?</b>,2 x 10-6,(EA),NR,'-,0.4964 unit decrease,[NR],LINC00917,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:86336274
rs28459952-<b>?</b>,2 x 10-6,(EA),NR,'-,0.4564 unit decrease,[NR],RNU6-1103P,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:24474482
rs3097847-<b>?</b>,1 x 10-6,(EA),NR,'-,0.3852 unit decrease,[NR],FGF18,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:171470204
rs4897220-<b>?</b>,2 x 10-6,(EA),NR,'-,0.1952 unit decrease,[NR],C6orf58,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:127568185
rs61880854-<b>?</b>,5 x 10-7,(EA),NR,'-,0.5055 unit increase,[NR],MMP26,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:4803398
rs72622154-<b>?</b>,3 x 10-6,(EA),NR,'-,0.3942 unit decrease,[NR],ITPR1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:4614354
rs72819126-<b>?</b>,1 x 10-6,(EA),NR,'-,0.5993 unit decrease,[NR],ASIC2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:33158862
rs76347219-<b>?</b>,7 x 10-7,(EA),NR,'-,0.9717 unit decrease,[NR],CLSTN2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:140147632
rs76620758-<b>?</b>,2 x 10-6,(EA),NR,'-,0.6556 unit decrease,[NR],PTBP2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,1:96910288
rs78553789-<b>?</b>,6 x 10-7,(EA),NR,'-,0.6956 unit decrease,[NR],MYO16,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:108904171
rs80205050-<b>?</b>,6 x 10-7,(EA),NR,'-,0.7611 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:30256624
rs8035887-<b>?</b>,4 x 10-7,(EA),NR,'-,0.6866 unit decrease,[NR],"FAM169B, IRAIN",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:98618223
GA012297-<b>?</b>,4 x 10-7,(Japanese),NR,'-,0.6818 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,Mapping not available
rs10838809-<b>?</b>,3 x 10-6,(Japanese),NR,'-,0.3947 unit increase,[NR],PTPRJ,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:48152460
rs11074046-<b>?</b>,2 x 10-6,(Japanese),NR,'-,0.4693 unit decrease,[NR],"DUXAP6, SLCO3A1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:92188429
rs112000748-<b>?</b>,1 x 10-6,(Japanese),NR,'-,0.2719 unit decrease,[NR],"PPIAP76, LINC01091",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:123994124
rs114951929-<b>?</b>,5 x 10-7,(Japanese),NR,'-,0.7627 unit decrease,[NR],TNK2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:195864852
rs189087047-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.3249 unit decrease,[NR],MED30,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:117639150
rs190164515-<b>?</b>,4 x 10-6,(Latino),NR,'-,0.7365 unit decrease,[NR],ALG1L9P,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:71813131
rs190480000-<b>?</b>,1 x 10-6,(Latino),NR,'-,0.9245 unit decrease,[NR],"LINC01467, SEL1L",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,14:81564777
rs2395909-<b>?</b>,2 x 10-6,(Latino),NR,'-,0.2462 unit increase,[NR],SLC26A4-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:107652218
rs34395537-<b>?</b>,3 x 10-7,(Latino),NR,'-,1.3226 unit decrease,[NR],CACYBPP2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:183628013
rs4285805-<b>?</b>,3 x 10-6,(Latino),NR,'-,0.2418 unit increase,[NR],LINC01435,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:107773994
rs60250264-<b>?</b>,2 x 10-6,(Latino),NR,'-,1.3059 unit decrease,[NR],PTPRD,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:8897187
rs60866311-<b>?</b>,9 x 10-7,(Latino),NR,'-,0.7469 unit decrease,[NR],"NPAS2-AS1, NPAS2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:100975599
rs61571577-<b>?</b>,5 x 10-7,(Latino),NR,'-,1.1768 unit decrease,[NR],TTC7A,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:47009297
rs62169186-<b>?</b>,3 x 10-6,(Latino),NR,'-,0.7196 unit decrease,[NR],GTDC1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:144303564
rs73099645-<b>?</b>,1 x 10-6,(Latino),NR,'-,0.6507 unit decrease,[NR],HECW1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:43187042
rs73939615-<b>?</b>,1 x 10-6,(Latino),NR,'-,1.2363 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:82125373
rs74760234-<b>?</b>,4 x 10-7,(Latino),NR,'-,1.2083 unit decrease,[NR],EFEMP1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:55798738
rs75575287-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.0865 unit decrease,[NR],DPF3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,14:72756121
rs7561107-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.0082 unit decrease,[NR],HS6ST1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:128271828
rs76124550-<b>?</b>,1 x 10-6,(Latino),NR,'-,1.0661 unit decrease,[NR],VTI1A,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:112626980
rs76632111-<b>?</b>,7 x 10-9,(Latino),NR,'-,1.2071 unit decrease,[NR],"RN7SL339P, U3",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:35441618
rs7675915-<b>?</b>,3 x 10-8,(Latino),NR,'-,0.6309 unit increase,[NR],STX18-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:4677180
rs78355147-<b>?</b>,5 x 10-7,(Latino),NR,'-,0.9913 unit decrease,[NR],CAPN13,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:30763879
rs79340079-<b>?</b>,3 x 10-6,(Latino),NR,'-,0.8904 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:62933349
rs80011011-<b>?</b>,3 x 10-7,(Latino),NR,'-,1.3328 unit decrease,[NR],HULC,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:8664924
rs80018415-<b>?</b>,8 x 10-7,(Latino),NR,'-,0.6193 unit decrease,[NR],TG,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:132904554
rs978571-<b>?</b>,3 x 10-6,(Latino),NR,'-,0.7898 unit increase,[NR],SORCS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:106655006
rs9912181-<b>?</b>,2 x 10-6,(Latino),NR,'-,0.6894 unit decrease,[NR],KRT20,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:40882989
rs9943451-<b>?</b>,3 x 10-6,(Latino),NR,'-,1.1339 unit decrease,[NR],LINC02665,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:7028608
rs72724928-<b>?</b>,9 x 10-7,(AA),NR,'-,1.5217 unit decrease,[NR],LINGO2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:28024196
rs72749828-<b>?</b>,2 x 10-6,(AA),NR,'-,0.8801 unit decrease,[NR],EMB,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:50324716
rs73869064-<b>?</b>,3 x 10-6,(AA),NR,'-,0.3879 unit decrease,[NR],"MED12L, IGSF10",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:151426056
rs75676075-<b>?</b>,7 x 10-6,(AA),NR,'-,0.5371 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,15:87214547
rs75984653-<b>?</b>,7 x 10-6,(AA),NR,'-,1.2881 unit decrease,[NR],KIAA1217,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:24068862
rs76248362-<b>?</b>,5 x 10-6,(AA),NR,'-,1.3521 unit decrease,[NR],MIPEP,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:23847637
rs763512-<b>?</b>,6 x 10-6,(AA),NR,'-,0.3996 unit increase,[NR],SYNRG,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:37529428
rs7669806-<b>?</b>,7 x 10-6,(AA),NR,'-,0.4845 unit decrease,[NR],CCNG2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:77425223
rs7678296-<b>?</b>,7 x 10-6,(AA),NR,'-,0.4535 unit decrease,[NR],MIR4801,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:37181024
rs7698280-<b>?</b>,5 x 10-6,(AA),NR,'-,0.3344 unit decrease,[NR],TECRL,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:64356524
rs77329626-<b>?</b>,8 x 10-6,(AA),NR,'-,1.4476 unit decrease,[NR],CCDC6,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:59904437
rs77924284-<b>?</b>,3 x 10-7,(AA),NR,'-,0.5406 unit decrease,[NR],RNU6-356P,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:41125666
rs77990856-<b>?</b>,5 x 10-11,(AA),NR,'-,1.9734 unit decrease,[NR],"MAPK4, RPLP0P11",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:50490517
rs78404372-<b>?</b>,7 x 10-7,(AA),NR,'-,0.8275 unit decrease,[NR],"Y_RNA, BMP7",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:57280737
rs78461346-<b>?</b>,8 x 10-6,(AA),NR,'-,1.2145 unit decrease,[NR],FOXK2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:82566308
rs78791096-<b>?</b>,8 x 10-6,(AA),NR,'-,0.5516 unit increase,[NR],LINC01559,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:13383212
rs78995442-<b>?</b>,5 x 10-6,(AA),NR,'-,0.6532 unit decrease,[NR],C6orf99,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:158910228
rs79211555-<b>?</b>,3 x 10-8,(AA),NR,'-,1.6521 unit decrease,[NR],RBFOX3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:79309121
rs79351035-<b>?</b>,7 x 10-6,(AA),NR,'-,0.8247 unit decrease,[NR],KCNE4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:223197727
rs79489058-<b>?</b>,5 x 10-6,(AA),NR,'-,1.3914 unit decrease,[NR],CHN2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:29416664
rs8098600-<b>?</b>,8 x 10-6,(AA),NR,'-,0.3827 unit decrease,[NR],"LINC01887, NAPG",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:10592716
rs10070219-<b>?</b>,7 x 10-6,(EA),NR,'-,0.3481 unit decrease,[0.2-0.5],"RPL35AP15, LINC00992",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:117367334
rs10958852-<b>?</b>,3 x 10-7,(EA),NR,'-,0.8906 unit decrease,[0.55-1.23],PTPRD,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:10060843
rs11019935-<b>?</b>,3 x 10-7,(EA),NR,'-,0.8885 unit decrease,[0.55-1.22],"GAPDHP70, GRM5-AS1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:88441800
rs113367091-<b>?</b>,3 x 10-6,(EA),NR,'-,0.8257 unit decrease,[0.48-1.17],"TRMT9B, RNU6-842P",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:13035349
rs16957091-<b>G</b>,3 x 10-7,,0.23,1.7,'-,[1.39-2.07],CDAN1,MGMT methylation in smokers,"smoking behavior, gene methylation measurement",GCST003031,15:42725228
rs997781-<b>A</b>,2 x 10-7,,0.29,1.63,'-,[1.36-1.95],ABCA6,MGMT methylation in smokers,"smoking behavior, gene methylation measurement",GCST003031,17:69121547
rs16906252-<b>?</b>,4 x 10-31,,NR,'-,'-,'-,MGMT,MGMT methylation in smokers,"smoking behavior, gene methylation measurement",GCST003031,10:129467281
rs79757846-<b>?</b>,4 x 10-6,(EA),NR,'-,0.9748 unit decrease,[0.57-1.38],LINC00882,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:106575615
rs78823151-<b>?</b>,8 x 10-6,(EA),NR,'-,0.6201 unit decrease,[0.35-0.89],CARMN,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:149428439
rs2329775-<b>?</b>,5 x 10-6,(EA),NR,'-,0.2225 unit decrease,[0.13-0.32],SUGCT,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:40442213
rs10488693-<b>?</b>,7 x 10-8,(Japanese),NR,'-,0.8403 unit decrease,[NR],DAGLA,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:61717684
rs10501157-<b>?</b>,7 x 10-9,(Japanese),NR,'-,0.8987 unit decrease,[NR],TRAF6,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:36485319
rs11642421-<b>?</b>,1 x 10-7,(Japanese),NR,'-,0.5307 unit decrease,[NR],"CHP2, ERN2",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:23738456
rs12458491-<b>?</b>,2 x 10-9,(Japanese),NR,'-,0.8417 unit decrease,[NR],RPL12P40,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:37727857
rs13019227-<b>?</b>,3 x 10-8,(Japanese),NR,'-,0.7808 unit decrease,[NR],THSD7B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:137168337
rs138450362-<b>?</b>,5 x 10-8,(Japanese),NR,'-,1.0668 unit decrease,[NR],HS3ST2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:22939292
rs139612726-<b>?</b>,8 x 10-8,(Japanese),NR,'-,0.8006 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:70783858
rs140701484-<b>?</b>,1 x 10-8,(Japanese),NR,'-,0.9447 unit decrease,[NR],MRPS22,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:139171721
rs145863439-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.9962 unit decrease,[NR],"WNK1, LINC02455",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:691668
rs1474107-<b>?</b>,5 x 10-10,(Japanese),NR,'-,1.0047 unit decrease,[NR],IFTAP,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:36769135
rs149005978-<b>?</b>,2 x 10-11,(Japanese),NR,'-,1.0831 unit decrease,[NR],PIK3CB,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:138783216
rs149914843-<b>?</b>,3 x 10-9,(Japanese),NR,'-,1.3074 unit decrease,[NR],OR5AN1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:59362639
rs150664883-<b>?</b>,5 x 10-9,(Japanese),NR,'-,0.4318 unit decrease,[NR],"CELF4, MIR4318",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:37566243
rs17455969-<b>?</b>,1 x 10-7,(Japanese),NR,'-,1.1128 unit decrease,[NR],NPAS3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,14:33029670
rs17534004-<b>?</b>,2 x 10-8,(Japanese),NR,'-,0.8173 unit increase,[NR],TEX26-AS1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:30895528
rs17807116-<b>?</b>,2 x 10-8,(Japanese),NR,'-,1.0307 unit decrease,[NR],IQCJ-SCHIP1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:159723391
rs184485201-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.9188 unit decrease,[NR],ASRGL1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:62374219
rs187568415-<b>?</b>,2 x 10-8,(Japanese),NR,'-,0.9328 unit decrease,[NR],"ZNF627, ZNF887P",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,19:11623811
rs77990856-<b>?</b>,4 x 10-11,(AA),NR,'-,1.7919 unit decrease,[NR],"MAPK4, RPLP0P11",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:50490517
rs142034933-<b>?</b>,5 x 10-10,(AA),NR,'-,1.3274 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:114906794
rs13271456-<b>?</b>,3 x 10-9,(AA),NR,'-,1.3337 unit decrease,[NR],PINX1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:10767736
rs143049324-<b>?</b>,6 x 10-9,(AA),NR,'-,1.2848 unit decrease,[NR],REPS2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:17027288
rs114619297-<b>?</b>,5 x 10-6,(EA),NR,'-,1.3777 unit decrease,[0.79-1.96],PIK3R5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:8885434
rs117041666-<b>?</b>,2 x 10-6,(EA),NR,'-,1.1009 unit decrease,[0.65-1.55],SAP18P1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:76053677
rs12220014-<b>?</b>,4 x 10-6,(EA),NR,'-,0.6201 unit decrease,[0.36-0.88],RNU6-598P,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:30288009
rs142316462-<b>?</b>,3 x 10-6,(EA),NR,'-,0.6756 unit increase,[0.4-0.96],DAG1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:49475886
rs142429341-<b>?</b>,4 x 10-6,(EA),NR,'-,0.3124 unit decrease,[0.18-0.44],NOL4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:33861956
rs145244554-<b>?</b>,5 x 10-6,(EA),NR,'-,0.6734 unit increase,[0.39-0.96],PDE11A,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:178090295
rs150734725-<b>?</b>,6 x 10-6,(EA),NR,'-,1.4012 unit decrease,[0.8-2],"LINC01821, HNRNPA1P47",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:194286481
rs182006024-<b>?</b>,4 x 10-6,(EA),NR,'-,0.6284 unit increase,[0.36-0.89],PLXNA4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:132133338
rs183497284-<b>?</b>,7 x 10-6,(EA),NR,'-,1.3425 unit increase,[0.77-1.92],ATP6V0D2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:86114530
rs2080364-<b>?</b>,2 x 10-6,(EA),NR,'-,0.2572 unit increase,[0.15-0.36],"RNA5SP427, RBL2",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:53342547
rs2532859-<b>?</b>,2 x 10-6,(EA),NR,'-,0.2726 unit decrease,[0.16-0.38],VWF,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:6006558
rs3097847-<b>?</b>,2 x 10-6,(EA),NR,'-,0.4669 unit decrease,[0.28-0.65],FGF18,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:171470204
rs3743714-<b>?</b>,7 x 10-6,(EA),NR,'-,0.4757 unit decrease,[0.27-0.68],TK2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:66549802
rs3807766-<b>?</b>,4 x 10-6,(EA),NR,'-,0.2122 unit decrease,[0.12-0.3],MAGI2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:78053573
rs3857747-<b>?</b>,1 x 10-6,(EA),NR,'-,0.2401 unit increase,[0.15-0.33],SUGCT,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:40322235
rs61880854-<b>?</b>,2 x 10-6,(EA),NR,'-,0.5821 unit increase,[0.34-0.82],MMP26,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:4803398
rs71363185-<b>?</b>,5 x 10-6,(EA),NR,'-,0.3871 unit decrease,[0.22-0.55],"ZNF519, MC2R",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:14010932
rs72923818-<b>?</b>,1 x 10-6,(EA),NR,'-,0.4612 unit increase,[0.28-0.65],DYM,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:49157384
rs73164810-<b>?</b>,7 x 10-7,(EA),NR,'-,0.4181 unit increase,[0.26-0.58],AIFM3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,22:20967502
rs73625555-<b>?</b>,2 x 10-6,(EA),NR,'-,1.0117 unit decrease,[0.6-1.43],LINC01440,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:55616161
rs75402058-<b>?</b>,7 x 10-6,(EA),NR,'-,0.9986 unit decrease,[0.57-1.43],RNA5SP220,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:140127710
rs756766-<b>?</b>,7 x 10-6,(EA),NR,'-,0.5607 unit decrease,[0.32-0.8],TMEM199,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:28362619
rs75927821-<b>?</b>,4 x 10-6,(EA),NR,'-,0.3466 unit decrease,[0.2-0.49],MCTP1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:95184169
rs77362122-<b>?</b>,7 x 10-6,(EA),NR,'-,0.4737 unit increase,[0.27-0.68],NTRK2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:84765758
rs78745845-<b>?</b>,3 x 10-6,(EA),NR,'-,1.0382 unit decrease,[0.61-1.47],"RNF10P1, BHLHE40",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:4993129
rs73198917-<b>?</b>,1 x 10-9,(AA),NR,'-,1.5266 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:22890680
rs79211555-<b>?</b>,3 x 10-9,(AA),NR,'-,1.5956 unit decrease,[NR],RBFOX3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,17:79309121
rs1014667-<b>?</b>,9 x 10-8,(AA),NR,'-,1.7115 unit decrease,[NR],NRXN1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:50521617
rs112827279-<b>?</b>,5 x 10-8,(AA),NR,'-,1.0337 unit decrease,[NR],ASB9,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:15234130
rs139157003-<b>?</b>,7 x 10-8,(AA),NR,'-,1.6118 unit decrease,[NR],DPY30,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:32021126
rs139214349-<b>?</b>,1 x 10-8,(AA),NR,'-,1.2786 unit decrease,[NR],LINC02472,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:29168543
rs1392502-<b>?</b>,1 x 10-8,(AA),NR,'-,0.8419 unit increase,[NR],APOOP5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:59753666
rs144363312-<b>?</b>,2 x 10-8,(AA),NR,'-,1.6807 unit decrease,[NR],"TWIST2, LINC01940",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:238918088
rs149432766-<b>?</b>,4 x 10-8,(AA),NR,'-,1.3762 unit decrease,[NR],USP37P1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:93801889
rs150798856-<b>?</b>,8 x 10-8,(AA),NR,'-,1.3265 unit decrease,[NR],PTCHD1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:23322339
rs182599614-<b>?</b>,7 x 10-8,(AA),NR,'-,1.4306 unit decrease,[NR],LINC01478,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:44422774
rs191209518-<b>?</b>,3 x 10-8,(AA),NR,'-,1.2269 unit decrease,[NR],NHSL2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:72109657
rs2945731-<b>?</b>,2 x 10-8,(AA),NR,'-,1.3036 unit decrease,[NR],"ST3GAL1-DT, Metazoa_SRP",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:133627845
rs34402840-<b>?</b>,9 x 10-8,(AA),NR,'-,1.5485 unit decrease,[NR],ANO5,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:21687041
rs55966191-<b>?</b>,9 x 10-8,(AA),NR,'-,0.9971 unit decrease,[NR],PGAM1P1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:58227651
rs58296637-<b>?</b>,2 x 10-8,(AA),NR,'-,1.6165 unit decrease,[NR],CNTNAP4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:76430039
rs72689705-<b>?</b>,5 x 10-8,(AA),NR,'-,0.7981 unit decrease,[NR],"ZBTB10, RPSAP47",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:80550062
rs113288656-<b>?</b>,2 x 10-7,(AA),NR,'-,1.1184 unit decrease,[NR],PHEX,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:22417389
rs113496184-<b>?</b>,2 x 10-7,(AA),NR,'-,1.256 unit decrease,[NR],WWOX,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:79006207
rs113626797-<b>?</b>,5 x 10-7,(AA),NR,'-,1.4247 unit decrease,[NR],ACTG1P22,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:81068213
rs12598815-<b>?</b>,1 x 10-7,(AA),NR,'-,1.2435 unit decrease,[NR],CDH13,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:82814603
rs139306621-<b>?</b>,2 x 10-7,(AA),NR,'-,0.9347 unit decrease,[NR],"PPATP2, RTL3",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:78678436
rs140520053-<b>?</b>,5 x 10-7,(AA),NR,'-,1.6277 unit decrease,[NR],CEACAM3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,19:41800015
rs149502810-<b>?</b>,3 x 10-7,(AA),NR,'-,1.9023 unit decrease,[NR],"COMMD9, LDLRAD3",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:36265280
rs17481720-<b>?</b>,4 x 10-7,(AA),NR,'-,1.2771 unit decrease,[NR],PTPA,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:129127015
rs189478926-<b>?</b>,5 x 10-9,(Japanese),NR,'-,0.8474 unit decrease,[NR],"SCGB2A1, SCGB1D1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,11:62196458
rs204664-<b>?</b>,9 x 10-8,(Japanese),NR,'-,0.5462 unit increase,[NR],"TCF15, CSNK2A1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:552161
rs41475954-<b>?</b>,4 x 10-9,(Japanese),NR,'-,0.6178 unit decrease,[NR],CELF4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:37505770
rs59876823-<b>?</b>,7 x 10-9,(Japanese),NR,'-,0.9446 unit decrease,[NR],PCCA-DT,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:100082270
rs7004520-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.5201 unit decrease,[NR],UBXN2B,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:31469533
rs7172971-<b>?</b>,1 x 10-8,(Japanese),NR,'-,0.8034 unit decrease,[NR],PLA2G4E,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,15:42040418
rs72772480-<b>?</b>,2 x 10-7,(Japanese),NR,'-,0.6071 unit decrease,[NR],USP31,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:23050620
rs75750649-<b>?</b>,3 x 10-8,(Japanese),NR,'-,0.8691 unit decrease,[NR],MGAT4C,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:86858583
rs75768999-<b>?</b>,2 x 10-9,(Japanese),NR,'-,0.6094 unit decrease,[NR],"CCDC6, LINC01553",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:59930437
rs77731990-<b>?</b>,3 x 10-8,(Japanese),NR,'-,1.1807 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,Mapping not available
rs79828856-<b>?</b>,8 x 10-8,(Japanese),NR,'-,0.6584 unit decrease,[NR],CELF4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,18:37456867
rs9422860-<b>?</b>,1 x 10-7,(Japanese),NR,'-,0.6912 unit decrease,[NR],MRPS21P6,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:125227554
rs10440708-<b>?</b>,8 x 10-8,(Latino),NR,'-,1.502 unit decrease,[NR],"RPL7AP33, BNIP1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:173223484
rs113991851-<b>?</b>,1 x 10-7,(Latino),NR,'-,1.3931 unit decrease,[NR],FRG1-DT,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:12025243
rs114114977-<b>?</b>,3 x 10-7,(Latino),NR,'-,0.8824 unit decrease,[NR],"DDX6P1, OR14J1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:29318457
rs114622739-<b>?</b>,2 x 10-7,(Latino),NR,'-,1.3251 unit decrease,[NR],"HNRNPA1P56, HMGB1P44",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,4:77975394
rs114780919-<b>?</b>,8 x 10-8,(Latino),NR,'-,1.7019 unit decrease,[NR],GRAMD1C,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:113931599
rs116383923-<b>?</b>,3 x 10-9,(Latino),NR,'-,1.4764 unit decrease,[NR],SNX29,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:12381345
rs11864332-<b>?</b>,3 x 10-9,(Latino),NR,'-,1.1289 unit decrease,[NR],"RPL35AP34, SHISA9",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:12883205
rs12346945-<b>?</b>,2 x 10-7,(Latino),NR,'-,1.3995 unit decrease,[NR],ERCC6L2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:96081777
rs12602300-<b>?</b>,1 x 10-7,(Latino),NR,'-,0.7551 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,17:70665494
rs137948794-<b>?</b>,2 x 10-8,(Latino),NR,'-,0.8728 unit decrease,[NR],IKZF4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,12:56014530
rs144529734-<b>?</b>,6 x 10-8,(Latino),NR,'-,1.301 unit decrease,[NR],PPIAP38,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:105647558
rs144704329-<b>?</b>,2 x 10-7,(Latino),NR,'-,1.5768 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:84778474
rs145242450-<b>?</b>,1 x 10-7,(Latino),NR,'-,1.6001 unit decrease,[NR],"HMGN2P26, LRRC77P",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:167952807
rs147484948-<b>?</b>,1 x 10-7,(Latino),NR,'-,1.2626 unit decrease,[NR],LINC00884,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:194517169
rs188674761-<b>?</b>,2 x 10-7,(Latino),NR,'-,1.1179 unit decrease,[NR],LINC01440,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:55624691
rs189087047-<b>?</b>,8 x 10-8,(Latino),NR,'-,1.6762 unit decrease,[NR],MED30,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:117639150
rs2224610-<b>?</b>,3 x 10-7,(Latino),NR,'-,1.3171 unit decrease,[NR],PAK5,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,20:9650739
rs2805062-<b>?</b>,1 x 10-10,(Latino),NR,'-,1.3293 unit decrease,[NR],IZUMO3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:24560579
rs34395537-<b>?</b>,8 x 10-10,(Latino),NR,'-,1.7295 unit decrease,[NR],CACYBPP2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,2:183628013
rs58144239-<b>?</b>,1 x 10-9,(Latino),NR,'-,1.2211 unit decrease,[NR],CPPED1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:12665652
rs58376408-<b>?</b>,2 x 10-9,(Latino),NR,'-,1.3522 unit decrease,[NR],"LINC01290, RNU6-633P",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:10504450
rs62024303-<b>?</b>,3 x 10-7,(Latino),NR,'-,1.2385 unit decrease,[NR],NTRK3-AS1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,15:88327931
rs7042315-<b>?</b>,6 x 10-8,(Latino),NR,'-,1.4753 unit decrease,[NR],HSD17B3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:96267007
rs73085315-<b>?</b>,2 x 10-10,(Latino),NR,'-,1.4698 unit decrease,[NR],MUC4,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:195778256
rs73505772-<b>?</b>,3 x 10-7,(Latino),NR,'-,1.3909 unit decrease,[NR],LINC00376,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,13:63164591
rs74851542-<b>?</b>,2 x 10-7,(Latino),NR,'-,1.1461 unit decrease,[NR],"TREML5P, TREM1",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,6:41264814
rs75030518-<b>?</b>,2 x 10-7,(Latino),NR,'-,1.4514 unit decrease,[NR],RUNX1,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,21:34941487
rs75728418-<b>?</b>,1 x 10-7,(Latino),NR,'-,1.2847 unit decrease,[NR],ABCA17P,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:7882576
rs7637688-<b>?</b>,7 x 10-8,(Latino),NR,'-,0.6713 unit increase,[NR],"ATP5MC1P3, PIK3CB",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,3:138884041
rs76409888-<b>?</b>,1 x 10-7,(Latino),NR,'-,1.7704 unit decrease,[NR],CHST3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,10:71964198
rs9924009-<b>?</b>,3 x 10-7,(Latino),NR,'-,1.0391 unit decrease,[NR],TXNDC11,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,16:11688193
rs118043898-<b>?</b>,5 x 10-8,(Latino),NR,'-,1.6762 unit decrease,[NR],'-,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,9:24431794
rs10077887-<b>?</b>,8 x 10-6,(Native Hawaiian),NR,'-,0.5383 unit increase,[NR],PURPL,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,5:27460098
rs113441626-<b>?</b>,8 x 10-8,(Native Hawaiian),NR,'-,1.3074 unit increase,[NR],NR2E3,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,15:71814833
rs113920924-<b>?</b>,9 x 10-6,(Native Hawaiian),NR,'-,1.0445 unit increase,[NR],PKM,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,15:72206596
rs114167782-<b>?</b>,2 x 10-7,(Native Hawaiian),NR,'-,1.2727 unit increase,[NR],"WNT2, CFTR",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:117299233
rs115169421-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.9626 unit increase,[NR],"LINC02318, TCL6",3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,14:95627510
rs117044419-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.7395 unit increase,[NR],HSPA8P13,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,8:46494994
rs6065855-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.6644 unit increase,[NR],WFDC11,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,20:45661494
rs61743495-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.9229 unit increase,[NR],CCDC154,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:1434454
rs62612828-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.9761 unit decrease,[NR],CYSLTR1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:78340040
rs6531565-<b>?</b>,6 x 10-7,(Native Hawaiian),NR,'-,0.5136 unit decrease,[NR],RELL1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:37660910
rs74383458-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.9327 unit increase,[NR],PWWP2B,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:132408041
rs74427637-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,1.2837 unit decrease,[NR],LINC01266,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:751144
rs74464075-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,1.3228 unit decrease,[NR],"TMEM243, TP53TG1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:87244761
rs7473757-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.7668 unit decrease,[NR],SSBL2P,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:62727259
rs76752037-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.826 unit increase,[NR],BRF1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,14:105261860
rs77040403-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.7427 unit decrease,[NR],COL13A1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:69881082
rs78211511-<b>?</b>,3 x 10-7,(Native Hawaiian),NR,'-,1.0443 unit decrease,[NR],MIR99AHG,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,21:16189964
rs80337801-<b>?</b>,3 x 10-7,(Native Hawaiian),NR,'-,0.9711 unit increase,[NR],LINC01331,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:74359173
rs55922880-<b>?</b>,1 x 10-9,,NR,'-,0.4066 unit decrease,[NR],AEBP2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,12:115179836
rs79900979-<b>?</b>,6 x 10-9,,NR,'-,0.4281 unit decrease,[NR],ACAP2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:195429768
rs115205687-<b>?</b>,4 x 10-8,,NR,'-,0.4891 unit decrease,[NR],PLCB1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,20:8915129
rs55821258-<b>?</b>,2 x 10-8,,NR,'-,0.2167 unit decrease,[NR],C8orf37-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,8:95279813
rs60188314-<b>?</b>,1 x 10-8,,NR,'-,0.4624 unit decrease,[NR],STK10,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:172111740
rs72666268-<b>?</b>,6 x 10-8,,NR,'-,0.3331 unit decrease,[NR],FGGY,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,1:59655756
rs7675915-<b>?</b>,3 x 10-8,,NR,'-,0.3501 unit increase,[NR],STX18-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:4677180
rs10912872-<b>?</b>,3 x 10-8,,NR,'-,0.1102 unit decrease,[NR],"GM2AP2, SRP14P4",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,1:171387110
rs112364629-<b>?</b>,6 x 10-7,,NR,'-,0.4197 unit decrease,[NR],MYRIP,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:39950732
rs140333256-<b>?</b>,1 x 10-7,,NR,'-,0.4046 unit decrease,[NR],ACAP2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:195298691
rs150066336-<b>?</b>,2 x 10-7,,NR,'-,0.6169 unit decrease,[NR],LINC01235,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:13475447
rs1514092-<b>?</b>,3 x 10-7,,NR,'-,0.264 unit decrease,[NR],LINC01495,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:22503808
rs17049612-<b>?</b>,6 x 10-7,,NR,'-,0.3986 unit decrease,[NR],"RAD18, CAV3",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:8822123
rs10856789-<b>?</b>,1 x 10-7,(Native Hawaiian),NR,'-,1.1678 unit increase,[NR],LINC01808,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:19581401
rs112591243-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.6857 unit decrease,[NR],"C21orf58, YBEY",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,21:46298882
rs112960054-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.6103 unit increase,[NR],LPXN,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:58564369
rs113196862-<b>?</b>,7 x 10-7,(Native Hawaiian),NR,'-,0.6231 unit increase,[NR],"OR10Q2P, OR5BC1P",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:58315137
rs115536975-<b>?</b>,3 x 10-7,(Native Hawaiian),NR,'-,1.0725 unit decrease,[NR],DOCK1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:126973570
rs117787235-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,0.679 unit decrease,[NR],RUNX2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:45633613
rs117807646-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.7472 unit decrease,[NR],NECTIN1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,11:119749203
rs117914390-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,1.2612 unit decrease,[NR],AFG1L,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:108441002
rs117926975-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,1.202 unit decrease,[NR],PCAT7,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,9:94595859
rs12854631-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.8076 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:58297412
rs137948999-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.8279 unit decrease,[NR],BEND2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:18194062
rs140267713-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,0.8404 unit decrease,[NR],TBC1D8B,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:106804838
rs140386998-<b>?</b>,6 x 10-7,(Native Hawaiian),NR,'-,0.7379 unit decrease,[NR],"ARL13A, CSGALNACT2P1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:100959983
rs143011308-<b>?</b>,4 x 10-7,(Native Hawaiian),NR,'-,0.8601 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:4117086
rs144773023-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.8408 unit decrease,[NR],"PWWP3B, CSGALNACT2P2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:106254643
rs146228471-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.832 unit decrease,[NR],"FNDC3CP, CYSLTR1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:78206936
rs146414513-<b>?</b>,7 x 10-7,(Native Hawaiian),NR,'-,0.8791 unit decrease,[NR],SERBP1P4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:91548679
rs146514374-<b>?</b>,1 x 10-7,(Native Hawaiian),NR,'-,1.0285 unit decrease,[NR],"VCX, STS",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:7839126
rs147168872-<b>?</b>,9 x 10-7,(Native Hawaiian),NR,'-,1.1117 unit decrease,[NR],SOS2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,14:50173277
rs147428850-<b>?</b>,8 x 10-7,(Native Hawaiian),NR,'-,0.8192 unit decrease,[NR],"P2RY10, P2RY10BP",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:79047973
rs147774538-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,1.0415 unit decrease,[NR],"ATF7IP2, RN7SL493P",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:10278663
rs148215758-<b>?</b>,2 x 10-7,(Native Hawaiian),NR,'-,1.1057 unit decrease,[NR],PHF8,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:54017674
rs149422347-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,1.482 unit increase,[NR],CACNA2D3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:54463747
rs16942556-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,1.1184 unit increase,[NR],ANXA2,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,15:60395052
rs17219051-<b>?</b>,6 x 10-7,(Native Hawaiian),NR,'-,0.8015 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:4330060
rs180781551-<b>?</b>,6 x 10-7,(Native Hawaiian),NR,'-,1.2508 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,6:48448376
rs181551482-<b>?</b>,4 x 10-6,(Native Hawaiian),NR,'-,0.7179 unit decrease,[NR],PABPC5-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:91399614
rs181869920-<b>?</b>,9 x 10-11,(Native Hawaiian),NR,'-,1.3873 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:79674625
rs182705894-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.8778 unit decrease,[NR],TAF1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:71404945
rs183056377-<b>?</b>,4 x 10-7,(Native Hawaiian),NR,'-,0.8009 unit decrease,[NR],GOT2P6,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:56034817
rs186826000-<b>?</b>,3 x 10-7,(Native Hawaiian),NR,'-,1.2654 unit increase,[NR],ATP5PBP4,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:153086712
rs187296392-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,1.1487 unit increase,[NR],"MRLN, CCDC6",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:59770640
rs188085108-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.7341 unit decrease,[NR],"RPL7P54, MIR4328",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:78854563
rs189894228-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,1.0929 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:90405245
rs191870197-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.9067 unit decrease,[NR],MIR325HG,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:76826573
rs191936903-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,1.1003 unit decrease,[NR],EGLN3,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,14:34027246
rs192657641-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.9198 unit decrease,[NR],RNA5SP508,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:76601629
rs2027099-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.2073 unit decrease,[NR],PCDH9,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,13:66468960
rs2316394-<b>?</b>,4 x 10-7,(Native Hawaiian),NR,'-,1.283 unit decrease,[NR],'-,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:16542330
rs4644421-<b>?</b>,1 x 10-6,(Native Hawaiian),NR,'-,0.9434 unit decrease,[NR],RNA5SP509,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:77090709
rs4716734-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,0.5754 unit decrease,[NR],"PTPRN2, DNAJB6",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:157441725
rs4732446-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,1.0501 unit decrease,[NR],CACNA2D1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,7:82372901
rs55952756-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,0.7218 unit decrease,[NR],"Y_RNA, FDPSP5",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:44460694
rs5912268-<b>?</b>,9 x 10-7,(Native Hawaiian),NR,'-,0.8072 unit decrease,[NR],"CTHRC1P1, KIF4CP",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:79276916
rs5916984-<b>?</b>,3 x 10-6,(Native Hawaiian),NR,'-,0.8342 unit decrease,[NR],"Y_RNA, CSGALNACT2P2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:106354763
rs5937507-<b>?</b>,2 x 10-8,(Native Hawaiian),NR,'-,1.2018 unit decrease,[NR],"MMADHCP1, PBDC1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:76197175
rs5938548-<b>?</b>,2 x 10-7,(Native Hawaiian),NR,'-,1.0852 unit decrease,[NR],"MAGEE1, LDHBP2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:76414569
rs5957117-<b>?</b>,6 x 10-7,(Native Hawaiian),NR,'-,0.9688 unit decrease,[NR],KIAA1210,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:119130439
rs5975063-<b>?</b>,5 x 10-6,(Native Hawaiian),NR,'-,0.9373 unit decrease,[NR],RPL32P35,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,X:128918288
rs60136336-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,0.7505 unit decrease,[NR],PROS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:93972003
rs17576670-<b>?</b>,6 x 10-7,,NR,'-,0.3445 unit decrease,[NR],"RSL24D1P2, EHBP1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:62589884
rs35476224-<b>?</b>,1 x 10-7,,NR,'-,0.3139 unit decrease,[NR],"TMEM271, PDE6B",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:597684
rs6874604-<b>?</b>,3 x 10-7,,NR,'-,0.4305 unit decrease,[NR],"UGT3A2, ARL2BPP5",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,5:162680373
rs72810761-<b>?</b>,7 x 10-7,,NR,'-,0.3118 unit decrease,[NR],"DNAJC1, ADIPOR1P1",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,10:22089029
rs72909131-<b>?</b>,7 x 10-7,,NR,'-,0.5037 unit decrease,[NR],"LINC00575, TMEM150C",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,4:82591688
rs73130949-<b>?</b>,2 x 10-7,,NR,'-,0.4934 unit decrease,[NR],LMCD1-AS1,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,3:7878962
rs73584251-<b>?</b>,4 x 10-7,,NR,'-,0.4242 unit decrease,[NR],"FKBP1A, NSFL1C",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,20:1420847
rs73962318-<b>?</b>,6 x 10-7,,NR,'-,0.3471 unit decrease,[NR],"ARHGAP15, MTND4P22",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:143097365
rs745109-<b>?</b>,8 x 10-7,,NR,'-,0.155 unit decrease,[NR],"RNF103-CHMP3, RNF103",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,2:86613946
rs75774303-<b>?</b>,5 x 10-7,,NR,'-,0.4062 unit decrease,[NR],SYT17,3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,16:19263230
rs9675861-<b>?</b>,1 x 10-6,(Japanese),NR,'-,0.395 unit decrease,[NR],"LRRC30, SLC25A51P2",3-hydroxy-1-methylpropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxy-1-methylpropylmercapturic acid measurement",GCST002957,18:7172525
rs9788721-<b>T</b>,5 x 10-10,(diff950),0.62,'-,0.08 unit decrease,NR,HYKK,Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,15:78510527
rs138544659-<b>T</b>,1 x 10-14,(diff950),0.7,'-,0.12 unit decrease,NR,CHRNA3,Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,15:78608359
rs13141641-<b>T</b>,2 x 10-11,(diff950),0.63,'-,0.09 unit increase,NR,"HHIP-AS1, KRT18P51",Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,4:144585304
rs13141641-<b>T</b>,6 x 10-18,(ratio950),0.62,'-,0.12 unit increase,NR,"HHIP-AS1, KRT18P51",Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,4:144585304
rs12914385-<b>T</b>,2 x 10-17,(ratio950),0.38,'-,0.11 unit increase,NR,CHRNA3,Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,15:78606381
rs2645694-<b>T</b>,2 x 10-8,(ratio950),0.3,'-,0.08 unit increase,NR,"SEPTIN11, SOWAHB",Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,4:76912794
rs75755010-<b>A</b>,3 x 10-8,(ratio950),0.08,'-,0.15 unit decrease,NR,TRAPPC9,Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,8:139983697
rs35374984-<b>A</b>,4 x 10-8,(ratio950),0.29,'-,0.1 unit increase,NR,"JCAD, BMI1",Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,10:29945261
rs9788721-<b>T</b>,7 x 10-12,(ratio950),0.62,'-,0.09 unit decrease,NR,HYKK,Emphysema distribution in smoking,"smoking behavior, emphysema pattern measurement",GCST003761,15:78510527
rs6004031-<b>T</b>,3 x 10-134,,NR,'-,0.6769 unit decrease,[0.63-0.73],'-,S-phenylmercapturic acid levels in smokers,"smoking behavior, urinary S-phenylmercapturic acid measurement",GCST003483,Mapping not available
rs6003958-<b>G</b>,2 x 10-46,,NR,'-,0.453 unit decrease,[0.39-0.51],"GSTT2B, MIF-AS1",S-phenylmercapturic acid levels in smokers,"smoking behavior, urinary S-phenylmercapturic acid measurement",GCST003483,22:23921902
POU4F1-AS1-<b>?</b>,2 x 10-8,(Latino),'-,'-,0.62 unit increase,[NR],'-,S-phenylmercapturic acid levels in smokers,"smoking behavior, urinary S-phenylmercapturic acid measurement",GCST003483,Mapping not available
rs8102683-<b>?</b>,4 x 10-42,,NR,'-,2.76 unit increase,[2.36-3.16],"CYP2A7, CYP2A6",Smoking behavior,smoking behavior,GCST001696,19:40857860
rs2106595-<b>G</b>,5 x 10-6,,NR,'-,0.88 unit increase,[0.51-1.25],ANKRD7,Smoking behavior,smoking behavior,GCST001696,7:118519495
rs1801272-<b>T</b>,5 x 10-6,,0.012,'-,9.4 unit decrease,[5.48-13.32],CYP2A6,Smoking behavior,smoking behavior,GCST001696,19:40848628
rs55958997-<b>?</b>,2 x 10-9,(EA),NR,'-,2.75 unit increase,[1.86-3.64],"CHRNA3, CHRNB4",Exhaled carbon monoxide levels,"smoking behavior, carbon monoxide exhalation measurement",GCST002584,15:78623530
rs4947642-<b>?</b>,1 x 10-6,"(SBP,Smoking)",NR,'-,'-,'-,RN7SL292P,Blood pressure (smoking interaction),"smoking behavior, smoking status measurement, systolic blood pressure",GCST002587,7:51797912
rs8010717-<b>?</b>,1 x 10-7,"(SBP,Smoking)",NR,'-,'-,'-,NRXN3,Blood pressure (smoking interaction),"smoking behavior, smoking status measurement, systolic blood pressure",GCST002587,14:79944098
rs6437740-<b>?</b>,2 x 10-7,(CPD),0.24,'-,0.1 cigarettes per day decrease,[NR],BBX,Smoking behavior,smoking behavior,GCST000349,3:107746970
rs910696-<b>?</b>,3 x 10-6,(CPD),0.31,'-,0.08 cigarettes per day increase,[NR],LINC01648,Smoking behavior,smoking behavior,GCST000349,1:30094749
rs7050529-<b>?</b>,6 x 10-6,(CPD),0.07,'-,0.06 cigarettes per day decrease,[NR],TRPC5,Smoking behavior,smoking behavior,GCST000349,X:111912005
rs912969-<b>?</b>,8 x 10-6,(SMKDU),0.07,'-,0.14 years decrease,[NR],'-,Smoking behavior,smoking behavior,GCST000349,13:103214754
rs17050782-<b>?</b>,8 x 10-6,(SMKAGE),0.21,'-,0.03 years increase,[NR],SETD7,Smoking behavior,smoking behavior,GCST000349,4:139501980
rs2268983-<b>?</b>,7 x 10-6,(CPDBI),0.51,1.52,'-,[NR],ACTN1,Smoking behavior,smoking behavior,GCST000349,14:68941980
rs886716-<b>?</b>,8 x 10-6,(CPDBI),0.69,1.52,'-,[NR],KIAA0087,Smoking behavior,smoking behavior,GCST000349,7:26517999
rs3027409-<b>?</b>,7 x 10-6,(CPDBI),0.95,1.73,'-,[NR],"MAOA, MAOB",Smoking behavior,smoking behavior,GCST000349,X:43747786
rs800082-<b>?</b>,3 x 10-6,(PKYRS),0.42,'-,0.12 pack years increase,[NR],EIF4E2P2,Smoking behavior,smoking behavior,GCST000349,3:144621363
rs1402279-<b>?</b>,5 x 10-6,(EVNV),0.95,1.51,'-,[NR],NAV3,Smoking behavior,smoking behavior,GCST000349,12:77335605
rs1847461-<b>?</b>,8 x 10-6,(CIGSTAT),0.94,1.8,'-,[NR],LINC02822,Smoking behavior,smoking behavior,GCST000349,12:90683731
rs3112740-<b>?</b>,6 x 10-6,(CPDBI),0.86,2.16,'-,[NR],RBFOX1,Smoking behavior,smoking behavior,GCST000349,16:7786295
rs6444087-<b>?</b>,9 x 10-6,(EVNV),0.26,1.28,'-,[NR],"TRA2B, IGF2BP2",Smoking behavior,smoking behavior,GCST000349,3:185904041
rs10989661-<b>?</b>,6 x 10-6,(CIGSTAT),0.74,1.68,'-,[NR],MTND3P4,Smoking behavior,smoking behavior,GCST000349,9:101860586
rs1889899-<b>?</b>,6 x 10-6,(EVNV),0.37,1.26,'-,[NR],CAAP1,Smoking behavior,smoking behavior,GCST000349,9:26789942
rs933688-<b>?</b>,6 x 10-6,(EVNV),0.17,1.48,'-,[NR],ARRDC3-AS1,Smoking behavior,smoking behavior,GCST000349,5:91466931
rs950063-<b>?</b>,9 x 10-6,(SMKDU),0.39,'-,0.08 years decrease,[NR],MIR2054,Smoking behavior,smoking behavior,GCST000349,4:125510764
rs7553864-<b>?</b>,3 x 10-6,(SMKDU),0.39,'-,0.08 years increase,[NR],LINC01140,Smoking behavior,smoking behavior,GCST000349,1:87147675
rs11082304-<b>?</b>,6 x 10-6,(SMKAGE),0.49,'-,0.03 years decrease,[NR],CABLES1,Smoking behavior,smoking behavior,GCST000349,18:23141009
rs758642-<b>?</b>,7 x 10-6,(CPD),0.34,'-,0.08 cigarettes per day increase,[NR],CAMKK1,Smoking behavior,smoking behavior,GCST000349,17:3883613
rs10411195-<b>?</b>,6 x 10-6,(CPD),0.03,'-,0.21 cigarettes per day decrease,[NR],'-,Smoking behavior,smoking behavior,GCST000349,Mapping not available
rs11134474-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,RNA5SP199,Smoking behavior,smoking behavior,GCST001286,5:155775518
rs1404697-<b>?</b>,8 x 10-6,(Heaviness of Smoking Index),NR,'-,'-,'-,"BUB3P1, C7orf66",Smoking behavior,smoking behavior,GCST001286,7:108904404
rs1404697-<b>?</b>,5 x 10-6,(Fagerstrom test for nicotine dependence),NR,'-,'-,'-,"BUB3P1, C7orf66",Smoking behavior,smoking behavior,GCST001286,7:108904404
rs848353-<b>?</b>,2 x 10-6,(Cigarettes smoked per day),NR,'-,'-,'-,"BUB3P1, C7orf66",Smoking behavior,smoking behavior,GCST001286,7:108908603
rs848353-<b>?</b>,3 x 10-7,(Fagerstrom test for nicotine dependence),NR,'-,'-,'-,"BUB3P1, C7orf66",Smoking behavior,smoking behavior,GCST001286,7:108908603
rs848353-<b>?</b>,9 x 10-7,(Heaviness of Smoking Index),NR,'-,'-,'-,"BUB3P1, C7orf66",Smoking behavior,smoking behavior,GCST001286,7:108908603
rs4537555-<b>G</b>,4 x 10-6,,0.11,'-,6.306 unit decrease,'-,HHAT,Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,1:210504207
rs10489858-<b>C</b>,9 x 10-6,,'-,'-,6.381 unit decrease,'-,"MICOS10-NBL1, NBL1, MICOS10",Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,1:19620762
rs2165220-<b>C</b>,4 x 10-6,,'-,'-,5.935 unit decrease,'-,MIR3681HG,Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,2:12040788
rs6753618-<b>A</b>,6 x 10-6,,'-,'-,4.316 unit increase,'-,GPR39,Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,2:132466818
rs17167368-<b>G</b>,8 x 10-6,,'-,'-,15.55 unit increase,'-,TMEM229A,Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,7:13691497
rs12427132-<b>G</b>,5 x 10-6,,'-,'-,8.328 unit increase,'-,"SLCO1A2, SLCO1B1",Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,12:21256361
rs28929474-<b>T</b>,4 x 10-8,,0.029,'-,13.62 unit decrease,'-,'-,Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,Mapping not available
rs8079868-<b>C</b>,6 x 10-7,,0.12,'-,6.669 unit decrease,'-,MYHAS,Post bronchodilator percent predicted FEV1 in smoking,"smoking behavior, forced expiratory volume",GCST006309,17:10617383
rs4537555-<b>G</b>,2 x 10-7,,0.11,'-,0.04418 unit decrease,[NR],HHAT,Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,1:210504207
rs6753618-<b>A</b>,6 x 10-6,,'-,'-,0.02683 unit increase,[NR],GPR39,Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,2:132466818
rs17167368-<b>G</b>,3 x 10-6,,'-,'-,0.101 unit increase,[NR],TMEM229A,Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,7:13691497
rs2210865-<b>G</b>,2 x 10-6,,'-,'-,0.02653 unit decrease,[NR],LINC01239,Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,9:22669167
rs28929474-<b>T</b>,1 x 10-8,,0.029,'-,0.08749 unit decrease,[NR],'-,Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,Mapping not available
rs360178-<b>T</b>,9 x 10-6,,'-,'-,0.03053 unit increase,[NR],RPL10L,Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,14:46625443
rs862225-<b>A</b>,3 x 10-6,,'-,'-,0.04879 unit increase,[NR],"ZCCHC14, JPH3",Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,16:87571155
rs10503023-<b>A</b>,1 x 10-6,,'-,'-,0.03109 unit decrease,[NR],"SEC11C, GRP",Post bronchodilator FEV1/FVC ratio in smoking,"smoking behavior, FEV/FEC ratio",GCST006310,18:59165543
rs113029345-<b>C</b>,1 x 10-41,,NR,'-,0.3592 unit increase,[0.31-0.41],"CYP2A6, CYP2A7",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40864271
rs76935404-<b>T</b>,1 x 10-25,,NR,'-,0.2489 unit increase,[0.2-0.29],"CYP2G1P, CYP2B7P",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40913389
rs10425738-<b>G</b>,1 x 10-24,,NR,'-,0.2425 unit decrease,[0.2-0.29],CYP2G1P,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40911822
rs11878604-<b>C</b>,7 x 10-24,,NR,'-,0.276 unit decrease,[0.22-0.33],"CYP2F2P, CYP2A6",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40827379
rs7247903-<b>G</b>,1 x 10-21,,NR,'-,0.3222 unit decrease,[0.26-0.39],"CYP2A7, CYP2A6",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40866570
rs2316205-<b>C</b>,4 x 10-14,,NR,'-,0.1786 unit increase,[0.13-0.22],"CYP2F2P, CYP2A6",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40840863
rs4079366-<b>T</b>,8 x 10-14,,NR,'-,0.1854 unit decrease,[0.14-0.23],CYP2A7,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40878770
rs73931391-<b>G</b>,2 x 10-12,,NR,'-,0.5852 unit decrease,[0.42-0.75],CYP2G1P,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40901969
rs2545770-<b>A</b>,4 x 10-11,,NR,'-,0.2012 unit decrease,[0.14-0.26],"CYP2F2P, CYP2T1P",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40818275
rs185308415-<b>G</b>,3 x 10-9,,NR,'-,0.3344 unit decrease,[0.22-0.44],CYP2T1P,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40811274
rs76617915-<b>A</b>,2 x 10-8,,NR,'-,0.6151 unit decrease,[0.4-0.83],"CYP2A7P1, CYP2G2P",Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:41032173
rs7507400-<b>T</b>,4 x 10-8,,NR,'-,0.1679 unit decrease,[0.11-0.23],CYP2F2P,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40824274
rs2045966-<b>G</b>,3 x 10-8,,NR,'-,0.2483 unit increase,[0.16-0.34],MTDH,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,8:97581926
rs56113850-<b>T</b>,1 x 10-50,,NR,'-,0.3644 unit decrease,[0.32-0.41],CYP2A6,Nicotine metabolite ratio in current smokers,"smoking behavior, nicotine metabolite ratio",GCST003629,19:40847202
rs6487668-<b>C</b>,7 x 10-7,(EA),0.2181,'-,'-,'-,PZP,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,12:9200312
rs9432230-<b>C</b>,5 x 10-7,(AA),0.893,'-,'-,'-,"C1orf198, RN7SL837P",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:230882365
rs734152-<b>G</b>,1 x 10-6,(EA),0.8804,'-,'-,'-,"FAM222A, FAM222A-AS1",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,12:109759971
rs59711329-<b>G</b>,1 x 10-6,(AA),0.9039,'-,'-,'-,ZNF417,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,19:57901128
rs79309730-<b>C</b>,2 x 10-6,(EA),0.9427,'-,'-,'-,SH3BP4,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:235039304
rs139018470-<b>T</b>,2 x 10-6,(AA),0.9549,'-,'-,'-,"GPR88, LINC01349",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:100602039
rs17506336-<b>C</b>,2 x 10-6,(AA),0.9017,'-,'-,'-,EXT1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,8:118097589
rs186167755-<b>C</b>,2 x 10-6,(AA),0.9796,'-,'-,'-,ADAMTSL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,9:18600278
rs6485603-<b>G</b>,5 x 10-6,(EA),0.5506,'-,'-,'-,"PRDM11, SYT13",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,11:45238465
rs143756124-<b>T</b>,5 x 10-6,(EA),0.932,'-,'-,'-,"RNMT, MC5R",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:13823130
rs6743806-<b>C</b>,5 x 10-6,(EA),0.7326,'-,'-,'-,"HIGD1AP4, RN7SL807P",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:223344398
rs13171357-<b>G</b>,5 x 10-6,(EA),0.7185,'-,'-,'-,SLC1A3,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,5:36694954
rs7194099-<b>A</b>,5 x 10-6,(EA),0.5561,'-,'-,'-,"BCAR4, ZC3H7A",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,16:11808105
rs180931486-<b>T</b>,6 x 10-6,(EA),0.9334,'-,'-,'-,MBP,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:77055585
rs536504-<b>C</b>,7 x 10-6,(EA),0.6995,'-,'-,'-,RASGEF1B,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,4:81840312
rs79652026-<b>C</b>,3 x 10-6,(AA),0.9413,'-,'-,'-,FIG4,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109737837
rs74932355-<b>T</b>,3 x 10-6,(AA),0.9063,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:236758796
rs28680895-<b>T</b>,4 x 10-6,(AA),0.9532,'-,'-,'-,"ZNF506, ZNF56",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,19:19814290
rs57091543-<b>C</b>,4 x 10-6,(AA),0.9511,'-,'-,'-,GALM,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:38677624
rs55894909-<b>G</b>,4 x 10-6,(AA),0.7259,'-,'-,'-,"RNU6-1304P, ENAH",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:225711351
rs13257626-<b>G</b>,9 x 10-6,(EA),0.9769,'-,'-,'-,U8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,8:71780350
rs570456-<b>C</b>,9 x 10-6,(EA),0.7392,'-,'-,'-,ALG8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,11:78112182
rs143916815-<b>G</b>,1 x 10-7,(AA),0.9768,'-,'-,'-,"C15orf54, LINC02694",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,15:39191714
rs7897478-<b>A</b>,1 x 10-7,(AA),0.9418,'-,'-,'-,JCAD,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,10:29945955
rs10243383-<b>T</b>,1 x 10-7,(AA),0.626,'-,'-,'-,RAPGEF5,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,7:22242733
rs115319209-<b>G</b>,2 x 10-7,(AA),0.969,'-,'-,'-,LINC01220,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,14:75298968
rs114969316-<b>A</b>,2 x 10-7,(AA),0.952,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:88460643
rs9487114-<b>C</b>,3 x 10-7,(AA),0.0635,'-,'-,'-,MICAL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109460597
rs76782312-<b>C</b>,4 x 10-7,(AA),0.94,'-,'-,'-,AK9,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109643865
rs35426224-<b>G</b>,1 x 10-6,(EA),0.9255,'-,'-,'-,EML1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,14:99783354
rs142383097-<b>A</b>,6 x 10-7,(AA),0.97,'-,'-,'-,DFFA,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:10461101
rs12036147-<b>A</b>,1 x 10-6,(EA),0.9116,'-,'-,'-,CHRM3,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,1:239835413
rs141980369-<b>G</b>,1 x 10-6,(AA),0.8988,'-,'-,'-,MCM9,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:118888344
rs7298108-<b>C</b>,2 x 10-6,(EA),0.8217,'-,'-,'-,"A2MP1, PZP",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,12:9223572
rs17118176-<b>A</b>,4 x 10-6,(EA),0.9373,'-,'-,'-,MDGA2,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,14:47216656
rs2252932-<b>A</b>,2 x 10-6,(AA),0.7384,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,13:55740831
rs185973901-<b>C</b>,2 x 10-6,(AA),0.9707,'-,'-,'-,ACTBP8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:88351556
rs2576789-<b>A</b>,2 x 10-6,(AA),0.41,'-,'-,'-,"GPR45, LINC01918",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,2:105194762
rs148701910-<b>C</b>,2 x 10-6,(AA),0.9333,'-,'-,'-,KLF2-DT,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,19:16310721
rs78489263-<b>A</b>,2 x 10-6,(AA),0.9488,'-,'-,'-,CDKAL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:20723562
rs13138395-<b>T</b>,2 x 10-6,(AA),0.6502,'-,'-,'-,LINC00290,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,4:181009808
rs80127896-<b>A</b>,3 x 10-6,(AA),0.965,'-,'-,'-,GMDS-DT,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:2518145
rs76913336-<b>C</b>,3 x 10-6,(AA),0.965,'-,'-,'-,GMDS-DT,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:2518745
rs9487113-<b>T</b>,3 x 10-6,(AA),0.9391,'-,'-,'-,MICAL1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,6:109458971
rs17744447-<b>A</b>,8 x 10-6,(EA),0.3458,'-,'-,'-,"CABYRP1, CACNA2D3",Depression in smokers,"smoking behavior, unipolar depression",GCST006427,3:54059392
rs567697-<b>T</b>,8 x 10-6,(EA),0.8451,'-,'-,'-,ALG8,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,11:78096117
rs76088896-<b>T</b>,9 x 10-6,(EA),0.8925,'-,'-,'-,LINC02246,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,21:14892473
rs73359384-<b>G</b>,4 x 10-6,(AA),0.9183,'-,'-,'-,LINC02074,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,17:74078057
rs150466001-<b>C</b>,4 x 10-6,(AA),0.9653,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:66348267
rs71358652-<b>C</b>,4 x 10-6,(AA),0.9742,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,18:64934582
rs16832899-<b>G</b>,4 x 10-6,(AA),0.205,'-,'-,'-,'-,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,3:182144627
rs76400352-<b>G</b>,4 x 10-6,(AA),0.9684,'-,'-,'-,FYB1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,5:39230117
rs184666-<b>T</b>,5 x 10-6,(AA),0.9142,'-,'-,'-,LINC02195,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,16:26606344
rs113021743-<b>C</b>,5 x 10-6,(AA),0.9525,'-,'-,'-,STX17-AS1,Depression in smokers,"smoking behavior, unipolar depression",GCST006427,9:99757506
rs2036527-<b>A</b>,2 x 10-8,(CPD),0.22,'-,0.04 unit increase,[0.026-0.054],"PSMA4, CHRNA5",Smoking behavior,smoking behavior,GCST001539,15:78559273
rs3101457-<b>A</b>,3 x 10-7,(CPD),0.75,'-,0.041 unit increase,[0.025-0.057],C1orf100,Smoking behavior,smoking behavior,GCST001539,1:244369912
rs547843-<b>C</b>,6 x 10-7,(CPD),0.65,'-,0.035 unit decrease,[0.021-0.049],LINC00929,Smoking behavior,smoking behavior,GCST001539,15:26178900
rs667282-<b>C</b>,2 x 10-7,(CPD),0.29,'-,0.033 unit increase,[0.021-0.045],CHRNA5,Smoking behavior,smoking behavior,GCST001539,15:78571130
rs1678618-<b>A</b>,8 x 10-7,(AOI),0.74,'-,0.06 unit decrease,[0.036-0.084],"CHST3, SPOCK2",Smoking behavior,smoking behavior,GCST001539,10:72046530
rs4888444-<b>A</b>,2 x 10-8,,0.9479,'-,0.025578208 unit increase,[0.017-0.034],TERF2IP,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:75656381
rs10461104-<b>A</b>,2 x 10-8,,0.634,'-,0.012726735 unit increase,[0.0083-0.0171],IGBP1P5,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:27488957
rs11844846-<b>A</b>,2 x 10-8,,0.3459,'-,0.012888573 unit decrease,[0.0084-0.0174],LINC02326,Smoking status (ever vs never smokers),smoking behavior,GCST007327,14:29018462
rs117898875-<b>T</b>,2 x 10-8,,0.9616,'-,0.031903576 unit decrease,[0.021-0.043],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:84223836
rs553785-<b>A</b>,2 x 10-8,,0.5048,'-,0.012229195 unit increase,[0.008-0.0165],"UBE2WP1, EEF1A1P11",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:96429769
rs1449435-<b>A</b>,2 x 10-8,,0.4232,'-,0.012346945 unit increase,[0.008-0.0167],NTM,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:132219023
rs10020574-<b>C</b>,2 x 10-8,,0.2601,'-,0.012847368 unit increase,[0.0084-0.0173],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:28061344
rs13160204-<b>A</b>,2 x 10-8,,0.3009,'-,0.012288251 unit increase,[0.008-0.0166],LINC02227,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:158307754
rs74873827-<b>A</b>,2 x 10-8,,0.905,'-,0.020756477 unit increase,[0.014-0.028],LINC01884,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:145545337
rs969650-<b>T</b>,2 x 10-8,,0.6432,'-,0.011741758 unit increase,[0.0076-0.0159],LINC01505,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:106615799
rs16972552-<b>C</b>,2 x 10-8,,0.8838,'-,0.017533675 unit decrease,[0.011-0.024],ZFHX3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:73776555
rs239245-<b>A</b>,2 x 10-8,,0.5332,'-,0.01124458 unit decrease,[0.0073-0.0152],ASCC3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:100642501
rs12053870-<b>T</b>,2 x 10-8,,0.4575,'-,0.011250435 unit decrease,[0.0073-0.0152],RBMS3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:118583668
rs12757183-<b>T</b>,2 x 10-8,,0.8017,'-,0.0140546365 unit increase,[0.0091-0.019],ESRRG,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:216747031
rs56081685-<b>T</b>,2 x 10-8,,0.6856,'-,0.013031693 unit increase,[0.0085-0.0176],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,13:58880006
rs7889-<b>C</b>,3 x 10-8,,0.3609,'-,0.012577614 unit increase,[0.0082-0.017],PRRC2A,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:31637671
rs7645872-<b>T</b>,3 x 10-8,,0.4827,'-,0.012088328 unit increase,[0.0078-0.0163],RARB,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:25168310
rs2652434-<b>T</b>,3 x 10-8,,0.4665,'-,0.011200736 unit decrease,[0.0073-0.0151],"KCNJ3, CBX3P6",Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:154886382
rs10751226-<b>T</b>,3 x 10-8,,0.826,'-,0.014731288 unit decrease,[0.0095-0.0199],"PLEKHB1, FAM168A",Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:73601207
rs905871-<b>A</b>,3 x 10-8,,0.658,'-,0.011745263 unit increase,[0.0076-0.0159],OR51D1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:4640055
rs1271272-<b>A</b>,3 x 10-8,,0.3147,'-,0.011995592 unit decrease,[0.0078-0.0162],KLF7,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:207090753
rs55646170-<b>T</b>,3 x 10-8,,0.9199,'-,0.02214514 unit decrease,[0.014-0.03],PLPPR5,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:98990375
rs2358443-<b>T</b>,3 x 10-8,,0.4251,'-,0.011234026 unit decrease,[0.0073-0.0152],"RPSAP24, OLA1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:174065288
rs3026629-<b>A</b>,3 x 10-8,,0.3482,'-,0.011653287 unit decrease,[0.0075-0.0158],MICALL1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,22:37933278
rs6058078-<b>C</b>,3 x 10-8,,0.4853,'-,0.011995146 unit decrease,[0.0077-0.0162],MAP1LC3A,Smoking status (ever vs never smokers),smoking behavior,GCST007327,20:34555019
rs4837631-<b>T</b>,7 x 10-9,,0.4517,'-,0.012634879 unit decrease,[0.0084-0.0169],BRINP1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:119299670
rs6720647-<b>A</b>,7 x 10-9,,0.7601,'-,0.013628829 unit decrease,[0.009-0.0182],THSD7B,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:136858118
rs6474609-<b>A</b>,7 x 10-9,,0.588,'-,0.01275978 unit decrease,[0.0084-0.0171],AKAP8P1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:10981069
rs11876432-<b>C</b>,7 x 10-9,,0.7514,'-,0.013449244 unit increase,[0.0089-0.018],SETBP1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:45089460
rs962472-<b>T</b>,8 x 10-9,,0.4923,'-,0.011598815 unit decrease,[0.0077-0.0155],PCDH15,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:54940837
rs78175438-<b>T</b>,8 x 10-9,,0.8713,'-,0.018702744 unit decrease,[0.012-0.025],BRWD1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,21:39291329
rs2236941-<b>T</b>,8 x 10-9,,0.3344,'-,0.0122805 unit increase,[0.0081-0.0165],SLC38A3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:50210391
rs55921136-<b>T</b>,8 x 10-9,,0.7966,'-,0.015542869 unit increase,[0.01-0.021],"SYT14, SERTAD4-AS1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:210185988
rs7124348-<b>A</b>,9 x 10-9,,0.7656,'-,0.013640967 unit decrease,[0.009-0.0183],OPCML,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:132515544
rs288175-<b>A</b>,1 x 10-8,,0.3298,'-,0.012248558 unit decrease,[0.0081-0.0164],FBXL17,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:108016378
rs4479577-<b>T</b>,1 x 10-8,,0.4813,'-,0.012443462 unit increase,[0.0082-0.0167],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:5682131
rs1174864-<b>A</b>,1 x 10-8,,0.5491,'-,0.011566963 unit increase,[0.0076-0.0155],POM121L12,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:53059866
rs12662631-<b>T</b>,1 x 10-8,,0.3185,'-,0.012332154 unit increase,[0.0081-0.0166],COPS5P1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:93132728
rs9395644-<b>A</b>,1 x 10-8,,0.8976,'-,0.020468287 unit increase,[0.013-0.027],FTH1P5,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:50955924
rs6061162-<b>T</b>,1 x 10-8,,0.9067,'-,0.019747043 unit increase,[0.013-0.027],DEFB116,Smoking status (ever vs never smokers),smoking behavior,GCST007327,20:31305698
rs9571576-<b>T</b>,1 x 10-8,,0.5056,'-,0.011463561 unit decrease,[0.0075-0.0154],PCDH9,Smoking status (ever vs never smokers),smoking behavior,GCST007327,13:66362001
rs2222016-<b>C</b>,1 x 10-8,,0.7316,'-,0.01291364 unit increase,[0.0085-0.0174],"RN7SKP141, UBBP1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:136385737
rs11779675-<b>A</b>,1 x 10-8,,0.3663,'-,0.012821359 unit decrease,[0.0084-0.0172],XKR6,Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:10980951
rs7130826-<b>T</b>,1 x 10-8,,0.7258,'-,0.01281377 unit increase,[0.0084-0.0172],OR7E14P,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:17016246
rs525444-<b>T</b>,1 x 10-8,,0.79,'-,0.015147359 unit increase,[0.0099-0.0204],LINC01234,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:113673156
rs745570-<b>A</b>,1 x 10-8,,0.4869,'-,0.011424577 unit increase,[0.0075-0.0154],"LINC01977, CBX8",Smoking status (ever vs never smokers),smoking behavior,GCST007327,17:79807926
rs10160101-<b>C</b>,1 x 10-8,,0.4018,'-,0.011641357 unit decrease,[0.0076-0.0157],BEND7,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:13507462
rs8047834-<b>A</b>,1 x 10-8,,0.7022,'-,0.012460934 unit increase,[0.0082-0.0168],"ZKSCAN2-DT, LINC02191",Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:25360395
rs2185913-<b>T</b>,1 x 10-8,,0.6993,'-,0.012406672 unit increase,[0.0081-0.0167],NRAP,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:113650475
rs2783130-<b>A</b>,1 x 10-8,,0.5229,'-,0.011386399 unit increase,[0.0074-0.0153],LINC01068,Smoking status (ever vs never smokers),smoking behavior,GCST007327,13:79596025
rs7160389-<b>T</b>,4 x 10-9,,0.5355,'-,0.011882559 unit decrease,[0.0079-0.0158],LINC02295,Smoking status (ever vs never smokers),smoking behavior,GCST007327,14:98184651
rs772921-<b>T</b>,4 x 10-9,,0.3415,'-,0.012490748 unit decrease,[0.0083-0.0166],IKZF4,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:56009793
rs13234909-<b>A</b>,4 x 10-9,,0.3966,'-,0.01210418 unit increase,[0.0081-0.0161],MAD1L1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:1827295
rs78058594-<b>A</b>,4 x 10-9,,0.9439,'-,0.027763488 unit increase,[0.019-0.037],"OPCML, NTM",Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:132410392
rs17348216-<b>T</b>,4 x 10-9,,0.1727,'-,0.015646625 unit decrease,[0.01-0.021],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:104588673
rs4354968-<b>A</b>,4 x 10-9,,0.5379,'-,0.01184849 unit increase,[0.0079-0.0158],CNTNAP4,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:76434236
rs10030552-<b>A</b>,4 x 10-9,,0.2604,'-,0.014528261 unit increase,[0.0097-0.0194],MAML3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:140051110
rs12825376-<b>T</b>,4 x 10-9,,0.116,'-,0.018421942 unit increase,[0.012-0.025],"SPPL3, ACADS",Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:120742136
rs6598539-<b>T</b>,4 x 10-9,,0.4883,'-,0.012742009 unit decrease,[0.0085-0.017],IGF1R,Smoking status (ever vs never smokers),smoking behavior,GCST007327,15:98661254
rs7115027-<b>T</b>,4 x 10-9,,0.8482,'-,0.016431743 unit decrease,[0.011-0.022],NCAM1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:112896664
rs11166986-<b>A</b>,4 x 10-9,,0.4904,'-,0.011794478 unit increase,[0.0079-0.0157],"PTK2, ERICD",Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:140646056
rs1981919-<b>A</b>,4 x 10-9,,0.1054,'-,0.019198174 unit increase,[0.013-0.026],SEMA6D,Smoking status (ever vs never smokers),smoking behavior,GCST007327,15:47463885
rs71367545-<b>A</b>,4 x 10-9,,0.2107,'-,0.015605067 unit increase,[0.01-0.021],"KCNG2, CTDP1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:79816337
rs11771982-<b>T</b>,5 x 10-9,,0.1541,'-,0.01631134 unit decrease,[0.011-0.022],PLXNA4,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:132617489
rs3800227-<b>A</b>,5 x 10-9,,0.2588,'-,0.013393484 unit decrease,[0.0089-0.0179],FOXO3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:108672958
rs6452791-<b>A</b>,5 x 10-9,,0.5434,'-,0.011770435 unit increase,[0.0078-0.0157],"LINC00461, TMEM161B-AS1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:88475276
rs56133711-<b>A</b>,5 x 10-9,,0.2619,'-,0.014390273 unit increase,[0.0096-0.0192],BDNF,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:27701787
rs72733235-<b>T</b>,5 x 10-9,,0.8378,'-,0.01716322 unit decrease,[0.011-0.023],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:38275775
rs1164598-<b>A</b>,6 x 10-9,,0.6207,'-,0.012046104 unit decrease,[0.008-0.0161],HS6ST3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,13:96449317
rs144528474-<b>A</b>,6 x 10-9,,0.9976,'-,0.12901536 unit increase,[0.086-0.172],WDPCP,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:63650871
rs11066971-<b>T</b>,6 x 10-9,,0.1454,'-,0.016561227 unit decrease,[0.011-0.022],"LINC02459, GLULP5",Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:114165055
rs11808210-<b>A</b>,6 x 10-9,,0.0777,'-,0.02180018 unit increase,[0.014-0.029],"CDC42BPA, LINC01641",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:227327348
rs3851186-<b>T</b>,7 x 10-9,,0.2116,'-,0.015413395 unit decrease,[0.01-0.021],"EED, Metazoa_SRP",Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:86220283
rs35891966-<b>A</b>,7 x 10-9,,0.0722,'-,0.024323925 unit decrease,[0.016-0.033],NAV2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:20107765
rs12930834-<b>A</b>,7 x 10-9,,0.7634,'-,0.013715122 unit increase,[0.0091-0.0183],ZFHX3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:72917728
rs4790870-<b>A</b>,3 x 10-10,,0.6102,'-,0.012981379 unit increase,[0.0089-0.017],SMG6,Smoking status (ever vs never smokers),smoking behavior,GCST007327,17:2066907
rs1373129-<b>A</b>,3 x 10-10,,0.4715,'-,0.012676746 unit decrease,[0.0087-0.0166],"NAMA, STX17-AS1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:99391416
rs7679162-<b>T</b>,3 x 10-10,,0.6599,'-,0.014406358 unit increase,[0.0099-0.0189],LINC02497,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:31181708
rs11134672-<b>A</b>,3 x 10-10,,0.6874,'-,0.013623063 unit increase,[0.0094-0.0179],RANBP17,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:170968816
rs2240294-<b>A</b>,3 x 10-10,,0.4478,'-,0.012697397 unit decrease,[0.0087-0.0167],DLX6-AS1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:96994945
rs883403-<b>T</b>,3 x 10-10,,0.8426,'-,0.017332198 unit increase,[0.012-0.023],"PTCD1, ATP5MF-PTCD1, ATP5MF, CPSF4",Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:99450355
rs2585817-<b>A</b>,5 x 10-13,,0.6181,'-,0.014932894 unit increase,[0.011-0.019],"LINC02758, METTL15",Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:28580674
rs4984916-<b>A</b>,7 x 10-13,,0.221,'-,0.017400982 unit decrease,[0.013-0.022],FBXL16,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:699057
rs10914684-<b>A</b>,1 x 10-12,,0.3282,'-,0.015183688 unit decrease,[0.011-0.019],PHC2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:33329971
rs3099769-<b>A</b>,2 x 10-12,,0.4091,'-,0.014361975 unit increase,[0.01-0.018],NTM,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:132318528
rs2419903-<b>T</b>,2 x 10-12,,0.4161,'-,0.014321689 unit decrease,[0.01-0.018],MIR4432HG,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:60300917
rs6119897-<b>A</b>,3 x 10-12,,0.2426,'-,0.016386494 unit increase,[0.012-0.021],NOL4L,Smoking status (ever vs never smokers),smoking behavior,GCST007327,20:32557613
rs74697736-<b>A</b>,3 x 10-12,,0.2881,'-,0.016718179 unit increase,[0.012-0.021],"TEX41, LINC01412",Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:144654704
rs7585579-<b>C</b>,3 x 10-12,,0.5061,'-,0.013979038 unit decrease,[0.01-0.018],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:59797722
rs1919621-<b>A</b>,4 x 10-12,,0.5283,'-,0.013966235 unit increase,[0.01-0.018],LINC01811,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:34380253
rs12030183-<b>T</b>,4 x 10-12,,0.6789,'-,0.0149065815 unit increase,[0.011-0.019],"SCMH1, FOXO6",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:41295548
rs6965740-<b>T</b>,5 x 10-12,,0.4535,'-,0.013907693 unit decrease,[0.01-0.0179],CTTNBP2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:117874786
rs4650277-<b>A</b>,6 x 10-12,,0.4344,'-,0.01508202 unit increase,[0.011-0.019],"TNNI3K, FPGT-TNNI3K",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:74528037
rs1469908-<b>T</b>,6 x 10-12,,0.5881,'-,0.014059351 unit decrease,[0.01-0.018],NQO1-DT,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:69730509
rs6852117-<b>C</b>,6 x 10-12,,0.5802,'-,0.0140188895 unit increase,[0.01-0.018],GALNTL6,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:172155737
rs12764388-<b>A</b>,6 x 10-12,,0.1134,'-,0.02181676 unit increase,[0.016-0.028],TRIM8,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:102653628
rs2697329-<b>A</b>,9 x 10-12,,0.71,'-,0.015110146 unit decrease,[0.011-0.019],TEX41,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:145134860
rs10994943-<b>T</b>,1 x 10-11,,0.581,'-,0.014953904 unit increase,[0.011-0.019],"ARID5B, LINC02625",Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:61831655
rs9423279-<b>C</b>,1 x 10-11,,0.3433,'-,0.015488954 unit increase,[0.011-0.02],CPXM2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:123920903
rs7754741-<b>T</b>,1 x 10-11,,0.7284,'-,0.015288658 unit decrease,[0.011-0.02],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:98301453
rs2340403-<b>T</b>,2 x 10-11,,0.6263,'-,0.0140000945 unit decrease,[0.0099-0.0181],LINC01360,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:73370094
rs597808-<b>A</b>,2 x 10-11,,0.4837,'-,0.014555817 unit increase,[0.01-0.019],ATXN2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:111535554
rs17151637-<b>T</b>,2 x 10-11,,0.2839,'-,0.014881184 unit decrease,[0.011-0.019],MSRA,Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:10295572
rs42417-<b>T</b>,3 x 10-11,,0.6902,'-,0.015655603 unit increase,[0.011-0.02],MCTP1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:94862585
rs1221976-<b>A</b>,3 x 10-11,,0.663,'-,0.014177998 unit decrease,[0.01-0.018],DCC,Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:52469766
rs77878475-<b>A</b>,3 x 10-11,,0.0856,'-,0.025840854 unit decrease,[0.018-0.033],"RPL7P47, GAN",Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:17964691
rs71471272-<b>A</b>,5 x 10-8,,0.0746,'-,0.022515325 unit increase,[0.014-0.031],NT5C2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:103245744
rs12895462-<b>T</b>,5 x 10-8,,0.8044,'-,0.013805939 unit increase,[0.0088-0.0188],TMEM63C,Smoking status (ever vs never smokers),smoking behavior,GCST007327,14:77149098
rs7575189-<b>A</b>,5 x 10-8,,0.5873,'-,0.011123441 unit decrease,[0.0071-0.0151],MAP3K20,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:173150440
rs7938812-<b>T</b>,7 x 10-48,,0.6095,'-,0.029930087 unit decrease,[0.026-0.034],NCAM1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:113040282
rs961414-<b>T</b>,7 x 10-28,,0.5328,'-,0.022034988 unit decrease,[0.018-0.026],RPL6P5,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:145356165
rs240955-<b>A</b>,4 x 10-23,,0.813,'-,0.025524102 unit decrease,[0.02-0.031],"REV3L, MFSD4B",Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:111339440
rs7092200-<b>T</b>,4 x 10-22,,0.5847,'-,0.019713078 unit decrease,[0.016-0.024],CNNM2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:103085115
rs11783093-<b>T</b>,7 x 10-22,,0.1663,'-,0.025915962 unit decrease,[0.021-0.031],GULOP,Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:27567832
rs1368550-<b>T</b>,1 x 10-21,,0.5189,'-,0.019237012 unit increase,[0.015-0.023],CRLF3P1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:103462197
rs34495106-<b>A</b>,2 x 10-20,,0.3722,'-,0.020761883 unit increase,[0.016-0.025],CADM2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:85601986
rs3911063-<b>T</b>,5 x 10-19,,0.6738,'-,0.019096201 unit increase,[0.015-0.023],CADM2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:85857778
rs7921378-<b>C</b>,3 x 10-18,,0.4809,'-,0.017524462 unit decrease,[0.014-0.021],ARID5B,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:61915126
rs6265-<b>T</b>,4 x 10-18,,0.1917,'-,0.02215149 unit decrease,[0.017-0.027],"BDNF-AS, BDNF",Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:27658369
rs1909590-<b>A</b>,4 x 10-16,,0.1481,'-,0.024852458 unit decrease,[0.019-0.031],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:118096996
rs1004787-<b>A</b>,4 x 10-16,,0.5303,'-,0.017661564 unit increase,[0.013-0.022],LINC01833,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:44931952
rs4664442-<b>A</b>,2 x 10-15,,0.4626,'-,0.015963325 unit increase,[0.012-0.02],SLC4A10,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:161971491
rs1435741-<b>A</b>,6 x 10-15,,0.432,'-,0.015804287 unit increase,[0.012-0.02],SEMA6D,Smoking status (ever vs never smokers),smoking behavior,GCST007327,15:47643646
rs13237637-<b>C</b>,6 x 10-14,,0.4965,'-,0.016295116 unit decrease,[0.012-0.021],SDK1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:3463575
rs4869058-<b>A</b>,8 x 10-14,,0.641,'-,0.01564975 unit decrease,[0.012-0.02],TENM2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:167565242
rs17417989-<b>T</b>,1 x 10-13,,0.2997,'-,0.017587531 unit increase,[0.013-0.022],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:112843134
rs7668995-<b>A</b>,1 x 10-13,,0.2924,'-,0.016343247 unit decrease,[0.012-0.021],TTC29,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:146998126
rs2310752-<b>A</b>,2 x 10-13,,0.4303,'-,0.014862391 unit decrease,[0.011-0.019],PDE4B,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:65926722
rs13258512-<b>A</b>,3 x 10-13,,0.5761,'-,0.014874498 unit increase,[0.011-0.019],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:91765205
rs11210892-<b>A</b>,4 x 10-13,,0.6733,'-,0.0155720515 unit decrease,[0.011-0.02],"PTPRF, KDM4A",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:43634413
rs13396935-<b>A</b>,4 x 10-13,,0.1773,'-,0.019117456 unit decrease,[0.014-0.024],TMEM18,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:653195
rs72678864-<b>A</b>,3 x 10-10,,0.1726,'-,0.018037062 unit decrease,[0.012-0.024],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:111500989
rs568599-<b>C</b>,3 x 10-10,,0.5401,'-,0.012652696 unit increase,[0.0087-0.0166],SORL1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:121665302
rs1267068-<b>T</b>,4 x 10-10,,0.6973,'-,0.013688575 unit increase,[0.0094-0.018],"TANK, TANK-AS1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:161155624
rs4949465-<b>T</b>,4 x 10-10,,0.8647,'-,0.01833924 unit decrease,[0.013-0.024],"ADGRB2, COL16A1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:31712888
rs28647734-<b>A</b>,4 x 10-10,,0.2109,'-,0.016591573 unit increase,[0.011-0.022],OLFM1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:135085187
rs1108879-<b>A</b>,5 x 10-10,,0.5549,'-,0.012595687 unit decrease,[0.0086-0.0166],SDK1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:3516500
rs17049905-<b>A</b>,5 x 10-10,,0.8948,'-,0.020396128 unit decrease,[0.014-0.027],LINC01122,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:59074437
rs12600773-<b>T</b>,6 x 10-10,,0.3539,'-,0.013006827 unit increase,[0.0089-0.0171],CA10,Smoking status (ever vs never smokers),smoking behavior,GCST007327,17:52258612
rs4814884-<b>T</b>,6 x 10-10,,0.5391,'-,0.012475368 unit increase,[0.0085-0.0164],SLC24A3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,20:19682649
rs10952199-<b>T</b>,6 x 10-10,,0.4283,'-,0.013566539 unit decrease,[0.0093-0.0179],"TFAMP1, ELFN1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:1625703
rs1931386-<b>C</b>,6 x 10-10,,0.4947,'-,0.012429827 unit increase,[0.0085-0.0164],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:11177422
rs13187930-<b>T</b>,6 x 10-10,,0.2597,'-,0.014171004 unit increase,[0.0097-0.0187],NDUFAF2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:61088344
rs4856463-<b>T</b>,7 x 10-10,,0.2175,'-,0.016243614 unit decrease,[0.011-0.021],PIGX,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:83589417
rs479971-<b>A</b>,7 x 10-10,,0.2741,'-,0.015013441 unit increase,[0.01-0.02],"CPSF6, C1GALT1P1",Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:69278691
rs9864951-<b>A</b>,7 x 10-10,,0.6467,'-,0.013980875 unit increase,[0.0095-0.0184],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:118221997
rs6714110-<b>A</b>,8 x 10-10,,0.0334,'-,0.034408204 unit increase,[0.023-0.045],TEX41,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:145060608
rs1891196-<b>A</b>,9 x 10-10,,0.5651,'-,0.012412241 unit decrease,[0.0084-0.0164],LINC01735,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:208545327
rs1109480-<b>A</b>,9 x 10-10,,0.3888,'-,0.0136243375 unit decrease,[0.0093-0.018],CABP1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:120645476
rs1136998-<b>A</b>,1 x 10-9,,0.1051,'-,0.020011662 unit decrease,[0.014-0.026],LRPPRC,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:43888044
rs4748779-<b>T</b>,1 x 10-9,,0.7244,'-,0.013735452 unit decrease,[0.0093-0.0181],DNAJC1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:21999203
rs13065007-<b>A</b>,1 x 10-9,,0.2649,'-,0.013855419 unit increase,[0.0094-0.0183],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:117803865
rs12211126-<b>T</b>,1 x 10-9,,0.5928,'-,0.012434233 unit decrease,[0.0084-0.0164],MUC22,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:66839558
rs1628768-<b>T</b>,1 x 10-9,,0.7651,'-,0.015497518 unit increase,[0.01-0.021],NT5C2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:103253237
rs12690535-<b>A</b>,1 x 10-9,,0.8108,'-,0.015510468 unit increase,[0.01-0.021],NYAP2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:225394657
rs13357015-<b>A</b>,2 x 10-9,,0.6361,'-,0.013587899 unit increase,[0.0092-0.018],RASGRF2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:80967584
rs35761479-<b>A</b>,3 x 10-11,,0.1212,'-,0.022095622 unit decrease,[0.016-0.029],TPM3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:154181718
rs1246265-<b>T</b>,3 x 10-11,,0.3046,'-,0.015632885 unit decrease,[0.011-0.02],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:84146830
rs4737525-<b>A</b>,4 x 10-11,,0.5113,'-,0.01328229 unit decrease,[0.0093-0.0172],TOX,Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:58887222
rs12042107-<b>T</b>,5 x 10-11,,0.4511,'-,0.01429985 unit increase,[0.01-0.019],"LINC02609, BARHL2",Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:90730619
rs2202237-<b>T</b>,6 x 10-11,,0.5314,'-,0.013188412 unit decrease,[0.0092-0.0171],CA10,Smoking status (ever vs never smokers),smoking behavior,GCST007327,17:52131424
rs76608582-<b>A</b>,6 x 10-11,,0.0475,'-,0.033407107 unit decrease,[0.023-0.043],HDGFL2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,19:4474728
rs1492546-<b>C</b>,9 x 10-11,,0.4489,'-,0.014153526 unit decrease,[0.0099-0.0184],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:80786611
rs12022778-<b>A</b>,1 x 10-10,,0.7884,'-,0.015913688 unit decrease,[0.011-0.021],ELAVL4,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:50138323
rs26251-<b>T</b>,1 x 10-10,,0.6294,'-,0.013416571 unit increase,[0.0093-0.0175],EFNA5,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:107501749
rs5003492-<b>A</b>,1 x 10-10,,0.4252,'-,0.01309682 unit increase,[0.0091-0.0171],RUNX1T1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,8:92183301
rs17669415-<b>C</b>,1 x 10-10,,0.6842,'-,0.01391182 unit increase,[0.0097-0.0181],DCC,Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:52358627
rs17733784-<b>T</b>,2 x 10-10,,0.6204,'-,0.013207491 unit increase,[0.0092-0.0173],LINC01905,Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:56052694
rs11255908-<b>T</b>,2 x 10-10,,0.7437,'-,0.01461856 unit decrease,[0.01-0.019],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:8760949
rs1430065-<b>T</b>,2 x 10-10,,0.2703,'-,0.01433919 unit increase,[0.0099-0.0188],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:103240616
rs4543592-<b>T</b>,3 x 10-10,,0.5205,'-,0.012717051 unit decrease,[0.0088-0.0167],CARM1P1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:3014254
rs7870475-<b>T</b>,3 x 10-10,,0.5251,'-,0.012688204 unit decrease,[0.0087-0.0166],"GAPVD1, Metazoa_SRP",Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:125371755
rs3818987-<b>T</b>,3 x 10-10,,0.4734,'-,0.013703931 unit decrease,[0.0094-0.018],LINC02520,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:37516830
rs3783177-<b>T</b>,2 x 10-9,,0.7579,'-,0.014104667 unit increase,[0.0095-0.0187],PCCA,Smoking status (ever vs never smokers),smoking behavior,GCST007327,13:100499106
rs11872397-<b>A</b>,2 x 10-9,,0.2599,'-,0.014873725 unit decrease,[0.01-0.02],ZNF407,Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:74823326
rs2324999-<b>T</b>,2 x 10-9,,0.2001,'-,0.0150866 unit increase,[0.01-0.02],CADM2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:86109735
rs12787182-<b>A</b>,2 x 10-9,,0.7094,'-,0.01328244 unit increase,[0.0089-0.0176],OR5A2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:59423338
rs10970595-<b>T</b>,2 x 10-9,,0.1165,'-,0.018772665 unit decrease,[0.013-0.025],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:31910766
rs17373738-<b>C</b>,2 x 10-9,,0.6177,'-,0.012387507 unit increase,[0.0083-0.0164],MAML3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:140014110
rs12535004-<b>T</b>,2 x 10-9,,0.7515,'-,0.015032493 unit decrease,[0.01-0.02],LINC01392,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:115307058
rs10780649-<b>T</b>,2 x 10-9,,0.4785,'-,0.013004407 unit decrease,[0.0087-0.0173],RMI1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,9:84088646
rs1825734-<b>T</b>,2 x 10-9,,0.8385,'-,0.016311856 unit increase,[0.011-0.022],CA10,Smoking status (ever vs never smokers),smoking behavior,GCST007327,17:52255197
rs1863161-<b>A</b>,2 x 10-9,,0.5585,'-,0.012076135 unit increase,[0.0081-0.016],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:59912389
rs1775370-<b>T</b>,2 x 10-9,,0.2479,'-,0.013873694 unit decrease,[0.0093-0.0184],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:72527173
rs10928235-<b>A</b>,3 x 10-9,,0.7482,'-,0.01378778 unit increase,[0.0093-0.0183],TEX41,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:144920547
rs2866724-<b>A</b>,3 x 10-9,,0.7316,'-,0.013502994 unit decrease,[0.0091-0.0179],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,16:13666295
rs2291256-<b>T</b>,3 x 10-9,,0.0914,'-,0.02076341 unit increase,[0.014-0.028],GOLGA3,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:132816737
rs2734971-<b>A</b>,3 x 10-9,,0.4653,'-,0.012956356 unit increase,[0.0087-0.0172],"HLA-G, HCP5B",Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:29866672
rs61902492-<b>A</b>,3 x 10-9,,0.7758,'-,0.015495721 unit decrease,[0.01-0.021],NCAM1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:113121199
rs1486900-<b>T</b>,3 x 10-9,,0.1747,'-,0.015755525 unit increase,[0.011-0.021],SEMA6D,Smoking status (ever vs never smokers),smoking behavior,GCST007327,15:47350689
rs176644-<b>T</b>,3 x 10-9,,0.4075,'-,0.012165012 unit decrease,[0.0082-0.0162],MIR9-3HG,Smoking status (ever vs never smokers),smoking behavior,GCST007327,15:89370401
rs4947121-<b>T</b>,3 x 10-9,,0.2276,'-,0.0142397415 unit decrease,[0.0095-0.0189],TRAF3IP2-AS1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:111513751
rs2939756-<b>A</b>,3 x 10-9,,0.4805,'-,0.011942013 unit decrease,[0.008-0.0159],LRRC4C,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:41414747
rs6432686-<b>T</b>,3 x 10-9,,0.7115,'-,0.013149164 unit increase,[0.0088-0.0175],SLC4A10,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:161468689
rs16951001-<b>T</b>,3 x 10-9,,0.4181,'-,0.012067796 unit increase,[0.0081-0.0161],MAP2K5,Smoking status (ever vs never smokers),smoking behavior,GCST007327,15:67561903
rs11165528-<b>T</b>,3 x 10-9,,0.4815,'-,0.012844953 unit decrease,[0.0086-0.0171],LINC02790,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:95967238
rs7333559-<b>A</b>,3 x 10-9,,0.7902,'-,0.015744165 unit decrease,[0.011-0.021],CLYBL,Smoking status (ever vs never smokers),smoking behavior,GCST007327,13:99894196
rs4680392-<b>T</b>,4 x 10-9,,0.328,'-,0.013638121 unit decrease,[0.0091-0.0182],SLC66A1L,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:157686540
rs10252114-<b>T</b>,3 x 10-8,,0.6182,'-,0.01233972 unit decrease,[0.008-0.0167],"FEZF1, CADPS2",Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:122315414
rs1150668-<b>T</b>,3 x 10-8,,0.5672,'-,0.011196799 unit increase,[0.0072-0.0152],ZNF192P1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:28162011
rs3980078-<b>A</b>,3 x 10-8,,0.1786,'-,0.015629334 unit decrease,[0.01-0.021],POLR1B,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:112570466
rs6971782-<b>T</b>,3 x 10-8,,0.3198,'-,0.011877323 unit decrease,[0.0077-0.0161],GALNT17,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:71061905
rs28459916-<b>A</b>,4 x 10-8,,0.1384,'-,0.01731356 unit decrease,[0.011-0.023],"LINC00989, GK2",Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:79409589
rs12476173-<b>A</b>,4 x 10-8,,0.6383,'-,0.0115080355 unit increase,[0.0074-0.0156],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:117490138
rs7295765-<b>A</b>,4 x 10-8,,0.7971,'-,0.014850353 unit decrease,[0.0096-0.0201],MGAT4C,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:86065262
rs4312833-<b>A</b>,4 x 10-8,,0.0889,'-,0.019415041 unit decrease,[0.012-0.026],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:51686320
rs143427404-<b>A</b>,4 x 10-8,,0.0111,'-,0.056930363 unit increase,[0.037-0.077],ITIH4,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:52826860
rs301805-<b>T</b>,4 x 10-8,,0.4227,'-,0.011173298 unit decrease,[0.0072-0.0152],RERE,Smoking status (ever vs never smokers),smoking behavior,GCST007327,1:8420956
rs12456711-<b>A</b>,4 x 10-8,,0.7351,'-,0.013501848 unit decrease,[0.0087-0.0183],"COLEC12, THOC1-DT",Smoking status (ever vs never smokers),smoking behavior,GCST007327,18:280897
rs2633725-<b>T</b>,4 x 10-8,,0.1529,'-,0.015322577 unit increase,[0.0099-0.0208],CACNA1D,Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:53717715
rs1944688-<b>A</b>,4 x 10-8,,0.779,'-,0.013280717 unit increase,[0.0085-0.018],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:121764755
rs12997449-<b>A</b>,4 x 10-8,,0.8741,'-,0.017940694 unit decrease,[0.012-0.024],"RNU5E-9P, OSBPL6",Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:178174845
rs9388686-<b>A</b>,4 x 10-8,,0.1773,'-,0.01442028 unit decrease,[0.0093-0.0196],LAMA2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,6:129104419
rs7901883-<b>A</b>,4 x 10-8,,0.2305,'-,0.013077027 unit decrease,[0.0084-0.0178],BTRC,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:101427081
rs1022261-<b>A</b>,4 x 10-8,,0.5056,'-,0.011013538 unit decrease,[0.0071-0.015],SEC63P2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,4:35474678
rs58695218-<b>A</b>,4 x 10-8,,0.8097,'-,0.015145234 unit increase,[0.0097-0.0206],POU6F2,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:39392731
rs12517438-<b>T</b>,4 x 10-8,,0.4591,'-,0.011043831 unit decrease,[0.0071-0.015],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,5:30841947
rs6438208-<b>A</b>,4 x 10-8,,0.2538,'-,0.012643845 unit decrease,[0.0081-0.0172],"ZBTB20, ZBTB20-AS5",Smoking status (ever vs never smokers),smoking behavior,GCST007327,3:114451425
rs550677-<b>A</b>,4 x 10-8,,0.4281,'-,0.011120387 unit increase,[0.0071-0.0151],TMEM132B,Smoking status (ever vs never smokers),smoking behavior,GCST007327,12:125326510
rs146127221-<b>T</b>,4 x 10-8,,0.0202,'-,0.042212132 unit increase,[0.027-0.057],GRID1,Smoking status (ever vs never smokers),smoking behavior,GCST007327,10:85705377
rs138045331-<b>A</b>,4 x 10-8,,0.9937,'-,0.07505571 unit decrease,[0.048-0.102],'-,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:122082314
rs10279261-<b>A</b>,5 x 10-8,,0.6167,'-,0.01130086 unit decrease,[0.0073-0.0154],EXOC4,Smoking status (ever vs never smokers),smoking behavior,GCST007327,7:133905093
rs550612-<b>A</b>,5 x 10-8,,0.7274,'-,0.012331902 unit increase,[0.0079-0.0168],THSD7B,Smoking status (ever vs never smokers),smoking behavior,GCST007327,2:136893930
rs1051730-<b>A</b>,2 x 10-69,,0.34,'-,0.8 CPD increase,[0.70-0.90],'-,Smoking behavior,smoking behavior,GCST000667,Mapping not available
rs4105144-<b>C</b>,2 x 10-12,,0.7,'-,0.39 CPD increase,[0.27-0.51],"CYP2A7, CYP2A6",Smoking behavior,smoking behavior,GCST000667,19:40852719
rs215614-<b>G</b>,2 x 10-7,,0.36,'-,0.22 CPD increase,[0.14-0.30],PDE1C,Smoking behavior,smoking behavior,GCST000667,7:32307723
rs6474412-<b>T</b>,1 x 10-8,,0.78,'-,0.29 CPD increase,[0.19-0.39],CHRNB3,Smoking behavior,smoking behavior,GCST000667,8:42695355
rs7260329-<b>G</b>,6 x 10-6,,0.69,'-,0.2 CPD increase,[0.12-0.28],CYP2B6,Smoking behavior,smoking behavior,GCST000667,19:41015733
rs1051730-<b>G</b>,3 x 10-73,(CPD),0.65,'-,1.02 CPD decrease,[0.91-1.13],'-,Smoking behavior,smoking behavior,GCST000666,Mapping not available
rs6265-<b>C</b>,2 x 10-8,(smoking initiation),0.79,1.06,'-,[1.04-1.08],"BDNF-AS, BDNF",Smoking behavior,smoking behavior,GCST000666,11:27658369
rs3025343-<b>G</b>,4 x 10-8,(smoking cessation),0.84,1.12,'-,[1.08-1.18],"DBH, FAM163B",Smoking behavior,smoking behavior,GCST000666,9:133613233
rs1329650-<b>T</b>,6 x 10-10,(CPD),0.28,'-,0.37 CPD decrease,[0.25-0.49],"PPP1R3C, RPS27P1",Smoking behavior,smoking behavior,GCST000666,10:91588363
rs3733829-<b>G</b>,1 x 10-8,(CPD),0.36,'-,0.33 CPD increase,[0.22-0.44],"RAB4B-EGLN2, EGLN2",Smoking behavior,smoking behavior,GCST000666,19:40804666
rs1051730-<b>G</b>,2 x 10-66,,0.66,'-,0.08 unit decrease,[0.07-0.09],'-,Smoking behavior,smoking behavior,GCST000668,Mapping not available
rs822531-<b>T</b>,2 x 10-6,,0.7837,'-,'-,'-,"RN7SL569P, RNY4",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:148932667
rs4868125-<b>C</b>,6 x 10-7,,0.3979,'-,'-,'-,"SMIM23, FBXW11",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:171854871
rs10041657-<b>A</b>,1 x 10-8,,0.2268,'-,'-,'-,FER,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:108816727
rs10041657-<b>A</b>,3 x 10-6,(men),0.2268,'-,'-,'-,FER,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:108816727
rs6556301-<b>T</b>,8 x 10-14,,0.3605,'-,'-,'-,"FGFR4, NSD1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:177100576
rs6556301-<b>T</b>,3 x 10-9,(men),0.3605,'-,'-,'-,"FGFR4, NSD1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:177100576
rs6556301-<b>T</b>,2 x 10-6,(women),0.3605,'-,'-,'-,"FGFR4, NSD1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:177100576
rs12207675-<b>T</b>,2 x 10-10,,0.8857,'-,'-,'-,"RPL26P20, H3P27",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:75528025
rs12207675-<b>T</b>,5 x 10-7,(women),0.8857,'-,'-,'-,"RPL26P20, H3P27",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:75528025
rs12207675-<b>T</b>,7 x 10-6,(men),0.8857,'-,'-,'-,"RPL26P20, H3P27",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:75528025
rs12493901-<b>A</b>,6 x 10-13,,0.4712,'-,'-,'-,FNDC3B,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:172204265
rs12493901-<b>A</b>,6 x 10-9,(men),0.4712,'-,'-,'-,FNDC3B,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:172204265
rs798502-<b>A</b>,1 x 10-6,(men),0.7108,'-,'-,'-,"AMZ1, GNA12",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:2750246
rs798502-<b>A</b>,6 x 10-6,,0.7108,'-,'-,'-,"AMZ1, GNA12",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:2750246
rs6570507-<b>A</b>,2 x 10-11,,0.3186,'-,'-,'-,ADGRG6,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:142358435
rs6570507-<b>A</b>,2 x 10-8,(men),0.3186,'-,'-,'-,ADGRG6,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:142358435
rs10195252-<b>T</b>,1 x 10-13,(women),0.5727,'-,'-,'-,COBLL1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:164656581
rs6470765-<b>A</b>,9 x 10-11,,NR,'-,'-,'-,"MTRF1LP2, CCDC26",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,8:129724451
rs6743226-<b>C</b>,3 x 10-11,,NR,'-,'-,'-,HDLBP,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:241297557
rs1812175-<b>A</b>,5 x 10-7,(men),0.1839,'-,'-,'-,"HHIP-AS1, HHIP",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:144653692
rs1812175-<b>A</b>,4 x 10-6,,0.1839,'-,'-,'-,"HHIP-AS1, HHIP",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:144653692
rs7773004-<b>A</b>,1 x 10-10,,0.4885,'-,'-,'-,"H2BC9, H3C8",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:26267527
rs7773004-<b>A</b>,1 x 10-8,(men),0.4885,'-,'-,'-,"H2BC9, H3C8",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:26267527
rs12127195-<b>A</b>,3 x 10-6,,0.3148,'-,'-,'-,'-,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:221136075
rs1776897-<b>T</b>,2 x 10-16,,0.8414,'-,'-,'-,"CYCSP55, HMGA1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:34227234
rs3888190-<b>A</b>,6 x 10-11,(men),0.3835,'-,0.0319 kg/m2 increase,[0.022-0.042],"ATP2A1, SH2B1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:28878165
rs11030104-<b>A</b>,5 x 10-11,(men),0.7872,'-,0.0375 kg/m2 increase,[0.026-0.049],"BDNF, BDNF-AS",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:27662970
rs11030104-<b>A</b>,5 x 10-22,,0.7872,'-,0.0403 kg/m2 increase,[0.032-0.049],"BDNF, BDNF-AS",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:27662970
rs11030104-<b>A</b>,1 x 10-13,(women),0.7872,'-,0.0426 kg/m2 increase,[0.031-0.054],"BDNF, BDNF-AS",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:27662970
rs1808579-<b>T</b>,1 x 10-6,(women),0.4656,'-,0.0216 kg/m2 decrease,[0.013-0.03],"RMC1, NPC1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:23524924
rs1808579-<b>T</b>,8 x 10-6,,0.4656,'-,0.0152 kg/m2 decrease,[0.0085-0.0219],"RMC1, NPC1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:23524924
rs2112347-<b>T</b>,5 x 10-8,(women),0.6128,'-,0.0233 kg/m2 increase,[0.015-0.032],"POC5, SLC25A5P9",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,5:75719417
rs2112347-<b>T</b>,1 x 10-13,,0.6128,'-,0.0242 kg/m2 increase,[0.018-0.031],"POC5, SLC25A5P9",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,5:75719417
rs2112347-<b>T</b>,4 x 10-7,(men),0.6128,'-,0.0243 kg/m2 increase,[0.015-0.034],"POC5, SLC25A5P9",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,5:75719417
rs205262-<b>A</b>,3 x 10-7,(women),0.694,'-,0.0255 kg/m2 decrease,[0.016-0.035],ILRUN,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:34595387
rs205262-<b>A</b>,3 x 10-9,,0.694,'-,0.0223 kg/m2 decrease,[0.015-0.03],ILRUN,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:34595387
rs13078960-<b>T</b>,7 x 10-8,(women),0.8065,'-,0.0293 kg/m2 decrease,[0.019-0.04],CADM2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:85758440
rs13078960-<b>T</b>,1 x 10-10,,0.8065,'-,0.0261 kg/m2 decrease,[0.018-0.034],CADM2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:85758440
rs9641123-<b>C</b>,2 x 10-6,(women),0.4166,'-,0.0238 kg/m2 increase,[0.014-0.034],CALCR,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:93568420
rs9641123-<b>C</b>,1 x 10-11,,0.4166,'-,0.0258 kg/m2 increase,[0.018-0.033],CALCR,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:93568420
rs9641123-<b>C</b>,3 x 10-7,(men),0.4166,'-,0.029 kg/m2 increase,[0.018-0.04],CALCR,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:93568420
rs2245368-<b>T</b>,6 x 10-8,(women),0.8036,'-,0.0378 kg/m2 decrease,[0.024-0.052],"DTX2P1, DTX2P1-UPK3BP1-PMS2P11",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:76978826
rs2245368-<b>T</b>,3 x 10-10,,0.8036,'-,0.0331 kg/m2 decrease,[0.023-0.043],"DTX2P1, DTX2P1-UPK3BP1-PMS2P11",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:76978826
rs13069244-<b>A</b>,6 x 10-10,,0.078,'-,0.031 kg/m2 increase,[0.021-0.041],CCDC39,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:180723384
rs4787491-<b>A</b>,2 x 10-9,,0.4825,'-,0.0201 kg/m2 decrease,[0.014-0.027],INO80E,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:30004016
rs4787491-<b>A</b>,6 x 10-6,(women),0.4825,'-,0.0198 kg/m2 decrease,[0.011-0.028],INO80E,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:30004016
rs1016287-<b>T</b>,8 x 10-8,,0.2819,'-,0.0196 kg/m2 increase,[0.012-0.027],LINC01122,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:59078490
rs1016287-<b>T</b>,2 x 10-6,(women),0.2819,'-,0.0223 kg/m2 increase,[0.013-0.032],LINC01122,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:59078490
rs3736485-<b>A</b>,2 x 10-6,,0.4757,'-,0.0151 kg/m2 increase,[0.0088-0.0214],DMXL2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,15:51456413
rs11583200-<b>T</b>,2 x 10-6,(women),0.5794,'-,0.0222 kg/m2 decrease,[0.013-0.031],ELAVL4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:50094148
rs2820292-<b>A</b>,2 x 10-10,,0.4644,'-,'-,'-,"IPO9-AS1, NAV1",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:201815159
rs2820292-<b>A</b>,4 x 10-7,(men),0.4644,'-,'-,'-,"IPO9-AS1, NAV1",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:201815159
rs3101336-<b>T</b>,3 x 10-16,,0.3916,'-,'-,'-,"NEGR1, RPL31P12",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:72285502
rs3101336-<b>T</b>,8 x 10-12,(men),0.3916,'-,'-,'-,"NEGR1, RPL31P12",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:72285502
rs3101336-<b>T</b>,4 x 10-7,(women),0.3916,'-,'-,'-,"NEGR1, RPL31P12",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:72285502
rs10132280-<b>A</b>,3 x 10-7,,0.3316,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,14:25458973
rs7141420-<b>T</b>,1 x 10-11,,0.5299,'-,'-,'-,NRXN3,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,14:79433111
rs7141420-<b>T</b>,3 x 10-11,(women),0.5299,'-,'-,'-,NRXN3,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,14:79433111
rs11191560-<b>T</b>,1 x 10-7,,0.9015,'-,'-,'-,NT5C2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,10:103109281
rs11191560-<b>T</b>,2 x 10-6,(women),0.9015,'-,'-,'-,NT5C2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,10:103109281
rs12429545-<b>A</b>,1 x 10-8,,0.1374,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,13:53528071
rs12429545-<b>A</b>,3 x 10-6,(women),0.1374,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,13:53528071
rs13191362-<b>A</b>,2 x 10-9,,0.8798,'-,'-,'-,PRKN,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:162612318
rs13191362-<b>A</b>,2 x 10-8,(women),0.8798,'-,'-,'-,PRKN,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:162612318
rs17094222-<b>T</b>,2 x 10-6,,0.7965,'-,'-,'-,"Metazoa_SRP, HIF1AN",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,10:100635683
rs17724992-<b>A</b>,3 x 10-6,,0.7369,'-,'-,'-,PGPEP1,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:18344015
rs12885454-<b>A</b>,3 x 10-6,,0.3494,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,14:29267632
rs11165643-<b>T</b>,1 x 10-6,,0.557,'-,'-,'-,EEF1A1P11,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:96458541
rs2287019-<b>T</b>,1 x 10-7,,0.1869,'-,'-,'-,QPCTL,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:45698914
rs6804842-<b>A</b>,1 x 10-8,,0.4416,'-,'-,'-,RNA5SP125,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:25064946
rs16851483-<b>T</b>,2 x 10-11,,0.0732,'-,'-,'-,RASA2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:141556594
rs16851483-<b>T</b>,3 x 10-7,(women),0.0732,'-,'-,'-,RASA2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:141556594
rs16851483-<b>T</b>,1 x 10-6,(men),0.0732,'-,'-,'-,RASA2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:141556594
rs1441264-<b>A</b>,3 x 10-6,,0.6192,'-,'-,'-,"CCT5P2, NIPA2P5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,13:79006784
rs2650492-<b>A</b>,4 x 10-7,,0.2933,'-,'-,'-,SBK1,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:28322090
rs4646404-<b>A</b>,9 x 10-6,,0.3318,'-,0.0181 unit decrease,[0.01-0.026],PEMT,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,17:17516885
rs10804591-<b>A</b>,3 x 10-8,(women),0.7415,'-,0.0339 unit increase,[0.022-0.046],"PLXND1, TMCC1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:129615390
rs17819328-<b>T</b>,9 x 10-10,(women),0.5694,'-,0.0294 unit decrease,[0.02-0.039],"PPARG, TSEN2",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:12447843
rs17819328-<b>T</b>,6 x 10-7,,0.5694,'-,0.0181 unit decrease,[0.011-0.025],"PPARG, TSEN2",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:12447843
rs13083798-<b>A</b>,1 x 10-8,,0.4986,'-,0.0198 unit increase,[0.013-0.027],PBRM1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:52615732
rs13083798-<b>A</b>,7 x 10-6,(women),0.4986,'-,0.0204 unit increase,[0.012-0.029],PBRM1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:52615732
rs1936805-<b>T</b>,5 x 10-7,(men),0.518,'-,0.026 unit increase,[0.016-0.036],RSPO3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:127130971
rs1936805-<b>T</b>,4 x 10-23,,0.518,'-,0.0345 unit increase,[0.028-0.041],RSPO3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:127130971
rs7766106-<b>T</b>,4 x 10-51,,0.486,'-,0.039 unit increase,[0.033-0.045],RSPO3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:127133993
rs1936805-<b>T</b>,6 x 10-20,(women),0.518,'-,0.0415 unit increase,[0.033-0.05],RSPO3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:127130971
rs7917772-<b>A</b>,7 x 10-6,,0.6136,'-,0.0161 unit increase,[0.009-0.0232],SFXN2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,10:102727686
rs7917772-<b>A</b>,5 x 10-8,(women),0.6136,'-,0.0253 unit increase,[0.016-0.034],SFXN2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,10:102727686
rs1440372-<b>T</b>,7 x 10-6,,0.2874,'-,0.0177 unit decrease,[0.01-0.025],SMAD6,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,15:66740813
rs17065323-<b>T</b>,1 x 10-8,(EA),0.006,'-,0.139 unit decrease,[0.092-0.186],"NRAD1, LINC00390",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,13:44053652
rs1534696-<b>A</b>,1 x 10-10,(women),0.5684,'-,0.032 unit decrease,[0.022-0.042],SNX10,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,7:26357619
rs1534696-<b>A</b>,3 x 10-6,,0.5684,'-,0.0175 unit decrease,[0.01-0.025],SNX10,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,7:26357619
rs12731372-<b>T</b>,8 x 10-7,,0.2363,'-,0.0204 unit decrease,[0.012-0.028],RNA5SP56,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:118310352
rs303084-<b>A</b>,8 x 10-6,,0.748,'-,0.02 unit increase,[0.011-0.029],SPATA5,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,4:123145793
rs12143789-<b>C</b>,2 x 10-7,,0.1892,'-,0.0235 unit increase,[0.015-0.032],TBX15,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:118954531
rs1106529-<b>A</b>,5 x 10-8,(men),0.7439,'-,0.0323 unit increase,[0.021-0.044],TBX15,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:118988874
rs1106529-<b>A</b>,3 x 10-17,,0.7439,'-,0.0334 unit increase,[0.026-0.041],TBX15,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:118988874
rs1106529-<b>A</b>,2 x 10-11,(women),0.7439,'-,0.0346 unit increase,[0.024-0.045],TBX15,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:118988874
rs2645294-<b>T</b>,7 x 10-10,(men),0.5659,'-,0.0323 unit increase,[0.022-0.042],WARS2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:119031964
rs2645294-<b>T</b>,1 x 10-21,,0.5659,'-,0.0331 unit increase,[0.026-0.04],WARS2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:119031964
rs2645294-<b>T</b>,6 x 10-14,(women),0.5659,'-,0.0341 unit increase,[0.025-0.043],WARS2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:119031964
rs10245353-<b>A</b>,4 x 10-10,(women),0.2306,'-,0.0371 unit increase,[0.026-0.049],'-,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,7:25818994
rs7830933-<b>A</b>,1 x 10-11,(women),0.7569,'-,0.0357 unit increase,[0.025-0.046],"NKX2-6, STC1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,8:23745811
rs12489828-<b>T</b>,2 x 10-6,,0.54,'-,0.0173 unit decrease,[0.01-0.024],NT5DC2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:52532998
rs2276824-<b>C</b>,2 x 10-7,,0.4352,'-,0.0193 unit increase,[0.012-0.027],PBRM1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:52603470
rs2276824-<b>C</b>,9 x 10-6,(women),0.4352,'-,0.0215 unit increase,[0.012-0.031],PBRM1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:52603470
rs13173241-<b>A</b>,2 x 10-6,(women),0.1961,'-,'-,'-,C5orf67,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:56565532
rs9435732-<b>T</b>,3 x 10-19,,0.2658,'-,'-,'-,"ATP13A2, MFAP2",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:16981663
rs9435732-<b>T</b>,2 x 10-12,(men),0.2658,'-,'-,'-,"ATP13A2, MFAP2",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:16981663
rs9435732-<b>T</b>,1 x 10-8,(women),0.2658,'-,'-,'-,"ATP13A2, MFAP2",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:16981663
rs12679556-<b>T</b>,1 x 10-7,,0.7067,'-,'-,'-,EYA1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,8:71601993
rs4141278-<b>T</b>,3 x 10-14,,0.7935,'-,'-,'-,'-,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:25817905
rs4141278-<b>T</b>,2 x 10-11,(women),0.7935,'-,'-,'-,'-,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:25817905
rs7830933-<b>A</b>,3 x 10-10,(women),0.7571,'-,'-,'-,"NKX2-6, STC1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,8:23745811
rs12489828-<b>T</b>,3 x 10-7,,0.5401,'-,'-,'-,NT5DC2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:52532998
rs12489828-<b>T</b>,1 x 10-6,(women),0.5401,'-,'-,'-,NT5DC2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:52532998
rs11144688-<b>A</b>,5 x 10-6,,0.1159,'-,'-,'-,PCSK5,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,9:75927370
rs3786897-<b>A</b>,3 x 10-7,,0.5764,'-,'-,'-,PEPD,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,19:33402102
rs2197271-<b>C</b>,2 x 10-9,,0.7215,'-,'-,'-,"PRKG2, RNU5A-2P",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:81239194
rs2197271-<b>C</b>,2 x 10-6,(men),0.7215,'-,'-,'-,"PRKG2, RNU5A-2P",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:81239194
rs6076699-<b>A</b>,3 x 10-6,"(EA, women)",NR,'-,'-,'-,RPS4XP2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,20:4586042
rs473902-<b>T</b>,9 x 10-8,,0.918,'-,'-,'-,PTCH1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,9:95493953
rs1545348-<b>T</b>,5 x 10-7,"(EA,men)",NR,'-,'-,'-,RAI14,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:34718238
rs2745353-<b>T</b>,3 x 10-12,(women),0.5202,'-,'-,'-,RSPO3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:127131790
rs2745353-<b>T</b>,2 x 10-11,,0.5202,'-,'-,'-,RSPO3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:127131790
rs11205277-<b>A</b>,4 x 10-14,,0.596,'-,'-,'-,"SF3B4, SV2A",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:149920979
rs11205277-<b>A</b>,1 x 10-9,(men),0.596,'-,'-,'-,"SF3B4, SV2A",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:149920979
rs11205277-<b>A</b>,5 x 10-7,(women),0.596,'-,'-,'-,"SF3B4, SV2A",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:149920979
rs272869-<b>A</b>,2 x 10-8,,0.4005,'-,'-,'-,"MIR3936HG, SLC22A4",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:132342304
rs7166081-<b>A</b>,8 x 10-10,,0.7599,'-,'-,'-,"AAGAB, SMAD3",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:67199963
rs7166081-<b>A</b>,8 x 10-9,(men),0.7599,'-,'-,'-,"AAGAB, SMAD3",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:67199963
rs7970350-<b>T</b>,7 x 10-7,(men),0.497,'-,'-,'-,"MIR6074, HMGA2",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:65966384
rs7970350-<b>T</b>,2 x 10-6,,0.497,'-,'-,'-,"MIR6074, HMGA2",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:65966384
rs7801581-<b>T</b>,1 x 10-7,,0.2502,'-,'-,'-,HOXA11,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:27184152
rs2071449-<b>A</b>,3 x 10-14,,0.3614,'-,'-,'-,"HOXC4, HOXC5",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:54034227
rs2071449-<b>A</b>,9 x 10-11,(men),0.3614,'-,'-,'-,"HOXC4, HOXC5",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:54034227
rs2071449-<b>A</b>,5 x 10-6,(women),0.3614,'-,'-,'-,"HOXC4, HOXC5",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:54034227
rs2214442-<b>A</b>,6 x 10-8,,0.5223,'-,'-,'-,ITGB8,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:20353164
rs849140-<b>T</b>,7 x 10-12,,0.4168,'-,'-,'-,JAZF1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:28144083
rs849140-<b>T</b>,3 x 10-7,(men),0.4168,'-,'-,'-,JAZF1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:28144083
rs849140-<b>T</b>,9 x 10-7,(women),0.4168,'-,'-,'-,JAZF1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:28144083
rs12608504-<b>A</b>,2 x 10-7,,0.3589,'-,'-,'-,"JUND, IQCN",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,19:18278325
rs16957304-<b>A</b>,2 x 10-11,,0.9298,'-,'-,'-,KCTD19,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,16:67301066
rs16957304-<b>A</b>,2 x 10-9,(women),0.9298,'-,'-,'-,KCTD19,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,16:67301066
rs17396340-<b>A</b>,2 x 10-13,,NR,'-,'-,'-,KIF1B,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:10226118
rs7684221-<b>A</b>,2 x 10-9,,0.1931,'-,'-,'-,LCORL,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:17955731
rs7684221-<b>A</b>,7 x 10-8,(men),0.1931,'-,'-,'-,LCORL,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:17955731
rs17451107-<b>T</b>,4 x 10-13,,0.6145,'-,'-,'-,"LINC00880, LEKR1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:157079820
rs17451107-<b>T</b>,2 x 10-11,(women),0.6145,'-,'-,'-,"LINC00880, LEKR1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:157079820
rs395962-<b>T</b>,5 x 10-14,,0.3169,'-,'-,'-,LIN28B,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:104949543
rs395962-<b>T</b>,1 x 10-12,(men),0.3169,'-,'-,'-,LIN28B,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:104949543
rs4886782-<b>A</b>,8 x 10-11,(men),0.3642,'-,'-,'-,LOXL1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:73936469
rs4886782-<b>A</b>,2 x 10-10,,0.3642,'-,'-,'-,LOXL1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:73936469
rs6715793-<b>T</b>,2 x 10-7,,0.4858,'-,'-,'-,LTBP1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:33154196
rs3897379-<b>A</b>,3 x 10-6,(women),0.1974,'-,'-,'-,ZC3H11B,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:219586391
rs1776897-<b>T</b>,1 x 10-13,(women),0.8414,'-,'-,'-,"CYCSP55, HMGA1",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:34227234
rs6567160-<b>T</b>,1 x 10-28,(women),0.7603,'-,0.0542 kg/m2 decrease,[0.045-0.064],"RNU4-17P, RPS3AP49",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:60161902
rs3817334-<b>T</b>,2 x 10-6,(women),0.3933,'-,0.02 kg/m2 increase,[0.012-0.028],MTCH2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:47629441
rs3817334-<b>T</b>,1 x 10-11,,0.3933,'-,0.0223 kg/m2 increase,[0.016-0.029],MTCH2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:47629441
rs3817334-<b>T</b>,1 x 10-7,(men),0.3933,'-,0.0254 kg/m2 increase,[0.016-0.035],MTCH2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:47629441
rs12016871-<b>T</b>,8 x 10-7,,0.1937,'-,0.0231 kg/m2 increase,[0.014-0.032],MTIF3,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,13:27443645
rs9925964-<b>A</b>,5 x 10-8,,0.6332,'-,0.0185 kg/m2 increase,[0.012-0.025],KAT8,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:31118574
rs2820292-<b>A</b>,1 x 10-7,(men),0.4644,'-,0.0244 kg/m2 decrease,[0.015-0.034],"IPO9-AS1, NAV1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:201815159
rs2820292-<b>A</b>,5 x 10-11,,0.4644,'-,0.0209 kg/m2 decrease,[0.015-0.027],"IPO9-AS1, NAV1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:201815159
rs2820292-<b>A</b>,6 x 10-6,(women),0.4644,'-,0.0189 kg/m2 decrease,[0.011-0.027],"IPO9-AS1, NAV1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:201815159
rs3101336-<b>T</b>,2 x 10-12,(men),0.3916,'-,0.0332 kg/m2 decrease,[0.024-0.042],"NEGR1, RPL31P12",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:72285502
rs3101336-<b>T</b>,1 x 10-15,,0.3916,'-,0.0274 kg/m2 decrease,[0.021-0.034],"NEGR1, RPL31P12",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:72285502
rs3101336-<b>T</b>,5 x 10-7,(women),0.3916,'-,0.023 kg/m2 decrease,[0.014-0.032],"NEGR1, RPL31P12",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:72285502
rs10132280-<b>A</b>,2 x 10-7,,0.3316,'-,0.0183 kg/m2 decrease,[0.011-0.025],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,14:25458973
rs7141420-<b>T</b>,5 x 10-12,,0.5299,'-,0.022 kg/m2 increase,[0.016-0.028],NRXN3,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,14:79433111
rs7141420-<b>T</b>,3 x 10-11,(women),0.5299,'-,0.0278 kg/m2 increase,[0.02-0.036],NRXN3,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,14:79433111
rs11191560-<b>T</b>,5 x 10-6,(women),0.9015,'-,0.0337 kg/m2 decrease,[0.019-0.048],NT5C2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,10:103109281
rs11191560-<b>T</b>,5 x 10-7,,0.9015,'-,0.028 kg/m2 decrease,[0.017-0.039],NT5C2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,10:103109281
rs12429545-<b>A</b>,4 x 10-9,,0.1374,'-,0.0296 kg/m2 increase,[0.02-0.039],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,13:53528071
rs12429545-<b>A</b>,2 x 10-6,(women),0.1374,'-,0.0329 kg/m2 increase,[0.019-0.046],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,13:53528071
rs13191362-<b>A</b>,9 x 10-10,,0.8798,'-,0.0315 kg/m2 increase,[0.022-0.041],PRKN,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:162612318
rs13191362-<b>A</b>,1 x 10-8,(women),0.8798,'-,0.0384 kg/m2 increase,[0.025-0.052],PRKN,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:162612318
rs17094222-<b>T</b>,2 x 10-6,,0.7965,'-,0.0197 kg/m2 decrease,[0.012-0.028],"Metazoa_SRP, HIF1AN",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,10:100635683
rs17724992-<b>A</b>,5 x 10-6,,0.7369,'-,0.0174 kg/m2 increase,[0.01-0.0248],PGPEP1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:18344015
rs12885454-<b>A</b>,1 x 10-6,,0.3494,'-,0.0165 kg/m2 decrease,[0.0098-0.0232],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,14:29267632
rs11165643-<b>T</b>,3 x 10-8,,0.557,'-,0.0177 kg/m2 increase,[0.011-0.024],EEF1A1P11,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:96458541
rs17024393-<b>T</b>,3 x 10-6,(men),0.9549,'-,0.0641 kg/m2 decrease,[0.037-0.091],GNAT2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:109612066
rs10938397-<b>A</b>,4 x 10-13,(men),0.5821,'-,0.0346 kg/m2 decrease,[0.025-0.044],LINC02273,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,4:45180510
rs10938397-<b>A</b>,2 x 10-23,,0.5821,'-,0.0329 kg/m2 decrease,[0.026-0.039],LINC02273,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,4:45180510
rs10938397-<b>A</b>,2 x 10-13,(women),0.5821,'-,0.032 kg/m2 decrease,[0.024-0.04],LINC02273,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,4:45180510
rs12446632-<b>A</b>,2 x 10-9,(men),0.1334,'-,0.0423 kg/m2 decrease,[0.029-0.056],GPRC5B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:19924067
rs12446632-<b>A</b>,1 x 10-10,,0.1334,'-,0.0328 kg/m2 decrease,[0.023-0.043],GPRC5B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:19924067
rs7899106-<b>A</b>,3 x 10-6,,0.9366,'-,0.0337 kg/m2 decrease,[0.02-0.048],GRID1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,10:85651147
rs7243357-<b>T</b>,4 x 10-8,,0.8196,'-,0.0232 kg/m2 increase,[0.015-0.031],"SEC11C, GRP",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:59216087
rs7243357-<b>T</b>,1 x 10-6,(men),0.8196,'-,0.0297 kg/m2 increase,[0.018-0.042],"SEC11C, GRP",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:59216087
rs1167827-<b>A</b>,5 x 10-6,(men),0.4293,'-,0.023 kg/m2 decrease,[0.013-0.033],HIP1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:75533848
rs1167827-<b>A</b>,6 x 10-8,,0.4293,'-,0.0199 kg/m2 decrease,[0.013-0.027],HIP1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:75533848
rs17405819-<b>T</b>,7 x 10-8,,0.7022,'-,0.019 kg/m2 increase,[0.012-0.026],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,8:75894349
rs13201877-<b>A</b>,5 x 10-6,,0.8661,'-,0.0221 kg/m2 decrease,[0.013-0.032],HLA-B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:137354404
rs2481665-<b>T</b>,3 x 10-11,(EA),0.561,'-,0.016 kg/m2 increase,[0.012-0.02],PATJ,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:62129005
rs2176040-<b>A</b>,2 x 10-7,(men),0.3557,'-,0.0253 kg/m2 increase,[0.016-0.035],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:226228086
rs29941-<b>A</b>,1 x 10-8,,0.3247,'-,0.0202 kg/m2 decrease,[0.013-0.027],KCTD15,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:33818627
rs12940622-<b>A</b>,7 x 10-7,(men),0.4324,'-,0.0232 kg/m2 decrease,[0.014-0.032],RPTOR,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,17:80641771
rs12940622-<b>A</b>,2 x 10-8,,0.4324,'-,0.0178 kg/m2 decrease,[0.012-0.024],RPTOR,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,17:80641771
rs10968576-<b>A</b>,9 x 10-10,(women),0.6952,'-,0.0279 kg/m2 decrease,[0.019-0.037],LINGO2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,9:28414341
rs10968576-<b>A</b>,3 x 10-13,,0.6952,'-,0.0256 kg/m2 decrease,[0.019-0.032],LINGO2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,9:28414341
rs10968576-<b>A</b>,7 x 10-6,(men),0.6952,'-,0.0228 kg/m2 decrease,[0.013-0.033],LINGO2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,9:28414341
rs16951275-<b>T</b>,5 x 10-14,,0.7478,'-,0.0281 kg/m2 increase,[0.021-0.035],MAP2K5,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,15:67784830
rs16951275-<b>T</b>,2 x 10-11,(women),0.7478,'-,0.0322 kg/m2 increase,[0.023-0.042],MAP2K5,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,15:67784830
rs6567160-<b>T</b>,1 x 10-31,(men),0.7603,'-,0.0635 kg/m2 decrease,[0.053-0.074],"RNU4-17P, RPS3AP49",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:60161902
rs6567160-<b>T</b>,3 x 10-54,,0.7603,'-,0.0579 kg/m2 decrease,[0.051-0.065],"RNU4-17P, RPS3AP49",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,18:60161902
rs1045241-<b>T</b>,3 x 10-9,(women),0.2896,'-,0.0301 unit decrease,[0.02-0.04],TNFAIP8,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:119393591
rs2001945-<b>G</b>,1 x 10-9,"(AA, women)",0.484,'-,0.022 unit increase,[0.014-0.03],TRIB1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,8:125465736
rs1358980-<b>T</b>,2 x 10-22,,0.4685,'-,0.0363 unit increase,[0.029-0.044],"VEGFA, LINC02537",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:43796814
rs1358980-<b>T</b>,2 x 10-26,(women),0.4685,'-,0.0532 unit increase,[0.043-0.063],"VEGFA, LINC02537",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:43796814
rs863750-<b>T</b>,3 x 10-8,,0.5861,'-,0.0208 unit increase,[0.014-0.028],RFLNA,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:124020897
rs863750-<b>T</b>,3 x 10-9,(women),0.5861,'-,0.031 unit increase,[0.021-0.041],RFLNA,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:124020897
rs2294239-<b>A</b>,8 x 10-9,,0.591,'-,0.0217 unit increase,[0.014-0.029],ZNRF3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,22:29053489
rs2294239-<b>A</b>,3 x 10-6,(women),0.591,'-,0.0242 unit increase,[0.014-0.034],ZNRF3,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,22:29053489
rs459193-<b>A</b>,2 x 10-7,"(AA, men)",0.264,'-,'-,'-,"C5orf67, RPL26P19",Waist-to-hip ratio adjusted for BMI (smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004506,5:56510924
rs30000-<b>G</b>,3 x 10-7,"(EA, men)",0.26,'-,'-,'-,"RPL26P19, C5orf67",Waist-to-hip ratio adjusted for BMI (smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004506,5:56507706
rs4141488-<b>T</b>,2 x 10-6,,0.499,'-,'-,'-,"RNA5SP403, LINC01195",Waist circumference adjusted for BMI (smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004502,16:9535210
rs6076699-<b>A</b>,2 x 10-6,"(EA, women)",0.973,'-,'-,'-,RPS4XP2,Waist circumference adjusted for BMI (smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004502,20:4586042
rs6772896-<b>T</b>,8 x 10-7,(women),0.6799,'-,'-,'-,ANAPC13,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:134484505
rs13210323-<b>A</b>,2 x 10-6,,0.7176,'-,'-,'-,ANKS1A,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:35037307
rs6012558-<b>A</b>,3 x 10-9,,NR,'-,'-,'-,"PREX1, ARFGEF2",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,20:48914749
rs1884897-<b>A</b>,7 x 10-10,,0.3739,'-,'-,'-,LINC01713,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,20:6632185
rs1884897-<b>A</b>,2 x 10-7,(women),0.3739,'-,'-,'-,LINC01713,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,20:6632185
rs882367-<b>T</b>,5 x 10-11,,0.6556,'-,'-,'-,"LINC02875, TBX4",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,17:61417213
rs882367-<b>T</b>,2 x 10-6,(men),0.6556,'-,'-,'-,"LINC02875, TBX4",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,17:61417213
rs882367-<b>T</b>,5 x 10-6,(women),0.6556,'-,'-,'-,"LINC02875, TBX4",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,17:61417213
rs4239436-<b>A</b>,5 x 10-24,,0.2027,'-,'-,'-,CABLES1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,18:23151966
rs4239436-<b>A</b>,4 x 10-14,(women),0.2027,'-,'-,'-,CABLES1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,18:23151966
rs1879529-<b>T</b>,8 x 10-8,,0.279,'-,'-,'-,ACAN,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:88871064
rs1879529-<b>T</b>,1 x 10-6,(women),0.279,'-,'-,'-,ACAN,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:88871064
rs4542783-<b>T</b>,3 x 10-8,,0.543,'-,'-,'-,MYO1F,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,19:8577276
rs11583200-<b>T</b>,3 x 10-6,,0.5794,'-,0.0161 kg/m2 decrease,[0.0094-0.0228],ELAVL4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:50094148
rs657452-<b>A</b>,3 x 10-6,,0.4068,'-,0.0167 kg/m2 increase,[0.0096-0.0238],AGBL4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:49124175
rs12629427-<b>C</b>,8 x 10-8,"(AA, women)",0.258,'-,0.021 kg/m2 increase,[0.013-0.029],"GAPDHP50, EPHA3",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:89096190
rs2173039-<b>C</b>,2 x 10-9,"(EA, women)",0.258,'-,0.024 kg/m2 increase,[0.016-0.032],"GAPDHP50, EPHA3",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:89093025
rs7599312-<b>A</b>,2 x 10-7,(women),0.2807,'-,0.0272 kg/m2 decrease,[0.017-0.037],ERBB4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:212548507
rs7599312-<b>A</b>,3 x 10-11,,0.2807,'-,0.0252 kg/m2 decrease,[0.018-0.033],ERBB4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:212548507
rs1516725-<b>T</b>,2 x 10-11,(women),0.1363,'-,0.0408 kg/m2 decrease,[0.029-0.053],"DGKG, ETV5",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:186106215
rs1516725-<b>T</b>,6 x 10-15,,0.1363,'-,0.0367 kg/m2 decrease,[0.027-0.046],"DGKG, ETV5",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:186106215
rs7138803-<b>A</b>,3 x 10-8,(men),0.3705,'-,0.027 kg/m2 increase,[0.017-0.037],"BCDIN3D, RPL35AP28",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,12:49853685
rs7138803-<b>A</b>,4 x 10-16,,0.3705,'-,0.029 kg/m2 increase,[0.022-0.036],"BCDIN3D, RPL35AP28",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,12:49853685
rs7138803-<b>A</b>,7 x 10-10,(women),0.3705,'-,0.0301 kg/m2 increase,[0.02-0.04],"BCDIN3D, RPL35AP28",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,12:49853685
rs12286929-<b>A</b>,4 x 10-8,,0.4783,'-,0.0175 kg/m2 decrease,[0.011-0.024],CADM1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:115151684
rs2365389-<b>T</b>,2 x 10-10,(men),0.4348,'-,0.0319 kg/m2 decrease,[0.022-0.042],FHIT,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:61250788
rs2365389-<b>T</b>,4 x 10-15,,0.4348,'-,0.0266 kg/m2 decrease,[0.02-0.033],FHIT,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:61250788
rs2365389-<b>T</b>,3 x 10-7,(women),0.4348,'-,0.0225 kg/m2 decrease,[0.014-0.031],FHIT,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:61250788
rs1460676-<b>T</b>,2 x 10-6,,0.8195,'-,0.02 kg/m2 decrease,[0.012-0.028],FIGN,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:163711179
rs9400239-<b>T</b>,2 x 10-6,,0.3467,'-,0.0163 kg/m2 decrease,[0.0096-0.023],FOXO3,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:108656460
rs1558902-<b>A</b>,5 x 10-59,(women),0.4028,'-,0.0707 kg/m2 increase,[0.062-0.079],FTO,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:53769662
rs1558902-<b>A</b>,3 x 10-110,,0.4028,'-,0.075 kg/m2 increase,[0.068-0.082],FTO,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:53769662
rs1558902-<b>A</b>,7 x 10-65,(men),0.4028,'-,0.0806 kg/m2 increase,[0.071-0.09],FTO,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:53769662
rs12401738-<b>A</b>,9 x 10-8,,0.339,'-,0.0184 kg/m2 increase,[0.012-0.025],"GIPC2, DNAJB4",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:77981077
rs12401738-<b>A</b>,4 x 10-6,(women),0.339,'-,0.0208 kg/m2 increase,[0.012-0.03],"GIPC2, DNAJB4",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:77981077
rs7715256-<b>T</b>,4 x 10-6,,0.574,'-,0.0151 kg/m2 decrease,[0.0086-0.0216],MFAP3,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,5:154158333
rs17024393-<b>T</b>,8 x 10-9,(women),0.9549,'-,0.0661 kg/m2 decrease,[0.044-0.089],GNAT2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:109612066
rs17024393-<b>T</b>,5 x 10-13,,0.9549,'-,0.0656 kg/m2 decrease,[0.048-0.083],GNAT2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:109612066
rs979012-<b>T</b>,5 x 10-8,,0.3522,'-,0.0201 unit increase,[0.013-0.027],LINC01713,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,20:6642727
rs7759742-<b>A</b>,1 x 10-9,,0.5117,'-,0.0217 unit increase,[0.015-0.029],"HLA-DRA, TSBP1-AS1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:32413959
rs7759742-<b>A</b>,3 x 10-6,(men),0.5117,'-,0.0248 unit increase,[0.014-0.035],"HLA-DRA, TSBP1-AS1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:32413959
rs1569135-<b>A</b>,2 x 10-8,,0.514,'-,0.0214 unit increase,[0.014-0.029],RNU6-989P,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:187250671
rs4765219-<b>A</b>,4 x 10-17,(women),0.3303,'-,0.0398 unit decrease,[0.031-0.049],CCDC92,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:123955563
rs4765219-<b>A</b>,1 x 10-13,,0.3303,'-,0.0274 unit decrease,[0.02-0.035],CCDC92,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:123955563
rs4081724-<b>A</b>,2 x 10-6,,0.1421,'-,0.0257 unit decrease,[0.015-0.036],"CEBPA-DT, RPS3AP50",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,19:33334040
rs2925979-<b>T</b>,2 x 10-6,,0.3065,'-,0.0193 unit increase,[0.011-0.027],CMIP,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,16:81501185
rs2925979-<b>T</b>,1 x 10-10,(women),0.3065,'-,0.0357 unit increase,[0.025-0.046],CMIP,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,16:81501185
rs1128249-<b>T</b>,4 x 10-28,(women),0.4179,'-,0.0515 unit decrease,[0.042-0.061],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164672114
rs12692737-<b>A</b>,5 x 10-8,(women),0.3083,'-,0.0298 unit decrease,[0.019-0.041],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164697799
rs1128249-<b>T</b>,8 x 10-16,,0.4179,'-,0.029 unit decrease,[0.022-0.036],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164672114
rs12692738-<b>T</b>,4 x 10-12,,0.7339,'-,0.0286 unit increase,[0.021-0.037],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164701742
rs12692738-<b>T</b>,3 x 10-22,(women),0.7339,'-,0.0525 unit increase,[0.042-0.063],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164701742
rs7705502-<b>A</b>,8 x 10-7,,0.3057,'-,0.0188 unit increase,[0.011-0.026],CPEB4,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:173893812
rs7705502-<b>A</b>,7 x 10-7,(women),0.3057,'-,0.0248 unit increase,[0.015-0.035],CPEB4,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:173893812
rs905938-<b>T</b>,6 x 10-7,,0.7406,'-,0.0225 unit increase,[0.014-0.031],DCST2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:155018913
rs905938-<b>T</b>,2 x 10-6,(women),0.7406,'-,0.0295 unit increase,[0.017-0.042],DCST2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:155018913
rs714515-<b>A</b>,1 x 10-11,(women),0.5576,'-,0.0314 unit decrease,[0.022-0.04],"PIGC, DNM3",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:172383850
rs714515-<b>A</b>,9 x 10-15,,0.5576,'-,0.0273 unit decrease,[0.02-0.034],"PIGC, DNM3",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:172383850
rs589428-<b>G</b>,1 x 10-17,(EA),0.65,'-,0.024 unit increase,[0.018-0.03],"EHMT2, EHMT2-AS1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:31880443
rs6090583-<b>A</b>,1 x 10-8,,0.495,'-,0.0201 unit increase,[0.013-0.027],EYA2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,20:46930192
rs6090583-<b>A</b>,2 x 10-7,(women),0.495,'-,0.024 unit increase,[0.015-0.033],EYA2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,20:46930192
rs1856293-<b>A</b>,1 x 10-7,(EA),0.517,'-,0.016 unit decrease,[0.01-0.022],"MTCYBP4, EYA4",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:133159801
rs9991328-<b>T</b>,5 x 10-9,,0.498,'-,0.0217 unit increase,[0.014-0.029],FAM13A,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,4:88791970
rs8066985-<b>A</b>,6 x 10-10,(women),0.4857,'-,0.0281 unit increase,[0.019-0.037],'-,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,17:70457204
rs8042543-<b>T</b>,1 x 10-7,(women),0.2071,'-,0.0313 unit decrease,[0.02-0.043],KLF13,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,15:31416060
rs8042543-<b>T</b>,2 x 10-9,,0.2071,'-,0.0272 unit decrease,[0.018-0.036],KLF13,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,15:31416060
rs17451107-<b>T</b>,2 x 10-9,,0.6131,'-,0.0214 unit increase,[0.014-0.028],"LINC00880, LEKR1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:157079820
rs17451107-<b>T</b>,4 x 10-7,(women),0.6131,'-,0.0238 unit increase,[0.015-0.033],"LINC00880, LEKR1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:157079820
rs1294410-<b>T</b>,7 x 10-11,(women),0.3725,'-,0.0306 unit decrease,[0.021-0.04],"BTF3P7, LY86",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:6738519
rs1294410-<b>T</b>,1 x 10-12,,0.3725,'-,0.0256 unit decrease,[0.019-0.033],"BTF3P7, LY86",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:6738519
rs765751-<b>C</b>,9 x 10-31,,0.611,'-,0.031 unit increase,[0.025-0.037],LYPLAL1-AS1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:219495884
rs2820443-<b>T</b>,4 x 10-16,,0.7255,'-,0.0314 unit increase,[0.024-0.039],ZC3H11B,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:219580167
rs2820443-<b>T</b>,7 x 10-28,(women),0.7255,'-,0.0565 unit increase,[0.046-0.067],ZC3H11B,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:219580167
rs11231693-<b>A</b>,3 x 10-6,,0.0973,'-,0.0336 unit increase,[0.019-0.048],"MACROD1, FLRT1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,11:64095140
rs11231693-<b>A</b>,1 x 10-6,(women),0.0973,'-,0.0447 unit increase,[0.027-0.063],"MACROD1, FLRT1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,11:64095140
rs9687846-<b>A</b>,8 x 10-6,(women),0.1927,'-,0.026 unit increase,[0.015-0.037],C5orf67,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:56566067
rs3936510-<b>T</b>,8 x 10-6,(women),0.1898,'-,0.0263 unit increase,[0.015-0.038],C5orf67,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:56565039
rs30000-<b>G</b>,3 x 10-17,"(EA, men)",0.26,'-,0.039 unit increase,[0.029-0.049],"RPL26P19, C5orf67",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:56507706
rs459193-<b>A</b>,4 x 10-20,"(AA, men)",0.264,'-,0.041 unit increase,[0.033-0.049],"C5orf67, RPL26P19",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:56510924
rs1385167-<b>A</b>,3 x 10-7,,0.8459,'-,0.0257 unit decrease,[0.016-0.035],'-,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:65973514
rs12679556-<b>T</b>,2 x 10-6,(women),0.7074,'-,0.0246 unit decrease,[0.014-0.035],EYA1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,8:71601993
rs12679556-<b>T</b>,1 x 10-9,,0.7074,'-,0.0241 unit decrease,[0.016-0.032],EYA1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,8:71601993
rs3902751-<b>A</b>,1 x 10-10,(women),0.3178,'-,0.033 unit increase,[0.023-0.043],'-,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,7:25822019
rs4542783-<b>T</b>,4 x 10-7,(women),0.543,'-,'-,'-,MYO1F,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,19:8577276
rs7697556-<b>T</b>,3 x 10-19,,NR,'-,'-,'-,ADAMTS3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,4:72649596
rs9860730-<b>A</b>,1 x 10-11,(women),0.6495,'-,'-,'-,ADAMTS9-AS2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:64715470
rs7162542-<b>C</b>,5 x 10-25,,0.4275,'-,'-,'-,ADAMTSL3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:83845538
rs7162542-<b>C</b>,2 x 10-16,(men),0.4275,'-,'-,'-,ADAMTSL3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:83845538
rs7162542-<b>C</b>,5 x 10-12,(women),0.4275,'-,'-,'-,ADAMTSL3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,15:83845538
rs6772896-<b>T</b>,7 x 10-13,,0.6799,'-,'-,'-,ANAPC13,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:134484505
rs6772896-<b>T</b>,4 x 10-7,(men),0.6799,'-,'-,'-,ANAPC13,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:134484505
rs4239436-<b>A</b>,4 x 10-13,(men),0.2027,'-,'-,'-,CABLES1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,18:23151966
rs2638953-<b>C</b>,1 x 10-12,,0.6764,'-,'-,'-,CCDC91,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:28381482
rs2638953-<b>C</b>,1 x 10-8,(men),0.6764,'-,'-,'-,CCDC91,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:28381482
rs10269774-<b>A</b>,2 x 10-9,,NR,'-,'-,'-,CDK6,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,7:92624658
rs3760318-<b>A</b>,6 x 10-7,(men),0.3801,'-,'-,'-,ADAP2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,17:30920697
rs3760318-<b>A</b>,7 x 10-7,,0.3801,'-,'-,'-,ADAP2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,17:30920697
rs10516107-<b>A</b>,4 x 10-6,(women),0.3058,'-,'-,'-,CPEB4,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:173921153
rs10516107-<b>A</b>,9 x 10-6,,0.3058,'-,'-,'-,CPEB4,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,5:173921153
rs6437061-<b>A</b>,3 x 10-6,(men),0.57,'-,'-,'-,DIS3L2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:232320342
rs12317176-<b>T</b>,8 x 10-18,(women),0.649,'-,'-,'-,"CCDC92, DNAH10",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:123920171
rs12317176-<b>T</b>,2 x 10-9,,0.649,'-,'-,'-,"CCDC92, DNAH10",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,12:123920171
rs12991495-<b>T</b>,1 x 10-11,,0.6973,'-,'-,'-,DNMT3A,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:25263901
rs12991495-<b>T</b>,2 x 10-10,(men),0.6973,'-,'-,'-,DNMT3A,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:25263901
rs4378999-<b>T</b>,3 x 10-10,,NR,'-,'-,'-,DOCK3,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:51171215
rs3791679-<b>A</b>,2 x 10-17,,0.7555,'-,'-,'-,EFEMP1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:55869757
rs3791679-<b>A</b>,5 x 10-12,(men),0.7555,'-,'-,'-,EFEMP1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:55869757
rs3791679-<b>A</b>,5 x 10-7,(women),0.7555,'-,'-,'-,EFEMP1,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,2:55869757
rs9991328-<b>T</b>,1 x 10-7,(women),0.498,'-,'-,'-,FAM13A,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,4:88791970
rs1358980-<b>T</b>,3 x 10-8,(women),0.4685,'-,'-,'-,"VEGFA, LINC02537",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:43796814
rs1936805-<b>T</b>,9 x 10-11,(women),0.518,'-,'-,'-,RSPO3,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:127130971
rs12679556-<b>T</b>,8 x 10-8,(women),0.7074,'-,'-,'-,EYA1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,8:71601993
rs1443512-<b>A</b>,5 x 10-7,(women),0.2662,'-,'-,'-,"HOXC12, HOXC13",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:53948900
rs10783615-<b>A</b>,4 x 10-9,(women),0.7973,'-,'-,'-,HOXC12,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:53955989
rs4765219-<b>A</b>,1 x 10-7,(women),0.3303,'-,'-,'-,CCDC92,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:123955563
rs7830933-<b>A</b>,2 x 10-6,(women),0.7569,'-,'-,'-,"NKX2-6, STC1",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,8:23745811
rs2645294-<b>T</b>,4 x 10-6,(men),0.5659,'-,'-,'-,WARS2,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:119031964
rs459193-<b>A</b>,2 x 10-9,(men),0.2796,'-,'-,'-,"C5orf67, RPL26P19",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,5:56510924
rs6556301-<b>T</b>,5 x 10-6,(men),0.3609,'-,'-,'-,"FGFR4, NSD1",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,5:177100576
rs2071449-<b>A</b>,6 x 10-6,(men),0.3602,'-,'-,'-,"HOXC4, HOXC5",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:54034227
rs12608504-<b>A</b>,2 x 10-6,(men),0.3583,'-,'-,'-,"JUND, IQCN",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,19:18278325
rs459193-<b>A</b>,2 x 10-17,(men),0.264,'-,'-,'-,"C5orf67, RPL26P19",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,5:56510924
rs2001945-<b>G</b>,2 x 10-6,(women),0.484,'-,'-,'-,TRIB1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,8:125465736
rs2071449-<b>A</b>,3 x 10-9,(men),0.365,'-,'-,'-,"HOXC4, HOXC5",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:54034227
rs12608504-<b>A</b>,2 x 10-8,(men),0.362,'-,'-,'-,"JUND, IQCN",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,19:18278325
rs10182181-<b>A</b>,2 x 10-12,(women),0.5182,'-,0.0329 kg/m2 decrease,[0.024-0.042],"ADCY3, DNAJC27",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:24927427
rs10182181-<b>A</b>,7 x 10-19,,0.5182,'-,0.0301 kg/m2 decrease,[0.023-0.037],"ADCY3, DNAJC27",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:24927427
rs10182181-<b>A</b>,5 x 10-8,(men),0.5182,'-,0.026 kg/m2 decrease,[0.017-0.035],"ADCY3, DNAJC27",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:24927427
rs7164727-<b>T</b>,2 x 10-7,,0.6483,'-,0.0179 kg/m2 increase,[0.011-0.025],"ADPGK-AS1, NPM1P42",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,15:72801650
rs6465468-<b>T</b>,8 x 10-7,,0.2957,'-,0.0183 kg/m2 increase,[0.011-0.026],ASB4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:95540202
rs6465468-<b>T</b>,6 x 10-7,(women),0.2957,'-,0.0237 kg/m2 increase,[0.014-0.033],ASB4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,7:95540202
rs3888190-<b>A</b>,6 x 10-10,(women),0.3835,'-,0.0262 kg/m2 increase,[0.018-0.034],"ATP2A1, SH2B1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:28878165
rs3888190-<b>A</b>,2 x 10-18,,0.3835,'-,0.029 kg/m2 increase,[0.023-0.035],"ATP2A1, SH2B1",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:28878165
rs1928295-<b>T</b>,7 x 10-7,(women),0.5549,'-,0.0222 kg/m2 increase,[0.013-0.031],RPL35AP22,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,9:117616205
rs13021737-<b>A</b>,3 x 10-28,(women),0.1701,'-,0.0631 kg/m2 decrease,[0.052-0.074],"TMEM18, LINC01875",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:632348
rs13021737-<b>A</b>,9 x 10-41,,0.1701,'-,0.0594 kg/m2 decrease,[0.051-0.068],"TMEM18, LINC01875",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:632348
rs13021737-<b>A</b>,3 x 10-17,(men),0.1701,'-,0.0564 kg/m2 decrease,[0.043-0.07],"TMEM18, LINC01875",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:632348
rs12566985-<b>A</b>,3 x 10-7,(women),0.5312,'-,0.0219 kg/m2 decrease,[0.013-0.03],"TNNI3K, FPGT-TNNI3K",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:74536509
rs12566985-<b>A</b>,2 x 10-8,,0.5312,'-,0.0184 kg/m2 decrease,[0.012-0.025],"TNNI3K, FPGT-TNNI3K",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:74536509
rs2075650-<b>A</b>,6 x 10-6,,0.8558,'-,0.0234 kg/m2 increase,[0.013-0.034],TOMM40,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:44892362
rs4256980-<b>C</b>,1 x 10-6,,0.3733,'-,0.0157 kg/m2 decrease,[0.0094-0.022],TRIM66,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,11:8652392
rs10733682-<b>A</b>,9 x 10-6,,0.467,'-,0.0156 kg/m2 increase,[0.0087-0.0225],LMX1B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,9:126698635
rs3810291-<b>A</b>,1 x 10-12,,0.6246,'-,0.0259 kg/m2 increase,[0.019-0.033],ZC3H4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:47065746
rs3810291-<b>A</b>,1 x 10-9,(women),0.6246,'-,0.0292 kg/m2 increase,[0.02-0.039],ZC3H4,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:47065746
rs6091540-<b>T</b>,1 x 10-6,,0.2731,'-,0.0177 kg/m2 decrease,[0.011-0.025],LINC01524,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,20:52471323
rs12940622-<b>A</b>,2 x 10-6,(men),0.4324,'-,'-,'-,RPTOR,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,17:80641771
rs10968576-<b>A</b>,1 x 10-11,,0.6952,'-,'-,'-,LINGO2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,9:28414341
rs10968576-<b>A</b>,2 x 10-8,(women),0.6952,'-,'-,'-,LINGO2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,9:28414341
rs16951275-<b>T</b>,4 x 10-13,,0.7478,'-,'-,'-,MAP2K5,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,15:67784830
rs16951275-<b>T</b>,9 x 10-11,(women),0.7478,'-,'-,'-,MAP2K5,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,15:67784830
rs6567160-<b>T</b>,4 x 10-55,,0.7603,'-,'-,'-,"RNU4-17P, RPS3AP49",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,18:60161902
rs6567160-<b>T</b>,1 x 10-31,(men),0.7603,'-,'-,'-,"RNU4-17P, RPS3AP49",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,18:60161902
rs6567160-<b>T</b>,4 x 10-28,(women),0.7603,'-,'-,'-,"RNU4-17P, RPS3AP49",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,18:60161902
rs3817334-<b>T</b>,7 x 10-12,,0.3933,'-,'-,'-,MTCH2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:47629441
rs3817334-<b>T</b>,4 x 10-7,(men),0.3933,'-,'-,'-,MTCH2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:47629441
rs3817334-<b>T</b>,3 x 10-6,(women),0.3933,'-,'-,'-,MTCH2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:47629441
rs12016871-<b>T</b>,2 x 10-7,,0.1937,'-,'-,'-,MTIF3,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,13:27443645
rs9925964-<b>A</b>,1 x 10-7,,0.6332,'-,'-,'-,KAT8,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:31118574
rs11165643-<b>T</b>,1 x 10-6,(women),0.557,'-,0.0209 kg/m2 increase,[0.012-0.029],EEF1A1P11,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:96458541
rs2287019-<b>T</b>,3 x 10-6,(men),0.1869,'-,0.0302 kg/m2 decrease,[0.017-0.043],QPCTL,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:45698914
rs2287019-<b>T</b>,7 x 10-9,,0.1869,'-,0.0276 kg/m2 decrease,[0.018-0.037],QPCTL,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,19:45698914
rs6804842-<b>A</b>,1 x 10-7,,0.4416,'-,0.0173 kg/m2 decrease,[0.011-0.024],RNA5SP125,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:25064946
rs16851483-<b>T</b>,2 x 10-6,(women),0.0732,'-,0.0456 kg/m2 increase,[0.027-0.064],RASA2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:141556594
rs16851483-<b>T</b>,3 x 10-12,,0.0732,'-,0.0502 kg/m2 increase,[0.036-0.064],RASA2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:141556594
rs16851483-<b>T</b>,9 x 10-8,(men),0.0732,'-,0.0554 kg/m2 increase,[0.035-0.076],RASA2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:141556594
rs1441264-<b>A</b>,9 x 10-6,,0.6192,'-,0.016 kg/m2 increase,[0.0089-0.0231],"CCT5P2, NIPA2P5",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,13:79006784
rs2650492-<b>A</b>,3 x 10-8,,0.2933,'-,0.0225 kg/m2 increase,[0.015-0.03],SBK1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,16:28322090
rs17001654-<b>C</b>,2 x 10-7,,0.8438,'-,0.0273 kg/m2 decrease,[0.017-0.038],SCARB2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,4:76208415
rs543874-<b>A</b>,3 x 10-31,(women),0.8024,'-,0.0601 kg/m2 decrease,[0.05-0.07],SEC16B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:177920345
rs543874-<b>A</b>,1 x 10-35,,0.8024,'-,0.0497 kg/m2 decrease,[0.042-0.058],SEC16B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:177920345
rs543874-<b>A</b>,2 x 10-9,(men),0.8024,'-,0.0353 kg/m2 decrease,[0.024-0.047],SEC16B,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,1:177920345
rs13107325-<b>T</b>,3 x 10-10,,0.0737,'-,0.0469 kg/m2 increase,[0.032-0.062],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,Mapping not available
rs13107325-<b>T</b>,4 x 10-9,(men),0.0737,'-,0.0607 kg/m2 increase,[0.041-0.081],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,Mapping not available
rs10929925-<b>C</b>,2 x 10-13,,0.559,'-,0.019 kg/m2 increase,[0.013-0.025],SILC1,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,2:6015425
rs6794880-<b>A</b>,5 x 10-9,,0.847,'-,0.022 kg/m2 increase,[0.014-0.03],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,3:84402361
rs9540493-<b>A</b>,8 x 10-8,,0.469,'-,0.0184 kg/m2 increase,[0.012-0.025],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,13:65631572
rs9540493-<b>A</b>,3 x 10-6,(women),0.469,'-,0.0206 kg/m2 increase,[0.012-0.029],'-,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,13:65631572
rs7903146-<b>T</b>,1 x 10-7,(men),0.2894,'-,0.0273 kg/m2 decrease,[0.017-0.037],TCF7L2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,10:112998590
rs7903146-<b>T</b>,1 x 10-7,,0.2894,'-,0.0195 kg/m2 decrease,[0.012-0.027],TCF7L2,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,10:112998590
rs2207139-<b>A</b>,4 x 10-12,(women),0.8269,'-,0.0392 kg/m2 decrease,[0.028-0.05],"RPS17P5, FTH1P5",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:50877777
rs2207139-<b>A</b>,9 x 10-19,,0.8269,'-,0.038 kg/m2 decrease,[0.03-0.046],"RPS17P5, FTH1P5",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:50877777
rs2207139-<b>A</b>,4 x 10-9,(men),0.8269,'-,0.0367 kg/m2 decrease,[0.024-0.049],"RPS17P5, FTH1P5",BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,6:50877777
rs1928295-<b>T</b>,1 x 10-8,,0.5549,'-,0.0191 kg/m2 increase,[0.013-0.026],RPL35AP22,BMI (adjusted for smoking behaviour),"smoking behavior, body mass index",GCST004495,9:117616205
rs9991328-<b>T</b>,3 x 10-13,(women),0.498,'-,0.0373 unit increase,[0.027-0.047],FAM13A,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,4:88791970
rs6556301-<b>T</b>,4 x 10-7,,0.3609,'-,0.0215 unit increase,[0.013-0.03],"FGFR4, NSD1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:177100576
rs6556301-<b>T</b>,4 x 10-7,(men),0.3609,'-,0.0294 unit increase,[0.018-0.041],"FGFR4, NSD1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:177100576
rs10919388-<b>A</b>,2 x 10-7,(women),0.28,'-,0.0293 unit decrease,[0.018-0.04],"GORAB-AS1, HAUS4P1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:170403362
rs10919388-<b>A</b>,8 x 10-8,,0.28,'-,0.022 unit decrease,[0.014-0.03],"GORAB-AS1, HAUS4P1",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,1:170403362
rs10195252-<b>T</b>,5 x 10-11,,0.575,'-,0.0253 unit increase,[0.018-0.033],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164656581
rs10195252-<b>T</b>,1 x 10-22,(women),0.575,'-,0.0518 unit increase,[0.041-0.062],COBLL1,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,2:164656581
rs1049281-<b>C</b>,1 x 10-18,,0.652,'-,0.026 unit increase,[0.02-0.032],HLA-C,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,6:31268790
rs7801581-<b>T</b>,8 x 10-9,,0.2506,'-,0.0248 unit increase,[0.016-0.033],HOXA11,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,7:27184152
rs7801581-<b>T</b>,3 x 10-6,(men),0.2506,'-,0.0293 unit increase,[0.017-0.042],HOXA11,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,7:27184152
rs10783615-<b>A</b>,7 x 10-11,(women),0.7973,'-,0.0412 unit decrease,[0.029-0.054],HOXC12,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:53955989
rs10783615-<b>A</b>,7 x 10-13,,0.7973,'-,0.035 unit decrease,[0.025-0.045],HOXC12,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:53955989
rs1443512-<b>A</b>,1 x 10-10,,0.2662,'-,0.0271 unit increase,[0.019-0.035],"HOXC12, HOXC13",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:53948900
rs1443512-<b>A</b>,2 x 10-11,(women),0.2662,'-,0.0394 unit increase,[0.028-0.051],"HOXC12, HOXC13",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:53948900
rs2071449-<b>A</b>,1 x 10-6,(women),0.3602,'-,0.0247 unit increase,[0.015-0.035],"HOXC4, HOXC5",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:54034227
rs2071449-<b>A</b>,6 x 10-13,,0.3602,'-,0.0285 unit increase,[0.021-0.036],"HOXC4, HOXC5",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:54034227
rs2071449-<b>A</b>,9 x 10-9,(men),0.3602,'-,0.0339 unit increase,[0.022-0.045],"HOXC4, HOXC5",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:54034227
rs2071449-<b>A</b>,3 x 10-12,"(AA, men)",0.365,'-,0.006 unit increase,[-0.00184-0.01384],"HOXC4, HOXC5",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:54034227
rs754133-<b>A</b>,2 x 10-12,"(EA, men)",0.361,'-,0.03 unit increase,[0.022-0.038],"HOXC6, HOXC4",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:54025136
rs10842707-<b>T</b>,1 x 10-13,,0.2246,'-,0.0309 unit increase,[0.023-0.039],"ITPR2, SSPN",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:26318431
rs10842707-<b>T</b>,9 x 10-16,(women),0.2246,'-,0.0446 unit increase,[0.034-0.055],"ITPR2, SSPN",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,12:26318431
rs12608504-<b>A</b>,3 x 10-9,,0.3583,'-,0.0227 unit increase,[0.015-0.03],"JUND, IQCN",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,19:18278325
rs12608504-<b>A</b>,3 x 10-11,"(AA, men)",0.362,'-,0.027 unit increase,[0.019-0.035],"JUND, IQCN",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,19:18278325
rs12608504-<b>A</b>,5 x 10-9,(men),0.3583,'-,0.0318 unit increase,[0.021-0.042],"JUND, IQCN",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,19:18278325
rs8066985-<b>A</b>,3 x 10-10,,0.4857,'-,0.0215 unit increase,[0.015-0.028],'-,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,17:70457204
rs849140-<b>T</b>,3 x 10-12,,0.4168,'-,0.0253 unit increase,[0.018-0.032],JAZF1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:28144083
rs998584-<b>A</b>,3 x 10-6,,0.4672,'-,0.0254 unit increase,[0.015-0.036],"LINC02537, VEGFA",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:43790159
rs2638953-<b>C</b>,2 x 10-12,,0.6764,'-,0.0258 unit increase,[0.019-0.033],CCDC91,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:28381482
rs6772896-<b>T</b>,1 x 10-12,,0.6799,'-,0.026 unit increase,[0.019-0.033],ANAPC13,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:134484505
rs17451107-<b>T</b>,6 x 10-13,,0.6145,'-,0.0263 unit increase,[0.019-0.034],"LINC00880, LEKR1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:157079820
rs7166081-<b>A</b>,2 x 10-10,,0.7599,'-,0.0266 unit increase,[0.018-0.035],"AAGAB, SMAD3",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:67199963
rs17396340-<b>A</b>,1 x 10-11,,0.132,'-,0.027 unit increase,[0.019-0.035],KIF1B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:10226118
rs395962-<b>T</b>,3 x 10-14,,0.3169,'-,0.0281 unit increase,[0.021-0.035],LIN28B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:104949543
rs2274432-<b>A</b>,3 x 10-14,,0.3486,'-,0.0283 unit increase,[0.021-0.036],TSEN15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:184051811
rs2071449-<b>A</b>,4 x 10-14,,0.3614,'-,0.0292 unit increase,[0.022-0.037],"HOXC4, HOXC5",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:54034227
rs4378999-<b>T</b>,8 x 10-11,,0.119,'-,0.03 unit increase,[0.02-0.04],DOCK3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:51171215
rs6556301-<b>T</b>,4 x 10-14,,0.3605,'-,0.0314 unit increase,[0.023-0.039],"FGFR4, NSD1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:177100576
rs7536458-<b>T</b>,2 x 10-15,,0.748,'-,0.0333 unit increase,[0.025-0.042],RNA5SP56,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:118321979
rs3791679-<b>A</b>,5 x 10-16,,0.7555,'-,0.0354 unit increase,[0.027-0.044],EFEMP1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:55869757
rs10923712-<b>A</b>,2 x 10-25,,0.6025,'-,0.0366 unit increase,[0.03-0.043],TBX15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:118962811
rs473902-<b>T</b>,6 x 10-8,,0.918,'-,0.0413 unit increase,[0.026-0.056],PTCH1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,9:95493953
rs16957304-<b>A</b>,8 x 10-11,,0.9298,'-,0.0599 unit increase,[0.042-0.078],KCTD19,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,16:67301066
rs10991437-<b>A</b>,8 x 10-8,,0.1167,'-,0.0294 unit increase,[0.019-0.04],CT70,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,9:104973639
rs10991437-<b>A</b>,3 x 10-6,(women),0.1167,'-,0.0341 unit increase,[0.02-0.048],CT70,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,9:104973639
rs2371767-<b>C</b>,1 x 10-22,(women),0.3027,'-,0.0515 unit decrease,[0.041-0.062],ADAMTS9-AS2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:64732582
rs2371767-<b>C</b>,5 x 10-18,,0.3027,'-,0.035 unit decrease,[0.027-0.043],ADAMTS9-AS2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:64732582
rs459193-<b>A</b>,9 x 10-13,,0.2796,'-,0.0278 unit increase,[0.02-0.035],"C5orf67, RPL26P19",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:56510924
rs459193-<b>A</b>,2 x 10-13,(men),0.2796,'-,0.0429 unit increase,[0.031-0.054],"C5orf67, RPL26P19",Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,5:56510924
rs670752-<b>A</b>,3 x 10-10,"(AA,women)",0.296,'-,0.024 unit increase,[0.016-0.032],BBX,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,3:107594133
rs12454712-<b>T</b>,7 x 10-6,(women),0.6153,'-,0.0304 unit increase,[0.017-0.044],BCL2,Waist-to-hip ratio adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004505,18:63178651
rs2047937-<b>T</b>,4 x 10-7,,0.5057,'-,0.0176 unit decrease,[0.011-0.024],ZNF423,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,16:49830880
rs4246302-<b>A</b>,5 x 10-6,,0.6969,'-,0.0173 unit decrease,[0.0099-0.0247],ADAMTS17,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:100147762
rs7970350-<b>T</b>,8 x 10-7,,0.497,'-,0.0172 unit decrease,[0.01-0.024],"MIR6074, HMGA2",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:65966384
rs1144-<b>T</b>,5 x 10-6,,0.6579,'-,0.0165 unit decrease,[0.0094-0.0236],SRPK2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:105115908
rs6012558-<b>A</b>,2 x 10-9,,0.412,'-,0.016 unit increase,[0.01-0.022],"PREX1, ARFGEF2",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,20:48914749
rs3862030-<b>A</b>,1 x 10-6,,0.5599,'-,0.0164 unit increase,[0.0097-0.0231],SUFU,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,10:102567827
rs10516107-<b>A</b>,8 x 10-6,,0.3058,'-,0.017 unit increase,[0.0096-0.0244],CPEB4,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:173921153
rs6743226-<b>C</b>,7 x 10-12,,0.543,'-,0.018 unit increase,[0.012-0.024],HDLBP,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:241297557
rs12127195-<b>A</b>,1 x 10-6,,0.3148,'-,0.0181 unit increase,[0.011-0.025],'-,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:221136075
rs13210323-<b>A</b>,2 x 10-6,,0.7176,'-,0.0183 unit increase,[0.011-0.026],ANKS1A,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:35037307
rs6715793-<b>T</b>,2 x 10-7,,0.4858,'-,0.0185 unit increase,[0.011-0.026],LTBP1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:33154196
rs10269774-<b>A</b>,3 x 10-10,,0.333,'-,0.019 unit increase,[0.013-0.025],CDK6,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:92624658
rs12608504-<b>A</b>,3 x 10-8,,0.3589,'-,0.0208 unit increase,[0.014-0.028],"JUND, IQCN",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,19:18278325
rs10041657-<b>A</b>,2 x 10-7,,0.2268,'-,0.021 unit increase,[0.013-0.029],FER,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:108816727
rs12317176-<b>T</b>,4 x 10-9,,0.649,'-,0.0211 unit increase,[0.014-0.028],"CCDC92, DNAH10",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:123920171
rs2745353-<b>T</b>,6 x 10-10,,0.5202,'-,0.0215 unit increase,[0.015-0.028],RSPO3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:127131790
rs7773004-<b>A</b>,5 x 10-11,,0.4885,'-,0.0225 unit increase,[0.016-0.029],"H2BC9, H3C8",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:26267527
rs7801581-<b>T</b>,9 x 10-8,,0.2502,'-,0.0228 unit increase,[0.014-0.031],HOXA11,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:27184152
rs1884897-<b>A</b>,7 x 10-10,,0.3739,'-,0.0229 unit increase,[0.016-0.03],LINC01713,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,20:6632185
rs9408815-<b>C</b>,1 x 10-11,,0.75,'-,0.023 unit increase,[0.017-0.029],LINC01505,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,9:106128240
rs4542783-<b>T</b>,1 x 10-8,,0.543,'-,0.0231 unit increase,[0.015-0.031],MYO1F,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,19:8577276
rs7697556-<b>T</b>,5 x 10-19,,0.486,'-,0.024 unit increase,[0.018-0.03],ADAMTS3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:72649596
rs6470765-<b>A</b>,3 x 10-12,,0.777,'-,0.024 unit increase,[0.018-0.03],"MTRF1LP2, CCDC26",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,8:129724451
rs822531-<b>T</b>,5 x 10-7,,0.7837,'-,0.0241 unit increase,[0.015-0.034],"RN7SL569P, RNY4",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:148932667
rs12991495-<b>T</b>,3 x 10-10,,0.6973,'-,0.0253 unit increase,[0.017-0.033],DNMT3A,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:25263901
rs1106529-<b>A</b>,4 x 10-9,,0.7439,'-,'-,'-,TBX15,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:118988874
rs2645294-<b>T</b>,1 x 10-9,,0.5659,'-,'-,'-,WARS2,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:119031964
rs10919388-<b>A</b>,2 x 10-6,,0.28,'-,'-,'-,"GORAB-AS1, HAUS4P1",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:170403362
rs714515-<b>A</b>,9 x 10-6,,0.5576,'-,'-,'-,"PIGC, DNM3",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:172383850
rs2820443-<b>T</b>,6 x 10-11,,0.7255,'-,'-,'-,ZC3H11B,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:219580167
rs2371767-<b>C</b>,6 x 10-13,,0.3027,'-,'-,'-,ADAMTS9-AS2,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,3:64732582
rs6556301-<b>T</b>,7 x 10-6,,0.3609,'-,'-,'-,"FGFR4, NSD1",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,5:177100576
rs7759742-<b>A</b>,1 x 10-8,,0.5117,'-,'-,'-,"HLA-DRA, TSBP1-AS1",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:32413959
rs1358980-<b>T</b>,5 x 10-7,,0.4685,'-,'-,'-,"VEGFA, LINC02537",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:43796814
rs1936805-<b>T</b>,2 x 10-12,,0.518,'-,'-,'-,RSPO3,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:127130971
rs12679556-<b>T</b>,5 x 10-8,,0.7074,'-,'-,'-,EYA1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,8:71601993
rs10842707-<b>T</b>,5 x 10-6,,0.2246,'-,'-,'-,"ITPR2, SSPN",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:26318431
rs1443512-<b>A</b>,5 x 10-7,,0.2662,'-,'-,'-,"HOXC12, HOXC13",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:53948900
rs10783615-<b>A</b>,2 x 10-10,,0.7973,'-,'-,'-,HOXC12,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:53955989
rs4765219-<b>A</b>,2 x 10-7,,0.3303,'-,'-,'-,CCDC92,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,12:123955563
rs8042543-<b>T</b>,7 x 10-6,,0.2071,'-,'-,'-,KLF13,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,15:31416060
rs6090583-<b>A</b>,3 x 10-7,,0.495,'-,'-,'-,EYA2,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,20:46930192
rs10919388-<b>A</b>,7 x 10-6,(women),0.28,'-,'-,'-,"GORAB-AS1, HAUS4P1",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:170403362
rs714515-<b>A</b>,7 x 10-6,(women),0.5576,'-,'-,'-,"PIGC, DNM3",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:172383850
rs2820443-<b>T</b>,2 x 10-17,(women),0.7255,'-,'-,'-,ZC3H11B,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:219580167
rs10195252-<b>T</b>,3 x 10-6,(women),0.575,'-,'-,'-,COBLL1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,2:164656581
rs1128249-<b>T</b>,2 x 10-9,(women),0.4179,'-,'-,'-,COBLL1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,2:164672114
rs12692738-<b>T</b>,4 x 10-7,(women),0.7339,'-,'-,'-,COBLL1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,2:164701742
rs17819328-<b>T</b>,6 x 10-6,(women),0.5694,'-,'-,'-,"PPARG, TSEN2",Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,3:12447843
rs2371767-<b>C</b>,1 x 10-15,(women),0.3027,'-,'-,'-,ADAMTS9-AS2,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,3:64732582
rs7536458-<b>T</b>,7 x 10-17,,0.748,'-,'-,'-,RNA5SP56,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:118321979
rs7536458-<b>T</b>,3 x 10-10,(men),0.748,'-,'-,'-,RNA5SP56,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:118321979
rs7536458-<b>T</b>,2 x 10-8,(women),0.748,'-,'-,'-,RNA5SP56,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:118321979
rs3862030-<b>A</b>,2 x 10-8,(women),0.5599,'-,'-,'-,SUFU,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,10:102567827
rs3862030-<b>A</b>,2 x 10-6,,0.5599,'-,'-,'-,SUFU,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,10:102567827
rs10923712-<b>A</b>,2 x 10-25,,0.6025,'-,'-,'-,TBX15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:118962811
rs10923712-<b>A</b>,3 x 10-17,(women),0.6025,'-,'-,'-,TBX15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:118962811
rs10923712-<b>A</b>,3 x 10-11,(men),0.6025,'-,'-,'-,TBX15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:118962811
rs12048049-<b>C</b>,5 x 10-10,,0.6885,'-,'-,'-,TGFB2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:218423955
rs12048049-<b>C</b>,8 x 10-8,(men),0.6885,'-,'-,'-,TGFB2,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:218423955
rs9408815-<b>C</b>,3 x 10-11,,NR,'-,'-,'-,LINC01505,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,9:106128240
rs9409082-<b>C</b>,7 x 10-11,,NR,'-,'-,'-,LINC01505,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,9:106138768
rs2160077-<b>A</b>,3 x 10-8,,0.4322,'-,'-,'-,"FBLN5, TRIP11",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,14:91962066
rs2160077-<b>A</b>,2 x 10-6,(men),0.4322,'-,'-,'-,"FBLN5, TRIP11",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,14:91962066
rs2274432-<b>A</b>,2 x 10-15,,0.3486,'-,'-,'-,TSEN15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:184051811
rs2274432-<b>A</b>,2 x 10-10,(women),0.3486,'-,'-,'-,TSEN15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:184051811
rs2274432-<b>A</b>,9 x 10-7,(men),0.3486,'-,'-,'-,TSEN15,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,1:184051811
rs998584-<b>A</b>,2 x 10-24,(women),0.4672,'-,'-,'-,"LINC02537, VEGFA",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:43790159
rs998584-<b>A</b>,1 x 10-13,,0.4672,'-,'-,'-,"LINC02537, VEGFA",Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,6:43790159
rs1344674-<b>A</b>,1 x 10-14,,0.5451,'-,'-,'-,ZBTB38,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:141406344
rs1344674-<b>A</b>,2 x 10-13,(men),0.5451,'-,'-,'-,ZBTB38,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,3:141406344
rs2047937-<b>T</b>,1 x 10-6,,0.5057,'-,'-,'-,ZNF423,Waist circumference adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist circumference",GCST004501,16:49830880
rs765751-<b>C</b>,8 x 10-22,,0.611,'-,'-,'-,LYPLAL1-AS1,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,1:219495884
rs1049281-<b>C</b>,2 x 10-10,,0.652,'-,'-,'-,HLA-C,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:31268790
rs7766106-<b>T</b>,3 x 10-34,,0.486,'-,'-,'-,RSPO3,Waist-to-hip ratio adjusted for BMI (joint analysis main effects and smoking interaction),"smoking behavior, BMI-adjusted waist-hip ratio",GCST004507,6:127133993
rs17001654-<b>C</b>,2 x 10-6,,0.8438,'-,'-,'-,SCARB2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,4:76208415
rs543874-<b>A</b>,6 x 10-35,,0.8024,'-,'-,'-,SEC16B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:177920345
rs543874-<b>A</b>,9 x 10-31,(women),0.8024,'-,'-,'-,SEC16B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:177920345
rs543874-<b>A</b>,2 x 10-9,(men),0.8024,'-,'-,'-,SEC16B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:177920345
rs13107325-<b>T</b>,2 x 10-10,,0.0737,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,Mapping not available
rs13107325-<b>T</b>,1 x 10-8,(men),0.0737,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,Mapping not available
rs10929925-<b>C</b>,1 x 10-12,,0.019,'-,'-,'-,SILC1,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:6015425
rs6794880-<b>A</b>,1 x 10-7,,0.847,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:84402361
rs9540493-<b>A</b>,8 x 10-7,,0.469,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,13:65631572
rs7903146-<b>T</b>,6 x 10-9,,0.2894,'-,'-,'-,TCF7L2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,10:112998590
rs7903146-<b>T</b>,4 x 10-8,(men),0.2894,'-,'-,'-,TCF7L2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,10:112998590
rs2207139-<b>A</b>,4 x 10-21,,0.8269,'-,'-,'-,"RPS17P5, FTH1P5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:50877777
rs2207139-<b>A</b>,2 x 10-13,(women),0.8269,'-,'-,'-,"RPS17P5, FTH1P5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:50877777
rs2207139-<b>A</b>,2 x 10-9,(men),0.8269,'-,'-,'-,"RPS17P5, FTH1P5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:50877777
rs1928295-<b>T</b>,1 x 10-8,,0.5549,'-,'-,'-,RPL35AP22,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,9:117616205
rs1928295-<b>T</b>,2 x 10-6,(women),0.5549,'-,'-,'-,RPL35AP22,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,9:117616205
rs13021737-<b>A</b>,8 x 10-40,,0.1701,'-,'-,'-,"TMEM18, LINC01875",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:632348
rs13021737-<b>A</b>,3 x 10-28,(women),0.1701,'-,'-,'-,"TMEM18, LINC01875",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:632348
rs13021737-<b>A</b>,1 x 10-15,(men),0.1701,'-,'-,'-,"TMEM18, LINC01875",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:632348
rs12566985-<b>A</b>,7 x 10-9,,0.5312,'-,'-,'-,"TNNI3K, FPGT-TNNI3K",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:74536509
rs12566985-<b>A</b>,8 x 10-7,(women),0.5312,'-,'-,'-,"TNNI3K, FPGT-TNNI3K",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:74536509
rs2075650-<b>A</b>,1 x 10-6,,0.8558,'-,'-,'-,TOMM40,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:44892362
rs4256980-<b>C</b>,5 x 10-6,,0.3733,'-,'-,'-,TRIM66,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:8652392
rs10733682-<b>A</b>,5 x 10-6,,0.467,'-,'-,'-,LMX1B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,9:126698635
rs3810291-<b>A</b>,1 x 10-13,,0.6246,'-,'-,'-,ZC3H4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:47065746
rs3791679-<b>A</b>,6 x 10-7,(women),0.7555,'-,0.0294 unit increase,[0.018-0.041],EFEMP1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:55869757
rs2274432-<b>A</b>,5 x 10-10,(women),0.3486,'-,0.0296 unit increase,[0.02-0.039],TSEN15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:184051811
rs2745353-<b>T</b>,6 x 10-12,(women),0.5202,'-,0.03 unit increase,[0.022-0.038],RSPO3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:127131790
rs7536458-<b>T</b>,1 x 10-8,(women),0.748,'-,0.0321 unit increase,[0.021-0.043],RNA5SP56,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:118321979
rs17451107-<b>T</b>,3 x 10-12,(women),0.6145,'-,0.0322 unit increase,[0.023-0.041],"LINC00880, LEKR1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:157079820
rs7830933-<b>A</b>,1 x 10-10,(women),0.7571,'-,0.0332 unit increase,[0.023-0.043],"NKX2-6, STC1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,8:23745811
rs9860730-<b>A</b>,5 x 10-13,(women),0.6495,'-,0.0344 unit increase,[0.025-0.044],ADAMTS9-AS2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:64715470
rs10195252-<b>T</b>,9 x 10-14,(women),0.5727,'-,0.038 unit increase,[0.028-0.048],COBLL1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:164656581
rs12317176-<b>T</b>,3 x 10-17,(women),0.649,'-,0.0383 unit increase,[0.029-0.047],"CCDC92, DNAH10",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:123920171
rs10923712-<b>A</b>,9 x 10-18,(women),0.6025,'-,0.0388 unit increase,[0.03-0.048],TBX15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:118962811
rs473902-<b>T</b>,6 x 10-6,(women),0.918,'-,0.0446 unit increase,[0.025-0.064],PTCH1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,9:95493953
rs7162542-<b>C</b>,1 x 10-14,(men),0.4275,'-,0.0381 unit decrease,[0.028-0.048],ADAMTSL3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:83845538
rs7684221-<b>A</b>,5 x 10-8,(men),0.1931,'-,0.0374 unit decrease,[0.024-0.051],LCORL,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:17955731
rs11205277-<b>A</b>,2 x 10-10,(men),0.596,'-,0.0354 unit decrease,[0.025-0.046],"SF3B4, SV2A",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:149920979
rs12207675-<b>T</b>,7 x 10-6,(men),0.8857,'-,0.0347 unit decrease,[0.02-0.05],"RPL26P20, H3P27",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:75528025
rs4886782-<b>A</b>,1 x 10-10,(men),0.3642,'-,0.0344 unit decrease,[0.024-0.045],LOXL1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:73936469
rs336396-<b>T</b>,3 x 10-6,,0.182,'-,'-,'-,INPP4B,BMI (smoking interaction),"smoking behavior, body mass index",GCST004496,4:142141658
rs12902602-<b>A</b>,6 x 10-13,,0.609,'-,'-,'-,CHRNB4,BMI (smoking interaction),"smoking behavior, body mass index",GCST004496,15:78675059
rs1776897-<b>T</b>,6 x 10-15,(women),0.8414,'-,0.0647 unit decrease,[0.048-0.081],"CYCSP55, HMGA1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:34227234
rs4239436-<b>A</b>,9 x 10-13,(women),0.2027,'-,0.0393 unit decrease,[0.029-0.05],CABLES1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,18:23151966
rs4141278-<b>T</b>,4 x 10-11,(women),0.7935,'-,0.0385 unit decrease,[0.027-0.05],'-,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:25817905
rs12207675-<b>T</b>,2 x 10-6,(women),0.8857,'-,0.0328 unit decrease,[0.019-0.046],"RPL26P20, H3P27",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:75528025
rs7162542-<b>C</b>,2 x 10-12,(women),0.4275,'-,0.0311 unit decrease,[0.022-0.04],ADAMTSL3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:83845538
rs11205277-<b>A</b>,4 x 10-7,(women),0.596,'-,0.0284 unit decrease,[0.017-0.039],"SF3B4, SV2A",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:149920979
rs9435732-<b>T</b>,5 x 10-8,(women),0.2658,'-,0.027 unit decrease,[0.017-0.037],"ATP13A2, MFAP2",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:16981663
rs1879529-<b>T</b>,9 x 10-7,(women),0.279,'-,0.0246 unit decrease,[0.015-0.034],ACAN,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:88871064
rs12679556-<b>T</b>,1 x 10-6,(women),0.7067,'-,0.0245 unit decrease,[0.015-0.034],EYA1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,8:71601993
rs12489828-<b>T</b>,4 x 10-7,(women),0.5401,'-,0.0229 unit decrease,[0.014-0.032],NT5DC2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:52532998
rs12493901-<b>A</b>,3 x 10-6,(women),0.4712,'-,0.0214 unit decrease,[0.012-0.03],FNDC3B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:172204265
rs4868125-<b>C</b>,6 x 10-6,(women),0.3979,'-,0.0212 unit decrease,[0.012-0.03],"SMIM23, FBXW11",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:171854871
rs2638953-<b>C</b>,5 x 10-6,(women),0.6764,'-,0.0212 unit increase,[0.012-0.03],CCDC91,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:28381482
rs6772896-<b>T</b>,6 x 10-7,(women),0.6799,'-,0.0231 unit increase,[0.014-0.032],ANAPC13,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:134484505
rs10516107-<b>A</b>,2 x 10-6,(women),0.3058,'-,0.0234 unit increase,[0.014-0.033],CPEB4,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:173921153
rs2071449-<b>A</b>,2 x 10-6,(women),0.3614,'-,0.0235 unit increase,[0.014-0.033],"HOXC4, HOXC5",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:54034227
rs3862030-<b>A</b>,2 x 10-8,(women),0.5599,'-,0.0244 unit increase,[0.016-0.033],SUFU,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,10:102567827
rs849140-<b>T</b>,3 x 10-7,(women),0.4168,'-,0.025 unit increase,[0.016-0.034],JAZF1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:28144083
rs1884897-<b>A</b>,3 x 10-7,(women),0.3739,'-,0.0254 unit increase,[0.016-0.035],LINC01713,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,20:6632185
rs13173241-<b>A</b>,2 x 10-6,(women),0.1961,'-,0.0264 unit increase,[0.016-0.037],C5orf67,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:56565532
rs4542783-<b>T</b>,6 x 10-7,(women),0.543,'-,0.027 unit increase,[0.016-0.038],MYO1F,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,19:8577276
rs6556301-<b>T</b>,2 x 10-6,(women),0.3605,'-,0.0272 unit increase,[0.016-0.038],"FGFR4, NSD1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:177100576
rs3897379-<b>A</b>,7 x 10-7,(women),0.1974,'-,0.0272 unit increase,[0.016-0.038],ZC3H11B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:219586391
rs998584-<b>A</b>,5 x 10-25,(women),0.4672,'-,0.0529 unit increase,[0.043-0.063],"LINC02537, VEGFA",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:43790159
rs16957304-<b>A</b>,7 x 10-9,(women),0.9298,'-,0.069 unit increase,[0.046-0.092],KCTD19,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,16:67301066
rs4239436-<b>A</b>,8 x 10-14,(men),0.2027,'-,0.0455 unit decrease,[0.034-0.057],CABLES1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,18:23151966
rs1776897-<b>T</b>,7 x 10-6,(men),0.8414,'-,0.0423 unit decrease,[0.024-0.061],"CYCSP55, HMGA1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:34227234
rs9435732-<b>T</b>,1 x 10-11,(men),0.2658,'-,0.038 unit decrease,[0.027-0.049],"ATP13A2, MFAP2",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:16981663
rs1344674-<b>A</b>,2 x 10-14,(men),0.5451,'-,0.0379 unit decrease,[0.028-0.048],ZBTB38,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:141406344
rs1812175-<b>A</b>,2 x 10-8,(men),0.1839,'-,0.0375 unit decrease,[0.024-0.051],"HHIP-AS1, HHIP",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:144653692
rs6570507-<b>A</b>,2 x 10-8,(men),0.3186,'-,0.0306 unit decrease,[0.02-0.041],ADGRG6,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:142358435
rs12048049-<b>C</b>,1 x 10-8,(men),0.6885,'-,0.0303 unit decrease,[0.02-0.041],TGFB2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:218423955
rs3810291-<b>A</b>,4 x 10-11,(women),0.6246,'-,'-,'-,ZC3H4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:47065746
rs6091540-<b>T</b>,3 x 10-6,,0.2731,'-,'-,'-,LINC01524,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,20:52471323
rs1809420-<b>T</b>,2 x 10-7,"(AA, men)",0.582,'-,'-,'-,ADAMTS7,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,15:78764427
rs10182181-<b>A</b>,1 x 10-18,,0.5182,'-,'-,'-,"ADCY3, DNAJC27",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:24927427
rs10182181-<b>A</b>,4 x 10-12,(women),0.5182,'-,'-,'-,"ADCY3, DNAJC27",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:24927427
rs10182181-<b>A</b>,7 x 10-8,(men),0.5182,'-,'-,'-,"ADCY3, DNAJC27",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:24927427
rs7164727-<b>T</b>,6 x 10-7,,0.6483,'-,'-,'-,"ADPGK-AS1, NPM1P42",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,15:72801650
rs6465468-<b>T</b>,7 x 10-7,(women),0.2957,'-,'-,'-,ASB4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:95540202
rs6465468-<b>T</b>,2 x 10-6,,0.2957,'-,'-,'-,ASB4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:95540202
rs3888190-<b>A</b>,6 x 10-18,,0.3835,'-,'-,'-,"ATP2A1, SH2B1",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:28878165
rs3888190-<b>A</b>,2 x 10-11,(men),0.3835,'-,'-,'-,"ATP2A1, SH2B1",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:28878165
rs3888190-<b>A</b>,3 x 10-8,(women),0.3835,'-,'-,'-,"ATP2A1, SH2B1",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:28878165
rs11030104-<b>A</b>,7 x 10-24,,0.7872,'-,'-,'-,"BDNF, BDNF-AS",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:27662970
rs11030104-<b>A</b>,3 x 10-14,(women),0.7872,'-,'-,'-,"BDNF, BDNF-AS",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:27662970
rs11030104-<b>A</b>,5 x 10-11,(men),0.7872,'-,'-,'-,"BDNF, BDNF-AS",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:27662970
rs2112347-<b>T</b>,2 x 10-12,,0.6128,'-,'-,'-,"POC5, SLC25A5P9",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,5:75719417
rs2112347-<b>T</b>,6 x 10-8,(men),0.6128,'-,'-,'-,"POC5, SLC25A5P9",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,5:75719417
rs2112347-<b>T</b>,7 x 10-7,(women),0.6128,'-,'-,'-,"POC5, SLC25A5P9",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,5:75719417
rs205262-<b>A</b>,3 x 10-9,,0.694,'-,'-,'-,ILRUN,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:34595387
rs205262-<b>A</b>,2 x 10-7,(women),0.694,'-,'-,'-,ILRUN,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:34595387
rs13078960-<b>T</b>,3 x 10-9,,0.8065,'-,'-,'-,CADM2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:85758440
rs13078960-<b>T</b>,3 x 10-7,(women),0.8065,'-,'-,'-,CADM2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:85758440
rs9641123-<b>C</b>,2 x 10-11,,0.4166,'-,'-,'-,CALCR,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:93568420
rs9641123-<b>C</b>,3 x 10-7,(men),0.4166,'-,'-,'-,CALCR,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:93568420
rs9641123-<b>C</b>,4 x 10-6,(women),0.4166,'-,'-,'-,CALCR,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:93568420
rs29941-<b>A</b>,2 x 10-8,,0.3247,'-,'-,'-,KCTD15,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:33818627
rs12940622-<b>A</b>,1 x 10-7,,0.4324,'-,'-,'-,RPTOR,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,17:80641771
rs1460676-<b>T</b>,2 x 10-6,,0.8195,'-,'-,'-,FIGN,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:163711179
rs1558902-<b>A</b>,2 x 10-115,,0.4028,'-,'-,'-,FTO,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:53769662
rs29941-<b>A</b>,9 x 10-6,(women),0.3247,'-,'-,'-,KCTD15,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,19:33818627
rs1558902-<b>A</b>,2 x 10-63,(women),0.4028,'-,'-,'-,FTO,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:53769662
rs1558902-<b>A</b>,2 x 10-62,(men),0.4028,'-,'-,'-,FTO,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:53769662
rs12401738-<b>A</b>,3 x 10-7,,0.339,'-,'-,'-,"GIPC2, DNAJB4",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:77981077
rs12401738-<b>A</b>,6 x 10-6,(women),0.339,'-,'-,'-,"GIPC2, DNAJB4",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:77981077
rs7715256-<b>T</b>,2 x 10-6,,0.574,'-,'-,'-,MFAP3,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,5:154158333
rs17024393-<b>T</b>,2 x 10-11,,0.9549,'-,'-,'-,GNAT2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:109612066
rs17024393-<b>T</b>,2 x 10-7,(women),0.9549,'-,'-,'-,GNAT2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:109612066
rs10938397-<b>A</b>,7 x 10-23,,0.5821,'-,'-,'-,LINC02273,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,4:45180510
rs10938397-<b>A</b>,2 x 10-13,(women),0.5821,'-,'-,'-,LINC02273,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,4:45180510
rs10938397-<b>A</b>,3 x 10-11,(men),0.5821,'-,'-,'-,LINC02273,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,4:45180510
rs12446632-<b>A</b>,3 x 10-11,,0.1334,'-,'-,'-,GPRC5B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:19924067
rs2197271-<b>C</b>,1 x 10-6,(men),0.7215,'-,0.0293 unit decrease,[0.017-0.041],"PRKG2, RNU5A-2P",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:81239194
rs12493901-<b>A</b>,3 x 10-8,(men),0.4712,'-,0.0275 unit decrease,[0.018-0.037],FNDC3B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:172204265
rs3760318-<b>A</b>,1 x 10-7,(men),0.3801,'-,0.0268 unit decrease,[0.017-0.037],ADAP2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,17:30920697
rs2160077-<b>A</b>,7 x 10-8,(men),0.4322,'-,0.0264 unit decrease,[0.017-0.036],"FBLN5, TRIP11",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,14:91962066
rs882367-<b>T</b>,6 x 10-7,(men),0.6556,'-,0.026 unit decrease,[0.016-0.036],"LINC02875, TBX4",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,17:61417213
rs7970350-<b>T</b>,3 x 10-7,(men),0.497,'-,0.0256 unit decrease,[0.016-0.035],"MIR6074, HMGA2",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:65966384
rs849140-<b>T</b>,3 x 10-7,(men),0.4168,'-,0.0254 unit increase,[0.016-0.035],JAZF1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:28144083
rs6437061-<b>A</b>,1 x 10-6,(men),0.57,'-,0.0257 unit increase,[0.015-0.036],DIS3L2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:232320342
rs2274432-<b>A</b>,5 x 10-7,(men),0.3486,'-,0.0265 unit increase,[0.016-0.037],TSEN15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:184051811
rs7801581-<b>T</b>,3 x 10-6,(men),0.2502,'-,0.0282 unit increase,[0.016-0.04],HOXA11,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:27184152
rs7773004-<b>A</b>,4 x 10-9,(men),0.4885,'-,0.0291 unit increase,[0.019-0.039],"H2BC9, H3C8",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:26267527
rs798502-<b>A</b>,2 x 10-7,(men),0.7108,'-,0.0298 unit increase,[0.019-0.041],"AMZ1, GNA12",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:2750246
rs6772896-<b>T</b>,2 x 10-8,(men),0.6799,'-,0.0299 unit increase,[0.02-0.04],ANAPC13,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:134484505
rs2638953-<b>C</b>,2 x 10-9,(men),0.6764,'-,0.0317 unit increase,[0.021-0.042],CCDC91,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:28381482
rs12991495-<b>T</b>,2 x 10-8,(men),0.6973,'-,0.0319 unit increase,[0.021-0.043],DNMT3A,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:25263901
rs10923712-<b>A</b>,2 x 10-11,(men),0.6025,'-,0.034 unit increase,[0.024-0.044],TBX15,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:118962811
rs7166081-<b>A</b>,1 x 10-9,(men),0.7599,'-,0.0351 unit increase,[0.024-0.046],"AAGAB, SMAD3",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:67199963
rs7536458-<b>T</b>,5 x 10-10,(men),0.748,'-,0.0355 unit increase,[0.024-0.047],RNA5SP56,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:118321979
rs6556301-<b>T</b>,9 x 10-11,(men),0.3605,'-,0.0359 unit increase,[0.025-0.047],"FGFR4, NSD1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:177100576
rs2071449-<b>A</b>,6 x 10-11,(men),0.3614,'-,0.0366 unit increase,[0.026-0.048],"HOXC4, HOXC5",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,12:54034227
rs395962-<b>T</b>,6 x 10-14,(men),0.3169,'-,0.0398 unit increase,[0.029-0.05],LIN28B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:104949543
rs3791679-<b>A</b>,2 x 10-12,(men),0.7555,'-,0.0409 unit increase,[0.03-0.052],EFEMP1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,2:55869757
rs1545348-<b>T</b>,1 x 10-7,"(EA,men)",0.743,'-,0.024 unit increase,[0.014-0.034],RAI14,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:34718238
rs1776897-<b>T</b>,7 x 10-17,,0.8414,'-,0.0536 unit decrease,[0.041-0.066],"CYCSP55, HMGA1",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:34227234
rs4239436-<b>A</b>,2 x 10-22,,0.2027,'-,0.0418 unit decrease,[0.033-0.05],CABLES1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,18:23151966
rs7162542-<b>C</b>,2 x 10-23,,0.4275,'-,0.0342 unit decrease,[0.028-0.041],ADAMTSL3,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:83845538
rs12207675-<b>T</b>,7 x 10-10,,0.8857,'-,0.0333 unit decrease,[0.023-0.044],"RPL26P20, H3P27",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:75528025
rs9435732-<b>T</b>,3 x 10-16,,0.2658,'-,0.0318 unit decrease,[0.024-0.039],"ATP13A2, MFAP2",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:16981663
rs4141278-<b>T</b>,1 x 10-12,,0.7935,'-,0.0315 unit decrease,[0.023-0.04],'-,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:25817905
rs11205277-<b>A</b>,3 x 10-14,,0.596,'-,0.0311 unit decrease,[0.023-0.039],"SF3B4, SV2A",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:149920979
rs11144688-<b>A</b>,4 x 10-6,,0.1159,'-,0.0308 unit decrease,[0.018-0.044],PCSK5,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,9:75927370
rs1344674-<b>A</b>,8 x 10-15,,0.5451,'-,0.0268 unit decrease,[0.02-0.033],ZBTB38,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:141406344
rs7684221-<b>A</b>,9 x 10-9,,0.1931,'-,0.0266 unit decrease,[0.018-0.036],LCORL,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:17955731
rs6570507-<b>A</b>,2 x 10-10,,0.3186,'-,0.0256 unit decrease,[0.018-0.033],ADGRG6,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,6:142358435
rs2197271-<b>C</b>,1 x 10-9,,0.7215,'-,0.0248 unit decrease,[0.017-0.033],"PRKG2, RNU5A-2P",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:81239194
rs1812175-<b>A</b>,4 x 10-7,,0.1839,'-,0.024 unit decrease,[0.015-0.033],"HHIP-AS1, HHIP",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,4:144653692
rs12493901-<b>A</b>,1 x 10-11,,0.4712,'-,0.0239 unit decrease,[0.017-0.031],FNDC3B,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:172204265
rs12048049-<b>C</b>,1 x 10-10,,0.6885,'-,0.0239 unit decrease,[0.017-0.031],TGFB2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,1:218423955
rs2214442-<b>A</b>,2 x 10-8,,0.5223,'-,0.0234 unit decrease,[0.015-0.032],ITGB8,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,7:20353164
rs4886782-<b>A</b>,1 x 10-9,,0.3642,'-,0.0228 unit decrease,[0.015-0.03],LOXL1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:73936469
rs882367-<b>T</b>,4 x 10-10,,0.6556,'-,0.0227 unit decrease,[0.016-0.03],"LINC02875, TBX4",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,17:61417213
rs12679556-<b>T</b>,1 x 10-8,,0.7067,'-,0.0221 unit decrease,[0.014-0.03],EYA1,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,8:71601993
rs1879529-<b>T</b>,1 x 10-7,,0.279,'-,0.0206 unit decrease,[0.013-0.028],ACAN,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,15:88871064
rs12330322-<b>T</b>,2 x 10-6,,0.2274,'-,0.0201 unit decrease,[0.012-0.028],RYBP,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:72406204
rs3760318-<b>A</b>,7 x 10-8,,0.3801,'-,0.0199 unit decrease,[0.013-0.027],ADAP2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,17:30920697
rs2160077-<b>A</b>,2 x 10-8,,0.4322,'-,0.0196 unit decrease,[0.013-0.026],"FBLN5, TRIP11",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,14:91962066
rs272869-<b>A</b>,2 x 10-8,,0.4005,'-,0.0194 unit decrease,[0.013-0.026],"MIR3936HG, SLC22A4",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:132342304
rs3786897-<b>A</b>,1 x 10-7,,0.5764,'-,0.0186 unit decrease,[0.012-0.025],PEPD,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,19:33402102
rs4868125-<b>C</b>,1 x 10-6,,0.3979,'-,0.0183 unit decrease,[0.011-0.026],"SMIM23, FBXW11",Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,5:171854871
rs12489828-<b>T</b>,7 x 10-7,,0.5401,'-,0.0179 unit decrease,[0.011-0.025],NT5DC2,Waist circumference adjusted for BMI (adjusted for smoking behaviour),"smoking behavior, BMI-adjusted waist circumference",GCST004500,3:52532998
rs3101336-<b>T</b>,4 x 10-8,,0.3916,'-,0.0389 kg/m2 decrease,[0.025-0.053],"NEGR1, RPL31P12",BMI in smokers,"smoking behavior, body mass index",GCST004498,1:72285502
rs6804842-<b>A</b>,9 x 10-6,,0.4416,'-,0.0303 kg/m2 decrease,[0.017-0.044],RNA5SP125,BMI in smokers,"smoking behavior, body mass index",GCST004498,3:25064946
rs543874-<b>A</b>,1 x 10-8,(women),0.8024,'-,0.065 kg/m2 decrease,[0.043-0.087],SEC16B,BMI in smokers,"smoking behavior, body mass index",GCST004498,1:177920345
rs543874-<b>A</b>,5 x 10-10,,0.8024,'-,0.0527 kg/m2 decrease,[0.036-0.069],SEC16B,BMI in smokers,"smoking behavior, body mass index",GCST004498,1:177920345
rs2207139-<b>A</b>,2 x 10-6,(women),0.8269,'-,0.0606 kg/m2 decrease,[0.036-0.085],"RPS17P5, FTH1P5",BMI in smokers,"smoking behavior, body mass index",GCST004498,6:50877777
rs2207139-<b>A</b>,3 x 10-10,,0.8269,'-,0.0579 kg/m2 decrease,[0.04-0.076],"RPS17P5, FTH1P5",BMI in smokers,"smoking behavior, body mass index",GCST004498,6:50877777
rs13021737-<b>A</b>,1 x 10-7,(women),0.1701,'-,0.0689 kg/m2 decrease,[0.043-0.094],"TMEM18, LINC01875",BMI in smokers,"smoking behavior, body mass index",GCST004498,2:632348
rs13021737-<b>A</b>,2 x 10-12,,0.1701,'-,0.0671 kg/m2 decrease,[0.048-0.086],"TMEM18, LINC01875",BMI in smokers,"smoking behavior, body mass index",GCST004498,2:632348
rs13021737-<b>A</b>,2 x 10-6,(men),0.1701,'-,0.0661 kg/m2 decrease,[0.039-0.093],"TMEM18, LINC01875",BMI in smokers,"smoking behavior, body mass index",GCST004498,2:632348
rs3810291-<b>A</b>,1 x 10-6,,0.6246,'-,0.0371 kg/m2 increase,[0.022-0.052],ZC3H4,BMI in smokers,"smoking behavior, body mass index",GCST004498,19:47065746
rs3810291-<b>A</b>,2 x 10-6,(women),0.6246,'-,0.0495 kg/m2 increase,[0.029-0.07],ZC3H4,BMI in smokers,"smoking behavior, body mass index",GCST004498,19:47065746
rs2245368-<b>T</b>,3 x 10-9,,0.8036,'-,'-,'-,"DTX2P1, DTX2P1-UPK3BP1-PMS2P11",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:76978826
rs2245368-<b>T</b>,6 x 10-7,(women),0.8036,'-,'-,'-,"DTX2P1, DTX2P1-UPK3BP1-PMS2P11",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:76978826
rs13069244-<b>A</b>,1 x 10-10,,0.078,'-,'-,'-,CCDC39,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:180723384
rs4787491-<b>A</b>,3 x 10-8,,0.4825,'-,'-,'-,INO80E,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:30004016
rs12902602-<b>A</b>,2 x 10-12,,0.609,'-,'-,'-,CHRNB4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,15:78675059
rs1016287-<b>T</b>,6 x 10-8,,0.2819,'-,'-,'-,LINC01122,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:59078490
rs1016287-<b>T</b>,4 x 10-6,(women),0.2819,'-,'-,'-,LINC01122,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:59078490
rs3736485-<b>A</b>,6 x 10-6,,0.4757,'-,'-,'-,DMXL2,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,15:51456413
rs657452-<b>A</b>,3 x 10-6,,0.4068,'-,'-,'-,AGBL4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:49124175
rs11583200-<b>T</b>,9 x 10-6,,0.5794,'-,'-,'-,ELAVL4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:50094148
rs11583200-<b>T</b>,9 x 10-6,(women),0.5794,'-,'-,'-,ELAVL4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:50094148
rs12629427-<b>C</b>,3 x 10-7,"(AA, women)",0.258,'-,'-,'-,"GAPDHP50, EPHA3",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:89096190
rs2173039-<b>C</b>,2 x 10-7,"(EA, women)",0.258,'-,'-,'-,"GAPDHP50, EPHA3",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:89093025
rs7599312-<b>A</b>,3 x 10-10,,0.2807,'-,'-,'-,ERBB4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:212548507
rs7599312-<b>A</b>,8 x 10-7,(women),0.2807,'-,'-,'-,ERBB4,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:212548507
rs1516725-<b>T</b>,3 x 10-16,,0.1363,'-,'-,'-,"DGKG, ETV5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:186106215
rs1516725-<b>T</b>,8 x 10-12,(women),0.1363,'-,'-,'-,"DGKG, ETV5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:186106215
rs1516725-<b>T</b>,6 x 10-6,(men),0.1363,'-,'-,'-,"DGKG, ETV5",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:186106215
rs7138803-<b>A</b>,3 x 10-15,,0.3705,'-,'-,'-,"BCDIN3D, RPL35AP28",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,12:49853685
rs7138803-<b>A</b>,3 x 10-10,(women),0.3705,'-,'-,'-,"BCDIN3D, RPL35AP28",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,12:49853685
rs7138803-<b>A</b>,6 x 10-7,(men),0.3705,'-,'-,'-,"BCDIN3D, RPL35AP28",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,12:49853685
rs12286929-<b>A</b>,4 x 10-8,,0.4783,'-,'-,'-,CADM1,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,11:115151684
rs2365389-<b>T</b>,2 x 10-16,,0.4348,'-,'-,'-,FHIT,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:61250788
rs2365389-<b>T</b>,1 x 10-11,(men),0.4348,'-,'-,'-,FHIT,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:61250788
rs2365389-<b>T</b>,3 x 10-8,(women),0.4348,'-,'-,'-,FHIT,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,3:61250788
rs3791679-<b>A</b>,2 x 10-7,,0.7555,'-,0.0468 unit increase,[0.029-0.064],EFEMP1,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,2:55869757
rs10041657-<b>A</b>,2 x 10-6,,0.2268,'-,0.0414 unit increase,[0.025-0.058],FER,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,5:108816727
rs395962-<b>T</b>,3 x 10-6,,0.3169,'-,0.0367 unit increase,[0.021-0.052],LIN28B,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,6:104949543
rs6556301-<b>T</b>,3 x 10-6,,0.3605,'-,0.0401 unit increase,[0.023-0.057],"FGFR4, NSD1",Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,5:177100576
rs12991495-<b>T</b>,4 x 10-6,,0.6973,'-,0.039 unit increase,[0.023-0.055],DNMT3A,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,2:25263901
rs1344674-<b>A</b>,6 x 10-6,,0.5451,'-,0.0329 unit decrease,[0.019-0.047],ZBTB38,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,3:141406344
rs1809420-<b>T</b>,1 x 10-7,"(AA, men)",0.582,'-,0.059 kg/m2 increase,[0.037-0.081],ADAMTS7,BMI in smokers,"smoking behavior, body mass index",GCST004498,15:78764427
rs11030104-<b>A</b>,7 x 10-6,(men),0.7872,'-,0.0554 kg/m2 increase,[0.031-0.08],"BDNF, BDNF-AS",BMI in smokers,"smoking behavior, body mass index",GCST004498,11:27662970
rs11030104-<b>A</b>,6 x 10-11,,0.7872,'-,0.0576 kg/m2 increase,[0.04-0.075],"BDNF, BDNF-AS",BMI in smokers,"smoking behavior, body mass index",GCST004498,11:27662970
rs11030104-<b>A</b>,2 x 10-6,(women),0.7872,'-,0.0595 kg/m2 increase,[0.035-0.084],"BDNF, BDNF-AS",BMI in smokers,"smoking behavior, body mass index",GCST004498,11:27662970
rs13069244-<b>A</b>,8 x 10-7,,0.078,'-,0.061 kg/m2 increase,[0.037-0.085],CCDC39,BMI in smokers,"smoking behavior, body mass index",GCST004498,3:180723384
rs12902602-<b>A</b>,7 x 10-13,,0.607,'-,0.044 kg/m2 increase,[0.032-0.056],CHRNB4,BMI in smokers,"smoking behavior, body mass index",GCST004498,15:78675059
rs1516725-<b>T</b>,7 x 10-9,,0.1363,'-,0.058 kg/m2 decrease,[0.038-0.078],"DGKG, ETV5",BMI in smokers,"smoking behavior, body mass index",GCST004498,3:186106215
rs7138803-<b>A</b>,1 x 10-6,,0.3705,'-,0.0364 kg/m2 increase,[0.022-0.051],"BCDIN3D, RPL35AP28",BMI in smokers,"smoking behavior, body mass index",GCST004498,12:49853685
rs2365389-<b>T</b>,3 x 10-6,(women),0.4348,'-,0.0453 kg/m2 decrease,[0.026-0.064],FHIT,BMI in smokers,"smoking behavior, body mass index",GCST004498,3:61250788
rs2365389-<b>T</b>,3 x 10-8,,0.4348,'-,0.0396 kg/m2 decrease,[0.026-0.054],FHIT,BMI in smokers,"smoking behavior, body mass index",GCST004498,3:61250788
rs1558902-<b>A</b>,8 x 10-39,,0.4028,'-,0.0936 kg/m2 increase,[0.079-0.108],FTO,BMI in smokers,"smoking behavior, body mass index",GCST004498,16:53769662
rs1558902-<b>A</b>,4 x 10-22,(women),0.4028,'-,0.0938 kg/m2 increase,[0.075-0.113],FTO,BMI in smokers,"smoking behavior, body mass index",GCST004498,16:53769662
rs1558902-<b>A</b>,9 x 10-21,(men),0.4028,'-,0.0948 kg/m2 increase,[0.075-0.115],FTO,BMI in smokers,"smoking behavior, body mass index",GCST004498,16:53769662
rs10938397-<b>A</b>,3 x 10-7,,0.5821,'-,0.036 kg/m2 decrease,[0.022-0.05],LINC02273,BMI in smokers,"smoking behavior, body mass index",GCST004498,4:45180510
rs12446632-<b>A</b>,2 x 10-6,,0.1334,'-,0.0501 kg/m2 decrease,[0.029-0.071],GPRC5B,BMI in smokers,"smoking behavior, body mass index",GCST004498,16:19924067
rs336396-<b>T</b>,5 x 10-6,,0.184,'-,0.043 kg/m2 increase,[0.025-0.061],INPP4B,BMI in smokers,"smoking behavior, body mass index",GCST004498,4:142141658
rs6567160-<b>T</b>,5 x 10-9,(men),0.7603,'-,0.0666 kg/m2 decrease,[0.044-0.089],"RNU4-17P, RPS3AP49",BMI in smokers,"smoking behavior, body mass index",GCST004498,18:60161902
rs6567160-<b>T</b>,2 x 10-14,,0.7603,'-,0.0611 kg/m2 decrease,[0.045-0.077],"RNU4-17P, RPS3AP49",BMI in smokers,"smoking behavior, body mass index",GCST004498,18:60161902
rs6567160-<b>T</b>,2 x 10-7,(women),0.7603,'-,0.056 kg/m2 decrease,[0.035-0.077],"RNU4-17P, RPS3AP49",BMI in smokers,"smoking behavior, body mass index",GCST004498,18:60161902
rs12446632-<b>A</b>,7 x 10-8,(men),0.1334,'-,'-,'-,GPRC5B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,16:19924067
rs7899106-<b>A</b>,5 x 10-6,,0.9366,'-,'-,'-,GRID1,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,10:85651147
rs7243357-<b>T</b>,6 x 10-8,,0.8196,'-,'-,'-,"SEC11C, GRP",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,18:59216087
rs7243357-<b>T</b>,3 x 10-6,(men),0.8196,'-,'-,'-,"SEC11C, GRP",Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,18:59216087
rs1167827-<b>A</b>,2 x 10-7,,0.4293,'-,'-,'-,HIP1,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,7:75533848
rs17405819-<b>T</b>,2 x 10-8,,0.7022,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,8:75894349
rs17405819-<b>T</b>,8 x 10-6,(women),0.7022,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,8:75894349
rs13201877-<b>A</b>,5 x 10-6,,0.8661,'-,'-,'-,HLA-B,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,6:137354404
rs2481665-<b>T</b>,2 x 10-8,(EA),0.561,'-,'-,'-,PATJ,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,1:62129005
rs2176040-<b>A</b>,3 x 10-7,(men),0.3557,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:226228086
rs2176040-<b>A</b>,2 x 10-6,,0.3557,'-,'-,'-,'-,Body mass index (joint analysis main effects and smoking interaction),"smoking behavior, body mass index",GCST004497,2:226228086
rs6570507-<b>A</b>,8 x 10-6,,0.3186,'-,0.0373 unit decrease,[0.021-0.054],ADGRG6,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,6:142358435
rs7684221-<b>A</b>,9 x 10-6,,0.1931,'-,0.0449 unit decrease,[0.025-0.065],LCORL,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,4:17955731
rs12991495-<b>T</b>,2 x 10-7,(men),0.6973,'-,0.0609 unit increase,[0.038-0.084],DNMT3A,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,2:25263901
rs12493901-<b>A</b>,9 x 10-6,(men),0.4712,'-,0.0464 unit decrease,[0.026-0.067],FNDC3B,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,3:172204265
rs395962-<b>T</b>,8 x 10-7,(men),0.3169,'-,0.0548 unit increase,[0.033-0.077],LIN28B,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,6:104949543
rs4886782-<b>A</b>,4 x 10-7,(men),0.3642,'-,0.0558 unit decrease,[0.034-0.077],LOXL1,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,15:73936469
rs9435732-<b>T</b>,1 x 10-9,,0.2658,'-,0.0496 unit decrease,[0.034-0.066],"ATP13A2, MFAP2",Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,1:16981663
rs12493901-<b>A</b>,7 x 10-8,,0.4712,'-,0.0399 unit decrease,[0.025-0.054],FNDC3B,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,3:172204265
rs4239436-<b>A</b>,1 x 10-7,,0.2027,'-,0.0474 unit decrease,[0.03-0.065],CABLES1,Waist circumference adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist circumference",GCST004503,18:23151966
rs2371767-<b>C</b>,5 x 10-6,(women),0.3027,'-,0.0307 unit decrease,[0.018-0.044],ADAMTS9-AS2,Waist-to-hip ratio adjusted for BMI in smokers,"smoking behavior, BMI-adjusted waist-hip ratio",GCST004509,3:64732582
rs6762267-<b>C</b>,7 x 10-31,,0.38,1.049,'-,[1.041-1.058],CADM2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,3:85463965
rs727644-<b>G</b>,4 x 10-14,,0.6,1.031,'-,[1.023-1.040],FOXP2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,7:114469294
rs62519827-<b>T</b>,6 x 10-11,,0.89,1.042,'-,[1.029-1.055],BHLHE22,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,8:64569390
rs9841382-<b>C</b>,7 x 10-11,,0.14,1.038,'-,[1.026-1.049],SOX2-OT,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,3:181690336
rs58560561-<b>G</b>,7 x 10-11,,0.65,1.028,'-,[1.019-1.036],SDCCAG8,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,1:243374427
rs992493-<b>T</b>,3 x 10-10,,0.19,1.033,'-,[1.023-1.043],TET2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,4:105259107
rs6923811-<b>T</b>,4 x 10-10,,0.68,1.027,'-,[1.019-1.036],"POM121L2, VN1R10P",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,6:27321997
rs7817124-<b>C</b>,6 x 10-10,,0.24,1.03,'-,[1.020-1.039],ZBTB10,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,8:80491773
rs4801000-<b>G</b>,3 x 10-9,,0.34,1.025,'-,[1.017-1.034],"LINC01415, LINC01416",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,18:55789712
rs4653015-<b>T</b>,4 x 10-9,,0.26,1.027,'-,[1.018-1.037],A3GALT2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,1:33310830
rs12476923-<b>A</b>,5 x 10-9,,0.34,1.025,'-,[1.017-1.034],TEX41,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,2:145072486
rs283914-<b>T</b>,5 x 10-9,,0.53,1.024,'-,[1.016-1.032],TBC1D5,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,3:17289157
rs4233093-<b>A</b>,5 x 10-9,,0.52,1.024,'-,[1.016-1.032],'-,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,1:72980562
rs7829912-<b>T</b>,6 x 10-9,,0.56,1.024,'-,[1.016-1.032],"DUSP26, BUD31P1",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,8:33621710
rs1381287-<b>T</b>,1 x 10-8,,0.46,1.023,'-,[1.015-1.032],LINC02295,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,14:98131215
rs28520003-<b>G</b>,1 x 10-8,,0.69,1.025,'-,[1.016-1.034],"WNT7B, LINC00899",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,22:46016089
rs12115650-<b>G</b>,2 x 10-8,,0.72,1.026,'-,[1.017-1.035],DENND1A,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,9:123605426
rs11226319-<b>A</b>,2 x 10-8,,0.16,1.032,'-,[1.021-1.043],LINC02552,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,11:104350845
rs1358391-<b>G</b>,2 x 10-8,,0.51,1.023,'-,[1.015-1.031],POLR2DP2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,7:115471784
rs12617392-<b>C</b>,2 x 10-8,,0.56,1.023,'-,[1.015-1.031],CGREF1,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,2:27113959
rs542883-<b>C</b>,2 x 10-8,,0.56,1.023,'-,[1.015-1.031],LINC01833,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,2:44916243
rs10823791-<b>T</b>,4 x 10-8,,0.4,1.023,'-,[1.015-1.031],CDH23,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,10:71578577
rs34905321-<b>T</b>,4 x 10-8,,0.57,1.022,'-,[1.014-1.031],"ZNF259P1, ARMC2",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,6:108809904
rs891124-<b>T</b>,4 x 10-8,,0.71,1.024,'-,[1.016-1.033],LINC02136,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,16:71406853
rs35914833-<b>T</b>,5 x 10-8,,0.68,1.024,'-,[1.015-1.033],"UNC79, PRIMA1",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,14:93716037
rs62250759-<b>G</b>,5 x 10-12,,NR,'-,0.064 unit decrease,[0.046-0.082],CADM2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST005415,3:85519876
rs3117340-<b>G</b>,7 x 10-9,,0.62,1.024,'-,[1.016-1.033],"OR2U1P, OR2G1P",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006810,6:29242819
rs4653015-<b>T</b>,2 x 10-7,,0.27,'-,0.032 unit increase,[0.02-0.044],A3GALT2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,1:33310830
rs4233093-<b>A</b>,3 x 10-8,,0.51,'-,0.03 unit increase,[0.02-0.04],'-,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,1:72980562
rs58560561-<b>T</b>,4 x 10-7,,0.36,'-,0.027 unit decrease,[0.017-0.037],SDCCAG8,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,1:243374427
rs9841382-<b>T</b>,7 x 10-13,,0.84,'-,0.052 unit decrease,[0.038-0.066],SOX2-OT,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,3:181690336
rs542883-<b>C</b>,9 x 10-8,,0.57,'-,0.029 unit increase,[0.019-0.039],LINC01833,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,2:44916243
rs12476923-<b>A</b>,4 x 10-8,,0.33,'-,0.029 unit increase,[0.019-0.039],TEX41,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,2:145072486
rs283914-<b>T</b>,4 x 10-25,,0.54,'-,0.056 unit decrease,[0.046-0.066],TBC1D5,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,3:17289157
rs6762267-<b>A</b>,7 x 10-13,,0.61,'-,0.052 unit decrease,[0.038-0.066],CADM2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,3:85463965
rs189335278-<b>A</b>,8 x 10-11,,0.11,'-,0.054 unit decrease,[0.038-0.07],CYP7B1,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,8:64595858
chr11:104700736-<b>A</b>,4 x 10-8,,0.26,'-,0.034 unit increase,[0.022-0.046],'-,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,Mapping not available
rs545973460-<b>A</b>,4 x 10-7,,0.34,'-,0.028 unit increase,[0.018-0.038],INSYN1-AS1,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,15:73771857
rs3117340-<b>T</b>,1 x 10-8,,0.38,'-,0.03 unit decrease,[0.02-0.04],"OR2U1P, OR2G1P",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,6:29242819
rs727644-<b>A</b>,2 x 10-12,,0.4,'-,0.038 unit decrease,[0.028-0.048],FOXP2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,7:114469294
rs1358391-<b>T</b>,1 x 10-6,,0.49,'-,0.026 unit decrease,[0.016-0.036],POLR2DP2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,7:115471784
rs7829912-<b>T</b>,7 x 10-9,,0.56,'-,0.031 unit increase,[0.021-0.041],"DUSP26, BUD31P1",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,8:33621710
rs62519827-<b>T</b>,8 x 10-10,,0.89,'-,0.051 unit increase,[0.035-0.067],BHLHE22,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,8:64569390
rs7817124-<b>C</b>,2 x 10-7,,0.26,'-,0.032 unit increase,[0.02-0.044],ZBTB10,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,8:80491773
rs12115650-<b>A</b>,2 x 10-7,,0.27,'-,0.032 unit decrease,[0.02-0.044],DENND1A,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,9:123605426
rs10823791-<b>A</b>,1 x 10-7,,0.6,'-,0.028 unit decrease,[0.018-0.038],CDH23,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,10:71578577
rs11226319-<b>A</b>,4 x 10-7,,0.16,'-,0.036 unit increase,[0.022-0.05],LINC02552,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,11:104350845
rs4653015-<b>T</b>,2 x 10-7,,0.27,'-,0.032 unit increase,[0.02-0.044],A3GALT2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,1:33310830
rs1381287-<b>T</b>,3 x 10-6,,0.45,'-,0.025 unit increase,[0.015-0.035],LINC02295,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,14:98131215
rs542883-<b>C</b>,9 x 10-8,,0.57,'-,0.029 unit increase,[0.019-0.039],LINC01833,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,2:44916243
rs283914-<b>T</b>,4 x 10-8,,0.54,'-,0.029 unit increase,[0.019-0.039],TBC1D5,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,3:17289157
rs992493-<b>T</b>,4 x 10-8,,0.19,'-,0.034 unit increase,[0.022-0.046],TET2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,4:105259107
rs1358391-<b>T</b>,1 x 10-6,,0.49,'-,0.026 unit decrease,[0.016-0.036],POLR2DP2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,7:115471784
rs7829912-<b>T</b>,7 x 10-9,,0.56,'-,0.031 unit increase,[0.021-0.041],"DUSP26, BUD31P1",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,8:33621710
rs7817124-<b>C</b>,2 x 10-7,,0.26,'-,0.032 unit increase,[0.02-0.044],ZBTB10,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,8:80491773
rs12115650-<b>A</b>,2 x 10-7,,0.27,'-,0.032 unit decrease,[0.02-0.044],DENND1A,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,9:123605426
rs10823791-<b>A</b>,1 x 10-7,,0.6,'-,0.028 unit decrease,[0.018-0.038],CDH23,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,10:71578577
rs35914833-<b>T</b>,3 x 10-7,,0.32,'-,0.028 unit decrease,[0.018-0.038],"UNC79, PRIMA1",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,14:93716037
rs1381287-<b>T</b>,3 x 10-6,,0.45,'-,0.025 unit increase,[0.015-0.035],LINC02295,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,14:98131215
rs4801000-<b>A</b>,1 x 10-7,,0.66,'-,0.029 unit decrease,[0.019-0.039],"LINC01415, LINC01416",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,18:55789712
rs28520003-<b>A</b>,1 x 10-6,,0.32,'-,0.026 unit decrease,[0.016-0.036],"WNT7B, LINC00899",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,22:46016089
rs560977020-<b>T</b>,3 x 10-10,,0.66,'-,0.034 unit increase,[0.024-0.044],AKT3,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,1:243649066
rs2304681-<b>A</b>,1 x 10-7,,0.37,'-,0.028 unit decrease,[0.018-0.038],KHK,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,2:27092384
rs542809491-<b>A</b>,4 x 10-23,,0.39,'-,0.053 unit increase,[0.043-0.063],CADM2,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,3:85568228
rs12617392-<b>A</b>,2 x 10-8,,0.45,'-,0.03 unit decrease,[0.02-0.04],CGREF1,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,2:27113959
rs188973463-<b>T</b>,4 x 10-9,,0.74,'-,0.037 unit increase,[0.025-0.049],"RSL24D1P1, H4C10P",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,6:27799064
rs566858049-<b>T</b>,7 x 10-9,,0.6,'-,0.031 unit increase,[0.021-0.041],"OR2U1P, OR2G1P",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,6:29262352
chr7:114156758-<b>G</b>,6 x 10-14,,0.64,'-,0.041 unit increase,[0.031-0.051],'-,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,Mapping not available
rs9841382-<b>T</b>,4 x 10-8,,0.84,'-,0.034 unit increase,[0.022-0.046],SOX2-OT,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,3:181690336
rs6923811-<b>T</b>,5 x 10-9,,0.67,'-,0.032 unit increase,[0.022-0.042],"POM121L2, VN1R10P",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,6:27321997
rs145206681-<b>T</b>,3 x 10-7,,0.06,'-,0.056 unit increase,[0.034-0.078],"CYB5B, NFAT5",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,16:69516583
rs35914833-<b>T</b>,3 x 10-7,,0.32,'-,0.028 unit decrease,[0.018-0.038],"UNC79, PRIMA1",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,14:93716037
rs4233093-<b>A</b>,3 x 10-8,,0.51,'-,0.03 unit increase,[0.02-0.04],'-,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,1:72980562
rs891124-<b>T</b>,9 x 10-8,,0.71,'-,0.029 unit increase,[0.019-0.039],LINC02136,Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,16:71406853
rs4801000-<b>A</b>,1 x 10-7,,0.66,'-,0.029 unit decrease,[0.019-0.039],"LINC01415, LINC01416",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,18:55789712
rs28520003-<b>A</b>,1 x 10-6,,0.32,'-,0.026 unit decrease,[0.016-0.036],"WNT7B, LINC00899",Self-reported risk-taking behaviour,risk-taking behaviour,GCST006461,22:46016089
rs13006079-<b>A</b>,9 x 10-9,,0.1822,'-,0.014456498 unit increase,[0.0095-0.0194],CYP2C56P,Adventurousness,risk-taking behaviour,GCST007324,2:164320031
rs2752914-<b>T</b>,1 x 10-8,,0.5966,'-,0.011349284 unit increase,[0.0075-0.0152],TSHZ2,Adventurousness,risk-taking behaviour,GCST007324,20:53001410
rs10067113-<b>T</b>,1 x 10-8,,0.6227,'-,0.011486698 unit increase,[0.0076-0.0154],RNU4-43P,Adventurousness,risk-taking behaviour,GCST007324,5:26016254
rs6807234-<b>A</b>,1 x 10-8,,0.1912,'-,0.014121367 unit increase,[0.0093-0.019],"SUMF1, LRRN1",Adventurousness,risk-taking behaviour,GCST007324,3:3837717
rs73108238-<b>T</b>,1 x 10-8,,0.2424,'-,0.012947185 unit decrease,[0.0085-0.0174],PCDH7,Adventurousness,risk-taking behaviour,GCST007324,4:30898569
rs11933823-<b>C</b>,1 x 10-8,,0.3188,'-,0.01189557 unit decrease,[0.0078-0.016],STPG2,Adventurousness,risk-taking behaviour,GCST007324,4:97261428
rs77915397-<b>A</b>,1 x 10-8,,0.932,'-,0.022012392 unit decrease,[0.014-0.03],CAMKMT,Adventurousness,risk-taking behaviour,GCST007324,2:44465920
rs1438026-<b>T</b>,1 x 10-8,,0.6721,'-,0.011802281 unit increase,[0.0078-0.0159],"MRPS18BP2, SNORA72",Adventurousness,risk-taking behaviour,GCST007324,2:139583451
rs35287272-<b>T</b>,1 x 10-8,,0.2908,'-,0.0121811135 unit decrease,[0.008-0.0164],'-,Adventurousness,risk-taking behaviour,GCST007324,16:51408723
rs1492436-<b>A</b>,1 x 10-8,,0.8352,'-,0.014871354 unit decrease,[0.0097-0.02],LINC02671,Adventurousness,risk-taking behaviour,GCST007324,10:64904379
rs9360234-<b>A</b>,1 x 10-8,,0.2327,'-,0.013054708 unit decrease,[0.0086-0.0176],RNU7-66P,Adventurousness,risk-taking behaviour,GCST007324,6:66811208
rs6500948-<b>A</b>,1 x 10-8,,0.8211,'-,0.014369997 unit decrease,[0.0094-0.0193],RBFOX1,Adventurousness,risk-taking behaviour,GCST007324,16:7321457
rs11710504-<b>T</b>,1 x 10-8,,0.9311,'-,0.021710156 unit decrease,[0.014-0.029],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85254399
rs72762188-<b>A</b>,1 x 10-8,,0.8023,'-,0.013804553 unit increase,[0.009-0.0186],LINC00924,Adventurousness,risk-taking behaviour,GCST007324,15:95466654
rs2722012-<b>A</b>,1 x 10-8,,0.1874,'-,0.014088698 unit increase,[0.0092-0.019],ZBTB20,Adventurousness,risk-taking behaviour,GCST007324,3:114415421
rs10817520-<b>T</b>,2 x 10-8,,0.3426,'-,0.011545872 unit increase,[0.0075-0.0156],ZNF618,Adventurousness,risk-taking behaviour,GCST007324,9:113793381
rs11047498-<b>T</b>,2 x 10-8,,0.3872,'-,0.011230925 unit decrease,[0.0073-0.0151],SOX5,Adventurousness,risk-taking behaviour,GCST007324,12:24557490
rs869730-<b>A</b>,2 x 10-8,,0.3943,'-,0.011156664 unit increase,[0.0073-0.015],SEMA6D,Adventurousness,risk-taking behaviour,GCST007324,15:47674555
rs62322696-<b>A</b>,2 x 10-8,,0.45,'-,0.010908743 unit increase,[0.0071-0.0147],BANK1,Adventurousness,risk-taking behaviour,GCST007324,4:101973132
rs4961729-<b>A</b>,2 x 10-8,,0.7829,'-,0.013137849 unit increase,[0.0085-0.0178],BNC2,Adventurousness,risk-taking behaviour,GCST007324,9:16676603
rs150949450-<b>T</b>,2 x 10-8,,0.9604,'-,0.02776872 unit decrease,[0.018-0.038],"LINC02791, CCDC18",Adventurousness,risk-taking behaviour,GCST007324,1:69272224
rs1616065-<b>C</b>,2 x 10-8,,0.4596,'-,0.0108643565 unit increase,[0.007-0.0147],"CEP126, CFAP300",Adventurousness,risk-taking behaviour,GCST007324,11:102021239
rs16998583-<b>C</b>,2 x 10-8,,0.826,'-,0.014271697 unit decrease,[0.0093-0.0193],BCAS1,Adventurousness,risk-taking behaviour,GCST007324,20:53937953
rs35377646-<b>A</b>,2 x 10-8,,0.8364,'-,0.01462654 unit decrease,[0.0095-0.0198],"LINC02671, ANXA2P3",Adventurousness,risk-taking behaviour,GCST007324,10:64892408
rs17260689-<b>T</b>,3 x 10-8,,0.3015,'-,0.011760388 unit decrease,[0.0076-0.0159],LINC02183,Adventurousness,risk-taking behaviour,GCST007324,16:54512901
rs17389284-<b>C</b>,5 x 10-9,,0.242,'-,0.0081 unit increase,[0.0054-0.0108],TSHZ2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,20:53071269
rs9539479-<b>A</b>,5 x 10-9,,0.471,'-,0.0069 unit increase,[0.0045-0.0093],"LINC01074, LINC01075",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,13:62316524
rs2889535-<b>T</b>,5 x 10-9,,0.291,'-,0.0076 unit decrease,[0.0051-0.0101],ARHGAP28,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:6879354
rs34591112-<b>T</b>,5 x 10-9,,0.21,'-,0.0085 unit increase,[0.0056-0.0114],CASP12,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:104812290
rs7572-<b>T</b>,5 x 10-9,,0.218,'-,0.0084 unit increase,[0.0057-0.0111],CD34,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:207886664
rs4408817-<b>T</b>,5 x 10-9,,0.628,'-,0.0071 unit decrease,[0.0047-0.0095],EP300-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,22:41184709
rs114900182-<b>C</b>,6 x 10-9,,0.932,'-,0.0136 unit increase,[0.0091-0.0181],LINC01572,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:72595157
rs2364400-<b>T</b>,7 x 10-9,,0.376,'-,0.0071 unit increase,[0.0047-0.0095],"SSR2, UBQLN4",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:156027382
rs1038804-<b>T</b>,7 x 10-9,,0.276,'-,0.0077 unit increase,[0.0052-0.0102],STK32C,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:132212943
rs9856337-<b>A</b>,7 x 10-9,,0.273,'-,0.0077 unit increase,[0.0052-0.0102],RNU6-1129P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:86200895
rs741273-<b>A</b>,8 x 10-9,,0.501,'-,0.0068 unit decrease,[0.0044-0.0092],FOXN3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:89399580
rs2932878-<b>A</b>,8 x 10-9,,0.837,'-,0.0092 unit decrease,[0.0061-0.0123],"ANXA2P3, LINC02671",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:64892082
rs62468774-<b>A</b>,8 x 10-9,,0.869,'-,0.0101 unit decrease,[0.0066-0.0136],MAGI2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:78419425
rs59739823-<b>T</b>,9 x 10-9,,0.144,'-,0.0097 unit increase,[0.0064-0.013],TRPC6,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:101597090
rs601676-<b>A</b>,9 x 10-9,,0.569,'-,0.0069 unit decrease,[0.0045-0.0093],DCDC1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:30735332
rs36055559-<b>A</b>,9 x 10-9,,0.163,'-,0.0093 unit increase,[0.0062-0.0124],"NRTN, DUS3L",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,19:5799422
rs113118573-<b>A</b>,9 x 10-9,,0.617,'-,0.007 unit decrease,[0.0046-0.0094],"LINC01905, LINC01416",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:56014206
rs4840523-<b>A</b>,1 x 10-8,,0.078,'-,0.0128 unit increase,[0.0085-0.0171],"XKR6, PINX1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10876206
rs62003775-<b>A</b>,1 x 10-8,,0.791,'-,0.0083 unit decrease,[0.0054-0.0112],GABRG3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:27450563
rs3846425-<b>T</b>,1 x 10-8,,0.37,'-,0.007 unit decrease,[0.0046-0.0094],SORCS2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:7292714
rs12537434-<b>A</b>,1 x 10-8,,0.263,'-,0.0077 unit decrease,[0.0052-0.0102],MKRN1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:140475530
rs6801781-<b>A</b>,1 x 10-8,,0.31,'-,0.0073 unit decrease,[0.0048-0.0098],FOXP1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:71583115
rs11699481-<b>T</b>,1 x 10-8,,0.547,'-,0.0068 unit decrease,[0.0044-0.0092],SLC12A5,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,20:46034836
rs11785335-<b>A</b>,1 x 10-8,,0.456,'-,0.0068 unit decrease,[0.0044-0.0092],BLK,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:11559134
rs1134634-<b>C</b>,1 x 10-8,,0.591,'-,0.0069 unit decrease,[0.0045-0.0093],CC2D2A,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:15601446
rs17153585-<b>T</b>,1 x 10-8,,0.856,'-,0.0096 unit decrease,[0.0063-0.0129],"LINC00208, GATA4",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:11647361
rs13030106-<b>C</b>,1 x 10-8,,0.299,'-,0.0074 unit increase,[0.0049-0.0099],KLHL29,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:23409766
rs6556803-<b>A</b>,1 x 10-8,,0.622,'-,0.0069 unit decrease,[0.0045-0.0093],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:165048824
rs13271691-<b>A</b>,1 x 10-8,,0.589,'-,0.0068 unit decrease,[0.0044-0.0092],PPP3CC,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:22467169
rs5174-<b>T</b>,1 x 10-8,,0.405,'-,0.0069 unit decrease,[0.0045-0.0093],LRP8,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:53247055
rs11942731-<b>A</b>,1 x 10-8,,0.241,'-,0.0079 unit decrease,[0.0052-0.0106],INPP4B,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:142565809
rs1486471-<b>A</b>,1 x 10-8,,0.67,'-,0.0071 unit decrease,[0.0046-0.0096],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,Mapping not available
rs11782670-<b>A</b>,1 x 10-8,,0.119,'-,0.0103 unit increase,[0.0068-0.0138],RP1L1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10607889
rs6586877-<b>T</b>,1 x 10-8,,0.441,'-,0.0067 unit decrease,[0.0043-0.0091],RN7SL474P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:16767663
rs12568728-<b>T</b>,1 x 10-8,,0.303,'-,0.0073 unit increase,[0.0048-0.0098],"LINC01712, LINC01725",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:83521960
rs143312104-<b>T</b>,1 x 10-8,,0.046,'-,0.0159 unit decrease,[0.01-0.021],LINC02742,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:28788055
rs4887305-<b>T</b>,1 x 10-8,,0.569,'-,0.0068 unit decrease,[0.0044-0.0092],LINC00052,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:87588543
rs2515055-<b>T</b>,2 x 10-8,,0.43,'-,0.0068 unit decrease,[0.0044-0.0092],SAMD12,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:118498793
rs72965482-<b>T</b>,2 x 10-8,,0.094,'-,0.0114 unit decrease,[0.0075-0.0153],"Y_RNA, GJA1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:121406898
rs10266287-<b>T</b>,2 x 10-8,,0.345,'-,0.007 unit increase,[0.0046-0.0094],LINC01004,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:104965556
rs62262269-<b>C</b>,2 x 10-12,,0.163,'-,0.0113 unit increase,[0.0082-0.0144],"LINC01471, LINC02016",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:127398602
rs12187443-<b>T</b>,2 x 10-12,,0.67,'-,0.0088 unit decrease,[0.0063-0.0113],MACIR,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:103324699
rs720300-<b>A</b>,2 x 10-12,,0.877,'-,0.0126 unit decrease,[0.0091-0.0161],SND1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:127967421
rs4276341-<b>T</b>,2 x 10-12,,0.333,'-,0.0088 unit decrease,[0.0063-0.0113],"SPINK2, REST",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:56881632
rs893946-<b>T</b>,2 x 10-12,,0.352,'-,0.0087 unit decrease,[0.0063-0.0111],TCF4,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:55315227
rs4328149-<b>A</b>,3 x 10-12,,0.632,'-,0.0086 unit increase,[0.0062-0.011],ATRNL1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:115255951
rs12210560-<b>T</b>,3 x 10-12,,0.35,'-,0.0086 unit decrease,[0.0062-0.011],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:67195310
rs13093086-<b>A</b>,3 x 10-12,,0.505,'-,0.0082 unit increase,[0.0058-0.0106],FOXP1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:71006011
rs2107139-<b>A</b>,3 x 10-12,,0.48,'-,0.0082 unit increase,[0.0058-0.0106],TAC1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:97748769
rs4479249-<b>T</b>,5 x 10-12,,0.177,'-,0.0107 unit increase,[0.0078-0.0136],RBFOX1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:7310131
rs6876405-<b>T</b>,5 x 10-12,,0.236,'-,0.0096 unit decrease,[0.0069-0.0123],EBF1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:158836472
rs10043722-<b>A</b>,6 x 10-12,,0.593,'-,0.0083 unit decrease,[0.0059-0.0107],CTNNA1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:138901252
rs2586786-<b>T</b>,6 x 10-12,,0.324,'-,0.0087 unit increase,[0.0062-0.0112],KIAA1328,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:37170724
rs10041849-<b>A</b>,8 x 10-12,,0.401,'-,0.0082 unit increase,[0.0058-0.0106],SEM1P1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:81887293
rs10190777-<b>C</b>,9 x 10-12,,0.572,'-,0.0081 unit increase,[0.0057-0.0105],DSTNP5,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:204310144
rs9329227-<b>C</b>,9 x 10-12,,0.634,'-,0.0084 unit increase,[0.006-0.0108],RP1L1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10624738
rs12202969-<b>A</b>,1 x 10-11,,0.483,'-,0.008 unit increase,[0.0056-0.0104],EIF4EBP2P3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:98128347
rs11650438-<b>A</b>,1 x 10-11,,0.471,'-,0.008 unit decrease,[0.0056-0.0104],PIGL,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,17:16330946
rs7013834-<b>A</b>,1 x 10-11,,0.116,'-,0.0125 unit increase,[0.009-0.016],TNKS,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:9557132
rs116493405-<b>A</b>,1 x 10-11,,0.058,'-,0.0171 unit increase,[0.012-0.022],ZBTB20,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:115014709
rs7192890-<b>T</b>,2 x 10-11,,0.523,'-,0.008 unit increase,[0.0056-0.0104],LINC02136,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:71418572
rs2897807-<b>A</b>,2 x 10-11,,0.513,'-,0.0079 unit increase,[0.0055-0.0103],CDH8,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:61625737
rs13196360-<b>T</b>,2 x 10-11,,0.5,'-,0.0079 unit decrease,[0.0055-0.0103],HIVEP1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:12009023
rs10191477-<b>T</b>,2 x 10-11,,0.386,'-,0.0081 unit decrease,[0.0057-0.0105],CAMKMT,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:44631548
rs2415725-<b>T</b>,2 x 10-11,,0.675,'-,0.0085 unit decrease,[0.006-0.011],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:42303972
rs1229984-<b>T</b>,4 x 10-22,,0.023,'-,0.083182804 unit decrease,[0.066-0.1],ADH1B,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,4:99318162
rs4676964-<b>T</b>,8 x 10-18,,0.5117,'-,0.022169843 unit increase,[0.017-0.027],FOXP1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:70985597
rs528301-<b>A</b>,3 x 10-16,,0.5523,'-,0.021161621 unit increase,[0.016-0.026],LINC01833,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:44927769
rs12244388-<b>A</b>,1 x 10-15,,0.3368,'-,0.021866972 unit increase,[0.017-0.027],"AS3MT, BORCS7-ASMT",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,10:102880295
rs13268621-<b>T</b>,2 x 10-14,,0.4948,'-,0.019714508 unit increase,[0.015-0.025],TOX,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,8:58899165
rs13107325-<b>T</b>,4 x 10-13,,0.0734,'-,0.035913233 unit decrease,[0.026-0.046],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,Mapping not available
rs828867-<b>A</b>,4 x 10-13,,0.5418,'-,0.01873034 unit increase,[0.014-0.024],TET3,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:74107335
rs1381274-<b>T</b>,6 x 10-13,,0.4628,'-,0.018584875 unit increase,[0.014-0.024],LINC02295,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,14:98188794
rs17199331-<b>T</b>,1 x 10-12,,0.097,'-,0.030997418 unit increase,[0.022-0.04],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:13653733
rs2075375-<b>T</b>,1 x 10-12,,0.5784,'-,0.018538518 unit decrease,[0.013-0.024],OTX1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:63053555
rs11075924-<b>A</b>,2 x 10-12,,0.4934,'-,0.01812527 unit increase,[0.013-0.023],"PMFBP1, LINC01572",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:72180714
rs145898511-<b>T</b>,4 x 10-12,,0.9742,'-,0.056338016 unit increase,[0.04-0.072],SENP7,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:101462406
rs34488670-<b>T</b>,8 x 10-12,,0.7885,'-,0.021578157 unit decrease,[0.015-0.028],SEMA6D,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,15:47392739
rs10174860-<b>C</b>,8 x 10-12,,0.5797,'-,0.01783643 unit increase,[0.013-0.023],MIR4432HG,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:60263603
rs462779-<b>A</b>,1 x 10-11,,0.8147,'-,0.02251373 unit decrease,[0.016-0.029],"MFSD4B, REV3L",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,6:111374684
rs254024-<b>T</b>,1 x 10-11,,0.4364,'-,0.01754736 unit increase,[0.012-0.023],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,5:104608319
rs4440591-<b>A</b>,2 x 10-11,,0.5788,'-,0.017484186 unit increase,[0.012-0.023],PRAG1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,8:91761081
rs2049045-<b>C</b>,3 x 10-11,,0.1868,'-,0.021908348 unit decrease,[0.015-0.028],"BDNF, BDNF-AS",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,11:27672694
rs12494510-<b>T</b>,4 x 10-11,,0.6984,'-,0.01854883 unit decrease,[0.013-0.024],"RNU6-1129P, CADM2",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:86140711
rs2647257-<b>A</b>,5 x 10-11,,0.6146,'-,0.017428176 unit increase,[0.012-0.023],TET2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,4:105278348
rs2930537-<b>A</b>,5 x 10-11,,0.2918,'-,0.01863045 unit increase,[0.013-0.024],RUNX1T1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,8:92172701
rs1837016-<b>T</b>,7 x 10-11,,0.6117,'-,0.017263984 unit decrease,[0.012-0.022],NQO1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:69723778
rs10226719-<b>C</b>,1 x 10-10,,0.2116,'-,0.020252833 unit decrease,[0.014-0.026],SDK1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,7:3570189
rs10939963-<b>A</b>,1 x 10-10,,0.612,'-,0.01697561 unit increase,[0.012-0.022],HMGB1P47,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,5:51451668
rs2388334-<b>A</b>,2 x 10-10,,0.5157,'-,0.016480226 unit decrease,[0.011-0.022],"EIF4EBP2P3, HLA-DRB5",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,6:98143746
rs1895270-<b>A</b>,2 x 10-8,,0.372,'-,0.0069 unit decrease,[0.0045-0.0093],LINC01470,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:153190407
rs2885697-<b>T</b>,2 x 10-8,,0.667,'-,0.0071 unit decrease,[0.0046-0.0096],SCMH1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:41078607
rs2491392-<b>C</b>,2 x 10-8,,0.694,'-,0.0072 unit decrease,[0.0047-0.0097],SORCS3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:104798186
rs2678949-<b>A</b>,2 x 10-8,,0.304,'-,0.0072 unit increase,[0.0047-0.0097],PRKCZ,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:2084904
rs10498754-<b>A</b>,2 x 10-8,,0.086,'-,0.0119 unit decrease,[0.0078-0.016],CUL9,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:43188422
rs4776361-<b>A</b>,2 x 10-8,,0.261,'-,0.0076 unit decrease,[0.0051-0.0101],"IQCH, IQCH-AS1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:67469718
rs11780136-<b>C</b>,2 x 10-8,,0.245,'-,0.0078 unit increase,[0.0051-0.0105],"PINX1, XKR6",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10875460
rs611499-<b>T</b>,2 x 10-8,,0.522,'-,0.0067 unit decrease,[0.0043-0.0091],RGS17,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:153129354
rs4270551-<b>A</b>,2 x 10-8,,0.134,'-,0.0097 unit increase,[0.0064-0.013],PCDH7,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:30701621
rs10235162-<b>T</b>,2 x 10-8,,0.223,'-,0.008 unit increase,[0.0053-0.0107],LINC01392,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:115198066
rs4271249-<b>T</b>,2 x 10-8,,0.591,'-,0.0067 unit increase,[0.0043-0.0091],DPYD,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:97933063
rs6438214-<b>A</b>,2 x 10-8,,0.234,'-,0.0078 unit increase,[0.0051-0.0105],ZBTB20,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:114611244
rs6958690-<b>A</b>,2 x 10-8,,0.784,'-,0.0081 unit decrease,[0.0054-0.0108],"RELN, POLR2DP2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:115498661
rs11073747-<b>A</b>,2 x 10-8,,0.591,'-,0.0067 unit increase,[0.0043-0.0091],NTRK3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:87830736
rs4472446-<b>T</b>,2 x 10-8,,0.542,'-,0.0066 unit increase,[0.0042-0.009],"Y_RNA, FKBP9",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:115807589
rs9508814-<b>C</b>,2 x 10-8,,0.424,'-,0.0067 unit decrease,[0.0043-0.0091],"Metazoa_SRP, USPL1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,13:30681959
rs2960659-<b>T</b>,2 x 10-8,,0.223,'-,0.008 unit decrease,[0.0053-0.0107],ATRNL1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:115874076
rs7802895-<b>A</b>,2 x 10-8,,0.135,'-,0.0096 unit increase,[0.0063-0.0129],ZNF800,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:127430431
rs72790163-<b>A</b>,2 x 10-8,,0.844,'-,0.0091 unit increase,[0.006-0.0122],CDH13,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:82953376
rs2798421-<b>A</b>,2 x 10-8,,0.276,'-,0.0074 unit decrease,[0.0049-0.0099],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:166292691
rs62257872-<b>T</b>,3 x 10-8,,0.613,'-,0.0068 unit decrease,[0.0044-0.0092],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:83484613
rs7838353-<b>T</b>,3 x 10-8,,0.446,'-,0.0066 unit increase,[0.0042-0.009],RNU6-1151P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:9270103
rs7036637-<b>C</b>,3 x 10-8,,0.372,'-,0.0068 unit decrease,[0.0044-0.0092],SLC24A2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:19695640
rs6897129-<b>A</b>,3 x 10-8,,0.667,'-,0.007 unit increase,[0.0045-0.0095],IPO11,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:62604283
rs13301002-<b>T</b>,3 x 10-8,,0.556,'-,0.0066 unit decrease,[0.0042-0.009],UBE2V1P10,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:85151055
rs3764002-<b>T</b>,2 x 10-17,,0.261,'-,0.0115 unit decrease,[0.009-0.014],WSCD2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:108224853
rs12520354-<b>A</b>,3 x 10-17,,0.256,'-,0.0114 unit increase,[0.0087-0.0141],RASGRF2-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:80952681
rs712707-<b>T</b>,7 x 10-17,,0.327,'-,0.0105 unit decrease,[0.008-0.013],SND1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:127682560
rs1344293-<b>T</b>,8 x 10-17,,0.524,'-,0.0098 unit increase,[0.0074-0.0122],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:59906023
rs4605551-<b>T</b>,1 x 10-16,,0.639,'-,0.0102 unit decrease,[0.0078-0.0126],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:86621314
rs1381287-<b>T</b>,1 x 10-16,,0.47,'-,0.0098 unit increase,[0.0074-0.0122],LINC02295,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:98131215
rs1694933-<b>A</b>,2 x 10-16,,0.484,'-,0.0097 unit decrease,[0.0073-0.0121],"LINC02025, CADM2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:84902565
rs173076-<b>A</b>,2 x 10-16,,0.593,'-,0.0099 unit increase,[0.0075-0.0123],"SIX3, KRTCAP2P1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:44948446
rs1233508-<b>T</b>,2 x 10-16,,0.463,'-,0.0098 unit decrease,[0.0074-0.0122],"TRIM27, LINC01556",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:28929856
rs2047134-<b>A</b>,3 x 10-16,,0.673,'-,0.0103 unit increase,[0.0078-0.0128],CUL3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:224482996
rs55745410-<b>A</b>,6 x 10-16,,0.644,'-,0.01 unit increase,[0.0076-0.0124],PHC2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:33337216
rs7624230-<b>C</b>,8 x 10-16,,0.112,'-,0.0151 unit increase,[0.011-0.019],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85744226
rs6426658-<b>A</b>,1 x 10-15,,0.402,'-,0.0097 unit increase,[0.0073-0.0121],EIF4G3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:21034683
rs58400863-<b>A</b>,1 x 10-15,,0.341,'-,0.01 unit decrease,[0.0076-0.0124],LINC02497,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:31182862
rs1988552-<b>A</b>,2 x 10-15,,0.087,'-,0.0166 unit increase,[0.012-0.021],"CADM2, CADM2-AS2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85800701
rs4836927-<b>C</b>,5 x 10-15,,0.688,'-,0.01 unit increase,[0.0075-0.0125],DENND1A,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:123478924
rs55678495-<b>A</b>,6 x 10-15,,0.159,'-,0.0126 unit increase,[0.0095-0.0157],NFASC,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:205009576
rs2239030-<b>A</b>,6 x 10-15,,0.432,'-,0.0093 unit increase,[0.0069-0.0117],CACNA1C,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:2226775
rs78841189-<b>A</b>,9 x 10-15,,0.138,'-,0.0133 unit decrease,[0.01-0.0166],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85429312
rs624244-<b>A</b>,2 x 10-14,,0.655,'-,0.0095 unit decrease,[0.0071-0.0119],TCF4,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:55516165
rs4717520-<b>A</b>,2 x 10-14,,0.65,'-,0.0095 unit increase,[0.0071-0.0119],AUTS2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:69740774
rs12879529-<b>A</b>,3 x 10-14,,0.335,'-,0.0095 unit increase,[0.007-0.012],PPP1R13B,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:103841217
rs4841028-<b>C</b>,3 x 10-14,,0.829,'-,0.0119 unit increase,[0.0088-0.015],"CLDN23, MFHAS1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:8748092
rs13116355-<b>A</b>,5 x 10-14,,0.671,'-,0.0095 unit decrease,[0.007-0.012],GABRB1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:47037298
rs332827-<b>A</b>,5 x 10-14,,0.457,'-,0.0089 unit decrease,[0.0065-0.0113],NFIA,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:61277488
rs72930763-<b>A</b>,1 x 10-10,,0.948,'-,0.0172 unit increase,[0.012-0.022],TCF4,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:55487656
rs75108536-<b>T</b>,1 x 10-10,,0.156,'-,0.0105 unit decrease,[0.0074-0.0136],LRFN2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:40408201
rs17691999-<b>A</b>,1 x 10-10,,0.519,'-,0.0076 unit increase,[0.0052-0.01],LINC01837,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,19:31963566
rs62425620-<b>T</b>,1 x 10-10,,0.367,'-,0.0079 unit decrease,[0.0055-0.0103],"DLL1, FAM120B",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:170296868
rs4533855-<b>C</b>,1 x 10-10,,0.555,'-,0.0076 unit increase,[0.0052-0.01],RNU4-43P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:26013153
rs114600294-<b>C</b>,1 x 10-10,,0.19,'-,0.0097 unit decrease,[0.0068-0.0126],SOX2-OT,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:181701579
rs1389799-<b>A</b>,1 x 10-10,,0.636,'-,0.0079 unit increase,[0.0055-0.0103],MSRB3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:65431066
rs78242064-<b>A</b>,2 x 10-10,,0.108,'-,0.0122 unit decrease,[0.0085-0.0159],FIGN,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:163648213
rs4782271-<b>A</b>,2 x 10-10,,0.828,'-,0.01 unit increase,[0.0069-0.0131],GRIN2A,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:10125560
rs28455852-<b>A</b>,2 x 10-10,,0.08,'-,0.0139 unit increase,[0.0096-0.0182],EPHA5,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:65580631
rs4915136-<b>A</b>,2 x 10-10,,0.4,'-,0.0077 unit increase,[0.0053-0.0101],LHX9,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:197941730
rs33429-<b>A</b>,2 x 10-10,,0.696,'-,0.0082 unit increase,[0.0057-0.0107],ZNF536,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,19:30448453
rs9992704-<b>A</b>,2 x 10-10,,0.239,'-,0.0088 unit decrease,[0.0061-0.0115],PCDH7,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:30951320
rs17147036-<b>T</b>,2 x 10-10,,0.579,'-,0.0076 unit increase,[0.0052-0.01],LINC02670,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:10019756
rs127384-<b>T</b>,2 x 10-10,,0.31,'-,0.0081 unit decrease,[0.0056-0.0106],PKN2-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:88325277
rs111650759-<b>T</b>,2 x 10-10,,0.059,'-,0.0159 unit decrease,[0.011-0.021],LINC00971,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:84794443
rs6776685-<b>T</b>,2 x 10-10,,0.591,'-,0.0076 unit increase,[0.0052-0.01],ARPP21,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:35691772
rs8074744-<b>A</b>,3 x 10-10,,0.615,'-,0.0077 unit decrease,[0.0053-0.0101],LINC01982,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,17:52382951
rs9967799-<b>A</b>,3 x 10-10,,0.921,'-,0.0138 unit decrease,[0.0095-0.0181],MAP2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:209430750
rs72932563-<b>A</b>,3 x 10-10,,0.037,'-,0.0197 unit decrease,[0.014-0.026],LINC01415,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:55770428
rs1388479-<b>A</b>,3 x 10-10,,0.299,'-,0.0081 unit decrease,[0.0056-0.0106],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:43968652
rs73047488-<b>C</b>,3 x 10-10,,0.344,'-,0.0078 unit increase,[0.0054-0.0102],GRIN2B,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:13605391
rs17260689-<b>T</b>,3 x 10-10,,0.298,'-,0.0082 unit decrease,[0.0057-0.0107],LINC02183,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:54512901
rs6265-<b>T</b>,3 x 10-10,,0.188,'-,0.0095 unit decrease,[0.0066-0.0124],"BDNF-AS, BDNF",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:27658369
rs2252225-<b>T</b>,4 x 10-10,,0.591,'-,0.0075 unit increase,[0.0051-0.0099],TSHZ2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,20:53005546
rs9815332-<b>T</b>,2 x 10-10,,0.5605,'-,0.016487602 unit increase,[0.011-0.022],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:118066126
rs1891196-<b>A</b>,2 x 10-10,,0.5657,'-,0.016509607 unit decrease,[0.011-0.022],LINC01735,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,1:208545327
rs10780650-<b>T</b>,3 x 10-10,,0.3609,'-,0.016931811 unit decrease,[0.012-0.022],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,9:84113542
rs76513770-<b>T</b>,4 x 10-10,,0.8714,'-,0.02411434 unit increase,[0.017-0.032],LINC01572,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:72471635
rs7680631-<b>T</b>,6 x 10-10,,0.7007,'-,0.01743317 unit increase,[0.012-0.023],INPP4B,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,4:142701643
rs359443-<b>A</b>,6 x 10-10,,0.1555,'-,0.021988163 unit decrease,[0.015-0.029],"LINC01485, CPEB4",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,5:173856262
rs624244-<b>A</b>,7 x 10-10,,0.6597,'-,0.01678442 unit decrease,[0.011-0.022],TCF4,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,18:55516165
rs10866054-<b>T</b>,7 x 10-10,,0.2975,'-,0.017356327 unit decrease,[0.012-0.023],CADPS,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:62404914
rs4552369-<b>A</b>,7 x 10-10,,0.3218,'-,0.016976219 unit increase,[0.012-0.022],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:83820302
rs1368546-<b>T</b>,8 x 10-10,,0.4431,'-,0.01593145 unit increase,[0.011-0.021],CRLF3P1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:103440906
rs322776-<b>T</b>,1 x 10-9,,0.4204,'-,0.015909763 unit decrease,[0.011-0.021],"MIR129-1, SND1",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,7:128119789
rs6474609-<b>A</b>,1 x 10-9,,0.588,'-,0.015916662 unit decrease,[0.011-0.021],AKAP8P1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,9:10981069
rs12363232-<b>T</b>,1 x 10-9,,0.3496,'-,0.016407467 unit decrease,[0.011-0.022],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,Mapping not available
rs4923555-<b>A</b>,1 x 10-9,,0.655,'-,0.016412318 unit increase,[0.011-0.022],LINC02758,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,11:28655314
rs66879815-<b>T</b>,1 x 10-9,,0.7943,'-,0.019282361 unit increase,[0.013-0.026],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:82683432
rs61799395-<b>C</b>,1 x 10-9,,0.2202,'-,0.01880294 unit decrease,[0.013-0.025],PDE4B,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,1:65942086
rs62135521-<b>T</b>,1 x 10-9,,0.049,'-,0.036076322 unit decrease,[0.024-0.048],"RNU6-566P, LRPPRC",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:44068863
rs62479657-<b>T</b>,2 x 10-9,,0.3594,'-,0.0161337 unit decrease,[0.011-0.021],PTPRN2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,7:158318697
rs12914977-<b>T</b>,2 x 10-9,,0.3908,'-,0.015834017 unit increase,[0.011-0.021],IGF1R,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,15:98661995
rs176413-<b>A</b>,2 x 10-9,,0.55,'-,0.015470056 unit increase,[0.01-0.021],BIRC6,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:32421779
rs4687552-<b>T</b>,2 x 10-9,,0.6593,'-,0.016208822 unit decrease,[0.011-0.022],ITIH3,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:52804386
rs17425189-<b>T</b>,3 x 10-9,,0.825,'-,0.020187248 unit increase,[0.014-0.027],DAB1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,1:57397277
rs35702515-<b>T</b>,3 x 10-9,,0.2334,'-,0.018106366 unit increase,[0.012-0.024],THSD7B,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:136785277
rs2533148-<b>T</b>,3 x 10-9,,0.5113,'-,0.015321704 unit decrease,[0.01-0.02],RNU4-74P,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,7:153765721
rs1110464-<b>T</b>,3 x 10-9,,0.5706,'-,0.015407745 unit decrease,[0.01-0.021],TRIM39,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,6:30328294
rs2063886-<b>A</b>,5 x 10-8,,0.308,'-,0.007 unit decrease,[0.0045-0.0095],CHL1-AS2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:181221
rs114916656-<b>T</b>,5 x 10-8,,0.077,'-,0.0122 unit decrease,[0.0079-0.0165],CTNNA1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:138671837
rs1374197-<b>A</b>,5 x 10-8,,0.525,'-,0.0065 unit increase,[0.0041-0.0089],TBC1D5,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:17353123
rs12216497-<b>T</b>,5 x 10-8,,0.557,'-,0.0065 unit decrease,[0.0041-0.0089],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:19028392
rs9806812-<b>A</b>,5 x 10-8,,0.284,'-,0.0072 unit increase,[0.0047-0.0097],GLG1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:74555294
rs937519-<b>T</b>,5 x 10-8,,0.052,'-,0.0146 unit increase,[0.0093-0.0199],FOXP1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:71537002
rs17233551-<b>A</b>,5 x 10-8,,0.874,'-,0.0098 unit increase,[0.0063-0.0133],SNORA25B,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:115660551
rs55795624-<b>T</b>,5 x 10-8,,0.929,'-,0.0126 unit decrease,[0.0081-0.0171],CAMKMT,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:44574753
rs4975077-<b>A</b>,5 x 10-8,,0.816,'-,0.0083 unit increase,[0.0054-0.0112],LINC01088,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:79188310
rs7567687-<b>T</b>,5 x 10-8,,0.533,'-,0.0065 unit increase,[0.0041-0.0089],LINC01854,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:129276753
rs6736012-<b>A</b>,5 x 10-8,,0.057,'-,0.0139 unit increase,[0.0088-0.019],LINC01965,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:104132646
rs6783138-<b>C</b>,1 x 10-90,,0.377,'-,0.0246 unit increase,[0.022-0.027],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85550770
rs727644-<b>A</b>,1 x 10-34,,0.418,'-,0.0147 unit decrease,[0.012-0.017],FOXP2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:114469294
rs4377898-<b>A</b>,8 x 10-31,,0.499,'-,0.0136 unit increase,[0.011-0.016],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:115370104
rs4841503-<b>A</b>,3 x 10-29,,0.479,'-,0.0133 unit increase,[0.011-0.016],XKR6,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:11166817
rs13095117-<b>A</b>,3 x 10-22,,0.392,'-,0.0117 unit increase,[0.0093-0.0141],SATB1-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:18704008
rs1531518-<b>A</b>,5 x 10-22,,0.334,'-,0.0121 unit decrease,[0.0096-0.0146],"LINC01416, LINC01415",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:55813137
rs6839705-<b>A</b>,1 x 10-21,,0.359,'-,0.0118 unit increase,[0.0094-0.0142],TET2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:105223578
rs12023775-<b>T</b>,5 x 10-21,,0.647,'-,0.0116 unit increase,[0.0092-0.014],SDCCAG8,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:243384043
rs62261746-<b>C</b>,1 x 10-20,,0.702,'-,0.0121 unit increase,[0.0096-0.0146],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85909804
rs4917766-<b>A</b>,7 x 10-20,,0.593,'-,0.011 unit decrease,[0.0086-0.0134],"RRP12, FRAT2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:97337434
rs72815624-<b>T</b>,2 x 10-19,,0.132,'-,0.0158 unit decrease,[0.012-0.019],"NF1, OMG",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,17:31289498
rs2953329-<b>A</b>,2 x 10-18,,0.593,'-,0.0106 unit increase,[0.0082-0.013],"LINC02774, AKT3",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:243862697
rs514465-<b>A</b>,2 x 10-18,,0.566,'-,0.0104 unit increase,[0.008-0.0128],GABRA2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:46283933
rs62519839-<b>T</b>,6 x 10-18,,0.112,'-,0.0161 unit decrease,[0.012-0.02],"BHLHE22, CYP7B1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:64585016
rs7003528-<b>T</b>,2 x 10-11,,0.329,'-,0.0085 unit increase,[0.006-0.011],RN7SL178P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:8578560
rs1115569-<b>T</b>,2 x 10-11,,0.555,'-,0.0079 unit increase,[0.0055-0.0103],"SNORD3G, BARHL2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:90677429
rs10173115-<b>A</b>,2 x 10-11,,0.46,'-,0.0079 unit decrease,[0.0055-0.0103],WDPCP,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:63128385
rs35788479-<b>A</b>,3 x 10-11,,0.145,'-,0.0112 unit increase,[0.0079-0.0145],SOX2-OT,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:181708766
rs2153515-<b>A</b>,3 x 10-11,,0.745,'-,0.009 unit decrease,[0.0063-0.0117],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,13:58909449
rs11750854-<b>A</b>,3 x 10-11,,0.45,'-,0.0079 unit decrease,[0.0055-0.0103],"ETF1, RPL7P19",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:138502433
rs11150623-<b>T</b>,3 x 10-11,,0.641,'-,0.0082 unit decrease,[0.0058-0.0106],SH2B1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:28869680
rs1433309-<b>A</b>,3 x 10-11,,0.555,'-,0.0079 unit decrease,[0.0055-0.0103],CRLF3P1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:103442825
rs12913243-<b>A</b>,3 x 10-11,,0.612,'-,0.008 unit increase,[0.0056-0.0104],"CD276, INSYN1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:73731433
rs1822518-<b>A</b>,4 x 10-11,,0.775,'-,0.0094 unit decrease,[0.0067-0.0121],CADPS2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:122340927
rs56047520-<b>T</b>,4 x 10-11,,0.754,'-,0.0091 unit decrease,[0.0064-0.0118],PDZPH1P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:103386912
rs34694866-<b>A</b>,5 x 10-11,,0.253,'-,0.0089 unit decrease,[0.0062-0.0116],LINC02128,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:50909284
rs34819186-<b>A</b>,5 x 10-11,,0.538,'-,0.0078 unit increase,[0.0054-0.0102],TSNARE1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:142281868
rs1909527-<b>A</b>,6 x 10-11,,0.478,'-,0.0077 unit increase,[0.0053-0.0101],"RARB, RNA5SP125",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:25114133
rs11986533-<b>T</b>,6 x 10-11,,0.903,'-,0.013 unit increase,[0.0091-0.0169],XKR6,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:11174575
rs12828944-<b>A</b>,7 x 10-11,,0.434,'-,0.0078 unit decrease,[0.0054-0.0102],TRHDE,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:72342530
rs11672104-<b>T</b>,7 x 10-11,,0.6,'-,0.0079 unit increase,[0.0055-0.0103],"DNAJB1, GIPC1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,19:14506482
rs359243-<b>T</b>,8 x 10-11,,0.394,'-,0.0079 unit decrease,[0.0055-0.0103],MIR4432HG,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:60248374
rs62501032-<b>A</b>,9 x 10-11,,0.171,'-,0.0102 unit increase,[0.0071-0.0133],ST18,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:52223072
rs10900460-<b>T</b>,9 x 10-11,,0.181,'-,0.0099 unit increase,[0.007-0.0128],DSTYK,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:205180462
rs2587505-<b>T</b>,9 x 10-11,,0.581,'-,0.0078 unit increase,[0.0054-0.0102],"CBX8, LINC01977",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,17:79810469
rs7965253-<b>T</b>,1 x 10-10,,0.349,'-,0.008 unit increase,[0.0056-0.0104],RBM19,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:113859837
rs4938247-<b>C</b>,1 x 10-10,,0.717,'-,0.0085 unit decrease,[0.006-0.011],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:116268683
rs684253-<b>T</b>,1 x 10-10,,0.635,'-,0.0079 unit decrease,[0.0055-0.0103],FOXP2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:114742853
rs3134950-<b>A</b>,1 x 10-10,,0.624,'-,0.0079 unit decrease,[0.0055-0.0103],"PPT2, PPT2-EGFL8",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:32159700
rs7981280-<b>T</b>,1 x 10-9,,0.296,'-,0.0078 unit decrease,[0.0053-0.0103],B3GLCT,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,13:31245254
rs9817394-<b>A</b>,1 x 10-9,,0.557,'-,0.0072 unit decrease,[0.0048-0.0096],ARMC10P1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:94477351
rs11736994-<b>A</b>,2 x 10-9,,0.266,'-,0.0081 unit increase,[0.0056-0.0106],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:179752836
rs9989410-<b>A</b>,2 x 10-9,,0.351,'-,0.0075 unit increase,[0.0051-0.0099],"CMTR2, CALB2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,16:71336115
rs949527-<b>T</b>,2 x 10-9,,0.647,'-,0.0075 unit decrease,[0.0051-0.0099],"ZNF618, UNQ6494",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:113790931
rs307984-<b>T</b>,2 x 10-9,,0.145,'-,0.0101 unit increase,[0.0068-0.0134],"MIR7515HG, LINC00487",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:6674328
rs3136272-<b>T</b>,2 x 10-9,,0.366,'-,0.0074 unit decrease,[0.005-0.0098],"FBXO11, MSH6",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:47789757
rs13438897-<b>C</b>,2 x 10-9,,0.818,'-,0.0092 unit decrease,[0.0063-0.0121],RN7SL178P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:8516672
rs11929291-<b>T</b>,2 x 10-9,,0.412,'-,0.0072 unit decrease,[0.0048-0.0096],SRRM1P2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:83867816
rs3765154-<b>T</b>,2 x 10-9,,0.298,'-,0.0078 unit increase,[0.0053-0.0103],"BCL11A, RN7SL361P",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:60556437
rs17328201-<b>T</b>,2 x 10-9,,0.812,'-,0.0091 unit decrease,[0.0062-0.012],CHL1-AS2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:174352
rs2066108-<b>A</b>,2 x 10-9,,0.167,'-,0.0095 unit increase,[0.0064-0.0126],ESRRG,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:216704150
rs7800879-<b>C</b>,2 x 10-9,,0.577,'-,0.0072 unit decrease,[0.0048-0.0096],POLR2DP2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:115478056
rs4240561-<b>A</b>,2 x 10-9,,0.71,'-,0.0078 unit decrease,[0.0053-0.0103],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:98374358
rs10905461-<b>T</b>,2 x 10-9,,0.257,'-,0.0081 unit increase,[0.0054-0.0108],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:8761588
rs1478364-<b>T</b>,2 x 10-9,,0.187,'-,0.0091 unit decrease,[0.0062-0.012],GRIA1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:153418825
rs59626664-<b>C</b>,2 x 10-9,,0.934,'-,0.0142 unit decrease,[0.0095-0.0189],ANKRD52,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:56243191
rs828867-<b>A</b>,2 x 10-9,,0.543,'-,0.0071 unit increase,[0.0047-0.0095],TET3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:74107335
rs6864713-<b>A</b>,2 x 10-9,,0.169,'-,0.0094 unit decrease,[0.0063-0.0125],"RASGRF2-AS1, MSH3",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:80905465
rs7621959-<b>A</b>,2 x 10-9,,0.098,'-,0.0118 unit increase,[0.0079-0.0157],LINC00971,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:84787811
rs4935987-<b>T</b>,3 x 10-9,,0.578,'-,0.0071 unit increase,[0.0047-0.0095],KIRREL3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:126732491
rs7099822-<b>C</b>,3 x 10-9,,0.421,'-,0.0071 unit increase,[0.0047-0.0095],STK32C,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:132296382
rs1169479-<b>T</b>,3 x 10-9,,0.564,'-,0.0071 unit decrease,[0.0047-0.0095],CCDC171,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:15895808
rs66679256-<b>T</b>,3 x 10-9,,0.448,'-,0.0071 unit increase,[0.0047-0.0095],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:18350275
rs4659805-<b>T</b>,3 x 10-9,,0.622,'-,0.0072 unit increase,[0.0048-0.0096],RYR2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:237696455
rs4326656-<b>A</b>,4 x 10-10,,0.709,'-,0.0081 unit decrease,[0.0056-0.0106],NEK7,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:198371345
rs182187235-<b>T</b>,4 x 10-10,,0.036,'-,0.0198 unit increase,[0.014-0.026],"SLC43A3, RNA5SP341",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:57435911
rs198801-<b>T</b>,4 x 10-10,,0.63,'-,0.0076 unit decrease,[0.0052-0.01],"H1-4, H2AC6",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:26139513
rs77110056-<b>A</b>,5 x 10-10,,0.101,'-,0.0122 unit increase,[0.0083-0.0161],"LINC02106, PARP8",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:50926120
rs2487818-<b>T</b>,5 x 10-10,,0.469,'-,0.0074 unit decrease,[0.005-0.0098],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:28569047
rs111257433-<b>A</b>,5 x 10-10,,0.14,'-,0.0106 unit increase,[0.0073-0.0139],LINC02211,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:25199044
rs13100903-<b>T</b>,6 x 10-10,,0.346,'-,0.0077 unit increase,[0.0053-0.0101],SEMA3F-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:50137139
rs76363701-<b>T</b>,6 x 10-10,,0.951,'-,0.0169 unit decrease,[0.012-0.022],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85386909
rs11600674-<b>A</b>,6 x 10-10,,0.838,'-,0.0099 unit decrease,[0.0068-0.013],LINC02742,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:28946454
rs11070529-<b>T</b>,6 x 10-10,,0.47,'-,0.0073 unit increase,[0.0049-0.0097],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:46511642
rs62258408-<b>T</b>,7 x 10-10,,0.962,'-,0.019 unit decrease,[0.013-0.025],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:84147197
rs55671930-<b>A</b>,7 x 10-10,,0.9,'-,0.0121 unit decrease,[0.0082-0.016],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:92366434
rs3001723-<b>A</b>,7 x 10-10,,0.3,'-,0.0079 unit increase,[0.0054-0.0104],PTPRF,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:43572014
rs11511923-<b>T</b>,7 x 10-10,,0.33,'-,0.0077 unit increase,[0.0052-0.0102],LRRC4C,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:41069380
rs6549007-<b>A</b>,8 x 10-10,,0.768,'-,0.0086 unit increase,[0.0059-0.0113],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:84995585
rs7594447-<b>A</b>,8 x 10-10,,0.848,'-,0.0101 unit increase,[0.007-0.0132],NRXN1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:51010884
rs207277-<b>A</b>,8 x 10-10,,0.493,'-,0.0073 unit increase,[0.0049-0.0097],BACH2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:90121550
rs13233131-<b>A</b>,8 x 10-10,,0.178,'-,0.0095 unit decrease,[0.0066-0.0124],CHRM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:136878034
rs62080072-<b>A</b>,1 x 10-9,,0.735,'-,0.0082 unit increase,[0.0057-0.0107],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,18:40594280
rs8078436-<b>T</b>,1 x 10-9,,0.444,'-,0.0073 unit decrease,[0.0049-0.0097],LINC00469,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,17:73899630
rs12971383-<b>A</b>,1 x 10-9,,0.884,'-,0.0113 unit decrease,[0.0078-0.0148],TSHZ3-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,19:31385786
rs2594220-<b>T</b>,1 x 10-9,,0.168,'-,0.0096 unit decrease,[0.0065-0.0127],"LINC01471, LINC02016",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:127474584
rs76861316-<b>T</b>,1 x 10-9,,0.081,'-,0.0133 unit increase,[0.009-0.0176],RUNX1T1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:91955438
rs9826959-<b>A</b>,1 x 10-9,,0.081,'-,0.0132 unit increase,[0.0089-0.0175],"LINC02025, CADM2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:84922595
rs9379328-<b>A</b>,1 x 10-9,,0.358,'-,0.0076 unit increase,[0.0052-0.01],"ARID1B, TMEM242",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:157241819
rs4889891-<b>A</b>,1 x 10-8,,0.4937,'-,0.014597506 unit decrease,[0.0095-0.0196],CBX8,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,17:79794855
rs10767658-<b>C</b>,1 x 10-8,,0.315,'-,0.01570858 unit increase,[0.01-0.021],BDNF-AS,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,11:27650705
rs74424378-<b>T</b>,2 x 10-8,,0.7637,'-,0.017082868 unit increase,[0.011-0.023],LINC01505,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,9:106568813
rs9853563-<b>T</b>,2 x 10-8,,0.9513,'-,0.03371559 unit decrease,[0.022-0.045],CADM2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:85367626
rs2401924-<b>C</b>,2 x 10-8,,0.4978,'-,0.0145140365 unit decrease,[0.0095-0.0196],POLR2DP2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,7:115417808
rs56368231-<b>A</b>,2 x 10-8,,0.1146,'-,0.022729428 unit increase,[0.015-0.031],"FZD7, RNU6-440P",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:201983939
rs11640031-<b>A</b>,2 x 10-8,,0.0802,'-,0.026657334 unit increase,[0.017-0.036],LINC02136,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:71400258
rs1506719-<b>T</b>,2 x 10-8,,0.507,'-,0.01448182 unit increase,[0.0094-0.0195],LRRC4C,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,11:41396711
rs113919848-<b>A</b>,2 x 10-8,,0.0626,'-,0.029819146 unit decrease,[0.019-0.04],CADM2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:86096131
rs77428094-<b>T</b>,2 x 10-8,,0.1932,'-,0.01829609 unit decrease,[0.012-0.025],"STON1, STON1-GTF2A1L",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:48551084
rs5030594-<b>T</b>,2 x 10-8,,0.3336,'-,0.015287408 unit increase,[0.0099-0.0206],CASP6,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,4:109690042
rs55986545-<b>T</b>,2 x 10-8,,0.2929,'-,0.015807368 unit increase,[0.01-0.021],DCC,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,18:52462222
rs6002676-<b>A</b>,2 x 10-8,,0.3833,'-,0.014796305 unit increase,[0.0096-0.02],TCF20,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,22:42301210
rs12621229-<b>A</b>,2 x 10-8,,0.3729,'-,0.014849665 unit decrease,[0.0096-0.0201],DPYSL5,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:59940392
rs2471739-<b>T</b>,3 x 10-8,,0.8059,'-,0.018065117 unit decrease,[0.012-0.024],MAPT,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,17:46002988
rs10865612-<b>T</b>,3 x 10-8,,0.6449,'-,0.014908903 unit increase,[0.0096-0.0202],"CADM2-AS2, CADM2",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:85819379
rs34161718-<b>T</b>,3 x 10-8,,0.2416,'-,0.016667467 unit decrease,[0.011-0.023],KIF26A,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,14:104153856
rs28602385-<b>A</b>,3 x 10-8,,0.3881,'-,0.014619326 unit decrease,[0.0094-0.0198],TCF4,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,18:55392089
rs7585579-<b>C</b>,3 x 10-8,,0.5087,'-,0.014212011 unit decrease,[0.0092-0.0193],'-,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:59797722
rs10026884-<b>A</b>,4 x 10-8,,0.6528,'-,0.0149048725 unit increase,[0.0096-0.0202],GABRB1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,4:47270375
rs79719017-<b>T</b>,4 x 10-8,,0.7009,'-,0.015497868 unit increase,[0.01-0.021],UBE2E3,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:181056036
rs56081191-<b>A</b>,4 x 10-8,,0.078,'-,0.02639789 unit increase,[0.017-0.036],"EIF4EBP2P3, MIR2113",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,6:98109856
rs6499595-<b>C</b>,4 x 10-8,,0.3987,'-,0.014426594 unit decrease,[0.0093-0.0196],ZFHX3,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:72900544
rs28576195-<b>T</b>,4 x 10-8,,0.3834,'-,0.014496166 unit increase,[0.0093-0.0197],BAHCC1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,17:81451573
rs11718065-<b>A</b>,5 x 10-8,,0.2883,'-,0.0155458 unit decrease,[0.01-0.0211],WDR82P1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:94925063
rs10145644-<b>A</b>,3 x 10-8,,0.36,'-,0.0068 unit increase,[0.0044-0.0092],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:29246309
rs12154502-<b>T</b>,3 x 10-8,,0.155,'-,0.0091 unit increase,[0.006-0.0122],FOXP2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:114181316
rs28556884-<b>T</b>,3 x 10-8,,0.744,'-,0.0075 unit decrease,[0.0048-0.0102],PRTG,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:55673323
rs75946928-<b>A</b>,3 x 10-8,,0.175,'-,0.0086 unit decrease,[0.0055-0.0117],PINX1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10811954
rs74715904-<b>A</b>,3 x 10-8,,0.909,'-,0.0114 unit increase,[0.0073-0.0155],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:45176064
rs12518552-<b>A</b>,3 x 10-8,,0.431,'-,0.0066 unit increase,[0.0042-0.009],C5orf64,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:61675292
rs76284431-<b>A</b>,4 x 10-8,,0.153,'-,0.009 unit increase,[0.0059-0.0121],LINC02295,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:98224586
rs79680096-<b>T</b>,4 x 10-8,,0.118,'-,0.0101 unit increase,[0.0066-0.0136],MSRA,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10308755
rs62378044-<b>A</b>,4 x 10-8,,0.51,'-,0.0065 unit increase,[0.0041-0.0089],LINC02147,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:117883560
rs11191442-<b>A</b>,4 x 10-8,,0.263,'-,0.0074 unit increase,[0.0049-0.0099],"BORCS7-ASMT, AS3MT",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:102883839
rs12406370-<b>T</b>,4 x 10-8,,0.172,'-,0.0086 unit decrease,[0.0055-0.0117],HIVEP3,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:41946093
rs13286845-<b>A</b>,4 x 10-8,,0.244,'-,0.0076 unit increase,[0.0049-0.0103],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:22934664
rs28592650-<b>C</b>,4 x 10-8,,0.863,'-,0.0094 unit increase,[0.0061-0.0127],CTSB,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:11849004
rs11124322-<b>A</b>,4 x 10-8,,0.452,'-,0.0065 unit increase,[0.0041-0.0089],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:22219520
rs1891248-<b>T</b>,4 x 10-8,,0.451,'-,0.0065 unit decrease,[0.0041-0.0089],RYR2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:237829735
rs6043521-<b>T</b>,4 x 10-8,,0.604,'-,0.0066 unit increase,[0.0042-0.009],MACROD2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,20:15759100
rs57952229-<b>C</b>,4 x 10-8,,0.147,'-,0.0092 unit decrease,[0.0059-0.0125],MSRA,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:10388013
rs13246546-<b>T</b>,4 x 10-8,,0.289,'-,0.0071 unit decrease,[0.0046-0.0096],FOXP2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:114112704
rs72673538-<b>C</b>,4 x 10-8,,0.285,'-,0.0072 unit decrease,[0.0047-0.0097],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:92261042
rs7947391-<b>A</b>,4 x 10-8,,0.411,'-,0.0066 unit decrease,[0.0042-0.009],"RNU1-84P, NPAS4",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:66419411
rs41264285-<b>T</b>,4 x 10-8,,0.212,'-,0.0079 unit increase,[0.0052-0.0106],ADAM15,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:155061442
rs10767744-<b>T</b>,4 x 10-8,,0.391,'-,0.0066 unit decrease,[0.0042-0.009],"LINC02742, LINC02758",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:28686128
rs7425093-<b>A</b>,4 x 10-8,,0.154,'-,0.009 unit increase,[0.0059-0.0121],VWC2L,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:214583229
rs2710606-<b>A</b>,4 x 10-8,,0.336,'-,0.0069 unit increase,[0.0044-0.0094],BIRC6,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:32586842
rs1011556-<b>A</b>,5 x 10-8,,0.721,'-,0.0072 unit increase,[0.0047-0.0097],RN7SKP181,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:96910603
rs10922907-<b>A</b>,3 x 10-9,,0.4497,'-,0.015331152 unit increase,[0.01-0.02],"LINC02609, BARHL2",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,1:90727492
rs446952-<b>T</b>,4 x 10-9,,0.4588,'-,0.015266644 unit decrease,[0.01-0.02],NFIA,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,1:61272964
rs2890772-<b>T</b>,4 x 10-9,,0.589,'-,0.015461642 unit increase,[0.01-0.021],RPL6P5,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:145417538
rs1549212-<b>T</b>,4 x 10-9,,0.6265,'-,0.015643803 unit decrease,[0.01-0.021],TENM2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,5:167569717
rs3760091-<b>C</b>,4 x 10-9,,0.6039,'-,0.015456795 unit decrease,[0.01-0.021],SULT1A1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:28609479
rs13357015-<b>A</b>,5 x 10-9,,0.6364,'-,0.01568601 unit increase,[0.01-0.021],RASGRF2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,5:80967584
rs10914684-<b>A</b>,5 x 10-9,,0.325,'-,0.016068757 unit decrease,[0.011-0.021],PHC2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,1:33329971
rs8032315-<b>A</b>,6 x 10-9,,0.3246,'-,0.016035372 unit decrease,[0.011-0.021],FURIN,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,15:90875067
rs72930755-<b>T</b>,6 x 10-9,,0.9465,'-,0.03336542 unit increase,[0.022-0.045],TCF4,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,18:55483919
rs2279829-<b>T</b>,6 x 10-9,,0.2149,'-,0.018225709 unit decrease,[0.012-0.024],ZIC4,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:147388532
rs4856463-<b>T</b>,6 x 10-9,,0.2172,'-,0.018146195 unit decrease,[0.012-0.024],PIGX,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:83589417
rs2652434-<b>T</b>,7 x 10-9,,0.4666,'-,0.0149776405 unit decrease,[0.0099-0.02],"KCNJ3, CBX3P6",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:154886382
rs6743766-<b>A</b>,7 x 10-9,,0.2062,'-,0.018468957 unit increase,[0.012-0.025],LRRTM4,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,2:76886034
rs3764002-<b>T</b>,7 x 10-9,,0.2616,'-,0.016980601 unit decrease,[0.011-0.023],WSCD2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,12:108224853
rs11592299-<b>A</b>,7 x 10-9,,0.2058,'-,0.018447189 unit increase,[0.012-0.025],"ACTR1A, MFSD13A",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,10:102466184
rs16918024-<b>T</b>,8 x 10-9,,0.0714,'-,0.02889868 unit decrease,[0.019-0.039],METTL15,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,11:28566879
rs7200801-<b>A</b>,8 x 10-9,,0.2852,'-,0.01646068 unit decrease,[0.011-0.022],"LINC02191, ZKSCAN2-DT",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:25340627
rs6789437-<b>A</b>,9 x 10-9,,0.1208,'-,0.022694703 unit decrease,[0.015-0.03],LINC02024,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:117645613
rs11867618-<b>A</b>,1 x 10-8,,0.1303,'-,0.021921 unit increase,[0.014-0.029],BPTF,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,17:67879471
rs16894116-<b>T</b>,1 x 10-8,,0.2376,'-,0.01732301 unit decrease,[0.011-0.023],COX11P1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,6:28447190
rs28457046-<b>C</b>,1 x 10-8,,0.4316,'-,0.0148285115 unit increase,[0.0097-0.0199],"LINC01471, LINC02016",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:127447554
rs9684742-<b>T</b>,1 x 10-8,,0.3199,'-,0.015746057 unit decrease,[0.01-0.021],"SPINK2, REST",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,4:56881140
rs3134950-<b>A</b>,1 x 10-8,,0.622,'-,0.01510972 unit decrease,[0.0099-0.0203],"PPT2, PPT2-EGFL8",Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,6:32159700
rs7986115-<b>A</b>,1 x 10-8,,0.636,'-,0.015178941 unit decrease,[0.0099-0.0204],PCCA,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,13:100093224
rs1078112-<b>A</b>,1 x 10-8,,0.3908,'-,0.014967991 unit decrease,[0.0098-0.0201],MAD1L1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,7:1838817
rs8082894-<b>A</b>,5 x 10-8,,0.3185,'-,0.015097994 unit decrease,[0.0097-0.0205],PTPRM,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,18:8379091
rs55942317-<b>A</b>,5 x 10-8,,0.09,'-,0.024579043 unit increase,[0.016-0.033],ZNF423,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,16:49592861
rs6807386-<b>T</b>,5 x 10-8,,0.6411,'-,0.014650735 unit decrease,[0.0094-0.0199],RPL21P71,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:147246815
rs75843224-<b>A</b>,6 x 10-14,,0.054,'-,0.0196 unit decrease,[0.015-0.025],EP300,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,22:41151150
rs984983-<b>T</b>,6 x 10-14,,0.868,'-,0.0131 unit decrease,[0.0098-0.0164],MIR29B2CHG,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:207861610
rs6732097-<b>T</b>,6 x 10-14,,0.466,'-,0.0089 unit decrease,[0.0065-0.0113],RNA5SP94,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:59787624
rs17437668-<b>T</b>,9 x 10-14,,0.201,'-,0.011 unit increase,[0.0081-0.0139],"WASHC3, NUP37",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:102069362
rs34661691-<b>T</b>,9 x 10-14,,0.867,'-,0.013 unit increase,[0.0097-0.0163],H2BC6,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:26173250
rs4865512-<b>A</b>,9 x 10-14,,0.616,'-,0.009 unit increase,[0.0066-0.0114],ISL1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:51365767
rs10935186-<b>T</b>,1 x 10-13,,0.598,'-,0.009 unit decrease,[0.0066-0.0114],STAG1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:136627364
rs475125-<b>A</b>,1 x 10-13,,0.507,'-,0.0088 unit decrease,[0.0064-0.0112],"ZNF259P1, ARMC2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:108817710
rs1669025-<b>A</b>,1 x 10-13,,0.507,'-,0.0088 unit decrease,[0.0064-0.0112],DGKI,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:137384309
rs35424804-<b>T</b>,1 x 10-13,,0.5,'-,0.0088 unit increase,[0.0064-0.0112],ARNTL,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:13227183
rs71637264-<b>A</b>,1 x 10-13,,0.805,'-,0.0111 unit increase,[0.0082-0.014],HNRNPA1P46,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:191075693
rs2176263-<b>C</b>,1 x 10-13,,0.603,'-,0.0089 unit increase,[0.0065-0.0113],ATAD2B,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:23869903
rs786250-<b>T</b>,2 x 10-13,,0.346,'-,0.0091 unit decrease,[0.0067-0.0115],TEX41,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:144944425
rs10835696-<b>A</b>,2 x 10-13,,0.702,'-,0.0095 unit decrease,[0.007-0.012],MPPED2-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:30645856
rs7817124-<b>C</b>,5 x 10-13,,0.247,'-,0.0099 unit increase,[0.0072-0.0126],ZBTB10,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:80491773
rs67361341-<b>A</b>,6 x 10-13,,0.388,'-,0.0087 unit decrease,[0.0063-0.0111],TSHZ3-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,19:31351096
rs760077-<b>A</b>,8 x 10-13,,0.403,'-,0.0086 unit decrease,[0.0062-0.011],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,Mapping not available
rs113338260-<b>T</b>,8 x 10-13,,0.786,'-,0.0103 unit decrease,[0.0076-0.013],MEF2C-AS1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:46004538
rs2920939-<b>A</b>,9 x 10-13,,0.598,'-,0.0086 unit increase,[0.0062-0.011],RUNX1T1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:92170373
rs983583-<b>T</b>,1 x 10-12,,0.388,'-,0.0086 unit increase,[0.0062-0.011],YWHAZ,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:100949682
rs34259390-<b>T</b>,1 x 10-12,,0.346,'-,0.0088 unit increase,[0.0064-0.0112],RN7SKP207,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,5:30038809
rs3783007-<b>T</b>,1 x 10-12,,0.621,'-,0.0086 unit increase,[0.0062-0.011],STK24,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,13:98457562
rs6778487-<b>T</b>,1 x 10-12,,0.681,'-,0.009 unit increase,[0.0065-0.0115],DIPK2A,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:144023025
rs1438026-<b>T</b>,1 x 10-12,,0.67,'-,0.0089 unit increase,[0.0064-0.0114],"MRPS18BP2, SNORA72",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:139583451
rs1119988-<b>T</b>,1 x 10-12,,0.589,'-,0.0085 unit decrease,[0.0061-0.0109],Y_RNA,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,12:60393384
rs4841237-<b>A</b>,3 x 10-9,,0.746,'-,0.008 unit decrease,[0.0053-0.0107],"MIR124-1HG, TNKS",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:9827373
rs10733661-<b>A</b>,3 x 10-9,,0.538,'-,0.007 unit increase,[0.0046-0.0094],DENND1A,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,9:123421025
rs3943782-<b>A</b>,3 x 10-9,,0.635,'-,0.0073 unit increase,[0.0049-0.0097],CADM2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:85339014
rs524278-<b>T</b>,3 x 10-9,,0.718,'-,0.0078 unit increase,[0.0053-0.0103],"RNU6-61P, SPRY2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,13:80343982
rs4702-<b>A</b>,3 x 10-9,,0.549,'-,0.007 unit decrease,[0.0046-0.0094],FURIN,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:90883330
rs2801191-<b>A</b>,3 x 10-9,,0.331,'-,0.0074 unit decrease,[0.0049-0.0099],PLXNA2,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,1:208279636
rs35590005-<b>C</b>,3 x 10-9,,0.488,'-,0.007 unit decrease,[0.0046-0.0094],NDUFB5P1,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,4:180564456
rs1435741-<b>A</b>,3 x 10-9,,0.433,'-,0.007 unit increase,[0.0046-0.0094],SEMA6D,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,15:47643646
rs9374194-<b>T</b>,4 x 10-9,,0.807,'-,0.0088 unit decrease,[0.0059-0.0117],CDK19,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,6:110678982
rs2577326-<b>A</b>,4 x 10-9,,0.184,'-,0.009 unit increase,[0.0061-0.0119],CACNA1D,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:53746055
rs12673949-<b>A</b>,4 x 10-9,,0.726,'-,0.0078 unit increase,[0.0053-0.0103],HIBADH,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:27561015
rs6731373-<b>A</b>,4 x 10-9,,0.342,'-,0.0073 unit decrease,[0.0049-0.0097],"PPP3R1, CNRIP1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:68275912
rs13031996-<b>A</b>,4 x 10-9,,0.656,'-,0.0073 unit increase,[0.0049-0.0097],RNU6-715P,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,2:147503472
rs2238199-<b>A</b>,4 x 10-9,,0.449,'-,0.007 unit increase,[0.0046-0.0094],RGS6,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,14:72332295
rs11813604-<b>T</b>,4 x 10-9,,0.699,'-,0.0076 unit decrease,[0.0051-0.0101],PCDH15,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,10:54889908
rs12806687-<b>C</b>,4 x 10-9,,0.339,'-,0.0073 unit increase,[0.0049-0.0097],LRP4,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:46903114
rs498547-<b>T</b>,4 x 10-9,,0.369,'-,0.0072 unit decrease,[0.0048-0.0096],SDHD,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,11:112101932
rs6084309-<b>C</b>,4 x 10-9,,0.854,'-,0.0098 unit increase,[0.0065-0.0131],ITPA,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,20:3222468
rs75619216-<b>T</b>,4 x 10-9,,0.052,'-,0.0157 unit increase,[0.01-0.021],'-,General risk tolerance (MTAG),risk-taking behaviour,GCST007325,3:43912969
rs10954935-<b>C</b>,5 x 10-9,,0.578,'-,0.007 unit increase,[0.0046-0.0094],"KCNU1, VENTXP5",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,8:33812861
rs10259338-<b>A</b>,5 x 10-9,,0.498,'-,0.0069 unit decrease,[0.0045-0.0093],"ZNF800, PRELID3BP10",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:127300567
rs7405743-<b>T</b>,5 x 10-9,,0.739,'-,0.0079 unit decrease,[0.0054-0.0104],"FBXO36P1, KPNA2",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,17:68047422
rs62062288-<b>A</b>,1 x 10-29,,0.2207,'-,0.035170935 unit decrease,[0.029-0.041],MAPT,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,17:46019187
rs6790699-<b>A</b>,6 x 10-27,,0.373,'-,0.0286348 unit increase,[0.023-0.034],CADM2,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,3:85575039
rs2155290-<b>C</b>,4 x 10-24,,0.617,'-,0.026843483 unit decrease,[0.022-0.032],NCAM1,Risk-taking tendency (4-domain principal component model),risk-taking behaviour,GCST007323,11:112980346
rs7653193-<b>A</b>,3 x 10-9,,0.317,'-,0.012405706 unit increase,[0.0083-0.0165],'-,Adventurousness,risk-taking behaviour,GCST007324,3:83822032
rs704660-<b>T</b>,3 x 10-9,,0.4044,'-,0.011755997 unit increase,[0.0079-0.0156],MPPED2,Adventurousness,risk-taking behaviour,GCST007324,11:30426451
rs941520-<b>A</b>,4 x 10-9,,0.4975,'-,0.011455808 unit increase,[0.0077-0.0153],'-,Adventurousness,risk-taking behaviour,GCST007324,Mapping not available
rs638722-<b>T</b>,4 x 10-9,,0.8208,'-,0.01492985 unit decrease,[0.01-0.0199],ZNF436-AS1,Adventurousness,risk-taking behaviour,GCST007324,1:23371124
rs79767800-<b>T</b>,4 x 10-9,,0.2129,'-,0.013978026 unit increase,[0.0093-0.0186],'-,Adventurousness,risk-taking behaviour,GCST007324,5:45965678
rs1927860-<b>A</b>,4 x 10-9,,0.6009,'-,0.011684407 unit decrease,[0.0078-0.0156],ZNF646P1,Adventurousness,risk-taking behaviour,GCST007324,13:53492761
rs13286845-<b>A</b>,4 x 10-9,,0.2477,'-,0.013239581 unit increase,[0.0088-0.0176],'-,Adventurousness,risk-taking behaviour,GCST007324,9:22934664
rs1805508-<b>C</b>,4 x 10-9,,0.628,'-,0.011790337 unit decrease,[0.0079-0.0157],GRIN2B,Adventurousness,risk-taking behaviour,GCST007324,12:13596897
rs55817211-<b>T</b>,4 x 10-9,,0.3007,'-,0.0124273645 unit decrease,[0.0083-0.0166],"BARHL2, SNORD3G",Adventurousness,risk-taking behaviour,GCST007324,1:90688763
rs6802472-<b>A</b>,4 x 10-9,,0.7825,'-,0.013801802 unit increase,[0.0092-0.0184],FOXP1,Adventurousness,risk-taking behaviour,GCST007324,3:70987843
rs2391448-<b>T</b>,4 x 10-9,,0.7313,'-,0.01284476 unit increase,[0.0086-0.0171],HIBADH,Adventurousness,risk-taking behaviour,GCST007324,7:27638566
rs4938247-<b>C</b>,5 x 10-9,,0.7145,'-,0.012578829 unit decrease,[0.0084-0.0168],'-,Adventurousness,risk-taking behaviour,GCST007324,11:116268683
rs75478074-<b>T</b>,5 x 10-9,,0.2425,'-,0.013217046 unit decrease,[0.0088-0.0177],'-,Adventurousness,risk-taking behaviour,GCST007324,12:59970869
rs13023277-<b>A</b>,5 x 10-9,,0.6618,'-,0.011969682 unit increase,[0.0079-0.016],RNU6-715P,Adventurousness,risk-taking behaviour,GCST007324,2:147514887
rs4473575-<b>T</b>,6 x 10-9,,0.9281,'-,0.021895241 unit decrease,[0.015-0.029],SATB1-AS1,Adventurousness,risk-taking behaviour,GCST007324,3:18687868
rs2813711-<b>A</b>,6 x 10-9,,0.1582,'-,0.015477735 unit increase,[0.01-0.021],ESRRG,Adventurousness,risk-taking behaviour,GCST007324,1:216706569
rs984983-<b>T</b>,6 x 10-9,,0.8679,'-,0.016672663 unit decrease,[0.011-0.022],MIR29B2CHG,Adventurousness,risk-taking behaviour,GCST007324,1:207861610
rs191780-<b>C</b>,6 x 10-9,,0.8422,'-,0.015472365 unit decrease,[0.01-0.021],RASGRF2,Adventurousness,risk-taking behaviour,GCST007324,5:81059805
rs17700977-<b>A</b>,6 x 10-9,,0.4069,'-,0.011473901 unit increase,[0.0076-0.0153],LINC02295,Adventurousness,risk-taking behaviour,GCST007324,14:98153631
rs2071342-<b>A</b>,6 x 10-9,,0.6435,'-,0.011758201 unit decrease,[0.0078-0.0157],ATP2A1,Adventurousness,risk-taking behaviour,GCST007324,16:28904112
rs1991797-<b>T</b>,7 x 10-9,,0.3254,'-,0.012005738 unit increase,[0.0079-0.0161],MACIR,Adventurousness,risk-taking behaviour,GCST007324,5:103286752
rs6962750-<b>T</b>,7 x 10-9,,0.7922,'-,0.013847006 unit increase,[0.0092-0.0185],SDK1,Adventurousness,risk-taking behaviour,GCST007324,7:3909051
rs524278-<b>T</b>,8 x 10-9,,0.7255,'-,0.012545946 unit increase,[0.0083-0.0168],"RNU6-61P, SPRY2",Adventurousness,risk-taking behaviour,GCST007324,13:80343982
rs117167357-<b>A</b>,8 x 10-9,,0.9309,'-,0.022044498 unit decrease,[0.015-0.03],CDH8,Adventurousness,risk-taking behaviour,GCST007324,16:61801391
rs6743594-<b>A</b>,9 x 10-9,,0.2993,'-,0.012191803 unit increase,[0.008-0.0163],MEAF6P1,Adventurousness,risk-taking behaviour,GCST007324,2:209244135
rs10433500-<b>A</b>,9 x 10-84,,0.6321,'-,0.03901553 unit decrease,[0.035-0.043],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85497648
rs13090941-<b>A</b>,3 x 10-21,,0.4953,'-,0.018347727 unit decrease,[0.015-0.022],SATB1-AS1,Adventurousness,risk-taking behaviour,GCST007324,3:18660544
rs10228494-<b>C</b>,1 x 10-19,,0.4473,'-,0.017694445 unit decrease,[0.014-0.022],FOXP2,Adventurousness,risk-taking behaviour,GCST007324,7:114443495
rs2905804-<b>T</b>,6 x 10-19,,0.2823,'-,0.019181518 unit decrease,[0.015-0.023],NF1,Adventurousness,risk-taking behaviour,GCST007324,17:31192977
rs534567-<b>A</b>,3 x 10-18,,0.4117,'-,0.01720256 unit decrease,[0.013-0.021],"SIX3, KRTCAP2P1",Adventurousness,risk-taking behaviour,GCST007324,2:44948382
rs513150-<b>A</b>,2 x 10-17,,0.6526,'-,0.017336262 unit increase,[0.013-0.021],AUTS2,Adventurousness,risk-taking behaviour,GCST007324,7:69710667
rs4840572-<b>A</b>,3 x 10-17,,0.3018,'-,0.01785755 unit increase,[0.014-0.022],"LINC00208, GATA4",Adventurousness,risk-taking behaviour,GCST007324,8:11585695
rs116275905-<b>A</b>,4 x 10-17,,0.0489,'-,0.03783505 unit increase,[0.029-0.047],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:84988729
rs77339131-<b>A</b>,3 x 10-16,,0.0598,'-,0.033474192 unit decrease,[0.025-0.041],EP300,Adventurousness,risk-taking behaviour,GCST007324,22:41174563
rs490434-<b>A</b>,1 x 10-15,,0.4214,'-,0.015756039 unit decrease,[0.012-0.02],"GABRG1, GABRA2",Adventurousness,risk-taking behaviour,GCST007324,4:46191262
rs8181326-<b>A</b>,1 x 10-15,,0.6495,'-,0.016249152 unit decrease,[0.012-0.02],"ARHGAP19-SLIT1, ARHGAP19",Adventurousness,risk-taking behaviour,GCST007324,10:97238438
rs734073-<b>T</b>,2 x 10-15,,0.755,'-,0.017859396 unit decrease,[0.013-0.022],FAM189B,Adventurousness,risk-taking behaviour,GCST007324,1:155248574
rs4605551-<b>T</b>,3 x 10-15,,0.6366,'-,0.01588298 unit decrease,[0.012-0.02],'-,Adventurousness,risk-taking behaviour,GCST007324,3:86621314
rs1319994-<b>T</b>,7 x 10-15,,0.5947,'-,0.015368677 unit decrease,[0.011-0.019],CDH8,Adventurousness,risk-taking behaviour,GCST007324,16:61617502
rs1694933-<b>A</b>,8 x 10-15,,0.4857,'-,0.015085031 unit decrease,[0.011-0.019],"LINC02025, CADM2",Adventurousness,risk-taking behaviour,GCST007324,3:84902565
rs10251192-<b>T</b>,8 x 10-15,,0.5473,'-,0.015127294 unit decrease,[0.011-0.019],'-,Adventurousness,risk-taking behaviour,GCST007324,7:115386405
rs12520354-<b>A</b>,1 x 10-14,,0.2613,'-,0.017090015 unit increase,[0.013-0.021],RASGRF2-AS1,Adventurousness,risk-taking behaviour,GCST007324,5:80952681
rs67379620-<b>T</b>,1 x 10-14,,0.1549,'-,0.020626264 unit decrease,[0.015-0.026],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85344761
rs12534625-<b>T</b>,7 x 10-14,,0.6518,'-,0.015249436 unit increase,[0.011-0.019],DGKI,Adventurousness,risk-taking behaviour,GCST007324,7:137382870
rs11111197-<b>T</b>,8 x 10-14,,0.2003,'-,0.018130047 unit increase,[0.013-0.023],PARPBP,Adventurousness,risk-taking behaviour,GCST007324,12:102185741
rs2133086-<b>A</b>,8 x 10-14,,0.4812,'-,0.014520518 unit increase,[0.011-0.018],TET2,Adventurousness,risk-taking behaviour,GCST007324,4:105257132
rs12023775-<b>T</b>,9 x 10-14,,0.6443,'-,0.015124699 unit increase,[0.011-0.019],SDCCAG8,Adventurousness,risk-taking behaviour,GCST007324,1:243384043
rs2919451-<b>T</b>,1 x 10-13,,0.3912,'-,0.014747182 unit decrease,[0.011-0.019],TCF4,Adventurousness,risk-taking behaviour,GCST007324,18:55417069
rs2953329-<b>A</b>,5 x 10-13,,0.594,'-,0.014254021 unit increase,[0.01-0.018],"LINC02774, AKT3",Adventurousness,risk-taking behaviour,GCST007324,1:243862697
rs12404954-<b>A</b>,6 x 10-13,,0.6059,'-,0.014318888 unit decrease,[0.01-0.018],HP1BP3,Adventurousness,risk-taking behaviour,GCST007324,1:20748234
rs2588978-<b>T</b>,5 x 10-11,,0.4804,'-,0.014819743 unit decrease,[0.01-0.019],LINC02625,Automobile speeding propensity,risk-taking behaviour,GCST007329,10:61799851
rs11208920-<b>A</b>,8 x 10-11,,0.4328,'-,0.014787062 unit decrease,[0.01-0.019],SGIP1,Automobile speeding propensity,risk-taking behaviour,GCST007329,1:66609629
rs575377383-<b>T</b>,8 x 10-11,,0.9292,'-,0.028524697 unit increase,[0.02-0.037],TNXB,Automobile speeding propensity,risk-taking behaviour,GCST007329,6:32041710
rs619466-<b>A</b>,1 x 10-10,,0.0938,'-,0.024843378 unit increase,[0.017-0.032],TCF4,Automobile speeding propensity,risk-taking behaviour,GCST007329,18:55531605
rs35514852-<b>T</b>,1 x 10-10,,0.3574,'-,0.015113897 unit decrease,[0.011-0.02],NOA1,Automobile speeding propensity,risk-taking behaviour,GCST007329,4:56969803
rs7201179-<b>T</b>,6 x 10-10,,0.4321,'-,0.014050871 unit increase,[0.0096-0.0185],CDH8,Automobile speeding propensity,risk-taking behaviour,GCST007329,16:62021842
rs13265333-<b>C</b>,7 x 10-10,,0.398,'-,0.014185216 unit decrease,[0.0097-0.0187],"MROH4P, ADGRB1",Automobile speeding propensity,risk-taking behaviour,GCST007329,8:142545124
rs12546399-<b>T</b>,1 x 10-9,,0.1107,'-,0.021878503 unit increase,[0.015-0.029],BHLHE22,Automobile speeding propensity,risk-taking behaviour,GCST007329,8:64575216
rs10858922-<b>A</b>,2 x 10-9,,0.2784,'-,0.015018993 unit increase,[0.01-0.02],"RNA5SP365, MRPL2P1",Automobile speeding propensity,risk-taking behaviour,GCST007329,12:89731312
rs9391786-<b>A</b>,2 x 10-9,,0.5802,'-,0.013639976 unit increase,[0.0092-0.0181],"HLA-DRB9, HLA-DRB5",Automobile speeding propensity,risk-taking behaviour,GCST007329,6:32480784
rs2433634-<b>A</b>,3 x 10-9,,0.7179,'-,0.01491602 unit decrease,[0.01-0.02],'-,Automobile speeding propensity,risk-taking behaviour,GCST007329,12:22907429
rs2652460-<b>A</b>,4 x 10-9,,0.4678,'-,0.0133310845 unit decrease,[0.0089-0.0178],KCNJ3,Automobile speeding propensity,risk-taking behaviour,GCST007329,2:154827826
rs55864511-<b>A</b>,4 x 10-9,,0.7597,'-,0.015510079 unit increase,[0.01-0.021],NFIC,Automobile speeding propensity,risk-taking behaviour,GCST007329,19:3361728
rs10753130-<b>T</b>,6 x 10-9,,0.1652,'-,0.017611401 unit increase,[0.012-0.024],PAPPA2,Automobile speeding propensity,risk-taking behaviour,GCST007329,1:176571989
rs9875381-<b>A</b>,8 x 10-9,,0.4,'-,0.013258126 unit decrease,[0.0088-0.0178],CADM2,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:85109582
rs2409691-<b>T</b>,9 x 10-9,,0.4822,'-,0.012960173 unit decrease,[0.0085-0.0174],XKR6,Automobile speeding propensity,risk-taking behaviour,GCST007329,8:11085766
rs6896357-<b>T</b>,9 x 10-9,,0.6484,'-,0.013553679 unit increase,[0.0089-0.0182],'-,Automobile speeding propensity,risk-taking behaviour,GCST007329,5:51533032
rs4801147-<b>T</b>,9 x 10-9,,0.5579,'-,0.013023804 unit increase,[0.0086-0.0175],"TCF4, RNA5SP459",Automobile speeding propensity,risk-taking behaviour,GCST007329,18:55205475
rs7643341-<b>T</b>,1 x 10-8,,0.4045,'-,0.012997491 unit decrease,[0.0085-0.0175],DIPK2A,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:144008138
rs761277-<b>A</b>,2 x 10-8,,0.6377,'-,0.013240951 unit increase,[0.0086-0.0178],MIR29B2CHG,Automobile speeding propensity,risk-taking behaviour,GCST007329,1:207819666
rs10465231-<b>T</b>,2 x 10-8,,0.5489,'-,0.012760806 unit decrease,[0.0083-0.0172],"GADD45G, SEMA4D",Automobile speeding propensity,risk-taking behaviour,GCST007329,9:89568498
rs4313803-<b>A</b>,2 x 10-8,,0.58,'-,0.012865377 unit decrease,[0.0084-0.0173],'-,Automobile speeding propensity,risk-taking behaviour,GCST007329,16:59214758
rs7291841-<b>A</b>,2 x 10-8,,0.5412,'-,0.012742966 unit decrease,[0.0083-0.0172],KCNJ4,Automobile speeding propensity,risk-taking behaviour,GCST007329,22:38435656
rs16864081-<b>T</b>,2 x 10-8,,0.2378,'-,0.014883163 unit increase,[0.0097-0.0201],"LINC01810, SOX11",Automobile speeding propensity,risk-taking behaviour,GCST007329,2:5730809
rs61106808-<b>C</b>,2 x 10-8,,0.8761,'-,0.019194333 unit decrease,[0.012-0.026],ARPC3,Automobile speeding propensity,risk-taking behaviour,GCST007329,12:110438204
rs28646179-<b>A</b>,8 x 10-13,,0.0532,'-,0.030969024 unit increase,[0.022-0.039],LINC02237,Adventurousness,risk-taking behaviour,GCST007324,8:111502783
rs9556958-<b>T</b>,9 x 10-13,,0.5202,'-,0.013883109 unit decrease,[0.01-0.018],"FARP1, STK24",Adventurousness,risk-taking behaviour,GCST007324,13:98447792
rs71637264-<b>A</b>,1 x 10-12,,0.8182,'-,0.017958388 unit increase,[0.013-0.023],HNRNPA1P46,Adventurousness,risk-taking behaviour,GCST007324,1:191075693
rs117928826-<b>T</b>,1 x 10-12,,0.9636,'-,0.036961664 unit increase,[0.027-0.047],AUTS2,Adventurousness,risk-taking behaviour,GCST007324,7:70367156
rs6790538-<b>C</b>,1 x 10-12,,0.5503,'-,0.013833275 unit decrease,[0.01-0.018],"CADM2, RNU6-1129P",Adventurousness,risk-taking behaviour,GCST007324,3:86154671
rs73130739-<b>T</b>,2 x 10-12,,0.9835,'-,0.05381465 unit decrease,[0.039-0.069],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85238146
rs6505239-<b>A</b>,2 x 10-12,,0.1348,'-,0.020031037 unit decrease,[0.014-0.026],RAB11FIP4,Adventurousness,risk-taking behaviour,GCST007324,17:31411053
rs112878517-<b>T</b>,4 x 10-12,,0.4022,'-,0.013751207 unit decrease,[0.0099-0.0176],"DNAJB1, GIPC1",Adventurousness,risk-taking behaviour,GCST007324,19:14507008
rs6465607-<b>C</b>,4 x 10-12,,0.5182,'-,0.013480934 unit decrease,[0.0097-0.0173],TAC1,Adventurousness,risk-taking behaviour,GCST007324,7:97725638
rs6131703-<b>A</b>,4 x 10-12,,0.6048,'-,0.013756217 unit increase,[0.0099-0.0176],MACROD2,Adventurousness,risk-taking behaviour,GCST007324,20:15774039
rs1988552-<b>A</b>,4 x 10-12,,0.0934,'-,0.0230817 unit increase,[0.017-0.03],"CADM2, CADM2-AS2",Adventurousness,risk-taking behaviour,GCST007324,3:85800701
rs7645787-<b>T</b>,5 x 10-12,,0.0029,'-,0.12461655 unit increase,[0.089-0.16],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85036563
rs13116355-<b>A</b>,7 x 10-12,,0.6679,'-,0.014133557 unit decrease,[0.01-0.018],GABRB1,Adventurousness,risk-taking behaviour,GCST007324,4:47037298
rs963349-<b>C</b>,1 x 10-11,,0.2616,'-,0.015008384 unit increase,[0.011-0.019],NLGN1,Adventurousness,risk-taking behaviour,GCST007324,3:173964050
rs11240317-<b>C</b>,2 x 10-11,,0.2987,'-,0.014185315 unit increase,[0.01-0.018],NFASC,Adventurousness,risk-taking behaviour,GCST007324,1:204951194
rs2654670-<b>A</b>,3 x 10-11,,0.5776,'-,0.0131029105 unit decrease,[0.0093-0.017],'-,Adventurousness,risk-taking behaviour,GCST007324,12:60592669
rs11589479-<b>A</b>,3 x 10-11,,0.1732,'-,0.01709262 unit decrease,[0.012-0.022],ADAM15,Adventurousness,risk-taking behaviour,GCST007324,1:155060832
rs294381-<b>T</b>,1 x 10-14,,0.2806,'-,0.01928015 unit increase,[0.014-0.024],MPPED2-AS1,Automobile speeding propensity,risk-taking behaviour,GCST007329,11:30586906
rs17516256-<b>A</b>,1 x 10-20,,0.6269,'-,0.021747468 unit decrease,[0.017-0.026],CADM2,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:85531438
rs362307-<b>T</b>,6 x 10-14,,0.0752,'-,0.03203624 unit decrease,[0.024-0.04],HTT,Automobile speeding propensity,risk-taking behaviour,GCST007329,4:3240118
rs11128203-<b>A</b>,1 x 10-13,,0.5344,'-,0.016751751 unit increase,[0.012-0.021],FOXP1,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:71015280
rs62062288-<b>A</b>,1 x 10-12,,0.2196,'-,0.019352188 unit decrease,[0.014-0.025],MAPT,Automobile speeding propensity,risk-taking behaviour,GCST007329,17:46019187
rs185819-<b>T</b>,2 x 10-12,,0.5357,'-,0.01581973 unit increase,[0.011-0.02],TNXB,Automobile speeding propensity,risk-taking behaviour,GCST007329,6:32082290
rs72828532-<b>T</b>,3 x 10-12,,0.8195,'-,0.020396648 unit decrease,[0.015-0.026],'-,Automobile speeding propensity,risk-taking behaviour,GCST007329,6:19065111
rs58294838-<b>C</b>,5 x 10-12,,0.8226,'-,0.020381948 unit increase,[0.015-0.026],FOXP1,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:71111210
rs6512302-<b>C</b>,3 x 10-8,,0.7461,'-,0.012388765 unit decrease,[0.008-0.0168],TCEA2,Adventurousness,risk-taking behaviour,GCST007324,20:64060197
rs1884123-<b>A</b>,3 x 10-8,,0.3614,'-,0.011205866 unit decrease,[0.0072-0.0152],"OR14J1, OR2U2P",Adventurousness,risk-taking behaviour,GCST007324,6:29288643
rs2071390-<b>T</b>,3 x 10-8,,0.1591,'-,0.014712622 unit decrease,[0.0095-0.0199],ALDOA,Adventurousness,risk-taking behaviour,GCST007324,16:30070046
rs7036637-<b>C</b>,3 x 10-8,,0.372,'-,0.01113186 unit decrease,[0.0072-0.0151],SLC24A2,Adventurousness,risk-taking behaviour,GCST007324,9:19695640
rs8078436-<b>T</b>,3 x 10-8,,0.4463,'-,0.010823515 unit decrease,[0.007-0.0146],LINC00469,Adventurousness,risk-taking behaviour,GCST007324,17:73899630
rs240619-<b>C</b>,3 x 10-8,,0.5527,'-,0.010819235 unit increase,[0.007-0.0146],"MAPK1, PPM1F",Adventurousness,risk-taking behaviour,GCST007324,22:21899707
rs61595816-<b>A</b>,3 x 10-8,,0.8489,'-,0.015017646 unit decrease,[0.0097-0.0203],MYT1L,Adventurousness,risk-taking behaviour,GCST007324,2:2209737
rs62519839-<b>T</b>,3 x 10-8,,0.1121,'-,0.01704201 unit decrease,[0.011-0.023],"BHLHE22, CYP7B1",Adventurousness,risk-taking behaviour,GCST007324,8:64585016
rs10085919-<b>A</b>,3 x 10-8,,0.8519,'-,0.015128596 unit increase,[0.0098-0.0205],XKR6,Adventurousness,risk-taking behaviour,GCST007324,8:11178547
rs983067-<b>T</b>,3 x 10-8,,0.3535,'-,0.011224413 unit increase,[0.0072-0.0152],NEO1,Adventurousness,risk-taking behaviour,GCST007324,15:73155579
rs73021449-<b>A</b>,3 x 10-8,,0.3579,'-,0.011177166 unit increase,[0.0072-0.0151],"LINC02067, SPTSSB",Adventurousness,risk-taking behaviour,GCST007324,3:161411153
rs34819186-<b>A</b>,3 x 10-8,,0.5463,'-,0.010758621 unit increase,[0.0069-0.0146],TSNARE1,Adventurousness,risk-taking behaviour,GCST007324,8:142281868
rs67361341-<b>A</b>,3 x 10-8,,0.3787,'-,0.011038266 unit decrease,[0.0071-0.015],TSHZ3-AS1,Adventurousness,risk-taking behaviour,GCST007324,19:31351096
rs56852527-<b>T</b>,4 x 10-8,,0.198,'-,0.013414376 unit decrease,[0.0086-0.0182],PHF21A,Adventurousness,risk-taking behaviour,GCST007324,11:46026833
rs1341729-<b>T</b>,4 x 10-8,,0.2962,'-,0.01170349 unit increase,[0.0075-0.0159],CCDC171,Adventurousness,risk-taking behaviour,GCST007324,9:15898230
rs4858708-<b>A</b>,4 x 10-8,,0.5161,'-,0.010681061 unit decrease,[0.0069-0.0145],"RARB, RNA5SP125",Adventurousness,risk-taking behaviour,GCST007324,3:25112621
rs4961705-<b>C</b>,4 x 10-8,,0.3494,'-,0.011193392 unit decrease,[0.0072-0.0152],C9orf92,Adventurousness,risk-taking behaviour,GCST007324,9:16347929
rs9345268-<b>T</b>,4 x 10-8,,0.3194,'-,0.011444262 unit increase,[0.0074-0.0155],LINC02531,Adventurousness,risk-taking behaviour,GCST007324,6:92692829
rs55745410-<b>A</b>,4 x 10-8,,0.6424,'-,0.011124581 unit increase,[0.0072-0.0151],PHC2,Adventurousness,risk-taking behaviour,GCST007324,1:33337216
rs2409095-<b>A</b>,4 x 10-8,,0.7514,'-,0.012336701 unit increase,[0.0079-0.0167],MFHAS1,Adventurousness,risk-taking behaviour,GCST007324,8:8829170
rs10822082-<b>T</b>,4 x 10-8,,0.5272,'-,0.010671918 unit decrease,[0.0069-0.0145],EGR2,Adventurousness,risk-taking behaviour,GCST007324,10:62917547
rs7136732-<b>C</b>,4 x 10-8,,0.8079,'-,0.013485254 unit increase,[0.0087-0.0183],'-,Adventurousness,risk-taking behaviour,GCST007324,12:97172398
rs116920450-<b>A</b>,4 x 10-8,,0.0136,'-,0.045842428 unit increase,[0.029-0.062],CACNA1G,Adventurousness,risk-taking behaviour,GCST007324,17:50575769
rs6576855-<b>T</b>,5 x 10-8,,0.4533,'-,0.010656122 unit decrease,[0.0068-0.0145],"LINC01712, LINC01725",Adventurousness,risk-taking behaviour,GCST007324,1:83564826
rs55749418-<b>A</b>,5 x 10-8,,0.0902,'-,0.018467033 unit increase,[0.012-0.025],"STAG1-DT, SLC35G2",Adventurousness,risk-taking behaviour,GCST007324,3:136766774
rs13135092-<b>A</b>,3 x 10-11,,0.9119,'-,0.022803178 unit increase,[0.016-0.03],SLC39A8,Adventurousness,risk-taking behaviour,GCST007324,4:102276925
rs4836094-<b>T</b>,3 x 10-11,,0.4157,'-,0.01309079 unit decrease,[0.0092-0.0169],LINC01170,Adventurousness,risk-taking behaviour,GCST007324,5:124521517
rs1388479-<b>A</b>,3 x 10-11,,0.2989,'-,0.014076608 unit decrease,[0.0099-0.0182],'-,Adventurousness,risk-taking behaviour,GCST007324,3:43968652
rs4238818-<b>A</b>,3 x 10-11,,0.2543,'-,0.014775469 unit decrease,[0.01-0.019],LINC02128,Adventurousness,risk-taking behaviour,GCST007324,16:50909881
rs139498-<b>C</b>,5 x 10-11,,0.447,'-,0.012839883 unit increase,[0.009-0.0167],RANGAP1,Adventurousness,risk-taking behaviour,GCST007324,22:41248230
rs78841189-<b>A</b>,5 x 10-11,,0.1336,'-,0.018749287 unit decrease,[0.013-0.024],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85429312
rs73529860-<b>T</b>,5 x 10-11,,0.1184,'-,0.019741016 unit decrease,[0.014-0.026],PTCH1,Adventurousness,risk-taking behaviour,GCST007324,9:95537018
rs4836927-<b>C</b>,5 x 10-11,,0.6861,'-,0.01373496 unit increase,[0.0096-0.0178],DENND1A,Adventurousness,risk-taking behaviour,GCST007324,9:123478924
rs720300-<b>A</b>,6 x 10-11,,0.8741,'-,0.019167446 unit decrease,[0.013-0.025],SND1,Adventurousness,risk-taking behaviour,GCST007324,7:127967421
rs2239030-<b>A</b>,7 x 10-11,,0.429,'-,0.012764932 unit increase,[0.0089-0.0166],CACNA1C,Adventurousness,risk-taking behaviour,GCST007324,12:2226775
rs6897129-<b>A</b>,1 x 10-10,,0.6678,'-,0.013310496 unit increase,[0.0093-0.0173],IPO11,Adventurousness,risk-taking behaviour,GCST007324,5:62604283
rs4276341-<b>T</b>,1 x 10-10,,0.3385,'-,0.01324254 unit decrease,[0.0092-0.0173],"SPINK2, REST",Adventurousness,risk-taking behaviour,GCST007324,4:56881632
rs10767869-<b>A</b>,1 x 10-10,,0.3187,'-,0.013414608 unit increase,[0.0093-0.0175],MPPED2-AS1,Adventurousness,risk-taking behaviour,GCST007324,11:30629102
rs10789436-<b>T</b>,1 x 10-10,,0.22,'-,0.015054529 unit increase,[0.01-0.02],PTPRF,Adventurousness,risk-taking behaviour,GCST007324,1:43575295
rs139162753-<b>T</b>,2 x 10-10,,0.9964,'-,0.1036072 unit decrease,[0.072-0.135],"RN7SKP284, RNU6-1129P",Adventurousness,risk-taking behaviour,GCST007324,3:86321023
rs1472302-<b>T</b>,2 x 10-10,,0.4765,'-,0.012418366 unit increase,[0.0086-0.0162],"CADM2, LINC02025",Adventurousness,risk-taking behaviour,GCST007324,3:84948747
rs2238199-<b>A</b>,3 x 10-10,,0.4453,'-,0.012294073 unit increase,[0.0085-0.0161],RGS6,Adventurousness,risk-taking behaviour,GCST007324,14:72332295
rs198535-<b>A</b>,3 x 10-10,,0.5848,'-,0.012395981 unit decrease,[0.0085-0.0163],CACNA1G-AS1,Adventurousness,risk-taking behaviour,GCST007324,17:50557691
rs4576809-<b>A</b>,3 x 10-10,,0.0945,'-,0.020828014 unit increase,[0.014-0.027],LINC02742,Adventurousness,risk-taking behaviour,GCST007324,11:28904615
rs812738-<b>T</b>,4 x 10-10,,0.6663,'-,0.012910676 unit increase,[0.0089-0.0169],"LINC01416, LINC01415",Adventurousness,risk-taking behaviour,GCST007324,18:55824518
rs2229868-<b>T</b>,5 x 10-10,,0.209,'-,0.014860554 unit increase,[0.01-0.02],CNTN2,Adventurousness,risk-taking behaviour,GCST007324,1:205072030
rs76363701-<b>T</b>,5 x 10-10,,0.951,'-,0.027949879 unit decrease,[0.019-0.037],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85386909
rs7732733-<b>A</b>,5 x 10-10,,0.7966,'-,0.014986587 unit increase,[0.01-0.02],EBF1,Adventurousness,risk-taking behaviour,GCST007324,5:158740184
rs7814131-<b>T</b>,5 x 10-10,,0.5366,'-,0.0120858075 unit increase,[0.0083-0.0159],"XKR6, LINC00529",Adventurousness,risk-taking behaviour,GCST007324,8:11241690
rs8080657-<b>A</b>,6 x 10-10,,0.5566,'-,0.012070813 unit decrease,[0.0082-0.0159],SHISA6,Adventurousness,risk-taking behaviour,GCST007324,17:11293214
rs7076367-<b>T</b>,7 x 10-10,,0.6035,'-,0.012252786 unit increase,[0.0084-0.0161],LINC02670,Adventurousness,risk-taking behaviour,GCST007324,10:10039337
rs307984-<b>T</b>,7 x 10-10,,0.1405,'-,0.017217096 unit increase,[0.012-0.023],"MIR7515HG, LINC00487",Adventurousness,risk-taking behaviour,GCST007324,2:6674328
rs60843830-<b>C</b>,7 x 10-10,,0.6638,'-,0.012652628 unit increase,[0.0086-0.0167],ALKAL2,Adventurousness,risk-taking behaviour,GCST007324,2:286756
rs2173934-<b>A</b>,7 x 10-10,,0.4076,'-,0.0121599715 unit increase,[0.0083-0.016],"ATG10, SEM1P1",Adventurousness,risk-taking behaviour,GCST007324,5:81902822
rs149418624-<b>A</b>,8 x 10-10,,0.2335,'-,0.014096475 unit decrease,[0.0096-0.0186],"PPIAP55, CYB561",Adventurousness,risk-taking behaviour,GCST007324,17:63462990
rs1393840-<b>T</b>,8 x 10-10,,0.4069,'-,0.01213559 unit decrease,[0.0083-0.016],'-,Adventurousness,risk-taking behaviour,GCST007324,14:42251954
rs10160758-<b>T</b>,8 x 10-10,,0.7309,'-,0.013438212 unit increase,[0.0091-0.0177],PC,Adventurousness,risk-taking behaviour,GCST007324,11:66905608
rs786247-<b>A</b>,9 x 10-10,,0.6415,'-,0.012397167 unit decrease,[0.0084-0.0164],TEX41,Adventurousness,risk-taking behaviour,GCST007324,2:144995713
rs17201148-<b>A</b>,9 x 10-10,,0.4212,'-,0.012029053 unit decrease,[0.0082-0.0159],LINC02180,Adventurousness,risk-taking behaviour,GCST007324,16:52095190
rs73219118-<b>T</b>,1 x 10-9,,0.6555,'-,0.012480152 unit increase,[0.0085-0.0165],LINC02497,Adventurousness,risk-taking behaviour,GCST007324,4:31203035
rs73132375-<b>A</b>,1 x 10-9,,0.8743,'-,0.01787506 unit increase,[0.012-0.024],CADM2,Adventurousness,risk-taking behaviour,GCST007324,3:85544981
rs11900075-<b>A</b>,1 x 10-9,,0.8648,'-,0.017267596 unit increase,[0.012-0.023],RN7SL283P,Adventurousness,risk-taking behaviour,GCST007324,2:139999827
rs6858066-<b>A</b>,1 x 10-9,,0.4835,'-,0.011758989 unit increase,[0.008-0.0156],ADGRL3,Adventurousness,risk-taking behaviour,GCST007324,4:61888602
rs1606492-<b>C</b>,2 x 10-9,,0.6101,'-,0.0120144915 unit decrease,[0.0081-0.0159],ZBTB20,Adventurousness,risk-taking behaviour,GCST007324,3:114595212
rs75108536-<b>T</b>,2 x 10-9,,0.1607,'-,0.015921356 unit decrease,[0.011-0.021],LRFN2,Adventurousness,risk-taking behaviour,GCST007324,6:40408201
rs2409652-<b>T</b>,2 x 10-9,,0.2566,'-,0.013383289 unit decrease,[0.009-0.0177],PINX1,Adventurousness,risk-taking behaviour,GCST007324,8:10821577
rs10987266-<b>T</b>,2 x 10-9,,0.061,'-,0.024362508 unit increase,[0.016-0.032],MVB12B,Adventurousness,risk-taking behaviour,GCST007324,9:126401183
rs2885697-<b>T</b>,2 x 10-9,,0.6692,'-,0.012388377 unit decrease,[0.0083-0.0164],SCMH1,Adventurousness,risk-taking behaviour,GCST007324,1:41078607
rs4792735-<b>A</b>,2 x 10-9,,0.5357,'-,0.011650354 unit increase,[0.0078-0.0155],PIGL,Adventurousness,risk-taking behaviour,GCST007324,17:16333074
rs6756470-<b>T</b>,2 x 10-9,,0.287,'-,0.012818652 unit decrease,[0.0086-0.017],"TMEFF2, CAVIN2-AS1",Adventurousness,risk-taking behaviour,GCST007324,2:191954304
rs10061911-<b>A</b>,2 x 10-9,,0.6582,'-,0.012213127 unit decrease,[0.0082-0.0162],'-,Adventurousness,risk-taking behaviour,GCST007324,5:30053284
rs331949-<b>T</b>,2 x 10-9,,0.6234,'-,0.011949507 unit increase,[0.008-0.0159],INPP4B,Adventurousness,risk-taking behaviour,GCST007324,4:142742053
rs3808072-<b>T</b>,2 x 10-9,,0.2623,'-,0.01315797 unit decrease,[0.0088-0.0175],SND1,Adventurousness,risk-taking behaviour,GCST007324,7:127955520
rs4734500-<b>T</b>,2 x 10-9,,0.6074,'-,0.011848674 unit decrease,[0.008-0.0157],RN7SL685P,Adventurousness,risk-taking behaviour,GCST007324,8:100957891
rs1171832-<b>C</b>,3 x 10-9,,0.5136,'-,0.01155309 unit increase,[0.0077-0.0154],"CCDC6, LINC01553",Adventurousness,risk-taking behaviour,GCST007324,10:59908059
rs75591122-<b>T</b>,3 x 10-8,,0.0906,'-,0.021788182 unit increase,[0.014-0.029],"DNPH1, TTBK1",Automobile speeding propensity,risk-taking behaviour,GCST007329,6:43237625
rs3922853-<b>A</b>,3 x 10-8,,0.1736,'-,0.016511729 unit decrease,[0.011-0.022],LINC01248,Automobile speeding propensity,risk-taking behaviour,GCST007329,2:5690467
rs9372625-<b>A</b>,3 x 10-8,,0.3824,'-,0.012836702 unit increase,[0.0083-0.0174],'-,Automobile speeding propensity,risk-taking behaviour,GCST007329,6:97896155
rs12325727-<b>A</b>,3 x 10-8,,0.4624,'-,0.012496208 unit increase,[0.0081-0.0169],"GIP, RNU1-42P",Automobile speeding propensity,risk-taking behaviour,GCST007329,17:48951110
rs9853563-<b>T</b>,3 x 10-8,,0.9514,'-,0.028906472 unit decrease,[0.019-0.039],CADM2,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:85367626
rs3021058-<b>A</b>,4 x 10-8,,0.5386,'-,0.012403218 unit increase,[0.008-0.0168],"HLA-DQB1, MTCO3P1",Automobile speeding propensity,risk-taking behaviour,GCST007329,6:32684582
rs299741-<b>A</b>,4 x 10-8,,0.4076,'-,0.012548543 unit decrease,[0.0081-0.017],CTIF,Automobile speeding propensity,risk-taking behaviour,GCST007329,18:48672119
rs13083798-<b>A</b>,5 x 10-8,,0.5137,'-,0.012325772 unit decrease,[0.0079-0.0167],PBRM1,Automobile speeding propensity,risk-taking behaviour,GCST007329,3:52615732
rs541421140-<b>C</b>,5 x 10-8,,0.4617,'-,0.0123484135 unit decrease,[0.0079-0.0168],"CDSN, PSORS1C1",Automobile speeding propensity,risk-taking behaviour,GCST007329,6:31117770
rs143894582-<b>C</b>,2 x 10-14,,0.9195,'-,1.7027 unit decrease,[1.27-2.14],PTPN11,Response to alcohol consumption (flushing response),response to alcohol,GCST005439,12:112469070
rs200848948-<b>G</b>,4 x 10-7,,0.464,'-,0.7149 unit increase,[0.44-0.99],'-,Response to alcohol consumption (flushing response),response to alcohol,GCST005439,2:53266605
rs397813807-<b>A</b>,4 x 10-6,,0.8135,'-,0.5386 unit increase,[0.31-0.77],NAALADL2,Response to alcohol consumption (flushing response),response to alcohol,GCST005439,3:175318979
rs10457526-<b>G</b>,5 x 10-6,,0.7298,'-,0.4796 unit increase,[0.27-0.69],"ARHGAP18, LAMA2",Response to alcohol consumption (flushing response),response to alcohol,GCST005439,6:129575356
rs74335618-<b>C</b>,3 x 10-6,,0.114,'-,0.7019 unit decrease,[0.41-1],ST7,Response to alcohol consumption (flushing response),response to alcohol,GCST005439,7:117175543
rs2925009-<b>C</b>,3 x 10-6,,0.6463,'-,0.4501 unit increase,[0.26-0.64],SIRLNT,Response to alcohol consumption (flushing response),response to alcohol,GCST005439,8:40280820
rs6578492-<b>A</b>,4 x 10-6,,0.5794,'-,0.4361 unit increase,[0.25-0.62],"DUSP8, MOB2",Response to alcohol consumption (flushing response),response to alcohol,GCST005439,11:1534014
rs671-<b>?</b>,5 x 10-26,,'-,'-,1.81 unit decrease,'-,ALDH2,Response to alcohol consumption (flushing response),response to alcohol,GCST002292,12:111803962
rs11158907-<b>?</b>,2 x 10-6,,'-,'-,0.556 unit increase,'-,SIPA1L1,Response to alcohol consumption (flushing response),response to alcohol,GCST002292,14:71520348
rs4909801-<b>?</b>,3 x 10-6,,'-,'-,0.534 unit increase,'-,NCRNA00250,Response to alcohol consumption (flushing response),response to alcohol,GCST002292,8:134866916
rs145005509-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,C1orf100,Initial alcohol sensitivity,response to alcohol,GCST006633,1:244309651
rs10788734-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"OR2T8, OR2W3",Initial alcohol sensitivity,response to alcohol,GCST006633,1:247912096
rs72806266-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,LINC01793,Initial alcohol sensitivity,response to alcohol,GCST006633,2:59274730
rs112834343-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,"AP1S3, MLXP1",Initial alcohol sensitivity,response to alcohol,GCST006633,2:223734978
rs17033567-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,SLC6A11,Initial alcohol sensitivity,response to alcohol,GCST006633,3:10872053
rs2336522-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,ZNF385D,Initial alcohol sensitivity,response to alcohol,GCST006633,3:21982028
rs112368179-<b>?</b>,8 x 10-6,,NR,'-,'-,'-,"BFSP2, CDV3",Initial alcohol sensitivity,response to alcohol,GCST006633,3:133499064
rs75536499-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,"TMEM271, PIGG",Initial alcohol sensitivity,response to alcohol,GCST006633,4:542637
rs115496994-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,ARHGAP24,Initial alcohol sensitivity,response to alcohol,GCST006633,4:85432552
rs10020261-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,WWC2,Initial alcohol sensitivity,response to alcohol,GCST006633,4:183250034
rs4869281-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,PCSK1,Initial alcohol sensitivity,response to alcohol,GCST006633,5:96315649
rs75886551-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,'-,Initial alcohol sensitivity,response to alcohol,GCST006633,6:51060459
rs11465543-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,IL17F,Initial alcohol sensitivity,response to alcohol,GCST006633,6:52243786
rs76563242-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,RARS2,Initial alcohol sensitivity,response to alcohol,GCST006633,6:87567414
rs62421504-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,LINC02518,Initial alcohol sensitivity,response to alcohol,GCST006633,6:113333595
rs206972-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,UNC93A,Initial alcohol sensitivity,response to alcohol,GCST006633,6:167276064
rs73133463-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,EGFR,Initial alcohol sensitivity,response to alcohol,GCST006633,7:55051808
rs2100160-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,FBXO25,Initial alcohol sensitivity,response to alcohol,GCST006633,8:477140
rs16905012-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,'-,Initial alcohol sensitivity,response to alcohol,GCST006633,8:133893495
rs11777857-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,'-,Initial alcohol sensitivity,response to alcohol,GCST006633,8:137533821
rs28373932-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,MAN1B1,Initial alcohol sensitivity,response to alcohol,GCST006633,9:137103590
rs76238752-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"C1QL3, RSU1",Initial alcohol sensitivity,response to alcohol,GCST006633,10:16572402
rs10825405-<b>?</b>,7 x 10-6,,NR,'-,'-,'-,PCDH15,Initial alcohol sensitivity,response to alcohol,GCST006633,10:54833105
rs75752490-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,LINC01515,Initial alcohol sensitivity,response to alcohol,GCST006633,10:65534026
rs61866256-<b>?</b>,6 x 10-7,,NR,'-,'-,'-,RNU1-65P,Initial alcohol sensitivity,response to alcohol,GCST006633,10:83922871
rs7076325-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,CYP2C23P,Initial alcohol sensitivity,response to alcohol,GCST006633,10:100108590
rs184338590-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,LINC01435,Initial alcohol sensitivity,response to alcohol,GCST006633,10:108019723
rs75794081-<b>?</b>,5 x 10-6,,NR,'-,'-,'-,ACTE1P,Initial alcohol sensitivity,response to alcohol,GCST006633,11:71358209
rs9547398-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,SLITRK6,Initial alcohol sensitivity,response to alcohol,GCST006633,13:85843505
rs1016246-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,CYB5AP5,Initial alcohol sensitivity,response to alcohol,GCST006633,14:26210194
rs116879015-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,SHF,Initial alcohol sensitivity,response to alcohol,GCST006633,15:45200754
rs146087183-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,CNGB1,Initial alcohol sensitivity,response to alcohol,GCST006633,16:57900176
rs7214066-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,TM4SF5,Initial alcohol sensitivity,response to alcohol,GCST006633,17:4775560
rs146298733-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,DLGAP1,Initial alcohol sensitivity,response to alcohol,GCST006633,18:4114529
rs4770359-<b>A</b>,6 x 10-8,(AA),0.816,'-,0.1601938 unit increase,[0.1-0.22],NUS1P2,Number of alcoholic drinks required to feel an effect (first five times drinking),response to alcohol,GCST008446,13:22977969
rs140154945-<b>T</b>,2 x 10-7,(EA),0.68,'-,0.07176893 unit decrease,[0.046-0.097],AFDN,Number of alcoholic drinks required to feel an effect (long-term average),response to alcohol,GCST008447,6:167929243
rs10647170-<b>T</b>,6 x 10-10,,0.96,'-,0.1396 unit decrease,[0.093-0.186],PRMT3,Number of alcoholic drinks required to feel an effect (long-term average),response to alcohol,GCST008447,11:20410501
rs11039389-<b>T</b>,2 x 10-9,,0.341432,'-,5.97 z score increase,'-,"NUP160, FNBP4",Feeling lonely,loneliness measurement,GCST006942,11:47774510
rs35184771-<b>T</b>,1 x 10-8,,0.344339,'-,5.67 z score decrease,'-,"CELF1, RAPSN",Feeling lonely,loneliness measurement,GCST006942,11:47453637
rs12364432-<b>A</b>,4 x 10-9,,0.339413,'-,5.87 z score decrease,'-,"PTPRJ, NUP160",Feeling lonely,loneliness measurement,GCST006942,11:47881331
rs74338595-<b>T</b>,9 x 10-9,,0.285559,'-,5.74 z score increase,'-,ERBB4,Feeling lonely,loneliness measurement,GCST006942,2:211885061
rs4958586-<b>A</b>,6 x 10-9,,0.377362,'-,5.83 z score increase,'-,LINC01470,Feeling lonely,loneliness measurement,GCST006942,5:152869007
rs7209581-<b>C</b>,3 x 10-8,,0.433605,'-,5.54 z score increase,'-,"ARHGAP27P2, RDM1P3",Feeling lonely,loneliness measurement,GCST006942,17:68178275
rs599550-<b>A</b>,7 x 10-11,,0.147785,'-,6.53 z score increase,'-,TCF4,Feeling lonely,loneliness measurement,GCST006942,18:55585157
rs1642294-<b>C</b>,1 x 10-9,,0.141475,'-,6.11 z score decrease,'-,"TCF4, LINC01415",Feeling lonely,loneliness measurement,GCST006942,18:55707682
rs12554512-<b>T</b>,5 x 10-8,,0.409986,'-,5.47 z score increase,'-,'-,Feeling lonely,loneliness measurement,GCST006942,9:23352295
rs7044244-<b>A</b>,2 x 10-10,,0.378475,'-,6.37 z score decrease,'-,PHF2,Feeling lonely,loneliness measurement,GCST006942,9:93635407
rs4465966-<b>A</b>,2 x 10-8,,0.429,'-,0.0046 unit increase,[0.003-0.0062],LINC02008,Loneliness,loneliness measurement,GCST006923,3:81960552
rs74338595-<b>T</b>,6 x 10-9,,0.71,'-,0.0052 unit increase,[0.0034-0.007],ERBB4,Loneliness,loneliness measurement,GCST006923,2:211885061
rs7737302-<b>C</b>,1 x 10-7,,0.733,'-,0.0049 unit increase,[0.0031-0.0067],"LINC01933, NMUR2",Loneliness,loneliness measurement,GCST006923,5:152328458
rs1966836-<b>A</b>,3 x 10-6,,0.289,'-,0.0042 unit increase,[0.0024-0.006],OR1S1,Loneliness,loneliness measurement,GCST006923,11:58214757
rs10456089-<b>G</b>,3 x 10-9,,0.921,'-,0.0093 unit increase,[0.0062-0.0124],"AMD1P4, HIVEP1",Loneliness,loneliness measurement,GCST006923,6:11959603
rs11605348-<b>G</b>,1 x 10-7,,0.65,'-,0.0045 unit increase,[0.0029-0.0061],"NDUFS3, FAM180B",Loneliness,loneliness measurement,GCST006923,11:47584931
rs30266-<b>G</b>,8 x 10-9,,0.672,'-,0.005 unit decrease,[0.0032-0.0068],'-,Loneliness,loneliness measurement,GCST006923,5:104636656
rs6430286-<b>G</b>,2 x 10-8,,0.576,'-,0.0047 unit increase,[0.0031-0.0063],MBD5,Loneliness,loneliness measurement,GCST006923,2:148076795
rs613872-<b>G</b>,5 x 10-14,,0.174,'-,0.008 unit decrease,[0.0058-0.0102],TCF4,Loneliness,loneliness measurement,GCST006923,18:55543071
rs10992800-<b>G</b>,7 x 10-11,,0.603,'-,0.0054 unit increase,[0.0038-0.007],PHF2,Loneliness,loneliness measurement,GCST006923,9:93611536
rs2069117-<b>A</b>,8 x 10-10,,0.368,'-,0.0051 unit decrease,[0.0035-0.0067],LINC01470,Loneliness,loneliness measurement,GCST006923,5:152864991
rs7770860-<b>T</b>,1 x 10-8,,0.627,'-,0.0047 unit decrease,[0.0031-0.0063],EPB41L2,Loneliness,loneliness measurement,GCST006923,6:130865253
rs62085660-<b>C</b>,6 x 10-9,,0.257,'-,0.0054 unit increase,[0.0036-0.0072],"FBXO36P1, LINC00674",Loneliness,loneliness measurement,GCST006923,17:68101598
rs773020-<b>G</b>,5 x 10-9,,0.1,'-,0.0079 unit decrease,[0.0054-0.0104],"Y_RNA, OSTF1",Loneliness,loneliness measurement,GCST006923,9:75153206
rs1022688-<b>G</b>,3 x 10-8,,0.67,'-,0.0048 unit decrease,[0.003-0.0066],ARFGEF2,Loneliness,loneliness measurement,GCST006923,20:49032319
rs613872-<b>G</b>,4 x 10-17,,0.173571,'-,0.022766946 unit decrease,[0.017-0.028],TCF4,Loneliness (MTAG),loneliness measurement,GCST006924,18:55543071
rs10992800-<b>G</b>,1 x 10-13,,0.603196,'-,0.015511454 unit increase,[0.011-0.02],PHF2,Loneliness (MTAG),loneliness measurement,GCST006924,9:93611536
rs2069117-<b>A</b>,2 x 10-11,,0.367531,'-,0.014259496 unit decrease,[0.01-0.018],LINC01470,Loneliness (MTAG),loneliness measurement,GCST006924,5:152864991
rs7770860-<b>T</b>,1 x 10-9,,0.626684,'-,0.012899768 unit decrease,[0.0087-0.0171],EPB41L2,Loneliness (MTAG),loneliness measurement,GCST006924,6:130865253
rs62085660-<b>C</b>,1 x 10-9,,0.257551,'-,0.014265623 unit increase,[0.0097-0.0189],"FBXO36P1, LINC00674",Loneliness (MTAG),loneliness measurement,GCST006924,17:68101598
rs773020-<b>G</b>,2 x 10-9,,0.100011,'-,0.020598795 unit decrease,[0.014-0.027],"Y_RNA, OSTF1",Loneliness (MTAG),loneliness measurement,GCST006924,9:75153206
rs1022688-<b>G</b>,3 x 10-9,,0.669916,'-,0.012942266 unit decrease,[0.0087-0.0172],ARFGEF2,Loneliness (MTAG),loneliness measurement,GCST006924,20:49032319
rs4465966-<b>A</b>,3 x 10-9,,0.429291,'-,0.012251281 unit increase,[0.0082-0.0163],LINC02008,Loneliness (MTAG),loneliness measurement,GCST006924,3:81960552
rs74338595-<b>T</b>,5 x 10-9,,0.710004,'-,0.01318363 unit increase,[0.0088-0.0176],ERBB4,Loneliness (MTAG),loneliness measurement,GCST006924,2:211885061
rs7737302-<b>C</b>,8 x 10-9,,0.733342,'-,0.013373127 unit increase,[0.0088-0.0179],"LINC01933, NMUR2",Loneliness (MTAG),loneliness measurement,GCST006924,5:152328458
rs1966836-<b>A</b>,8 x 10-9,,0.288827,'-,0.01304139 unit increase,[0.0086-0.0175],OR1S1,Loneliness (MTAG),loneliness measurement,GCST006924,11:58214757
rs10456089-<b>G</b>,9 x 10-9,,0.920701,'-,0.02174949 unit increase,[0.014-0.029],"AMD1P4, HIVEP1",Loneliness (MTAG),loneliness measurement,GCST006924,6:11959603
rs11605348-<b>G</b>,1 x 10-8,,0.649676,'-,0.012172433 unit increase,[0.008-0.0164],"NDUFS3, FAM180B",Loneliness (MTAG),loneliness measurement,GCST006924,11:47584931
rs30266-<b>G</b>,2 x 10-8,,0.671476,'-,0.012251923 unit decrease,[0.008-0.0165],'-,Loneliness (MTAG),loneliness measurement,GCST006924,5:104636656
rs6430286-<b>G</b>,2 x 10-8,,0.576235,'-,0.011610381 unit increase,[0.0075-0.0157],MBD5,Loneliness (MTAG),loneliness measurement,GCST006924,2:148076795
rs1031831-<b>C</b>,5 x 10-10,,0.668197,'-,0.013511165 unit decrease,[0.0092-0.0178],"LINC01415, TCF4",Loneliness (MTAG),loneliness measurement,GCST006924,18:55680027
rs34656763-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,LINC01740,Loneliness (multivariate analysis),loneliness measurement,GCST003773,1:212555047
rs2219412-<b>?</b>,7 x 10-6,(EA),NR,'-,'-,'-,ABCF2P1,Loneliness (multivariate analysis),loneliness measurement,GCST003773,3:88298061
rs79740699-<b>?</b>,6 x 10-6,(EA),NR,'-,'-,'-,LINC02261,Loneliness (multivariate analysis),loneliness measurement,GCST003773,4:27295977
rs6828799-<b>?</b>,4 x 10-6,(EA),NR,'-,'-,'-,'-,Loneliness (multivariate analysis),loneliness measurement,GCST003773,4:120523895
rs4773505-<b>?</b>,7 x 10-6,(EA),NR,'-,'-,'-,LINC02336,Loneliness (multivariate analysis),loneliness measurement,GCST003773,13:89756837
rs10893420-<b>?</b>,7 x 10-6,(EA),NR,'-,'-,'-,CNTN5,Loneliness (multivariate analysis),loneliness measurement,GCST003773,11:99499913
rs76554764-<b>?</b>,9 x 10-7,(EA),'-,'-,0.536 unit increase,[0.32-0.75],"LINC01778, LAPTM5",Loneliness (linear analysis),loneliness measurement,GCST003772,1:30778876
rs60380162-<b>?</b>,8 x 10-6,(EA),'-,'-,0.119 unit increase,[0.067-0.171],LINC02801,Loneliness (linear analysis),loneliness measurement,GCST003772,1:87233649
rs34656763-<b>?</b>,1 x 10-7,(EA),'-,'-,0.157 unit increase,[0.099-0.215],LINC01740,Loneliness (linear analysis),loneliness measurement,GCST003772,1:212555047
rs72908868-<b>?</b>,7 x 10-6,(EA),'-,'-,0.269 unit increase,[0.15-0.39],HDAC4,Loneliness (linear analysis),loneliness measurement,GCST003772,2:185409300
rs79198916-<b>?</b>,8 x 10-6,(EA),'-,'-,0.248 unit increase,[0.14-0.36],"SLC6A1, SLC6A11",Loneliness (linear analysis),loneliness measurement,GCST003772,3:10946371
rs11918760-<b>?</b>,9 x 10-6,(EA),'-,'-,0.118 unit increase,[0.066-0.17],"LINC02031, ATP11B",Loneliness (linear analysis),loneliness measurement,GCST003772,3:182718548
rs10478463-<b>?</b>,2 x 10-6,(EA),'-,'-,0.408 unit increase,[0.24-0.58],PRR16,Loneliness (linear analysis),loneliness measurement,GCST003772,5:120442341
rs6865418-<b>?</b>,3 x 10-6,(EA),'-,'-,0.162 unit decrease,[0.094-0.23],CCDC69,Loneliness (linear analysis),loneliness measurement,GCST003772,5:151207785
rs17718467-<b>?</b>,8 x 10-6,(EA),'-,'-,0.346 unit increase,[0.19-0.5],"SNORA70, LINC01526",Loneliness (linear analysis),loneliness measurement,GCST003772,6:81791045
rs2484135-<b>?</b>,5 x 10-6,(EA),NR,'-,'-,'-,MACF1,Loneliness (multivariate analysis),loneliness measurement,GCST003773,1:39202068
rs62179815-<b>?</b>,5 x 10-6,(EA),NR,'-,'-,'-,PLCL1,Loneliness (multivariate analysis),loneliness measurement,GCST003773,2:198563006
rs41290676-<b>?</b>,4 x 10-6,(EA),NR,'-,'-,'-,CDC25A,Loneliness (multivariate analysis),loneliness measurement,GCST003773,3:48164135
rs142233735-<b>?</b>,8 x 10-6,(EA),NR,'-,'-,'-,LINC02058,Loneliness (multivariate analysis),loneliness measurement,GCST003773,5:93000772
rs189144591-<b>?</b>,3 x 10-6,(EA),NR,'-,'-,'-,LINC02234,Loneliness (multivariate analysis),loneliness measurement,GCST003773,5:97917003
rs693006-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,MBOAT1,Loneliness (multivariate analysis),loneliness measurement,GCST003773,6:20064317
rs77774742-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,'-,Loneliness (multivariate analysis),loneliness measurement,GCST003773,6:145025756
rs324457-<b>?</b>,3 x 10-6,(EA),NR,'-,'-,'-,PTPRD,Loneliness (multivariate analysis),loneliness measurement,GCST003773,9:9054621
rs62561934-<b>?</b>,4 x 10-7,(EA),NR,'-,'-,'-,RASEF,Loneliness (multivariate analysis),loneliness measurement,GCST003773,9:83091392
rs147455943-<b>?</b>,5 x 10-6,(EA),NR,'-,'-,'-,PRKG1,Loneliness (multivariate analysis),loneliness measurement,GCST003773,10:51495239
rs74161807-<b>?</b>,4 x 10-6,(EA),NR,'-,'-,'-,"PNLIPRP2, PNLIPRP1",Loneliness (multivariate analysis),loneliness measurement,GCST003773,10:116616888
rs9619254-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,"SLC5A4, SLC5A4-AS1",Loneliness (multivariate analysis),loneliness measurement,GCST003773,22:32231277
rs208346-<b>?</b>,7 x 10-6,(EA),'-,'-,0.115 unit decrease,[0.065-0.165],"AMZ1, GNA12",Loneliness (linear analysis),loneliness measurement,GCST003772,7:2760052
rs117067567-<b>?</b>,7 x 10-6,(EA),'-,'-,0.351 unit increase,[0.2-0.5],"CHN2, CPVL",Loneliness (linear analysis),loneliness measurement,GCST003772,7:29149381
rs324457-<b>?</b>,7 x 10-6,(EA),'-,'-,0.112 unit increase,[0.063-0.161],PTPRD,Loneliness (linear analysis),loneliness measurement,GCST003772,9:9054621
rs78173384-<b>?</b>,2 x 10-6,(EA),'-,'-,0.374 unit increase,[0.22-0.53],"DCAF10, EXOSC3",Loneliness (linear analysis),loneliness measurement,GCST003772,9:37823248
rs149411702-<b>?</b>,2 x 10-6,(EA),'-,'-,0.376 unit increase,[0.22-0.53],SHB,Loneliness (linear analysis),loneliness measurement,GCST003772,9:37934586
rs2420316-<b>?</b>,8 x 10-7,(EA),'-,'-,0.205 unit increase,[0.12-0.29],PNLIPRP2,Loneliness (linear analysis),loneliness measurement,GCST003772,10:116639866
rs73580459-<b>?</b>,8 x 10-6,(EA),'-,'-,0.256 unit increase,[0.14-0.37],"FADS2, LINC02151",Loneliness (linear analysis),loneliness measurement,GCST003772,11:116438996
rs12579764-<b>?</b>,5 x 10-6,(EA),'-,'-,0.223 unit decrease,[0.13-0.32],SUDS3,Loneliness (linear analysis),loneliness measurement,GCST003772,12:118435624
rs1897656-<b>?</b>,7 x 10-6,(EA),'-,'-,0.212 unit decrease,[0.12-0.3],AGBL1,Loneliness (linear analysis),loneliness measurement,GCST003772,15:86987341
rs62435770-<b>?</b>,3 x 10-6,(EA),NR,'-,0.0567 unit decrease,[0.033-0.08],"LINC01615, TMEM244",Loneliness,loneliness measurement,GCST003771,6:169069612
rs7808252-<b>?</b>,6 x 10-6,(EA),NR,'-,0.0503 unit increase,[0.029-0.072],AGAP3,Loneliness,loneliness measurement,GCST003771,7:151128752
rs324457-<b>?</b>,6 x 10-6,(EA),NR,'-,0.0405 unit increase,[0.023-0.058],PTPRD,Loneliness,loneliness measurement,GCST003771,9:9054621
rs7847445-<b>?</b>,5 x 10-6,(EA),NR,'-,0.0517 unit increase,[0.03-0.074],OBP2B,Loneliness,loneliness measurement,GCST003771,9:26570615
rs114516436-<b>?</b>,2 x 10-6,(EA),NR,'-,'-,'-,"BTNL2, TSBP1-AS1",Loneliness (multivariate analysis),loneliness measurement,GCST003773,6:32394234
rs74161807-<b>?</b>,1 x 10-6,(EA),NR,'-,0.0785 unit increase,[0.047-0.11],"PNLIPRP2, PNLIPRP1",Loneliness,loneliness measurement,GCST003771,10:116616888
rs1278398-<b>?</b>,1 x 10-6,(EA),NR,'-,0.0445 unit increase,[0.026-0.063],ADAM12,Loneliness,loneliness measurement,GCST003771,10:126120627
rs73580459-<b>?</b>,5 x 10-6,(EA),NR,'-,0.0965 unit increase,[0.055-0.138],"FADS2, LINC02151",Loneliness,loneliness measurement,GCST003771,11:116438996
rs1897656-<b>?</b>,7 x 10-6,(EA),NR,'-,0.0771 unit decrease,[0.044-0.111],AGBL1,Loneliness,loneliness measurement,GCST003771,15:86987341
rs76554764-<b>?</b>,2 x 10-6,(EA),NR,'-,0.192 unit increase,[0.11-0.27],"LINC01778, LAPTM5",Loneliness,loneliness measurement,GCST003771,1:30778876
rs78649567-<b>?</b>,3 x 10-6,(EA),NR,'-,0.107 unit decrease,[0.062-0.152],'-,Loneliness,loneliness measurement,GCST003771,20:16870240
rs116256240-<b>?</b>,2 x 10-6,(EA),NR,'-,0.173 unit increase,[0.1-0.24],CNTN6,Loneliness,loneliness measurement,GCST003771,3:1385090
rs706084-<b>?</b>,3 x 10-6,(EA),NR,'-,0.0723 unit increase,[0.042-0.102],HDAC9,Loneliness,loneliness measurement,GCST003771,7:18612492
rs12156277-<b>?</b>,2 x 10-6,(EA),NR,'-,0.0465 unit decrease,[0.027-0.066],CSMD1,Loneliness,loneliness measurement,GCST003771,8:3314878
rs75816778-<b>?</b>,5 x 10-6,(EA),NR,'-,0.167 unit increase,[0.095-0.239],UBXN2B,Loneliness,loneliness measurement,GCST003771,8:58383000
rs140109554-<b>?</b>,8 x 10-6,(EA),NR,'-,0.127 unit increase,[0.071-0.183],EXD3,Loneliness,loneliness measurement,GCST003771,9:137316808
rs12579764-<b>?</b>,8 x 10-6,(EA),NR,'-,0.0787 unit decrease,[0.044-0.113],SUDS3,Loneliness,loneliness measurement,GCST003771,12:118435624
rs8109071-<b>?</b>,8 x 10-7,(EA),NR,'-,0.0526 unit decrease,[0.032-0.073],SYDE1,Loneliness,loneliness measurement,GCST003771,19:15113414
rs34656763-<b>?</b>,7 x 10-7,(EA),NR,'-,0.053 unit increase,[0.032-0.074],LINC01740,Loneliness,loneliness measurement,GCST003771,1:212555047
rs62209635-<b>?</b>,3 x 10-7,(EA),NR,'-,0.0674 unit decrease,[0.042-0.093],"TPM3P2, CHMP4B",Loneliness,loneliness measurement,GCST003771,20:33871778
rs79210778-<b>?</b>,4 x 10-6,(EA),NR,'-,0.135 unit increase,[0.077-0.193],EI24P1,Loneliness,loneliness measurement,GCST003771,3:176109009
rs77766537-<b>?</b>,6 x 10-6,(EA),NR,'-,0.141 unit increase,[0.08-0.202],EDIL3,Loneliness,loneliness measurement,GCST003771,5:84200037
rs17718467-<b>?</b>,4 x 10-6,(EA),NR,'-,0.126 unit increase,[0.072-0.18],"SNORA70, LINC01526",Loneliness,loneliness measurement,GCST003771,6:81791045
rs599550-<b>?</b>,6 x 10-14,,NR,'-,0.03 unit decrease,[0.022-0.038],TCF4,Loneliness,loneliness measurement,GCST009463,18:55585157
rs72627233-<b>?</b>,1 x 10-8,,NR,'-,0.02 unit decrease,[0.012-0.028],"LINC01415, LINC01416",Loneliness,loneliness measurement,GCST009463,18:55819493
rs12458015-<b>?</b>,1 x 10-9,,NR,'-,0.02 unit decrease,[0.014-0.026],TCF4,Loneliness,loneliness measurement,GCST009463,18:55638504
rs13291079-<b>?</b>,2 x 10-11,,NR,'-,0.02 unit increase,[0.014-0.026],PHF2,Loneliness,loneliness measurement,GCST009463,9:93598368
rs4958586-<b>?</b>,2 x 10-10,,NR,'-,0.02 unit decrease,[0.014-0.026],LINC01470,Loneliness,loneliness measurement,GCST009463,5:152869007
rs773020-<b>?</b>,1 x 10-9,,NR,'-,0.03 unit decrease,[0.02-0.04],"Y_RNA, OSTF1",Loneliness,loneliness measurement,GCST009463,9:75153206
rs74338595-<b>?</b>,2 x 10-9,,NR,'-,0.02 unit increase,[0.014-0.026],ERBB4,Loneliness,loneliness measurement,GCST009463,2:211885061
rs7626596-<b>?</b>,3 x 10-9,,NR,'-,0.02 unit increase,[0.014-0.026],LINC02008,Loneliness,loneliness measurement,GCST009463,3:81951529
rs171697-<b>?</b>,5 x 10-9,,NR,'-,0.02 unit decrease,[0.014-0.026],'-,Loneliness,loneliness measurement,GCST009463,5:104620815
rs11867618-<b>?</b>,7 x 10-9,,NR,'-,0.02 unit decrease,[0.012-0.028],BPTF,Loneliness,loneliness measurement,GCST009463,17:67879471
rs7209581-<b>?</b>,5 x 10-8,,NR,'-,0.02 unit decrease,[0.014-0.026],"ARHGAP27P2, RDM1P3",Loneliness,loneliness measurement,GCST009463,17:68178275
rs7770860-<b>?</b>,9 x 10-9,,NR,'-,0.02 unit decrease,[0.014-0.026],EPB41L2,Loneliness,loneliness measurement,GCST009463,6:130865253
rs348258-<b>?</b>,1 x 10-8,,NR,'-,0.02 unit decrease,[0.014-0.026],STAU1,Loneliness,loneliness measurement,GCST009463,20:49152451
rs10456089-<b>?</b>,2 x 10-8,,NR,'-,0.04 unit increase,[0.028-0.052],"AMD1P4, HIVEP1",Loneliness,loneliness measurement,GCST009463,6:11959603
rs11068917-<b>?</b>,2 x 10-8,,NR,'-,0.02 unit decrease,[0.012-0.028],TAOK3,Loneliness,loneliness measurement,GCST009463,12:118353315
rs62347916-<b>?</b>,3 x 10-8,,NR,'-,0.02 unit increase,[0.014-0.026],C5orf17,Loneliness,loneliness measurement,GCST009463,5:24239889
rs2732650-<b>?</b>,3 x 10-8,,NR,'-,0.02 unit decrease,[0.012-0.028],"MAPK8IP1P1, ARL17B",Loneliness,loneliness measurement,GCST009463,17:46267622
rs11039265-<b>?</b>,5 x 10-8,,NR,'-,0.02 unit increase,[0.014-0.026],CELF1,Loneliness,loneliness measurement,GCST009463,11:47501662
rs159960-<b>?</b>,5 x 10-8,,NR,'-,0.02 unit increase,[0.014-0.026],RERE,Loneliness,loneliness measurement,GCST009463,1:8416368
rs114134414-<b>C</b>,9 x 10-7,,0.03,'-,2.15 unit increase,'-,"FPGT-TNNI3K, TNNI3K",Fear of medical pain (dental),fear of medical pain measurement,GCST004707,1:74242875
chr2:99411513-<b>A</b>,1 x 10-6,,0.14,'-,1.29 unit decrease,'-,'-,Fear of medical pain (dental),fear of medical pain measurement,GCST004707,Mapping not available
rs72965720-<b>C</b>,2 x 10-7,,0.08,'-,1.43 unit increase,'-,"LINC02536, THEMIS",Fear of medical pain (dental),fear of medical pain measurement,GCST004707,6:127702236
rs9901616-<b>T</b>,8 x 10-7,,0.03,'-,2.31 unit decrease,'-,"MIR4733HG, RNF135",Fear of medical pain (dental),fear of medical pain measurement,GCST004707,17:31009727
rs10422046-<b>A</b>,1 x 10-6,,0.11,'-,1.38 unit increase,'-,"WDR18, ARID3A",Fear of medical pain (dental),fear of medical pain measurement,GCST004707,19:982968
rs5979239-<b>A</b>,2 x 10-6,,0.04,'-,2.04 unit decrease,'-,WWC3,Fear of medical pain (dental),fear of medical pain measurement,GCST004707,X:10041953
rs12705959-<b>?</b>,3 x 10-7,"(SBP,CPD)",NR,'-,'-,'-,FOXP2,Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,7:114358191
rs6989684-<b>?</b>,4 x 10-6,"(SBP,CPD)",NR,'-,'-,'-,"MAL2, COLEC10",Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,8:119130800
rs9533282-<b>?</b>,2 x 10-6,"(SBP,CPD)",NR,'-,'-,'-,FRY,Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,13:32053511
rs9561252-<b>?</b>,6 x 10-7,"(SBP,CPD)",NR,'-,'-,'-,LINC00363,Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,13:93077032
rs8010717-<b>?</b>,3 x 10-7,"(SBP,CPD)",NR,'-,'-,'-,NRXN3,Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,14:79944098
rs937741-<b>?</b>,5 x 10-7,"(SBP,CPD)",NR,'-,'-,'-,"HERC2P6, GOLGA8S",Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,15:23402264
rs4573996-<b>?</b>,3 x 10-7,"(SBP,CPD)",NR,'-,'-,'-,'-,Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,18:78734592
rs133980-<b>?</b>,2 x 10-8,"(SBP,CPD)",NR,'-,'-,'-,'-,Blood pressure (smoking interaction),"systolic blood pressure, cigarettes per day measurement",GCST002587,22:27626764
rs7615952-<b>?</b>,4 x 10-6,"(DBP,CPD)",NR,'-,'-,'-,ALG1L,Blood pressure (smoking interaction),"diastolic blood pressure, cigarettes per day measurement",GCST002587,3:125930560
rs10275663-<b>?</b>,8 x 10-7,"(DBP,CPD)",NR,'-,'-,'-,GRB10,Blood pressure (smoking interaction),"diastolic blood pressure, cigarettes per day measurement",GCST002587,7:50729988
rs78277894-<b>A</b>,6 x 10-13,,0.336,'-,0.04 unit increase,[-0.11288-0.19288],GULOP,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009405,8:27571675
rs2435355-<b>C</b>,4 x 10-8,,0.195,'-,0.036 unit decrease,[-0.14628-0.21828],RET,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009405,10:43129385
rs79105258-<b>A</b>,5 x 10-17,,0.257,'-,0.055 unit increase,[-0.12728-0.23728],CUX2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009405,12:111280427
rs13329271-<b>C</b>,3 x 10-16,,0.516,'-,0.044 unit decrease,[-0.10496-0.19296],"CHRNB4, CHRNA3",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009405,15:78621888
rs56129017-<b>T</b>,2 x 10-96,,0.26,'-,0.131 unit increase,[0.0095-0.2525],CYP2G1P,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009405,19:40911043
rs3733829-<b>A</b>,3 x 10-19,,0.61,'-,0.048 unit decrease,[0.038-0.058],"RAB4B-EGLN2, EGLN2",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009405,19:40804666
rs56129017-<b>T</b>,6 x 10-9,,0.26,'-,0.084 unit increase,[0.057-0.111],CYP2G1P,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009406,19:40911043
rs78277894-<b>A</b>,1 x 10-13,,0.336,'-,0.046 unit increase,[-0.15-0.242],GULOP,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009407,8:27571675
rs2435355-<b>C</b>,3 x 10-7,,0.195,'-,0.038 unit decrease,[-0.1972-0.2732],RET,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009407,10:43129385
rs79105258-<b>A</b>,9 x 10-18,,0.257,'-,0.062 unit increase,[-0.17124-0.29524],CUX2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009407,12:111280427
rs13329271-<b>C</b>,2 x 10-13,,0.516,'-,0.044 unit decrease,[-0.14808-0.23608],"CHRNB4, CHRNA3",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009407,15:78621888
rs56129017-<b>T</b>,2 x 10-88,,0.26,'-,0.139 unit increase,[-0.08248-0.36048],CYP2G1P,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009407,19:40911043
rs860873-<b>A</b>,4 x 10-8,,0.47,'-,0.106 increase,[0.069-0.143],CNN3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009968,1:94921652
rs72740955-<b>T</b>,7 x 10-12,,0.349,'-,0.142 increase,[0.1-0.18],"PSMA4, CHRNA5",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST009968,15:78557437
rs294778-<b>G</b>,2 x 10-15,,0.079,'-,0.303 unit increase,[0.23-0.38],UGT2B10,Smoking intensity (cotinine levels/cigarettes per day),"cotinine measurement, cigarettes per day measurement",GCST009966,4:68816837
rs56113850-<b>T</b>,3 x 10-13,,0.447,'-,0.155 unit increase,[0.11-0.2],CYP2A6,Smoking intensity (cotinine levels/cigarettes per day),"cotinine measurement, cigarettes per day measurement",GCST009966,19:40847202
rs3025386-<b>C</b>,1 x 10-8,,NR,'-,0.017 unit decrease,NR,DBH,Cigarettes smoked per day (current),cigarettes per day measurement,GCST011700,9:133637642
rs12914385-<b>T</b>,4 x 10-10,,NR,'-,0.014 unit increase,NR,CHRNA3,Cigarettes smoked per day (current),cigarettes per day measurement,GCST011700,15:78606381
rs11697662-<b>C</b>,7 x 10-9,,NR,'-,0.016 unit increase,NR,CHRNA4,Cigarettes smoked per day (current),cigarettes per day measurement,GCST011700,20:63360653
rs7571606-<b>A</b>,5 x 10-9,,NR,'-,0.027 unit increase,NR,RPL6P5,Cigarettes smoked per day (past),cigarettes per day measurement,GCST011699,2:145365490
rs8040868-<b>C</b>,2 x 10-20,,NR,'-,0.044 unit increase,NR,CHRNA3,Cigarettes smoked per day (past),cigarettes per day measurement,GCST011699,15:78618839
rs12459249-<b>T</b>,1 x 10-11,,NR,'-,0.033 unit decrease,NR,"CYP2F2P, CYP2A6",Cigarettes smoked per day (past),cigarettes per day measurement,GCST011699,19:40833991
rs1372626-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,DCC,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST003779,18:52471437
rs3806243-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SWT1,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008804,1:185157734
rs2072659-<b>G</b>,4 x 10-8,,0.102,'-,0.0369 unit decrease,[0.024-0.05],CHRNB2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,1:154576045
rs2488808-<b>A</b>,3 x 10-8,,0.308,'-,0.0246 unit decrease,[0.016-0.033],"NOP14, NOP14-AS1",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,4:2959986
rs7806224-<b>C</b>,1 x 10-10,,0.371,'-,0.0244 unit increase,[0.017-0.032],PDE1C,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,7:32233495
rs6474412-<b>T</b>,3 x 10-16,,0.775,'-,0.0352 unit increase,[0.027-0.044],CHRNB3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,8:42695355
rs1217106-<b>G</b>,4 x 10-9,,0.782,'-,0.0291 unit decrease,[0.019-0.039],"RN7SKP135, LINC01414",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,8:63655112
rs3025343-<b>A</b>,6 x 10-11,,0.117,'-,0.0368 unit increase,[0.026-0.048],"DBH, FAM163B",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,9:133613233
rs113469106-<b>A</b>,9 x 10-9,,0.057,'-,0.0505 unit increase,[0.033-0.068],"HSPA8P5, CCND2-AS1",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,12:4159565
rs8034191-<b>C</b>,1 x 10-139,,0.341,'-,0.0956 unit increase,[0.088-0.103],'-,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,Mapping not available
rs36015615-<b>A</b>,3 x 10-8,,1.63E-04,'-,1.16 unit increase,[0.75-1.57],STARD3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,17:39658434
rs56113850-<b>C</b>,3 x 10-68,,0.575,'-,0.0719 unit increase,[0.064-0.08],CYP2A6,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,19:40847202
rs6011779-<b>T</b>,7 x 10-10,,0.806,'-,0.0317 unit decrease,[0.022-0.042],CHRNA4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,20:63352965
rs16969968-<b>A</b>,3 x 10-139,,0.34,'-,0.096 unit increase,[0.089-0.103],CHRNA5,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008809,15:78590583
rs10426903-<b>?</b>,3 x 10-8,,NR,'-,0.041 unit increase,[0.027-0.055],CYP2G1P,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008027,19:40911814
rs149354778-<b>?</b>,6 x 10-9,,NR,'-,0.338 unit decrease,[0.22-0.45],"TRIL, CREB5",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008027,7:28904414
rs182996728-<b>?</b>,3 x 10-8,,NR,'-,0.113 unit decrease,[0.074-0.152],RSL24D1P4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008027,1:242798356
rs182996728-<b>?</b>,2 x 10-6,(Native Hawaiian),NR,'-,0.1004309 unit decrease,[0.059-0.142],RSL24D1P4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008027,1:242798356
rs149354778-<b>?</b>,9 x 10-10,(AA),NR,'-,0.3687335 unit decrease,[0.25-0.49],"TRIL, CREB5",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST008027,7:28904414
rs1412076-<b>?</b>,2 x 10-7,,NR,'-,0.1 unit increase,[0.061-0.139],"NTNG2, MED27",Current cigarettes per day in chronic obstructive pulmonary disease,"chronic obstructive pulmonary disease, cigarettes per day measurement",GCST005917,9:132157503
rs9599114-<b>?</b>,8 x 10-8,,NR,'-,0.11 unit increase,[0.071-0.149],PCDH9,Current cigarettes per day in chronic obstructive pulmonary disease,"chronic obstructive pulmonary disease, cigarettes per day measurement",GCST005917,13:66412999
rs182317-<b>T</b>,1 x 10-9,,0.355,'-,0.01558777 unit decrease,[0.011-0.021],"RHCG, MIR9-3HG",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:89400370
rs1592485-<b>A</b>,1 x 10-10,,0.611,'-,0.016153201 unit decrease,[0.011-0.021],C16orf97,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,16:52059637
rs12924872-<b>T</b>,4 x 10-8,,0.463,'-,0.013411901 unit decrease,[0.0086-0.0182],'-,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,Mapping not available
rs258321-<b>G</b>,2 x 10-10,,0.429,'-,0.0157962 unit increase,[0.011-0.021],CDK10,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,16:89690065
rs4144686-<b>A</b>,1 x 10-8,,0.167,'-,0.018551348 unit decrease,[0.012-0.025],TCF4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,18:55584494
rs4485470-<b>A</b>,7 x 10-10,,0.592,'-,0.01527059 unit decrease,[0.01-0.02],LINC01924,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,18:64457828
rs59208569-<b>C</b>,2 x 10-10,,0.829,'-,0.020476315 unit increase,[0.014-0.027],ZBTB7A,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,19:4044426
rs143200968-<b>C</b>,7 x 10-28,"(Conditioned on chr19:41371480, chr19:41353107)",0.0251,'-,0.08610489 unit decrease,[0.071-0.102],"CYP2F2P, CYP2A6",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,19:40832942
rs56113850-<b>C</b>,4 x 10-99,,0.555,'-,0.0523096 unit increase,[0.047-0.057],CYP2A6,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,19:40847202
rs8192726-<b>A</b>,8 x 10-16,"(Conditioned on chr19:41338847, chr19:41371480, chr19:41353107)",0.0679,'-,0.039343726 unit decrease,[0.03-0.049],CYP2A6,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,19:40848591
rs117824460-<b>G</b>,8 x 10-35,(Conditioned on chr19:41353107),0.026,'-,0.09525982 unit decrease,[0.08-0.11],"CYP2A7, CYP2A6",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,19:40865575
rs6078373-<b>A</b>,9 x 10-11,,0.402,'-,0.016073052 unit increase,[0.011-0.021],"BTBD3, LINC00687",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,20:11882852
rs1737894-<b>G</b>,1 x 10-11,,0.408,'-,0.016856 unit increase,[0.012-0.022],NOL4L,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,20:32466899
rs2273500-<b>C</b>,3 x 10-26,,0.147,'-,0.036385704 unit increase,[0.03-0.043],CHRNA4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,20:63355597
rs7281463-<b>C</b>,3 x 10-8,,0.413,'-,0.013677968 unit increase,[0.0088-0.0185],"RPL23AP12, PCBP2P1",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,21:39148857
rs215600-<b>A</b>,4 x 10-21,,0.645,'-,0.024002468 unit decrease,[0.019-0.029],PDE1C,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,7:32294030
rs62447179-<b>A</b>,1 x 10-8,,0.298,'-,0.015267791 unit decrease,[0.01-0.02],IKZF1,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,7:50300013
rs2741351-<b>C</b>,9 x 10-9,(Conditioned on chr8:27442127),0.826,'-,0.018475844 unit increase,[0.012-0.025],GULOP,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,8:27560523
rs73229090-<b>A</b>,1 x 10-11,,0.112,'-,0.026211383 unit increase,[0.019-0.034],GULOP,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,8:27584610
rs13253502-<b>A</b>,2 x 10-8,(Conditioned on chr8:42578059),0.407,'-,0.013842282 unit decrease,[0.009-0.0187],SMIM19,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,8:42586875
rs4236926-<b>G</b>,8 x 10-33,,0.766,'-,0.034267057 unit increase,[0.029-0.04],CHRNB3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,8:42722916
rs790564-<b>C</b>,1 x 10-10,,0.729,'-,0.01762409 unit decrease,[0.012-0.023],LINC01414,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,8:63691660
rs75596189-<b>T</b>,2 x 10-20,(Conditioned on chr9:136502369),0.112,'-,0.035800464 unit increase,[0.028-0.043],FAM163B,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,9:133603579
rs3025383-<b>C</b>,1 x 10-23,,0.187,'-,0.031379756 unit decrease,[0.025-0.037],DBH,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,9:133637247
rs7951365-<b>C</b>,2 x 10-11,,0.31,'-,0.017756414 unit increase,[0.013-0.023],SOX6,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,11:16355498
rs10742683-<b>A</b>,5 x 10-8,,0.415,'-,0.01348842 unit decrease,[0.0086-0.0183],"HSD17B12, MIR129-2",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,11:43646075
rs113001570-<b>T</b>,1 x 10-9,,0.0667,'-,0.02980134 unit increase,[0.02-0.039],"ZNF408, F2",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,11:46715862
rs7125588-<b>G</b>,7 x 10-12,,0.429,'-,0.01689971 unit decrease,[0.012-0.022],DRD2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,11:113565350
rs11846838-<b>A</b>,5 x 10-9,,0.327,'-,0.015177023 unit increase,[0.01-0.02],ZFYVE21,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,14:103718400
rs1115019-<b>C</b>,2 x 10-9,,0.79,'-,0.017859358 unit decrease,[0.012-0.024],TCF12,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:56849033
rs632811-<b>G</b>,2 x 10-10,,0.33,'-,0.017750626 unit decrease,[0.012-0.023],"ZNF444P1, MINDY2",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:58862851
rs4886550-<b>G</b>,5 x 10-9,"(Conditioned on chr15:78836288, chr15:78812098, chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046)",0.288,'-,0.019931013 unit decrease,[0.013-0.027],"COMMD4P1, ADAMTS7P3",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:77951237
rs12438181-<b>A</b>,5 x 10-10,"(Conditioned on chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046)",0.218,'-,0.018525843 unit decrease,[0.013-0.024],HYKK,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78519756
rs10519203-<b>A</b>,3 x 10-286,,0.655,'-,0.09361804 unit decrease,[0.089-0.099],HYKK,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78521704
rs28438420-<b>T</b>,1 x 10-12,"(Conditioned on chr15:78812098, chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046)",0.554,'-,0.017560912 unit increase,[0.013-0.022],PSMA4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78543946
rs72740955-<b>T</b>,2 x 10-34,"(Conditioned on chr15:78908565, chr15:78814046)",0.337,'-,0.031752326 unit increase,[0.027-0.037],"PSMA4, CHRNA5",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78557437
rs146009840-<b>T</b>,2 x 10-17,"(Conditioned on chr15:78849779, chr15:78908565, chr15:78814046)",0.335,'-,0.022120172 unit increase,[0.017-0.027],CHRNA3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78613835
rs28681284-<b>T</b>,2 x 10-58,(Conditioned on chr15:78814046),0.21,'-,0.048676305 unit decrease,[0.043-0.055],CHRNA3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78616223
rs8040868-<b>C</b>,2 x 10-10,"(Conditioned on chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046)",0.4,'-,0.016012004 unit increase,[0.011-0.021],CHRNA3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78618839
rs3743063-<b>C</b>,2 x 10-11,"(Conditioned on chr15:78243579, chr15:78836288, chr15:78812098, chr15:78911181, chr15:78906177, chr15:78849779, chr15:78908565, chr15:78814046)",0.562,'-,0.016716857 unit decrease,[0.012-0.022],ADAMTS7,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,15:78772829
rs11264100-<b>G</b>,2 x 10-9,,0.876,'-,0.022165932 unit decrease,[0.015-0.029],"EFCAB14P1, SFPQ",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,1:35126025
rs2072659-<b>G</b>,3 x 10-13,,0.0986,'-,0.029984204 unit decrease,[0.022-0.038],CHRNB2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,1:154576045
rs34973462-<b>T</b>,6 x 10-9,,0.334,'-,0.015072901 unit increase,[0.01-0.0201],COP1,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,1:176024684
rs7599488-<b>T</b>,9 x 10-9,,0.437,'-,0.014121279 unit increase,[0.0093-0.0189],BCL11A,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,2:60491212
rs78408772-<b>T</b>,5 x 10-8,,0.102,'-,0.021996435 unit decrease,[0.014-0.03],RN7SL18P,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,2:62483473
rs10204824-<b>G</b>,1 x 10-12,,0.639,'-,0.017977731 unit decrease,[0.013-0.023],RNA5SP106,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,2:147615152
rs2084533-<b>T</b>,7 x 10-10,,0.321,'-,0.016117558 unit increase,[0.011-0.021],PLCL2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,3:16831428
rs7431710-<b>A</b>,1 x 10-12,,0.654,'-,0.018289817 unit decrease,[0.013-0.023],SLC25A20,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,3:48898150
rs2236951-<b>C</b>,2 x 10-8,,0.2,'-,0.017190572 unit decrease,[0.011-0.023],CACNA2D2,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,3:50383650
rs699165-<b>G</b>,8 x 10-9,,0.745,'-,0.016118657 unit increase,[0.011-0.022],STAG1,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,3:136505855
rs28813180-<b>A</b>,2 x 10-10,,0.498,'-,0.015495869 unit decrease,[0.011-0.02],RSRC1,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,3:158366129
rs1024323-<b>T</b>,9 x 10-9,,0.382,'-,0.014415942 unit decrease,[0.0095-0.0193],GRK4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,4:3004316
rs11940255-<b>A</b>,2 x 10-10,,0.717,'-,0.017157527 unit decrease,[0.012-0.022],MIR1269A,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,4:66220570
rs10454798-<b>T</b>,2 x 10-8,(Conditioned on chr4:67086288),0.253,'-,0.015841978 unit increase,[0.01-0.021],'-,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,4:67115112
rs7766641-<b>A</b>,3 x 10-10,,0.272,'-,0.01728421 unit decrease,[0.012-0.023],H2BC6,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007459,6:26183874
rs6663484-<b>G</b>,2 x 10-10,,0.361,'-,0.0145221 unit increase,[0.01-0.019],PHC2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:33412953
rs56319043-<b>T</b>,4 x 10-8,,0.244,'-,0.0140718 unit decrease,[0.0091-0.0191],KDM4A-AS1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:43705540
rs12733544-<b>A</b>,7 x 10-11,,0.322,'-,0.0152603 unit increase,[0.011-0.02],ELAVL4,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:50097141
rs12760107-<b>A</b>,5 x 10-9,,0.232,'-,0.0151801 unit decrease,[0.01-0.02],PDE4B,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:65838961
rs7530705-<b>A</b>,3 x 10-9,,0.845,'-,0.0179039 unit decrease,[0.012-0.024],'-,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:73507311
rs2133204-<b>A</b>,4 x 10-8,,0.413,'-,0.0121792 unit decrease,[0.0078-0.0165],AK5,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:77508799
rs2072659-<b>G</b>,7 x 10-16,,0.0986,'-,0.0314007 unit decrease,[0.024-0.039],CHRNB2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:154576045
rs2901785-<b>A</b>,6 x 10-9,,0.431,'-,0.0128143 unit decrease,[0.0085-0.0171],RABGAP1L-DT,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:174135605
rs34973462-<b>T</b>,1 x 10-9,,0.334,'-,0.0141909 unit increase,[0.0096-0.0188],COP1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,1:176024684
rs6731872-<b>G</b>,2 x 10-11,,0.832,'-,0.0195868 unit increase,[0.014-0.025],"LINC01875, TMEM18",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:624205
rs10193722-<b>C</b>,9 x 10-9,,0.457,'-,0.0125677 unit increase,[0.0083-0.0169],KCNH7,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:22216642
rs11693885-<b>A</b>,4 x 10-10,,0.45,'-,0.0137482 unit increase,[0.0094-0.0181],'-,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:59894911
rs359253-<b>A</b>,1 x 10-9,,0.638,'-,0.013783 unit increase,[0.0094-0.0182],MIR4432HG,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:60254821
rs7599488-<b>T</b>,2 x 10-10,,0.437,'-,0.013978 unit increase,[0.0097-0.0183],BCL11A,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:60491212
rs78408772-<b>T</b>,5 x 10-11,,0.102,'-,0.024119 unit decrease,[0.017-0.031],RN7SL18P,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:62483473
rs10204824-<b>G</b>,7 x 10-14,,0.639,'-,0.0172155 unit decrease,[0.013-0.022],RNA5SP106,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:147615152
rs3769943-<b>C</b>,4 x 10-10,,0.301,'-,0.0148686 unit increase,[0.01-0.02],SCN2A,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:165329494
rs76585135-<b>G</b>,1 x 10-8,,0.213,'-,0.0153225 unit increase,[0.01-0.021],'-,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,2:185188165
rs2084533-<b>T</b>,5 x 10-13,,0.321,'-,0.0168791 unit increase,[0.012-0.021],PLCL2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,3:16831428
rs6550775-<b>G</b>,5 x 10-9,,0.366,'-,0.0140855 unit increase,[0.0094-0.0188],SATB1-AS1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,3:18461124
rs7636057-<b>T</b>,3 x 10-17,,0.657,'-,0.0194149 unit decrease,[0.015-0.024],ARIH2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,3:48955149
rs853866-<b>A</b>,1 x 10-9,,0.408,'-,0.0144869 unit decrease,[0.0098-0.0191],"FOXP1, EIF4E3",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,3:71599717
rs699165-<b>G</b>,1 x 10-10,,0.745,'-,0.0161225 unit increase,[0.011-0.021],STAG1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,3:136505855
rs28813180-<b>A</b>,3 x 10-10,,0.498,'-,0.013713 unit decrease,[0.0094-0.018],RSRC1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,3:158366129
rs2032463-<b>C</b>,2 x 10-10,,0.424,'-,0.0141412 unit decrease,[0.0098-0.0185],"NOP14-AS1, NOP14",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,4:2940261
rs11940255-<b>A</b>,3 x 10-13,,0.717,'-,0.0177446 unit decrease,[0.013-0.023],MIR1269A,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,4:66220570
rs10454798-<b>T</b>,2 x 10-12,,0.253,'-,0.0175904 unit increase,[0.013-0.022],'-,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,4:67115112
rs2304608-<b>A</b>,5 x 10-8,,0.154,'-,0.0164578 unit increase,[0.011-0.022],LINC00461,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,5:88666480
rs10900901-<b>C</b>,2 x 10-8,,0.293,'-,0.0134093 unit increase,[0.0087-0.0181],FBXL17,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,5:107989485
rs329118-<b>T</b>,4 x 10-8,,0.426,'-,0.0120861 unit decrease,[0.0078-0.0164],JADE2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,5:134525973
rs7766641-<b>A</b>,5 x 10-15,,0.272,'-,0.019262 unit decrease,[0.014-0.024],H2BC6,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,6:26183874
rs215600-<b>A</b>,8 x 10-27,,0.645,'-,0.0243837 unit decrease,[0.02-0.029],PDE1C,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,7:32294030
rs62447179-<b>A</b>,5 x 10-8,,0.298,'-,0.0130548 unit decrease,[0.0084-0.0177],IKZF1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,7:50300013
rs10240199-<b>C</b>,6 x 10-9,,0.106,'-,0.020573 unit decrease,[0.014-0.028],TMEM225B,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,7:99599555
rs10261857-<b>A</b>,3 x 10-8,,0.617,'-,0.0131482 unit decrease,[0.0085-0.0178],LINC01392,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,7:115319193
rs71519637-<b>T</b>,9 x 10-9,,0.103,'-,0.0207781 unit increase,[0.014-0.028],CHRNA2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,8:27476581
rs7459838-<b>A</b>,1 x 10-32,,0.766,'-,0.0308344 unit increase,[0.026-0.036],CHRNB3,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,8:42729136
rs10110699-<b>C</b>,2 x 10-8,,0.837,'-,0.0167425 unit decrease,[0.011-0.023],RN7SKP135,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,8:63598717
rs365552-<b>A</b>,1 x 10-8,,0.536,'-,0.01243 unit increase,[0.0081-0.0167],RABEPK,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,9:125225230
rs3025312-<b>A</b>,5 x 10-15,,0.0438,'-,0.0422391 unit decrease,[0.032-0.053],FAM163B,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,9:133594162
rs3025327-<b>C</b>,2 x 10-40,,0.111,'-,0.0463005 unit increase,[0.039-0.053],FAM163B,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,9:133602222
rs3025383-<b>C</b>,5 x 10-29,,0.187,'-,0.0314888 unit decrease,[0.026-0.037],DBH,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,9:133637247
rs2182517-<b>T</b>,3 x 10-9,,0.243,'-,0.0151166 unit increase,[0.01-0.02],'-,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,10:8789196
rs61876492-<b>C</b>,9 x 10-9,,0.38,'-,0.012904 unit increase,[0.0085-0.0173],BTAF1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,10:92026800
rs9645569-<b>A</b>,4 x 10-9,,0.147,'-,0.0184447 unit increase,[0.012-0.025],SFXN2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,10:102736841
rs10832501-<b>G</b>,2 x 10-7,,0.541,'-,0.0114324 unit increase,[0.0071-0.0157],LINC02751,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:15666257
rs7951365-<b>C</b>,9 x 10-16,,0.31,'-,0.019028 unit increase,[0.014-0.024],SOX6,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:16355498
rs6265-<b>T</b>,7 x 10-7,,0.181,'-,0.014062 unit decrease,[0.0085-0.0196],"BDNF-AS, BDNF",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:27658369
rs7127383-<b>T</b>,2 x 10-8,,0.602,'-,0.0126262 unit increase,[0.0083-0.017],METTL15,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:28570040
rs10128753-<b>A</b>,3 x 10-8,,0.386,'-,0.0124742 unit decrease,[0.0081-0.0169],DCDC1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:31313877
rs7114842-<b>C</b>,4 x 10-9,,0.295,'-,0.014098 unit increase,[0.0094-0.0188],HSD17B12,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:43817881
rs17197116-<b>C</b>,2 x 10-11,,0.0835,'-,0.0266115 unit increase,[0.019-0.034],AMBRA1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:46498752
rs2734838-<b>G</b>,1 x 10-9,,0.604,'-,0.013594 unit decrease,[0.0092-0.018],DRD2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:113415779
rs7125588-<b>G</b>,1 x 10-12,,0.429,'-,0.0157092 unit decrease,[0.011-0.02],DRD2,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,11:113565350
rs10846380-<b>T</b>,1 x 10-10,,0.41,'-,0.014287 unit decrease,[0.0099-0.0187],"MGST1, LMO3",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,12:16594100
rs10785131-<b>T</b>,7 x 10-9,,0.167,'-,0.0170535 unit decrease,[0.011-0.023],ATXN7L3B,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,12:74569401
rs2241208-<b>C</b>,8 x 10-10,,0.522,'-,0.013382 unit increase,[0.0091-0.0177],UBE3B,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,12:109524990
rs4884468-<b>G</b>,1 x 10-8,,0.561,'-,0.0132652 unit decrease,[0.0087-0.0178],ZNF646P1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,13:53461200
rs710284-<b>C</b>,4 x 10-11,,0.416,'-,0.0146211 unit increase,[0.01-0.019],"LINC01550, LINC02295",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,14:98066203
rs11846838-<b>A</b>,3 x 10-12,,0.327,'-,0.0163456 unit increase,[0.012-0.021],ZFYVE21,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,14:103718400
rs1435742-<b>G</b>,2 x 10-8,,0.447,'-,0.0124702 unit increase,[0.0081-0.0168],SEMA6D,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:47643588
rs7281463-<b>C</b>,2 x 10-10,,0.413,'-,0.0141604 unit increase,[0.0098-0.0185],"RPL23AP12, PCBP2P1",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,21:39148857
rs403694-<b>T</b>,3 x 10-8,,0.537,'-,0.0121441 unit increase,[0.0078-0.0164],ADARB1,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,21:45147710
rs1115019-<b>C</b>,2 x 10-11,,0.79,'-,0.0179093 unit decrease,[0.013-0.023],TCF12,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:56849033
rs632811-<b>G</b>,4 x 10-12,,0.33,'-,0.0171946 unit decrease,[0.012-0.022],"ZNF444P1, MINDY2",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:58862851
rs4375600-<b>G</b>,7 x 10-8,,0.913,'-,0.0208323 unit decrease,[0.013-0.028],RORA,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:61304925
rs10519203-<b>A</b>,1 x 10-262,,0.655,'-,0.0798364 unit decrease,[0.075-0.084],HYKK,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:78521704
rs2229961-<b>A</b>,2 x 10-24,,0.015,'-,0.100925 unit increase,[0.082-0.12],CHRNA5,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:78588410
rs11637630-<b>A</b>,4 x 10-167,,0.773,'-,0.0721336 unit increase,[0.067-0.077],CHRNA3,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:78607377
rs182317-<b>T</b>,4 x 10-10,,0.355,'-,0.0144895 unit decrease,[0.01-0.019],"RHCG, MIR9-3HG",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,15:89400370
rs12599074-<b>A</b>,1 x 10-10,,0.608,'-,0.0143378 unit decrease,[0.01-0.0187],C16orf97,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,16:52059115
rs4783722-<b>C</b>,4 x 10-12,,0.413,'-,0.01543 unit decrease,[0.011-0.02],"NFAT5, CYB5B",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,16:69548009
rs61747555-<b>G</b>,3 x 10-8,,0.22,'-,0.0146363 unit decrease,[0.0094-0.0198],"IST1, ATXN1L",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,16:71851520
rs4785587-<b>A</b>,6 x 10-13,,0.523,'-,0.0160173 unit decrease,[0.012-0.02],"SPATA2L, VPS9D1",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,16:89706211
rs34039488-<b>A</b>,6 x 10-10,,0.157,'-,0.0187094 unit decrease,[0.013-0.025],"SEZ6, PIPOX",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,17:28993214
rs28397663-<b>T</b>,2 x 10-8,,0.365,'-,0.0129928 unit increase,[0.0085-0.0175],FLJ40194,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,17:49250821
rs11872159-<b>C</b>,5 x 10-9,,0.177,'-,0.0167508 unit increase,[0.011-0.022],'-,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,18:53748720
rs4144686-<b>A</b>,9 x 10-9,,0.167,'-,0.0168007 unit decrease,[0.011-0.023],TCF4,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,18:55584494
rs11663346-<b>T</b>,3 x 10-10,,0.582,'-,0.0139519 unit decrease,[0.0096-0.0183],LINC01924,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,18:64485223
rs59208569-<b>C</b>,3 x 10-11,,0.829,'-,0.019826 unit increase,[0.014-0.026],ZBTB7A,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,19:4044426
rs76112798-<b>T</b>,2 x 10-18,,0.0697,'-,0.0388783 unit decrease,[0.03-0.048],"CYP2F2P, CYP2A6",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,19:40837795
rs56113850-<b>C</b>,5 x 10-58,,0.555,'-,0.0361686 unit increase,[0.032-0.041],CYP2A6,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,19:40847202
rs28399442-<b>A</b>,4 x 10-24,,0.0256,'-,0.071775 unit decrease,[0.058-0.086],CYP2A6,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,19:40848553
rs117824460-<b>G</b>,1 x 10-33,,0.026,'-,0.0878402 unit decrease,[0.074-0.102],"CYP2A7, CYP2A6",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,19:40865575
rs6078373-<b>A</b>,1 x 10-9,,0.402,'-,0.0135594 unit increase,[0.0092-0.0179],"BTBD3, LINC00687",Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,20:11882852
rs1737894-<b>G</b>,8 x 10-15,,0.408,'-,0.0172715 unit increase,[0.013-0.022],NOL4L,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,20:32466899
rs2273500-<b>C</b>,2 x 10-39,,0.147,'-,0.041068 unit increase,[0.035-0.047],CHRNA4,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,20:63355597
rs62207961-<b>T</b>,9 x 10-7,,0.0357,'-,0.0309433 unit increase,[0.019-0.043],CHRNA4,Cigarettes smoked per day (MTAG),cigarettes per day measurement,GCST007463,20:63372074
rs2960306-<b>T</b>,1 x 10-9,,0.34,'-,0.024 unit decrease,[0.014-0.034],GRK4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,4:2988772
rs6474412-<b>T</b>,2 x 10-21,,NR,'-,0.043 unit increase,[0.031-0.055],CHRNB3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,8:42695355
rs3733829-<b>G</b>,2 x 10-9,,NR,'-,0.025 unit increase,[0.015-0.035],"RAB4B-EGLN2, EGLN2",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,19:40804666
rs2273506-<b>A</b>,9 x 10-7,,NR,'-,0.03 unit increase,[0.01-0.05],CHRNA4,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,20:63359587
rs1051730-<b>A</b>,6 x 10-121,,NR,'-,0.101 unit increase,[0.091-0.111],'-,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,Mapping not available
rs28399442-<b>A</b>,2 x 10-12,,0.013,'-,'-,'-,CYP2A6,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,19:40848553
rs3865453-<b>T</b>,3 x 10-12,,0.0654,'-,'-,'-,"CYP2A6, CYP2F2P",Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,19:40832651
rs938682-<b>A</b>,2 x 10-69,,0.764,'-,'-,'-,CHRNA3,Smoking behaviour (cigarettes smoked per day),cigarettes per day measurement,GCST007602,15:78604205
APOE-<b>?</b>,1 x 10-49,,NR,'-,'-,'-,'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST006806,Mapping not available
rs116530595-<b>T</b>,9 x 10-6,(liability model),0.018,'-,0.26 unit increase,[0.14-0.38],"TXN, C9orf152",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:110213589
rs147582129-<b>T</b>,9 x 10-6,(liability model),0.016,'-,0.28 unit increase,[0.16-0.4],FAT3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:92422052
rs72998574-<b>T</b>,2 x 10-6,(liability model),0.022,'-,0.28 unit increase,[0.16-0.4],R3HDM2P2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:103969846
rs144471255-<b>A</b>,3 x 10-6,(liability model),0.018,'-,0.31 unit increase,[0.17-0.45],RDX,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:110058188
rs144216026-<b>A</b>,8 x 10-6,(liability model),0.017,'-,0.31 unit increase,[0.17-0.45],ABCA8,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:68920354
rs137869973-<b>T</b>,2 x 10-7,(liability model),0.025,'-,0.31 unit increase,[0.19-0.43],KCTD9P6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:31236084
rs72840936-<b>C</b>,5 x 10-7,(liability model),0.018,'-,0.32 unit increase,[0.2-0.44],STEAP3-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:119266116
rs148587130-<b>T</b>,7 x 10-6,(liability model),0.013,'-,0.36 unit increase,[0.2-0.52],NEK10,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:27236975
rs185126971-<b>A</b>,8 x 10-6,(liability model),0.011,'-,0.37 unit increase,[0.21-0.53],"ERO1A, PSMC6",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,14:52702250
rs73239797-<b>A</b>,2 x 10-6,(liability model),0.013,'-,0.39 unit increase,[0.23-0.55],"RNU7-188P, SEM1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:96446404
rs113884973-<b>C</b>,8 x 10-6,(liability model),0.008,'-,0.43 unit increase,[0.23-0.63],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:53256902
rs182972826-<b>T</b>,4 x 10-6,(liability model),0.007,'-,0.44 unit increase,[0.24-0.64],SEC24B,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:109534350
rs112920270-<b>A</b>,9 x 10-6,(liability model),0.008,'-,0.45 unit increase,[0.25-0.65],STK31,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:23931916
rs141104697-<b>A</b>,8 x 10-6,(liability model),0.007,'-,0.46 unit increase,[0.26-0.66],GTF2H3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:123635804
rs144464515-<b>C</b>,2 x 10-6,(liability model),0.01,'-,0.46 unit increase,[0.26-0.66],"ZNRF4, PTPRS",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:5417482
rs191707442-<b>T</b>,6 x 10-6,(liability model),0.008,'-,0.47 unit increase,[0.27-0.67],PPP1R3B,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:9182000
rs150269952-<b>T</b>,6 x 10-6,(liability model),0.009,'-,0.48 unit increase,[0.26-0.7],RASSF5,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:206526352
rs144998240-<b>A</b>,8 x 10-7,(liability model),0.006,'-,0.5 unit increase,[0.3-0.7],COL25A1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:109251730
rs138543081-<b>T</b>,1 x 10-6,(liability model),0.009,'-,0.5 unit increase,[0.3-0.7],ZNF462,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:107043881
rs192013290-<b>T</b>,1 x 10-6,(liability model),0.006,'-,0.51 unit increase,[0.29-0.73],HMCN1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:185780742
rs144077517-<b>A</b>,2 x 10-6,(liability model),0.005,'-,0.54 unit increase,[0.32-0.76],SCAPER,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:76352686
rs142835438-<b>A</b>,8 x 10-7,(liability model),0.007,'-,0.54 unit increase,[0.32-0.76],"ZBTB10, RPSAP47",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:80555470
rs184695264-<b>T</b>,4 x 10-6,(liability model),0.005,'-,0.58 unit increase,[0.33-0.83],LINC02421,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:67780260
rs921390-<b>T</b>,1 x 10-6,(liability model),0.005,'-,0.58 unit increase,[0.34-0.82],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:4515659
rs150291119-<b>A</b>,3 x 10-6,(liability model),0.005,'-,0.6 unit increase,[0.35-0.85],NAALADL2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:174769522
rs186542490-<b>A</b>,8 x 10-6,(liability model),0.006,'-,0.6 unit increase,[0.35-0.85],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:78644638
rs186076999-<b>T</b>,7 x 10-6,(liability model),0.006,'-,0.62 unit increase,[0.35-0.89],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:20013543
rs141521929-<b>T</b>,4 x 10-6,(liability model),0.005,'-,0.62 unit increase,[0.37-0.87],TUSC1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:25669750
rs73865608-<b>A</b>,1 x 10-6,(liability model),0.004,'-,0.63 unit increase,[0.38-0.88],"LINC02273, RNA5SP169",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:152043740
rs184614511-<b>T</b>,6 x 10-6,(liability model),0.005,'-,0.64 unit increase,[0.37-0.91],KSR2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:117861676
rs193129245-<b>A</b>,1 x 10-6,(liability model),0.005,'-,0.67 unit increase,[0.4-0.94],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:23318629
rs150061627-<b>T</b>,5 x 10-6,(liability model),0.004,'-,0.68 unit increase,[0.39-0.97],"MIR548Y, MDGA2",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,14:47737481
rs190457471-<b>A</b>,5 x 10-6,(liability model),0.004,'-,0.68 unit increase,[0.39-0.97],"OSER1-DT, GDAP1L1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,20:44233181
rs141387448-<b>T</b>,4 x 10-6,(liability model),0.005,'-,0.68 unit increase,[0.39-0.97],"ZNF438, LINC02664",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,10:31115466
rs117760708-<b>T</b>,3 x 10-6,(liability model),0.004,'-,0.73 unit increase,[0.42-1.04],JPH3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:87653662
rs187423924-<b>A</b>,4 x 10-6,(liability model),0.004,'-,0.74 unit increase,[0.43-1.05],AQP4-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,18:26735845
rs181634374-<b>T</b>,8 x 10-6,(liability model),0.003,'-,0.77 unit increase,[0.44-1.1],RPL23AP44,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:121563422
rs145228677-<b>C</b>,7 x 10-6,(liability model),0.004,'-,0.79 unit increase,[0.44-1.14],RPS18P12,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:14641688
rs188699384-<b>A</b>,5 x 10-6,(liability model),0.003,'-,0.79 unit increase,[0.46-1.12],MIR924HG,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,18:39619094
rs148003968-<b>A</b>,5 x 10-6,(liability model),0.003,'-,0.81 unit increase,[0.46-1.16],TFEB,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:41696609
rs185867524-<b>A</b>,5 x 10-6,(liability model),0.004,'-,0.86 unit increase,[0.49-1.23],DNAH6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:84597852
rs117756856-<b>A</b>,9 x 10-6,(liability model),0.003,'-,0.89 unit increase,[0.5-1.28],HDAC9,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:18212452
rs184457411-<b>A</b>,8 x 10-6,(liability model),0.003,'-,0.92 unit increase,[0.51-1.33],SHANK2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:70820116
rs180751169-<b>T</b>,5 x 10-6,(liability model),0.002,'-,0.94 unit increase,[0.53-1.35],"ADAM18, ADAM3A",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:39576416
rs188392327-<b>A</b>,2 x 10-6,(liability model),0.002,'-,0.99 unit increase,[0.58-1.4],"UGT1A8, UGT1A10",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:233651485
rs192232892-<b>T</b>,3 x 10-6,(liability model),0.002,'-,0.99 unit increase,[0.58-1.4],TBXAS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:139942249
rs149839710-<b>A</b>,9 x 10-6,(liability model),0.002,'-,1 unit increase,[0.55-1.45],"KIFC3, CNGB1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:57869386
rs150631144-<b>T</b>,1 x 10-7,(liability model),0.002,'-,1.13 unit increase,[0.72-1.54],RNU6-909P,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:28577827
rs243034-<b>C</b>,1 x 10-6,,0.394,1.521,'-,[1.28-1.76],MIR4432HG,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,2:60375757
rs1353581-<b>?</b>,5 x 10-6,,0.234,1.5384616,'-,[1.43-1.65],'-,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,4:189068835
rs10968750-<b>T</b>,2 x 10-6,,0.941,2.633,'-,[1.77-3.5],LINGO2,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,9:28753984
rs2666895-<b>?</b>,4 x 10-7,,0.092,1.992032,'-,[1.87-2.11],"MIR7154, CHST1",Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,11:45689480
rs3814837-<b>?</b>,3 x 10-6,,0.247,1.55521,'-,[1.45-1.66],CATSPERB,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,14:91725006
rs11909995-<b>?</b>,4 x 10-6,,0.176,1.6207455,'-,[1.51-1.74],ATP5PF,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,21:25725147
rs429358-<b>?</b>,2 x 10-30,,0.21,5.24,'-,[5.19-5.29],'-,Alzheimer's disease in hypertension-negative individuals,Alzheimer's disease,GCST008437,Mapping not available
rs10405693-<b>?</b>,3 x 10-14,,NR,1.3981868,'-,'-,"NECTIN2, BCAM",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44823407
rs10402271-<b>?</b>,7 x 10-14,,NR,1.3904976,'-,'-,"BCAM, NECTIN2",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44825957
rs8103315-<b>?</b>,4 x 10-6,,NR,1.3527919,'-,'-,BCL3,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44750911
rs2298369-<b>?</b>,3 x 10-7,(females),NR,1.3267368,'-,'-,"MIR155HG, MRPL39",Alzheimer's disease,Alzheimer's disease,GCST007600,21:25583969
rs10953322-<b>?</b>,5 x 10-6,,NR,1.3187115,'-,'-,"SERPINE1, TRIM56",Alzheimer's disease,Alzheimer's disease,GCST007600,7:101103377
rs6838792-<b>?</b>,2 x 10-6,(females),NR,1.2961394,'-,'-,STK32B,Alzheimer's disease,Alzheimer's disease,GCST007600,4:5096839
rs2298369-<b>?</b>,4 x 10-7,,NR,1.2475969,'-,'-,"MIR155HG, MRPL39",Alzheimer's disease,Alzheimer's disease,GCST007600,21:25583969
rs4961664-<b>?</b>,4 x 10-6,,NR,1.2335871,'-,'-,"CCDC171, C9orf92",Alzheimer's disease,Alzheimer's disease,GCST007600,9:16161235
rs10794342-<b>?</b>,4 x 10-6,,NR,1.2132727,'-,'-,AP2A2,Alzheimer's disease,Alzheimer's disease,GCST007600,11:924904
rs6859-<b>A</b>,6 x 10-13,(females),0.42469,1.570301,'-,[1.39-1.75],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44878777
rs7259620-<b>G</b>,6 x 10-16,(females),0.568643,1.665856,'-,[1.47-1.86],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44904531
rs1160985-<b>C</b>,4 x 10-16,(females),0.564781,1.669499,'-,[1.48-1.86],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44900155
rs1172922-<b>A</b>,5 x 10-6,(females),0.117523,1.407788,'-,[1.22-1.6],"OR7E109P, DIRAS2",Alzheimer's disease,Alzheimer's disease,GCST007600,9:90726252
rs405509-<b>T</b>,4 x 10-14,(females),0.49585,1.596079,'-,[1.41-1.78],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44905579
rs769450-<b>G</b>,3 x 10-13,(females),0.614728,1.604012,'-,[1.41-1.79],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44907187
rs8106922-<b>A</b>,6 x 10-14,(females),0.618134,1.62673,'-,[1.43-1.82],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44898409
rs7412-<b>C</b>,1 x 10-7,(females),0.9279,2.065872,'-,[1.58-2.55],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44908822
rs1160985-<b>C</b>,3 x 10-8,(males),0.563262,1.629703,'-,[1.37-1.89],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44900155
rs405509-<b>T</b>,1 x 10-8,(males),0.498083,1.640389,'-,[1.38-1.9],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44905579
rs6859-<b>A</b>,1 x 10-9,(males),0.433641,1.677747,'-,[1.42-1.94],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44878777
rs7259620-<b>G</b>,2 x 10-9,(males),0.567196,1.700015,'-,[1.43-1.97],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44904531
rs5969117-<b>C</b>,1 x 10-6,(males),0.295488,1.490488,'-,[1.27-1.71],'-,Alzheimer's disease,Alzheimer's disease,GCST007600,X:87181248
rs769450-<b>G</b>,2 x 10-7,(males),0.610827,1.600702,'-,[1.34-1.86],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44907187
rs8106922-<b>A</b>,6 x 10-8,(males),0.611921,1.6359,'-,[1.37-1.9],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44898409
rs10426423-<b>C</b>,3 x 10-6,,0.620314,1.265674,'-,[1.15-1.38],"NECTIN2, BCAM",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44844996
rs1871047-<b>A</b>,2 x 10-6,,0.619781,1.270037,'-,[1.15-1.39],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44848489
rs440277-<b>G</b>,2 x 10-7,,0.691681,1.321105,'-,[1.19-1.45],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44857967
rs769450-<b>G</b>,6 x 10-19,,0.61311,1.59501,'-,[1.44-1.75],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44907187
rs6859-<b>A</b>,2 x 10-21,,0.428373,1.599071,'-,[1.45-1.75],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44878777
rs405509-<b>T</b>,2 x 10-21,,0.496776,1.613847,'-,[1.46-1.77],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44905579
rs8106922-<b>A</b>,2 x 10-20,,0.615581,1.624312,'-,[1.47-1.78],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44898409
rs1160985-<b>C</b>,1 x 10-22,,0.564132,1.653124,'-,[1.49-1.81],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44900155
rs7259620-<b>G</b>,2 x 10-23,,0.568042,1.6754,'-,[1.51-1.84],"TOMM40, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44904531
rs7412-<b>C</b>,4 x 10-13,,0.928632,2.214072,'-,[1.79-2.64],APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44908822
rs35242772-<b>C</b>,1 x 10-6,,0.356238,1.230973,'-,[1.13-1.33],MIR302F,Alzheimer's disease,Alzheimer's disease,GCST007600,18:30214382
rs912322-<b>A</b>,1 x 10-6,,0.73251,1.259729,'-,[1.15-1.37],MYO16,Alzheimer's disease,Alzheimer's disease,GCST007600,13:109155938
rs283814-<b>G</b>,9 x 10-6,,0.933446,1.588872,'-,[1.3-1.88],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44885967
rs77657034-<b>G</b>,5 x 10-6,,0.9924,6.912992,'-,[3.02-10.81],MAP4K4,Alzheimer's disease,Alzheimer's disease,GCST007600,2:101857264
rs483082-<b>?</b>,1 x 10-37,(females),0.734105,2.6149259,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44912921
rs283815-<b>?</b>,9 x 10-23,(males),0.753336,2.794014,'-,'-,NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44887076
rs483082-<b>?</b>,1 x 10-62,,0.738441,2.6436493,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44912921
rs2233083-<b>?</b>,1 x 10-6,,NR,7.2292986,'-,'-,MAPK7,Alzheimer's disease,Alzheimer's disease,GCST007600,17:19383150
rs12450778-<b>?</b>,2 x 10-6,(females),NR,2.4201357,'-,'-,"EPOP, SRCIN1",Alzheimer's disease,Alzheimer's disease,GCST007600,17:38658216
rs429358-<b>?</b>,2 x 10-91,,NR,3.9972339,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,Mapping not available
rs429358-<b>?</b>,1 x 10-53,(females),NR,3.921738,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,Mapping not available
rs157580-<b>?</b>,4 x 10-9,(males),NR,1.7230357,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892009
rs769449-<b>?</b>,2 x 10-83,,NR,3.8717523,'-,'-,APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44906745
rs429358-<b>?</b>,3 x 10-31,(males),NR,3.8628085,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,Mapping not available
rs769449-<b>?</b>,6 x 10-47,(females),NR,3.7354689,'-,'-,APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44906745
rs73165159-<b>?</b>,3 x 10-6,(males),NR,3.3545792,'-,'-,"CENPM, LINC00634",Alzheimer's disease,Alzheimer's disease,GCST007600,22:41950038
rs4420638-<b>?</b>,2 x 10-24,(males),NR,3.3425252,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919689
rs56131196-<b>?</b>,3 x 10-24,(males),NR,3.3117516,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919589
rs71352238-<b>?</b>,2 x 10-25,(males),NR,3.295186,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44891079
rs2075650-<b>?</b>,8 x 10-26,(males),NR,3.2904043,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892362
rs11969759-<b>?</b>,2 x 10-6,(females),NR,1.6222337,'-,'-,TNXB,Alzheimer's disease,Alzheimer's disease,GCST007600,6:32053353
rs405697-<b>?</b>,1 x 10-13,,NR,1.5548013,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44901434
rs405697-<b>?</b>,1 x 10-8,(females),NR,1.5508373,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44901434
rs584007-<b>?</b>,2 x 10-9,(females),NR,1.5096664,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44913221
rs439401-<b>?</b>,3 x 10-9,(females),NR,1.5058857,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44911194
rs1497197-<b>?</b>,3 x 10-6,,NR,1.4972146,'-,'-,LHX1-DT,Alzheimer's disease,Alzheimer's disease,GCST007600,17:36819274
rs2075650-<b>?</b>,1 x 10-39,(females),NR,3.1072497,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892362
rs439401-<b>?</b>,6 x 10-14,,NR,1.486781,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44911194
rs116593898-<b>?</b>,3 x 10-6,,NR,3.0120482,'-,'-,SFT2D2,Alzheimer's disease,Alzheimer's disease,GCST007600,1:168232648
rs7963314-<b>?</b>,3 x 10-6,(females),NR,1.4279574,'-,'-,LINC02414,Alzheimer's disease,Alzheimer's disease,GCST007600,12:131573284
rs157582-<b>?</b>,1 x 10-23,(males),NR,2.8279662,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892962
rs10402271-<b>?</b>,2 x 10-9,(females),NR,1.4007349,'-,'-,"BCAM, NECTIN2",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44825957
rs157582-<b>?</b>,2 x 10-35,(females),NR,2.6219604,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892962
rs77104831-<b>?</b>,2 x 10-6,(males),NR,4.27716,'-,'-,FBXL13,Alzheimer's disease,Alzheimer's disease,GCST007600,7:102911421
rs7561207-<b>?</b>,4 x 10-6,(females),NR,2.1267998,'-,'-,ANTXR1,Alzheimer's disease,Alzheimer's disease,GCST007600,2:69138666
rs12450778-<b>?</b>,2 x 10-6,,NR,2.0929258,'-,'-,"EPOP, SRCIN1",Alzheimer's disease,Alzheimer's disease,GCST007600,17:38658216
rs769449-<b>?</b>,7 x 10-30,(males),NR,3.921353,'-,'-,APOE,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44906745
rs157580-<b>?</b>,4 x 10-23,,NR,1.7063565,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892009
rs157580-<b>?</b>,6 x 10-14,(females),NR,1.6891578,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892009
rs76252969-<b>?</b>,5 x 10-6,,NR,1.68319,'-,'-,"RPL13AP7, RNA5SP489",Alzheimer's disease,Alzheimer's disease,GCST007600,21:25277446
rs2282079-<b>?</b>,4 x 10-6,,NR,1.6799409,'-,'-,"PAX5, RPL32P21",Alzheimer's disease,Alzheimer's disease,GCST007600,9:37036250
rs8103315-<b>?</b>,2 x 10-6,(males),NR,1.6666555,'-,'-,BCL3,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44750911
rs9862849-<b>?</b>,3 x 10-6,(males),NR,1.6597484,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST007600,3:66855351
rs62402815-<b>?</b>,4 x 10-7,(females),NR,1.6387721,'-,'-,LNC-LBCS,Alzheimer's disease,Alzheimer's disease,GCST007600,6:19350484
rs111436800-<b>?</b>,5 x 10-6,,NR,1.6282058,'-,'-,Y_RNA,Alzheimer's disease,Alzheimer's disease,GCST007600,21:23456358
rs56131196-<b>?</b>,6 x 10-77,,NR,3.2625577,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919589
rs4420638-<b>?</b>,9 x 10-77,,NR,3.2591338,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919689
rs2075650-<b>?</b>,2 x 10-71,,NR,3.2239969,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892362
rs56131196-<b>?</b>,4 x 10-48,(females),NR,3.2052002,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919589
rs4420638-<b>?</b>,8 x 10-48,(females),NR,3.1868043,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44919689
rs71352238-<b>?</b>,7 x 10-69,,NR,3.181876,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44891079
rs584007-<b>?</b>,3 x 10-14,,NR,1.4945852,'-,'-,"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44913221
rs71352238-<b>?</b>,6 x 10-38,(females),NR,3.0343766,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44891079
rs62402815-<b>?</b>,2 x 10-6,,NR,1.4489708,'-,'-,LNC-LBCS,Alzheimer's disease,Alzheimer's disease,GCST007600,6:19350484
rs10405693-<b>?</b>,1 x 10-9,(females),NR,1.4069744,'-,'-,"NECTIN2, BCAM",Alzheimer's disease,Alzheimer's disease,GCST007600,19:44823407
rs157582-<b>?</b>,4 x 10-63,,NR,2.7341528,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST007600,19:44892962
rs34925435-<b>?</b>,5 x 10-6,(males),NR,2.7270248,'-,'-,"TMCC1-DT, TRH",Alzheimer's disease,Alzheimer's disease,GCST007600,3:129947221
rs2075650-<b>?</b>,2 x 10-7,,'-,1.5,'-,[NR],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST006121,19:44892362
rs2075650-<b>?</b>,5 x 10-7,,NR,1.5,'-,[NR],TOMM40,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST006120,19:44892362
rs78210707-<b>?</b>,4 x 10-6,,0.011,2.67,'-,[2.54-2.80],GRIN2B,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,12:13763366
rs28868104-<b>?</b>,4 x 10-7,,0.131,1.4534883,'-,[1.36-1.55],'-,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,3:104241993
rs1925458-<b>?</b>,1 x 10-6,,0.117,1.552795,'-,[1.45-1.66],'-,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,6:23378723
rs75036080-<b>?</b>,3 x 10-6,,0.02,2.0576131,'-,[1.93-2.19],"C12orf40, SLC2A13",Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,12:39882501
rs429358-<b>?</b>,6 x 10-43,,0.147,3.26,'-,[3.21-3.31],'-,Alzheimer's disease in hypertension,"Alzheimer's disease, hypertension",GCST008438,Mapping not available
rs11967676-<b>G</b>,9 x 10-8,,0.08,'-,1.07 unit decrease,[0.7-1.44],'-,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST006990,6:48747159
rs4955783-<b>G</b>,5 x 10-7,,0.49,'-,0.61 unit decrease,[0.39-0.83],GOLIM4,Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, t-tau measurement",GCST006991,3:168031109
rs181850653-<b>T</b>,9 x 10-7,,0.03,'-,1.59 unit decrease,[0.98-2.2],"RNU6-363P, C5orf22",Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, t-tau measurement",GCST006991,5:31575350
rs80011616-<b>A</b>,2 x 10-7,,0.14,'-,0.92 unit decrease,[0.61-1.23],RNF165,Cerebrospinal fluid t-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, t-tau measurement",GCST006991,18:46404184
rs114090132-<b>T</b>,8 x 10-7,,0.02,'-,2.46 unit decrease,[1.54-3.38],SLC25A48,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,5:135810905
rs117556552-<b>T</b>,5 x 10-7,,0.05,'-,2.21 unit decrease,[1.41-3.01],ANO3,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,11:26498505
rs117908734-<b>T</b>,1 x 10-6,,0.02,'-,3.03 unit decrease,[1.89-4.17],'-,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,14:98492717
rs8039237-<b>C</b>,1 x 10-7,,0.03,'-,0.79 unit increase,[0.52-1.06],'-,Cerebrospinal fluid p-tau levels in Alzheimer's disease dementia,"Alzheimer's disease, p-tau measurement",GCST006992,15:94845722
rs186911969-<b>T</b>,3 x 10-7,,0.02,'-,3.65 unit increase,[2.32-4.98],"ACTL8, ERICH3",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,1:17877570
rs137929838-<b>T</b>,3 x 10-7,,0.03,'-,1.59 unit increase,[1.02-2.16],COLGALT2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,1:183941302
rs7576531-<b>T</b>,1 x 10-6,,0.04,'-,1.64 unit increase,[1.01-2.27],ABCB11,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,2:168969959
rs140442947-<b>C</b>,1 x 10-7,,0.01,'-,2.83 unit increase,[1.85-3.81],GSK3B,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,3:119865430
rs116105213-<b>C</b>,4 x 10-7,,0.02,'-,2.73 unit increase,[1.73-3.73],ARAP2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,4:36187535
rs17488073-<b>G</b>,2 x 10-7,,0.16,'-,0.83 unit increase,[0.54-1.12],IRF2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,4:184407819
rs182645021-<b>C</b>,5 x 10-7,,0.01,'-,2.69 unit increase,[1.69-3.69],"RN7SL221P, FARS2",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,6:5877202
rs10455152-<b>C</b>,8 x 10-7,,0.23,'-,0.69 unit increase,[0.44-0.94],"KRT18P64, LINC02535",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,6:85308630
rs79846291-<b>T</b>,2 x 10-8,,0.02,'-,1.85 unit increase,[1.24-2.46],LINC00271,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,6:135756791
rs149454736-<b>T</b>,2 x 10-7,,0.03,'-,1.72 unit increase,[1.11-2.33],AKAP9,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,7:92101277
rs139934868-<b>G</b>,1 x 10-7,,0.06,'-,1.53 unit increase,[1-2.06],DSCAML1,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,11:117780161
rs78927322-<b>G</b>,1 x 10-7,,0.01,'-,2.85 unit increase,[1.85-3.85],IL34,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,16:70602635
rs146446983-<b>C</b>,7 x 10-7,,0.02,'-,2.59 unit increase,[1.61-3.57],GPR160P2,Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,17:31761101
rs62125664-<b>A</b>,6 x 10-7,,0.02,'-,2.23 unit increase,[1.39-3.07],"LINC01838, ZNF30-AS1",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,19:34915156
rs75627662-<b>T</b>,8 x 10-7,,0.27,'-,0.51 unit decrease,[0.31-0.71],"APOC1, APOE",Hippocampal volume in Alzheimer's disease dementia,"Alzheimer's disease, hippocampal volume",GCST006993,19:44910319
rs147906088-<b>T</b>,8 x 10-8,,0.02,'-,1.76 unit decrease,[1.15-2.37],"LINC01445, VSTM2A",Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,7:54496119
rs56214552-<b>G</b>,4 x 10-7,,0.26,'-,0.44 unit increase,[0.28-0.6],TRIQK,Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,8:93011994
rs6479525-<b>A</b>,9 x 10-7,,0.34,'-,0.39 unit decrease,[0.23-0.55],LINC01508,Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,9:90331096
rs62187521-<b>T</b>,5 x 10-7,,0.03,'-,1.33 unit decrease,[0.84-1.82],RSPO4,Logical memory (immediate recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006994,20:959154
rs72639058-<b>T</b>,5 x 10-7,,0.17,'-,0.47 unit decrease,[0.29-0.65],KAZN,Logical memory (delayed recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006995,1:13913797
rs117905930-<b>T</b>,7 x 10-8,,0.02,'-,1.59 unit decrease,[1.04-2.14],"PCNPP2, S1PR3",Logical memory (delayed recall) in Alzheimer's disease dementia,"Alzheimer's disease, memory performance",GCST006995,9:88973603
rs429358-<b>C</b>,4 x 10-43,,0.126,2.39,'-,[2.11-2.70],'-,Alzheimer's disease (onset at age over 80),Alzheimer's disease,GCST009497,Mapping not available
rs7412-<b>C</b>,6 x 10-12,,0.93,1.8518518,'-,[1.54-2.22],APOE,Alzheimer's disease (onset at age over 80),Alzheimer's disease,GCST009497,19:44908822
rs7412-<b>C</b>,3 x 10-33,,0.947,2.173913,'-,[1.89-2.44],APOE,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44908822
rs111371860-<b>A</b>,1 x 10-12,,0.961,1.6949153,'-,[1.45-1.92],"BCAM, NECTIN2",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44842530
rs440446-<b>G</b>,9 x 10-59,,0.686,1.6393442,'-,[1.56-1.75],APOE,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44905910
rs449647-<b>A</b>,9 x 10-22,,0.887,1.6129031,'-,[1.45-1.79],"APOE, TOMM40",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44905307
rs78986976-<b>G</b>,5 x 10-8,,0.968,1.5384616,'-,[1.32-1.79],"NECTIN2, BCAM",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44826181
rs35568738-<b>G</b>,9 x 10-10,,0.953,1.4925373,'-,[1.32-1.69],TOMM40,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44899461
rs71352239-<b>C</b>,3 x 10-14,,0.807,1.4492754,'-,[1.32-1.59],"APOC1P1, APOC1",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44926286
rs2967668-<b>A</b>,3 x 10-11,,0.913,1.4084507,'-,[1.28-1.56],CBLC,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44799694
rs76692773-<b>C</b>,4 x 10-9,,0.937,1.4084507,'-,[1.27-1.59],TOMM40,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44890954
rs4803748-<b>C</b>,3 x 10-16,,0.617,1.2820514,'-,[1.22-1.37],"CEACAM16-AS1, BCL3",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44743791
rs3851179-<b>C</b>,1 x 10-8,,0.648,1.1764705,'-,[1.11-1.23],"RNU6-560P, LINC02695",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,11:86157598
rs13025717-<b>T</b>,8 x 10-10,,0.295,1.2,'-,[1.13-1.28],"NIFKP9, BIN1",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,2:127128582
rs3818361-<b>A</b>,5 x 10-9,,0.204,1.21,'-,[1.14-1.29],CR1,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,1:207611623
rs35336243-<b>T</b>,2 x 10-9,,0.293,1.24,'-,[1.15-1.33],"APOC1P1, APOC4",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44939262
rs7561528-<b>A</b>,2 x 10-15,,0.37,1.26,'-,[1.19-1.33],"BIN1, NIFKP9",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,2:127132061
rs79638902-<b>T</b>,1 x 10-10,,0.127,1.33,'-,[1.22-1.45],CEACAM16-AS1,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44718495
rs74846209-<b>T</b>,9 x 10-16,,0.101,1.43,'-,[1.31-1.56],"PPP1R37, MARK4",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:45146841
rs6859-<b>A</b>,7 x 10-39,,0.47,1.44,'-,[1.36-1.52],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44878777
rs4803764-<b>C</b>,1 x 10-34,,0.282,1.52,'-,[1.42-1.63],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44854120
rs192775394-<b>C</b>,8 x 10-9,,0.018,1.88,'-,[1.52-2.33],"MARK4, TRAPPC6A",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:45168224
rs60049679-<b>C</b>,1 x 10-17,,0.038,2.07,'-,[1.75-2.44],"APOC1P1, APOC1",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44926451
rs144261139-<b>A</b>,1 x 10-10,,0.012,2.37,'-,[1.82-3.09],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44882099
rs141441332-<b>A</b>,1 x 10-11,,0.012,2.57,'-,[1.96-3.38],"APOC1P1, APOC4",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44935318
rs28399664-<b>G</b>,6 x 10-16,,0.017,2.59,'-,[2.06-3.26],"NECTIN2, BCAM",Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44821499
rs138607350-<b>G</b>,6 x 10-14,,0.014,2.66,'-,[2.06-3.43],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44860563
rs79701229-<b>A</b>,2 x 10-9,,0.006,3.35,'-,[2.26-4.95],NECTIN2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:44881674
rs429358-<b>C</b>,5 x 10-286,,0.248,3.93,'-,[3.65-4.23],'-,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,Mapping not available
rs12805422-<b>?</b>,2 x 10-13,,'-,'-,'-,'-,"CRY2, SLC35C1",Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,11:45818338
rs1483121-<b>?</b>,6 x 10-10,,'-,'-,'-,'-,"OR4C3, OR4S1",Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,11:48311808
rs17747324-<b>?</b>,5 x 10-9,,'-,'-,'-,'-,TCF7L2,Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,10:112992744
rs10501320-<b>?</b>,3 x 10-16,,'-,'-,'-,'-,MADD,Alzheimer's disease or fasting glucose levels (pleiotropy),"Alzheimer's disease, fasting blood glucose measurement",GCST007825,11:47272248
rs6656401-<b>?</b>,4 x 10-15,,'-,'-,'-,'-,CR1,Alzheimer's disease or fasting insulin levels (pleiotropy),"Alzheimer's disease, fasting blood insulin measurement",GCST007826,1:207518704
rs4803750-<b>?</b>,7 x 10-13,,'-,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or fasting insulin levels (pleiotropy),"Alzheimer's disease, fasting blood insulin measurement",GCST007826,19:44744370
rs2279590-<b>?</b>,1 x 10-17,,'-,'-,'-,'-,CLU,Alzheimer's disease or fasting insulin levels (pleiotropy),"Alzheimer's disease, fasting blood insulin measurement",GCST007826,8:27598736
rs157595-<b>?</b>,1 x 10-97,,'-,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44922203
rs261291-<b>?</b>,4 x 10-84,,'-,'-,'-,'-,ALDH1A2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,15:58387979
rs77301115-<b>?</b>,7 x 10-74,,'-,'-,'-,'-,TOMM40,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44893716
rs58826447-<b>?</b>,7 x 10-54,,'-,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44825122
rs406315-<b>?</b>,5 x 10-50,,'-,'-,'-,'-,NECTIN2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44880859
rs41290120-<b>?</b>,3 x 10-36,,'-,'-,'-,'-,NECTIN2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44879418
rs2740488-<b>?</b>,9 x 10-33,,'-,'-,'-,'-,ABCA1,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,9:104899461
rs6733839-<b>?</b>,3 x 10-25,,'-,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,2:127135234
rs141622900-<b>?</b>,3 x 10-24,,'-,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44923535
rs12148780-<b>?</b>,1 x 10-22,,'-,'-,'-,'-,ALDH1A2,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,15:58289090
rs7254723-<b>?</b>,7 x 10-22,,'-,'-,'-,'-,"CLPTM1, APOC4-APOC2",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44952664
rs2678379-<b>?</b>,1 x 10-19,,'-,'-,'-,'-,APOB,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,2:21003688
rs10792832-<b>?</b>,1 x 10-14,,'-,'-,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,11:86156833
rs35816125-<b>?</b>,2 x 10-12,,'-,'-,'-,'-,LIPG,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,18:49562460
rs10401176-<b>?</b>,3 x 10-12,,'-,'-,'-,'-,BCL3,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44750234
rs5754166-<b>?</b>,4 x 10-12,,'-,'-,'-,'-,UBE2L3,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,22:21576488
rs10426401-<b>?</b>,3 x 10-11,,'-,'-,'-,'-,"CEACAM16-AS1, PVR",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:44644419
rs10808026-<b>?</b>,1 x 10-10,,'-,'-,'-,'-,EPHA1,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,7:143402040
rs189590409-<b>A</b>,2 x 10-7,(between families),NR,'-,5.243 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:113715373
rs149038799-<b>A</b>,7 x 10-8,(between families),NR,'-,5.382 unit increase,'-,"LINC01151, SMILR",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:122446223
rs118152978-<b>A</b>,2 x 10-10,(between families),NR,'-,6.359 unit decrease,'-,LINC00861,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:126341293
rs10975167-<b>T</b>,8 x 10-7,(between families),NR,'-,4.928 unit increase,'-,PDCD1LG2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:5538407
rs147338646-<b>A</b>,5 x 10-7,(within families),NR,'-,5.009 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:11812813
rs78496360-<b>A</b>,5 x 10-7,(between families),NR,'-,5.026 unit decrease,'-,MTATP6P30,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:31499715
rs147213018-<b>A</b>,2 x 10-7,(between families),NR,'-,5.213 unit increase,'-,"ATP5MFP3, RFC5P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:77060964
rs7047415-<b>T</b>,3 x 10-7,(between families),NR,'-,5.096 unit increase,'-,LINC00476,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:95778950
rs12378800-<b>A</b>,2 x 10-7,(between families),NR,'-,5.218 unit increase,'-,"FOXE1, TRMO",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:97869538
rs1774093-<b>A</b>,7 x 10-7,(between families),NR,'-,4.956 unit decrease,'-,MTND3P4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:101884874
rs139090762-<b>A</b>,8 x 10-8,(between families),NR,'-,5.358 unit increase,'-,PNPLA7,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,9:137522127
rs181666690-<b>T</b>,1 x 10-7,(within families),NR,'-,5.289 unit decrease,'-,WAC,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:28563093
rs146650065-<b>A</b>,4 x 10-8,(between families),NR,'-,5.471 unit decrease,'-,JCAD,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:29940940
rs211257-<b>C</b>,2 x 10-8,(between families),NR,'-,5.641 unit decrease,'-,"RN7SL825P, RPL34P19",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:31991363
rs117850870-<b>C</b>,1 x 10-6,(between families),NR,'-,4.893 unit decrease,'-,C10orf71,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:49315703
rs61860854-<b>T</b>,3 x 10-11,(between families),NR,'-,6.651 unit decrease,'-,"MRPL50P4, SLC16A9",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:59580135
rs79538733-<b>A</b>,5 x 10-7,(between families),NR,'-,5.015 unit increase,'-,"LINC02651, RPL5P26",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:69741141
rs190780914-<b>T</b>,5 x 10-8,(between families),NR,'-,5.452 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:83190139
rs73320584-<b>A</b>,7 x 10-7,(between families),NR,'-,4.96 unit decrease,'-,LINC02653,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:90473719
rs73310256-<b>T</b>,3 x 10-7,(between families),NR,'-,5.123 unit decrease,'-,"HTR7, LINC02653",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:90679092
rs117792039-<b>A</b>,2 x 10-7,(between families),NR,'-,5.158 unit increase,'-,SORCS3,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,10:105050857
rs188188267-<b>T</b>,5 x 10-7,(between families),NR,'-,5.024 unit increase,'-,"LINC02752, ZBED5-AS1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:10951303
rs117250828-<b>A</b>,3 x 10-7,(between families),NR,'-,5.134 unit decrease,'-,MICAL2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:12171710
rs115514216-<b>T</b>,3 x 10-9,(between families),NR,'-,5.958 unit decrease,'-,LINC02699,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:25871035
rs139675748-<b>T</b>,2 x 10-9,(between families),NR,'-,6.022 unit increase,'-,"HSD17B12, MIR129-2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:43611658
rs56146971-<b>A</b>,8 x 10-7,(between families),NR,'-,4.941 unit decrease,'-,"CCDC88C, PPP4R3A",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:91453757
rs117161928-<b>A</b>,1 x 10-7,(between families),NR,'-,5.294 unit decrease,'-,"FAM181A-AS1, FAM181A",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:93925359
rs57602116-<b>A</b>,3 x 10-7,(between families),NR,'-,5.136 unit increase,'-,RPL15P2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:94816883
rs150511909-<b>T</b>,4 x 10-9,(between families),NR,'-,5.892 unit decrease,'-,LINC02325,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,14:97442349
rs8033755-<b>A</b>,1 x 10-7,(between families),NR,'-,5.299 unit decrease,'-,HERC2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:28136400
rs149916999-<b>A</b>,1 x 10-7,(between families),NR,'-,5.334 unit increase,'-,TRPM1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:31116066
rs142200609-<b>T</b>,3 x 10-7,(within families),NR,'-,5.118 unit increase,'-,THSD4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:71449755
rs62013859-<b>T</b>,4 x 10-7,(between families),NR,'-,5.094 unit increase,'-,AGBL1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,15:86283609
rs189794920-<b>A</b>,6 x 10-7,(between families),NR,'-,4.999 unit decrease,'-,"PDPK1, PDPK2P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:2608384
rs118099348-<b>T</b>,1 x 10-9,(between families),NR,'-,6.05 unit increase,'-,TMC5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:19423707
rs145049847-<b>C</b>,8 x 10-9,(between families),NR,'-,5.771 unit decrease,'-,SDR42E2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:22190681
rs77414823-<b>T</b>,2 x 10-7,(between families),NR,'-,5.24 unit decrease,'-,"NCOA5LP, RPL34P29",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:49948846
rs150252171-<b>A</b>,2 x 10-7,(between families),NR,'-,5.224 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:62536445
rs79358781-<b>A</b>,1 x 10-7,(between families),NR,'-,5.268 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:80264653
rs137967137-<b>A</b>,1 x 10-7,(between families),NR,'-,5.331 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:80433296
rs77894924-<b>A</b>,2 x 10-7,(between families),NR,'-,5.208 unit increase,'-,CDH13,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:83521415
rs78910009-<b>T</b>,5 x 10-7,(between families),NR,'-,5.024 unit increase,'-,"FENDRR, LINC00917",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:86374577
rs111816999-<b>T</b>,7 x 10-7,(between families),NR,'-,4.967 unit decrease,'-,ALOX12-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:6979124
rs139471609-<b>A</b>,6 x 10-8,(between families),NR,'-,5.433 unit increase,'-,COX10-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:13791198
rs56176358-<b>T</b>,6 x 10-7,(between families),NR,'-,5.004 unit increase,'-,"MPP3, CD300LG",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:43843285
rs79480822-<b>T</b>,7 x 10-7,(between families),NR,'-,4.952 unit increase,'-,DCAF7,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:63576864
rs34111070-<b>T</b>,1 x 10-6,(between families),NR,'-,4.892 unit decrease,'-,STRADA,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:63716838
rs71377714-<b>T</b>,3 x 10-7,(between families),NR,'-,5.128 unit increase,'-,TCAM1P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:63852268
rs16973424-<b>A</b>,3 x 10-7,(between families),NR,'-,5.144 unit decrease,'-,ABCA8,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:68907860
rs149464898-<b>T</b>,3 x 10-7,(between families),NR,'-,5.136 unit increase,'-,"RPL12P37, RPTOR",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,17:80973533
rs62076840-<b>A</b>,8 x 10-7,(between families),NR,'-,4.927 unit increase,'-,L3MBTL4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:5958062
rs183708309-<b>T</b>,6 x 10-7,(between families),NR,'-,5.001 unit decrease,'-,LAMA1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:6974460
rs142176337-<b>T</b>,8 x 10-8,(between families),NR,'-,5.36 unit decrease,'-,"NFE2L3P1, PMAIP1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:59914255
rs138098194-<b>A</b>,4 x 10-7,(between families),NR,'-,5.084 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,18:66840171
rs148273964-<b>A</b>,8 x 10-7,(between families),NR,'-,4.936 unit decrease,'-,"RAB3D, TSPAN16",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:11323255
rs9304861-<b>A</b>,4 x 10-7,(between families),NR,'-,5.082 unit decrease,'-,"LINC01801, ZNF599",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:34780984
rs2927694-<b>C</b>,8 x 10-7,(between families),NR,'-,4.928 unit increase,'-,ZNF813,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:53470531
rs113118940-<b>T</b>,1 x 10-8,(between families),NR,'-,5.733 unit increase,'-,"CST8, CST13P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:23514209
rs147525344-<b>T</b>,5 x 10-9,(between families),NR,'-,5.856 unit decrease,'-,"CSTP2, CST1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:23762403
rs115786578-<b>A</b>,6 x 10-7,(between families),NR,'-,4.992 unit increase,'-,"RPS2P1, ASIP",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:34149795
rs147775533-<b>T</b>,6 x 10-7,(between families),NR,'-,4.993 unit increase,'-,"LINC01271, RN7SL636P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,20:50382958
rs2409317-<b>T</b>,4 x 10-7,(between families),NR,'-,5.088 unit decrease,'-,U6,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:28702102
rs147991290-<b>T</b>,3 x 10-9,(between families),NR,'-,5.943 unit decrease,'-,SYNJ1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:32716160
rs189677472-<b>A</b>,1 x 10-7,(between families),NR,'-,5.324 unit decrease,'-,"PDE9A, LINC01671",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:42641102
rs857551-<b>A</b>,7 x 10-7,(between families),NR,'-,4.949 unit increase,'-,"LINC01679, SIK1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:43410112
rs79985863-<b>T</b>,8 x 10-7,(between families),NR,'-,4.925 unit increase,'-,COL18A1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,21:45486796
rs141503849-<b>T</b>,5 x 10-7,(between families),NR,'-,5.042 unit increase,'-,SEPTIN5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:19704370
rs117496069-<b>T</b>,5 x 10-7,(between families),NR,'-,5.043 unit increase,'-,"TEX33, TST",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:37009621
rs150927461-<b>T</b>,4 x 10-7,(between families),NR,'-,5.08 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:48098836
rs4420638-<b>A</b>,2 x 10-16,(between families),NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:44919689
rs17639982-<b>C</b>,8 x 10-9,(between families),NR,'-,5.774 unit decrease,'-,LINC01117,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:176778182
rs1347297-<b>T</b>,5 x 10-8,(within families),NR,'-,5.469 unit increase,'-,OSBPL6,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:178380259
rs6927354-<b>T</b>,5 x 10-8,(between families),NR,'-,5.44 unit decrease,'-,F13A1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:6316080
rs16887604-<b>T</b>,3 x 10-8,(between families),NR,'-,5.544 unit increase,'-,RNU6-261P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:76439941
rs183826639-<b>T</b>,1 x 10-12,(within families),NR,'-,7.098 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:75905029
rs11961710-<b>A</b>,7 x 10-7,(between families),NR,'-,4.95 unit increase,'-,LINC02518,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:113399037
rs190204665-<b>T</b>,1 x 10-7,(between families),NR,'-,5.259 unit increase,'-,"F2R, F2RL1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:76793184
rs116300850-<b>T</b>,7 x 10-7,(between families),NR,'-,4.963 unit increase,'-,WDR41,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:77556409
rs17069431-<b>T</b>,6 x 10-7,(between families),NR,'-,4.994 unit increase,'-,FILNC1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:139874946
rs34804891-<b>T</b>,6 x 10-8,(between families),NR,'-,5.425 unit increase,'-,SNX9,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:157844754
rs9293513-<b>A</b>,5 x 10-7,(between families),NR,'-,5.035 unit increase,'-,MEF2C-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:89337967
rs77780208-<b>A</b>,9 x 10-7,(between families),NR,'-,4.917 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:105543433
rs4705644-<b>A</b>,9 x 10-7,(between families),NR,'-,4.905 unit decrease,'-,KCNN2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:114241467
rs56357845-<b>A</b>,7 x 10-7,(between families),NR,'-,4.958 unit increase,'-,CHN2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:29210652
rs190338033-<b>A</b>,2 x 10-7,(between families),NR,'-,5.167 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:119985478
rs7702102-<b>A</b>,5 x 10-7,(between families),NR,'-,5.034 unit decrease,'-,"ZCCHC10, Y_RNA",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:132994460
rs188951355-<b>T</b>,9 x 10-7,(between families),NR,'-,4.911 unit increase,'-,RNU7-156P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:143553786
rs2962508-<b>T</b>,4 x 10-8,(between families),NR,'-,5.499 unit increase,'-,LARS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:146158952
rs186127414-<b>A</b>,2 x 10-7,(between families),NR,'-,5.17 unit increase,'-,G3BP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:151801825
rs143766413-<b>C</b>,5 x 10-7,(between families),NR,'-,5.024 unit increase,'-,"HAND1, CIR1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:154557919
rs61142792-<b>T</b>,4 x 10-7,(between families),NR,'-,5.083 unit increase,'-,"TMED9, FAM193B-DT",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:177556462
rs188911996-<b>A</b>,2 x 10-8,(between families),NR,'-,5.578 unit increase,'-,KDM1B,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:18173684
rs62400067-<b>T</b>,4 x 10-7,(between families),NR,'-,5.092 unit increase,'-,CDKAL1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:20592753
rs543844-<b>A</b>,1 x 10-7,(between families),NR,'-,5.323 unit decrease,'-,CDC5L,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:44457063
rs61510607-<b>T</b>,5 x 10-7,(between families),NR,'-,5.012 unit decrease,'-,"EN2, BLACE",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:155432020
rs188420713-<b>T</b>,2 x 10-10,(between families),NR,'-,6.328 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:37276671
rs4557697-<b>A</b>,8 x 10-9,(between families),NR,'-,5.761 unit decrease,'-,NKAIN3,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:62931072
rs6908580-<b>T</b>,3 x 10-7,(between families),NR,'-,5.099 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:91867653
rs182838111-<b>T</b>,2 x 10-7,(between families),NR,'-,5.233 unit increase,'-,PPP1R42,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:66977235
rs847012-<b>C</b>,3 x 10-7,(within families),NR,'-,5.096 unit increase,'-,"SOBP, SCML4",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:107689329
rs11742761-<b>A</b>,3 x 10-7,(between families),NR,'-,5.107 unit decrease,'-,FGF10,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:44301065
rs17062407-<b>A</b>,2 x 10-7,(between families),NR,'-,5.2 unit increase,'-,EYA4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:133383011
rs4896030-<b>A</b>,6 x 10-7,(between families),NR,'-,4.988 unit increase,'-,SGK1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:134242215
rs186292051-<b>T</b>,2 x 10-7,(between families),NR,'-,5.17 unit increase,'-,MEF2C-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:89030013
rs141568462-<b>T</b>,2 x 10-7,(between families),NR,'-,5.183 unit decrease,'-,MEF2C-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:89179048
rs116886320-<b>A</b>,3 x 10-7,(between families),NR,'-,5.116 unit increase,'-,TULP4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:158508928
rs183600932-<b>T</b>,1 x 10-8,(between families),NR,'-,5.706 unit increase,'-,PHF14,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:11018769
rs12374991-<b>T</b>,5 x 10-7,(between families),NR,'-,5.046 unit increase,'-,"NPM1P11, PHF14",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:11188315
rs77296444-<b>A</b>,2 x 10-7,(between families),NR,'-,5.183 unit increase,'-,"LINC02214, RPS17P2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:116719736
rs138090874-<b>A</b>,4 x 10-8,(between families),NR,'-,5.511 unit increase,'-,NEUROD6,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:31262777
rs11773349-<b>A</b>,6 x 10-7,(between families),NR,'-,4.991 unit decrease,'-,"MTDHP1, ZNF117",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:64946786
rs118071777-<b>A</b>,7 x 10-7,(between families),NR,'-,4.951 unit increase,'-,"EEF1A1P28, PQLC1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:88614935
rs75290158-<b>A</b>,8 x 10-7,(between families),NR,'-,4.943 unit increase,'-,DLX5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:97023147
rs62496419-<b>A</b>,5 x 10-7,(between families),NR,'-,5.027 unit increase,'-,AP1S2P1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:97350347
rs12706411-<b>T</b>,8 x 10-7,(between families),NR,'-,4.928 unit increase,'-,CADPS2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:122425165
rs71574743-<b>T</b>,1 x 10-7,(between families),NR,'-,5.329 unit increase,'-,IQUB,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:123404453
rs116932763-<b>A</b>,2 x 10-7,(between families),NR,'-,5.171 unit increase,'-,ZNF862,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:149851920
rs191603973-<b>C</b>,7 x 10-7,(between families),NR,'-,4.962 unit decrease,'-,INSIG1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:155309976
rs185968827-<b>A</b>,2 x 10-7,(between families),NR,'-,5.158 unit increase,'-,DST,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:56843712
rs140996952-<b>T</b>,9 x 10-7,(between families),NR,'-,4.912 unit decrease,'-,KHDRBS2-OT1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:61662196
rs36099249-<b>T</b>,7 x 10-8,(between families),NR,'-,5.39 unit decrease,'-,COL12A1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:75180632
rs191342285-<b>A</b>,2 x 10-7,(between families),NR,'-,5.233 unit decrease,'-,"C8orf44-SGK3, SGK3",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:66786417
rs140633572-<b>A</b>,5 x 10-7,(between families),NR,'-,5.03 unit decrease,'-,LINC02532,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,6:106832060
rs192093332-<b>A</b>,2 x 10-7,(between families),NR,'-,5.179 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:83267319
rs76070545-<b>T</b>,1 x 10-7,(between families),NR,'-,5.262 unit decrease,'-,"FZD6, CTHRC1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:103359219
rs11062987-<b>A</b>,7 x 10-7,(between families),NR,'-,4.964 unit decrease,'-,HSPA8P5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:4063960
rs116938548-<b>T</b>,2 x 10-7,(between families),NR,'-,5.24 unit increase,'-,"GAU1, NDUFA9",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:4699085
rs3794318-<b>A</b>,5 x 10-7,(between families),NR,'-,5.043 unit decrease,'-,AICDA,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:8605947
rs117154046-<b>A</b>,6 x 10-7,(between families),NR,'-,5.001 unit increase,'-,OVCH1-AS1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:29389844
rs79335261-<b>T</b>,7 x 10-8,(between families),NR,'-,5.399 unit increase,'-,"PA2G4, ERBB3",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:56103857
rs187293782-<b>T</b>,7 x 10-9,(between families),NR,'-,5.78 unit increase,'-,SNORA70,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:75763576
rs190909796-<b>T</b>,5 x 10-7,(between families),NR,'-,5.038 unit increase,'-,"RNU7-106P, OTOGL",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:80080902
rs117483990-<b>T</b>,1 x 10-9,(between families),NR,'-,6.07 unit decrease,'-,"BRWD1P2, RNU6-148P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:89830937
rs185806653-<b>A</b>,8 x 10-7,(between families),NR,'-,4.932 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:127489593
rs144288546-<b>A</b>,2 x 10-8,(between families),NR,'-,5.634 unit increase,'-,TMEM132C,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,12:128585137
rs61960582-<b>A</b>,8 x 10-7,(between families),NR,'-,4.927 unit increase,'-,"MRPS31P4, LINC00345",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:52557892
rs61956285-<b>T</b>,1 x 10-6,(between families),NR,'-,4.902 unit increase,'-,RABEPKP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:71297394
rs189465671-<b>T</b>,2 x 10-7,(between families),NR,'-,5.246 unit increase,'-,"ARF4P4, LINC00377",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:80962230
rs9546312-<b>T</b>,9 x 10-7,(between families),NR,'-,4.92 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:83172816
rs6491411-<b>A</b>,9 x 10-7,(between families),NR,'-,4.911 unit decrease,'-,FARP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:98252314
rs117969561-<b>T</b>,9 x 10-7,(between families),NR,'-,4.909 unit increase,'-,GGACT,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:100558935
rs115694210-<b>A</b>,1 x 10-7,(between families),NR,'-,5.336 unit decrease,'-,LINC00343,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:105740230
rs150813880-<b>A</b>,1 x 10-6,(between families),NR,'-,4.895 unit increase,'-,MYO16,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:109140829
rs3850930-<b>A</b>,6 x 10-7,(between families),NR,'-,4.991 unit increase,'-,TRIM51CP,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:48948392
rs2313143-<b>A</b>,2 x 10-7,(between families),NR,'-,5.224 unit increase,'-,GTF2IP11,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:50114007
rs141218484-<b>T</b>,9 x 10-8,(between families),NR,'-,5.336 unit decrease,'-,AHNAK,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:62481191
rs117983694-<b>A</b>,7 x 10-8,(between families),NR,'-,5.399 unit decrease,'-,CCDC89,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:85685837
rs3911569-<b>A</b>,3 x 10-7,(between families),NR,'-,5.145 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:95362871
rs188168326-<b>T</b>,9 x 10-8,(between families),NR,'-,5.352 unit increase,'-,"LINC02763, LINC02762",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:112392241
rs11220271-<b>A</b>,5 x 10-7,(between families),NR,'-,5.033 unit increase,'-,DDX25,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,11:125907477
rs76930906-<b>A</b>,3 x 10-11,(between families),NR,'-,6.631 unit decrease,'-,LINC02268,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:174174724
rs75718659-<b>T</b>,4 x 10-7,(between families),NR,'-,5.052 unit increase,'-,"MRPS36P2, FAT1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:186821932
rs11749176-<b>A</b>,2 x 10-7,(between families),NR,'-,5.218 unit increase,'-,RNU6-381P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,5:44145829
rs79781504-<b>A</b>,2 x 10-8,(between families),NR,'-,5.603 unit decrease,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,8:83837822
rs146168866-<b>A</b>,9 x 10-8,(within families),NR,'-,5.348 unit increase,'-,LAMP1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,13:113312674
rs75885813-<b>A</b>,4 x 10-10,(within families),NR,'-,6.258 unit decrease,'-,RBFOX1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,16:7091262
rs56131196-<b>A</b>,3 x 10-24,(within families),NR,'-,10.157 unit increase,'-,"APOC1, APOC1P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,19:44919589
rs144191434-<b>A</b>,2 x 10-7,(between families),NR,'-,5.189 unit increase,'-,ARVCF,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,22:20016577
rs2445130-<b>A</b>,8 x 10-7,(between families),NR,'-,4.933 unit increase,'-,HSPG2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:21911229
rs56039743-<b>T</b>,3 x 10-7,(between families),NR,'-,5.112 unit decrease,'-,UBXN11,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:26294315
rs12041233-<b>A</b>,6 x 10-9,(between families),NR,'-,5.825 unit increase,'-,"RPS29P6, RNA5SP43",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:37287106
rs182798940-<b>T</b>,7 x 10-7,(between families),NR,'-,4.971 unit increase,'-,"HYI, SZT2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:43453815
rs143083071-<b>A</b>,1 x 10-8,(between families),NR,'-,5.734 unit increase,'-,PLPPR4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:99242198
rs11588387-<b>T</b>,1 x 10-6,(between families),NR,'-,4.893 unit increase,'-,AHCYL1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:109995242
rs79036927-<b>A</b>,1 x 10-6,(between families),NR,'-,4.896 unit decrease,'-,NMNAT1P2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:164275038
rs181424343-<b>A</b>,8 x 10-8,(within families),NR,'-,5.375 unit increase,'-,TGFB2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:218421142
rs36060340-<b>A</b>,7 x 10-7,(between families),NR,'-,4.975 unit increase,'-,RNU4-77P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,1:233487182
rs148822902-<b>C</b>,1 x 10-6,(between families),NR,'-,4.901 unit decrease,'-,RNU6-649P,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:4989398
rs75009721-<b>T</b>,2 x 10-8,(between families),NR,'-,5.66 unit increase,'-,ITSN2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:24254185
rs183562580-<b>A</b>,6 x 10-7,(within families),NR,'-,4.996 unit decrease,'-,OTOF,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:26471784
rs186552003-<b>A</b>,8 x 10-7,(within families),NR,'-,4.943 unit increase,'-,MSH2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:47443115
rs186166314-<b>A</b>,9 x 10-8,(between families),NR,'-,5.355 unit decrease,'-,"PPP1R21-DT, FOXN2",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:48435898
rs191975838-<b>T</b>,5 x 10-8,(between families),NR,'-,5.467 unit decrease,'-,CCDC12P1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:51894529
rs115291397-<b>A</b>,2 x 10-9,(between families),NR,'-,6.033 unit decrease,'-,LINC01185,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:60832908
rs182928794-<b>T</b>,8 x 10-7,(between families),NR,'-,4.927 unit increase,'-,"RAB1A, SNORA74",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:65140292
rs140661185-<b>A</b>,1 x 10-6,(between families),NR,'-,4.893 unit decrease,'-,SPRED2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:65382753
rs2970989-<b>T</b>,4 x 10-8,(between families),NR,'-,5.479 unit decrease,'-,LINC01868,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:100697607
rs186971130-<b>A</b>,1 x 10-7,(between families),NR,'-,5.311 unit increase,'-,LINC01965,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:104003000
rs181319480-<b>T</b>,4 x 10-7,(between families),NR,'-,5.086 unit decrease,'-,CFAP20DC,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:58807331
rs7609954-<b>T</b>,4 x 10-8,(between families),NR,'-,5.492 unit increase,'-,PTPRG,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:61650482
rs58920042-<b>T</b>,8 x 10-7,(between families),NR,'-,4.931 unit increase,'-,LINC00877,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:71931938
rs142710255-<b>A</b>,3 x 10-7,(between families),NR,'-,5.135 unit decrease,'-,LINC02008,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:82012036
rs190500289-<b>A</b>,8 x 10-7,(between families),NR,'-,4.934 unit increase,'-,INHCAP,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:133712051
rs28582745-<b>A</b>,9 x 10-7,(between families),NR,'-,4.912 unit increase,'-,"RNU6-637P, TERC",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:169741537
rs189421534-<b>A</b>,2 x 10-8,(between families),NR,'-,5.646 unit increase,'-,"SNRPCP13, ENPP7P11",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:9590409
rs147028191-<b>A</b>,1 x 10-9,(between families),NR,'-,6.062 unit increase,'-,GABRA2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:46412095
rs183757472-<b>A</b>,1 x 10-9,(between families),NR,'-,6.062 unit decrease,'-,RAC1P2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:46689227
rs115809613-<b>A</b>,1 x 10-8,(between families),NR,'-,5.688 unit decrease,'-,"NDUFS5P4, RNU7-149P",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:98971324
rs115641191-<b>T</b>,2 x 10-7,(between families),NR,'-,5.237 unit increase,'-,BANK1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:102133052
rs72728723-<b>A</b>,2 x 10-7,(between families),NR,'-,5.201 unit increase,'-,SETD7,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:139599374
rs143638193-<b>T</b>,4 x 10-9,(between families),NR,'-,5.895 unit increase,'-,"RN7SL152P, TBC1D9",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:140579551
rs3931397-<b>T</b>,6 x 10-7,(between families),NR,'-,4.984 unit increase,'-,NR3C2,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:148158346
rs13133687-<b>A</b>,7 x 10-7,(between families),NR,'-,4.966 unit increase,'-,ANXA10,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:168062923
rs9994441-<b>C</b>,6 x 10-7,(between families),NR,'-,4.99 unit increase,'-,SH3RF1,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,4:169173411
rs982100-<b>A</b>,4 x 10-7,(between families),NR,'-,5.08 unit increase,'-,DDX18,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:117717968
rs140009341-<b>A</b>,2 x 10-7,(between families),NR,'-,5.186 unit increase,'-,RN7SKP141,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:136433314
rs116677506-<b>A</b>,7 x 10-7,(between families),NR,'-,4.955 unit decrease,'-,"CTAGE14P, B3GALT1-AS1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:167746937
rs75286889-<b>A</b>,7 x 10-8,(between families),NR,'-,5.379 unit increase,'-,"Y_RNA, LRRC2P1",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:174268728
rs1443024-<b>A</b>,6 x 10-7,(between families),NR,'-,4.999 unit increase,'-,"FAM228B, ZNF804A",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:184511570
rs187402274-<b>C</b>,1 x 10-7,(between families),NR,'-,5.264 unit increase,'-,'-,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:220047457
rs59904869-<b>C</b>,4 x 10-7,(between families),NR,'-,5.054 unit decrease,'-,COL4A4,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,2:227138926
rs148471206-<b>T</b>,5 x 10-7,(between families),NR,'-,5.023 unit increase,'-,"RANP7, SALL4P5",Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:22933695
rs7374058-<b>T</b>,3 x 10-7,(between families),NR,'-,5.137 unit increase,'-,HMGB3P12,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,3:26205084
rs75002042-<b>T</b>,5 x 10-8,(adjusted for APOE),0.92,1.59,'-,[1.33-1.85],FBXL7,Alzheimer's disease (late onset),Alzheimer's disease,GCST002983,5:15669858
rs7431992-<b>A</b>,2 x 10-6,(adjusted for APOE),0.1,1.46,'-,[1.25-1.71],CACNA2D3,Alzheimer's disease (late onset),Alzheimer's disease,GCST002983,3:54319213
rs394819-<b>T</b>,8 x 10-11,,0.07,1.89,'-,[1.55-2.3],TOMM40,Alzheimer's disease (late onset),Alzheimer's disease,GCST002983,19:44901322
rs271066-<b>?</b>,3 x 10-6,,NR,'-,0.6491 unit decrease,'-,'-,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,3:6336008
rs704454-<b>?</b>,3 x 10-6,,NR,'-,0.5038 unit increase,'-,ADAMTS9-AS2,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,3:64941350
rs1466662-<b>?</b>,5 x 10-7,,NR,'-,0.9595 unit decrease,'-,DCHS2,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,4:154426241
rs2034764-<b>?</b>,4 x 10-6,,NR,'-,0.879 unit increase,'-,PUM3,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,9:2742771
rs17429217-<b>?</b>,3 x 10-6,,NR,'-,2.436 unit increase,'-,HRK,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,12:116857528
rs3743162-<b>?</b>,9 x 10-6,,NR,'-,0.8828 unit decrease,'-,SLC28A1,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,15:84887738
rs4420638-<b>?</b>,1 x 10-12,,NR,'-,2.2018 unit increase,'-,"APOC1, APOC1P1",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,19:44919689
rs10517270-<b>?</b>,4 x 10-6,,NR,'-,3.3056 unit decrease,'-,'-,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,4:33201518
rs2104362-<b>?</b>,7 x 10-6,,NR,'-,0.8441 unit increase,'-,"LINC01016, MLN",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,6:33857581
rs12933233-<b>?</b>,8 x 10-6,,NR,'-,0.7869 unit increase,'-,'-,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,Mapping not available
rs1037757-<b>?</b>,8 x 10-6,,NR,'-,4.5618 unit decrease,'-,"OACYLP, SEC11C",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,18:59084822
rs3743162-<b>?</b>,9 x 10-6,,NR,'-,0.88 unit decrease,'-,SLC28A1,Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,15:84887738
rs12816806-<b>?</b>,9 x 10-6,,NR,'-,0.8384 unit increase,'-,"RBM19, DYNLL1P4",Alzheimer's disease (age of onset),"Alzheimer's disease, age at onset",GCST001280,12:113810386
rs4937314-<b>C</b>,7 x 10-6,,0.17,'-,'-,'-,LINC02098,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,11:128319206
rs11848070-<b>C</b>,6 x 10-6,,0.25,'-,'-,'-,PCNX1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,14:71040884
rs6085820-<b>A</b>,9 x 10-6,,0.09,'-,'-,'-,'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,20:6999988
rs4145462-<b>T</b>,1 x 10-6,,0.05,'-,'-,'-,MPZL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,1:167749262
rs41458646-<b>G</b>,8 x 10-6,,0.17,'-,'-,'-,'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,2:23016071
rs6738181-<b>A</b>,5 x 10-6,,0.19,'-,'-,'-,DSTNP5,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,2:204263298
rs7638995-<b>A</b>,2 x 10-6,,0.11,'-,'-,'-,"FRMD4B, LMOD3",Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,3:69124224
rs11983798-<b>T</b>,1 x 10-6,,0.08,'-,'-,'-,ATXN7L1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,7:105640741
rs6468852-<b>G</b>,1 x 10-6,,0.13,'-,'-,'-,MAILR,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,8:102963761
rs9969729-<b>A</b>,2 x 10-6,,0.08,'-,'-,'-,SLC25A6P5,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,9:105869669
rs12361953-<b>C</b>,8 x 10-7,,0.15,'-,'-,'-,LUZP2,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,11:24589584
rs472926-<b>C</b>,3 x 10-6,,0.15,'-,'-,'-,CDON,Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,11:126035363
rs17767225-<b>T</b>,8 x 10-6,,0.2,'-,'-,'-,"FOXN3, PCNX1",Alzheimer's disease (late onset),Alzheimer's disease,GCST001658,14:71199580
rs2075650-<b>G</b>,9 x 10-116,,'-,4.48,'-,[NR],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST002422,19:44892362
rs249153-<b>C</b>,4 x 10-7,,'-,1.41,'-,[NR],NDUFA12,Alzheimer's disease,Alzheimer's disease,GCST002422,12:94930613
rs13178362-<b>T</b>,7 x 10-7,,'-,1.3333,'-,[NR],HPRT1P2,Alzheimer's disease,Alzheimer's disease,GCST002422,5:30178906
rs474951-<b>T</b>,1 x 10-6,,'-,1.2658,'-,[NR],"MS4A2, MS4A3",Alzheimer's disease,Alzheimer's disease,GCST002422,11:60071148
rs1552244-<b>A</b>,2 x 10-6,,'-,1.32,'-,[NR],"FANCD2OS, FANCD2",Alzheimer's disease,Alzheimer's disease,GCST002422,3:10093893
rs157580-<b>?</b>,1 x 10-40,,NR,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000313,19:44892009
rs4298437-<b>A</b>,2 x 10-6,,0.26,'-,'-,'-,RELN,Alzheimer's disease,Alzheimer's disease,GCST000676,7:103985430
rs11782819-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,LINCR-0001,Alzheimer's disease,Alzheimer's disease,GCST000676,8:10477271
APOE-<b>E3</b>,4 x 10-9,,NR,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST001372,Mapping not available
APOE-<b>E4</b>,7 x 10-16,,NR,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST001372,Mapping not available
rs2243170-<b>?</b>,7 x 10-7,,'-,1.65,'-,[NR],IL19,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,1:206836565
rs7588354-<b>?</b>,1 x 10-6,,'-,1.5151515,'-,[NR],"NCKAP5, RN7SKP93",Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,2:133575190
rs2400749-<b>?</b>,2 x 10-6,,'-,1.3888888,'-,[NR],CCDC85C,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,14:99570681
rs840163-<b>?</b>,2 x 10-6,,'-,1.4,'-,[NR],SDR9C7,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,12:56926927
rs4474465-<b>?</b>,3 x 10-6,,'-,1.44,'-,[NR],NARS2,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,11:78493334
rs6695033-<b>?</b>,3 x 10-6,,'-,2.71,'-,[NR],ALDH4A1,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,1:18875425
rs11601321-<b>?</b>,8 x 10-6,,'-,1.63,'-,[NR],PKNOX2,Alzheimer's disease (survival time),"Alzheimer's disease, survival time",GCST002775,11:125323700
rs4420638-<b>?</b>,1 x 10-39,,NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST000121,19:44919689
rs4509693-<b>?</b>,6 x 10-6,,0.18,'-,'-,'-,PAX2,Alzheimer's disease,Alzheimer's disease,GCST000484,10:100741814
rs7539409-<b>?</b>,1 x 10-6,,0.18,'-,'-,'-,LINC01725,Alzheimer's disease,Alzheimer's disease,GCST000484,1:83789052
rs9390537-<b>?</b>,8 x 10-6,,0.22,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST000484,6:148102235
rs690705-<b>?</b>,6 x 10-7,,0.25,'-,'-,'-,VDAC1P12,Alzheimer's disease,Alzheimer's disease,GCST000484,13:34080781
rs2075650-<b>?</b>,3 x 10-11,,0.15,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000484,19:44892362
rs2573905-<b>?</b>,2 x 10-7,,0.46,1.29,'-,[1.17-1.42],PCDH11X,Alzheimer's disease,Alzheimer's disease,GCST000315,X:92147221
rs6859-<b>A</b>,6 x 10-14,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST000237,19:44878777
rs727153-<b>C</b>,3 x 10-6,,0.52,1.63,'-,[1.37-1.95],LRAT,Alzheimer's disease,Alzheimer's disease,GCST000237,4:154733269
rs4420638-<b>?</b>,1 x 10-39,,NR,4.01,'-,[NR],"APOC1, APOC1P1",Alzheimer's disease (late onset),Alzheimer's disease,GCST000018,19:44919689
rs4676049-<b>A</b>,4 x 10-8,,0.08,1.76,'-,[1.44-2.15],EDAR,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,2:109018801
rs2075650-<b>G</b>,5 x 10-36,,0.2,2.94,'-,[2.48-3.47],TOMM40,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,19:44892362
rs6859-<b>A</b>,1 x 10-7,,0.46,1.41,'-,[1.24-1.60],NECTIN2,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,19:44878777
rs11754661-<b>A</b>,2 x 10-10,,0.07,2.1,'-,[1.67-2.64],MTHFD1L,Alzheimer's disease (late onset),Alzheimer's disease,GCST000808,6:150885942
rs17006206-<b>G</b>,2 x 10-6,,0.1,2.05,'-,[1.52-2.76],SLC4A1AP,Alzheimer's disease,Alzheimer's disease,GCST001342,2:27684606
rs956225-<b>A</b>,9 x 10-6,,NR,3.33,'-,[1.96-5.56],HAS2-AS1,Alzheimer's disease,Alzheimer's disease,GCST001342,8:121897448
rs340849-<b>?</b>,8 x 10-6,,NR,1.69,'-,[1.33-2.13],PROX1-AS1,Alzheimer's disease,Alzheimer's disease,GCST001342,1:213944747
rs11889338-<b>A</b>,9 x 10-6,,0.26,1.55,'-,[1.28-1.88],ZFYVE9P2,Alzheimer's disease,Alzheimer's disease,GCST001342,2:17246318
rs2221154-<b>?</b>,3 x 10-6,,NR,1.75,'-,[1.39-2.22],RBMS3,Alzheimer's disease,Alzheimer's disease,GCST001342,3:28887369
rs1923775-<b>T</b>,6 x 10-6,,0.25,1.6,'-,[1.30-1.95],"POLN, HAUS3",Alzheimer's disease,Alzheimer's disease,GCST001342,4:2101369
rs10273775-<b>G</b>,9 x 10-6,,0.42,1.52,'-,[1.27-1.84],CNTNAP2,Alzheimer's disease,Alzheimer's disease,GCST001342,7:147200311
rs10850408-<b>?</b>,9 x 10-7,,NR,1.59,'-,[1.32-1.92],'-,Alzheimer's disease,Alzheimer's disease,GCST001342,12:114942588
rs912330-<b>?</b>,4 x 10-6,,NR,1.85,'-,[1.43-2.44],STK24,Alzheimer's disease,Alzheimer's disease,GCST001342,13:98479040
rs6859-<b>A</b>,5 x 10-7,,NR,1.58,'-,[NR],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST001342,19:44878777
rs17511627-<b>C</b>,5 x 10-6,,0.17,1.75,'-,[1.37-2.22],"ATP8A2P3, RNF6",Alzheimer's disease,Alzheimer's disease,GCST001342,13:26150190
rs12989701-<b>?</b>,3 x 10-10,,NR,1.23,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST000986,2:127130409
rs744373-<b>?</b>,1 x 10-10,,NR,1.19,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST000986,2:127137039
rs2061333-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,"ZNF225, ZNF224",Alzheimer's disease,Alzheimer's disease,GCST000310,19:44110055
rs11610206-<b>?</b>,3 x 10-7,,NR,'-,'-,'-,"PCED1B, PPIAP45",Alzheimer's disease,Alzheimer's disease,GCST000310,12:47245743
rs12044355-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,"TSNAX-DISC1, DISC1",Alzheimer's disease,Alzheimer's disease,GCST000310,1:231708601
rs11023139-<b>?</b>,7 x 10-11,,0.05,'-,0.31 unit decrease,'-,SPON1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,11:14202800
rs326946-<b>?</b>,7 x 10-7,,0.17,'-,0.16 unit decrease,'-,ARHGAP20,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,11:110628530
rs147845115-<b>?</b>,3 x 10-7,,0.03,'-,0.29 unit decrease,'-,SLC4A8,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,12:51484976
rs61144803-<b>?</b>,5 x 10-8,,0.04,'-,0.16 unit decrease,'-,CRADD,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,12:93841389
rs1399439-<b>?</b>,4 x 10-7,,0.04,'-,0.2 unit decrease,'-,ANO4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,12:100827461
rs143258881-<b>?</b>,7 x 10-8,,0.03,'-,0.29 unit decrease,'-,GPC6,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,13:93293605
rs17393344-<b>?</b>,2 x 10-8,,0.06,'-,0.26 unit decrease,'-,MYO16,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,13:108821598
rs115102486-<b>?</b>,2 x 10-8,,0.03,'-,0.31 unit decrease,'-,CLMN,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,14:95298227
rs74006954-<b>?</b>,3 x 10-7,,0.03,'-,0.28 unit decrease,'-,GABRG3,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,15:27467498
rs17301739-<b>?</b>,2 x 10-6,,0.07,'-,0.28 unit decrease,'-,"LIPC-AS1, LIPC, ALDH1A2",Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,15:58438440
rs8045064-<b>?</b>,4 x 10-8,,0.05,'-,0.21 unit decrease,'-,"LINC01567, TNRC6A",Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,16:24664268
rs9934540-<b>?</b>,4 x 10-7,,0.03,'-,0.25 unit decrease,'-,VAT1L,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,16:77842866
rs4794202-<b>?</b>,8 x 10-8,,0.08,'-,0.19 unit decrease,'-,SP6,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,17:47853173
rs117964204-<b>?</b>,1 x 10-9,,0.04,'-,0.28 unit decrease,'-,CACNA1G,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,17:50614721
rs72832584-<b>?</b>,1 x 10-11,,0.05,'-,0.3 unit decrease,'-,BCAS3,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,17:61215075
rs7245858-<b>?</b>,2 x 10-6,,0.04,'-,0.28 unit decrease,'-,PPIAP59,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,19:50927340
rs34972666-<b>?</b>,3 x 10-8,,0.11,'-,0.23 unit decrease,'-,TGM6,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,20:2404326
rs75617873-<b>?</b>,5 x 10-7,,0.03,'-,0.17 unit decrease,'-,PARVB,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,22:44130225
rs17172199-<b>?</b>,1 x 10-6,,0.08,'-,0.28 unit decrease,'-,HECW1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:43337677
rs2421847-<b>?</b>,9 x 10-7,,0.04,'-,0.26 unit decrease,'-,PRRC2C,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,1:171588461
rs12091371-<b>?</b>,7 x 10-8,,0.07,'-,0.17 unit decrease,'-,FMN2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,1:240441752
rs6738962-<b>?</b>,1 x 10-8,,0.04,'-,0.18 unit decrease,'-,CTNNA2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,2:80054047
rs78022502-<b>?</b>,2 x 10-6,,0.06,'-,0.23 unit decrease,'-,LIMS2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,2:127638592
rs538867-<b>?</b>,1 x 10-7,,0.03,'-,0.26 unit decrease,'-,MOBP,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,3:39471787
rs78647349-<b>?</b>,5 x 10-7,,0.04,'-,0.3 unit decrease,'-,STK32B,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,4:5235426
rs340635-<b>?</b>,2 x 10-7,,0.03,'-,0.23 unit decrease,'-,AFF1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,4:87010252
rs4700060-<b>?</b>,1 x 10-8,,0.1,'-,0.21 unit decrease,'-,ANKRD55,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:56214829
rs112724034-<b>?</b>,9 x 10-13,,0.03,'-,0.31 unit decrease,'-,PGAM5P1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:109885325
rs77636885-<b>?</b>,2 x 10-6,,0.03,'-,0.3 unit decrease,'-,CAMK4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:111383489
rs116348108-<b>?</b>,9 x 10-7,,0.04,'-,0.28 unit decrease,'-,DMXL1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:119099432
rs143954261-<b>?</b>,8 x 10-7,,0.04,'-,0.29 unit decrease,'-,MEGF10,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:127393758
rs146579248-<b>?</b>,4 x 10-7,,0.04,'-,0.21 unit decrease,'-,LINC01184,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:128046610
rs148763909-<b>?</b>,1 x 10-8,,0.03,'-,0.15 unit decrease,'-,SAP30L,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,5:154457546
rs117780815-<b>?</b>,6 x 10-7,,0.03,'-,0.31 unit decrease,'-,NKAIN2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,6:124005082
rs11154851-<b>?</b>,1 x 10-8,,0.04,'-,0.25 unit decrease,'-,PDE7B,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,6:136046867
rs75253868-<b>?</b>,2 x 10-6,,0.03,'-,0.26 unit decrease,'-,PLEKHG1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,6:150781694
rs58370486-<b>?</b>,6 x 10-11,,0.03,'-,0.36 unit decrease,'-,BZW2,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:16668236
rs1861525-<b>?</b>,2 x 10-7,,0.03,'-,0.25 unit decrease,'-,CYCS,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:25121983
rs2392492-<b>?</b>,1 x 10-6,,0.04,'-,0.32 unit decrease,'-,ELMO1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:37325592
rs11770757-<b>?</b>,5 x 10-7,,0.04,'-,0.16 unit decrease,'-,EXOC4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,7:134063193
rs73660619-<b>?</b>,8 x 10-7,,0.06,'-,0.26 unit decrease,'-,CSMD1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,8:3230651
rs7009219-<b>?</b>,5 x 10-7,,0.06,'-,0.16 unit decrease,'-,ST18,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,8:52301705
rs4836694-<b>?</b>,7 x 10-7,,0.11,'-,0.21 unit decrease,'-,NCS1,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,9:130177513
rs118048115-<b>?</b>,6 x 10-7,,0.04,'-,0.34 unit decrease,'-,PLPP4,Alzheimer's disease (cognitive decline),Alzheimer's disease,GCST001915,10:120519964
rs10496731-<b>G</b>,2 x 10-8,,0.48,'-,'-,'-,"CCNT2-AS1, ACMSD",Alzheimer's disease or body fat percentage (pleiotropy),"Alzheimer's disease, body fat percentage",GCST90013832,2:134840058
rs442495-<b>T</b>,2 x 10-10,,0.65,'-,'-,'-,ADAM10,Alzheimer's disease or diastolic blood pressure (pleiotropy),"Alzheimer's disease, diastolic blood pressure",GCST90013835,15:58730416
rs4308-<b>G</b>,7 x 10-15,,0.63,'-,'-,'-,ACE,Alzheimer's disease or diastolic blood pressure (pleiotropy),"Alzheimer's disease, diastolic blood pressure",GCST90013835,17:63482264
rs144867634-<b>T</b>,8 x 10-8,,0.98,'-,'-,'-,DOCK4,Alzheimer's disease or diastolic blood pressure (pleiotropy),"Alzheimer's disease, diastolic blood pressure",GCST90013835,7:111940111
rs12595082-<b>C</b>,3 x 10-8,,0.81,'-,'-,'-,SPPL2A,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST90013836,15:50715532
rs4308-<b>G</b>,8 x 10-15,,0.63,'-,'-,'-,ACE,Alzheimer's disease or systolic blood pressure (pleiotropy),"Alzheimer's disease, systolic blood pressure",GCST90013838,17:63482264
rs4575098-<b>A</b>,4 x 10-13,,0.22,'-,'-,'-,ADAMTS4,Alzheimer's disease or waist-hip ratio (pleiotropy),"Alzheimer's disease, waist-hip ratio",GCST90013842,1:161185602
rs144573434-<b>T</b>,5 x 10-7,(liability model),0.997,'-,1.14 unit decrease,[0.69-1.59],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:81079667
rs145282773-<b>T</b>,2 x 10-6,(liability model),0.997,'-,1.04 unit decrease,[0.61-1.47],"HMGA2, HMGA2-AS1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:65859519
rs147285445-<b>T</b>,4 x 10-6,(liability model),0.998,'-,1.03 unit decrease,[0.6-1.46],ANKRD22,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,10:88850285
rs186891871-<b>C</b>,9 x 10-6,(liability model),0.998,'-,0.98 unit decrease,[0.55-1.41],ADGRL2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:81589710
rs141976661-<b>A</b>,5 x 10-7,(liability model),0.997,'-,0.88 unit decrease,[0.55-1.21],LINC00624,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:147483513
rs139638356-<b>T</b>,2 x 10-6,(liability model),0.996,'-,0.83 unit decrease,[0.48-1.18],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:80903300
rs185170954-<b>A</b>,9 x 10-6,(liability model),0.997,'-,0.82 unit decrease,[0.47-1.17],SEMA3A,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:83870966
rs115798104-<b>A</b>,9 x 10-7,(liability model),0.997,'-,0.8 unit decrease,[0.49-1.11],MECOM,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:169273046
rs181696879-<b>A</b>,4 x 10-7,(liability model),0.994,'-,0.67 unit decrease,[0.42-0.92],MCPH1-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:6680850
rs138449900-<b>C</b>,3 x 10-6,(liability model),0.996,'-,0.66 unit decrease,[0.39-0.93],"CNTNAP5, RN7SKP102",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:123951121
rs141846544-<b>T</b>,9 x 10-6,(liability model),0.996,'-,0.65 unit decrease,[0.36-0.94],"RNU6-1213P, Y_RNA",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:80432793
rs117022236-<b>A</b>,4 x 10-6,(liability model),0.995,'-,0.63 unit decrease,[0.36-0.9],AKR7A3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:19288434
rs140587050-<b>C</b>,5 x 10-6,(liability model),0.995,'-,0.63 unit decrease,[0.36-0.9],IRAK1BP1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:78889320
rs183291664-<b>T</b>,3 x 10-6,(liability model),0.996,'-,0.58 unit decrease,[0.34-0.82],SCAPER,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:76713822
rs8077028-<b>T</b>,1 x 10-6,(liability model),0.751,'-,0.09 unit decrease,[0.051-0.129],"CEP295NL, TIMP2",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:78891959
rs2244526-<b>T</b>,6 x 10-6,(liability model),0.824,'-,0.09 unit decrease,[0.051-0.129],SELP,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:169617708
rs17022021-<b>T</b>,8 x 10-6,(liability model),0.843,'-,0.09 unit decrease,[0.051-0.129],RBMS3,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:28837197
rs1034435-<b>A</b>,3 x 10-6,(liability model),0.659,'-,0.07 unit decrease,[0.031-0.109],TAFA5,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,22:48492443
rs4760243-<b>A</b>,8 x 10-6,(liability model),0.566,'-,0.07 unit decrease,[0.031-0.109],"LINC02388, LRIG3",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:58828030
rs7260181-<b>T</b>,8 x 10-6,(liability model),0.57,'-,0.07 unit decrease,[0.031-0.109],PPP5D1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:46595170
rs12716755-<b>A</b>,6 x 10-6,(liability model),0.608,'-,0.07 unit increase,[0.031-0.109],"USP10, KLHL36",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:84699678
rs3820443-<b>T</b>,1 x 10-6,(liability model),0.611,'-,0.07 unit increase,[0.031-0.109],PIFO,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:111350283
rs846858-<b>A</b>,3 x 10-6,(liability model),0.272,'-,0.08 unit increase,[0.041-0.119],IGSF23,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:44625528
rs5771225-<b>T</b>,5 x 10-6,(liability model),0.217,'-,0.09 unit increase,[0.051-0.129],SELENOO,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,22:50201044
rs7313581-<b>T</b>,8 x 10-7,(liability model),0.218,'-,0.09 unit increase,[0.051-0.129],KRAS,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:25269783
rs2699450-<b>A</b>,4 x 10-6,(liability model),0.211,'-,0.09 unit increase,[0.051-0.129],"CDCA7L, RAPGEF5",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:22018573
rs6945197-<b>T</b>,6 x 10-6,(liability model),0.16,'-,0.09 unit increase,[0.051-0.129],"ZP3P2, PLXNA4",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:136477062
rs184992198-<b>T</b>,2 x 10-6,(liability model),0.816,'-,0.11 unit increase,[0.071-0.149],"BNIP3P13, ZNF90",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:20064649
rs115972394-<b>A</b>,6 x 10-6,(liability model),0.147,'-,0.11 unit increase,[0.051-0.169],ATP6V0E2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:149924921
rs73215707-<b>T</b>,8 x 10-6,(liability model),0.908,'-,0.12 unit increase,[0.061-0.179],CYRIA,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:16736702
rs79926713-<b>T</b>,8 x 10-6,(liability model),0.082,'-,0.13 unit increase,[0.071-0.189],SYNGAP1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:33427745
rs73732514-<b>A</b>,2 x 10-6,(liability model),0.929,'-,0.14 unit increase,[0.081-0.199],CTD-2194D22.4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:1983817
rs62177277-<b>T</b>,2 x 10-6,(liability model),0.056,'-,0.16 unit increase,[0.1-0.22],SESTD1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:179139721
rs73681522-<b>A</b>,4 x 10-6,(liability model),0.051,'-,0.16 unit increase,[0.082-0.238],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:13656708
rs2234017-<b>C</b>,7 x 10-6,(liability model),0.056,'-,0.17 unit increase,[0.092-0.248],TAS2R5,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:141791266
rs147597631-<b>T</b>,2 x 10-6,(liability model),0.061,'-,0.18 unit increase,[0.1-0.26],"TCF15, CSNK2A1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,20:566915
rs145848414-<b>A</b>,3 x 10-6,(liability model),0.04,'-,0.21 unit increase,[0.13-0.29],"HIGD1AP3, SUMO2P6",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:174587111
rs147985478-<b>A</b>,3 x 10-6,(liability model),0.977,'-,0.25 unit increase,[0.15-0.35],PRANCR,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:69997949
rs116050881-<b>T</b>,6 x 10-7,(liability model),0.026,'-,0.25 unit increase,[0.15-0.35],LINC01725,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:29684252
rs181990369-<b>A</b>,4 x 10-6,(liability model),0.988,'-,0.37 unit decrease,[0.21-0.53],DLC1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:13182155
rs181228315-<b>A</b>,2 x 10-6,(liability model),0.986,'-,0.35 unit decrease,[0.21-0.49],TMEM94,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:75453551
rs147150305-<b>A</b>,4 x 10-7,(liability model),0.984,'-,0.35 unit decrease,[0.21-0.49],PLCL1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:198252846
rs187295598-<b>T</b>,6 x 10-6,(liability model),0.988,'-,0.34 unit decrease,[0.18-0.5],GPR180,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,13:94628579
rs142660142-<b>T</b>,2 x 10-6,(liability model),0.986,'-,0.34 unit decrease,[0.2-0.48],LINGO1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:77611050
rs77544685-<b>T</b>,5 x 10-6,(liability model),0.013,'-,0.33 unit decrease,[0.19-0.47],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:116082456
rs144167489-<b>T</b>,2 x 10-6,(liability model),0.017,'-,0.32 unit decrease,[0.18-0.46],"SUMO1P2, LINC00626",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:168874774
rs75635567-<b>T</b>,5 x 10-6,(liability model),0.985,'-,0.3 unit decrease,[0.16-0.44],"BAALC-AS1, BAALC",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,8:103186989
rs146997164-<b>C</b>,9 x 10-6,(liability model),0.97,'-,0.26 unit decrease,[0.14-0.38],"OR7E39P, CCZ1B",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:6830481
rs146322114-<b>A</b>,2 x 10-6,(liability model),0.029,'-,0.25 unit decrease,[0.15-0.35],PCSK6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,15:101501820
rs12661302-<b>C</b>,3 x 10-6,(liability model),0.977,'-,0.25 unit decrease,[0.15-0.35],'-,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,6:103817252
rs186588455-<b>A</b>,6 x 10-6,(liability model),0.964,'-,0.22 unit decrease,[0.12-0.32],"MRPL45, NPEPPSP1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,17:38287606
rs115443594-<b>T</b>,4 x 10-6,(liability model),0.966,'-,0.22 unit decrease,[0.12-0.32],PRPF19P1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,18:65993723
rs114179644-<b>T</b>,8 x 10-6,(liability model),0.969,'-,0.21 unit decrease,[0.11-0.31],CPSF6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:69160349
rs145840463-<b>A</b>,6 x 10-6,(liability model),0.036,'-,0.21 unit decrease,[0.11-0.31],CFAP74,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:1950293
rs10075047-<b>A</b>,5 x 10-6,(liability model),0.032,'-,0.21 unit decrease,[0.11-0.31],"CCDC112, CTNNA1P1",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:115357977
rs10060040-<b>A</b>,8 x 10-6,(liability model),0.053,'-,0.17 unit decrease,[0.092-0.248],"ADGRV1, CTNND2",Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:11930025
rs62179067-<b>T</b>,8 x 10-7,(liability model),0.941,'-,0.16 unit decrease,[0.1-0.22],SESTD1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:179270456
rs56249755-<b>A</b>,5 x 10-7,(liability model),0.939,'-,0.16 unit decrease,[0.1-0.22],FAM240B,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:38711009
rs115317194-<b>T</b>,2 x 10-6,(liability model),0.067,'-,0.15 unit decrease,[0.091-0.209],SLMAP,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:57830215
rs75770912-<b>A</b>,8 x 10-6,(liability model),0.074,'-,0.14 unit decrease,[0.081-0.199],AOX1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:200653321
rs7698880-<b>C</b>,2 x 10-6,(liability model),0.124,'-,0.14 unit decrease,[0.081-0.199],UNC93B4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:4148701
rs76816469-<b>T</b>,1 x 10-6,(liability model),0.101,'-,0.12 unit decrease,[0.061-0.179],CDH1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,16:68759780
rs61233297-<b>A</b>,8 x 10-6,(liability model),0.094,'-,0.11 unit decrease,[0.051-0.169],IQGAP2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:76567335
rs853656-<b>T</b>,4 x 10-6,(liability model),0.167,'-,0.09 unit decrease,[0.051-0.129],RASSF8,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,12:25965239
rs142076474-<b>A</b>,4 x 10-6,(liability model),0.994,'-,0.58 unit decrease,[0.34-0.82],CEP63,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,3:134501479
rs181299481-<b>A</b>,4 x 10-6,(liability model),0.994,'-,0.58 unit decrease,[0.33-0.83],RNY4P18,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,9:111149099
rs191404864-<b>A</b>,5 x 10-6,(liability model),0.006,'-,0.53 unit decrease,[0.29-0.77],BICRA,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,19:47635083
rs112404845-<b>A</b>,4 x 10-8,(liability model),0.991,'-,0.47 unit decrease,[0.29-0.65],ROBO2P1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,7:51510325
rs183256737-<b>A</b>,2 x 10-6,(liability model),0.993,'-,0.46 unit decrease,[0.26-0.66],SEC24B-AS1,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,4:109373310
rs79930850-<b>A</b>,3 x 10-6,(liability model),0.99,'-,0.45 unit decrease,[0.25-0.65],CASP12,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:104874043
rs143261188-<b>C</b>,3 x 10-6,(liability model),0.992,'-,0.44 unit decrease,[0.24-0.64],TENM4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,11:78938571
rs115078773-<b>A</b>,7 x 10-6,(liability model),0.992,'-,0.44 unit decrease,[0.24-0.64],TMCO4,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,1:19693032
rs139195876-<b>A</b>,2 x 10-6,(liability model),0.99,'-,0.43 unit decrease,[0.25-0.61],NACAP6,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,5:16262936
rs16961023-<b>C</b>,5 x 10-8,(liability model),0.985,'-,0.41 unit decrease,[0.27-0.55],SLC10A2,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,13:103011595
rs72842919-<b>A</b>,5 x 10-7,(liability model),0.985,'-,0.38 unit decrease,[0.22-0.54],RPS20P10,Late-onset Alzheimer's disease,late-onset Alzheimers disease,GCST003815,2:71938176
rs17090219-<b>?</b>,9 x 10-8,,'-,'-,5.15 unit increase,[3.33-6.97],TXNL1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,18:56523802
rs3936289-<b>?</b>,5 x 10-7,,'-,'-,3.34 unit increase,[2.09-4.59],ST6GAL1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,3:187037169
rs56378310-<b>?</b>,2 x 10-6,,'-,'-,2.98 unit decrease,[1.8-4.16],RAB20,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,13:110537326
rs192470679-<b>?</b>,2 x 10-6,,'-,'-,2.89 unit increase,[1.73-4.05],PDS5B,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,13:32716722
rs11121365-<b>?</b>,2 x 10-6,,'-,'-,5.76 unit increase,[3.45-8.07],SPSB1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,1:9297665
rs2484-<b>?</b>,3 x 10-6,,'-,'-,4.53 unit increase,[2.69-6.37],BDH1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,3:197541698
rs10903488-<b>?</b>,3 x 10-6,,'-,'-,4.58 unit increase,[2.7-6.46],ADARB2,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,10:1563803
rs6016505-<b>?</b>,4 x 10-6,,'-,'-,'-,'-,TOP1,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,20:41049649
rs314277-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,LIN28B,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,6:104959787
rs57905270-<b>?</b>,5 x 10-6,,'-,'-,'-,'-,C2orf83,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,2:227621998
rs12525341-<b>?</b>,8 x 10-6,,'-,'-,'-,'-,TIAM2,Accelerated cognitive decline after conversion of mild cognitive impairment to Alzheimer's disease (Alzhiemer's diagnosis trajectory interaction),"Alzheimer's disease, cognitive decline measurement, Cognitive impairment",GCST004253,6:155173590
rs10078434-<b>T</b>,7 x 10-8,,0.09,'-,1.1 unit decrease,[0.73-1.47],"RPL7P19, ETF1",Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST006990,5:138496342
rs283812-<b>C</b>,3 x 10-7,,0.29,'-,0.55 unit decrease,[0.35-0.75],NECTIN2,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST006990,19:44885311
rs11605427-<b>?</b>,8 x 10-17,,NR,'-,'-,'-,"MS4A6A, LINC02705",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60161199
rs501945-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MS4A2, MS4A3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60076769
rs580064-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MS4A2, LINC02705",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60101646
rs7108879-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MS4A4A,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60313801
rs56157503-<b>?</b>,8 x 10-9,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86152038
rs7114401-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86128893
rs10792832-<b>?</b>,6 x 10-33,,NR,1.1004289,'-,[1.08330873363297- 1.1178195976052],"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86156833
rs527162-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,PICALM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86004693
rs17745409-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PICALM, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86101743
rs7129687-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86160142
rs61904266-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, LINC02695",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86160172
rs11218343-<b>?</b>,1 x 10-9,,NR,1.0624738,'-,'-,SORL1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:121564878
rs17125924-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,FERMT2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:52924962
rs8008388-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:92470346
rs593742-<b>?</b>,6 x 10-11,,NR,1.06,'-,[1.04- 1.07],"ADAM10, SNORD3P1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,15:58753575
rs889555-<b>?</b>,3 x 10-8,,NR,1.0526316,'-,'-,BCKDK,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,16:31111250
rs73976310-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ZNF232,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:5110917
rs6504163-<b>?</b>,5 x 10-9,,NR,1.05,'-,[1.03- 1.07],"PPIAP55, CYB561",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:63468418
rs3752231-<b>?</b>,6 x 10-11,,NR,'-,'-,'-,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:1043639
rs3795065-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"ABCA7, CNN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:1039445
rs80257887-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,CEACAM20,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44516798
rs142034848-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CEACAM19, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44673285
rs73046410-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44549809
rs143459034-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44854769
rs56261258-<b>?</b>,1 x 10-21,,NR,'-,'-,'-,"PVR, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44646342
rs4802240-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44849547
rs283814-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44885967
rs61679753-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44897490
rs148601586-<b>?</b>,2 x 10-43,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44843409
rs112380717-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45019803
rs2927468-<b>?</b>,4 x 10-108,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44854682
rs4803760-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44830577
rs11668738-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44844304
rs2972558-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44852884
rs73050293-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44876489
rs375972689-<b>?</b>,1 x 10-32,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44857231
rs8112526-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44857505
rs406456-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879460
rs35568738-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44899461
rs157580-<b>?</b>,2 x 10-208,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44892009
rs11669338-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879727
rs760136-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44900601
rs405697-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44901434
rs157595-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44922203
rs8106813-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,APOC1P1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44928401
rs141864196-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44902242
rs150639620-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44878035
rs41290120-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879418
rs138235833-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44912028
rs283810-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44884984
rs346758-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45222481
rs346763-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"EXOC3L2, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45226017
rs12461144-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45220448
rs62118504-<b>?</b>,5 x 10-14,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45231493
rs11667829-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45236417
rs6069736-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,"CSTF1, CASS4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,20:56408019
rs9271192-<b>?</b>,7 x 10-10,,NR,1.0530598,'-,'-,"HLA-DRB1, HLA-DQA1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:32610753
rs2718058-<b>?</b>,2 x 10-6,,NR,1.0383158,'-,'-,"GPR141, EPDR1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:37801932
rs10838725-<b>?</b>,2 x 10-6,,NR,1.0392507,'-,[1.02288186365195- 1.05588153898494],CELF1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:47536319
rs769446-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, TOMM40",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44905371
rs12721109-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC4, APOC4-APOC2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44943964
rs1081105-<b>?</b>,1 x 10-162,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44909698
rs7254133-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC4, APOC1P1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44935297
rs60049679-<b>?</b>,2 x 10-70,,NR,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44926451
rs4263041-<b>?</b>,5 x 10-10,,NR,'-,'-,'-,"APOC1P1, APOC4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44935386
rs2376866-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CLPTM1, RELB",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44997454
rs35194383-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45012792
rs4803791-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,Mapping not available
rs117612135-<b>?</b>,9 x 10-31,,NR,'-,'-,'-,"RELB, CLPTM1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45001269
rs76856627-<b>?</b>,9 x 10-11,,NR,'-,'-,'-,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45040497
rs78620885-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, GEMIN7, GEMIN7-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45087826
rs112481437-<b>?</b>,6 x 10-15,,NR,'-,'-,'-,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45045877
rs7251911-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45079144
rs145903417-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PPP1R37, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45125846
rs149495476-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BLOC1S3, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45193381
rs138137383-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,"MARK4, PPP1R37",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45098343
rs12461065-<b>?</b>,1 x 10-17,,NR,'-,'-,'-,"PPP1R37, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45102050
rs8100183-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, GEMIN7-AS1, GEMIN7",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45081434
rs17643262-<b>?</b>,2 x 10-30,,NR,'-,'-,'-,"MARK4, PPP1R37",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45128558
rs10408847-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, PPP1R37",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45131424
rs12463049-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45187692
rs111243475-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45188312
rs595290-<b>?</b>,7 x 10-21,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45205150
rs620807-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BLOC1S3, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45203694
rs7480193-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86150377
rs7113976-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86158695
rs580887-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, PICALM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86120391
rs7938634-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PICALM, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86134431
rs11603136-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"RNU6-560P, LINC02695",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:86163280
rs12881735-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:92466484
rs12590654-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,14:92472511
rs7225151-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"SCIMP, ZNF594-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:5233752
rs3845261-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"ZFP3, ZNF232",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:5104941
rs4311-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ACE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,17:63483402
rs4147929-<b>?</b>,3 x 10-8,,NR,1.0491707,'-,[1.03-1.07],ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:1063444
rs11083742-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44567824
rs2734897-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,AGFG2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100561944
rs2293479-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,AP4M1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100106335
rs866500-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CASTOR3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100242838
rs858502-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CASTOR3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100245730
rs35305377-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"STAG3L5P, STAG3L5P-PVRIG2P-PILRB",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100341332
rs7810606-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143411065
rs56402156-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143406388
rs3935067-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143407238
rs62472729-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143418968
rs11771145-<b>?</b>,4 x 10-11,,NR,1.0548515,'-,[1.04-1.07],EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143413669
rs7805776-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143427203
rs9640386-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:143435090
rs28834970-<b>?</b>,6 x 10-16,,NR,1.0666256,'-,[1.05003132808944-1.08348207689744],PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27337604
rs10109834-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27354759
rs2741342-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CHRNA2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27472579
rs79145239-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,CHRNA2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27462330
rs2269461-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,EPHX2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27541103
rs4236673-<b>?</b>,4 x 10-25,,NR,'-,'-,'-,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27607412
rs4732728-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,GULOP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27584004
rs9331908-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27606101
rs576748-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CLU, SCARA3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27629399
rs485902-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"SCARA3, CLU",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,8:27632442
rs7920721-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,"ECHDC3, USP6NL-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,10:11678309
rs12292911-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"PSMC3, RAPSN",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:47427521
rs3740688-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,SPI1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:47358789
rs640345-<b>T</b>,8 x 10-9,,0.824,1.3157895,'-,[1.19-1.45],KIR3DL2,Alzheimer's disease (onset between ages 58 and 79),Alzheimer's disease,GCST009496,19:54851404
rs9899728-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,"RNU6-362P, MRPL58",Alzheimer's disease or small vessel stroke,"Alzheimer's disease, small vessel stroke",GCST003423,17:75022679
rs17774966-<b>?</b>,8 x 10-6,,NR,'-,0.153 unit increase,[NR],'-,Entorhinal cortical thickness (Alzheimer's disease interaction),"Alzheimer's disease, cortical thickness",GCST000889,9:25551359
rs1925690-<b>?</b>,3 x 10-8,,NR,'-,0.0003 unit increase,[NR],ZNF292,Entorhinal cortical volume (Alzheimer's disease interaction),"Alzheimer's disease, entorhinal cortical volume",GCST000893,6:87157345
rs4670766-<b>?</b>,2 x 10-6,,NR,'-,0.005 unit decrease,[NR],CDC42EP3,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,2:37713399
rs10937470-<b>?</b>,9 x 10-6,,NR,'-,0.004 unit decrease,[NR],UTS2B,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,3:191283019
rs2084385-<b>?</b>,5 x 10-6,,NR,'-,0.006 unit increase,[NR],PAK2,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,3:196826996
rs7805803-<b>?</b>,9 x 10-6,,NR,'-,0.004 unit decrease,[NR],SPATA48,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,7:50185795
rs263238-<b>?</b>,2 x 10-6,,NR,'-,0.006 unit increase,[NR],ADCY8,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,8:130799787
rs12555345-<b>?</b>,5 x 10-6,,NR,'-,0.004 unit decrease,[NR],CTAGE12P,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,9:27630564
rs10512049-<b>?</b>,3 x 10-6,,NR,'-,0.007 unit decrease,[NR],OTX2P1,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,9:75661759
rs990324-<b>?</b>,5 x 10-6,,NR,'-,0.006 unit decrease,'-,"LINC00423, PDS5B",Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,13:32813108
rs9574199-<b>?</b>,7 x 10-6,,NR,'-,0.004 unit increase,[NR],OBI1-AS1,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,13:78234779
rs4318070-<b>?</b>,7 x 10-6,,NR,'-,0.004 unit decrease,[NR],FARP1,Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,13:98308508
rs3784609-<b>?</b>,3 x 10-6,,NR,'-,0.005 unit decrease,[NR],"RORA-AS1, RORA",Total ventricular volume (Alzheimer's disease interaction),"Alzheimer's disease, brain volume measurement",GCST000892,15:60618351
rs1857353-<b>?</b>,2 x 10-6,,NR,'-,0.016 unit decrease,[NR],SLC44A5,Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,1:75448141
rs9846480-<b>?</b>,8 x 10-6,,NR,'-,0.009 unit increase,[NR],NME9,Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,3:138306554
rs3905000-<b>?</b>,9 x 10-6,,NR,'-,0.013 unit increase,[NR],ABCA1,Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,9:104894789
rs2852894-<b>?</b>,1 x 10-6,,NR,'-,0.016 unit decrease,[NR],"RNU6-952P, YAP1",Whole-brain volume (Alzheimer's disease interaction),"Alzheimer's disease, whole-brain volume",GCST000895,11:102284743
rs1992269-<b>A</b>,1 x 10-6,,0.076,1.66,'-,[1.35-2.03],AIDAP3,Alzheimer's disease (late onset),Alzheimer's disease,GCST002954,18:1872316
rs802571-<b>T</b>,1 x 10-6,(noncarrier),0.916,1.923077,'-,[1.47-2.50],CNTNAP2,Alzheimer's disease (late onset),Alzheimer's disease,GCST002954,7:146265094
rs11613092-<b>G</b>,7 x 10-6,(noncarrier),0.093,1.64,'-,[1.32-2.04],SUDS3,Alzheimer's disease (late onset),Alzheimer's disease,GCST002954,12:118455443
rs1800795-<b>?</b>,7 x 10-8,,'-,'-,0.375 unit increase,[NR],"IL6, STEAP1B, IL6-AS1",Cerebrospinal fluid clusterin levels in APOEe4- carriers,"Alzheimer's disease, cerebrospinal fluid clusterin measurement",GCST003137,7:22727026
rs56755606-<b>A</b>,1 x 10-7,(GEE model),NR,'-,1.1021 unit decrease,[0.7-1.51],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:179046443
rs11723502-<b>T</b>,9 x 10-6,(GEE model),NR,'-,0.51405 unit decrease,[0.29-0.74],"LINC01093, MIR3945HG",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:184883166
rs72712682-<b>G</b>,6 x 10-6,(GEE model),NR,'-,0.58942 unit decrease,[0.33-0.85],F11-AS1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:186419433
rs150052082-<b>T</b>,2 x 10-6,(GEE model),NR,'-,1.1459 unit decrease,[0.68-1.62],SLC6A3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:1418892
rs149799089-<b>T</b>,1 x 10-6,(GEE model),NR,'-,0.91021 unit decrease,[0.55-1.28],PDE4D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:59464462
rs148373370-<b>A</b>,5 x 10-6,(GEE model),NR,'-,1.1872 unit decrease,[0.68-1.7],TMEM174,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:73210437
rs71654380-<b>C</b>,3 x 10-6,(GEE model),NR,'-,0.93659 unit decrease,[0.54-1.33],"LIX1-AS1, LINC01340",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:97450102
rs13435934-<b>A</b>,5 x 10-6,(GEE model),NR,'-,0.65998 unit decrease,[0.38-0.94],PJA2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:109410936
rs77152330-<b>A</b>,7 x 10-6,(GEE model),NR,'-,1.1042 unit decrease,[0.62-1.58],LINC02208,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:118294256
rs4895368-<b>T</b>,4 x 10-6,(GEE model),NR,'-,0.87692 unit decrease,[0.5-1.25],TNFAIP8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:119351201
chr5:124938416-<b>C</b>,6 x 10-7,(GEE model),NR,'-,1.1527 unit decrease,[0.7-1.61],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs78049001-<b>A</b>,3 x 10-8,(GEE model),NR,'-,0.8685 unit decrease,[0.56-1.17],"LINC02039, GRAMD2B",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:126272219
rs6596201-<b>A</b>,8 x 10-6,(GEE model),NR,'-,0.82968 unit decrease,[0.47-1.19],C5orf66,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:135155460
rs150117434-<b>T</b>,6 x 10-6,(GEE model),NR,'-,1.1035 unit decrease,[0.62-1.58],COL23A1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,5:178502420
rs145578678-<b>C</b>,3 x 10-6,(GEE model),NR,'-,1.1492 unit increase,[0.67-1.63],DEK,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:18229415
rs9380681-<b>T</b>,1 x 10-6,(GEE model),NR,'-,0.46432 unit increase,[0.28-0.65],"MIR4462, MDGA1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:37562679
rs73449416-<b>A</b>,4 x 10-7,(GEE model),NR,'-,1.0698 unit increase,[0.65-1.49],"RNA5SP208, RNU6-280P",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:67513240
rs76190283-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.87975 unit decrease,[0.52-1.24],TENT5A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:81540046
rs185296986-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.95756 unit decrease,[0.57-1.35],CYCSP17,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:95466536
rs182244165-<b>C</b>,9 x 10-6,(GEE model),NR,'-,0.89476 unit decrease,[0.5-1.29],HSF2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:122379209
rs79102053-<b>A</b>,3 x 10-7,(GEE model),NR,'-,1.004 unit decrease,[0.62-1.39],PLEKHG1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:150814249
rs7787594-<b>T</b>,4 x 10-6,(GEE model),NR,'-,0.40398 unit decrease,[0.23-0.58],PER3P1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:9676532
rs73084930-<b>G</b>,1 x 10-6,(GEE model),NR,'-,0.69382 unit decrease,[0.41-0.97],RNU6-1103P,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:24490721
rs39447-<b>C</b>,2 x 10-6,(GEE model),NR,'-,0.52406 unit increase,[0.31-0.74],CYCS,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:25089373
rs13228275-<b>T</b>,4 x 10-7,(GEE model),NR,'-,0.93231 unit decrease,[0.57-1.29],AMPH,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:38422579
chr7:48804308-<b>C</b>,9 x 10-10,(GEE model),NR,'-,1.5803 unit decrease,[1.07-2.09],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs10234213-<b>G</b>,1 x 10-7,(GEE model),NR,'-,1.1717 unit decrease,[0.74-1.6],"HGF, DDX43P3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:81631105
rs28381924-<b>A</b>,5 x 10-8,(GEE model),NR,'-,1.0778 unit decrease,[0.69-1.46],ABCB1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:87543786
rs76542556-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.84971 unit decrease,[0.5-1.2],"BET1, GNG11",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:93933243
chr7:102553128-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.95805 unit increase,[0.54-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs180725393-<b>C</b>,4 x 10-7,(GEE model),NR,'-,1.0867 unit increase,[0.67-1.51],NAPEPLD,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:103145984
rs147874219-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.96543 unit increase,[0.54-1.39],DPY19L2P2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:103263955
chr7:103017132-<b>CAGA</b>,6 x 10-7,(GEE model),NR,'-,1.0651 unit increase,[0.65-1.48],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs10953388-<b>T</b>,8 x 10-6,(GEE model),NR,'-,0.43339 unit decrease,[0.24-0.62],RELN,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:103545824
rs62489373-<b>G</b>,4 x 10-6,(GEE model),NR,'-,1.0309 unit decrease,[0.59-1.47],ZP3P2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:136467453
rs28491578-<b>T</b>,8 x 10-7,(GEE model),NR,'-,0.82735 unit increase,[0.5-1.16],DGKI,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:137828192
rs60465337-<b>C</b>,9 x 10-7,(GEE model),NR,'-,1.028 unit increase,[0.62-1.44],CNTNAP2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:148107001
rs189842957-<b>T</b>,6 x 10-6,(GEE model),NR,'-,0.51509 unit decrease,[0.29-0.74],"XRCC2, 5S_rRNA",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:152641544
chr8:14944492-<b>CAA</b>,4 x 10-6,(GEE model),NR,'-,0.87757 unit increase,[0.5-1.25],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs6985143-<b>C</b>,3 x 10-8,(GEE model),NR,'-,1.1407 unit decrease,[0.74-1.55],MSR1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:16108576
rs77048708-<b>G</b>,6 x 10-6,(GEE model),NR,'-,0.67354 unit decrease,[0.38-0.97],STC1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:23939348
rs17357035-<b>A</b>,8 x 10-6,(GEE model),NR,'-,1.0025 unit decrease,[0.56-1.44],UNC5D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:35746651
rs72637528-<b>G</b>,1 x 10-7,(GEE model),NR,'-,1.1324 unit decrease,[0.72-1.55],UNC5D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:35848592
rs142214173-<b>G</b>,1 x 10-8,(GEE model),NR,'-,1.2016 unit decrease,[0.79-1.62],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36006420
rs138297249-<b>G</b>,5 x 10-7,(GEE model),NR,'-,1.128 unit decrease,[0.69-1.57],MTCYBP19,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36187530
rs187649623-<b>T</b>,4 x 10-7,(GEE model),NR,'-,1.3596 unit decrease,[0.83-1.89],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36471595
rs151108108-<b>T</b>,2 x 10-6,(GEE model),NR,'-,1.2808 unit decrease,[0.75-1.81],RPL23P10,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:36613876
rs74972376-<b>G</b>,5 x 10-6,(GEE model),NR,'-,1.1597 unit increase,[0.66-1.66],ANXA13,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:123708021
rs6992906-<b>G</b>,3 x 10-6,(GEE model),NR,'-,0.86346 unit increase,[0.5-1.23],PVT1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:127857208
rs16904657-<b>A</b>,6 x 10-6,(GEE model),NR,'-,0.64115 unit decrease,[0.36-0.92],KCNQ3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,8:132318791
rs7560412-<b>C</b>,2 x 10-6,(GEE model),NR,'-,0.68478 unit decrease,[0.4-0.97],"UBXN4, R3HDM1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:135727526
rs12070360-<b>C</b>,5 x 10-6,(GEE model),NR,'-,0.75133 unit decrease,[0.43-1.07],RPSAP20,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:56296719
rs11689493-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.4526 unit decrease,[0.27-0.64],"CDCA7, JPT1P1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:173394711
rs141385851-<b>G</b>,3 x 10-6,(GEE model),NR,'-,0.85234 unit decrease,[0.49-1.21],"RNU7-62P, UBE2U",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:64352304
rs62192855-<b>G</b>,5 x 10-6,(GEE model),NR,'-,0.70881 unit decrease,[0.41-1.01],"CRYGD, CRYGC",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:208128047
rs74567324-<b>T</b>,5 x 10-7,(GEE model),NR,'-,1.3319 unit decrease,[0.81-1.85],"Y_RNA, NRBF2P3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:110784619
rs76119111-<b>G</b>,6 x 10-7,(GEE model),NR,'-,1.4893 unit increase,[0.9-2.08],FARSB,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:222619881
rs9814965-<b>A</b>,3 x 10-6,(GEE model),NR,'-,0.8509 unit decrease,[0.5-1.21],LMCD1-AS1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:7994605
rs16844046-<b>A</b>,2 x 10-7,(GEE model),NR,'-,1.2387 unit decrease,[0.77-1.71],"LINC01222, MIR181A1HG",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:199004936
rs79379488-<b>A</b>,1 x 10-6,(GEE model),NR,'-,1.3364 unit increase,[0.8-1.88],"ST13P19, HHAT",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:210306349
rs12137733-<b>C</b>,2 x 10-8,(GEE model),NR,'-,0.83305 unit decrease,[0.54-1.12],U3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:221521649
rs1764346-<b>T</b>,1 x 10-6,(GEE model),NR,'-,0.72017 unit decrease,[0.43-1.01],ENAH,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:225494483
rs116233900-<b>T</b>,1 x 10-7,(GEE model),NR,'-,1.0543 unit decrease,[0.67-1.44],KRT18P32,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:238566133
rs9833127-<b>G</b>,3 x 10-6,(GEE model),NR,'-,0.78263 unit decrease,[0.45-1.11],GPR156,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:120222474
rs34166650-<b>A</b>,6 x 10-7,(GEE model),NR,'-,0.44474 unit decrease,[0.27-0.62],RPL21P71,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:147275608
chr3:159754413-<b>CA</b>,4 x 10-6,(GEE model),NR,'-,1.3097 unit increase,[0.75-1.87],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs79221325-<b>G</b>,7 x 10-8,(GEE model),NR,'-,1.4982 unit increase,[0.95-2.04],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:162297342
rs4857800-<b>T</b>,8 x 10-6,(GEE model),NR,'-,0.40043 unit decrease,[0.22-0.58],LINC01208,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:176900051
rs13121626-<b>A</b>,2 x 10-6,(GEE model),NR,'-,0.51147 unit decrease,[0.3-0.72],CLNK,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:10489927
rs184621768-<b>A</b>,2 x 10-8,(GEE model),NR,'-,1.2709 unit decrease,[0.82-1.72],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:65977824
rs6850546-<b>A</b>,3 x 10-6,(GEE model),NR,'-,1.2771 unit increase,[0.74-1.82],ENOPH1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:82449681
rs17034334-<b>T</b>,2 x 10-7,(GEE model),NR,'-,0.54164 unit increase,[0.34-0.75],LINC02503,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:104132856
rs76098257-<b>T</b>,2 x 10-7,(GEE model),NR,'-,0.87288 unit decrease,[0.55-1.2],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:160150870
rs6546173-<b>C</b>,2 x 10-6,(GEE model),NR,'-,0.75928 unit decrease,[0.45-1.07],KRT18P33,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:65672385
rs58170570-<b>G</b>,9 x 10-6,(GEE model),NR,'-,1.0055 unit increase,[0.56-1.45],"RPL27AP4, ILRUNP1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:106342796
rs79784973-<b>G</b>,1 x 10-6,(GEE model),NR,'-,0.97698 unit decrease,[0.58-1.37],ANAPC1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:111620617
rs80178823-<b>C</b>,3 x 10-6,(GEE model),NR,'-,1.1552 unit decrease,[0.67-1.64],"CZIB, MAGOH",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:53223405
rs111535588-<b>G</b>,5 x 10-8,(GEE model),NR,'-,0.83287 unit decrease,[0.53-1.13],SCN2A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:165296141
rs76600213-<b>T</b>,8 x 10-6,(GEE model),NR,'-,0.99358 unit increase,[0.56-1.43],LINC01748,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:60526484
rs147710719-<b>C</b>,2 x 10-6,(GEE model),NR,'-,1.0539 unit decrease,[0.62-1.49],"ARHGAP15, SCHLAP1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:180605464
rs7523405-<b>A</b>,3 x 10-6,(GEE model),NR,'-,1.0999 unit decrease,[0.64-1.56],NEGR1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:71880109
rs1525608-<b>A</b>,6 x 10-6,(GEE model),NR,'-,0.40478 unit decrease,[0.23-0.58],"PSMB3P2, IGFBP2",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:216629032
rs17033324-<b>C</b>,2 x 10-12,(GEE model),NR,'-,1.2284 unit decrease,[0.89-1.57],LINC01765,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:115169958
rs2265081-<b>C</b>,5 x 10-8,(GEE model),NR,'-,1.054 unit increase,[0.68-1.43],"RN7SL44P, S100A6",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:153527732
rs192099504-<b>C</b>,7 x 10-7,(GEE model),NR,'-,0.90541 unit decrease,[0.55-1.26],SNRK,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:43305720
chr3:44643004-<b>GA</b>,6 x 10-6,(GEE model),NR,'-,0.74072 unit decrease,[0.42-1.06],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs952365-<b>A</b>,5 x 10-7,(GEE model),NR,'-,0.8233 unit decrease,[0.5-1.14],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:105262407
rs13101183-<b>T</b>,6 x 10-7,(GEE model),NR,'-,0.99061 unit decrease,[0.6-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:117260229
rs9812918-<b>C</b>,7 x 10-7,(GEE model),NR,'-,0.49768 unit decrease,[0.3-0.69],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,3:118331871
chr3:118177672-<b>A</b>,8 x 10-6,(GEE model),NR,'-,0.45133 unit decrease,[0.25-0.65],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr1:239050971-<b>A</b>,2 x 10-6,(GEE model),NR,'-,1.0635 unit increase,[0.62-1.5],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs16837642-<b>T</b>,1 x 10-7,(GEE model),NR,'-,0.88226 unit decrease,[0.56-1.21],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,1:238994295
rs78401062-<b>C</b>,5 x 10-6,(GEE model),NR,'-,0.71892 unit decrease,[0.41-1.03],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:5450224
chr2:9046230-<b>AGG</b>,3 x 10-6,(GEE model),NR,'-,1.0132 unit decrease,[0.59-1.44],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr2:9156797-<b>CA</b>,7 x 10-6,(GEE model),NR,'-,0.95779 unit decrease,[0.54-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr2:35083087-<b>G</b>,3 x 10-7,(GEE model),NR,'-,0.46041 unit decrease,[0.28-0.64],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs75207608-<b>G</b>,5 x 10-6,(GEE model),NR,'-,0.99573 unit decrease,[0.57-1.42],CCDC85A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:56441694
rs17048196-<b>A</b>,1 x 10-7,(GEE model),NR,'-,1.0356 unit decrease,[0.65-1.42],LLPHP3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:56583247
rs78144564-<b>A</b>,3 x 10-7,(GEE model),NR,'-,0.92865 unit decrease,[0.57-1.29],"LINC02245, LINC02576",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:65037716
rs115101230-<b>C</b>,4 x 10-7,(GEE model),NR,'-,1.066 unit decrease,[0.65-1.48],RNA5SP173,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,4:178408010
rs73026046-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.7973 unit decrease,[0.45-1.15],PATE3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:125791197
rs78356676-<b>C</b>,8 x 10-7,(GEE model),NR,'-,0.98241 unit increase,[0.59-1.37],SLC2A14,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:7824330
rs12303711-<b>A</b>,7 x 10-6,(GEE model),NR,'-,0.82933 unit increase,[0.47-1.19],LINC00477,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:24581194
rs34528337-<b>C</b>,3 x 10-6,(GEE model),NR,'-,1.2485 unit decrease,[0.72-1.77],LINC01479,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:67926217
chr12:102082121-<b>CG</b>,2 x 10-7,(GEE model),NR,'-,0.92584 unit increase,[0.58-1.27],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs80086666-<b>T</b>,7 x 10-6,(GEE model),NR,'-,0.88148 unit decrease,[0.5-1.27],"LINC00424, RN7SL766P",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:21809886
rs1590594-<b>C</b>,3 x 10-8,(GEE model),NR,'-,1.1951 unit increase,[0.77-1.62],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:47612501
rs36180537-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.88672 unit decrease,[0.52-1.26],LINC02335,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:55131671
rs11620044-<b>G</b>,7 x 10-6,(GEE model),NR,'-,0.98684 unit decrease,[0.56-1.42],DNAJA1P1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:58831133
rs118102991-<b>A</b>,5 x 10-6,(GEE model),NR,'-,1.0582 unit decrease,[0.6-1.51],HMGN2P39,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:59005492
rs9599110-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.8945 unit decrease,[0.53-1.26],PCDH9,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:66405989
rs79538982-<b>G</b>,2 x 10-9,(GEE model),NR,'-,1.4337 unit decrease,[0.96-1.9],"LINC00348, MTCL1P1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:70946701
rs7985509-<b>G</b>,1 x 10-8,(GEE model),NR,'-,0.81664 unit increase,[0.54-1.1],"LINC00564, DPPA3P3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:81170245
chr13:93655779-<b>AACTC</b>,1 x 10-6,(GEE model),NR,'-,1.2061 unit increase,[0.72-1.7],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs9559817-<b>A</b>,1 x 10-6,(GEE model),NR,'-,0.45677 unit decrease,[0.27-0.64],COL4A2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:110472624
rs57611377-<b>T</b>,1 x 10-7,(GEE model),NR,'-,0.95611 unit increase,[0.6-1.31],STXBP6,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:24804695
rs950010-<b>G</b>,2 x 10-7,(GEE model),NR,'-,0.96362 unit decrease,[0.6-1.33],GNG2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:51970017
rs138656381-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.93839 unit decrease,[0.55-1.33],FUT8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:65495566
rs79666627-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.89637 unit decrease,[0.5-1.29],FUT8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:65755293
rs117045930-<b>C</b>,1 x 10-7,(GEE model),NR,'-,1.273 unit decrease,[0.8-1.75],"SERPINA9, SERPINA11",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,14:94454310
rs2899492-<b>C</b>,6 x 10-7,(GEE model),NR,'-,0.62012 unit increase,[0.38-0.86],FAM214A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:52641065
rs150550955-<b>G</b>,2 x 10-7,(GEE model),NR,'-,1.2447 unit decrease,[0.78-1.71],PRTG,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:55719171
chr15:68055986-<b>A</b>,2 x 10-6,(GEE model),NR,'-,0.72052 unit decrease,[0.42-1.02],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs58226358-<b>T</b>,2 x 10-6,(GEE model),NR,'-,1.0128 unit decrease,[0.6-1.43],ADAMTS7P3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:77983053
rs186706570-<b>C</b>,4 x 10-7,(GEE model),NR,'-,1.0482 unit decrease,[0.64-1.45],LINC01579,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:93798258
rs79116212-<b>G</b>,5 x 10-7,(GEE model),NR,'-,0.87308 unit decrease,[0.53-1.21],VLDLR-AS1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:2448654
rs10122329-<b>G</b>,2 x 10-8,(GEE model),NR,'-,1.0368 unit increase,[0.67-1.4],"PUM3, GPS2P1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:2844360
chr9:17646666-<b>T</b>,3 x 10-6,(GEE model),NR,'-,1.0588 unit decrease,[0.61-1.51],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs10963978-<b>G</b>,2 x 10-6,(GEE model),NR,'-,1.1215 unit decrease,[0.66-1.58],PLIN2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:19139572
rs3731249-<b>C</b>,6 x 10-6,(GEE model),NR,'-,1.2609 unit decrease,[0.71-1.81],CDKN2A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:21970917
chr9:72111879-<b>AC</b>,8 x 10-7,(GEE model),NR,'-,0.67226 unit decrease,[0.4-0.94],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr9:75841708-<b>AT</b>,6 x 10-7,(GEE model),NR,'-,0.87695 unit increase,[0.53-1.22],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
chr9:80358202-<b>C</b>,3 x 10-7,(GEE model),NR,'-,0.99635 unit decrease,[0.62-1.38],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs7028759-<b>T</b>,2 x 10-6,(GEE model),NR,'-,0.67689 unit increase,[0.4-0.96],TRMO,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:97915601
rs3824497-<b>A</b>,4 x 10-6,(GEE model),NR,'-,0.72886 unit decrease,[0.42-1.04],GABBR2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:98453701
rs12686004-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.60571 unit increase,[0.36-0.86],ABCA1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:104891145
rs79523756-<b>C</b>,2 x 10-9,(GEE model),NR,'-,0.75083 unit decrease,[0.5-1],"KIF12, COL27A1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:114127254
rs10819287-<b>C</b>,3 x 10-9,(GEE model),NR,'-,1.1125 unit increase,[0.75-1.48],SLC2A8,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:127404103
rs11250601-<b>C</b>,8 x 10-6,(GEE model),NR,'-,0.82215 unit decrease,[0.46-1.18],"ADARB2-AS1, ADARB2",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:1537583
rs148405458-<b>C</b>,4 x 10-8,(GEE model),NR,'-,1.0014 unit decrease,[0.64-1.36],LINC02668,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:3254357
rs181259817-<b>C</b>,4 x 10-6,(GEE model),NR,'-,0.92002 unit decrease,[0.53-1.31],PRKG1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:51756590
rs61851911-<b>G</b>,1 x 10-6,(GEE model),NR,'-,0.88856 unit decrease,[0.53-1.24],MRPS35P3,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:58077561
rs11195365-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.67448 unit decrease,[0.4-0.95],PDCD4,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:110883279
chr10:112774958-<b>A</b>,9 x 10-7,(GEE model),NR,'-,0.75765 unit decrease,[0.45-1.06],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs182768834-<b>G</b>,2 x 10-6,(GEE model),NR,'-,0.87088 unit decrease,[0.52-1.23],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:129071311
rs72957958-<b>C</b>,7 x 10-6,(GEE model),NR,'-,0.84577 unit increase,[0.48-1.21],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:38108548
rs188620244-<b>G</b>,5 x 10-7,(GEE model),NR,'-,1.0576 unit increase,[0.65-1.47],"RNA5SP349, SNORD39",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:109218136
rs185433085-<b>C</b>,7 x 10-6,(GEE model),NR,'-,0.8837 unit decrease,[0.5-1.27],RNF214,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:117235353
rs74498740-<b>C</b>,5 x 10-7,(GEE model),NR,'-,1.228 unit increase,[0.75-1.71],DSCAML1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:117659180
rs73017762-<b>C</b>,1 x 10-6,(GEE model),NR,'-,1.0541 unit decrease,[0.63-1.48],FEZ1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,11:125560085
rs641615-<b>G</b>,4 x 10-7,(LME model),NR,'-,0.53685 unit decrease,[0.33-0.74],KRT5,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:52519125
rs10785192-<b>T</b>,2 x 10-6,(LME model),NR,'-,0.79444 unit decrease,[0.47-1.12],"KRR1, GLIPR1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:75491985
rs58107565-<b>G</b>,9 x 10-6,(LME model),NR,'-,0.47969 unit decrease,[0.27-0.69],TMEM132D,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,12:129673196
rs80187936-<b>C</b>,7 x 10-6,(LME model),NR,'-,1.0617 unit decrease,[0.6-1.53],ATP8A2,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,13:25959811
rs4534807-<b>C</b>,3 x 10-6,(LME model),NR,'-,0.47135 unit increase,[0.27-0.67],"TMCO5B, RYR3-DT",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:33283306
rs4776063-<b>C</b>,6 x 10-6,(LME model),NR,'-,0.5229 unit increase,[0.3-0.75],FAM214A,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:52611849
rs12913603-<b>A</b>,7 x 10-6,(LME model),NR,'-,0.4172 unit decrease,[0.24-0.6],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:70376485
rs3176205-<b>T</b>,1 x 10-7,(LME model),NR,'-,0.4721 unit decrease,[0.3-0.65],POLG,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,15:89322461
rs138299341-<b>A</b>,2 x 10-6,(LME model),NR,'-,1.2753 unit increase,[0.75-1.81],RNU1-23P,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,20:24272354
rs12924820-<b>A</b>,2 x 10-6,(GEE model),NR,'-,0.47702 unit decrease,[0.28-0.67],"ATF7IP2, RN7SL493P",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:10274092
rs62030649-<b>G</b>,7 x 10-8,(GEE model),NR,'-,1.0277 unit decrease,[0.65-1.4],PRKCB,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:23860811
rs4949142-<b>A</b>,6 x 10-7,(GEE model),NR,'-,0.59647 unit decrease,[0.36-0.83],LINC02165,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:63720296
rs59395068-<b>T</b>,4 x 10-6,(GEE model),NR,'-,1.1214 unit increase,[0.64-1.6],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,16:79447990
chr17:9322274-<b>CCT</b>,4 x 10-6,(GEE model),NR,'-,0.44997 unit decrease,[0.26-0.64],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs79343067-<b>T</b>,4 x 10-6,(GEE model),NR,'-,1.2663 unit increase,[0.73-1.81],HDAC5,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:44119096
rs74592000-<b>C</b>,1 x 10-6,(GEE model),NR,'-,0.96807 unit increase,[0.57-1.36],LINC01982,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:52478681
chr17:56010692-<b>CCT</b>,4 x 10-6,(GEE model),NR,'-,0.45109 unit increase,[0.26-0.64],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs55994995-<b>A</b>,1 x 10-6,(GEE model),NR,'-,0.96571 unit decrease,[0.57-1.36],"GRB2, SLC25A19",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:75313351
rs2650243-<b>A</b>,1 x 10-6,(GEE model),NR,'-,0.81205 unit increase,[0.48-1.14],TBC1D16,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,17:79935540
rs1994558-<b>A</b>,7 x 10-6,(GEE model),NR,'-,0.41538 unit decrease,[0.23-0.6],CTIF,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,18:48806024
rs594284-<b>T</b>,1 x 10-8,(GEE model),NR,'-,0.90559 unit decrease,[0.59-1.22],LINC01916,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,18:65373686
rs73620745-<b>G</b>,6 x 10-6,(GEE model),NR,'-,1.2914 unit decrease,[0.73-1.85],"PIEZO1P1, EDN3",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,20:59377140
rs742720-<b>T</b>,6 x 10-6,(GEE model),NR,'-,0.73415 unit decrease,[0.42-1.05],PPIAP1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,21:20862645
rs35108539-<b>T</b>,7 x 10-6,(GEE model),NR,'-,0.40059 unit increase,[0.23-0.58],"KRTAP7-1, KRTAP11-1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,21:30864151
chr2:19395907-<b>T</b>,9 x 10-6,(LME model),NR,'-,0.72481 unit increase,[0.41-1.04],'-,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,Mapping not available
rs192269070-<b>A</b>,4 x 10-6,(LME model),NR,'-,1.2594 unit increase,[0.73-1.79],"ANAPC1P3, MIR4771-1",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:87124603
rs10182651-<b>A</b>,1 x 10-9,(LME model),NR,'-,0.63574 unit decrease,[0.43-0.84],"UGT1A12P, USP40",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,2:233575317
rs111747604-<b>C</b>,9 x 10-6,(LME model),NR,'-,0.85339 unit increase,[0.48-1.23],MBOAT1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:20177687
rs45604140-<b>C</b>,7 x 10-6,(LME model),NR,'-,0.65899 unit decrease,[0.37-0.95],PTK7,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:43131869
rs77801015-<b>A</b>,1 x 10-6,(LME model),NR,'-,0.82996 unit decrease,[0.5-1.16],MIR4643,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:91471198
rs4897203-<b>T</b>,1 x 10-6,(LME model),NR,'-,0.75243 unit increase,[0.45-1.05],TRDN,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,6:123371601
rs34919929-<b>G</b>,7 x 10-7,(LME model),NR,'-,0.48295 unit increase,[0.29-0.67],ZCWPW1,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,7:100414711
rs117754360-<b>C</b>,6 x 10-6,(LME model),NR,'-,0.98912 unit decrease,[0.56-1.42],LINC00587,Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,9:102673902
rs1545045-<b>A</b>,2 x 10-6,(LME model),NR,'-,0.5362 unit increase,[0.32-0.76],"TEX36-AS1, RPS27P18",Rate of cognitive decline in Alzheimer's disease,"Alzheimer's disease, cognitive decline measurement",GCST010567,10:125501459
rs12151021-<b>?</b>,2 x 10-13,,NR,'-,0.0772974 unit increase,'-,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:1050875
rs4147918-<b>?</b>,8 x 10-7,,NR,'-,0.120111 unit decrease,'-,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:1058177
rs4311-<b>?</b>,1 x 10-8,,NR,'-,0.0542811 unit decrease,'-,ACE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,17:63483402
rs3730025-<b>?</b>,3 x 10-7,,NR,'-,0.199405 unit increase,'-,ACE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,17:63480412
rs4775044-<b>?</b>,4 x 10-6,,NR,'-,0.0438743 unit decrease,'-,ALDH1A2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,15:58392768
rs442495-<b>?</b>,3 x 10-11,,NR,'-,0.0675868 unit decrease,'-,ADAM10,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,15:58730416
rs4817090-<b>?</b>,1 x 10-7,,NR,'-,0.0530908 unit increase,'-,APP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,21:26161943
rs2830489-<b>?</b>,3 x 10-8,,NR,'-,0.0589648 unit decrease,'-,ADAMTS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,21:26775872
rs7412-<b>?</b>,4 x 10-123,,NR,'-,0.435261 unit decrease,'-,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44908822
rs111358663-<b>?</b>,3 x 10-16,,NR,'-,0.353882 unit decrease,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44693688
rs4803774-<b>?</b>,5 x 10-15,,NR,'-,0.0747163 unit increase,'-,"APOC4-APOC2, APOC2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44947615
rs3112440-<b>?</b>,2 x 10-14,,NR,'-,0.102341 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44864753
rs71171301-<b>?</b>,5 x 10-29,,NR,'-,0.171993 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44879835
rs35194062-<b>?</b>,8 x 10-18,,NR,'-,0.198766 unit increase,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:45001919
rs283813-<b>?</b>,8 x 10-28,,NR,'-,0.20705 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44885917
rs138607350-<b>?</b>,4 x 10-102,,NR,'-,1.03437 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44860563
rs146275714-<b>?</b>,1 x 10-300,,NR,'-,1.11415 unit increase,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44862190
rs429358-<b>?</b>,1 x 10-300,,NR,'-,1.17924 unit increase,'-,'-,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,Mapping not available
rs12691088-<b>?</b>,1 x 10-300,,NR,'-,1.18305 unit increase,'-,APOC1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,19:44915229
rs7584040-<b>?</b>,2 x 10-6,,NR,'-,0.0537322 unit increase,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:127105648
rs6733839-<b>?</b>,1 x 10-54,,NR,'-,0.155615 unit increase,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:127135234
rs867230-<b>?</b>,8 x 10-26,,NR,'-,0.105124 unit decrease,'-,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,8:27610986
rs73223431-<b>?</b>,2 x 10-15,,NR,'-,0.0790484 unit increase,'-,PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,8:27362470
rs12703526-<b>?</b>,1 x 10-11,,NR,'-,0.0654321 unit decrease,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,7:143410495
rs10265814-<b>?</b>,3 x 10-10,,NR,'-,0.0607201 unit increase,'-,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,7:143424528
rs143080277-<b>?</b>,1 x 10-12,,NR,'-,0.520528 unit increase,'-,NCK2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:105749599
rs116038905-<b>?</b>,3 x 10-6,,NR,'-,0.150266 unit decrease,'-,NCK2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,2:105805908
rs3857580-<b>?</b>,1 x 10-7,,NR,'-,0.0503548 unit decrease,'-,TREML5P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,6:41248596
rs114812713-<b>?</b>,1 x 10-12,,NR,'-,0.208485 unit increase,'-,OARD1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,6:41066261
rs187370608-<b>?</b>,2 x 10-23,,NR,'-,0.796876 unit increase,'-,UNC5CL,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST90012877,6:40974457
rs56131196-<b>A</b>,4 x 10-12,(Cortical Ab),0.29,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,19:44919589
rs6857-<b>T</b>,1 x 10-10,(Cortical Ab),0.28,'-,'-,'-,NECTIN2,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,19:44888997
rs59007384-<b>T</b>,7 x 10-9,(Cortical Ab),0.32,'-,'-,'-,TOMM40,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,19:44893408
rs7702276-<b>T</b>,1 x 10-6,(Cortical Ab),0.36,'-,'-,'-,MFSD4BP1,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,5:52509908
rs24449894-<b>A</b>,2 x 10-6,(Cortical Ab),0.17,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,Mapping not available
rs7039300-<b>G</b>,2 x 10-6,(Cortical Ab),0.23,'-,'-,'-,"RPL3P11, ATP5PDP3",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,9:14064742
rs9384488-<b>A</b>,3 x 10-6,(Cortical Ab),0.35,'-,'-,'-,"H3P28, ARID1B",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,6:156688247
rs10219670-<b>C</b>,4 x 10-6,(Cortical Ab),0.42,'-,'-,'-,CASC18,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,12:105714941
Position173336636-<b>A</b>,6 x 10-7,(Cortical Ab),0.43,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,Mapping not available
rs509208-<b>G</b>,3 x 10-8,(Cortical Ab),0.16,'-,'-,'-,CCDC66,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,3:166296681
rs113524839-<b>T</b>,8 x 10-7,(Cortical Ab),0.11,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,5:84788958
rs1422438-<b>G</b>,6 x 10-7,(Cortical Ab),0.3,'-,'-,'-,"RN7SL782P, RN7SKP122",Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,5:107775475
rs429358-<b>C</b>,5 x 10-14,(Cortical Ab),0.28,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, amyloid-beta measurement",GCST001868,Mapping not available
rs62209-<b>C</b>,2 x 10-7,(APOE E4 homozygotes),NR,2.04,'-,[1.56-2.67],CELF2,Alzheimer's disease (late onset),Alzheimer's disease,GCST000980,10:10958376
rs4968782-<b>G</b>,4 x 10-12,(Angiotensin-converting enzyme),NR,'-,'-,'-,"PPIAP55, CYB561",Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"angiotensin-converting enzyme measurement, Alzheimer's disease, Alzheimer's disease biomarker measurement",GCST002665,17:63471115
rs61812598-<b>G</b>,6 x 10-63,(Interleukin-6 receptor),NR,'-,'-,'-,IL6R,Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"Alzheimer's disease, interleukin-6 measurement, Alzheimer's disease biomarker measurement",GCST002665,1:154447611
rs6808835-<b>G</b>,2 x 10-13,(Macrophage Inflammatory protein-1 beta),NR,'-,'-,'-,CCRL2,Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"Alzheimer's disease, CCL4 measurement, Alzheimer's disease biomarker measurement",GCST002665,3:46408373
rs573521-<b>A</b>,2 x 10-44,(Matrix metalloproteinase-3),NR,'-,'-,'-,"MMP3, MMP12",Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"matrix metalloproteinase measurement, Alzheimer's disease, Alzheimer's disease biomarker measurement",GCST002665,11:102846249
rs2228467-<b>G</b>,4 x 10-18,(Monocyte chemotactic protein 1),NR,'-,'-,'-,"ACKR2, KRBOX1, CYP8B1",Cerebrospinal fluid levels of Alzheimer's disease-related proteins,"Alzheimer's disease, Alzheimer's disease biomarker measurement, CCL2 measurement",GCST002665,3:42864624
rs75932628-<b>T</b>,2 x 10-12,,0.0063,2.9,'-,[2.16-3.91],TREM2,Alzheimer's disease,Alzheimer's disease,GCST001743,6:41161514
rs2373115-<b>G</b>,1 x 10-10,,0.7,4.06,'-,[2.81-14.69],GAB2,Alzheimer's disease (late onset),Alzheimer's disease,GCST000046,11:78380104
rs2121433-<b>?</b>,1 x 10-6,(t-tau),NR,'-,'-,'-,"EPC2, RNU2-9P",Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST000900,2:148800291
rs157580-<b>?</b>,1 x 10-6,(AB1-42),NR,'-,'-,'-,TOMM40,Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST000900,19:44892009
rs7364180-<b>?</b>,1 x 10-6,(AB1-42),NR,'-,'-,'-,CCDC134,Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST000900,22:41822852
rs4499362-<b>?</b>,1 x 10-6,(t-tau/AB1-42),NR,'-,'-,'-,"RNU2-9P, EPC2",Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement, t-tau measurement",GCST000900,2:148810827
rs2075650-<b>?</b>,1 x 10-6,"(p-tau181p/AB1-42, t-tau/AB1-42)",NR,'-,'-,'-,TOMM40,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement",GCST000900,19:44892362
rs429358-<b>?</b>,1 x 10-6,"(AB1-42, p-tau181p, p-tau181p/AB1-42, t-tau/AB1-42)",NR,'-,'-,'-,'-,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement, beta-amyloid 1-42 measurement, t-tau measurement",GCST000900,Mapping not available
rs439401-<b>?</b>,1 x 10-6,(AB1-42),NR,'-,'-,'-,"APOC1, APOE",Alzheimer's disease biomarkers,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST000900,19:44911194
rs4420638-<b>?</b>,8 x 10-149,,NR,3.45,'-,[NR],"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST001529,19:44919689
rs11738335-<b>?</b>,5 x 10-6,,NR,1.2,'-,[NR],C5orf64,Alzheimer's disease,Alzheimer's disease,GCST001529,5:61654384
rs12808148-<b>?</b>,1 x 10-6,,NR,1.23,'-,[NR],"MMP12, MMP3",Alzheimer's disease,Alzheimer's disease,GCST001529,11:102862432
rs1357692-<b>?</b>,9 x 10-6,,NR,1.16,'-,[NR],DHFRP3,Alzheimer's disease,Alzheimer's disease,GCST001529,2:107062032
rs7561528-<b>?</b>,6 x 10-11,,NR,1.25,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease,Alzheimer's disease,GCST001529,2:127132061
rs17817600-<b>?</b>,2 x 10-8,,NR,1.33,'-,[NR],PICALM,Alzheimer's disease,Alzheimer's disease,GCST001529,11:85966428
rs3748140-<b>?</b>,3 x 10-7,,NR,2.43,'-,[NR],PPP1R3B,Alzheimer's disease,Alzheimer's disease,GCST001529,8:9141509
rs6856768-<b>?</b>,5 x 10-6,,NR,1.18,'-,[NR],RN7SKP199,Alzheimer's disease,Alzheimer's disease,GCST001529,4:30466544
rs9832461-<b>A</b>,4 x 10-6,,0.24,'-,3785.6 unit increase,[NR],NFU1P1,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,3:39708102
rs1448284-<b>T</b>,2 x 10-6,,0.03,'-,9939.9 unit increase,[NR],MAPRE1P2,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,4:33078033
rs11055612-<b>C</b>,3 x 10-6,,0.5,'-,3371.6 unit decrease,[NR],GRIN2B,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,12:13770394
rs7155434-<b>A</b>,8 x 10-6,,0.27,'-,3643 unit increase,[NR],NRXN3,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,14:78308963
rs2456930-<b>G</b>,3 x 10-7,,0.38,'-,3843.9 unit increase,[NR],TLN2,Brain structure (temporal lobe volume),Alzheimer's disease,GCST000614,15:62395140
rs17636071-<b>G</b>,2 x 10-6,(MMSE),0.09,'-,4.74 unit decrease,[NR],'-,Response to cholinesterase inhibitors in Alzheimer's disease,"response to cholinesterase inhibitor, Alzheimer's disease",GCST001835,Mapping not available
rs2270875-<b>G</b>,9 x 10-6,(MMSE),0.16,'-,2.84 unit decrease,[NR],EFR3A,Response to cholinesterase inhibitors in Alzheimer's disease,"response to cholinesterase inhibitor, Alzheimer's disease",GCST001835,8:131987689
rs17798800-<b>?</b>,7 x 10-6,(cases vs. controls),0.71,2.63,'-,[1.72-4],LINC02343,Response to cholinesterase inhibitors in Alzheimer's disease,"response to cholinesterase inhibitor, Alzheimer's disease",GCST001835,13:34376390
rs11159647-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,'-,Alzheimer's disease,Alzheimer's disease,GCST000255,14:84308865
rs3826656-<b>?</b>,6 x 10-6,,NR,'-,'-,'-,"CD33, SIGLEC22P",Alzheimer's disease,Alzheimer's disease,GCST000255,19:51223357
rs16839220-<b>G</b>,5 x 10-6,,0.8,1.8867927,'-,[1.61-2.16],'-,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,Mapping not available
rs2289506-<b>T</b>,3 x 10-7,,0.34,1.61,'-,[1.43-1.79],NIT2,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,3:100346058
rs9369477-<b>C</b>,2 x 10-7,,0.08,2.0408163,'-,[1.77-2.32],"AARS2, SPATS1",Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,6:44340892
rs9372110-<b>A</b>,2 x 10-7,,0.06,2.16,'-,[1.87-2.45],RN7SKP211,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,6:105869321
rs2046197-<b>C</b>,3 x 10-7,,0.59,1.66,'-,[1.46-1.86],CSMD1,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,8:3762230
rs8021600-<b>G</b>,3 x 10-6,,0.08,1.9607843,'-,[1.69-2.24],'-,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,14:43701423
rs8091629-<b>G</b>,2 x 10-6,,0.1,1.8518518,'-,[1.60-2.11],SLC14A2,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,18:45640366
rs698842-<b>A</b>,2 x 10-6,,0.22,1.96,'-,[1.69-2.23],NRXN1,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,2:50662958
rs10175975-<b>T</b>,3 x 10-6,,0.19,1.99,'-,[1.7-2.28],LINC01793,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,2:59202672
rs78872508-<b>C</b>,2 x 10-6,,0.13,2.2222223,'-,[1.89-2.56],HDAC9,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,7:18976853
rs4348488-<b>C</b>,3 x 10-6,,0.21,1.97,'-,[1.68-2.26],BMP1,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,8:22166649
rs17089546-<b>A</b>,3 x 10-6,,0.25,1.86,'-,[1.61-2.11],NKX2-6,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,8:23714294
rs74717330-<b>A</b>,2 x 10-6,,0.05,3.09,'-,[2.62-3.56],"HNF4G, PKMP4",Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,8:75384073
rs191325450-<b>G</b>,2 x 10-6,,0.09,2.3255813,'-,[1.97-2.68],RPS19P6,Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,9:80763069
rs4543939-<b>A</b>,4 x 10-6,,0.43,2.43,'-,[2.06-2.8],"LINC02746, SNRPGP16",Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,11:92934492
rs1977412-<b>C</b>,6 x 10-7,,0.14,1.5625,'-,[1.39-1.74],AGT,Alzheimer's disease with memory domain impairment,"Alzheimer's disease, memory impairment",GCST007330,1:230716523
rs9937469-<b>T</b>,2 x 10-6,,0.06,2.14,'-,[1.83-2.45],RPL21P119,Alzheimer's disease with memory domain impairment,"Alzheimer's disease, memory impairment",GCST007330,16:9158799
rs2795228-<b>T</b>,6 x 10-7,,0.18,1.6949153,'-,[1.48-1.91],LINC01712,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,1:83475611
rs484947-<b>C</b>,2 x 10-6,,0.38,1.5625,'-,[1.37-1.76],LINC02815,Alzheimer's disease with visuospatial domain impairment,"Alzheimer's disease, visuospatial impairment",GCST007318,1:229029741
rs8059356-<b>A</b>,6 x 10-7,,0.21,2.23,'-,[1.92-2.54],"LINC00917, LINC01081",Alzheimer's disease with multiple cognitive domain impairments,"Alzheimer's disease, Cognitive impairment",GCST007332,16:86323639
rs4972634-<b>T</b>,4 x 10-6,,0.59,1.31,'-,[1.19-1.43],"RPSAP24, LINC01960",Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,2:174042477
rs11708767-<b>A</b>,3 x 10-7,,0.43,1.33,'-,[1.21-1.45],MED12L,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,3:151401938
rs4533991-<b>T</b>,2 x 10-6,,0.46,1.32,'-,[1.2-1.44],'-,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,6:51233850
rs78358979-<b>A</b>,5 x 10-7,,0.06,1.76,'-,[1.54-1.98],'-,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,6:86795185
rs6978679-<b>A</b>,2 x 10-6,,0.73,1.36,'-,[1.24-1.48],"CDHR3, SYPL1",Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,7:106078297
rs72839770-<b>T</b>,4 x 10-6,,0.36,1.31,'-,[1.19-1.43],DVL2,Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,17:7228873
rs7264688-<b>T</b>,5 x 10-6,,0.67,1.47,'-,[1.31-1.63],"MGME1, OVOL2",Alzheimer's disease with no specific cognitive domain impairment,Alzheimer's disease,GCST007333,20:17974063
rs11642612-<b>A</b>,2 x 10-8,,0.62,'-,'-,'-,DOC2A,Alzheimer's disease or LDL levels (pleiotropy),"Alzheimer's disease, low density lipoprotein cholesterol measurement",GCST90013837,16:30018874
rs7225151-<b>?</b>,1 x 10-8,,NR,1.1,'-,[1.06-1.14],"SCIMP, ZNF594-DT",Alzheimer's disease,Alzheimer's disease,GCST009021,17:5233752
rs429358-<b>C</b>,1 x 10-62,,0.17,2.27,'-,[2.5-2.06],'-,Alzheimer's disease,Alzheimer's disease,GCST009020,Mapping not available
rs429358-<b>C</b>,6 x 10-14,,0.17,1.69,'-,[1.93-1.47],'-,Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD+),"Alzheimer's disease, vascular dementia",GCST009025,Mapping not available
rs429358-<b>C</b>,1 x 10-64,,0.17,2.39,'-,[2.64-2.17],'-,Alzheimer’s disease (clinical subgroup AD+),Alzheimer's disease,GCST009022,Mapping not available
rs429358-<b>C</b>,1 x 10-76,,0.17,2.71,'-,[3.01-2.44],'-,Alzheimer’s disease (clinical subgroup AD++),Alzheimer's disease,GCST009023,Mapping not available
rs429358-<b>C</b>,1 x 10-75,,0.17,2.92,'-,[3.27-2.6],'-,Alzheimer’s disease (clinical subgroup AD+++),Alzheimer's disease,GCST009024,Mapping not available
rs117834366-<b>A</b>,2 x 10-8,,0.011,6.03,'-,[3.22-11.2],CNTNAP2,Alzheimer’s disease and/or vascular dementia (clinical subgroup VaD++),"Alzheimer's disease, vascular dementia",GCST009026,7:147937799
rs6733839-<b>?</b>,5 x 10-20,,NR,1.23,'-,[1.18 – 1.28],"NIFKP9, BIN1",Alzheimer's disease,Alzheimer's disease,GCST009019,2:127135234
rs983392-<b>?</b>,5 x 10-8,,NR,1.1235955,'-,'-,"LINC02705, MS4A2",Alzheimer's disease,Alzheimer's disease,GCST009019,11:60156035
rs10792832-<b>?</b>,2 x 10-11,,NR,1.1627907,'-,'-,"LINC02695, RNU6-560P",Alzheimer's disease,Alzheimer's disease,GCST009019,11:86156833
rs429358-<b>?</b>,2 x 10-303,,NR,3.21,'-,[3.02 – 3.41],'-,Alzheimer's disease,Alzheimer's disease,GCST009019,Mapping not available
rs3865444-<b>?</b>,7 x 10-6,,NR,1.1111112,'-,'-,"CD33, SIGLEC22P",Alzheimer's disease,Alzheimer's disease,GCST009019,19:51224706
rs4704171-<b>?</b>,1 x 10-8,,NR,1.18,'-,[1.11-1.24],ANKRD31,Alzheimer's disease,Alzheimer's disease,GCST009019,5:75072429
rs11218343-<b>?</b>,1 x 10-10,,NR,1.2820514,'-,[1.37-1.19],SORL1,Alzheimer's disease,Alzheimer's disease,GCST009021,11:121564878
rs2732703-<b>?</b>,1 x 10-7,,NR,1.1627907,'-,[1.23-1.1],ARL17B,Alzheimer's disease,Alzheimer's disease,GCST009021,17:46275856
rs9331896-<b>?</b>,6 x 10-15,,NR,1.1363636,'-,[1.16-1.1],CLU,Alzheimer's disease,Alzheimer's disease,GCST009021,8:27610169
rs10792832-<b>?</b>,4 x 10-18,,NR,1.1363636,'-,[1.1-1.16],"LINC02695, RNU6-560P",Alzheimer's disease,Alzheimer's disease,GCST009021,11:86156833
rs983392-<b>?</b>,9 x 10-13,,NR,1.1111112,'-,[1.08-1.15],"LINC02705, MS4A2",Alzheimer's disease,Alzheimer's disease,GCST009021,11:60156035
rs11771145-<b>?</b>,5 x 10-10,,NR,1.098901,'-,[1.06-1.14],EPHA1-AS1,Alzheimer's disease,Alzheimer's disease,GCST009021,7:143413669
rs10498633-<b>?</b>,1 x 10-6,,NR,1.0869565,'-,[1.05-1.14],SLC24A4,Alzheimer's disease,Alzheimer's disease,GCST009021,14:92460608
rs3865444-<b>?</b>,4 x 10-8,,NR,1.0869565,'-,[1.05-1.12],"CD33, SIGLEC22P",Alzheimer's disease,Alzheimer's disease,GCST009021,19:51224706
rs190982-<b>?</b>,4 x 10-6,,NR,1.0752687,'-,[1.11-1.04],MEF2C-AS1,Alzheimer's disease,Alzheimer's disease,GCST009021,5:88927603
rs1476679-<b>?</b>,2 x 10-6,,NR,1.0752687,'-,[1.11-1.04],ZCWPW1,Alzheimer's disease,Alzheimer's disease,GCST009021,7:100406823
rs2718058-<b>?</b>,2 x 10-6,,NR,1.0638298,'-,[1.10-1.03],"GPR141, EPDR1",Alzheimer's disease,Alzheimer's disease,GCST009021,7:37801932
rs10838725-<b>?</b>,3 x 10-6,,NR,1.07,'-,[1.04-1.10],CELF1,Alzheimer's disease,Alzheimer's disease,GCST009021,11:47536319
rs9271192-<b>?</b>,5 x 10-7,,NR,1.09,'-,[1.13-1.05],"HLA-DRB1, HLA-DQA1",Alzheimer's disease,Alzheimer's disease,GCST009021,6:32610753
rs28834970-<b>?</b>,6 x 10-9,,NR,1.09,'-,[1.12-1.06],PTK2B,Alzheimer's disease,Alzheimer's disease,GCST009021,8:27337604
rs10948363-<b>?</b>,5 x 10-9,,NR,1.1,'-,[1.13-1.06],CD2AP,Alzheimer's disease,Alzheimer's disease,GCST009021,6:47520026
rs4147929-<b>?</b>,3 x 10-9,,NR,1.12,'-,[1.08-1.17],ABCA7,Alzheimer's disease,Alzheimer's disease,GCST009021,19:1063444
rs6656401-<b>?</b>,2 x 10-14,,NR,1.15,'-,[1.11-1.19],CR1,Alzheimer's disease,Alzheimer's disease,GCST009021,1:207518704
rs6733839-<b>?</b>,3 x 10-30,,NR,1.2,'-,[1.16-1.23],"NIFKP9, BIN1",Alzheimer's disease,Alzheimer's disease,GCST009021,2:127135234
rs10098778-<b>?</b>,2 x 10-8,,NR,1.0638298,'-,[1.04-1.09],NDUFAF6,Alzheimer's disease,Alzheimer's disease,GCST009021,8:94979792
rs9381563-<b>C</b>,3 x 10-10,,0.355,'-,6.33 z-unit increase,NR,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:47464901
rs11257238-<b>C</b>,1 x 10-8,,0.375,'-,5.69 z-unit increase,NR,"ECHDC3, USP6NL-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,10:11675398
rs2081545-<b>A</b>,2 x 10-15,,0.381,'-,7.97 z-unit decrease,NR,MS4A4A,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:60190907
rs4236673-<b>A</b>,3 x 10-19,,0.391,'-,8.98 z-unit decrease,NR,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27607412
rs4663105-<b>C</b>,3 x 10-44,,0.415,'-,13.94 z-unit increase,NR,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:127133851
rs2632516-<b>C</b>,1 x 10-6,,0.455,'-,4.9 z-unit decrease,NR,TSPOAP1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,17:58331728
rs28394864-<b>A</b>,2 x 10-8,,0.473,'-,5.62 z-unit increase,NR,"PHB, ZNF652",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,17:49373413
rs7810606-<b>T</b>,4 x 10-11,,0.5,'-,6.62 z-unit decrease,NR,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:143411065
rs7412-<b>T</b>,1 x 10-99,,0.07994,'-,21.199877 z-unit decrease,NR,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44908822
rs138607350-<b>G</b>,3 x 10-65,,0.00629,'-,17.060017 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44860563
rs79701229-<b>A</b>,1 x 10-64,,0.01276,'-,16.990263 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44881674
rs10407439-<b>A</b>,1 x 10-58,,0.296,'-,16.138115 z-unit decrease,NR,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44838691
rs2965169-<b>C</b>,3 x 10-57,,0.3883,'-,15.944032 z-unit decrease,NR,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44747899
rs116949436-<b>A</b>,7 x 10-50,,0.01073,'-,14.848961 z-unit increase,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44960129
rs55923289-<b>C</b>,3 x 10-44,,0.13,'-,13.958599 z-unit increase,NR,"CEACAM16-AS1, BCL3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44737327
rs28469095-<b>C</b>,2 x 10-38,,0.09149,'-,12.963469 z-unit increase,NR,"MARK4, NKPD1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45152075
rs111371860-<b>T</b>,6 x 10-35,,0.06009,'-,12.327317 z-unit decrease,NR,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44842530
rs2967668-<b>G</b>,7 x 10-25,,0.1098,'-,10.3022 z-unit decrease,NR,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44799694
rs76692773-<b>T</b>,9 x 10-24,,0.07319,'-,10.04716 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44890954
rs11672748-<b>G</b>,1 x 10-23,,0.3171,'-,10.028075 z-unit increase,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44986934
rs595290-<b>C</b>,7 x 10-23,,0.1582,'-,9.847612 z-unit increase,NR,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45205150
rs346757-<b>C</b>,2 x 10-22,,0.08386,'-,9.756002 z-unit increase,NR,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45222190
rs34874378-<b>A</b>,9 x 10-22,,0.04366,'-,9.593067 z-unit increase,NR,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45013623
rs183427010-<b>A</b>,3 x 10-21,,0.004629,'-,9.459884 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44863241
rs111740474-<b>A</b>,5 x 10-21,,0.01165,'-,9.402366 z-unit increase,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44720227
rs1160984-<b>T</b>,2 x 10-20,,0.05762,'-,9.292308 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44900667
rs11665676-<b>T</b>,1 x 10-19,,0.05183,'-,9.089448 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44875462
rs561654715-<b>A</b>,9 x 10-19,,0.002832,'-,8.842536 z-unit increase,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44890947
rs55840414-<b>A</b>,5 x 10-18,,0.1183,'-,8.655959 z-unit decrease,NR,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44840322
rs112481437-<b>A</b>,1 x 10-17,,0.02337,'-,8.578216 z-unit increase,NR,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45045877
rs203709-<b>A</b>,4 x 10-17,,0.2645,'-,8.408471 z-unit decrease,NR,"CEACAM16-AS1, PVR",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44658298
rs11881756-<b>C</b>,5 x 10-17,,0.1138,'-,8.381871 z-unit decrease,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44717621
rs76856627-<b>G</b>,1 x 10-16,,0.0329,'-,8.306043 z-unit increase,NR,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45040497
rs60239918-<b>T</b>,2 x 10-15,,0.03999,'-,7.945099 z-unit increase,NR,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45077114
rs41290100-<b>T</b>,2 x 10-15,,0.02432,'-,7.9216814 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44867684
rs846876-<b>C</b>,1 x 10-14,,0.3755,'-,7.715924 z-unit decrease,NR,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44576817
rs147188206-<b>C</b>,3 x 10-14,,0.008636,'-,7.5976734 z-unit increase,NR,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45049329
rs2965164-<b>T</b>,1 x 10-13,,0.3456,'-,7.438834 z-unit decrease,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44698782
rs41290108-<b>C</b>,3 x 10-13,,0.03803,'-,7.317556 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44874585
rs547509922-<b>T</b>,3 x 10-13,,0.003614,'-,7.314314 z-unit increase,NR,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44828004
rs62118504-<b>G</b>,5 x 10-13,,0.3957,'-,7.2163415 z-unit decrease,NR,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45231493
rs35194383-<b>T</b>,8 x 10-13,,0.4234,'-,7.1647267 z-unit increase,NR,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45012792
rs80257887-<b>A</b>,1 x 10-12,,0.03562,'-,7.089606 z-unit increase,NR,CEACAM20,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44516798
rs75161053-<b>A</b>,2 x 10-12,,0.04757,'-,7.0672655 z-unit increase,NR,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44544863
rs142412517-<b>T</b>,2 x 10-12,,0.001157,'-,7.033927 z-unit increase,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44900801
rs12461144-<b>T</b>,4 x 10-12,,0.1266,'-,6.9530225 z-unit increase,NR,"MARK4, EXOC3L2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45220448
rs142092405-<b>G</b>,6 x 10-12,,0.00433,'-,6.8754373 z-unit increase,NR,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44820087
rs150820726-<b>T</b>,1 x 10-11,,0.008836,'-,6.80423 z-unit increase,NR,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44723891
rs183321458-<b>A</b>,2 x 10-11,,0.003582,'-,6.7473207 z-unit increase,NR,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45077818
rs539159088-<b>C</b>,2 x 10-11,,0.01086,'-,6.705168 z-unit increase,NR,"CEACAM16-AS1, IGSF23",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44634022
rs576651896-<b>G</b>,2 x 10-11,,0.004649,'-,6.6975107 z-unit increase,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44960141
rs186110295-<b>T</b>,4 x 10-11,,0.01273,'-,6.5884266 z-unit increase,NR,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44730236
rs78986976-<b>A</b>,8 x 10-11,,0.05489,'-,6.508301 z-unit decrease,NR,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44826181
rs204907-<b>G</b>,9 x 10-11,,0.049,'-,6.482148 z-unit decrease,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44958739
rs141864196-<b>A</b>,3 x 10-10,,0.02628,'-,6.313068 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44902242
rs114036675-<b>A</b>,3 x 10-10,,0.002756,'-,6.2855 z-unit increase,NR,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44759439
rs3752241-<b>G</b>,4 x 10-10,,0.1656,'-,6.273173 z-unit decrease,NR,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:1053525
rs11083743-<b>C</b>,1 x 10-9,,0.2682,'-,6.0971603 z-unit increase,NR,IGSF23,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44621921
rs34181358-<b>A</b>,3 x 10-9,,0.1063,'-,5.9258137 z-unit decrease,NR,CHRNA2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27465457
rs204480-<b>T</b>,6 x 10-9,,0.2501,'-,5.81275 z-unit decrease,NR,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44973854
rs10421247-<b>C</b>,7 x 10-9,,0.4994,'-,5.801472 z-unit decrease,NR,"NKPD1, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45154228
rs419010-<b>C</b>,8 x 10-9,,0.4477,'-,5.773656 z-unit decrease,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44865063
rs9653111-<b>T</b>,1 x 10-8,,0.1298,'-,5.6693845 z-unit decrease,NR,"GEMIN7-AS1, MARK4, GEMIN7",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45089217
rs769452-<b>C</b>,2 x 10-8,,0.001629,'-,5.5855217 z-unit increase,NR,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44907853
rs143332484-<b>T</b>,3 x 10-8,,0.009954,'-,5.5406914 z-unit increase,NR,TREM2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:41161469
rs4727449-<b>T</b>,3 x 10-8,,0.1607,'-,5.5144157 z-unit increase,NR,STAG3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:100188127
rs123187-<b>A</b>,4 x 10-8,,0.3694,'-,5.504638 z-unit decrease,NR,"RPS16P9, CKM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45327689
rs10498633-<b>T</b>,2 x 10-7,,NR,'-,5.17 z-unit decrease,NR,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,14:92460608
rs10792832-<b>A</b>,7 x 10-18,,0.3702,'-,8.61 z-unit decrease,NR,"LINC02695, RNU6-560P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:86156833
rs10948363-<b>G</b>,1 x 10-8,,0.2754,'-,5.72 z-unit increase,NR,CD2AP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:47520026
rs1081105-<b>C</b>,1 x 10-231,,0.02756,'-,32.50298 z-unit increase,NR,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44909698
rs157580-<b>G</b>,8 x 10-220,,0.3949,'-,31.6502 z-unit decrease,NR,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44892009
rs6859-<b>A</b>,1 x 10-152,,0.4218,'-,26.320562 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44878777
rs2075650-<b>?</b>,6 x 10-14,,NR,2.03167,'-,[1.67959-2.45755],TOMM40,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,19:44892362
rs6714710-<b>?</b>,1 x 10-6,,NR,1.48999,'-,[1.26062-1.7611],ZAP70,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,2:97728623
rs4965006-<b>?</b>,4 x 10-6,,NR,1.59605,'-,[1.29704-1.96399],PUS1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,12:131934988
rs2777802-<b>?</b>,6 x 10-6,,NR,1.4778666,'-,[NR],ABCA1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,9:104807056
rs11637445-<b>?</b>,6 x 10-6,,NR,1.4859304,'-,[NR],MAP2K5,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,15:67699268
rs1014897-<b>?</b>,6 x 10-6,,NR,1.4817307,'-,[NR],ANGPT4,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,20:914814
rs8038734-<b>?</b>,6 x 10-6,,NR,2.1375377,'-,[NR],ARIH1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,15:72519061
rs4997950-<b>?</b>,7 x 10-6,,NR,1.6716651,'-,[NR],"LINC01098, LINC01099",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,4:177819494
rs10061074-<b>?</b>,7 x 10-6,,NR,2.73556,'-,[1.72367-4.34148],"HIGD1AP3, MSX2",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,5:174705751
rs17125439-<b>?</b>,8 x 10-6,,NR,1.51359,'-,[1.2572-1.82226],"BCL10, DDAH1",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,1:85302696
rs433852-<b>?</b>,8 x 10-6,,NR,1.6849171,'-,[NR],FAM83E,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,19:48613847
rs7805053-<b>?</b>,8 x 10-6,,NR,1.5306224,'-,[NR],PER3P1,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,7:9684086
rs1340425-<b>?</b>,8 x 10-6,,NR,1.63103,'-,[1.28704-2.06695],RNU4ATAC8P,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,1:73920165
rs12134133-<b>?</b>,9 x 10-6,,NR,1.46044,'-,[1.22756-1.73751],"C4BPAP2, CD55",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,1:207284500
rs10071932-<b>?</b>,9 x 10-6,,NR,1.4506525,'-,[NR],"SALL4P1, GPBP1",Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,5:57358044
rs2525776-<b>?</b>,1 x 10-8,,NR,3.3,'-,[2.1-5.1],'-,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,7:81272303
rs76854344-<b>?</b>,8 x 10-10,,NR,1.9,'-,[1.5-2.3],CNTNAP5,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,2:123995579
rs72907046-<b>?</b>,1 x 10-9,,NR,3.2,'-,[2.1-4.9],TENT5A,Posterior cortical atrophy and Alzheimer's disease,"Alzheimer's disease, Posterior cortical atrophy",GCST003452,6:81418166
rs11168036-<b>T</b>,7 x 10-9,,0.5,1.08,'-,[1.06-1.10],"HBEGF, PFDN1",Alzheimer's disease,Alzheimer's disease,GCST004246,5:140327854
rs7920721-<b>G</b>,3 x 10-8,,0.4,1.08,'-,[1.06-1.10],"ECHDC3, USP6NL-AS1",Alzheimer's disease,Alzheimer's disease,GCST004246,10:11678309
rs2632516-<b>?</b>,4 x 10-8,,0.6,1.0869565,'-,[1.06-1.1],TSPOAP1-AS1,Alzheimer's disease,Alzheimer's disease,GCST004246,17:58331728
rs283811-<b>G</b>,7 x 10-9,(AA),NR,1.34,'-,[1.21-1.47],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44885243
rs6857-<b>T</b>,6 x 10-7,(AA),NR,1.27,'-,[1.15-1.40],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44888997
rs283811-<b>G</b>,1 x 10-15,(Japanese),NR,2.56,'-,[2.02-3.24],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44885243
rs6857-<b>T</b>,7 x 10-18,(Japanese),NR,3.22,'-,[2.45-4.24],NECTIN2,Alzheimer's disease,Alzheimer's disease,GCST004246,19:44888997
rs483082-<b>T</b>,1 x 10-15,(Japanese),NR,2.8,'-,[2.17-3.61],"APOC1, APOE",Alzheimer's disease,Alzheimer's disease,GCST004246,19:44912921
rs11168036-<b>T</b>,7 x 10-9,,NR,1.08,'-,[1.06-1.10],"HBEGF, PFDN1",Alzheimer's disease,Alzheimer's disease,GCST004246,5:140327854
rs12358692-<b>T</b>,3 x 10-8,,NR,1.0869565,'-,[1.04-1.12],"ECHDC3, USP6NL-AS1",Alzheimer's disease,Alzheimer's disease,GCST004246,10:11679103
rs2632516-<b>G</b>,4 x 10-8,,NR,1.0869565,'-,[1.06-1.1],TSPOAP1-AS1,Alzheimer's disease,Alzheimer's disease,GCST004246,17:58331728
rs9749589-<b>T</b>,2 x 10-8,,'-,1.3157895,'-,[1.2-1.45],NFIC,Alzheimer's disease (APOE e4 interaction),Alzheimer's disease,GCST004247,19:3405594
rs11168036-<b>T</b>,1 x 10-6,,NR,1.11,'-,[1.06-1.15],"HBEGF, PFDN1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST004249,5:140327854
rs11257238-<b>T</b>,5 x 10-9,,NR,1.14,'-,[1.10-1.18],"ECHDC3, USP6NL-AS1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST004249,10:11675398
rs2632516-<b>G</b>,4 x 10-6,,NR,1.098901,'-,[1.05-1.14],TSPOAP1-AS1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST004249,17:58331728
rs429358-<b>C</b>,3 x 10-7,,0.2968,2.256,'-,[1.6552-3.0749],'-,Alzheimer's disease,Alzheimer's disease,GCST90013665,Mapping not available
rs2075650-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST002429,19:44892362
rs17169634-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,BMPER,Alzheimer's disease,Alzheimer's disease,GCST002429,7:34054385
rs75847378-<b>?</b>,7 x 10-7,,NR,'-,'-,'-,SLC8A1-AS1,Alzheimer's disease,Alzheimer's disease,GCST002429,2:39954377
rs62256378-<b>A</b>,3 x 10-12,,0.061,'-,0.71 unit increase,[0.51-0.91],SUCLG2,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST002531,3:67406609
rs429358-<b>?</b>,4 x 10-17,,0.442,'-,0.4 unit decrease,[0.30-0.50],'-,Cerebrospinal AB1-42 levels in Alzheimer's disease dementia,"Alzheimer's disease, beta-amyloid 1-42 measurement",GCST002531,Mapping not available
rs2075650-<b>G</b>,1 x 10-295,,0.14,2.53,'-,[2.41-2.66],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000682,19:44892362
rs1562990-<b>?</b>,4 x 10-11,,0.58,1.14,'-,[1.10-1.18],MS4A4A,Alzheimer's disease,Alzheimer's disease,GCST001087,11:60255614
rs157580-<b>?</b>,8 x 10-89,,NR,1.69,'-,[NR],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST001087,19:44892009
rs536841-<b>?</b>,3 x 10-9,,NR,1.16,'-,[NR],"PICALM, RNU6-560P",Alzheimer's disease,Alzheimer's disease,GCST001087,11:86076782
rs569214-<b>?</b>,4 x 10-8,,NR,1.14,'-,[NR],"CLU, SCARA3",Alzheimer's disease,Alzheimer's disease,GCST001087,8:27630273
rs744373-<b>?</b>,2 x 10-9,,NR,1.18,'-,[NR],"BIN1, NIFKP9",Alzheimer's disease,Alzheimer's disease,GCST001087,2:127137039
"rs9331888-<b>G</b>, rs2279590-<b>C</b>, rs11136000-<b>C</b>",6 x 10-10,,0.26,1.22,'-,[1.14-1.29],CLU; CLU; No mapped genes,Alzheimer's disease,Alzheimer's disease,GCST000480,8:27611345|8:27598736
"rs6656401-<b>A</b>, rs3818361-<b>A</b>",3 x 10-10,(AA),0.18,1.22,'-,[1.15-1.30],CR1; CR1,Alzheimer's disease,Alzheimer's disease,GCST000480,1:207518704|1:207611623
rs2075650-<b>?</b>,2 x 10-16,,0.9,'-,'-,'-,TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000480,19:44892362
rs4420638-<b>?</b>,2 x 10-44,,NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease,Alzheimer's disease,GCST000124,19:44919689
rs11218343-<b>?</b>,2 x 10-9,,0.96,1.23,'-,[1.15-1.33],SORL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001947,11:121564878
rs519113-<b>G</b>,5 x 10-39,(Japanese),0.29,2.09,'-,[1.87-2.34],NECTIN2,Alzheimer's disease (late onset),Alzheimer's disease,GCST001947,19:44873027
rs9877502-<b>A</b>,5 x 10-9,(tau),NR,'-,0.052 unit increase,[NR],GMNC,Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST001951,3:190951729
rs769449-<b>A</b>,2 x 10-16,(tau),NR,'-,0.082 unit increase,[NR],APOE,Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST001951,19:44906745
rs769449-<b>A</b>,2 x 10-18,(ptau),NR,'-,0.091 unit increase,[NR],APOE,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement",GCST001951,19:44906745
rs514716-<b>G</b>,1 x 10-8,(tau),NR,'-,0.071 unit decrease,[NR],GLIS3,Alzheimer's disease biomarkers,"Alzheimer's disease, t-tau measurement",GCST001951,9:3929424
rs514716-<b>G</b>,3 x 10-9,(ptau),NR,'-,0.072 unit decrease,[NR],GLIS3,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement",GCST001951,9:3929424
rs6922617-<b>A</b>,4 x 10-8,(ptau),NR,'-,0.094 unit decrease,[NR],NCR2,Alzheimer's disease biomarkers,"Alzheimer's disease, p-tau measurement",GCST001951,6:41368363
rs115550680-<b>G</b>,2 x 10-9,,0.07,1.79,'-,[1.47-2.12],ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST001963,19:1050421
rs145848414-<b>A</b>,7 x 10-8,,0.04,2.29,'-,[1.69-3.09],"HIGD1AP3, SUMO2P6",Alzheimer's disease (late onset),Alzheimer's disease,GCST001963,5:174587111
rs4746003-<b>?</b>,6 x 10-6,,0.25,1.3,'-,[NR],"LINC02651, RPL5P26",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,10:69778536
rs4576506-<b>?</b>,1 x 10-6,,0.06,1.66,'-,[NR],"HMGB3P23, MTCO3P30",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,9:31546474
rs733175-<b>?</b>,5 x 10-6,,0.18,1.37,'-,[NR],SLC2A9,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,4:10048517
rs10792830-<b>?</b>,6 x 10-6,,0.44,1.25,'-,[NR],"RNU6-560P, PICALM",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,11:86127766
rs16970672-<b>?</b>,2 x 10-6,,0.29,1.29,'-,[NR],"RNU1-80P, TNRC6C",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,17:77948568
rs4038131-<b>?</b>,6 x 10-7,,0.93,1.5384616,'-,[NR],VSNL1,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,2:17593765
rs10207628-<b>?</b>,1 x 10-6,,0.81,1.4084507,'-,[NR],BIN1,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,2:127094445
rs9811423-<b>?</b>,4 x 10-6,,0.47,1.28,'-,[NR],"NEPRO, LINC02044",Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,3:113103475
rs1464108-<b>?</b>,8 x 10-6,,0.32,1.28,'-,[NR],RIMBP2,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,12:130537465
rs11006923-<b>?</b>,9 x 10-6,,0.95,1.5873016,'-,[NR],MPP7,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,10:28216015
rs157582-<b>?</b>,9 x 10-52,,0.26,2.3,'-,[NR],TOMM40,Psychosis and Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001285,19:44892962
rs753129-<b>?</b>,3 x 10-7,,0.76,1.5151515,'-,[NR],"RNU6-276P, EXOC1L",Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,4:55802265
rs257016-<b>?</b>,4 x 10-6,,0.63,1.4285715,'-,[NR],'-,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,5:123821728
rs6509701-<b>?</b>,5 x 10-6,,0.7,1.4084507,'-,[NR],ZNF320,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,19:52880932
rs3764640-<b>?</b>,8 x 10-6,,0.79,1.4705882,'-,[NR],STK11,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,19:1207239
rs11252926-<b>?</b>,8 x 10-6,,0.64,1.3888888,'-,[NR],DIP2C,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,10:520439
rs2969775-<b>?</b>,2 x 10-6,,0.63,1.4705882,'-,[NR],MSH2,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,2:47658337
rs16922670-<b>?</b>,7 x 10-6,,0.14,1.63,'-,[NR],LINC01492,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,9:103261938
rs17716202-<b>?</b>,8 x 10-6,,0.94,2.2222223,'-,[NR],C5orf67,Psychosis in Alzheimer's disease,"Alzheimer's disease, psychotic symptoms",GCST001282,5:56609071
rs7175766-<b>?</b> x rs3733980-<b>?</b>,7 x 10-10,(men),NR,'-,'-,'-,No mapped genes x WWC1,Alzheimer's disease (SNP x SNP interaction),Alzheimer's disease,GCST008056,5:168441804
rs1477307-<b>?</b> x rs4077746-<b>?</b>,2 x 10-6,(men),NR,'-,'-,'-,No mapped genes x TLN2,Alzheimer's disease (SNP x SNP interaction),Alzheimer's disease,GCST008056,15:62623147
rs28715896-<b>G</b>,4 x 10-6,,0.43,1.5873016,'-,[1.39-1.78],ERBB4,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,2:211695376
rs75337321-<b>T</b>,5 x 10-6,,0.06,2.21,'-,[1.88-2.54],CACNA2D3,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,3:54550560
rs13374908-<b>A</b>,2 x 10-6,,0.24,1.59,'-,[1.39-1.79],FAM163A,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,1:179780639
rs10222981-<b>T</b>,1 x 10-6,,0.08,2.06,'-,[1.77-2.35],"BLOC1S4, KIAA0232",Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,4:6759326
rs61835453-<b>C</b>,8 x 10-7,,0.06,2.173913,'-,[1.86-2.49],'-,Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,10:2717604
rs365521-<b>G</b>,1 x 10-6,,0.53,1.5873016,'-,[1.39-1.78],"MIR633, TRMT112P3",Alzheimer's disease with language domain impairment,"Alzheimer's disease, language impairment",GCST007334,17:62944934
rs9469112-<b>T</b>,1 x 10-10,,0.1734,'-,6.4424515 z-unit increase,NR,"HLA-DRA, HLA-DRB9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:32447376
rs16830122-<b>A</b>,2 x 10-6,,0.13,1.17,'-,[1.10-1.25],KCNN3,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,1:154713065
rs4663105-<b>C</b>,2 x 10-12,,0.43,1.19,'-,[1.13-1.24],"BIN1, NIFKP9",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,2:127133851
rs16847609-<b>A</b>,5 x 10-7,,0.09,1.19,'-,[1.11-1.28],"HSPA8P9, CLDN18",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,3:137931894
rs13146780-<b>C</b>,3 x 10-6,,0.05,1.23,'-,[1.13-1.34],RN7SL193P,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,4:43849075
rs78538083-<b>C</b>,8 x 10-6,,0.06,1.32,'-,[1.17-1.48],IL21-AS1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,4:122647254
rs71636213-<b>G</b>,9 x 10-6,,0.1,1.18,'-,[1.10-1.27],"SERINC5, KRT18P45",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:80285949
rs382216-<b>C</b>,2 x 10-7,,0.64,1.1494253,'-,[1.09-1.22],CDC42SE2,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131351444
rs6890695-<b>G</b>,6 x 10-7,,0.79,1.1494253,'-,[1.09-1.22],RAPGEF6,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131552731
rs758324-<b>T</b>,4 x 10-7,,0.81,1.1627907,'-,[1.1-1.22],FNIP1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131773852
rs142958719-<b>G</b>,3 x 10-7,,0.82,1.1627907,'-,[1.1-1.23],MEIKIN,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131897266
rs476428-<b>G</b>,2 x 10-7,,0.81,1.1627907,'-,[1.1-1.23],ACSL6,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:131965922
rs11168036-<b>T</b>,3 x 10-7,,0.5,1.12,'-,[1.07-1.17],"HBEGF, PFDN1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,5:140327854
rs11761441-<b>G</b>,2 x 10-6,,0.46,1.12,'-,[1.07-1.17],'-,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,7:82377
rs10807828-<b>C</b>,7 x 10-6,,0.51,1.098901,'-,[1.05-1.15],'-,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,7:25528235
rs75045569-<b>T</b>,8 x 10-6,,0.83,1.1494253,'-,[1.08-1.22],EPHA1-AS1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,7:143412115
rs2279590-<b>C</b>,2 x 10-6,,0.6,1.1235955,'-,[1.08-1.18],CLU,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,8:27598736
rs7920721-<b>G</b>,3 x 10-6,,0.38,1.12,'-,[1.07-1.17],"ECHDC3, USP6NL-AS1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,10:11678309
rs59616746-<b>C</b>,1 x 10-6,,0.85,1.2987013,'-,[1.18-1.45],SH2D4B,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,10:80629227
rs61310603-<b>T</b>,8 x 10-6,,0.84,1.1904762,'-,[1.11-1.3],'-,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,10:128547890
rs1582763-<b>G</b>,2 x 10-9,,0.63,1.1494253,'-,[1.1-1.2],MS4A4A,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,11:60254475
rs3851179-<b>C</b>,2 x 10-6,,0.65,1.1235955,'-,[1.06-1.18],"RNU6-560P, LINC02695",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,11:86157598
rs10498633-<b>G</b>,4 x 10-7,,0.78,1.1494253,'-,[1.09-1.22],SLC24A4,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,14:92460608
rs7207400-<b>T</b>,5 x 10-6,,0.75,1.1363636,'-,[1.08-1.2],LINC02210-CRHR1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:45746994
rs2732703-<b>T</b>,6 x 10-9,,0.87,1.369863,'-,[1.23-1.54],ARL17B,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:46275856
rs199499-<b>C</b>,6 x 10-6,,0.81,1.1627907,'-,[1.09-1.23],WNT3,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:46788132
rs71380849-<b>A</b>,9 x 10-7,,0.05,1.47,'-,[1.26-1.71],"CDR2L, HID1-AS1",Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,17:74979653
rs6110969-<b>T</b>,3 x 10-6,,0.08,1.2,'-,[1.11-1.29],PPIAP17,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,20:16216865
rs59043219-<b>A</b>,9 x 10-6,,0.37,1.19,'-,[1.10-1.28],IRF6,Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,1:209797265
rs1936246-<b>T</b>,2 x 10-13,,0.43,1.04,'-,[1.03-1.05],"RBBP4P4, GAPDHP15",Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,6:58045670
rs116139393-<b>C</b>,3 x 10-8,,0.84,1.098901,'-,[1.06-1.12],PMS2CL,Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,7:6732029
rs1595014-<b>T</b>,4 x 10-6,,0.72,1.1904762,'-,[1.11-1.28],TMEM106B,Alzheimer's disease (APOE e4 interaction),"Alzheimer's disease, APOE carrier status",GCST002814,7:12148903
rs10792832-<b>G</b>,4 x 10-6,,0.65,1.14,'-,[1.08-1.19],"LINC02695, RNU6-560P",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,11:86156833
rs679515-<b>T</b>,4 x 10-9,,0.21,1.22,'-,[1.14-1.30],CR1,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,1:207577223
rs6733839-<b>T</b>,1 x 10-9,,0.41,1.2,'-,[1.13-1.27],"NIFKP9, BIN1",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:127135234
rs1125355-<b>A</b>,4 x 10-6,,0.26,1.16,'-,[1.09-1.23],DAPL1,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:158844068
rs17366218-<b>A</b>,2 x 10-6,,0.95,1.5384616,'-,[1.28-1.85],PDE1A,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:182154019
rs178585-<b>C</b>,4 x 10-6,,0.47,1.13,'-,[1.07-1.19],'-,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,2:211107743
rs71316816-<b>C</b>,9 x 10-6,,0.92,1.25,'-,[1.14-1.37],CADM2,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,3:85855884
rs9869689-<b>T</b>,3 x 10-6,,0.1,1.21,'-,[1.12-1.31],FBXO40,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,3:121607829
rs10018288-<b>G</b>,4 x 10-6,,0.19,1.16,'-,[1.09-1.24],"LINC00290, LINC02500",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,4:181180536
rs2876189-<b>G</b>,6 x 10-6,,0.31,1.14,'-,[1.08-1.21],OFCC1,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,6:10101984
rs1129187-<b>T</b>,7 x 10-6,,0.45,1.13,'-,[1.07-1.19],PEX6,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,6:42964462
rs59406683-<b>A</b>,6 x 10-6,,0.89,1.2048193,'-,[1.11-1.3],'-,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,7:110142514
rs9331896-<b>T</b>,3 x 10-9,,0.62,1.1904762,'-,[1.12-1.25],CLU,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,8:27610169
rs639012-<b>G</b>,1 x 10-7,,0.7,1.1627907,'-,[1.1-1.22],PICALM,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,11:85970540
rs471470-<b>A</b>,3 x 10-8,,0.68,1.1627907,'-,[1.1-1.23],"RNU6-560P, PICALM",Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,11:86120499
rs2854437-<b>G</b>,2 x 10-6,,0.87,1.2345679,'-,[1.14-1.35],SORD,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,15:45065212
rs721146-<b>A</b>,4 x 10-6,,0.21,1.17,'-,[1.09-1.25],LINC01684,Alzheimer's disease in APOE e4+ carriers,Alzheimer's disease,GCST002813,21:24540925
rs2271920-<b>A</b>,8 x 10-6,,0.39,1.11,'-,[1.06-1.16],PTK2B,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,8:27458600
rs11218343-<b>T</b>,9 x 10-6,,0.96,1.3,'-,[1.16-1.45],SORL1,Alzheimer's disease in APOE e4- carriers,Alzheimer's disease,GCST002817,11:121564878
rs11136000-<b>?</b>,9 x 10-10,,0.6,1.16,'-,[1.11-1.22],'-,Alzheimer's disease,Alzheimer's disease,GCST000479,Mapping not available
rs3851179-<b>?</b>,1 x 10-9,,0.63,1.16,'-,[1.11-1.22],"RNU6-560P, LINC02695",Alzheimer's disease,Alzheimer's disease,GCST000479,11:86157598
rs2075650-<b>?</b>,2 x 10-157,,0.15,2.53,'-,[2.37-2.71],TOMM40,Alzheimer's disease,Alzheimer's disease,GCST000479,19:44892362
"rs7081208-<b>A</b>, rs17314229-<b>C</b>, rs2446581-<b>A</b>",1 x 10-10,,0.028,1.68,'-,[1.43-1.96],FRMD4A; No mapped genes; No mapped genes,Alzheimer's disease,Alzheimer's disease,GCST001449,10:13949865
rs168193-<b>?</b>,9 x 10-7,(model 1),'-,0.79,'-,[0.72-0.87],RN7SL553P,Alzheimer's disease,Alzheimer's disease,GCST011696,3:5260392
rs2633682-<b>?</b>,9 x 10-7,(model 1),'-,0.78,'-,[0.71-0.86],'-,Alzheimer's disease,Alzheimer's disease,GCST011696,3:104690364
rs9516245-<b>?</b>,4 x 10-7,(model 2),'-,1.73,'-,[1.39-2.15],GPC6,Alzheimer's disease,Alzheimer's disease,GCST011696,13:93507547
rs3745495-<b>?</b>,4 x 10-7,(model 2),'-,1.39,'-,[1.23-1.56],VRK3,Alzheimer's disease,Alzheimer's disease,GCST011696,19:50021075
rs115684722-<b>?</b>,6 x 10-7,(model 1),'-,12.6,'-,[4.66-34.45],RN7SL299P,Alzheimer's disease,Alzheimer's disease,GCST011696,1:232240417
rs184179037-<b>?</b>,2 x 10-7,(model 1),'-,5,'-,[2.27-9.18],WDR70,Alzheimer's disease,Alzheimer's disease,GCST011696,5:37483838
rs569584007-<b>?</b>,9 x 10-8,(model 2),'-,10.48,'-,[4.42-24.83],HNRNPKP3,Alzheimer's disease,Alzheimer's disease,GCST011696,11:43145292
rs115816806-<b>?</b>,5 x 10-7,(model 2),'-,6.55,'-,[3.17-13.53],"ACER3, TSKU",Alzheimer's disease,Alzheimer's disease,GCST011696,11:76830796
rs75739461-<b>?</b>,1 x 10-6,(model 2),'-,3.03,'-,[1.93-4.76],"RERGL, PIK3C2G",Alzheimer's disease,Alzheimer's disease,GCST011696,12:18318612
rs570487962-<b>?</b>,2 x 10-9,(model 2),'-,0.1,'-,[0.05-0.22],LINC02254,Alzheimer's disease,Alzheimer's disease,GCST011696,15:97449455
rs79537509-<b>?</b>,5 x 10-7,(model 2),'-,4.61,'-,[2.51-8.47],LINC02152,Alzheimer's disease,Alzheimer's disease,GCST011696,16:8238399
rs145848414-<b>?</b>,2 x 10-6,(model 1),'-,1.78,'-,[1.41-2.25],"HIGD1AP3, SUMO2P6",Alzheimer's disease,Alzheimer's disease,GCST011696,5:174587111
rs115550680-<b>?</b>,4 x 10-7,(model 2),'-,1.58,'-,[1.32-1.88],ABCA7,Alzheimer's disease,Alzheimer's disease,GCST011696,19:1050421
rs157591-<b>?</b>,2 x 10-25,(model 1),'-,1.93,'-,[1.72-2.17],"APOC1P1, APOC1",Alzheimer's disease,Alzheimer's disease,GCST011696,19:44920677
rs112404845-<b>A</b>,5 x 10-6,(model 2),0.008,'-,1.05 unit increase,[0.60-1.50],ROBO2P1,Alzheimer's disease,Alzheimer's disease,GCST011696,7:51510325
rs78194510-<b>?</b>,4 x 10-9,,'-,'-,'-,'-,SCARB1,Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,12:124853790
rs759819-<b>?</b>,6 x 10-12,,'-,'-,'-,'-,"LILRA5, MIR4752",Alzheimer's disease or HDL levels (pleiotropy),"Alzheimer's disease, high density lipoprotein cholesterol measurement",GCST007827,19:54304302
rs7561528-<b>A</b>,4 x 10-14,,0.35,1.17,'-,[1.13-1.22],"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,2:127132061
rs4938933-<b>?</b>,8 x 10-12,,0.61,1.12,'-,[1.09-1.15],MS4A4A,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,11:60266956
rs6701713-<b>A</b>,5 x 10-10,,0.2,1.16,'-,[1.11-1.22],CR1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,1:207612944
rs1532278-<b>?</b>,8 x 10-8,,0.64,1.12,'-,[1.08-1.18],CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,8:27608798
rs561655-<b>?</b>,7 x 10-11,,0.66,1.15,'-,[1.10-1.19],"PICALM, RNU6-560P",Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,11:86089237
rs3752246-<b>G</b>,6 x 10-7,,0.19,1.15,'-,[1.09-1.21],ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,19:1056493
rs9349407-<b>C</b>,9 x 10-9,,0.27,1.11,'-,[1.07-1.15],CD2AP,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,6:47485642
rs3865444-<b>?</b>,2 x 10-9,,0.7,1.1,'-,[1.08-1.14],"CD33, SIGLEC22P",Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,19:51224706
rs11767557-<b>?</b>,6 x 10-10,,0.81,1.11,'-,[1.08-1.16],EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST001026,7:143412046
rs3764650-<b>?</b>,5 x 10-17,,0.1,1.23,'-,[1.18-1.30],ABCA7,Alzheimer's disease,Alzheimer's disease,GCST001025,19:1046521
rs3818361-<b>?</b>,4 x 10-14,,0.19,1.18,'-,[1.13-1.24],CR1,Alzheimer's disease,Alzheimer's disease,GCST001025,1:207611623
rs11670070-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,IGSF23,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44628686
rs2919845-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CEACAM19, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44677956
rs118104581-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44557839
rs79638902-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44718495
rs2965162-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44695666
rs2965164-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44698782
rs76670936-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44693311
rs62117160-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44728895
rs73037426-<b>?</b>,4 x 10-22,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44719517
rs150820726-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44723891
rs2965169-<b>?</b>,1 x 10-49,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44747899
rs112450640-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44793107
rs28399657-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44815094
rs41290100-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44867684
rs28399637-<b>?</b>,7 x 10-120,,NR,'-,'-,'-,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44820881
rs2889414-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44794671
rs1786140-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"LINC02705, MS4A2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60141154
rs4939338-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,MS4A6E,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,11:60331752
rs11666329-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44851039
rs4803764-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44854120
rs55840414-<b>?</b>,2 x 10-15,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44840322
rs56394238-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44832419
rs111371860-<b>?</b>,5 x 10-24,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44842530
rs41289512-<b>?</b>,5 x 10-175,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44848259
rs28399664-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44821499
rs75161053-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM22P,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44544863
rs2965156-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44685157
rs73035597-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44696254
rs8103315-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44750911
rs203709-<b>?</b>,7 x 10-17,,NR,'-,'-,'-,"CEACAM16-AS1, PVR",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44658298
rs2965163-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44697256
rs12150984-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44698757
rs11881756-<b>?</b>,1 x 10-14,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44717621
rs10401176-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44750234
rs62117205-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44752009
rs2927437-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44738381
rs12459810-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44746404
rs7254776-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CEACAM16-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44724478
rs8100197-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCL3,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44750325
rs2967668-<b>?</b>,4 x 10-18,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44799694
rs112262807-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44828429
rs1466435-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44839558
rs140824606-<b>?</b>,4 x 10-26,,NR,'-,'-,'-,"BCAM, CBLC",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44807827
rs186110295-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCL3, CEACAM16-AS1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44730236
rs1135062-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44819487
rs10412413-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44824052
rs12974942-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44849230
rs78986976-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44826181
rs77241309-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44845920
rs12978931-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44860443
rs10407439-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NECTIN2, BCAM",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44838691
rs2972562-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BCAM, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44840407
rs393584-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44874077
rs117310449-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"TOMM40, NECTIN2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44890259
rs412776-<b>?</b>,5 x 10-15,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44876259
rs6859-<b>?</b>,1 x 10-155,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44878777
rs3852860-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44879709
rs11668327-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,TOMM40,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44895376
rs1081106-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44910109
rs59325138-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOE, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44913034
rs449647-<b>?</b>,2 x 10-58,,NR,'-,'-,'-,"APOE, TOMM40",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44905307
rs365653-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44858389
rs7412-<b>?</b>,2 x 10-76,,NR,'-,'-,'-,APOE,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44908822
rs148933445-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CBLC,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44799247
rs144311893-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC1, APOC1P1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44920687
rs3925681-<b>?</b>,7 x 10-162,,NR,'-,'-,'-,APOC1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44917843
rs71352239-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC1P1, APOC1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44926286
rs73045691-<b>?</b>,2 x 10-19,,NR,'-,'-,'-,"APOC1P1, APOC4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44937272
rs9304644-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"APOC2, APOC4-APOC2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44946776
rs34874378-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45013623
rs57270598-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CLPTM1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:44982891
rs114248186-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RELB,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45020861
rs147188206-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,CLASRP,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45049329
rs60239918-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,GEMIN7-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45077114
rs536518226-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"PPP1R37, MARK4",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45137507
rs73566293-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"MARK4, BLOC1S3",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,19:45209421
rs6701713-<b>?</b>,9 x 10-24,,NR,'-,'-,'-,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,1:207612944
rs12036785-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,1:207619564
rs11118328-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CR1L,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,1:207677194
rs17014873-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127072643
rs1060743-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127068957
rs6733839-<b>?</b>,2 x 10-64,,NR,1.1470575,'-,[1.12899064608461-1.16541354700668],"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127135234
rs10194375-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127082205
rs72838215-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127104478
rs6431219-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,BIN1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127104557
rs4663099-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127120856
rs35103166-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127124606
rs7575209-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127126547
rs58682665-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127127671
rs13025765-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"BIN1, NIFKP9",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127128657
rs13031703-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127129099
rs745717-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127136321
rs730482-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:127136908
rs35349669-<b>?</b>,2 x 10-10,,NR,1.0525334,'-,[1.03595530394875-1.06937674771915],INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:233159830
rs10933431-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,2:233117202
rs9381563-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47464901
rs9395255-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47424807
rs9395288-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"CD2AP, ADGRF2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47630389
rs10948374-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,ADGRF2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,6:47679485
rs1859788-<b>?</b>,3 x 10-18,,NR,'-,'-,'-,PILRA,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST005922,7:100374211
rs610932-<b>?</b>,2 x 10-14,,0.58,1.11,'-,[1.09-1.15],"MS4A6A, LINC02705",Alzheimer's disease,Alzheimer's disease,GCST001025,11:60171834
rs744373-<b>?</b>,3 x 10-14,,0.29,1.17,'-,[1.12-1.21],"BIN1, NIFKP9",Alzheimer's disease,Alzheimer's disease,GCST001025,2:127137039
rs7920721-<b>G</b>,3 x 10-7,,0.387,1.07,'-,[1.04-1.10],"ECHDC3, USP6NL-AS1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,10:11678309
rs10751667-<b>T</b>,6 x 10-7,,0.634,1.0753,'-,[1.04-1.1],AP2A2,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:941941
rs7295246-<b>G</b>,3 x 10-7,,0.406,1.07,'-,[1.04-1.10],"ADAMTS20, EEF1A1P17",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,12:43573874
rs2337406-<b>C</b>,3 x 10-7,,0.897,1.1494,'-,[1.09-1.2],"IGHV3-71, IGHV2-70",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,14:106772332
rs8035452-<b>T</b>,3 x 10-7,,0.661,1.0753,'-,[1.04-1.1],SPPL2A,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,15:50748601
rs74615166-<b>C</b>,4 x 10-7,,0.02,1.29,'-,[1.17-1.42],TRIP4,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,15:64433291
rs7225151-<b>A</b>,4 x 10-7,,0.121,1.1,'-,[1.06-1.15],"SCIMP, ZNF594-DT",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,17:5233752
chr17:61538148-<b>A</b>,3 x 10-7,,0.018,1.34,'-,[1.20-1.50],'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,Mapping not available
rs3865444-<b>C</b>,3 x 10-6,,0.693,1.06,'-,[1.04-1.1],"CD33, SIGLEC22P",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,19:51224706
rs2718058-<b>A</b>,5 x 10-9,,0.627,1.0753,'-,[1.05-1.11],"GPR141, EPDR1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,7:37801932
rs7274581-<b>T</b>,3 x 10-8,,0.917,1.1364,'-,[1.09-1.19],CASS4,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,20:56443204
rs11218343-<b>T</b>,1 x 10-14,,0.961,1.2987,'-,[1.22-1.39],SORL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:121564878
rs6656401-<b>A</b>,6 x 10-24,,0.197,1.18,'-,[1.14-1.22],CR1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,1:207518704
rs6733839-<b>T</b>,7 x 10-44,,0.409,1.22,'-,[1.18-1.25],"NIFKP9, BIN1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,2:127135234
rs10948363-<b>G</b>,5 x 10-11,,0.266,1.1,'-,[1.07-1.13],CD2AP,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,6:47520026
rs11771145-<b>G</b>,1 x 10-13,,0.662,1.1111,'-,[1.08-1.14],EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,7:143413669
rs9331896-<b>T</b>,3 x 10-25,,0.621,1.1628,'-,[1.12-1.19],CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,8:27610169
rs983392-<b>A</b>,6 x 10-16,,0.597,1.1111,'-,[1.09-1.15],"LINC02705, MS4A2",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:60156035
rs10792832-<b>G</b>,9 x 10-26,,0.642,1.1494,'-,[1.12-1.18],"LINC02695, RNU6-560P",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:86156833
rs4147929-<b>A</b>,1 x 10-15,,0.19,1.15,'-,[1.11-1.19],ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,19:1063444
rs35349669-<b>T</b>,3 x 10-8,,0.488,1.08,'-,[1.05-1.11],INPP5D,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,2:233159830
rs190982-<b>A</b>,3 x 10-8,,0.592,1.0753,'-,[1.05-1.11],MEF2C-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,5:88927603
rs1476679-<b>T</b>,6 x 10-10,,0.713,1.0989,'-,[1.06-1.12],ZCWPW1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,7:100406823
rs10838725-<b>C</b>,1 x 10-8,,0.316,1.08,'-,[1.05-1.11],CELF1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,11:47536319
rs17125944-<b>C</b>,8 x 10-9,,0.092,1.14,'-,[1.09-1.19],FERMT2,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,14:52933911
rs9271192-<b>C</b>,3 x 10-12,,0.276,1.11,'-,[1.08-1.18],"HLA-DRB1, HLA-DQA1",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,6:32610753
rs28834970-<b>C</b>,7 x 10-14,,0.366,1.1,'-,[1.08-1.13],PTK2B,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,8:27337604
rs10498633-<b>G</b>,6 x 10-9,,0.783,1.0989,'-,[1.06-1.14],SLC24A4,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,14:92460608
rs6678275-<b>C</b>,3 x 10-7,,0.169,1.09,'-,[1.05-1.13],'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,1:193656103
rs6448799-<b>T</b>,7 x 10-8,,0.3,1.08,'-,[1.05-1.11],'-,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,4:11628425
rs72807343-<b>T</b>,7 x 10-7,,0.016,1.35,'-,[1.20-1.52],SQSTM1,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,5:179811261
rs9381040-<b>C</b>,6 x 10-7,,0.703,1.0753,'-,[1.04-1.1],"TREML2, TREM2",Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,6:41186912
rs7818382-<b>T</b>,8 x 10-8,,0.469,1.07,'-,[1.04-1.10],NDUFAF6,Alzheimer's disease (late onset),Alzheimer's disease,GCST002245,8:95041772
rs7274581-<b>C</b>,3 x 10-8,,0.084,'-,5.53 z-unit decrease,NR,CASS4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,20:56443204
rs9331896-<b>C</b>,7 x 10-17,,0.4107,'-,8.35 z-unit decrease,NR,CLU,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27610169
rs983392-<b>G</b>,2 x 10-11,,0.4083,'-,6.71 z-unit decrease,NR,"LINC02705, MS4A2",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:60156035
rs114360492-<b>T</b>,2 x 10-9,,2.59E-04,'-,5.99 z-unit increase,NR,CNTNAP2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:146252937
rs184384746-<b>T</b>,1 x 10-8,,0.002,'-,5.69 z-unit increase,NR,"HESX1, IL17RD",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,3:57192122
rs187370608-<b>A</b>,1 x 10-16,,0.002,'-,8.26 z-unit increase,NR,UNC5CL,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:40974457
rs76726049-<b>C</b>,3 x 10-8,,0.014,'-,5.52 z-unit increase,NR,ALPK2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,18:58522227
rs41289512-<b>G</b>,6 x 10-276,,0.039,'-,35.5 z-unit increase,NR,NECTIN2,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44848259
rs76320948-<b>T</b>,5 x 10-8,,0.046,'-,5.46 z-unit increase,NR,MEIOSIN,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:45738583
rs6014724-<b>G</b>,7 x 10-10,,0.089,'-,6.18 z-unit decrease,NR,CASS4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,20:56423488
rs113260531-<b>A</b>,9 x 10-10,,0.12,'-,6.12 z-unit increase,NR,ZNF594-DT,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,17:5235685
rs117618017-<b>T</b>,3 x 10-8,,0.132,'-,5.52 z-unit increase,NR,APH1B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,15:63277703
rs111278892-<b>G</b>,8 x 10-11,,0.161,'-,6.5 z-unit increase,NR,"CNN2, ABCA7",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:1039324
rs2093760-<b>A</b>,1 x 10-18,,0.205,'-,8.82 z-unit increase,NR,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,1:207613483
rs10933431-<b>G</b>,9 x 10-10,,0.235,'-,6.13 z-unit decrease,NR,INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:233117202
rs4575098-<b>A</b>,2 x 10-10,,0.24,'-,6.36 z-unit increase,NR,ADAMTS4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,1:161185602
rs6448453-<b>A</b>,2 x 10-9,,0.252,'-,6 z-unit increase,NR,'-,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,4:11024404
rs59735493-<b>A</b>,4 x 10-8,,0.3,'-,5.49 z-unit decrease,NR,KAT8,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,16:31121779
rs1859788-<b>A</b>,2 x 10-15,,0.31,'-,7.93 z-unit decrease,NR,PILRA,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:100374211
rs867611-<b>G</b>,2 x 10-18,,0.314,'-,8.75 z-unit decrease,NR,PICALM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:86065502
rs3865444-<b>A</b>,6 x 10-9,,0.32,'-,5.81 z-unit decrease,NR,"CD33, SIGLEC22P",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:51224706
rs442495-<b>C</b>,1 x 10-9,,0.32,'-,6.07 z-unit decrease,NR,ADAM10,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,15:58730416
rs12590654-<b>A</b>,2 x 10-10,,0.344,'-,6.39 z-unit decrease,NR,SLC24A4,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,14:92472511
rs41289512-<b>G</b>,3 x 10-194,,NR,'-,29.735075 z-score increase,NR,NECTIN2,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,19:44848259
rs4663105-<b>C</b>,4 x 10-29,,NR,'-,11.21158 z-score increase,NR,"BIN1, NIFKP9",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:127133851
rs2632516-<b>C</b>,1 x 10-9,,NR,'-,6.0526648 z-score decrease,NR,TSPOAP1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,17:58331728
rs6014724-<b>G</b>,9 x 10-8,,NR,'-,5.351533 z-score decrease,NR,CASS4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,20:56423488
rs9381563-<b>C</b>,5 x 10-9,,NR,'-,5.835869 z-score increase,NR,"B3GNTL1P2, CD2AP-DT",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:47464901
rs3865444-<b>A</b>,4 x 10-8,,NR,'-,5.4802556 z-score decrease,NR,"CD33, SIGLEC22P",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,19:51224706
rs4236673-<b>A</b>,6 x 10-20,,NR,'-,9.13808 z-score decrease,NR,CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,8:27607412
rs11257242-<b>C</b>,2 x 10-8,,NR,'-,5.5817 z-score decrease,NR,"ECHDC3, USP6NL-AS1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,10:11679120
rs11763230-<b>T</b>,3 x 10-11,,NR,'-,6.6686625 z-score decrease,NR,EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:143411748
rs9269853-<b>A</b>,3 x 10-8,,NR,'-,5.5623274 z-score increase,NR,HLA-DRB1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:32582545
rs7657553-<b>A</b>,2 x 10-8,,NR,'-,5.5982833 z-score increase,NR,LINC02360,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,4:11721611
rs10933431-<b>G</b>,2 x 10-6,,NR,'-,4.7898254 z-score decrease,NR,INPP5D,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:233117202
rs7935829-<b>G</b>,8 x 10-13,,NR,'-,7.1575665 z-score decrease,NR,MS4A6A,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:60175342
rs113260531-<b>A</b>,3 x 10-6,,NR,'-,4.6568017 z-score increase,NR,ZNF594-DT,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,17:5235685
rs12590654-<b>A</b>,2 x 10-8,,NR,'-,5.614125 z-score decrease,NR,SLC24A4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,14:92472511
rs8093731-<b>T</b>,5 x 10-8,,NR,'-,5.4649644 z-score decrease,NR,DSG2,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,18:31508995
rs1859788-<b>A</b>,6 x 10-9,,NR,'-,5.8154516 z-score decrease,NR,PILRA,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:100374211
rs6656401-<b>A</b>,1 x 10-17,,NR,'-,8.54 z-score increase,NR,CR1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,1:207518704
rs6733839-<b>T</b>,1 x 10-29,,NR,'-,11.3 z-score increase,NR,"NIFKP9, BIN1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:127135234
rs35349669-<b>T</b>,8 x 10-6,,NR,'-,4.46 z-score increase,NR,INPP5D,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,2:233159830
rs9271192-<b>C</b>,5 x 10-7,,NR,'-,5.02 z-score increase,NR,"HLA-DRB1, HLA-DQA1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:32610753
rs10948363-<b>G</b>,7 x 10-8,,NR,'-,5.39 z-score increase,NR,CD2AP,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,6:47520026
rs2718058-<b>G</b>,1 x 10-6,,NR,'-,4.87 z-score decrease,NR,"GPR141, EPDR1",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:37801932
rs1476679-<b>C</b>,2 x 10-7,,NR,'-,5.21 z-score decrease,NR,ZCWPW1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:100406823
rs11771145-<b>A</b>,4 x 10-8,,NR,'-,5.49 z-score decrease,NR,EPHA1-AS1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,7:143413669
rs28399637-<b>A</b>,2 x 10-143,,0.3156,'-,25.508192 z-unit increase,NR,BCAM,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:44820881
rs11218343-<b>C</b>,1 x 10-11,,0.03743,'-,6.79 z-unit decrease,NR,SORL1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,11:121564878
rs11771145-<b>A</b>,1 x 10-6,,0.3085,'-,4.88 z-unit decrease,NR,EPHA1-AS1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:143413669
rs1476679-<b>C</b>,6 x 10-14,,0.3085,'-,7.51 z-unit decrease,NR,ZCWPW1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,7:100406823
rs28834970-<b>C</b>,1 x 10-11,,0.3644,'-,6.8 z-unit increase,NR,PTK2B,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,8:27337604
rs35349669-<b>T</b>,5 x 10-9,,0.4983,'-,5.85 z-unit increase,NR,INPP5D,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:233159830
rs4147929-<b>A</b>,6 x 10-7,,NR,'-,5.01 z-unit increase,NR,ABCA7,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,19:1063444
rs6656401-<b>A</b>,4 x 10-18,,0.1782,'-,8.67 z-unit increase,NR,CR1,Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,1:207518704
rs6733839-<b>T</b>,1 x 10-29,,0.3797,'-,11.3 z-unit increase,NR,"NIFKP9, BIN1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,2:127135234
rs28834970-<b>C</b>,7 x 10-8,,NR,'-,5.39 z-score increase,NR,PTK2B,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,8:27337604
rs9331896-<b>C</b>,1 x 10-18,,NR,'-,8.82 z-score decrease,NR,CLU,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,8:27610169
rs983392-<b>G</b>,5 x 10-11,,NR,'-,6.56 z-score decrease,NR,"LINC02705, MS4A2",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:60156035
rs10792832-<b>A</b>,1 x 10-17,,NR,'-,8.56 z-score decrease,NR,"LINC02695, RNU6-560P",Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:86156833
rs11218343-<b>C</b>,6 x 10-11,,NR,'-,6.55 z-score decrease,NR,SORL1,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,11:121564878
rs10498633-<b>T</b>,1 x 10-7,,NR,'-,5.3 z-score decrease,NR,SLC24A4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,14:92460608
rs4147929-<b>A</b>,9 x 10-9,,NR,'-,5.76 z-score increase,NR,ABCA7,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,19:1063444
rs7274581-<b>C</b>,2 x 10-7,,NR,'-,5.21 z-score decrease,NR,CASS4,Alzheimer's disease (late onset),Alzheimer's disease,GCST007319,20:56443204
rs9271192-<b>C</b>,4 x 10-8,,0.2751,'-,5.49 z-unit increase,NR,"HLA-DRB1, HLA-DQA1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:32610753
rs6931277-<b>T</b>,8 x 10-11,,0.153,'-,6.49 z-unit decrease,NR,"HLA-DQA1, HLA-DRB1",Alzheimer's disease or family history of Alzheimer's disease,"Alzheimer's disease, family history of Alzheimer’s disease",GCST007320,6:32615580
rs1060743-<b>?</b>,5 x 10-8,,NR,1.1066935,'-,'-,BIN1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,2:127068957
rs1532278-<b>?</b>,6 x 10-10,,NR,1.1177499,'-,'-,CLU,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,8:27608798
rs3865444-<b>?</b>,2 x 10-6,,NR,1.0942049,'-,'-,"CD33, SIGLEC22P",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,19:51224706
rs6656401-<b>?</b>,7 x 10-11,,NR,1.1725225,'-,'-,CR1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,1:207518704
rs7232-<b>?</b>,6 x 10-7,,NR,1.0942651,'-,'-,MS4A6A,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:60173126
rs7412-<b>?</b>,3 x 10-105,,NR,2.3065467,'-,'-,APOE,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,19:44908822
rs143332484-<b>T</b>,2 x 10-14,,NR,1.6665556,'-,[1.46-1.90],TREM2,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,6:41161469
rs616338-<b>T</b>,5 x 10-10,,NR,1.4296066,'-,[1.3-1.6],ABI3,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,17:49219935
rs72824905-<b>?</b>,5 x 10-10,,NR,1.4756235,'-,[1.25-1.67],PLCG2,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,16:81908423
rs75932628-<b>T</b>,5 x 10-24,,NR,2.4557426,'-,[2.06-2.92],TREM2,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,6:41161514
rs78541046-<b>?</b>,2 x 10-6,(adjusted),NR,6.2228026,'-,[2.94-12.5],RHBDF1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,16:63029
rs11828907-<b>C</b>,2 x 10-7,,NR,4.4935546,'-,[2.55-7.92],AHNAK,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:62521506
rs139967528-<b>G</b>,6 x 10-10,,NR,6.119662,'-,[3.45-10.9],ATP5F1C,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,10:7799848
rs201850688-<b>G</b>,9 x 10-6,,NR,1.804889,'-,[1.39-2.34],BSG,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,19:572671
rs201879533-<b>?</b>,4 x 10-6,(adjusted),NR,5.6306844,'-,[2.7-12.5],THSD4,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,15:71746912
rs56009889-<b>?</b>,6 x 10-7,,NR,3.0578122,'-,[1.96-4.76],"ATM, C11orf65",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:108326169
rs148619105-<b>?</b>,1 x 10-7,,NR,1.8587084,'-,[1.47-2.33],TECTA,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST005549,11:121146015
rs7185636-<b>T</b>,2 x 10-8,,0.82,1.0869565,'-,[1.05-1.12],IQCK,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,16:19796841
rs593742-<b>A</b>,7 x 10-9,,0.705,1.0752687,'-,[1.05-1.1],"ADAM10, SNORD3P1",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,15:58753575
rs2830500-<b>C</b>,3 x 10-8,,0.692,1.0752687,'-,[1.04-1.1],ADAMTS1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,21:26784537
rs4735340-<b>T</b>,9 x 10-8,,0.524,1.0638298,'-,[1.04-1.09],NDUFAF6,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,8:94964023
rs10467994-<b>T</b>,4 x 10-7,,0.667,1.0638298,'-,[1.04-1.09],SPPL2A,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,15:50716490
rs2632516-<b>G</b>,5 x 10-8,,0.56,1.0638298,'-,[1.04-1.1],TSPOAP1-AS1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,17:58331728
rs7295246-<b>G</b>,4 x 10-7,,0.413,1.06,'-,[1.04-1.08],"ADAMTS20, EEF1A1P17",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,12:43573874
rs7920721-<b>G</b>,2 x 10-11,,0.39,1.08,'-,[1.06-1.11],"ECHDC3, USP6NL-AS1",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,10:11678309
rs138190086-<b>A</b>,5 x 10-9,,0.02,1.3,'-,[1.19-1.42],"PPIAP55, CYB561",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,17:63460787
rs114812713-<b>C</b>,2 x 10-13,,0.03,1.32,'-,[1.22-1.42],OARD1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,6:41066261
rs62039712-<b>A</b>,4 x 10-8,,0.116,1.16,'-,[1.10-1.23],RNA5SP431,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,16:79321960
rs35868327-<b>T</b>,3 x 10-7,,0.987,1.4705882,'-,[1.27-1.69],'-,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,5:53369400
rs71618613-<b>A</b>,3 x 10-7,,0.99,1.4084507,'-,[1.23-1.59],LINC02109,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,5:29005878
rs190094306-<b>?</b>,4 x 10-6,,NR,1.62,'-,[1.32-1.99],NHLRC3,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,13:39050685
rs187857322-<b>?</b>,2 x 10-6,,NR,1.63,'-,[1.33-2.00],"OR7E59P, OR7E136P",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,7:6869229
rs192326911-<b>?</b>,3 x 10-6,,NR,1.65,'-,[1.34-2.04],"STAU2-AS1, RDH10-AS1",Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,8:73378103
rs192098867-<b>?</b>,7 x 10-6,,NR,1.2987013,'-,[1.16-1.47],TRPM1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,15:31149558
rs35833468-<b>?</b>,3 x 10-6,,NR,1.0869565,'-,[1.04-1.12],EGLN3,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,14:33974720
rs190217640-<b>?</b>,7 x 10-6,,NR,1.4492754,'-,[1.23-1.69],NEGR1,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,1:71755908
rs19213255-<b>?</b>,4 x 10-6,,NR,1.3333333,'-,[1.18-1.49],'-,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,Mapping not available
rs182921547-<b>?</b>,8 x 10-7,,NR,1.38,'-,[1.21-1.56],'-,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,4:32832588
rs8111708-<b>?</b>,2 x 10-6,,NR,1.06,'-,[1.03-1.09],ELL,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,19:18448066
rs11038990-<b>?</b>,6 x 10-6,,NR,1.09,'-,[1.05-1.13],CKAP5,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,11:46783211
rs6806784-<b>?</b>,4 x 10-6,,NR,1.53,'-,[1.28-1.83],SENP7,Alzheimer's disease (late onset),late-onset Alzheimers disease,GCST007511,3:101508591
rs4317424-<b>C</b>,2 x 10-7,(right hemisphere),NR,'-,236.3 mm3 increase,'-,"ATP5PBP6, FILNC1",Caudate volume in trauma-exposed individuals,"response to trauma exposure, caudate nucleus volume",GCST005240,6:139631503
rs34720850-<b>?</b>,8 x 10-7,(right hemisphere),NR,'-,423.5 mm3 increase,'-,NKAIN3,Caudate volume in trauma-exposed individuals,"response to trauma exposure, caudate nucleus volume",GCST005240,8:62497764
rs55886168-<b>T</b>,6 x 10-8,(right hemisphere),NR,'-,79.33 mm3 increase,'-,LINC01522,Nucleus accumbens volume in trauma-exposed individuals,"response to trauma exposure, nucleus accumbens volume",GCST005241,20:47989202
rs2824791-<b>?</b>,3 x 10-7,(right hemisphere),NR,'-,'-,'-,TMPRSS15,Nucleus accumbens volume in trauma-exposed individuals,"response to trauma exposure, nucleus accumbens volume",GCST005241,21:18385363
rs13140180-<b>?</b>,3 x 10-7,(right hemisphere),NR,'-,'-,'-,'-,Nucleus accumbens volume in trauma-exposed individuals,"response to trauma exposure, nucleus accumbens volume",GCST005241,4:130610205
rs4053747-<b>?</b>,4 x 10-7,(right hemisphere),NR,'-,'-,'-,"NDUFA5P9, RAB1AP2",Nucleus accumbens volume in trauma-exposed individuals,"response to trauma exposure, nucleus accumbens volume",GCST005241,6:86196243
rs55685119-<b>?</b>,7 x 10-8,(right hemisphere),NR,'-,'-,'-,TMEM132D,Pallidum volume in trauma-exposed individuals,"pallidum volume, response to trauma exposure",GCST005242,12:129414769
rs34043524-<b>G</b>,2 x 10-7,(right hemisphere),NR,'-,'-,'-,TRAM1L1,Lateral ventricle volume in trauma-exposed individuals,"lateral ventricle volume measurement, response to trauma exposure",GCST005286,4:117069298
rs6667389-<b>G</b>,2 x 10-6,(Hispanic),0.08394,'-,4.183 unit increase,[2.51-5.86],OR11L1,Post traumatic stress disorder symptom count in trauma-exposed individuals,"response to trauma exposure, post-traumatic stress disorder symptom measurement",GCST005550,1:247841312
rs34465541-<b>C</b>,3 x 10-8,,0.07,2.0408163,'-,NR,'-,Post-traumatic stress disorder symptoms in trauma-exposed soldiers,"response to trauma exposure, post-traumatic stress disorder symptom measurement",GCST008270,4:141865374
rs10022302-<b>G</b>,8 x 10-7,,0.08,2.0408163,'-,NR,GPRIN3,Post-traumatic stress disorder symptoms in trauma-exposed soldiers,"response to trauma exposure, post-traumatic stress disorder symptom measurement",GCST008270,4:89269701
rs78092837-<b>G</b>,1 x 10-6,,0.04,2.4390244,'-,NR,GRID1,Post-traumatic stress disorder symptoms in trauma-exposed soldiers,"response to trauma exposure, post-traumatic stress disorder symptom measurement",GCST008270,10:85866672
rs1433375-<b>A</b>,3 x 10-8,"(AA, initial)",0.17,'-,2.69 unit increase,[1.75-3.63],'-,Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,4:129416904
rs1667284-<b>A</b>,4 x 10-6,"(AA, initial)",0.14,'-,2.2 unit increase,[1.28-3.12],B4GALT6,Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,18:31646245
rs7843718-<b>G</b>,5 x 10-6,"(AA, initial)",0.18,'-,1.86 unit increase,[1.06-2.66],"Metazoa_SRP, MTND2P7",Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,8:133722977
rs11086862-<b>C</b>,5 x 10-6,"(AA, initial)",0.44,'-,2 unit increase,[1.14-2.86],PTPRT,Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,20:43125961
rs991639-<b>A</b>,1 x 10-6,"(AA, initial)",0.13,'-,2.24 unit increase,[1.34-3.14],"CHL1-AS2, LINC01986",Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,3:47829
rs975144-<b>C</b>,2 x 10-6,,0.156642,1.1363636,'-,[1.08-1.19],"PIWIL1, RIMBP2",Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,12:130383941
rs6897863-<b>A</b>,2 x 10-6,,0.591422,1.1363636,'-,[1.08-1.19],POLD2P1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,5:93176775
rs1466234-<b>C</b>,2 x 10-6,,0.356152,1.1350738,'-,[1.08-1.19],STK33,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,11:8377300
rs12692981-<b>T</b>,4 x 10-6,,0.846775,1.1350738,'-,[1.08-1.19],DLX2-DT,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,2:172127288
rs7780440-<b>T</b>,4 x 10-6,,0.710804,1.1337868,'-,[1.08-1.19],"MTURN, RPS27P16",Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,7:30167063
rs7675845-<b>A</b>,4 x 10-6,,0.617914,1.1312217,'-,[1.08-1.19],MAPK10,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,4:86462123
rs11835187-<b>C</b>,6 x 10-6,,0.793253,1.1312217,'-,[1.08-1.19],LINC02823,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,12:91431781
rs183674373-<b>G</b>,6 x 10-6,,0.989473,1.1299435,'-,[1.08-1.18],"MIR6082, LINC02504",Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,4:171254787
rs112548923-<b>T</b>,6 x 10-6,,0.9640619,1.1299435,'-,[1.08-1.18],OTX2-AS1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,14:57151481
rs12215021-<b>T</b>,7 x 10-6,,0.75568,1.1299435,'-,[1.07-1.19],SAMD3,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,6:130289648
rs62080330-<b>C</b>,7 x 10-6,,0.790407,1.1299435,'-,[1.07-1.19],PYY,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,17:43997592
rs62393099-<b>C</b>,7 x 10-6,,0.9689499,1.1286682,'-,[1.07-1.18],HULC,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,6:8806815
rs116463691-<b>T</b>,7 x 10-6,,0.9758602,1.1286682,'-,[1.07-1.18],PDE4D,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,5:59137097
rs389931-<b>T</b>,7 x 10-6,,0.9064421,1.1273957,'-,[1.07-1.18],OR5V1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,6:29409890
rs116980813-<b>C</b>,6 x 10-6,,0.00959488,1.12,'-,[1.07-1.17],LINC02131,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,16:77601798
rs118135766-<b>C</b>,8 x 10-6,,0.0135946,1.12,'-,[1.07-1.17],NCOA2,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,8:70111154
rs62578598-<b>T</b>,8 x 10-6,,0.0547323,1.121,'-,[1.07-1.17],CFAP77,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,9:132532706
rs139808721-<b>C</b>,8 x 10-6,,0.00886312,1.123,'-,[1.07-1.18],KCNK1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,1:233708428
rs72555707-<b>G</b>,5 x 10-6,,0.0221079,1.124,'-,[1.07-1.18],NT5C3A,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,7:33062615
rs62451225-<b>T</b>,7 x 10-6,,0.231933,1.124,'-,[1.07-1.18],BBS9,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,7:33501113
rs7864275-<b>T</b>,9 x 10-6,,0.416121,1.127,'-,[1.07-1.18],CDKN2B-AS1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,9:22161213
rs2189024-<b>C</b>,9 x 10-6,,0.716871,1.128,'-,[1.07-1.18],DNAH11,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,7:21845405
rs58627364-<b>T</b>,3 x 10-6,,0.139818,1.129,'-,[1.08-1.18],TET1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,10:68560479
rs1494821-<b>A</b>,3 x 10-6,,0.362682,1.132,'-,[1.08-1.19],RPL35AP15,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,5:117254912
rs57647669-<b>T</b>,3 x 10-6,,0.128671,1.133,'-,[1.08-1.19],PLD5,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,1:242380323
rs3119481-<b>A</b>,2 x 10-6,,0.0965416,1.134,'-,[1.08-1.19],ANKRD30BP1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,21:13413825
rs7171476-<b>T</b>,9 x 10-7,,0.324605,1.137,'-,[1.08-1.19],'-,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,15:61389205
rs2733642-<b>C</b>,2 x 10-6,,0.508475,1.137,'-,[1.08-1.19],MYBPC1,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,12:101571074
rs7123421-<b>C</b>,7 x 10-6,,0.0354136,1.139,'-,[1.08-1.2],RNU6-783P,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,11:23861702
rs6976860-<b>G</b>,6 x 10-7,,0.333289,1.142,'-,[1.09-1.2],PHTF2,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,7:77822829
rs11138705-<b>C</b>,2 x 10-6,,0.748896,1.143,'-,[1.09-1.2],MTCO1P51,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,9:80506630
rs74940569-<b>A</b>,3 x 10-6,,0.0119381,1.175,'-,[1.11-1.24],ANKS1B,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,12:99582570
rs2702468-<b>C</b>,2 x 10-7,,0.00153272,1.48,'-,[1.33-1.63],'-,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,8:36176467
rs148690419-<b>C</b>,5 x 10-7,,0.9889853,1.1467891,'-,[1.09-1.2],ILVBL,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,19:15122514
rs11713276-<b>G</b>,1 x 10-6,,0.085638,1.1415524,'-,[1.09-1.2],MAP3K13,Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,3:185354520
rs78450446-<b>C</b>,4 x 10-6,,0.878216,1.1389521,'-,[1.08-1.2],"LINC02389, WIF1",Trauma exposure in major depressive disorder-negative individuals,response to trauma exposure,GCST009984,12:64990810
rs6976860-<b>T</b>,7 x 10-6,,0.666711,1.1235955,'-,[1.07-1.18],PHTF2,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,7:77822829
rs612711-<b>T</b>,9 x 10-6,,0.414926,1.1223345,'-,[1.07-1.17],MRPL37,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:54220701
rs325502-<b>G</b>,8 x 10-6,,0.422234,1.1223345,'-,[1.07-1.18],'-,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,5:104672432
rs73133999-<b>G</b>,7 x 10-6,,0.9644714,1.1210762,'-,[1.07-1.17],ST3GAL6-AS1,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,3:98715123
rs145189127-<b>G</b>,7 x 10-6,,0.0228545,1.117,'-,[1.07-1.17],"MIR557, QRSL1P1",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:168405362
rs78994374-<b>A</b>,9 x 10-6,,0.0200533,1.118,'-,[1.07-1.17],MAP3K5,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,6:136623641
rs17526879-<b>G</b>,9 x 10-6,,0.019323,1.121,'-,[1.07-1.17],LINC01742,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,20:57976061
rs142592479-<b>A</b>,4 x 10-6,,0.0226635,1.122,'-,[1.07-1.17],'-,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,2:49555287
rs111629393-<b>G</b>,8 x 10-6,,0.329171,1.123,'-,[1.07-1.18],NELL1,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,11:21292600
rs1390496-<b>G</b>,5 x 10-6,,0.743567,1.126,'-,[1.07-1.18],LINC01036,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:187307421
rs17676433-<b>T</b>,2 x 10-6,,0.031546,1.127,'-,[1.08-1.18],GRK5,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,10:119348012
rs147542932-<b>C</b>,3 x 10-6,,0.0605838,1.128,'-,[1.08-1.18],KCNT2,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:196204734
rs4312987-<b>T</b>,2 x 10-6,,0.592484,1.13,'-,[1.08-1.18],"KLHL31, LRRC1",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,6:53720234
rs13214628-<b>G</b>,1 x 10-6,,0.9730667,1.1337868,'-,[1.08-1.19],"VNN2, VNN3",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,6:132741777
rs73176142-<b>C</b>,3 x 10-6,,0.982012,1.1273957,'-,[1.08-1.18],"RNU6-348P, PLD1",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,3:171542960
rs10468608-<b>C</b>,5 x 10-6,,0.627944,1.126126,'-,[1.07-1.18],"MAP2K3, EIF1P5",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,17:21283048
rs35099409-<b>T</b>,5 x 10-6,,0.9511414,1.1248593,'-,[1.07-1.18],INTS9,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,8:28876569
rs2498010-<b>A</b>,6 x 10-6,,0.372037,1.1248593,'-,[1.07-1.18],'-,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,10:84826084
rs10892733-<b>T</b>,6 x 10-6,,0.706353,1.1235955,'-,[1.07-1.18],"SC5D, BMPR1AP2",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,11:121344415
rs79954464-<b>G</b>,7 x 10-6,,0.9710358,1.1235955,'-,[1.07-1.18],"ZNF683, LIN28A",Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,1:26402358
rs138567168-<b>C</b>,5 x 10-6,,0.9811409,1.1235955,'-,[1.07-1.18],TRIM44,Major depressive disorder in trauma exposed individuals,"unipolar depression, response to trauma exposure, trauma exposure measurement",GCST009980,11:35778692
rs11710497-<b>A</b>,1 x 10-7,(mean),0.11,'-,5.29 z-score decrease,'-,SLC6A1,Longitudinal alcohol consumption,longitudinal alcohol consumption measurement,GCST002981,3:11004210
rs12257178-<b>A</b>,5 x 10-7,(trajectory),0.39,'-,5.04 z-score decrease,'-,BTBD7P2,Longitudinal alcohol consumption,longitudinal alcohol consumption measurement,GCST002981,10:111256470
rs694424-<b>G</b>,5 x 10-7,(trajectory),0.12,'-,5.01 z-score decrease,'-,IGSF9B,Longitudinal alcohol consumption,longitudinal alcohol consumption measurement,GCST002981,11:133954644
rs1984450-<b>A</b>,3 x 10-7,(trajectory),0.1,'-,5.15 z-score decrease,'-,ZNF578,Longitudinal alcohol consumption,longitudinal alcohol consumption measurement,GCST002981,19:52510546
rs4898641-<b>G</b>,1 x 10-6,(mean),0.06,'-,4.88 z-score decrease,'-,MIPOL1,Longitudinal alcohol consumption,longitudinal alcohol consumption measurement,GCST002981,14:37544582
rs7031417-<b>C</b>,1 x 10-8,(mean),0.07,'-,5.68 z-score decrease,'-,SPATA31C2,Longitudinal alcohol consumption,longitudinal alcohol consumption measurement,GCST002981,9:88211338
rs1260326-<b>C</b>,2 x 10-16,(EA),0.591,'-,0.04477 unit increase,[0.034-0.055],'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs2961816-<b>A</b>,1 x 10-8,,0.683,'-,5.74 z score increase,NR,"RNU6-480P, RNU6-1296P",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,5:51147857
rs12639940-<b>A</b>,3 x 10-9,(EA),0.614,'-,0.03295 unit increase,[0.022-0.044],KLB,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:39419361
rs62033408-<b>A</b>,1 x 10-19,,0.678,'-,9.08 z score increase,NR,FTO,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,16:53794050
rs13107325-<b>C</b>,1 x 10-25,(EA),0.921,'-,0.1034 unit increase,[0.084-0.123],'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs142997686-<b>?</b>,5 x 10-9,,0.384,'-,5.84 z score increase,NR,BAHCC1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:81452134
rs2961817-<b>A</b>,7 x 10-9,(EA),0.657,'-,0.03316 unit increase,[0.022-0.044],"RNU6-480P, RNU6-1296P",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,5:51147229
rs12425096-<b>A</b>,5 x 10-8,(EA),0.775,'-,0.0349 unit increase,[0.022-0.047],"SCN8A, SLC4A8",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,12:51586675
rs9937709-<b>A</b>,4 x 10-16,(EA),0.587,'-,0.04399 unit increase,[0.033-0.055],FTO,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,16:53786901
rs4794018-<b>C</b>,2 x 10-8,(EA),0.337,'-,0.03221 unit increase,[0.021-0.044],IGF2BP1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:49016036
rs1229984-<b>C</b>,4 x 10-16,(Latino),0.938,'-,0.349 unit increase,[0.26-0.43],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs60610174-<b>A</b>,3 x 10-8,"(EA, women)",0.0693,'-,0.1567 unit increase,[0.1-0.21],"ZMYM2, ZMYM5",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,13:19895213
rs41355452-<b>A</b>,4 x 10-8,"(AA, women)",0.13,'-,0.1468 unit decrease,[0.094-0.199],LINC01440,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,20:55641990
rs1260326-<b>C</b>,2 x 10-16,,0.652,'-,8.22 z score increase,NR,'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs2683616-<b>A</b>,5 x 10-10,,0.624,'-,6.22 z score increase,NR,"VRK2, ACTG1P22",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,2:57808420
rs12639940-<b>A</b>,3 x 10-9,,0.613,'-,5.93 z score increase,NR,KLB,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:39419361
rs142783062-<b>?</b>,1 x 10-22,,0.345,'-,9.82 z score increase,NR,"ADH1C, ADH1B",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99349804
rs4423856-<b>T</b>,1 x 10-8,,0.796,'-,5.66 z score increase,NR,DCLK2,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:150063705
rs2717071-<b>A</b>,1 x 10-9,(EA),0.628,'-,0.03377 unit increase,[0.023-0.045],ACTG1P22,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,2:57803827
rs4841132-<b>A</b>,4 x 10-8,,0.101,'-,5.46 z score increase,NR,"RNU6-526P, RNU6-1151P",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,8:9326086
rs1229984-<b>C</b>,5 x 10-102,(EA),0.97,'-,0.3402 unit increase,[0.31-0.37],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs1229978-<b>C</b>,1 x 10-14,(EA),0.403,'-,0.04224 unit increase,[0.031-0.053],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99335042
rs9902512-<b>C</b>,6 x 10-9,,0.664,'-,5.81 z score decrease,NR,IGF2BP1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:49016912
rs62339861-<b>C</b>,3 x 10-8,(EA),0.792,'-,0.03685 unit increase,[0.024-0.05],DCLK2,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:150062269
rs75723348-<b>T</b>,1 x 10-8,,0.736,'-,5.55 z score increase,NR,"Y_RNA, RBX1",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,22:41024675
rs185177474-<b>A</b>,2 x 10-8,(EA),0.031,'-,0.0887 unit increase,[0.058-0.12],"KCTD16, RN7SKP246",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,5:144509770
rs35572189-<b>A</b>,8 x 10-10,(EA),0.368,'-,0.03454 unit increase,[0.024-0.046],BAHCC1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:81451999
rs150627184-<b>C</b>,7 x 10-21,(AA),0.809,'-,0.112 unit increase,[0.089-0.135],"ADH1A, ADH6",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99242230
rs1229984-<b>C</b>,1 x 10-19,(AA),0.989,'-,0.412 unit increase,[0.32-0.5],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs3782886-<b>C</b>,5 x 10-17,(East Asian),0.205,'-,0.602 unit decrease,[0.46-0.74],BRAP,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,12:111672685
rs1229984-<b>C</b>,4 x 10-133,,0.97,'-,24.56 z score increase,NR,ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs13107325-<b>C</b>,2 x 10-30,,0.937,'-,11.45 z score increase,NR,'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs147627531-<b>?</b>,6 x 10-7,,NR,'-,0.0484 unit decrease,[0.029-0.067],KCNIP4,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,4:20989760
rs1961890-<b>?</b>,5 x 10-6,,NR,'-,0.0135 unit decrease,[0.0076-0.0194],"VMA21, Metazoa_SRP",Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,X:151306549
rs71573331-<b>?</b>,2 x 10-6,,NR,'-,0.0374 unit increase,[0.022-0.053],UNC5CL,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,6:40973880
rs1861419-<b>?</b>,2 x 10-6,,NR,'-,0.0254 unit decrease,[0.015-0.036],PDSS2,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,6:107218241
rs201621461-<b>?</b>,5 x 10-6,,NR,'-,0.0476 unit increase,[0.027-0.068],PRKN,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,6:162385454
rs56031910-<b>?</b>,3 x 10-6,,NR,'-,0.0418 unit increase,[0.024-0.059],"C7orf65, PKD1L1",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,7:47669440
rs7078410-<b>?</b>,3 x 10-6,,NR,'-,0.0157 unit decrease,[0.009-0.0224],"NKX2-3, SLC25A28",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,10:99569213
rs61862113-<b>?</b>,4 x 10-6,,NR,'-,0.0489 unit increase,[0.028-0.07],ADGRA1,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,10:133114370
rs139971893-<b>?</b>,4 x 10-6,,NR,'-,0.0461 unit increase,[0.027-0.066],LUZP2,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,11:24814829
rs4876-<b>?</b>,5 x 10-6,,NR,'-,0.015 unit decrease,[0.0085-0.0215],RCN1,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,11:32103432
rs56401602-<b>?</b>,4 x 10-6,,NR,'-,0.034 unit increase,[0.02-0.048],NCOR2,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,12:61293021
rs1574170-<b>?</b>,2 x 10-6,,NR,'-,0.0187 unit increase,[0.011-0.026],RASA3,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,13:114098367
rs75861629-<b>?</b>,4 x 10-6,,NR,'-,0.0704 unit decrease,[0.04-0.1],RAD51B,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,14:67877017
rs17352842-<b>?</b>,3 x 10-6,,NR,'-,0.0213 unit decrease,[0.012-0.03],"DUT, FBN1",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,15:48402014
rs76861960-<b>?</b>,8 x 10-7,,NR,'-,0.0592 unit decrease,[0.036-0.083],LINC02131,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,16:77565542
rs165110-<b>?</b>,4 x 10-6,,NR,'-,0.0162 unit increase,[0.0093-0.0231],'-,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,18:77682029
rs8182496-<b>?</b>,1 x 10-6,,NR,'-,0.0166 unit decrease,[0.0099-0.0233],"RNA5SP471, LINC02841",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,19:31643033
rs2268282-<b>?</b>,2 x 10-6,,NR,'-,0.0219 unit increase,[0.013-0.031],RUNX1,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,21:34845505
rs2024641-<b>?</b>,2 x 10-7,,NR,'-,0.0175 unit decrease,[0.011-0.024],"RBFOX2, APOL5",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,22:35734507
rs3747207-<b>?</b>,3 x 10-9,,NR,'-,0.0238 unit increase,[0.016-0.032],PNPLA3,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,22:43928975
rs319991-<b>?</b>,2 x 10-7,,NR,'-,0.0118 unit increase,[0.0073-0.0163],AGBL4,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,1:48651222
rs2268793-<b>?</b>,3 x 10-6,,NR,'-,0.0199 unit decrease,[0.012-0.028],"NGF-AS1, NGF",Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,1:115289162
rs141519390-<b>?</b>,2 x 10-6,,NR,'-,0.0384 unit decrease,[0.023-0.054],CTNNA2,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,2:80169559
rs72815665-<b>?</b>,4 x 10-6,,NR,'-,0.0316 unit increase,[0.018-0.045],ZAP70,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,2:97726238
rs71614157-<b>?</b>,4 x 10-6,,NR,'-,0.0426 unit increase,[0.025-0.061],ITGA9,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,3:37627455
rs73135034-<b>?</b>,3 x 10-6,,NR,'-,0.0341 unit decrease,[0.02-0.048],MAGI1,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,3:65793276
rs28432746-<b>?</b>,2 x 10-6,,NR,'-,0.0134 unit decrease,[0.0079-0.0189],GPRIN3,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,4:89255792
rs115169076-<b>?</b>,5 x 10-6,,NR,'-,0.0392 unit increase,[0.022-0.056],ADAMTS12,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,5:33686563
rs76092496-<b>?</b>,5 x 10-6,,NR,'-,0.0394 unit decrease,[0.023-0.056],'-,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,7:13462209
rs7794614-<b>?</b>,5 x 10-6,,NR,'-,0.0103 unit decrease,[0.0058-0.0148],CNTNAP2,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,7:147117159
rs191610380-<b>?</b>,2 x 10-7,,NR,'-,0.0318 unit increase,[0.02-0.044],PPP2R2A,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,8:26368897
rs9314736-<b>?</b>,3 x 10-6,,NR,'-,0.0138 unit increase,[0.0079-0.0197],NTRK2,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,9:84884337
rs118107800-<b>?</b>,1 x 10-6,,NR,'-,0.0408 unit increase,[0.024-0.057],PDCD4-AS1,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,10:110871498
rs76053346-<b>?</b>,3 x 10-7,,NR,'-,0.0431 unit increase,[0.027-0.06],SHOC2,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,10:110996333
rs12256545-<b>?</b>,5 x 10-6,,NR,'-,0.0295 unit increase,[0.017-0.042],"RPS27P18, TEX36-AS1",Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,10:125563348
rs12906285-<b>?</b>,2 x 10-6,,NR,'-,0.0241 unit decrease,[0.014-0.034],POLR2M,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,15:57742121
rs3747207-<b>?</b>,6 x 10-8,,NR,'-,0.0143 unit increase,[0.0092-0.0194],PNPLA3,Aspartate aminotransferase levels in excessive alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007377,22:43928975
rs141835214-<b>?</b>,3 x 10-6,,NR,'-,0.1647 unit increase,[0.096-0.234],"LINC02800, GRHL3-AS1",Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,1:24249251
rs77872903-<b>?</b>,3 x 10-6,,NR,'-,0.1645 unit increase,[0.096-0.233],MIPEPP2,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,1:238720828
rs2902041-<b>?</b>,2 x 10-6,,NR,'-,0.0672 unit increase,[0.04-0.095],LINC01812,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,2:67887766
rs62243445-<b>?</b>,2 x 10-6,,NR,'-,0.1282 unit increase,[0.075-0.181],RAD18,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,3:8843644
rs116137224-<b>?</b>,4 x 10-6,,NR,'-,0.1753 unit increase,[0.1-0.25],NDST4,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,4:115087321
rs62379337-<b>?</b>,3 x 10-6,,NR,'-,0.151 unit increase,[0.088-0.214],LINC01847,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,5:159739352
rs59694261-<b>?</b>,5 x 10-6,,NR,'-,0.0799 unit decrease,[0.046-0.114],'-,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,8:141966278
rs12551941-<b>?</b>,4 x 10-6,,NR,'-,0.1347 unit decrease,[0.078-0.191],'-,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,9:29568838
rs117289048-<b>?</b>,2 x 10-6,,NR,'-,0.1631 unit increase,[0.096-0.23],"HSPA8P17, FTLP4",Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,9:30942564
rs111532669-<b>?</b>,8 x 10-8,,NR,'-,0.1596 unit increase,[0.1-0.22],PTCH1,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,9:95446682
rs117751356-<b>?</b>,4 x 10-6,,NR,'-,0.1583 unit increase,[0.092-0.225],"YAP1, RNU6-952P",Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,11:102240710
rs7122144-<b>?</b>,3 x 10-7,,NR,'-,0.0802 unit increase,[0.05-0.111],"RPS27P20, BARX2",Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,11:129520077
rs147502517-<b>?</b>,2 x 10-6,,NR,'-,0.2088 unit increase,[0.12-0.29],PAH,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,12:102871642
rs62053747-<b>?</b>,2 x 10-6,,NR,'-,0.1448 unit increase,[0.085-0.205],DOC2B,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,17:151596
rs138424361-<b>?</b>,4 x 10-6,,NR,'-,0.2271 unit increase,[0.13-0.32],CDH20,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,18:61567782
rs11088550-<b>?</b>,5 x 10-6,,NR,'-,0.0756 unit increase,[0.043-0.108],MX1,Alanine aminotransferase levels in low alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007379,21:41464067
rs61766495-<b>?</b>,4 x 10-6,,NR,'-,0.1504 unit increase,[0.087-0.214],IGSF21,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,1:18139561
rs137866734-<b>?</b>,9 x 10-7,,NR,'-,0.1581 unit increase,[0.095-0.221],ABCA4,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,1:94074274
rs77213573-<b>?</b>,1 x 10-6,,NR,'-,0.093 unit increase,[0.056-0.13],"PPP2R5A, LINC02608",Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,1:212260231
rs113975060-<b>?</b>,2 x 10-6,,NR,'-,0.1371 unit increase,[0.081-0.193],'-,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,1:239271245
rs2902041-<b>?</b>,2 x 10-6,,NR,'-,0.0491 unit increase,[0.029-0.069],LINC01812,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,2:67887766
rs2077217-<b>?</b>,2 x 10-6,,NR,'-,0.1495 unit increase,[0.089-0.21],THRB-AS1,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,3:24504645
rs2371605-<b>?</b>,6 x 10-7,,NR,'-,0.1546 unit increase,[0.094-0.215],"RBMS3, RBMS3-AS3",Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,3:29256913
rs146064236-<b>?</b>,3 x 10-6,,NR,'-,0.1318 unit increase,[0.077-0.186],KALRN,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,3:124288055
rs73154660-<b>?</b>,9 x 10-7,,NR,'-,0.1677 unit increase,[0.1-0.23],"RNA5SP146, VEPH1",Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,3:157229738
rs6813907-<b>?</b>,3 x 10-6,,NR,'-,0.0342 unit increase,[0.02-0.049],RNU6-931P,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,4:45559415
rs79303598-<b>?</b>,1 x 10-6,,NR,'-,0.0958 unit increase,[0.058-0.134],ADAMTS6,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,5:65249673
rs76622665-<b>?</b>,5 x 10-9,,NR,'-,0.1594 unit increase,[0.11-0.21],ADAMTS6,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,5:65395057
rs34925196-<b>?</b>,2 x 10-6,,NR,'-,0.1442 unit increase,[0.085-0.204],TRAPPC13,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,5:65660730
rs71641008-<b>?</b>,4 x 10-6,,NR,'-,0.0763 unit increase,[0.044-0.109],FAM172A,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,5:94077633
rs144032011-<b>?</b>,2 x 10-6,,NR,'-,0.1577 unit increase,[0.093-0.222],WDR55,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,5:140666585
rs6899983-<b>?</b>,2 x 10-7,,NR,'-,0.1467 unit increase,[0.092-0.202],VARS1,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,6:31791154
rs34173-<b>?</b>,3 x 10-7,,NR,'-,0.041 unit decrease,[0.026-0.056],PPP1R17,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,7:31695649
rs78442079-<b>?</b>,5 x 10-6,,NR,'-,0.0639 unit increase,[0.037-0.091],CSMD1,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,8:3316317
rs118163641-<b>?</b>,3 x 10-6,,NR,'-,0.1618 unit increase,[0.094-0.23],"MOS, PLAG1",Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,8:56131860
rs7017297-<b>?</b>,4 x 10-6,,NR,'-,0.0771 unit increase,[0.045-0.109],KHDRBS3,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,8:135590885
rs117983281-<b>?</b>,2 x 10-7,,NR,'-,0.1449 unit increase,[0.091-0.199],PUM3,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,9:2809077
rs10769902-<b>?</b>,4 x 10-6,,NR,'-,0.0364 unit increase,[0.021-0.052],"LMO1, STK33",Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,11:8336341
rs17342773-<b>?</b>,7 x 10-7,,NR,'-,0.1314 unit increase,[0.08-0.183],ABTB2,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,11:34322165
rs113034494-<b>?</b>,3 x 10-6,,NR,'-,0.0882 unit increase,[0.052-0.125],TUBB4BP4,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,11:91952037
rs12803802-<b>?</b>,1 x 10-6,,NR,'-,0.0874 unit increase,[0.053-0.122],SLC35F2,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,11:107800953
rs145863953-<b>?</b>,4 x 10-6,,NR,'-,0.1638 unit increase,[0.094-0.233],MUC19,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,12:40421822
rs875899-<b>?</b>,4 x 10-6,,NR,'-,0.1253 unit increase,[0.072-0.178],SLC25A3,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,12:98595029
rs686288-<b>?</b>,1 x 10-6,,NR,'-,0.0731 unit decrease,[0.044-0.102],ANO4,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,12:100982873
rs12580745-<b>?</b>,5 x 10-7,,NR,'-,0.165 unit increase,[0.1-0.23],TMEM132D,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,12:129167622
rs73266512-<b>?</b>,5 x 10-6,,NR,'-,0.0747 unit increase,[0.043-0.106],TTC6,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,14:37932464
rs117922352-<b>?</b>,2 x 10-6,,NR,'-,0.1708 unit increase,[0.1-0.24],LINC00520,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,14:55822322
rs289737-<b>?</b>,5 x 10-6,,NR,'-,0.037 unit increase,[0.021-0.053],NLRC5,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,16:56998230
rs7188913-<b>?</b>,2 x 10-6,,NR,'-,0.0869 unit increase,[0.051-0.123],"RPS27P27, Metazoa_SRP",Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,16:59006456
rs192422186-<b>?</b>,4 x 10-6,,NR,'-,0.1473 unit increase,[0.085-0.21],CFDP1,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,16:75394552
rs7186082-<b>?</b>,4 x 10-6,,NR,'-,0.0339 unit increase,[0.02-0.048],PIEZO1,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,16:88717495
rs138424361-<b>?</b>,1 x 10-6,,NR,'-,0.1739 unit increase,[0.1-0.24],CDH20,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,18:61567782
rs117736555-<b>?</b>,3 x 10-6,,NR,'-,0.1121 unit increase,[0.066-0.159],KIF16B,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,20:16532468
rs13058191-<b>?</b>,4 x 10-6,,NR,'-,0.1545 unit increase,[0.089-0.22],C22orf34,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,22:49380054
rs546833-<b>?</b>,3 x 10-6,,NR,'-,0.0357 unit decrease,[0.021-0.051],OPCML,Aspartate aminotransferase levels in low alcohol consumption,"aspartate aminotransferase measurement, alcohol consumption measurement",GCST007378,11:133225897
rs9436480-<b>?</b>,7 x 10-7,,NR,'-,0.0285 unit increase,[0.017-0.04],CDCP2,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,1:54151583
rs10184783-<b>?</b>,3 x 10-6,,NR,'-,0.0155 unit increase,[0.009-0.022],"STON1-GTF2A1L, STON1",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,2:48532706
rs12998401-<b>?</b>,2 x 10-6,,NR,'-,0.0212 unit increase,[0.012-0.03],ARHGEF4,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,2:131033226
rs149456251-<b>?</b>,5 x 10-6,,NR,'-,0.0603 unit increase,[0.035-0.086],CDK7P1,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,2:157117474
rs10029941-<b>?</b>,4 x 10-6,,NR,'-,0.021 unit increase,[0.012-0.03],AFAP1,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,4:7798884
rs148836387-<b>?</b>,4 x 10-6,,NR,'-,0.0726 unit increase,[0.042-0.104],ATP10D,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,4:47563339
rs13354102-<b>?</b>,3 x 10-6,,NR,'-,0.0171 unit increase,[0.0098-0.0244],"LINC01455, CMYA5",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,5:79839330
rs78009468-<b>?</b>,2 x 10-6,,NR,'-,0.0673 unit decrease,[0.04-0.095],'-,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,5:117146931
rs201022-<b>?</b>,6 x 10-7,,NR,'-,0.0193 unit decrease,[0.012-0.027],LY86,Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,6:6669940
rs12404679-<b>C</b>,4 x 10-7,,0.937,'-,0.7003 unit increase,[0.43-0.97],SLC2A1-AS1,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,1:42992787
rs10916143-<b>A</b>,8 x 10-7,,0.6305,'-,0.2458 unit decrease,[0.15-0.34],LINC01641,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,1:227427047
rs35769988-<b>A</b>,9 x 10-6,,0.4075,'-,0.2141 unit decrease,[0.12-0.31],IGFBP7,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,4:57050723
rs6951271-<b>A</b>,6 x 10-6,,0.645,'-,0.2306 unit decrease,[0.13-0.33],"TRBV29-1, PGBD4P1",Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,7:142726593
rs551692767-<b>C</b>,2 x 10-6,,0.277,'-,0.3431 unit increase,[0.2-0.49],LAMC3,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,9:131051366
rs2837900-<b>C</b>,6 x 10-6,,0.555,'-,0.3101 unit increase,[0.18-0.44],'-,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,21:41014748
rs2895596-<b>A</b>,3 x 10-6,,0.181,'-,0.2863 unit decrease,[0.17-0.41],FRMD4A,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,10:14224086
rs149212747-<b>A</b>,2 x 10-12,,0.9104,'-,0.5885 unit increase,[0.43-0.75],LINC02356,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,12:111398968
rs61908460-<b>C</b>,7 x 10-6,,0.925,'-,0.5753 unit increase,[0.32-0.83],CCDC77,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,12:414895
rs75913810-<b>A</b>,9 x 10-7,,0.232,'-,0.3941 unit decrease,[0.24-0.55],CPNE5,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,6:36800584
rs4356720-<b>A</b>,9 x 10-6,,0.8535,'-,0.2929 unit decrease,[0.16-0.42],TSHZ2,Alcohol consumption (max-drinks),alcohol consumption measurement,GCST005441,20:53055771
rs3803167-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,CUX2,Excessive alcohol consumption,alcohol consumption measurement,GCST011979,12:111347782
rs2189271-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,RPH3A,Excessive alcohol consumption,alcohol consumption measurement,GCST011979,12:112762488
rs4646776-<b>?</b>,2 x 10-96,,NR,'-,'-,'-,ALDH2,Excessive alcohol consumption,alcohol consumption measurement,GCST011979,12:111792215
rs1260326-<b>G</b>,7 x 10-24,,0.38,'-,0.03 unit decrease,[0.024-0.036],'-,Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,Mapping not available
rs13078384-<b>A</b>,2 x 10-9,,0.31,'-,0.018 unit increase,[0.012-0.024],CADM2,Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,3:85215116
rs8012947-<b>A</b>,4 x 10-8,,0.28,'-,0.017 unit increase,[0.011-0.023],ARID4A,Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,14:58317737
rs114026228-<b>C</b>,4 x 10-13,(men),0.005,'-,0.032 unit decrease,[0.024-0.04],TSPAN5,Alcohol consumption,alcohol consumption measurement,GCST004886,4:98646767
rs145452708-<b>C</b>,4 x 10-13,(men),0.01,'-,0.031 unit decrease,[0.023-0.039],ADH1B,Alcohol consumption,alcohol consumption measurement,GCST004886,4:99327485
rs28712821-<b>A</b>,7 x 10-11,(men),0.4,'-,0.029 unit decrease,[0.021-0.037],KLB,Alcohol consumption,alcohol consumption measurement,GCST004886,4:39412160
rs29001570-<b>C</b>,1 x 10-10,(men),0.006,'-,0.028 unit decrease,[0.02-0.036],ADH5,Alcohol consumption,alcohol consumption measurement,GCST004886,4:99073254
rs140089781-<b>A</b>,4 x 10-8,(men),0.001,'-,0.024 unit decrease,[0.016-0.032],CTNNA2,Alcohol consumption,alcohol consumption measurement,GCST004886,2:79852585
rs145452708-<b>C</b>,3 x 10-19,(women),0.01,'-,0.037 unit decrease,[0.029-0.045],ADH1B,Alcohol consumption,alcohol consumption measurement,GCST004886,4:99327485
rs144198753-<b>T</b>,5 x 10-16,(women),0.008,'-,0.033 unit decrease,[0.025-0.041],"EIF4E, BTF3P13",Alcohol consumption,alcohol consumption measurement,GCST004886,4:98792199
rs11127048-<b>G</b>,1 x 10-16,(women),0.38,'-,0.035 unit decrease,[0.027-0.043],"GCKR, C2orf16",Alcohol consumption,alcohol consumption measurement,GCST004886,2:27529596
rs11940694-<b>A</b>,9 x 10-10,(women),0.39,'-,0.026 unit decrease,[0.018-0.034],KLB,Alcohol consumption,alcohol consumption measurement,GCST004886,4:39413373
rs29001570-<b>C</b>,1 x 10-9,(women),0.006,'-,0.025 unit decrease,[0.017-0.033],ADH5,Alcohol consumption,alcohol consumption measurement,GCST004886,4:99073254
rs1376935-<b>A</b>,4 x 10-10,(women),0.32,'-,0.026 unit increase,[0.018-0.034],CADM2,Alcohol consumption,alcohol consumption measurement,GCST004886,3:85187275
rs67028245-<b>A</b>,4 x 10-8,(women),0.4,'-,0.023 unit decrease,[0.015-0.031],CADM2,Alcohol consumption,alcohol consumption measurement,GCST004886,3:85345622
rs145452708-<b>C</b>,1 x 10-30,,0.01,'-,0.034 unit decrease,[0.028-0.04],ADH1B,Alcohol consumption,alcohol consumption measurement,GCST004886,4:99327485
rs193099203-<b>T</b>,4 x 10-25,,0.007,'-,0.031 unit decrease,[0.025-0.037],"BTF3P13, TSPAN5",Alcohol consumption,alcohol consumption measurement,GCST004886,4:98708866
rs1260326-<b>T</b>,1 x 10-21,,0.39,'-,0.028 unit decrease,[0.022-0.034],'-,Alcohol consumption,alcohol consumption measurement,GCST004886,Mapping not available
rs11940694-<b>A</b>,8 x 10-19,,0.39,'-,0.027 unit decrease,[0.021-0.033],KLB,Alcohol consumption,alcohol consumption measurement,GCST004886,4:39413373
rs29001570-<b>C</b>,1 x 10-18,,0.006,'-,0.026 unit decrease,[0.02-0.032],ADH5,Alcohol consumption,alcohol consumption measurement,GCST004886,4:99073254
rs9841829-<b>G</b>,3 x 10-10,,0.23,'-,0.019 unit increase,[0.013-0.025],CADM2,Alcohol consumption,alcohol consumption measurement,GCST004886,3:85520211
rs35081954-<b>CTG</b>,2 x 10-9,,0.42,'-,0.018 unit increase,[0.012-0.024],"ADH1B, ADH1C",Alcohol consumption,alcohol consumption measurement,GCST004886,4:99349662
chr18:72124965-<b>CCTCCCG</b>,2 x 10-8,,0.05,'-,0.017 unit increase,[0.011-0.023],'-,Alcohol consumption,alcohol consumption measurement,GCST004886,Mapping not available
rs145452708-<b>C</b>,1 x 10-30,,0.01,'-,0.035 unit decrease,[0.029-0.041],ADH1B,Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,4:99327485
rs193099203-<b>T</b>,3 x 10-25,,0.007,'-,0.032 unit decrease,[0.026-0.038],"BTF3P13, TSPAN5",Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,4:98708866
rs11940694-<b>A</b>,6 x 10-18,,0.39,'-,0.027 unit decrease,[0.021-0.033],KLB,Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,4:39413373
rs29001570-<b>C</b>,1 x 10-16,,0.006,'-,0.025 unit decrease,[0.019-0.031],ADH5,Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,4:99073254
rs2298755-<b>G</b>,1 x 10-9,,0.41,'-,0.019 unit increase,[0.013-0.025],"ADH1C, ADH1B",Alcohol consumption in current drinkers,alcohol consumption measurement,GCST004887,4:99339881
rs4665985-<b>C</b>,1 x 10-6,"(EA, adjusted for lean body mass)",0.28,'-,0.04 drinks per week increase,[0.02-0.05],"GCKR, C2orf16",Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,2:27531011
rs4665985-<b>C</b>,2 x 10-8,,0.28,'-,0.04 drinks per week increase,[0.03-0.05],"GCKR, C2orf16",Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,2:27531011
rs7686419-<b>A</b>,9 x 10-8,"(EA, adjusted for lean body mass)",0.47,'-,0.03 drinks per week decrease,[0.05-0.02],"KLB, RNU6-887P",Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,4:39404750
rs7686419-<b>A</b>,9 x 10-11,,0.47,'-,0.04 drinks per week decrease,[0.05-0.03],"KLB, RNU6-887P",Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,4:39404750
rs1229984-<b>T</b>,3 x 10-32,(EA),0.05,'-,0.19 drinks per week decrease,[0.22-0.16],ADH1B,Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,4:99318162
rs1229984-<b>T</b>,3 x 10-6,"(Hispanic/Latino, adjusted for lean body mass)",0.05,'-,0.21 drinks per week decrease,[0.30-0.12],ADH1B,Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,4:99318162
rs780094-<b>T</b>,2 x 10-7,(EA),0.41,'-,0.034 unit decrease,'-,'-,Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,Mapping not available
rs11940694-<b>A</b>,1 x 10-7,(EA),0.42,'-,0.035 unit decrease,'-,KLB,Alcohol consumption (drinks per week),"alcohol consumption measurement, alcohol drinking",GCST004405,4:39413373
rs671-<b>?</b>,2 x 10-72,(East Asian),0.9995,2.5,'-,[2.00-3.33],ALDH2,Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,12:111803962
rs10849915-<b>C</b>,4 x 10-28,(East Asian),0.23,1.7,'-,'-,CCDC63,Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,12:110895818
rs2072134-<b>A</b>,3 x 10-16,(East Asian),0.16,1.58,'-,'-,OAS3,Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,12:112971371
rs1229984-<b>?</b>,2 x 10-20,(EA),0.95,1.27,'-,[1.19-1.35],ADH1B,Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,4:99318162
rs1229984-<b>?</b>,4 x 10-7,(Hispanic/Latino),0.93,1.39,'-,[1.18-1.69],ADH1B,Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,4:99318162
rs2074356-<b>A</b>,6 x 10-48,(East Asian),0.14,2.41,'-,'-,HECTD4,Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,12:112207597
rs12229654-<b>G</b>,2 x 10-48,(East Asian),0.18,2.31,'-,'-,"CUX2, LINC01405",Alcohol consumption (drinkers vs non-drinkers),"alcohol consumption measurement, alcohol drinking",GCST004404,12:110976657
rs182344113-<b>G</b>,2 x 10-7,,0.002,'-,0.168 unit increase,[0.105-0.232],"KCNJ10, LINC01133",Alcohol consumption over the past year,alcohol consumption measurement,GCST004990,1:159994652
rs141973904-<b>T</b>,4 x 10-7,,0.023,'-,0.047 unit decrease,[0.027-0.067],"ADH1B, ADH1C",Alcohol consumption over the past year,alcohol consumption measurement,GCST004990,4:99341085
rs183472573-<b>C</b>,1 x 10-6,,0.976,'-,0.052 unit decrease,[0.074-0.031],WNT4,Alcohol consumption over the past year,alcohol consumption measurement,GCST004990,1:22142579
rs4791735-<b>T</b>,1 x 10-6,,0.276,'-,0.015 unit decrease,[0.021-0.009],"MYH10, CCDC42",Alcohol consumption over the past year,alcohol consumption measurement,GCST004990,17:8695689
rs8059260-<b>G</b>,2 x 10-6,,0.16,'-,0.017 unit decrease,[0.0092-0.0248],CLEC16A,Alcohol consumption over the past year,alcohol consumption measurement,GCST004990,16:10966294
rs7979478-<b>?</b>,3 x 10-15,,NR,'-,0.035 unit decrease,[0.026-0.044],HNF1A,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,12:120982460
rs7151779-<b>?</b>,2 x 10-12,,NR,'-,0.0342 unit increase,[0.025-0.044],"LBHD2, EXOC3L4",Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,14:103099825
rs340005-<b>?</b>,4 x 10-9,,NR,'-,0.0254 unit decrease,[0.017-0.034],"RORA-AS1, RORA",Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,15:60585831
rs2414679-<b>?</b>,2 x 10-8,,NR,'-,0.023 unit increase,[0.015-0.031],RORA,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,15:60687613
rs79035353-<b>?</b>,4 x 10-6,,NR,'-,0.0901 unit increase,[0.052-0.129],THSD4,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,15:71617890
rs2006092-<b>?</b>,1 x 10-15,,NR,'-,0.046 unit increase,[0.038-0.054],GGT1,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,22:24599701
rs1497406-<b>?</b>,4 x 10-7,,NR,'-,0.0211 unit decrease,[0.013-0.029],"ARHGEF19-AS1, EPHA2",Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,1:16178825
rs1128456-<b>?</b>,4 x 10-6,,NR,'-,0.0251 unit increase,[0.015-0.036],C1orf35,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,1:228102142
rs7528353-<b>?</b>,3 x 10-6,,NR,'-,0.0191 unit decrease,[0.011-0.027],RYR2,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,1:237425165
rs13031382-<b>?</b>,5 x 10-6,,NR,'-,0.0231 unit decrease,[0.013-0.033],HPCAL1,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,2:10346191
rs73082161-<b>?</b>,2 x 10-6,,NR,'-,0.0286 unit decrease,[0.017-0.04],'-,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,2:210884941
rs13084607-<b>?</b>,1 x 10-6,,NR,'-,0.0211 unit decrease,[0.013-0.03],ARPP21,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,3:35736301
rs9273379-<b>?</b>,2 x 10-6,,NR,'-,0.0267 unit decrease,[0.016-0.038],"HLA-DQB1, HLA-DQA1",Alanine aminotransferase levels in excessive alcohol consumption,"serum alanine aminotransferase measurement, alcohol consumption measurement",GCST007381,6:32659104
rs748057-<b>?</b>,3 x 10-6,,NR,'-,0.0196 unit increase,[0.011-0.028],LINC02261,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,4:27266720
rs35146602-<b>?</b>,3 x 10-7,,NR,'-,0.0285 unit increase,[0.018-0.039],ZNF827,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,4:145866089
rs142774111-<b>?</b>,2 x 10-6,,NR,'-,0.0743 unit increase,[0.044-0.105],"MARCHF6, Y_RNA",Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,5:10341588
rs475655-<b>?</b>,5 x 10-6,,NR,'-,0.0537 unit increase,[0.031-0.077],LHFPL2,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,5:78721945
rs115958812-<b>?</b>,3 x 10-6,,NR,'-,0.0644 unit decrease,[0.037-0.092],KCNN2,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,5:114075120
rs9348981-<b>?</b>,3 x 10-6,,NR,'-,0.0211 unit decrease,[0.012-0.03],FKBP5,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,6:35719472
rs149527135-<b>?</b>,2 x 10-6,,NR,'-,0.0903 unit increase,[0.053-0.127],ZNF292,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,6:87253192
rs55841617-<b>?</b>,4 x 10-6,,NR,'-,0.0378 unit decrease,[0.022-0.054],CSMD1,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,8:4204092
rs62522261-<b>?</b>,1 x 10-7,,NR,'-,0.0994 unit increase,[0.063-0.136],CSMD3,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,8:113453042
rs62520133-<b>?</b>,5 x 10-6,,NR,'-,0.0605 unit increase,[0.035-0.086],'-,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,8:113569863
rs117322666-<b>?</b>,8 x 10-7,,NR,'-,0.0709 unit increase,[0.043-0.099],SLC24A2,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,9:19586969
rs71487170-<b>?</b>,1 x 10-6,,NR,'-,0.0927 unit increase,[0.055-0.13],LINC01519,Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,10:85123642
rs2158027-<b>?</b>,3 x 10-6,,NR,'-,0.0195 unit decrease,[0.011-0.028],"RNU6-1243P, RAB3IL1",Gamma glutamyl transferase levels in low alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007380,11:61937735
rs35940164-<b>?</b>,3 x 10-6,,NR,'-,0.0653 unit decrease,[0.038-0.093],LINC02089,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,17:52871557
rs143327921-<b>?</b>,4 x 10-6,,NR,'-,0.2441 unit increase,[0.14-0.35],ZSWIM5,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,1:45193460
rs79844428-<b>?</b>,3 x 10-6,,NR,'-,0.2358 unit increase,[0.14-0.33],EDAR,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,2:108984352
rs6709554-<b>?</b>,9 x 10-7,,NR,'-,0.0713 unit increase,[0.043-0.1],IKZF2,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,2:213147784
rs75373974-<b>?</b>,2 x 10-6,,NR,'-,0.1829 unit increase,[0.11-0.26],GRM7-AS3,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,3:6683078
rs374858907-<b>?</b>,3 x 10-6,,NR,'-,0.2245 unit increase,[0.13-0.32],"LINC02171, LINC00955",Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,4:3663429
rs7666392-<b>?</b>,3 x 10-6,,NR,'-,0.3102 unit increase,[0.18-0.44],"JAKMIP1, C4orf50",Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,4:6158076
rs76118093-<b>?</b>,4 x 10-6,,NR,'-,0.1204 unit decrease,[0.07-0.171],"LRGUK, EXOC4",Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,7:134070485
rs117791138-<b>?</b>,1 x 10-6,,NR,'-,0.2042 unit increase,[0.12-0.29],"BCAT1, BRI3P2",Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,12:24965415
rs116914846-<b>?</b>,4 x 10-6,,NR,'-,0.2936 unit increase,[0.17-0.42],CPM,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,12:69055431
rs708339-<b>?</b>,3 x 10-6,,NR,'-,0.0716 unit increase,[0.042-0.101],"LINC02418, LINC02419",Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,12:130051788
rs78026071-<b>?</b>,2 x 10-6,,NR,'-,0.26 unit increase,[0.15-0.37],TJP1,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,15:29813456
rs146846403-<b>?</b>,7 x 10-7,,NR,'-,0.2789 unit increase,[0.17-0.39],JPH3,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,16:87609135
rs17634144-<b>?</b>,9 x 10-8,,NR,'-,0.3307 unit increase,[0.21-0.45],"MTCO1P40, LINC02876",Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,17:53014891
rs111688157-<b>?</b>,2 x 10-6,,NR,'-,0.2627 unit increase,[0.16-0.37],PTPRM,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,18:8251506
rs5979144-<b>?</b>,1 x 10-7,,NR,'-,0.1878 unit decrease,[0.12-0.26],TBL1X,Gamma glutamyl transferase levels in excessive alcohol consumption,"serum gamma-glutamyl transferase measurement, alcohol consumption measurement",GCST007376,X:9658212
rs116420771-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,LINC01320,Testosterone levels x alcohol consumption (drinks per week) interaction,"alcohol consumption measurement, testosterone measurement",GCST011152,2:34220430
rs114191463-<b>?</b>,7 x 10-8,,NR,'-,'-,'-,SLMAP,Testosterone levels x alcohol consumption (drinks per week) interaction,"alcohol consumption measurement, testosterone measurement",GCST011152,3:57883372
rs1260326-<b>C</b>,1 x 10-13,,0.612,'-,7.391 z score increase,NR,'-,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,Mapping not available
rs13130794-<b>T</b>,6 x 10-16,,0.632,'-,8.096 z score increase,NR,KLB,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,4:39420622
rs144198753-<b>C</b>,4 x 10-29,,0.991,'-,10.994 z score increase,NR,"EIF4E, BTF3P13",Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,4:98792199
rs1229984-<b>C</b>,2 x 10-66,,0.98,'-,17.209 z score increase,NR,ADH1B,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,4:99318162
rs76062146-<b>G</b>,2 x 10-7,,0.972,'-,5.193 z score increase,NR,BANK1,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,4:101535173
rs13107325-<b>C</b>,7 x 10-9,,0.928,'-,5.798 z score increase,NR,'-,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,Mapping not available
rs10790449-<b>C</b>,6 x 10-6,,0.463,'-,4.532 z score increase,NR,SORL1,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,11:121630697
rs55872725-<b>C</b>,1 x 10-7,,0.599,'-,5.305 z score increase,NR,FTO,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,16:53775211
rs1635291-<b>A</b>,7 x 10-9,,0.754,'-,5.803 z score increase,NR,LINC02210-CRHR1,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,17:45674547
rs11214609-<b>G</b>,4 x 10-9,,0.395,1.06,'-,[1.04-1.08],DRD2,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST009797,11:113445380
rs1229984-<b>?</b>,4 x 10-19,,NR,'-,0.07 unit increase,[0.055-0.085],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST009800,4:99318162
rs671-<b>?</b>,1 x 10-450,,NR,'-,0.43 unit decrease,[0.41-0.45],ALDH2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST009800,12:111803962
rs11940694-<b>?</b>,4 x 10-6,,NR,'-,0.027 unit decrease,[0.015-0.039],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST009800,4:39413373
rs685395-<b>?</b>,2 x 10-8,(males),NR,'-,'-,'-,DYNC2H1,Spine bone mineral density and alcohol drinking,"alcohol consumption measurement, spine bone mineral density",GCST003919,11:103196731
rs1260326-<b>C</b>,6 x 10-9,,NR,'-,0.007 unit increase,[0.005-0.009],'-,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,Mapping not available
rs11940694-<b>G</b>,5 x 10-17,,NR,'-,0.009 unit increase,[0.007-0.011],KLB,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,4:39413373
rs146788033-<b>G</b>,4 x 10-17,,NR,'-,0.04 unit decrease,[0.032-0.048],METAP1,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,4:99019987
rs11733695-<b>A</b>,2 x 10-21,,NR,'-,0.06 unit decrease,[0.048-0.072],"PCNAP1, ADH6",Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,4:99201759
rs1229984-<b>C</b>,4 x 10-56,,NR,'-,0.05 unit increase,[0.044-0.056],ADH1B,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,4:99318162
rs13107325-<b>T</b>,3 x 10-10,,NR,'-,0.01 unit decrease,[0.0061-0.0139],'-,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,Mapping not available
rs11039364-<b>T</b>,3 x 10-9,,NR,'-,0.007 unit increase,[0.005-0.009],FNBP4,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,11:47748068
rs72771074-<b>C</b>,5 x 10-8,,NR,'-,0.007 unit increase,[0.005-0.009],GPR139,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,16:19991201
rs62062288-<b>A</b>,2 x 10-9,,NR,'-,0.008 unit decrease,[0.006-0.01],MAPT,Alcohol use disorder (consumption score),alcohol consumption measurement,GCST006718,17:46019187
rs17002342-<b>T</b>,9 x 10-6,(AA),0.13,'-,0.61 unit increase,[0.34-0.88],SEPTIN11,Waist-to-hip circumference ratio (alcohol intake interaction),"alcohol consumption measurement, waist-hip ratio",GCST004579,4:77034052
rs11021499-<b>A</b>,2 x 10-6,,NR,'-,0.39 unit decrease,[NR],MAML2,Waist-to-hip circumference ratio (alcohol intake interaction),"alcohol consumption measurement, waist-hip ratio",GCST004579,11:96258965
rs10212363-<b>A</b>,2 x 10-6,(Hispanic),0.22,'-,0.73 unit increase,[0.43-1.02],ZPLD1,Waist-to-hip circumference ratio (alcohol intake interaction),"alcohol consumption measurement, waist-hip ratio",GCST004579,3:102129717
rs8008758-<b>A</b>,3 x 10-6,(AA),0.25,'-,0.39 unit increase,[0.23-0.55],U3,Body mass index (alcohol intake interaction),"alcohol consumption measurement, body mass index",GCST001753,14:101223708
rs2788032-<b>C</b>,6 x 10-6,(Hispanic),0.08,'-,0.15 unit increase,[0.09-0.22],LRP8,Body mass index (alcohol intake interaction),"alcohol consumption measurement, body mass index",GCST001753,1:53311959
rs2144134-<b>G</b>,4 x 10-6,,NR,'-,0.09 unit decrease,[NR],SPTLC3,Body mass index (alcohol intake interaction),"alcohol consumption measurement, body mass index",GCST001753,20:13167505
rs1229984-<b>?</b>,1 x 10-49,,NR,'-,14.821 z score decrease,NR,ADH1B,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,4:99318162
rs2291317-<b>?</b>,2 x 10-8,,NR,'-,5.575 z score decrease,NR,XPO7,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,8:21969651
rs1577857-<b>?</b>,4 x 10-8,,NR,'-,5.484 z score increase,NR,LINC02661,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,10:108812501
rs7931459-<b>?</b>,5 x 10-8,,NR,'-,5.465 z score decrease,NR,"METTL15, LINC02758",Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,11:28626638
rs1360983-<b>?</b>,1 x 10-8,,NR,'-,5.733 z score increase,NR,FGF14,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,13:102215758
rs61667602-<b>?</b>,1 x 10-13,,NR,'-,7.439 z score increase,NR,LINC02210-CRHR1,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,17:45707983
rs1229984-<b>C</b>,5 x 10-47,(EA),NR,'-,0.3553 unit decrease,NR,ADH1B,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,4:99318162
rs7821592-<b>?</b>,4 x 10-8,(EA),NR,'-,0.04764 unit increase,NR,XPO7,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,8:21954019
rs1577857-<b>?</b>,4 x 10-8,(EA),NR,'-,0.05391 unit increase,NR,LINC02661,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,10:108812501
rs77804065-<b>T</b>,2 x 10-12,(EA),NR,'-,0.0711 unit decrease,NR,LINC02210-CRHR1,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,17:45733530
rs2066702-<b>A</b>,2 x 10-12,(AA),NR,'-,0.1996 unit decrease,[0.14-0.26],ADH1B,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,4:99307860
rs2821239-<b>A</b>,8 x 10-7,(AA),NR,'-,0.11811 unit increase,[0.071-0.165],NEGR1,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,1:72124510
rs1047980-<b>G</b>,9 x 10-6,(AA),NR,'-,0.101615 unit decrease,[0.057-0.146],LAMC2,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,1:183223169
rs6704155-<b>G</b>,5 x 10-7,(AA),NR,'-,0.160377 unit increase,[0.098-0.223],"ZC3H11B, SLC30A10",Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,1:219625903
rs11126811-<b>T</b>,4 x 10-6,(AA),NR,'-,0.242138 unit increase,[0.14-0.35],"LINC01815, CHMP4AP1",Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,2:81439274
rs1836216-<b>T</b>,5 x 10-6,(AA),NR,'-,0.127612 unit decrease,[0.073-0.182],NCKAP5,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,2:133208605
rs13059189-<b>A</b>,1 x 10-6,(AA),NR,'-,0.146423 unit increase,[0.087-0.206],TKT,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,3:53254459
rs35536048-<b>G</b>,1 x 10-6,(AA),NR,'-,0.166266 unit increase,[0.099-0.234],CACNA1D,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,3:53354923
rs28712290-<b>C</b>,6 x 10-7,(AA),NR,'-,0.158073 unit decrease,[0.096-0.22],ADH7,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,4:99414735
rs77010227-<b>C</b>,7 x 10-6,(AA),NR,'-,0.239639 unit decrease,[0.14-0.34],MTTP,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,4:99583284
rs57537217-<b>T</b>,8 x 10-6,(AA),NR,'-,0.187021 unit increase,[0.1-0.27],COL25A1,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,4:108819029
rs78059257-<b>A</b>,4 x 10-6,(AA),NR,'-,0.191557 unit decrease,[0.11-0.27],RANBP17,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,5:171094748
rs78030332-<b>C</b>,8 x 10-6,(AA),NR,'-,0.206225 unit increase,[0.12-0.3],ANKS1A,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,6:34990272
rs139712926-<b>T</b>,1 x 10-6,(AA),NR,'-,0.181911 unit decrease,[0.11-0.26],ZDHHC14,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,6:157618795
rs79159052-<b>A</b>,9 x 10-6,(AA),NR,'-,0.282349 unit decrease,[0.16-0.41],IQCE,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,7:2583290
rs1468452-<b>C</b>,9 x 10-6,(AA),NR,'-,0.129278 unit decrease,[0.072-0.186],GLI3,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,7:42214902
rs78957667-<b>G</b>,5 x 10-7,(AA),NR,'-,0.305659 unit decrease,[0.19-0.42],CSMD1,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,8:3979073
rs11137393-<b>A</b>,6 x 10-6,(AA),NR,'-,0.187703 unit decrease,[0.11-0.27],TUBBP5,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,9:138154845
rs12230739-<b>G</b>,1 x 10-6,(AA),NR,'-,0.334187 unit increase,[0.2-0.47],"ADI1P3, LINC02156",Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,12:47458874
rs1791618-<b>T</b>,9 x 10-6,(AA),NR,'-,0.105573 unit decrease,[0.059-0.152],KRT84,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,12:52378740
rs434483-<b>T</b>,6 x 10-6,(AA),NR,'-,0.338996 unit decrease,[0.19-0.49],"KCNMB4, RNU4-65P",Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,12:70436641
rs2584020-<b>C</b>,7 x 10-7,(AA),NR,'-,0.118069 unit decrease,[0.071-0.165],PTPRB,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,12:70636434
rs1336702-<b>C</b>,1 x 10-6,(AA),NR,'-,0.169759 unit increase,[0.1-0.24],FGF14,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,13:102210081
rs77052388-<b>T</b>,5 x 10-6,(AA),NR,'-,0.168044 unit increase,[0.096-0.24],BRMS1L,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,14:35889032
rs188224937-<b>C</b>,9 x 10-6,(AA),NR,'-,0.388101 unit decrease,[0.22-0.56],ZNF90,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,19:20079600
rs1058882-<b>T</b>,7 x 10-6,(AA),NR,'-,0.191689 unit decrease,[0.11-0.28],SNRNP70,Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,19:49108062
rs114086924-<b>G</b>,1 x 10-6,(AA),NR,'-,0.377809 unit decrease,[0.23-0.53],"RCAN1, CLIC6",Maximum habitual alcohol consumption,alcohol consumption measurement,GCST008675,21:34667619
rs5758343-<b>T</b>,2 x 10-9,,0.7959,'-,0.015397981 unit increase,[0.01-0.02],"TOB2, TEF",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,22:41420648
rs17884691-<b>A</b>,4 x 10-8,,0.241,'-,0.013613835 unit decrease,[0.0088-0.0185],MIRLET7BHG,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,22:46085743
rs7547416-<b>A</b>,3 x 10-9,,0.562,'-,0.010312716 unit increase,[0.0069-0.0137],PDE4B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,1:65953404
rs2817866-<b>A</b>,1 x 10-8,,0.428,'-,0.009987169 unit increase,[0.0066-0.0134],PTGER3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,1:71037764
rs12124523-<b>T</b>,5 x 10-9,,0.0928,'-,0.01771722 unit decrease,[0.012-0.024],NEGR1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,1:72155780
rs10753661-<b>A</b>,9 x 10-9,,0.702,'-,0.011386297 unit decrease,[0.0075-0.0153],LMX1A,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,1:165150555
rs28680958-<b>A</b>,2 x 10-10,,0.23,'-,0.013069956 unit decrease,[0.009-0.0171],ZBTB37,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,1:173879670
rs823099-<b>A</b>,3 x 10-8,,0.417,'-,0.010231842 unit increase,[0.0066-0.0138],"NUCKS1, Metazoa_SRP",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,1:205700194
rs1260326-<b>C</b>,1 x 10-45,,0.595,'-,0.024939064 unit increase,[0.021-0.028],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,Mapping not available
rs75199129-<b>T</b>,4 x 10-11,,0.0387,'-,0.030089665 unit decrease,[0.021-0.039],"RNU6-566P, LRPPRC",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:44071636
rs518853-<b>A</b>,3 x 10-22,,0.603,'-,0.017128013 unit increase,[0.014-0.021],LINC01833,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:44914079
rs2717018-<b>T</b>,5 x 10-12,,0.642,'-,0.01237443 unit increase,[0.0089-0.0159],"ACTG1P22, VRK2",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:57808356
rs6739804-<b>C</b>,1 x 10-11,,0.66,'-,0.012945168 unit decrease,[0.0092-0.0167],EHBP1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:63042469
rs10184268-<b>T</b>,8 x 10-9,,0.239,'-,0.011646146 unit increase,[0.0077-0.0156],ALMS1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:73399916
rs13024996-<b>A</b>,1 x 10-13,,0.352,'-,0.013351299 unit decrease,[0.0098-0.0169],ARHGAP15,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:143467646
rs56337305-<b>C</b>,5 x 10-8,,0.375,'-,0.010282829 unit decrease,[0.0066-0.014],"CUL3, CCDC195",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:224610843
rs925735-<b>G</b>,3 x 10-11,,0.632,'-,0.011878559 unit decrease,[0.0084-0.0154],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,2:226314914
rs13093886-<b>A</b>,2 x 10-8,,0.282,'-,0.010814633 unit decrease,[0.0071-0.0146],"RNU6-281P, FOXP1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:70905361
rs11127893-<b>T</b>,2 x 10-18,,0.652,'-,0.01585235 unit decrease,[0.012-0.019],CADM2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:85475020
rs147711594-<b>T</b>,3 x 10-8,,0.0212,'-,0.033799578 unit decrease,[0.022-0.046],"ACTR3P3, IMPG2",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:101174511
rs60654199-<b>A</b>,5 x 10-9,,0.067,'-,0.020264836 unit decrease,[0.013-0.027],RASA2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:141548453
rs13077520-<b>C</b>,8 x 10-10,,0.225,'-,0.012711265 unit decrease,[0.0087-0.0168],PLCH1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:155617055
rs6787172-<b>G</b>,5 x 10-9,,0.546,'-,0.010621488 unit decrease,[0.0071-0.0142],RSRC1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:158470022
rs7618629-<b>G</b>,2 x 10-8,,0.772,'-,0.011685334 unit increase,[0.0076-0.0158],PSMD2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,3:184305273
rs12646808-<b>C</b>,1 x 10-8,,0.338,'-,0.011208944 unit decrease,[0.0074-0.015],MSANTD1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:3248101
rs12639940-<b>G</b>,2 x 10-56,,0.379,'-,0.028283842 unit decrease,[0.025-0.032],KLB,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:39419361
rs16854020-<b>A</b>,4 x 10-10,,0.127,'-,0.016957017 unit increase,[0.012-0.022],BEND4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:42115542
rs75967634-<b>T</b>,2 x 10-11,,0.00288,'-,0.12015295 unit decrease,[0.085-0.155],ADH1B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:99307859
rs1229984-<b>C</b>,7 x 10-280,,0.953,'-,0.15401822 unit increase,[0.15-0.16],ADH1B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:99318162
rs1154433-<b>G</b>,3 x 10-36,,0.399,'-,0.022084095 unit increase,[0.019-0.026],ADH1B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:99332551
rs13135092-<b>G</b>,2 x 10-35,,0.0725,'-,0.041750107 unit decrease,[0.035-0.048],SLC39A8,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:102276925
rs4690727-<b>G</b>,3 x 10-11,,0.728,'-,0.012848434 unit increase,[0.009-0.0166],INPP4B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:142727426
rs13116270-<b>A</b>,3 x 10-10,,0.181,'-,0.014111718 unit increase,[0.0097-0.0185],GALNT7,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,4:173211834
rs4916723-<b>C</b>,9 x 10-10,,0.404,'-,0.011411703 unit decrease,[0.0078-0.0151],LINC00461,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,5:88558577
rs12513758-<b>G</b>,3 x 10-9,,0.161,'-,0.014246159 unit decrease,[0.0095-0.019],AFF4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,5:132904247
rs55872084-<b>T</b>,4 x 10-8,,0.218,'-,0.012075497 unit increase,[0.0078-0.0164],SGCD,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,5:156474993
rs34908430-<b>T</b>,2 x 10-8,,0.299,'-,0.010560681 unit decrease,[0.0069-0.0143],SP8,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:20784995
rs10085696-<b>G</b>,5 x 10-11,,0.201,'-,0.014756182 unit decrease,[0.01-0.019],AUTS2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:70318034
rs34958196-<b>A</b>,3 x 10-10,,0.129,'-,0.016678618 unit increase,[0.011-0.022],"MLXIPL, VPS37D",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:73628771
rs34659651-<b>A</b>,3 x 10-8,,0.19,'-,0.012532386 unit increase,[0.0081-0.0169],"VPS37D, MLXIPL",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:73652336
rs10267346-<b>C</b>,2 x 10-9,,0.169,'-,0.0144452425 unit decrease,[0.0097-0.0192],MYH16,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:99301144
rs2299409-<b>A</b>,3 x 10-11,,0.493,'-,0.011443348 unit decrease,[0.0081-0.0148],ORC5,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:104171723
rs2098112-<b>A</b>,5 x 10-14,,0.472,'-,0.013104477 unit increase,[0.0097-0.0165],DPP6,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,7:153790859
rs1838420-<b>T</b>,4 x 10-9,,0.489,'-,0.010147839 unit increase,[0.0068-0.0135],LINC01414,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,8:64048298
rs1484559-<b>C</b>,2 x 10-8,,0.779,'-,0.012253313 unit increase,[0.008-0.0165],RUNX1T1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,8:92099304
rs28601761-<b>G</b>,6 x 10-11,,0.405,'-,0.012143825 unit increase,[0.0085-0.0158],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,Mapping not available
rs7028386-<b>A</b>,3 x 10-9,,0.28,'-,0.011358867 unit decrease,[0.0076-0.0151],LINC01505,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,9:106591257
rs13288470-<b>T</b>,3 x 10-9,,0.119,'-,0.016645709 unit decrease,[0.011-0.022],RALGPS1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,9:126926280
rs10883451-<b>C</b>,3 x 10-8,,0.447,'-,0.009604758 unit decrease,[0.0062-0.013],ERLIN1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,10:100164661
rs7893734-<b>T</b>,7 x 10-12,,0.242,'-,0.013765078 unit decrease,[0.0098-0.0177],LINC02661,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,10:108758894
rs2239017-<b>G</b>,2 x 10-8,,0.4015,'-,0.011839363 unit increase,[0.0077-0.016],CACNA1C,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:2180485
rs536112833-<b>A</b>,2 x 10-8,,0.0013,'-,0.22408608 unit increase,[0.15-0.3],RERGL,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:18214752
rs10783446-<b>C</b>,6 x 10-12,,0.5338,'-,0.014149228 unit decrease,[0.01-0.018],SLC4A8,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:51487941
rs61934664-<b>A</b>,7 x 10-11,,0.495,'-,0.013408667 unit decrease,[0.0094-0.0174],ACSS3,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:81214279
rs2274793-<b>T</b>,8 x 10-10,,0.3264,'-,0.013471862 unit decrease,[0.0092-0.0178],OTX2-AS1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,14:56817250
rs2348072-<b>A</b>,3 x 10-12,,0.7247,'-,0.016113289 unit decrease,[0.012-0.021],"PSMA3-AS1, ARMH4",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,14:58277034
rs28929474-<b>T</b>,2 x 10-12,,0.0184,'-,0.05428487 unit decrease,[0.039-0.069],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,Mapping not available
rs11160767-<b>A</b>,2 x 10-8,,0.5908,'-,0.011985002 unit decrease,[0.0078-0.0162],LINC00637,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,14:103850396
rs281296-<b>A</b>,2 x 10-9,,0.3568,'-,0.012968086 unit increase,[0.0087-0.0172],SEMA6D,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,15:47392813
rs72768626-<b>G</b>,8 x 10-14,,0.0552,'-,0.034006946 unit decrease,[0.025-0.043],TNRC6A,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:24681727
rs34836-<b>G</b>,2 x 10-10,,0.4388,'-,0.015736584 unit decrease,[0.011-0.021],CLN3,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:28483502
rs9932605-<b>G</b>,3 x 10-10,,0.4829,'-,0.013063563 unit decrease,[0.009-0.0171],PPP4C,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:30080727
rs1421085-<b>C</b>,6 x 10-14,,0.4067,'-,0.015630115 unit decrease,[0.012-0.02],FTO,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:53767042
rs56387295-<b>A</b>,7 x 10-10,,0.1373,'-,0.01855728 unit increase,[0.013-0.024],DHODH,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:72021437
rs1104608-<b>C</b>,8 x 10-12,,0.4264,'-,0.017191948 unit decrease,[0.012-0.022],ZFHX3,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:73878689
rs11117258-<b>G</b>,5 x 10-8,,0.3062,'-,0.014578905 unit increase,[0.0093-0.0198],GINS2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:85686052
rs8067440-<b>A</b>,2 x 10-8,,0.6193,'-,0.01177361 unit increase,[0.0076-0.0159],NF1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,17:31381137
rs9899069-<b>G</b>,2 x 10-8,,0.1614,'-,0.015609549 unit decrease,[0.01-0.021],FBXL20,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,17:39384519
rs1724429-<b>G</b>,7 x 10-16,,0.2,'-,0.024308164 unit decrease,[0.018-0.03],"DND1P1, RDM1P1",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,17:45584654
rs7242858-<b>A</b>,1 x 10-8,,0.1856,'-,0.015081556 unit decrease,[0.0099-0.0203],"NPM1P1, KC6",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,18:41721634
rs72926982-<b>A</b>,5 x 10-9,,0.0759,'-,0.02274412 unit decrease,[0.015-0.03],TCF4,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,18:55420753
rs973579-<b>G</b>,8 x 10-19,,0.4895,'-,0.018226894 unit increase,[0.014-0.022],RASIP1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,19:48738719
rs6136465-<b>A</b>,1 x 10-8,,0.3967,'-,0.012194927 unit decrease,[0.008-0.0164],"DTD1, DTD1-AS1",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,20:18678750
rs7275426-<b>T</b>,2 x 10-8,,0.5731,'-,0.013196155 unit decrease,[0.0086-0.0178],LINC00945,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,21:33063313
rs17004922-<b>A</b>,3 x 10-8,,0.0141,'-,0.0483869 unit increase,[0.031-0.066],ADORA2A-AS1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,22:24448980
rs34908430-<b>T</b>,2 x 10-9,,0.2986,'-,0.013548642 unit decrease,[0.0091-0.018],SP8,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:20784995
rs13229395-<b>C</b>,1 x 10-8,,0.2568,'-,0.013321201 unit decrease,[0.0087-0.0179],AUTS2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:70034958
rs13235543-<b>T</b>,3 x 10-10,,0.1248,'-,0.019551052 unit increase,[0.013-0.026],MLXIPL,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:73599571
rs34659651-<b>A</b>,5 x 10-8,,0.1786,'-,0.014983003 unit increase,[0.0096-0.0204],"VPS37D, MLXIPL",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:73652336
rs3801288-<b>G</b>,7 x 10-9,,0.1288,'-,0.020856725 unit decrease,[0.014-0.028],ARPC1A,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:99348285
rs2299409-<b>A</b>,6 x 10-11,,0.5342,'-,0.013525672 unit decrease,[0.0095-0.0176],ORC5,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:104171723
rs2098112-<b>A</b>,2 x 10-13,,0.4733,'-,0.015274133 unit increase,[0.011-0.019],DPP6,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:153790859
rs1838420-<b>T</b>,4 x 10-10,,0.4825,'-,0.012794922 unit increase,[0.0088-0.0168],LINC01414,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,8:64048298
rs1484559-<b>C</b>,2 x 10-8,,0.7831,'-,0.016629806 unit increase,[0.011-0.022],RUNX1T1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,8:92099304
rs28601761-<b>G</b>,2 x 10-10,,0.4168,'-,0.015814032 unit increase,[0.011-0.021],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,Mapping not available
rs4743007-<b>C</b>,6 x 10-9,,0.3069,'-,0.015266576 unit decrease,[0.01-0.02],LINC01505,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,9:106567163
rs13288470-<b>T</b>,3 x 10-8,,0.1236,'-,0.020470936 unit decrease,[0.013-0.028],RALGPS1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,9:126926280
rs2244956-<b>C</b>,3 x 10-8,,0.3646,'-,0.011841185 unit increase,[0.0077-0.016],"GAPDHP21, PCDH15",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,10:55654719
rs2862954-<b>C</b>,2 x 10-8,,0.4872,'-,0.0114293415 unit decrease,[0.0074-0.0154],ERLIN1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,10:100152307
rs7906104-<b>T</b>,1 x 10-13,,0.253,'-,0.017513618 unit decrease,[0.013-0.022],LINC02661,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,10:108737343
rs4244804-<b>T</b>,4 x 10-8,,0.5389,'-,0.011321873 unit decrease,[0.0073-0.0154],"STK33, TRIM66",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:8596003
rs2049045-<b>C</b>,2 x 10-9,,0.1877,'-,0.018764045 unit decrease,[0.013-0.025],"BDNF, BDNF-AS",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:27672694
rs4756121-<b>C</b>,3 x 10-9,,0.6861,'-,0.013354769 unit increase,[0.009-0.0177],CSTF3-DT,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:33182613
rs1044796-<b>T</b>,8 x 10-9,,0.1913,'-,0.01542923 unit increase,[0.01-0.021],CREB3L1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:46321392
rs11039448-<b>T</b>,8 x 10-13,,0.5582,'-,0.014937313 unit decrease,[0.011-0.019],"PTPRJ, NUP160",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:47896864
rs17602038-<b>C</b>,9 x 10-21,,0.3734,'-,0.019764803 unit decrease,[0.016-0.024],DRD2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:113493969
rs6589386-<b>T</b>,3 x 10-18,,0.4323,'-,0.018040625 unit decrease,[0.014-0.022],DRD2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:113573031
rs58257470-<b>T</b>,9 x 10-11,,0.2739,'-,0.015010054 unit increase,[0.01-0.02],TMPRSS5,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:113612242
rs10790112-<b>C</b>,6 x 10-12,,0.8443,'-,0.0194534 unit increase,[0.014-0.025],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:116225532
rs1783835-<b>G</b>,2 x 10-13,,0.5431,'-,0.015108303 unit increase,[0.011-0.019],SORL1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:121672215
rs7547416-<b>A</b>,8 x 10-12,,0.5637,'-,0.014121004 unit increase,[0.01-0.018],PDE4B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:65953404
rs12048727-<b>G</b>,1 x 10-9,,0.3296,'-,0.013247359 unit increase,[0.009-0.0175],ZRANB2-AS2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:71303782
rs6671130-<b>G</b>,4 x 10-8,,0.5974,'-,0.011673218 unit decrease,[0.0075-0.0159],"LINC01360, S100A16",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:73386004
rs7552830-<b>T</b>,3 x 10-9,,0.449,'-,0.012276363 unit decrease,[0.0082-0.0163],RABGAP1L,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:174321643
rs227178-<b>T</b>,2 x 10-8,,0.425,'-,0.0116836615 unit increase,[0.0076-0.0157],SYT14,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:210043601
rs1260326-<b>C</b>,2 x 10-42,,0.5967,'-,0.028574824 unit increase,[0.024-0.033],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,Mapping not available
rs75199129-<b>T</b>,2 x 10-9,,0.039,'-,0.032751746 unit decrease,[0.022-0.043],"RNU6-566P, LRPPRC",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:44071636
rs570436-<b>T</b>,3 x 10-23,,0.569,'-,0.02082119 unit increase,[0.017-0.025],LINC01833,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:44915534
rs2717018-<b>T</b>,5 x 10-15,,0.6278,'-,0.016609011 unit increase,[0.012-0.021],"ACTG1P22, VRK2",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:57808356
rs6739804-<b>C</b>,4 x 10-10,,0.6796,'-,0.01627811 unit decrease,[0.011-0.021],EHBP1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:63042469
rs13024996-<b>A</b>,3 x 10-13,,0.3676,'-,0.015542448 unit decrease,[0.011-0.02],ARHGAP15,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:143467646
rs925735-<b>G</b>,1 x 10-12,,0.6379,'-,0.015132835 unit decrease,[0.011-0.019],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:226314914
rs11127893-<b>T</b>,3 x 10-17,,0.6461,'-,0.01816653 unit decrease,[0.014-0.022],CADM2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,3:85475020
rs13077520-<b>C</b>,6 x 10-9,,0.2167,'-,0.014556526 unit decrease,[0.0097-0.0194],PLCH1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,3:155617055
rs12646808-<b>C</b>,5 x 10-8,,0.3448,'-,0.014283394 unit decrease,[0.0092-0.0194],MSANTD1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:3248101
rs13125440-<b>G</b>,2 x 10-47,,0.3813,'-,0.030801678 unit decrease,[0.027-0.035],KLB,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:39420704
rs713287-<b>C</b>,1 x 10-8,,0.523,'-,0.01169676 unit increase,[0.0077-0.0157],GABRA4,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:46938359
rs75967634-<b>T</b>,6 x 10-13,,0.003,'-,0.14565828 unit decrease,[0.11-0.19],ADH1B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:99307859
rs1229984-<b>C</b>,6 x 10-267,,0.9698,'-,0.24346012 unit increase,[0.23-0.26],ADH1B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:99318162
rs1154433-<b>G</b>,1 x 10-35,,0.4076,'-,0.026113842 unit increase,[0.022-0.03],ADH1B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:99332551
rs13135092-<b>G</b>,3 x 10-42,,0.0808,'-,0.051934656 unit decrease,[0.044-0.059],SLC39A8,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:102276925
rs1425522-<b>G</b>,8 x 10-11,,0.8654,'-,0.019668229 unit increase,[0.014-0.026],INPP4B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:142572060
rs13116270-<b>A</b>,2 x 10-9,,0.1727,'-,0.016330346 unit increase,[0.011-0.022],GALNT7,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:173211834
rs17691542-<b>C</b>,5 x 10-8,,0.1597,'-,0.0153036 unit decrease,[0.0098-0.0208],AFF4,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,5:132943535
rs11642529-<b>C</b>,7 x 10-10,,0.149,'-,0.015019847 unit increase,[0.01-0.02],AP1G1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:71765856
rs1104608-<b>C</b>,4 x 10-12,,0.418,'-,0.012959148 unit decrease,[0.0093-0.0166],ZFHX3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:73878689
rs13332432-<b>G</b>,4 x 10-11,,0.296,'-,0.013294072 unit increase,[0.0093-0.0172],GINS2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:85688203
rs34121753-<b>G</b>,1 x 10-9,,0.532,'-,0.0110421395 unit increase,[0.0075-0.0146],DNAH2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,17:7830515
rs8067440-<b>A</b>,4 x 10-9,,0.609,'-,0.010402472 unit increase,[0.0069-0.0139],NF1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,17:31381137
rs55692232-<b>A</b>,7 x 10-21,,0.205,'-,0.020043388 unit decrease,[0.016-0.024],KANSL1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,17:46086957
rs7217900-<b>C</b>,4 x 10-9,,0.685,'-,0.010914072 unit increase,[0.0073-0.0145],RPTOR,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,17:80554951
rs72926982-<b>A</b>,3 x 10-9,,0.0764,'-,0.01931871 unit decrease,[0.013-0.026],TCF4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,18:55420753
rs973579-<b>G</b>,3 x 10-20,,0.462,'-,0.015974265 unit increase,[0.013-0.019],RASIP1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,19:48738719
rs28429420-<b>A</b>,4 x 10-9,,0.395,'-,0.010665695 unit decrease,[0.0071-0.0142],"DTD1, DTD1-AS1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,20:18675886
rs1000005-<b>C</b>,3 x 10-8,,0.588,'-,0.009815596 unit decrease,[0.0063-0.0133],LINC00945,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,21:33060745
rs5758343-<b>T</b>,6 x 10-10,,0.785,'-,0.013365218 unit increase,[0.0091-0.0176],"TOB2, TEF",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,22:41420648
rs17884691-<b>A</b>,7 x 10-9,,0.221,'-,0.01245443 unit decrease,[0.0082-0.0167],MIRLET7BHG,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,22:46085743
rs61741649-<b>T</b>,8 x 10-9,,0.0625,'-,0.020515254 unit increase,[0.014-0.027],TRIM66,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:8646535
rs36029218-<b>T</b>,6 x 10-10,,0.219,'-,0.01287532 unit decrease,[0.0088-0.0169],"BDNF-AS, LINC00678",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:27626824
rs4756121-<b>C</b>,2 x 10-10,,0.665,'-,0.011897904 unit increase,[0.0082-0.0156],CSTF3-DT,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:33182613
rs1044796-<b>T</b>,5 x 10-9,,0.197,'-,0.013272876 unit increase,[0.0088-0.0177],CREB3L1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:46321392
rs7107726-<b>A</b>,4 x 10-18,,0.321,'-,0.016075108 unit decrease,[0.012-0.02],SLC39A13,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:47407694
rs17602038-<b>C</b>,3 x 10-19,,0.349,'-,0.01614164 unit decrease,[0.013-0.02],DRD2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:113493969
rs17613838-<b>C</b>,5 x 10-11,,0.161,'-,0.015382202 unit increase,[0.011-0.02],ZW10,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:113767455
rs7104334-<b>T</b>,5 x 10-12,,0.754,'-,0.013777 unit increase,[0.0099-0.0177],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:116220135
rs1783835-<b>G</b>,5 x 10-12,,0.536,'-,0.011926755 unit increase,[0.0085-0.0153],SORL1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,11:121672215
rs7132908-<b>A</b>,5 x 10-9,,0.367,'-,0.010468613 unit decrease,[0.007-0.014],FAIM2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,12:49869365
rs2135831-<b>G</b>,1 x 10-11,,0.544,'-,0.01167156 unit decrease,[0.0083-0.0151],SLC4A8,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,12:51485047
rs61934664-<b>A</b>,4 x 10-11,,0.476,'-,0.011366487 unit decrease,[0.008-0.0147],ACSS3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,12:81214279
rs147865473-<b>G</b>,5 x 10-8,,0.0378,'-,0.02484716 unit decrease,[0.016-0.034],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,12:87393704
rs6538292-<b>G</b>,2 x 10-8,,0.623,'-,0.010414693 unit decrease,[0.0068-0.0141],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,12:91679781
rs12869810-<b>C</b>,2 x 10-8,,0.5,'-,0.009684276 unit decrease,[0.0063-0.0131],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,13:67514913
rs2274793-<b>T</b>,1 x 10-11,,0.329,'-,0.012425059 unit decrease,[0.0088-0.016],OTX2-AS1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,14:56817250
rs2348072-<b>A</b>,2 x 10-12,,0.727,'-,0.013562599 unit decrease,[0.0098-0.0174],"PSMA3-AS1, ARMH4",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,14:58277034
rs28929474-<b>T</b>,2 x 10-14,,0.0154,'-,0.053747147 unit decrease,[0.04-0.068],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,Mapping not available
rs1025143-<b>C</b>,4 x 10-9,,0.377,'-,0.0104990015 unit increase,[0.007-0.014],SEMA6D,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,15:47392862
rs2472297-<b>T</b>,3 x 10-8,,0.206,'-,0.011993645 unit increase,[0.0078-0.0162],"CYP1A2, CYP1A1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,15:74735539
rs1496876-<b>A</b>,5 x 10-9,,0.378,'-,0.010397063 unit increase,[0.0069-0.0139],"AGBL1-AS1, AGBL1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,15:86310520
rs72768626-<b>G</b>,1 x 10-13,,0.0649,'-,0.026186276 unit decrease,[0.019-0.033],TNRC6A,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:24681727
rs34836-<b>G</b>,8 x 10-13,,0.453,'-,0.013143449 unit decrease,[0.0095-0.0167],CLN3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:28483502
rs9932605-<b>G</b>,1 x 10-10,,0.474,'-,0.011322941 unit decrease,[0.0079-0.0148],PPP4C,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:30080727
rs1558902-<b>A</b>,4 x 10-12,,0.4,'-,0.012179407 unit decrease,[0.0087-0.0156],FTO,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST010543,16:53769662
rs780569-<b>A</b>,8 x 10-9,,0.708,'-,0.0161 unit decrease,[0.011-0.022],"LINC01777, LINC01646",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,1:4509376
rs3886141-<b>C</b>,2 x 10-8,,0.409,'-,0.0145 unit decrease,[0.0094-0.0196],"RWDD3, LINC01760",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,1:95265032
rs10753661-<b>A</b>,8 x 10-9,,0.684,'-,0.0157 unit decrease,[0.01-0.021],LMX1A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,1:165150555
rs1260326-<b>C</b>,5 x 10-40,,0.608,'-,0.0321 unit increase,[0.027-0.037],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,Mapping not available
rs75120545-<b>T</b>,6 x 10-9,,0.0302,'-,0.043 unit decrease,[0.028-0.058],LRPPRC,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,2:44044357
rs528301-<b>A</b>,7 x 10-17,,0.553,'-,0.0213 unit increase,[0.016-0.026],LINC01833,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,2:44927769
rs4233567-<b>T</b>,9 x 10-10,,0.364,'-,0.0161 unit decrease,[0.011-0.021],ARHGAP15,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,2:143514807
rs1872552-<b>A</b>,3 x 10-11,,0.399,'-,0.0172 unit increase,[0.012-0.022],CADM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,3:84999937
rs6780346-<b>T</b>,1 x 10-10,,0.621,'-,0.0168 unit decrease,[0.012-0.022],CADM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,3:85544434
rs28712821-<b>A</b>,2 x 10-42,,0.608,'-,0.0355 unit increase,[0.03-0.041],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:39412160
rs16854020-<b>A</b>,1 x 10-9,,0.13,'-,0.023 unit increase,[0.016-0.03],BEND4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:42115542
rs143118954-<b>A</b>,2 x 10-9,,0.00233,'-,0.157 unit decrease,[0.11-0.21],COX7A2P2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:96932729
rs143475242-<b>T</b>,2 x 10-12,,0.00341,'-,0.153 unit decrease,[0.11-0.2],"STPG2-AS1, STPG2",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:97452667
rs1727284-<b>G</b>,1 x 10-12,,0.00147,'-,0.235 unit decrease,[0.17-0.3],STPG2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:98058431
rs144198753-<b>T</b>,4 x 10-68,,0.00935,'-,0.23 unit decrease,[0.2-0.26],"EIF4E, BTF3P13",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:98792199
rs1229984-<b>C</b>,2 x 10-173,,0.98,'-,0.246 unit increase,[0.23-0.26],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:99318162
rs150021439-<b>T</b>,1 x 10-22,,0.0044,'-,0.188 unit decrease,[0.15-0.23],H2AZ1-DT,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:99998097
rs13107325-<b>T</b>,5 x 10-17,,0.0721,'-,0.0383 unit decrease,[0.029-0.047],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,Mapping not available
rs11943397-<b>C</b>,1 x 10-8,,0.629,'-,0.0149 unit increase,[0.0098-0.02],INPP4B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:142696151
rs9349379-<b>G</b>,3 x 10-8,,0.406,'-,0.0134 unit increase,[0.0087-0.0181],PHACTR1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,6:12903725
rs6978841-<b>A</b>,2 x 10-8,,0.184,'-,0.0183 unit decrease,[0.012-0.025],AUTS2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,7:70328394
rs6969458-<b>A</b>,2 x 10-11,,0.466,'-,0.017 unit increase,[0.012-0.022],DPP6,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,7:153792640
rs55932213-<b>G</b>,1 x 10-8,,0.746,'-,0.0165 unit increase,[0.011-0.022],LINC01505,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,9:105993341
rs4743009-<b>A</b>,7 x 10-9,,0.201,'-,0.0183 unit decrease,[0.012-0.025],LINC01505,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,9:106567955
rs61873510-<b>T</b>,7 x 10-9,,0.326,'-,0.0157 unit decrease,[0.01-0.021],"Y_RNA, PAX2",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,10:100866753
rs4756121-<b>C</b>,6 x 10-11,,0.688,'-,0.0179 unit increase,[0.013-0.023],CSTF3-DT,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,11:33182613
rs11604680-<b>G</b>,2 x 10-10,,0.32,'-,0.0174 unit decrease,[0.012-0.023],"RAPSN, PSMC3",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,11:47435988
rs4309187-<b>C</b>,1 x 10-11,,0.684,'-,0.0185 unit increase,[0.013-0.024],DRD2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,11:113541721
rs1894071-<b>G</b>,4 x 10-8,,0.857,'-,0.0199 unit increase,[0.013-0.027],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,11:116202950
rs10790449-<b>C</b>,7 x 10-9,,0.465,'-,0.0147 unit increase,[0.0097-0.0197],SORL1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,11:121630697
rs962961-<b>T</b>,4 x 10-9,,0.326,'-,0.0159 unit decrease,[0.011-0.021],"OTX2, OTX2-AS1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,14:56814436
rs57044214-<b>A</b>,3 x 10-9,,0.284,'-,0.0166 unit increase,[0.011-0.022],ARID4A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,14:58367191
rs28929474-<b>T</b>,2 x 10-11,,0.0198,'-,0.0568 unit decrease,[0.04-0.073],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,Mapping not available
rs17177078-<b>T</b>,4 x 10-9,,0.0554,'-,0.0327 unit decrease,[0.022-0.044],TNRC6A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,16:24799360
rs4788084-<b>T</b>,2 x 10-8,,0.418,'-,0.0134 unit decrease,[0.0087-0.0181],"IL27, NUPR1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,16:28528527
rs1800566-<b>A</b>,2 x 10-8,,0.183,'-,0.0172 unit increase,[0.011-0.023],NQO1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,16:69711242
rs11648570-<b>C</b>,2 x 10-8,,0.107,'-,0.023 unit increase,[0.015-0.031],LINC01572,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,16:72323065
rs1104608-<b>C</b>,2 x 10-10,,0.426,'-,0.0163 unit decrease,[0.011-0.021],ZFHX3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,16:73878689
rs62055691-<b>C</b>,2 x 10-23,,0.225,'-,0.0303 unit decrease,[0.024-0.036],LINC02210-CRHR1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,17:45677484
rs2469933-<b>A</b>,2 x 10-22,,0.225,'-,0.0295 unit decrease,[0.024-0.035],KANSL1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,17:46208165
rs199528-<b>T</b>,5 x 10-21,,0.223,'-,0.0286 unit decrease,[0.023-0.035],WNT3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,17:46765770
rs62092069-<b>A</b>,2 x 10-8,,0.373,'-,0.0148 unit increase,[0.0097-0.0199],RIT2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,18:43155566
rs838145-<b>A</b>,9 x 10-12,,0.541,'-,0.0174 unit decrease,[0.012-0.022],IZUMO1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,19:48745473
rs62217022-<b>G</b>,1 x 10-8,,0.396,'-,0.0148 unit decrease,[0.0097-0.0199],DTD1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,20:18712436
rs61734341-<b>C</b>,1 x 10-8,,0.0598,'-,0.0285 unit decrease,[0.019-0.038],BPIFB2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,20:33019745
rs9607812-<b>A</b>,7 x 10-10,,0.187,'-,0.02 unit decrease,[0.014-0.026],"CSDC2, POLR3H",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,22:41545239
rs17884691-<b>A</b>,1 x 10-8,,0.248,'-,0.0168 unit decrease,[0.011-0.023],MIRLET7BHG,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,22:46085743
rs1260326-<b>C</b>,5 x 10-40,,0.61,'-,0.032 unit increase,[0.027-0.037],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,Mapping not available
rs1229984-<b>C</b>,2 x 10-173,,0.98,'-,0.25 unit increase,[0.23-0.27],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,4:99318162
rs28929474-<b>T</b>,2 x 10-11,,0.02,'-,0.057 unit decrease,[0.04-0.074],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,Mapping not available
rs1800566-<b>A</b>,2 x 10-8,,0.18,'-,0.017 unit increase,[0.011-0.023],NQO1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST008811,16:69711242
rs9409565-<b>C</b>,2 x 10-8,(Light-to-moderate drinkers),NR,1.35,'-,[1.21-1.49],"RNU6-669P, MFSD14B",Colorectal cancer (alcohol consumption interaction),"colorectal cancer, alcohol consumption measurement",GCST003873,9:94488752
rs9409565-<b>C</b>,1 x 10-7,(light/moderate and heavy drinkers),NR,1.23,'-,[1.04-1.45],"RNU6-669P, MFSD14B",Colorectal cancer (alcohol consumption interaction),"colorectal cancer, alcohol consumption measurement",GCST003873,9:94488752
rs2294426-<b>?</b>,4 x 10-8,"(Maternal alcohol consumption, 1df)",NR,'-,'-,'-,ADTRP,Orofacial clefts (maternal alcohol consumption interaction),"alcohol consumption measurement, Orofacial clefting syndrome, cleft lip",GCST001082,6:11729849
rs1536895-<b>C</b>,3 x 10-7,"(Maternal alcohol consumption, 1df)",0.065,'-,'-,'-,SMC2-DT,Orofacial clefts (maternal alcohol consumption interaction),"alcohol consumption measurement, Orofacial clefting syndrome, cleft lip",GCST001082,9:104031445
rs62466318-<b>T</b>,7 x 10-10,,0.204,'-,0.01704703 unit increase,[0.012-0.022],"VPS37D, MLXIPL",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:73627755
rs17884691-<b>A</b>,9 x 10-10,,0.2475,'-,0.015824584 unit decrease,[0.011-0.021],MIRLET7BHG,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,22:46085743
rs35807116-<b>T</b>,1 x 10-9,,0.6061,'-,0.01388089 unit increase,[0.0094-0.0184],"LINC02255, CYP11A1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,15:74375612
rs142488468-<b>C</b>,2 x 10-9,,0.1816,'-,0.017358616 unit decrease,[0.012-0.023],RN7SKP278,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,10:108996101
rs1230148-<b>T</b>,2 x 10-9,,0.3642,'-,0.013839498 unit decrease,[0.0093-0.0184],FAM177A1P1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98956251
rs75543135-<b>A</b>,3 x 10-9,,0.1152,'-,0.020827942 unit increase,[0.014-0.028],POU2F2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,19:42098921
rs13413953-<b>T</b>,3 x 10-9,,0.6401,'-,0.013782091 unit increase,[0.0092-0.0183],ARHGAP15,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,2:143479467
rs756747-<b>T</b>,4 x 10-9,,0.4803,'-,0.013182213 unit decrease,[0.0088-0.0176],"RELN, ORC5",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:104056092
rs151010045-<b>T</b>,4 x 10-9,,0.9668,'-,0.0366548 unit decrease,[0.024-0.049],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:39424775
rs77294902-<b>A</b>,5 x 10-9,,0.2209,'-,0.015762493 unit decrease,[0.01-0.021],"TNFSF12, Y_RNA",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,17:7548761
rs9349379-<b>A</b>,5 x 10-9,,0.5942,'-,0.013316712 unit decrease,[0.0089-0.0178],PHACTR1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,6:12903725
rs1788030-<b>T</b>,5 x 10-9,,0.4581,'-,0.013104249 unit decrease,[0.0087-0.0175],TCF4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,18:55377967
rs4815364-<b>A</b>,5 x 10-9,,0.6062,'-,0.013353928 unit increase,[0.0089-0.0178],ACSS1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,20:25055075
rs9607812-<b>A</b>,5 x 10-9,,0.1878,'-,0.016680405 unit decrease,[0.011-0.022],"CSDC2, POLR3H",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,22:41545239
rs7630012-<b>A</b>,7 x 10-9,,0.5665,'-,0.013055859 unit increase,[0.0086-0.0175],EXOG,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,3:38510759
rs12673949-<b>A</b>,8 x 10-9,,0.7238,'-,0.014402959 unit increase,[0.0095-0.0193],HIBADH,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:27561015
rs7620901-<b>T</b>,8 x 10-9,,0.4167,'-,0.013057636 unit decrease,[0.0086-0.0175],OTOL1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,3:161589528
rs2274793-<b>T</b>,8 x 10-9,,0.327,'-,0.013708469 unit decrease,[0.009-0.0184],OTX2-AS1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,14:56817250
rs11773627-<b>T</b>,9 x 10-9,,0.807,'-,0.016232817 unit decrease,[0.011-0.022],MAD1L1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:1963098
rs35572189-<b>A</b>,1 x 10-8,,0.3629,'-,0.013307061 unit increase,[0.0088-0.0179],BAHCC1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,17:81451999
rs2520099-<b>T</b>,1 x 10-8,,0.7306,'-,0.01438478 unit decrease,[0.0095-0.0193],BRD3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,9:134053017
rs114112910-<b>A</b>,1 x 10-8,,0.9829,'-,0.04920817 unit decrease,[0.032-0.066],"ADH1B, ADH7",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99392193
rs10819272-<b>T</b>,1 x 10-8,,0.5742,'-,0.012831995 unit increase,[0.0084-0.0173],RALGPS1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,9:127192055
rs142338804-<b>A</b>,1 x 10-8,,0.0229,'-,0.04241714 unit decrease,[0.028-0.057],SENP7,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,3:101487319
rs10891547-<b>A</b>,2 x 10-8,,0.5082,'-,0.012622424 unit decrease,[0.0082-0.017],ANKK1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:113396496
rs9822731-<b>T</b>,4 x 10-15,,0.7753,'-,0.021035347 unit decrease,[0.016-0.026],CADM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,3:85356351
rs4699680-<b>A</b>,4 x 10-15,,0.9603,'-,0.044903457 unit increase,[0.034-0.056],"BTF3P13, EIF4E",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98837981
rs17601612-<b>C</b>,2 x 10-13,,0.3828,'-,0.016807118 unit decrease,[0.012-0.021],DRD2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:113447023
rs283412-<b>A</b>,7 x 10-13,,0.0231,'-,0.053402204 unit decrease,[0.039-0.068],"ADH1B, ADH1C",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99346515
rs485425-<b>C</b>,5 x 10-12,,0.4532,'-,0.015480648 unit decrease,[0.011-0.02],SORL1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:121674276
rs62307576-<b>A</b>,8 x 10-12,,0.0023,'-,0.15947579 unit decrease,[0.11-0.21],H2AZ1-DT,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:100163834
rs4916723-<b>A</b>,1 x 10-11,,0.5775,'-,0.015352736 unit increase,[0.011-0.02],LINC00461,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,5:88558577
rs838145-<b>A</b>,2 x 10-11,,0.5417,'-,0.015065683 unit decrease,[0.011-0.019],IZUMO1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,19:48745473
rs2622237-<b>A</b>,2 x 10-11,,0.5765,'-,0.015079147 unit decrease,[0.011-0.02],DPP6,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:153791984
rs62325464-<b>A</b>,2 x 10-11,,0.0292,'-,0.04425342 unit decrease,[0.031-0.057],"BTF3P13, TSPAN5",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98689442
rs62135525-<b>T</b>,3 x 10-11,,0.0495,'-,0.0342315 unit decrease,[0.024-0.044],"LRPPRC, RNU6-566P",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,2:44072740
rs113079736-<b>A</b>,3 x 10-11,,0.4018,'-,0.015113383 unit decrease,[0.011-0.02],SH2B1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,16:28848862
rs62307263-<b>T</b>,3 x 10-11,,0.1018,'-,0.0244556 unit decrease,[0.017-0.032],"ADH1A, ADH6",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99245955
rs9832119-<b>A</b>,9 x 10-11,,0.7025,'-,0.015824541 unit increase,[0.011-0.021],"LINC02025, CADM2",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,3:84923525
rs1568450-<b>A</b>,1 x 10-10,,0.3716,'-,0.014815973 unit decrease,[0.01-0.019],ACTG1P22,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,2:57784562
rs12124523-<b>T</b>,2 x 10-10,,0.1087,'-,0.022904875 unit decrease,[0.016-0.03],NEGR1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,1:72155780
rs11692435-<b>A</b>,2 x 10-10,,0.0839,'-,0.025667628 unit increase,[0.018-0.034],ACTR1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,2:97658891
rs61873510-<b>T</b>,2 x 10-10,,0.3272,'-,0.015114287 unit decrease,[0.01-0.02],"Y_RNA, PAX2",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,10:100866753
rs4975016-<b>T</b>,2 x 10-10,,0.1999,'-,0.017656706 unit increase,[0.012-0.023],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:39438099
rs1969097-<b>A</b>,3 x 10-10,,0.9433,'-,0.030320859 unit increase,[0.021-0.04],"ADH7, C4orf17",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99487037
rs13013484-<b>A</b>,3 x 10-10,,0.7271,'-,0.01574197 unit decrease,[0.011-0.021],"MRPL33, LINC01460",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,2:27765954
rs780569-<b>A</b>,4 x 10-10,,0.7075,'-,0.015331182 unit decrease,[0.011-0.02],"LINC01777, LINC01646",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,1:4509376
rs2858088-<b>A</b>,5 x 10-10,,0.3813,'-,0.01425575 unit decrease,[0.0098-0.0188],MSANTD1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:3266983
rs72768626-<b>A</b>,6 x 10-10,,0.9441,'-,0.030120945 unit increase,[0.021-0.04],TNRC6A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,16:24681727
rs28929474-<b>T</b>,7 x 10-10,,0.0201,'-,0.048947606 unit decrease,[0.033-0.065],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,Mapping not available
rs4146003-<b>A</b>,2 x 10-8,,0.4425,'-,0.012675812 unit increase,[0.0083-0.0171],"TSPAN5, BTF3P13",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98711171
rs10474277-<b>A</b>,2 x 10-8,,0.8841,'-,0.0196681 unit decrease,[0.013-0.027],"LINC02060, TMEM161B-AS1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,5:88418887
rs7688435-<b>T</b>,2 x 10-8,,0.1382,'-,0.018201021 unit decrease,[0.012-0.025],INPP4B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:142587186
rs7206303-<b>A</b>,2 x 10-8,,0.2375,'-,0.014760507 unit increase,[0.0096-0.0199],RBFOX1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,16:7298160
rs1076884-<b>C</b>,2 x 10-8,,0.2252,'-,0.014976 unit increase,[0.0097-0.0202],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,16:13653946
rs34908430-<b>T</b>,2 x 10-8,,0.2995,'-,0.013633174 unit decrease,[0.0089-0.0184],SP8,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:20784995
rs7940127-<b>T</b>,2 x 10-8,,0.1369,'-,0.01816633 unit decrease,[0.012-0.025],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:116231671
rs322776-<b>T</b>,2 x 10-8,,0.4205,'-,0.012627372 unit decrease,[0.0082-0.0171],"MIR129-1, SND1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,7:128119789
rs77123275-<b>T</b>,3 x 10-8,,0.0523,'-,0.027908385 unit increase,[0.018-0.038],RORB-AS1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,9:74459181
rs1713675-<b>A</b>,3 x 10-8,,0.5149,'-,0.012396359 unit decrease,[0.008-0.0168],ATF4P4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:113790627
rs2079227-<b>A</b>,3 x 10-8,,0.4694,'-,0.012380583 unit increase,[0.008-0.0168],"SERGEF, KCNC1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:17810453
rs55932213-<b>A</b>,3 x 10-8,,0.2543,'-,0.014134835 unit decrease,[0.0091-0.0192],LINC01505,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,9:105993341
rs303753-<b>A</b>,4 x 10-8,,0.3461,'-,0.012924593 unit decrease,[0.0083-0.0175],"RMC1, RIOK3",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,18:23494958
rs78119163-<b>A</b>,4 x 10-8,,0.8827,'-,0.01904569 unit increase,[0.012-0.026],NAMPTP2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,5:144937109
rs7132908-<b>A</b>,4 x 10-8,,0.3842,'-,0.012576572 unit decrease,[0.0081-0.0171],FAIM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,12:49869365
rs4775792-<b>T</b>,4 x 10-8,,0.3684,'-,0.012681771 unit increase,[0.0081-0.0172],SECISBP2L,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,15:48995881
rs34121753-<b>A</b>,5 x 10-8,,0.4211,'-,0.012322057 unit decrease,[0.0079-0.0168],DNAH2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,17:7830515
rs2424645-<b>A</b>,5 x 10-8,,0.6535,'-,0.012785072 unit increase,[0.0082-0.0174],SYNDIG1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,20:24739390
rs11071294-<b>A</b>,5 x 10-8,,0.7735,'-,0.014534944 unit increase,[0.0093-0.0198],ZNF280D,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,15:56785360
rs1260326-<b>T</b>,1 x 10-52,,0.3929,'-,0.034923363 unit decrease,[0.03-0.039],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,Mapping not available
rs11940694-<b>A</b>,3 x 10-41,,0.3928,'-,0.030738968 unit decrease,[0.026-0.035],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:39413373
rs1229984-<b>T</b>,8 x 10-202,,0.0228,'-,0.2266165 unit decrease,[0.21-0.24],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99318162
rs62055546-<b>A</b>,8 x 10-25,,0.7779,'-,0.027622232 unit increase,[0.022-0.033],MAPT-AS1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,17:45887201
rs13107325-<b>T</b>,1 x 10-24,,0.0744,'-,0.04357754 unit decrease,[0.035-0.052],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,Mapping not available
rs71612659-<b>A</b>,9 x 10-24,,0.0577,'-,0.04810517 unit decrease,[0.039-0.057],BTF3P13,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98769896
rs188514326-<b>C</b>,3 x 10-23,,0.0037,'-,0.18278082 unit decrease,[0.15-0.22],H2AZ1-DT,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:100261610
rs113659074-<b>T</b>,1 x 10-22,,0.0606,'-,0.04589464 unit decrease,[0.037-0.055],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99331151
rs1789892-<b>A</b>,5 x 10-22,,0.4198,'-,0.021832775 unit increase,[0.017-0.026],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,Mapping not available
rs62305782-<b>T</b>,1 x 10-20,,0.1165,'-,0.032479502 unit increase,[0.026-0.039],"ADH1B, ADH7",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:99371952
rs528301-<b>A</b>,1 x 10-19,,0.5525,'-,0.020386197 unit increase,[0.016-0.025],LINC01833,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,2:44927769
rs846008-<b>A</b>,2 x 10-18,,0.9975,'-,0.19523498 unit increase,[0.15-0.24],TSPAN5,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98578691
rs143092959-<b>A</b>,9 x 10-18,,0.9957,'-,0.14633937 unit increase,[0.11-0.18],TSPAN5,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98543945
rs11604680-<b>A</b>,7 x 10-17,,0.6793,'-,0.019941581 unit increase,[0.015-0.025],"RAPSN, PSMC3",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,11:47435988
rs192822960-<b>A</b>,2 x 10-16,,0.0015,'-,0.2379943 unit decrease,[0.18-0.29],"METAP1, NDUFS5P4",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,4:98990355
rs113443718-<b>A</b>,3 x 10-15,,0.3095,'-,0.01906697 unit decrease,[0.014-0.024],SEZ6L2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007328,16:29880863
rs780094-<b>T</b>,2 x 10-7,,0.4,'-,0.0102 unit decrease,[0.0065-0.0139],'-,Alcohol consumption,alcohol consumption measurement,GCST004026,Mapping not available
rs197273-<b>A</b>,7 x 10-8,,0.49,'-,0.0103 unit decrease,[0.0066-0.0140],"TANK-AS1, THORLNC",Alcohol consumption,alcohol consumption measurement,GCST004026,2:161038152
rs11940694-<b>A</b>,9 x 10-12,,0.42,'-,0.0136 unit decrease,[0.0097-0.0175],KLB,Alcohol consumption,alcohol consumption measurement,GCST004026,4:39413373
rs12599112-<b>A</b>,5 x 10-8,,NR,'-,0.0733 unit decrease,[0.048-0.099],CDH13,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST004027,16:82685106
rs10927848-<b>A</b>,2 x 10-7,,NR,'-,0.0343 unit decrease,[0.021-0.047],SLC25A34-AS1,Alcohol consumption (heavy vs. light/non-drinkers),alcohol consumption measurement,GCST004027,1:15749411
rs1991556-<b>A</b>,5 x 10-23,,0.22,'-,0.012 unit decrease,[0.01-0.014],MAPT,Alcohol consumption,alcohol consumption measurement,GCST008757,17:46006036
rs1004787-<b>A</b>,7 x 10-17,,0.54,'-,0.009 unit increase,[0.007-0.011],LINC01833,Alcohol consumption,alcohol consumption measurement,GCST008757,2:44931952
rs13107325-<b>T</b>,1 x 10-15,,0.07,'-,0.016 unit decrease,[0.012-0.02],'-,Alcohol consumption,alcohol consumption measurement,GCST008757,Mapping not available
rs838145-<b>A</b>,3 x 10-15,,0.55,'-,0.008 unit decrease,[0.006-0.01],IZUMO1,Alcohol consumption,alcohol consumption measurement,GCST008757,19:48745473
rs1104608-<b>C</b>,1 x 10-14,,0.43,'-,0.008 unit decrease,[0.006-0.01],ZFHX3,Alcohol consumption,alcohol consumption measurement,GCST008757,16:73878689
rs2071305-<b>A</b>,5 x 10-14,,0.69,'-,0.009 unit increase,[0.007-0.011],MYBPC3,Alcohol consumption,alcohol consumption measurement,GCST008757,11:47349406
rs7121986-<b>T</b>,6 x 10-14,,0.37,'-,0.008 unit decrease,[0.006-0.01],"OPCML, DRD2",Alcohol consumption,alcohol consumption measurement,GCST008757,11:113484722
rs6969458-<b>A</b>,6 x 10-14,,0.47,'-,0.008 unit increase,[0.006-0.01],DPP6,Alcohol consumption,alcohol consumption measurement,GCST008757,7:153792640
rs74424378-<b>T</b>,2 x 10-13,,0.76,'-,0.009 unit increase,[0.007-0.011],LINC01505,Alcohol consumption,alcohol consumption measurement,GCST008757,9:106568813
rs13024996-<b>A</b>,4 x 10-13,,0.37,'-,0.008 unit decrease,[0.006-0.01],ARHGAP15,Alcohol consumption,alcohol consumption measurement,GCST008757,2:143467646
rs34060476-<b>A</b>,5 x 10-13,,0.87,'-,0.011 unit decrease,[0.0071-0.0149],MLXIPL,Alcohol consumption,alcohol consumption measurement,GCST008757,7:73623626
rs61873510-<b>T</b>,5 x 10-13,,0.33,'-,0.008 unit decrease,[0.006-0.01],"Y_RNA, PAX2",Alcohol consumption,alcohol consumption measurement,GCST008757,10:100866753
rs1421085-<b>T</b>,9 x 10-13,,0.6,'-,0.008 unit decrease,[0.006-0.01],FTO,Alcohol consumption,alcohol consumption measurement,GCST008757,16:53767042
rs11648570-<b>T</b>,2 x 10-12,,0.89,'-,0.012 unit decrease,[0.0081-0.0159],LINC01572,Alcohol consumption,alcohol consumption measurement,GCST008757,16:72323065
rs2277499-<b>T</b>,2 x 10-12,,0.34,'-,0.008 unit decrease,[0.006-0.01],OTX2,Alcohol consumption,alcohol consumption measurement,GCST008757,14:56804409
rs2310752-<b>A</b>,3 x 10-12,,0.43,'-,0.007 unit decrease,[0.005-0.009],PDE4B,Alcohol consumption,alcohol consumption measurement,GCST008757,1:65926722
rs112635299-<b>T</b>,4 x 10-12,,0.02,'-,0.025 unit decrease,[0.017-0.033],"SERPINA1, SERPINA2",Alcohol consumption,alcohol consumption measurement,GCST008757,14:94371805
rs780569-<b>A</b>,5 x 10-12,,0.71,'-,0.008 unit decrease,[0.006-0.01],"LINC01777, LINC01646",Alcohol consumption,alcohol consumption measurement,GCST008757,1:4509376
rs10496076-<b>T</b>,1 x 10-11,,0.37,'-,0.007 unit decrease,[0.005-0.009],ACTG1P22,Alcohol consumption,alcohol consumption measurement,GCST008757,2:57715852
rs71414193-<b>A</b>,2 x 10-11,,0.19,'-,0.009 unit decrease,[0.007-0.011],"ACTR10, ARMH4",Alcohol consumption,alcohol consumption measurement,GCST008757,14:58218583
rs16854020-<b>A</b>,3 x 10-11,,0.13,'-,0.01 unit increase,[0.0061-0.0139],BEND4,Alcohol consumption,alcohol consumption measurement,GCST008757,4:42115542
rs485425-<b>C</b>,6 x 10-11,,0.45,'-,0.007 unit decrease,[0.005-0.009],SORL1,Alcohol consumption,alcohol consumption measurement,GCST008757,11:121674276
rs113443718-<b>A</b>,7 x 10-11,,0.31,'-,0.007 unit decrease,[0.005-0.009],SEZ6L2,Alcohol consumption,alcohol consumption measurement,GCST008757,16:29880863
rs57281063-<b>A</b>,8 x 10-11,,0.41,'-,0.007 unit increase,[0.005-0.009],"CBX5, SCAT2",Alcohol consumption,alcohol consumption measurement,GCST008757,12:54266643
rs72768626-<b>A</b>,1 x 10-10,,0.94,'-,0.014 unit increase,[0.01-0.018],TNRC6A,Alcohol consumption,alcohol consumption measurement,GCST008757,16:24681727
rs227179-<b>A</b>,1 x 10-10,,0.59,'-,0.007 unit decrease,[0.005-0.009],SYT14,Alcohol consumption,alcohol consumption measurement,GCST008757,1:210043386
rs9320010-<b>A</b>,1 x 10-10,,0.6,'-,0.007 unit increase,[0.005-0.009],TCF4,Alcohol consumption,alcohol consumption measurement,GCST008757,18:55386666
rs2726034-<b>T</b>,1 x 10-10,,0.68,'-,0.007 unit increase,[0.005-0.009],"NPIPB6, SBK1",Alcohol consumption,alcohol consumption measurement,GCST008757,16:28325561
rs13390019-<b>T</b>,2 x 10-10,,0.87,'-,0.01 unit increase,[0.0061-0.0139],ANKRD36,Alcohol consumption,alcohol consumption measurement,GCST008757,2:97131943
rs7517344-<b>A</b>,2 x 10-10,,0.17,'-,0.009 unit increase,[0.007-0.011],LINC02808,Alcohol consumption,alcohol consumption measurement,GCST008757,1:50246289
rs4916723-<b>A</b>,2 x 10-10,,0.58,'-,0.007 unit increase,[0.005-0.009],LINC00461,Alcohol consumption,alcohol consumption measurement,GCST008757,5:88558577
rs10249167-<b>A</b>,3 x 10-10,,0.87,'-,0.01 unit increase,[0.0061-0.0139],ARPC1B,Alcohol consumption,alcohol consumption measurement,GCST008757,7:99383256
rs7640-<b>C</b>,4 x 10-10,,0.8,'-,0.008 unit increase,[0.006-0.01],WRAP53,Alcohol consumption,alcohol consumption measurement,GCST008757,17:7703404
rs4794015-<b>A</b>,4 x 10-10,,0.41,'-,0.007 unit increase,[0.005-0.009],"GIP, IGF2BP1",Alcohol consumption,alcohol consumption measurement,GCST008757,17:48990464
rs1053651-<b>A</b>,1 x 10-9,,0.27,'-,0.007 unit decrease,[0.005-0.009],TCAP,Alcohol consumption,alcohol consumption measurement,GCST008757,17:39666058
rs7698119-<b>A</b>,1 x 10-9,,0.49,'-,0.006 unit decrease,[0.004-0.008],"APOBEC3AP1, LINC01612",Alcohol consumption,alcohol consumption measurement,GCST008757,4:170149759
rs12312693-<b>T</b>,2 x 10-9,,0.55,'-,0.006 unit decrease,[0.004-0.008],STAT6,Alcohol consumption,alcohol consumption measurement,GCST008757,12:57117951
rs7958704-<b>T</b>,2 x 10-9,,0.41,'-,0.006 unit decrease,[0.004-0.008],SCN8A,Alcohol consumption,alcohol consumption measurement,GCST008757,12:51590565
rs11114787-<b>T</b>,2 x 10-9,,0.27,'-,0.007 unit increase,[0.005-0.009],ACSS3,Alcohol consumption,alcohol consumption measurement,GCST008757,12:81201921
rs2356369-<b>T</b>,2 x 10-9,,0.52,'-,0.006 unit decrease,[0.004-0.008],LINC01414,Alcohol consumption,alcohol consumption measurement,GCST008757,8:64044325
rs12031875-<b>A</b>,2 x 10-9,,0.82,'-,0.008 unit decrease,[0.006-0.01],ZRANB2-AS2,Alcohol consumption,alcohol consumption measurement,GCST008757,1:71119414
rs12646808-<b>T</b>,2 x 10-9,,0.66,'-,0.007 unit increase,[0.005-0.009],MSANTD1,Alcohol consumption,alcohol consumption measurement,GCST008757,4:3248101
rs10078588-<b>A</b>,3 x 10-9,,0.52,'-,0.006 unit increase,[0.004-0.008],TENM2,Alcohol consumption,alcohol consumption measurement,GCST008757,5:167389171
rs748919-<b>T</b>,3 x 10-9,,0.79,'-,0.008 unit increase,[0.006-0.01],IGSF9B,Alcohol consumption,alcohol consumption measurement,GCST008757,11:133913337
rs785293-<b>A</b>,3 x 10-9,,0.57,'-,0.006 unit decrease,[0.004-0.008],MIR4431,Alcohol consumption,alcohol consumption measurement,GCST008757,2:52796166
rs988748-<b>C</b>,4 x 10-9,,0.21,'-,0.008 unit decrease,[0.006-0.01],BDNF,Alcohol consumption,alcohol consumption measurement,GCST008757,11:27703198
rs145452708-<b>C</b>,1 x 10-125,,0.0136,'-,0.0136 unit decrease,[0.0042-0.023],ADH1B,Alcohol consumption,alcohol consumption measurement,GCST008757,4:99327485
rs11940694-<b>A</b>,3 x 10-68,,0.3938,'-,0.0185 unit decrease,[0.016-0.021],KLB,Alcohol consumption,alcohol consumption measurement,GCST008757,4:39413373
rs1260326-<b>T</b>,2 x 10-60,,0.3939,'-,0.0173 unit decrease,[0.015-0.019],'-,Alcohol consumption,alcohol consumption measurement,GCST008757,Mapping not available
rs9841829-<b>T</b>,2 x 10-17,,0.7725,'-,0.0104 unit decrease,[0.008-0.0128],CADM2,Alcohol consumption,alcohol consumption measurement,GCST008757,3:85520211
rs6943555-<b>A</b>,3 x 10-6,,0.24,'-,0.0056 unit decrease,[0.0032-0.008],AUTS2,Alcohol consumption,alcohol consumption measurement,GCST008757,7:70341037
rs1260326-<b>C</b>,8 x 10-45,,0.601,'-,0.020889835 unit increase,[0.018-0.024],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,Mapping not available
rs2178197-<b>G</b>,2 x 10-9,(Conditioned on chr2:27730940),0.569083,'-,0.008781445 unit decrease,[0.0059-0.0117],GPN1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:27637684
rs13383034-<b>T</b>,6 x 10-22,,0.329,'-,0.014926977 unit increase,[0.012-0.018],LINC01833,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:44928137
rs1004787-<b>A</b>,8 x 10-9,(Conditioned on chr2:45155276),0.550918,'-,0.008442835 unit increase,[0.0056-0.0113],LINC01833,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:44931952
rs13032049-<b>G</b>,3 x 10-10,,0.283,'-,0.01019455 unit increase,[0.007-0.0134],WDPCP,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:63354372
rs828867-<b>A</b>,2 x 10-9,,0.545,'-,0.008757157 unit increase,[0.0059-0.0116],TET3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:74107335
rs11692435-<b>A</b>,3 x 10-11,,0.0852,'-,0.017449895 unit increase,[0.012-0.023],ACTR1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:97658891
rs13024996-<b>A</b>,6 x 10-13,,0.364,'-,0.010912645 unit decrease,[0.0079-0.0139],ARHGAP15,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:143467646
rs72859280-<b>T</b>,4 x 10-9,,0.0362,'-,0.022885324 unit increase,[0.015-0.031],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:147198725
rs56337305-<b>C</b>,2 x 10-10,,0.383,'-,0.009588381 unit decrease,[0.0066-0.0125],"CUL3, CCDC195",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:224610843
rs13094887-<b>T</b>,9 x 10-11,,0.301,'-,0.010309671 unit decrease,[0.0072-0.0134],FOXP1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:70919280
rs62250685-<b>G</b>,1 x 10-21,,0.614,'-,0.014357061 unit decrease,[0.011-0.017],CADM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:85408090
rs74664784-<b>C</b>,2 x 10-14,(Conditioned on chr3:85457240),0.359,'-,0.012656173 unit decrease,[0.0094-0.0159],CADM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:85426142
rs13066454-<b>T</b>,4 x 10-9,,0.398,'-,0.008775946 unit decrease,[0.0059-0.0117],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:94275411
rs9838144-<b>C</b>,3 x 10-8,,0.209,'-,0.009964223 unit decrease,[0.0065-0.0135],CPNE4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:131857443
rs2011092-<b>C</b>,7 x 10-9,(Conditioned on chr3:141267295),0.338643,'-,0.008900405 unit decrease,[0.0059-0.0119],ZBTB38,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:141405765
rs60654199-<b>A</b>,3 x 10-8,,0.0629,'-,0.016660294 unit decrease,[0.011-0.023],RASA2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:141548453
rs6787172-<b>G</b>,4 x 10-8,,0.554,'-,0.008030894 unit decrease,[0.0052-0.0109],RSRC1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,3:158470022
rs3748034-<b>T</b>,2 x 10-8,,0.143,'-,0.011740341 unit decrease,[0.0077-0.0158],HGFAC,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:3444364
rs7682824-<b>T</b>,3 x 10-8,"(Conditioned on chr4:39418965, chr4:39414993)",0.548,'-,0.008356086 unit increase,[0.0054-0.0113],"RNU6-887P, KLB",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:39404634
rs11940694-<b>G</b>,3 x 10-68,,0.597,'-,0.025949908 unit increase,[0.023-0.029],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:39413373
rs35538052-<b>A</b>,1 x 10-8,(Conditioned on chr4:39414993),0.379,'-,0.008524877 unit decrease,[0.0056-0.0115],KLB,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:39417345
rs4501255-<b>G</b>,5 x 10-10,,0.235,'-,0.010693415 unit increase,[0.0073-0.0141],BEND4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:42149289
rs12499107-<b>G</b>,4 x 10-9,"(Conditioned on chr4:100273594, chr4:99713350,chr4:101243023 ,chr4:100000136, chr4:100254520, chr4:100443853, chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319)",0.131202,'-,0.012661209 unit increase,[0.0084-0.0169],"ADH1A, BTF3P13",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:98757540
rs144198753-<b>T</b>,1 x 10-12,"(Conditioned on chr4:101243023, chr4:100000136,chr4:100254520 ,chr4:100443853, chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319)",0.016315,'-,0.04182707 unit decrease,[0.03-0.053],"EIF4E, BTF3P13",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:98792199
rs378421-<b>A</b>,5 x 10-14,,0.404,'-,0.011205474 unit decrease,[0.0083-0.0141],"NPIPB9, EIF3C",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:28743363
rs113443718-<b>A</b>,1 x 10-10,,0.305,'-,0.010208258 unit decrease,[0.0071-0.0133],SEZ6L2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:29880863
rs62044525-<b>G</b>,1 x 10-10,,0.184,'-,0.01217318 unit decrease,[0.0085-0.0159],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:64838687
rs7185555-<b>C</b>,4 x 10-8,,0.153,'-,0.011100514 unit decrease,[0.0071-0.0151],"HAS3, TANGO6",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:69097378
rs79616692-<b>C</b>,4 x 10-12,,0.108,'-,0.016302273 unit increase,[0.012-0.021],LINC01572,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:72304608
rs1104608-<b>C</b>,1 x 10-13,,0.425,'-,0.010974988 unit decrease,[0.0081-0.0139],ZFHX3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:73878689
rs4548913-<b>A</b>,3 x 10-8,,0.632,'-,0.008359953 unit decrease,[0.0054-0.0113],SRR,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,17:2306594
rs3803800-<b>G</b>,2 x 10-10,,0.786,'-,0.011378876 unit increase,[0.0079-0.0149],"TNFSF12-TNFSF13, TNFSF13",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,17:7559652
rs2854334-<b>G</b>,8 x 10-10,,0.615,'-,0.009220984 unit increase,[0.0063-0.0122],"NF1, RAB11FIP4",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,17:31388482
chr17:44246624-<b>A</b>,2 x 10-17,,0.215,'-,0.021800138 unit decrease,[0.017-0.027],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,Mapping not available
rs10438820-<b>T</b>,2 x 10-8,,0.702,'-,0.008971778 unit increase,[0.0058-0.0121],RPTOR,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,17:80550797
rs9950000-<b>T</b>,9 x 10-10,,0.395,'-,0.009117697 unit decrease,[0.0062-0.012],TCF4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,18:55384938
rs4092465-<b>G</b>,4 x 10-8,,0.635,'-,0.008291878 unit decrease,[0.0053-0.0113],"ONECUT2, ST8SIA3",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,18:57413205
rs281379-<b>A</b>,5 x 10-21,,0.508,'-,0.013722336 unit increase,[0.011-0.017],"FUT2, MAMSTR",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,19:48711017
rs4815364-<b>A</b>,1 x 10-8,,0.616,'-,0.008582356 unit increase,[0.0056-0.0115],ACSS1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,20:25055075
rs9607814-<b>A</b>,4 x 10-8,,0.2,'-,0.010181001 unit decrease,[0.0065-0.0138],"POLR3H, CSDC2",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,22:41550515
rs55932213-<b>G</b>,1 x 10-8,(Conditioned on chr9:109345993),0.736387,'-,0.009488271 unit increase,[0.0062-0.0127],LINC01505,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,9:105993341
rs10978550-<b>C</b>,7 x 10-11,,0.206,'-,0.011748331 unit decrease,[0.0082-0.0153],LINC01505,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,9:106583712
rs7074871-<b>A</b>,2 x 10-8,,0.255,'-,0.00939985 unit decrease,[0.0061-0.0127],LINC02661,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,10:108748048
rs17665139-<b>T</b>,2 x 10-8,,0.149,'-,0.011560138 unit decrease,[0.0075-0.0156],LINC02641,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,10:123334364
rs7950166-<b>T</b>,1 x 10-10,,0.637,'-,0.009799202 unit decrease,[0.0068-0.0128],TRIM66,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:8620671
rs11030084-<b>T</b>,2 x 10-8,,0.184,'-,0.010606819 unit decrease,[0.0069-0.0143],"BDNF-AS, LINC00678",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:27622178
rs56030824-<b>A</b>,1 x 10-13,,0.322,'-,0.011601888 unit decrease,[0.0085-0.0147],SPI1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:47375802
rs10750025-<b>T</b>,5 x 10-11,,0.686,'-,0.010321447 unit increase,[0.0072-0.0134],DRD2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:113553320
rs1713676-<b>G</b>,4 x 10-8,(Conditioned on chr11:113424042),0.522454,'-,0.007991984 unit decrease,[0.0051-0.0109],ATF4P4,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:113789854
rs4938230-<b>A</b>,1 x 10-10,,0.842,'-,0.012810377 unit increase,[0.0089-0.0167],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:116204284
rs682011-<b>C</b>,2 x 10-8,,0.559,'-,0.008212447 unit increase,[0.0053-0.0111],SORL1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:121673577
rs12795042-<b>C</b>,3 x 10-8,,0.623,'-,0.008319009 unit decrease,[0.0054-0.0113],LINC02743,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,11:133788273
rs10876188-<b>T</b>,5 x 10-8,,0.457,'-,0.007986853 unit decrease,[0.0051-0.0109],SLC4A8,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,12:51502098
rs3809162-<b>G</b>,1 x 10-9,,0.397,'-,0.009060925 unit increase,[0.0061-0.012],HNRNPA1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,12:54280451
rs10506274-<b>T</b>,6 x 10-10,,0.484,'-,0.009037403 unit decrease,[0.0062-0.0119],ACSS3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,12:81207685
rs4842786-<b>A</b>,3 x 10-9,,0.584,'-,0.008797801 unit decrease,[0.0059-0.0117],LINC02404,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,12:91777014
rs500321-<b>T</b>,5 x 10-9,,0.736,'-,0.009669361 unit decrease,[0.0064-0.0129],WASF3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,13:26550223
rs1123285-<b>G</b>,8 x 10-9,,0.335,'-,0.008897365 unit decrease,[0.0059-0.0119],OTX2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,14:56807801
rs2180870-<b>C</b>,1 x 10-8,,0.135,'-,0.012177537 unit decrease,[0.008-0.0164],ARID4A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,14:58316061
rs28929474-<b>T</b>,1 x 10-11,,0.0183,'-,0.036799625 unit decrease,[0.026-0.047],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,Mapping not available
rs11625650-<b>A</b>,3 x 10-8,,0.233,'-,0.009568091 unit decrease,[0.0062-0.0129],KIF26A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,14:104143801
rs2472297-<b>T</b>,3 x 10-10,,0.249,'-,0.010606047 unit increase,[0.0073-0.0139],"CYP1A2, CYP1A1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,15:74735539
rs12907323-<b>G</b>,1 x 10-8,,0.411,'-,0.008496596 unit increase,[0.0056-0.0114],AGBL1,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,15:86252781
rs2764771-<b>A</b>,4 x 10-10,,0.307,'-,0.009890596 unit increase,[0.0068-0.013],GPR139,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:20002471
rs17177078-<b>T</b>,1 x 10-13,,0.0626,'-,0.02231549 unit decrease,[0.016-0.028],TNRC6A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,16:24799360
rs705687-<b>G</b>,8 x 10-10,,0.785,'-,0.010904017 unit decrease,[0.0074-0.0144],"LINC01777, LINC01646",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:4488393
rs58107686-<b>A</b>,8 x 10-10,,0.328,'-,0.009747126 unit decrease,[0.0066-0.0129],PHC2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:33371733
rs12088813-<b>C</b>,2 x 10-8,,0.267,'-,0.009329047 unit decrease,[0.0061-0.0126],PDE4B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:65942017
rs5024204-<b>T</b>,3 x 10-9,,0.278,'-,0.009702711 unit increase,[0.0065-0.0129],PTGER3,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:71026207
rs10753661-<b>A</b>,4 x 10-8,,0.684,'-,0.008638128 unit decrease,[0.0056-0.0117],LMX1A,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:165150555
rs28680958-<b>A</b>,5 x 10-10,,0.217,'-,0.010996457 unit decrease,[0.0075-0.0145],ZBTB37,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:173879670
rs823114-<b>A</b>,2 x 10-9,,0.553,'-,0.00876774 unit increase,[0.0059-0.0116],"RAB29, NUCKS1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,1:205750404
rs77165542-<b>T</b>,6 x 10-11,,0.0349,'-,0.026010899 unit decrease,[0.018-0.034],"LINC01874, LINC01865",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,2:430975
rs1154414-<b>C</b>,4 x 10-17,"(Conditioned on chr4:100254520, chr4:100443853,chr4:100286085 ,chr4:100260679, chr4:100444363, chr4:100239319)",0.141063,'-,0.017630372 unit increase,[0.014-0.022],ADH5,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99078985
rs1229984-<b>C</b>,2 x 10-308,,0.963,'-,0.15053357 unit increase,[0.14-0.16],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99318162
rs10028756-<b>A</b>,1 x 10-17,"(Conditioned on chr4:100443853, chr4:100286085,chr4:100260679 ,chr4:100444363, chr4:100239319)",0.129457,'-,0.018574761 unit decrease,[0.014-0.023],ADH1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99333363
rs561222871-<b>T</b>,7 x 10-27,"(Conditioned on chr4:100444363, chr4:100239319)",0.047377,'-,0.03880677 unit decrease,[0.032-0.046],"ADH1C, ADH1B",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99339522
rs36052336-<b>G</b>,1 x 10-9,"(Conditioned on chr4:99713350, chr4:101243023,chr4:100000136 ,chr4:100254520, chr4:100443853, chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319)",0.061496,'-,0.018428808 unit decrease,[0.012-0.024],"ADH1B, ADH1C",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99352437
rs2165670-<b>A</b>,2 x 10-22,"(Conditioned on chr4:100260679, chr4:100444363,chr4:100239319)",0.106337,'-,0.02308038 unit increase,[0.018-0.028],"ADH7, ADH1B",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99364928
rs17029090-<b>G</b>,5 x 10-21,"(Conditioned on chr4:100286085, chr4:100260679,chr4:100444363 ,chr4:100239319)",0.019896,'-,0.049127366 unit decrease,[0.039-0.059],C4orf17,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99522696
rs79139602-<b>T</b>,2 x 10-32,(Conditioned on chr4:100239319),0.021061,'-,0.06027231 unit increase,[0.05-0.07],C4orf17,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:99523206
rs4699791-<b>A</b>,7 x 10-14,"(Conditioned on chr4:100000136, chr4:100254520,chr4:100443853 ,chr4:100286085, chr4:100260679, chr4:100444363, chr4:100239319)",0.095726,'-,0.018570721 unit increase,[0.014-0.023],EMCN,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:100321866
rs13107325-<b>T</b>,2 x 10-22,,0.0722,'-,0.027504515 unit decrease,[0.022-0.033],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,Mapping not available
rs4690727-<b>G</b>,2 x 10-11,,0.718,'-,0.010816985 unit increase,[0.0076-0.014],INPP4B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:142727426
rs10004020-<b>A</b>,2 x 10-8,,0.72,'-,0.009052333 unit increase,[0.0059-0.0122],"LINC02273, RNA5SP169",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:152047220
rs12651313-<b>G</b>,4 x 10-9,,0.443,'-,0.008642927 unit decrease,[0.0058-0.0115],"LINC01612, APOBEC3AP1",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,4:170165242
rs4916723-<b>C</b>,2 x 10-11,,0.416,'-,0.009952257 unit decrease,[0.0071-0.0129],LINC00461,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,5:88558577
rs12655091-<b>A</b>,1 x 10-8,,0.53,'-,0.008312109 unit decrease,[0.0054-0.0112],NAMPTP2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,5:145032772
rs55872084-<b>T</b>,6 x 10-9,,0.235,'-,0.009978744 unit increase,[0.0066-0.0133],SGCD,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,5:156474993
rs11739827-<b>T</b>,1 x 10-8,,0.451,'-,0.008375229 unit decrease,[0.0055-0.0113],TENM2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,5:167376316
rs10085696-<b>G</b>,1 x 10-9,,0.186,'-,0.011408902 unit decrease,[0.0077-0.0151],AUTS2,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,7:70318034
rs6460047-<b>C</b>,1 x 10-10,,0.208,'-,0.011623538 unit increase,[0.0081-0.0151],"MLXIPL, VPS37D",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,7:73628113
rs10236149-<b>G</b>,1 x 10-9,,0.123,'-,0.013498145 unit decrease,[0.0091-0.0178],ARPC1B,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,7:99379892
rs35034355-<b>A</b>,3 x 10-8,,0.521,'-,0.008096817 unit decrease,[0.0052-0.011],ORC5,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,7:104199667
rs6951574-<b>C</b>,2 x 10-19,,0.458,'-,0.013222216 unit increase,[0.01-0.016],DPP6,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,7:153792659
rs13250583-<b>T</b>,5 x 10-8,,0.213,'-,0.009717545 unit decrease,[0.0062-0.0132],LINC02153,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,8:21092406
rs1217091-<b>C</b>,7 x 10-11,,0.812,'-,0.012160827 unit increase,[0.0085-0.0158],"LINC01414, RN7SKP135",Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,8:63614841
rs28601761-<b>G</b>,7 x 10-10,,0.42,'-,0.009102878 unit increase,[0.0062-0.012],'-,Alcohol consumption (drinks per week),alcohol consumption measurement,GCST007461,Mapping not available
rs2950218-<b>T</b>,8 x 10-9,,0.706,'-,0.00838151 unit increase,[0.0055-0.0112],C5orf64,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:61731215
rs13357015-<b>A</b>,3 x 10-9,,0.645,'-,0.00818496 unit increase,[0.0055-0.0109],RASGRF2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:80967584
rs10068110-<b>T</b>,7 x 10-9,,0.201,'-,0.00955412 unit increase,[0.0063-0.0128],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:88032069
rs12655091-<b>A</b>,2 x 10-8,,0.53,'-,0.00740093 unit decrease,[0.0048-0.01],NAMPTP2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:145032772
rs55872084-<b>T</b>,9 x 10-9,,0.235,'-,0.00895569 unit increase,[0.0059-0.012],SGCD,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:156474993
rs11739827-<b>T</b>,6 x 10-9,,0.451,'-,0.00781981 unit decrease,[0.0052-0.0105],TENM2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:167376316
rs10978550-<b>C</b>,2 x 10-12,,0.206,'-,0.0115167 unit decrease,[0.0083-0.0147],LINC01505,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,9:106583712
rs2297605-<b>A</b>,2 x 10-8,,0.459,'-,0.00768614 unit increase,[0.005-0.0104],NR5A1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,9:124493169
rs12572486-<b>C</b>,9 x 10-10,,0.259,'-,0.00925838 unit decrease,[0.0063-0.0122],LINC02661,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,10:108785324
rs17665139-<b>T</b>,7 x 10-10,,0.149,'-,0.0114182 unit decrease,[0.0078-0.015],LINC02641,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,10:123334364
rs61861298-<b>C</b>,4 x 10-8,,0.233,'-,0.00857442 unit decrease,[0.0055-0.0116],GPR26,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,10:123658771
rs7950166-<b>T</b>,1 x 10-10,,0.637,'-,0.00880867 unit decrease,[0.0061-0.0115],TRIM66,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:8620671
rs11030084-<b>T</b>,2 x 10-13,,0.184,'-,0.0124831 unit decrease,[0.0091-0.0158],"BDNF-AS, LINC00678",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:27622178
rs11030380-<b>T</b>,3 x 10-6,,0.6,'-,0.00631481 unit increase,[0.0037-0.009],METTL15,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:28569621
rs11604680-<b>G</b>,4 x 10-16,,0.321,'-,0.0115081 unit decrease,[0.0087-0.0143],"RAPSN, PSMC3",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:47435988
rs1940728-<b>T</b>,3 x 10-14,,0.403,'-,0.0103804 unit increase,[0.0077-0.0131],NCAM1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:112981473
rs6589379-<b>T</b>,6 x 10-11,,0.638,'-,0.00898363 unit increase,[0.0063-0.0117],DRD2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:113503845
rs17542254-<b>G</b>,5 x 10-11,,0.275,'-,0.0096932 unit increase,[0.0068-0.0126],"CLDN25, ATF4P4",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:113784974
rs4938230-<b>A</b>,2 x 10-11,,0.842,'-,0.0121162 unit increase,[0.0086-0.0157],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:116204284
rs9325144-<b>T</b>,1 x 10-8,,0.348,'-,0.00788455 unit decrease,[0.0052-0.0106],CPNE8,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:38624871
rs2193749-<b>C</b>,1 x 10-7,,0.513,'-,0.00692773 unit increase,[0.0043-0.0095],ARID2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:45741029
rs11615710-<b>G</b>,2 x 10-9,,0.207,'-,0.00980909 unit decrease,[0.0066-0.013],SPATS2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:49493002
rs7956306-<b>A</b>,2 x 10-10,,0.459,'-,0.00842972 unit decrease,[0.0058-0.011],SLC4A8,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:51440224
rs10506274-<b>T</b>,8 x 10-11,,0.484,'-,0.00856984 unit decrease,[0.006-0.0112],ACSS3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:81207685
rs4842786-<b>A</b>,2 x 10-10,,0.584,'-,0.00852538 unit decrease,[0.0059-0.0112],LINC02404,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:91777014
rs1426371-<b>A</b>,6 x 10-9,,0.259,'-,0.00886039 unit decrease,[0.0059-0.0119],WSCD2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,12:108236003
rs500321-<b>T</b>,1 x 10-9,,0.736,'-,0.00905072 unit decrease,[0.0061-0.012],WASF3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,13:26550223
rs1937529-<b>T</b>,1 x 10-9,,0.521,'-,0.00797547 unit decrease,[0.0054-0.0106],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,13:67533729
rs1123285-<b>G</b>,2 x 10-11,,0.335,'-,0.00944268 unit decrease,[0.0067-0.0122],OTX2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,14:56807801
rs111908763-<b>T</b>,2 x 10-8,,0.193,'-,0.00934652 unit decrease,[0.0061-0.0126],NRXN3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,14:79466480
rs12881175-<b>C</b>,5 x 10-7,,0.906,'-,0.0113529 unit increase,[0.0069-0.0158],NRXN3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,14:79880190
rs1286127-<b>T</b>,5 x 10-9,,0.551,'-,0.00776001 unit decrease,[0.0052-0.0104],RPS6KA5,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,14:90923997
rs28929474-<b>T</b>,7 x 10-13,,0.0183,'-,0.0353946 unit decrease,[0.026-0.045],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,Mapping not available
rs7146019-<b>G</b>,2 x 10-8,,0.578,'-,0.00765154 unit increase,[0.005-0.0103],BCL11B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,14:99268647
rs11625650-<b>A</b>,2 x 10-11,,0.233,'-,0.010895 unit decrease,[0.0077-0.0141],KIF26A,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,14:104143801
rs1025143-<b>C</b>,1 x 10-10,,0.357,'-,0.00890796 unit increase,[0.0062-0.0116],SEMA6D,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,15:47392862
rs2472297-<b>T</b>,9 x 10-11,,0.249,'-,0.00996419 unit increase,[0.007-0.013],"CYP1A2, CYP1A1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,15:74735539
rs12907323-<b>G</b>,9 x 10-11,,0.411,'-,0.00871045 unit increase,[0.0061-0.0113],AGBL1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,15:86252781
rs705687-<b>G</b>,1 x 10-11,,0.785,'-,0.0109027 unit decrease,[0.0077-0.0141],"LINC01777, LINC01646",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:4488393
rs58107686-<b>A</b>,2 x 10-12,,0.328,'-,0.0100772 unit decrease,[0.0073-0.0129],PHC2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:33371733
rs1416706-<b>A</b>,6 x 10-10,,0.669,'-,0.00870364 unit increase,[0.006-0.0115],P3R3URF-PIK3R3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:46137172
rs2997084-<b>G</b>,9 x 10-13,,0.433,'-,0.00955653 unit decrease,[0.0069-0.0122],PDE4B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:65928049
rs66904764-<b>C</b>,3 x 10-12,,0.278,'-,0.010265 unit increase,[0.0074-0.0132],PTGER3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:71027956
rs6671130-<b>G</b>,4 x 10-9,,0.601,'-,0.00808366 unit decrease,[0.0054-0.0108],"LINC01360, S100A16",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:73386004
rs10753661-<b>A</b>,6 x 10-9,,0.684,'-,0.00824938 unit decrease,[0.0055-0.011],LMX1A,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:165150555
rs28680958-<b>A</b>,7 x 10-13,,0.217,'-,0.0114771 unit decrease,[0.0083-0.0146],ZBTB37,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:173879670
rs823114-<b>A</b>,2 x 10-11,,0.553,'-,0.00893543 unit increase,[0.0063-0.0115],"RAB29, NUCKS1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,1:205750404
rs62104180-<b>A</b>,9 x 10-15,,0.0489,'-,0.0249782 unit decrease,[0.019-0.031],LINC01874,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:466003
rs6731872-<b>G</b>,4 x 10-9,,0.826,'-,0.0102333 unit increase,[0.0068-0.0136],"LINC01875, TMEM18",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:624205
rs115056666-<b>T</b>,8 x 10-9,,0.0665,'-,0.0153424 unit increase,[0.01-0.021],MYT1L,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:2005643
rs13392329-<b>T</b>,6 x 10-7,,0.327,'-,0.00706146 unit decrease,[0.0043-0.0098],ASXL2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:25842723
rs1260326-<b>C</b>,3 x 10-44,,0.601,'-,0.0187927 unit increase,[0.016-0.021],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,Mapping not available
rs2754511-<b>T</b>,6 x 10-8,,0.328,'-,0.00773373 unit decrease,[0.0049-0.0105],BIRC6,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:32545090
rs10166377-<b>A</b>,4 x 10-8,,0.165,'-,0.00983451 unit decrease,[0.0063-0.0134],"RNU6-566P, LRPPRC",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:44085558
rs1004787-<b>A</b>,5 x 10-32,,0.551,'-,0.0157003 unit increase,[0.013-0.018],LINC01833,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:44931952
rs11125166-<b>C</b>,9 x 10-10,,0.731,'-,0.0091545 unit decrease,[0.0062-0.0121],"FOXN2, RN7SKP224",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:48235785
rs883323-<b>T</b>,6 x 10-9,,0.624,'-,0.00792932 unit decrease,[0.0053-0.0106],TENM2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:167560739
rs3117334-<b>T</b>,7 x 10-9,,0.501,'-,0.00785988 unit increase,[0.0052-0.0105],"OR2U1P, OR2G1P",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:29249737
rs9277636-<b>G</b>,3 x 10-8,,0.153,'-,0.0105227 unit increase,[0.0068-0.0143],HLA-DPB2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:33114735
rs10948615-<b>C</b>,4 x 10-8,,0.306,'-,0.00783127 unit decrease,[0.005-0.0106],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:51474623
rs4421172-<b>T</b>,4 x 10-9,,0.627,'-,0.00803814 unit decrease,[0.0054-0.0107],MIR4643,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:91492001
rs968050-<b>T</b>,2 x 10-11,,0.483,'-,0.00884588 unit increase,[0.0063-0.0114],EIF4EBP2P3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:98126684
rs6931356-<b>T</b>,4 x 10-8,,0.698,'-,0.00791963 unit increase,[0.0051-0.0107],MCHR2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:99899631
rs4945704-<b>A</b>,4 x 10-8,,0.414,'-,0.00740538 unit decrease,[0.0048-0.01],HACE1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:104631849
rs2235997-<b>A</b>,4 x 10-9,,0.498,'-,0.00785877 unit decrease,[0.0052-0.0105],NR2E1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,6:108168806
rs113072763-<b>G</b>,9 x 10-9,,0.0212,'-,0.0273045 unit decrease,[0.018-0.037],SDK1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:3719298
rs12701709-<b>A</b>,2 x 10-8,,0.771,'-,0.00879478 unit decrease,[0.0057-0.0119],POU6F2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:39271268
rs10085696-<b>G</b>,1 x 10-11,,0.186,'-,0.0114574 unit decrease,[0.0081-0.0148],AUTS2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:70318034
rs6460047-<b>C</b>,4 x 10-11,,0.208,'-,0.0108214 unit increase,[0.0076-0.014],"MLXIPL, VPS37D",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:73628113
rs10236149-<b>G</b>,4 x 10-13,,0.123,'-,0.0146241 unit decrease,[0.011-0.019],ARPC1B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:99379892
rs2299409-<b>A</b>,2 x 10-9,,0.529,'-,0.00786772 unit decrease,[0.0053-0.0105],ORC5,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:104171723
rs339095-<b>G</b>,2 x 10-8,,0.497,'-,0.00744603 unit decrease,[0.0049-0.01],CALU,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:128765993
rs1349405-<b>A</b>,1 x 10-8,,0.35,'-,0.00792449 unit decrease,[0.0052-0.0106],PLXNA4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:132222789
rs6951574-<b>C</b>,9 x 10-23,,0.458,'-,0.0135261 unit increase,[0.011-0.016],DPP6,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,7:153792659
rs13250583-<b>T</b>,6 x 10-9,,0.213,'-,0.00936684 unit decrease,[0.0062-0.0125],LINC02153,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,8:21092406
rs72630922-<b>A</b>,2 x 10-8,,0.419,'-,0.00750852 unit decrease,[0.0049-0.0101],VENTXP5,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,8:33804883
rs6982152-<b>C</b>,4 x 10-15,,0.763,'-,0.012229 unit increase,[0.0092-0.0153],LINC01414,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,8:63866456
rs1814032-<b>A</b>,3 x 10-11,,0.224,'-,0.011071 unit decrease,[0.0078-0.0143],RUNX1T1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,8:91993219
rs28601761-<b>G</b>,3 x 10-10,,0.42,'-,0.00849258 unit increase,[0.0059-0.0111],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,Mapping not available
rs2771046-<b>A</b>,2 x 10-8,,0.188,'-,0.00946371 unit increase,[0.0062-0.0128],ELAVL2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,9:23810890
rs55932213-<b>G</b>,5 x 10-9,,0.736,'-,0.0089515 unit increase,[0.006-0.0119],LINC01505,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,9:105993341
rs2717063-<b>A</b>,5 x 10-11,,0.588,'-,0.0088418 unit increase,[0.0062-0.0115],VRK2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:57883834
rs13032049-<b>G</b>,2 x 10-13,,0.283,'-,0.0108326 unit increase,[0.008-0.0137],WDPCP,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:63354372
rs828867-<b>A</b>,8 x 10-13,,0.545,'-,0.00957418 unit increase,[0.007-0.0122],TET3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:74107335
rs11692435-<b>A</b>,3 x 10-15,,0.0852,'-,0.0189977 unit increase,[0.014-0.024],ACTR1B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:97658891
rs13392222-<b>C</b>,1 x 10-7,,0.139,'-,0.01011 unit decrease,[0.0064-0.0139],AFF3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:100055946
rs1534454-<b>T</b>,3 x 10-9,,0.272,'-,0.00918866 unit increase,[0.0061-0.0122],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:103161259
rs7581524-<b>T</b>,2 x 10-9,,0.279,'-,0.00884175 unit increase,[0.006-0.0117],"VINAC1P, TTL",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:112476739
rs13024996-<b>A</b>,2 x 10-15,,0.364,'-,0.010881 unit decrease,[0.0082-0.0136],ARHGAP15,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:143467646
rs72859280-<b>T</b>,4 x 10-11,,0.0362,'-,0.0241072 unit increase,[0.017-0.031],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:147198725
rs12466127-<b>A</b>,2 x 10-11,,0.376,'-,0.00922632 unit increase,[0.0065-0.0119],SLC4A10,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:161958752
rs13002088-<b>A</b>,4 x 10-8,,0.784,'-,0.00879412 unit increase,[0.0057-0.0119],NFE2L2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:177307190
rs12185569-<b>A</b>,4 x 10-8,,0.249,'-,0.00838359 unit decrease,[0.0054-0.0114],"FZD7, RNU6-440P",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:202010829
rs147537311-<b>T</b>,4 x 10-8,,0.0885,'-,0.0128269 unit decrease,[0.0083-0.0174],INO80D,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:206026557
rs7594223-<b>C</b>,2 x 10-14,,0.382,'-,0.010429 unit decrease,[0.0078-0.0131],"CCDC195, CUL3",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:224608268
rs2972155-<b>G</b>,1 x 10-8,,0.646,'-,0.00786986 unit decrease,[0.0052-0.0106],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:226252982
rs67714256-<b>C</b>,8 x 10-8,,0.346,'-,0.00744434 unit decrease,[0.0047-0.0102],SPHKAP,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,2:228108667
rs2300669-<b>A</b>,4 x 10-8,,0.386,'-,0.00741178 unit decrease,[0.0048-0.0101],EXOG,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:38499827
rs13094887-<b>T</b>,3 x 10-15,,0.301,'-,0.0114029 unit decrease,[0.0086-0.0142],FOXP1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:70919280
rs13068318-<b>T</b>,2 x 10-9,,0.207,'-,0.00975306 unit increase,[0.0066-0.0129],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:81271963
rs62250685-<b>G</b>,1 x 10-31,,0.614,'-,0.0158444 unit decrease,[0.013-0.019],CADM2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:85408090
rs13066454-<b>T</b>,3 x 10-11,,0.398,'-,0.00895544 unit decrease,[0.0063-0.0116],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:94275411
rs1378835-<b>G</b>,2 x 10-9,,0.546,'-,0.00795323 unit increase,[0.0054-0.0105],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:117934569
rs9838144-<b>C</b>,4 x 10-9,,0.209,'-,0.00971521 unit decrease,[0.0065-0.0129],CPNE4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:131857443
rs6777420-<b>T</b>,3 x 10-8,,0.131,'-,0.0110558 unit increase,[0.0071-0.015],"GK5, XRN1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:142284027
rs2279829-<b>T</b>,1 x 10-8,,0.215,'-,0.00918408 unit decrease,[0.006-0.0123],ZIC4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:147388532
rs7618629-<b>G</b>,5 x 10-8,,0.754,'-,0.00842028 unit increase,[0.0054-0.0114],PSMD2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:184305273
rs3748034-<b>T</b>,4 x 10-9,,0.143,'-,0.0112741 unit decrease,[0.0075-0.015],HGFAC,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:3444364
rs11728253-<b>T</b>,1 x 10-8,,0.733,'-,0.00868565 unit decrease,[0.0057-0.0117],ABLIM2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:8027236
rs13148010-<b>A</b>,2 x 10-8,,0.421,'-,0.00752374 unit decrease,[0.0049-0.0101],EEF1A1P21,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:29693076
rs11940694-<b>G</b>,4 x 10-64,,0.597,'-,0.0228615 unit increase,[0.02-0.026],KLB,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:39413373
rs6856819-<b>G</b>,2 x 10-9,,0.235,'-,0.00936338 unit increase,[0.0063-0.0124],BEND4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:42148196
rs4699680-<b>A</b>,6 x 10-22,,0.957,'-,0.0313325 unit increase,[0.025-0.038],"BTF3P13, EIF4E",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:98837981
rs3846449-<b>C</b>,2 x 10-17,,0.222,'-,0.0134997 unit decrease,[0.01-0.017],"ADH1C, ADH1B",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:99337969
rs141973904-<b>T</b>,3 x 10-139,,0.0168,'-,0.133706 unit decrease,[0.12-0.14],"ADH1B, ADH1C",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:99341085
rs1714524-<b>T</b>,6 x 10-10,,0.551,'-,0.00818671 unit decrease,[0.0056-0.0108],"RSRC1, MLF1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,3:158555307
rs283412-<b>G</b>,1 x 10-21,,0.973,'-,0.0392146 unit increase,[0.031-0.047],"ADH1B, ADH1C",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:99346515
rs112519623-<b>A</b>,4 x 10-6,,0.0159,'-,0.0255335 unit decrease,[0.015-0.036],SLC39A8,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:102263082
rs13107325-<b>T</b>,1 x 10-23,,0.0722,'-,0.0256461 unit decrease,[0.021-0.031],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,Mapping not available
rs6845321-<b>T</b>,2 x 10-8,,0.306,'-,0.00803745 unit increase,[0.0052-0.0109],"LARP7, OSTCP4",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:112674713
rs4690727-<b>G</b>,9 x 10-14,,0.718,'-,0.0109605 unit increase,[0.0081-0.0138],INPP4B,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:142727426
rs7655455-<b>T</b>,7 x 10-10,,0.664,'-,0.00861357 unit increase,[0.0059-0.0113],"LINC02273, RNA5SP169",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:152046789
rs12651313-<b>G</b>,2 x 10-8,,0.443,'-,0.00747515 unit decrease,[0.0049-0.0101],"LINC01612, APOBEC3AP1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,4:170165242
rs6451575-<b>T</b>,2 x 10-9,,0.573,'-,0.00799836 unit decrease,[0.0054-0.0106],CDH18,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:19958948
rs2080870-<b>T</b>,6 x 10-9,,0.747,'-,0.00881017 unit decrease,[0.0058-0.0118],NDUFAF2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,5:61092486
rs2764771-<b>A</b>,3 x 10-8,,0.307,'-,0.00801632 unit increase,[0.0052-0.0108],GPR139,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:20002471
rs17177078-<b>T</b>,6 x 10-16,,0.0626,'-,0.0220624 unit decrease,[0.017-0.027],TNRC6A,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:24799360
rs8047349-<b>G</b>,1 x 10-11,,0.699,'-,0.00981266 unit increase,[0.007-0.0126],"ZKSCAN2-DT, LINC02191",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:25360286
rs378421-<b>A</b>,4 x 10-15,,0.404,'-,0.0121791 unit decrease,[0.0091-0.0152],"NPIPB9, EIF3C",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:28743363
rs9934579-<b>A</b>,4 x 10-10,,0.135,'-,0.0121585 unit decrease,[0.0084-0.016],Y_RNA,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:30463535
rs59367532-<b>G</b>,8 x 10-10,,0.254,'-,0.00935679 unit decrease,[0.0064-0.0123],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:64498474
rs112500154-<b>A</b>,5 x 10-10,,0.185,'-,0.0106394 unit decrease,[0.0073-0.014],PPIAP48,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:64801089
rs7185555-<b>C</b>,2 x 10-10,,0.153,'-,0.011718 unit decrease,[0.0081-0.0153],"HAS3, TANGO6",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:69097378
rs74980679-<b>T</b>,1 x 10-13,,0.144,'-,0.0140935 unit increase,[0.01-0.018],AP1G1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:71745407
rs1104608-<b>C</b>,3 x 10-12,,0.425,'-,0.00948981 unit decrease,[0.0068-0.0122],ZFHX3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,16:73878689
rs4548913-<b>A</b>,7 x 10-8,,0.632,'-,0.00747532 unit decrease,[0.0048-0.0102],SRR,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:2306594
rs3803800-<b>G</b>,4 x 10-11,,0.786,'-,0.0106875 unit increase,[0.0075-0.0139],"TNFSF12-TNFSF13, TNFSF13",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:7559652
rs34121753-<b>G</b>,5 x 10-14,,0.572,'-,0.0101504 unit increase,[0.0075-0.0128],DNAH2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:7830515
rs9893690-<b>T</b>,1 x 10-9,,0.643,'-,0.00841086 unit increase,[0.0057-0.0111],TOM1L2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:17850532
rs2525565-<b>C</b>,6 x 10-11,,0.619,'-,0.00885905 unit increase,[0.0062-0.0115],NF1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:31339570
rs2668680-<b>C</b>,4 x 10-19,,0.177,'-,0.0174888 unit decrease,[0.014-0.021],"RDM1P1, DND1P1",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:45582609
rs10438820-<b>T</b>,3 x 10-9,,0.702,'-,0.00850176 unit increase,[0.0057-0.0113],RPTOR,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:80550797
rs8074498-<b>A</b>,1 x 10-8,,0.574,'-,0.0079286 unit decrease,[0.0052-0.0106],ASPSCR1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,17:81996668
rs8097672-<b>T</b>,2 x 10-9,,0.147,'-,0.0112319 unit increase,[0.0076-0.0149],AIDAP3,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,18:1839600
rs2872041-<b>A</b>,4 x 10-11,,0.455,'-,0.00875237 unit decrease,[0.0062-0.0114],TCF4,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,18:55397260
rs4092465-<b>G</b>,2 x 10-9,,0.635,'-,0.00824661 unit decrease,[0.0055-0.011],"ONECUT2, ST8SIA3",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,18:57413205
rs8106871-<b>T</b>,1 x 10-8,,0.118,'-,0.0116998 unit increase,[0.0077-0.0157],POU2F2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,19:42147448
rs281379-<b>A</b>,4 x 10-21,,0.508,'-,0.0125087 unit increase,[0.0099-0.0151],"FUT2, MAMSTR",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,19:48711017
rs4815364-<b>A</b>,2 x 10-10,,0.616,'-,0.0086305 unit increase,[0.006-0.0113],ACSS1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,20:25055075
rs17389284-<b>C</b>,1 x 10-8,,0.247,'-,0.00905474 unit increase,[0.0059-0.0122],TSHZ2,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,20:53071269
rs3761422-<b>C</b>,3 x 10-8,,0.607,'-,0.00750734 unit increase,[0.0049-0.0102],"SPECC1L-ADORA2A, ADORA2A-AS1, ADORA2A",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,22:24430704
rs9613472-<b>G</b>,3 x 10-8,,0.54,'-,0.00747007 unit increase,[0.0048-0.0101],'-,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,22:27576518
rs9607814-<b>A</b>,3 x 10-10,,0.2,'-,0.0105989 unit decrease,[0.0073-0.0139],"POLR3H, CSDC2",Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,22:41550515
rs530916-<b>G</b>,1 x 10-12,,0.558,'-,0.00945064 unit increase,[0.0068-0.0121],SORL1,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:121678383
rs2132489-<b>T</b>,7 x 10-10,,0.567,'-,0.0082326 unit increase,[0.0056-0.0108],LINC02743,Alcohol consumption (drinks per week) (MTAG),alcohol consumption measurement,GCST007472,11:133777699
rs11065979-<b>T</b>,4 x 10-21,(EA),0.45,'-,'-,'-,"BRAP, ATXN2-AS",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:111621753
rs2013002-<b>T</b>,2 x 10-19,(EA),0.45,'-,'-,'-,"ACAD10, ALDH2",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:111762346
rs7953257-<b>A</b>,8 x 10-19,(EA),0.45,'-,'-,'-,HECTD4,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:112246417
rs1579381-<b>C</b>,3 x 10-13,(EA),0.89,'-,'-,'-,'-,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:115118002
rs3753584-<b>T</b>,5 x 10-18,(EA),0.84,'-,'-,'-,MTHFR,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,1:11804529
rs72640287-<b>T</b>,3 x 10-9,(EA),0.04,'-,'-,'-,"SBF1P2, RNU5E-1",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,1:11905735
rs79211428-<b>T</b>,3 x 10-10,(EA),0.14,'-,'-,'-,ULK4,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,3:41880318
rs988397-<b>T</b>,2 x 10-11,(EA),0.45,'-,'-,'-,MECOM,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,3:169381003
rs7497026-<b>T</b>,3 x 10-13,(EA),0.45,'-,'-,'-,"COX5A, FAM219B",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,15:74916208
rs1894400-<b>T</b>,2 x 10-19,(EA),0.32,'-,'-,'-,FES,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,15:90885725
rs11099097-<b>T</b>,8 x 10-15,(EA),0.28,'-,'-,'-,"PRDM8, FGF5",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,4:80246155
rs13139571-<b>A</b>,3 x 10-9,(EA),0.24,'-,'-,'-,GUCY1A1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,4:155724361
rs3792765-<b>A</b>,5 x 10-9,(EA),0.61,'-,'-,'-,NPR3,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,5:32713730
rs7209400-<b>T</b>,2 x 10-9,(EA),0.55,'-,'-,'-,"ZNF652, PHB",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,17:49372695
rs198851-<b>T</b>,1 x 10-16,(EA),0.15,'-,'-,'-,"H4C3, H1-6",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,6:26104404
rs1801253-<b>C</b>,9 x 10-9,(EA),0.73,'-,'-,'-,ADRB1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,10:114045297
rs10255839-<b>A</b>,4 x 10-11,"(AA, Asian, EA)",0.87,'-,'-,'-,EVX1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,7:27249498
rs2306363-<b>T</b>,1 x 10-10,"(AA, EA)",0.19,'-,'-,'-,SIPA1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,11:65638129
rs73437358-<b>A</b>,1 x 10-16,"(AA, EA)",0.16,'-,'-,'-,ATP2B1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:89678299
rs17035646-<b>A</b>,1 x 10-11,"(AA, EA)",0.34,'-,'-,'-,CASZ1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,1:10736490
rs13306556-<b>T</b>,3 x 10-9,"(AA, EA)",0.11,'-,'-,'-,MTHFR,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,1:11792053
rs1275986-<b>A</b>,5 x 10-11,"(AA, EA)",0.59,'-,'-,'-,"KCNK3, RPL37P11",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,2:26689211
rs7622665-<b>T</b>,4 x 10-18,"(AA, EA)",0.2,'-,'-,'-,ULK4,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,3:41929251
rs8029440-<b>A</b>,1 x 10-17,"(AA, EA)",0.35,'-,'-,'-,"FURIN, RN7SL363P",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,15:90866284
rs16998073-<b>A</b>,2 x 10-14,"(AA, EA)",0.71,'-,'-,'-,"PRDM8, FGF5",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,4:80263187
rs11725969-<b>T</b>,2 x 10-8,"(AA, EA)",0.25,'-,'-,'-,GUCY1A1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,4:155705436
rs7209400-<b>T</b>,1 x 10-10,"(AA, EA)",0.54,'-,'-,'-,"ZNF652, PHB",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,17:49372695
rs6108787-<b>T</b>,7 x 10-13,"(AA, EA)",0.54,'-,'-,'-,"FAT1P1, LINC02871",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,20:10986566
rs73306888-<b>A</b>,4 x 10-11,"(AA, EA)",0.14,'-,'-,'-,ZNF831,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,20:59173534
rs7922049-<b>A</b>,2 x 10-10,"(AA, EA)",0.14,'-,'-,'-,CABCOCO1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,10:61702607
rs438885-<b>A</b>,2 x 10-9,"(Asian, EA)",0.42,'-,'-,'-,PRPS1P1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,2:164195781
rs1290784-<b>T</b>,2 x 10-11,"(Asian, EA)",0.38,'-,'-,'-,MECOM,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,3:169379112
rs1350193-<b>C</b>,3 x 10-13,"(Asian, EA)",0.68,'-,'-,'-,CSK,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,15:74791940
rs10059884-<b>A</b>,3 x 10-13,"(Asian, EA)",0.59,'-,'-,'-,NPR3,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,5:32832368
rs62434109-<b>T</b>,4 x 10-12,"(Asian, EA)",0.94,'-,'-,'-,PLEKHG1,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,6:150654176
rs5883070-<b>?</b>,4 x 10-8,"(Asian, EA)",0.06,'-,'-,'-,"HOTTIP, EVX1-AS",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,7:27240227
rs604723-<b>T</b>,4 x 10-11,(EA),0.28,'-,'-,'-,ARHGAP42,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,11:100739815
rs10743353-<b>T</b>,6 x 10-10,(EA),0.71,'-,'-,'-,LINC02398,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:20047028
rs1689040-<b>T</b>,3 x 10-21,(EA),0.4,'-,'-,'-,"ATP2B1, POC1B-AS1",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:89584456
rs1980235-<b>A</b>,9 x 10-11,(EA),0.68,'-,'-,'-,"ATP2B1-AS1, RNA5SP365",Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:89717005
rs7137828-<b>T</b>,4 x 10-24,(EA),0.51,'-,'-,'-,ATXN2,Diastolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"diastolic blood pressure, alcohol consumption measurement",GCST006169,12:111494996
rs11200509-<b>C</b>,1 x 10-8,(AA),0.17,'-,'-,'-,"TACC2, BTBD16",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,10:122256927
rs794899-<b>T</b>,2 x 10-13,"(AA, EA)",0.18,'-,'-,'-,"GEMIN2P2, TRAK1",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,3:41987230
rs871606-<b>T</b>,6 x 10-12,"(AA, EA)",0.89,'-,'-,'-,RPL21P44,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,4:53933078
rs3828591-<b>C</b>,9 x 10-13,"(AA, EA)",0.4,'-,'-,'-,NPR3,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,5:32713002
rs62481856-<b>A</b>,4 x 10-33,"(AA, EA)",0.2,'-,'-,'-,LINC02577,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,7:106771636
rs7823056-<b>A</b>,3 x 10-11,"(AA, EA)",0.5,'-,'-,'-,RN7SL178P,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,8:8525195
rs34112166-<b>A</b>,4 x 10-17,"(AA, EA)",0.21,'-,'-,'-,"MIR548AZ, CCN3",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,8:119388292
rs3781962-<b>C</b>,3 x 10-12,"(Asian, EA)",0.59,'-,'-,'-,LSP1,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,11:1886379
rs7909591-<b>T</b>,8 x 10-11,"(Asian, EA)",0.31,'-,'-,'-,"BORCS7-ASMT, AS3MT",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,10:102899261
rs7302816-<b>A</b>,6 x 10-11,(EA),0.8,'-,'-,'-,"ATP2B1, POC1B-AS1",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,12:89556543
rs10858917-<b>A</b>,2 x 10-12,(EA),0.79,'-,'-,'-,ATP2B1,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,12:89695013
rs794905-<b>T</b>,2 x 10-11,(EA),0.84,'-,'-,'-,"TRAK1, GEMIN2P2",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,3:41993238
rs62481856-<b>A</b>,5 x 10-32,(EA),0.2,'-,'-,'-,LINC02577,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,7:106771636
rs2980755-<b>A</b>,1 x 10-10,(EA),0.55,'-,'-,'-,RN7SL178P,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,8:8506173
rs4841569-<b>A</b>,5 x 10-11,(EA),0.42,'-,'-,'-,"GATA4, LINC00208",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,8:11594668
rs1461695-<b>A</b>,1 x 10-15,(EA),0.26,'-,'-,'-,CCN3,Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,8:119432061
rs7909591-<b>T</b>,7 x 10-10,(EA),0.28,'-,'-,'-,"BORCS7-ASMT, AS3MT",Pulse pressure x alcohol consumption (light vs heavy) interaction (2df test),"pulse pressure measurement, alcohol consumption measurement",GCST006171,10:102899261
rs62434109-<b>T</b>,1 x 10-10,"(Asian, EA)",0.94,'-,'-,'-,PLEKHG1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,6:150654176
rs5883070-<b>?</b>,3 x 10-9,"(Asian, EA)",0.06,'-,'-,'-,"HOTTIP, EVX1-AS",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,7:27240227
rs588321-<b>C</b>,8 x 10-17,(EA),0.4,'-,'-,'-,LSP1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,11:1875727
rs2681485-<b>A</b>,2 x 10-23,(EA),0.6,'-,'-,'-,ATP2B1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,12:89631845
rs7310615-<b>C</b>,4 x 10-14,(EA),0.5,'-,'-,'-,SH2B3,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,12:111427245
rs35441-<b>T</b>,5 x 10-11,(EA),0.39,'-,'-,'-,'-,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,12:115115310
rs17035646-<b>A</b>,9 x 10-13,(EA),0.34,'-,'-,'-,CASZ1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,1:10736490
rs3753584-<b>T</b>,3 x 10-19,(EA),0.84,'-,'-,'-,MTHFR,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,1:11804529
rs1290784-<b>T</b>,5 x 10-12,(EA),0.45,'-,'-,'-,MECOM,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,3:169379112
rs11636952-<b>T</b>,4 x 10-14,(EA),0.32,'-,'-,'-,LMAN1L,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,15:74821981
rs12899430-<b>T</b>,1 x 10-11,(EA),0.47,'-,'-,'-,COX5A,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,15:74936759
rs1573643-<b>T</b>,5 x 10-22,(EA),0.67,'-,'-,'-,FURIN,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,15:90877743
rs11099097-<b>T</b>,1 x 10-14,(EA),0.28,'-,'-,'-,"PRDM8, FGF5",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,4:80246155
rs3762988-<b>T</b>,6 x 10-13,(EA),0.39,'-,'-,'-,NPR3,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,5:32709547
rs2980755-<b>A</b>,3 x 10-11,(EA),0.55,'-,'-,'-,RN7SL178P,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:8506173
rs656319-<b>A</b>,2 x 10-12,(EA),0.45,'-,'-,'-,"MIR124-1HG, MSRA",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:9956901
rs7832708-<b>T</b>,6 x 10-13,(EA),0.49,'-,'-,'-,MSRA,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:10332530
rs10096777-<b>A</b>,4 x 10-14,(EA),0.56,'-,'-,'-,RP1L1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:10660990
rs4841465-<b>T</b>,1 x 10-12,(EA),0.52,'-,'-,'-,XKR6,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:10962344
rs13255193-<b>T</b>,6 x 10-10,(EA),0.46,'-,'-,'-,FAM167A,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:11451683
rs13280442-<b>C</b>,5 x 10-14,(EA),0.55,'-,'-,'-,"GATA4, LINC00208",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:11610048
rs17613287-<b>A</b>,7 x 10-12,(EA),0.66,'-,'-,'-,CACNB2,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,10:18430748
rs2484294-<b>A</b>,2 x 10-9,(EA),0.72,'-,'-,'-,ADRB1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,10:114032303
rs10255839-<b>A</b>,1 x 10-13,"(AA, Asian, EA)",0.87,'-,'-,'-,EVX1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,7:27249498
rs2306363-<b>T</b>,3 x 10-11,"(AA, EA)",0.19,'-,'-,'-,SIPA1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,11:65638129
rs4759319-<b>T</b>,4 x 10-8,"(AA, EA)",0.36,'-,'-,'-,HOXC4,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,12:54030947
rs4842676-<b>C</b>,4 x 10-19,"(AA, EA)",0.82,'-,'-,'-,ATP2B1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,12:89698005
rs17035646-<b>A</b>,5 x 10-14,"(AA, EA)",0.34,'-,'-,'-,CASZ1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,1:10736490
rs17037452-<b>A</b>,1 x 10-21,"(AA, EA)",0.84,'-,'-,'-,CLCN6,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,1:11835618
rs1275978-<b>T</b>,6 x 10-14,"(AA, EA)",0.59,'-,'-,'-,KCNK3,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,2:26700227
rs16998073-<b>A</b>,3 x 10-15,"(AA, EA)",0.71,'-,'-,'-,"PRDM8, FGF5",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,4:80263187
rs11725969-<b>T</b>,1 x 10-8,"(AA, EA)",0.25,'-,'-,'-,GUCY1A1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,4:155705436
rs1952652-<b>A</b>,4 x 10-10,"(AA, EA)",0.65,'-,'-,'-,LINC02227,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,5:158384080
rs7209400-<b>T</b>,5 x 10-9,"(AA, EA)",0.54,'-,'-,'-,"ZNF652, PHB",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,17:49372695
rs17693945-<b>T</b>,2 x 10-9,"(AA, EA)",0.41,'-,'-,'-,MSRA,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:10248500
rs9969436-<b>T</b>,3 x 10-9,"(AA, EA)",0.47,'-,'-,'-,XKR6,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:10985149
rs6108787-<b>T</b>,9 x 10-13,"(AA, EA)",0.54,'-,'-,'-,"FAT1P1, LINC02871",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,20:10986566
rs6026740-<b>A</b>,8 x 10-10,"(AA, EA)",0.86,'-,'-,'-,ZNF831,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,20:59165293
rs7922049-<b>A</b>,9 x 10-10,"(AA, EA)",0.14,'-,'-,'-,CABCOCO1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,10:61702607
rs438885-<b>A</b>,6 x 10-12,"(Asian, EA)",0.42,'-,'-,'-,PRPS1P1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,2:164195781
rs1290786-<b>T</b>,4 x 10-12,"(Asian, EA)",0.36,'-,'-,'-,MECOM,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,3:169379593
rs2301249-<b>T</b>,1 x 10-15,"(Asian, EA)",0.32,'-,'-,'-,CSK,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,15:74800043
rs10059884-<b>A</b>,7 x 10-17,"(Asian, EA)",0.59,'-,'-,'-,NPR3,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,5:32832368
rs62434111-<b>A</b>,9 x 10-14,"(Asian, EA)",0.06,'-,'-,'-,PLEKHG1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,6:150656822
rs5883070-<b>?</b>,2 x 10-9,"(Asian, EA)",0.06,'-,'-,'-,"HOTTIP, EVX1-AS",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,7:27240227
rs633185-<b>C</b>,2 x 10-12,(EA),0.71,'-,'-,'-,ARHGAP42,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,11:100722807
rs2681485-<b>A</b>,3 x 10-25,(EA),0.6,'-,'-,'-,ATP2B1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,12:89631845
rs7310615-<b>C</b>,5 x 10-20,(EA),0.5,'-,'-,'-,SH2B3,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,12:111427245
rs11065979-<b>T</b>,1 x 10-16,(EA),0.45,'-,'-,'-,"BRAP, ATXN2-AS",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,12:111621753
rs35441-<b>T</b>,2 x 10-12,(EA),0.39,'-,'-,'-,'-,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,12:115115310
rs3753584-<b>T</b>,1 x 10-20,(EA),0.84,'-,'-,'-,MTHFR,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,1:11804529
rs2643826-<b>T</b>,2 x 10-10,(EA),0.45,'-,'-,'-,"Y_RNA, RNU1-96P",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,3:27521497
rs1290784-<b>T</b>,5 x 10-13,(EA),0.45,'-,'-,'-,MECOM,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,3:169379112
rs11636952-<b>T</b>,3 x 10-15,(EA),0.32,'-,'-,'-,LMAN1L,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,15:74821981
rs1894400-<b>T</b>,6 x 10-23,(EA),0.32,'-,'-,'-,FES,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,15:90885725
rs11099097-<b>T</b>,3 x 10-16,(EA),0.28,'-,'-,'-,"PRDM8, FGF5",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,4:80246155
rs13139571-<b>A</b>,2 x 10-9,(EA),0.24,'-,'-,'-,GUCY1A1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,4:155724361
rs198851-<b>T</b>,7 x 10-15,(EA),0.15,'-,'-,'-,"H4C3, H1-6",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,6:26104404
rs656319-<b>A</b>,8 x 10-11,(EA),0.45,'-,'-,'-,"MIR124-1HG, MSRA",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:9956901
rs17693945-<b>T</b>,4 x 10-9,(EA),0.4196,'-,'-,'-,MSRA,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:10248500
rs4841409-<b>A</b>,6 x 10-12,(EA),0.44,'-,'-,'-,RP1L1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:10658864
rs9969436-<b>T</b>,2 x 10-8,(EA),0.4846,'-,'-,'-,XKR6,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:10985149
rs17807624-<b>T</b>,3 x 10-11,(EA),0.35,'-,'-,'-,"LINC00208, GATA4",Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,8:11605506
rs2484294-<b>A</b>,1 x 10-10,(EA),0.72,'-,'-,'-,ADRB1,Mean arterial pressure x alcohol consumption (light vs heavy) interaction (2df test),"mean arterial pressure, alcohol consumption measurement",GCST006172,10:114032303
rs10255839-<b>A</b>,8 x 10-13,"(AA, Asian, EA)",0.87,'-,'-,'-,EVX1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,7:27249498
rs2306363-<b>T</b>,2 x 10-10,"(AA, EA)",0.19,'-,'-,'-,SIPA1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,11:65638129
rs4759319-<b>T</b>,5 x 10-8,"(AA, EA)",0.36,'-,'-,'-,HOXC4,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,12:54030947
rs17035646-<b>A</b>,7 x 10-14,"(AA, EA)",0.34,'-,'-,'-,CASZ1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,1:10736490
rs17037452-<b>A</b>,6 x 10-20,"(AA, EA)",0.84,'-,'-,'-,CLCN6,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,1:11835618
rs1731249-<b>A</b>,1 x 10-13,"(AA, EA)",0.59,'-,'-,'-,KCNK3,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,2:26697157
rs16998073-<b>A</b>,5 x 10-13,"(AA, EA)",0.71,'-,'-,'-,"PRDM8, FGF5",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,4:80263187
rs3828591-<b>C</b>,3 x 10-17,"(AA, EA)",0.4,'-,'-,'-,NPR3,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,5:32713002
rs1952652-<b>A</b>,3 x 10-11,"(AA, EA)",0.65,'-,'-,'-,LINC02227,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,5:158384080
rs2392929-<b>T</b>,1 x 10-14,"(AA, EA)",0.8,'-,'-,'-,LINC02577,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,7:106773623
rs7823056-<b>A</b>,1 x 10-11,"(AA, EA)",0.41,'-,'-,'-,RN7SL178P,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:8525195
rs4841294-<b>A</b>,3 x 10-10,"(AA, EA)",0.43,'-,'-,'-,MSRA,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,8:10247558
rs1887320-<b>A</b>,2 x 10-9,"(AA, EA)",0.46,'-,'-,'-,"FAT1P1, LINC02871",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,20:10985350
rs576603-<b>T</b>,1 x 10-18,"(Asian, EA)",0.47,'-,'-,'-,"LSP1, LINC01150",Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,11:1892909
rs11023906-<b>A</b>,1 x 10-9,"(Asian, EA)",0.21,'-,'-,'-,SOX6,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,11:16302860
rs438885-<b>A</b>,2 x 10-13,"(Asian, EA)",0.42,'-,'-,'-,PRPS1P1,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,2:164195781
rs60605842-<b>A</b>,4 x 10-8,"(Asian, EA)",0.55,'-,'-,'-,SLC4A7,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,3:27439550
rs2014590-<b>T</b>,5 x 10-10,"(Asian, EA)",0.56,'-,'-,'-,MECOM,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,3:169428709
rs2301249-<b>T</b>,5 x 10-14,"(Asian, EA)",0.32,'-,'-,'-,CSK,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,15:74800043
rs1133322-<b>A</b>,4 x 10-12,"(Asian, EA)",0.55,'-,'-,'-,COX5A,Systolic blood pressure x alcohol consumption (light vs heavy) interaction (2df test),"systolic blood pressure, alcohol consumption measurement",GCST006170,15:74920016
rs4665972-<b>C</b>,2 x 10-15,,NR,'-,'-,'-,'-,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,Mapping not available
rs2050058-<b>A</b>,2 x 10-15,,NR,'-,'-,'-,ZHX3,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,20:41278348
rs8178824-<b>T</b>,1 x 10-14,,NR,'-,'-,'-,APOH,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,17:66228657
rs114165349-<b>C</b>,2 x 10-14,,NR,'-,'-,'-,ARID1A,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:26695422
rs1584063-<b>A</b>,1 x 10-13,,NR,'-,'-,'-,"GSTM5P1, SYN2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,3:12225355
rs13210143-<b>A</b>,1 x 10-13,,NR,'-,'-,'-,"FRK, NT5DC1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:116068473
rs2575876-<b>A</b>,3 x 10-13,,NR,'-,'-,'-,ABCA1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:104903458
rs7904973-<b>T</b>,4 x 10-13,,NR,'-,'-,'-,C10orf88,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:122934071
rs7570971-<b>A</b>,6 x 10-13,,NR,'-,'-,'-,RAB3GAP1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:135080336
rs7096937-<b>C</b>,7 x 10-13,,NR,'-,'-,'-,GPAM,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:112190660
rs10176901-<b>A</b>,9 x 10-13,,NR,'-,'-,'-,ABCB11,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:168974151
rs753833181-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,N4BP2L1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,13:32402503
rs55809639-<b>A</b>,2 x 10-12,,NR,'-,'-,'-,"INSIG2, RN7SL111P",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:118085225
rs1800961-<b>T</b>,3 x 10-12,,NR,'-,'-,'-,HNF4A,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,20:44413724
rs509728-<b>C</b>,1 x 10-11,,NR,'-,'-,'-,"LINC02702, BUD13",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:116662450
rs7310615-<b>G</b>,2 x 10-11,,NR,'-,'-,'-,SH2B3,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,12:111427245
rs5014650-<b>A</b>,4 x 10-11,,NR,'-,'-,'-,"PLG, LPA",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:160678471
rs2763981-<b>A</b>,5 x 10-11,,NR,'-,'-,'-,SLC44A4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:31872244
rs2328223-<b>C</b>,8 x 10-11,,NR,'-,'-,'-,RNU6-192P,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,20:17865277
rs9496567-<b>A</b>,1 x 10-9,,NR,'-,'-,'-,PRDX2P4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:100154877
rs73729083-<b>C</b>,2 x 10-9,,NR,'-,'-,'-,CREB3L2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:137875053
rs2911971-<b>G</b>,4 x 10-9,,NR,'-,'-,'-,AGPAT5,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:6750113
rs13108218-<b>G</b>,6 x 10-9,,NR,'-,'-,'-,'-,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,Mapping not available
rs4418728-<b>T</b>,1 x 10-8,,NR,'-,'-,'-,"CYP26A1, NIP7P1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:93079967
rs201445483-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,SMC6,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:17708821
rs6907508-<b>G</b>,1 x 10-8,,NR,'-,'-,'-,ILRUN,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:34624313
rs9989419-<b>G</b>,3 x 10-8,,NR,'-,'-,'-,"HERPUD1, CETP",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,16:56951227
rs7035578-<b>A</b>,3 x 10-8,,NR,'-,'-,'-,PCSK5,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:76130261
rs13284665-<b>G</b>,4 x 10-8,,NR,'-,'-,'-,ZER1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:128751091
rs10761716-<b>G</b>,9 x 10-8,,NR,'-,'-,'-,"RNU6-543P, NRBF2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:63122540
rs10832961-<b>G</b>,9 x 10-8,,NR,'-,'-,'-,SPTY2D1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:18632410
rs72729610-<b>G</b>,3 x 10-7,,NR,'-,'-,'-,TRIM2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,4:153269813
rs1495743-<b>C</b>,3 x 10-7,,NR,'-,'-,'-,NAT2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:18415790
rs2156552-<b>T</b>,3 x 10-7,,NR,'-,'-,'-,SMUG1P1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,18:49655298
rs7140110-<b>C</b>,4 x 10-6,,NR,'-,'-,'-,"GAS6-AS1, GAS6",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,13:113841051
rs7528419-<b>G</b>,2 x 10-193,(EA),NR,'-,'-,'-,CELSR2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:109274570
rs143020224-<b>G</b>,2 x 10-193,(EA),NR,'-,'-,'-,SMARCA4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:11076648
rs2304128-<b>T</b>,2 x 10-193,(EA),NR,'-,'-,'-,GMIP,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:19635342
rs10066168-<b>T</b>,2 x 10-193,(EA),NR,'-,'-,'-,HAVCR1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,5:157057207
rs581411-<b>A</b>,2 x 10-193,(EA),NR,'-,'-,'-,"TDRD15, APOB",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:21066560
rs1531517-<b>A</b>,2 x 10-177,(EA),NR,'-,'-,'-,"CEACAM16-AS1, BCL3",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:44738916
rs11591147-<b>T</b>,3 x 10-176,(EA),NR,'-,'-,'-,PCSK9,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:55039974
rs495828-<b>T</b>,4 x 10-103,(EA),NR,'-,'-,'-,"ABO, Y_RNA",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:133279294
rs2954021-<b>G</b>,3 x 10-78,(EA),NR,'-,'-,'-,TRIB1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:125469835
rs4299376-<b>T</b>,4 x 10-74,(EA),NR,'-,'-,'-,ABCG8,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:43845437
rs4495740-<b>G</b>,1 x 10-54,(EA),NR,'-,'-,'-,DOCK7,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:62658794
rs174566-<b>G</b>,3 x 10-47,(EA),NR,'-,'-,'-,"FADS1, FADS2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:61824890
rs3794695-<b>T</b>,3 x 10-43,(EA),NR,'-,'-,'-,"HPR, TXNL4B",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,16:72063928
rs117753190-<b>G</b>,9 x 10-33,(EA),NR,'-,'-,'-,ABCA6,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,17:69140184
rs4841132-<b>G</b>,2 x 10-32,(EA),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:9326086
rs2235215-<b>C</b>,2 x 10-29,(EA),NR,'-,'-,'-,MYLIP,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:16130925
rs217381-<b>G</b>,7 x 10-27,(EA),NR,'-,'-,'-,DDX56,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:44566618
rs486142-<b>A</b>,1 x 10-26,(EA),NR,'-,'-,'-,"LINC01132, LINC00184",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:234712862
rs2244608-<b>G</b>,3 x 10-26,(EA),NR,'-,'-,'-,"HNF1A, HNF1A-AS1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,12:120979185
rs76970536-<b>A</b>,7 x 10-25,(EA),NR,'-,'-,'-,ST3GAL4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:126380785
rs10957054-<b>T</b>,2 x 10-23,(EA),NR,'-,'-,'-,UBXN2B,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:58423997
rs66476925-<b>C</b>,6 x 10-23,(EA),NR,'-,'-,'-,DNAH11,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:21571781
rs35866622-<b>T</b>,2 x 10-20,(EA),NR,'-,'-,'-,MAMSTR,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:48714803
rs56204645-<b>C</b>,1 x 10-18,(EA),NR,'-,'-,'-,"TRMT112P7, RP1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:54509209
rs200174418-<b>?</b>,2 x 10-18,(EA),NR,'-,'-,'-,CERT1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,5:75449704
rs1128249-<b>T</b>,6 x 10-17,(EA),NR,'-,'-,'-,COBLL1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:164672114
rs11870935-<b>A</b>,3 x 10-16,(EA),NR,'-,'-,'-,KPNB1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,17:47655239
rs9438905-<b>G</b>,8 x 10-16,(EA),NR,'-,'-,'-,MACO1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:25437686
rs2642438-<b>G</b>,3 x 10-15,(EA),NR,'-,'-,'-,MTARC1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:220796686
rs114165349-<b>C</b>,4 x 10-15,(EA),NR,'-,'-,'-,ARID1A,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:26695422
rs6573778-<b>C</b>,2 x 10-13,(EA),NR,'-,'-,'-,NYNRIN,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,14:24403003
rs8178824-<b>T</b>,3 x 10-13,(EA),NR,'-,'-,'-,APOH,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,17:66228657
rs2328223-<b>C</b>,9 x 10-13,(EA),NR,'-,'-,'-,RNU6-192P,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,20:17865277
rs4722551-<b>C</b>,2 x 10-12,(EA),NR,'-,'-,'-,MIR148A,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:25952206
rs4665972-<b>C</b>,2 x 10-12,(EA),NR,'-,'-,'-,'-,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,Mapping not available
rs360804-<b>A</b>,2 x 10-12,(EA),NR,'-,'-,'-,EHBP1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:62712262
rs509728-<b>C</b>,3 x 10-12,(EA),NR,'-,'-,'-,"LINC02702, BUD13",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:116662450
rs55809639-<b>A</b>,4 x 10-12,(EA),NR,'-,'-,'-,"INSIG2, RN7SL111P",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:118085225
rs13210143-<b>A</b>,8 x 10-12,(EA),NR,'-,'-,'-,"FRK, NT5DC1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:116068473
rs10176901-<b>A</b>,2 x 10-11,(EA),NR,'-,'-,'-,ABCB11,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:168974151
rs2763981-<b>A</b>,3 x 10-11,(EA),NR,'-,'-,'-,SLC44A4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:31872244
rs10832961-<b>G</b>,5 x 10-11,(EA),NR,'-,'-,'-,SPTY2D1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:18632410
rs9496567-<b>A</b>,9 x 10-11,(EA),NR,'-,'-,'-,PRDX2P4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:100154877
rs9989419-<b>G</b>,2 x 10-10,(EA),NR,'-,'-,'-,"HERPUD1, CETP",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,16:56951227
rs2575876-<b>A</b>,6 x 10-10,(EA),NR,'-,'-,'-,ABCA1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:104903458
rs7570971-<b>A</b>,7 x 10-10,(EA),NR,'-,'-,'-,RAB3GAP1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:135080336
rs7904973-<b>T</b>,8 x 10-10,(EA),NR,'-,'-,'-,C10orf88,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:122934071
rs1800961-<b>T</b>,1 x 10-9,(EA),NR,'-,'-,'-,HNF4A,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,20:44413724
rs753833181-<b>?</b>,1 x 10-9,(EA),NR,'-,'-,'-,N4BP2L1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,13:32402503
rs2050058-<b>A</b>,1 x 10-9,(EA),NR,'-,'-,'-,ZHX3,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,20:41278348
rs1584063-<b>A</b>,4 x 10-9,(EA),NR,'-,'-,'-,"GSTM5P1, SYN2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,3:12225355
rs7035578-<b>A</b>,6 x 10-9,(EA),NR,'-,'-,'-,PCSK5,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:76130261
rs2911971-<b>G</b>,1 x 10-8,(EA),NR,'-,'-,'-,AGPAT5,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:6750113
rs7310615-<b>G</b>,2 x 10-8,(EA),NR,'-,'-,'-,SH2B3,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,12:111427245
rs7096937-<b>C</b>,2 x 10-8,(EA),NR,'-,'-,'-,GPAM,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:112190660
rs5014650-<b>A</b>,4 x 10-8,(EA),NR,'-,'-,'-,"PLG, LPA",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:160678471
rs13108218-<b>G</b>,4 x 10-8,(EA),NR,'-,'-,'-,'-,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,Mapping not available
rs6907508-<b>G</b>,4 x 10-7,(EA),NR,'-,'-,'-,ILRUN,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:34624313
rs72729610-<b>G</b>,5 x 10-7,(EA),NR,'-,'-,'-,TRIM2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,4:153269813
rs13284665-<b>G</b>,7 x 10-7,(EA),NR,'-,'-,'-,ZER1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:128751091
rs1495743-<b>C</b>,8 x 10-7,(EA),NR,'-,'-,'-,NAT2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:18415790
rs1689788-<b>C</b>,8 x 10-7,(EA),NR,'-,'-,'-,LINC01344,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:182175287
rs2749008-<b>T</b>,9 x 10-7,(EA),NR,'-,'-,'-,GSTA2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:52761322
rs4418728-<b>T</b>,9 x 10-7,(EA),NR,'-,'-,'-,"CYP26A1, NIP7P1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:93079967
rs10761716-<b>G</b>,1 x 10-6,(EA),NR,'-,'-,'-,"RNU6-543P, NRBF2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,10:63122540
rs1154988-<b>A</b>,7 x 10-6,(EA),NR,'-,'-,'-,"MSL2, PCCB",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,3:136206349
rs7528419-<b>G</b>,9 x 10-35,(AA),NR,'-,'-,'-,CELSR2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:109274570
rs581411-<b>A</b>,2 x 10-11,(AA),NR,'-,'-,'-,"TDRD15, APOB",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:21066560
rs143020224-<b>G</b>,3 x 10-9,(AA),NR,'-,'-,'-,SMARCA4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:11076648
rs73729083-<b>C</b>,3 x 10-7,(AA),NR,'-,'-,'-,CREB3L2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:137875053
rs7528419-<b>G</b>,1 x 10-45,(Asian),NR,'-,'-,'-,CELSR2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:109274570
rs581411-<b>A</b>,4 x 10-13,(Asian),NR,'-,'-,'-,"TDRD15, APOB",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:21066560
rs143020224-<b>G</b>,4 x 10-11,(Asian),NR,'-,'-,'-,SMARCA4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:11076648
rs3794695-<b>T</b>,3 x 10-10,(Asian),NR,'-,'-,'-,"HPR, TXNL4B",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,16:72063928
rs2954021-<b>G</b>,6 x 10-10,(Asian),NR,'-,'-,'-,TRIB1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:125469835
rs4841132-<b>G</b>,2 x 10-7,(Asian),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:9326086
rs495828-<b>T</b>,3 x 10-7,(Asian),NR,'-,'-,'-,"ABO, Y_RNA",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:133279294
rs6573778-<b>C</b>,9 x 10-6,(Asian),NR,'-,'-,'-,NYNRIN,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,14:24403003
rs7528419-<b>G</b>,6 x 10-49,(Hispanic),NR,'-,'-,'-,CELSR2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:109274570
rs581411-<b>A</b>,2 x 10-22,(Hispanic),NR,'-,'-,'-,"TDRD15, APOB",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:21066560
rs143020224-<b>G</b>,7 x 10-19,(Hispanic),NR,'-,'-,'-,SMARCA4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:11076648
rs4299376-<b>T</b>,1 x 10-9,(Hispanic),NR,'-,'-,'-,ABCG8,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:43845437
rs495828-<b>T</b>,2 x 10-8,(Hispanic),NR,'-,'-,'-,"ABO, Y_RNA",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:133279294
rs174566-<b>G</b>,6 x 10-8,(Hispanic),NR,'-,'-,'-,"FADS1, FADS2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:61824890
rs2954021-<b>G</b>,1 x 10-6,(Hispanic),NR,'-,'-,'-,TRIB1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:125469835
rs3794695-<b>T</b>,1 x 10-6,(Hispanic),NR,'-,'-,'-,"HPR, TXNL4B",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,16:72063928
rs7528419-<b>G</b>,5 x 10-226,,NR,'-,'-,'-,CELSR2,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:109274570
rs143020224-<b>G</b>,5 x 10-226,,NR,'-,'-,'-,SMARCA4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:11076648
rs2304128-<b>T</b>,5 x 10-226,,NR,'-,'-,'-,GMIP,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:19635342
rs10066168-<b>T</b>,5 x 10-226,,NR,'-,'-,'-,HAVCR1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,5:157057207
rs581411-<b>A</b>,5 x 10-226,,NR,'-,'-,'-,"TDRD15, APOB",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:21066560
rs11591147-<b>T</b>,4 x 10-171,,NR,'-,'-,'-,PCSK9,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:55039974
rs495828-<b>T</b>,1 x 10-114,,NR,'-,'-,'-,"ABO, Y_RNA",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,9:133279294
rs4299376-<b>T</b>,6 x 10-86,,NR,'-,'-,'-,ABCG8,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:43845437
rs2954021-<b>G</b>,1 x 10-85,,NR,'-,'-,'-,TRIB1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:125469835
rs1531517-<b>A</b>,1 x 10-83,,NR,'-,'-,'-,"CEACAM16-AS1, BCL3",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:44738916
rs4495740-<b>G</b>,2 x 10-57,,NR,'-,'-,'-,DOCK7,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:62658794
rs3794695-<b>T</b>,8 x 10-54,,NR,'-,'-,'-,"HPR, TXNL4B",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,16:72063928
rs174566-<b>G</b>,8 x 10-49,,NR,'-,'-,'-,"FADS1, FADS2",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:61824890
rs4841132-<b>G</b>,7 x 10-42,,NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:9326086
rs117753190-<b>G</b>,6 x 10-32,,NR,'-,'-,'-,ABCA6,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,17:69140184
rs486142-<b>A</b>,1 x 10-31,,NR,'-,'-,'-,"LINC01132, LINC00184",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:234712862
rs217381-<b>G</b>,3 x 10-29,,NR,'-,'-,'-,DDX56,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:44566618
rs10957054-<b>T</b>,3 x 10-27,,NR,'-,'-,'-,UBXN2B,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:58423997
rs35866622-<b>T</b>,2 x 10-26,,NR,'-,'-,'-,MAMSTR,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,19:48714803
rs2244608-<b>G</b>,2 x 10-25,,NR,'-,'-,'-,"HNF1A, HNF1A-AS1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,12:120979185
rs2235215-<b>C</b>,8 x 10-25,,NR,'-,'-,'-,MYLIP,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,6:16130925
rs66476925-<b>C</b>,3 x 10-24,,NR,'-,'-,'-,DNAH11,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:21571781
rs76970536-<b>A</b>,3 x 10-22,,NR,'-,'-,'-,ST3GAL4,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,11:126380785
rs11870935-<b>A</b>,6 x 10-22,,NR,'-,'-,'-,KPNB1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,17:47655239
rs2642438-<b>G</b>,6 x 10-22,,NR,'-,'-,'-,MTARC1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:220796686
rs9438905-<b>G</b>,9 x 10-21,,NR,'-,'-,'-,MACO1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,1:25437686
rs6573778-<b>C</b>,2 x 10-19,,NR,'-,'-,'-,NYNRIN,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,14:24403003
rs360804-<b>A</b>,6 x 10-19,,NR,'-,'-,'-,EHBP1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:62712262
rs200174418-<b>?</b>,1 x 10-18,,NR,'-,'-,'-,CERT1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,5:75449704
rs56204645-<b>C</b>,1 x 10-17,,NR,'-,'-,'-,"TRMT112P7, RP1",LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,8:54509209
rs1128249-<b>T</b>,1 x 10-16,,NR,'-,'-,'-,COBLL1,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,2:164672114
rs4722551-<b>C</b>,9 x 10-16,,NR,'-,'-,'-,MIR148A,LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"low density lipoprotein cholesterol measurement, alcohol consumption measurement",GCST008078,7:25952206
rs9989419-<b>G</b>,8 x 10-216,(EA),NR,'-,'-,'-,"HERPUD1, CETP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:56951227
rs287-<b>G</b>,8 x 10-216,(EA),NR,'-,'-,'-,LPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:19958045
rs2043082-<b>A</b>,4 x 10-186,(EA),NR,'-,'-,'-,ALDH1A2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:58382109
rs2575876-<b>A</b>,2 x 10-79,(EA),NR,'-,'-,'-,ABCA1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,9:104903458
rs2156552-<b>T</b>,2 x 10-79,(EA),NR,'-,'-,'-,SMUG1P1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,18:49655298
rs4841132-<b>G</b>,9 x 10-71,(EA),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:9326086
rs10127775-<b>T</b>,5 x 10-50,(EA),NR,'-,'-,'-,GALNT2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:230160042
rs367070-<b>G</b>,3 x 10-48,(EA),NR,'-,'-,'-,"LILRA5, MIR4752",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:54296648
rs1800961-<b>T</b>,4 x 10-47,(EA),NR,'-,'-,'-,HNF4A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:44413724
rs2954021-<b>G</b>,1 x 10-45,(EA),NR,'-,'-,'-,TRIB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:125469835
rs6073958-<b>C</b>,2 x 10-45,(EA),NR,'-,'-,'-,"PCIF1, PLTP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:45923216
rs4470970-<b>G</b>,6 x 10-45,(EA),NR,'-,'-,'-,"CD36, SEMA3C",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:80715045
rs174566-<b>G</b>,3 x 10-40,(EA),NR,'-,'-,'-,"FADS1, FADS2",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:61824890
rs255056-<b>C</b>,4 x 10-39,(EA),NR,'-,'-,'-,"DPEP2, DPEP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:67982282
rs1215112-<b>A</b>,2 x 10-38,(EA),NR,'-,'-,'-,TTC39B,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,9:15303585
rs150844304-<b>C</b>,7 x 10-33,(EA),NR,'-,'-,'-,TP53BP1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:43434427
rs13135092-<b>G</b>,2 x 10-32,(EA),NR,'-,'-,'-,SLC39A8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:102276925
rs112259268-<b>A</b>,7 x 10-31,(EA),NR,'-,'-,'-,"CFAP97D1, MPP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:43797377
rs11762784-<b>A</b>,3 x 10-30,(EA),NR,'-,'-,'-,"H4P1, KLF14",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:130739885
rs116843064-<b>A</b>,7 x 10-30,(EA),NR,'-,'-,'-,ANGPTL4,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:8364439
rs509728-<b>C</b>,4 x 10-29,(EA),NR,'-,'-,'-,"LINC02702, BUD13",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:116662450
rs881844-<b>G</b>,2 x 10-28,(EA),NR,'-,'-,'-,STARD3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:39653965
rs10769254-<b>C</b>,5 x 10-28,(EA),NR,'-,'-,'-,MYBPC3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:47340914
rs10744826-<b>G</b>,1 x 10-13,(EA),NR,'-,'-,'-,UBE3B,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:109527707
rs11967262-<b>G</b>,1 x 10-13,(EA),NR,'-,'-,'-,"VEGFA, LINC02537",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:43792590
rs2642438-<b>G</b>,2 x 10-13,(EA),NR,'-,'-,'-,MTARC1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:220796686
rs2013208-<b>T</b>,3 x 10-13,(EA),NR,'-,'-,'-,"RBM6, RBM5",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:50091966
rs1689788-<b>C</b>,5 x 10-13,(EA),NR,'-,'-,'-,LINC01344,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:182175287
rs7445-<b>T</b>,1 x 10-12,(EA),NR,'-,'-,'-,UBE2L3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,22:21622758
rs190528931-<b>A</b>,1 x 10-12,(EA),NR,'-,'-,'-,MACROD1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:64143801
rs28873836-<b>C</b>,2 x 10-12,(EA),NR,'-,'-,'-,"ZNF577, FPR3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:51811402
rs12753251-<b>A</b>,2 x 10-12,(EA),NR,'-,'-,'-,"C1orf220, RNA5SP69",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:178560763
rs1047891-<b>A</b>,4 x 10-12,(EA),NR,'-,'-,'-,CPS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:210675783
rs80080062-<b>G</b>,6 x 10-12,(EA),NR,'-,'-,'-,ETV5,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:186094380
rs56144648-<b>A</b>,7 x 10-12,(EA),NR,'-,'-,'-,CCND3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:42021004
rs56960668-<b>A</b>,9 x 10-12,(EA),NR,'-,'-,'-,"GPIHBP1, ZFP41",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:143218568
rs4820323-<b>G</b>,5 x 10-11,(EA),NR,'-,'-,'-,"PLA2G6, MAFF",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,22:38203760
rs11246533-<b>T</b>,7 x 10-11,(EA),NR,'-,'-,'-,OR4A6P,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:54742025
rs836546-<b>A</b>,1 x 10-10,(EA),NR,'-,'-,'-,DAGLB,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:6440037
rs41266779-<b>T</b>,1 x 10-10,(EA),NR,'-,'-,'-,"H3C1, H4C1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:26021644
rs6907508-<b>G</b>,2 x 10-10,(EA),NR,'-,'-,'-,ILRUN,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:34624313
rs57457691-<b>C</b>,5 x 10-10,(EA),NR,'-,'-,'-,PEPD,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:33420799
chr16:53822169-<b>?</b>,8 x 10-10,(EA),NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,Mapping not available
rs58084604-<b>T</b>,1 x 10-9,(EA),NR,'-,'-,'-,RNU4-17P,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,18:60182196
rs28364406-<b>T</b>,2 x 10-9,(EA),NR,'-,'-,'-,CAPN3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:42387225
rs10955992-<b>C</b>,5 x 10-9,(EA),NR,'-,'-,'-,SNTB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:120860224
rs2963472-<b>A</b>,6 x 10-9,(EA),NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,5:158572014
rs4898521-<b>A</b>,1 x 10-8,(EA),NR,'-,'-,'-,"DNAJC22, SPATS2",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:49361379
rs4418728-<b>T</b>,1 x 10-8,(EA),NR,'-,'-,'-,"CYP26A1, NIP7P1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:93079967
rs3802548-<b>A</b>,2 x 10-8,(EA),NR,'-,'-,'-,MARCHF8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:45457297
rs1806895-<b>C</b>,2 x 10-8,(EA),NR,'-,'-,'-,DGAT2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:75762670
rs235314-<b>T</b>,2 x 10-8,(EA),NR,'-,'-,'-,PTTG1IP,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,21:44851537
rs56076449-<b>G</b>,3 x 10-8,(EA),NR,'-,'-,'-,"HSPA4, FSTL4",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,5:133106498
rs76127683-<b>C</b>,4 x 10-8,(EA),NR,'-,'-,'-,"LACTB, TPM1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:63099163
rs5014650-<b>A</b>,4 x 10-8,(EA),NR,'-,'-,'-,"PLG, LPA",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:160678471
rs78459082-<b>C</b>,6 x 10-8,(EA),NR,'-,'-,'-,PDE3A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:20289851
rs11870935-<b>A</b>,7 x 10-8,(EA),NR,'-,'-,'-,KPNB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:47655239
rs10713774-<b>?</b>,1 x 10-7,(EA),NR,'-,'-,'-,LINC02357,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:26048829
rs60695258-<b>T</b>,2 x 10-7,(EA),NR,'-,'-,'-,AFF1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:87101557
rs72729610-<b>G</b>,2 x 10-7,(EA),NR,'-,'-,'-,TRIM2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:153269813
rs4911477-<b>C</b>,4 x 10-7,(EA),NR,'-,'-,'-,PROCR,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:35193182
rs34311866-<b>C</b>,6 x 10-7,(EA),NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,Mapping not available
rs4804411-<b>C</b>,9 x 10-7,(EA),NR,'-,'-,'-,INSR,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:7222366
rs4495740-<b>G</b>,1 x 10-6,(EA),NR,'-,'-,'-,DOCK7,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:62658794
rs76970536-<b>A</b>,2 x 10-6,(EA),NR,'-,'-,'-,ST3GAL4,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:126380785
rs7310615-<b>G</b>,6 x 10-6,(EA),NR,'-,'-,'-,SH2B3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:111427245
rs255056-<b>C</b>,2 x 10-16,(AA),NR,'-,'-,'-,"DPEP2, DPEP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:67982282
rs4841132-<b>G</b>,2 x 10-12,(AA),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:9326086
rs287-<b>G</b>,7 x 10-12,(AA),NR,'-,'-,'-,LPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:19958045
rs6073958-<b>C</b>,9 x 10-10,(AA),NR,'-,'-,'-,"PCIF1, PLTP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:45923216
rs2043082-<b>A</b>,1 x 10-8,(AA),NR,'-,'-,'-,ALDH1A2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:58382109
rs34621310-<b>T</b>,4 x 10-8,(AA),NR,'-,'-,'-,CDH16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:66910277
rs4470970-<b>G</b>,5 x 10-8,(AA),NR,'-,'-,'-,"CD36, SEMA3C",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:80715045
rs7528419-<b>G</b>,2 x 10-27,(EA),NR,'-,'-,'-,CELSR2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:109274570
rs2972143-<b>G</b>,4 x 10-25,(EA),NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:226251649
rs1128249-<b>T</b>,1 x 10-23,(EA),NR,'-,'-,'-,COBLL1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:164672114
rs2925979-<b>C</b>,1 x 10-22,(EA),NR,'-,'-,'-,CMIP,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:81501185
rs8071884-<b>G</b>,3 x 10-21,(EA),NR,'-,'-,'-,PGS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:78401977
rs79624003-<b>G</b>,3 x 10-21,(EA),NR,'-,'-,'-,MLXIPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:73598455
rs2737216-<b>T</b>,2 x 10-20,(EA),NR,'-,'-,'-,TRPS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:115617852
rs6461354-<b>T</b>,2 x 10-19,(EA),NR,'-,'-,'-,SNX13,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:17874977
rs114165349-<b>C</b>,4 x 10-19,(EA),NR,'-,'-,'-,ARID1A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:26695422
rs57276302-<b>A</b>,7 x 10-19,(EA),NR,'-,'-,'-,SCARB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:124879441
rs540730-<b>C</b>,8 x 10-19,(EA),NR,'-,'-,'-,R3HDM2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:57413331
rs4847240-<b>G</b>,1 x 10-17,(EA),NR,'-,'-,'-,DR1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:93352389
rs11230661-<b>A</b>,2 x 10-17,(EA),NR,'-,'-,'-,OR4P1P,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:55683837
rs4660303-<b>A</b>,5 x 10-17,(EA),NR,'-,'-,'-,"HEYL, PABPC4",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:39594801
rs1154988-<b>A</b>,9 x 10-17,(EA),NR,'-,'-,'-,"MSL2, PCCB",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:136206349
rs1531517-<b>A</b>,4 x 10-16,(EA),NR,'-,'-,'-,"CEACAM16-AS1, BCL3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:44738916
rs28487964-<b>A</b>,6 x 10-16,(EA),NR,'-,'-,'-,CTDSPL2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:44492177
rs465002-<b>T</b>,1 x 10-15,(EA),NR,'-,'-,'-,C5orf67,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,5:56512648
rs7096937-<b>C</b>,2 x 10-15,(EA),NR,'-,'-,'-,GPAM,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:112190660
rs2908522-<b>G</b>,4 x 10-15,(EA),NR,'-,'-,'-,LINC01625,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:139514262
rs17451107-<b>C</b>,8 x 10-15,(EA),NR,'-,'-,'-,"LINC00880, LEKR1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:157079820
rs7298909-<b>T</b>,1 x 10-14,(EA),NR,'-,'-,'-,SBNO1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:123346392
rs9491694-<b>A</b>,5 x 10-14,(EA),NR,'-,'-,'-,RSPO3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:127115955
rs45490496-<b>T</b>,7 x 10-14,(EA),NR,'-,'-,'-,"LINC00638, ZBTB42",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,14:104806341
rs658118-<b>T</b>,7 x 10-14,(EA),NR,'-,'-,'-,FOLH1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:49233490
rs4418728-<b>T</b>,4 x 10-6,(AA),NR,'-,'-,'-,"CYP26A1, NIP7P1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:93079967
rs174566-<b>G</b>,5 x 10-6,(AA),NR,'-,'-,'-,"FADS1, FADS2",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:61824890
rs2043082-<b>A</b>,3 x 10-97,(Asian),NR,'-,'-,'-,ALDH1A2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:58382109
rs2575876-<b>A</b>,2 x 10-74,(Asian),NR,'-,'-,'-,ABCA1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,9:104903458
rs287-<b>G</b>,3 x 10-69,(Asian),NR,'-,'-,'-,LPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:19958045
rs2156552-<b>T</b>,1 x 10-26,(Asian),NR,'-,'-,'-,SMUG1P1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,18:49655298
rs57276302-<b>A</b>,1 x 10-24,(Asian),NR,'-,'-,'-,SCARB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:124879441
rs255056-<b>C</b>,3 x 10-23,(Asian),NR,'-,'-,'-,"DPEP2, DPEP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:67982282
rs9989419-<b>G</b>,4 x 10-20,(Asian),NR,'-,'-,'-,"HERPUD1, CETP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:56951227
rs2925979-<b>C</b>,5 x 10-14,(Asian),NR,'-,'-,'-,CMIP,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:81501185
rs2737216-<b>T</b>,2 x 10-13,(Asian),NR,'-,'-,'-,TRPS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:115617852
rs7298909-<b>T</b>,3 x 10-13,(Asian),NR,'-,'-,'-,SBNO1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:123346392
rs7445-<b>T</b>,5 x 10-11,(Asian),NR,'-,'-,'-,UBE2L3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,22:21622758
rs1806895-<b>C</b>,6 x 10-11,(Asian),NR,'-,'-,'-,DGAT2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:75762670
rs4847240-<b>G</b>,5 x 10-10,(Asian),NR,'-,'-,'-,DR1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:93352389
rs10127775-<b>T</b>,9 x 10-10,(Asian),NR,'-,'-,'-,GALNT2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:230160042
rs4841132-<b>G</b>,6 x 10-9,(Asian),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:9326086
rs10769254-<b>C</b>,2 x 10-8,(Asian),NR,'-,'-,'-,MYBPC3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:47340914
rs6461354-<b>T</b>,4 x 10-8,(Asian),NR,'-,'-,'-,SNX13,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:17874977
rs235314-<b>T</b>,8 x 10-8,(Asian),NR,'-,'-,'-,PTTG1IP,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,21:44851537
rs7096937-<b>C</b>,1 x 10-7,(Asian),NR,'-,'-,'-,GPAM,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:112190660
rs10744826-<b>G</b>,2 x 10-7,(Asian),NR,'-,'-,'-,UBE3B,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:109527707
rs4660303-<b>A</b>,3 x 10-7,(Asian),NR,'-,'-,'-,"HEYL, PABPC4",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:39594801
rs6073958-<b>C</b>,1 x 10-6,(Asian),NR,'-,'-,'-,"PCIF1, PLTP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:45923216
rs1800961-<b>T</b>,1 x 10-6,(Asian),NR,'-,'-,'-,HNF4A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:44413724
rs465002-<b>T</b>,1 x 10-6,(Asian),NR,'-,'-,'-,C5orf67,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,5:56512648
rs4418728-<b>T</b>,4 x 10-6,(Asian),NR,'-,'-,'-,"CYP26A1, NIP7P1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:93079967
rs79624003-<b>G</b>,8 x 10-6,(Asian),NR,'-,'-,'-,MLXIPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:73598455
rs2642438-<b>G</b>,9 x 10-6,(Asian),NR,'-,'-,'-,MTARC1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:220796686
rs9989419-<b>G</b>,4 x 10-23,(Hispanic),NR,'-,'-,'-,"HERPUD1, CETP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:56951227
rs4841132-<b>G</b>,9 x 10-23,(Hispanic),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:9326086
rs1800961-<b>T</b>,9 x 10-17,(Hispanic),NR,'-,'-,'-,HNF4A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:44413724
rs287-<b>G</b>,1 x 10-16,(Hispanic),NR,'-,'-,'-,LPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:19958045
rs2043082-<b>A</b>,6 x 10-14,(Hispanic),NR,'-,'-,'-,ALDH1A2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:58382109
rs255056-<b>C</b>,1 x 10-10,(Hispanic),NR,'-,'-,'-,"DPEP2, DPEP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:67982282
rs2575876-<b>A</b>,3 x 10-7,(Hispanic),NR,'-,'-,'-,ABCA1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,9:104903458
rs174566-<b>G</b>,2 x 10-6,(Hispanic),NR,'-,'-,'-,"FADS1, FADS2",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:61824890
rs9989419-<b>G</b>,6 x 10-299,,NR,'-,'-,'-,"HERPUD1, CETP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:56951227
rs287-<b>G</b>,6 x 10-299,,NR,'-,'-,'-,LPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:19958045
rs2043082-<b>A</b>,3 x 10-294,,NR,'-,'-,'-,ALDH1A2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:58382109
rs2575876-<b>A</b>,9 x 10-154,,NR,'-,'-,'-,ABCA1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,9:104903458
rs2156552-<b>T</b>,6 x 10-106,,NR,'-,'-,'-,SMUG1P1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,18:49655298
rs4841132-<b>G</b>,8 x 10-106,,NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:9326086
rs255056-<b>C</b>,5 x 10-81,,NR,'-,'-,'-,"DPEP2, DPEP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:67982282
rs1800961-<b>T</b>,5 x 10-64,,NR,'-,'-,'-,HNF4A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:44413724
rs10127775-<b>T</b>,1 x 10-58,,NR,'-,'-,'-,GALNT2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:230160042
rs6073958-<b>C</b>,8 x 10-56,,NR,'-,'-,'-,"PCIF1, PLTP",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,20:45923216
rs367070-<b>G</b>,4 x 10-55,,NR,'-,'-,'-,"LILRA5, MIR4752",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:54296648
rs4470970-<b>G</b>,6 x 10-51,,NR,'-,'-,'-,"CD36, SEMA3C",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:80715045
rs57276302-<b>A</b>,7 x 10-44,,NR,'-,'-,'-,SCARB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:124879441
rs174566-<b>G</b>,7 x 10-42,,NR,'-,'-,'-,"FADS1, FADS2",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:61824890
rs1215112-<b>A</b>,4 x 10-41,,NR,'-,'-,'-,TTC39B,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,9:15303585
rs2954021-<b>G</b>,5 x 10-39,,NR,'-,'-,'-,TRIB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:125469835
rs2925979-<b>C</b>,8 x 10-39,,NR,'-,'-,'-,CMIP,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:81501185
rs112259268-<b>A</b>,9 x 10-34,,NR,'-,'-,'-,"CFAP97D1, MPP3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:43797377
rs13135092-<b>G</b>,2 x 10-33,,NR,'-,'-,'-,SLC39A8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:102276925
rs150844304-<b>C</b>,3 x 10-33,,NR,'-,'-,'-,TP53BP1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:43434427
rs11762784-<b>A</b>,6 x 10-32,,NR,'-,'-,'-,"H4P1, KLF14",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:130739885
rs2737216-<b>T</b>,2 x 10-31,,NR,'-,'-,'-,TRPS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:115617852
rs509728-<b>C</b>,4 x 10-30,,NR,'-,'-,'-,"LINC02702, BUD13",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:116662450
rs116843064-<b>A</b>,8 x 10-30,,NR,'-,'-,'-,ANGPTL4,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:8364439
rs7298909-<b>T</b>,2 x 10-29,,NR,'-,'-,'-,SBNO1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:123346392
rs10769254-<b>C</b>,4 x 10-29,,NR,'-,'-,'-,MYBPC3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:47340914
rs6461354-<b>T</b>,1 x 10-28,,NR,'-,'-,'-,SNX13,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:17874977
rs7528419-<b>G</b>,4 x 10-28,,NR,'-,'-,'-,CELSR2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:109274570
rs4847240-<b>G</b>,4 x 10-28,,NR,'-,'-,'-,DR1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:93352389
rs8071884-<b>G</b>,6 x 10-28,,NR,'-,'-,'-,PGS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:78401977
rs2972143-<b>G</b>,6 x 10-28,,NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:226251649
rs881844-<b>G</b>,8 x 10-28,,NR,'-,'-,'-,STARD3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:39653965
rs7096937-<b>C</b>,3 x 10-27,,NR,'-,'-,'-,GPAM,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:112190660
rs79624003-<b>G</b>,1 x 10-25,,NR,'-,'-,'-,MLXIPL,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:73598455
rs10744826-<b>G</b>,1 x 10-24,,NR,'-,'-,'-,UBE3B,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:109527707
rs7445-<b>T</b>,1 x 10-24,,NR,'-,'-,'-,UBE2L3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,22:21622758
rs4660303-<b>A</b>,4 x 10-24,,NR,'-,'-,'-,"HEYL, PABPC4",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:39594801
rs465002-<b>T</b>,1 x 10-22,,NR,'-,'-,'-,C5orf67,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,5:56512648
rs11967262-<b>G</b>,2 x 10-22,,NR,'-,'-,'-,"VEGFA, LINC02537",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:43792590
rs1128249-<b>T</b>,5 x 10-22,,NR,'-,'-,'-,COBLL1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:164672114
rs1806895-<b>C</b>,3 x 10-21,,NR,'-,'-,'-,DGAT2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:75762670
rs17451107-<b>C</b>,9 x 10-20,,NR,'-,'-,'-,"LINC00880, LEKR1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:157079820
rs45490496-<b>T</b>,3 x 10-19,,NR,'-,'-,'-,"LINC00638, ZBTB42",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,14:104806341
rs540730-<b>C</b>,7 x 10-19,,NR,'-,'-,'-,R3HDM2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:57413331
rs1689788-<b>C</b>,1 x 10-18,,NR,'-,'-,'-,LINC01344,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:182175287
rs114165349-<b>C</b>,2 x 10-18,,NR,'-,'-,'-,ARID1A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:26695422
rs2642438-<b>G</b>,8 x 10-18,,NR,'-,'-,'-,MTARC1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:220796686
rs2013208-<b>T</b>,3 x 10-17,,NR,'-,'-,'-,"RBM6, RBM5",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:50091966
rs28487964-<b>A</b>,1 x 10-16,,NR,'-,'-,'-,CTDSPL2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:44492177
rs4418728-<b>T</b>,1 x 10-16,,NR,'-,'-,'-,"CYP26A1, NIP7P1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:93079967
rs11230661-<b>A</b>,1 x 10-16,,NR,'-,'-,'-,OR4P1P,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:55683837
rs235314-<b>T</b>,3 x 10-16,,NR,'-,'-,'-,PTTG1IP,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,21:44851537
rs2908522-<b>G</b>,4 x 10-16,,NR,'-,'-,'-,LINC01625,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:139514262
rs1047891-<b>A</b>,5 x 10-16,,NR,'-,'-,'-,CPS1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:210675783
rs56960668-<b>A</b>,7 x 10-16,,NR,'-,'-,'-,"GPIHBP1, ZFP41",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:143218568
rs28873836-<b>C</b>,8 x 10-16,,NR,'-,'-,'-,"ZNF577, FPR3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:51811402
rs836546-<b>A</b>,4 x 10-15,,NR,'-,'-,'-,DAGLB,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:6440037
rs10955992-<b>C</b>,2 x 10-14,,NR,'-,'-,'-,SNTB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,8:120860224
rs1154988-<b>A</b>,3 x 10-14,,NR,'-,'-,'-,"MSL2, PCCB",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:136206349
rs12753251-<b>A</b>,2 x 10-13,,NR,'-,'-,'-,"C1orf220, RNA5SP69",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:178560763
rs80080062-<b>G</b>,1 x 10-12,,NR,'-,'-,'-,ETV5,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,3:186094380
rs190528931-<b>A</b>,5 x 10-12,,NR,'-,'-,'-,MACROD1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:64143801
rs60695258-<b>T</b>,1 x 10-11,,NR,'-,'-,'-,AFF1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:87101557
rs58084604-<b>T</b>,2 x 10-11,,NR,'-,'-,'-,RNU4-17P,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,18:60182196
rs78459082-<b>C</b>,3 x 10-11,,NR,'-,'-,'-,PDE3A,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:20289851
rs57457691-<b>C</b>,5 x 10-11,,NR,'-,'-,'-,PEPD,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:33420799
rs28364406-<b>T</b>,7 x 10-11,,NR,'-,'-,'-,CAPN3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:42387225
rs9491694-<b>A</b>,2 x 10-10,,NR,'-,'-,'-,RSPO3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:127115955
rs41266779-<b>T</b>,2 x 10-10,,NR,'-,'-,'-,"H3C1, H4C1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:26021644
rs56144648-<b>A</b>,6 x 10-10,,NR,'-,'-,'-,CCND3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:42021004
rs6907508-<b>G</b>,8 x 10-10,,NR,'-,'-,'-,ILRUN,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:34624313
rs2963472-<b>A</b>,8 x 10-10,,NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,5:158572014
rs3802548-<b>A</b>,1 x 10-9,,NR,'-,'-,'-,MARCHF8,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,10:45457297
rs4820323-<b>G</b>,2 x 10-9,,NR,'-,'-,'-,"PLA2G6, MAFF",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,22:38203760
rs658118-<b>T</b>,4 x 10-9,,NR,'-,'-,'-,FOLH1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:49233490
rs76127683-<b>C</b>,5 x 10-9,,NR,'-,'-,'-,"LACTB, TPM1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,15:63099163
rs1531517-<b>A</b>,5 x 10-9,,NR,'-,'-,'-,"CEACAM16-AS1, BCL3",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,19:44738916
rs72729610-<b>G</b>,6 x 10-9,,NR,'-,'-,'-,TRIM2,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:153269813
rs10713774-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,LINC02357,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,4:26048829
rs5014650-<b>A</b>,3 x 10-8,,NR,'-,'-,'-,"PLG, LPA",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,6:160678471
rs4898521-<b>A</b>,3 x 10-8,,NR,'-,'-,'-,"DNAJC22, SPATS2",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:49361379
chr16:53822169-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,Mapping not available
rs34311866-<b>C</b>,8 x 10-8,,NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,Mapping not available
rs2244608-<b>G</b>,1 x 10-7,,NR,'-,'-,'-,"HNF1A, HNF1A-AS1",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:120979185
rs11870935-<b>A</b>,2 x 10-7,,NR,'-,'-,'-,KPNB1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,17:47655239
rs7310615-<b>G</b>,3 x 10-7,,NR,'-,'-,'-,SH2B3,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,12:111427245
rs4495740-<b>G</b>,3 x 10-7,,NR,'-,'-,'-,DOCK7,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,1:62658794
rs34621310-<b>T</b>,8 x 10-7,,NR,'-,'-,'-,CDH16,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,16:66910277
rs2972143-<b>G</b>,2 x 10-15,(EA),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:226251649
rs2043082-<b>A</b>,6 x 10-15,(EA),NR,'-,'-,'-,ALDH1A2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:58382109
rs1111336-<b>C</b>,3 x 10-13,(EA),NR,'-,'-,'-,"PLB1, FOSL2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:28435029
rs1154988-<b>A</b>,1 x 10-12,(EA),NR,'-,'-,'-,"MSL2, PCCB",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,3:136206349
rs1090107-<b>G</b>,1 x 10-12,(EA),NR,'-,'-,'-,NEIL2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:11775019
rs4418728-<b>T</b>,4 x 10-12,(EA),NR,'-,'-,'-,"CYP26A1, NIP7P1",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:93079967
rs540730-<b>C</b>,5 x 10-12,(EA),NR,'-,'-,'-,R3HDM2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,12:57413331
rs28364406-<b>T</b>,5 x 10-12,(EA),NR,'-,'-,'-,CAPN3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:42387225
rs2925979-<b>C</b>,1 x 10-11,(EA),NR,'-,'-,'-,CMIP,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:81501185
rs34311866-<b>C</b>,2 x 10-11,(EA),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs28487964-<b>A</b>,2 x 10-11,(EA),NR,'-,'-,'-,CTDSPL2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:44492177
rs3794695-<b>T</b>,1 x 10-10,(EA),NR,'-,'-,'-,"HPR, TXNL4B",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:72063928
rs4804411-<b>C</b>,1 x 10-10,(EA),NR,'-,'-,'-,INSR,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:7222366
rs2896635-<b>A</b>,2 x 10-10,(EA),NR,'-,'-,'-,ARNTL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:13338198
rs9491694-<b>A</b>,3 x 10-10,(EA),NR,'-,'-,'-,RSPO3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:127115955
rs465002-<b>T</b>,4 x 10-10,(EA),NR,'-,'-,'-,C5orf67,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:56512648
rs2575876-<b>A</b>,5 x 10-10,(EA),NR,'-,'-,'-,ABCA1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,9:104903458
rs41274050-<b>T</b>,1 x 10-9,(EA),NR,'-,'-,'-,"A1CF, ASAH2B",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:50814012
rs9989419-<b>G</b>,2 x 10-9,(EA),NR,'-,'-,'-,"HERPUD1, CETP",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:56951227
rs35866622-<b>T</b>,2 x 10-9,(EA),NR,'-,'-,'-,MAMSTR,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:48714803
rs190528931-<b>A</b>,2 x 10-9,(EA),NR,'-,'-,'-,MACROD1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:64143801
rs7140110-<b>C</b>,2 x 10-8,(EA),NR,'-,'-,'-,"GAS6-AS1, GAS6",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,13:113841051
rs4722551-<b>C</b>,2 x 10-8,(EA),NR,'-,'-,'-,MIR148A,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:25952206
rs2749008-<b>T</b>,3 x 10-8,(EA),NR,'-,'-,'-,GSTA2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:52761322
rs2963472-<b>A</b>,3 x 10-8,(EA),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:158572014
rs287-<b>G</b>,4 x 10-200,,NR,'-,'-,'-,LPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:19958045
rs79624003-<b>G</b>,4 x 10-200,,NR,'-,'-,'-,MLXIPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:73598455
rs2954021-<b>G</b>,4 x 10-169,,NR,'-,'-,'-,TRIB1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:125469835
rs509728-<b>C</b>,6 x 10-142,,NR,'-,'-,'-,"LINC02702, BUD13",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:116662450
rs4495740-<b>G</b>,3 x 10-123,,NR,'-,'-,'-,DOCK7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:62658794
rs174566-<b>G</b>,5 x 10-68,,NR,'-,'-,'-,"FADS1, FADS2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:61824890
rs6073958-<b>C</b>,1 x 10-43,,NR,'-,'-,'-,"PCIF1, PLTP",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,20:45923216
rs2304128-<b>T</b>,2 x 10-39,,NR,'-,'-,'-,GMIP,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:19635342
rs2043082-<b>A</b>,8 x 10-34,,NR,'-,'-,'-,ALDH1A2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:58382109
rs60695258-<b>T</b>,1 x 10-33,,NR,'-,'-,'-,AFF1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,4:87101557
rs150844304-<b>C</b>,3 x 10-33,,NR,'-,'-,'-,TP53BP1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:43434427
rs11967262-<b>G</b>,3 x 10-32,,NR,'-,'-,'-,"VEGFA, LINC02537",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:43792590
rs10127775-<b>T</b>,9 x 10-31,,NR,'-,'-,'-,GALNT2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:230160042
rs13108218-<b>G</b>,8 x 10-29,,NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs1495743-<b>C</b>,2 x 10-28,,NR,'-,'-,'-,NAT2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:18415790
rs2908522-<b>G</b>,2 x 10-26,,NR,'-,'-,'-,LINC01625,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:139514262
rs4418728-<b>T</b>,3 x 10-25,,NR,'-,'-,'-,"CYP26A1, NIP7P1",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:93079967
rs11762784-<b>A</b>,6 x 10-25,,NR,'-,'-,'-,"H4P1, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885
rs10761716-<b>G</b>,2 x 10-24,,NR,'-,'-,'-,"RNU6-543P, NRBF2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:63122540
rs2972143-<b>G</b>,8 x 10-22,,NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:226251649
rs116843064-<b>A</b>,4 x 10-21,,NR,'-,'-,'-,ANGPTL4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:8364439
rs2925979-<b>C</b>,5 x 10-21,,NR,'-,'-,'-,CMIP,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:81501185
rs112259268-<b>A</b>,5 x 10-21,,NR,'-,'-,'-,"CFAP97D1, MPP3",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,17:43797377
rs1128249-<b>T</b>,4 x 10-18,,NR,'-,'-,'-,COBLL1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:164672114
rs465002-<b>T</b>,1 x 10-16,,NR,'-,'-,'-,C5orf67,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:56512648
rs2896635-<b>A</b>,4 x 10-15,,NR,'-,'-,'-,ARNTL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:13338198
rs4841132-<b>G</b>,5 x 10-15,,NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:9326086
rs2763981-<b>A</b>,8 x 10-14,,NR,'-,'-,'-,SLC44A4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:31872244
rs4820323-<b>G</b>,4 x 10-13,,NR,'-,'-,'-,"PLA2G6, MAFF",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,22:38203760
rs1154988-<b>A</b>,6 x 10-13,,NR,'-,'-,'-,"MSL2, PCCB",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,3:136206349
rs2749008-<b>T</b>,1 x 10-12,,NR,'-,'-,'-,GSTA2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:52761322
rs28364406-<b>T</b>,2 x 10-12,,NR,'-,'-,'-,CAPN3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:42387225
rs540730-<b>C</b>,5 x 10-12,,NR,'-,'-,'-,R3HDM2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,12:57413331
rs28487964-<b>A</b>,5 x 10-12,,NR,'-,'-,'-,CTDSPL2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:44492177
rs7096937-<b>C</b>,9 x 10-12,,NR,'-,'-,'-,GPAM,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:112190660
rs3794695-<b>T</b>,2 x 10-11,,NR,'-,'-,'-,"HPR, TXNL4B",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:72063928
rs2963472-<b>A</b>,3 x 10-11,,NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:158572014
rs4722551-<b>C</b>,4 x 10-11,,NR,'-,'-,'-,MIR148A,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:25952206
rs56076449-<b>G</b>,9 x 10-11,,NR,'-,'-,'-,"HSPA4, FSTL4",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:133106498
rs1090107-<b>G</b>,1 x 10-10,,NR,'-,'-,'-,NEIL2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:11775019
rs7140110-<b>C</b>,1 x 10-10,,NR,'-,'-,'-,"GAS6-AS1, GAS6",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,13:113841051
rs8071884-<b>G</b>,4 x 10-10,,NR,'-,'-,'-,PGS1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,17:78401977
rs2575876-<b>A</b>,4 x 10-10,,NR,'-,'-,'-,ABCA1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,9:104903458
rs35866622-<b>T</b>,4 x 10-10,,NR,'-,'-,'-,MAMSTR,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:48714803
rs9989419-<b>G</b>,5 x 10-10,,NR,'-,'-,'-,"HERPUD1, CETP",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:56951227
rs9491694-<b>A</b>,1 x 10-9,,NR,'-,'-,'-,RSPO3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:127115955
rs34311866-<b>C</b>,3 x 10-9,,NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs41274050-<b>T</b>,4 x 10-9,,NR,'-,'-,'-,"A1CF, ASAH2B",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:50814012
rs2642438-<b>G</b>,7 x 10-9,,NR,'-,'-,'-,MTARC1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:220796686
rs10769254-<b>C</b>,1 x 10-8,,NR,'-,'-,'-,MYBPC3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:47340914
rs10957054-<b>T</b>,3 x 10-8,,NR,'-,'-,'-,UBXN2B,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:58423997
rs6063050-<b>C</b>,5 x 10-8,,NR,'-,'-,'-,EYA2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,20:46975601
rs190528931-<b>A</b>,6 x 10-8,,NR,'-,'-,'-,MACROD1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:64143801
rs58084604-<b>T</b>,7 x 10-8,,NR,'-,'-,'-,RNU4-17P,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,18:60182196
rs11870935-<b>A</b>,1 x 10-7,,NR,'-,'-,'-,KPNB1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,17:47655239
rs57457691-<b>C</b>,1 x 10-7,,NR,'-,'-,'-,PEPD,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:33420799
rs4804411-<b>C</b>,1 x 10-6,,NR,'-,'-,'-,INSR,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:7222366
rs4847240-<b>G</b>,1 x 10-6,,NR,'-,'-,'-,DR1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:93352389
rs114165349-<b>C</b>,2 x 10-6,,NR,'-,'-,'-,ARID1A,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:26695422
rs10713774-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,LINC02357,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,4:26048829
rs1111336-<b>C</b>,3 x 10-6,,NR,'-,'-,'-,"PLB1, FOSL2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:28435029
rs10066168-<b>T</b>,3 x 10-6,,NR,'-,'-,'-,HAVCR1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:157057207
rs581411-<b>A</b>,6 x 10-6,,NR,'-,'-,'-,"TDRD15, APOB",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:21066560
rs6461354-<b>T</b>,7 x 10-6,,NR,'-,'-,'-,SNX13,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:17874977
rs4660303-<b>A</b>,9 x 10-6,,NR,'-,'-,'-,"HEYL, PABPC4",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:39594801
rs60695258-<b>T</b>,1 x 10-15,(Asian),NR,'-,'-,'-,AFF1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,4:87101557
rs13108218-<b>G</b>,6 x 10-15,(Asian),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs4418728-<b>T</b>,1 x 10-12,(Asian),NR,'-,'-,'-,"CYP26A1, NIP7P1",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:93079967
rs509728-<b>C</b>,1 x 10-11,(Asian),NR,'-,'-,'-,"LINC02702, BUD13",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:116662450
rs1495743-<b>C</b>,2 x 10-11,(Asian),NR,'-,'-,'-,NAT2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:18415790
rs6073958-<b>C</b>,5 x 10-11,(Asian),NR,'-,'-,'-,"PCIF1, PLTP",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,20:45923216
rs11967262-<b>G</b>,1 x 10-8,(Asian),NR,'-,'-,'-,"VEGFA, LINC02537",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:43792590
rs2925979-<b>C</b>,4 x 10-8,(Asian),NR,'-,'-,'-,CMIP,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,16:81501185
rs495828-<b>T</b>,2 x 10-7,(Asian),NR,'-,'-,'-,"ABO, Y_RNA",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,9:133279294
rs2972143-<b>G</b>,3 x 10-7,(Asian),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:226251649
rs2642438-<b>G</b>,3 x 10-7,(Asian),NR,'-,'-,'-,MTARC1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:220796686
rs4847240-<b>G</b>,1 x 10-6,(Asian),NR,'-,'-,'-,DR1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:93352389
rs10761716-<b>G</b>,1 x 10-6,(Asian),NR,'-,'-,'-,"RNU6-543P, NRBF2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:63122540
rs465002-<b>T</b>,5 x 10-6,(Asian),NR,'-,'-,'-,C5orf67,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:56512648
rs8071884-<b>G</b>,6 x 10-6,(Asian),NR,'-,'-,'-,PGS1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,17:78401977
rs7096937-<b>C</b>,7 x 10-6,(Asian),NR,'-,'-,'-,GPAM,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:112190660
rs4665972-<b>C</b>,9 x 10-29,(Hispanic),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs287-<b>G</b>,5 x 10-16,(Hispanic),NR,'-,'-,'-,LPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:19958045
rs79624003-<b>G</b>,2 x 10-13,(Hispanic),NR,'-,'-,'-,MLXIPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:73598455
rs2954021-<b>G</b>,2 x 10-12,(Hispanic),NR,'-,'-,'-,TRIB1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:125469835
rs4495740-<b>G</b>,2 x 10-12,(Hispanic),NR,'-,'-,'-,DOCK7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:62658794
rs174566-<b>G</b>,1 x 10-8,(Hispanic),NR,'-,'-,'-,"FADS1, FADS2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:61824890
rs11762784-<b>A</b>,1 x 10-6,(Hispanic),NR,'-,'-,'-,"H4P1, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885
rs509728-<b>C</b>,4 x 10-6,(Hispanic),NR,'-,'-,'-,"LINC02702, BUD13",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:116662450
rs4665972-<b>C</b>,4 x 10-200,,NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs56076449-<b>G</b>,4 x 10-7,(EA),NR,'-,'-,'-,"HSPA4, FSTL4",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,5:133106498
rs5014650-<b>A</b>,5 x 10-7,(EA),NR,'-,'-,'-,"PLG, LPA",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:160678471
rs6063050-<b>C</b>,5 x 10-7,(EA),NR,'-,'-,'-,EYA2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,20:46975601
rs10769254-<b>C</b>,6 x 10-7,(EA),NR,'-,'-,'-,MYBPC3,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:47340914
rs4841132-<b>G</b>,1 x 10-6,(EA),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:9326086
rs10713774-<b>?</b>,1 x 10-6,(EA),NR,'-,'-,'-,LINC02357,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,4:26048829
rs114165349-<b>C</b>,1 x 10-6,(EA),NR,'-,'-,'-,ARID1A,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:26695422
rs11870935-<b>A</b>,2 x 10-6,(EA),NR,'-,'-,'-,KPNB1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,17:47655239
rs10957054-<b>T</b>,5 x 10-6,(EA),NR,'-,'-,'-,UBXN2B,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:58423997
rs287-<b>G</b>,9 x 10-11,(AA),NR,'-,'-,'-,LPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:19958045
rs4665972-<b>C</b>,5 x 10-9,(AA),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs4495740-<b>G</b>,9 x 10-9,(AA),NR,'-,'-,'-,DOCK7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:62658794
rs6073958-<b>C</b>,9 x 10-8,(AA),NR,'-,'-,'-,"PCIF1, PLTP",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,20:45923216
rs174566-<b>G</b>,5 x 10-7,(AA),NR,'-,'-,'-,"FADS1, FADS2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:61824890
rs4841132-<b>G</b>,2 x 10-6,(AA),NR,'-,'-,'-,"RNU6-526P, RNU6-1151P",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:9326086
rs79624003-<b>G</b>,5 x 10-6,(AA),NR,'-,'-,'-,MLXIPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:73598455
rs287-<b>G</b>,9 x 10-136,(Asian),NR,'-,'-,'-,LPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:19958045
rs4665972-<b>C</b>,7 x 10-75,(Asian),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs79624003-<b>G</b>,2 x 10-57,(Asian),NR,'-,'-,'-,MLXIPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:73598455
rs2954021-<b>G</b>,2 x 10-46,(Asian),NR,'-,'-,'-,TRIB1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:125469835
rs4495740-<b>G</b>,7 x 10-39,(Asian),NR,'-,'-,'-,DOCK7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:62658794
rs2043082-<b>A</b>,8 x 10-17,(Asian),NR,'-,'-,'-,ALDH1A2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:58382109
rs174566-<b>G</b>,2 x 10-16,(Asian),NR,'-,'-,'-,"FADS1, FADS2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:61824890
rs4820323-<b>G</b>,5 x 10-8,(EA),NR,'-,'-,'-,"PLA2G6, MAFF",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,22:38203760
rs7096937-<b>C</b>,2 x 10-7,(EA),NR,'-,'-,'-,GPAM,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:112190660
chr12:7725904-<b>?</b>,1 x 10-6,,NR,'-,'-,'-,'-,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,Mapping not available
rs11246533-<b>T</b>,7 x 10-6,,NR,'-,'-,'-,OR4A6P,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,11:54742025
rs7570971-<b>A</b>,8 x 10-6,,NR,'-,'-,'-,RAB3GAP1,HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,2:135080336
rs287-<b>G</b>,2 x 10-198,(EA),NR,'-,'-,'-,LPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:19958045
rs4665972-<b>C</b>,1 x 10-237,(EA),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs79624003-<b>G</b>,5 x 10-136,(EA),NR,'-,'-,'-,MLXIPL,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:73598455
rs509728-<b>C</b>,3 x 10-132,(EA),NR,'-,'-,'-,"LINC02702, BUD13",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:116662450
rs2954021-<b>G</b>,3 x 10-127,(EA),NR,'-,'-,'-,TRIB1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:125469835
rs4495740-<b>G</b>,3 x 10-72,(EA),NR,'-,'-,'-,DOCK7,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:62658794
rs174566-<b>G</b>,6 x 10-44,(EA),NR,'-,'-,'-,"FADS1, FADS2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,11:61824890
rs2304128-<b>T</b>,8 x 10-44,(EA),NR,'-,'-,'-,GMIP,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:19635342
rs150844304-<b>C</b>,1 x 10-31,(EA),NR,'-,'-,'-,TP53BP1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,15:43434427
rs6073958-<b>C</b>,5 x 10-27,(EA),NR,'-,'-,'-,"PCIF1, PLTP",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,20:45923216
rs10127775-<b>T</b>,1 x 10-24,(EA),NR,'-,'-,'-,GALNT2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,1:230160042
rs11967262-<b>G</b>,6 x 10-21,(EA),NR,'-,'-,'-,"VEGFA, LINC02537",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:43792590
rs112259268-<b>A</b>,8 x 10-20,(EA),NR,'-,'-,'-,"CFAP97D1, MPP3",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,17:43797377
rs116843064-<b>A</b>,2 x 10-19,(EA),NR,'-,'-,'-,ANGPTL4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,19:8364439
rs2763981-<b>A</b>,1 x 10-18,(EA),NR,'-,'-,'-,SLC44A4,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:31872244
rs2908522-<b>G</b>,3 x 10-18,(EA),NR,'-,'-,'-,LINC01625,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,6:139514262
rs11762784-<b>A</b>,2 x 10-17,(EA),NR,'-,'-,'-,"H4P1, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885
rs13108218-<b>G</b>,2 x 10-17,(EA),NR,'-,'-,'-,'-,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,Mapping not available
rs60695258-<b>T</b>,2 x 10-17,(EA),NR,'-,'-,'-,AFF1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,4:87101557
rs10761716-<b>G</b>,2 x 10-16,(EA),NR,'-,'-,'-,"RNU6-543P, NRBF2",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,10:63122540
rs1495743-<b>C</b>,3 x 10-16,(EA),NR,'-,'-,'-,NAT2,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,8:18415790
rs1128249-<b>T</b>,4 x 10-16,(EA),NR,'-,'-,'-,COBLL1,Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,2:164672114
rs916264-<b>A</b>,5 x 10-8,,NR,'-,3.09 unit increase,NR,APOL2,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,22:36237790
rs1327265-<b>A</b>,6 x 10-7,,NR,'-,2.17 unit increase,NR,'-,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,6:51306610
rs17014720-<b>T</b>,1 x 10-6,,NR,'-,2.45 unit increase,NR,LINC01320,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,2:34103624
rs1571695-<b>A</b>,8 x 10-6,,NR,'-,1.99 unit increase,NR,"RCAN1, CLIC6",Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,21:34651056
rs10051946-<b>?</b>,2 x 10-7,(EA),NR,'-,'-,'-,RNU6-718P,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,5:120238715
rs13253048-<b>?</b>,9 x 10-7,(EA),NR,'-,'-,'-,LINC00251,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,8:65190078
rs2157250-<b>?</b>,4 x 10-7,(EA),NR,'-,'-,'-,APOL2,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,22:36235645
rs12059231-<b>?</b>,3 x 10-6,(AA),NR,'-,'-,'-,ACOT11,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,1:54580003
rs10913472-<b>?</b>,9 x 10-6,(AA),NR,'-,'-,'-,"CRYZL2P-SEC16B, SEC16B",Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,1:177960419
rs10996604-<b>?</b>,9 x 10-6,(AA),NR,'-,'-,'-,LINC01515,Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,10:65706190
rs11085919-<b>?</b>,9 x 10-7,(AA),NR,'-,'-,'-,"OR7A1P, OR7A18P",Epigenetic age acceleration in alcohol use disorder,"alcohol use disorder measurement, aging",GCST008748,19:14890285
rs1260326-<b>T</b>,9 x 10-13,,NR,'-,7.15 z score decrease,[NR],'-,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,Mapping not available
rs4953148-<b>A</b>,2 x 10-8,,NR,'-,5.59 z score decrease,[NR],LINC01833,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,2:44925383
rs1920650-<b>T</b>,2 x 10-8,,NR,'-,5.63 z score decrease,[NR],"ARL14, RPL6P8",Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,3:160617800
rs11940694-<b>A</b>,7 x 10-21,,NR,'-,9.38 z score decrease,[NR],KLB,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:39413373
rs4975012-<b>A</b>,3 x 10-9,,NR,'-,5.94 z score increase,[NR],KLB,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:39421892
rs146788033-<b>A</b>,1 x 10-25,,NR,'-,10.48 z score increase,[NR],METAP1,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:99019987
rs11733695-<b>A</b>,3 x 10-30,,NR,'-,11.42 z score decrease,[NR],"PCNAP1, ADH6",Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:99201759
rs3114045-<b>T</b>,7 x 10-13,,NR,'-,7.18 z score decrease,[NR],ADH1B,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:99331403
rs188514326-<b>C</b>,4 x 10-8,,NR,'-,5.49 z score decrease,[NR],H2AZ1-DT,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:100261610
rs13135092-<b>A</b>,3 x 10-14,,NR,'-,7.59 z score increase,[NR],SLC39A8,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,4:102276925
rs35040843-<b>T</b>,3 x 10-8,,NR,'-,5.55 z score increase,[NR],'-,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,8:92329269
rs7078436-<b>A</b>,1 x 10-8,,NR,'-,5.74 z score increase,[NR],JCAD,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,10:30089934
rs2293576-<b>A</b>,6 x 10-9,,NR,'-,5.83 z score increase,[NR],SLC39A13,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,11:47413435
rs62062288-<b>A</b>,5 x 10-10,,NR,'-,6.21 z score decrease,[NR],MAPT,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,17:46019187
rs492602-<b>A</b>,3 x 10-8,,NR,'-,5.57 z score decrease,[NR],FUT2,Alcohol use disorder (total score),alcohol use disorder measurement,GCST006716,19:48703160
rs1433375-<b>A</b>,3 x 10-8,"(AA, initial)",0.17,'-,2.69 unit increase,[1.75-3.63],'-,Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,4:129416904
rs1667284-<b>A</b>,4 x 10-6,"(AA, initial)",0.14,'-,2.2 unit increase,[1.28-3.12],B4GALT6,Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,18:31646245
rs7843718-<b>G</b>,5 x 10-6,"(AA, initial)",0.18,'-,1.86 unit increase,[1.06-2.66],"Metazoa_SRP, MTND2P7",Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,8:133722977
rs11086862-<b>C</b>,5 x 10-6,"(AA, initial)",0.44,'-,2 unit increase,[1.14-2.86],PTPRT,Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,20:43125961
rs991639-<b>A</b>,1 x 10-6,"(AA, initial)",0.13,'-,2.24 unit increase,[1.34-3.14],"CHL1-AS2, LINC01986",Problematic alcohol use in trauma-exposed individuals,"alcohol use disorder measurement, response to trauma exposure",GCST005236,3:47829
rs5758343-<b>T</b>,2 x 10-9,,0.7959,'-,0.015397981 unit increase,[0.01-0.02],"TOB2, TEF",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,22:41420648
rs17884691-<b>A</b>,4 x 10-8,,0.241,'-,0.013613835 unit decrease,[0.0088-0.0185],MIRLET7BHG,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,22:46085743
rs2239017-<b>G</b>,2 x 10-8,,0.4015,'-,0.011839363 unit increase,[0.0077-0.016],CACNA1C,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:2180485
rs536112833-<b>A</b>,2 x 10-8,,0.0013,'-,0.22408608 unit increase,[0.15-0.3],RERGL,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:18214752
rs10783446-<b>C</b>,6 x 10-12,,0.5338,'-,0.014149228 unit decrease,[0.01-0.018],SLC4A8,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:51487941
rs61934664-<b>A</b>,7 x 10-11,,0.495,'-,0.013408667 unit decrease,[0.0094-0.0174],ACSS3,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,12:81214279
rs2274793-<b>T</b>,8 x 10-10,,0.3264,'-,0.013471862 unit decrease,[0.0092-0.0178],OTX2-AS1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,14:56817250
rs2348072-<b>A</b>,3 x 10-12,,0.7247,'-,0.016113289 unit decrease,[0.012-0.021],"PSMA3-AS1, ARMH4",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,14:58277034
rs28929474-<b>T</b>,2 x 10-12,,0.0184,'-,0.05428487 unit decrease,[0.039-0.069],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,Mapping not available
rs11160767-<b>A</b>,2 x 10-8,,0.5908,'-,0.011985002 unit decrease,[0.0078-0.0162],LINC00637,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,14:103850396
rs281296-<b>A</b>,2 x 10-9,,0.3568,'-,0.012968086 unit increase,[0.0087-0.0172],SEMA6D,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,15:47392813
rs72768626-<b>G</b>,8 x 10-14,,0.0552,'-,0.034006946 unit decrease,[0.025-0.043],TNRC6A,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:24681727
rs34836-<b>G</b>,2 x 10-10,,0.4388,'-,0.015736584 unit decrease,[0.011-0.021],CLN3,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:28483502
rs9932605-<b>G</b>,3 x 10-10,,0.4829,'-,0.013063563 unit decrease,[0.009-0.0171],PPP4C,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:30080727
rs1421085-<b>C</b>,6 x 10-14,,0.4067,'-,0.015630115 unit decrease,[0.012-0.02],FTO,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:53767042
rs56387295-<b>A</b>,7 x 10-10,,0.1373,'-,0.01855728 unit increase,[0.013-0.024],DHODH,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:72021437
rs1104608-<b>C</b>,8 x 10-12,,0.4264,'-,0.017191948 unit decrease,[0.012-0.022],ZFHX3,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:73878689
rs11117258-<b>G</b>,5 x 10-8,,0.3062,'-,0.014578905 unit increase,[0.0093-0.0198],GINS2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,16:85686052
rs8067440-<b>A</b>,2 x 10-8,,0.6193,'-,0.01177361 unit increase,[0.0076-0.0159],NF1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,17:31381137
rs9899069-<b>G</b>,2 x 10-8,,0.1614,'-,0.015609549 unit decrease,[0.01-0.021],FBXL20,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,17:39384519
rs1724429-<b>G</b>,7 x 10-16,,0.2,'-,0.024308164 unit decrease,[0.018-0.03],"DND1P1, RDM1P1",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,17:45584654
rs7242858-<b>A</b>,1 x 10-8,,0.1856,'-,0.015081556 unit decrease,[0.0099-0.0203],"NPM1P1, KC6",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,18:41721634
rs72926982-<b>A</b>,5 x 10-9,,0.0759,'-,0.02274412 unit decrease,[0.015-0.03],TCF4,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,18:55420753
rs973579-<b>G</b>,8 x 10-19,,0.4895,'-,0.018226894 unit increase,[0.014-0.022],RASIP1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,19:48738719
rs6136465-<b>A</b>,1 x 10-8,,0.3967,'-,0.012194927 unit decrease,[0.008-0.0164],"DTD1, DTD1-AS1",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,20:18678750
rs7275426-<b>T</b>,2 x 10-8,,0.5731,'-,0.013196155 unit decrease,[0.0086-0.0178],LINC00945,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,21:33063313
rs17004922-<b>A</b>,3 x 10-8,,0.0141,'-,0.0483869 unit increase,[0.031-0.066],ADORA2A-AS1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,22:24448980
rs34908430-<b>T</b>,2 x 10-9,,0.2986,'-,0.013548642 unit decrease,[0.0091-0.018],SP8,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:20784995
rs13229395-<b>C</b>,1 x 10-8,,0.2568,'-,0.013321201 unit decrease,[0.0087-0.0179],AUTS2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:70034958
rs13235543-<b>T</b>,3 x 10-10,,0.1248,'-,0.019551052 unit increase,[0.013-0.026],MLXIPL,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:73599571
rs34659651-<b>A</b>,5 x 10-8,,0.1786,'-,0.014983003 unit increase,[0.0096-0.0204],"VPS37D, MLXIPL",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:73652336
rs3801288-<b>G</b>,7 x 10-9,,0.1288,'-,0.020856725 unit decrease,[0.014-0.028],ARPC1A,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:99348285
rs2299409-<b>A</b>,6 x 10-11,,0.5342,'-,0.013525672 unit decrease,[0.0095-0.0176],ORC5,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:104171723
rs2098112-<b>A</b>,2 x 10-13,,0.4733,'-,0.015274133 unit increase,[0.011-0.019],DPP6,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,7:153790859
rs1838420-<b>T</b>,4 x 10-10,,0.4825,'-,0.012794922 unit increase,[0.0088-0.0168],LINC01414,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,8:64048298
rs1484559-<b>C</b>,2 x 10-8,,0.7831,'-,0.016629806 unit increase,[0.011-0.022],RUNX1T1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,8:92099304
rs28601761-<b>G</b>,2 x 10-10,,0.4168,'-,0.015814032 unit increase,[0.011-0.021],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,Mapping not available
rs4743007-<b>C</b>,6 x 10-9,,0.3069,'-,0.015266576 unit decrease,[0.01-0.02],LINC01505,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,9:106567163
rs13288470-<b>T</b>,3 x 10-8,,0.1236,'-,0.020470936 unit decrease,[0.013-0.028],RALGPS1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,9:126926280
rs2244956-<b>C</b>,3 x 10-8,,0.3646,'-,0.011841185 unit increase,[0.0077-0.016],"GAPDHP21, PCDH15",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,10:55654719
rs2862954-<b>C</b>,2 x 10-8,,0.4872,'-,0.0114293415 unit decrease,[0.0074-0.0154],ERLIN1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,10:100152307
rs7906104-<b>T</b>,1 x 10-13,,0.253,'-,0.017513618 unit decrease,[0.013-0.022],LINC02661,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,10:108737343
rs4244804-<b>T</b>,4 x 10-8,,0.5389,'-,0.011321873 unit decrease,[0.0073-0.0154],"STK33, TRIM66",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:8596003
rs2049045-<b>C</b>,2 x 10-9,,0.1877,'-,0.018764045 unit decrease,[0.013-0.025],"BDNF, BDNF-AS",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:27672694
rs4756121-<b>C</b>,3 x 10-9,,0.6861,'-,0.013354769 unit increase,[0.009-0.0177],CSTF3-DT,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:33182613
rs1044796-<b>T</b>,8 x 10-9,,0.1913,'-,0.01542923 unit increase,[0.01-0.021],CREB3L1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:46321392
rs11039448-<b>T</b>,8 x 10-13,,0.5582,'-,0.014937313 unit decrease,[0.011-0.019],"PTPRJ, NUP160",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:47896864
rs17602038-<b>C</b>,9 x 10-21,,0.3734,'-,0.019764803 unit decrease,[0.016-0.024],DRD2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:113493969
rs6589386-<b>T</b>,3 x 10-18,,0.4323,'-,0.018040625 unit decrease,[0.014-0.022],DRD2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:113573031
rs58257470-<b>T</b>,9 x 10-11,,0.2739,'-,0.015010054 unit increase,[0.01-0.02],TMPRSS5,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:113612242
rs10790112-<b>C</b>,6 x 10-12,,0.8443,'-,0.0194534 unit increase,[0.014-0.025],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:116225532
rs1783835-<b>G</b>,2 x 10-13,,0.5431,'-,0.015108303 unit increase,[0.011-0.019],SORL1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,11:121672215
rs1229984-<b>T</b>,3 x 10-107,,0.0302,'-,22 z score decrease,[NR],ADH1B,Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:99318162
rs7693958-<b>A</b>,5 x 10-10,,0.074,'-,6.234 z score decrease,[NR],"C4orf17, ADH7",Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:99489065
rs148382129-<b>T</b>,3 x 10-23,,0.0075,'-,9.95 z score decrease,[NR],H2AZ1-DT,Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:99963963
rs142151894-<b>C</b>,3 x 10-11,,0.0032,'-,6.642 z score decrease,[NR],EMCN,Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:100577893
rs13135092-<b>A</b>,2 x 10-31,,0.9192,'-,11.673 z score increase,[NR],SLC39A8,Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:102276925
rs2533200-<b>C</b>,2 x 10-8,,0.5163,'-,5.631 z score decrease,[NR],DPP6,Problematic alcohol use,alcohol use disorder measurement,GCST010546,7:153791989
rs2582405-<b>T</b>,9 x 10-9,,0.237,'-,5.751 z score increase,[NR],LINC00968,Problematic alcohol use,alcohol use disorder measurement,GCST010546,8:56512315
rs7900002-<b>T</b>,4 x 10-8,,0.6012,'-,5.503 z score decrease,[NR],UNC5B,Problematic alcohol use,alcohol use disorder measurement,GCST010546,10:71148194
rs56722963-<b>T</b>,2 x 10-10,,0.2551,'-,6.374 z score decrease,[NR],LINC02661,Problematic alcohol use,alcohol use disorder measurement,GCST010546,10:108778076
rs34806762-<b>T</b>,2 x 10-8,,0.128,'-,5.596 z score increase,[NR],RN7SKP278,Problematic alcohol use,alcohol use disorder measurement,GCST010546,10:109006885
rs10717830-<b>G</b>,1 x 10-10,,0.674,'-,6.422 z score increase,[NR],"SLC39A13, MIR4487",Problematic alcohol use,alcohol use disorder measurement,GCST010546,11:47402370
rs576859-<b>A</b>,1 x 10-8,,0.3272,'-,5.67 z score increase,[NR],TMX2,Problematic alcohol use,alcohol use disorder measurement,GCST010546,11:57713151
rs138084129-<b>A</b>,5 x 10-15,,0.6274,'-,7.824 z score increase,[NR],DRD2,Problematic alcohol use,alcohol use disorder measurement,GCST010546,11:113486989
rs1783835-<b>A</b>,2 x 10-9,,0.4569,'-,5.979 z score decrease,[NR],SORL1,Problematic alcohol use,alcohol use disorder measurement,GCST010546,11:121672215
rs12296477-<b>C</b>,4 x 10-8,,0.5469,'-,5.484 z score increase,[NR],SLC4A8,Problematic alcohol use,alcohol use disorder measurement,GCST010546,12:51510076
rs61974485-<b>T</b>,4 x 10-8,,0.2646,'-,5.506 z score increase,[NR],ARID4A,Problematic alcohol use,alcohol use disorder measurement,GCST010546,14:58299185
rs8008020-<b>T</b>,1 x 10-9,,0.4175,'-,6.062 z score increase,[NR],"LINC00637, ATP5MJ",Problematic alcohol use,alcohol use disorder measurement,GCST010546,14:103889546
rs72768626-<b>A</b>,2 x 10-8,,0.9448,'-,5.591 z score increase,[NR],TNRC6A,Problematic alcohol use,alcohol use disorder measurement,GCST010546,16:24681727
rs9937709-<b>A</b>,4 x 10-11,,0.585,'-,6.602 z score increase,[NR],FTO,Problematic alcohol use,alcohol use disorder measurement,GCST010546,16:53786901
rs492602-<b>A</b>,8 x 10-10,,0.5076,'-,6.143 z score decrease,[NR],FUT2,Problematic alcohol use,alcohol use disorder measurement,GCST010546,19:48703160
rs9926289-<b>A</b>,7 x 10-13,,0.3977,'-,7.174 unit decrease,[NR],FTO,Alcohol use disorder,alcohol use disorder measurement,GCST010545,16:53786591
rs7547416-<b>A</b>,8 x 10-12,,0.5637,'-,0.014121004 unit increase,[0.01-0.018],PDE4B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:65953404
rs12048727-<b>G</b>,1 x 10-9,,0.3296,'-,0.013247359 unit increase,[0.009-0.0175],ZRANB2-AS2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:71303782
rs6671130-<b>G</b>,4 x 10-8,,0.5974,'-,0.011673218 unit decrease,[0.0075-0.0159],"LINC01360, S100A16",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:73386004
rs7552830-<b>T</b>,3 x 10-9,,0.449,'-,0.012276363 unit decrease,[0.0082-0.0163],RABGAP1L,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:174321643
rs227178-<b>T</b>,2 x 10-8,,0.425,'-,0.0116836615 unit increase,[0.0076-0.0157],SYT14,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,1:210043601
rs1260326-<b>C</b>,2 x 10-42,,0.5967,'-,0.028574824 unit increase,[0.024-0.033],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,Mapping not available
rs75199129-<b>T</b>,2 x 10-9,,0.039,'-,0.032751746 unit decrease,[0.022-0.043],"RNU6-566P, LRPPRC",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:44071636
rs570436-<b>T</b>,3 x 10-23,,0.569,'-,0.02082119 unit increase,[0.017-0.025],LINC01833,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:44915534
rs2717018-<b>T</b>,5 x 10-15,,0.6278,'-,0.016609011 unit increase,[0.012-0.021],"ACTG1P22, VRK2",Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:57808356
rs6739804-<b>C</b>,4 x 10-10,,0.6796,'-,0.01627811 unit decrease,[0.011-0.021],EHBP1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:63042469
rs13024996-<b>A</b>,3 x 10-13,,0.3676,'-,0.015542448 unit decrease,[0.011-0.02],ARHGAP15,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:143467646
rs925735-<b>G</b>,1 x 10-12,,0.6379,'-,0.015132835 unit decrease,[0.011-0.019],'-,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,2:226314914
rs11127893-<b>T</b>,3 x 10-17,,0.6461,'-,0.01816653 unit decrease,[0.014-0.022],CADM2,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,3:85475020
rs13077520-<b>C</b>,6 x 10-9,,0.2167,'-,0.014556526 unit decrease,[0.0097-0.0194],PLCH1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,3:155617055
rs12646808-<b>C</b>,5 x 10-8,,0.3448,'-,0.014283394 unit decrease,[0.0092-0.0194],MSANTD1,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:3248101
rs13125440-<b>G</b>,2 x 10-47,,0.3813,'-,0.030801678 unit decrease,[0.027-0.035],KLB,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:39420704
rs713287-<b>C</b>,1 x 10-8,,0.523,'-,0.01169676 unit increase,[0.0077-0.0157],GABRA4,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:46938359
rs75967634-<b>T</b>,6 x 10-13,,0.003,'-,0.14565828 unit decrease,[0.11-0.19],ADH1B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:99307859
rs1229984-<b>C</b>,6 x 10-267,,0.9698,'-,0.24346012 unit increase,[0.23-0.26],ADH1B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:99318162
rs1154433-<b>G</b>,1 x 10-35,,0.4076,'-,0.026113842 unit increase,[0.022-0.03],ADH1B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:99332551
rs13135092-<b>G</b>,3 x 10-42,,0.0808,'-,0.051934656 unit decrease,[0.044-0.059],SLC39A8,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:102276925
rs1425522-<b>G</b>,8 x 10-11,,0.8654,'-,0.019668229 unit increase,[0.014-0.026],INPP4B,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:142572060
rs13116270-<b>A</b>,2 x 10-9,,0.1727,'-,0.016330346 unit increase,[0.011-0.022],GALNT7,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,4:173211834
rs17691542-<b>C</b>,5 x 10-8,,0.1597,'-,0.0153036 unit decrease,[0.0098-0.0208],AFF4,Problematic alcohol use (MTAG),"alcohol use disorder measurement, alcohol consumption measurement",GCST010544,5:132943535
rs12743648-<b>T</b>,5 x 10-9,,0.2342,'-,5.836 unit decrease,[NR],PDE4B,Alcohol use disorder,alcohol use disorder measurement,GCST010545,1:65962819
rs61767420-<b>A</b>,2 x 10-8,,0.4128,'-,5.601 unit increase,[NR],LINC01360,Alcohol use disorder,alcohol use disorder measurement,GCST010545,1:73382927
rs11336847-<b>A</b>,5 x 10-16,,0.5996,'-,8.109 unit increase,[NR],"GCKR, C2orf16",Alcohol use disorder,alcohol use disorder measurement,GCST010545,2:27526126
rs494904-<b>T</b>,2 x 10-12,,0.5894,'-,7.014 unit decrease,[NR],LINC01833,Alcohol use disorder,alcohol use disorder measurement,GCST010545,2:44914041
rs1402398-<b>A</b>,3 x 10-9,,0.6279,'-,5.94 unit increase,[NR],"VRK2, ACTG1P22",Alcohol use disorder,alcohol use disorder measurement,GCST010545,2:57815106
rs13411140-<b>T</b>,3 x 10-8,,0.3627,'-,5.539 unit decrease,[NR],ARHGAP15,Alcohol use disorder,alcohol use disorder measurement,GCST010545,2:143458242
rs2713557-<b>T</b>,2 x 10-8,,0.3562,'-,5.619 unit increase,[NR],'-,Alcohol use disorder,alcohol use disorder measurement,GCST010545,2:226306887
rs13129401-<b>A</b>,7 x 10-12,,0.4537,'-,6.851 unit decrease,[NR],"RNU6-887P, KLB",Alcohol use disorder,alcohol use disorder measurement,GCST010545,4:39403252
rs2141284-<b>A</b>,5 x 10-14,,0.0059,'-,7.533 unit decrease,[NR],"EIF4E, BTF3P13",Alcohol use disorder,alcohol use disorder measurement,GCST010545,4:98783016
rs1229984-<b>T</b>,3 x 10-107,,0.0302,'-,22 unit decrease,[NR],ADH1B,Alcohol use disorder,alcohol use disorder measurement,GCST010545,4:99318162
rs11463615-<b>A</b>,6 x 10-9,,0.8866,'-,5.804 unit increase,[NR],MTTP,Alcohol use disorder,alcohol use disorder measurement,GCST010545,4:99586990
rs148382129-<b>T</b>,6 x 10-16,,0.0079,'-,8.098 unit decrease,[NR],H2AZ1-DT,Alcohol use disorder,alcohol use disorder measurement,GCST010545,4:99963963
rs13107325-<b>T</b>,8 x 10-19,,0.0792,'-,8.864 unit decrease,[NR],'-,Alcohol use disorder,alcohol use disorder measurement,GCST010545,Mapping not available
rs12192123-<b>A</b>,2 x 10-8,,0.2321,'-,5.593 unit decrease,[NR],MICB-DT,Alcohol use disorder,alcohol use disorder measurement,GCST010545,6:31491565
rs67672396-<b>T</b>,4 x 10-8,,0.2803,'-,5.503 unit decrease,[NR],'-,Alcohol use disorder,alcohol use disorder measurement,GCST010545,6:51446876
rs10270358-<b>A</b>,2 x 10-9,,0.3182,'-,6.039 unit increase,[NR],LINC01392,Alcohol use disorder,alcohol use disorder measurement,GCST010545,7:115308297
rs4240624-<b>A</b>,6 x 10-9,,0.9127,'-,5.82 unit increase,[NR],'-,Alcohol use disorder,alcohol use disorder measurement,GCST010545,Mapping not available
rs11366076-<b>T</b>,3 x 10-9,,0.1622,'-,5.933 unit decrease,[NR],CNTLN,Alcohol use disorder,alcohol use disorder measurement,GCST010545,9:17237275
rs7073987-<b>T</b>,7 x 10-9,,0.2587,'-,5.791 unit decrease,[NR],LINC02661,Alcohol use disorder,alcohol use disorder measurement,GCST010545,10:108806110
rs7117878-<b>A</b>,8 x 10-9,,0.3163,'-,5.763 unit increase,[NR],CLP1,Alcohol use disorder,alcohol use disorder measurement,GCST010545,11:57653985
rs6589386-<b>T</b>,7 x 10-12,,0.4238,'-,6.856 unit decrease,[NR],DRD2,Alcohol use disorder,alcohol use disorder measurement,GCST010545,11:113573031
rs140239378-<b>A</b>,7 x 10-9,,0.7803,'-,5.8 unit increase,[NR],'-,Alcohol use disorder,alcohol use disorder measurement,GCST010545,11:121753465
rs61974485-<b>T</b>,4 x 10-8,,0.2662,'-,5.503 unit increase,[NR],ARID4A,Alcohol use disorder,alcohol use disorder measurement,GCST010545,14:58299185
rs8008020-<b>T</b>,2 x 10-8,,0.4162,'-,5.632 unit increase,[NR],"LINC00637, ATP5MJ",Alcohol use disorder,alcohol use disorder measurement,GCST010545,14:103889546
rs73403005-<b>A</b>,6 x 10-9,,0.8414,'-,5.815 unit decrease,[NR],SEMA6D,Alcohol use disorder,alcohol use disorder measurement,GCST010545,15:47352977
rs6421482-<b>A</b>,3 x 10-10,,0.4363,'-,6.315 z score decrease,[NR],PDE4B,Problematic alcohol use,alcohol use disorder measurement,GCST010546,1:65954222
rs61767420-<b>A</b>,1 x 10-8,,0.3999,'-,5.714 z score increase,[NR],LINC01360,Problematic alcohol use,alcohol use disorder measurement,GCST010546,1:73382927
rs1260326-<b>T</b>,1 x 10-20,,0.4033,'-,9.296 z score decrease,[NR],'-,Problematic alcohol use,alcohol use disorder measurement,GCST010546,Mapping not available
rs494904-<b>T</b>,2 x 10-15,,0.5961,'-,7.926 z score decrease,[NR],LINC01833,Problematic alcohol use,alcohol use disorder measurement,GCST010546,2:44914041
rs1402398-<b>A</b>,1 x 10-12,,0.6274,'-,7.098 z score increase,[NR],"VRK2, ACTG1P22",Problematic alcohol use,alcohol use disorder measurement,GCST010546,2:57815106
rs9679319-<b>T</b>,2 x 10-9,,0.4797,'-,6.01 z score decrease,[NR],"LINC02478, CRLF3P1",Problematic alcohol use,alcohol use disorder measurement,GCST010546,2:103517974
rs13382553-<b>A</b>,2 x 10-9,,0.766,'-,6.001 z score decrease,[NR],THSD7B,Problematic alcohol use,alcohol use disorder measurement,GCST010546,2:137506661
rs2673136-<b>A</b>,4 x 10-9,,0.6387,'-,5.872 z score decrease,[NR],'-,Problematic alcohol use,alcohol use disorder measurement,GCST010546,2:226299937
rs62250713-<b>A</b>,1 x 10-9,,0.368,'-,6.049 z score increase,[NR],CADM2,Problematic alcohol use,alcohol use disorder measurement,GCST010546,3:85464643
rs13129401-<b>A</b>,5 x 10-19,,0.4532,'-,8.906 z score decrease,[NR],"RNU6-887P, KLB",Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:39403252
rs144198753-<b>T</b>,2 x 10-22,,0.0122,'-,9.726 z score decrease,[NR],"EIF4E, BTF3P13",Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:98792199
rs2602856-<b>A</b>,1 x 10-8,,0.6611,'-,5.738 z score decrease,[NR],"ADH5, ADH4",Problematic alcohol use,alcohol use disorder measurement,GCST010546,4:99107994
rs1260326-<b>C</b>,2 x 10-16,(EA),0.591,'-,0.04477 unit increase,[0.034-0.055],'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs2961816-<b>A</b>,1 x 10-8,,0.683,'-,5.74 z score increase,NR,"RNU6-480P, RNU6-1296P",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,5:51147857
rs12639940-<b>A</b>,3 x 10-9,(EA),0.614,'-,0.03295 unit increase,[0.022-0.044],KLB,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:39419361
rs62033408-<b>A</b>,1 x 10-19,,0.678,'-,9.08 z score increase,NR,FTO,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,16:53794050
rs13107325-<b>C</b>,1 x 10-25,(EA),0.921,'-,0.1034 unit increase,[0.084-0.123],'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs142997686-<b>?</b>,5 x 10-9,,0.384,'-,5.84 z score increase,NR,BAHCC1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:81452134
rs2961817-<b>A</b>,7 x 10-9,(EA),0.657,'-,0.03316 unit increase,[0.022-0.044],"RNU6-480P, RNU6-1296P",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,5:51147229
rs12425096-<b>A</b>,5 x 10-8,(EA),0.775,'-,0.0349 unit increase,[0.022-0.047],"SCN8A, SLC4A8",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,12:51586675
rs9937709-<b>A</b>,4 x 10-16,(EA),0.587,'-,0.04399 unit increase,[0.033-0.055],FTO,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,16:53786901
rs4794018-<b>C</b>,2 x 10-8,(EA),0.337,'-,0.03221 unit increase,[0.021-0.044],IGF2BP1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:49016036
rs1229984-<b>C</b>,4 x 10-16,(Latino),0.938,'-,0.349 unit increase,[0.26-0.43],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs60610174-<b>A</b>,3 x 10-8,"(EA, women)",0.0693,'-,0.1567 unit increase,[0.1-0.21],"ZMYM2, ZMYM5",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,13:19895213
rs41355452-<b>A</b>,4 x 10-8,"(AA, women)",0.13,'-,0.1468 unit decrease,[0.094-0.199],LINC01440,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,20:55641990
rs1260326-<b>C</b>,2 x 10-16,,0.652,'-,8.22 z score increase,NR,'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs2683616-<b>A</b>,5 x 10-10,,0.624,'-,6.22 z score increase,NR,"VRK2, ACTG1P22",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,2:57808420
rs12639940-<b>A</b>,3 x 10-9,,0.613,'-,5.93 z score increase,NR,KLB,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:39419361
rs142783062-<b>?</b>,1 x 10-22,,0.345,'-,9.82 z score increase,NR,"ADH1C, ADH1B",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99349804
rs4423856-<b>T</b>,1 x 10-8,,0.796,'-,5.66 z score increase,NR,DCLK2,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:150063705
rs2717071-<b>A</b>,1 x 10-9,(EA),0.628,'-,0.03377 unit increase,[0.023-0.045],ACTG1P22,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,2:57803827
rs4841132-<b>A</b>,4 x 10-8,,0.101,'-,5.46 z score increase,NR,"RNU6-526P, RNU6-1151P",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,8:9326086
rs1229984-<b>C</b>,5 x 10-102,(EA),0.97,'-,0.3402 unit increase,[0.31-0.37],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs1229978-<b>C</b>,1 x 10-14,(EA),0.403,'-,0.04224 unit increase,[0.031-0.053],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99335042
rs9902512-<b>C</b>,6 x 10-9,,0.664,'-,5.81 z score decrease,NR,IGF2BP1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:49016912
rs62339861-<b>C</b>,3 x 10-8,(EA),0.792,'-,0.03685 unit increase,[0.024-0.05],DCLK2,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:150062269
rs75723348-<b>T</b>,1 x 10-8,,0.736,'-,5.55 z score increase,NR,"Y_RNA, RBX1",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,22:41024675
rs185177474-<b>A</b>,2 x 10-8,(EA),0.031,'-,0.0887 unit increase,[0.058-0.12],"KCTD16, RN7SKP246",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,5:144509770
rs35572189-<b>A</b>,8 x 10-10,(EA),0.368,'-,0.03454 unit increase,[0.024-0.046],BAHCC1,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,17:81451999
rs150627184-<b>C</b>,7 x 10-21,(AA),0.809,'-,0.112 unit increase,[0.089-0.135],"ADH1A, ADH6",Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99242230
rs1229984-<b>C</b>,1 x 10-19,(AA),0.989,'-,0.412 unit increase,[0.32-0.5],ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs3782886-<b>C</b>,5 x 10-17,(East Asian),0.205,'-,0.602 unit decrease,[0.46-0.74],BRAP,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,12:111672685
rs1229984-<b>C</b>,4 x 10-133,,0.97,'-,24.56 z score increase,NR,ADH1B,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,4:99318162
rs13107325-<b>C</b>,2 x 10-30,,0.937,'-,11.45 z score increase,NR,'-,Alcohol use disorder (consumption score),"alcohol use disorder measurement, longitudinal alcohol consumption measurement",GCST008258,Mapping not available
rs2066702-<b>G</b>,5 x 10-24,(AA),0.193,1.1889193,'-,[1.16-1.22],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99307860
rs1154433-<b>G</b>,1 x 10-14,(EA),0.596,1.0699764,'-,[1.05-1.09],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99332551
rs11075992-<b>T</b>,2 x 10-10,(EA),0.395,1.056859,'-,[1.04-1.07],FTO,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,16:53786154
rs13107325-<b>C</b>,3 x 10-14,(EA),0.921,1.1325,'-,[1.1-1.16],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs17125651-<b>C</b>,8 x 10-9,(EA),0.134,1.074,'-,[1.05-1.1],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,10:109063325
rs4715221-<b>A</b>,1 x 10-8,(EA),0.698,1.0546,'-,[1.04-1.07],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,6:51495005
rs4936277-<b>A</b>,3 x 10-11,(EA),0.56,1.059,'-,[1.04-1.08],DRD2,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,11:113561238
rs1229984-<b>C</b>,6 x 10-17,(Latino),0.938,1.7746,'-,[1.64-1.91],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99318162
rs1229984-<b>C</b>,5 x 10-85,,0.969,'-,19.54 z score increase,NR,ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99318162
rs1612735-<b>T</b>,8 x 10-19,,0.656,'-,8.86 z score decrease,NR,"ADH1B, ADH1C",Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99336850
rs13107325-<b>C</b>,3 x 10-14,,0.937,'-,7.6 z score increase,NR,'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs9378160-<b>C</b>,2 x 10-8,(Latino),0.719,1.1890606,'-,[1.13-1.25],MICB,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,6:31500215
rs570436-<b>T</b>,2 x 10-10,(EA),0.423,1.0577533,'-,[1.04-1.08],LINC01833,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,2:44915534
rs72716801-<b>G</b>,5 x 10-8,"(AA, women)",0.968,1.886,'-,[1.66-2.11],CASC11,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,8:127636481
rs72900220-<b>A</b>,3 x 10-9,(AA),0.961,1.2376,'-,[1.17-1.31],"BTF3P13, TSPAN5",Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:98671846
rs1229984-<b>C</b>,5 x 10-74,(EA),0.97,1.742,'-,[1.68-1.8],ADH1B,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99318162
rs1260326-<b>C</b>,1 x 10-16,(EA),0.591,1.0749,'-,[1.06-1.09],'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs141424017-<b>T</b>,3 x 10-8,(EA),0.222,1.059,'-,[1.04-1.08],LINC01392,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,7:115311377
rs1260326-<b>C</b>,2 x 10-13,,0.651,'-,7.33 z score increase,NR,'-,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,Mapping not available
rs4936277-<b>A</b>,1 x 10-13,,0.599,'-,7.44 z score increase,NR,DRD2,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,11:113561238
rs1421085-<b>T</b>,2 x 10-11,,0.67,'-,6.69 z score increase,NR,FTO,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,16:53767042
rs540606-<b>A</b>,9 x 10-11,,0.409,'-,6.49 z score decrease,NR,"LINC01833, LINC00299",Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,2:44911368
rs5860563-<b>?</b>,1 x 10-9,,0.722,'-,6.21 z score decrease,NR,ADH4,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,4:99126007
rs7906104-<b>T</b>,3 x 10-9,,0.271,'-,5.98 z score decrease,NR,LINC02661,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,10:108737343
rs61902812-<b>A</b>,2 x 10-8,,0.306,'-,5.59 z score decrease,NR,DRD2,Alcohol use disorder,"alcohol use disorder measurement, alcohol dependence",GCST008259,11:113503698
